PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Edayoshi, M; Yamaguchi, J; Fujiwara, H				Edayoshi, Mina; Yamaguchi, Junichi; Fujiwara, Haruhiko			Protruding Structures on Caterpillars Are Controlled by Ectopic Wnt1 Expression	PLOS ONE			English	Article							KNOBBED MUTANT; PATTERN; EVOLUTION; SILKWORM; EPIDERMIS; WINGLESS; GENES	Spine-like or protruding structures, which may be aposematic for predators, are often observed in multiple segments of lepidopteran larvae (caterpillars). For example, the larvae of the Chinese wheel butterfly, Byasa alcinous, display many protrusions on their backs as a warning that they are toxic. Although these protrusions are formed by an integument lined with single-layered epidermal cells, the molecular mechanisms underlying their formation have remained unclear. In this study, we focused on a spontaneous mutant of the silkworm, Bombyx mori, Knobbed, which shows similar protrusions to B. alcinous and demonstrates that Wnt1 plays a crucial role in the formation of protrusion structures. Using both transgene expression and RNAi-based knockdown approaches, we showed that Wnt1 designates the position where epidermal cells excessively proliferate, leading to the generation of knobbed structures. Furthermore, in the B. alcinous larvae, Wnt1 was also specifically expressed in association with the protrusions. Our results suggest that Wnt1 plays a role in the formation of protrusions on the larval body, and is conserved broadly among diverse species in Lepidoptera.	[Edayoshi, Mina; Yamaguchi, Junichi; Fujiwara, Haruhiko] Univ Tokyo Biosci, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan		Fujiwara, H (corresponding author), Univ Tokyo Biosci, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	haruh@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20017007];  [22128005]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was support by Grant-in-Aid for Scientific Research on Priority Areas "Comparative Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan 20017007 to HF, and Grants-in-Aid for Scientific Research 22128005 to HF.	Ando T, 2013, DEVELOPMENT, V140, P454, DOI 10.1242/dev.085241; Dichtel-Danjoy ML, 2013, CELL DEATH DIFFER, V20, P108, DOI 10.1038/cdd.2012.100; Futahashi R, 2006, INSECT BIOCHEM MOLEC, V36, P63, DOI 10.1016/j.ibmb.2005.11.002; Futahashi R, 2008, DEV GENES EVOL, V218, P491, DOI 10.1007/s00427-008-0243-y; Futahashi R, 2008, SCIENCE, V319, P1061, DOI 10.1126/science.1149786; Futahashi R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-46; Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904; Grant JB, 2007, J ANIM ECOL, V76, P439, DOI 10.1111/j.1365-2656.2007.01216.x; KATO Y, 1977, Zoological Magazine (Tokyo), V86, P250; KATO Y, 1977, J INSECT PHYSIOL, V23, P1095, DOI 10.1016/0022-1910(77)90138-X; Kawasaki H, 2001, INVERTEBR REPROD DEV, V40, P109, DOI 10.1080/07924259.2001.9652711; KIGUCHI K, 1981, J INSECT PHYSIOL, V27, P805, DOI 10.1016/0022-1910(81)90072-X; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marian RG, 1995, MOL MODEL SYSTEMS LE, P299; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; Prudic KL, 2007, P NATL ACAD SCI USA, V104, P19381, DOI 10.1073/pnas.0705478104; Sherratt TN, 2003, AM NAT, V162, P377, DOI 10.1086/378047; Shimura S, 2011, INT J WILD SILKMOTH, V16, P77; Shimura Sachiko, 2012, Journal of Insect Biotechnology and Sericology, V81, P69; Shimura Sachiko, 2009, Journal of Insect Biotechnology and Sericology, V78, P165; Tanaka Y., 1916, J COLL AGR TOHOKU IM, V7, P129; Tazima Y, 1964, GENETICS SILKWORM; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896; WIKLUND C, 1985, EVOLUTION, V39, P1155, DOI 10.1111/j.1558-5646.1985.tb00456.x; Yamaguchi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025469; Yamaguchi Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3063; Yoda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5936	30	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121736	10.1371/journal.pone.0121736	http://dx.doi.org/10.1371/journal.pone.0121736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815728	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600113
J	Mohamed, F; Endre, Z; Jayamanne, S; Pianta, T; Peake, P; Palangasinghe, C; Chathuranga, U; Jayasekera, K; Wunnapuk, K; Shihana, F; Shahmy, S; Buckley, N				Mohamed, Fahim; Endre, Zoltan; Jayamanne, Shaluka; Pianta, Timothy; Peake, Philip; Palangasinghe, Chathura; Chathuranga, Umesh; Jayasekera, Kithsiri; Wunnapuk, Klintean; Shihana, Fathima; Shahmy, Seyed; Buckley, Nicholas			Mechanisms Underlying Early Rapid Increases in Creatinine in Paraquat Poisoning	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; SERUM CYSTATIN-C; GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; CLINICAL-FEATURES; CLEARANCE; MARKER; DEFINITION; PREDICTION; BIOMARKERS	Background Acute kidney injury (AKI) is common after severe paraquat poisoning and usually heralds a fatal outcome. The rapid large increases in serum creatinine (Cr) exceed that which can be explained by creatinine kinetics based on loss of glomerular filtration rate (GFR). Methods and Findings This prospective multi-centre study compared the kinetics of two surrogate markers of GFR, serum creatinine and serum cystatin C (CysC), following paraquat poisoning to understand and assess renal functional loss after paraquat poisoning. Sixty-six acute paraquat poisoning patients admitted to medical units of five hospitals were included. Relative changes in creatinine and CysC were monitored in serial blood and urine samples, and influences of non-renal factors were also studied. Results Forty-eight of 66 patients developed AKI (AKIN criteria), with 37 (56%) developing moderate to severe AKI (AKIN stage 2 or 3). The 37 patients showed rapid increases in creatinine of >100% within 24 hours, >200% within 48 hours and >300% by 72 hours and 17 of the 37 died. CysC concentration increased by 50% at 24 hours in the same 37 patients and then remained constant. The creatinine/CysC ratio increased 8 fold over 72 hours. There was a modest fall in urinary creatinine and serum/urine creatinine ratios and a moderate increase in urinary paraquat during first three days. Conclusion Loss of renal function contributes modestly to the large increases in creatinine following paraquat poisoning. The rapid rise in serum creatinine most probably represents increased production of creatine and creatinine to meet the energy demand following severe oxidative stress. Minor contributions include increased cyclisation of creatine to creatinine because of acidosis and competitive or non-competitive inhibition of creatinine secretion. Creatinine is not a good marker of renal functional loss after paraquat poisoning and renal injury should be evaluated using more specific biomarkers of renal injury.	[Mohamed, Fahim; Jayamanne, Shaluka; Palangasinghe, Chathura; Chathuranga, Umesh; Jayasekera, Kithsiri; Shihana, Fathima; Shahmy, Seyed; Buckley, Nicholas] Univ Peradeniya, South Asian Clin Toxicol Res Collaborat, Peradeniya, Sri Lanka; [Mohamed, Fahim; Buckley, Nicholas] Univ New S Wales, Prince Wales Clin Sch, Professorial Med Unit, Clin Pharmacol & Toxicol Grp, Sydney, NSW, Australia; [Mohamed, Fahim] Univ Peradeniya, Fac Allied Hlth Sci, Dept Pharm, Peradeniya, Sri Lanka; [Mohamed, Fahim; Endre, Zoltan; Pianta, Timothy; Peake, Philip] Univ New S Wales, Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia; [Mohamed, Fahim; Endre, Zoltan; Pianta, Timothy; Peake, Philip] Univ New S Wales, Sch Clin, Sydney, NSW, Australia; [Wunnapuk, Klintean] Univ Queensland, Sch Med, Therapeut Res Ctr, Brisbane, Qld, Australia; [Buckley, Nicholas] Univ Sydney, Sydney Med Sch, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2006, Australia	University of Peradeniya; University of New South Wales Sydney; University of Peradeniya; University of New South Wales Sydney; University of New South Wales Sydney; University of Queensland; University of Sydney	Endre, Z (corresponding author), Univ New S Wales, Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia.	z.endre@unsw.edu.au	Buckley, Nicholas A/D-4030-2012; Shahmy, Seyed/I-7654-2017; Wunnapuk, Klintean/AAZ-8536-2020; Endre, Zoltan/A-3331-2009	Buckley, Nicholas A/0000-0002-6326-4711; Shahmy, Seyed/0000-0002-2339-1572; Wunnapuk, Klintean/0000-0003-0770-2657; Endre, Zoltan/0000-0002-4782-8695; Mohamed, Fahim/0000-0003-2849-7269; Shihana, Fathima/0000-0002-6362-1221; Pianta, Timothy/0000-0002-9196-4889	National Health and Medical Research Council (NHMRC) [1011772]; Australian Government [2241_2011]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR)	The project was funded by the National Health and Medical Research Council (NHMRC) project grant 1011772. FM received an Endeavour Postgraduate Scholarship from the Australian Government (2241_2011). The funding body had no role in the design and execution of this study or interpretation of the data or decision to submit the manuscript.	AITKEN RG, 1994, ANN CLIN BIOCHEM, V31, P198, DOI 10.1177/000456329403100218; Bagshaw SM, 2008, CRIT CARE MED, V36, pS152, DOI 10.1097/CCM.0b013e318168c613; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BORSOOK H, 1947, J BIOL CHEM, V168, P493; Chen Y, 2007, J PHARMACOL EXP THER, V322, P695, DOI 10.1124/jpet.107.123554; CHIOU WL, 1975, J CLIN PHARMACOL, V15, P427, DOI 10.1002/j.1552-4604.1975.tb02364.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Darby D, 2012, ANN CLIN BIOCHEM, V49, P292, DOI 10.1258/acb.2011.011114; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; Doi K, 2009, J AM SOC NEPHROL, V20, P1217, DOI 10.1681/ASN.2008060617; Eddleston M, 2003, QJM-INT J MED, V96, P809, DOI 10.1093/qjmed/hcg137; Endre ZH, 2011, AM J PHYSIOL-RENAL, V301, pF697, DOI 10.1152/ajprenal.00448.2010; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Gil HW, 2009, CLIN TOXICOL, V47, P870, DOI 10.3109/15563650903306651; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Hantson Philippe, 2008, J Forensic Leg Med, V15, P48, DOI 10.1016/j.jcfm.2006.09.003; Ienaga K, 2007, RENAL FAILURE, V29, P279, DOI 10.1080/08860220701219863; Ienaga K, 2011, DRUG DISCOV THER, V5, P162, DOI 10.5582/ddt.2011.v5.4.162; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jelliffe R, 2002, AM J NEPHROL, V22, P320, DOI 10.1159/000065221; Jonker JW, 2003, MOL CELL BIOL, V23, P7902, DOI 10.1128/MCB.23.21.7902-7908.2003; Kim SJ, 2009, NEPHROL DIAL TRANSPL, V24, P1226, DOI 10.1093/ndt/gfn615; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Lee EY, 2002, TOXICOL IND HEALTH, V18, P201, DOI 10.1191/0748233702th141oa; Lee WJ, 2009, INT ARCH OCC ENV HEA, V82, P365, DOI 10.1007/s00420-008-0343-z; Matsumoto S, 2006, TRANSPL P, V38, P2009, DOI 10.1016/j.transproceed.2006.06.104; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Molck AM, 1997, TOXICOLOGY, V122, P123, DOI 10.1016/S0300-483X(97)00088-7; NARAYANAN S, 1980, CLIN CHEM, V26, P1119; Nejat M, 2010, NEPHROL DIAL TRANSPL, V25, P3283, DOI 10.1093/ndt/gfq176; Panteghini M, 2008, SCAND J CLIN LAB INV, V68, P84, DOI 10.1080/00365510802149978; Pickering JW, 2010, CLIN J AM SOC NEPHRO, V5, P1165, DOI 10.2215/CJN.08531109; PRICE LA, 1995, PATHOLOGY, V27, P154, DOI 10.1080/00313029500169772; RagoucySengler C, 1996, HUM EXP TOXICOL, V15, P265, DOI 10.1177/096032719601500315; Ralib AM, 2012, J AM SOC NEPHROL, V23, P322, DOI 10.1681/ASN.2011040325; Roberts DM, 2007, CLIN PHARMACOKINET, V46, P897, DOI 10.2165/00003088-200746110-00001; Roberts DM, 2011, TOXICOL LETT, V202, P69, DOI 10.1016/j.toxlet.2011.01.024; ROSE MS, 1976, BIOCHEM PHARMACOL, V25, P419, DOI 10.1016/0006-2952(76)90344-0; Rule AD, 2006, KIDNEY INT, V69, P399, DOI 10.1038/sj.ki.5000073; Sjostrom P, 2004, CLIN NEPHROL, V62, P241; Tabata N, 1999, FORENSIC SCI INT, V100, P117, DOI 10.1016/S0379-0738(98)00190-X; Tenstad O, 1996, SCAND J CLIN LAB INV, V56, P409, DOI 10.3109/00365519609088795; Uchino S, 2010, CURR OPIN CRIT CARE, V16, P562, DOI 10.1097/MCC.0b013e32833ea7f3; Urakami Y, 2004, PHARM RES-DORDR, V21, P976, DOI 10.1023/B:PHAM.0000029286.45788.ad; Urakami Yumiko, 2005, Drug Metab Pharmacokinet, V20, P200, DOI 10.2133/dmpk.20.200; Uzun H, 2005, CLIN BIOCHEM, V38, P792, DOI 10.1016/j.clinbiochem.2005.05.012; VAZIRI ND, 1979, ARCH INTERN MED, V139, P172, DOI 10.1001/archinte.139.2.172; Visweswaran P, 1999, CRIT CARE CLIN, V15, P415, DOI 10.1016/S0749-0704(05)70061-0; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Warren JD, 2002, MUSCLE NERVE, V25, P332, DOI 10.1002/mus.10053; WEBB DB, 1981, LANCET, V1, P1424; Wiesli P, 2003, CLIN CHIM ACTA, V338, P87, DOI 10.1016/j.cccn.2003.07.022; WRIGHT SH, 1995, BBA-BIOMEMBRANES, V1240, P18, DOI 10.1016/0005-2736(95)00166-0; Wunnapuk K, 2011, J CHROMATOGR B, V879, P3047, DOI 10.1016/j.jchromb.2011.09.008; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yashiro M, 2012, CLIN EXP NEPHROL, V16, P570, DOI 10.1007/s10157-012-0602-x	58	26	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122357	10.1371/journal.pone.0122357	http://dx.doi.org/10.1371/journal.pone.0122357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815837	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600170
J	Pisoni, A; Turi, Z; Raithel, A; Ambrus, GG; Alekseichuk, I; Schacht, A; Paulus, W; Antal, A				Pisoni, Alberto; Turi, Zsolt; Raithel, Almuth; Ambrus, Geza Gergely; Alekseichuk, Ivan; Schacht, Annekathrin; Paulus, Walter; Antal, Andrea			Separating Recognition Processes of Declarative Memory via Anodal tDCS: Boosting Old Item Recognition by Temporal and New Item Detection by Parietal Stimulation	PLOS ONE			English	Article							EPISODIC MEMORY; FALSE RECOGNITION; MOTOR CORTEX; RETRIEVAL; LOBE; CONFIDENCE; SYSTEMS; NONOCCURRENCES; DISSOCIATION; BRAIN	There is emerging evidence from imaging studies that parietal and temporal cortices act together to achieve successful recognition of declarative information; nevertheless, the precise role of these regions remains elusive. To evaluate the role of these brain areas in declarative memory retrieval, we applied bilateral tDCS, with anode over the left and cathode over the right parietal or temporal cortices separately, during the recognition phase of a verbal learning paradigm using a balanced old-new decision task. In a parallel group design, we tested three different groups of healthy adults, matched for demographic and neurocognitive status: two groups received bilateral active stimulation of either the parietal or the temporal cortex, while a third group received sham stimulation. Accuracy, discriminability index (d') and reaction times of recognition memory performance were measurements of interest. The d' sensitivity index and accuracy percentage improved in both active stimulation groups, as compared with the sham one, while reaction times remained unaffected. Moreover, the analysis of accuracy revealed a different effect of tDCS for old and new item recognition. While the temporal group showed enhanced performance for old item recognition, the parietal group was better at correctly recognising new ones. Our results support an active role of both of these areas in memory retrieval, possibly underpinning different stages of the recognition process.	[Pisoni, Alberto; Turi, Zsolt; Raithel, Almuth; Ambrus, Geza Gergely; Alekseichuk, Ivan; Paulus, Walter; Antal, Andrea] Univ Gottingen, Univ Med Ctr, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Pisoni, Alberto] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Ambrus, Geza Gergely] Univ Jena, Inst Psychol, Jena, Germany; [Schacht, Annekathrin] Univ Gottingen, CRC Text Struct, D-37073 Gottingen, Germany	University of Gottingen; University of Milano-Bicocca; Friedrich Schiller University of Jena; University of Gottingen	Pisoni, A (corresponding author), Univ Gottingen, Univ Med Ctr, Dept Clin Neurophysiol, D-37073 Gottingen, Germany.	a.pisoni1@campus.unimib.it; zsoltturi@gmail.com	Ambrus, Géza Gergely/G-2716-2014; Paulus, Walter/A-3544-2009; Alekseichuk, Ivan/B-2340-2014; PISONI, ALBERTO/M-6958-2017	Ambrus, Géza Gergely/0000-0002-8400-8178; Paulus, Walter/0000-0001-5549-8377; Alekseichuk, Ivan/0000-0002-2205-4910; PISONI, ALBERTO/0000-0002-8231-9255; Turi, Zsolt/0000-0002-8130-7949	Bernstein Focus Neurotechnology [01GQ0810]	Bernstein Focus Neurotechnology	This study was supported by Bernstein Focus Neurotechnology (01GQ0810) (W.P.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baddeley A, 1998, CURR OPIN NEUROBIOL, V8, P234, DOI 10.1016/S0959-4388(98)80145-1; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Berryhill ME, 2007, J NEUROSCI, V27, P14415, DOI 10.1523/JNEUROSCI.4163-07.2007; Berryhill ME, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00031; Boggio PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004959; Borst JP, 2013, P NATL ACAD SCI USA, V110, P1628, DOI 10.1073/pnas.1221572110; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Davidson PSR, 2008, NEUROPSYCHOLOGIA, V46, P1743, DOI 10.1016/j.neuropsychologia.2008.01.011; De Rosario-Martinez Helios, 2013, PHIA POSTH INT AN R; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Finnigan S, 2002, NEUROPSYCHOLOGIA, V40, P2288, DOI 10.1016/S0028-3932(02)00113-6; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Ghetti S, 2003, J MEM LANG, V48, P722, DOI 10.1016/S0749-596X(03)00005-6; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Jacobson L, 2012, BRAIN RES, V1439, P66, DOI 10.1016/j.brainres.2011.12.036; Javadi AH, 2012, BRAIN STIMUL, V5, P468, DOI 10.1016/j.brs.2011.08.003; Javadi AH, 2012, BRAIN STIMUL, V5, P231, DOI 10.1016/j.brs.2011.06.007; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kim H, 2007, J NEUROSCI, V27, P12190, DOI 10.1523/JNEUROSCI.3408-07.2007; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Leube DT, 2003, COGNITIVE BRAIN RES, V18, P97, DOI 10.1016/j.cogbrainres.2003.09.008; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; Nessler D, 2003, PSYCHOPHYSIOLOGY, V40, P146, DOI 10.1111/1469-8986.00015; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; Ofen N, 2007, NAT NEUROSCI, V10, P1198, DOI 10.1038/nn1950; Ofen N, 2012, J NEUROSCI, V32, P10012, DOI 10.1523/JNEUROSCI.1082-11.2012; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palazova M, 2013, BRAIN LANG, V125, P264, DOI 10.1016/j.bandl.2013.02.008; Pergolizzi D, 2015, NEUROPSYCHOLOGIA, V66, P88, DOI 10.1016/j.neuropsychologia.2014.11.012; RCore Team, 2020, R LANG ENV STAT COMP; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Sandrini M, 2012, NEUROPSYCHOLOGIA, V50, P396, DOI 10.1016/j.neuropsychologia.2011.12.011; Schacter DL, 1999, J MEM LANG, V40, P1, DOI 10.1006/jmla.1998.2611; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shannon BJ, 2004, J NEUROSCI, V24, P10084, DOI 10.1523/JNEUROSCI.2625-04.2004; Simons JS, 2010, CEREB CORTEX, V20, P479, DOI 10.1093/cercor/bhp116; Singmann H., 2014, AFEX ANAL FACTORIAL; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; STRACK F, 1994, J MEM LANG, V33, P203, DOI 10.1006/jmla.1994.1010; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; van den Noort M, 2008, EUR J PSYCHOL ASSESS, V24, P35, DOI 10.1027/1015-5759.24.1.35; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; Wixted JT, 2004, PSYCHON B REV, V11, P616, DOI 10.3758/BF03196616; Wolk DA, 2006, BRAIN RES, V1096, P148, DOI 10.1016/j.brainres.2006.04.050	58	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0123085	10.1371/journal.pone.0123085	http://dx.doi.org/10.1371/journal.pone.0123085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816233	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600205
J	Lipp, I; Evans, CJ; Lewis, C; Murphy, K; Wise, RG; Caseras, X				Lipp, Ilona; Evans, C. John; Lewis, Caroline; Murphy, Kevin; Wise, Richard G.; Caseras, Xavier			The Relationship between Fearfulness, GABA plus , and Fear-Related BOLD Responses in the Insula	PLOS ONE			English	Article							AMINOBUTYRIC-ACID LEVELS; BRAIN ACTIVATION; ANTERIOR CINGULATE; PANIC DISORDER; EMOTIONAL STIMULI; MENSTRUAL-CYCLE; DEFAULT MODE; SPECTROSCOPY; AMYGDALA; ROBUST	The inhibitory neurotransmitter GABA plays a crucial role in anxiety and fear, but its relationship to brain activation during fear reactions is not clear. Previous studies suggest that GABA agonists lead to an attenuation of emotion-processing related BOLD signals in the insula. The aim of this study was to investigate the relationship between GABA concentration and fear-related BOLD responses in this region. In 44 female participants with different levels of fearfulness, GABA concentration in the left insula was measured using a GABA+ MRS acquisition during rest; additionally, BOLD signals were obtained during performance of a fear provocation paradigm. Fearfulness was not associated with GABA+ in the left insula, but could predict fear-related BOLD responses in a cluster in the left anterior insula. The BOLD signal change in this cluster did not correlate with GABA+ concentration. However, we found a significant positive correlation between GABA+ concentration and fear-related BOLD responses in a different cluster that included parts of the left insula, amygdala and putamen. Our findings indicate that low insular GABA concentration is not a predisposition for fearfulness, and that several factors influence whether a correlation between GABA and BOLD can be found.	[Lipp, Ilona; Evans, C. John; Lewis, Caroline; Murphy, Kevin; Wise, Richard G.] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff CF10 3AX, S Glam, Wales; [Lipp, Ilona; Caseras, Xavier] Cardiff Univ, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Caseras, X (corresponding author), Cardiff Univ, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales.	CaserasX@cardiff.ac.uk	Evans, C. John/A-8054-2010; Lipp, Ilona/M-7113-2017; Murphy, Kevin/A-1581-2010	Evans, C. John/0000-0002-6619-4245; Lipp, Ilona/0000-0002-5644-2057; Murphy, Kevin/0000-0002-6516-313X; Caseras, Xavier/0000-0002-8490-6891	Cardiff University President's Research Scholarship; Wellcome Trust Career Development Fellowship; Higher Education Funding Council for Wales; Medical Research Council [MR/L010305/1] Funding Source: researchfish	Cardiff University President's Research Scholarship; Wellcome Trust Career Development Fellowship(Wellcome Trust); Higher Education Funding Council for Wales(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	IL: Cardiff University President's Research Scholarship (funded data collection and analysis). KM: Wellcome Trust Career Development Fellowship (the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript). RGW/XC: Higher Education Funding Council for Wales (the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript).	Andersson J.L.R., 2007, TR07JA1 FMRIB; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Caseras X, 2013, HUM BRAIN MAPP, V34, P1220, DOI 10.1002/hbm.21503; Caseras X, 2010, EUR J NEUROSCI, V32, P1414, DOI 10.1111/j.1460-9568.2010.07424.x; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Del-Ben CM, 2012, J PSYCHOPHARMACOL, V26, P443, DOI 10.1177/0269881110389092; Donahue MJ, 2010, NEUROIMAGE, V53, P392, DOI 10.1016/j.neuroimage.2010.07.017; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Epperson CN, 2002, ARCH GEN PSYCHIAT, V59, P851, DOI 10.1001/archpsyc.59.9.851; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; GEER JH, 1965, BEHAV RES THER, V3, P45, DOI 10.1016/0005-7967(65)90040-9; Geramita M, 2011, NMR BIOMED, V24, P1089, DOI 10.1002/nbm.1662; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P556, DOI 10.1001/archpsyc.58.6.556; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Ham BJ, 2007, PROG NEURO-PSYCHOPH, V31, P403, DOI 10.1016/j.pnpbp.2006.10.011; Harada M, 2011, HUM BRAIN MAPP, V32, P828, DOI 10.1002/hbm.21086; Hasler G, 2010, AM J PSYCHIAT, V167, P1226, DOI 10.1176/appi.ajp.2010.09070994; Hasler G, 2009, BIOL PSYCHIAT, V65, P273, DOI 10.1016/j.biopsych.2008.06.023; Henry PG, 2001, MAGNET RESON MED, V45, P517, DOI 10.1002/1522-2594(200103)45:3<517::AID-MRM1068>3.0.CO;2-6; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jenkinson M., 2004, 10 INT C FUNCT MAPP; Lang P.J., 2008, A8 U FLOR; Lang PJ, 1980, TECHNOLOGY MENTAL HL; Lauritzen M, 2012, NEUROIMAGE, V62, P1040, DOI 10.1016/j.neuroimage.2012.01.040; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lueken U, 2011, NEUROIMAGE, V56, P363, DOI 10.1016/j.neuroimage.2011.02.015; Makkar SR, 2010, NEUROPSYCHOPHARMACOL, V35, P1625, DOI 10.1038/npp.2010.53; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Michels L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031933; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Muris P, 1996, J BEHAV THER EXP PSY, V27, P241, DOI 10.1016/S0005-7916(96)00022-5; Muthukumaraswamy SD, 2012, HUM BRAIN MAPP, V33, P455, DOI 10.1002/hbm.21223; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Nutt DJ, 2001, BRIT J PSYCHIAT, V179, P390, DOI 10.1192/bjp.179.5.390; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Pernet CR, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00606; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Poldrack RA, 2010, FDN ISSUES HUMAN BRA, P147, DOI DOI 10.7551/MITPRESS/9780262014021.001.0001; Puts NAJ, 2012, PROG NUCL MAG RES SP, V60, P29, DOI 10.1016/j.pnmrs.2011.06.001; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rosso IM, 2014, DEPRESS ANXIETY, V31, P115, DOI 10.1002/da.22155; Schienle A, 2005, NEUROSCI LETT, V388, P1, DOI 10.1016/j.neulet.2005.06.025; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spielberger C. D., 1970, SELF EVALUATION QUES; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Stevens JS, 2012, NEUROPSYCHOLOGIA, V50, P1578, DOI 10.1016/j.neuropsychologia.2012.03.011; Straube T, 2006, NEUROIMAGE, V29, P125, DOI 10.1016/j.neuroimage.2005.07.007; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; SZYMANSKI J, 1995, J BEHAV THER EXP PSY, V26, P31, DOI 10.1016/0005-7916(94)00072-T; Wendt J, 2008, PSYCHOPHYSIOLOGY, V45, P205, DOI 10.1111/j.1469-8986.2007.00620.x; Wiebking C, 2014, NEUROIMAGE, V86, P10, DOI 10.1016/j.neuroimage.2013.04.042; Wise RG, 2007, MAGN RESON IMAGING, V25, P801, DOI 10.1016/j.mri.2007.03.016; Worsley KJ, 2001, FUNCTIONAL FMRI INTR; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	68	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120101	10.1371/journal.pone.0120101	http://dx.doi.org/10.1371/journal.pone.0120101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811453	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000356353700038
J	Pannell, R; Li, S; Gurewich, V				Pannell, Ralph; Li, Shelley; Gurewich, Victor			Highly Effective Fibrinolysis by a Sequential Synergistic Combination of Mini-Dose tPA plus Low-Dose Mutant proUK	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; SINGLE-CHAIN UROKINASE; CLOT LYSIS; T-PA; PROUROKINASE MUTANT; GLU-PLASMINOGEN; SUCCESSFUL THROMBOLYSIS; ARTERIAL REOCCLUSION; INTRINSIC ACTIVITY	Results of thrombolysis by monotherapy with either tPA or proUK have not lived up to expectations. Since these natural activators are inherently complementary, this property can be utilized to a synergistic advantage; and yet, this has undergone little evaluation. ProUK is no longer available because at pharmacological concentrations it converts to UK in plasma. Therefore, a single site proUK mutant, M5, was developed to address this problem and was used in this study. Fibrinolysis was measured using preformed fluoresceinated 24 h old clots in a plasma milieu rather than by the standard automated method, because proUK/M5 is sensitive to inactivation by thrombin and activation by plasmin. The shortest 50% clot lysis time that could be achieved by tPA or M5 alone was determined: mean times were 55 and 48 minutes respectively. These bench marks were matched by 6% of the tPA monotherapy dose combined with 40% that of M5: mean lysis time 47 minutes with less associated fibrinogenolysis. Results showed that the tPA effect was limited to initiating fibrinolysis which was completed by M5 and then tcM5. Plasma C1-inhibitor inhibited fibrinogenolysis by M5, providing protection from side effects not available for proUK. In conclusion, by utilizing the complementary properties and sequential modes of action of each activator, more efficient fibrinolysis with less non-specific effects can be achieved than with traditional monotherapy. In vivo validation is needed, but in a previous clinical trial using a similar combination of tPA and proUK ( 5% and 50% monotherapy doses) very promising results have already been obtained.	[Pannell, Ralph; Li, Shelley; Gurewich, Victor] Harvard Univ, Sch Med, Mt Auburn Hosp, Vasc Res Lab, Cambridge, MA 02138 USA	Harvard University; Mount Auburn Hospital	Gurewich, V (corresponding author), Harvard Univ, Sch Med, Mt Auburn Hosp, Vasc Res Lab, Cambridge, MA 02138 USA.	vgurewich@tsillc.net			Vascular Laboratory, Inc. (a non-profit research entity in Massachussetts) [FIN 23-7375422]	Vascular Laboratory, Inc. (a non-profit research entity in Massachussetts)	This study was funded by Vascular Laboratory, Inc. (a non-profit research entity in Massachussetts FIN 23-7375422). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862; COLLEN D, 1986, THROMB HAEMOSTASIS, V56, P35; Dmitry V, 1996, J BIOL CHEM, V271, P2133; FLEURY V, 1993, J BIOL CHEM, V268, P18554; GULBA DC, 1988, LANCET, V2, P97; GULBA DC, 1991, CIRCULATION, V83, P937, DOI 10.1161/01.CIR.83.3.937; GUREWICH V, 1987, THROMB HAEMOSTASIS, V57, P372; Gurewich V, 2006, J THROMB HAEMOST, V4, P1559, DOI 10.1111/j.1538-7836.2006.01993.x; GUREWICH V, 1987, J AM COLL CARDIOL, V10, pB16, DOI 10.1016/S0735-1097(87)80423-0; GUREWICH V, 1988, J CLIN INVEST, V82, P1956, DOI 10.1172/JCI113815; GUREWICH V, 1993, CIRCULATION, V87, P1759, DOI 10.1161/01.CIR.87.5.1759; Gurewich V, 2009, THROMB HAEMOSTASIS, V102, P279, DOI 10.1160/TH08-09-0598; Gurwitz JH, 1998, ANN INTERN MED, V129, P597, DOI 10.7326/0003-4819-129-8-199810150-00002; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; HARPEL PC, 1985, J BIOL CHEM, V260, P4432; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; Kleindorfer D, 2008, STROKE, V39, P924, DOI 10.1161/STROKEAHA.107.490375; LIU JN, 1992, BIOCHEMISTRY-US, V31, P6311, DOI 10.1021/bi00142a021; Liu JN, 2002, CIRC RES, V90, P757, DOI 10.1161/01.RES.0000014825.71092.BD; Liu JN, 1996, BIOCHEMISTRY-US, V35, P14070, DOI 10.1021/bi9605393; LIU JN, 1992, J BIOL CHEM, V267, P15289; LIU JN, 1991, J CLIN INVEST, V88, P2012, DOI 10.1172/JCI115528; MEYER J, 1989, LANCET, V1, P863; Michels, 1995, J Thromb Thrombolysis, V2, P117, DOI 10.1007/BF01064379; Pannell R, 2007, J THROMB HAEMOST, V5, P1047, DOI 10.1111/j.1538-7836.2007.02453.x; PANNELL R, 1987, BLOOD, V69, P22; PANNELL R, 1988, J CLIN INVEST, V81, P853, DOI 10.1172/JCI113394; PANNELL R, 1992, FIBRINOLYSIS, V6, P1, DOI 10.1016/0268-9499(92)90041-F; Petersen LC, 1997, EUR J BIOCHEM, V245, P316, DOI 10.1111/j.1432-1033.1997.00316.x; Rapaport E., 1993, J MYOCARDIAL ISCHEMI, V5, P15; RAPOLD HJ, 1991, BLOOD, V78, P1490; RIJKEN DC, 1982, J BIOL CHEM, V257, P2920; Rubiera M, 2005, STROKE, V36, P1452, DOI 10.1161/01.STR.0000170711.43405.81; Saqqur M, 2007, STROKE, V38, P69, DOI 10.1161/01.STR.0000251800.01964.f6; SUENSON E, 1984, EUR J BIOCHEM, V140, P513, DOI 10.1111/j.1432-1033.1984.tb08132.x; Sun ZY, 1997, J BIOL CHEM, V272, P23818, DOI 10.1074/jbc.272.38.23818; Tebbe U, 1998, J AM COLL CARDIOL, V31, P487, DOI 10.1016/S0735-1097(97)00553-6; Tomasi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021999; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; VANZONNEVELD AJ, 1986, J BIOL CHEM, V261, P14214; VARADI A, 1984, BIOCHEMISTRY-US, V23, P2108, DOI 10.1021/bi00304a036; VOSKUILEN M, 1987, J BIOL CHEM, V262, P5944; Weaver WD, 1994, J AM COLL CARDIOL, V241, P242; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15730, DOI 10.1021/bi001847a; ZARICH SW, 1995, J AM COLL CARDIOL, V26, P374, DOI 10.1016/0735-1097(95)80009-6	45	9	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122018	10.1371/journal.pone.0122018	http://dx.doi.org/10.1371/journal.pone.0122018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811605	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700165
J	Reinders, J; Sonntag, R; Vot, L; Gibney, C; Nowack, M; Kretzer, JP				Reinders, Joern; Sonntag, Robert; Vot, Leo; Gibney, Christian; Nowack, Moritz; Kretzer, Jan Philippe			Wear Testing of Moderate Activities of Daily Living Using In Vivo Measured Knee Joint Loading	PLOS ONE			English	Article							CROSS-LINKED-POLYETHYLENE; FIXED-BEARING; TIBIAL COMPONENT; ARTHROPLASTY; REPLACEMENT; SIMULATION; MOTION; KINEMATICS; OSTEOLYSIS; FREQUENCY	Resumption of daily living activities is a basic expectation for patients provided with total knee replacements. However, there is a lack of knowledge regarding the impact of different activities on the wear performance. In this study the wear performance under application of different daily activities has been analyzed. In vivo load data for walking, walking downstairs/upstairs, sitting down/standing up, and cycling (50W& 120 W) has been standardized for wear testing. Wear testing of each activity was carried out on a knee wear simulator. Additionally, ISO walking was tested for reasons of comparison. Wear was assessed gravimetrically and wear particles were analyzed. In vivo walking produced the highest overall wear rates, which were determined to be three times higher than ISO walking. Moderate wear rates were determined for walking upstairs and downstairs. Low wear rates were determined for standing up/sitting down and cycling at power levels of 50W and 120 W. The largest wear particles were observed for cycling. Walking based on in vivo data has been shown to be the most wear-relevant activity. Highly demanding activities (stair climbing) produced considerably less wear. Taking into account the expected number of loads, low-impact activities like cycling may have a greater impact on articular wear than highly demanding activities.	[Reinders, Joern; Sonntag, Robert; Vot, Leo; Gibney, Christian; Nowack, Moritz; Kretzer, Jan Philippe] Univ Heidelberg Hosp, Trauma Surg & Spinal Cord Injury, Ctr Orthoped, Clin Orthoped & Trauma Surg,Lab Biomech & Implant, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kretzer, JP (corresponding author), Univ Heidelberg Hosp, Trauma Surg & Spinal Cord Injury, Ctr Orthoped, Clin Orthoped & Trauma Surg,Lab Biomech & Implant, Heidelberg, Germany.	philippe.kretzer@med.uni-heidelberg.de		Reinders, Jorn/0000-0002-8258-7735	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	The authors acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, F187705 ASTM; [Anonymous], 1424312009 ISO; Barnett PI, 2001, J MATER SCI-MATER M, V12, P1039, DOI 10.1023/A:1012894023657; Battenberg AK, 2013, CLIN ORTHOP RELAT R, V471, P386, DOI 10.1007/s11999-012-2497-y; Baykal D, 2014, J MECH BEHAV BIOMED, V31, P117, DOI 10.1016/j.jmbbm.2013.05.020; Bergmann G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086035; ERICSON MO, 1986, AM J SPORT MED, V14, P285, DOI 10.1177/036354658601400407; Fisher J, 2004, KNEE, V11, P173, DOI 10.1016/j.knee.2003.10.002; Gallo J, 2013, ACTA BIOMATER, V9, P8046, DOI 10.1016/j.actbio.2013.05.005; Galvin AL, 2009, J BIOMECH, V42, P1898, DOI 10.1016/j.jbiomech.2009.05.010; Goodman Stuart B, 2013, Instr Course Lect, V62, P201; Grupp TM, 2013, J BIOMECH, V46, P491, DOI 10.1016/j.jbiomech.2012.10.017; Hamai S, 2008, J ORTHOP RES, V26, P1556, DOI 10.1002/jor.20671; Harris WH, 2012, CLIN ORTHOP RELAT R, V470, P3077, DOI 10.1007/s11999-012-2330-7; Heller MO, 2003, LANGENBECK ARCH SURG, V388, P291, DOI 10.1007/s00423-003-0406-2; Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219; Jassim SS, 2014, BONE JOINT J, V96B, P923, DOI 10.1302/0301-620X.96B7.31585; Jones DL, 2012, J ARTHROPLASTY, V27, P1289, DOI 10.1016/j.arth.2011.10.030; Kim YH, 2012, J BONE JOINT SURG AM, V94A, P1378, DOI 10.2106/JBJS.K.01229; Kretzer JP, 2008, J MED DEVICES, V2, DOI 10.1115/1.2979746; Kretzer JP, 2011, ACTA BIOMATER, V7, P710, DOI 10.1016/j.actbio.2010.09.031; Kretzer JP, 2010, J BIOMECH, V43, P1092, DOI 10.1016/j.jbiomech.2009.12.016; Kuster MS, 2002, SPORTS MED, V32, P433, DOI 10.2165/00007256-200232070-00003; Kutzner I, 2010, J BIOMECH, V43, P2164, DOI 10.1016/j.jbiomech.2010.03.046; Mancuso CA, 2001, J BONE JOINT SURG AM, V83A, P1005, DOI 10.2106/00004623-200107000-00005; Mazzucco D, 2004, CLIN ORTHOP RELAT R, P17, DOI 10.1097/01.blo.0000150315.47697.b9; McEwen HMJ, 2001, J MATER SCI-MATER M, V12, P1049, DOI 10.1023/A:1012850224565; MCNAMARA JL, 1994, CLIN ORTHOP RELAT R, P104; Morlock M, 2001, J BIOMECH, V34, P873, DOI 10.1016/S0021-9290(01)00035-5; Muratoglu OK, 2002, CLIN ORTHOP RELAT R, P89, DOI 10.1097/01.blo.0000036526.46246.6c; Nevelos J, 2004, KNEE, V11, P163, DOI 10.1016/j.knee.2004.01.004; Reinders J, 2014, J MATER SCI-MATER M, V25, P2463, DOI 10.1007/s10856-014-5271-8; Ritter MA, 2011, J BONE JOINT SURG AM, V93A, P1588, DOI 10.2106/JBJS.J.00772; Rowe PJ, 2000, GAIT POSTURE, V12, P143, DOI 10.1016/S0966-6362(00)00060-6; Sathasivam S, 2001, J BIOMED MATER RES, V58, P282, DOI 10.1002/1097-4636(2001)58:3<282::AID-JBM1018>3.0.CO;2-S; Schmalzried TP, 2000, CLIN ORTHOP RELAT R, P36; Schroder C, 2013, ACTA BIOMATER, V9, P9485, DOI 10.1016/j.actbio.2013.07.039; Schroer WC, 2013, J ARTHROPLASTY, V28, P116, DOI 10.1016/j.arth.2013.04.056; Schwartz AJ, 2010, CLIN ORTHOP RELAT R, V468, P2160, DOI 10.1007/s11999-010-1360-2; Schwenke T, 2013, WEAR, V301, P168, DOI 10.1016/j.wear.2013.01.069; Schwiesau J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/567374; Schwiesau J, 2013, MED ENG PHYS, V35, P1204, DOI 10.1016/j.medengphy.2012.12.015; Schwiesau J, 2013, MED ENG PHYS, V35, P591, DOI 10.1016/j.medengphy.2012.07.003; SEEDHOM BB, 1985, ANN RHEUM DIS, V44, P838, DOI 10.1136/ard.44.12.838; Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32; Srivastava A, 2012, KNEE, V19, P560, DOI 10.1016/j.knee.2011.11.003; Turell M, 2003, WEAR, V255, P1034, DOI 10.1016/S0043-1648(03)00357-0; Utzschneider S, 2009, ACTA BIOMATER, V5, P2495, DOI 10.1016/j.actbio.2009.03.016	48	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0123155	10.1371/journal.pone.0123155	http://dx.doi.org/10.1371/journal.pone.0123155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811996	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700215
J	Wang, YG; Xu, Q; Lu, HM; Lin, L; Wang, LY; Xu, H; Cui, XY; Zhang, H; Li, TT; Hua, YJ				Wang, Yunguang; Xu, Qiang; Lu, Huiming; Lin, Lin; Wang, Liangyan; Xu, Hong; Cui, Xianyan; Zhang, Hui; Li, Tingting; Hua, Yuejin			Protease Activity of PprI Facilitates DNA Damage Response: Mn(2+)-Dependence and Substrate Sequence-Specificity of the Proteolytic Reaction	PLOS ONE			English	Article							DEINOCOCCUS-RADIODURANS; ESCHERICHIA-COLI; CHROMATIN IMMUNOPRECIPITATION; EXTREME RADIORESISTANCE; GAMMA-RADIATION; SPECIATION; REGULATOR; DYNAMICS; IRRE	The extremophilic bacterium Deinococcus radiodurans exhibits an extraordinary resistance to ionizing radiation. Previous studies established that a protein named PprI, which exists only in the Deinococcus-Thermus family, acts as a general switch to orchestrate the expression of a number of DNA damage response (DDR) proteins involved in cellular radio-resistance. Here we show that the regulatory mechanism of PprI depends on its Mn(2+)-dependent protease activity toward DdrO, a transcription factor that suppresses DDR genes' expression. Recognition sequence-specificity around the PprI cleavage site is essential for DNA damage repair in vivo. PprI and DdrO mediate a novel DNA damage response pathway differing from the classic LexA-mediated SOS response system found in radiation-sensitive bacterium Escherichia coli. This PprI-mediated pathway in D. radiodurans is indispensable for its extreme radio-resistance and therefore its elucidation significantly advances our understanding of the DNA damage repair mechanism in this amazing organism.	[Wang, Yunguang; Lin, Lin; Wang, Liangyan; Xu, Hong; Cui, Xianyan; Zhang, Hui; Li, Tingting; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Chinese Minist Agr Nucl Agr Sci, Key Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Qiang] Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Zhejiang Key Lab Radiat Oncol, Hangzhou, Zhejiang, Peoples R China; [Lu, Huiming] NIA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA	Zhejiang University; Zhejiang Cancer Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Hua, YJ (corresponding author), Zhejiang Univ, Inst Nucl Agr Sci, Chinese Minist Agr Nucl Agr Sci, Key Lab, Hangzhou 310003, Zhejiang, Peoples R China.	yjhua@zju.edu.cn	Lu, Huiming/ABG-1372-2021	Lu, Huiming/0000-0002-2743-7419	National Basic Research Program of China [2015CB910600]; National Natural Science Foundation of China [31210103904, 31370102]; Ministry of Agriculture of China [2014ZX08009003-002]; Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China [201103007]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China	This work was supported by National Basic Research Program of China (2015CB910600), grants from National Natural Science Foundation of China (31210103904, 31370102), a major project for genetically modified organisms breeding from the Ministry of Agriculture of China (2014ZX08009003-002), a grant from Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China (201103007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTISTA JR, 1990, PROG CLIN BIOL RES, V340, P169; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cox MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000815; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; Gao GJ, 2003, DNA REPAIR, V2, P1419, DOI 10.1016/j.dnarep.2003.08.012; GOTTESMAN S, 1981, CELL, V23, P1, DOI 10.1016/0092-8674(81)90261-0; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Hsu HF, 2011, BIOCHEMISTRY-US, V50, P8270, DOI 10.1021/bi200423t; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Kim JI, 2006, J MICROBIOL, V44, P508; Kota S, 2014, J GENET, V93, P349, DOI 10.1007/s12041-014-0382-z; Kota S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085288; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lu HM, 2012, DNA REPAIR, V11, P139, DOI 10.1016/j.dnarep.2011.10.013; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; Ludanyi M, 2014, MOL MICROBIOL, V94, P434, DOI 10.1111/mmi.12774; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Narumi I, 2002, J BACTERIOL, V184, P614, DOI 10.1128/JB.184.2.614.2002; Ngo KV, 2013, J BIOL CHEM, V288, P21351, DOI 10.1074/jbc.M113.459230; Radman M, 1975, Basic Life Sci, V5A, P355; Sharma A, 2013, P NATL ACAD SCI USA, V110, P5945, DOI 10.1073/pnas.1303376110; Sheng DH, 2004, J BIOCHEM, V136, P787, DOI 10.1093/jb/mvh188; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; Tabares LC, 2013, J BIOL CHEM, V288, P5050, DOI 10.1074/jbc.C112.444992; Trompouki E, 2011, METHOD CELL BIOL, V104, P341, DOI 10.1016/B978-0-12-374814-0.00019-7; Vujicic-Zagar A, 2009, J MOL BIOL, V386, P704, DOI 10.1016/j.jmb.2008.12.062; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200	33	41	43	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122071	10.1371/journal.pone.0122071	http://dx.doi.org/10.1371/journal.pone.0122071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811789	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700167
J	Binning, SA; Ros, AFH; Nusbaumer, D; Roche, DG				Binning, Sandra A.; Ros, Albert F. H.; Nusbaumer, David; Roche, Dominique G.			Physiological Plasticity to Water Flow Habitat in the Damselfish, Acanthochromis polyacanthus: Linking Phenotype to Performance	PLOS ONE			English	Article							CORAL-REEF FISH; SWIMMING PERFORMANCE; RESPIRATORY METABOLISM; AEROBIC CAPACITY; LABRIFORM FISH; MORPHOLOGY; EXERCISE; BODY; ENERGETICS; SHAPE	The relationships among animal form, function and performance are complex, and vary across environments. Therefore, it can be difficult to identify morphological and/or physiological traits responsible for enhancing performance in a given habitat. In fishes, differences in swimming performance across water flow gradients are related to morphological variation among and within species. However, physiological traits related to performance have been less well studied. We experimentally reared juvenile damselfish, Acanthochromis polyacanthus, under different water flow regimes to test 1) whether aspects of swimming physiology and morphology show plastic responses to water flow, 2) whether trait divergence correlates with swimming performance and 3) whether flow environment relates to performance differences observed in wild fish. We found that maximum metabolic rate, aerobic scope and blood haematocrit were higher in wave-reared fish compared to fish reared in low water flow. However, pectoral fin shape, which tends to correlate with sustained swimming performance, did not differ between rearing treatments or collection sites. Maximum metabolic rate was the best overall predictor of individual swimming performance; fin shape and fish total length were 3.3 and 3.7 times less likely than maximum metabolic rate to explain differences in critical swimming speed. Performance differences induced in fish reared in different flow environments were less pronounced than in wild fish but similar in direction. Our results suggest that exposure to water motion induces plastic physiological changes which enhance swimming performance in A. polyacanthus. Thus, functional relationships between fish morphology and performance across flow habitats should also consider differences in physiology.	[Binning, Sandra A.; Roche, Dominique G.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Binning, Sandra A.; Roche, Dominique G.] Australian Natl Univ, ARC Ctr Excellence Coral Reef Studies, Canberra, ACT, Australia; [Binning, Sandra A.; Ros, Albert F. H.; Nusbaumer, David; Roche, Dominique G.] Univ Neuchatel, Ecoethol Inst Biol, CH-2000 Neuchatel, Switzerland	Australian National University; Australian National University; University of Neuchatel	Binning, SA (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	sandra.binning@unine.ch	Ros, Albert FH/I-7726-2015	Ros, Albert FH/0000-0003-3241-9722; Roche, Dominique/0000-0002-3326-864X; Binning, Sandra/0000-0002-2804-9979	Australian Research Council Centre of Excellence for Coral Reef Studies; Australian National University; Natural Sciences and Engineering Research Council of Canada; Australian Society for Fish Biology; Society for Integrative and Comparative Biology; Great Barrier Reef Marine Park Authority; Total Diving in Montreal; Ian Potter Doctoral Fellowship at Lizard Island (Lizard Island Research Station, a facility of the Australian Museum)	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian National University(Australian National University); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Society for Fish Biology; Society for Integrative and Comparative Biology; Great Barrier Reef Marine Park Authority; Total Diving in Montreal; Ian Potter Doctoral Fellowship at Lizard Island (Lizard Island Research Station, a facility of the Australian Museum)	This study was funded by The Australian Research Council Centre of Excellence for Coral Reef Studies, The Australian National University, The Natural Sciences and Engineering Research Council of Canada, The Australian Society for Fish Biology, The Society for Integrative and Comparative Biology, The Great Barrier Reef Marine Park Authority, Total Diving in Montreal and an Ian Potter Doctoral Fellowship at Lizard Island (Lizard Island Research Station, a facility of the Australian Museum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Bay LK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-248; Bell W. H, 1970, Rep. Fish. Res. Bd Can., VNo. 195, P1; Bellwood DR, 2002, FUNCT ECOL, V16, P557, DOI 10.1046/j.1365-2435.2002.00655.x; Binning SA, 2011, J FISH BIOL, V79, P812, DOI 10.1111/j.1095-8649.2011.03070.x; Binning SA, 2014, DATABASE FIGSHARE, DOI [10.6084/m9.figshare.923561, DOI 10.6084/M9.FIGSHARE.923561]; Binning SA, 2015, ECOLOGY, V96, P828, DOI 10.1890/14-0426.1; Binning SA, 2014, OECOLOGIA, V174, P623, DOI 10.1007/s00442-013-2794-5; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BUTLER PJ, 1988, J PHYSIOL-LONDON, V401, P347, DOI 10.1113/jphysiol.1988.sp017166; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; Davison W, 1997, COMP BIOCHEM PHYS A, V117, P67, DOI 10.1016/S0300-9629(96)00284-8; Denny M, 2002, J EXP BIOL, V205, P1355; DOHERTY PJ, 1994, MAR BIOL, V121, P11, DOI 10.1007/BF00349469; Domenici P, 2003, EXPTL BIOL REV, P137; Drucker EG, 2000, J EXP BIOL, V203, P2379; Eme J, 2009, J COMP PHYSIOL B, V179, P921, DOI 10.1007/s00360-009-0374-0; Enders EC, 2003, CAN J FISH AQUAT SCI, V60, P1149, DOI 10.1139/F03-101; Fast MD, 2008, FISH SHELLFISH IMMUN, V24, P194, DOI 10.1016/j.fsi.2007.10.009; Fulton CJ, 2013, CORAL REEFS, V32, P685, DOI 10.1007/s00338-013-1039-8; Fulton Christopher J., 2010, P374, DOI 10.1201/b10190-13; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; Gallaugher P., 1998, Fish Physiology, V17, P185, DOI 10.1016/S1546-5098(08)60262-9; Gerstner CL, 1999, CAN J ZOOL, V77, P1102, DOI 10.1139/cjz-77-7-1102; Hayne KJR, 2013, J EXP BIOL, V216, P1717, DOI 10.1242/jeb.078964; He W, 2013, COMP BIOCHEM PHYS A, V166, P308, DOI 10.1016/j.cbpa.2013.07.003; Heatwole SJ, 2013, MAR BIOL, V160, P677, DOI 10.1007/s00227-012-2123-2; Imre I, 2002, J FISH BIOL, V61, P1171, DOI 10.1006/jfbi.2002.2131; Johansen JL, 2008, MAR ECOL PROG SER, V360, P219, DOI 10.3354/meps07482; Johansen JL, 2011, GLOBAL CHANGE BIOL, V17, P2971, DOI 10.1111/j.1365-2486.2011.02436.x; Johansen JL, 2010, MAR ECOL PROG SER, V420, P221, DOI 10.3354/meps08885; Johansen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083240; Johnson JB, 2008, EVOLUTION, V62, P1243, DOI 10.1111/j.1558-5646.2008.00343.x; Kavanagh KD, 2000, B MAR SCI, V66, P321; Kemi OJ, 2002, J APPL PHYSIOL, V93, P1301, DOI 10.1152/japplphysiol.00231.2002; Kieffer JD, 2010, COMP BIOCHEM PHYS A, V156, P163, DOI 10.1016/j.cbpa.2010.02.009; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Lauder George V., 1996, P55; Lauder GV, 2004, IEEE J OCEANIC ENG, V29, P556, DOI 10.1109/JOE.2004.833219; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x; Madin JS, 2012, J EXP BIOL, V215, P968, DOI 10.1242/jeb.061002; McKenzie DJ, 2001, CAN J FISH AQUAT SCI, V58, P1104, DOI 10.1139/cjfas-58-6-1104; Menard A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038450; Miller-Sims VC, 2008, MOL ECOL, V17, P5036, DOI 10.1111/j.1365-294X.2008.03986.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nelson JA, 2015, ENVIRON BIOL FISH, V98, P1431, DOI 10.1007/s10641-014-0369-x; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Owerkowicz T, 2008, COMP BIOCHEM PHYS A, V150, P211, DOI 10.1016/j.cbpa.2008.04.594; Packard GC, 1999, COMP BIOCHEM PHYS A, V122, P37, DOI 10.1016/S1095-6433(98)10170-8; Pakkasmaa S, 2000, EVOL ECOL, V14, P721, DOI 10.1023/A:1011691810801; Pink JR, 2014, MAR BIOL, V161, P1103, DOI 10.1007/s00227-014-2403-0; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; Plaut I, 2000, J EXP BIOL, V203, P813; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Roche DG, 2014, J EXP BIOL, V217, P414, DOI 10.1242/jeb.085811; Roche DG, 2013, J EXP BIOL, V216, P2103, DOI 10.1242/jeb.082925; Soares MC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1547; STEFFENSEN JF, 1984, COMP BIOCHEM PHYS A, V79, P437, DOI 10.1016/0300-9629(84)90541-3; Svendsen JC, 2010, J EXP BIOL, V213, P2177, DOI 10.1242/jeb.041368; Vogel S., 1994, LIFE MOVING FLUIDS P; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Wainwright PC, 2002, ENVIRON BIOL FISH, V65, P47, DOI 10.1023/A:1019671131001; Wainwright Peter C., 1994, P42; Walker JA, 2000, P ROY SOC B-BIOL SCI, V267, P1875, DOI 10.1098/rspb.2000.1224; Walker JA, 2002, INTEGR COMP BIOL, V42, P1032, DOI 10.1093/icb/42.5.1032; Walker JA, 2002, J EXP BIOL, V205, P177; Walker JA, 2007, AM NAT, V170, P681, DOI 10.1086/521957; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Webb P.W., 1975, B FISH RES BOARD CAN, V190, P1, DOI DOI 10.1002/RRA.1371; Yan GJ, 2013, J EVOLUTION BIOL, V26, P1802, DOI 10.1111/jeb.12182; Yavno S, 2013, J EVOLUTION BIOL, V26, P2383, DOI 10.1111/jeb.12230; Zhao WW, 2012, FISH PHYSIOL BIOCHEM, V38, P1367, DOI 10.1007/s10695-012-9624-2	77	18	18	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121983	10.1371/journal.pone.0121983	http://dx.doi.org/10.1371/journal.pone.0121983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807560	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000194
J	Dayem, AA; Choi, HY; Kim, YB; Cho, SG				Dayem, Ahmed Abdal; Choi, Hye Yeon; Kim, Young Bong; Cho, Ssang-Goo			Antiviral Effect of Methylated Flavonol Isorhamnetin against Influenza	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; NEURAMINIDASE INHIBITORS; ANTIOXIDANT; AUTOPHAGY; OSELTAMIVIR; QUERCETIN; BAICALEIN; HEMAGGLUTININ; METABOLISM; HOSPITALIZATIONS	Influenza is an infectious respiratory disease with frequent seasonal epidemics that causes a high rate of mortality and morbidity in humans, poultry, and animals. Influenza is a serious economic concern due to the costly countermeasures it necessitates. In this study, we compared the antiviral activities of several flavonols and other flavonoids with similar, but distinct, hydroxyl or methyl substitution patterns at the 3, 3', and 4' positions of the 15-carbon flavonoid skeleton, and found that the strongest antiviral effect was induced by isorhamnetin. Similar to quercetin and kaempferol, isorhamnetin possesses a hydroxyl group on the C ring, but it has a 3'-methyl group on the B ring that is absent in quercetin and kaempferol. Co-treatment and pre-treatment with isorhamnetin produced a strong antiviral effect against the influenza virus A/PR/08/34(H1N1). However, isorhamnetin showed the most potent antiviral potency when administered after viral exposure (post-treatment method) in vitro. Isorhamnetin treatment reduced virus-induced ROS generation and blocked cytoplasmic lysosome acidification and the lipidation of microtubule associated protein1 light chain 3-B (LC3B). Oral administration of isorhamnetin in mice infected with the influenza A virus significantly decreased lung virus titer by 2 folds, increased the survival rate which ranged from 70-80%, and decreased body weight loss by 25%. In addition, isorhamnetin decreased the virus titer in ovo using embryonated chicken eggs. The structure-activity relationship (SAR) of isorhamnetin could explain its strong anti-influenza virus potency; the methyl group located on the B ring of isorhamnetin may contribute to its strong antiviral potency against influenza virus in comparison with other flavonoids.	[Dayem, Ahmed Abdal; Choi, Hye Yeon; Cho, Ssang-Goo] Konkuk Univ, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea; [Dayem, Ahmed Abdal; Choi, Hye Yeon; Cho, Ssang-Goo] Konkuk Univ, IDASI, Seoul, South Korea; [Kim, Young Bong] Konkuk Univ, Dept Bioind Technol, Seoul, South Korea	Konkuk University; Konkuk University; Konkuk University	Cho, SG (corresponding author), Konkuk Univ, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea.	ssangoo@konkuk.ac.kr	CHOI, HYEYEON/O-1234-2019; Dayem, Ahmed M Abdal/D-4773-2011	Dayem, Ahmed M Abdal/0000-0003-3873-9903; Cho, Ssang-Goo/0000-0002-0968-7932	Konkuk University	Konkuk University	This paper was supported by Konkuk University in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08; Bouvier NM, 2012, J VIROL, V86, P7268, DOI 10.1128/JVI.07242-12; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55; Chang YS, 2010, J CHIN CHEM SOC-TAIP, V57, P916, DOI 10.1002/jccs.201000127; Chen C, 2012, J ASIAN NAT PROD RES, V14, P877, DOI 10.1080/10286020.2012.702108; Chen LL, 2011, ANTIVIR RES, V91, P314, DOI 10.1016/j.antiviral.2011.07.008; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Choi HJ, 2009, EUR J PHARM SCI, V37, P329, DOI 10.1016/j.ejps.2009.03.002; Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI 10.1517/14728220802517901 ; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; Fremont L, 1999, LIFE SCI, V64, P2511, DOI 10.1016/S0024-3205(99)00209-X; Gangehei L, 2010, PHYTOMEDICINE, V17, P1047, DOI 10.1016/j.phymed.2010.03.016; Ginting TE, 2012, J VIROL, V86, P121, DOI 10.1128/JVI.06085-11; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Han D, 2014, CELL TRANSPLANT; Hayden FG, 2006, CURR OPIN INFECT DIS, V19, P169, DOI 10.1097/01.qco.0000216628.51563.b1; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hollman PCH, 1997, BIOMED PHARMACOTHER, V51, P305, DOI 10.1016/S0753-3322(97)88045-6; Hossain MK, 2014, J MICROBIOL, V52, P521, DOI 10.1007/s12275-014-4212-z; Ibarra M, 2002, PLANTA MED, V68, P307, DOI 10.1055/s-2002-26752; Jeong HJ, 2009, BIOORGAN MED CHEM, V17, P6816, DOI 10.1016/j.bmc.2009.08.036; Kim JH, 2012, LEUKEMIA RES, V36, P1157, DOI 10.1016/j.leukres.2012.05.018; Kumar S, 2013, SCIENTIFICWORLD J; Landis-Piwowar K R, 2008, Curr Mol Pharmacol, V1, P233; Lee ER, 2007, BIOL PHARM BULL, V30, P32, DOI 10.1248/bpb.30.32; Lee ER, 2011, CELL PHYSIOL BIOCHEM, V27, P513, DOI 10.1159/000329973; Li SM, 2009, J FUNCT FOODS, V1, P2, DOI 10.1016/j.jff.2008.09.003; Liao HR, 2006, J CHIN CHEM SOC-TAIP, V53, P1251, DOI 10.1002/jccs.200600167; Liu AL, 2008, BIOORGAN MED CHEM, V16, P7141, DOI 10.1016/j.bmc.2008.06.049; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Marjuki H, 2009, ADV VIROL, V2009, DOI 10.1155/2009/294520; de Carvalho RSM, 2011, BEHAV BRAIN RES, V221, P75, DOI 10.1016/j.bbr.2011.02.038; Mata M, 2011, BIOCHEM PHARMACOL, V82, P548, DOI 10.1016/j.bcp.2011.05.014; Medic-Saric M, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-33; Meijer A, 2014, ANTIVIR RES, V110, P31, DOI 10.1016/j.antiviral.2014.07.001; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morand C, 1998, AM J PHYSIOL-REG I, V275, pR212, DOI 10.1152/ajpregu.1998.275.1.R212; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Panda VS, 2009, ALTERN MED REV, V14, P161; REED L. J., 1938, AMER JOUR HYG, V27, P493; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Sithisarn P, 2013, ANTIVIR RES, V97, P41, DOI 10.1016/j.antiviral.2012.10.004; Smee DF, 2010, ANTIMICROB AGENTS CH, V54, P126, DOI 10.1128/AAC.00933-09; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Spencer JPE, 2004, ARCH BIOCHEM BIOPHYS, V423, P148, DOI 10.1016/j.abb.2003.11.010; Sun B, 2012, J CELL BIOCHEM, V113, P473, DOI 10.1002/jcb.23371; Walle T, 2007, BIOCHEM PHARMACOL, V73, P1288, DOI 10.1016/j.bcp.2006.12.028; Wang LS, 2006, J AGR FOOD CHEM, V54, P9798, DOI 10.1021/jf0620719; Wen X, 2006, DRUG METAB DISPOS, V34, P1786, DOI 10.1124/dmd.106.011122; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447; Zhang SQ, 2013, J NEUROSCI RES, V91, P1239, DOI 10.1002/jnr.23244; Zhirnov OP, 2013, J VIROL, V87, P13107, DOI 10.1128/JVI.02148-13; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	62	73	74	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121610	10.1371/journal.pone.0121610	http://dx.doi.org/10.1371/journal.pone.0121610			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806943	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000165
J	Kwok, H; Chan, KW; Chan, KH; Chiang, AKS				Kwok, Hin; Chan, Koon Wing; Chan, Kwok Hung; Chiang, Alan Kwok Shing			Distribution, Persistence and Interchange of Epstein-Barr Virus Strains among PBMC, Plasma and Saliva of Primary Infection Subjects	PLOS ONE			English	Article							HETERODUPLEX TRACKING ASSAY; LYMPHOID-CELL LINES; NASOPHARYNGEAL CARCINOMA; SEQUENCE VARIATION; NUCLEAR ANTIGEN-2; HODGKINS-DISEASE; CARRIER STATE; GENE; MONONUCLEOSIS; INDIVIDUALS	Our study aimed at investigating the distribution, persistence and interchange of viral strains among peripheral blood mononuclear cells (PBMC), plasma and saliva of primary Epstein-Barr virus (EBV) infection subjects. Twelve infectious mononucleosis (IM) patients and eight asymptomatic individuals (AS) with primary EBV infection were followed longitudinally at several time points for one year from the time of diagnosis, when blood and saliva samples were collected and separated into PBMC, plasma and saliva, representing circulating B cell, plasma and epithelial cell compartments, respectively. To survey the viral strains, genotyping assays for the natural polymorphisms in two latent EBV genes, EBNA2 and LMP1, were performed and consisted of real-time PCR on EBNA2 to distinguish type 1 and 2 viruses, fluorescent-based 30-bp typing assay on LMP1 to distinguish deletion and wild type LMP1, and fluorescent-based heteroduplex tracking assays on both EBNA2 and LMP1 to distinguish defined polymorphic variants. No discernible differences were observed between IM patients and AS. Multiple viral strains were acquired early at the start of infection. Stable persistence of dominant EBV strains in the same tissue compartment was observed throughout the longitudinal samples. LMP1-defined strains, China 1, China 2 and Mediterranean+, were the most common strains observed. EBNA2-defined groups 1 and 3e predominated the PBMC and saliva compartments. Concordance of EBNA2 and LMP1 strains between PBMC and saliva suggested ready interchange of viruses between circulating B cell and epithelial cell pools, whilst discordance of viral strains observed between plasma and PBMC/saliva indicated presence of viral pools in other undetermined tissue compartments. Taken together, the results indicated that the distribution, persistence and interchange of viral strains among the tissue compartments are more complex than those proposed by the current model of EBV life cycle.	[Kwok, Hin; Chan, Koon Wing; Chiang, Alan Kwok Shing] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China; [Chan, Kwok Hung] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Chiang, AKS (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China.	chiangak@hku.hk	Chan, Kwok Hung/ABD-5399-2021; Chiang, Alan/L-8849-2018	Chiang, Alan/0000-0002-1089-5325	Research Grant Council General Research Fund (GRF) [HKU763208M]; Conference and Research Grant (CRCG) CRCG [104002548, 104002068]; EBV research grant of AKSC [200004525]; University of Hong Kong's postgraduate studentship; Hotung Paediatrics Education and Research Fund	Research Grant Council General Research Fund (GRF); Conference and Research Grant (CRCG) CRCG; EBV research grant of AKSC; University of Hong Kong's postgraduate studentship; Hotung Paediatrics Education and Research Fund	This study was funded by Research Grant Council General Research Fund (GRF) HKU763208M, Conference and Research Grant (CRCG) CRCG#104002548 and 104002068, and EBV research grant 200004525 of AKSC. HK was supported by The University of Hong Kong's postgraduate studentship and Hotung Paediatrics Education and Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAMID M, 1992, VIROLOGY, V190, P168, DOI 10.1016/0042-6822(92)91202-6; AITKEN C, 1994, J GEN VIROL, V75, P95, DOI 10.1099/0022-1317-75-1-95; ANAGNOSTOPOULOS I, 1995, BLOOD, V85, P744, DOI 10.1182/blood.V85.3.744.bloodjournal853744; Beyari MM, 2003, J INFECT DIS, V188, P678, DOI 10.1086/377504; BROCKSMITH D, 1991, J PATHOL, V165, P11, DOI 10.1002/path.1711650104; CHEN ML, 1992, ONCOGENE, V7, P2131; Chiang AKS, 1999, INT J CANCER, V80, P356, DOI 10.1002/(SICI)1097-0215(19990129)80:3&lt;356::AID-IJC4&gt;3.0.CO;2-D; DAMBAUGH T, 1984, P NATL ACAD SCI-BIOL, V81, P7632, DOI 10.1073/pnas.81.23.7632; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; Gallagher A, 1999, INT J CANCER, V84, P442, DOI 10.1002/(SICI)1097-0215(19990820)84:4<442::AID-IJC20>3.3.CO;2-A; Gutierrez MI, 1998, BLOOD, V92, P600, DOI 10.1182/blood.V92.2.600.414k33_600_606; Gutierrez MI, 1997, J GEN VIROL, V78, P1663, DOI 10.1099/0022-1317-78-7-1663; HU LF, 1991, J GEN VIROL, V72, P2399, DOI 10.1099/0022-1317-72-10-2399; Juliano JJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-47; LIDIN B, 1975, INTERVIROLOGY, V5, P205; LUNG ML, 1991, VIROLOGY, V185, P67, DOI 10.1016/0042-6822(91)90754-Y; LUNG ML, 1991, J INFECT DIS, V164, P213; Mackay C R, 1992, Semin Immunol, V4, P51; Meyer-Konig U, 1998, LANCET, V352, P1280, DOI 10.1016/S0140-6736(05)70487-6; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; MILLER WE, 1994, J GEN VIROL, V75, P2729, DOI 10.1099/0022-1317-75-10-2729; Niedobitek G, 1997, J PATHOL, V182, P151, DOI 10.1002/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3; Peh SC, 2002, PATHOLOGY, V34, P446, DOI 10.1080/0031302021000009379; PULVERTAFT RJV, 1964, LANCET, V1, P238; Resch W, 2001, P NATL ACAD SCI USA, V98, P176, DOI 10.1073/pnas.011511298; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Sandvej K, 2000, J PATHOL, V191, P127, DOI 10.1002/(SICI)1096-9896(200006)191:2<127::AID-PATH614>3.0.CO;2-E; SAWAI M, 1990, EXP CELL RES, V187, P4, DOI 10.1016/0014-4827(90)90108-M; Schuster V, 1996, BLOOD, V87, P1579, DOI 10.1182/blood.V87.4.1579.bloodjournal8741579; Sitki-Green D, 2003, J VIROL, V77, P1840, DOI 10.1128/JVI.77.3.1840-1847.2003; Sitki-Green D, 2002, J VIROL, V76, P9645, DOI 10.1128/JVI.76.19.9645-9656.2002; Sitki-Green DL, 2004, J INFECT DIS, V189, P483, DOI 10.1086/380800; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Srivastava G, 2000, BLOOD, V95, P2443, DOI 10.1182/blood.V95.7.2443.007k18_2443_2445; Sung NS, 1998, INT J CANCER, V76, P207, DOI 10.1002/(SICI)1097-0215(19980413)76:2&lt;207::AID-IJC7&gt;3.0.CO;2-0; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Tierney RJ, 2006, J INFECT DIS, V193, P287, DOI 10.1086/498913; Walling DM, 2003, J VIROL, V77, P6546, DOI 10.1128/JVI.77.11.6546-6550.2003; Walling DM, 1999, J INFECT DIS, V179, P763, DOI 10.1086/314672; YAO QY, 1991, J GEN VIROL, V72, P1579, DOI 10.1099/0022-1317-72-7-1579; Yao QY, 1998, J VIROL, V72, P4352, DOI 10.1128/JVI.72.5.4352-4363.1998; Yao QY, 1996, J VIROL, V70, P4884, DOI 10.1128/JVI.70.8.4884-4894.1996; YAO QY, 1985, CHINESE MED J-PEKING, V98, P191	43	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120710	10.1371/journal.pone.0120710	http://dx.doi.org/10.1371/journal.pone.0120710			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807555	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000098
J	Li, CH; Li, YX; Shi, YS; Song, YC; Zhang, DF; Buckler, ES; Zhang, ZW; Wang, TY; Li, Y				Li, Chunhui; Li, Yongxiang; Shi, Yunsu; Song, Yanchun; Zhang, Dengfeng; Buckler, Edward S.; Zhang, Zhiwu; Wang, Tianyu; Li, Yu			Genetic Control of the Leaf Angle and Leaf Orientation Value as Revealed by Ultra-High Density Maps in Three Connected Maize Populations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOMIC PREDICTION; LIGHT INTERCEPTION; YIELD COMPONENTS; ARCHITECTURE; QTL; PHOTOSYNTHESIS; ASSOCIATION; HYBRIDS; CANOPY	Plant architecture is a key factor for high productivity maize because ideal plant architecture with an erect leaf angle and optimum leaf orientation value allow for more efficient light capture during photosynthesis and better wind circulation under dense planting conditions. To extend our understanding of the genetic mechanisms involved in leaf-related traits, three connected recombination inbred line (RIL) populations including 538 RILs were genotyped by genotyping-by-sequencing (GBS) method and phenotyped for the leaf angle and related traits in six environments. We conducted single population quantitative trait locus (QTL) mapping and joint linkage analysis based on high-density recombination bin maps constructed from GBS genotype data. A total of 45 QTLs with phenotypic effects ranging from 1.2% to 29.2% were detected for four leaf architecture traits by using joint linkage mapping across the three populations. All the QTLs identified for each trait could explain approximately 60% of the phenotypic variance. Four QTLs were located on small genomic regions where candidate genes were found. Genomic predictions from a genomic best linear unbiased prediction (GBLUP) model explained 45 +/- 9% to 68 +/- 8% of the variation in the remaining RILs for the four traits. These results extend our understanding of the genetics of leaf traits and can be used in genomic prediction to accelerate plant architecture improvement.	[Li, Chunhui; Li, Yongxiang; Shi, Yunsu; Song, Yanchun; Zhang, Dengfeng; Wang, Tianyu; Li, Yu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Buckler, Edward S.; Zhang, Zhiwu] Cornell Univ, Inst Genom Div, Ithaca, NY USA	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Cornell University	Wang, TY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China.	wangtianyu@263.net; liyu03@caas.cn	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Zhang, zs/GXN-3521-2022; li, yongxiang/GPW-6930-2022; Zhang, Zhiwu/P-6156-2016; li, yong/HDN-3885-2022	Buckler, Edward/0000-0002-3100-371X; Zhang, Zhiwu/0000-0002-5784-9684; 	Ministry of Science and Technology [2011CB100105, 2011DFA30450]; National Natural Science Foundation [91335206]; US-NSF [0820619, 1238014]; USDA-ARS	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); US-NSF(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by the Ministry of Science and Technology (2011CB100105, 2011DFA30450), National Natural Science Foundation (91335206), US-NSF(0820619, 1238014), USDA-ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Blanc G, 2006, THEOR APPL GENET, V113, P206, DOI 10.1007/s00122-006-0287-1; Bolduc N, 2009, PLANT CELL, V21, P1647, DOI 10.1105/tpc.109.068221; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Chen ZL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-433; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2014, THEOR APPL GENET, V127, P1795, DOI 10.1007/s00122-014-2341-8; Duvick DN, 2005, MAYDICA, V50, P193; Duvick DN, 2005, CONTRIBUTION BREEDIN, P83; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Juarez MT, 2004, DEVELOPMENT, V131, P4533, DOI 10.1242/dev.01328; KERSTETTER R, 1994, PLANT CELL, V6, P1877, DOI 10.1105/tpc.6.12.1877; Ku LX, 2012, J EXP BOT, V63, P261, DOI 10.1093/jxb/err277; Ku LX, 2010, THEOR APPL GENET, V121, P951, DOI 10.1007/s00122-010-1364-z; Li HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017573; Li S, 1997, BEIJING AGR SCI, V15, P19; Li YL, 2009, EUPHYTICA, V169, P273, DOI 10.1007/s10681-009-9966-8; Li Y, 2011, CROP SCI, V51, P2391, DOI 10.2135/cropsci2011.03.0148; [黎裕 Li Yu], 2010, [玉米科学, Maize Science], V18, P1; Lu Ming, 2007, Yichuan, V29, P1131, DOI 10.1360/yc-007-1131; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mickelson SM, 2002, CROP SCI, V42, P1902, DOI 10.2135/cropsci2002.1902; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Peiffer JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067066; Pelleschi S, 2006, MOL BREEDING, V17, P21, DOI 10.1007/s11032-005-1031-2; PEPPER GE, 1977, CROP SCI, V17, P883, DOI 10.2135/cropsci1977.0011183X001700060017x; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; Technow F, 2014, GENETICS, V197, P1343, DOI 10.1534/genetics.114.165860; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vazin F, 2010, PLANTA DANINHA, V28, P455, DOI 10.1590/S0100-83582010000300001; Verhoeven KJF, 2006, HEREDITY, V96, P139, DOI 10.1038/sj.hdy.6800763; Wang J, 2012, QTL ICIMAPPING SOFTW; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Wang TY, 2011, CROP SCI, V51, P512, DOI 10.2135/cropsci2010.06.0383; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Yu H, 2011, PLOS ONE, V6; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu YongTao, 2006, Journal of Maize Sciences, V14, P88; Zhang J, 2014, J EXP BOT, V65, P5063, DOI 10.1093/jxb/eru271	44	66	74	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121624	10.1371/journal.pone.0121624	http://dx.doi.org/10.1371/journal.pone.0121624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807369	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000168
J	Patrut, A; von Reden, KF; Danthu, P; Pock-Tsy, JML; Patrut, RT; Lowy, DA				Patrut, Adrian; von Reden, Karl F.; Danthu, Pascal; Pock-Tsy, Jean-Michel Leong; Patrut, Roxana T.; Lowy, Daniel A.			Searching for the Oldest Baobab of Madagascar: Radiocarbon Investigation of Large Adansonia rubrostipa Trees	PLOS ONE			English	Article							PERFORMANCE; CARBON	We extended our research on the architecture, growth and age of trees belonging to the genus Adansonia, by starting to investigate large individuals of the most widespread Malagasy species. Our research also intends to identify the oldest baobabs of Madagascar. Here we present results of the radiocarbon investigation of the two most representative Adansonia rubrostipa (fony baobab) specimens, which are located in south-western Madagascar, in the Tsimanampetsotse National Park. We found that the fony baobab called "Grandmother" consists of 3 perfectly fused stems of different ages. The radiocarbon date of the oldest sample was found to be 1136 +/- 16 BP. We estimated that the oldest part of this tree, which is mainly hollow, has an age close to 1,600 yr. This value is comparable to the age of the oldest Adansonia digitata (African baobab) specimens. By its age, the Grandmother is a major candidate for the oldest baobab of Madagascar. The second investigated specimen, called the "polygamous baobab", consists of 6 partially fused stems of different ages. According to dating results, this fony baobab is 1,000 yr old. This research is the first investigation of the structure and age of Malagasy baobabs.	[Patrut, Adrian] Univ Babes Bolyai, Fac Chem, R-3400 Cluj Napoca, Romania; [von Reden, Karl F.] Woods Hole Oceanog Inst, Dept Geol & Geophys, NOSAMS Facil, Woods Hole, MA 02543 USA; [Danthu, Pascal] UPR BSEF, Cirad, Montpellier, France; [Danthu, Pascal; Pock-Tsy, Jean-Michel Leong] DP Forets & Biodiversit, Antananarivo, Madagascar; [Patrut, Roxana T.] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania; [Lowy, Daniel A.] Nova Univ, No Virginia Community Coll, Alexandria, VA USA	Babes Bolyai University from Cluj; Woods Hole Oceanographic Institution; CIRAD; Babes Bolyai University from Cluj	Patrut, A (corresponding author), Univ Babes Bolyai, Fac Chem, R-3400 Cluj Napoca, Romania.	apatrut@gmail.com	Lowy, Daniel A/C-3265-2016; Patrut, Adrian/C-3566-2012	Patrut, Adrian/0000-0002-9862-6735; Patrut, Roxana/0000-0002-8691-2160	Romanian Ministry of National Education CNCS-UEFISCDI [PN-II-ID-PCE-2013-76]; Directorate For Geosciences [1239667] Funding Source: National Science Foundation	Romanian Ministry of National Education CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The research was fully funded by the Romanian Ministry of National Education CNCS-UEFISCDI under grant PN-II-ID-PCE-2013-76 (URL: http://uefiscdi.gov.ro/). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BAUM DA, 1995, ANN MO BOT GARD, V82, P440, DOI 10.2307/2399893; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Olsson I.U., 1986, P273; Pakenham T., 2004, REMARKABLE BAOBAB; Patrut A, 2007, TREE PHYSIOL, V27, P1569, DOI 10.1093/treephys/27.11.1569; Patrut A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117193; Patrut A, 2013, NUCL INSTRUM METH B, V294, P622, DOI 10.1016/j.nimb.2012.04.025; Patrut A, 2011, ANN FOREST SCI, V68, P993, DOI 10.1007/s13595-011-0107-x; Patrut A, 2010, RADIOCARBON, V52, P727; Patrut A, 2010, NUCL INSTRUM METH B, V268, P910, DOI 10.1016/j.nimb.2009.10.062; Pettigrew JD, 2012, TAXON, V61, P1240, DOI 10.1002/tax.616006; Povinec PP, 2009, RADIOCARBON, V51, P45, DOI 10.1017/S0033822200033701; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Roberts ML, 2010, RADIOCARBON, V52, P228, DOI 10.1017/S0033822200045252; SOFER Z, 1980, ANAL CHEM, V52, P1389, DOI 10.1021/ac50058a063; Vieilledent G, 2013, BIOL CONSERV, V166, P11, DOI 10.1016/j.biocon.2013.06.007; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; Wickens G.E., 2008, BAOBABS PACHYCAULS A, DOI DOI 10.1007/978-1-4020-6431-9	18	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121170	10.1371/journal.pone.0121170	http://dx.doi.org/10.1371/journal.pone.0121170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806967	gold, Green Published			2022-12-26	WOS:000351880000133
J	Rendell, VR; Gilman, RH; Valencia, E; Galdos-Cardenas, G; Verastegui, M; Sanchez, L; Acosta, J; Sanchez, G; Ferrufino, L; LaFuente, C; Abastoflor, MD; Colanzi, R; Bern, C				Rendell, Victoria R.; Gilman, Robert H.; Valencia, Edward; Galdos-Cardenas, Gerson; Verastegui, Manuela; Sanchez, Leny; Acosta, Janet; Sanchez, Gerardo; Ferrufino, Lisbeth; LaFuente, Carlos; del Carmen Abastoflor, Maria; Colanzi, Rony; Bern, Caryn			Trypanosoma cruzi-Infected Pregnant Women without Vector Exposure Have Higher Parasitemia Levels: Implications for Congenital Transmission Risk	PLOS ONE			English	Article							EXCRETED-SECRETED ANTIGENS; CHAGAS-DISEASE; MOTHERS; SALTA; ASSAY; SERODIAGNOSIS; EPIDEMIOLOGY; PREVALENCE; MORBIDITY; MORTALITY	Background Congenital transmission is a major source of new Trypanosoma cruzi infections, and as vector and blood bank control continue to improve, the proportion due to congenital infection will grow. A major unanswered question is why reported transmission rates from T. cruzi-infected mothers vary so widely among study populations. Women with high parasite loads during pregnancy are more likely to transmit to their infants, but the factors that govern maternal parasite load are largely unknown. Better understanding of these factors could enable prioritization of screening programs to target women most at risk of transmission to their infants. Methodology/Principal Findings We screened pregnant women presenting for delivery in a large urban hospital in Bolivia and followed infants of infected women for congenital Chagas disease. Of 596 women screened, 128 (21.5%) had confirmed T. cruzi infection; transmission occurred from 15 (11.7%) infected women to their infants. Parasite loads were significantly higher among women who transmitted compared to those who did not. Congenital transmission occurred from 31.3% (9/29), 15.4% (4/26) and 0% (0/62) of women with high, moderate and low parasite load, respectively (chi x(2) for trend 18.2; p < 0.0001). Twin births were associated with higher transmission risk and higher maternal parasite loads. Infected women without reported vector exposure had significantly higher parasite loads than those who had lived in an infested house (median 26.4 vs 0 parasites/mL; p < 0.001) with an inverse relationship between years of living in an infested house and parasite load. Conclusions/Significance We hypothesize that sustained vector-borne parasite exposure and repeated superinfection by T. cruzi may act as an immune booster, allowing women to maintain effective control of the parasite despite the down-regulation of late pregnancy.	[Rendell, Victoria R.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Gilman, Robert H.; Galdos-Cardenas, Gerson] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Valencia, Edward; Verastegui, Manuela; Sanchez, Leny; Acosta, Janet; Sanchez, Gerardo] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru; [Ferrufino, Lisbeth; Colanzi, Rony] Univ Catolica Boliviana, Santa Cruz, Bolivia; [LaFuente, Carlos; del Carmen Abastoflor, Maria] Hosp Univ Japones, Santa Cruz, Bolivia; [Bern, Caryn] Univ San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94117 USA	Duke University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano Heredia; University of San Francisco	Bern, C (corresponding author), Univ San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94117 USA.	Caryn.Bern2@ucsf.edu		Bern, Caryn/0000-0001-8195-7303; Sanchez Justo, Leny/0000-0003-1167-1566; Sanchez Garcia, Gerardo J./0000-0002-1181-9594; Verastegui, Manuela/0000-0002-7500-1353	National Institutes of Health (NIH) [R01-AI087776]; NIH Global Research Training Grant [D43 TW006581]; Asociacion Benefica PRISMA; FOGARTY INTERNATIONAL CENTER [D43TW006581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087776, R01AI107028] Funding Source: NIH RePORTER; Medical Research Council [MR/K007467/1] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Global Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asociacion Benefica PRISMA; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Institutes of Health (NIH) R01-AI087776, NIH Global Research Training Grant D43 TW006581 and discretionary funds awarded to RHG from Asociacion Benefica PRISMA (www.prisma.org.pe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Vega C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002304; ANDRADE SG, 1982, T ROY SOC TROP MED H, V76, P123, DOI 10.1016/0035-9203(82)90036-0; ARCAVI M, 1993, MEDICINA-BUENOS AIRE, V53, P217; Azogue E, 1991, Rev Soc Bras Med Trop, V24, P105; Azogue E, 1995, Rev Soc Bras Med Trop, V28, P39, DOI 10.1590/S0037-86821995000100007; AZOGUE E, 1985, T ROY SOC TROP MED H, V79, P176, DOI 10.1016/0035-9203(85)90328-1; Basombrio MA, 1999, MEDICINA-BUENOS AIRE, V59, P143; Bern C, 2011, ADV PARASIT, V75, P19, DOI 10.1016/B978-0-12-385863-4.00002-2; Bern C, 2009, CLIN INFECT DIS, V49, P1667, DOI 10.1086/648070; Bittencourt A L, 1974, Rev Inst Med Trop Sao Paulo, V16, P197; BITTENCOURT AL, 1992, REV I MED TROP, V34, P403, DOI 10.1590/S0036-46651992000500006; BITTENCOURT AL, 1985, J TROP PEDIATRICS, V31, P242, DOI 10.1093/tropej/31.5.242; Blanco SB, 2000, TROP MED INT HEALTH, V5, P293, DOI 10.1046/j.1365-3156.2000.00548.x; Burgos JM, 2007, INT J PARASITOL, V37, P1319, DOI 10.1016/j.ijpara.2007.04.015; Corrales RM, 2009, INFECT GENET EVOL, V9, P278, DOI 10.1016/j.meegid.2008.12.008; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; FEILIJ H, 1983, J CLIN MICROBIOL, V18, P327, DOI 10.1128/JCM.18.2.327-330.1983; Hermann E, 2004, J INFECT DIS, V189, P1274, DOI 10.1086/382511; Menezes C A, 1992, Rev Soc Bras Med Trop, V25, P109, DOI 10.1590/S0037-86821992000200004; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; Mora MC, 2005, J PARASITOL, V91, P1468, DOI 10.1645/GE-549R.1; Negrette OS, 2005, PEDIATRICS, V115, pE668, DOI 10.1542/peds.2004-1732; Mar AO, 2006, ARCH MED RES, V37, P774, DOI 10.1016/j.arcmed.2006.02.006; Organizacion Panamericana de la Salud, 2006, OPSHDMCD42506; Dias JCP, 2009, MEM I OSWALDO CRUZ, V104, P41, DOI 10.1590/S0074-02762009000900007; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Programa Nacional de Control de Chagas, 2007, CHAG CONG ESTR DIAGN, P1; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Russomando G, 1998, AM J TROP MED HYG, V59, P487, DOI 10.4269/ajtmh.1998.59.487; Samuels AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002358; Schenone H, 1987, Bol Chil Parasitol, V42, P71; Schenone H, 1991, Bol Chil Parasitol, V46, P19; Suzuki Shunji, 2004, Archives of Gynecology and Obstetrics, V270, P260, DOI 10.1007/s00404-003-0549-y; Ticona CAM, 2005, REV PANAM SALUD PUBL, V17, P147, DOI 10.1590/S1020-49892005000300001; Torrico F, 2006, TROP MED INT HEALTH, V11, P628, DOI 10.1111/j.1365-3156.2006.01623.x; Torrico F, 2004, AM J TROP MED HYG, V70, P201, DOI 10.4269/ajtmh.2004.70.201; Umezawa ES, 1996, J CLIN MICROBIOL, V34, P2143, DOI 10.1128/JCM.34.9.2143-2147.1996; Umezawa ES, 2001, DIAGN MICR INFEC DIS, V39, P169, DOI 10.1016/S0732-8893(01)00216-4; Virreira M, 2007, AM J TROP MED HYG, V77, P102, DOI 10.4269/ajtmh.2007.77.102; World Health Organization [WHO], 2002, CONTR CHAG DIS 2 REP, P1; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	41	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119527	10.1371/journal.pone.0119527	http://dx.doi.org/10.1371/journal.pone.0119527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807498	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000033
J	Yu, FL; Lu, J; Liu, XM; Gazave, E; Chang, DN; Raj, S; Hunter-Zinck, H; Blekhman, R; Arbiza, L; Van Hout, C; Morrison, A; Johnson, AD; Bis, J; Cupples, LA; Psaty, BM; Muzny, D; Yu, J; Gibbs, RA; Keinan, A; Clark, AG; Boerwinkle, E				Yu, Fuli; Lu, Jian; Liu, Xiaoming; Gazave, Elodie; Chang, Diana; Raj, Srilakshmi; Hunter-Zinck, Haley; Blekhman, Ran; Arbiza, Leonardo; Van Hout, Cris; Morrison, Alanna; Johnson, Andrew D.; Bis, Joshua; Cupples, L. Adrienne; Psaty, Bruce M.; Muzny, Donna; Yu, Jin; Gibbs, Richard A.; Keinan, Alon; Clark, Andrew G.; Boerwinkle, Eric			Population Genomic Analysis of 962 Whole Genome Sequences of Humans Reveals Natural Selection in Non-Coding Regions	PLOS ONE			English	Article							GENETIC-VARIATION; HAPLOTYPE STRUCTURE; POSITIVE SELECTION; WIDE ASSOCIATION; PIWI PROTEINS; VARIANTS; RNAS; EVOLUTION; DESIGN; GROWTH	Whole genome analysis in large samples from a single population is needed to provide adequate power to assess relative strengths of natural selection across different functional components of the genome. In this study, we analyzed next-generation sequencing data from 962 European Americans, and found that as expected approximately 60% of the top 1% of positive selection signals lie in intergenic regions, 33% in intronic regions, and slightly over 1% in coding regions. Several detailed functional annotation categories in intergenic regions showed statistically significant enrichment in positively selected loci when compared to the null distribution of the genomic span of ENCODE categories. There was a significant enrichment of purifying selection signals detected in enhancers, transcription factor binding sites, microRNAs and target sites, but not on lincRNA or piRNAs, suggesting different evolutionary constraints for these domains. Loci in "repressed or low activity regions" and loci near or overlapping the transcription start site were the most significantly over-represented annotations among the top 1% of signals for positive selection.	[Yu, Fuli; Muzny, Donna; Yu, Jin; Gibbs, Richard A.; Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Mol & Human Genet Dept, Houston, TX 77030 USA; [Lu, Jian; Gazave, Elodie; Chang, Diana; Raj, Srilakshmi; Hunter-Zinck, Haley; Blekhman, Ran; Arbiza, Leonardo; Van Hout, Cris; Keinan, Alon; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Liu, Xiaoming; Morrison, Alanna; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Johnson, Andrew D.; Cupples, L. Adrienne] Natl Heart Lung & Blood Inst NHLBI Framingham Hea, Framingham, MA USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Yu, Fuli] Tianjin Med Univ, Gen Hosp, Inst Neurol, Tianjin, Peoples R China; [Lu, Jian] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Ctr Bioinformat,Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Baylor College of Medicine; Cornell University; University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tianjin Medical University; Peking University	Yu, FL (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Mol & Human Genet Dept, Houston, TX 77030 USA.	fyu@bcm.edu; Eric.Boerwinkle@uth.tmc.edu	Liu, Xiaoming/C-2743-2008; Johnson, Andrew D/G-6520-2013; Van Hout, Cristopher V./AAQ-3494-2021; Yu, Jin/E-3732-2013	Liu, Xiaoming/0000-0001-8285-5528; Johnson, Andrew D/0000-0001-6369-5178; Van Hout, Cristopher V./0000-0001-9689-5344; Keinan, Alon/0000-0002-9760-1122; Blekhman, Ran/0000-0003-3218-613X; Gazave, Elodie/0000-0002-6972-7051; Morrison, Alanna/0000-0001-6381-4296; Yu, Jin/0000-0002-2990-6602; Cupples, L. Adrienne/0000-0003-0273-7965; Clark, Andrew/0000-0001-7159-8511	NHLBI [N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-45133, HHSN268201200036C, HL080295, HL08762, HL105756 N01-HC-2519552];  [HHSN268201100005C];  [HHSN268201100006C];  [HHSN268201100009C];  [HHSN268201100008C];  [HHSN268201100007C];  [HHSN268201100010C];  [HHSN268201100011C];  [HHSN268201100012C]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC085083, N01HC085081, N01HC025195, N01HC045133, N01HC085086, N01HC085080, N01HC055222, N01HC085085, N01HC035129, N01HC085082, N01HC015103, N01HC085084, N01HC075150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, R01HL080295, U01HL080295, ZIAHL006170, R01HL087652] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108805] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C, NHLBI contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HHSN268201200036C and HL080295, HL087652, HL105756 N01-HC-25195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. grants	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Cann HM, 2002, SCIENCE, V296, P261; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gazave E, 2014, P NATL ACAD SCI USA, V111, P757, DOI 10.1073/pnas.1310398110; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gravel S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004023; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Liu XM, 2012, METHODS ECOL EVOL, V3, P624, DOI 10.1111/j.2041-210X.2012.00194.x; Liu XM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S24; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; Myers SR, 2003, GENETICS, V163, P375; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Stenson Peter D, 2009, Hum Genomics, V4, P69; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang K, 2010, NUCL ACIDS RES, V38; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Y, 2013, GENOME RES; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	62	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121644	10.1371/journal.pone.0121644	http://dx.doi.org/10.1371/journal.pone.0121644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807536	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000170
J	Yu, SJ; Liao, EC; She, ML; Chang, DTM; Tsai, JJ				Yu, Sheng-Jie; Liao, En-Chih; She, Meei-Ling; Chang, Dah-Tsyr Margaret; Tsai, Jaw-Ji			Cell-Penetrating Peptide Derived from Human Eosinophil Cationic Protein Inhibits Mite Allergen Der p 2 Induced Inflammasome Activation	PLOS ONE			English	Article							DUST-MITE; AIRWAYS DISEASE; CUTTING EDGE; ASTHMA; RECOGNITION; RECOMBINANT; IL-1-BETA; MEMBRANE; RELEASE	Newly discovered cell penetration peptides derived from human eosinophil cationic proteins (CPPecp) have the characteristic of cell internalization, but the effect of CPPecp on immunomodulation has not been clarified. House dust mite (HDM) major allergen, Der p 2, can induce proinflammatory cytokine production which contributes to airway inflammation and allergic asthma. However, the mechanism of Der p 2 on NLRP3 inflammasome activation remains unclear. The aim of this study was to investigate the immunomodulatory effect of CPPecp on inhibition of Der p 2 induced inflammasome activation. We showed that proinflammatory cytokines IL-1 beta, IL-6 and IL-8 were significantly upregulated in peripheral blood mononuclear cells (PBMCs) derived from HDM allergic patients after Der p 2 stimulation. Expression of NLRP3, ASC, Caspase-1, IL-1 beta and Caspase-1 activity was upregulated in THP-1 cells after Der p 2 stimulation. Proinflammatory cytokine production, NLRP3 inflammasome activation and caspase-1 activity were downregulated in THP-1 cells and CD14+ cells co-cultured with Der p 2 and CPPecp. The immunomodulatory effect of CPPecp was through upregulation of IFN-alpha production but not induction of autophagy. These results suggested Der p 2 plays an important role in NLRP3 inflammasome activation and CPPecp has the potential to be a novel anti-inflammatory agent for allergic inflammation treatment in the future.	[Yu, Sheng-Jie; She, Meei-Ling; Tsai, Jaw-Ji] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Yu, Sheng-Jie; Liao, En-Chih; She, Meei-Ling] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Liao, En-Chih] Da Yeh Univ, Dept BioInd Technol, Changhua, Taiwan; [Liao, En-Chih] Jen Ten Coll Med, Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Chang, Dah-Tsyr Margaret] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Tsai, Jaw-Ji] Taichung Vet Gen Hosp, Sect Allergy Immunol & Rheumatol, Dept Internal Med, Taichung, Taiwan; [Tsai, Jaw-Ji] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan	National Chung Hsing University; Taichung Veterans General Hospital; Da Yeh University; National Tsing Hua University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Tsai, JJ (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.	jawji@vghtc.gov.tw	Sheu, Meei-Ling/AAT-3401-2020; Yu, Sheng-Jie/K-7631-2019	Sheu, Meei-Ling/0000-0002-0431-1282; 	Taichung Veterans General Hospital, University System of Taiwan [TCVGH-101G624, TCVGH-103G623]	Taichung Veterans General Hospital, University System of Taiwan	This work was supported by a grant from Taichung Veterans General Hospital, University System of Taiwan (TCVGH-101G624, TCVGH-103G623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042; Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006; Broz Petr, 2013, Methods Mol Biol, V1040, P65, DOI 10.1007/978-1-62703-523-1_6; Chan LLY, 2012, AUTOPHAGY, V8, P1371, DOI 10.4161/auto.21028; Chen G, 2010, SENSORS-BASEL, V10, P97, DOI 10.3390/s100100097; Chen KW, 2008, MOL IMMUNOL, V45, P2486, DOI 10.1016/j.molimm.2008.01.006; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Fang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057318; Feng M, 2012, BIOSCI TRENDS, V6, P7, DOI 10.5582/bst.2012.v6.1.7; Fu LS, 2013, INT J IMMUNOPATH PH, V26, P349, DOI 10.1177/039463201302600208; Garden FL, 2013, CLIN EXP ALLERGY, V43, P633, DOI 10.1111/cea.12095; Georgy Mary S, 2012, Allergy Asthma Proc, V33 Suppl 1, P9, DOI 10.2500/aap.2012.33.3533; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gupta P, 2004, ALLERGY ASTHMA PROC, V25, pS7; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Jacquet A, 2011, TRENDS MOL MED, V17, P604, DOI 10.1016/j.molmed.2011.05.014; Kinyanjui MW, 2008, CAN J PHYSIOL PHARM, V86, P1, DOI [10.1139/Y07-125, 10.1139/y07-125]; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Liu SH, 2010, CELL MOL LIFE SCI, V67, P1465, DOI 10.1007/s00018-009-0255-4; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; McCusker CT, 2007, J IMMUNOL, V179, P2556, DOI 10.4049/jimmunol.179.4.2556; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nasti TH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1111, DOI 10.1111/j.1751-1097.2012.01182.x; Rodgers MA, 2014, ANTIOXID REDOX SIGN, V20, P495, DOI 10.1089/ars.2013.5347; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; Sahoo M, 2011, THESCIENTIFICWORLDJO, V11, P2037, DOI 10.1100/2011/212680; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Torrent M, 2008, BIOCHEMISTRY-US, V47, P3544, DOI 10.1021/bi702065b; Torrent M, 2009, BIOCHEM J, V421, P425, DOI 10.1042/BJ20082330; Triantafilou K, 2013, THORAX, V68, P66, DOI 10.1136/thoraxjnl-2012-202182; Tsai JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023249; Ulrik CS, 1999, AM J RESP CRIT CARE, V160, P40, DOI 10.1164/ajrccm.160.1.9806059; Veeranki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027040; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wu CC, 2009, ANN ALLERG ASTHMA IM, V102, P216, DOI 10.1016/S1081-1206(10)60084-1	40	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121393	10.1371/journal.pone.0121393	http://dx.doi.org/10.1371/journal.pone.0121393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807144	Green Published, gold			2022-12-26	WOS:000351880000150
J	Du, J; Hong, SL; Dong, L; Cheng, B; Lin, L; Zhao, B; Chen, YG; Chen, X				Du, Jun; Hong, Senlian; Dong, Lu; Cheng, Bo; Lin, Liang; Zhao, Bing; Chen, Ye-Guang; Chen, Xing			Dynamic Sialylation in Transforming Growth Factor- (TGF-)-induced Epithelial to Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Cell Signaling; Epithelial-Mesenchymal Transition (EMT); Glycosylation; Sialic Acid; TGF-	TGF-BETA; CANCER-CELLS; ALTERED GLYCOSYLATION; PROTEIN GLYCOSYLATION; PROTEOMIC ANALYSIS; TUMOR-CELLS; SIALIC-ACID; PROGRESSION; GLYCANS; SIALYLTRANSFERASES	Background: Changes in cell surface sialylation have recently been implicated in mediating epithelial-mesenchymal transition (EMT). Results: Cell surface sialylation was first down-regulated but then reverted and up-regulated during EMT, and inhibition of sialylation promoted EMT. Conclusion: Sialylation dynamics plays an important role in regulating EMT. Significance: Sialylation may have important functions in EMT-related diseases. Epithelial-mesenchymal transition (EMT) is a fundamental process in embryonic development and organ formation. Aberrant regulation of EMT often leads to tumor progression. Changes in cell surface sialylation have recently been implicated in mediating EMT. Herein we report the visualization of dynamic changes of sialylation and glycoproteomic analysis of newly synthesized sialylated proteins in EMT by metabolic labeling of sialylated glycans with azides, followed by click labeling with fluorophores or affinity tags. We discovered that sialylation was down-regulated during EMT but then reverted and up-regulated in the mesenchymal state after EMT, accompanied by mRNA expression level changes of genes involved in the sialic acid biosynthesis. Quantitative proteomic analysis identified a list of sialylated proteins whose biosynthesis was dynamically regulated during EMT. Sialylation of cell surface adherent receptor integrin (4) was found to be down-regulated, which may regulate integrin functions during EMT. Furthermore, a global sialylation inhibitor was used to probe the functional role of sialylation during EMT. We found that inhibition of sialylation promoted EMT. Taken together, our findings suggest the important role of sialylation in regulating EMT and imply its possible function in related pathophysiological events, such as cancer metastasis.	[Du, Jun; Zhao, Bing; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Hong, Senlian; Dong, Lu; Cheng, Bo; Lin, Liang; Chen, Xing] Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Coll Chem & Mol Engn,Synthet & Funct, Beijing 100871, Peoples R China; [Hong, Senlian; Dong, Lu; Cheng, Bo; Lin, Liang; Chen, Xing] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Peking University; Peking University	Chen, YG (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn; xingchen@pku.edu.cn	Chen, Ye-Guang/L-6998-2019	Chen, Xing/0000-0002-3058-7370	National Basic Research Program of China (973 Program) [2012CB917303, 2013CB933700, 2011CB943803]; National Natural Science Foundation of China [21172013, 91127034, 31221064, 31330049]; Peking-Tsinghua Center for Life Sciences	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking-Tsinghua Center for Life Sciences	This work was supported by National Basic Research Program of China (973 Program) Grants 2012CB917303 (to X. C.) and 2013CB933700 and 2011CB943803 (to Y.-G. C.) and National Natural Science Foundation of China Grants 21172013 and 91127034 (to X. C.) and 31221064 and 31330049 (to Y.-G. C.).; Supported in part by a postdoctoral fellowship from the Peking-Tsinghua Center for Life Sciences.	Baritaki S, 2009, ONCOGENE, V28, P3573, DOI 10.1038/onc.2009.214; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Guan F, 2010, FASEB J, V24, P4889, DOI 10.1096/fj.10-162107; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Hagiwara S, 2010, ONCOGENE, V29, P2181, DOI 10.1038/onc.2009.506; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karhemo PR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00192; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Macauley MS, 2014, J BIOL CHEM, V289, P35149, DOI 10.1074/jbc.M114.606517; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Latini FRM, 2013, BLOOD CELL MOL DIS, V50, P161, DOI 10.1016/j.bcmd.2012.10.009; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Sawa M, 2006, P NATL ACAD SCI USA, V103, P12371, DOI 10.1073/pnas.0605418103; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Smith BA, 2001, CANCER RES, V61, P1678; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; TAYLORPAPADIMITRIOU J, 1994, TRENDS BIOTECHNOL, V12, P227, DOI 10.1016/0167-7799(94)90121-X; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Xie R, 2014, ANGEW CHEM INT EDIT, V53, P14082, DOI 10.1002/anie.201408442; Xie R, 2012, J AM CHEM SOC, V134, P9914, DOI 10.1021/ja303853y; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zadran S, 2014, P NATL ACAD SCI USA, V111, P13235, DOI 10.1073/pnas.1414714111; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhou Dapeng, 2011, Front Biosci (Schol Ed), V3, P1520	49	43	45	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12000	12013		10.1074/jbc.M115.636969	http://dx.doi.org/10.1074/jbc.M115.636969			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809486	hybrid, Green Published			2022-12-26	WOS:000354388600016
J	Amoras, EDG; Gomes, STM; Freitas, FB; Santana, BB; Ishak, G; de Araujo, MTF; Demachki, S; Conde, SRSD; Ishak, MDO; Ishak, R; Vallinoto, ACR				Graca Amoras, Ednelza da Silva; Monteiro Gomes, Samara Tatielle; Freitas, Felipe Bonfim; Santana, Barbara Brasil; Ishak, Geraldo; Ferreira de Araujo, Marialva Tereza; Demachki, Samia; Souza da Silva Conde, Simone Regina; Guimaraes Ishak, Marluisa de Oliveira; Ishak, Ricardo; Rosario Vallinoto, Antonio Carlos			NGF and P75(NTR) Gene Expression Is Associated with the Hepatic Fibrosis Stage Due to Viral and Non-Viral Causes	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; STELLATE CELLS; C VIRUS; LIVER FIBROSIS; UNDERGO APOPTOSIS; FIBROGENESIS; LEPTIN; PROLIFERATION; MECHANISM; CORE	This study evaluated the relative mRNA expression levels of nerve growth factor (NGF) and the p75 neurothrophin receptor (p75(NTR)) in different histological stages of human liver disease. Fifty-one liver biopsy specimens obtained from patients with hepatitis B virus (n=6), hepatitis C virus (n=28), and non-viral hepatitis - (n=9) and standard histological liver (n=8) as controls (CT) were subjected to qPCR and histopathological exams. Our data revealed a significant difference in the NGF expression levels between the three patient groups and the Control group. p75(NTR) expression levels in the HCV and NVH groups were higher than those observed in the HBV and Control groups. In cases of liver cirrhosis, higher p75(NTR) mRNA expression was observed, whereas NGF was expressed at higher levels in patients with hepatic fibrosis. NGF expression was lower in the F1 liver fibrosis stage, and p75(NTR) receptor expression continuously and proportionately increased compared to the increase in the degree of fibrosis and was significantly higher in livers in fibrosis stages 3 and 4. The hepatic levels of NGF and p75(NTR) were decreased and increased, respectively, relative to the stage of inflammatory activity. A positive correlation between p75(NTR) and NGF gene expression was observed in livers with mild to moderate fibrosis, though not in cases of severe fibrosis and cirrhosis. Conclusion Our results demonstrate that the course of chronic liver disease can be regulated by NGF and p75(NTR), which function by decreasing or inhibiting hepatocyte regeneration and proliferation.	[Graca Amoras, Ednelza da Silva; Monteiro Gomes, Samara Tatielle; Freitas, Felipe Bonfim; Santana, Barbara Brasil; Guimaraes Ishak, Marluisa de Oliveira; Ishak, Ricardo; Rosario Vallinoto, Antonio Carlos] Fed Univ Para, UFPA, Inst Biol Sci, Virol Lab, Belem, Para, Brazil; [Ishak, Geraldo] Fed Univ Para, UFPA, Joao de Barros Barreto Hosp, Belem, Para, Brazil; [Ferreira de Araujo, Marialva Tereza; Demachki, Samia; Souza da Silva Conde, Simone Regina] Fed Univ Para, UFPA, Inst Hlth Sci, Sch Med, Belem, Para, Brazil; [Souza da Silva Conde, Simone Regina] Holy House Mercy Fdn Para Santa Casa Misericordia, Hepatol Outpatient Serv, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Vallinoto, ACR (corresponding author), Fed Univ Para, UFPA, Inst Biol Sci, Virol Lab, Belem, Para, Brazil.	vallinoto@ufpa.br	Vallinoto, Antonio Carlos/AAL-9501-2020; Gomes, Samara Tatielle Monteiro/GVT-9626-2022	Vallinoto, Antonio Carlos/0000-0003-1135-6507; /0000-0001-7079-4844	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq); Dean of Research and Graduate Studies Office (Pro-Reitoria de Pesquisa e Pos-Graduacao-PROPESP/UFPA)	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Dean of Research and Graduate Studies Office (Pro-Reitoria de Pesquisa e Pos-Graduacao-PROPESP/UFPA)	This study was funded by the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq) and by the Dean of Research and Graduate Studies Office (Pro-Reitoria de Pesquisa e Pos-Graduacao-PROPESP/UFPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guirao AA, 2006, ENFERM INFEC MICR CL, V24, P264, DOI 10.1016/S0213-005X(06)73773-9; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; [Anonymous], 2008, BIOESTAT 5 0 APLICAC; Asai K, 2006, LIVER INT, V26, P595, DOI 10.1111/j.1478-3231.2006.01267.x; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Benyon RC, 2000, GUT, V46, P443, DOI 10.1136/gut.46.4.443; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; Gabele E, 2003, FRONT BIOSCI-LANDMRK, V8, pD69, DOI 10.2741/887; Gayotto LC, 2000, GED, V19, P137; GraphPad Software Inc, 2007, PRISM DAT AN SOFTW S; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Ikejima K, 2007, J GASTROEN HEPATOL, V22, pS87, DOI 10.1111/j.1440-1746.2007.04961.x; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701; Leclercq IA, 2002, J HEPATOL, V37, P206, DOI 10.1016/S0168-8278(02)00102-2; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020; London Roslyn M, 2007, Clin Liver Dis, V11, P55, DOI 10.1016/j.cld.2007.02.010; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; MITA E, 1994, BIOCHEM BIOPH RES CO, V204, P468, DOI 10.1006/bbrc.1994.2483; Novo E, 2006, GUT, V55, P1174, DOI 10.1136/gut.2005.082701; Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4; Oakley F, 2009, GASTROENTEROLOGY, V136, P2334, DOI 10.1053/j.gastro.2009.02.081; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; PINZANI M, 1995, PHARMACOL THERAPEUT, V66, P387, DOI 10.1016/0163-7258(94)00072-B; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Ryder SD, 2004, GUT, V53, P451, DOI 10.1136/gut.2003.021691; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Shin JY, 2005, EXP MOL MED, V37, P138, DOI 10.1038/emm.2005.19; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Uyama N, 2002, J HEPATOL, V36, P590, DOI 10.1016/S0168-8278(02)00023-5; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2; Zaman A, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.06.044	41	9	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121754	10.1371/journal.pone.0121754	http://dx.doi.org/10.1371/journal.pone.0121754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816145	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600116
J	Melis, C; Herfindal, I; Dahl, F; Ahlen, PA				Melis, Claudia; Herfindal, Ivar; Dahl, Fredrik; Ahlen, Per-Arne			Individual and Temporal Variation in Habitat Association of an Alien Carnivore at Its Invasion Front	PLOS ONE			English	Article							DOG NYCTEREUTES-PROCYONOIDES; RACCOON DOG; SOUTHERN BRANDENBURG; LOCATION DATA; HOME-RANGE; SPACE USE; SELECTION; DISPERSAL; MORTALITY; DIET	Gathering information on how invasive species utilize the habitat is important, in order to better aim actions to reduce their negative impact. We studied habitat use and selection of 55 GPS-marked raccoon dogs (30 males, 25 females) at their invasion front in Northern Sweden, with particular focus on differences between males and females, between movement states, and between seasons and times of the day. Daily movement pattern was used to classify GPS-locations into dispersing and settled. We focused on both anthropogenic and natural landscape characteristics. Since we did not have any a priori knowledge about the spatial scale of raccoon dog habitat selection, we first assessed how landscape characteristics of random points changed with distance from the GPS-location they were paired to. Because changes in habitat use became less pronounced at approximately 5 km for all variables, we focused on habitat use at two spatial scales: fine (500 m) and coarse (5 km). Habitat selection was strongest at the coarse scale, and reflected the results found for habitat use. Raccoon dogs selected agricultural areas and wetlands, lower altitudes, and shallow slopes, and avoided forests, open natural areas, and areas close to water and roads. There were no differences in habitat selection between males and females, or between movement states. This lack of sexual segregation increases the probability of encountering potential mates during dispersal, and therefore the likelihood for reproduction in new areas. The seasonal and diurnal pattern of habitat use may provide guidance for where and when to aim management efforts.	[Melis, Claudia; Herfindal, Ivar] Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Dept Biol, N-7034 Trondheim, Norway; [Dahl, Fredrik; Ahlen, Per-Arne] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Ahlen, Per-Arne] Swedish Assoc Hunting & Wildlife Management, SE-61191 Nykoping, Sweden	Norwegian University of Science & Technology (NTNU); Swedish University of Agricultural Sciences	Melis, C (corresponding author), Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Dept Biol, N-7034 Trondheim, Norway.	cozyredwolf@hotmail.com	Melis, Claudia/Y-3538-2019; Melis, Claudia/AAK-9267-2020; Herfindal, Ivar/A-4609-2015; Melis, Claudia/B-5411-2009	Melis, Claudia/0000-0001-8315-9129; Herfindal, Ivar/0000-0002-5860-9252; 	Norwegian Environment Agency; Swedish Environmental Protection Agency; LIFE+ [NAT/SE/000344]	Norwegian Environment Agency; Swedish Environmental Protection Agency; LIFE+	The study was funded by the Norwegian Environment Agency www.miljodirektoratet.no, the Swedish Environmental Protection Agency http://www.swedishepa.se/, and LIFE+ http://ec.europa.eu/environment/life/funding/lifeplus.htm (NAT/SE/000344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; [Anonymous], 2013, MAPTOOLS TOOLS READI; [Anonymous], 2014, R LANG ENV STAT COMP; Baltrnaite L, 2006, ACTA ZOOLOGICA LITHU, V16, P46; Bjorneraas K, 2012, OECOLOGIA, V168, P231, DOI 10.1007/s00442-011-2072-3; Bjorneraas K, 2011, WILDLIFE BIOL, V17, P44, DOI 10.2981/10-073; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bowler DE, 2009, J ANIM ECOL, V78, P1234, DOI 10.1111/j.1365-2656.2009.01580.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Coelho CM, 2008, J MAMMAL, V89, P97, DOI 10.1644/06-MAMM-A-383.1; Dahl Fredrik, 2010, Aliens (Auckland), V30, P59; Drygala F, 2008, MAMM BIOL, V73, P371, DOI 10.1016/j.mambio.2007.09.005; Drygala F, 2010, WILDLIFE BIOL, V16, P150, DOI 10.2981/08-076; European Environment Agency, 2007, 172007 EEA; Gerlach G, 2000, CONSERV BIOL, V14, P1066, DOI 10.1046/j.1523-1739.2000.98519.x; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Grignolio S, 2007, J WILDLIFE MANAGE, V71, P713, DOI 10.2193/2005-675; Hanski I., 1999, METAPOPULATION ECOLO; HELLE E, 1993, J MAMMAL, V74, P936, DOI 10.2307/1382432; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kauhala K, 1998, ACTA THERIOL, V43, P301, DOI 10.4098/AT.arch.98-25; KAUHALA K, 1993, J ZOOL, V231, P95, DOI 10.1111/j.1469-7998.1993.tb05355.x; KAUHALA K, 1993, ACTA THERIOL, V38, P139, DOI 10.4098/AT.arch.93-12; Kauhala K, 2001, ECOGRAPHY, V24, P151, DOI 10.1034/j.1600-0587.2001.240205.x; KAUHALA K, 1993, Z SAUGETIERKD, V58, P129; Kauhala K, 2007, MAMM BIOL, V72, P342, DOI 10.1016/j.mambio.2006.10.006; Kauhala K, 2011, CURR ZOOL, V57, P584, DOI 10.1093/czoolo/57.5.584; Kauhala K, 2010, ACTA THERIOL, V55, P231, DOI 10.4098/j.at.0001-7051.040.2009; Kowalczyk R, 2009, ANN ZOOL FENN, V46, P291, DOI 10.5735/086.046.0406; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Lockwood JL, 2007, INVASION ECOLOGY; Manly B.F.J., 2002, RESOURCE SELECTION A; Mazza G, 2014, ETHOL ECOL EVOL, V26, P112, DOI 10.1080/03949370.2013.863225; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Seidler RG, 2012, J ETHOL, V30, P345, DOI 10.1007/s10164-012-0330-4; Selva N, 2003, ECOSCIENCE, V10, P303, DOI 10.1080/11956860.2003.11682778; Sidorovich VE, 2000, Z SAUGETIERKD, V65, P271; Spence CE, 1999, CAN VET J, V40, P118; Sundell J, 2012, J ANIM ECOL, V81, P747, DOI 10.1111/j.1365-2656.2012.01956.x; Sutor A, 2008, EUR J WILDLIFE RES, V54, P321, DOI 10.1007/s10344-007-0153-8; Sutor A, 2014, ACTA THERIOL, V59, P49, DOI 10.1007/s13364-013-0138-9; Sutor A, 2013, FOLIA ZOOL, V62, P235; Sutor A, 2010, ACTA THERIOL, V55, P165, DOI 10.4098/j.at.0001-7051.035.2009; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155; WARD O G, 1990, Mammalian Species, P1, DOI 10.2307/3504213; WEIDEMA IR, 2000, NORD, V13, P1	50	5	6	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122492	10.1371/journal.pone.0122492	http://dx.doi.org/10.1371/journal.pone.0122492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815509	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600184
J	Necela, BM; Crozier, JA; Andorfer, CA; Lewis-Tuffin, L; Kachergus, JM; Geiger, XJ; Kalari, KR; Serie, DJ; Sun, ZF; Aspita, AM; O'Shannessy, DJ; Maltzman, JD; McCullough, AE; Pockaj, BA; Cunliffe, HE; Ballman, KV; Thompson, EA; Perez, EA				Necela, Brian M.; Crozier, Jennifer A.; Andorfer, Cathy A.; Lewis-Tuffin, Laura; Kachergus, Jennifer M.; Geiger, Xochiquetzal J.; Kalari, Krishna R.; Serie, Daniel J.; Sun, Zhifu; Aspita, Alvaro Moreno; O'Shannessy, Daniel J.; Maltzman, Julia D.; McCullough, Ann E.; Pockaj, Barbara A.; Cunliffe, Heather E.; Ballman, Karla V.; Thompson, E. Aubrey; Perez, Edith A.			Folate Receptor-alpha (FOLR1) Expression and Function in Triple Negative Tumors	PLOS ONE			English	Article							EARLY BREAST-CANCER; CLINICAL-IMPLICATIONS; ESTROGEN-RECEPTOR; BINDING-PROTEIN; OVEREXPRESSION; HETEROGENEITY; GENE; TRASTUZUMAB; MODULATION; STRATEGIES	Folate receptor alpha (FOLR1) has been identified as a potential prognostic and therapeutic target in a number of cancers. A correlation has been shown between intense overexpression of FOLR1 in breast tumors and poor prognosis, yet there is limited examination of the distribution of FOLR1 across clinically relevant breast cancer subtypes. To explore this further, we used RNA-seq data from multiple patient cohorts to analyze the distribution of FOLR1 mRNA across breast cancer subtypes comprised of estrogen receptor positive (ER+), human epidermal growth factor receptor positive (HER2+), and triple negative (TNBC) tumors. FOLR1 expression varied within breast tumor subtypes; triple negative/basal tumors were significantly associated with increased expression of FOLR1 mRNA, compared to ER+ and HER2+ tumors. However, subsets of high level FOLR1 expressing tumors were observed in all clinical subtypes. These observations were supported by immunohistochemical analysis of tissue microarrays, with the largest number of 3+ positive tumors and highest H-scores of any subtype represented by triple negatives, and lowest by ER+ tumors. FOLR1 expression did not correlate to common clinicopathological parameters such as tumor stage and nodal status. To delineate the importance of FOLR1 overexpression in triple negative cancers, RNA-interference was used to deplete FOLR1 in overexpressing triple negative cell breast lines. Loss of FOLR1 resulted in growth inhibition, whereas FOLR1 overexpression promoted folate uptake and growth advantage in low folate conditions. Taken together, our data suggests patients with triple negative cancers expressing high FOLR1 expression represent an important population of patients that may benefit from targeted anti-FOLR1 therapy. This may prove particularly helpful for a large number of patients who would typically be classified as triple negative and who to this point have been left without any targeted treatment options.	[Necela, Brian M.; Andorfer, Cathy A.; Lewis-Tuffin, Laura; Kachergus, Jennifer M.; Thompson, E. Aubrey; Perez, Edith A.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Crozier, Jennifer A.; Aspita, Alvaro Moreno] Mayo Clin, Dept Hematol & Oncol, Jacksonville, FL 32224 USA; [Geiger, Xochiquetzal J.] Mayo Clin, Dept Pathol & Lab Med, Jacksonville, FL 32224 USA; [Kalari, Krishna R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Serie, Daniel J.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Sun, Zhifu; Ballman, Karla V.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [O'Shannessy, Daniel J.] Morphotek, Dept Translat Med & Diagnost, Exton, PA USA; [Maltzman, Julia D.] Morphotek, Dept Clin Dev, Exton, PA USA; [McCullough, Ann E.; Pockaj, Barbara A.] Mayo Clin, Dept Lab Med & Pathol, Scottsdale, AZ USA; [Cunliffe, Heather E.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; University of Otago	Thompson, EA (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	thompson.aubrey@mayo.edu		Ballman, Karla/0000-0002-4492-0357; Kalari, Krishna/0000-0001-8944-8378; Sun, Zhifu/0000-0001-8461-7523	Mayo Clinic Cancer Center [P30 CA15083]; Breast Cancer Research Foundation; Florida Bankhead-Coley Research Program; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER	Mayo Clinic Cancer Center; Breast Cancer Research Foundation; Florida Bankhead-Coley Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Breast Cancer Research Foundation, Mayo Clinic Cancer Center (P30 CA15083) and the Florida Bankhead-Coley Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Asmann YW, 2011, NUCL ACIDS RES, V39; Bagnoli M, 2000, ONCOGENE, V19, P4754, DOI 10.1038/sj.onc.1203839; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Evans CO, 2003, CANCER RES, V63, P4218; Fornier M, 2012, BREAST J, V18, P41, DOI 10.1111/j.1524-4741.2011.01175.x; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hartmann LC, 2007, INT J CANCER, V121, P938, DOI 10.1002/ijc.22811; Irshad S, 2011, CURR OPIN ONCOL, V23, P566, DOI 10.1097/CCO.0b013e32834bf8ae; Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712; Kelley KMM, 2003, CANCER RES, V63, P2820; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leamon CP, 2007, INT J CANCER, V121, P1585, DOI 10.1002/ijc.22853; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lin JM, 2013, CANCER BIOL THER, V14, P1032, DOI 10.4161/cbt.26106; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Maurer AH, 2014, J NUCL MED, V55, P701, DOI 10.2967/jnumed.113.133074; Mayer IA, 2014, CLIN CANCER RES, V20, P782, DOI 10.1158/1078-0432.CCR-13-0583; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; O'Shannessy DJ, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-22; O'Shannessy DJ, 2011, ONCOTARGET, V2, P1227; Palmieri FM, 2010, CLIN J ONCOL NURS, V14, P326, DOI 10.1188/10.CJON.326-336; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; ROCHMAN H, 1985, CANCER DETECT PREV, V8, P71; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Siu MKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047201; Sun Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021073; Toffoli G, 1997, INT J CANCER, V74, P193, DOI 10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WEITMAN SD, 1992, CANCER RES, V52, P6708; Zhang Z, 2014, ARCH PATHOL LAB MED, V138, P890, DOI 10.5858/arpa.2013-0309-OA	36	81	81	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122209	10.1371/journal.pone.0122209	http://dx.doi.org/10.1371/journal.pone.0122209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816016	Green Published, gold			2022-12-26	WOS:000352133600155
J	Park, JY; Hiroshima, Y; Lee, JY; Maawy, AA; Hoffman, RM; Bouvet, M				Park, Jeong Youp; Hiroshima, Yukihiko; Lee, Jin Young; Maawy, Ali A.; Hoffman, Robert M.; Bouvet, Michael			MUC1 Selectively Targets Human Pancreatic Cancer in Orthotopic Nude Mouse Models	PLOS ONE			English	Article							FLUORESCENCE-GUIDED SURGERY; REAL-TIME; IMAGING-SYSTEM; OVARIAN-CANCER; LIVE MICE; TUMOR; ANTIBODY; CELLS; SURVIVAL; GROWTH	The goal of this study was to determine whether MUC1 antibody conjugated with a fluorophore could be used to visualize pancreatic cancer. Anti-MUC1 (CT2) antibody was conjugated with 550 nm or 650 nm fluorophores. Nude mouse were used to make subcutaneous and orthotopic models of pancreatic cancer. Western blot and flow cytometric analysis confirmed the expression of MUC1 in human pancreatic cancer cell lines including BxPC-3 and Panc-1. Immunocytochemistry with fluorophore conjugated anti-MUC1 antibody demonstrated fluorescent areas on the membrane of Panc-1 cancer cells. After injecting the conjugated anti-MUC1 antibodies via the tail vein, subcutaneously transplanted Panc-1 and BxPC-3 tumors emitted strong fluorescent signals. In the subcutaneous tumor models, the fluorescent signal from the conjugated anti-MUC1 antibody was noted around the margin of the tumor and space between the cells. The conjugated anti-MUC1 antibody bound the tumor in orthotopically-transplanted Panc-1 and BxPC-3 models enabling the tumors to be imaged. This study showed that fluorophore conjugated anti-MUC1 antibodies could visualize pancreatic tumors in vitro and in vivo and may help to improve the diagnosis and treatment of pancreatic cancer.	[Park, Jeong Youp; Hiroshima, Yukihiko; Maawy, Ali A.; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Park, Jeong Youp; Hiroshima, Yukihiko; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Park, Jeong Youp; Lee, Jin Young] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Hiroshima, Yukihiko] Yokohama City Univ, Grad Sch Med, Dept Surg, Yokohama, Kanagawa 232, Japan; [Bouvet, Michael] VA San Diego Healthcare Syst, Surg Serv, San Diego, CA USA	University of California System; University of California San Diego; Anti Cancer Inc; Yonsei University; Yonsei University Health System; Yokohama City University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Bouvet, M (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	mbouvet@ucsd.edu		Park, Jeong Youp/0000-0003-0110-8606	National Cancer Institute [CA142669, CA132971]; Korea Research Foundation under the basic research promotion fund of the Ministry of Education and Health Resources Development of Korea [20100022990]; NATIONAL CANCER INSTITUTE [R01CA132971, R01CA142669] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Korea Research Foundation under the basic research promotion fund of the Ministry of Education and Health Resources Development of Korea(Ministry of Education (MOE), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Cancer Institute CA142669 and CA132971 (to MB and AntiCancer, Inc.), and a grant from the Korea Research Foundation under the basic research promotion fund of the Ministry of Education and Health Resources Development of Korea 20100022990 (to JYP). The funder provided support in the form of salaries for authors [MB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Bouvet M, 2000, CLIN EXP METASTAS, V18, P213, DOI 10.1023/A:1006767405609; Bouvet M, 2002, CANCER RES, V62, P1534; Bunger S, 2011, J CANCER RES CLIN, V137, P375, DOI 10.1007/s00432-010-0965-x; Chen R, 2005, MOL CELL PROTEOMICS, V4, P523, DOI 10.1074/mcp.R500004-MCP200; Eser S, 2011, P NATL ACAD SCI USA, V108, P9945, DOI 10.1073/pnas.1100890108; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FURUKAWA T, 1993, CANCER RES, V53, P3070; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Gillespie AM, 2000, ANN ONCOL, V11, P735, DOI 10.1023/A:1008349300781; Gold DV, 2006, J CLIN ONCOL, V24, P252, DOI 10.1200/JCO.2005.02.8282; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kumar P., 2012, INT J ENG RES TECHNO, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0042712; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Maawy AA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126016; Medarova Z, 2006, INT J CANCER, V118, P2796, DOI 10.1002/ijc.21672; Metildi CA, 2014, J AM COLL SURGEONS, V219, P132, DOI 10.1016/j.jamcollsurg.2014.02.021; Metildi CA, 2014, ANN SURG ONCOL, V21, P1405, DOI 10.1245/s10434-014-3495-y; Neesse A, 2013, GUT, V62, P1034, DOI 10.1136/gutjnl-2012-302577; Pecher G, 2002, CANCER IMMUNOL IMMUN, V51, P669, DOI 10.1007/s00262-002-0317-z; Pegram MD, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2409; Pichinuk E, 2012, CANCER RES, V72, P3324, DOI 10.1158/0008-5472.CAN-12-0067; Prinssen HM, 1998, CANCER IMMUNOL IMMUN, V47, P39, DOI 10.1007/s002620050502; Qu CF, 2004, BRIT J CANCER, V91, P2086, DOI 10.1038/sj.bjc.6602232; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Uchugonova A, 2013, J CELL BIOCHEM, V114, P99, DOI 10.1002/jcb.24305; Winter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040157; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yamauchi K, 2012, ANTICANCER RES, V32, P39; Yang M, 2007, CANCER RES, V67, P5195, DOI 10.1158/0008-5472.CAN-06-4590	33	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122100	10.1371/journal.pone.0122100	http://dx.doi.org/10.1371/journal.pone.0122100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815753	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600145
J	Tariq, M; Chen, R; Yuan, HY; Liu, YJ; Wu, YA; Wang, JY; Xia, C				Tariq, Mansoor; Chen, Rong; Yuan, Hongyu; Liu, Yanjie; Wu, Yanan; Wang, Junya; Xia, Chun			De Novo Transcriptomic Analysis of Peripheral Blood Lymphocytes from the Chinese Goose: Gene Discovery and Immune System Pathway Description	PLOS ONE			English	Article							MOLECULAR-CLONING; ANSER-CYGNOIDES; TISSUE DISTRIBUTION; FUNCTIONAL-ANALYSIS; HUMAN-COMPLEMENT; CDNA CLONING; C1 COMPLEX; EXPRESSION; SEQUENCES; DATABASE	Background The Chinese goose is one of the most economically important poultry birds and is a natural reservoir for many avian viruses. However, the nature and regulation of the innate and adaptive immune systems of this waterfowl species are not completely understood due to limited information on the goose genome. Recently, transcriptome sequencing technology was applied in the genomic studies focused on novel gene discovery. Thus, this study described the transcriptome of the goose peripheral blood lymphocytes to identify immunity relevant genes. Principal Findings De novo transcriptome assembly of the goose peripheral blood lymphocytes was sequenced by Illumina-Solexa technology. In total, 211,198 unigenes were assembled from the 69.36 million cleaned reads. The average length, N50 size and the maximum length of the assembled unigenes were 687 bp, 1,298 bp and 18,992 bp, respectively. A total of 36,854 unigenes showed similarity by BLAST search against the NCBI non-redundant (Nr) protein database. For functional classification, 163,161 unigenes were comprised of three Gene Ontology (Go) categories and 67 subcategories. A total of 15,334 unigenes were annotated into 25 eukaryotic orthologous groups (KOGs) categories. Kyoto Encyclopedia of Genes and Genomes (KEGG) database annotated 39,585 unigenes into six biological functional groups and 308 pathways. Among the 2,757 unigenes that participated in the 15 immune system KEGG pathways, 125 of the most important immune relevant genes were summarized and analyzed by STRING analysis to identify gene interactions and relationships. Moreover, 10 genes were confirmed by PCR and analyzed. Of these 125 unigenes, 109 unigenes, approximately 87%, were not previously identified in the goose. Conclusion This de novo transcriptome analysis could provide important Chinese goose sequence information and highlights the value of new gene discovery, pathways investigation and immune system gene identification, and comparison with other avian species as useful tools to understand the goose immune system.	[Tariq, Mansoor; Chen, Rong; Yuan, Hongyu; Liu, Yanjie; Wu, Yanan; Wang, Junya; Xia, Chun] China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing, Peoples R China; [Tariq, Mansoor] Sindh Agr Univ, Fac Anim Husb & Vet Sci, Dept Vet Pathol, Tandojam, Sindh, Pakistan; [Xia, Chun] Minist Agr China, Key Lab Zoonosis, Beijing, Peoples R China	China Agricultural University; Sindh Agricultural University; Ministry of Agriculture & Rural Affairs	Xia, C (corresponding author), China Agr Univ, Coll Vet Med, Dept Microbiol & Immunol, Beijing, Peoples R China.	xiachun@cau.edu.cn	Tariq, Mansoor/AHB-9145-2022	Tariq, Mansoor/0000-0001-5708-2834; Xia, Chun/0000-0002-3444-0624	state key program of the National Natural Science Foundation of China [31230074]; 973 Project of the China Ministry of Science and Technology [2013CB835302]	state key program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project of the China Ministry of Science and Technology	This work was funded by the state key program of the National Natural Science Foundation of China (Grant No. 31230074) and the 973 Project of the China Ministry of Science and Technology (Grant No. 2013CB835302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis Z, 2013, VET PATHOL, V50, P638, DOI 10.1177/0300985812467470; Bally I, 2013, P NATL ACAD SCI USA, V110, P8650, DOI 10.1073/pnas.1304894110; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Brier S, 2010, J BIOL CHEM, V285, P32251, DOI 10.1074/jbc.M110.149112; Che RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087940; Dan WB, 2007, VET IMMUNOL IMMUNOP, V118, P113, DOI 10.1016/j.vetimm.2007.03.012; Ding N, 2014, ANIM SCI J, V85, P650, DOI 10.1111/asj.12197; Fang Q, 2012, MOL IMMUNOL, V52, P117, DOI 10.1016/j.molimm.2012.05.005; Girija UV, 2013, P NATL ACAD SCI USA, V110, P13916, DOI 10.1073/pnas.1311113110; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kishore W, 2004, IMMUNOL LETT, V95, P113, DOI 10.1016/j.imlet.2004.06.015; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li CJ, 2011, BRIT POULTRY SCI, V52, P318, DOI 10.1080/00071668.2011.581270; Li HT, 2007, VET IMMUNOL IMMUNOP, V117, P67, DOI 10.1016/j.vetimm.2007.01.009; Luan XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113211; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; REID KBM, 1979, BIOCHEM J, V179, P367, DOI 10.1042/bj1790367; Roest Crollius H, 2005, GENOME RES, V15, P1675, DOI 10.1101/gr.3735805; Scott TR, 2004, POULTRY SCI, V83, P574, DOI 10.1093/ps/83.4.574; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang F, 2012, BRIT POULTRY SCI, V53, P741, DOI 10.1080/00071668.2012.746639; Wei S, 2013, RES VET SCI; Xia C, 2005, VET IMMUNOL IMMUNOP, V107, P291, DOI 10.1016/j.vetimm.2005.05.005; Xu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055496; Yan XL, 2013, GENE, V519, P298, DOI 10.1016/j.gene.2013.02.007; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao QR, 2013, GENE, V529, P332, DOI 10.1016/j.gene.2013.07.104; Zhou JY, 2005, CYTOKINE, V30, P328, DOI 10.1016/j.cyto.2004.12.015	35	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121015	10.1371/journal.pone.0121015	http://dx.doi.org/10.1371/journal.pone.0121015			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816068	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600059
J	Wang, J; Xiang, B; Lin, HY; Liu, HY; Freed, D; Arora, RC; Tian, GH				Wang, Jian; Xiang, Bo; Lin, Hung Yu; Liu, Hongyu; Freed, Darren; Arora, Rakesh C.; Tian, Ganghong			Differential MR Delayed Enhancement Patterns of Chronic Myocardial Infarction between Extracellular and Intravascular Contrast Media	PLOS ONE			English	Article							MICROVASCULAR OBSTRUCTION; DISTRIBUTION VOLUME; TIME-COURSE; PERFUSION; CINE; REPRODUCIBILITY; AGENT; VIABILITY; INJURY; CANINE	Objectives Because the distribution volume and mechanism of extracellular and intravascular MR contrast media differ considerably, the enhancement pattern of chronic myocardial infarction with extracellular or intravascular media might also be different. This study aims to investigate the differences in MR enhancement patterns of chronic myocardial infarction between extracellular and intravascular contrast media. Materials and Methods Twenty pigs with myocardial infarction underwent cine MRI, first pass perfusion MRI and delayed enhancement MRI with extracellular or intravascular media at four weeks after coronary occlusion. Myocardial blood flow (MBF) was determined with microsphere measurement. The infarction histopathological changes were evaluated by hematoxylin and eosin staining and Masson's trichrome method. Results Cine MRI revealed the reduced wall thickening in chronic infarction compared with normal myocardium. Moreover, significant wall thinning in chronic infarction was observed in cine MRI. Peak first-pass signal intensity didn't significantly differ between chronic infarction and normal myocardium no matter what kinds of contrast media. At the following delayed enhancement phase, extracellular media-enhanced signal intensity was significantly higher in chronic infarction than in normal myocardium. Conversely, intravascular media-enhanced signal intensity was almost equivalent among chronic infarction and normal myocardium. At four weeks after infarction, MBF in chronic infarction approached to that in normal myocardium. Large thick-walled vessels were detected at peri-infarction zones. The cardiomyocytes were replaced by scar tissue consisting of dilated blood vessels and discrete fibers of collagen. Conclusions Chronic infarction was characterized by the significantly reduced wall thickening and the definite wall thinning. First-pass myocardial perfusion defect was not detected in chronic infarction with two media due to the significantly recovered MBF and well-developed collateral vessels. Infarction remodeling enlarged the extracellular compartment, which was available for extracellular media but not accessible to intravascular media. Extracellular media identified chronic infarction as the hyper-enhancement; nonetheless, intravascular media didn't provide delayed enhancement.	[Wang, Jian] Huazhong Univ Sci & Technol, Dept Vasc Surg, Union Hosp, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Wang, Jian; Xiang, Bo; Lin, Hung Yu; Freed, Darren; Arora, Rakesh C.; Tian, Ganghong] Natl Res Council Canada, Winnipeg, MB R3B 1Y6, Canada; [Wang, Jian; Xiang, Bo; Freed, Darren; Arora, Rakesh C.; Tian, Ganghong] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R3E 3P5, Canada; [Liu, Hongyu] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiac Surg, Harbin 150081, Heilongjiang, Peoples R China; [Freed, Darren] St Boniface Gen Hosp, Cardiac Sci Program, Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada	Huazhong University of Science & Technology; National Research Council Canada; University of Manitoba; Harbin Medical University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Wang, J (corresponding author), Huazhong Univ Sci & Technol, Dept Vasc Surg, Union Hosp, Tongji Med Coll, 1277 Jiefang St, Wuhan 430022, Hubei, Peoples R China.	jianwang1030@126.com		Freed, Darren/0000-0002-6239-1444	National Natural Sciences Foundation of China [81200105]; China Postdoctoral Science Foundation [20100470050]; Canadian Institute of Health Research (CIHR); National Research Council of Canada (NRC)	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Research Council of Canada (NRC)	This study was supported by the National Natural Sciences Foundation of China (No. 81200105), the China Postdoctoral Science Foundation funded Project (No. 20100470050), Canadian Institute of Health Research (CIHR), and National Research Council of Canada (NRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSIO G, 1989, CIRCULATION, V80, P1846, DOI 10.1161/01.CIR.80.6.1846; Arheden H, 2000, RADIOLOGY, V215, P520, DOI 10.1148/radiology.215.2.r00ma38520; BAER FM, 1992, AM HEART J, V123, P636; Bremerich J, 1998, J AM COLL CARDIOL, V32, P787, DOI 10.1016/S0735-1097(98)00315-5; Bulow H, 2005, HEART, V91, P1158, DOI 10.1136/hrt.2004.045609; Choi SI, 2000, JMRI-J MAGN RESON IM, V11, P476, DOI 10.1002/(SICI)1522-2586(200005)11:5<476::AID-JMRI2>3.0.CO;2-5; Dobaczewski M, 2006, CELL TISSUE RES, V324, P475, DOI 10.1007/s00441-005-0144-6; Kramer MF, 1998, CELL TISSUE RES, V291, P97; Krittayaphong R, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-41; Kroft LJM, 1999, JMRI-J MAGN RESON IM, V10, P170; Morales C, 2002, CARDIOVASC PATHOL, V11, P339, DOI 10.1016/S1054-8807(02)00115-1; Nahrendorf M, 2000, J CARDIOV MAGN RESON, V2, P171, DOI 10.3109/10976640009146565; Nahrendorf M, 2001, J MAGN RESON IMAGING, V14, P547, DOI 10.1002/jmri.1218; PATTYNAMA PMT, 1993, RADIOLOGY, V187, P261, DOI 10.1148/radiology.187.1.8451425; Port M, 2001, INVEST RADIOL, V36, P445, DOI 10.1097/00004424-200108000-00002; Ramani K, 1998, CIRCULATION, V98, P2687, DOI 10.1161/01.CIR.98.24.2687; Rehwald WG, 2002, CIRCULATION, V105, P224, DOI 10.1161/hc0202.102016; Rochitte CE, 1998, CIRCULATION, V98, P1006, DOI 10.1161/01.CIR.98.10.1006; ROTH DM, 1987, AM J PHYSIOL, V253, pH1279, DOI 10.1152/ajpheart.1987.253.5.H1279; Saeed M, 1998, JMRI-J MAGN RESON IM, V8, P561, DOI 10.1002/jmri.1880080308; SEMELKA RC, 1990, RADIOLOGY, V174, P763, DOI 10.1148/radiology.174.3.2305059; Thomson LEJ, 2004, J MAGN RESON IMAGING, V19, P771, DOI 10.1002/jmri.20075; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; TONG CY, 1993, MAGNET RESON MED, V30, P337, DOI 10.1002/mrm.1910300310; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; Wang J, 2008, ACTA PHARMACOL SIN, V29, P65, DOI 10.1111/j.1745-7254.2008.00656.x; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096463; WEINMANN HJ, 1984, AM J ROENTGENOL, V142, P619, DOI 10.2214/ajr.142.3.619; WHITE FC, 1992, CIRC RES, V71, P1490, DOI 10.1161/01.RES.71.6.1490; Wilke N, 1997, RADIOLOGY, V204, P373, DOI 10.1148/radiology.204.2.9240523; Yang YS, 2012, QUANT IMAGING MED SU, V2, P12, DOI 10.3978/j.issn.2223-4292.2011.12.02	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121326	10.1371/journal.pone.0121326	http://dx.doi.org/10.1371/journal.pone.0121326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816056	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600083
J	Zhang, ZC; Tian, H; Lv, P; Wang, WP; Jia, ZQ; Wang, SN; Zhou, CY; Gao, XJ				Zhang, Zhichun; Tian, Hua; Lv, Ping; Wang, Weiping; Jia, Zhuqing; Wang, Sainan; Zhou, Chunyan; Gao, Xuejun			Transcriptional Factor DLX3 Promotes the Gene Expression of Enamel Matrix Proteins during Amelogenesis	PLOS ONE			English	Article							DIFFERENTIATION; IMPERFECTA; MUTATION; DELETION; CELLS; HOMEOPROTEINS; PHENOTYPE; LINEAGE; MURINE	Mutation of distal-less homeobox 3 (DLX3) is responsible for human tricho-dento-osseous syndrome (TDO) with amelogenesis imperfecta, indicating a crucial role of DLX3 in amelogenesis. However, the expression pattern of DLX3 and its specific function in amelogenesis remain largely unknown. The aim of this study was to investigate the effects of DLX3 on enamel matrix protein (EMP) genes. By immunohistochemistry assays of mouse tooth germs, stronger immunostaining of DLX3 protein was identified in ameloblasts in the secretory stage than in the pre-secretory and maturation stages, and the same pattern was found for Dlx3 mRNA using Realtime PCR. In a mouse ameloblast cell lineage, forced expression of DLX3 up-regulated the expression of the EMP genes Amelx, Enam, Klk4, and Odam, whereas knockdown of DLX3 down-regulated these four EMP genes. Further, bioinformatics, chromatin immunoprecipitation, and luciferase assays revealed that DLX3 transactivated Enam, Amelx, and Odam through direct binding to their enhancer regions. Particularly, over-expression of mutant-DLX3 (c.571_574delGGGG, responsible for TDO) inhibited the activation function of DLX3 on expression levels and promoter activities of the Enam, Amelx, and Odam genes. Together, our data show that DLX3 promotes the expression of the EMP genes Amelx, Enam, Klk4, and Odam in amelogenesis, while mutant-DLX3 disrupts this regulatory function, thus providing insights into the molecular mechanisms underlying the enamel defects of TDO disease.	[Zhang, Zhichun; Tian, Hua; Lv, Ping; Wang, Sainan; Gao, Xuejun] Peking Univ, Sch & Hosp Stomatol, Dept Cariol & Endodontol, Beijing 100871, Peoples R China; [Wang, Weiping; Jia, Zhuqing; Zhou, Chunyan] Peking Univ, Dept Biochem & Mol Biol, Sch Basic Med Sci, Beijing 100871, Peoples R China	Peking University; Peking University	Tian, H (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Cariol & Endodontol, Beijing 100871, Peoples R China.	hua_tian@bjmu.edu.cn; chunyanzhou@bjmu.edu.cn			National Natural Science Foundation of China [NSFC 81300839]; Specialized Research Fund for the Doctoral Program of Higher Education [20130001120109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by National Natural Science Foundation of China (NSFC 81300839) (http://www.nsfc.gov.cn/); Specialized Research Fund for the Doctoral Program of Higher Education (20130001120109) (http://www.cutech.edu.cn/cn/index.htm). The funders above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Batayneh OB, 2012, INT J DENT, V2012, DOI 10.1155/2012/514692; Bartlett John D, 2013, ISRN Dent, V2013, P684607, DOI 10.1155/2013/684607; Beanan MJ, 2000, DEV DYNAM, V218, P545, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1026>3.0.CO;2-B; Bei M, 2009, J EXP ZOOL PART B, V312B, P437, DOI 10.1002/jez.b.21261; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Choi SJ, 2010, DEV BIOL, V344, P682, DOI 10.1016/j.ydbio.2010.05.499; Choi SJ, 2008, BONE, V42, P162, DOI 10.1016/j.bone.2007.08.047; Duverger O, 2008, J CELL PHYSIOL, V216, P337, DOI 10.1002/jcp.21491; Duverger O, 2008, J BIOL CHEM, V283, P20198, DOI 10.1074/jbc.M709562200; Duverger O, 2012, J BIOL CHEM, V287, P12230, DOI 10.1074/jbc.M111.326900; Ghoul-Mazgar S, 2005, BONE, V37, P799, DOI 10.1016/j.bone.2005.03.020; Gibson CW, 2011, J ORAL BIOSCI, V53, P248, DOI 10.2330/joralbiosci.53.248; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hu JCC, 2007, ORTHOD CRANIOFAC RES, V10, P45, DOI 10.1111/j.1601-6343.2007.00384.x; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Hu JCC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089303; Hu JCC, 2003, CRIT REV ORAL BIOL M, V14, P387, DOI 10.1177/154411130301400602; Hu YY, 2008, EUR J ORAL SCI, V116, P113, DOI 10.1111/j.1600-0722.2007.00519.x; Hu YY, 2011, EUR J ORAL SCI, V119, P217, DOI 10.1111/j.1600-0722.2011.00859.x; Lechguer AN, 2009, J EXP ZOOL PART B, V312B, P399, DOI 10.1002/jez.b.21256; Lee HK, 2012, GENE EXPR PATTERNS, V12, P102, DOI 10.1016/j.gep.2012.02.002; Lezot F, 2008, J CELL PHYSIOL, V216, P688, DOI 10.1002/jcp.21448; Li XY, 2012, J ENDODONT, V38, P1504, DOI 10.1016/j.joen.2012.07.009; Lv P, 2006, EUR J ORAL SCI, V114, P93, DOI 10.1111/j.1600-0722.2006.00270.x; Miletich I, 2003, HUM MOL GENET, V12, pR69, DOI 10.1093/hmg/ddg085; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nieminen P, 2011, CELLS TISSUES ORGANS, V194, P49, DOI 10.1159/000322561; Poulter JA, 2014, HUM MOL GENET, V23, P5317, DOI 10.1093/hmg/ddu247; Price JA, 1998, HUM MOL GENET, V7, P563, DOI 10.1093/hmg/7.3.563; Tian H, 2010, BIOCHEM BIOPH RES CO, V398, P519, DOI 10.1016/j.bbrc.2010.06.111; Viale-Bouroncle S, 2012, STEM CELLS DEV, V21, P1936, DOI 10.1089/scd.2011.0422; Wright JT, 2006, EUR J ORAL SCI, V114, P13, DOI 10.1111/j.1600-0722.2006.00291.x; Wright JT, 2011, CELLS TISSUES ORGANS, V194, P279, DOI 10.1159/000324339; Wright JT, 2003, CONNECT TISSUE RES, V44, P72, DOI 10.1080/03008200390152124; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhao ZY, 2000, DEV GENES EVOL, V210, P270, DOI 10.1007/s004270050314	37	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121288	10.1371/journal.pone.0121288	http://dx.doi.org/10.1371/journal.pone.0121288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815730	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600081
J	Lebel, K; Boissy, P; Hamel, M; Duval, C				Lebel, Karina; Boissy, Patrick; Hamel, Mathieu; Duval, Christian			Inertial Measures of Motion for Clinical Biomechanics: Comparative Assessment of Accuracy under Controlled Conditions - Changes in Accuracy over Time	PLOS ONE			English	Article							KNEE ARTHROPLASTY	Background Interest in 3D inertial motion tracking devices (AHRS) has been growing rapidly among the biomechanical community. Although the convenience of such tracking devices seems to open a whole new world of possibilities for evaluation in clinical biomechanics, its limitations haven't been extensively documented. The objectives of this study are: 1) to assess the change in absolute and relative accuracy of multiple units of 3 commercially available AHRS over time; and 2) to identify different sources of errors affecting AHRS accuracy and to document how they may affect the measurements over time. Methods This study used an instrumented Gimbal table on which AHRS modules were carefully attached and put through a series of velocity-controlled sustained motions including 2 minutes motion trials (2MT) and 12 minutes multiple dynamic phases motion trials (12MDP). Absolute accuracy was assessed by comparison of the AHRS orientation measurements to those of an optical gold standard. Relative accuracy was evaluated using the variation in relative orientation between modules during the trials. Findings Both absolute and relative accuracy decreased over time during 2MT. 12MDP trials showed a significant decrease in accuracy over multiple phases, but accuracy could be enhanced significantly by resetting the reference point and/or compensating for initial Inertial frame estimation reference for each phase. Interpretation The variation in AHRS accuracy observed between the different systems and with time can be attributed in part to the dynamic estimation error, but also and foremost, to the ability of AHRS units to locate the same Inertial frame. Conclusions Mean accuracies obtained under the Gimbal table sustained conditions of motion suggest that AHRS are promising tools for clinical mobility assessment under constrained conditions of use. However, improvement in magnetic compensation and alignment between AHRS modules are desirable in order for AHRS to reach their full potential in capturing clinical outcomes. Conclusions Mean accuracies obtained under the Gimbal table sustained conditions of motion suggest that AHRS are promising tools for clinical mobility assessment under constrained conditions of use. However, improvement in magnetic compensation and alignment between AHRS modules are desirable in order for AHRS to reach their full potential in capturing clinical outcomes.	[Lebel, Karina; Boissy, Patrick] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Surg, Orthoped Serv, Sherbrooke, PQ J1K 2R1, Canada; [Lebel, Karina; Boissy, Patrick; Hamel, Mathieu] Res Ctr Aging, Sherbrooke, PQ, Canada; [Lebel, Karina; Boissy, Patrick] Univ Sherbrooke, Interdisciplinary Inst Technol Innovat 3IT, Sherbrooke, PQ J1K 2R1, Canada; [Duval, Christian] Univ Quebec, Dept Kinesiol, Montreal, PQ H3C 3P8, Canada; [Duval, Christian] Univ Geriatrie Montreal, Ctr Rech Inst, Montreal, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Quebec; University of Quebec Montreal; Universite de Montreal	Boissy, P (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Surg, Orthoped Serv, Sherbrooke, PQ J1K 2R1, Canada.	patrick.boissy@usherbrooke.ca	Boissy, Patrick/F-7068-2016	Boissy, Patrick/0000-0001-6582-4519	Canadian Institutes for Health Research (CIHR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by a grant from the Canadian Institutes for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan A, 2011, GAIT POSTURE, V34, P320, DOI 10.1016/j.gaitpost.2011.05.018; BURDETT RG, 1986, PHYS THER, V66, P677, DOI 10.1093/ptj/66.5.677; Cutti Andrea Giovanni, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5912; Edwards JZ, 2004, J ARTHROPLASTY, V19, P369, DOI 10.1016/j.arth.2003.12.001; Lebel K, 2014, INT C BIOM EL DEV AN; Lebel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079945; Miner AL, 2003, J ARTHROPLASTY, V18, P286, DOI 10.1054/arth.2003.50046; Picerno P, 2011, GAIT POSTURE, V33, P373, DOI 10.1016/j.gaitpost.2010.12.006; Piriyaprasarth P, 2007, KNEE, V14, P2, DOI 10.1016/j.knee.2006.10.006; Saidu Ismaila Adamu, 2011, J Midlife Health, V2, P65, DOI 10.4103/0976-7800.92526; Schmitz A, 2014, J BIOMECH, V47, P587, DOI 10.1016/j.jbiomech.2013.11.031	11	42	42	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0118361	10.1371/journal.pone.0118361	http://dx.doi.org/10.1371/journal.pone.0118361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811838	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700005
J	Mendlovic, F; Cruz-Rivera, M; Avila, G; Vaughan, G; Flisser, A				Mendlovic, Fela; Cruz-Rivera, Mayra; Avila, Guillermina; Vaughan, Gilberto; Flisser, Ana			Cytokine, Antibody and Proliferative Cellular Responses Elicited by Taenia solium Calreticulin upon Experimental Infection in Hamsters	PLOS ONE			English	Article							IMMUNE-RESPONSE; HELMINTH INFECTIONS; INTESTINAL-MUCOSA; T-CELLS; B-CELLS; MECHANISMS; EXPRESSION; HOST; NEUROCYSTICERCOSIS; CYSTICERCOSIS	Taenia solium causes two diseases in humans, cysticercosis and taeniosis. Tapeworm carriers are the main risk factor for neurocysticercosis. Limited information is available about the immune response elicited by the adult parasite, particularly the induction of Th2 responses, frequently associated to helminth infections. Calreticulin is a ubiquitous, multifunctional protein involved in cellular calcium homeostasis, which has been suggested to play a role in the regulation of immune responses. In this work, we assessed the effect of recombinant T. solium calreticulin (rTsCRT) on the cytokine, humoral and cellular responses upon experimental infection in Syrian Golden hamsters (Mesocricetus auratus). Animals were infected with T. solium cysticerci and euthanized at different times after infection. Specific serum antibodies, proliferative responses in mesenteric lymph nodes and spleen cells, as well as cytokines messenger RNA (mRNA) were analyzed. The results showed that one third of the infected animals elicited anti-rTsCRT IgG antibodies. Interestingly, mesenteric lymph node (MLN) cells from either infected or non-infected animals did not proliferate upon in vitro stimulation with rTsCRT. Additionally, stimulation with a tapeworm crude extract resulted in increased expression of IL-4 and IL-5 mRNA. Upon stimulation, rTsCRT increased the expression levels of IL-10 in spleen and MLN cells from uninfected and infected hamsters. The results showed that rTsCRT favors a Th2-biased immune response characterized by the induction of IL-10 in mucosal and systemic lymphoid organs. Here we provide the first data on the cytokine, antibody and cellular responses to rTsCRT upon in vitro stimulation during taeniasis.	[Mendlovic, Fela; Cruz-Rivera, Mayra; Avila, Guillermina; Flisser, Ana] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Mendlovic, Fela] Univ Anahuac, Fac Ciencias Salud, Mexico City 52786, DF, Mexico; [Vaughan, Gilberto] AV BioSci, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Anahuac	Flisser, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Av Univ 3000, Mexico City 04510, DF, Mexico.	flisser@unam.mx		Avila, Guillermina/0000-0003-1607-3741; Flisser, Ana/0000-0002-1744-8480	AV BioSciences	AV BioSciences	AV BioSciences provided support in the form of salary for GV at the time of consultancy, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen JE, 1996, INT ARCH ALLERGY IMM, V109, P3, DOI 10.1159/000237225; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Avila G, 2003, PARASITOL RES, V89, P284, DOI 10.1007/s00436-002-0605-8; Avila G, 2002, INT J PARASITOL, V32, P1301, DOI 10.1016/S0020-7519(02)00124-8; Avila G, 2008, ANN NY ACAD SCI, V1149, P170, DOI 10.1196/annals.1428.079; Balic A, 2006, INT IMMUNOL, V18, P1421, DOI 10.1093/intimm/dxl075; Bancroft AJ, 1998, CHEM IMMUNOL, V71, P192; de Meis J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00216; de Meis J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000417; El Gengehi N, 2000, J PARASITOL, V86, P993, DOI 10.1645/0022-3395(2000)086[0993:ASMKBI]2.0.CO;2; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Espitia CM, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-31; Figueiredo CA, 2010, INFECT IMMUN, V78, P3160, DOI 10.1128/IAI.01228-09; Flisser A, 2003, ACTA TROP, V87, P43, DOI 10.1016/S0001-706X(03)00054-8; Flisser A, 2010, PARASITOLOGY, V137, P347, DOI 10.1017/S0031182010000272; Fonseca-Coronado S, 2011, EXP PARASITOL, V127, P313, DOI 10.1016/j.exppara.2010.07.017; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Hernandez JLR, 2013, INT J PARASITOL, V43, P233, DOI 10.1016/j.ijpara.2012.09.005; Leon-Cabrera S, 2012, EXP PARASITOL, V132, P334, DOI 10.1016/j.exppara.2012.08.006; Leon-Cabrera S, 2009, METHODS, V49, P346, DOI 10.1016/j.ymeth.2009.07.007; Liu Q, 2007, J IMMUNOL, V179, P3821, DOI 10.4049/jimmunol.179.6.3821; Loukas A, 2001, CLIN MICROBIOL REV, V14, P689, DOI 10.1128/CMR.14.4.689-703.2001; Mann ER, 2014, WORLD J GASTROENTERO, V20, P9653, DOI 10.3748/wjg.v20.i29.9653; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Mendlovic F, 2004, J PARASITOL, V90, P891, DOI 10.1645/GE-3325RN; Mendlovic F, 2006, J PARASITOL, V92, P789, DOI 10.1645/GE-724R1.1; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Nagaraj SH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000301; Olatunde B O, 1994, Afr J Med Med Sci, V23, P221; Pabst O, 2009, J MOL MED-JMM, V87, P945, DOI 10.1007/s00109-009-0502-z; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Persaud R, 2007, INT J PARASITOL, V37, P393, DOI 10.1016/j.ijpara.2006.09.012; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rzepecka J, 2009, MOL IMMUNOL, V46, P1109, DOI 10.1016/j.molimm.2008.10.032; SARTIGUTIERREZ EJ, 1988, TROP MED PARASITOL, V39, P194; Sorvillo FJ, 2007, EMERG INFECT DIS, V13, P230, DOI 10.3201/eid1302.060527; Verma A, 2011, MED MICROBIOL IMMUN, V200, P255, DOI 10.1007/s00430-011-0198-x; Wang WA, 2012, INT J BIOCHEM CELL B, V44, P842, DOI 10.1016/j.biocel.2012.02.009; Yazdanbakhsh M, 2005, CURR OPIN ALLERGY CL, V5, P386, DOI 10.1097/01.all.0000182541.52971.eb	41	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121321	10.1371/journal.pone.0121321	http://dx.doi.org/10.1371/journal.pone.0121321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811778	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700095
J	Valiente-Soriano, FJ; Salinas-Navarro, M; Jimenez-Lopez, M; Alarcon-Martinez, L; Ortin-Martinez, A; Bernal-Garro, JM; Aviles-Trigueros, M; Agudo-Barriuso, M; Villegas-Perez, MP; Vidal-Sanz, M				Valiente-Soriano, Francisco J.; Salinas-Navarro, Manuel; Jimenez-Lopez, Manuel; Alarcon-Martinez, Luis; Ortin-Martinez, Arturo; Bernal-Garro, Jose M.; Aviles-Trigueros, Marcelino; Agudo-Barriuso, Marta; Villegas-Perez, Maria P.; Vidal-Sanz, Manuel			Effects of Ocular Hypertension in the Visual System of Pigmented Mice	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ELEVATED INTRAOCULAR-PRESSURE; HEREDITARY OPTIC NEUROPATHY; LATERAL GENICULATE-NUCLEUS; PUPILLARY LIGHT REFLEX; ALBINO SWISS MICE; EXPERIMENTAL GLAUCOMA; MOUSE MODEL; ADULT ALBINO; SPATIAL-DISTRIBUTION	To study the effects of ocular hypertension (OHT) on the visual system of C57BL/6 pigmented mice, the limbal and episcleral veins of the left eye were laser photocoagulated (LP). LP increased the intraocular pressure during the first five days (d), reaching basal values at 7d. To investigate the effect of OHT on the retinal ganglion cell (RGC) retrograde axonal transport, hydroxistilbamidine methanesulfonate (OHSt) was applied to both superior colliculi (SCi) and the retinas were dissected 2 or 4 weeks after LP. To determine RGC survival, these same retinas were immunoreacted against Brn3a (general RGC population) and melanopsin (intrinsically photosensitive RGCs, m(+)RGCs). To study whether OHT affected non-RGC neurons in the ganglion cell layer (GCL), RGCs were immunodetected with Brn3a and all GCL nuclei counterstained with DAPI in a group of animals examined 4 weeks post-LP. Innervation of the SCi was examined at 10 days, 8 or 14 weeks after LP with the orthogradely transported cholera toxin subunit-B. OHT resulted in diffuse and sectorial loss of OHSt+RGCs (50% at 2 weeks and 62% at 4 weeks) and in a comparable loss of Brn3a+RGCs at the same time intervals. m+RGCs decreased to 59% at 2 weeks and to 46% at 4 weeks, such loss was diffuse, did not parallel the sectorial loss of the general RGC population and was more severe in the superior-temporal retina. In the GCL, cell loss is selective for RGCs and does not affect other non-RGC neurons. The retinotectal innervation appeared significantly reduced at 10 days (55.7%) and did not progress further up to 14 weeks (46.6%). Thus, LP-induced OHT results in retrograde degeneration of RGCs and m+RGCs, as well as in the loss of CTB-labelled retinotectal terminals.	[Valiente-Soriano, Francisco J.; Salinas-Navarro, Manuel; Jimenez-Lopez, Manuel; Alarcon-Martinez, Luis; Ortin-Martinez, Arturo; Bernal-Garro, Jose M.; Aviles-Trigueros, Marcelino; Agudo-Barriuso, Marta; Villegas-Perez, Maria P.; Vidal-Sanz, Manuel] Univ Murcia, Fac Med, Dept Oftalmol, E-30100 Murcia, Spain; [Valiente-Soriano, Francisco J.; Salinas-Navarro, Manuel; Jimenez-Lopez, Manuel; Alarcon-Martinez, Luis; Ortin-Martinez, Arturo; Bernal-Garro, Jose M.; Aviles-Trigueros, Marcelino; Agudo-Barriuso, Marta; Villegas-Perez, Maria P.; Vidal-Sanz, Manuel] Inst Murciano Invest Biosanitaria Virgen de la Ar, Murcia 30100, Spain	University of Murcia	Vidal-Sanz, M (corresponding author), Univ Murcia, Fac Med, Dept Oftalmol, E-30100 Murcia, Spain.	manuel.vidal@um.es	Avilés-Trigueros, Marcelino/K-2622-2012; Valiente-Soriano, Francisco J./Z-4980-2019; Agudo-Barriuso, Marta/B-7100-2016; Vidal-Sanz, Manuel/J-6989-2016	Avilés-Trigueros, Marcelino/0000-0001-9711-2196; Agudo-Barriuso, Marta/0000-0002-8566-9277; Vidal-Sanz, Manuel/0000-0002-9216-1615; Valiente-Soriano, Francisco J,/0000-0002-1837-6589; Ortin Martinez, Arturo/0000-0003-0492-6604	Spanish Ministry of Economy and Competitiveness [SAF-2012-38328]; ISCIII-FEDER "Una manera de hacer Europa" [PI13/00643, PI13/01266, RETICS: RD12/0034/0014]	Spanish Ministry of Economy and Competitiveness(Spanish Government); ISCIII-FEDER "Una manera de hacer Europa"	Financial support for these studies was obtained from: Spanish Ministry of Economy and Competitiveness: SAF-2012-38328; ISCIII-FEDER "Una manera de hacer Europa" PI13/00643, PI13/01266, RETICS: RD12/0034/0014.	Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P4314, DOI 10.1167/iovs.03-0137; Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P1581, DOI 10.1167/iovs.02-0759; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Cone FE, 2010, EXP EYE RES, V91, P415, DOI 10.1016/j.exer.2010.06.018; Crish SD, 2011, NEUROSCIENCE, V176, P1, DOI 10.1016/j.neuroscience.2010.12.036; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Cuenca N, 2010, EXP EYE RES, V91, P273, DOI 10.1016/j.exer.2010.05.020; Cui Q, 2015, NEUROSCIENCE, V284, P845, DOI 10.1016/j.neuroscience.2014.11.002; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; de Hoz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083733; de Zavalia N, 2011, J NEUROCHEM, V117, P904, DOI 10.1111/j.1471-4159.2011.07260.x; Dekeyster E, 2015, CURR EYE RES, V23, P1; DeParis SW, 2012, MOL VIS, V18, P2814; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Filippopoulos T, 2006, INVEST OPHTH VIS SCI, V47, P1968, DOI 10.1167/iovs.05-0955; Fu CT, 2010, INVEST OPHTH VIS SCI, V51, P980, DOI 10.1167/iovs.09-4324; Galindo-Romero C, 2013, EXP EYE RES, V108, P84, DOI 10.1016/j.exer.2012.12.010; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Gross Ronald L, 2003, Trans Am Ophthalmol Soc, V101, P163; Grozdanic SD, 2003, INVEST OPHTH VIS SCI, V44, P4337, DOI 10.1167/iovs.03-0015; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; Holcombe DJ, 2008, BRIT J OPHTHALMOL, V92, P683, DOI 10.1136/bjo.2007.133223; Hughes S, 2013, CURR BIOL, V23, P1696, DOI 10.1016/j.cub.2013.07.010; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Kankipati L, 2011, INVEST OPHTH VIS SCI, V52, P2287, DOI 10.1167/iovs.10-6023; Kawasaki A, 2014, EXP EYE RES, V120, P161, DOI 10.1016/j.exer.2013.11.005; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46, P3188, DOI 10.1167/iovs.05-0321; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Mabuchi F, 2003, INVEST OPHTH VIS SCI, V44, P4321, DOI 10.1167/iovs.03-0138; Mayor-Torroglosa S, 2005, INVEST OPHTH VIS SCI, V46, P3825, DOI 10.1167/iovs.05-0392; Moon JI, 2005, CELL TISSUE RES, V320, P51, DOI 10.1007/s00441-004-1062-8; Morrison JC, 2008, PROG BRAIN RES, V173, P285, DOI 10.1016/S0079-6123(08)01121-7; Moura ALA, 2013, INVEST OPHTH VIS SCI, V54, P4471, DOI 10.1167/iovs.12-11137; Muller LPD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093274; Nadal-Nicolas FM, 2015, EXP EYE RES, V131, P12, DOI 10.1016/j.exer.2014.12.005; Nadal-Nicolas FM, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00099; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Nissen C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00015; Ortin-Martinez A, 2015, EXP EYE RES, V132, P17, DOI 10.1016/j.exer.2015.01.006; Ortin-Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113798; Ortin-Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102392; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; Panagis L, 2010, INVEST OPHTH VIS SCI, V51, P2024, DOI 10.1167/iovs.09-3560; de Lara MJP, 2014, EXP EYE RES, V122, P40, DOI 10.1016/j.exer.2014.02.022; Perez-Rico C, 2010, EXP EYE RES, V91, P578, DOI 10.1016/j.exer.2010.07.012; PERRY VH, 1979, EXP BRAIN RES, V35, P85; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; QUIGLEY HA, 1979, OPHTHALMOLOGY, V86, P1803; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Ramirez AI, 2010, INVEST OPHTH VIS SCI, V51, P5690, DOI 10.1167/iovs.10-5248; Reichstein D, 2007, EXP EYE RES, V84, P13, DOI 10.1016/j.exer.2006.08.009; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Rojas B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-133; Ruiz-Ederra J, 2006, EXP EYE RES, V82, P879, DOI 10.1016/j.exer.2005.10.019; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; Salvador-Silva M, 2000, J COMP NEUROL, V417, P431, DOI 10.1002/(SICI)1096-9861(20000221)417:4<431::AID-CNE4>3.0.CO;2-G; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Sawada A, 1999, EXP EYE RES, V69, P525, DOI 10.1006/exer.1999.0732; Schlamp CL, 2013, MOL VIS, V19, P1387; Semo M, 2014, EXP EYE RES, V119, P8, DOI 10.1016/j.exer.2013.11.013; Semo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015009; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; Soto I, 2011, INVEST OPHTH VIS SCI, V52, P434, DOI 10.1167/iovs.10-5856; Trigueros MA, 2000, J NEUROSCI, V20, P361, DOI 10.1523/JNEUROSCI.20-01-00361.2000; Valiente-Soriano F., 2008, INVEST OPHTHALMOL VI, P49; Valiente-Soriano FJ, 2009, INVEST OPHTHALMOL VI, V50; Valiente-Soriano FJ, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00131; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vidal-Sanz M, 2007, EYE, V21, pS42, DOI 10.1038/sj.eye.6702888; Vidal-Sanz M, 2002, PROG BRAIN RES, V137, P443; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; Vugler A, 2015, NEUROSCIENCE, V286, P60, DOI 10.1016/j.neuroscience.2014.11.044; Vugler AA, 2008, VISUAL NEUROSCI, V25, P125, DOI 10.1017/S0952523808080309; Wang HZ, 2008, CHINESE MED J-PEKING, V121, P1015, DOI 10.1097/00029330-200806010-00010; Ward NJ, 2014, J NEUROSCI, V34, P3161, DOI 10.1523/JNEUROSCI.4089-13.2014; Whiteley SJO, 1998, EXP NEUROL, V154, P560, DOI 10.1006/exnr.1998.6959; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Yucel YH, 2001, INVEST OPHTH VIS SCI, V42, P3216; Yucel YH, 2000, ARCH OPHTHALMOL-CHIC, V118, P378; Yun HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107446; Zhang Q, 2013, SCI CHINA LIFE SCI, V56, P720, DOI 10.1007/s11427-013-4493-1	99	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121134	10.1371/journal.pone.0121134	http://dx.doi.org/10.1371/journal.pone.0121134			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811653	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700085
J	Verduzco, D; Lloyd, M; Xu, LP; Ibrahim-Hashim, A; Balagurunathan, Y; Gatenby, RA; Gillies, RJ				Verduzco, Daniel; Lloyd, Mark; Xu, Liping; Ibrahim-Hashim, Arig; Balagurunathan, Yoganand; Gatenby, Robert A.; Gillies, Robert J.			Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance	PLOS ONE			English	Article							ETOPOSIDE-INDUCED APOPTOSIS; TUMOR HYPOXIA; INTRATUMOR HETEROGENEITY; EVOLUTIONARY DYNAMICS; CELLULAR ADAPTATION; DRUG-RESISTANCE; EXPRESSION; PH; MICROENVIRONMENT; CARCINOGENESIS	Hypoxia in tumors correlates with greater risk of metastases, increased invasiveness, and resistance to systemic and radiation therapy. The evolutionary dynamics that links specific adaptations to hypoxia with these observed tumor properties have not been well investigated. While some tumor populations may experience fixed hypoxia, cyclical and stochastic transitions from normoxia to hypoxia are commonly observed in vivo. Although some phenotypic adaptations to this cyclic hypoxia are likely reversible, we hypothesize that some adaptations may become fixed through mutations promoted by hypoxia-induced genomic instability. Here we seek to identify genetic alterations and corresponding stable phenotypes that emerge following cyclic hypoxia. Although these changes may originate as adaptations to this specific environmental stress, their fixation in the tumor genome may result in their observation in tumors from regions of normoxia, a condition known as pseudohypoxia. We exposed several epithelial cell lines to 50 cycles of hypoxia-normoxia, followed by culture in normoxia over a period of several months. Molecular analyses demonstrated permanent changes in expression of several oncogenes and tumor-suppressors, including p53, E-cadherin, and Hif-1 alpha. These changes were associated with increased resistance to multiple cytotoxins, increased survival in hypoxia and increased anchorage-independent growth. These results suggest cycles of hypoxia encountered in early cancers can select for specific and stable genotypic and phenotypic properties that persist even in normoxic conditions, which may promote tumor progression and resistance to therapy.	[Verduzco, Daniel; Xu, Liping; Ibrahim-Hashim, Arig; Balagurunathan, Yoganand; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Lloyd, Mark] H Lee Moffitt Canc Ctr & Res Inst, Analyt Microscopy Core, Tampa, FL USA; [Gatenby, Robert A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Verduzco, D (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	daniel.verduzco@moffitt.org	Balagurunathan, Yoganand/AAF-9163-2020; Balagurunathan, Yoganand/AAH-9139-2021	Balagurunathan, Yoganand/0000-0002-5598-4727; Gillies, Robert/0000-0002-8888-7747	National Institutes of Health, NIH.gov [01CA077575, U54CA143970]; Moffitt Cancer Center, moffitt.org [P30CA076292]; NATIONAL CANCER INSTITUTE [U54CA143970, R01CA077575, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health, NIH.gov(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Cancer Center, moffitt.org; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by 01CA077575 and U54CA143970 (National Institutes of Health, NIH.gov), and P30CA076292 (Moffitt Cancer Center, moffitt.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airley R, 2001, CLIN CANCER RES, V7, P928; Aktipis CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026100; Bailey KM, 2012, ADV PHARMACOL, V65, P63, DOI 10.1016/B978-0-12-397927-8.00004-X; Baudelet C, 2006, NMR BIOMED, V19, P69, DOI 10.1002/nbm.1002; Bayer C, 2012, STRAHLENTHER ONKOL, V188, P616, DOI 10.1007/s00066-012-0085-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Bindra RS, 2005, MUTAT RES-FUND MOL M, V569, P75, DOI 10.1016/j.mrfmmm.2004.03.013; Braun RD, 1999, AM J PHYSIOL-HEART C, V277, pH551, DOI 10.1152/ajpheart.1999.277.2.H551; Brazdova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059567; Cardaci Simone, 2012, Int J Cell Biol, V2012, P161837, DOI 10.1155/2012/161837; Cattaneo MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029680; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Cosse JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-61; Dewhirst MW, 2007, CANCER RES, V67, P854, DOI 10.1158/0008-5472.CAN-06-4744; Dewhirst MW, 1996, BRIT J CANCER, V74, pS247; FLETCHER GH, 1984, AM J CLIN ONCOL-CANC, V7, P617, DOI 10.1097/00000421-198412000-00007; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gatenby RA, 2010, NAT REV CANCER, V10, P526, DOI 10.1038/nrc2892; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Gilead Assaf, 1999, Neoplasia (New York), V1, P226, DOI 10.1038/sj.neo.7900032; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Ginzinger DG, 2000, CANCER RES, V60, P5405; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Ibrahim-Hashim A, 2012, J UROLOGY, V188, P624, DOI 10.1016/j.juro.2012.03.113; Jubb AM, 2010, J CELL MOL MED, V14, P18, DOI 10.1111/j.1582-4934.2009.00944.x; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Meng AX, 2005, RADIOTHER ONCOL, V76, P168, DOI 10.1016/j.radonc.2005.06.025; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Pires IM, 2010, CANCER RES, V70, P925, DOI 10.1158/0008-5472.CAN-09-2715; Piret JP, 2006, EXP CELL RES, V312, P2908, DOI 10.1016/j.yexcr.2006.05.018; RICE GC, 1986, P NATL ACAD SCI USA, V83, P5978, DOI 10.1073/pnas.83.16.5978; Santore MT, 2002, AM J PHYSIOL-LUNG C, V282, pL727, DOI 10.1152/ajplung.00281.2001; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Vikhanskaya F, 2005, CLIN CANCER RES, V11, P4348, DOI 10.1158/1078-0432.CCR-04-1547; Wojtkowiak JW, 2012, CANCER RES, V72, P3938, DOI 10.1158/0008-5472.CAN-11-3881; Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c; Wykoff CC, 2000, CANCER RES, V60, P7075; Yachida S, 2013, ONCOGENE, V18, P29; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	59	49	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120958	10.1371/journal.pone.0120958	http://dx.doi.org/10.1371/journal.pone.0120958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811878	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700069
J	Altmann-Schneider, I; de Craen, AJM; van den Berg-Huysmans, AA; Slagboom, P; Westendorp, RGJ; van Buchem, MA; van der Grond, J				Altmann-Schneider, Irmhild; de Craen, Anton J. M.; van den Berg-Huysmans, Annette A.; Slagboom, Pieternella; Westendorp, Rudi G. J.; van Buchem, Mark A.; van der Grond, Jeroen			An In Vivo Study on Brain Microstructure in Biological and Chronological Ageing	PLOS ONE			English	Article							MAGNETIZATION-TRANSFER RATIO; AUSTRIAN STROKE PREVENTION; AGE-RELATED DIFFERENCES; WHITE-MATTER CHANGES; NORMAL ADULT BRAIN; LEIDEN LONGEVITY; FAMILIAL LONGEVITY; DIFFUSION TENSOR; TISSUE CHANGES; GRAY-MATTER	This study aimed to investigate whether magnetization transfer imaging (MTI) parameters of cortical gray and white matter and subcortical gray matter structures differ between subjects enriched for human familial longevity and control subjects to provide a thorough description of the brain phenotype of familial longevity. Moreover, we aimed to describe cerebral ageing effects on MTI parameters in an elderly cohort. All subjects were included from the Leiden Longevity Study and underwent 3 Tesla MTI of the brain. In total, 183 offspring of nonagenarian siblings, who are enriched for familial factors of longevity, were contrasted with 163 environmentally and age-matched controls. No differences in cortical and subcortical gray matter and white matter MTI parameters were found between offspring and control subjects using histogram-based and voxel-wise analyses. Cortical gray matter and white matter MTI parameters decreased with increasing chronological age (all p < 0.001). Decrease of white matter magnetization transfer ratio (MTR) was homogeneous throughout the whole mean white matter skeleton except for parts of the callosal splenium and partly the posterior limb of the internal capsule and superior region of the corona radiata (p < 0.05). Mean MTR of subcortical gray matter structures decreased with increasing age (p amygdala, caudate nucleus and putamen < 0.001; p pallidum = 0.001, p thalamus = 0.002). In conclusion, the brain phenotype of human familial longevity is - at a mean age of 66 years - not characterized by preserved macromolecular brain tissue integrity.	[Altmann-Schneider, Irmhild; van den Berg-Huysmans, Annette A.; van Buchem, Mark A.; van der Grond, Jeroen] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [de Craen, Anton J. M.; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Slagboom, Pieternella] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [de Craen, Anton J. M.; Slagboom, Pieternella; Westendorp, Rudi G. J.; van Buchem, Mark A.; van der Grond, Jeroen] Netherlands Consortium Hlth Ageing, Leiden, Netherlands; [Westendorp, Rudi G. J.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen	Altmann-Schneider, I (corresponding author), Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands.	i.altmann-schneider@lumc.nl	Slagboom, P. Eline/R-4790-2016; van Buchem, Mark/AAC-9843-2022	Slagboom, P. Eline/0000-0002-2875-4723; van Buchem, Mark/0000-0003-1881-1998; Altmann-Schneider, Irmhild/0000-0003-2477-5743	Innovation-Oriented Research Program on Genomics [SenterNovem IGE05007]; Netherlands Consortium for Healthy Ageing [050-060-810]; European Commission [FP7] [Health-F2-2010-259772]	Innovation-Oriented Research Program on Genomics; Netherlands Consortium for Healthy Ageing; European Commission [FP7](European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the Innovation-Oriented Research Program on Genomics [SenterNovem IGE05007], the Netherlands Consortium for Healthy Ageing [grant number 050-060-810] and the European Commission funded project Switchbox [FP7, Health-F2-2010-259772]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann-Schneider I, 2013, ANN NEUROL; Altmann-Schneider I, 2012, STROKE; Andersson J.L.R., 2007, TR07JA1 FMRIB; Armstrong CL, 2004, AM J NEURORADIOL, V25, P977; Bartzokis G, 2004, NEUROBIOL AGING, V25, P843, DOI 10.1016/j.neurobiolaging.2003.09.005; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benedetti B, 2006, NEUROLOGY, V66, P535, DOI 10.1212/01.wnl.0000198510.73363.c6; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bodini B, 2014, HUM BRAIN MAPP, V35, P723, DOI 10.1002/hbm.22196; Bos SD, 2013, ANN RHEUM DIS, V72, P1669, DOI 10.1136/annrheumdis-2012-202013; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Callaghan MF, 2014, NEUROBIOL AGING, V35, P1862, DOI 10.1016/j.neurobiolaging.2014.02.008; Cook LL, 2004, J MAGN RESON IMAGING, V20, P563, DOI 10.1002/jmri.20171; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; de Goeij MCM, 2014, EXP GERONTOL, V51, P65, DOI 10.1016/j.exger.2013.12.012; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Ge YL, 2002, AM J NEURORADIOL, V23, P1334; GROSSMAN RI, 1994, RADIOGRAPHICS, V14, P279, DOI 10.1148/radiographics.14.2.8190954; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Holland PR, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.009; Homayoon N, 2013, CLIN NEUROL NEUROSUR, V115, P1317, DOI 10.1016/j.clineuro.2012.12.016; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Mascalchi M, 2014, J MAGN RESON IMAGING, V40, P360, DOI 10.1002/jmri.24355; Ou XW, 2009, MAGN RESON MED, V61, P364, DOI 10.1002/mrm.21850; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Ropele S, 2010, AM J NEURORADIOL, V31, P1297, DOI 10.3174/ajnr.A2042; Rozing MP, 2010, J CLIN ENDOCR METAB, V95, P4979, DOI 10.1210/jc.2010-0875; Schiavone F, 2009, J MAGN RESON IMAGING, V29, P23, DOI 10.1002/jmri.21572; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Seiler S, 2014, J ALZHEIMERS DIS, V42, pS229, DOI 10.3233/JAD-132750; Silver NC, 1997, J NEUROL NEUROSUR PS, V62, P223, DOI 10.1136/jnnp.62.3.223; Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stanisz GJ, 1999, MAGN RESON MED, V42, P1128, DOI 10.1002/(SICI)1522-2594(199912)42:6<1128::AID-MRM18>3.0.CO;2-9; Sullivan EV, 2010, DEV NEUROPSYCHOL, V35, P233, DOI 10.1080/87565641003689556; Vaarhorst AAM, 2011, AGE, V33, P219, DOI 10.1007/s11357-010-9172-6; van den Bogaard SJA, 2012, AM J NEURORADIOL, V33, P884, DOI 10.3174/ajnr.A2868; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; vanBuchem MA, 1996, MAGN RESON MED, V36, P632, DOI 10.1002/mrm.1910360420; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	51	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120778	10.1371/journal.pone.0120778	http://dx.doi.org/10.1371/journal.pone.0120778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807271	gold, Green Published			2022-12-26	WOS:000351880000103
J	Ayoub, MA; Zhang, Y; Kelly, RS; See, HB; Johnstone, EKM; McCall, EA; Williams, JH; Kelly, DJ; Pfleger, KDG				Ayoub, Mohammed Akli; Zhang, Yuan; Kelly, Robyn S.; See, Heng B.; Johnstone, Elizabeth K. M.; McCall, Elizabeth A.; Williams, James H.; Kelly, Darren J.; Pfleger, Kevin D. G.			Functional Interaction between Angiotensin II Receptor Type 1 and Chemokine (C-C Motif) Receptor 2 with Implications for Chronic Kidney Disease	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; KAPPA-B ACTIVATION; MACROPHAGE INFILTRATION; RENAL INJURY; EXPRESSION; RAT; HETEROMERIZATION; RECRUITMENT; INHIBITION; APOPTOSIS	Understanding functional interactions between G protein-coupled receptors is of great physiological and pathophysiological importance. Heteromerization provides one important potential mechanism for such interaction between different signalling pathways via macromolecular complex formation. Previous studies suggested a functional interplay between angiotensin II receptor type 1 (AT(1)) and Chemokine (C-C motif) Receptor 2 (CCR2). However the molecular mechanisms are not understood. We investigated AT(1)-CCR2 functional interaction in vitro using bioluminescence resonance energy transfer in HEK293 cells and in vivo using subtotal-nephrectomized rats as a well-established model for chronic kidney disease. Our data revealed functional heteromers of these receptors resulting in CCR2-G alpha i1 coupling being sensitive to AT(1) activation, as well as apparent enhanced beta-arrestin2 recruitment with agonist co-stimulation that is synergistically reversed by combined antagonist treatment. Moreover, we present in vivo findings where combined treatment with AT(1)- and CCR2-selective inhibitors was synergistically beneficial in terms of decreasing proteinuria, reducing podocyte loss and preventing renal injury independent of blood pressure in the subtotal-nephrectomized rat model. Our findings further support a role for G protein-coupled receptor functional heteromerization in pathophysiology and provide insights into previous observations indicating the importance of AT(1)-CCR2 functional interaction in inflammation, renal and hypertensive disorders.	[Ayoub, Mohammed Akli; See, Heng B.; Johnstone, Elizabeth K. M.; Pfleger, Kevin D. G.] QEII Med Ctr, Harry Perkins Inst Med Res, Mol Endocrinol & Pharmacol, Nedlands, WA, Australia; [Ayoub, Mohammed Akli; See, Heng B.; Johnstone, Elizabeth K. M.; Pfleger, Kevin D. G.] Univ Western Australia, Med Res Ctr, Crawley, WA, Australia; [Zhang, Yuan; Kelly, Robyn S.; Kelly, Darren J.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [McCall, Elizabeth A.; Williams, James H.; Pfleger, Kevin D. G.] Dimerix Biosci Ltd, Nedlands, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; St Vincent's Hospital Melbourne; University of Melbourne	Kelly, DJ (corresponding author), Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia.	darrenjk@unimelb.edu.au; kevin.pfleger@perkins.uwa.edu.au	Johnstone, Liz/Z-2629-2019; Johnstone, Elizabeth/D-8163-2017	Johnstone, Liz/0000-0001-7990-371X; Johnstone, Elizabeth/0000-0001-7990-371X; Pfleger, Kevin/0000-0001-8261-9189; Kelly, Darren/0000-0003-4850-3929; AYOUB, Mohammed Akli/0000-0003-0022-578X; Williams, James/0000-0002-0950-1958	Dimerix Bioscience Limited - Australian Government's Commercialisation Australia scheme; Australian Research Council (ARC) via Discovery Project [DP120101297]; Richard Walter Gibbon Medical Research Scholarship from The University of Western Australia; NHMRC Senior Research Fellowship [566867]	Dimerix Bioscience Limited - Australian Government's Commercialisation Australia scheme; Australian Research Council (ARC) via Discovery Project(Australian Research Council); Richard Walter Gibbon Medical Research Scholarship from The University of Western Australia; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was partly funded by Dimerix Bioscience Limited (www.dimerix.com), who was itself supported by the Australian Government's Commercialisation Australia scheme. Subsequently, this work was funded in part by the Australian Research Council (ARC; www.arc.gov.au) via Discovery Project Grant DP120101297 (KDGP, DJK and MAA). KDGP was an ARC Future Fellow (FT100100271) and is now a National Health and Medical Research Council of Australia (NHMRC; www.nhmrc.gov.au) RD Wright Fellow (1085842). EKMJ was funded by the Richard Walter Gibbon Medical Research Scholarship from The University of Western Australia (www.uwa.edu.au). DJK was funded by a NHMRC Senior Research Fellowship (566867). Other than EAM, JHW and KDGP, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; ALLEN TJ, 1990, DIABETES, V39, P1182, DOI 10.2337/diabetes.39.10.1182; [Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.06.003; Armando S, 2014, FASEB J; Armstrong SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065885; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Ayoub MA, 2009, J BIOL CHEM, V284, P29136, DOI 10.1074/jbc.M109.042333; Bresgen N, 2008, J CELL PHYSIOL, V217, P800, DOI 10.1002/jcp.21555; Burt D, 2007, AM J PATHOL, V171, P1789, DOI 10.2353/ajpath.2007.070398; Chen XH, 2013, J MOL HISTOL, V44, P597, DOI 10.1007/s10735-013-9505-8; Dai Q, 2007, BRIT J PHARMACOL, V152, P1042, DOI 10.1038/sj.bjp.0707454; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; de Lourdes Gonzalez-Hernandez M., 2010, Autonomic & Autacoid Pharmacology, V30, P167, DOI 10.1111/j.1474-8673.2009.00446.x; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fujinaka H, 1997, J AM SOC NEPHROL, V8, P1174; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Giunti S, 2006, HYPERTENSION, V48, P519, DOI 10.1161/01.HYP.0000240331.32352.0c; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; HAYSLETT JP, 1979, PHYSIOL REV, V59, P137, DOI 10.1152/physrev.1979.59.1.137; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Hoffmann S, 2004, J AM SOC NEPHROL, V15, P1475, DOI 10.1097/01.ASN.0000127988.42710.A7; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Jaeger WC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00026; Kelly DJ, 2009, NEPHROL DIAL TRANSPL, V24, P1782, DOI 10.1093/ndt/gfn729; Kelly DJ, 2003, NEPHROL DIAL TRANSPL, V18, P1286, DOI 10.1093/ndt/gfg176; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384; Liao TD, 2008, HYPERTENSION, V52, P256, DOI 10.1161/HYPERTENSIONAHA.108.112706; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Mellado M, 1998, J IMMUNOL, V161, P805; Metcalfe W, 2007, NEPHROL DIAL TRANSPL, V22, P26, DOI 10.1093/ndt/gfm446; Mustafa S, 2012, J BIOL CHEM, V287, P12952, DOI 10.1074/jbc.M111.322834; Nam BY, 2012, APOPTOSIS, V17, P1, DOI 10.1007/s10495-011-0661-6; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; NIKOLICPATERSON DJ, 1994, KIDNEY INT, V45, pS79; Ozawa Y, 2007, AM J PHYSIOL-RENAL, V292, pF330, DOI 10.1152/ajprenal.00059.2006; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; SABADINI E, 1988, AM J KIDNEY DIS, V12, P307, DOI 10.1016/S0272-6386(88)80225-7; Sakai N, 1999, Nihon Jinzo Gakkai Shi, V41, P704; Schiller B, 1997, NEPHROL DIAL TRANSPL, V12, P430, DOI 10.1093/ndt/12.3.430; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Segerer S, 2001, AM J KIDNEY DIS, V37, P518; Sharma M, 1998, AM J PHYSIOL-RENAL, V274, pF623; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shikata K, 2001, CONTRIB NEPHROL, V134, P46; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Taal MW, 2000, KIDNEY INT, V58, P1664, DOI 10.1046/j.1523-1755.2000.00327.x; Tarabra E, 2009, DIABETES, V58, P2109, DOI 10.2337/db08-0895; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Tsukuda K, 2011, BIOCHEM BIOPH RES CO, V409, P275, DOI 10.1016/j.bbrc.2011.04.142; Urushihara M, 2011, HYPERTENSION, V57, P586, DOI 10.1161/HYPERTENSIONAHA.110.165704; VANGOOR H, 1992, LAB INVEST, V66, P564; Wada T, 1996, FASEB J, V10, P1418, DOI 10.1096/fasebj.10.12.8903512; WATKINS PJ, 1972, Q J MED, V41, P437; Watts AO, 2013, BRIT J PHARMACOL, V168, P1662, DOI 10.1111/bph.12064; Wolf G, 2007, NEPHRON PHYSIOL, V106, P26, DOI 10.1159/000101797; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Yokoyama H, 1998, J LEUKOCYTE BIOL, V63, P493, DOI 10.1002/jlb.63.4.493	65	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119803	10.1371/journal.pone.0119803	http://dx.doi.org/10.1371/journal.pone.0119803			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807547	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000042
J	Genzor, P; Bortvin, A				Genzor, Pavol; Bortvin, Alex			A Unique HMG-Box Domain of Mouse Maelstrom Binds Structured RNA but Not Double Stranded DNA	PLOS ONE			English	Article							4-WAY JUNCTION DNA; METHYLATION DYNAMICS; TRANSCRIPTION FACTOR; MOLECULAR-DYNAMICS; HOLLIDAY JUNCTION; PIRNA BIOGENESIS; PROTEIN; SEQUENCE; SPECIFICITY; RECOGNITION	Piwi-interacting piRNAs are a major and essential class of small RNAs in the animal germ cells with a prominent role in transposon control. Efficient piRNA biogenesis and function require a cohort of proteins conserved throughout the animal kingdom. Here we studied Maelstrom (MAEL), which is essential for piRNA biogenesis and germ cell differentiation in flies and mice. MAEL contains a high mobility group (HMG)-box domain and a Maelstrom-specific domain with a presumptive RNase H-fold. We employed a combination of sequence analyses, structural and biochemical approaches to evaluate and compare nucleic acid binding of mouse MAEL HMG-box to that of canonical HMG-box domain proteins (SRY and HMGB1a). MAEL HMG-box failed to bind double-stranded (ds) DNA but bound to structured RNA. We also identified important roles of a novel cluster of arginine residues in MAEL HMG-box in these interactions. Cumulatively, our results suggest that the MAEL HMG-box domain may contribute to MAEL function in selective processing of retrotransposon RNA into piRNAs. In this regard, a cellular role of MAEL HMG-box domain is reminiscent of that of HMGB1 as a sentinel of immunogenic nucleic acids in the innate immune response.	[Genzor, Pavol; Bortvin, Alex] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21210 USA; [Genzor, Pavol] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Johns Hopkins University	Bortvin, A (corresponding author), Carnegie Inst Sci, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.	bortvin@ciwemb.edu	Genzor, Pavol/ABA-7935-2021	Bortvin, Alex/0000-0003-0987-1905; Genzor, Pavol/0000-0002-3316-5659	Carnegie Institution for Science	Carnegie Institution for Science	This work was supported by Carnegie Institution for Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Bell AJ, 2008, BIOCHEM BIOPH RES CO, V377, P262, DOI 10.1016/j.bbrc.2008.09.131; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Carpenter ML, 1996, NUCLEIC ACIDS RES, V24, P1594, DOI 10.1093/nar/24.9.1594; Castaneda J, 2014, EMBO J, V33, P1999, DOI 10.15252/embj.201386855; Castaneda J, 2011, MUTAT RES-FUND MOL M, V714, P95, DOI 10.1016/j.mrfmmm.2011.05.002; Chen ZD, 1996, BIOTECHNIQUES, V21, P820; COPENHAVER GP, 1994, NUCLEIC ACIDS RES, V22, P2651, DOI 10.1093/nar/22.13.2651; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Eichman BF, 2002, J MOL BIOL, V320, P1037, DOI 10.1016/S0022-2836(02)00540-5; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Fu Q, 2014, SPERMATOGENESIS, V4, pe27889, DOI [DOI 10.4161/SPMG.27889, 10.4161/spmg.27889]; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guenther UP, 2013, NATURE, V502, P385, DOI 10.1038/nature12543; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; He Q, 2000, BIOCHEMISTRY-US, V39, P14426, DOI 10.1021/bi001700j; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hohng S, 2004, J MOL BIOL, V336, P69, DOI 10.1016/j.jmb.2003.12.014; Hyeon C, 2012, NAT CHEM, V4, P907, DOI [10.1038/nchem.1463, 10.1038/NCHEM.1463]; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Ku HY, 2014, NATL SCI REV, V1, P205, DOI 10.1093/nsr/nwu014; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Laing C, 2012, NUCLEIC ACIDS RES, V40, P487, DOI 10.1093/nar/gkr629; Laing C, 2009, J MOL BIOL, V390, P547, DOI 10.1016/j.jmb.2009.04.084; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; Lees-Murdock DJ, 2008, EPIGENETICS-US, V3, P5, DOI 10.4161/epi.3.1.5553; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; LILLEY DMJ, 1993, ANNU REV BIOPH BIOM, V22, P299, DOI 10.1146/annurev.bb.22.060193.001503; Majorek KA, 2014, NUCLEIC ACIDS RES, V42, P4160, DOI 10.1093/nar/gkt1414; Malki S, 2014, DEV CELL, V29, P521, DOI 10.1016/j.devcel.2014.04.027; Mani SR, 2013, MOL REPROD DEV, V80, P632, DOI 10.1002/mrd.22195; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Mertin S, 1999, NUCLEIC ACIDS RES, V27, P1359, DOI 10.1093/nar/27.5.1359; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Moore S, ROUND THE HORN SITE; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Ohno T, 2000, BIOCHEM BIOPH RES CO, V271, P492, DOI 10.1006/bbrc.2000.2656; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; Pek JW, 2012, DEVELOPMENT, V139, P4505, DOI 10.1242/dev.082867; Pek JW, 2012, DEVELOPMENT, V139, P2255, DOI 10.1242/dev.073304; Pek JW, 2009, DEV CELL, V17, P417, DOI 10.1016/j.devcel.2009.07.017; Pohler JRG, 1998, EMBO J, V17, P817, DOI 10.1093/emboj/17.3.817; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Ryder Sean P., 2008, V488, P99, DOI 10.1007/978-1-60327-475-3_7; Sato K, 2011, GENE DEV, V25, P2361, DOI 10.1101/gad.174110.111; SCHICHMAN SA, 1993, MOL BIOL EVOL, V10, P552; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; SEVERYNSE DM, 1992, MAMM GENOME, V2, P41, DOI 10.1007/BF00570439; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Siomi MC, 2010, GENE DEV, V24, P636, DOI 10.1101/gad.1899210; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Soullier S, 1999, J MOL EVOL, V48, P517, DOI 10.1007/PL00006495; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Tomizawa T, 2005, SOLUTION STRUCTURE H; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Turnage MA, 2000, MOL CELL BIOL, V20, P8198, DOI 10.1128/MCB.20.21.8198-8208.2000; van der Heijden GW, 2010, CURR OPIN CELL BIOL, V22, P752, DOI 10.1016/j.ceb.2010.08.014; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb M, 1999, J MOL BIOL, V294, P373, DOI 10.1006/jmbi.1999.3150; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Weiss MA, 1997, J BIOMOL STRUCT DYN, V15, P177, DOI 10.1080/07391102.1997.10508185; West SM, 2010, J BIOMOL STRUCT DYN, V27, P861, DOI 10.1080/07391102.2010.10508587; Wheatley EG, 2012, BIOPHYS J, V102, P552, DOI 10.1016/j.bpj.2011.11.4023; Xin H, 2000, NUCLEIC ACIDS RES, V28, P4044, DOI 10.1093/nar/28.20.4044; Yanai H, 2011, P NATL ACAD SCI USA, V108, P11542, DOI 10.1073/pnas.1108535108; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yu J, 2004, NUCLEIC ACIDS RES, V32, P6683, DOI 10.1093/nar/gkh1006; Zappulla DC, 2004, P NATL ACAD SCI USA, V101, P10024, DOI 10.1073/pnas.0403641101; Zhang DP, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-48; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zlatanova J, 1998, FASEB J, V12, P421, DOI 10.1096/fasebj.12.6.421; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	91	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120268	10.1371/journal.pone.0120268	http://dx.doi.org/10.1371/journal.pone.0120268			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807393	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000072
J	Klistorner, A; Vootakuru, N; Wang, CY; Yiannikas, C; Graham, SL; Parratt, J; Garrick, R; Levin, N; Masters, L; Lagopoulos, J; Barnett, MH				Klistorner, Alexander; Vootakuru, Nikitha; Wang, Chenyu; Yiannikas, Con; Graham, Stuart L.; Parratt, John; Garrick, Raymond; Levin, Netta; Masters, Lynette; Lagopoulos, Jim; Barnett, Michael H.			Decoding Diffusivity in Multiple Sclerosis: Analysis of Optic Radiation Lesional and Non-Lesional White Matter	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TENSOR IMAGING DETECTS; CENTRAL-NERVOUS-SYSTEM; WALLERIAN DEGENERATION; AXONAL DEGENERATION; WATER DIFFUSION; NEURONAL DEATH; SPINAL-CORD; CORPUS-CALLOSUM; PYRAMIDAL TRACT	Objectives Diffusion tensor imaging (DTI) has been suggested as a new promising tool in MS that may provide greater pathological specificity than conventional MRI, helping, therefore, to elucidate disease pathogenesis and monitor therapeutic efficacy. However, the pathological substrates that underpin alterations in brain tissue diffusivity are not yet fully delineated. Tract-specific DTI analysis has previously been proposed in an attempt to alleviate this problem. Here, we extended this approach by segmenting a single tract into areas bound by seemingly similar pathological processes, which may better delineate the potential association between DTI metrics and underlying tissue damage. Method Several compartments were segmented in optic radiation (OR) of 50 relapsing-remitting MS patients including T2 lesions, proximal and distal parts of fibers transected by lesion and fibers with no discernable pathology throughout the entire length of the OR. Results Asymmetry analysis between lesional and non-lesional fibers demonstrated a marked increase in Radial Diffusivity (RD), which was topographically limited to focal T2 lesions and potentially relates to the lesional myelin loss. A relative elevation of Axial Diffusivity (AD) in the distal part of the lesional fibers was observed in a distribution consistent with Wallerian degeneration, while diffusivity in the proximal portion of transected axons remained normal. A moderate, but significant elevation of RD in OR non-lesional fibers was strongly associated with the global (but not local) T2 lesion burden and is probably related to microscopic demyelination undetected by conventional MRI. Conclusion This study highlights the utility of the compartmentalization approach in elucidating the pathological substrates of diffusivity and demonstrates the presence of tissue-specific patterns of altered diffusivity in MS, providing further evidence that DTI is a sensitive marker of tissue damage in both lesions and NAWM. Our results suggest that, at least within the OR, parallel and perpendicular diffusivities are affected by tissue restructuring related to distinct pathological processes.	[Klistorner, Alexander] Univ Sydney, Save Sight Inst, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Klistorner, Alexander; Graham, Stuart L.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Vootakuru, Nikitha] Westmead Hosp, Sydney, NSW, Australia; [Wang, Chenyu; Masters, Lynette; Lagopoulos, Jim; Barnett, Michael H.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Yiannikas, Con; Parratt, John] Royal N Shore Hosp, Sydney, NSW, Australia; [Garrick, Raymond] St Vincent Hosp, Sydney, NSW, Australia; [Levin, Netta] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel	University of Sydney; Macquarie University; University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; St Vincents Hospital Sydney; Hebrew University of Jerusalem; Hadassah University Medical Center	Klistorner, A (corresponding author), Univ Sydney, Save Sight Inst, Dept Ophthalmol, Sydney, NSW 2006, Australia.	sasha@eye.usyd.edu.au		Klistorner, Alexander/0000-0003-0361-6399; Graham, Stuart/0000-0001-7519-969X	Save Neuron grant (Novartis); National MS Society (US); Sydney Hospital Foundation; Claffy Foundation	Save Neuron grant (Novartis); National MS Society (US)(National Multiple Sclerosis Society); Sydney Hospital Foundation; Claffy Foundation	The work was supported by Save Neuron grant (Novartis), grants from National MS Society (US), Sydney Hospital and Claffy Foundations grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Al-Abdulla NA, 2002, NEUROSCIENCE, V115, P7, DOI 10.1016/S0306-4522(02)00363-9; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Aung WY, 2014, IMAGING MED, V5, P427, DOI DOI 10.2217/IIM.13.49.DIFFUSI0N; BARBOSA S, 1994, MAGN RESON IMAGING, V12, P33, DOI 10.1016/0730-725X(94)92350-7; BARNES D, 1991, BRAIN, V114, P1271, DOI 10.1093/brain/114.3.1271; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BIGNAMI A, 1969, BRAIN RES, V13, P444, DOI 10.1016/0006-8993(69)90259-5; Bjartmar C, 2003, NEUROTOX RES, V5, P157, DOI 10.1007/BF03033380; Bjartmar C, 2001, NEUROLOGY, V57, P1248, DOI 10.1212/WNL.57.7.1248; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; COOK RD, 1973, BRAIN RES, V61, P191, DOI 10.1016/0006-8993(73)90527-1; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; Dasgupta A, 2013, ASN NEURO, V5, P99, DOI 10.1042/AN20120088; Dekkers MPJ, 2013, J CELL BIOL, V203, P385, DOI 10.1083/jcb.201306136; Diem R, 2005, MULT SCLER; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Finn JT, 2000, J NEUROSCI, V20, P1333; Fox RJ, 2011, AM J NEURORADIOL, V32, P85, DOI 10.3174/ajnr.A2238; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Grassel D, 2010, CEREBROVASC DIS, V30, P380, DOI 10.1159/000319573; Grecchi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044935; Hendrickson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046918; Hobom M, 2004, BRAIN PATHOL, V14, P148, DOI 10.1111/j.1750-3639.2004.tb00047.x; Janve VA, 2013, NEUROIMAGE, V74, P298, DOI 10.1016/j.neuroimage.2013.02.034; Kern KC, 2011, NEUROIMAGE, V55, P1169, DOI 10.1016/j.neuroimage.2010.10.077; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Klawiter EC, 2012, MULT SCLER J, V18, P1259, DOI 10.1177/1352458512436593; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Klistorner A, 2014, NEUROLOGY, V82, P2165, DOI 10.1212/WNL.0000000000000522; Kolasinski J, 2012, BRAIN, V135, P2938, DOI 10.1093/brain/aws242; Lai C, 2014, ACTA RADIOL, V55, P114, DOI 10.1177/0284185113492456; LASSMANN H, 1994, ANN NEUROL, V36, pS42, DOI 10.1002/ana.410360713; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Lin F, 2007, AM J NEURORADIOL; Liu M, 2013, NEUROIMAGE, V74, P128, DOI 10.1016/j.neuroimage.2013.01.069; Liu Y, 2012, J CLIN NEUROSCI, V19, P1689, DOI 10.1016/j.jocn.2012.03.022; LUDWIN SK, 1990, ACTA NEUROPATHOL, V80, P184, DOI 10.1007/BF00308922; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Mistry N, 2011, MULT SCLER J, V17, P1313, DOI 10.1177/1352458511415305; Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd; Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003; Oh J, 2004, J NEUROL NEUROSUR PS, V75, P1281, DOI 10.1136/jnnp.2004.039032; ORMEROD IEC, 1987, BRAIN, V110, P1579, DOI 10.1093/brain/110.6.1579; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; PRINEAS J, 1975, HUM PATHOL, V6, P531, DOI 10.1016/S0046-8177(75)80040-2; PRINEAS JW, 1978, NEUROLOGY, V28, P68, DOI 10.1212/WNL.28.9_Part_2.68; Qin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041441; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Raff MC, 2002, SCIENCE, P296; Reich DS, 2009, ARCH NEUROL-CHICAGO, V66, P998, DOI 10.1001/archneurol.2009.107; Reichardt HM, 2012, CURR PHARM DESIGN, V18, P4453; Repici M, 2003, NEUROSCIENCE, V117, P859, DOI 10.1016/S0306-4522(02)00968-5; Rocca MA, 2013, MULT SCLER J, V19, P1610, DOI 10.1177/1352458513485146; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Suhs KW, 2014, J NEUROPATH EXP NEUR, V73, P507, DOI 10.1097/NEN.0000000000000073; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Viscomi M. T., 2014, MOL NEUROBIOL; Werring DJ, 2000, BRAIN, V123, P1667, DOI 10.1093/brain/123.8.1667; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yu CS, 2009, NEUROIMAGE, V47, P451, DOI 10.1016/j.neuroimage.2009.04.066; Zacharaki T, 2010, BRAIN RES, V1344, P62, DOI 10.1016/j.brainres.2010.05.021; Zhang X, 2011, INVEST OPHTH VIS SCI, V52, P7001, DOI 10.1167/iovs.11-7619; Zollinger LV, 2011, J MAGN RESON IMAGING, V33, P557, DOI 10.1002/jmri.22502	83	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122114	10.1371/journal.pone.0122114	http://dx.doi.org/10.1371/journal.pone.0122114			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807541	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000202
J	Mezzarane, RA; Magalhaes, FH; Chaud, VM; Elias, LA; Kohn, AF				Mezzarane, Rinaldo Andre; Magalhaes, Fernando Henrique; Chaud, Vitor Martins; Elias, Leonardo Abdala; Kohn, Andre Fabio			Enhanced D1 and D2 Inhibitions Induced by Low-Frequency Trains of Conditioning Stimuli: Differential Effects on H- and T-Reflexes and Possible Mechanisms	PLOS ONE			English	Article							POST-ACTIVATION DEPRESSION; HUMAN SOLEUS MUSCLE; HUMAN LOWER-LIMB; PRESYNAPTIC INHIBITION; SPINAL-CORD; SYNAPTIC DEPRESSION; STRETCH REFLEXES; IA AFFERENTS; HUMANS; SENSITIVITY	Mechanically evoked reflexes have been postulated to be less sensitive to presynaptic inhibition (PSI) than the H-reflex. This has implications on investigations of spinal cord neurophysiology that are based on the T-reflex. Preceding studies have shown an enhanced effect of PSI on the H-reflex when a train of similar to 10 conditioning stimuli at 1 Hz was applied to the nerve of the antagonist muscle. The main questions to be addressed in the present study are if indeed T-reflexes are less sensitive to PSI and whether (and to what extent and by what possible mechanisms) the effect of low frequency conditioning, found previously for the H-reflex, can be reproduced on T-reflexes from the soleus muscle. We explored two different conditioning-to-test (C-T) intervals: 15 and 100 ms (corresponding to D1 and D2 inhibitions, respectively). Test stimuli consisted of either electrical pulses applied to the posterior tibial nerve to elicit H-reflexes or mechanical percussion to the Achilles tendon to elicit T-reflexes. The 1 Hz train of conditioning electrical stimuli delivered to the common peroneal nerve induced a stronger effect of PSI as compared to a single conditioning pulse, for both reflexes (T and H), regardless of C-T-intervals. Moreover, the conditioning train of pulses (with respect to a single conditioning pulse) was proportionally more effective for T-reflexes as compared to H-reflexes (irrespective of the C-T interval), which might be associated with the differential contingent of Ia afferents activated by mechanical and electrical test stimuli. A conceivable explanation for the enhanced PSI effect in response to a train of stimuli is the occurrence of homosynaptic depression at synapses on inhibitory interneurons interposed within the PSI pathway. The present results add to the discussion of the sensitivity of the stretch reflex pathway to PSI and its functional role.	[Mezzarane, Rinaldo Andre] Univ Brasilia, UnB, Coll Phys Educ, Lab Signal Proc & Motor Control, Brasilia, DF, Brazil; [Mezzarane, Rinaldo Andre; Magalhaes, Fernando Henrique; Chaud, Vitor Martins; Elias, Leonardo Abdala; Kohn, Andre Fabio] Univ Sao Paulo, PTC, Escola Politecn, Biomed Engn Lab, Sao Paulo, Brazil; [Magalhaes, Fernando Henrique] Univ Sao Paulo, EACH, Sch Arts Sci & Humanities, Sao Paulo, Brazil; [Chaud, Vitor Martins] Univ Fed Triangulo Mineiro, Dept Elect Engn, Uberaba, Brazil; [Elias, Leonardo Abdala] Univ Estadual Campinas, UNICAMP, Sch Elect & Comp Engn, Dept Biomed Engn, Campinas, SP, Brazil	Universidade de Brasilia; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Universidade Estadual de Campinas	Mezzarane, RA (corresponding author), Univ Brasilia, UnB, Coll Phys Educ, Lab Signal Proc & Motor Control, Brasilia, DF, Brazil.	rimezza@gmail.com	MEZZARANE, Rinaldo A/I-2862-2013; Magalhães, Fernando Henrique/A-1894-2013; Kohn, Andre F/N-4982-2016; Elias, Leonardo Abdala/C-4169-2008	Magalhães, Fernando Henrique/0000-0003-0783-6102; Kohn, Andre F/0000-0002-9770-3348; Elias, Leonardo Abdala/0000-0003-4488-3063; Mezzarane, Rinaldo/0000-0001-9659-4015	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [476830/2013-3, 303313/2011-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/15522-4, 2011/13222-6, 2013/10433-1, 2011/17193-0, 2009/15802-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	RAM was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (476830/2013-3) (http://www.cnpq.br/), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://www.capes.gov.br/), and a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2010/15522-4) (http://www.fapesp.br/). FHM was a recipient of a fellowship from FAPESP (2011/13222-6). LAE was supported by FAPESP (2009/15802-0 and 2013/10433-1). This work was also supported by a grant from FAPESP to AFK (2011/17193-0) and a fellowship to AFK by CNPq (303313/2011-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKE D, 1983, J PHYSIOL-LONDON, V339, P535, DOI 10.1113/jphysiol.1983.sp014732; CAPADAY C, 1995, CAN J PHYSIOL PHARM, V73, P436, DOI 10.1139/y95-056; CAPADAY C, 1987, J PHYSIOL-LONDON, V392, P513, DOI 10.1113/jphysiol.1987.sp016794; CAPEK R, 1977, J NEUROPHYSIOL, V40, P95, DOI 10.1152/jn.1977.40.1.95; CRONE C, 1990, EXP BRAIN RES, V81, P35; Dafkin C, 2013, MUSCLE NERVE, V47, P81, DOI 10.1002/mus.23487; DAVIS GW, 1994, TRENDS NEUROSCI, V17, P9, DOI 10.1016/0166-2236(94)90028-0; Dietz V, 2003, CLIN NEUROPHYSIOL, V114, P1379, DOI 10.1016/S1388-2457(03)00120-2; Fornari MCD, 2008, NEUROSCI LETT, V440, P193, DOI 10.1016/j.neulet.2008.05.075; Enriguez-Denton M, 2002, J NEUROPHYSIOL, V88, P1664, DOI 10.1152/jn.00950.2001; Faist M, 1996, EXP BRAIN RES, V109, P441; Floeter MK, 1997, ELECTROMYOGR MOTOR C, V105, P470; FOURNIER E, 1984, EXP BRAIN RES, V56, P193; Grey MJ, 2008, EXP BRAIN RES, V185, P189, DOI 10.1007/s00221-007-1142-6; Hammar I, 2002, EXP BRAIN RES, V145, P126, DOI 10.1007/s00221-002-1098-5; Hultborn H, 1996, EXP BRAIN RES, V108, P450; Iles JF, 1996, J PHYSIOL-LONDON, V491, P197, DOI 10.1113/jphysiol.1996.sp021207; JANKOWSKA E, 1981, J NEUROPHYSIOL, V46, P506, DOI 10.1152/jn.1981.46.3.506; Knash ME, 2003, EXP BRAIN RES, V153, P366, DOI 10.1007/s00221-003-1628-9; Kohn AF, 1997, EXP BRAIN RES, V116, P375, DOI 10.1007/PL00005765; Lamy JC, 2005, EXP BRAIN RES, V166, P248, DOI 10.1007/s00221-005-2360-4; Lapole T, 2012, APPL PHYSIOL NUTR ME, V37, P657, DOI [10.1139/H2012-032, 10.1139/h2012-032]; Leonard CT, 1999, BRAIN RES, V817, P1, DOI 10.1016/S0006-8993(98)01096-8; LEVTOV A, 1983, J NEUROPHYSIOL, V50, P379, DOI 10.1152/jn.1983.50.2.379; LEVTOV A, 1992, J PHYSIOL-LONDON, V447, P149, DOI 10.1113/jphysiol.1992.sp018996; LLEWELLYN M, 1990, EXP BRAIN RES, V83, P22; Magalhaes FH, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-26; Magalhaes FH, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-32; Mezzarane RA, 2002, J NEUROPHYSIOL, V87, P2074, DOI 10.1152/jn.00129.2001; Mezzarane RA, 2013, ELECTRODIAGNOSIS NEW, P57; Mezzarane RA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00136; Mezzarane RA, 2011, EXP BRAIN RES, V208, P157, DOI 10.1007/s00221-010-2467-0; Mezzarane RA, 2007, EXP BRAIN RES, V180, P377, DOI 10.1007/s00221-007-0865-8; Mezzarane RA, 2012, J NEUROPHYSIOL, V108, P1176, DOI 10.1152/jn.00831.2011; Mineva A, 1993, Electromyogr Clin Neurophysiol, V33, P235; MIZUNO Y, 1971, J NEUROPHYSIOL, V34, P1010, DOI 10.1152/jn.1971.34.6.1010; Morita H, 1998, J NEUROPHYSIOL, V80, P610, DOI 10.1152/jn.1998.80.2.610; Nakajima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076313; Nordlund MM, 2004, NEUROSCI LETT, V366, P250, DOI 10.1016/j.neulet.2004.05.044; Ozmerdivenli R, 2002, PHYSIOL RES, V51, P395; PANIZZA M, 1989, MUSCLE NERVE, V12, P576, DOI 10.1002/mus.880120708; PEROT C, 1991, EUR J APPL PHYSIOL O, V63, P368, DOI 10.1007/BF00364464; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Roche N, 2012, CLIN NEUROPHYSIOL, V123, P1391, DOI 10.1016/j.clinph.2011.11.006; Rossi-Durand C, 2002, SOMATOSENS MOT RES, V19, P286, DOI 10.1080/0899022021000037755; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; RUDOMIN P, 1983, J NEUROPHYSIOL, V50, P743, DOI 10.1152/jn.1983.50.4.743; Rudomin P, 2009, EXP BRAIN RES, V196, P139, DOI 10.1007/s00221-009-1758-9; Sinkjaer T, 1996, J NEUROPHYSIOL, V76, P1112, DOI 10.1152/jn.1996.76.2.1112; VANBOXTEL A, 1986, J NEUROPHYSIOL, V55, P551, DOI 10.1152/jn.1986.55.3.551	50	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121496	10.1371/journal.pone.0121496	http://dx.doi.org/10.1371/journal.pone.0121496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807195	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000158
J	Shen, ZC; Luo, B; Chen, JN; Chao, Y; Shao, CK; Liu, QQ; Wang, Y				Shen, Zhi-chao; Luo, Bing; Chen, Jian-ning; Chao, Yan; Shao, Chun-kui; Liu, Qian-qian; Wang, Yun			High Prevalence of the EBER Variant EB-8m in Endemic Nasopharyngeal Carcinomas	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; T-CELL-LYMPHOMA; GASTRIC-CARCINOMA; GENE POLYMORPHISMS; SEQUENCE VARIATION; DELETION VARIANT; HODGKINS-DISEASE; HEALTHY DONORS; EBV TYPE; GROWTH	Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) are the most highly expressed transcripts in all EBV-associated tumors and are involved in both lymphoid and epithelioid carcinogenesis. Our previous study on Chinese isolates from non-endemic area of nasopharyngeal carcinoma (NPC) identified new EBER variants (EB-8m and EB-10m) which were less common but relatively more frequent in NPC cases than healthy donors. In the present study, we determined the EBER variants in NPC cases and healthy donors from endemic and non-endemic areas of NPC within China and compared the EBER variants, in relation to the genotypes at BamHI F region (prototype F and f variant), between population groups and between two areas. According to the phylogenetic tree, four EBER variants (EB-6m, EB-8m, EB-10m and B95-8) were identified. EB-6m was dominant in all population groups except for endemic NPC group, in which EB-8m was dominant. EB-8m was more common in endemic NPC cases (82.0%, 41/50) than non-endemic NPC cases (33.7%, 32/95) (p<0.0001), and it was also more frequent in healthy donors from endemic area (32.4%, 24/74) than healthy donors from non-endemic area (1.1%, 1/92) (p<0.0001). More importantly, the EB-8m was more prevalent in NPC cases than healthy donors in both areas (p<0.0001). The f variant, which has been suggested to associate with endemic NPC, demonstrated preferential linkage with EB-8m in endemic isolates, however, the EB-8m variant seemed to be more specific to NPC isolates than f variant. These results reveal high prevalence of EBER EB-8m variant in endemic NPC cases, suggesting an association between NPC development and EBV isolates carrying EB-8m variant. Our finding identified a small healthy population group that shares the same viral strain which predominates in NPC cases. It could be interesting to carry extensive cohort studies following these individuals to evaluate the risk to develop NPC.	[Shen, Zhi-chao; Luo, Bing; Liu, Qian-qian; Wang, Yun] Qingdao Univ, Coll Med, Dept Med Microbiol, Qingdao 266071, Peoples R China; [Chen, Jian-ning; Shao, Chun-kui] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Chao, Yan] Guangdong Prov Hosp Tradit Chinese Med, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China	Qingdao University; Sun Yat Sen University; Guangzhou University of Chinese Medicine	Wang, Y (corresponding author), Qingdao Univ, Coll Med, Dept Med Microbiol, Qingdao 266071, Peoples R China.	qdwangyun@aliyun.com	liu, qian/HDM-2936-2022		National Natural Science Foundation of China [81171571]; Science and Technology plan project of Qingdao City, China [13-1-3-50-nsh]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology plan project of Qingdao City, China	This work was supported by grants from the National Natural Science Foundation of China (81171571, http://www.nsfc.gov.cn) and the Science and Technology plan project of Qingdao City, China (13-1-3-50-nsh, http://www.qdstc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRAND JR, 1989, J VIROL, V63, P983, DOI 10.1128/JVI.63.2.983-986.1989; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; CHANG YS, 1995, INT J CANCER, V62, P673, DOI 10.1002/ijc.2910620605; Chen HL, 1996, J VIROL, V70, P7301, DOI 10.1128/JVI.70.10.7301-7305.1996; Chen JN, 2011, VIRUS RES, V160, P191, DOI 10.1016/j.virusres.2011.06.011; Chen JN, 2010, J MED VIROL, V82, P658, DOI 10.1002/jmv.21731; Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170; Cheung ST, 1998, INT J CANCER, V76, P399, DOI 10.1002/(SICI)1097-0215(19980504)76:3<399::AID-IJC18>3.0.CO;2-6; Cheung ST, 1996, INT J CANCER, V66, P711, DOI 10.1002/(SICI)1097-0215(19960529)66:5<711::AID-IJC21>3.0.CO;2-5; Dolan A, 2006, VIROLOGY, V350, P164, DOI 10.1016/j.virol.2006.01.015; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; FRANK D, 1995, BLOOD, V85, P1396, DOI 10.1182/blood.V85.5.1396.bloodjournal8551396; HU LF, 1993, ONCOGENE, V8, P1575; Hutajulu Susanna H, 2010, Infect Agent Cancer, V5, P16, DOI 10.1186/1750-9378-5-16; Iwakiri D, 2005, ONCOGENE, V24, P1767, DOI 10.1038/sj.onc.1208357; Iwakiri D, 2003, CANCER RES, V63, P7062; Khanim F, 1996, BLOOD, V88, P3491, DOI 10.1182/blood.V88.9.3491.bloodjournal8893491; Klemenc P, 2006, J MED VIROL, V78, P1083, DOI 10.1002/jmv.20666; KNECHT H, 1993, BLOOD, V82, P2937; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; Kwok H, 2014, J VIROL, V88, P10662, DOI 10.1128/JVI.01665-14; Kwok H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036939; Lee WK, 1998, IN VITRO CELL DEV-AN, V34, P97, DOI 10.1007/s11626-998-0090-1; Lei HY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-804; Li DJ, 2009, J MED VIROL, V81, P1253, DOI 10.1002/jmv.21503; LIN JC, 1993, BLOOD, V81, P3372; Lin Z, 2013, J VIROL, V87, P1172, DOI 10.1128/JVI.02517-12; Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11; Lo AKF, 2004, INT J CANCER, V109, P919, DOI 10.1002/ijc.20051; LUNG ML, 1990, VIROLOGY, V177, P44, DOI 10.1016/0042-6822(90)90458-4; LUNG ML, 1991, VIROLOGY, V185, P67, DOI 10.1016/0042-6822(91)90754-Y; Mainou BA, 2006, J VIROL, V80, P6458, DOI 10.1128/JVI.00135-06; Menin C, 1996, MOL CELL PROBE, V10, P453, DOI 10.1006/mcpr.1996.0062; Nanbo A, 2002, REV MED VIROL, V12, P321, DOI 10.1002/rmv.363; Nie YH, 2013, ARCH VIROL, V158, P1031, DOI 10.1007/s00705-012-1578-2; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Ruf IK, 2000, J VIROL, V74, P10223, DOI 10.1128/JVI.74.21.10223-10228.2000; Sandvej K, 2000, J PATHOL, V191, P127, DOI 10.1002/(SICI)1096-9896(200006)191:2<127::AID-PATH614>3.0.CO;2-E; Schuster V, 1996, BLOOD, V87, P1579, DOI 10.1182/blood.V87.4.1579.bloodjournal8741579; Takada K, 2012, SEMIN CANCER BIOL, V22, P162, DOI 10.1016/j.semcancer.2011.12.007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Tsai MH, 2013, CELL REP, V5, P458, DOI 10.1016/j.celrep.2013.09.012; Tsao SW, 2014, ORAL ONCOL, V50, P330, DOI 10.1016/j.oraloncology.2014.02.006; Van Rensburg EJ, 2000, ANTICANCER RES, V20, P1953; Wang JT, 2003, J MED VIROL, V69, P417, DOI 10.1002/jmv.10305; Wang Y, 2007, INTERVIROLOGY, V50, P229, DOI 10.1159/000100566; Wang Y, 2012, VIRUS RES, V166, P23, DOI 10.1016/j.virusres.2012.02.022; Wang Y, 2010, J MED VIROL, V82, P829, DOI 10.1002/jmv.21714; Wang Y, 2010, VIRUS RES, V147, P258, DOI 10.1016/j.virusres.2009.11.010; Wong HL, 2005, MOL CARCINOGEN, V44, P92, DOI 10.1002/mc.20133; Wu SJ, 1996, J MED VIROL, V50, P314, DOI 10.1002/(SICI)1096-9071(199612)50:4&lt;314::AID-JMV6&gt;3.0.CO;2-B; Wu Y, 2007, J VIROL, V81, P11236, DOI 10.1128/JVI.00579-07; Xiaoshi Z., 2001, J PRACT ONCOL, V16, P301; Yajima M, 2005, J VIROL, V79, P4298, DOI 10.1128/JVI.79.7.4298-4307.2005; Young LS, 2006, NAT REV CANCER, V4, P757; Zeng MS, 2005, J VIROL, V79, P15323, DOI 10.1128/JVI.79.24.15323-15330.2005; Zhang XS, 2004, CANCER LETT, V211, P11, DOI 10.1016/j.canlet.2004.01.035; Zhang XS, 2002, CANCER LETT, V176, P65, DOI 10.1016/S0304-3835(01)00733-9; Zhou XG, 2001, J GEN VIROL, V82, P1157, DOI 10.1099/0022-1317-82-5-1157	62	10	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121420	10.1371/journal.pone.0121420	http://dx.doi.org/10.1371/journal.pone.0121420			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807550	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000154
J	Techtmann, SM; Fortney, JL; Ayers, KA; Joyner, DC; Linley, TD; Pfiffner, SM; Hazen, TC				Techtmann, Stephen M.; Fortney, Julian L.; Ayers, Kati A.; Joyner, Dominique C.; Linley, Thomas D.; Pfiffner, Susan M.; Hazen, Terry C.			The Unique Chemistry of Eastern Mediterranean Water Masses Selects for Distinct Microbial Communities by Depth	PLOS ONE			English	Article							DEEP-SEA FAN; PHOSPHORUS STARVATION; BACTERIAL COMMUNITIES; ASSEMBLAGES; PROCHLOROCOCCUS; LIMITATION; OXIDATION; SEDIMENT; AMMONIA; SHAPES	The waters of the Eastern Mediterranean are characterized by unique physical and chemical properties within separate water masses occupying different depths. Distinct water masses are present throughout the oceans, which drive thermohaline circulation. These water masses may contain specific microbial assemblages. The goal of this study was to examine the effect of physical and geological phenomena on the microbial community of the Eastern Mediterranean water column. Chemical measurements were combined with phospholipid fatty acid (PLFA) analysis and high-throughput 16S rRNA sequencing to characterize the microbial community in the water column at five sites. We demonstrate that the chemistry and microbial community of the water column were stratified into three distinct water masses. The salinity and nutrient concentrations vary between these water masses. Nutrient concentrations increased with depth, and salinity was highest in the intermediate water mass. Our PLFA analysis indicated different lipid classes were abundant in each water mass, suggesting that distinct groups of microbes inhabit these water masses. 16S rRNA gene sequencing confirmed the presence of distinct microbial communities in each water mass. Taxa involved in autotrophic nitrogen cycling were enriched in the intermediate water mass suggesting that microbes in this water mass may be important to the nitrogen cycle of the Eastern Mediterranean. The Eastern Mediterranean also contains numerous active hydrocarbon seeps. We sampled above the North Alex Mud Volcano, in order to test the effect of these geological features on the microbial community in the adjacent water column. The community in the waters overlaying the mud volcano was distinct from other communities collected at similar depths and was enriched in known hydrocarbon degrading taxa. Our results demonstrate that physical phenomena such stratification as well as geological phenomena such as mud volcanoes strongly affect microbial community structure in the Eastern Mediterranean water column.	[Techtmann, Stephen M.; Fortney, Julian L.; Joyner, Dominique C.; Hazen, Terry C.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA; [Techtmann, Stephen M.; Fortney, Julian L.; Ayers, Kati A.; Joyner, Dominique C.; Pfiffner, Susan M.; Hazen, Terry C.] Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA; [Ayers, Kati A.; Hazen, Terry C.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Linley, Thomas D.] Univ Aberdeen, Ocean Lab, Newburgh, Aberdeen, Scotland; [Pfiffner, Susan M.; Hazen, Terry C.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Hazen, Terry C.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Aberdeen; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Techtmann, SM (corresponding author), Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA.	stephen.techtmann@gmail.com	Hazen, Terry C/C-1076-2012	Hazen, Terry C/0000-0002-2536-9993	University of Tennessee [A13-0119-001]; BP America [A13-0119-001]	University of Tennessee; BP America	This research was supported by contract A13-0119-001 Deep Sea Basin Microbiology between the University of Tennessee and BP America. The sponsors helped to organize sample collection but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HE, 2010, ENVIRON MICROBIOL, V12, P1319, DOI 10.1111/j.1462-2920.2010.02176.x; Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; Alves Junior N, 2014, ARCH MICROBIOL, V10, P1; Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ARMSTRONG FA, 1967, DEEP-SEA RES, V14, P381, DOI 10.1016/0011-7471(67)90082-4; Aronesty E, EA UTILS COMMAND LIN; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; BETHOUX JP, 1986, LIMNOL OCEANOGR, V31, P1353, DOI 10.4319/lo.1986.31.6.1353; Bouman HA, 2011, ENV MICROBIOL REP, V3, P473, DOI 10.1111/j.1758-2229.2011.00241.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Dalsgaard T, 2005, RES MICROBIOL, V156, P457, DOI 10.1016/j.resmic.2005.01.011; Dang HY, 2010, APPL ENVIRON MICROB, V76, P7036, DOI 10.1128/AEM.01264-10; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dupre S, 2010, MAR GEOL, V275, P1, DOI 10.1016/j.margeo.2010.04.003; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fagervold SK, 2014, ISME J, V8, P2327, DOI 10.1038/ismej.2014.86; Feingersch R, 2010, ISME J, V4, P78, DOI 10.1038/ismej.2009.92; Felden J, 2013, BIOGEOSCIENCES, V10, P3269, DOI 10.5194/bg-10-3269-2013; Fernandez-Gomez B, 2013, ISME J, V7, P1026, DOI 10.1038/ismej.2012.169; Findlay R., 1993, HDB METHODS AQUATIC, P271; FRANCISCO DE, 1973, T AM MICROSC SOC, V92, P416, DOI 10.2307/3225245; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Glaubitz S, 2013, APPL ENVIRON MICROB, V79, P2767, DOI 10.1128/AEM.03777-12; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Green CT, 2000, HYDROGEOL J, V8, P126, DOI 10.1007/s100400050013; Hamdan LJ, 2013, ISME J, V7, P685, DOI 10.1038/ismej.2012.143; Hazen TC, 2013, CURR OPIN BIOTECH, V24, P526, DOI 10.1016/j.copbio.2012.10.020; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Heijs SK, 2008, FEMS MICROBIOL ECOL, V64, P362, DOI 10.1111/j.1574-6941.2008.00463.x; Ibello V, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041635; Kelley D., OCE ANAL OCEANOGRAPH; Kerouel R, 1997, MAR CHEM, V57, P265, DOI 10.1016/S0304-4203(97)00040-6; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Krom MD, 2010, PROG OCEANOGR, V85, P236, DOI 10.1016/j.pocean.2010.03.003; Krumhardt KM, 2013, ENVIRON MICROBIOL, V15, P2114, DOI 10.1111/1462-2920.12079; Lamy D, 2011, BIOGEOSCIENCES, V8, P973, DOI 10.5194/bg-8-973-2011; Loncke L, 2004, MAR PETROL GEOL, V21, P669, DOI 10.1016/j.marpetgeo.2004.02.004; Loncke L, 2006, MAR PETROL GEOL, V23, P297, DOI 10.1016/j.marpetgeo.2006.01.001; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mastalerz V, 2009, GEOCHIM COSMOCHIM AC, V73, P3849, DOI 10.1016/j.gca.2008.12.030; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; Mills CT, 2006, MAR CHEM, V98, P197, DOI 10.1016/j.marchem.2005.10.001; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Oksanen J., **DATA OBJECT**; Omoregie EO, 2009, MAR GEOL, V261, P114, DOI 10.1016/j.margeo.2009.02.001; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Pantoja S, 2002, DEEP-SEA RES PT I, V49, P1609, DOI 10.1016/S0967-0637(02)00066-3; R Core Team, R LANG ENV STAT COMP; Rahav E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00227; Reistetter EN, 2013, ENVIRON MICROBIOL, V15, P2129, DOI 10.1111/1462-2920.12129; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Ritt B, 2011, MAR BIOL, V158, P1187, DOI 10.1007/s00227-011-1679-6; Roberts DW., 2007, LABDSV ORDINATION MU; Schlitzer R., 2014, OCEAN DATA VIEW; Seymour JR, 2012, ENV MICROBIOL REP, V4, P548, DOI 10.1111/j.1758-2229.2012.00362.x; Sheik CS, 2014, ENVIRON MICROBIOL, V16, P304, DOI 10.1111/1462-2920.12165; Skliris N, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P29, DOI 10.1007/978-94-007-6704-1_3; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Thingstad TF, 2005, SCIENCE, V309, P1068, DOI 10.1126/science.1112632; Urakawa H, 2014, LIMNOL OCEANOGR, V59, P1321, DOI 10.4319/lo.2014.59.4.1321; Varela MM, 2008, ENVIRON MICROBIOL, V10, P1903, DOI 10.1111/j.1462-2920.2008.01627.x; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White D.C., 1998, TECHNIQUES MICROBIAL; WHITE DC, 1996, MANUAL ENV MICROBIOL, P91; Wilkins D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3457; Yogev T, 2011, ENVIRON MICROBIOL, V13, P854, DOI 10.1111/j.1462-2920.2010.02402.x; Yokokawa T, 2010, AQUAT MICROB ECOL, V59, P185, DOI 10.3354/ame01393	81	44	46	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120605	10.1371/journal.pone.0120605	http://dx.doi.org/10.1371/journal.pone.0120605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807542	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000090
J	Titus, BM; Daly, M; Exton, DA				Titus, Benjamin M.; Daly, Marymegan; Exton, Dan A.			Do Reef Fish Habituate to Diver Presence? Evidence from Two Reef Sites with Contrasting Historical Levels of SCUBA Intensity in the Bay Islands, Honduras	PLOS ONE			English	Article							UNDERWATER BREATHING APPARATUS; FLIGHT INITIATION DISTANCE; HUMAN DISTURBANCE; BEHAVIORAL-RESPONSES; CORAL-REEF; POPULATIONS; PREDATORS; RATES; SEA	Contact between humans and the marine environment is increasing, but the capacity of communities to adapt to human presence remains largely unknown. The popularization of SCUBA diving has added a new dimension to human impacts in aquatic systems and, although individual-level impacts have been identified, cumulative effects on ecosystem function and community-wide responses are unclear. In principle, habituation may mitigate the consequences of human presence on the biology of an individual and allow the quick resumption of its ecological roles, but this has not been documented in aquatic systems. Here, we investigate the short-term impact of human presence and the long-term habituation potential of reef-fish communities to recreational SCUBA divers by studying symbiotic cleaning interactions on coral reefs with differing levels of historical contact with divers. We show that incidences of human contact result in a smaller decline in ecosystem function and more rapid resumption of baseline services on a reef in Utila, Honduras that has heavy historical levels of SCUBA diver presence, compared to an un-dived reef site in the Cayos Cochinos Marine Protected Area (CCMPA). Nonetheless, despite the generally smaller change in ecosystem function and decades of regular contact with divers, cleaning behavior is suppressed by >50% at Utila when divers are present. We hypothesize that community-wide habituation of reef fish is not fully achievable and may be biologically restricted to only partial habituation. Differential responses to human presence impacts the interpretation and execution of behavioral research where SCUBA is the predominant means of data collection, and provides an important rationale for future research investigating the interplay between human presence, ecosystem function, and community structure on coral reefs.	[Titus, Benjamin M.; Daly, Marymegan] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Titus, Benjamin M.; Exton, Dan A.] Operat Wallacea, Spilsby, Lincs, England	University System of Ohio; Ohio State University	Titus, BM (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA.	titus.42@osu.edu	Daly, Marymegan/F-9178-2011; Exton, Dan/L-5695-2019	Exton, Dan/0000-0001-8885-5828; Titus, Benjamin/0000-0002-0401-1570	Operation Wallacea; Ohio State University Museum of Biological Diversity Trautman Fund; Ohio State University Open Access Fund	Operation Wallacea; Ohio State University Museum of Biological Diversity Trautman Fund; Ohio State University Open Access Fund	This work was funded by Operation Wallacea and The Ohio State University Museum of Biological Diversity Trautman Fund. Partial funding for Open Access provided by The Ohio State University Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Operation Wallacea provided support in the form of salaries for authors [BT, DE], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; Becker JH, 2004, CORAL REEFS, V23, P515, DOI 10.1007/s00338-004-0429-3; Biro PA, 2003, ECOLOGY, V84, P2419, DOI 10.1890/02-0416; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Briones-Fourzan P, 2012, MAR ECOL PROG SER, V470, P55, DOI 10.3354/meps10030; Bshary R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-21; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Cote IM, 1998, J FISH BIOL, V53, P256, DOI 10.1111/j.1095-8649.1998.tb01031.x; Dearden P, 2010, ENVIRON MONIT ASSESS, V163, P531, DOI 10.1007/s10661-009-0855-3; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Domenici P, 2010, J MAR BIOL ASSOC UK, V88, P625; Fowler GS, 1999, BIOL CONSERV, V90, P143, DOI 10.1016/S0006-3207(99)00026-9; Fox RJ, 2008, MAR BIOL, V154, P325, DOI 10.1007/s00227-008-0927-x; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Huebner LK, 2012, J MAR BIOL ASSOC UK, V92, P1557, DOI 10.1017/S0025315411001822; IBM Corp, 2012, IBM SPSS STAT MAC VE; Jack KM, 2008, AM J PRIMATOL, V70, P490, DOI 10.1002/ajp.20512; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; JOHNSON WS, 1988, ENVIRON BIOL FISH, V23, P225, DOI 10.1007/BF00004913; Kerr GD, 2004, J HERPETOL, V38, P519, DOI 10.1670/13-04A; Klailova M, 2010, AM J PRIMATOL, V72, P897, DOI 10.1002/ajp.20829; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Li CW, 2011, APPL ANIM BEHAV SCI, V129, P146, DOI 10.1016/j.applanim.2010.11.013; Lobel P.S., 2005, P AM AC UND SCI U CO, P49; Longo GO, 2012, J FISH BIOL, V81, P1773, DOI 10.1111/j.1095-8649.2012.03441.x; McCammon A, 2010, CORAL REEFS, V29, P419, DOI 10.1007/s00338-009-0583-8; NELSON DR, 1977, AM ZOOL, V17, P501; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Radford CA, 2005, MAR FRESHW BEHAV PHY, V38, P259, DOI 10.1080/10236240500333908; Seifert DD, 2013, THE OBSERVER EFFECT; Sih A, 2013, ANIM BEHAV, V85, P1077, DOI 10.1016/j.anbehav.2013.02.017; Thomas K, 2003, BIOL CONSERV, V109, P67, DOI 10.1016/S0006-3207(02)00137-4	36	39	39	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119645	10.1371/journal.pone.0119645	http://dx.doi.org/10.1371/journal.pone.0119645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807543	Green Submitted, gold, Green Published			2022-12-26	WOS:000351880000034
J	Zhu, L; Yin, QY; Irwin, DM; Zhang, SY				Zhu, Lei; Yin, Qiuyuan; Irwin, David M.; Zhang, Shuyi			Phosphoenolpyruvate Carboxykinase 1 Gene (Pck1) Displays Parallel Evolution between Old World and New World Fruit Bats	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; AMINO-ACID SITES; METABOLISM; GLUCONEOGENESIS; CONVERGENT; INFERENCE; ENERGY; GLYCERONEOGENESIS; HYPOGLYCEMIA; HEPATOCYTES	Bats are an ideal mammalian group for exploring adaptations to fasting due to their large variety of diets and because fasting is a regular part of their life cycle. Mammals fed on a carbohydrate-rich diet experience a rapid decrease in blood glucose levels during a fast, thus, the development of mechanisms to resist the consequences of regular fasts, experienced on a daily basis, must have been crucial in the evolution of frugivorous bats. Phosphoenolpyruvate carboxykinase 1 (PEPCK1, encoded by the Pck1 gene) is the rate-limiting enzyme in gluconeogenesis and is largely responsible for the maintenance of glucose homeostasis during fasting in fruit-eating bats. To test whether Pck1 has experienced adaptive evolution in frugivorous bats, we obtained Pck1 coding sequence from 20 species of bats, including five Old World fruit bats (OWFBs) (Pteropodidae) and two New World fruit bats (NWFBs) (Phyllostomidae). Our molecular evolutionary analyses of these sequences revealed that Pck1 was under purifying selection in both Old World and New World fruit bats with no evidence of positive selection detected in either ancestral branch leading to fruit bats. Interestingly, however, six specific amino acid substitutions were detected on the ancestral lineage of OWFBs. In addition, we found considerable evidence for parallel evolution, at the amino acid level, between the PEPCK1 sequences of Old World fruit bats and New World fruit bats. Test for parallel evolution showed that four parallel substitutions (Q276R, R503H, I558V and Q593R) were driven by natural selection. Our study provides evidence that Pck1 underwent parallel evolution between Old World and New World fruit bats, two lineages of mammals that feed on a carbohydrate-rich diet and experience regular periods of fasting as part of their life cycle.	[Zhu, Lei; Yin, Qiuyuan; Zhang, Shuyi] E China Normal Univ, Inst Mol Ecol & Evolut, SKLEC, Shanghai 200062, Peoples R China; [Zhu, Lei; Yin, Qiuyuan; Zhang, Shuyi] E China Normal Univ, IECR, Shanghai 200062, Peoples R China; [Zhu, Lei; Yin, Qiuyuan; Zhang, Shuyi] E China Normal Univ, IAIR, Shanghai 200062, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	East China Normal University; East China Normal University; East China Normal University; University of Toronto	Zhang, SY (corresponding author), E China Normal Univ, Inst Mol Ecol & Evolut, SKLEC, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn		Irwin, David/0000-0001-6131-4933	Key Construction Program of the National '985 Project'; Key Construction Program of the National '211 Project'; Shanghai Excellent Academic Leaders Project [11XD1402000]	Key Construction Program of the National '985 Project'; Key Construction Program of the National '211 Project'; Shanghai Excellent Academic Leaders Project	This work was supported by the Key Construction Program of the National '985 Project' and '211 Project' and Shanghai Excellent Academic Leaders Project (Grant No. 11XD1402000) to SZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 1996, BATS BIOL BEHAV; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; AUSTAD SN, 1991, J GERONTOL, V46, pB47, DOI 10.1093/geronj/46.2.B47; Bassett JE, 2004, COMP BIOCHEM PHYS A, V137, P271, DOI 10.1016/j.cbpb.2003.10.002; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Ben-Hamo Miriam, 2012, P257; Bickham JW, 2004, MOL PHYLOGENET EVOL, V33, P333, DOI 10.1016/j.ympev.2004.06.012; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; BOYLE PJ, 1989, AM J PHYSIOL, V256, pE651, DOI 10.1152/ajpendo.1989.256.5.E651; Brunner Y, 2009, J PROTEOMICS, V71, P576, DOI 10.1016/j.jprot.2008.10.002; Cadoudal T, 2008, M S-MED SCI, V24, P407, DOI 10.1051/medsci/2008244407; Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; DASILVA RSM, 1990, COMP BIOCHEM PHYS A, V96, P415, DOI 10.1016/0300-9629(90)90105-2; Davies KTJ, 2012, HEREDITY, V108, P480, DOI 10.1038/hdy.2011.119; Dunten P, 2002, J MOL BIOL, V316, P257, DOI 10.1006/jmbi.2001.5364; Ferrier D, 2011, LIPPINCOTTS ILLUSTRA; Goto M, 2001, PEDIATR RES, V49, P552, DOI 10.1203/00006450-200104000-00018; Hanson R W, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P203; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; HANSON RW, 1976, GLUCONEOGENESIS ITS; Harrison JF, 2000, ANNU REV PHYSIOL, V62, P179, DOI 10.1146/annurev.physiol.62.1.179; Houten SM, 2013, HUM MOL GENET, V22, P5249, DOI 10.1093/hmg/ddt382; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Johnson TA, 2012, BIOCHEMISTRY-US, V51, P9547, DOI 10.1021/bi301278t; KEEGAN DJ, 1977, COMP BIOCHEM PHYS A, V58, P349, DOI 10.1016/0300-9629(77)90153-0; KETTELHUT IC, 1980, AM J PHYSIOL, V239, pR437, DOI 10.1152/ajpregu.1980.239.5.R437; Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002; Korine C, 1999, J COMP PHYSIOL B, V169, P280, DOI 10.1007/s003600050222; Kunz TH, 2006, BAT ECOLOGY; Lardy H, 1972, ENZYMES, P117; Liu Y, 2012, MOL BIOL EVOL, V29, P1507, DOI 10.1093/molbev/mss013; Liu Y, 2012, MOL BIOL EVOL, V29, P1441, DOI 10.1093/molbev/msr310; Maddison W., 2018, MESQUITE MODULAR SYS; McCue M.D., 2012, COMP PHYSL FASTING S; Mithieux G, 2009, CURR OPIN CLIN NUTR, V12, P419, DOI 10.1097/MCO.0b013e32832c4d6a; Munshi-South J, 2010, AGEING RES REV, V9, P12, DOI 10.1016/j.arr.2009.07.006; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neuweiler G., 2000, BIOL BATS; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Pinheiro EC, 2006, COMP BIOCHEM PHYS B, V143, P279, DOI 10.1016/j.cbpb.2005.11.013; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, STAT BIOL HEALTH, P125, DOI 10.1007/0-387-27733-1_6; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pride DT, 2000, SWAAP TOOL ANAL SUBS; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Segura Julian, 2013, Med Clin (Barc), V141 Suppl 2, P26, DOI 10.1016/S0025-7753(13)70060-5; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Shen B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062307; Shen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033197; Shen YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008838; Shrayyef MZ, 2010, PRINCIPLES OF DIABETES MELLITUS, SECOND EDITION, P19, DOI 10.1007/978-0-387-09841-8_2; Szewczak JM, 1997, AM ZOOL, V37, P92; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VEIGA JAS, 1982, BRAZ J MED BIOL RES, V15, P175; Voigt CC, 2011, BIOTROPICA, V43, P108, DOI 10.1111/j.1744-7429.2010.00632.x; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YU H, 1993, GENOMICS, V15, P219, DOI 10.1006/geno.1993.1040; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789; Zhang QH, 2014, FASEB J, V28; Zhou XM, 2012, SYST BIOL, V61, P150, DOI 10.1093/sysbio/syr089	69	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0118666	10.1371/journal.pone.0118666	http://dx.doi.org/10.1371/journal.pone.0118666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807515	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000009
J	Noh, KT; Son, KH; Jung, ID; Kang, TH; Choi, CH; Park, YM				Noh, Kyung Tae; Son, Kwang Hee; Jung, In Duk; Kang, Tae Heung; Choi, Chang Hun; Park, Yeong-Min			Glycogen Synthase Kinase-3 (GSK-3) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon--induced Indoleamine 2,3-Dioxygenase Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; dendritic cell; glycogen synthase kinase 3 (GSK-3); indoleamine-pyrrole 2; 3-dioxygenase (IDO1); interferon; cancer vaccine	IFN-GAMMA; REJECTION; ACTIVATION; TOLERANCE; STAT1; GENE; LPS	Background: IDO functions as a crucial mediator of tumor-mediated immune tolerance. Results: Here, we found that GSK-3-dependent IDO expression in the dendritic cell plays a role in anti-tumor activity via the regulation of CD8(+) T-cell proliferation and CTL activity. Conclusion: GSK-3 activity functions in the immune enhancement-mediated anti-tumor response via IDO regulation. Significance: We proved the effectiveness of the GSK-3-dependent IDO regulatory mechanism in DC-based cancer vaccination. Indoleamine 2,3-dioxygenase (IDO) functions as a crucial mediator of tumor-mediated immune tolerance by causing T-cell suppression via tryptophan starvation in a tumor environment. Glycogen synthase kinase-3 (GSK-3) is also involved in immune and anti-tumor responses. However, the relativity of these proteins has not been as well defined. Here, we found that GSK-3-dependent IDO expression in the dendritic cell (DC) plays a role in anti-tumor activity via the regulation of CD8(+) T-cell polarization and cytotoxic T lymphocyte activity. By the inhibition of GSK-3, attenuated IDO expression and impaired JAK1/2-Stat signaling crucial for IDO expression were observed. Protein kinase C (PKC) activity and the interaction between JAK1/2 and Stat3, which are important for IDO expression, were also reduced by GSK-3 inhibition. CD8(+) T-cell proliferation mediated by OVA-pulsed DC was blocked by interferon (IFN)--induced IDO expression via GSK-3 activity. Specific cytotoxic T lymphocyte activity mediated by OVA-pulsed DC against OVA-expressing EG7 thymoma cells but not OVA-nonexpressing EL4 thymoma cells was also attenuated by the expressed IDO via IFN--induced activation of GSK-3. Furthermore, tumor growth that was suppressed with OVA-pulsed DC vaccination was restored by IDO-expressing DC via IFN--induced activation of GSK-3 in an OVA-expressing murine EG7 thymoma model. Taken together, DC-based immune response mediated by interferon--induced IDO expression via GSK-3 activity not only regulates CD8(+) T-cell proliferation and cytotoxic T lymphocyte activity but also modulates OVA-pulsed DC vaccination against EG7 thymoma.	[Noh, Kyung Tae; Choi, Chang Hun] Armed Forces Med Res Inst, Dept Infect Dis, Taejon 305878, South Korea; [Son, Kwang Hee; Jung, In Duk; Kang, Tae Heung; Park, Yeong-Min] Konkuk Univ, Sch Med, Dept Immunol, Lab Dendrit Cell Differentiat & Regulat, Chungju 380701, South Korea	Konkuk University; Konkuk University Medical Center	Noh, KT (corresponding author), Armed Forces Med Res Inst, Dept Infect Dis, 90bun, Taejon 305878, South Korea.	nkt2062@hanmail.net; immun3023@kku.ac.kr			Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science and Technology [2012R1A1A2042924, 2012R1A2A1A03008433]	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science and Technology	This work was supported by the Basic Science Research Program Grants 2012R1A1A2042924 and 2012R1A2A1A03008433 through National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Chon SY, 1996, J BIOL CHEM, V271, P17247, DOI 10.1074/jbc.271.29.17247; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ferrantini M, 2008, CYTOKINE GROWTH F R, V19, P93, DOI 10.1016/j.cytogfr.2007.10.003; Friberg M, 2002, INT J CANCER, V101, P151, DOI 10.1002/ijc.10645; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jeong YI, 2009, J BIOL CHEM, V284, P3700, DOI 10.1074/jbc.M807328200; Lin CF, 2008, J CELL BIOCHEM, V105, P746, DOI 10.1002/jcb.21868; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Noh KT, 2011, EXP CELL RES, V317, P1663, DOI 10.1016/j.yexcr.2011.03.022; Noh KT, 2010, FEBS LETT, V584, P4097, DOI 10.1016/j.febslet.2010.08.029; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; TAKIKAWA O, 1990, J IMMUNOL, V145, P1246; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Zhang YY, 2000, BLOOD, V95, P138	26	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12394	12402		10.1074/jbc.M114.628578	http://dx.doi.org/10.1074/jbc.M114.628578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25814664	Green Published, hybrid			2022-12-26	WOS:000354388600047
J	Blazquez, R; Sanchez-Margallo, FM; Crisostomo, V; Baez, C; Maestre, J; Garcia-Lindo, M; Usoon, A; Alvarez, V; Casado, JG				Blazquez, Rebeca; Miguel Sanchez-Margallo, Francisco; Crisostomo, Veronica; Baez, Claudia; Maestre, Juan; Garcia-Lindo, Monica; Uson, Alejandra; Alvarez, Veronica; Casado, Javier G.			Intrapericardial Administration of Mesenchymal Stem Cells in a Large Animal Model: A Bio-Distribution Analysis	PLOS ONE			English	Article							VENTRICULAR-ARRHYTHMIAS; CARDIOVASCULAR-DISEASE; TECHNICAL FEASIBILITY; MYOCARDIAL-INFARCTION; HEART-FAILURE; DELIVERY; THERAPY; INTRACORONARY; INJECTION; ACCESS	The appropriate administration route for cardiovascular cell therapy is essential to ensure the viability, proliferative potential, homing capacity and implantation of transferred cells. At the present, the intrapericardial administration of pharmacological agents is considered an efficient method for the treatment of cardiovascular diseases. However, only a few reports have addressed the question whether the intrapericardial delivery of Mesenchymal Stem Cells (MSCs) could be an optimal administration route. This work firstly aimed to analyze the pericardial fluid as a cell-delivery vehicle. Moreover, the in vivo biodistribution pattern of intrapericardially administered MSCs was evaluated in a clinically relevant large animal model. Our in vitro results firstly showed that, MSCs viability, proliferative behavior and phenotypic profile were unaffected by exposure to pericardial fluid. Secondly, in vivo cell tracking by magnetic resonance imaging, histological examination and Y-chromosome amplification clearly demonstrated the presence of MSCs in pericardium, ventricles (left and right) and atrium (left and right) when MSCs were administered into the pericardial space. In conclusion, here we demonstrate that pericardial fluid is a suitable vehicle for MSCs and intrapericardial route provides an optimal retention and implantation of MSCs.	[Blazquez, Rebeca; Miguel Sanchez-Margallo, Francisco; Uson, Alejandra; Alvarez, Veronica; Casado, Javier G.] Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain; [Crisostomo, Veronica; Baez, Claudia; Maestre, Juan] Minimally Invas Surg Ctr, Endoluminal Therapy & Diag, Caceres, Spain; [Garcia-Lindo, Monica] Minimally Invas Surg Ctr, Anaesthet Unit, Caceres, Spain		Casado, JG (corresponding author), Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain.	jgarcia@ccmijesususon.com	Sánchez Margallo, Francisco Miguel Miguel/I-5605-2019; Pérez, Verónica Álvarez/AAP-1021-2020; Blazquez, Rebeca/D-9523-2017; Blazquez Duran, Rebeca/A-9008-2015; Garcia, Javier/X-4319-2018; Blázquez, Rebeca/Q-2588-2019; García, Javier/AAH-1330-2020; G Casado, Javier/ABE-9043-2021	Sánchez Margallo, Francisco Miguel Miguel/0000-0003-2138-988X; Pérez, Verónica Álvarez/0000-0002-7319-6089; Blazquez, Rebeca/0000-0002-1149-8305; Blazquez Duran, Rebeca/0000-0002-1149-8305; Blázquez, Rebeca/0000-0002-1149-8305; Crisostomo, Veronica/0000-0003-1740-7029; Baez Diaz, Claudia/0000-0001-9031-2929; G Casado, Javier/0000-0001-6797-7287	Redes tematicas de investigacion cooperativa en salud [RD12/0042/0025, 242038]; GobEx; FSE [TE12066, TA13042]; FEDER [IB13123]	Redes tematicas de investigacion cooperativa en salud; GobEx; FSE(European Social Fund (ESF)); FEDER(European Commission)	This work was supported in part by two grants from Redes tematicas de investigacion cooperativa en salud (RD12/0042/0025 to FMSM and CB) and European FP7-HEALTH-2009-1.4-3 (Grant Agreement 242038). Two grants from GobEx cofinanced by FSE (TE12066 to RB and TA13042 to JGC). One grant from GobEx cofinanced by FEDER to JGC (IB13123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Berman SMC, 2013, MAGN RESON MED, V69, P255, DOI 10.1002/mrm.24216; Bull E, 2014, INT J NANOMED, V9, P1641, DOI 10.2147/IJN.S48979; Casado JG, 2013, STEM CELL REV REP, V9, P184, DOI 10.1007/s12015-013-9430-y; Crisostomo V, 2013, ISRN CARDIOL; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; Fei L, 1997, CIRCULATION, V96, P4044; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; Fukushima S, 2013, FUTUR CARDIOL, V9, P215, DOI [10.2217/FCA.12.85, 10.2217/fca.12.85]; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Grieve SM, 2010, CIRC-HEART FAIL, V3, pE5, DOI 10.1161/CIRCHEARTFAILURE.109.931360; Gomez-Mauricio RG, 2013, EUR J PHARM BIOPHARM, V84, P29, DOI 10.1016/j.ejpb.2012.11.028; Hoogduijn MJ, 2011, HUM GENE THER, V22, P1587, DOI 10.1089/hum.2011.039; Huang NF, 2009, REGEN MED, V4, P527, DOI 10.2217/RME.09.32; Hyun JS, 2013, BIOTECHNOL ADV, V31, P736, DOI 10.1016/j.biotechadv.2012.11.003; Ittrich H, 2013, ROFO-FORTSCHR RONTG, V185, P1149, DOI 10.1055/s-0033-1335438; Jasmin, 2012, Methods Mol Biol, V906, P239, DOI 10.1007/978-1-61779-953-2_18; Kornowski R, 2000, CIRCULATION, V101, P454, DOI 10.1161/01.CIR.101.4.454; Ladage D, 2011, GENE THER, V18, P979, DOI 10.1038/gt.2011.52; Laham RJ, 2003, CATHETER CARDIO INTE, V58, P375, DOI 10.1002/ccd.10378; Laham RJ, 2000, J PHARMACOL EXP THER, V292, P795; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Maisch B, 2012, HERZ, V37, P644, DOI 10.1007/s00059-012-3679-9; Mazo M, 2011, J CARDIOVASC TRANSL, V4, P145, DOI 10.1007/s12265-010-9246-y; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Plant AL, 2013, STEM CELLS DEV, V22, P2457, DOI 10.1089/scd.2013.0188; RIEMANN D, 1994, INT ARCH ALLERGY IMM, V104, P48, DOI 10.1159/000236708; Ruiz-Esparza GU, 2013, INT J NANOMED, V8, P629, DOI 10.2147/IJN.S30599; Rupp H, 2010, HERZ, V35, P458, DOI 10.1007/s00059-010-3382-7; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sharma R, 2007, STEM CELLS DEV, V16, P517, DOI 10.1089/scd.2006.0070; Sheng CC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/547902; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Sun F, 2006, RADIOLOGY, V238, P719, DOI 10.1148/radiol.2382042182; Sun F, 2012, J INVASIVE CARDIOL, V24, P210; Trivedi P, 2010, STEM CELLS DEV, V19, P1109, DOI 10.1089/scd.2009.0465; van Ramshorst J, 2011, J CARDIOVASC TRANSL, V4, P182, DOI 10.1007/s12265-010-9249-8; Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Xiao YF, 2008, AM J PHYSIOL-HEART C, V294, pH2212, DOI 10.1152/ajpheart.91502.2007; Yang Y, 2012, NMR BIOMED, V25, P227, DOI 10.1002/nbm.1735	43	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122377	10.1371/journal.pone.0122377	http://dx.doi.org/10.1371/journal.pone.0122377			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816232	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600173
J	Jia, XJ; Ying, LH; Zhou, X; Wu, XC; Lin, CD				Jia, Xuji; Ying, Liuhua; Zhou, Xiao; Wu, Xinchun; Lin, Chongde			The Effects of Extraversion, Social Support on the Posttraumatic Stress Disorder and Posttraumatic Growth of Adolescent Survivors of the Wenchuan Earthquake	PLOS ONE			English	Article							PERSONAL RELATIONSHIPS; CHILD SURVIVORS; BREAST-CANCER; PTSD SYMPTOMS; RISK-FACTORS; PREDICTORS; TRAUMA; ADJUSTMENT; NETWORKS; STUDENTS	Objective The aim of this study was to examine the relationships among extraversion, social support, posttraumatic stress disorder and posttraumatic growth among adolescent survivors of the Wenchuan earthquake. Methods Six hundred thirty-eight participants were selected from the survivors of the 2008 Wenchuan earthquake. Participants completed four main questionnaires, including the Extraversion Subscale, the Social Support Scale, the Child PTSD Symptom Scale, and the Posttraumatic Growth Inventory. Results A bivariate correlation analysis revealed significant correlations among extraversion, social support, posttraumatic stress disorder and posttraumatic growth. Extraversion had significant indirect effects on posttraumatic stress disorder (beta = -.037, p < .01) and posttraumatic growth (beta = .077, p < .001) through social support. The results also indicated that extraversion had a significant direct effect on posttraumatic growth and a nonsignificant direct effect on posttraumatic stress disorder. Conclusions Social support fully mediates the relationship between extraversion and posttraumatic stress disorder and partially mediates the relationship between extraversion and posttraumatic growth. Psychological interventions and care for survivors of the earthquake should include the various functions and sources of social support and how they serve to benefit individuals.	[Jia, Xuji; Zhou, Xiao; Wu, Xinchun; Lin, Chongde] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China; [Ying, Liuhua] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University; Zhejiang Sci-Tech University	Lin, CD (corresponding author), Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China.	linchongde@263.net			Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China [08JZD0026]	Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China(Ministry of Education, China)	This study was supported by Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China (Grant number: 08JZD0026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck G, 1996, J PERS, V64, P899, DOI 10.1111/j.1467-6494.1996.tb00948.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; AMIRKHAN JH, 1995, J PERS, V63, P189, DOI 10.1111/j.1467-6494.1995.tb00807.x; An Y, 2013, PSYCHOL DEV ED, V29, P653; Andrews B, 2003, J TRAUMA STRESS, V16, P421, DOI 10.1023/A:1024478305142; Andrykowski MA, 1998, J TRAUMA STRESS, V11, P189, DOI 10.1023/A:1024490718043; Antoni MH, 2001, HEALTH PSYCHOL, V20, P20, DOI 10.1037/0278-6133.20.1.20; Bensimon M, 2012, PERS INDIV DIFFER, V52, P782, DOI 10.1016/j.paid.2012.01.011; Boyraz G, 2012, DEATH STUD, V36, P519, DOI 10.1080/07481187.2011.553331; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Costa P.T., 1985, NEO PERSONALITY INVE; Cryder CH, 2006, AM J ORTHOPSYCHIAT, V76, P65, DOI 10.1037/0002-9432.76.1.65; Dekel S, 2012, PSYCHOL TRAUMA-US, V4, P94, DOI 10.1037/a0021865; Dorfel D, 2008, J LOSS TRAUMA, V13, P422, DOI 10.1080/15325020701742136; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Fauerbach JA, 2000, J NERV MENT DIS, V188, P510, DOI 10.1097/00005053-200008000-00006; Fleeson W, 2002, J PERS SOC PSYCHOL, V83, P1409, DOI 10.1037//0022-3514.83.6.1409; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; FURMAN W, 1992, CHILD DEV, V63, P103, DOI 10.2307/1130905; FURMAN W, 1985, DEV PSYCHOL, V21, P1016, DOI 10.1037/0012-1649.21.6.1016; Giannopoulou Ioanna, 2006, Clin Child Psychol Psychiatry, V11, P543; Guay S, 2006, J TRAUMA STRESS, V19, P327, DOI 10.1002/jts.20124; Halamandaris KF, 1997, PERS INDIV DIFFER, V22, P93, DOI 10.1016/S0191-8869(96)00175-4; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Hou ZJ., 2014, PSYCHOLL DEV ED, V30, P82; Jelusic I, 2010, COLLEGIUM ANTROPOL, V34, P853; Johnson RJ, 2007, APPL PSYCHOL-INT REV, V56, P428, DOI 10.1111/j.1464-0597.2007.00296.x; JOSEPH S, 1993, J TRAUMA STRESS, V6, P271, DOI 10.1007/BF00974121; Karanci AN, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.17303; Kilmer RP, 2010, CHILD DEV, V81, P1211, DOI 10.1111/j.1467-8624.2010.01463.x; Kilmer RP, 2009, J TRAUMA STRESS, V22, P248, DOI 10.1002/jts.20410; Lauterbach D, 2001, J TRAUMA STRESS, V14, P29; Lawrence JW, 2003, J BURN CARE REHABIL, V24, P63, DOI 10.1097/00004630-200301000-00016; [雷雳 Lei Li], 2006, [心理学报, Acta Psychologica Sinica], V38, P375; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Liu WJ., 2012, PSYCHOL DEV ED, V28, P625, DOI DOI 10.16187/J.CNKI.ISSN1001-4918.2012.06.011; Lu L, 1997, J SOC PSYCHOL, V137, P618, DOI 10.1080/00224549709595483; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Meyerson DA, 2011, CLIN PSYCHOL REV, V31, P949, DOI 10.1016/j.cpr.2011.06.003; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Paris J, 2000, HARVARD REV PSYCHIAT, V8, P175, DOI 10.1093/hrp/8.4.175; Park CL, 2004, PSYCHOL INQ, V15, P69; Park CL, 2008, AM J ORTHOPSYCHIAT, V78, P300, DOI 10.1037/a0014054; Russell DW, 1997, J PERS, V65, P649, DOI 10.1111/j.1467-6494.1997.tb00330.x; Salter E, 2004, J TRAUMA STRESS, V17, P335, DOI 10.1023/B:JOTS.0000038482.53911.01; Schaefer JA, 1998, LEA SER PER CLIN PSY, P99; Schmidt SD, 2012, J HEALTH PSYCHOL, V17, P1033, DOI 10.1177/1359105311429203; Schnurr PP, 2004, J TRAUMA STRESS, V17, P85, DOI 10.1023/B:JOTS.0000022614.21794.f4; Schnurr PP, 2000, J CONSULT CLIN PSYCH, V68, P258, DOI 10.1037//0022-006X.68.2.258; SCHNURR PP, 1999, PROG PSYCH, P191; Schroevers MJ, 2010, PSYCHO-ONCOLOGY, V19, P46, DOI 10.1002/pon.1501; Schroevers MJ, 2004, PSYCHO-ONCOLOGY, V13, P740, DOI 10.1002/pon.780; Shakespeare-Finch J., 2005, TRAUMATOLOGY, V11, P325, DOI [10.1177/153476560501100410, DOI 10.1177/153476560501100410]; Sheikh AI, 2004, J CLIN PSYCHOL MED S, V11, P265, DOI 10.1023/B:JOCS.0000045346.76242.73; Shigemoto Y, 2013, PSYCHOL TRAUMA-US, V5, P128, DOI 10.1037/a0026647; STOKES JP, 1985, J PERS SOC PSYCHOL, V48, P981, DOI 10.1037/0022-3514.48.4.981; Swickert RJ, 2002, PERS INDIV DIFFER, V32, P877, DOI 10.1016/S0191-8869(01)00093-9; Taku K, 2008, DEATH STUD, V32, P428, DOI 10.1080/07481180801974745; Tang CSK, 2006, J PSYCHOSOM RES, V61, P699, DOI 10.1016/j.jpsychores.2006.07.014; Tanriverd D, 2012, ASIAN PAC J CANCER P, V13, P4311, DOI 10.7314/APJCP.2012.13.9.4311; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Val EB, 2006, J LOSS TRAUMA, V11, P409, DOI 10.1080/15325020600685519; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; Wolchik SA, 2008, OMEGA-J DEATH DYING, V58, P107, DOI 10.2190/OM.58.2.b; Xu KB, 2014, J LOSS TRAUMA, V19, P229, DOI 10.1080/15325024.2013.791516; Ying LH, 2014, PSYCHOL TRAUMA-US, V6, P192, DOI 10.1037/a0031964; Ying LH, 2013, EUR CHILD ADOLES PSY, V22, P567, DOI 10.1007/s00787-013-0400-3; Ying LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089401; Yu XN, 2010, J AFFECT DISORDERS, V123, P327, DOI 10.1016/j.jad.2009.09.019; Zhou H., 2000, PSYCHOL DEV ED, V16, P48, DOI DOI 10.16187/J.CNKI.ISSN1001-4918.2000.01.009; Zoellner LA, 1999, J TRAUMA STRESS, V12, P689, DOI 10.1023/A:1024777303848; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	73	32	35	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121480	10.1371/journal.pone.0121480	http://dx.doi.org/10.1371/journal.pone.0121480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25815720	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600097
J	Segura, R; Prim, N; Montemayor, M; Valls, ME; Munoz, C				Segura, Remedios; Prim, Nuria; Montemayor, Michel; Eugenia Valls, Maria; Munoz, Carme			Predominant Virulent IbA10G2 Subtype of Cryptosporidium hominis in Human Isolates in Barcelona: A Five-Year Study	PLOS ONE			English	Article							SPP.; PARASITES	Background Cryptosporidium infection is a worldwide cause of diarrheal disease. To gain insight into the epidemiology of the infection in a certain geographic area, molecular methods are needed to determine the species/genotypes and subtypes. Methodology/Principal Findings From 2004 to 2009, 161 cryptosporidiosis cases were detected in two hospitals in Barcelona. Diagnosis was performed by microscopic observation of oocysts in stool specimens following modified Ziehl-Neelsen staining. Most cases (82%) occurred in children. The number of cases increased in summer and autumn. Molecular characterization of Cryptosporidium was performed in 69 specimens, and C. hominis and C. parvum were identified in 88.4% and 10.1% of the cases, respectively. C. meleagridis was detected in one specimen. Subtyping based on the gp60 polymorphism showed six subtypes, four C. hominis and two C. parvum. Subtype IbA10G2 was the most prevalent subtype corresponding to 90% of all C. hominis isolates. This is the first report on the distribution of specific Cryptosporidium subtypes from humans in Spain. Conclusions/Significance In our geographic area, the anthroponotic behavior of C. hominis, the lower infective dose, and the higher virulence of certain subtypes may contribute to the high incidence of human cryptosporidiosis caused by the IbA10G2 subtype. Further studies should include populations with asymptomatic shedding of the parasite.	[Segura, Remedios; Prim, Nuria; Montemayor, Michel; Munoz, Carme] Hosp Santa Creu & Sant Pau, Microbiol Serv, Barcelona 08041, Spain; [Eugenia Valls, Maria] Hosp Clin Barcelona, Microbiol Serv, E-08036 Barcelona, Spain; [Munoz, Carme] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain	Hospital of Santa Creu i Sant Pau; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona	Prim, N (corresponding author), Hosp Santa Creu & Sant Pau, Microbiol Serv, Barcelona 08041, Spain.	nprim@santpau.cat	Munoz, Carmen/P-9183-2015	Munoz-Batet, Carmen/0000-0002-4150-8834; Segura, Remedios/0000-0001-7923-4448				Abal-Fabeiro JL, 2014, PARASITOLOGY, V141, P491, DOI 10.1017/S0031182013001807; Artieda J, 2012, EUROSURVEILLANCE, V17, P23; Carmena D, 2007, J APPL MICROBIOL, V102, P619, DOI 10.1111/j.1365-2672.2006.03193.x; CASEMORE DP, 1991, J CLIN PATHOL, V44, P445, DOI 10.1136/jcp.44.6.445; Castro-Hermida JA, 2008, SCI TOTAL ENVIRON, V405, P45, DOI 10.1016/j.scitotenv.2008.06.040; Chalmers RM, 2008, EMERG INFECT DIS, V14, P496, DOI 10.3201/eid1403.071320; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Fournet N, 2013, Euro Surveill, V18; Galmes A., 2003, EUROSURVEILLANCE, V7, P2275; Kosek M, 2001, Lancet Infect Dis, V1, P262, DOI 10.1016/S1473-3099(01)00121-9; Li N, 2013, EMERG INFECT DIS, V19, P1573, DOI 10.3201/eid1910.121361; Navarro-i-Martinez L, 2013, ENFERM INFEC MICR CL, V31, P506, DOI 10.1016/j.eimc.2012.11.005; Navarro-i-Martinez L, 2011, ENFERM INFEC MICR CL, V29, P135, DOI 10.1016/j.eimc.2010.12.002; Pedraza-Diaz S, 2001, J INFECTION, V42, P243, DOI 10.1053/jinf.2001.0839; PettoelloMantovani M, 1995, PEDIATR INFECT DIS J, V14, P1042, DOI 10.1097/00006454-199512000-00003; Salyer SJ, 2001, PLOS NEGLECT TROP D, V6, pe1597; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; Llorent MT, 2007, PARASITOL INT, V56, P201, DOI 10.1016/j.parint.2007.02.003; The ANOFEL Cryptosporidium National Network, 2010, EURO SURVEIL, V15, P19642; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Zhu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043682; Zintl A, 2009, EPIDEMIOL INFECT, V137, P270, DOI 10.1017/S0950268808000769	24	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121753	10.1371/journal.pone.0121753	http://dx.doi.org/10.1371/journal.pone.0121753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816024	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600115
J	Taylor, AM; MacGillivray, TJ; Henderson, RD; Ilzina, L; Dhillon, B; Starr, JM; Deary, IJ				Taylor, Adele M.; MacGillivray, Thomas J.; Henderson, Ross D.; Ilzina, Lasma; Dhillon, Baljean; Starr, John M.; Deary, Ian J.			Retinal Vascular Fractal Dimension, Childhood IQ, and Cognitive Ability in Old Age: The Lothian Birth Cohort Study 1936	PLOS ONE			English	Article							SMALL VESSEL DISEASE; MICROVASCULAR ABNORMALITIES; DIABETIC-RETINOPATHY; ATHEROSCLEROSIS RISK; INTELLIGENCE; ARTERIOLAR; DEMENTIA; GEOMETRY; NETWORK; BRAIN	Purpose Cerebral microvascular disease is associated with dementia. Differences in the topography of the retinal vascular network may be a marker for cerebrovascular disease. The association between cerebral microvascular state and non-pathological cognitive ageing is less clear, particularly because studies are rarely able to adjust for pre-morbid cognitive ability level. We measured retinal vascular fractal dimension (D-f) as a potential marker of cerebral microvascular disease. We examined the extent to which it contributes to differences in non-pathological cognitive ability in old age, after adjusting for childhood mental ability. Methods Participants from the Lothian Birth Cohort 1936 Study (LBC1936) had cognitive ability assessments and retinal photographs taken of both eyes aged around 73 years (n = 648). IQ scores were available from childhood. Retinal vascular D-f was calculated with monofractal and multifractal analysis, performed on custom-written software. Multiple regression models were applied to determine associations between retinal vascular D-f and general cognitive ability (g), processing speed, and memory. Results Only three out of 24 comparisons (two eyes x four D-f parameters x three cognitive measures) were found to be significant. This is little more than would be expected by chance. No single association was verified by an equivalent association in the contralateral eye. Conclusions The results show little evidence that fractal measures of retinal vascular differences are associated with non-pathological cognitive ageing.	[Taylor, Adele M.; Henderson, Ross D.; Ilzina, Lasma; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [MacGillivray, Thomas J.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [MacGillivray, Thomas J.] Univ Edinburgh, Clin Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [MacGillivray, Thomas J.] Univ Edinburgh, Clin Res Facil, Edinburgh, Midlothian, Scotland; [Dhillon, Baljean] Princess Alexandra Eye Pavil, Dept Ophthalmol, Edinburgh, Midlothian, Scotland; [Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	MacGillivray, TJ (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	T.J.MacGillivray@ed.ac.uk; I.Deary@ed.ac.uk	Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X; MacGillivray, Tom/0000-0001-5120-0086	UK (The Disconnected Mind project); UK's Biotechnology and Biological Sciences Research Council; Economic and Social Research Council; Medical Research Council [MR/K026992/1]; MRC [G0700704] Funding Source: UKRI; Medical Research Council [G0700704] Funding Source: researchfish	UK (The Disconnected Mind project); UK's Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research and LBC1936 phenotype collection were supported by Age UK (The Disconnected Mind project). JMS and IJD are members of The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (http://www.ccace.ed.ac.uk) - part of the cross council Lifelong Health and Wellbeing Initiative - which is supported by funding from the UK's Biotechnology and Biological Sciences Research Council, the Economic and Social Research Council and the Medical Research Council (MR/K026992/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avakian A, 2002, CURR EYE RES, V24, P274, DOI 10.1076/ceyr.24.4.274.8411; Azemin MZC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.04.010; Baker ML, 2007, STROKE, V38, P2041, DOI 10.1161/STROKEAHA.107.483586; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cheung CYL, 2014, ALZHEIMERS DEMENT, V10, P135, DOI 10.1016/j.jalz.2013.06.009; Cheung CYL, 2014, J STROKE CEREBROVASC, V23, P43, DOI 10.1016/j.jstrokecerebrovasdis.2012.09.002; Cheung N, 2009, DIABETES CARE, V32, P106, DOI 10.2337/dc08-1233; Cheung N, 2010, BRAIN, V133, P1987, DOI 10.1093/brain/awq127; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooper LS, 2006, STROKE, V37, P82, DOI 10.1161/01.STR.0000195134.04355.e5; Corley J, 2010, PSYCHOL AGING, V25, P867, DOI 10.1037/a0020301; DAXER A, 1993, GRAEF ARCH CLIN EXP, V231, P681, DOI 10.1007/BF00919281; Deary I.J., 2009, LIFETIME INTELLIGENC; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2010, Psychol Sci Public Interest, V11, P53, DOI 10.1177/1529100610387081; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, NEUROIMAGE, V22, P1466, DOI 10.1016/j.neuroimage.2004.03.047; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Ding J, 2008, BRIT J OPHTHALMOL, V92, P1017, DOI 10.1136/bjo.2008.141994; Doubal FN, 2010, NEUROLOGY, V74, P1102, DOI 10.1212/WNL.0b013e3181d7d8b4; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Gow AJ, 2011, PSYCHOL AGING, V26, P232, DOI 10.1037/a0021072; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Klein R, 2003, OPHTHALMOLOGY, V110, P2118, DOI 10.1016/S0161-6420(03)00863-7; Knopman DS, 2007, BRIT J RADIOL, V80, pS121, DOI 10.1259/bjr/75681080; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; LAM L, 1992, IEEE T PATTERN ANAL, V14, P869, DOI 10.1109/34.161346; LANDINI G, 1995, INVEST OPHTH VIS SCI, V36, P2749; Li HT, 2010, ACTA OPHTHALMOL, V88, pe234, DOI 10.1111/j.1755-3768.2010.01975.x; Liew G, 2011, EUR HEART J, V32, P422, DOI 10.1093/eurheartj/ehq431; Liew G, 2009, J AM GERIATR SOC, V57, P1892, DOI 10.1111/j.1532-5415.2009.02459.x; Longstreth WT, 2007, AM J EPIDEMIOL, V165, P78, DOI 10.1093/aje/kwj350; Luciano M, 2009, PSYCHOL AGING, V24, P129, DOI 10.1037/a0014780; MacGillivray TJ, 2007, P ANN INT IEEE EMBS, P6456; MacGillivray TJ, 2012, HUMAN EYE IMAGING MO, P23; MAINSTER MA, 1990, EYE, V4, P235, DOI 10.1038/eye.1990.33; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Parsons-Wingerter P, 2000, ARTERIOSCL THROM VAS, V20, P1250, DOI 10.1161/01.ATV.20.5.1250; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Patton N, 2007, INVEST OPHTH VIS SCI, V48, P1995, DOI 10.1167/iovs.06-1123; Qiu C, 2010, NEUROLOGY, V75, P2221, DOI 10.1212/WNL.0b013e3182020349; Scottish Council for Research in Education (SCRE), 1949, TREND SCOTT INT COMP; SCRE, 1933, INT SCOTT CHILDR NAT; Shalev I, 2013, PSYCHOL SCI, V24, P1198, DOI 10.1177/0956797612470959; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; Thompson CS, 2009, STROKE, V40, pE322, DOI 10.1161/STROKEAHA.108.542266; Wechsler D, 1998, WAIS IIIUK ADM SCORI; Wechsler D., 1998, WMS IIIUK ADM SCORIN; Wensor M, 1999, ARCH OPHTHALMOL-CHIC, V117, P658; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P1007, DOI 10.1136/bjo.86.9.1007; Wong TY, 2002, STROKE, V33, P1487, DOI 10.1161/01.STR.0000016789.56668.43; Zamir M, 2001, J THEOR BIOL, V212, P183, DOI 10.1006/jtbi.2001.2367	57	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121119	10.1371/journal.pone.0121119	http://dx.doi.org/10.1371/journal.pone.0121119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816017	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600067
J	Wong, MML; Gujaria-Verma, N; Ramsay, L; Yuan, HY; Caron, C; Diapari, M; Vandenberg, A; Bett, KE				Wong, Melissa M. L.; Gujaria-Verma, Neha; Ramsay, Larissa; Yuan, Hai Ying; Caron, Carolyn; Diapari, Marwan; Vandenberg, Albert; Bett, Kirstin E.			Classification and Characterization of Species within the Genus Lens Using Genotyping-by-Sequencing (GBS)	PLOS ONE			English	Article							COLLETOTRICHUM-TRUNCATUM; GENETIC-RELATIONSHIPS; POPULATION-STRUCTURE; CULTIVATED LENTIL; WILD; PHYLOGENY; RAPD; HYBRIDIZATION; RESISTANCE; DIVERSITY	Lentil (Lens culinaris ssp. culinaris) is a nutritious and affordable pulse with an ancient crop domestication history. The genus Lens consists of seven taxa, however, there are many discrepancies in the taxon and gene pool classification of lentil and its wild relatives. Due to the narrow genetic basis of cultivated lentil, there is a need towards better understanding of the relationships amongst wild germplasm to assist introgression of favourable genes into lentil breeding programs. Genotyping-by-sequencing (GBS) is an easy and affordable method that allows multiplexing of up to 384 samples or more per library to generate genome-wide single nucleotide Polymorphism (SNP) markers. In this study, we aimed to characterize our lentil germplasm collection using a two-enzyme GBS approach. We constructed two 96-plex GBS libraries with a total of 60 accessions where some accessions had several samples and each sample was sequenced in two technical replicates. We developed an automated GBS pipeline and detected a total of 266,356 genome-wide SNPs. After filtering low quality and redundant SNPs based on haplotype information, we constructed a maximum-likelihood tree using 5,389 SNPs. The phylogenetic tree grouped the germplasm collection into their respective taxa with strong support. Based on phylogenetic tree and STRUCTURE analysis, we identified four gene pools, namely L. culinaris/L. orientalis/L. tomentosus, L. lamottei/L. odemensis, L. ervoides and L. nigricans which form primary, secondary, tertiary and quaternary gene pools, respectively. We discovered sequencing bias problems likely due to DNA quality and observed severe run-to-run variation in the wild lentils. We examined the authenticity of the germplasm collection and identified 17% misclassified samples. Our study demonstrated that GBS is a promising and affordable tool for screening by plant breeders interested in crop wild relatives.	[Wong, Melissa M. L.; Gujaria-Verma, Neha; Ramsay, Larissa; Yuan, Hai Ying; Caron, Carolyn; Diapari, Marwan; Vandenberg, Albert; Bett, Kirstin E.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK S7N 5A8, Canada	University of Saskatchewan	Bett, KE (corresponding author), Univ Saskatchewan, Dept Plant Sci, 51 Campus Dr, Saskatoon, SK S7N 5A8, Canada.	k.bett@usask.ca	Yuan, Hai Ying/X-3311-2019	Yuan, Hai Ying/0000-0002-4049-3036; Caron, Carolyn/0000-0003-1251-7405; Ramsay, Larissa/0000-0002-8768-5959; Vandenberg, Albert/0000-0001-6177-1392	Saskatchewan Ministry of Agriculture's Agriculture Development Fund [20110236]; Saskatchewan Pulse Growers contract [BRE1202]; Natural Sciences and Engineering Research Council of Canada [IRCPJ 395994-09]	Saskatchewan Ministry of Agriculture's Agriculture Development Fund; Saskatchewan Pulse Growers contract; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Saskatchewan Ministry of Agriculture's Agriculture Development Fund contract # 20110236 (http://www.agriculture.gov.sk.ca); Saskatchewan Pulse Growers contract # BRE1202 (http://www.saskpulse.com/); Natural Sciences and Engineering Research Council of Canada # IRCPJ 395994-09 (http://www.nserccrsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOELWAFA A, 1995, THEOR APPL GENET, V90, P335, DOI 10.1007/BF00221974; Ahmad M, 1996, THEOR APPL GENET, V92, P1091, DOI 10.1007/BF00224054; Ahmad M, 1996, THEOR APPL GENET, V93, P788, DOI 10.1007/BF00224077; Alo F, 2011, J HERED, V102, P315, DOI 10.1093/jhered/esr015; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Daley T, 2013, NAT METHODS, V10, P325, DOI 10.1038/nmeth.2375; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dossett M, 2012, ACTA HORTIC, V946, P49, DOI 10.17660/ActaHortic.2012.946.4; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Erskine W, 1998, EUPHYTICA, V101, P207, DOI 10.1023/A:1018306723777; Escudero M, 2014, MOL PHYLOGENET EVOL, V79, P359, DOI 10.1016/j.ympev.2014.06.026; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferguson ME, 2000, BOT J LINN SOC, V133, P41, DOI 10.1111/j.1095-8339.2000.tb01536.x; Fernandez-Aparicio M, 2009, PLANT BREEDING, V128, P266, DOI 10.1111/j.1439-0523.2008.01559.x; Fiala JV, 2009, CROP SCI, V49, P825, DOI 10.2135/cropsci2008.05.0260; Fratini R, 2006, EUPHYTICA, V150, P271, DOI 10.1007/s10681-006-9118-3; Ge Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099414; Girma G, 2014, THEOR APPL GENET, V127, P1783, DOI 10.1007/s00122-014-2339-2; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; HAVEY MJ, 1989, THEOR APPL GENET, V77, P839, DOI 10.1007/BF00268336; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kole C, 2011, LENS WILD CROP RELAT, P127; Kostamo K, 2013, ANN BOT-LONDON, V111, P713, DOI 10.1093/aob/mct029; Labate JA, 2014, GENOME, V57, P169, DOI 10.1139/gen-2014-0003; LADIZINSKY G, 1979, EUPHYTICA, V28, P179, DOI 10.1007/BF00029189; LADIZINSKY G, 1985, THEOR APPL GENET, V70, P97, DOI 10.1007/BF00264489; LADIZINSKY G, 1993, CRIT REV PLANT SCI, V12, P169, DOI 10.1080/713608047; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-104; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Mayer MS, 2002, PLANT SYST EVOL, V232, P145, DOI 10.1007/s006060200038; MAYER MS, 1994, THEOR APPL GENET, V87, P773, DOI 10.1007/BF00221128; MUEHLBAUER FJ, 1995, ADV AGRON, V54, P283, DOI 10.1016/S0065-2113(08)60902-5; Muehlbauer FJ, 2005, GEN RESOUR CHROM ENG, V1, P219; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Podder R, 2013, PLANT GENET RESOUR-C, V11, P26, DOI 10.1017/S1479262112000329; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Samec D, 2014, FOOD RES INT, V60, P266, DOI 10.1016/j.foodres.2013.07.015; Schaefer H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-250; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schreier AD, 2012, CAN J FISH AQUAT SCI, V69, P1968, DOI 10.1139/f2012-120; SHARMA SK, 1995, THEOR APPL GENET, V91, P647, DOI 10.1007/BF00223292; Sharma SK, 1996, THEOR APPL GENET, V93, P751, DOI 10.1007/BF00224072; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Sint D, 2012, METHODS ECOL EVOL, V3, P898, DOI 10.1111/j.2041-210X.2012.00215.x; Smit A, 1996, REPEATMASKER OPEN 30; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Sonnante G, 2003, ANN BOT-LONDON, V91, P49, DOI 10.1093/aob/mcg007; Spindel J, 2013, THEOR APPL GENET, V126, P2699, DOI 10.1007/s00122-013-2166-x; Suvorova G, 2014, CZECH J GENET PLANT, V50, P130, DOI 10.17221/231/2013-CJGPB; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Tullu A, 2006, GENET RESOUR CROP EV, V53, P111, DOI 10.1007/s10722-004-1586-5; Tullu A, 2010, GENET RESOUR CROP EV, V57, P1053, DOI 10.1007/s10722-010-9547-7; Uitdewilligen JGAML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062355; Vail S, 2012, FIELD CROP RES, V126, P145, DOI 10.1016/j.fcr.2011.10.002; van de Wouw M, 2011, CROP SCI, V51, P736, DOI 10.2135/cropsci2010.09.0511; vanOss H, 1997, THEOR APPL GENET, V94, P452, DOI 10.1007/s001220050436; Verma P, 2014, MOL BIOL REP, P1; Yadav S, 2007, GENETICS AND CYTOGEN, P187; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; ZOHARY D, 1972, ECON BOT, V26, P326, DOI 10.1007/BF02860702; ZOHARY D, 1973, SCIENCE, V182, P887, DOI 10.1126/science.182.4115.887	76	67	72	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122025	10.1371/journal.pone.0122025	http://dx.doi.org/10.1371/journal.pone.0122025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815480	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600136
J	Wu, Q; Tan, C; Wang, B; Zhou, P				Wu, Qi; Tan, Chuan; Wang, Bo; Zhou, Ping			Behavioral Immune System and Ingroup Derogation: The Effects of Infectious Diseases on Ingroup Derogation Attitudes	PLOS ONE			English	Article							IN-GROUP; BLACK-SHEEP; GROUP BIAS; PATHOGEN PREVALENCE; SOCIAL CATEGORIZATION; ASSORTATIVE SOCIALITY; AVOIDANCE MECHANISMS; CULTURAL-DIFFERENCES; PERCEIVED THREAT; ETHNOCENTRISM	From evolutionary reasoning, we derived a novel hypothesis that ingroup derogation is an evolved response of behavioral immune system which follows the smoke detector principle and the functional flexibility principle. This hypothesis was tested and supported across three experiments. In Experiment 1, participants' group membership was manipulated by using a minimal group paradigm. The results indicated that mere social categorization alone-a heuristic cue that implies the differentiation between "us" and "them"-was sufficient to elicit ingroup derogation among Chinese participants, and, such an intergroup bias was positively associated with the perceived vulnerability to diseases, which was also more consistently associated with ingroup attitudes. Experiment 2 extended and partially replicated Experiment 1 by showing that when there were cues of diseases in the immediate physical environment, Chinese participants exaggerated their attitudes of ingroup derogation. The results also showed that this effect was mainly driven by outgroup attraction. Experiment 3 changed the method of disease manipulation, and found that Chinese participants responded more strongly to disease cues originating from ingroup members and that they endorsed more ingroup derogation attitudes even when the ingroup and outgroup members were both displaying cues of diseases. Taken together, these results reveal the previously unexplored effects of infectious diseases on ingroup derogation attitudes, and suggest an interesting linkage between the evolved behavioral immune system and the ingroup derogation.	[Wu, Qi; Tan, Chuan; Zhou, Ping] Hunan Normal Univ, Dept Psychol, Cognit & Human Behav Key Lab Hunan Prov, Changsha, Hunan, Peoples R China; [Wang, Bo] Cent Univ Finance & Econ, Sch Social Dev, Dept Psychol, Beijing, Peoples R China	Hunan Normal University; Central University of Finance & Economics	Zhou, P (corresponding author), Hunan Normal Univ, Dept Psychol, Cognit & Human Behav Key Lab Hunan Prov, Changsha, Hunan, Peoples R China.	pingzhouhunnu@gmail.com	Wu, Qi/AHE-9532-2022		National Natural Science Foundation of China [31300870]; Hunan Normal University [13XQN01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Normal University	This work was supported by the National Natural Science Foundation of China (Grant 31300870) and the Hunan Normal University (Grant 13XQN01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G, 1958, THE NATURE OF PREJUD; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Cashdan E, 2013, HUM NATURE-INT BIOS, V24, P59, DOI 10.1007/s12110-012-9159-3; Cottrell CA, 2005, J PERS SOC PSYCHOL, V88, P770, DOI 10.1037/0022-3514.88.5.770; Cottrell CA, 2013, FRONT SOC PSYCHOL, P29; Cuddy AJC, 2009, BRIT J SOC PSYCHOL, V48, P1, DOI 10.1348/014466608X314935; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; DIENER E, 1995, SOC INDIC RES, V34, P7, DOI 10.1007/BF01078966; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; Endo Y, 2000, PERS SOC PSYCHOL B, V26, P1571, DOI 10.1177/01461672002612011; Eysenck HJ, 1975, MANUAL EYESENCK PERS; Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P2587, DOI 10.1098/rspb.2008.0688; Fincher CL, 2008, OIKOS, V117, P1289, DOI 10.1111/j.0030-1299.2008.16684.x; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P1279, DOI 10.1098/rspb.2008.0094; Fincher CL, 2012, BEHAV BRAIN SCI, V35, P99, DOI 10.1017/S0140525X11001774; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Heine SJ, 1997, J PERS SOC PSYCHOL, V72, P1268, DOI 10.1037/0022-3514.72.6.1268; HEWSTONE M, 1985, J PERS SOC PSYCHOL, V48, P614, DOI 10.1037/0022-3514.48.3.614; Hruschka DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063642; Huang JY, 2011, PSYCHOL SCI, V22, P1550, DOI 10.1177/0956797611417261; JAHODA G, 1972, EUR J SOC PSYCHOL, V2, P19, DOI 10.1002/ejsp.2420020104; Jost JT, 2002, J EXP SOC PSYCHOL, V38, P586, DOI 10.1016/S0022-1031(02)00505-X; Jost JT, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P89; Kavaliers M, 2005, NEUROSCI BIOBEHAV R, V29, P1347, DOI 10.1016/j.neubiorev.2005.04.011; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; LEE YT, 1993, J CROSS CULT PSYCHOL, V24, P298, DOI 10.1177/0022022193243003; LEE YT, 1995, PERS SOC PSYCHOL B, V21, P610, DOI 10.1177/0146167295216007; Leeuwen F, 2012, EVOL HUM BEHAV, V33, P429, DOI DOI 10.1016/j.evolhumbehav.2011.12.005; Letendre K, 2010, BIOL REV, V85, P669, DOI 10.1111/j.1469-185X.2010.00133.x; Lewis AC, 2010, J SOC PSYCHOL, V150, P211, DOI 10.1080/00224540903366388; Lund EM, 2014, EVOL HUM BEHAV, V35, P336, DOI 10.1016/j.evolhumbehav.2014.03.004; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Ma-Kellams C, 2011, PERS SOC PSYCHOL B, V37, P15, DOI 10.1177/0146167210388193; MARQUES JM, 1988, EUR J SOC PSYCHOL, V18, P1, DOI 10.1002/ejsp.2420180102; Miller SL, 2012, J PERS SOC PSYCHOL, V102, P1198, DOI 10.1037/a0027198; Miller SL, 2011, PSYCHOL SCI, V22, P1467, DOI 10.1177/0956797611420166; Mortensen CR, 2010, PSYCHOL SCI, V21, P440, DOI 10.1177/0956797610361706; Murray DR, 2013, PERS INDIV DIFFER, V54, P103, DOI 10.1016/j.paid.2012.08.021; Murray DR, 2012, EUR J SOC PSYCHOL, V42, P180, DOI 10.1002/ejsp.863; Murray DR, 2011, PERS SOC PSYCHOL B, V37, P318, DOI 10.1177/0146167210394451; Navarrete CD, 2007, EVOL HUM BEHAV, V28, P60, DOI 10.1016/j.evolhumbehav.2006.06.002; Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001; Neuberg SL, 2011, NEUROSCI BIOBEHAV R, V35, P1042, DOI 10.1016/j.neubiorev.2010.08.011; Park JH, 2003, J NONVERBAL BEHAV, V27, P65, DOI 10.1023/A:1023910408854; Park JH, 2007, EVOL HUM BEHAV, V28, P410, DOI 10.1016/j.evolhumbehav.2007.05.008; Park JH, 2013, J SOC PSYCHOL, V153, P212, DOI 10.1080/00224545.2012.721812; Pinto IR, 2010, J PERS SOC PSYCHOL, V99, P107, DOI 10.1037/a0018187; Rand DG, 2009, P NATL ACAD SCI USA, V106, P6187, DOI 10.1073/pnas.0811552106; Reese G, 2013, SOC COGNITION, V31, P482; Ruffle BJ, 2006, J ECON BEHAV ORGAN, V60, P147, DOI 10.1016/j.jebo.2004.07.007; Ryan S, 2012, EVOL HUM BEHAV, V33, P639, DOI 10.1016/j.evolhumbehav.2012.04.001; Schaller M, 2008, J PERS SOC PSYCHOL, V95, P212, DOI 10.1037/0022-3514.95.1.212; Schaller M, 2012, ADV EXP SOC PSYCHOL, V46, P1, DOI 10.1016/B978-0-12-394281-4.00001-5; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Schaller M, 2011, PHILOS T R SOC B, V366, P3418, DOI 10.1098/rstb.2011.0029; Schaller M, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P243; Snibbe AC, 2003, J CROSS CULT PSYCHOL, V34, P581, DOI 10.1177/0022022103256480; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Talhelm T, 2014, SCIENCE, V344, P603, DOI 10.1126/science.1246850; Terrizzi JA, 2013, EVOL HUM BEHAV, V34, P99, DOI 10.1016/j.evolhumbehav.2012.10.003; Thornhill R., 2014, PARASITE STRESS THEO, DOI DOI 10.1007/978-3-319-08040-6; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; Tybur JM, 2011, PSYCHOL SCI, V22, P478, DOI 10.1177/0956797611400096; Van Vugt M, 2009, SOC PERSONAL PSYCHOL, V3, P927, DOI 10.1111/j.1751-9004.2009.00221.x; Wang SF, 2010, IEEE T MULTIMEDIA, V12, P682, DOI 10.1109/TMM.2010.2060716; Wong JJ, 2009, EXPERT SYST APPL, V36, P804, DOI 10.1016/j.eswa.2007.10.030; Wu BP, 2012, PERS INDIV DIFFER, V53, P50, DOI 10.1016/j.paid.2012.02.023; Yamagishi T, 2009, EVOL HUM BEHAV, V30, P229, DOI 10.1016/j.evolhumbehav.2009.02.004; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032932	70	12	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122794	10.1371/journal.pone.0122794	http://dx.doi.org/10.1371/journal.pone.0122794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816247	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600197
J	Zhao, YF; Zhu, L; Zhou, T; Zhang, QX; Shi, SF; Liu, LJ; Lv, JC; Zhang, H				Zhao, Yanfeng; Zhu, Li; Zhou, Tong; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong			Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; EPIDERMAL-GROWTH-FACTOR; CHEMOKINE RECEPTORS; EXPRESSION; GLYCOSYLATION; MARKERS; INJURY	Background IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide. In recent years, consistent efforts have been made to develop new non-invasive biomarkers for IgAN progression. In our previous in vitro study we found mesangial derived CXCL1 as a contributor for kidney injury, and observed higher urinary CXCL1 levels in patients with IgAN. It implied that the urinary CXCL1 might be a potential biomarker. Methods In the present study, we enrolled 425 IgAN patients with follow-up data and detected their urinary CXCL1 levels at the time of renal biopsy, to explore the predictive value of urinary CXCL1 in IgAN progression. Urinary CXCL1 levels were measured using enzyme-linked immunosorbent assay. Results Urinary CXCL1 levels were associated with presently well established predictors of IgAN progression, including SBP (r = 0.138, p = 0.004), DBP (r = 0.114, p = 0.019), proteinuria (r = 0.155, p = 0.001), eGFR (r = -0.259, p< 0.001) and tubular atrophy and interstitial fibrosis (r = 0.181, p< 0.001). After adjusted for them, higher levels of urinary CXCL1 were independently associated with a greater risk of deterioration in renal function (HR, per s.d. increment of natural log-transformed CXCL1: 1.748; 95% CI: 1.222-2.499, P = 0.002). Furthermore, time-dependent receiver operating characteristic (ROC) curve showed that urinary CXCL1, when combined with proteinuria and eGFR, could enhance the prognostic value of these traditional predictors for IgAN progression. Conclusions The results in our present study suggested urinary CXCL1 as a new non-invasive predictor of IgAN progression.	[Zhao, Yanfeng; Zhu, Li; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong] Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China; [Zhao, Yanfeng; Zhu, Li; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong] Peking Univ, Inst Nephrol, Beijing 100871, Peoples R China; [Zhao, Yanfeng; Zhu, Li; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Zhao, Yanfeng; Zhu, Li; Zhang, Qingxian; Shi, Sufang; Liu, Lijun; Lv, Jicheng; Zhang, Hong] Peking Univ, Key Lab Chron Kidney Dis Prevent & Treatment, Minist Educ, Beijing 100871, Peoples R China; [Zhou, Tong] First Peoples Hosp Aksu Dist, Div Renal, Dept Med, Xinjiang, Peoples R China	Peking University; Peking University; Peking University	Zhu, L (corresponding author), Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100871, Peoples R China.	funnyzhuli@bjmu.edu.cn			Major State Basic Research Development Program of China (973 program) [2012CB517700]; Natural Science Foundation for Innovation Research Group of China [81321064]; National Science Foundation of China [81470945]; Beijing Natural Science Foundation [7131016]; Capital of Clinical Characteristics and the Applied Research Fund [Z141107002514037]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation for Innovation Research Group of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Capital of Clinical Characteristics and the Applied Research Fund	Funding: This work was supported by grants from the Major State Basic Research Development Program of China (973 program, No. 2012CB517700) to HZ; Natural Science Foundation for Innovation Research Group of China (81321064) to HZ; National Science Foundation of China (Grant No. 81470945) to LZ; The Beijing Natural Science Foundation (Grant No. 7131016) to HZ and the Capital of Clinical Characteristics and the Applied Research Fund to LZ (Z141107002514037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Bennett MR, 2007, NEPHRON EXP NEPHROL, V107, pE30, DOI 10.1159/000106775; Chintakuntlawar AV, 2009, J INTERF CYTOK RES, V29, P657, DOI 10.1089/jir.2009.0006; Coppo R, 2004, KIDNEY INT, V65, P1544, DOI 10.1111/j.1523-1755.2004.05407.x; DAMICO G, 1987, Q J MED, V64, P709; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Hara M, 2007, CLIN J AM SOC NEPHRO, V2, P231, DOI 10.2215/CJN.01470506; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Kidney Diseases Improving Global Outcomes (KDIGO), 2012, KIDNEY INT S, V2, P259, DOI DOI 10.1038/KISUP.2012.30; Kwoh C, 2006, ANNU REV PATHOL-MECH, V1, P349, DOI 10.1146/annurev.pathol.1.110304.100119; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liu L, 2014, J CLIN IMMUNOL, V34, P224, DOI 10.1007/s10875-013-9970-6; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; Nirodi C, 2001, J BIOL CHEM, V276, P26122, DOI 10.1074/jbc.M102872200; Novak J, 2000, MOL IMMUNOL, V37, P1047, DOI 10.1016/S0161-5890(01)00019-0; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Rocchetti MT, 2013, CLIN J AM SOC NEPHRO, V8, P1115, DOI 10.2215/CJN.05950612; Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Stangou M, 2013, CLIN NEPHROL, V80, P203, DOI 10.5414/CN107836; Stangou M, 2009, NEPHROLOGY, V14, P613, DOI 10.1111/j.1440-1797.2008.01051.x; Torres DD, 2008, KIDNEY INT, V73, P327, DOI 10.1038/sj.ki.5002621; van der Veen BS, 2009, CLIN EXP IMMUNOL, V158, P143, DOI 10.1111/j.1365-2249.2009.03993.x; Verbeke H, 2011, CYTOKINE GROWTH F R, V22, P345, DOI 10.1016/j.cytogfr.2011.09.002; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Zhu LH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054028, 10.1371/journal.pone.0065680]	28	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119033	10.1371/journal.pone.0119033	http://dx.doi.org/10.1371/journal.pone.0119033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816025	gold, Green Submitted, Green Published			2022-12-26	WOS:000352133600011
J	Aldrich, MC; Munro, HM; Mumma, M; Grogan, EL; Massion, PP; Blackwell, TS; Blot, WJ				Aldrich, Melinda C.; Munro, Heather M.; Mumma, Michael; Grogan, Eric L.; Massion, Pierre P.; Blackwell, Timothy S.; Blot, William J.			Chronic Obstructive Pulmonary Disease and Subsequent Overall and Lung Cancer Mortality in Low-Income Adults	PLOS ONE			English	Article							SOUTHERN COMMUNITY COHORT; NATIONAL-HEALTH; COPD; RISK; COMORBIDITIES; PREVALENCE; DIAGNOSIS; OUTCOMES; IMPACT	Background Chronic obstructive pulmonary disease (COPD) is a known risk factor for lung cancer and a leading cause of mortality in the U.S., but its impact may not be fully appreciated, especially among low-income populations in the southeast where COPD prevalence and lung cancer incidence are elevated. Methods We conducted a prospective study among 26,927 low-income adults age 40-79 in the Southern Community Cohort Study who had a Center for Medicare and Medicaid Services (CMS) encounter prior to enrollment and were followed for a median of over 6 years. Using a validated algorithm for assessing COPD from CMS claims data, we estimated COPD prevalence and potential misreporting. From Cox proportional hazard models, we computed overall and lung cancer-specific mortality according to COPD status. Results The overall prevalence of CMS-diagnosed COPD was 16%, but was twice as high among whites as blacks. Only 35% of these individuals, however, self-reported having COPD, with underreporting significantly greater for blacks than whites. Smoking-adjusted all-cause mortality was increased by 1.7-fold and lung cancer mortality by 2.3-fold among those with a CMS COPD diagnosis, with similar patterns in blacks and whites, but no excess was found among those self-reporting COPD and without CMS confirmation. Conclusion The prevalence of COPD in this low-income population may be greater than previously recognized and misreporting is common. COPD is associated with elevated lung cancer mortality, even among those not self-reporting the condition.	[Aldrich, Melinda C.; Grogan, Eric L.] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN 37235 USA; [Aldrich, Melinda C.; Blot, William J.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Munro, Heather M.; Mumma, Michael; Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Grogan, Eric L.] Tennessee Valley Hlth Syst Vet Affairs, Nashville, TN USA; [Massion, Pierre P.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Div Pulm & Crit Care Med,Thorac Program, Nashville, TN USA; [Blackwell, Timothy S.] Vanderbilt Univ, Med Ctr, Dept Med, Dept Cell & Dev Biol, Nashville, TN USA; [Blackwell, Timothy S.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University	Aldrich, MC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN 37235 USA.	melinda.aldrich@vanderbilt.edu			National Cancer Institute at the National Institutes of Health [R01 CA092447, R01 CA092447-08S1, K07 CA172294]; NATIONAL CANCER INSTITUTE [R01CA092447, K07CA172294] Funding Source: NIH RePORTER; Veterans Affairs [IK2HX000758] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Cancer Institute [www.cancer.gov] at the National Institutes of Health [R01 CA092447 including a supplement from the American Recovery and Reinvestment Act (R01 CA092447-08S1) and K07 CA172294]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami Lara J, 2011, Natl Health Stat Report, P1; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Balkan A, 2016, CLIN RESPIR J, V10, P48, DOI 10.1111/crj.12180; Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Brenner DR, 2012, AM J EPIDEMIOL, V176, P573, DOI 10.1093/aje/kws151; Chamberlain AM, 2009, ETHNIC DIS, V19, P308; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Eisner MD, 2011, J EPIDEMIOL COMMUN H, V65, P26, DOI 10.1136/jech.2009.089722; Foster Talia S, 2006, COPD, V3, P211, DOI 10.1080/15412550601009396; Hansel NN, 2013, COPD, V10, P20, DOI 10.3109/15412555.2012.727921; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Kiri VA, 2010, PRIM CARE RESP J, V19, P57, DOI 10.4104/pcrj.2009.00048; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mannino DM, 2006, THORAX, V61, P472, DOI 10.1136/thx.2005.052449; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; Mannino DM, 2003, J INTERN MED, V254, P540, DOI 10.1111/j.1365-2796.2003.01211.x; Mapel DW, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-43; Miller Jeffrey D, 2005, COPD, V2, P311, DOI 10.1080/15412550500218221; Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023; Rana JS, 2004, DIABETES CARE, V27, P2478, DOI 10.2337/diacare.27.10.2478; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P1433, DOI 10.1001/jama.2012.404; Shin JI, 2014, NAT REV CANCER, V14, DOI 10.1038/nrc3477-c1; Signorello LB, 2005, J NATL MED ASSOC, V97, P972; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Stein BD, 2012, CHEST, V141, P87, DOI 10.1378/chest.11-0024; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; Turner MC, 2007, AM J RESP CRIT CARE, V176, P285, DOI 10.1164/rccm.200612-1792OC; Willyard C, 2012, NATURE, V489, pS8, DOI 10.1038/489S8a; Young RP, 2014, RESP MED, V108, P813, DOI 10.1016/j.rmed.2013.06.022; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Zhai RH, 2014, CHEST, V145, P346, DOI 10.1378/chest.13-1176	36	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121805	10.1371/journal.pone.0121805	http://dx.doi.org/10.1371/journal.pone.0121805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811837	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700140
J	Olofsson, SE; Nodin, B; Gaber, A; Eberhard, J; Uhlen, M; Jirstrom, K; Jerkeman, M				Olofsson, Sven-Erik; Nodin, Bjorn; Gaber, Alexander; Eberhard, Jakob; Uhlen, Mathias; Jirstrom, Karin; Jerkeman, Mats			Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer	PLOS ONE			English	Article							EUROPEAN CONSENSUS CONFERENCE; DECREASED EXPRESSION; INTERMEDIATE-RISK; TUMOR PROGRESSION; POOR-PROGNOSIS; GROUP EGCCCG; CHEMOTHERAPY; DIAGNOSIS; UPDATE	Background Expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate with favourable clinicopathological parameters and prognosis in several cancer diseases. The aim of this study was to examine the expression and prognostic ability of RBM3 in patients with testicular non-seminomatous germ cell tumours (NSGCT). Patients and Methods Immunohistochemical RBM3 expression was analysed in tissue microarrays with tumours from 206 patients. Chi-square test was applied to analyze associations between RBM3 expression and clinicopathological parameters. Kaplan-Meier analysis was used to assess the impact of RBM3 expression on cancer-specific survival (CSS) and failure-free survival (FFS). Cox regression proportional hazards models were used to estimate the relative risk for failure. Results In the entire cohort, there was a significant association between clinical stage (p=0.044) and RBM3 expression. Weak RBM3 expression correlated with a significantly reduced FFS [79.3% versus 90.4%(p=0.019)] and CSS [87.5% versus 97.3% (p=0.047)]. For patients with metastatic disease (n = 88), significant associations were found between RBM3 expression and IGCCC group (p=0.007). The FFS was significantly inferior for patients with low tumour-specific RBM3 expression [59.3% versus 79.0% (p=0.013)], and this association remained significant in a multivariable model for patients with metastatic disease (HR=3.67; 95% CI 1.14, 11.89). Conclusion Low RBM3 expression is an independent predictor of treatment failure in metastatic NSGCT, in relation to the prognostic factors included in the International Germ Cell Consensus Classification (IGCCC). These findings suggest that RBM3 may be a potential biomarker for treatment stratification in patients with metastatic non-seminomatous germ cell tumours, and therefore merit further validation.	[Olofsson, Sven-Erik; Nodin, Bjorn; Gaber, Alexander; Eberhard, Jakob; Jirstrom, Karin; Jerkeman, Mats] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden; [Uhlen, Mathias] Royal Inst Technol, AlbaNova Univ Ctr, Sci Life Lab, Stockholm, Sweden; [Uhlen, Mathias] Royal Inst Technol, AlbaNova Univ Ctr, Sch Biotechnol, Stockholm, Sweden	Lund University; Skane University Hospital; Royal Institute of Technology; Royal Institute of Technology	Olofsson, SE (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden.	sven-erik.olofsson@med.lu.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; 	Landstinget Kronoberg; Knut and Alice Wallenberg Foundation; Lund University Faculty of Medicine; University Hospital Research Grants	Landstinget Kronoberg; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund University Faculty of Medicine; University Hospital Research Grants	This work was supported by the Landstinget Kronoberg to SEO, the Knut and Alice Wallenberg Foundation to KJ, and the Lund University Faculty of Medicine and University Hospital Research Grants to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers P, 2012, ACTAS UROL ESP, V36, P127, DOI [10.1016/j.acuro.2011.06.017, 10.1016/j.acuroe.2012.05.002]; [Anonymous], 1995, SWEDISH NORWEGIAN TE; Bartkova J, 2007, INT J ANDROL, V30, P282, DOI 10.1111/j.1365-2605.2007.00772.x; Boman K, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-17; Breiman L, 1993, CLASSIFICATION REGRE; Culine S, 2008, J CLIN ONCOL, V26, P421, DOI 10.1200/JCO.2007.13.8461; Danno S, 2000, AM J PATHOL, V156, P1685, DOI 10.1016/S0002-9440(10)65039-0; Ehlen Asa, 2011, Transl Oncol, V4, P212; Ehlen A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-78; Fossa SD, 2005, BRIT J CANCER, V93, P1209, DOI 10.1038/sj.bjc.6602830; Hjelm B, 2011, PROTEOM CLIN APPL, V5, P624, DOI 10.1002/prca.201100020; Jogi A, 2009, MODERN PATHOL, V22, P1564, DOI 10.1038/modpathol.2009.124; Jonsson L, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-11; Jonsson L, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-91; Jonsson L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-114; Krege S, 2008, EUR UROL, V53, P478, DOI 10.1016/j.eururo.2007.12.024; Krege S, 2008, EUR UROL, V53, P497, DOI 10.1016/j.eururo.2007.12.025; Mead GM, 1997, J CLIN ONCOL, V15, P594; Olofsson SE, 2011, J CLIN ONCOL, V29, P2032, DOI 10.1200/JCO.2010.29.1278; PECKHAM MJ, 1985, LANCET, V1, P8; Sureban SM, 2008, ONCOGENE, V27, P4544, DOI 10.1038/onc.2008.97; Tandstad T, 2011, J CLIN ONCOL, V29, P719, DOI 10.1200/JCO.2010.30.1044; van Dijk MR, 2006, EUR J CANCER, V42, P820, DOI 10.1016/j.ejca.2005.08.043; Wellmann S, 2010, PEDIATR RES, V67, P35, DOI 10.1203/PDR.0b013e3181c13326	24	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121300	10.1371/journal.pone.0121300	http://dx.doi.org/10.1371/journal.pone.0121300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811459	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700092
J	Chan, N; He, SK; Spee, CK; Ishikawa, K; Hinton, DR				Chan, Nymph; He, Shikun; Spee, Christine K.; Ishikawa, Keijiro; Hinton, David R.			Attenuation of Choroidal Neovascularization by Histone Deacetylase Inhibitor	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MACULAR DEGENERATION; RETINAL NEOVASCULARIZATION; MESENCHYMAL TRANSITION; IN-VITRO; PROGENITOR CELLS; FACTOR RECEPTORS; TISSUE-FIBROSIS	Choroidal neovascularization (CNV) is a blinding complication of age-related macular degeneration that manifests as the growth of immature choroidal blood vessels through Bruch's membrane, where they can leak fluid or hemorrhage under the retina. Here, we demonstrate that the histone deacetylase inhibitor (HDACi) trichostatin A (TSA) can down-regulate the pro-angiogenic hypoxia-inducible factor-1 alpha and vascular endothelial growth factor (VEGF), and up-regulate the anti-angiogenic and neuro-protective pigment epithelium derived factor in human retinal pigment epithelial (RPE) cells. Most strikingly, TSA markedly down-regulates the expression of VEGF receptor-2 in human vascular endothelial cells and, thus, can knock down pro-angiogenic cell signaling. Additionally, TSA suppresses CNV-associated wound healing response and RPE epithelial-mesenchymal transdifferentiation. In the laser-induced model of CNV using C57Bl/6 mice, systemic administration of TSA significantly reduces fluorescein leakage and the size of CNV lesions at post-laser days 7 and 14 as well as the immunohistochemical expression of VEGF, VEGFR2, and smooth muscle actin in CNV lesions at post-laser day 7. This report suggests that TSA, and possibly HDACi's in general, should be further evaluated for their therapeutic potential for the treatment of CNV.	[Chan, Nymph; He, Shikun; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [He, Shikun; Spee, Christine K.; Ishikawa, Keijiro; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Chan, Nymph] Doheny Eye Inst, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; Doheny Eye Institute	Hinton, DR (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	dhinton@med.usc.edu			Arnold and Mabel Beckman Foundation; National Institutes of Health [EY01545]; National Institutes of Health Core grants [EY003040, P30CA014089]; NATIONAL EYE INSTITUTE [R01EY001545] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Core grants; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a grant from the Arnold and Mabel Beckman Foundation to the Doheny Eye Institute (DRH, NC), National Institutes of Health Grant EY01545 (DRH) and National Institutes of Health Core grants EY003040 (DRH) and P30CA014089 (DRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; Bartok B, 2014, J IMMUNOL, V192, P2063, DOI 10.4049/jimmunol.1300950; Bergersen L, 1999, NEUROSCIENCE, V90, P319, DOI 10.1016/S0306-4522(98)00427-8; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Browning AC, 2005, BRIT J OPHTHALMOL, V89, P1343, DOI 10.1136/bjo.2004.063602; Bruderer M, 2013, J VASC RES, V50, P265, DOI 10.1159/000353287; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Castellarin AA, 1998, RETINA-J RET VIT DIS, V18, P143, DOI 10.1097/00006982-199818020-00008; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Chou CW, 2008, FEBS LETT, V582, P4059, DOI 10.1016/j.febslet.2008.10.048; Codd R, 2009, INT J BIOCHEM CELL B, V41, P736, DOI 10.1016/j.biocel.2008.05.026; Crosson CE, 2010, INVEST OPHTH VIS SCI, V51, P3639, DOI 10.1167/iovs.09-4538; Das A, 1999, ARCH OPHTHALMOL-CHIC, V117, P498; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Deroanne CF, 2002, ONCOGENE, V21, P427, DOI 10.1038/sj.onc.1205108; Dutta D, 2010, J BIOL CHEM, V285, P41567, DOI 10.1074/jbc.M110.190025; ELNER VM, 1990, AM J PATHOL, V136, P745; Fan J, 2013, INVEST OPHTH VIS SCI, V54, P4072, DOI 10.1167/iovs.12-11529; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fong GH, 2009, J MOL MED-JMM, V87, P549, DOI 10.1007/s00109-009-0458-z; Frank RN, 1996, AM J OPHTHALMOL, V122, P393, DOI 10.1016/S0002-9394(14)72066-5; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gamulescu MA, 2006, EXP EYE RES, V83, P212, DOI 10.1016/j.exer.2005.12.007; Gao GQ, 2002, J BIOL CHEM, V277, P9492, DOI 10.1074/jbc.M108004200; Gao GQ, 2001, FEBS LETT, V489, P270, DOI 10.1016/S0014-5793(01)02110-X; Gehlbach P, 2003, GENE THER, V10, P637, DOI 10.1038/sj.gt.3301931; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Geng H, 2011, J BIOL CHEM, V286, P38095, DOI 10.1074/jbc.M111.257055; Gesbert F, 2000, J BIOL CHEM, V275, P39223, DOI 10.1074/jbc.M007291200; GRIERSON I, 1994, EYE, V8, P255, DOI 10.1038/eye.1994.54; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; He PM, 1998, BIOCHEM BIOPH RES CO, V249, P253, DOI 10.1006/bbrc.1998.9087; He SK, 2005, INVEST OPHTH VIS SCI, V46, P4772, DOI 10.1167/iovs.05-0502; Hirami Y, 2009, JPN J OPHTHALMOL, V53, P396, DOI 10.1007/s10384-009-0669-4; Hirasawa M, 2011, MOL VIS, V17, P1222; Hoffmann S, 1998, GRAEF ARCH CLIN EXP, V236, P779, DOI 10.1007/s004170050158; Huang J, 2014, MOL CELL BIOCHEM, V390, P115, DOI 10.1007/s11010-014-1962-1; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Iordache F, 2012, INT J MOL SCI, V13, P15074, DOI 10.3390/ijms131115074; IRUELAARISPE ML, 1991, P NATL ACAD SCI USA, V88, P5026, DOI 10.1073/pnas.88.11.5026; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Jablonski MM, 2000, J NEUROSCI, V20, P7149; Kim JY, 2009, EPIGENETICS-US, V4, P313, DOI 10.4161/epi.4.5.9160; Kim JH, 2009, MOL PHARMACEUT, V6, P513, DOI 10.1021/mp800178b; KORTE GE, 1984, INVEST OPHTH VIS SCI, V25, P1135; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Majka S, 2002, INVEST OPHTH VIS SCI, V43, P260; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Mottet D, 2007, CIRC RES, V101, P1237, DOI 10.1161/CIRCRESAHA.107.149377; Nagineni CN, 2003, J CELL PHYSIOL, V197, P453, DOI 10.1002/jcp.10378; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ogata N, 1997, CURR EYE RES, V16, P9, DOI 10.1076/ceyr.16.1.9.5121; Ogata N, 2001, GRAEF ARCH CLIN EXP, V239, P87, DOI 10.1007/s004170000235; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Park JH, 2008, BIOCHEM BIOPH RES CO, V368, P318, DOI 10.1016/j.bbrc.2008.01.056; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Qian DZ, 2004, CANCER RES, V64, P6626, DOI 10.1158/0008-5472.CAN-04-0540; Qin L, 2010, AM J PATHOL, V177, P1915, DOI 10.2353/ajpath.2010.100011; Recalde S, 2011, INVEST OPHTH VIS SCI, V52, P7090, DOI 10.1167/iovs.11-7300; Rossig L, 2005, J EXP MED, V201, P1825, DOI 10.1084/jem.20042097; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Ruchko MV, 2009, FREE RADICAL BIO MED, V46, P352, DOI 10.1016/j.freeradbiomed.2008.09.038; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; SAKAMOTO T, 1995, ARCH OPHTHALMOL-CHIC, V113, P512, DOI 10.1001/archopht.1995.01100040134039; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Sasakawa Y, 2003, BIOCHEM PHARMACOL, V66, P897, DOI 10.1016/S0006-2952(03)00411-8; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; SEREGARD S, 1994, GRAEF ARCH CLIN EXP, V232, P325, DOI 10.1007/BF00175983; Sheridan CM, 2009, GRAEF ARCH CLIN EXP, V247, P1361, DOI 10.1007/s00417-009-1133-3; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sreekumar PG, 2008, INVEST OPHTH VIS SCI, V49, P1210, DOI 10.1167/iovs.07-0667; SUGASAWA K, 1994, CELL STRUCT FUNCT, V19, P21, DOI 10.1247/csf.19.21; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Tandon A, 2012, J REFRACT SURG, V28, P285, DOI 10.3928/1081597X-20120210-01; TANIWAKI T, 1995, J NEUROCHEM, V64, P2509; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wang HB, 2011, INVEST OPHTH VIS SCI, V52, P8271, DOI 10.1167/iovs.11-8230; Wang QE, 2013, NUCLEIC ACIDS RES, V41, P1722, DOI 10.1093/nar/gks1312; Watanabe D, 2005, RETINA-J RET VIT DIS, V25, P911, DOI 10.1097/00006982-200510000-00015; Xiao W, 2014, J CELL MOL MED, V18, P646, DOI 10.1111/jcmm.12212; Yao QY, 2014, BLOOD, V123, P2429, DOI 10.1182/blood-2013-06-508689; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zgouras D, 2004, BIOCHEM BIOPH RES CO, V316, P693, DOI 10.1016/j.bbrc.2004.02.105; ZHANG NL, 1993, INVEST OPHTH VIS SCI, V34, P2412; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008	99	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120587	10.1371/journal.pone.0120587	http://dx.doi.org/10.1371/journal.pone.0120587			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807249	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000087
J	Hou, QJ; Fang, D; Liang, JR; Zhou, LX				Hou, Qingjie; Fang, Di; Liang, Jianru; Zhou, Lixiang			Significance of Oxygen Supply in Jarosite Biosynthesis Promoted by Acidithiobacillus ferrooxidans	PLOS ONE			English	Article							ACID-MINE DRAINAGE; FERROUS SULFATE; IRON; SCHWERTMANNITE; OXIDATION; PRECIPITATION; SULFIDIZATION; FERRIHYDRITE; BIOOXIDATION; RECOVERY	Jarosite [(Na+, K+, NH4+, H3O+)Fe-3(SO4)(2)(OH)(6)] is an efficient scavenger for trace metals in Fe- and SO42--rich acidic water. During the biosynthesis of jarosite promoted by Acidithiobacillus ferrooxidans, the continuous supply of high oxygen levels is a common practice that results in high costs. To evaluate the function of oxygen in jarosite production by A. ferrooxidans, three groups of batch experiments with different oxygen supply levels (i.e., loading volume percentages of FeSO4 solution of 20%, 40%, and 70% v/v in the flasks), as well as three groups of sealed flask experiments with different limiting oxygen supply conditions (i.e., the solutions were not sealed at the initial stage of the ferrous oxidation reaction by paraffin but were rather sealed at the end of the ferrous oxidation reaction at 48 h), were tested. The formed Fe-precipitates were characterized via X-ray powder diffraction and scanning electron microscope-energy dispersive spectral analysis. The results showed that the biosynthesis of jarosite by A. ferrooxidans LX5 could be achieved at a wide range of solution loading volume percentages. The rate and efficiency of the jarosite biosynthesis were poorly correlated with the concentration of dissolved oxygen in the reaction solution. Similar jarosite precipitates, expressed as KFe3 (SO4)(2)(OH)(6) with Fe/S molar ratios between 1.61 and 1.68, were uniformly formed in unsealed and 48 h sealed flasks. These experimental results suggested that the supply of O-2 was only essential in the period of the oxidation of ferrous iron to ferric but was not required in the period of ferric precipitation.	[Hou, Qingjie; Fang, Di; Liang, Jianru; Zhou, Lixiang] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, LX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.	lxzhou@njau.edu.cn	Zhou, Li/GSE-4531-2022		National Natural Science Foundation of China [41371476, 21377057, 21477054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Natural Science Foundation of China (41371476, 21377057 and 21477054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], APHA STAND METH EX W; Bai SY, 2012, MAT SCI ENG C-MATER, V32, P2323, DOI 10.1016/j.msec.2012.07.003; Barham RJ, 1997, J MATER RES, V12, P2751, DOI 10.1557/JMR.1997.0366; Biliana G, 2005, CHEM GEOL, V215, P499; Carlson L, 2002, ENVIRON SCI TECHNOL, V36, P1712, DOI 10.1021/es0110271; Cruz FLS, 2010, HYDROMETALLURGY, V105, P103, DOI 10.1016/j.hydromet.2010.08.006; Daoud J, 2006, MINER ENG, V19, P960, DOI 10.1016/j.mineng.2005.10.024; Dutrizac JE, 2010, HYDROMETALLURGY, V102, P55, DOI 10.1016/j.hydromet.2010.02.004; Egal M, 2009, CHEM GEOL, V265, P432, DOI 10.1016/j.chemgeo.2009.05.008; Gleisner M, 2006, CHEM GEOL, V225, P16, DOI 10.1016/j.chemgeo.2005.07.020; Han HS, 2014, J HAZARD MATER, V278, P49, DOI 10.1016/j.jhazmat.2014.05.091; Huang S, 2012, MAT SCI ENG C-MATER, V32, P916, DOI 10.1016/j.msec.2012.02.012; JENSEN AB, 1995, PROCESS BIOCHEM, V30, P225, DOI 10.1016/0032-9592(95)95721-T; Johnston SG, 2012, CHEM GEOL, V334, P9, DOI 10.1016/j.chemgeo.2012.09.045; Kaksonen AH, 2014, HYDROMETALLURGY, V147, P264, DOI 10.1016/j.hydromet.2014.04.015; Kanzaki Y, 2013, GEOCHIM COSMOCHIM AC, V123, P338, DOI 10.1016/j.gca.2013.06.014; Khorasanipour M, 2011, APPL GEOCHEM, V26, P714, DOI 10.1016/j.apgeochem.2011.01.030; Lazaridis NK, 2005, CHEMOSPHERE, V58, P65, DOI 10.1016/j.chemosphere.2004.09.007; Liao YH, 2009, APPL GEOCHEM, V24, P1739, DOI 10.1016/j.apgeochem.2009.05.003; Madden MEE, 2012, GEOCHIM COSMOCHIM AC, V91, P306, DOI 10.1016/j.gca.2012.05.001; Mahiroglu A, 2009, J HAZARD MATER, V166, P782, DOI 10.1016/j.jhazmat.2008.11.119; Majzlan J, 2004, GEOCHIM COSMOCHIM AC, V68, P1049, DOI 10.1016/S0016-7037(03)00371-5; Mousavi SM, 2006, FUEL, V85, P2555, DOI 10.1016/j.fuel.2006.05.020; Ohmura N, 2002, J BACTERIOL, V184, P2081, DOI 10.1128/JB.184.8.2081-2087.2002; Pappu A, 2006, SCI TOTAL ENVIRON, V359, P232, DOI 10.1016/j.scitotenv.2005.04.024; Silva LFO, 2013, SCI TOTAL ENVIRON, V447, P169, DOI 10.1016/j.scitotenv.2012.12.013; SILVERMAN MP, 1959, J BACTERIOL, V77, P642, DOI 10.1128/JB.77.5.642-647.1959; Song YW, 2014, HYDROMETALLURGY, V143, P23, DOI 10.1016/j.hydromet.2014.01.003; Sun LX, 2012, HYDROMETALLURGY, V127, P99, DOI 10.1016/j.hydromet.2012.07.007; Wang HM, 2006, MAT SCI ENG C-BIO S, V26, P588, DOI 10.1016/j.msec.2005.04.009; Wang JW, 2009, J HAZARD MATER, V172, P1100, DOI 10.1016/j.jhazmat.2009.07.102; Wang M, 2012, HYDROMETALLURGY, V125, P152, DOI 10.1016/j.hydromet.2012.06.003; Wang YJ, 2006, POLYM DEGRAD STABIL, V91, P2408, DOI 10.1016/j.polymdegradstab.2006.03.015	33	8	8	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120966	10.1371/journal.pone.0120966	http://dx.doi.org/10.1371/journal.pone.0120966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807372	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000120
J	Lin, FY; Lin, CW; Yang, SF; Lee, WJ; Lin, YW; Lee, LM; Chang, JL; Weng, WC; Lin, CH; Chien, MH				Lin, Feng-Yan; Lin, Chiao-Wen; Yang, Shun-Fa; Lee, Wei-Jiunn; Lin, Yung-Wei; Lee, Liang-Ming; Chang, Junn-Liang; Weng, Wei-Chun; Lin, Chien-Huang; Chien, Ming-Hsien			Interactions between Environmental Factors and Melatonin Receptor Type 1A Polymorphism in Relation to Oral Cancer Susceptibility and Clinicopathologic Development	PLOS ONE			English	Article							NECK-CANCER; GENE; PHARMACOLOGY; ASSOCIATION; CONSUMPTION; INHIBITION; MECHANISMS; MTNR1A; CELLS; RISK	Background The purpose of this study was to explore the combined effect of melatonin receptor type 1A (MTNR1A) gene polymorphisms and exposure to environmental carcinogens on the susceptibility and clinicopathological characteristics of oral cancer. Methodology and Principal Findings Three polymorphisms of the MTNR1A gene from 618 patients with oral cancer and 560 non-cancer controls were analyzed by real-time polymerase chain reaction (PCR). The CTA haplotype of the studied MTNR1A polymorphisms (rs2119882, rs13140012, rs6553010) was related to a higher risk of oral cancer. Moreover, MTNR1A gene polymorphisms exhibited synergistic effects of environmental factors (betel quid and tobacco use) on the susceptibility of oral cancer. Finally, oral-cancer patients with betel quid-chewing habit who had T/T allele of MTNR1A rs13140012 were at higher risk for developing an advanced clinical stage and lymph node metastasis. Conclusion These results support gene-environment interactions of MTNR1A polymorphisms with smoking and betel quid-chewing habits possibly altering oral-cancer susceptibility and metastasis.	[Lin, Feng-Yan; Yang, Shun-Fa; Weng, Wei-Chun] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Feng-Yan] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung 40201, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung 40201, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 40201, Taiwan; [Lee, Wei-Jiunn; Lin, Yung-Wei; Lee, Liang-Ming] Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan; [Chang, Junn-Liang] Taoyuan Armed Forces Gen Hosp, Dept Med Management, Taoyuan, Taoyuan County, Taiwan; [Chang, Junn-Liang] Natl Def Med Ctr, Dept Pathol, Sch Med, Taipei, Taiwan; [Weng, Wei-Chun] Tungs Taichung MetroHarbor Hosp, Dept Surg, Div Urol, Taichung, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; National Defense Medical Center; Tungs' Taichung MetroHarbor Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chien, MH (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan.	mhchien1976@gmail.com	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Lin, Chien-Huang/0000-0002-0916-8737	National Science Council [NSC102-2320-B-038-038-MY3]; Taoyuan Armed Forces General Hospital [TAFGH-103-29]	National Science Council(Ministry of Science and Technology, Taiwan); Taoyuan Armed Forces General Hospital	This study was supported by a grant from the National Science Council (NSC102-2320-B-038-038-MY3) and a grant from Taoyuan Armed Forces General Hospital (TAFGH-103-29). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biolchini F, 2005, Minerva Stomatol, V54, P405; Bizzarri M, 2013, EXPERT OPIN THER TAR, V17, P1483, DOI 10.1517/14728222.2013.834890; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Califano J, 1996, CANCER RES, V56, P2488; Chien MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051051; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Collins A, 2003, CANCER LETT, V189, P49, DOI 10.1016/S0304-3835(02)00502-5; Cutando A, 2014, ONCOL LETT, V7, P923, DOI 10.3892/ol.2014.1813; Deming SL, 2012, BREAST CANCER RES TR, V132, P693, DOI 10.1007/s10549-011-1884-5; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; Esposito T, 2012, NEPHROL DIAL TRANSPL, V27, P210, DOI 10.1093/ndt/gfr216; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goncalves ND, 2014, ANTI-CANCER AGENT ME, V14, P1302, DOI 10.2174/1871520614666140812110246; Ha EY, 2005, J PINEAL RES, V39, P201, DOI 10.1111/j.1600-079X.2005.00237.x; Hsieh YP, 2014, HEAD NECK; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnston JD, 2007, MOL CELL ENDOCRINOL, V268, P59, DOI 10.1016/j.mce.2007.01.015; Jones MP, 2000, CANCER LETT, V151, P133, DOI 10.1016/S0304-3835(99)00394-8; Jung B, 2006, CANCER RES, V66, P9789, DOI 10.1158/0008-5472.CAN-06-1776; Lai L, 2009, BREAST CANCER RES TR, V118, P293, DOI 10.1007/s10549-008-0220-1; Li C, 2011, GYNECOL OBSTET INVES, V72, P130, DOI 10.1159/000323542; Martin V, 2006, CANCER RES, V66, P1081, DOI 10.1158/0008-5472.CAN-05-2354; Nakamura E, 2008, CANCER SCI, V99, P1390, DOI 10.1111/j.1349-7006.2008.00838.x; Ram PT, 2002, CANCER LETT, V179, P141, DOI 10.1016/S0304-3835(01)00873-4; Reiter RJ, 2004, J PINEAL RES, V37, P213, DOI 10.1111/j.1600-079X.2004.00165.x; Reynolds PR, 2006, AM J RESP CELL MOL, V35, P314, DOI 10.1165/rcmb.2005-0428OC; Samimi-Fard S, 2011, J PINEAL RES, V51, P400, DOI 10.1111/j.1600-079X.2011.00903.x; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Schwartz SM, 2001, CANCER EPIDEM BIOMAR, V10, P1137; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Tang DW, 2004, TOXICOL LETT, V152, P235, DOI 10.1016/j.toxlet.2004.05.005; Vijayalaxmi, 2002, J CLIN ONCOL, V20, P2575, DOI 10.1200/JCO.2002.11.004; Wang YY, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-99; Wu HJ, 2005, J TOXICOL ENV HEAL A, V68, P1511, DOI 10.1080/15287390590967478; Xia Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050107; Yang YH, 2005, J ORAL PATHOL MED, V34, P596, DOI 10.1111/j.1600-0714.2005.00266.x; Yen TT, 2008, EUR ARCH OTO-RHINO-L, V265, P1403, DOI 10.1007/s00405-008-0659-z	41	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121677	10.1371/journal.pone.0121677	http://dx.doi.org/10.1371/journal.pone.0121677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806809	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000172
J	Lindegren, ML; Griffin, MR; Williams, JV; Edwards, KM; Zhu, YW; Mitchel, E; Fry, AM; Schaffner, W; Talbot, HK				Lindegren, Mary Louise; Griffin, Marie R.; Williams, John V.; Edwards, Kathryn M.; Zhu, Yuwei; Mitchel, Ed; Fry, Alicia M.; Schaffner, William; Talbot, H. Keipp			Antiviral Treatment among Older Adults Hospitalized with Influenza, 2006-2012	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; SEASONAL INFLUENZA; RAPID INFLUENZA; MANAGEMENT; INFECTION; IMPACT; DIAGNOSIS; CHILDREN; VACCINE	Objective To describe antiviral use among older, hospitalized adults during six influenza seasons (2006-2012) in Davidson County, Tennessee, USA. Methods Among adults >= 50 years old hospitalized with symptoms of respiratory illness or non-localizing fever, we collected information on provider-initiated influenza testing and nasal/throat swabs for influenza by RT-PCR in a research laboratory, and calculated the proportion treated with antivirals. Results We enrolled 1753 adults hospitalized with acute respiratory illness. Only 26% (457/1753) of enrolled patients had provider-initiated influenza testing. Thirty-eight patients had a positive clinical laboratory test, representing 2.2% of total patients and 8.3% of tested patients. Among the 38 subjects with clinical laboratory-confirmed influenza, 26.3% received antivirals compared to only 4.5% of those with negative clinical influenza tests and 0.7% of those not tested (p< 0.001). There were 125 (7.1%) patients who tested positive for influenza in the research laboratory. Of those with research laboratory-confirmed influenza, 0.9%, 2.7%, and 2.8% received antivirals (p = .046) during pre-pandemic, pandemic, and post-pandemic influenza seasons, respectively. Both research laboratory-confirmed influenza (adjusted odds ratio [AOR] 3.04 95% CI 1.26-7.35) and clinical laboratory-confirmed influenza (AOR 3.05, 95% CI 1.07-8.71) were independently associated with antiviral treatment. Severity of disease, presence of a high-risk condition, and symptom duration were not associated with antiviral use. Conclusions In urban Tennessee, antiviral use was low in patients recognized to have influenza by the provider as well as those unrecognized to have influenza. The use of antivirals remained low despite recommendations to treat all hospitalized patients with confirmed or suspected influenza.	[Lindegren, Mary Louise; Williams, John V.; Edwards, Kathryn M.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Griffin, Marie R.; Schaffner, William; Talbot, H. Keipp] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Griffin, Marie R.; Schaffner, William] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Griffin, Marie R.] VA TN Valley Hlth Care Syst, Midsouth Geriatr Res Educ & Clin Ctr, Nashville, TN USA; [Williams, John V.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Edwards, Kathryn M.] Vanderbilt Univ, Sch Med, Dept Pediat, Vanderbilt Vaccine Res Program, Nashville, TN 37212 USA; [Zhu, Yuwei; Mitchel, Ed] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Fry, Alicia M.] Ctr Dis Control & Prevent, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Centers for Disease Control & Prevention - USA	Lindegren, ML (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA.	Marylou.lindegren@Vanderbilt.edu	Williams, John/ABE-3227-2020; Williams, John/F-6962-2010	Williams, John/0000-0001-8377-5175; Williams, John/0000-0001-8377-5175	VTEU [N01 AI25462, 1U181P000184-01]; Centers for Disease Control and Prevention [200-2008-24624]; NIH/NCRR [5 K12 RR017697-05]; NIAID [1K23AI074863-01]; CTSA from the National Center for Advancing Translational Sciences [UL1TR000445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025462, K23AI074863] Funding Source: NIH RePORTER	VTEU; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was through multiple sources: Surveillance for the first two years was funded by the VTEU (N01 AI25462) (Kathryn M. Edwards MD, site PI), during years 3-5 by CDC (1U181P000184-01) (Marie Griffin MD, site PI), and in the final year by the Centers for Disease Control and Prevention (contract 200-2008-24624 to RTI International). Dr. Talbot received salary support and career development from the NIH/NCRR (5 K12 RR017697-05), and from the NIAID (1K23AI074863-01). This project was also supported by CTSA award No. UL1TR000445 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health or the views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggerstaff M, 2012, AM J PUBLIC HEALTH, V102, pE21, DOI 10.2105/AJPH.2012.300651; Bonner AB, 2003, PEDIATRICS, V112, P363, DOI 10.1542/peds.112.2.363; Centers for Disease CaP, 2009, UPD INT REC US ANT M; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; Chen Q, 2014, J INFECT DIS; Doshi S, 2011, J INFECT DIS, V204, P1848, DOI 10.1093/infdis/jir648; Dugas AF, 2013, ANN EMERG MED, V62, P80, DOI 10.1016/j.annemergmed.2013.01.005; Falsey AR, 2007, ARCH INTERN MED, V167, P354, DOI 10.1001/archinte.167.4.ioi60207; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Garg S, 2012, CLIN INFECT DIS, V55, pE18, DOI 10.1093/cid/cis442; Gorelick KJ, 2005, NEW ENGL J MED, V353, P422; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Havers F, 2014, USE INFLUENZA ANTIVI; Hernandez JE, 2012, INFLUENZA OTHER RESP, V6, P305, DOI 10.1111/j.1750-2659.2011.00303.x; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jennings LC, 2009, INFLUENZA OTHER RESP, V3, P91, DOI 10.1111/j.1750-2659.2009.00079.x; Katz MA, 2009, INFLUENZA OTHER RESP, V3, P29, DOI 10.1111/j.1750-2659.2009.00070.x; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Poehling KA, 2013, PEDIATRICS, V131, P207, DOI 10.1542/peds.2012-1255; Rothberg MB, 2006, CLIN INFECT DIS, V42, P95, DOI 10.1086/498517; Rothberg MB, 2003, ANN INTERN MED, V139, P321, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00007; Talbot HK, 2013, CLIN INFECT DIS, V56, P1774, DOI 10.1093/cid/cit124; Talbot HK, 2011, J INFECT DIS, V203, P500, DOI 10.1093/infdis/jiq076; Talbot HK, 2010, INFECT CONT HOSP EP, V31, P683, DOI 10.1086/653202; Talbot HK, 2010, CLIN INFECT DIS, V50, P747, DOI 10.1086/650486; Taylor G, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-2; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Walsh EE, 2007, J INFECT DIS, V195, P1046, DOI 10.1086/511986; You JHS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033123; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	38	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121952	10.1371/journal.pone.0121952	http://dx.doi.org/10.1371/journal.pone.0121952			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807314	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000191
J	Mazumder, TH; Chakraborty, S				Mazumder, Tarikul Huda; Chakraborty, Supriyo			Gaining Insights into the Codon Usage Patterns of TP53 Gene across Eight Mammalian Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; CATALOG USAGE; BIAS; SELECTION; EXPRESSION; GENOME; TRANSLATION; DROSOPHILA; P53; CAENORHABDITIS	TP53 gene is known as the "guardian of the genome" as it plays a vital role in regulating cell cycle, cell proliferation, DNA damage repair, initiation of programmed cell death and suppressing tumor growth. Non uniform usage of synonymous codons for a specific amino acid during translation of protein known as codon usage bias (CUB) is a unique property of the genome and shows species specific deviation. Analysis of codon usage bias with compositional dynamics of coding sequences has contributed to the better understanding of the molecular mechanism and the evolution of a particular gene. In this study, the complete nucleotide coding sequences of TP53 gene from eight different mammalian species were used for CUB analysis. Our results showed that the codon usage patterns in TP53 gene across different mammalian species has been influenced by GC bias particularly GC(3) and a moderate bias exists in the codon usage of TP53 gene. Moreover, we observed that nature has highly favored the most over represented codon CTG for leucine amino acid but selected against the ATA codon for isoleucine in TP53 gene across all mammalian species during the course of evolution.	[Mazumder, Tarikul Huda; Chakraborty, Supriyo] Assam Univ, Dept Biotechnol, Silchar 788011, Assam, India	Assam University	Chakraborty, S (corresponding author), Assam Univ, Dept Biotechnol, Silchar 788011, Assam, India.	supriyoch_2008@rediffmail.com		Mazumder, Tarikul Huda/0000-0002-5773-6372				Ahn I, 2009, EXP MOL MED, V41, P746, DOI 10.3858/emm.2009.41.10.081; AKASHI H, 1995, GENETICS, V139, P1067; Behura SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043111; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Dass JFP, 2012, GENE, V503, P92, DOI 10.1016/j.gene.2012.03.057; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Fox JM, 2010, DNA RES, V17, P185, DOI 10.1093/dnares/dsq012; GRANTHAM R, 1981, NUCLEIC ACIDS RES, V9, pR43; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006; Hassan Sameer, 2009, Advances in Bioinformatics, V2009, P316936, DOI 10.1155/2009/316936; Hooper SD, 2000, NUCLEIC ACIDS RES, V28, P3517, DOI 10.1093/nar/28.18.3517; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Karlin S, 1996, J MOL BIOL, V262, P459, DOI 10.1006/jmbi.1996.0528; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; LI WH, 1987, J MOL EVOL, V24, P337, DOI 10.1007/BF02134132; Lithwick G, 2005, NUCLEIC ACIDS RES, V33, P1051, DOI 10.1093/nar/gki261; Liu H, 2012, GENET MOL RES, V11, P4695, DOI 10.4238/2012.October.17.3; Ma JM, 2002, BIOSYSTEMS, V65, P199, DOI 10.1016/S0303-2647(02)00016-3; Mandlik V, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-142; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; McInerney JO, 1998, P NATL ACAD SCI USA, V95, P10698, DOI 10.1073/pnas.95.18.10698; Miyasaka H, 2002, J MOL EVOL, V55, P52, DOI 10.1007/s00239-001-0090-1; Nabiyouni M, 2013, GENE, V519, P113, DOI 10.1016/j.gene.2013.01.033; Nair RR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-492; Palidwor GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013431; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Roymondal U, 2009, DNA RES, V16, P13, DOI 10.1093/dnares/dsn029; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Supek F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-182; Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xu C, 2011, EVOL BIOINFORM, V7, P271, DOI 10.4137/EBO.S8092; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284	48	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121709	10.1371/journal.pone.0121709	http://dx.doi.org/10.1371/journal.pone.0121709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807269	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000175
J	Meeraus, WH; Petersen, I; Gilbert, R				Meeraus, Wilhelmine Hadler; Petersen, Irene; Gilbert, Ruth			Association between Antibiotic Prescribing in Pregnancy and Cerebral Palsy or Epilepsy in Children Born at Term: A Cohort Study Using The Health Improvement Network	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; PRESCRIPTION DRUG-USE; MATERNAL INFECTIONS; FETAL SAFETY; PRIMARY-CARE; RISK; ERYTHROMYCIN; AZITHROMYCIN; CHILDHOOD; HYPOXIA	Background Between 19%-44% pregnant women are prescribed antibiotics during pregnancy. A single, large randomised-controlled-trial (ORACLE Childhood Study II) found an increased risk of childhood cerebral palsy and possibly epilepsy following prophylactic antibiotic use in pregnant women with spontaneous preterm labour. We ascertained whether this outcome could be reproduced across the population of babies delivered at term and prospectively followed in primary-care using data from The Health Improvement Network. Methods We determined the risk of cerebral palsy or epilepsy in children whose mothers were prescribed antibiotics during pregnancy using a cohort of 195,909 women linked to their live, term-born, singleton children. We compared the effect of antibiotic class, number of courses and timing of prescribing in pregnancy. Analyses were adjusted for maternal risk factors (e.g. recorded infection, age, chronic conditions, social deprivation, smoking status). Children were followed until age seven years or cessation of registration with the primary-care practitioner. Results In total, 64,623 (33.0%) women were prescribed antibiotics in pregnancy and 1,170 (0.60%) children had records indicating cerebral palsy or epilepsy. Adjusted analyses showed no association between prescribing of any antibiotic and cerebral palsy or epilepsy (adj. HR 1.04, 95% CI 0.91-1.19). However, compared with penicillins, macrolides were associated with an increased risk of cerebral palsy or epilepsy (adj. HR 1.78, 95% CI 1.18-2.69; number needed to harm 153, 95% CI 71-671). Conclusions We found no overall association between antibiotic prescribing in pregnancy and cerebral palsy and/or epilepsy in childhood. However, our finding of an increased risk of cerebral palsy or epilepsy associated with macrolide prescribing in pregnancy adds to evidence that macrolide use is associated with serious harm.	[Meeraus, Wilhelmine Hadler; Gilbert, Ruth] UCL Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Meeraus, Wilhelmine Hadler; Petersen, Irene] UCL Res Dept Primary Care & Populat Hlth, London, England; [Gilbert, Ruth] Farr Inst Hlth Informat Res, London, England	University of London; University College London; University of London; University College London	Gilbert, R (corresponding author), UCL Inst Child Hlth, Populat Policy & Practice Programme, London, England.	r.gilbert@ucl.ac.uk	; Petersen, Irene/C-5702-2009	Gilbert, Ruth/0000-0001-9347-2709; Petersen, Irene/0000-0002-0037-7524	Medical Research Council (MRC) in its capacity as the MRC Centre of Epidemiology for Child Health; MRC [G0601726]; ESRC [ES/L007517/1] Funding Source: UKRI; MRC [G0400546] Funding Source: UKRI; Economic and Social Research Council [ES/L007517/1] Funding Source: researchfish; Medical Research Council [G0400546, MR/K006584/1, G0601726] Funding Source: researchfish	Medical Research Council (MRC) in its capacity as the MRC Centre of Epidemiology for Child Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UCL Institute of Child Health benefited from funding support from the Medical Research Council (MRC) in its capacity as the MRC Centre of Epidemiology for Child Health. WM's time was funded by a studentship grant from the MRC. IP received funding from the MRC (grant code G0601726). RG is an investigator with the Farr Institute of Health Informatics Research London. The funders had no role in study design, data analysis, decision to publish or preparation of the manuscript.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Andersen JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053327; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Bakker MK, 2006, BJOG-INT J OBSTET GY, V113, P559, DOI 10.1111/j.1471-0528.2006.00927.x; Bjorn Anne-Mette Bay, 2011, Clin Epidemiol, V3, P149, DOI 10.2147/CLEP.S17747; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bourke Alison, 2004, Inform Prim Care, V12, P171; Bril F, 2010, CURR DRUG SAF, V5, P85, DOI 10.2174/157488610789869184; Charlton RA, 2014, PHARMACOEPIDEM DR S, V23, P586, DOI 10.1002/pds.3613; Colbourn TE, 2007, HLTH TECHNOL ASSESS, V11; Crespin S, 2011, DRUG SAFETY, V34, P595, DOI 10.2165/11589170-000000000-00000; Crider KS, 2009, ARCH PEDIAT ADOL MED, V163, P978, DOI 10.1001/archpediatrics.2009.188; CSD EPIC, 2010, THIN DAT GUID RES VE; Danielson BR, 2001, CURR PHARM DESIGN, V7, P787, DOI 10.2174/1381612013397744; Danielsson BR, 2007, REPROD TOXICOL, V24, P42, DOI 10.1016/j.reprotox.2007.04.005; Daw JR, 2012, CLIN THER, V34, P239, DOI 10.1016/j.clinthera.2011.11.025; Devasia RA, 2009, AM J MED SCI, V337, P176, DOI 10.1097/MAJ.0b013e318184e72f; Dinur AB, 2013, ANTIMICROB AGENTS CH, V57, P3307, DOI 10.1128/AAC.01691-12; Guo DH, 2010, PHARMAZIE, V65, P631, DOI 10.1691/ph.2010.0644; Heikkinen T, 2000, BRIT J OBSTET GYNAEC, V107, P770, DOI 10.1111/j.1471-0528.2000.tb13339.x; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Himmelmann K, 2011, ACTA OBSTET GYN SCAN, V90, P1070, DOI 10.1111/j.1600-0412.2011.01217.x; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; Joint Formulary Committee, 2009, BRIT NATL FORMULARY; Jones D, 2008, W36 SPL; Kallen B, 2006, REPROD TOXICOL, V21, P221, DOI 10.1016/j.reprotox.2005.11.006; Kallen BAJ, 2005, REPROD TOXICOL, V20, P209, DOI 10.1016/j.reprotox.2005.01.010; Kallen B, 2014, EUR J CLIN PHARMACOL, V70, P355, DOI 10.1007/s00228-013-1624-3; Kendall G, 2005, EARLY HUM DEV, V81, P27, DOI 10.1016/j.earlhumdev.2004.10.012; Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; KOREN G, 1989, AM J OBSTET GYNECOL, V160, P1190, DOI 10.1016/0002-9378(89)90186-5; Koren G, 1998, NEW ENGL J MED, V338, P1128, DOI 10.1056/NEJM199804163381607; Langley JM, 2004, PEDIATRICS, V114, pE96, DOI 10.1542/peds.114.1.e96; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Lieberman D, 2002, DIAGN MICR INFEC DIS, V42, P21, DOI 10.1016/S0732-8893(01)00324-8; Lin KJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.023; Macnab A., 2012, BRAIN DAMAGE BRIDING, P1; Marlow N, 2012, DEV MED CHILD NEUROL, V54, P640, DOI 10.1111/j.1469-8749.2012.04274.x; Matsui D, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/796590; Meeraus WH, 2011, PHARMACOEPIDEM DR S, V20, pS54; Meeraus WH, 2013, ARCH DIS CHILD, V98, P195, DOI 10.1136/archdischild-2012-302237; Miller JE, 2013, PAEDIATR PERINAT EP, V27, P542, DOI 10.1111/ppe.12082; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Norgaard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030850; Ostrea EM, 2004, PEDIATR CLIN N AM, V51, P539, DOI 10.1016/j.pcl.2004.01.001; Petersen I, 2010, J ANTIMICROB CHEMOTH, V65, P2238, DOI 10.1093/jac/dkq307; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Royal College of Obstetricians and Gynaecologists, 2013, 33 RCOG; Schembri S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1235; Smaill F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000490.pub2; Stokholm J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082932; Sun Y, 2008, PEDIATRICS, V121, pE1100, DOI 10.1542/peds.2007-2316; Svanstrom H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4930; Tin W, 1998, ARCH DIS CHILD-FETAL, V79, pF83, DOI 10.1136/fn.79.2.F83; VANNUCCI RC, 1990, PEDIATR RES, V27, P317, DOI 10.1203/00006450-199004000-00001; Vazquez JC, 2003, COCHRANE DATABASE SY; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Ye X, 2008, CLIN THER, V30, P358, DOI 10.1016/j.clinthera.2008.01.023	65	32	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122034	10.1371/journal.pone.0122034	http://dx.doi.org/10.1371/journal.pone.0122034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807115	Green Published, gold			2022-12-26	WOS:000351880000198
J	Ogawa, W; Minato, Y; Dodan, H; Onishi, M; Tsuchiya, T; Kuroda, T				Ogawa, Wakano; Minato, Yusuke; Dodan, Hayata; Onishi, Motoyasu; Tsuchiya, Tomofusa; Kuroda, Teruo			Characterization of MATE-Type Multidrug Efflux Pumps from Klebsiella pneumoniae MGH78578	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; ESCHERICHIA-COLI; VIBRIO-PARAHAEMOLYTICUS; PROTEIN NORM; TRANSPORTER; FAMILY; GENES; CLONING; ANTIPORTER; EXPRESSION	We previously described the cloning of genes related to drug resistance from Klebsiella pneumoniae MGH78578. Of these, we identified a putative gene encoding a MATE-type multidrug efflux pump, and named it ketM. Escherichia coli KAM32 possessing ketM on a plasmid showed increased minimum inhibitory concentrations for norfloxacin, ciprofloxacin, cefotaxime, acriflavine, Hoechst 33342, and 4', 6-diamidino-2-phenyl indole (DAPI). The active efflux of DAPI was observed in E. coli KAM32 possessing ketM on a plasmid. The expression of mRNA for ketM was observed in K. pneumoniae cells, and we subsequently disrupted ketM in K. pneumoniae ATCC10031. However, no significant changes were observed in drug resistance levels between the parental strain ATCC10031 and ketM disruptant, SKYM. Therefore, we concluded that KetM was a multidrug efflux pump, that did not significantly contribute to intrinsic resistance to antimicrobial chemicals in K. pneumoniae. MATE-type transporters are considered to be secondary transporters; therefore, we investigated the coupling cations of KetM. DAPI efflux by KetM was observed when lactate was added to produce a proton motive force, indicating that KetM effluxed substrates using a proton motive force. However, the weak efflux of DAPI by KetM was also noted when NaCl was added to the assay mixture without lactate. This result suggests that KetM may utilize proton and sodium motive forces.	[Ogawa, Wakano] Daiichi Univ Pharm, Dept Microbiol & Biochem, Fukuoka, Japan; [Ogawa, Wakano; Minato, Yusuke; Dodan, Hayata; Onishi, Motoyasu; Kuroda, Teruo] Okayama Univ, Dept Microbiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Tsuchiya, Tomofusa] Ritsumeikan Univ, Coll Pharmaceut Sci, Dept Microbiol, Shiga, Japan	Okayama University; Ritsumeikan University	Ogawa, W (corresponding author), Daiichi Univ Pharm, Dept Microbiol & Biochem, Fukuoka, Japan.	wogawa@daiichi-cps.ac.jp	Ogawa, Wakano/AAI-2887-2020; KURODA, Teruo/B-2028-2011; OGAWA, Wakano/B-1997-2011; Minato, Yusuke/B-9510-2018	Minato, Yusuke/0000-0002-0888-8564; Onishi, Motoyasu/0000-0002-7660-2986	Ministry of Education, Culture, Sports, Science and Technology of Japan [16390131, 22590064]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Research Project Number: 16390131, http://kaken.nii.ac.jp/d/p/16390131.en.html, and Research Project Number: 22590064, http://kaken.nii.ac.jp/d/p/22590064.en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown DG, 2007, APPL ENVIRON MICROB, V73, P2777, DOI 10.1128/AEM.00984-06; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Hashimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059525; He GX, 2011, ARCH MICROBIOL, V193, P759, DOI 10.1007/s00203-011-0738-1; He GX, 2004, J BACTERIOL, V186, P262, DOI 10.1128/JB.186.1.262-265.2004; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Hiasa M, 2007, AM J PHYSIOL-CELL PH, V293, pC1437, DOI 10.1152/ajpcell.00280.2007; Hiasa M, 2006, AM J PHYSIOL-CELL PH, V291, pC678, DOI 10.1152/ajpcell.00090.2006; Huda MN, 2003, MICROBIOL IMMUNOL, V47, P419, DOI 10.1111/j.1348-0421.2003.tb03379.x; Huda MN, 2001, FEMS MICROBIOL LETT, V203, P235, DOI 10.1111/j.1574-6968.2001.tb10847.x; Jin Y, 2014, J BIOL CHEM, V289, P14624, DOI 10.1074/jbc.M113.546770; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Komatsu T, 2011, INT J BIOCHEM CELL B, V43, P913, DOI 10.1016/j.biocel.2011.03.005; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Ogawa W, 2005, BIOL PHARM BULL, V28, P1505, DOI 10.1248/bpb.28.1505; Ogawa W, 1998, J BACTERIOL, V180, P6749, DOI 10.1128/JB.180.24.6749-6752.1998; Ogawa W, 2012, GENE, V498, P177, DOI 10.1016/j.gene.2012.02.008; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Onishi M, 2014, GENE, V534, P313, DOI 10.1016/j.gene.2013.10.029; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; PETERSON KR, 1985, MOL GEN GENET, V201, P14, DOI 10.1007/BF00397979; Rodriguez-Beltran J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034791; Singh AK, 2006, ANTIMICROB AGENTS CH, V50, P3717, DOI 10.1128/AAC.00460-06; Song JN, 2014, PROTEINS, V82, P240, DOI 10.1002/prot.24368; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Tanihara Y, 2007, BIOCHEM PHARMACOL, V74, P359, DOI 10.1016/j.bcp.2007.04.010; Terada T, 2008, BIOCHEM PHARMACOL, V75, P1689, DOI 10.1016/j.bcp.2007.12.008; Tocci N, 2013, ANTIMICROB AGENTS CH, V57, P248, DOI 10.1128/AAC.01298-12; Tsuda M, 2007, AM J PHYSIOL-RENAL, V292, pF593, DOI 10.1152/ajprenal.00312.2006; VANDERREST ME, 1992, J BACTERIOL, V174, P4893, DOI 10.1128/JB.174.15.4893-4898.1992	40	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121619	10.1371/journal.pone.0121619	http://dx.doi.org/10.1371/journal.pone.0121619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807080	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000166
J	Perron, GG; Whyte, L; Turnbaugh, PJ; Goordial, J; Hanage, WP; Dantas, G; Desai, MM				Perron, Gabriel G.; Whyte, Lyle; Turnbaugh, Peter J.; Goordial, Jacqueline; Hanage, William P.; Dantas, Gautam; Desai, Michael M.			Functional Characterization of Bacteria Isolated from Ancient Arctic Soil Exposes Diverse Resistance Mechanisms to Modern Antibiotics	PLOS ONE			English	Article							BETA-LACTAMASES; MICROBIAL DIVERSITY; EVOLUTION; BIOSYNTHESIS; PERMAFROST; ICE; CONTAMINATION; METAGENOMICS; EMERGENCE; WORLDWIDE	Using functional metagenomics to study the resistomes of bacterial communities isolated from different layers of the Canadian high Arctic permafrost, we show that microbial communities harbored diverse resistance mechanisms at least 5,000 years ago. Among bacteria sampled from the ancient layers of a permafrost core, we isolated eight genes conferring clinical levels of resistance against aminoglycoside, beta-lactam and tetracycline antibiotics that are naturally produced by microorganisms. Among these resistance genes, four also conferred resistance against amikacin, a modern semi-synthetic antibiotic that does not naturally occur in microorganisms. In bacteria sampled from the overlaying active layer, we isolated ten different genes conferring resistance to all six antibiotics tested in this study, including aminoglycoside, beta-lactam and tetracycline variants that are naturally produced by microorganisms as well as semi-synthetic variants produced in the laboratory. On average, we found that resistance genes found in permafrost bacteria conferred lower levels of resistance against clinically relevant antibiotics than resistance genes sampled from the active layer. Our results demonstrate that antibiotic resistance genes were functionally diverse prior to the anthropogenic use of antibiotics, contributing to the evolution of natural reservoirs of resistance genes.	[Perron, Gabriel G.; Turnbaugh, Peter J.; Desai, Michael M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Perron, Gabriel G.; Desai, Michael M.] Harvard Univ, Dept Evolutionary & Organism Biol, Cambridge, MA 02138 USA; [Perron, Gabriel G.] Bard Coll, Biol Program, Annandale on Hudson, NY 12504 USA; [Whyte, Lyle; Goordial, Jacqueline] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Turnbaugh, Peter J.] Univ Calif San Francisco, Hooper Fdn, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Hanage, William P.] Harvard Univ, Sch Publ, Dept Epidemiol, Boston, MA 02115 USA; [Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Desai, Michael M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; McGill University; University of California System; University of California San Francisco; Harvard University; Washington University (WUSTL); Washington University (WUSTL); Harvard University	Perron, GG (corresponding author), Harvard Univ, FAS Ctr Syst Biol, 52 Oxford St, Cambridge, MA 02138 USA.	gperron@bard.edu; mmdesai@fas.harvard.edu	Hanage, Bill/CAF-1813-2022	Turnbaugh, Peter/0000-0002-0888-2875; Desai, Michael/0000-0002-9581-1150; Goordial, Jacqueline/0000-0001-5005-673X; Dantas, Gautam/0000-0003-0455-8370	Fonds de Recherche du Quebec - Nature et technologies; Natural Sciences and Engineering Research Council of Canada Banting fellowships program; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Harvard Milton Fund	Fonds de Recherche du Quebec - Nature et technologies; Natural Sciences and Engineering Research Council of Canada Banting fellowships program(Natural Sciences and Engineering Research Council of Canada (NSERC)); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Harvard Milton Fund	The authors would like to acknowledge support from the following funders: (GGP) Fonds de Recherche du Quebec - Nature et technologies (www.fqr.gouv.qc.ca) and the Natural Sciences and Engineering Research Council of Canada Banting fellowships program (www.nserc-crsng.gc.ca); (MMD) the James S. McDonnell Foundation (www.jsmf.org), the Alfred P. Sloan Foundation (www.sloan.org), and the Harvard Milton Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACRED P, 1967, NATURE, V215, P25, DOI 10.1038/215025a0; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Brakhage AA, 1998, MICROBIOL MOL BIOL R, V62, P547, DOI 10.1128/MMBR.62.3.547-585.1998; Brakhage AA, 2009, PHYTOCHEMISTRY, V70, P1801, DOI 10.1016/j.phytochem.2009.09.011; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; CLARIDGE CA, 1960, NATURE, V187, P237, DOI 10.1038/187237a0; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Craig JW, 2010, APPL ENVIRON MICROB, V76, P1633, DOI 10.1128/AEM.02169-09; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2012, CURR OPIN MICROBIOL, V15, P577, DOI 10.1016/j.mib.2012.07.004; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Drummund AJ, 2011, GENEIOUS V5 4; DUGGAR BM, 1948, ANN NY ACAD SCI, V51, P177, DOI 10.1111/j.1749-6632.1948.tb27262.x; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Fuste E, 2012, FUTURE MICROBIOL, V7, P781, DOI [10.2217/FMB.12.40, 10.2217/fmb.12.40]; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hall BG, 2004, DRUG RESIST UPDATE, V7, P111, DOI 10.1016/j.drup.2004.02.003; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Houndt T, 2000, APPL ENVIRON MICROB, V66, P5406, DOI 10.1128/AEM.66.12.5406-5409.2000; Hu RM, 2008, LETT APPL MICROBIOL, V47, P457, DOI 10.1111/j.1472-765X.2008.02438.x; HUGHES VM, 1983, NATURE, V302, P725, DOI 10.1038/302725a0; Jacoby GA, 2013, ANTIMICROB AGENTS CH, V57, P1930, DOI 10.1128/AAC.02080-12; Juck DF, 2005, APPL ENVIRON MICROB, V71, P1035, DOI 10.1128/AEM.71.2.1035-1041.2005; KAWAGUCHI H, 1976, J INFECT DIS, V134, pS242, DOI 10.1093/infdis/135.Supplement_2.S242; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; KNUDSEN ET, 1967, BMJ-BRIT MED J, V3, P75, DOI 10.1136/bmj.3.5557.75; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Llewellyn NM, 2006, NAT PROD REP, V23, P864, DOI 10.1039/b604709m; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Lusk RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110808; MacLean RC, 2010, NAT REV GENET, V11, P405, DOI 10.1038/nrg2778; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; MAZZEI T, 1976, J INFECT DIS, V134, pS374, DOI 10.1093/infdis/135.Supplement_2.S374; MEYER RD, 1977, J INFECT DIS, V136, P449, DOI 10.1093/infdis/136.3.449; Miller RV, 2011, POLAR MICROBIOLOGY; Mindlin SZ, 2008, RUSS J GENET+, V44, P27, DOI 10.1134/S1022795408010043; Mykytczuk NCS, 2012, INT J SYST EVOL MICR, V62, P1937, DOI 10.1099/ijs.0.035782-0; Perron GG, 2007, P R SOC B, V274, P2351, DOI 10.1098/rspb.2007.0640; Perron GG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003749; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poirel Laurent, 2005, Antimicrob Agents Chemother, V49, P3523, DOI 10.1128/AAC.49.8.3523-3525.2005; Popowska M, 2012, ANTIMICROB AGENTS CH, V56, P1434, DOI 10.1128/AAC.05766-11; Qu WB, 2009, BIOINFORMATICS, V25, P276, DOI 10.1093/bioinformatics/btn614; REIMANN H, 1974, J ORG CHEM, V39, P1451, DOI 10.1021/jo00924a001; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; Rokem JS, 2007, NAT PROD REP, V24, P1262, DOI 10.1039/b617765b; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; Shen ZY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-143; Slekovec C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049300; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Steven B, 2008, ENVIRON MICROBIOL, V10, P3388, DOI 10.1111/j.1462-2920.2008.01746.x; Steven B, 2007, FEMS MICROBIOL ECOL, V59, P513, DOI 10.1111/j.1574-6941.2006.00247.x; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Tishkov VI, 2010, ACTA NATURAE, V2, P47, DOI 10.32607/20758251-2010-2-3-47-61; von Wittenau MS., 1962, J AM CHEM SOC, V84, P2645; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010; Wright GD, 2012, TRENDS MICROBIOL; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Yumoto I, 2013, COLD ADAPTED MICROOR, P220; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	83	120	128	8	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0069533	10.1371/journal.pone.0069533	http://dx.doi.org/10.1371/journal.pone.0069533			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807523	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000001
J	Schmitt-Ney, M; Camussi, G				Schmitt-Ney, Michel; Camussi, Giovanni			The PAX3-FOXO1 Fusion Protein Present in Rhabdomyosarcoma Interferes with Normal FOXO Activity and the TGF-beta Pathway	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FKHR; ALVEOLAR RHABDOMYOSARCOMA; GENE-EXPRESSION; TUMOR SUPPRESSION; TARGET GENE; STEM-CELL; PAX3-FKHR; GROWTH; PAX3; DIFFERENTIATION	PAX3-FOXO1 (PAX3-FKHR) is the fusion protein produced by the genomic translocation that characterizes the alveolar subtype of Rhabdomyosarcoma, a pediatric sarcoma with myogenic phenotype. PAX3-FOXO1 is an aberrant but functional transcription factor. It retains PAX3-DNA-binding activity and functionally overlaps PAX3 function while also disturbing it, in particular its role in myogenic differentiation. We herein show that PAX3-FOXO1 interferes with normal FOXO function. PAX3-FOXO1 affects FOXO-family member transactivation capability and the FOXO-dependent TGF-beta response. PAX3-FOXO1 may contribute to tumor formation by inhibiting the tumor suppressor activities which are characteristic of both FOXO family members and TGF-beta pathways. The recognition of this mechanism raises new questions about how FOXO family members function.	[Schmitt-Ney, Michel] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; Univ Turin, Dept Med Sci, Turin, Italy	University of Turin; University of Turin	Schmitt-Ney, M (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	michel.schmitt-ney@unito.it	Camussi, Giovanni/J-7624-2016	Camussi, Giovanni/0000-0003-2795-232X	AIRC [IG12890]	AIRC(Fondazione AIRC per la ricerca sul cancro)	The work has been supported by AIRC, IG12890 grant to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubarak B, 2009, CHANNELS, V3, P233; Anderson MJ, 2001, P NATL ACAD SCI USA, V98, P1589, DOI 10.1073/pnas.98.4.1589; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; CAHILL MA, 1994, FEBS LETT, V344, P105, DOI 10.1016/0014-5793(94)00320-3; Charytonowicz E, 2009, CANCER LETT, V279, P126, DOI 10.1016/j.canlet.2008.09.039; Czymai T, 2010, J BIOL CHEM, V285, P10163, DOI 10.1074/jbc.M109.056663; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; del Peso L, 1999, ONCOGENE, V18, P7328, DOI 10.1038/sj.onc.1203159; Dimova EY, 2010, ANTIOXID REDOX SIGN, V13, P413, DOI 10.1089/ars.2009.2999; Ebauer M, 2007, ONCOGENE, V26, P7267, DOI 10.1038/sj.onc.1210525; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Ferrari A, 2011, PEDIATR BLOOD CANCER, V57, P943, DOI 10.1002/pbc.23252; Finckenstein FG, 2008, ONCOGENE, V27, P2004, DOI 10.1038/sj.onc.1210835; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hecker RM, 2010, ONCOGENE, V29, P3942, DOI 10.1038/onc.2010.145; Hettmer S, 2010, NAT MED, V16, P171, DOI 10.1038/nm0210-171; Hinson ARP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00183; Jag UR, 2009, MOL ENDOCRINOL, V23, P1587, DOI 10.1210/me.2008-0421; Jensen KS, 2001, EMBO J, V30, P4554; Jung YA, 2009, BIOCHEM BIOPH RES CO, V386, P757, DOI 10.1016/j.bbrc.2009.06.124; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kikuchi K, 2008, BIOCHEM BIOPH RES CO, V365, P568, DOI 10.1016/j.bbrc.2007.11.017; Lagutina I, 2002, MOL CELL BIOL, V22, P7204, DOI 10.1128/MCB.22.20.7204-7216.2002; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; LOLLINI PL, 1991, INVAS METAST, V11, P116; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mercado GE, 2007, CURR MOL MED, V7, P47, DOI 10.2174/156652407779940440; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Scuoppo C, 2007, EXP CELL RES, V313, P2308, DOI 10.1016/j.yexcr.2007.02.037; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; So CW, 2002, MOL CELL BIOL, V22, P6542, DOI 10.1128/MCB.22.18.6542-6552.2002; Stopa M, 2000, J BIOL CHEM, V275, P29308, DOI 10.1074/jbc.M003282200; Sun MM, 2014, ONCOGENE, V33, P2075, DOI 10.1038/onc.2013.165; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang LX, 2011, P NATL ACAD SCI USA, V108, pE803, DOI 10.1073/pnas.1103423108; Wang SL, 2010, CANCER SCI, V101, P1108, DOI 10.1111/j.1349-7006.2010.01512.x; Xia SJ, 2009, AM J PATHOL, V175, P2600, DOI 10.2353/ajpath.2009.090192; Yamada T, 2006, BIOCHEM BIOPH RES CO, V347, P1138, DOI 10.1016/j.bbrc.2006.07.032; Ye L, 2005, CHINESE MED J-PEKING, V118, P678; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830	52	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121474	10.1371/journal.pone.0121474	http://dx.doi.org/10.1371/journal.pone.0121474			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806826	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000156
J	Han, SM; Coh, YR; Ahn, JO; Jang, G; Yum, SY; Kang, SK; Lee, HW; Youn, HY				Han, Sei-Myoung; Coh, Ye-Rin; Ahn, Jin-Ok; Jang, Goo; Yum, Soo Young; Kang, Sung-Keun; Lee, Hee-Woo; Youn, Hwa-Young			Enhanced Hepatogenic Transdifferentiation of Human Adipose Tissue Mesenchymal Stem Cells by Gene Engineering with Oct4 and Sox2	PLOS ONE			English	Article							IN-VITRO; LIVER-REGENERATION; STROMAL CELLS; DIFFERENTIATION; CIRRHOSIS; MARROW; THERAPY; REPAIR; VIVO; PLURIPOTENCY	Adipose tissue mesenchymal stem cells (ATMSCs) represent an attractive tool for the establishment of a successful stem cell-based therapy in the field of liver regeneration medicine. ATMSCs overexpressing Oct4 and Sox2 (Oct4/Sox2-ATMSCs) showed enhanced proliferation and multipotency. Hence, we hypothesized that Oct4 and Sox2 can increase "transdifferentiation" of ATMSCs into cells of the hepatic lineage. In this study, we generated Oct4- and Sox2-overexpressing human ATMSCs by liposomal transfection. We confirmed the expression of mesenchymal stem cell surface markers without morphological alterations in both red-fluorescent protein (RFP) (control)-and Oct4/Sox2-ATMSCs by flow cytometry. After induction of differentiation into hepatocyte-like cells, the morphology of ATMSCs changed and they began to appear as round or polygonal epithelioid cells. Hepatic markers were evaluated by reverse transcription-polymerase chain reaction and confirmed by immunofluorescence. The results showed that albumin was strongly expressed in hepatogenic differentiated Oct4/Sox2-ATMSCs, whereas the expression level of a-fetoprotein was lower than that of RFP-ATMSCs. The functionality of hepatocytes was evaluated by periodic acid-Schiff (PAS) staining and urea assays. The number of PAS-positive cells was significantly higher and urea production was significantly higher in Oct4/Sox2-ATMSCs compared to that in RFP-ATMSCs. Taken together, the hepatocyte-like cells derived from Oct4/Sox2-ATMSCs were mature hepatocytes, possibly functional hepatocytes with enhanced capacity to store glycogen and produce urea. In this study, we demonstrated the enhanced transdifferentiation of Oct4-and Sox2-overexpressing ATMSCs into hepatocyte-like cells that have enhanced hepatocyte-specific functions. Therefore, we expect that Oct4/Sox2-ATMSCs may become a very useful source for hepatocyte regeneration or liver cell transplantation.	[Han, Sei-Myoung; Coh, Ye-Rin; Ahn, Jin-Ok; Youn, Hwa-Young] Seoul Natl Univ, Dept Vet Internal Med, Coll Vet Med, Seoul 151742, South Korea; [Jang, Goo; Yum, Soo Young] Seoul Natl Univ, Dept Theriogenol & Biotechnol, Coll Vet Med, Seoul 151742, South Korea; [Kang, Sung-Keun] K STEMCELL Co Ltd, Stem Cell Res Ctr, Seoul 153768, South Korea; [Lee, Hee-Woo; Youn, Hwa-Young] Seoul Natl Univ, Res Inst Vet Sci, Coll Vet Med, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, HW (corresponding author), Seoul Natl Univ, Res Inst Vet Sci, Coll Vet Med, Seoul 151742, South Korea.	lhwdinks90@gmail.com; hyyoun@snu.ac.kr		Yum, Soo Young/0000-0002-9922-9168	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2007693]; Research Institute for Veterinary Science; BK21 Plus Program for Veterinary Science, Seoul National University; IPET [109023-05-5-CG000]; Stem Cell Research Center of K-STEMCELL Co Ltd.	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); Research Institute for Veterinary Science; BK21 Plus Program for Veterinary Science, Seoul National University; IPET(Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); Stem Cell Research Center of K-STEMCELL Co Ltd.	Funding: This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2007693). This study was partially supported by the Research Institute for Veterinary Science and BK21 Plus Program for Veterinary Science, Seoul National University and IPET#109023-05-5-CG000. Sung-Keun Kang is an employee of Stem Cell Research Center of K-STEMCELL Co Ltd. and received support in the form of salary to fund this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Aurich H, 2009, GUT, V58, P570, DOI 10.1136/gut.2008.154880; Ayatollahi Maryam, 2011, World J Stem Cells, V3, P113, DOI 10.4252/wjsc.v3.i12.113; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chen Z, 2010, PANMINERVA MED, V52, P149; Drosos I, 2013, STEM CELL REV REP, V9, P668, DOI 10.1007/s12015-013-9437-4; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Fan CG, 2011, STEM CELL REV REP, V7, P195, DOI 10.1007/s12015-010-9168-8; Han SM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.28; Hwang S, 2012, CELL BIOL INT, V36, P279, DOI 10.1042/CBI20110325; Ishikawa T, 2010, CURR STEM CELL RES T, V5, P182, DOI 10.2174/157488810791268636; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jung KH, 2011, INT J ONCOL, V39, P137, DOI 10.3892/ijo.2011.1016; Jung YJ, 2012, STEM CELLS, V30, P42, DOI 10.1002/stem.727; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Lee HJ, 2012, DIFFERENTIATION, V84, P223, DOI 10.1016/j.diff.2012.05.007; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Leelawat K, 2010, INT J MOL SCI, V11, P4905, DOI 10.3390/ijms11124905; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Maton A.J.H.C.W.M.S.J.M.Q.W.D.L.J.D.W., 1993, HUMAN BIOL HLTH; Meyerrose T, 2010, ADV DRUG DELIVER REV, V62, P1167, DOI 10.1016/j.addr.2010.09.013; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Piryaei A, 2011, STEM CELL REV REP, V7, P103, DOI 10.1007/s12015-010-9126-5; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prasajak P, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/762196; Pulavendran S, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-15; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Sato F, 1999, LIVER, V19, P481; Saulnier N, 2010, DIGEST LIVER DIS, V42, P895, DOI 10.1016/j.dld.2010.04.013; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Sherlock S, 2002, DIS LIVER BILIARY SY; Snykers S, 2006, TOXICOL SCI, V94, P330, DOI 10.1093/toxsci/kfl058; Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412; Song L, 2004, MOL THER, V9, P607, DOI 10.1016/j.ymthe.2004.01.017; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568	47	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0108874	10.1371/journal.pone.0108874	http://dx.doi.org/10.1371/journal.pone.0108874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815812	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600002
J	Xue, MQ; Zhu, LW; Zhang, J; Qiu, JH; Du, GC; Qiao, ZL; Jin, GH; Gao, FG; Zhang, QQ				Xue, Maoqiang; Zhu, Liuwei; Zhang, Jie; Qiu, Jinhua; Du, Guicheng; Qiao, Zhiliang; Jin, Guanghui; Gao, Fengguang; Zhang, Qiqing			Low Dose Nicotine Attenuates A beta Neurotoxicity through Activation Early Growth Response Gene 1 Pathway	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SH-SY5Y CELLS; ACETYLCHOLINE-RECEPTOR; OXIDATIVE STRESS; EXPRESSION; EGR-1; PROTEIN; PHOSPHORYLATION; CYTOTOXICITY; APOPTOSIS	Epidemiological studies indicate that smoking is negatively correlated with the incidence and development of Alzheimer's disease (AD). Nicotine was reported to be the active factor. However, the detailed mechanisms still remain to be fully elucidated. Early growth response gene 1 (EGR-1) plays important roles in several important biological processes such as promoting cell growth, differentiation, anti oxidative stress, and apoptosis, but few in the pathogenesis of AD. In the present study, we show that nicotine can activate the MAPK/ERK/EGR-1 signaling pathway partially through a7 nAChR. In addition, the up-regulation of EGR-1 by nicotine can also increase the phosphorylation of CyclinD1 which contributes to the attenuation of amyloid-beta (A beta(25-35)) -induced neurotoxicity. Although nicotine and A beta(25-35) can activate EGR-1, the expression of EGR-1 is down-regulated following treatment with nicotine and A beta(25-35). This study demonstrates that low dose nicotine attenuates A beta(25-35)-induced neurotoxicity in vitro and in vivo through activating EGR-1 pathway.	[Xue, Maoqiang; Zhang, Qiqing] Xiamen Univ, Coll Chem & Chem Engn, Xiamen 361005, Fujian, Peoples R China; [Xue, Maoqiang; Zhang, Qiqing] Xiamen Univ, Inst Biomed Engn, Dept Biomat, Coll Mat, Xiamen 361005, Fujian, Peoples R China; [Xue, Maoqiang; Zhu, Liuwei; Zhang, Jie; Qiu, Jinhua; Du, Guicheng; Qiao, Zhiliang; Jin, Guanghui; Gao, Fengguang] Xiamen Univ, Dept Basic Med Sci, Coll Med, Xiamen 361005, Fujian, Peoples R China; [Zhang, Qiqing] Chinese Acad Med Sci, Inst Biomed Engn, Tianjin 300192, Peoples R China; [Zhang, Qiqing] Peking Union Med Coll, Key Lab Biomed Mat Tianjin, Tianjin 300192, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of BioMedical Engineering - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, QQ (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Xiamen 361005, Fujian, Peoples R China.	zhangqiq@xmu.edu.cn	Zhang, Jie/A-5426-2010		National Science Foundation in China [2014J01375, 81271421]; Natural Science Foundation of Fujian Province of China [2013J01147, 2014J06019]; Program for New Century Excellent Talents in University	National Science Foundation in China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Funding: This work was supported by National Science Foundation in China (2014J01375; 81271421). The Natural Science Foundation of Fujian Province of China (Grant: 2013J01147; and 2014J06019). This work was also supported by Program for New Century Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 1996, P NATL ACAD SCI USA, V93, P13547, DOI 10.1073/pnas.93.24.13547; Alkadhi KA, 2010, MOL CELL NEUROSCI, V45, P289, DOI 10.1016/j.mcn.2010.06.018; Bakalash S, 2011, INVEST OPHTH VIS SCI, V52, P9033, DOI 10.1167/iovs.11-7498; Begum S, 2012, EXPERT REV MOL DIAGN, V12, P93, DOI 10.1586/ERM.11.84; BIEDLER JL, 1978, CANCER RES, V38, P3751; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chasseigneaux S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016301; Choi JE, 2010, INT J DERMATOL, V49, P158, DOI 10.1111/j.1365-4632.2009.04210.x; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; Cui WY, 2012, AMINO ACIDS, V43, P1157, DOI 10.1007/s00726-011-1171-0; Das JR, 2009, NEUROTOX RES, V16, P194, DOI 10.1007/s12640-009-9040-2; Gao SB, 2009, ONCOGENE, V28, P4095, DOI 10.1038/onc.2009.273; Huang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029102; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kawamata J, 2011, J ALZHEIMERS DIS, V24, P95, DOI 10.3233/JAD-2011-110173; Kenney JW, 2010, NEUROPSYCHOPHARMACOL, V35, P483, DOI 10.1038/npp.2009.153; Lacoste B, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-57; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Mihailescu S, 2000, ARCH MED RES, V31, P131, DOI 10.1016/S0188-4409(99)00087-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Minet E, 2001, EXP CELL RES, V265, P114, DOI 10.1006/excr.2001.5180; Muthaiyah B, 2011, NEUROCHEM RES, V36, P2096, DOI 10.1007/s11064-011-0533-z; Oddvar M, 2013, OXID MED CELL LONGEV; Pagel JI, 2012, INT J MOL SCI, V13, P13104, DOI 10.3390/ijms131013104; Qi XL, 2013, NEUROCHEM INT, V62, P79, DOI 10.1016/j.neuint.2012.11.012; Roberts BR, 2012, J NEUROCHEM, V120, P149, DOI 10.1111/j.1471-4159.2011.07500.x; Soriano Joan B, 2011, Proc Am Thorac Soc, V8, P363, DOI 10.1513/pats.201102-017RM; Srivareerat M, 2011, NEUROBIOL AGING, V32, P834, DOI 10.1016/j.neurobiolaging.2009.04.015; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Talka R, 2013, EUR J PHARMACOL, V701, P57, DOI 10.1016/j.ejphar.2013.01.005; Vazquez-Padron RI, 2010, CARDIOVASC RES, V88, P296, DOI 10.1093/cvr/cvq213; Wallace TL, 2011, BIOCHEM PHARMACOL, V82, P891, DOI 10.1016/j.bcp.2011.06.034; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Yan YX, 1997, J BIOL CHEM, V272, P33181, DOI 10.1074/jbc.272.52.33181; Zeitlin R, 2011, BRAIN RES, V1417, P127, DOI 10.1016/j.brainres.2011.08.036; Zhang X, 2011, EUR J PHARM SCI, V42, P540, DOI 10.1016/j.ejps.2011.02.009	40	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120267	10.1371/journal.pone.0120267	http://dx.doi.org/10.1371/journal.pone.0120267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815723	Green Submitted, gold, Green Published			2022-12-26	WOS:000352133600033
J	Zhang, J; Zhang, BC; Sun, L				Zhang, Jian; Zhang, Bao Cun; Sun, Li			P247 and P523: Two In Vivo-Expressed Megalocytivirus Proteins That Induce Protective Immunity and Are Essential to Viral Infection	PLOS ONE			English	Article							TURBOT SCOPHTHALMUS-MAXIMUS; FLOUNDER PARALICHTHYS-OLIVACEUS; COMPLETE GENOME SEQUENCE; RED-SEA BREAM; SEPTICEMIA VIRUS VHSV; IRIDOVIRUS-LIKE AGENT; DNA VACCINE; RAINBOW-TROUT; ONCORHYNCHUS-MYKISS; CULTURED FISH	Megalocytivirus is a DNA virus with a broad host range among teleost fish. Although the complete genome sequences of a number of megalocytivirus isolates have been reported, the functions of most of the genes of this virus are unknown. In this study, we selected two megalocytivirus immunogens, P247 and P523, which were expressed during host infection and, when in the form of DNA vaccines (pCN247 and pCN523 respectively), elicited strong protectivity against lethal megalocytivirus challenge in a turbot (Scophthalmus maximus) model. Compared to control fish, fish vaccinated with pCN247 and pCN523 exhibited drastically reduced viral loads in tissues and high levels of survival rates. Immune response analysis showed that pCN247 and pCN523 (i) induced production of specific serum antibodies, (ii) caused generation of cytotoxic immune cells and specific memory immune cells that responded to secondary antigen stimulation, and (iii) upregulated the expression of genes involved in innate and adaptive immunity. To examine the potential role of P247 and P523 in viral infection, the expression of P247 and P523 was knocked down by siRNA. Subsequent in vivo infection study showed that P247 and P523 knockdown significantly impaired viral replication. Furthermore, whole-genome transcriptome analysis revealed that P247 and P523 knockdown altered the expression profiles of 26 and 41 viral genes, respectively, putatively participating in diverse aspects of viral infection. Taken together, these results indicate that P247 and P523 induce protective immunity in teleost and play fundamental roles essential to viral replication. These observations provide the first evidence that suggests a likely link between the protectivity of viral immunogens and their biological significance in viral replication.	[Zhang, Jian; Zhang, Bao Cun; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhang, Jian; Zhang, Bao Cun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lsun@qdio.ac.cn		Zhang, Bao-cun/0000-0001-6104-0848	National Basic Research Program of China [2012CB114406]; Taishan Scholar Program of Shandong Province	National Basic Research Program of China(National Basic Research Program of China); Taishan Scholar Program of Shandong Province	This work was supported by the grants of the National Basic Research Program of China (2012CB114406) and the Taishan Scholar Program of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KG, 2009, ANTIVIR RES, V82, P166, DOI 10.1016/j.antiviral.2008.12.007; Byon JY, 2005, FISH SHELLFISH IMMUN, V18, P135, DOI 10.1016/j.fsi.2004.06.008; Caipang CMA, 2006, FISH SHELLFISH IMMUN, V21, P130, DOI 10.1016/j.fsi.2005.10.012; Castro R, 2014, VACCINE, V32, P1160, DOI 10.1016/j.vaccine.2013.11.062; Chaves-Pozo E, 2012, FISH SHELLFISH IMMUN, V33, P1159, DOI 10.1016/j.fsi.2012.09.002; Chen XH, 2003, J FISH DIS, V26, P615, DOI 10.1046/j.1365-2761.2003.00494.x; CHINCHAR VG, 2005, VIRUS TAXONOMY, P145; Cuesta A, 2010, VACCINE, V28, P3291, DOI 10.1016/j.vaccine.2010.02.106; Cuesta A, 2009, VACCINE, V27, P280, DOI 10.1016/j.vaccine.2008.10.029; de las Heras AI, 2010, FISH SHELLFISH IMMUN, V28, P562, DOI 10.1016/j.fsi.2009.12.006; de las Heras AI, 2009, FISH SHELLFISH IMMUN, V27, P120, DOI 10.1016/j.fsi.2008.11.021; Do JW, 2005, DIS AQUAT ORGAN, V64, P193, DOI 10.3354/dao064193; Do JW, 2004, VIROLOGY, V325, P351, DOI 10.1016/j.virol.2004.05.008; Dong ZQ, 2013, GENETICS, V193, P1065, DOI 10.1534/genetics.112.147892; Evensen O, 2013, FISH SHELLFISH IMMUN, V35, P1751, DOI 10.1016/j.fsi.2013.10.021; Fischer U, 2013, FISH SHELLFISH IMMUN, V35, P197, DOI 10.1016/j.fsi.2013.04.018; Garver KA, 2005, DIS AQUAT ORGAN, V64, P13, DOI 10.3354/dao064013; Ge Q, 2004, VIRUS RES, V102, P37, DOI 10.1016/j.virusres.2004.01.013; He JG, 2000, J FISH DIS, V23, P219, DOI 10.1046/j.1365-2761.2000.00213.x; He JG, 2001, VIROLOGY, V291, P126, DOI 10.1006/viro.2001.1208; Hu YH, 2011, VACCINE, V29, P4328, DOI 10.1016/j.vaccine.2011.04.021; Hu YH, 2010, FISH SHELLFISH IMMUN, V28, P678, DOI 10.1016/j.fsi.2010.01.001; Huelsmann PM, 2006, ANTIVIR RES, V69, P1, DOI 10.1016/j.antiviral.2005.10.001; Jeong JB, 2006, AQUACULTURE, V255, P105, DOI 10.1016/j.aquaculture.2005.12.015; Jiao XD, 2009, VACCINE, V27, P5195, DOI 10.1016/j.vaccine.2009.06.071; Kawakami H, 2002, FISH PATHOL, V37, P45, DOI 10.3147/jsfp.37.45; Kim WS, 2005, DIS AQUAT ORGAN, V64, P175, DOI 10.3354/dao064175; Kurita J, 2002, FISHERIES SCI S2, V68, P1113, DOI [10.2331/fishsci.68.sup2_1113, DOI 10.2331/FISHSCI.68.SUP2_1113]; Kurita J, 2012, VIRUSES-BASEL, V4, P521, DOI 10.3390/v4040521; Lee NS, 2009, J COMP PATHOL, V141, P63, DOI 10.1016/j.jcpa.2009.03.008; Li MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096222; Liu CS, 2010, VACCINE, V28, P4153, DOI 10.1016/j.vaccine.2010.04.016; Lorenzen N, 2013, REV SCI TECH, V24, P201; Lu L, 2005, VIROLOGY, V339, P81, DOI 10.1016/j.virol.2005.05.021; Mikalsen AB, 2005, VACCINE, V23, P4895, DOI 10.1016/j.vaccine.2005.05.025; Murakami M, 2005, MICROBIOL IMMUNOL, V49, P1047, DOI 10.1111/j.1348-0421.2005.tb03701.x; Nakanishi T, 2011, DEV COMP IMMUNOL, V35, P1317, DOI 10.1016/j.dci.2011.03.033; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Pereiro P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104509; Salgado-Miranda C, 2013, EXPERT REV VACCINES, V12, P567, DOI [10.1586/ERV.13.38, 10.1586/erv.13.38]; Sanchez E, 2007, DEV COMP IMMUNOL, V31, P916, DOI 10.1016/j.dci.2006.12.008; Shi CY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-159; Shi CY, 2004, AQUACULTURE, V236, P11, DOI 10.1016/j.aquaculture.2003.11.007; Shinmoto H, 2009, APPL ENVIRON MICROB, V75, P3535, DOI 10.1128/AEM.02255-08; Sun K, 2009, VACCINE, V27, P2733, DOI 10.1016/j.vaccine.2009.03.012; Sun Y, 2011, VACCINE, V29, P2051, DOI 10.1016/j.vaccine.2011.01.013; Tonheim TC, 2008, FISH SHELLFISH IMMUN, V25, P1, DOI 10.1016/j.fsi.2008.03.007; Utke K, 2008, DEV COMP IMMUNOL, V32, P239, DOI 10.1016/j.dci.2007.05.010; Utke K, 2007, FISH SHELLFISH IMMUN, V22, P182, DOI 10.1016/j.fsi.2006.04.008; Wang CS, 2003, J FISH DIS, V26, P127, DOI 10.1046/j.1365-2761.2003.00441.x; Wang WL, 2011, FISH SHELLFISH IMMUN, V31, P10, DOI 10.1016/j.fsi.2011.01.015; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Whittington RJ, 2010, J FISH DIS, V33, P95, DOI 10.1111/j.1365-2761.2009.01110.x; Whitton JL, 1999, VACCINE, V17, P1612, DOI 10.1016/S0264-410X(98)00418-6; Xiao YM, 2013, MAR BIOTECHNOL, V15, P716, DOI 10.1007/s10126-013-9520-5; Zhang BC, 2013, DIS AQUAT ORGAN, V104, P203, DOI 10.3354/dao02587; Zhang J, 2013, J PROTEOMICS, V91, P430, DOI 10.1016/j.jprot.2013.07.033; Zhang J, 2013, VET IMMUNOL IMMUNOP, V152, P303, DOI 10.1016/j.vetimm.2012.12.018; Zhang M, 2012, FISH SHELLFISH IMMUN, V33, P1192, DOI 10.1016/j.fsi.2012.09.010; Zhang M, 2012, AQUAC RES, V43, P556, DOI 10.1111/j.1365-2109.2011.02861.x; Zhou JX, 2014, J FISH DIS, V37, P319, DOI 10.1111/jfd.12105; Zhou ZX, 2014, DEV COMP IMMUNOL, V44, P124, DOI 10.1016/j.dci.2013.12.002; Zhu R, 2013, FISH SHELLFISH IMMUN, V35, P918, DOI 10.1016/j.fsi.2013.07.002	63	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121282	10.1371/journal.pone.0121282	http://dx.doi.org/10.1371/journal.pone.0121282			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815484	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600080
J	Buitrago, DH; Patnaik, SK; Kadota, K; Kannisto, E; Jones, DR; Adusumilli, PS				Buitrago, Daniel H.; Patnaik, Santosh K.; Kadota, Kyuichi; Kannisto, Eric; Jones, David R.; Adusumilli, Prasad S.			Small RNA Sequencing for Profiling MicroRNAs in Long-Term Preserved Formalin-Fixed and Paraffin-Embedded Non-Small Cell Lung Cancer Tumor Specimens	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; TISSUE SAMPLES; FROZEN; NORMALIZATION; RECURRENCE; SIGNATURES; CARCINOMA; PROGNOSIS; GENOMICS; FEATURES	Background The preservation of microRNAs in formalin-fixed and paraffin-embedded (FFPE) tissue makes them particularly useful for biomarker studies. The utility of small RNA sequencing for microRNA expression profiling of FFPE samples has yet to be determined. Methods Total RNA was extracted from de-paraffinized and proteinase K-treated FFPE specimens (15-20 years old) of 8 human lung adenocarcinoma tumors by affinity chromatography on silica columns. MicroRNAs in the RNA preparations were quantified by the Illumina HiSeq 2000 sequencing platform with sequencing libraries prepared with the TruSeq Small RNA Sample Preparation Kit (version 2.0) to obtain unpaired reads of 50 b for small RNA fragments. MicroRNAs were also quantified using Agilent Human miRNA (release 16.0) microarrays that can detect 1,205 mature microRNAs and by quantitative reverse transcription (RT)-PCR assays. Results Between 9.1-16.9 million reads were obtained by small RNA sequencing of extracted RNA samples. Of these, only 0.6-2.3% (mean = 1.5%) represented microRNAs. The sequencing method detected 454-625 microRNAs/sample (mean = 550) compared with 200-349 (mean = 286) microRNAs detected by microarray. In Spearman correlation analyses, the average correlation coefficient for the 126 microRNAs detected in all samples by both methods was 0.37, and >0.5 for 63 microRNAs. In correlation analyses of the sequencing- and RT-PCR-based measurements, the coefficients were 0.19-0.95 (mean = 0.73) and >0.7, respectively, for 7 of 9 examined microRNAs. The average inter-replicate Spearman correlation coefficient for the sequencing method was 0.81. Conclusions Small RNA sequencing can be used to obtain microRNA profiles of FFPE tissue specimens with performance characteristics similar to those of microarrays, in spite of the fragmentation of ribosomal and messenger RNAs that reduces the method's informative capacity. The accuracy of the method can conceivably be improved by increasing sequencing depth and/or depleting FFPE tissue RNAs of ribosomal RNA fragments.	[Buitrago, Daniel H.; Kadota, Kyuichi; Jones, David R.; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, New York, NY 10021 USA; [Kadota, Kyuichi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA; [Patnaik, Santosh K.; Kannisto, Eric] Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute	Adusumilli, PS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10021 USA.	adusumip@mskcc.org	Kadota, Kyuichi/AAY-2676-2021	Kadota, Kyuichi/0000-0002-6835-453X	National Institutes of Health [R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P30 CA008748, P50 CA086438-13]; US Department of Defense [PR101053, LC110202]; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE [P50CA086438, R21CA164585, U54CA137788, R21CA164568, R01CA136705, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors' laboratory work is supported by grants from the National Institutes of Health (R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P30 CA008748, and P50 CA086438-13), the US Department of Defense (PR101053 and LC110202), and Mr. William H. Goodwin and Mrs. Alice Goodwin, the Commonwealth Foundation for Cancer Research, and the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Bolger AM, 2014, BIOINFORMATICS; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen ZT, 2011, METHODS MOL BIOL, V733, P93, DOI 10.1007/978-1-61779-089-8_7; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kelly AD, 2013, GENOMICS, V102, P8, DOI 10.1016/j.ygeno.2013.03.008; Kolbert CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052517; Le Quesne J, 2012, J PATHOL, V227, P306, DOI 10.1002/path.3983; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Li SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074286; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu AH, 2011, METHODS MOL BIOL, V724, P259, DOI 10.1007/978-1-61779-055-3_16; Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Lopez-Romero Pedro, 2010, BMC Res Notes, V3, P18, DOI 10.1186/1756-0500-3-18; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma ZH, 2009, J MOL DIAGN, V11, P420, DOI 10.2353/jmoldx.2009.090041; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Nuovo GJ, 2010, METHODS, V52, P307, DOI 10.1016/j.ymeth.2010.08.009; O'Neil Dominic, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0419s103; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Patnaik Santosh Kumar, 2012, BMC Res Notes, V5, P40, DOI 10.1186/1756-0500-5-40; Peiro-Chova L, 2013, VIRCHOWS ARCH, V463, P765, DOI 10.1007/s00428-013-1485-2; Plieskatt JL, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-3; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Siebolts U, 2009, J CLIN PATHOL, V62, P84, DOI 10.1136/jcp.2008.058339; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Streichert T, 2012, MOL BIOTECHNOL, V50, P159, DOI 10.1007/s12033-011-9427-1; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	52	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121521	10.1371/journal.pone.0121521	http://dx.doi.org/10.1371/journal.pone.0121521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812157	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700107
J	Dalili, H; Nili, F; Sheikh, M; Hardani, AK; Shariat, M; Nayeri, F				Dalili, Hosein; Nili, Firouzeh; Sheikh, Mahdi; Hardani, Amir Kamal; Shariat, Mamak; Nayeri, Fatemeh			Comparison of the Four Proposed Apgar Scoring Systems in the Assessment of Birth Asphyxia and Adverse Early Neurologic Outcomes	PLOS ONE			English	Article							PERINATAL ASPHYXIA; SCORES; INFANTS; CARE	Objectives To compare the Conventional, Specified, Expanded and Combined Apgar scoring systems in predicting birth asphyxia and the adverse early neurologic outcomes. Methods This prospective cohort study was conducted on 464 admitted neonates. In the delivery room, after delivery the umbilical cord was double clamped and a blood samples was obtained from the umbilical artery for blood gas analysis, meanwhile on the 1-, 5- and 10-minutes Conventional, Specified, Expanded, and Combined Apgar scores were recorded. Then the neonates were followed and intracranial ultrasound imaging was performed, and the following information were recorded: the occurrence of birth asphyxia, hypoxic Ischemic Encephalopathy (HIE), intraventricular hemorrhage (IVH), and neonatal seizure. Results The Combined-Apgar score had the highest sensitivity (97%) and specificity (99%) in predicting birth asphyxia, followed by the Specified-Apgar score that was also highly sensitive (95%) and specific (97%). The Expanded-Apgar score was highly specific (95%) but not sensitive (67%) and the Conventional-Apgar score had the lowest sensitivity (81%) and low specificity (81%) in predicting birth asphyxia. When adjusted for gestational age, only the low 5-minute Combined-Apgar score was independently associated with the occurrence of HIE (B = 1.61, P = 0.02) and IVH (B = 2.8, P = 0.01). Conclusions The newly proposed Combined-Apgar score is highly sensitive and specific in predicting birth asphyxia and also is a good predictor of the occurrence of HIE and IVH in asphyxiated neonates.	[Dalili, Hosein; Nili, Firouzeh; Sheikh, Mahdi; Hardani, Amir Kamal; Shariat, Mamak; Nayeri, Fatemeh] Univ Tehran Med Sci, Vali Asr Hosp, Maternal Fetal & Neonatal Res Ctr, Tehran, Iran; [Dalili, Hosein; Sheikh, Mahdi; Shariat, Mamak; Nayeri, Fatemeh] Univ Tehran Med Sci, Vali Asr Hosp, Breastfeeding Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences	Sheikh, M (corresponding author), Univ Tehran Med Sci, Vali Asr Hosp, Maternal Fetal & Neonatal Res Ctr, Tehran, Iran.	mahdisheikh@gmail.com	Sheikh, Mahdi/E-9455-2015; hardani, amirkamal/N-1234-2017	Sheikh, Mahdi/0000-0003-3972-7824; hardani, amirkamal/0000-0002-7734-4181				ACOG Committee on Obstetric Practice, 2006, Obstet Gynecol, V108, P1319; [American College of Obstetricians and Guneologlsts American Academy of Pediatrics], 2006, OBSTET GYNECOL, V107, P1209; [Anonymous], 1989, LANCET, V1, P591; APGAR V, 1953, Curr Res Anesth Analg, V32, P260; BEHNKE M, 1989, AM J PERINAT, V6, P18, DOI 10.1055/s-2007-999536; Fahey J, 2005, J MIDWIFERY WOM HEAL, V50, P498, DOI 10.1016/j.jmwh.2005.08.007; Lopriore E, 2004, BRIT MED J, V329, P143, DOI 10.1136/bmj.38117.665197.F7; MARLOW N, 1992, ARCH DIS CHILD-FETAL, V67, P765, DOI 10.1136/adc.67.7_Spec_No.765; MARTINANCEL A, 1995, J PEDIATR-US, V127, P786, DOI 10.1016/S0022-3476(95)70174-5; Misra P K, 1994, Indian Pediatr, V31, P1215; Ondoa-Onama C, 2003, East Afr Med J, V80, P22; Padayachee N, 2013, S AFR J CHILD HEALTH, V7, P89, DOI 10.7196/SAJCH.574; Rudiger M, 2012, NEOREVIEWS, V13, pe336, DOI [10.1542/neo.13-6-e336, DOI 10.1097/PCC.0B013E318253C945]; Rudiger M, 2006, PEDIATRICS, V118, P1314, DOI 10.1542/peds.2006-1254; Rudiger M, 2011, EARLY HUM DEV, V87, P749, DOI 10.1016/j.earlhumdev.2011.08.019; Rudiger M, 2009, ACTA PAEDIATR, V98, P1433, DOI 10.1111/j.1651-2227.2009.01347.x; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; SOCOL ML, 1994, AM J OBSTET GYNECOL, V170, P991, DOI 10.1016/S0002-9378(94)70092-3; SYKES GS, 1982, LANCET, V1, P494; THORNBERG E, 1995, ACTA PAEDIATR, V84, P927, DOI 10.1111/j.1651-2227.1995.tb13794.x; Whitelaw A, 2002, CURR OPIN PEDIATR, V14, P664, DOI 10.1097/00008480-200212000-00002	21	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122116	10.1371/journal.pone.0122116	http://dx.doi.org/10.1371/journal.pone.0122116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811904	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700169
J	Grousl, T; Opekarova, M; Stradalova, V; Hasek, J; Malinsky, J				Grousl, Tomas; Opekarova, Miroslava; Stradalova, Vendula; Hasek, Jiri; Malinsky, Jan			Evolutionarily Conserved 5 '-3 ' Exoribonuclease Xrn1 Accumulates at Plasma Membrane-Associated Eisosomes in Post-Diauxic Yeast	PLOS ONE			English	Article							MAMMALIAN STRESS GRANULES; CYTOPLASMIC PROCESSING BODIES; EUKARYOTIC MESSENGER-RNAS; SACCHAROMYCES-CEREVISIAE; P-BODIES; GLOBAL ANALYSIS; SIGNALING PATHWAY; BUDDING YEAST; PROTEINS; DEGRADATION	Regulation of gene expression on the level of translation and mRNA turnover is widely conserved evolutionarily. We have found that the main mRNA decay enzyme, exoribonuclease Xrn1, accumulates at the plasma membrane-associated eisosomes after glucose exhaustion in a culture of the yeast S. cerevisiae. Eisosomal localization of Xrn1 is not achieved in cells lacking the main component of eisosomes, Pil1, or Sur7, the protein accumulating at the membrane compartment of Can1 (MCC) - the eisosome-organized plasma membrane microdomain. In contrast to the conditions of diauxic shift, when Xrn1 accumulates in processing bodies (P-bodies), or acute heat stress, in which these cytosolic accumulations of Xrn1 associate with eIF3a/Rpg1-containing stress granules, Xrn1 is not accompanied by other mRNA-decay machinery components when it accumulates at eisosomes in post-diauxic cells. It is important that Xrn1 is released from eisosomes after addition of fermentable substrate. We suggest that this spatial segregation of Xrn1 from the rest of the mRNA-decay machinery reflects a general regulatory mechanism, in which the key enzyme is kept separate from the rest of mRNA decay factors in resting cells but ready for immediate use when fermentable nutrients emerge and appropriate metabolism reprogramming is required. In particular, the localization of Xrn1 to the eisosome, together with previously published data, accents the relevance of this plasma membrane-associated compartment as a multipotent regulatory site.	[Grousl, Tomas; Hasek, Jiri] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic; [Opekarova, Miroslava; Stradalova, Vendula; Malinsky, Jan] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Hasek, J (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Videnska 1083, Prague, Czech Republic.	hasek@biomed.cas.cz; malinsky@biomed.cas.cz	Malinsky, Jan/H-2484-2014; Groušl, Tomáš/AAF-3655-2019; Groušl, Tomáš/I-1727-2014; Hasek, Jiri/H-2427-2014	Malinsky, Jan/0000-0002-1433-0989; Groušl, Tomáš/0000-0002-6996-1323; Groušl, Tomáš/0000-0002-6996-1323; Hasek, Jiri/0000-0001-6634-2386; Opekarova, Miroslava/0000-0002-2898-6014	Czech Science Foundation [P302/11/0146, 15-10641S, P304/12/0480]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was financially supported by the Czech Science Foundation (projects P302/11/0146 and 15-10641S to M.O., V.S. and J.M.; P304/12/0480 to T.G. and J.H.) and by the institutional grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2014, J CELL SCI, V127, P4443, DOI 10.1242/jcs.152975; Alvarez FJ, 2008, MOL BIOL CELL, V19, P5214, DOI 10.1091/mbc.E08-05-0479; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Aragon AD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r9; Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; Balagopal V, 2012, BBA-GENE REGUL MECH, V1819, P593, DOI 10.1016/j.bbagrm.2012.01.001; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Brach T, 2011, J CELL SCI, V124, P328, DOI 10.1242/jcs.078519; Brachmann CB, 1998, YEAST, V14, P115; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Douglas LM, 2014, ANNU REV MICROBIOL, V68, P377, DOI 10.1146/annurev-micro-091313-103507; Dupont S, 2010, BBA-BIOMEMBRANES, V1798, P975, DOI 10.1016/j.bbamem.2010.01.015; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Frohlich F, 2014, MOL BIOL CELL, V25, P2797, DOI 10.1091/mbc.E13-11-0639; Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Karotki L, 2011, J CELL BIOL, V195, P889, DOI 10.1083/jcb.201104040; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200; Luo GZ, 2011, J BIOL CHEM, V286, P8759, DOI 10.1074/jbc.M110.196030; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malinsky J, 2013, ANNU REV PLANT BIOL, V64, P501, DOI 10.1146/annurev-arplant-050312-120103; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Murashko ON, 2012, P NATL ACAD SCI USA, V109, P7019, DOI 10.1073/pnas.1120181109; Nagarajan VK, 2013, BBA-GENE REGUL MECH, V1829, P590, DOI 10.1016/j.bbagrm.2013.03.005; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Ramachandran V, 2011, MOL CELL, V43, P973, DOI 10.1016/j.molcel.2011.06.032; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Shah KH, 2013, GENETICS, V193, P109, DOI 10.1534/genetics.112.146993; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Stradalova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035132; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Walther TC, 2007, EMBO J, V26, P4946, DOI 10.1038/sj.emboj.7601933; Zhang XP, 2004, J BIOL CHEM, V279, P22030, DOI 10.1074/jbc.M400299200	59	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122770	10.1371/journal.pone.0122770	http://dx.doi.org/10.1371/journal.pone.0122770			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811606	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700201
J	Nagiec, MM; Skepner, AP; Negri, J; Eichhorn, M; Kuperwasser, N; Comer, E; Muncipinto, G; Subramanian, A; Clish, C; Musunuru, K; Duvall, JR; Foley, M; Perez, JR; Palmer, MAJ				Nagiec, Marek M.; Skepner, Adam P.; Negri, Joseph; Eichhorn, Michelle; Kuperwasser, Nicolas; Comer, Eamon; Muncipinto, Giovanni; Subramanian, Aravind; Clish, Clary; Musunuru, Kiran; Duvall, Jeremy R.; Foley, Michael; Perez, Jose R.; Palmer, Michelle A. J.			Modulators of Hepatic Lipoprotein Metabolism Identified in a Search for Small-Molecule Inducers of Tribbles Pseudokinase 1 Expression	PLOS ONE			English	Article							HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; ACTIVATED PROTEIN-KINASE; RECEPTOR MESSENGER-RNA; HEPG2 CELLS; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; ONCOSTATIN-M; CARDIOVASCULAR-DISEASE; LDL-C; TRIB1	Recent genome wide association studies have linked tribbles pseudokinase 1 (TRIB1) to the risk of coronary artery disease (CAD). Based on the observations that increased expression of TRIB1 reduces secretion of VLDL and is associated with lower plasma levels of LDL cholesterol and triglycerides, higher plasma levels of HDL cholesterol and reduced risk for myocardial infarction, we carried out a high throughput phenotypic screen based on quantitative RT-PCR assay to identify compounds that induce TRIB1 expression in human HepG2 hepatoma cells. In a screen of a collection of diversity-oriented synthesis (DOS)-derived compounds, we identified a series of benzofuran-based compounds that upregulate TRIB1 expression and phenocopy the effects of TRIB1 cDNA overexpression, as they inhibit triglyceride synthesis and apoB secretion in cells. In addition, the compounds downregulate expression of MTTP and APOC3, key components of the lipoprotein assembly pathway. However, CRISPR-Cas9 induced chromosomal disruption of the TRIB1 locus in HepG2 cells, while confirming its regulatory role in lipoprotein metabolism, demonstrated that the effects of benzofurans persist in TRIB1-null cells indicating that TRIB1 is sufficient but not necessary to transmit the effects of the drug. Remarkably, active benzofurans, as well as natural products capable of TRIB1 upregulation, also modulate hepatic cell cholesterol metabolism by elevating the expression of LDLR transcript and LDL receptor protein, while reducing the levels of PCSK9 transcript and secreted PCSK9 protein and stimulating LDL uptake. The effects of benzofurans are not masked by cholesterol depletion and are independent of the SREBP-2 regulatory circuit, indicating that these compounds represent a novel class of chemically tractable small-molecule modulators that shift cellular lipoprotein metabolism in HepG2 cells from lipogenesis to scavenging.	[Nagiec, Marek M.; Skepner, Adam P.; Negri, Joseph; Eichhorn, Michelle; Comer, Eamon; Muncipinto, Giovanni; Duvall, Jeremy R.; Foley, Michael; Perez, Jose R.; Palmer, Michelle A. J.] Broad Inst MIT & Harvard, Ctr Sci Therapeut, Therapeut Platform, Cambridge, MA 02142 USA; [Subramanian, Aravind] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA USA; [Clish, Clary] Broad Inst MIT & Harvard, Metabolite Profiling Platform, Cambridge, MA USA; [Kuperwasser, Nicolas; Musunuru, Kiran] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Nagiec, MM (corresponding author), Broad Inst MIT & Harvard, Ctr Sci Therapeut, Therapeut Platform, Cambridge, MA 02142 USA.	marek@broadinstitute.org; cellnetworx@gmail.com	Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021	Clish, Clary B/0000-0001-8259-9245	Broad Institute Gift; National Institutes of Health (NIH) Molecular Libraries Probe Production Centers Network (MLPCN) Program; NIH Library of Integrated Network-Based Cellular Signatures (LINCS) Program; NIH [R00-HL098364]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL098364, R00HL098364] Funding Source: NIH RePORTER	Broad Institute Gift; National Institutes of Health (NIH) Molecular Libraries Probe Production Centers Network (MLPCN) Program; NIH Library of Integrated Network-Based Cellular Signatures (LINCS) Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was sponsored in part by the Broad Institute Gift, the National Institutes of Health (NIH) Molecular Libraries Probe Production Centers Network (MLPCN) Program (http://mli.nih.gov/mli/mlpcn/), the NIH Library of Integrated Network-Based Cellular Signatures (LINCS) Program (http://www.lincsproject.org/), and NIH grant R00-HL098364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Cao AQ, 2011, J LIPID RES, V52, P518, DOI 10.1194/jlr.M010603; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Chou DHC, 2011, ACS MED CHEM LETT, V2, P698, DOI 10.1021/ml200120m; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Desai NR, 2013, CIRCULATION, V128, P962, DOI 10.1161/CIRCULATIONAHA.113.001969; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Duan QN, 2014, NUCLEIC ACIDS RES, V42, pW449, DOI 10.1093/nar/gku476; Gerard B, 2013, J ORG CHEM, V78, P5160, DOI 10.1021/jo4000916; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huff MW, 2013, CIRC RES, V112, P1405, DOI 10.1161/CIRCRESAHA.113.301464; Ishizuka Y, 2014, J MOL ENDOCRINOL, V52, P145, DOI 10.1530/JME-13-0243; Jammart B, 2013, J VIROL, V87, P5065, DOI 10.1128/JVI.01405-12; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kiss-Toth E, 2011, BIOCHEM SOC T, V39, P684, DOI 10.1042/BST0390684; Kong W, 2005, J LIPID RES, V46, P1163, DOI 10.1194/jlr.M400425-JLR200; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kotzka J, 2010, ATHEROSCLEROSIS, V213, P156, DOI 10.1016/j.atherosclerosis.2010.08.046; Li C, 1999, J BIOL CHEM, V274, P6747, DOI 10.1074/jbc.274.10.6747; Liang KL, 2013, BLOOD, V121, P4265, DOI 10.1182/blood-2012-12-471300; Lowe JT, 2012, J ORG CHEM, V77, P7187, DOI 10.1021/jo300974j; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mulvihill EE, 2011, DIABETES, V60, P1446, DOI 10.2337/db10-0589; Ollila HM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.20; Pak YK, 1996, J LIPID RES, V37, P985; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Schaefer GI, 2013, J AM CHEM SOC, V135, P9675, DOI 10.1021/ja400034k; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schreiber SL, 2009, NATURE, V457, P153, DOI 10.1038/457153a; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Soubeyrand S, 2013, BBA-MOL CELL RES, V1833, P3405, DOI 10.1016/j.bbamcr.2013.10.001; Stein EA, 2012, CIRCULATION, V126, P2283, DOI 10.1161/CIRCULATIONAHA.112.104125; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Sung HY, 2007, J BIOL CHEM, V282, P18379, DOI 10.1074/jbc.M610792200; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tsai J, 2007, ARTERIOSCL THROM VAS, V27, P211, DOI 10.1161/01.ATV.0000249861.80471.96; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Vargas NB, 2009, J LIPID RES, V50, P386, DOI 10.1194/jlr.M800316-JLR200; Yashiro T, 2013, ATHEROSCLEROSIS, V226, P95, DOI 10.1016/j.atherosclerosis.2012.09.033; Zhang F, 2002, J LIPID RES, V43, P1477, DOI 10.1194/jlr.M200126-JLR200	57	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120295	10.1371/journal.pone.0120295	http://dx.doi.org/10.1371/journal.pone.0120295			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811180	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700045
J	Snider, DM; Venkiteswaran, JJ; Schiff, SL; Spoelstra, J				Snider, David M.; Venkiteswaran, Jason J.; Schiff, Sherry L.; Spoelstra, John			From the Ground Up: Global Nitrous Oxide Sources are Constrained by Stable Isotope Values	PLOS ONE			English	Article							SUBTROPICAL NORTH PACIFIC; WASTE-WATER TREATMENT; N2O ISOTOPOMERS; ABUNDANCE; RATIOS; SOIL; EMISSIONS; FOREST; BUDGET; O-18	Rising concentrations of nitrous oxide (N2O) in the atmosphere are causing widespread concern because this trace gas plays a key role in the destruction of stratospheric ozone and it is a strong greenhouse gas. The successful mitigation of N2O emissions requires a solid understanding of the relative importance of all N2O sources and sinks. Stable isotope ratio measurements (delta N-15-N2O and delta O-18-N2O), including the intramolecular distribution of N-15 (site preference), are one way to track different sources if they are isotopically distinct. 'Top-down' isotope mass-balance studies have had limited success balancing the global N2O budget thus far because the isotopic signatures of soil, freshwater, and marine sources are poorly constrained and a comprehensive analysis of global N2O stable isotope measurements has not been done. Here we used a robust analysis of all available in situ measurements to define key global N2O sources. We showed that the marine source is isotopically distinct from soil and freshwater N2O (the continental source). Further, the global average source (sum of all natural and anthropogenic sources) is largely controlled by soils and freshwaters. These findings substantiate past modelling studies that relied on several assumptions about the global N2O cycle. Finally, a two-box-model and a Bayesian isotope mixing model revealed marine and continental N2O sources have relative contributions of 24-26% and 74-76% to the total, respectively. Further, the Bayesian modeling exercise indicated the N2O flux from freshwaters may be much larger than currently thought.	[Snider, David M.; Spoelstra, John] Environm Canada, Canada Ctr Inland Waters, Natl Water Res Inst, Burlington, ON L7R 4A6, Canada; [Venkiteswaran, Jason J.] Wilfrid Laurier Univ, Dept Geog & Environm Studies, Waterloo, ON N2L 3C5, Canada; [Venkiteswaran, Jason J.; Schiff, Sherry L.; Spoelstra, John] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	Environment & Climate Change Canada; Canada Centre for Inland Waters (CCIW); National Water Research Institute; Wilfrid Laurier University; University of Waterloo	Snider, DM (corresponding author), Environm Canada, Canada Ctr Inland Waters, Natl Water Res Inst, Burlington, ON L7R 4A6, Canada.	dave.snider@ec.gc.ca; jvenkiteswaran@wlu.ca		Venkiteswaran, Jason J./0000-0002-6574-7071	Natural Sciences and Engineering Research Council of Canada [STPGP 322062-05, STPGP 365226-08, STPGP 381058-09, STPGP 357056-07, RGPIN 33854]; BIOCAP [STPGP 336807-06]; Ontario Ministry of Agriculture and Food [09M1, 11M1]; Canadian Foundation for Climate and Atmospheric Sciences [GR-428]; Banting Postdoctoral Fellowship; Norfolk Land Stewardship Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); BIOCAP; Ontario Ministry of Agriculture and Food; Canadian Foundation for Climate and Atmospheric Sciences; Banting Postdoctoral Fellowship; Norfolk Land Stewardship Council	This research was supported by the Natural Sciences and Engineering Research Council of Canada 'Strategic Projects' awarded to SLS: STPGP 322062-05, STPGP 365226-08, STPGP 381058-09, www.nserc-crsng.gc.ca; Natural Sciences and Engineering Research Council of Canada 'Strategic Project' co-funded by BIOCAP awarded to SLS: STPGP 336807-06, www.nserc-crsng.gc.ca and www.biocap.ca; Natural Sciences and Engineering Research Council of Canada 'Strategic Project' awarded to JS and SLS: STPGP 357056-07, www.nserc-crsng.gc.ca; Natural Sciences and Engineering Research Council of Canada 'Discovery Grant' awarded to SLS: RGPIN 33854, www.nserc-crsng.gc.ca; Ontario Ministry of Agriculture and Food ' Environmental Sustainability Directed Research Program' projects awarded to JS: Project 09M1, Project 11M1, www.omafra.gov.on.ca; Canadian Foundation for Climate and Atmospheric Sciences project awarded to SLS: GR-428; Banting Postdoctoral Fellowship awarded to DMS, www.banting.fellowships-bourses.gc.ca; and Norfolk Land Stewardship Council project awarded to JS, www.hnstewardshipcouncils.org/norfolk_land_stewardship_council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batschelet E, 1981, CIRCULAR STAT BIOL; Bauer B, 2008, BEHAV RES METHODS, V40, P858, DOI 10.3758/BRM.40.3.858; Baulch HM, 2011, ENVIRON SCI TECHNOL, V45, P4682, DOI 10.1021/es104116a; Boontanon N, 2000, NATURWISSENSCHAFTEN, V87, P188, DOI 10.1007/s001140050701; Croteau P, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013117; Dore JE, 1998, NATURE, V396, P63, DOI 10.1038/23921; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Frame CH, 2014, GLOBAL BIOGEOCHEM CY, V28, P1262, DOI 10.1002/2013GB004790; Ishijima K, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007208; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kaiser J, 2006, ATMOS CHEM PHYS, V6, P3535, DOI 10.5194/acp-6-3535-2006; Kaiser J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003613; KIM KR, 1993, SCIENCE, V262, P1855, DOI 10.1126/science.262.5141.1855; KIM KR, 1990, NATURE, V347, P58, DOI 10.1038/347058a0; Koba K, 2009, GEOCHIM COSMOCHIM AC, V73, P3115, DOI 10.1016/j.gca.2009.03.022; Koehler B, 2012, BIOGEOCHEMISTRY, V111, P695, DOI 10.1007/s10533-012-9711-6; Kool DM, 2009, RAPID COMMUN MASS SP, V23, P104, DOI 10.1002/rcm.3859; Li L, 2014, J HYDROL, V519, P1882, DOI 10.1016/j.jhydrol.2014.09.037; Maeda K, 2010, APPL ENVIRON MICROB, V76, P1555, DOI 10.1128/AEM.01394-09; Mander U, 2014, ENVIRON SCI TECHNOL, V48, P11910, DOI 10.1021/es501727h; Mandernack KW, 2000, J GEOPHYS RES-ATMOS, V105, P17709, DOI 10.1029/2000JD900055; Mohn J, 2014, RAPID COMMUN MASS SP, V28, P1995, DOI 10.1002/rcm.6982; Naqvi SWA, 1998, NATURE, V394, P462, DOI 10.1038/28828; Ogawa M, 2005, CHEMOSPHERE, V61, P877, DOI 10.1016/j.chemosphere.2005.04.096; Ogawa M, 2005, ATMOS ENVIRON, V39, P3421, DOI 10.1016/j.atmosenv.2005.01.059; Ostrom NE, 2010, SOIL BIOL BIOCHEM, V42, P499, DOI 10.1016/j.soilbio.2009.12.003; Park S, 2012, NAT GEOSCI, V5, P261, DOI [10.1038/ngeo1421, 10.1038/NGEO1421]; Park S, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003615; Park SY, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003731; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Perez T, 2000, GLOBAL BIOGEOCHEM CY, V14, P525, DOI 10.1029/1999GB001181; Perez T, 2001, J GEOPHYS RES-ATMOS, V106, P9869, DOI 10.1029/2000JD900809; Peters B, 2014, GEOCHIM COSMOCHIM AC, V135, P87, DOI 10.1016/j.gca.2014.03.024; Prather MJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051440; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Priscu JC, 2008, LIMNOL OCEANOGR, V53, P2439, DOI 10.4319/lo.2008.53.6.2439; Rahn T, 2000, GLOBAL BIOGEOCHEM CY, V14, P537, DOI 10.1029/1999GB900070; Rahn T, 1997, SCIENCE, V278, P1776, DOI 10.1126/science.278.5344.1776; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rock L, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008330; Rockmann T, 2003, ATMOS CHEM PHYS, V3, P315; Samarkin VA, 2010, NAT GEOSCI, V3, P341, DOI 10.1038/NGEO847; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Sasaki Y, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001589; Smemo KA, 2011, NUTR CYCL AGROECOSYS, V91, P145, DOI 10.1007/s10705-011-9452-2; Snider DM, 2013, GEOCHIM COSMOCHIM AC, V112, P102, DOI 10.1016/j.gca.2013.03.003; Snider DM, 2012, GLOBAL CHANGE BIOL, V18, P356, DOI 10.1111/j.1365-2486.2011.02547.x; Sowers T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001911; Stock B.C., 2013, MIXSIAR GUI USER MAN; Stocker TF, 2013, CONTRIBUTIONS WORKIN; Thuss SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090641; Townsend-Small A, 2014, J GEOPHYS RES-OCEANS, V119, P3158, DOI 10.1002/2013JC009580; Townsend-Small A, 2011, J ENVIRON QUAL, V40, P1542, DOI 10.2134/jeq2011.0059; Townsend-Small A, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001494; Toyoda S, 2001, J GEOPHYS RES-ATMOS, V106, P7515, DOI 10.1029/2000JD900680; Toyoda S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014311; Toyoda S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004316; Toyoda S, 2008, RAPID COMMUN MASS SP, V22, P603, DOI 10.1002/rcm.3400; Toyoda S, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003769; Toyoda S, 2011, ENVIRON SCI TECHNOL, V45, P917, DOI 10.1021/es102985u; Toyoda S, 2009, RAPID COMMUN MASS SP, V23, P809, DOI 10.1002/rcm.3945; Toyoda S, 2013, J GEOPHYS RES-ATMOS, V118, P3369, DOI 10.1002/jgrd.50221; Tumendelger A, 2014, RAPID COMMUN MASS SP, V28, P1883, DOI 10.1002/rcm.6973; Van Groenigen JW, 2005, RAPID COMMUN MASS SP, V19, P1289, DOI 10.1002/rcm.1929; Well R, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000044; Well R, 2012, GEOCHIM COSMOCHIM AC, V90, P265, DOI 10.1016/j.gca.2012.04.045; Westley MB, 2006, DEEP-SEA RES PT II, V53, P1802, DOI 10.1016/j.dsr2.2006.03.012; Xiong ZQ, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000827; Yamagishi H, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000227; Yamulki S, 2001, RAPID COMMUN MASS SP, V15, P1263, DOI 10.1002/rcm.352; Yang H, 2014, ENVIRON SCI TECHNOL, V48, P10707, DOI 10.1021/es501912d; Yano M, 2014, SOIL BIOL BIOCHEM, V70, P66, DOI 10.1016/j.soilbio.2013.11.026; Yoshida N, 2000, NATURE, V405, P330, DOI 10.1038/35012558; Yoshinari T, 1997, MAR CHEM, V56, P253, DOI 10.1016/S0304-4203(96)00073-4; Zhu RB, 2008, RAPID COMMUN MASS SP, V22, P3570, DOI 10.1002/rcm.3762; Zou Y, 2014, SOIL BIOL BIOCHEM, V77, P276, DOI 10.1016/j.soilbio.2014.06.016	76	36	37	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0118954	10.1371/journal.pone.0118954	http://dx.doi.org/10.1371/journal.pone.0118954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811179	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700009
J	Yockney, IJ; Latham, MC; Rouco, C; Cross, ML; Nugent, G				Yockney, Ivor J.; Latham, M. Cecilia; Rouco, Carlos; Cross, Martin L.; Nugent, Graham			Quantifying Short-Term Foraging Movements in a Marsupial Pest to Improve Targeted Lethal Control and Disease Surveillance	PLOS ONE			English	Article							SMALL-MAMMAL PESTS; POSSUMS TRICHOSURUS-VULPECULA; NEW-ZEALAND; BRUSHTAIL POSSUMS; COLLAR PERFORMANCE; GPS TELEMETRY; TUBERCULOSIS; ECOSYSTEM; ECOLOGY; BAIT	In New Zealand, the introduced marsupial brushtail possum (Trichosurus vulpecula) is a pest species subject to control measures, primarily to limit its ability to transmit bovine tuberculosis (TB) to livestock and for conservation protection. To better define parameters for targeted possum control and TB surveillance, we here applied a novel approach to analyzing GPS data obtained from 44 possums fitted with radio-tracking collars, producing estimates of the animals' short-term nocturnal foraging patterns based on 1-, 3- or 5-nights' contiguous data. Studies were conducted within two semi-arid montane regions of New Zealand's South Island High Country: these regions support low-density possum populations (<2 possums/ha) in which the animals' home ranges are on average larger than in high-density populations in forested habitat. Possum foraging range width (FRW) estimates increased with increasing monitoring periods, from 150-200m based on a single night's movement data to 300-400m based on 5 nights' data. The largest average FRW estimates were recorded in winter and spring, and the smallest in summer. The results suggest that traps or poison-bait stations (for lethal control) or monitoring devices (for TB surveillance), set for >3 consecutive nights at 150 minterval spacings, would likely place >95% of the possums in this type of habitat at risk of encountering these devices, year-round. Modelling control efficacy against operational expenditure, based on these estimations, identified the relative cost-effectiveness of various strategies that could be applied to a typical aerial poisoning operation, to reduce the ongoing TB vectorial risk that possums pose in the High Country regions. These habitat-specific findings are likely to be more relevant than the conventional pest control and monitoring methodologies developed for possums in their more typical forested habitat.	[Yockney, Ivor J.; Latham, M. Cecilia; Cross, Martin L.; Nugent, Graham] Landcare Res, Dept Wildlife Ecol & Management, Lincoln, New Zealand; [Rouco, Carlos] Landcare Res, Dept Wildlife Ecol & Management, Dunedin, New Zealand	Landcare Research - New Zealand; Landcare Research - New Zealand	Nugent, G (corresponding author), Landcare Res, Dept Wildlife Ecol & Management, Lincoln, New Zealand.	nugentg@landcareresearch.co.nz	Rouco, Carlos Rouco/I-3088-2015	Rouco, Carlos Rouco/0000-0003-1026-3253; Nugent, Graham/0000-0001-6223-8450	TBfree New Zealand (AHB) [R-10762]; New Zealand government's Ministry of Business, Innovation and Employment [C09X0803]	TBfree New Zealand (AHB); New Zealand government's Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This study was supported by research project grants from TBfree New Zealand (AHB project number R-10762) and the New Zealand government's Ministry of Business, Innovation and Employment (project number C09X0803). The funders played no part in the interpretation of data or presentation of results in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2013, EPIDEMIOL INFECT, V141, P1509, DOI 10.1017/S095026881200310X; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2009, NATL BOVINE TUBERCUL; Byrom AE, 2008, LC0708110, P1; Cliquet F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001535; Cochran WW, 1969, WILDLIFE MANAGEMENT, P507; Cowan Phil, 2000, P24; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; Efford Murray, 2000, P47; Girard I, 2002, J WILDLIFE MANAGE, V66, P1290, DOI 10.2307/3802962; Glen AS, 2012, NEW ZEAL J ECOL, V36, P29; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Kauhala K, 2005, WILDLIFE BIOL, V11, P193, DOI 10.2981/0909-6396(2005)11[193:HROMHL]2.0.CO;2; Kemere P., 2000, P 3 NWRC SPEC S EC C, P109; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Mooney H.A., 2000, INVASIVE SPECIES CHA; Morgan David, 2000, P143; NPCA, 2002, NAT PEST CONTR AG PU; NPCA, 2008, NAT PEST CONTR AG PU; NPCA, 2011, NAT PEST CONTR AG PU; Nugent G, 2013, NEW ZEAL J ECOL, V37, P246; Nugent G, 2013, PREV VET MED, V109, P168, DOI 10.1016/j.prevetmed.2012.09.008; Nugent G, 2012, PEST MANAG SCI, V68, P1374, DOI 10.1002/ps.3315; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; Ogilvie SC, 2002, NZ PLANT PROTECT, V59, P28; PCE, 2011, EV US 1080 PRED POIS; Porphyre T, 2013, WILDLIFE RES, V40, P578, DOI 10.1071/WR13028; Rauzon Mark J., 2007, Marine Ornithology, V35, P97; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Rouco C, 2013, NEW ZEAL J ECOL, V37, P12; Saunders G., 2007, IMPROVING MANAGEMENT; Smith DHV, 2015, NEW ZEAL J ECOL, V39, P201; Sweetapple P, 2011, NEW ZEAL J ECOL, V32, P152; Warburton B, 2014, POSSUM COST CONTROL; Warburton Bruce, 2000, P132; Yockney IJ, 2013, EPIDEMIOL INFECT, V141, P1407, DOI 10.1017/S0950268813000289	38	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121865	10.1371/journal.pone.0121865	http://dx.doi.org/10.1371/journal.pone.0121865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811977	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700151
J	Zhu, J; Hou, Q; Dong, XD; Wang, ZL; Chen, XY; Zheng, DD; Zhou, LL; He, C; Liu, MY; Tu, LL; Qu, J				Zhu, Jun; Hou, Qiang; Dong, Xiang Da; Wang, Zhenlian; Chen, Xiaoyan; Zheng, Dandan; Zhou, Linglin; He, Chao; Liu, Mingyao; Tu, LiLi; Qu, Jia			Targeted Deletion of the Murine Lgr4 Gene Decreases Lens Epithelial Cell Resistance to Oxidative Stress and Induces Age-Related Cataract Formation	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; POSTNATAL-DEVELOPMENT; WNT/BETA-CATENIN; DOWN-REGULATION; GPR48; PROLIFERATION; RECEPTORS; EGFR; KNOCKOUT; CATALASE	Oxidative stress contributes to the formation of cataracts. The leucine rich repeat containing G protein-coupled receptor 4 (LGR4, also known as GPR48), is important in many developmental processes. Since deletion of Lgr4 has previously been shown to lead to cataract formation in mice, we sought to determine the specific role that Lgr4 plays in the formation of cataracts. Initially, the lens opacities of Lgr4(-/-) mice at different ages without ocular anterior segment dysgenesis (ASD) were evaluated with slit-lamp biomicroscopy. Lenses from both Lgr4(-/-) and wild-type mice were subjected to oxidation induced protein denaturation to assess the ability of the lens to withstand oxidation. The expression of antioxidant enzymes was evaluated with real-time quantitative PCR. Phenotypically, Lgr4(-/-) mice showed earlier onset of lens opacification and higher incidence of cataract formation compared with wildtype mice of similar age. In addition, Lgr4(-/-) mice demonstrated increased sensitivity to environmental oxidative damage, as evidenced by altered protein expression. Real-time quantitative PCR showed that two prominent antioxidant defense enzymes, catalase (CAT) and superoxidase dismutase-1 (SOD1), were significantly decreased in the lens epithelial cells of Lgr4(-/-) mice. Our results suggest that the deletion of Lgr4 can lead to premature cataract formation, as well as progressive deterioration with aging. Oxidative stress and altered expression of several antioxidant defense enzymes contribute to the formation of cataracts.	[Zhu, Jun; Hou, Qiang; Wang, Zhenlian; Chen, Xiaoyan; Zheng, Dandan; Zhou, Linglin; He, Chao; Tu, LiLi; Qu, Jia] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Zhu, Jun; Hou, Qiang; Wang, Zhenlian; Chen, Xiaoyan; Zheng, Dandan; Zhou, Linglin; He, Chao; Tu, LiLi; Qu, Jia] Zhejiang Prov Key Lab Ophthalmol & Optometry, State Key Lab Cultivat Base, Minist Hlth Peoples Republ China, Wenzhou, Zhejiang, Peoples R China; [Zhu, Jun; Hou, Qiang; Wang, Zhenlian; Chen, Xiaoyan; Zheng, Dandan; Zhou, Linglin; He, Chao; Tu, LiLi; Qu, Jia] Zhejiang Prov Key Lab Ophthalmol & Optometry, Key Lab Vis Sci, Minist Hlth Peoples Republ China, Wenzhou, Zhejiang, Peoples R China; [Zhu, Jun; Hou, Qiang; Wang, Zhenlian; Chen, Xiaoyan; Zheng, Dandan; Zhou, Linglin; He, Chao; Tu, LiLi; Qu, Jia] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Dong, Xiang Da] Columbia Univ, Stamford Hosp, Dept Surg, Stamford, CT USA; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX USA	Wenzhou Medical University; Columbia University; Stamford Hospital; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Qu, J (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.	jqu@wz.zj.cn	chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022	Liu, Mingyao/0000-0001-7339-5048	National Natural Science Foundation of China [81100671, 81201657]; Zhejiang Provincial Natural Science Foundation of China [Y2110609]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	Support was provided by National Natural Science Foundation of China Grants 81100671 for Q. Hou and 81201657 for Z. Wang; Zhejiang Provincial Natural Science Foundation of China Grant Y2110609 for Q. Hou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastawrous A, 2013, BRIT J OPHTHALMOL, V97, P1237, DOI 10.1136/bjophthalmol-2013-303135; Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Bhabak KP, 2010, ACCOUNTS CHEM RES, V43, P1408, DOI 10.1021/ar100059g; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen KCW, 2007, MOL VIS, V13, P374; Chong CCW, 2009, EXP EYE RES, V88, P307, DOI 10.1016/j.exer.2008.07.018; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Mathias RT, 2004, EXP EYE RES, V78, P689, DOI 10.1016/j.exer.2003.07.001; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Pan HJ, 2014, ENDOCRINOLOGY, V155, P3624, DOI 10.1210/en.2013-2183; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Siwko S, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/987494; Spector A, 2000, J OCUL PHARMACOL TH, V16, P193, DOI 10.1089/jop.2000.16.193; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Wang F, 2014, J MOL ENDOCRINOL, V52, P133, DOI 10.1530/JME-13-0042; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Wang ZL, 2010, FEBS LETT, V584, P4057, DOI 10.1016/j.febslet.2010.08.028; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wu JH, 2013, CARCINOGENESIS, V34, P2861, DOI 10.1093/carcin/bgt229; Xie Y, 2013, EMBO REP, V14, P1120, DOI 10.1038/embor.2013.167; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Yi TF, 2014, J BIOL CHEM, V289, P8767, DOI 10.1074/jbc.M113.530816; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zhang J, 2008, INVEST OPHTH VIS SCI, V49, P5476, DOI 10.1167/iovs.08-2179; Zhang Y, 2011, MOL VIS, V17, P2325; Zheng Y, 2010, MOL VIS, V16, P1467; Zhu YB, 2013, ASIAN PAC J CANCER P, V14, P4775, DOI 10.7314/APJCP.2013.14.8.4775	39	15	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119599	10.1371/journal.pone.0119599	http://dx.doi.org/10.1371/journal.pone.0119599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811370	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700019
J	Blumenfeld, Z; Velisar, A; Koop, MM; Hill, BC; Shreve, LA; Quinn, EJ; Kilbane, C; Yu, H; Henderson, JM; Bronte-Stewart, H				Blumenfeld, Zack; Velisar, Anca; Koop, Mandy Miller; Hill, Bruce C.; Shreve, Lauren A.; Quinn, Emma J.; Kilbane, Camilla; Yu, Hong; Henderson, Jaimie M.; Bronte-Stewart, Helen			Sixty Hertz Neurostimulation Amplifies Subthalamic Neural Synchrony in Parkinson's Disease	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; HIGH-FREQUENCY STIMULATION; LOCAL-FIELD POTENTIALS; BASAL GANGLIA; STN-DBS; PATHOLOGICAL SYNCHRONIZATION; OSCILLATORY ACTIVITY; GLOBUS-PALLIDUS; CEREBRAL-CORTEX; BETA-ACTIVITY	High frequency subthalamic nucleus (STN) deep brain stimulation (DBS) improves the cardinal motor signs of Parkinson's disease (PD) and attenuates STN alpha/beta band neural synchrony in a voltage-dependent manner. While there is a growing interest in the behavioral effects of lower frequency (60 Hz) DBS, little is known about its effect on STN neural synchrony. Here we demonstrate for the first time that during intra-operative 60 Hz STN DBS, one or more bands of resting state neural synchrony were amplified in the STN in PD. We recorded intra-operative STN resting state local field potentials (LFPs) from twenty-eight STNs in seventeen PD subjects after placement of the DBS lead (model 3389, Medtronic, Inc.) before and during three randomized neurostimulation sets (130 Hz/1.35V, 130 Hz/2V, 60 Hz/2V). During 130 Hz/2V DBS, baseline (no DBS) STN alpha (8 - 12 Hz) and beta (13 - 35 Hz) band power decreased (N=14, P < 0.001 for both), whereas during 60 Hz/2V DBS, alpha band and peak frequency power increased (P = 0.012, P = 0.007, respectively). The effect of 60 Hz/2V DBS opposed that of power-equivalent (130 Hz/1.35V) DBS (alpha: P < 0.001, beta: P = 0.006). These results show that intra-operative 60 Hz STN DBS amplified whereas 130 Hz STN DBS attenuated resting state neural synchrony in PD; the effects were frequency-specific. We demonstrate that neurostimulation may be useful as a tool to selectively modulate resting state resonant bands of neural synchrony and to investigate its influence on motor and non-motor behaviors in PD and other neuropsychiatric diseases.	[Blumenfeld, Zack; Velisar, Anca; Koop, Mandy Miller; Hill, Bruce C.; Shreve, Lauren A.; Quinn, Emma J.; Kilbane, Camilla; Henderson, Jaimie M.; Bronte-Stewart, Helen] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Kilbane, Camilla; Yu, Hong; Henderson, Jaimie M.; Bronte-Stewart, Helen] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA	Stanford University; Stanford University	Bronte-Stewart, H (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	hbs@stanford.edu	KIlbane, Camilla/AAG-2801-2020	Blumenfeld, Zack/0000-0002-4627-5582; Velisar, Anca/0000-0002-8349-7782; Henderson, Jaimie/0000-0002-3276-2267; Shreve, Lauren/0000-0001-8858-0502	John A. Blume Foundation; Robert and Ruth Halperin Foundation; Cahill Family Foundation	John A. Blume Foundation; Robert and Ruth Halperin Foundation; Cahill Family Foundation	Support from the John A. Blume Foundation (HBS), Robert and Ruth Halperin Foundation (HBS), and Cahill Family Foundation (HBS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Alonso-Frech F, 2006, BRAIN, V129, P1748, DOI 10.1093/brain/awl103; Anderson ME, 2003, J NEUROPHYSIOL, V89, P1150, DOI 10.1152/jn.00475.2002; Birdno MJ, 2008, NEUROTHERAPEUTICS, V5, P14, DOI 10.1016/j.nurt.2007.10.067; Bronte-Stewart H, 2013, SOC NEUROSCI ABSTR; Bronte-Stewart H, 2010, NEUROSURGERY, V67, P1088, DOI 10.1227/NEU.0b013e3181ecc887; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Brozova H, 2009, NEUROLOGY, V72, P770, DOI 10.1212/01.wnl.0000339385.187472.7d; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Courtemanche R, 2003, J NEUROSCI, V23, P11741; de Solages C, 2010, EXP NEUROL, V221, P260, DOI 10.1016/j.expneurol.2009.11.012; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Gatev P, 2009, CEREB CORTEX, V19, P1330, DOI 10.1093/cercor/bhn171; Giannicola G, 2012, EXP NEUROL, V237, P312, DOI 10.1016/j.expneurol.2012.06.012; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grill WM, 2004, NEUROREPORT, V15, P1137, DOI 10.1097/00001756-200405190-00011; HABER SN, 1993, J COMP NEUROL, V329, P111, DOI 10.1002/cne.903290108; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Haynes WIA, 2013, J NEUROSCI, V33, P4804, DOI 10.1523/JNEUROSCI.4674-12.2013; Kang GY, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00032; Khoo HM, 2014, MOVEMENT DISORD, V29, P270, DOI 10.1002/mds.25810; Koop M. Miller, 2013, Society for Neuroscience Abstract Viewer and Itinerary Planner, V43; Koop MM, 2006, MOVEMENT DISORD, V21, P673, DOI 10.1002/mds.20796; Koss AM, 2005, ANN NEUROL, V58, P168, DOI 10.1002/ana.20525; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Kuhn AA, 2008, J NEUROSCI, V28, P6165, DOI 10.1523/JNEUROSCI.0282-08.2008; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; Lalo E, 2008, J NEUROSCI, V28, P3008, DOI 10.1523/JNEUROSCI.5295-07.2008; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; LIMOUSIN P, 1995, LANCET, V345, P91, DOI 10.1016/S0140-6736(95)90062-4; Little S, 2012, EXP NEUROL, V236, P383, DOI 10.1016/j.expneurol.2012.04.024; Magill PJ, 2001, NEUROSCIENCE, V106, P313, DOI 10.1016/S0306-4522(01)00281-0; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; Marceglia S, 2007, EXPERT REV MED DEVIC, V4, P605, DOI 10.1586/17434440.4.5.605; Marsden JF, 2001, BRAIN, V124, P378, DOI 10.1093/brain/124.2.378; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; Montgomery EB, 2008, NEUROSCI BIOBEHAV R, V32, P388, DOI 10.1016/j.neubiorev.2007.06.003; Montgomery EB, 2007, PARKINSONISM RELAT D, V13, P455, DOI 10.1016/j.parkreldis.2007.07.020; Moreau C, 2008, NEUROLOGY, V71, P80, DOI 10.1212/01.wnl.0000303972.16279.46; Moreau C, 2011, MOVEMENT DISORD, V26, P659, DOI 10.1002/mds.23538; Moshel S, 2013, FRONT HUM NEUROSCI, V7, P1, DOI [10.3389/fnhum.2013.00001, DOI 10.3389/FNHUM.2013.00001]; Nambu A, 1996, J NEUROSCI, V16, P2671; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Ray NJ, 2008, EXP NEUROL, V213, P108, DOI 10.1016/j.expneurol.2008.05.008; Rodriguez-Oroz MC, 2012, MOVEMENT DISORD, V27, P1718, DOI 10.1002/mds.25214; Rosa M, 2011, NEUROSIGNALS, V19, P151, DOI 10.1159/000328508; Shreve LA, 2013, SOC NEUROSCI ABSTR; Sidiropoulos C, 2013, J NEUROL, V260, P2306, DOI 10.1007/s00415-013-6983-2; Stegemoller EL, 2013, NEUROREHABILITATION, V33, P305, DOI 10.3233/NRE-130960; Tavares ALT, 2005, MOVEMENT DISORD, V20, P1286, DOI 10.1002/mds.20556; Velisar A, 2013, SOC NEUROSCI ABSTR; Weinberger M, 2006, J NEUROPHYSIOL, V96, P3248, DOI 10.1152/jn.00697.2006; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Whitmer D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00155; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016	64	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121067	10.1371/journal.pone.0121067	http://dx.doi.org/10.1371/journal.pone.0121067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807463	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000129
J	Chianini, F; Cosseddu, GM; Steele, P; Hamilton, S; Hawthorn, J; Siso, S; Pang, Y; Finlayson, J; Eaton, SL; Reid, HW; Dagleish, MP; Di Bari, MA; D'Agostino, C; Agrimi, U; Terry, L; Nonno, R				Chianini, Francesca; Cosseddu, Gian Mario; Steele, Philip; Hamilton, Scott; Hawthorn, Jeremy; Siso, Silvia; Pang, Yvonne; Finlayson, Jeanie; Eaton, Samantha L.; Reid, Hugh W.; Dagleish, Mark P.; Di Bari, Michele Angelo; D'Agostino, Claudia; Agrimi, Umberto; Terry, Linda; Nonno, Romolo			Correlation between Infectivity and Disease Associated Prion Protein in the Nervous System and Selected Edible Tissues of Naturally Affected Scrapie Sheep	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; SUFFOLK SHEEP; PRECLINICAL SCRAPIE; PRP ACCUMULATION; DIAGNOSIS; PATHOGENESIS; KIDNEYS; GLAREOLUS; GENOTYPE	The transmissible spongiform encephalopathies (TSEs) or prion diseases are a group of fatal neurodegenerative disorders characterised by the accumulation of a pathological form of a host protein known as prion protein (PrP). The validation of abnormal PrP detection techniques is fundamental to allow the use of high-throughput laboratory based tests, avoiding the limitations of bioassays. We used scrapie, a prototype TSE, to examine the relationship between infectivity and laboratory based diagnostic tools. The data may help to optimise strategies to prevent exposure of humans to small ruminant TSE material via the food chain. Abnormal PrP distribution/accumulation was assessed by immunohistochemistry (IHC), Western blot (WB) and ELISA in samples from four animals. In addition, infectivity was detected using a sensitive bank vole bioassay with selected samples from two of the four sheep and protein misfolding cyclic amplification using bank vole brain as substrate (vPMCA) was also carried out in selected samples from one animal. Lymph nodes, oculomotor muscles, sciatic nerve and kidney were positive by IHC, WB and ELISA, although at levels 100-1000 fold lower than the brain, and contained detectable infectivity by bioassay. Tissues not infectious by bioassay were also negative by all laboratory tests including PMCA. Although discrepancies were observed in tissues with very low levels of abnormal PrP, there was an overall good correlation between IHC, WB, ELISA and bioassay results. Most importantly, there was a good correlation between the detection of abnormal PrP in tissues using laboratory tests and the levels of infectivity even when the titre was low. These findings provide useful information for risk modellers and represent a first step toward the validation of laboratory tests used to quantify prion infectivity, which would greatly aid TSE risk assessment policies.	[Chianini, Francesca; Steele, Philip; Hamilton, Scott; Pang, Yvonne; Finlayson, Jeanie; Eaton, Samantha L.; Reid, Hugh W.; Dagleish, Mark P.] Moredun Res Inst, Penicuik EH26 0PZ, Midlothian, Scotland; [Cosseddu, Gian Mario; Di Bari, Michele Angelo; D'Agostino, Claudia; Agrimi, Umberto; Nonno, Romolo] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Hawthorn, Jeremy; Terry, Linda] Anim & Plant Hlth Agcy APHA Weybridge, Addlestone KT15 3NB, Surrey, England; [Siso, Silvia] Anim & Plant Hlth Agcy APHA Lasswade, Penicuik EH26 0PZ, Midlothian, Scotland	Moredun Research Institute; Istituto Superiore di Sanita (ISS); Animal & Plant Health Agency UK	Chianini, F (corresponding author), Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland.	francesca.chianini@moredun.ac.uk	D'AGOSTINO, CLAUDIA/C-8326-2015; Siso, Silvia/X-7690-2019; NONNO, ROMOLO/C-8323-2015; Di Bari, Michele Angelo/Q-5028-2019; Di Bari, Michele Angelo/C-8327-2015; Chianini, Francesca/K-1451-2013; SISO, SILVIA/D-4240-2009; Cosseddu, Gian Mario/J-1046-2014	D'AGOSTINO, CLAUDIA/0000-0002-0696-1641; NONNO, ROMOLO/0000-0001-7556-1564; Di Bari, Michele Angelo/0000-0003-0943-6823; Di Bari, Michele Angelo/0000-0003-0943-6823; Chianini, Francesca/0000-0001-9962-446X; Cosseddu, Gian Mario/0000-0001-8031-1762	Food Standard Agency [MO3059, MO3060]; DEFRA [SE1949]	Food Standard Agency; DEFRA(Department for Environment, Food & Rural Affairs (DEFRA))	Funding for this experiment was provided by Food Standard Agency (http://www.food.gov.uk/) grants MO3059 and MO3060 and by DEFRA (https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs) grant SE1949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Andreoletti O, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1875; Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Boerner S, 2013, LAB ANIM-UK, V47, P106, DOI 10.1177/0023677213476856; Cartoni C, 2005, J CHROMATOGR A, V1081, P122, DOI 10.1016/j.chroma.2005.04.035; Casalone C, 2005, J VIROL, V79, P5847, DOI 10.1128/JVI.79.9.5847-5849.2005; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; Chianini F, 2013, VET IMMUNOL IMMUNOP, V152, P348, DOI 10.1016/j.vetimm.2013.01.005; Cosseddu GM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002370; Di Bari MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003219; Di Bari MA, 2008, J GEN VIROL, V89, P2975, DOI 10.1099/vir.0.2008/005520-0; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Everest SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019737; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Gonzalez L, 2006, VET REC, V158, P325, DOI 10.1136/vr.158.10.325; Gonzalez L, 2005, VET REC, V156, P846, DOI 10.1136/vr.156.26.846-b; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gonzalez L, 2012, J GEN VIROL, V93, P2518, DOI 10.1099/vir.0.045849-0; Gonzalez L, 2012, J GEN VIROL, V93, P203, DOI 10.1099/vir.0.034652-0; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Hamilton MA, 1977, ENVIRON SCI TECHNOL, V11, P414; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Liberski PP, 2012, FOLIA NEUROPATHOL, V50, P1; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; McGovern GP, 2013, INORG CHEM, V52, P13865, DOI 10.1021/ic401486y; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Siso S, 2008, J PATHOL, V215, P126, DOI 10.1002/path.2336; Siso S, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327-b; Spiropoulos J, 2011, EMERG INFECT DIS, V17, P2253, DOI 10.3201/eid1712.110333; van Keulen LJM, 2008, ARCH VIROL, V153, P445, DOI 10.1007/s00705-007-0007-4; van Keulen LJM, 2000, ARCH VIROL, P57; Vascellari M, 2005, ARCH VIROL, V150, P1959, DOI 10.1007/s00705-005-0564-3; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; Wilson R, 2012, J GEN VIROL, V93, P1624, DOI 10.1099/vir.0.042507-0	40	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122785	10.1371/journal.pone.0122785	http://dx.doi.org/10.1371/journal.pone.0122785			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807559	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000226
J	Costedoat, S; Corbera, E; Ezzine-De-Blas, D; Honey-Roses, J; Baylis, K; Castillo-Santiago, MA				Costedoat, Sebastien; Corbera, Esteve; Ezzine-de-Blas, Driss; Honey-Roses, Jordi; Baylis, Kathy; Angel Castillo-Santiago, Miguel			How Effective Are Biodiversity Conservation Payments in Mexico?	PLOS ONE			English	Article							ECOSYSTEM SERVICES; ENVIRONMENTAL SERVICES; NATIONAL PAYMENTS; COMMON PROPERTY; FORESTRY; DEFORESTATION; PROGRAMS; DESIGN; MONEY	We assess the additional forest cover protected by 13 rural communities located in the southern state of Chiapas, Mexico, as a result of the economic incentives received through the country's national program of payments for biodiversity conservation. We use spatially explicit data at the intra-community level to define a credible counterfactual of conservation outcomes. We use covariate-matching specifications associated with spatially explicit variables and difference-in-difference estimators to determine the treatment effect. We estimate that the additional conservation represents between 12 and 14.7 percent of forest area enrolled in the program in comparison to control areas. Despite this high degree of additionality, we also observe lack of compliance in some plots participating in the PES program. This lack of compliance casts doubt on the ability of payments alone to guarantee long-term additionality in context of high deforestation rates, even with an augmented program budget or extension of participation to communities not yet enrolled.	[Costedoat, Sebastien; Corbera, Esteve] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, E-08193 Barcelona, Spain; [Corbera, Esteve] Univ Autonoma Barcelona, Dept Econ & Econ Hist, E-08193 Barcelona, Spain; [Ezzine-de-Blas, Driss] CIRAD, Montpellier, France; [Honey-Roses, Jordi] Univ British Columbia, Sch Community & Reg Planning, Vancouver, BC V5Z 1M9, Canada; [Baylis, Kathy] Univ Illinois, Agr & Consumer Econ Dept, Urbana, IL 61801 USA; [Angel Castillo-Santiago, Miguel] Colegio Frontera Sur, Lab Anal Informac Geog, San Cristobal de las Casa, Chiapas, Mexico	Autonomous University of Barcelona; Autonomous University of Barcelona; CIRAD; University of British Columbia; University of Illinois System; University of Illinois Urbana-Champaign; El Colegio de la Frontera Sur (ECOSUR)	Costedoat, S (corresponding author), Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, E-08193 Barcelona, Spain.	sebastien.costedoat@uab.cat	Castillo-Santiago, Miguel A/B-8371-2014; Honey-Rosés, Jordi/H-3364-2019; Costedoat, Sébastien/J-1483-2019; Corbera, Esteve/C-5368-2015	Castillo-Santiago, Miguel A/0000-0002-3024-5514; Honey-Rosés, Jordi/0000-0003-0097-1811; Costedoat, Sébastien/0000-0002-9496-4542; Corbera, Esteve/0000-0001-7970-4411	Biodiversa Framework Project INVALUABLE: Values, Markets, and Policies for Biodiversity and Ecosystem Services [PRI-PIMBDV-2011- 1072]; 'Ramn y Cajal' research fellowship (Corbera) - Spanish Research, Development and Innovation Secretariat [RYC-2010-07183]; USDA-NIFA Hatch project [470-362]	Biodiversa Framework Project INVALUABLE: Values, Markets, and Policies for Biodiversity and Ecosystem Services; 'Ramn y Cajal' research fellowship (Corbera) - Spanish Research, Development and Innovation Secretariat; USDA-NIFA Hatch project	SC, EC, DE: Biodiversa Framework Project INVALUABLE: Values, Markets, and Policies for Biodiversity and Ecosystem Services (PRI-PIMBDV-2011- 1072), http://www.biodiversa.org/118. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EC: 'Ramn y Cajal' research fellowship (Corbera) granted by the Spanish Research, Development and Innovation Secretariat (RYC-2010-07183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KB: USDA-NIFA Hatch project number #470-362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Garcia J, 2007, J ENVIRON ECON MANAG, V53, P141, DOI 10.1016/j.jeem.2006.09.004; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Alix-Garcia JM, 2014, ONLY ONE TREE EACH S; Arriagada RA, 2012, LAND EC; Barsimantov J, 2012, J ENVIRON DEV, V21, P414, DOI 10.1177/1070496512447249; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Blackman A, 2013, FOREST POLICY ECON, V34, P1, DOI 10.1016/j.forpol.2013.04.006; Carabias J, 2009, ANALISIS SOCIOAMBIEN; Carabias J., 2012, EVALUACION IMPACTOS; Corbera E, 2009, ECOL ECON, V68, P743, DOI 10.1016/j.ecolecon.2008.06.008; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Ferraro PJ., 2009, J SUSTAIN FOREST, V28, P525, DOI DOI 10.1080/10549810802701234; FRA, 2010, FRA2010132 UN FAO; GARcIA-GIL J.G., 1992, RESERVA BIOSFERA MON, P39; Greenstone M, 2009, J ENVIRON ECON MANAG, V57, P21, DOI 10.1016/j.jeem.2008.02.004; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Huang M., 2009, Journal of Sustainable Forestry, V28, P551, DOI 10.1080/10549810902794287; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Jindal R, 2008, NAT RESOUR FORUM, V32, P116, DOI 10.1111/j.1477-8947.2008.00176.x; Kosoy N, 2008, GEOFORUM, V39, P2073, DOI 10.1016/j.geoforum.2008.08.007; Landell-Mills N, 2002, SILVER BULLET FOOLS; Milne S, 2009, ORYX, V43, P530, DOI 10.1017/S0030605309990330; Miteva DA, 2012, OXFORD REV ECON POL, V28, P69, DOI 10.1093/oxrep/grs009; Munoz-Pina C., 2011, REV ESP ESTUD AGROSO, V228, P87; Munoz-Pina C, 2008, ECOL ECON, V65, P725, DOI 10.1016/j.ecolecon.2007.07.031; Muradian R, 2010, ECOL ECON, V69, P1202, DOI 10.1016/j.ecolecon.2009.11.006; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Shapiro-Garza E, 2013, GEOFORUM, V46, P5, DOI 10.1016/j.geoforum.2012.11.018; Sims K.R.E., 2014, CONSERV BIOL; Sommerville MM, 2009, ECOL SOC, V14; Soto-Pinto L, 2012, DEFORESTATION WORLD; Southgate D., 2009, Journal of Sustainable Forestry, V28, P497, DOI 10.1080/10549810902794493; Tacconi L, 2012, ECOL ECON, V73, P29, DOI 10.1016/j.ecolecon.2011.09.028; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010; Wunder S, 2007, CONSERV BIOL, V21, P48, DOI 10.1111/j.1523-1739.2006.00559.x	43	60	62	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119881	10.1371/journal.pone.0119881	http://dx.doi.org/10.1371/journal.pone.0119881			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25807118	Green Published, gold			2022-12-26	WOS:000351880000046
J	El Assar, M; Angulo, J; Santos-Ruiz, M; Moreno, P; Novials, A; Villanueva-Penacarrillo, ML; Rodriguez-Manas, L				El Assar, Mariam; Angulo, Javier; Santos-Ruiz, Marta; Moreno, Paola; Novials, Anna; Luisa Villanueva-Penacarrillo, Maria; Rodriguez-Manas, Leocadio			Differential Effect of Amylin on Endothelial-Dependent Vasodilation in Mesenteric Arteries from Control and Insulin Resistant Rats	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; CELL DYSFUNCTION; NADPH OXIDASE; GLUCOSE; HUMANS; RELAXATION; OBESITY; DETERMINANTS	Insulin resistance (IR) is frequently associated with endothelial dysfunction and has been proposed to play a major role in cardiovascular disease (CVD). On the other hand, amylin has long been related to IR. However the role of amylin in the vascular dysfunction associated to IR is not well addressed. Therefore, the aim of the study was to assess the effect of acute treatment with amylin on endothelium-dependent vasodilation of isolated mesenteric arteries from control (CR) and insulin resistant (IRR) rats and to evaluate the possible mechanisms involved. Five week-old male Wistar rats received 20% D-fructose dissolved in drinking water for 8 weeks and were compared with age-matched CR. Plasmatic levels of glucose, insulin and amylin were measured. Mesenteric microvessels were dissected and mounted in wire myographs to evaluate endothelium-dependent vasodilation to acetylcholine. IRR displayed a significant increase in plasmatic levels of glucose, insulin and amylin and reduced endothelium-dependent relaxation when compared to CR. Acute treatment of mesenteric arteries with r-amylin (40 pM) deteriorated endothelium-dependent responses in CR. Amylin-induced reduction of endothelial responses was unaffected by the H2O2 scavenger, catalase, but was prevented by the extracellular superoxide scavenger, superoxide dismutase (SOD) or the NADPH oxidase inhibitor (VAS2870). By opposite, amylin failed to further inhibit the impaired relaxation in mesenteric arteries of IRR. SOD, or VAS2870, but not catalase, ameliorated the impairment of endothelium-dependent relaxation in IRR. At concentrations present in insulin resistance conditions, amylin impairs endothelium-dependent vasodilation in mircrovessels from rats with preserved vascular function and low levels of endogenous amylin. In IRR with established endothelial dysfunction and elevated levels of amylin, additional exposure to this peptide has no effect on endothelial vasodilation. Increased superoxide generation through NADPH oxidase activity may be a common link involved in the endothelial dysfunction associated to insulin resistance and to amylin exposure in CR.	[El Assar, Mariam; Rodriguez-Manas, Leocadio] Hosp Univ Getafe, Fdn Invest Biomed, Madrid, Spain; [Angulo, Javier] Hosp Ramon & Cajal, Inst Ramon y Cajal Invest Sanitaria IRYCIS, E-28034 Madrid, Spain; [Santos-Ruiz, Marta] Hosp Univ Getafe, Serv Anal Clin, Madrid, Spain; [Moreno, Paola] NIDDK, Digest Dis Branch, NIH, Bethesda, MD 20892 USA; [Novials, Anna] Hosp Clin Barcelona, Ctr Invest Biomed Red Diabet Enfermedad & Enferme, Inst Invest Biomed August Pi I Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain; [Luisa Villanueva-Penacarrillo, Maria] Fdn Jimenez Diaz, Ctr Invest Biomed Red Diabet Enfermedad & Enferme, IIS, Dept Metab Nutr & Hormones, Madrid, Spain; [Rodriguez-Manas, Leocadio] Hosp Univ Getafe, Serv Geriatr, Madrid, Spain	Hospital Universitario de Getafe; Hospital Universitario Ramon y Cajal; Hospital Universitario de Getafe; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Fundacion Jimenez Diaz; Hospital Universitario de Getafe	Rodriguez-Manas, L (corresponding author), Hosp Univ Getafe, Fdn Invest Biomed, Madrid, Spain.	leocadio.rodriguez@salud.madrid.org		Novials, Anna/0000-0003-0465-2949; Rodriguez-Manas, Leocadio/0000-0002-6551-1333	Ministerio de Economia y Competitividad; Fondos FEDER (Instituto de Salud Carlos III) [PI10/02781, PI11/01068, RETICEF RD12/0043]; Spanish Government; Fundacion Mutua Madrilena [AP/103152012]	Ministerio de Economia y Competitividad(Spanish Government); Fondos FEDER (Instituto de Salud Carlos III); Spanish Government(Spanish GovernmentEuropean Commission); Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	The present work was funded by grants from the Ministerio de Economia y Competitividad and cofunded by Fondos FEDER (Instituto de Salud Carlos III, PI10/02781, PI11/01068, RETICEF RD12/0043), Spanish Government, and by Fundacion Mutua Madrilena (AP/103152012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WA, 2007, DIABETES CARE, V30, P2369, DOI 10.2337/dc07-0649; BUTLER PC, 1990, DIABETES, V39, P752, DOI 10.2337/diabetes.39.6.752; Cancelas J, 2008, HORM METAB RES, V40, P459, DOI 10.1055/s-2008-1065318; Despa S, 2012, CIRC RES, V110, P598, DOI [10.1161/CIRCRESAHA.111.258285, 10.1161/circresaha.111.258285]; Duncan ER, 2007, AM J PHYSIOL-ENDOC M, V293, pE1311, DOI 10.1152/ajpendo.00299.2007; El Assar M, 2015, BRIT J PHARMACOL, V172, P1277, DOI 10.1111/bph.12993; El Assar M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-263; Fujii N, 2008, HEART VESSELS, V23, P9, DOI 10.1007/s00380-007-1002-0; Golpon HA, 2001, REGUL PEPTIDES, V102, P81, DOI 10.1016/S0167-0115(01)00300-7; Guzik TJ, 2006, ARTERIOSCL THROM VAS, V26, P333, DOI 10.1161/01.ATV.0000196651.64776.51; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Hasbak P, 2001, BRIT J PHARMACOL, V133, P1405, DOI 10.1038/sj.bjp.0704210; James S, 2010, FERTIL STERIL, V94, P211, DOI 10.1016/j.fertnstert.2009.02.086; Katakam PVG, 1999, J CARDIOVASC PHARM, V34, P461, DOI 10.1097/00005344-199909000-00022; Kearney MT, 2008, EXP PHYSIOL, V93, P158, DOI 10.1113/expphysiol.2007.039172; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; Lteif AA, 2005, CIRCULATION, V112, P32, DOI 10.1161/CIRCULATIONAHA.104.520130; Luk'yantseva GV, 2001, B EXP BIOL MED+, V132, P932, DOI 10.1023/A:1013646723338; Lutz TA, 2006, PHYSIOL BEHAV, V89, P465, DOI 10.1016/j.physbeh.2006.04.001; Lutz TA, 2010, AM J PHYSIOL-REG I, V298, pR1475, DOI 10.1152/ajpregu.00703.2009; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matveyenko AV, 2006, DIABETES, V55, P2106, DOI 10.2337/db05-1672; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Meyers Melissa R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P365, DOI 10.1097/MED.0b013e3282be90a8; MITSUKAWA T, 1990, DIABETES, V39, P639, DOI 10.2337/diabetes.39.5.639; Moreno P, 2012, J MOL ENDOCRINOL, V48, P37, DOI 10.1530/JME-11-0127; Muniyappa R, 2013, REV ENDOCR METAB DIS, V14, P5, DOI 10.1007/s11154-012-9229-1; Nikiforova AB, 2013, ANAL BIOCHEM, V440, P189, DOI 10.1016/j.ab.2013.05.029; Novials A, 2007, J CLIN ENDOCR METAB, V92, P1446, DOI 10.1210/jc.2006-1980; Nuche-Berenguer B, 2009, CALCIFIED TISSUE INT, V84, P453, DOI 10.1007/s00223-009-9220-3; Reaven G, 2012, ARTERIOSCL THROM VAS, V32, P1754, DOI 10.1161/ATVBAHA.111.241885; Rodriguez-Manas L, 2003, DIABETOLOGIA, V46, P556, DOI 10.1007/s00125-003-1056-1; Schelbert HR, 2009, J AM COLL CARDIOL, V53, pS3, DOI 10.1016/j.jacc.2008.09.053; Schramm A, 2012, VASC PHARMACOL, V56, P216, DOI 10.1016/j.vph.2012.02.012; Scuteri A, 2013, EXP GERONTOL, V48, P64, DOI 10.1016/j.exger.2012.02.009; Seals DR, 2006, EXP GERONTOL, V41, P501, DOI 10.1016/j.exger.2006.01.001; Shinozaki K, 1999, DIABETES, V48, P2437, DOI 10.2337/diabetes.48.12.2437; SOWA R, 1990, DIABETOLOGIA, V33, P118, DOI 10.1007/BF00401051; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Sukumar P, 2013, DIABETES, V62, P2130, DOI 10.2337/db12-1294; Sun QA, 2012, FREE RADICAL BIO MED, V52, P1897, DOI 10.1016/j.freeradbiomed.2012.02.046; Suzuki M, 2007, DIABETES RES CLIN PR, V76, P12, DOI 10.1016/j.diabres.2006.07.033; Thacker EL, 2011, STROKE, V42, P3347, DOI 10.1161/STROKEAHA.111.620773; Tran LT, 2009, MOL CELL BIOCHEM, V332, P145, DOI 10.1007/s11010-009-0184-4; Vara D, 2014, CURR MOL MED, V14, P1103, DOI 10.2174/1566524014666140603114010; Vazzana N, 2011, CURR MED CHEM, V18, P5267, DOI 10.2174/092986711798184299; Villanueva-Penacarrillo ML, 2001, ENDOCRINE, V15, P241, DOI 10.1385/ENDO:15:2:241; Young Andrew, 2005, Adv Pharmacol, V52, P19, DOI 10.1016/S1054-3589(05)52002-7; Young EJ, 2008, DIABETOLOGIA, V51, P872, DOI 10.1007/s00125-008-0934-y; Zheng XY, 2010, ACTA DIABETOL, V47, P265, DOI 10.1007/s00592-010-0201-9; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	51	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120479	10.1371/journal.pone.0120479	http://dx.doi.org/10.1371/journal.pone.0120479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807378	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000080
J	Filer, A; Antczak, P; Parsonage, GN; Legault, HM; O'Toole, M; Pearson, MJ; Thomas, AM; Scheel-Toellner, D; Raza, K; Buckley, CD; Falciani, F				Filer, Andrew; Antczak, Philipp; Parsonage, Greg N.; Legault, Holly M.; O'Toole, Margot; Pearson, Mark J.; Thomas, Andrew M.; Scheel-Toellner, Dagmar; Raza, Karim; Buckley, Christopher D.; Falciani, Francesco			Stromal Transcriptional Profiles Reveal Hierarchies of Anatomical Site, Serum Response and Disease and Identify Disease Specific Pathways	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; ALPHA(V)BETA(3) INTEGRIN; EXPRESSION; GROWTH; GENES; CELLS; PROTEIN; SYNOVIOCYTES; ACTIVATION	Synovial fibroblasts in persistent inflammatory arthritis have been suggested to have parallels with cancer growth and wound healing, both of which involve a stereotypical serum response programme. We tested the hypothesis that a serum response programme can be used to classify diseased tissues, and investigated the serum response programme in fibroblasts from multiple anatomical sites and two diseases. To test our hypothesis we utilized a bioinformatics approach to explore a publicly available microarray dataset including rheumatoid arthritis (RA), osteoarthritis (OA) and normal synovial tissue, then extended those findings in a new microarray dataset representing matched synovial, bone marrow and skin fibroblasts cultured from RA and OA patients undergoing arthroplasty. The classical fibroblast serum response programme discretely classified RA, OA and normal synovial tissues. Analysis of low and high serum treated fibroblast microarray data revealed a hierarchy of control, with anatomical site the most powerful classifier followed by response to serum and then disease. In contrast to skin and bone marrow fibroblasts, exposure of synovial fibroblasts to serum led to convergence of RA and OA expression profiles. Pathway analysis revealed three inter-linked gene networks characterising OA synovial fibroblasts: Cell remodelling through insulin-like growth factors, differentiation and angiogenesis through_3 integrin, and regulation of apoptosis through CD44. We have demonstrated that Fibroblast serum response signatures define disease at the tissue level, and that an OA specific, serum dependent repression of genes involved in cell adhesion, extracellular matrix remodelling and apoptosis is a critical discriminator between cultured OA and RA synovial fibroblasts.	[Filer, Andrew; Scheel-Toellner, Dagmar; Raza, Karim; Buckley, Christopher D.] Univ Birmingham, Queen Elizabeth Hosp, Coll Med & Dent Sci,Sch Immun & Infect, Rheumatol Res Grp,Ctr Muscoloskeletal Ageing Res, Birmingham B15 2WD, W Midlands, England; [Filer, Andrew] Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2WB, W Midlands, England; [Antczak, Philipp; Falciani, Francesco] Univ Liverpool, Inst Integrat Biol, Ctr Computat Biol & Modelling CCBM, Liverpool L69 3BX, Merseyside, England; [Parsonage, Greg N.] Univ Birmingham, Coll Med & Dent Sci, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Legault, Holly M.; O'Toole, Margot] Wyeth Res, Biol Technol, Cambridge, MA 02140 USA; [Pearson, Mark J.] Univ Birmingham, Queen Elizabeth Hosp, MRC ARUK Ctr Musculoskeletal Ageing Res, Sch Immun & Infect,Coll Med & Dent Sci, Birmingham B15 2WD, W Midlands, England; [Thomas, Andrew M.] Royal Orthopaed Hosp NHS Fdn Trust, Birmingham, W Midlands, England; [Raza, Karim; Buckley, Christopher D.] Sandwell & West Birmingham Hosp NHS Trust, Birmingham B18 7QH, W Midlands, England	University of Birmingham; University of Birmingham; University of Liverpool; University of Birmingham; Pfizer; University of Birmingham; Royal Orthopaedic Hospital	Filer, A (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Coll Med & Dent Sci,Sch Immun & Infect, Rheumatol Res Grp,Ctr Muscoloskeletal Ageing Res, Birmingham B15 2WD, W Midlands, England.	a.filer@bham.ac.uk; f.falciani@liv.ac.uk	Antczak, Philipp/L-5879-2019; Filer, Andrew/AAP-9179-2021; Buckley, Christopher/AAN-6378-2021; Raza, Karim/AAN-3089-2021	Antczak, Philipp/0000-0001-9600-7757; Filer, Andrew/0000-0001-8164-6249; Buckley, Christopher/0000-0001-6924-6402; Raza, Karim/0000-0003-1570-1232; Pearson, Mark/0000-0003-4553-4375	Medical Research Council; Arthritis Research UK [18547]; European Union [305549]; Wyeth; BBSRC/EraSysBio Linknet [BB/I004556/1]; Biotechnology and Biological Sciences Research Council [BB/I004556/1] Funding Source: researchfish; Versus Arthritis [19791, 19593, 20088] Funding Source: researchfish; BBSRC [BB/I004556/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); European Union(European Commission); Wyeth(Wyeth); BBSRC/EraSysBio Linknet(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by research grants from the Medical Research Council and Arthritis Research UK (Grant 18547). The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 305549. AF, CB and KR have received research grant funding from Wyeth. Partially funded by the BBSRC/EraSysBio Linknet BB/I004556/1 grant to FF.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bauer S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2080; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Del Rey MJ, 2012, ANN RHEUM DIS, V71, P275, DOI 10.1136/annrheumdis-2011-200281; Denk AE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2955; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Edderkaoui M, 2007, J BIOL CHEM, V282, P26646, DOI 10.1074/jbc.M702836200; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Filer A, 2006, ARTHRITIS RHEUM, V54, P2096, DOI 10.1002/art.21930; Graf K, 2000, HYPERTENSION, V35, P978, DOI 10.1161/01.HYP.35.4.978; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2485; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Izquierdo E, 2011, ARTHRITIS RHEUM-US, V63, P2575, DOI 10.1002/art.30433; Kanamori M, 2004, CANCER RES, V64, P2751, DOI 10.1158/0008-5472.CAN-03-3354; Kasperkovitz P, 2004, FIBROBLAST LIKE SYNO; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Lainer-Carr D, 2007, NAT CLIN PRACT RHEUM, V3, P434, DOI 10.1038/ncprheum0559; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; MullerLadner U, 1996, AM J PATHOL, V149, P1607; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nguyen TDT, 2006, GENE CHROMOSOME CANC, V45, P918, DOI 10.1002/gcc.20355; Ohshima S, 2003, ARTHRITIS RHEUM-US, V48, P2788, DOI 10.1002/art.11287; Oka N, 2005, CANCER RES, V65, P7546, DOI 10.1158/0008-5472.CAN-05-1197; Oslejskova L, 2008, ANN RHEUM DIS, V67, P1499, DOI 10.1136/ard.2007.079905; Pap T, 2000, ARTHRITIS RES, V2, P59, DOI 10.1186/ar69; Parsonage G, 2003, THROMB HAEMOSTASIS, V90, P688, DOI 10.1160/TH03-04-0208; R Core Team, 2020, R LANG ENV STAT COMP; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roberts MS, 2003, J BIOL CHEM, V278, P1975, DOI 10.1074/jbc.M208607200; Scaife S, 2004, RHEUMATOLOGY, V43, P1346, DOI 10.1093/rheumatology/keh347; Seki T, 1998, ARTHRITIS RHEUM-US, V41, P1356, DOI 10.1002/1529-0131(199808)41:8<1356::AID-ART4>3.0.CO;2-X; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Watanabe N, 2002, BIOCHEM BIOPH RES CO, V294, P1121, DOI 10.1016/S0006-291X(02)00608-3	43	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120917	10.1371/journal.pone.0120917	http://dx.doi.org/10.1371/journal.pone.0120917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807374	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000351880000112
J	Sajja, RK; Green, KN; Cucullo, L				Sajja, Ravi K.; Green, Kayla N.; Cucullo, Luca			Altered Nrf2 Signaling Mediates Hypoglycemia-Induced Blood-Brain Barrier Endothelial Dysfunction In Vitro	PLOS ONE			English	Article							MITOCHONDRIAL OXIDATIVE STRESS; JUNCTION PROTEINS; VASCULAR-DISEASE; DEFENSE PATHWAY; EXPRESSION; GLUCOSE; CELLS; STABILITY; RESPONSES; PROTECTS	Hypoglycemia impairs blood-brain barrier (BBB) endothelial function; a major hallmark in the pathogenesis of various CNS disorders. Previously, we have demonstrated that prolonged hypoglycemic exposure down-regulated BBB endothelial NF-E2 related factor-2 (Nrf2) expression; a redox-sensitive transcriptional factor that regulates endothelial function. Here, we sought to determine the functional role of Nrf2 in preserving BBB integrity and molecular mechanisms underlying hypoglycemia-induced Nrf2 down-regulation in vitro using human cerebral microvascular endothelial cell line (hCMEC/D3). Cell monolayers were exposed to normal or hypoglycemic (5.5 or 2.2mM D-glucose) media for 3-24h. Pharmacological or gene manipulation (by silencing RNA) approaches were used to investigate specific molecular pathways implicated in hypoglycemia-induced Nrf2 degradation. BBB integrity was assessed by paracellular permeability to labeled dextrans of increasing molecular sizes (4-70kDa). Silencing Nrf2 expression in hCMEC/D3 cells abrogated the expression of claudin-5 and VE-cadherin, while ZO-1 was up-regulated. These effects were paralleled by a decrease in electrical resistance of hCMEC/D3 monolayers and potential increase in permeability to all labeled dextrans. Hypoglycemic exposure (3-24h) led to progressive and sustained down-regulation of Nrf2 (without affecting mRNA) and its target, NQO-1, with a concomitant increase in the cytosolic pool of E3 ubiquitin ligase, Siah2 (but not Keap1). Pretreatment with protease inhibitor MG132, or selective knock-down of Siah2 (but not Keap1) significantly attenuated hypoglycemia-induced Nrf2 destabilization. While hypoglycemic exposure triggered a significant increase in BBB permeability to dextrans, silencing Siah2 gene abrogated the effects of hypoglycemia and restored BBB integrity. In summary, our data indicate a potential role for Nrf2 signaling in regulating tight junction integrity and maintaining BBB function. Nrf2 suppression by increased Siah2-driven proteasomal degradation mediates hypoglycemia-evoked endothelial dysfunction and loss of BBB integrity. Overall, this study suggests that sustained activation of endothelial Nrf2 signaling could have therapeutic potential to prevent hypoglycemia-induced cerebrovascular dysfunction.	[Sajja, Ravi K.; Cucullo, Luca] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA; [Green, Kayla N.] Texas Christian Univ, Dept Chem, Ft Worth, TX 76129 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Christian University	Cucullo, L (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA.	luca.cucullo@ttuhsc.edu	Green, Kayla N./P-3481-2014; Cucullo, Luca/X-2765-2019	Green, Kayla N./0000-0001-8816-7646; Cucullo, Luca/0000-0002-2827-7162	Alternative Research and Development Fund; National Institutes of Health/National Institute on Drug Abuse [R01-DA029121-01A1]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029121] Funding Source: NIH RePORTER	Alternative Research and Development Fund; National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Alternative Research and Development Fund to Dr. Luca Cucullo and in part by National Institutes of Health/National Institute on Drug Abuse R01-DA029121-01A1 to Dr. Luca Cucullo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Alfieri A, 2013, FREE RADICAL BIO MED, V65, P1012, DOI 10.1016/j.freeradbiomed.2013.08.190; Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; Artus C, 2014, J CEREBR BLOOD F MET, V34, P433, DOI 10.1038/jcbfm.2013.213; Baba K, 2013, J BIOL CHEM, V288, P18393, DOI 10.1074/jbc.M112.438762; Benardais K, 2013, NEUROSCI LETT, V555, P165, DOI 10.1016/j.neulet.2013.09.038; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Ceriello A, 2013, DIABETES CARE, V36, P2346, DOI 10.2337/dc12-2469; Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021; Coisne C, 2011, ANTIOXID REDOX SIGN, V15, P1285, DOI 10.1089/ars.2011.3929; Crunkhorn S, 2012, NAT REV DRUG DISCOV, V11, P96, DOI 10.1038/nrd3655; Cryer PE, 2007, J CLIN INVEST, V117, P868, DOI 10.1172/JCI31669; Cucullo L, 2008, J CEREBR BLOOD F MET, V28, P312, DOI 10.1038/sj.jcbfm.9600525; Daniels BP, 2013, J NEUROSCI METH, V212, P173, DOI 10.1016/j.jneumeth.2012.10.001; Emery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021586; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Freeman LR, 2012, BBA-MOL BASIS DIS, V1822, P822, DOI 10.1016/j.bbadis.2011.12.009; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Horani MH, 2003, CURR PHARM DESIGN, V9, P833, DOI 10.2174/1381612033455314; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Joy NG, 2010, DIABETES CARE, V33, P1529, DOI 10.2337/dc09-0354; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Li T, 2014, BRAIN RES, V1558, P90, DOI 10.1016/j.brainres.2014.02.036; Lincoln KM, 2013, CHEM COMMUN, V49, P2712, DOI 10.1039/c2cc36808k; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Muneer PMA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-23; Naik P, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-51; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2013, MOL PHARMACEUT, V10, P289, DOI 10.1021/mp3004308; Palmiotti CA, 2014, PHARM RES-DORDR, V31, P3229, DOI 10.1007/s11095-014-1464-6; Pang HY, 2011, THESCIENTIFICWORLDJO, V11, P1056, DOI 10.1100/tsw.2011.98; Sahin K, 2013, LIFE SCI, V93, P1039, DOI 10.1016/j.lfs.2013.10.009; Sajja RK, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-8; Singh P, 2004, MOL CELL BIOCHEM, V260, P153, DOI 10.1023/B:MCBI.0000026067.08356.13; Soma T, 2004, EXP CELL RES, V300, P202, DOI 10.1016/j.yexcr.2004.07.012; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Terashima J, 2011, DRUG METAB PHARMACOK, V26, P577, DOI 10.2133/dmpk.DMPK-11-RG-054; Toth AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100152; Wang JL, 2012, ARTERIOSCL THROM VAS, V32, P712, DOI 10.1161/ATVBAHA.111.227389; Wang XQ, 2014, J NEUROSCI, V34, P8585, DOI 10.1523/JNEUROSCI.2935-13.2014; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	50	44	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122358	10.1371/journal.pone.0122358	http://dx.doi.org/10.1371/journal.pone.0122358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807533	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000218
J	Svennerholm, K; Haney, M; Biber, B; Ulfhammer, E; Saluveer, O; Larsson, P; Omerovic, E; Jern, S; Bergh, N				Svennerholm, Kristina; Haney, Michael; Biber, Bjorn; Ulfhammer, Erik; Saluveer, Ott; Larsson, Pia; Omerovic, Elmir; Jern, Sverker; Bergh, Niklas			Histone Deacetylase Inhibition Enhances Tissue Plasminogen Activator Release Capacity in Atherosclerotic Man	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; T-PA RELEASE; IN-VIVO; FIBRINOLYTIC CAPACITY; HUMAN VASCULATURE; DISEASE; PLASMA; STIMULATION; ACETYLATION; THROMBOSIS	The expression of the tissue plasminogen activator (t-PA) gene appears to be under epigenetic control and can be affected by histone deacetylation inhibition. The study aimed to test if histone deacetalyase inhibitor treatment lead to increased t-PA release or reduced exhaustion in t-PA release in response to stimulation, as well as change in plasminogen activator inhibitor-1 (PAI-1) in subjects with coronary disease. In this clinical study, 16 post-myocardial infarction subjects, the perfused forearm model was used with isoprenaline provocation during 20 minutes, to stimulate local t-PA release. Each subject was measured twice on the same day (repeated stimuli sequences) as well as on two different occasions, without treatment and after four weeks of treatment with valproic acid (500 mg, twice daily). Net forearm release for t-PA in response to isoprenaline at minutes 1.5, 3, 6, 9, 12, 15 and 18 was measured, allowing assessment of cumulative t-PA release. There was a reduction in the exhaustion of cumulative t-PA release during repeated and prolonged stimulation with valproic acid treatment compared to non-treatment. Plasma PAI-1 antigen was decreased following treatment compared to non-treatment (18.4 +/- 10.0 vs. 11.0 +/- 7.1 nano-grams/ml respectively, mean with 95% confidence interval). These findings demonstrate that histone deacetylation inhibition increases the capacity for endogenous t-PA release in subjects with vascular disease. Furthermore, the fibrinolytic balance is favored with suppressed PAI-1 levels. More studies are needed to establish the clinical relevance of these findings.	[Svennerholm, Kristina; Biber, Bjorn] Univ Gothenburg, Anesthesiol & Intens Care Med, Inst Clin Sci, Sahlgrenska Acad, Gothenburg, Sweden; [Ulfhammer, Erik; Saluveer, Ott; Larsson, Pia; Omerovic, Elmir; Jern, Sverker; Bergh, Niklas] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Haney, Michael] Umea Univ, Anesthesiol & Intens Care Med, Inst Surg & Perioperat Sci, Umea, Sweden	University of Gothenburg; University of Gothenburg; Umea University	Haney, M (corresponding author), Umea Univ, Anesthesiol & Intens Care Med, Inst Surg & Perioperat Sci, Umea, Sweden.	michael.haney@umu.se	Haney, Michael/N-5707-2015	Haney, Michael/0000-0002-4049-8910; Larsson, Pia/0000-0001-9115-4213; Ulfhammer, Erik/0000-0002-6326-5175	Swedish Research Council [521-2012-2392]; Swedish Heart-Lung Foundation [HLF-20120369, HLR-20110321, HLF-20100617]; University of Gothenburg; Sahlgrenska University Hospital (ALF-LUA), Gothenburg; Umea University, Umea, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); University of Gothenburg; Sahlgrenska University Hospital (ALF-LUA), Gothenburg; Umea University, Umea, Sweden	This work was supported by The Swedish Research Council: 521-2012-2392 (www.vr.se), Swedish Heart-Lung Foundation (www.hjartlungfonden.se) [HLF-20120369, HLR-20110321, and HLF-20100617], the University of Gothenburg, the Sahlgrenska University Hospital (ALF-LUA), Gothenburg, and Umea University, Umea, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; Aspelin T, 2005, J THROMB HAEMOST, V3, P1947, DOI 10.1111/j.1538-7836.2005.01514.x; Aspelin T, 2012, BLOOD COAGUL FIBRIN, V23, P714, DOI 10.1097/MBC.0b013e328357d388; BOOTH NA, 1988, BRIT J HAEMATOL, V70, P327, DOI 10.1111/j.1365-2141.1988.tb02490.x; Brown NJ, 1999, HYPERTENSION, V33, P1431, DOI 10.1161/01.HYP.33.6.1431; Chandler WL, 1997, CIRCULATION, V96, P761; Cho KS, 2013, GLIA, V61, P694, DOI 10.1002/glia.22463; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Devries SR, 1987, FIBRINOLYSIS, V1, P12; Dunoyer-Geindre S, 2011, CARDIOVASC RES, V90, P457, DOI 10.1093/cvr/cvr028; FOX KAA, 1985, CIRCULATION, V72, P1346, DOI 10.1161/01.CIR.72.6.1346; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hrafnkelsdottir T, 1998, LANCET, V352, P1597, DOI 10.1016/S0140-6736(05)61044-6; Hrafnkelsdottir T, 2001, THROMB HAEMOSTASIS, V85, P875; Ichiyama T, 2000, BRAIN RES, V857, P246, DOI 10.1016/S0006-8993(99)02439-7; Jern C, 1997, THROMB HAEMOSTASIS, V78, P1150; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kathiresan S, 2006, ARTERIOSCL THROM VAS, V26, P1405, DOI 10.1161/01.ATV.0000222011.13026.25; Larsson P, 2013, J THROMB THROMBOLYS, V35, P185, DOI 10.1007/s11239-012-0831-6; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; Newby DE, 2001, CIRCULATION, V103, P1936; Oliver JJ, 2005, ARTERIOSCL THROM VAS, V25, P2470, DOI 10.1161/01.ATV.0000189309.05924.88; Osterlund B, 2008, ACTA ANAESTH SCAND, V52, P1375, DOI 10.1111/j.1399-6576.2008.01741.x; Robinson SD, 2007, ARTERIOSCL THROM VAS, V27, P1651, DOI 10.1161/ATVBAHA.107.143248; Saluveer O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107582; Stein CM, 1998, J AM COLL CARDIOL, V32, P117, DOI 10.1016/S0735-1097(98)00210-1; Svennerholm K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097260; Van Guilder GP, 2005, AM J PHYSIOL-ENDOC M, V289, pE807, DOI 10.1152/ajpendo.00072.2005; Wall U, 1997, J HYPERTENS, V15, P1641, DOI 10.1097/00004872-199715120-00066; Willeit P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055175; Witherow FN, 2002, J AM COLL CARDIOL, V40, P961, DOI 10.1016/S0735-1097(02)02061-2; ZAMARRON C, 1984, THROMB RES, V35, P335, DOI 10.1016/0049-3848(84)90364-5	32	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121196	10.1371/journal.pone.0121196	http://dx.doi.org/10.1371/journal.pone.0121196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807501	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000137
J	Yang, ZH; Iizuka, R; Funatsu, T				Yang, Zhuohao; Iizuka, Ryo; Funatsu, Takashi			Nascent SecM Chain Outside the Ribosome Reinforces Translation Arrest	PLOS ONE			English	Article							ESCHERICHIA-COLI SECA; PURIFIED COMPONENTS; PROTEIN-SYNTHESIS; MESSENGER-RNA; EXIT TUNNEL; A-SITE; DISPLAY; TRANSLOCON; COMPLEXES; SELECTION	SecM, a bacterial secretion monitor protein, contains a specific amino acid sequence at its C-terminus, called arrest sequence, which interacts with the ribosomal tunnel and arrests its own translation. The arrest sequence is sufficient and necessary for stable translation arrest. However, some previous studies have suggested that the nascent chain outside the ribosome affects the stability of translation arrest. To clarify this issue, we performed in vitro translation assays with HaloTag proteins fused to the C-terminal fragment of E. coli SecM containing the arrest sequence or the full-length SecM. We showed that the translation of HaloTag proteins, which are fused to the fragment, is not effectively arrested, whereas the translation of HaloTag protein fused to full-length SecM is arrested efficiently. In addition, we observed that the nascent SecM chain outside the ribosome markedly stabilizes the translation arrest. These results indicate that changes in the nascent polypeptide chain outside the ribosome can affect the stability of translation arrest; the nascent SecM chain outside the ribosome stabilizes the translation arrest.	[Yang, Zhuohao; Iizuka, Ryo; Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Tokyo, Japan	University of Tokyo	Funatsu, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Bioanalyt Chem, Tokyo, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308; Iizuka, Ryo/0000-0002-9328-5628	Japan Society for the Promotion of Science [22020006, 24710247, 24370061, 25650046]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research on Priority Areas (22020006 to RI), Young Scientists (B) (24710247 to RI), Scientific Research (B) (24370061 to TF) and Exploratory Research (25650046 to TF) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhushan S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000581; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; Contreras-Martinez LM, 2007, J MOL BIOL, V372, P513, DOI 10.1016/j.jmb.2007.06.070; Cutler TA, 2007, J MOL BIOL, V371, P308, DOI 10.1016/j.jmb.2007.05.077; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Iizuka R, 2011, METHODS MOL BIOL, V778, P215, DOI 10.1007/978-1-61779-261-8_14; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Ito K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028413; Jha SS, 2012, JOVE-J VIS EXP, V64, pe4027; Lawrence MG, 2008, J BACTERIOL, V190, P5862, DOI 10.1128/JB.00632-08; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Matsuura T, 2003, FEBS LETT, V539, P24, DOI 10.1016/S0014-5793(03)00178-9; Matsuura T, 2007, BIOCHEM BIOPH RES CO, V352, P372, DOI 10.1016/j.bbrc.2006.11.050; McNicholas P, 1997, J MOL BIOL, V265, P128, DOI 10.1006/jmbi.1996.0723; Mills BM, 2011, BIOPHYS J, V100, P756, DOI 10.1016/j.bpj.2010.12.3710; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakamori K, 2014, FEBS LETT, V588, P3098, DOI 10.1016/j.febslet.2014.06.038; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Ohana RF, 2009, PROTEIN EXPRES PURIF, V68, P110, DOI 10.1016/j.pep.2009.05.010; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Oliver D, 1998, J BACTERIOL, V180, P5240, DOI 10.1128/JB.180.19.5240-5242.1998; Osada E, 2009, J BIOCHEM, V145, P693, DOI 10.1093/jb/mvp027; Rutkowska A, 2009, FEBS LETT, V583, P2407, DOI 10.1016/j.febslet.2009.06.041; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Tsai A, 2014, CELL REP, V7, P1521, DOI 10.1016/j.celrep.2014.04.033; Uemura S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn338; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yap MN, 2009, MOL CELL, V34, P201, DOI 10.1016/j.molcel.2009.04.002	35	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122017	10.1371/journal.pone.0122017	http://dx.doi.org/10.1371/journal.pone.0122017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806953	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000197
J	Zhang, ZX; He, F; Constantine, R; Baker, ML; Baehr, W; Schmid, MF; Wensel, TG; Agosto, MA				Zhang, Zhixian; He, Feng; Constantine, Ryan; Baker, Matthew L.; Baehr, Wolfgang; Schmid, Michael F.; Wensel, Theodore G.; Agosto, Melina A.			Domain Organization and Conformational Plasticity of the G Protein Effector, PDE6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD CGMP-PHOSPHODIESTERASE; CYCLIC-GMP PHOSPHODIESTERASE; INHIBITORY GAMMA-SUBUNIT; OUTER SEGMENT PHOSPHODIESTERASE; PHOTORECEPTOR PHOSPHODIESTERASE; CATALYTIC SUBUNITS; GAF DOMAINS; STRUCTURAL BASIS; BINDING-PROTEIN; DELTA-SUBUNIT	The cGMP phosphodiesterase of rod photoreceptor cells, PDE6, is the key effector enzyme in phototransduction. Two large catalytic subunits, PDE6 alpha and -beta, each contain one catalytic domain and two non-catalytic GAF domains, whereas two small inhibitory PDE6 gamma subunits allow tight regulation by the G protein transducin. The structure of holo-PDE6 in complex with the ROS-1 antibody Fab fragment was determined by cryoelectron microscopy. The similar to 11 angstrom map revealed previously unseen features of PDE6, and each domain was readily fit with high resolution structures. A structure of PDE6 in complex with prenyl-binding protein ( PrBP/delta) indicated the location of the PDE6 C-terminal prenylations. Reconstructions of complexes with Fab fragments bound to N or C termini of PDE6 gamma revealed that PDE6 gamma stretches from the catalytic domain at one end of the holoenzyme to the GAF-A domain at the other. Removal of PDE6 gamma caused dramatic structural rearrangements, which were reversed upon its restoration.	[Zhang, Zhixian; He, Feng; Baker, Matthew L.; Schmid, Michael F.; Wensel, Theodore G.; Agosto, Melina A.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Constantine, Ryan; Baehr, Wolfgang] Univ Utah, Dept Ophthalmol, Moran Eye Ctr, Salt Lake City, UT 84132 USA	Baylor College of Medicine; Utah System of Higher Education; University of Utah	Wensel, TG (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA.	twensel@bcm.edu	Regan, Clinton/E-6250-2012	Wensel, Theodore/0000-0003-3518-9352; Agosto, Melina/0000-0002-3647-1926; Schmid, Michael/0000-0003-1077-5750	National Institutes of Health [R01-EY07981, R01-EY008123, P41-GM103832, P41-RR002250]; Welch Foundation [Q-0035]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250, P41RR001081] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007981, R01EY008123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311, P41GM103832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-EY07981 (to T. G. W.), R01-EY008123 (to W. B.), P41-GM103832, and P41-RR002250. This work was also supported by the Welch Foundation, Q-0035.	ANANT JS, 1992, J BIOL CHEM, V267, P687; ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; BROWN RL, 1989, P NATL ACAD SCI USA, V86, P4922, DOI 10.1073/pnas.86.13.4922; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; CATTY P, 1991, EUR J BIOCHEM, V199, P263, DOI 10.1111/j.1432-1033.1991.tb16119.x; CATTY P, 1992, J BIOL CHEM, V267, P19489; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cook TA, 2000, BIOCHEMISTRY-US, V39, P13516, DOI 10.1021/bi001070l; Cote Rick H., 2005, V307, P141; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; Francis SH, 2001, PROG NUCLEIC ACID RE, V65, P1; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky AE, 2000, J BIOL CHEM, V275, P41258, DOI 10.1074/jbc.M008094200; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2010, J BIOL CHEM, V285, P15209, DOI 10.1074/jbc.M109.086116; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; He F, 2004, J BIOL CHEM, V279, P8986, DOI 10.1074/jbc.M311488200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; HURWITZ RL, 1984, J BIOL CHEM, V259, P8612; HURWITZ RL, 1984, ADV CYCLIC NUCL PROT, V17, P239; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; Kajimura N, 2002, J STRUCT BIOL, V139, P27, DOI 10.1016/S1047-8477(02)00502-6; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; LEE RH, 1985, INVEST OPHTH VIS SCI, V26, P1569; LIEBMAN PA, 1982, VISION RES, V22, P1475, DOI 10.1016/0042-6989(82)90212-7; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; Litman BJ, 2001, J MOL NEUROSCI, V16, P237, DOI 10.1385/JMN:16:2-3:237; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MALINSKI JA, 1992, BIOCHEMISTRY-US, V31, P9502, DOI 10.1021/bi00154a024; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez SE, 2008, J BIOL CHEM, V283, P25913, DOI 10.1074/jbc.M802891200; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; MILLER JL, 1987, BIOCHIM BIOPHYS ACTA, V898, P81, DOI 10.1016/0005-2736(87)90111-8; Mitchell DC, 2003, J PEDIATR-US, V143, pS80, DOI 10.1067/S0022-3476(03)00405-0; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schmid MF, 2008, J STRUCT BIOL, V161, P243, DOI 10.1016/j.jsb.2007.09.018; SITARAMAYYA A, 1986, BIOCHEMISTRY-US, V25, P651, DOI 10.1021/bi00351a021; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Trakhanov S, 1999, ACTA CRYSTALLOGR D, V55, P122, DOI 10.1107/S090744499800938X; Walz J, 1997, J STRUCT BIOL, V120, P387, DOI 10.1006/jsbi.1997.3934; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; Wensel Theodore G., 2005, V307, P289; Yamazaki M, 2002, J BIOL CHEM, V277, P40675, DOI 10.1074/jbc.M203469200; Zeng-Elmore X, 2014, J MOL BIOL, V426, P3713, DOI 10.1016/j.jmb.2014.07.033; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406	64	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12833	12843		10.1074/jbc.M115.647636	http://dx.doi.org/10.1074/jbc.M115.647636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25809480	hybrid, Green Published			2022-12-26	WOS:000354569000034
J	Cursino, L; Athinuwat, D; Patel, KR; Galvani, CD; Zaini, PA; Li, YX; De la Fuente, L; Hoch, HC; Burr, TJ; Mowery, P				Cursino, Luciana; Athinuwat, Dusit; Patel, Kelly R.; Galvani, Cheryl D.; Zaini, Paulo A.; Li, Yaxin; De la Fuente, Leonardo; Hoch, Harvey C.; Burr, Thomas J.; Mowery, Patricia			Characterization of the Xylella fastidiosa PD1671 Gene Encoding Degenerate c-di-GMP GGDEF/EAL Domains, and Its Role in the Development of Pierce's Disease	PLOS ONE			English	Article							INTERVESSEL PIT MEMBRANES; AFFECT TWITCHING MOTILITY; BIOFILM FORMATION; PSEUDOMONAS-FLUORESCENS; IV PILI; REGULATORY PATHWAYS; SIGNAL-TRANSDUCTION; RESPONSE REGULATOR; PLANT VIRULENCE; EXPRESSION	Xylella fastidiosa is an important phytopathogenic bacterium that causes many serious plant diseases including Pierce's disease of grapevines. X. fastidiosa is thought to induce disease by colonizing and clogging xylem vessels through the formation of cell aggregates and bacterial biofilms. Here we examine the role in X. fastidiosa virulence of an uncharacterized gene, PD1671, annotated as a two-component response regulator with potential GGDEF and EAL domains. GGDEF domains are found in c-di-GMP diguanylate cyclases while EAL domains are found in phosphodiesterases, and these domains are for c-di-GMP production and turnover, respectively. Functional analysis of the PD1671 gene revealed that it affected multiple X. fastidiosa virulence-related phenotypes. A Tn5 PD1671 mutant had a hypervirulent phenotype in grapevines presumably due to enhanced expression of gum genes leading to increased exopolysaccharide levels that resulted in elevated biofilm formation. Interestingly, the PD1671 mutant also had decreased motility in vitro but did not show a reduced distribution in grapevines following inoculation. Given these responses, the putative PD1671 protein may be a negative regulator of X. fastidiosa virulence.	[Cursino, Luciana; Athinuwat, Dusit; Galvani, Cheryl D.; Zaini, Paulo A.; Li, Yaxin; De la Fuente, Leonardo; Hoch, Harvey C.; Burr, Thomas J.] Cornell Univ, New York State Agr Expt Stn, Dept Plant Pathol & Plant Microbe Biol, Geneva, NY 14456 USA; [Cursino, Luciana; Patel, Kelly R.; Galvani, Cheryl D.; Mowery, Patricia] Hobart & William Smith Coll Geneva, Dept Biol, New York, NY 14456 USA	Cornell University	Mowery, P (corresponding author), Hobart & William Smith Coll Geneva, Dept Biol, New York, NY 14456 USA.	mowery@hws.edu	De La Fuente, Leonardo/A-2012-2013	De La Fuente, Leonardo/0000-0002-0027-4840	University of California Pierce's Disease Research Grants Program [2010-287, SA7465]; Nanobiotechnology Center, an STC program of the National Science Foundation [ECS-304 9876771]	University of California Pierce's Disease Research Grants Program; Nanobiotechnology Center, an STC program of the National Science Foundation	Support was provided by the University of California Pierce's Disease Research Grants Program #2010-287 and #SA7465 to PM, HCH, and TJB [http://www.piercesdisease.org/grants/manage], and Nanobiotechnology Center, an STC program of the National Science Foundation, under agreement no. ECS-304 9876771 to HCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero CB, 2005, MOL PLANT PATHOL, V6, P43, DOI 10.1111/j.1364-3703.2004.00262.x; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Bourgault R, 2002, ANAL BIOCHEM, V300, P87, DOI 10.1006/abio.2001.5450; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Chatterjee S, 2008, P NATL ACAD SCI USA, V105, P2670, DOI 10.1073/pnas.0712236105; Chatterjee S, 2010, MOL PLANT MICROBE IN, V23, P1356, DOI 10.1094/MPMI-03-10-0057; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cursino L, 2011, MOL PLANT MICROBE IN, V24, P1198, DOI 10.1094/MPMI-10-10-0252; Cursino L, 2009, FEMS MICROBIOL LETT, V299, P193, DOI 10.1111/j.1574-6968.2009.01747.x; da Silva FR, 2001, FEMS MICROBIOL LETT, V203, P165, DOI 10.1111/j.1574-6968.2001.tb10836.x; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; DAVIS MJ, 1980, PHYTOPATHOLOGY, V70, P425, DOI 10.1094/Phyto-70-425; De La Fuente L, 2007, J BACTERIOL, V189, P7507, DOI 10.1128/JB.00934-07; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; de Souza AA, 2004, FEMS MICROBIOL LETT, V237, P341, DOI [10.1016/j.femsle.2004.06.055, 10.1111/j.1574-6968.2004.tb09716.x]; de Souza AA, 2003, MOL PLANT MICROBE IN, V16, P867, DOI 10.1094/MPMI.2003.16.10.867; de Souza AA, 2013, APPL ENVIRON MICROB, V79, P3444, DOI 10.1128/AEM.03834-12; Ellis EA, 2010, BOTANY, V88, P596, DOI 10.1139/B10-025; Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Guilhabert MR, 2001, MOL PLANT MICROBE IN, V14, P701, DOI 10.1094/MPMI.2001.14.6.701; Gupta K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015072; HILL BL, 1995, PHYTOPATHOLOGY, V85, P1368, DOI 10.1094/Phyto-85-1368; HOBBS M, 1993, MOL MICROBIOL, V7, P669, DOI 10.1111/j.1365-2958.1993.tb01158.x; HOPKINS DL, 1984, HORTSCIENCE, V19, P419; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katzen F, 1998, J BACTERIOL, V180, P1607, DOI 10.1128/JB.180.7.1607-1617.1998; Killiny N, 2013, MOL PLANT MICROBE IN, V26, P1044, DOI 10.1094/MPMI-09-12-0211-R; Kim SY, 2009, BIOTECHNOL LETT, V31, P265, DOI 10.1007/s10529-008-9858-3; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Levet-Paulo M, 2011, J BIOL CHEM, V286, P31136, DOI 10.1074/jbc.M111.231340; Li YX, 2007, MICROBIOL-SGM, V153, P719, DOI 10.1099/mic.0.2006/002311-0; Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Matsumoto A, 2012, MICROBIOLOGYOPEN, V1, P33, DOI 10.1002/mbo3.6; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Meng YZ, 2005, J BACTERIOL, V187, P5560, DOI 10.1128/JB.187.16.5560-5567.2005; MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Neto JFDS, 2008, ARCH MICROBIOL, V189, P249, DOI 10.1007/s00203-007-0314-x; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; Osterberg S, 2013, ENV MICROBIOL REP, V5, P556, DOI 10.1111/1758-2229.12045; Pashalidis S, 2005, OMICS, V9, P77, DOI 10.1089/omi.2005.9.77; Perez-Donoso AG, 2010, PLANT PHYSIOL, V152, P1748, DOI 10.1104/pp.109.148791; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Roper MC, 2007, APPL ENVIRON MICROB, V73, P7252, DOI 10.1128/AEM.00895-07; Roper MC, 2007, MOL PLANT MICROBE IN, V20, P411, DOI 10.1094/MPMI-20-4-0411; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; Scarpari LM, 2003, FEMS MICROBIOL LETT, V222, P83, DOI 10.1016/S0378-1097(03)00251-9; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Shi XY, 2007, APPL ENVIRON MICROB, V73, P6748, DOI 10.1128/AEM.01232-07; Shi XY, 2009, APPL ENVIRON MICROB, V75, P2275, DOI 10.1128/AEM.01964-08; Shi XY, 2010, FEMS MICROBIOL LETT, V304, P82, DOI 10.1111/j.1574-6968.2009.01885.x; Silva MS, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-58; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Sun QA, 2011, PLANT PHYSIOL, V155, P1976, DOI 10.1104/pp.110.168807; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200; Thowthampitak J, 2008, PHYTOPATHOLOGY, V98, P1252, DOI 10.1094/PHYTO-98-12-1252; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Varani AM, 2012, GENET MOL BIOL, V35, P149, DOI 10.1590/S1415-47572012005000019; Yang FH, 2014, MOL PLANT MICROBE IN, V27, P578, DOI 10.1094/MPMI-12-13-0371-R; Zaini PA, 2009, FEMS MICROBIOL LETT, V295, P129, DOI 10.1111/j.1574-6968.2009.01597.x	80	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121851	10.1371/journal.pone.0121851	http://dx.doi.org/10.1371/journal.pone.0121851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811864	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700150
J	Jhawar, S; Singh, P; Torres, D; Ramirez-Valle, F; Kassem, H; Banerjee, T; Dolgalev, I; Heguy, A; Zavadil, J; Lowenstein, J				Jhawar, Sachin; Singh, Prabhjot; Torres, Daniel; Ramirez-Valle, Francisco; Kassem, Hania; Banerjee, Trina; Dolgalev, Igor; Heguy, Adriana; Zavadil, Jiri; Lowenstein, Jerome			Functional Genomic Analysis Identifies Indoxyl Sulfate as a Major, Poorly Dialyzable Uremic Toxin in End-Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ORGANIC ANION TRANSPORTERS; RELATIVE CONTRIBUTION; GENE-EXPRESSION; ORAL ADSORBENT; DIALYSIS; PROTEIN; BINDING; INDUCTION; ADEQUACY	Background Chronic renal failure is characterized by progressive renal scarring and accelerated arteriosclerotic cardiovascular disease despite what is considered to be adequate hemodialysis or peritoneal dialysis. In rodents with reduced renal mass, renal scarring has been attributed to poorly filtered, small protein-bound molecules. The best studied of these is indoxyl sulfate (IS). Methods We have attempted to establish whether there are uremic toxins that are not effectively removed by hemodialysis. We examined plasma from patients undergoing hemodialysis, employing global gene expression in normal human renal cortical cells incubated in pre- and post-dialysis plasma as a reporter system. Responses in cells incubated with pre- and post-dialysis uremic plasma (n = 10) were compared with responses elicited by plasma from control subjects (n = 5). The effects of adding IS to control plasma and of adding probenecid to uremic plasma were examined. Plasma concentrations of IS were measured by HPLC (high pressure liquid chromatography). Results Gene expression in our reporter system revealed dysregulation of 1912 genes in cells incubated with pre-dialysis uremic plasma. In cells incubated in post-dialysis plasma, the expression of 537 of those genes returned to baseline but the majority of them (1375) remained dysregulated. IS concentration was markedly elevated in pre- and post-dialysis plasma. Addition of IS to control plasma simulated more than 80% of the effects of uremic plasma on gene expression; the addition of probenecid, an organic anion transport (OAT) inhibitor, to uremic plasma reversed the changes in gene expression. Conclusion These findings provide evidence that hemodialysis fails to effectively clear one or more solutes that effect gene expression, in our reporter system, from the plasma of patients with uremia. The finding that gene dysregulation was simulated by the addition of IS to control plasma and inhibited by addition of an OAT inhibitor to uremic plasma identifies IS as a major, poorly dialyzable, uremic toxin. The signaling pathways initiated by IS and possibly other solutes not effectively removed by dialysis may participate in the pathogenesis of renal scarring and uremic vasculopathy.	[Jhawar, Sachin; Singh, Prabhjot; Torres, Daniel; Kassem, Hania; Banerjee, Trina; Dolgalev, Igor; Heguy, Adriana; Zavadil, Jiri; Lowenstein, Jerome] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Ramirez-Valle, Francisco] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Heguy, Adriana; Zavadil, Jiri] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Heguy, Adriana; Zavadil, Jiri] NYU, Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA	New York University; NYU Langone Medical Center; University of California System; University of California San Francisco; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Lowenstein, J (corresponding author), NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	Jerome.Lowenstein@nyumc.org	Zavadil, Jiri/ABG-1780-2020; Jhawar, Sachin R/M-1587-2017; Heguy, Adriana/GPP-3907-2022; Dolgalev, Igor/AAY-6406-2020	Zavadil, Jiri/0000-0003-0640-5562; Jhawar, Sachin R/0000-0001-8604-4757; Dolgalev, Igor/0000-0003-4451-126X; Lowenstein, Jerome/0000-0002-2090-2015	National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000038]; NYU Genome Technology Center [NIH/NCI P30 CA016087-30]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NYU Genome Technology Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by grant UL1 TR000038 from the National Center for Advancing Translational Sciences, National Institutes of Health and NYU Genome Technology Center (supported in part by NIH/NCI P30 CA016087-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, USRDS 2013 ANN DAT R; Aoyama I, 2003, AM J KIDNEY DIS, V41, pS8, DOI 10.1053/ajkd.2003.50075; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; BOWMER CJ, 1982, BIOCHEM PHARMACOL, V31, P319, DOI 10.1016/0006-2952(82)90177-0; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhondt A, 2000, KIDNEY INT, V58, pS47, DOI 10.1046/j.1523-1755.2000.07606.x; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Ferrell N, 2010, BIOTECHNOL BIOENG, V107, P707, DOI 10.1002/bit.22835; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; GRANTHAM JJ, 1973, J CLIN INVEST, V52, P2441, DOI 10.1172/JCI107435; Hage FG, 2009, J AM COLL CARDIOL, V53, P2129, DOI 10.1016/j.jacc.2009.02.047; Himmelfarb J, 2006, CLIN J AM SOC NEPHRO, V1, P896, DOI 10.2215/CJN.10911105; Humes HD, 1999, KIDNEY INT, V55, P2502, DOI 10.1046/j.1523-1755.1999.00486.x; Iwasaki Y, 2011, THER APHER DIAL, V15, P151, DOI 10.1111/j.1744-9987.2010.00888.x; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Klammt S, 2012, NEPHROL DIAL TRANSPL, V27, P2377, DOI 10.1093/ndt/gfr616; KOLFF WJ, 1997, J AM SOC NEPHROL, V8, P1959; Lameire N, 2001, KIDNEY INT, V59, pS292, DOI 10.1046/j.1523-1755.2001.59780292.x; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Lowenstein J, 2012, KIDNEY INT, V82, P1033, DOI 10.1038/ki.2012.290; Lowenstein J, 2011, FASEB J, V25, P1781, DOI 10.1096/fj.11-0602ufm; Marquez IO, 2011, CLIN J AM SOC NEPHRO, V6, P290, DOI 10.2215/CJN.06100710; Masereeuw R, 2014, SEMIN NEPHROL, V34, P191, DOI 10.1016/j.semnephrol.2014.02.010; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Miyazaki T, 1997, KIDNEY INT, V52, pS15; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Niwa T, 1997, KIDNEY INT, V52, pS23; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Schulman G, 2006, AM J KIDNEY DIS, V47, P565, DOI 10.1053/j.ajkd.2005.12.036; SCRIBNER BH, 1960, T AM SOC ART INT ORG, V6, P88; Sekine T, 2006, AM J PHYSIOL-RENAL, V290, pF251, DOI 10.1152/ajprenal.00439.2004; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swann JR, 2011, J PROTEOME RES, V10, P3590, DOI 10.1021/pr200243t; Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Viaene L, 2013, BIOPHARM DRUG DISPOS, V34, P165, DOI 10.1002/bdd.1834; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610	45	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0118703	10.1371/journal.pone.0118703	http://dx.doi.org/10.1371/journal.pone.0118703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811877	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700006
J	Mu, Y; Liu, Y; Li, LW; Tian, C; Zhou, HY; Zhang, Q; Yan, B				Mu, Yan; Liu, Yin; Li, Liwen; Tian, Cong; Zhou, Hongyu; Zhang, Qiu; Yan, Bing			The Novel Tubulin Polymerization Inhibitor MHPT Exhibits Selective Anti-Tumor Activity against Rhabdomyosarcoma In Vitro and In Vivo	PLOS ONE			English	Article							CELL-CYCLE ARREST; THIAZOLIDINONE DERIVATIVES; INDUCED APOPTOSIS; P53 FUNCTION; CANCER; MECHANISMS; MICROTUBULES; TARGET; TAXOL; SENSITIZATION	The dose-limiting toxicity caused by standard chemotherapy has become a major roadblock to successful rhabdomyosarcoma chemotherapy. By screening a thiazolidinone library including 372 compounds, a novel synthetic compound, 2-((4-hydroxyphenyl)imino)-5-(3-methoxybenzylidene)thiazolidin-4-one (MHPT), was identified as a potent and selective anti-rhabdomyosarcoma agent. MHPT inhibited 50% of the growth of the rhabdomyosarcoma cell lines RD and SJ-RH30 at 0.44 mu M and 1.35 mu M, respectively, while displaying no obvious toxicity against normal human fibroblast cells at 100 mu M. Further investigation revealed that MHPT suppressed the polymerization of tubulin, leading to rhabdomyosarcoma cell growth arrest at the G2/M phase followed by apoptosis. In vivo, MHPT inhibited tumor growth by 48.6% relative to the vehicle control after 5 intraperitoneal injections of 40 mg/kg without appreciable toxicity to normal tissues and systems in an RD xenograft mouse model, while vincristine caused lethal toxicity when similar growth inhibition was achieved. As a moderate tubulin polymerization inhibitor compared with vincristine, MHPT requires a more dynamic tubulin to exert its cytotoxicity, which is a situation that only exists in cancer cells. This attribute may account for the low toxicity of MHPT in normal cells. Our data suggest that MHPT has the potential to be further developed into a selective anti-rhabdomyosarcoma drug with low toxicity.	[Mu, Yan; Liu, Yin; Li, Liwen; Tian, Cong; Zhou, Hongyu; Zhang, Qiu; Yan, Bing] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhang, Q (corresponding author), Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Shandong, Peoples R China.	zhangqiufcn@gmail.com; drbingyan@yahoo.com	ZHOU, HONGYU/E-7031-2011		National Natural Science Foundation of China [90913006, 20902054, 21307077]; Ministry of Education of China [20130131120007]; China Postdoctoral Science Foundation [2013M541920, 2014T70642]; Natural Science Foundation of Shandong Province [ZR2013BQ026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This research was supported by the National Natural Science Foundation of China (90913006, 20902054, and 21307077), Doctoral Fund of the Ministry of Education of China (20130131120007), China Postdoctoral Science Foundation funded project (2013M541920, 2014T70642) and Natural Science Foundation of Shandong Province (ZR2013BQ026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Arndt CAS, 2009, J CLIN ONCOL, V27, P5182, DOI 10.1200/JCO.2009.22.3768; Bacher G, 2001, CANCER RES, V61, P392; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Breitfeld PP, 2005, ONCOLOGIST, V10, P518, DOI 10.1634/theoncologist.10-7-518; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; CASEY EB, 1973, BRAIN, V96, P69, DOI 10.1093/brain/96.1.69; Catalano MG, 2007, ENDOCR-RELAT CANCER, V14, P839, DOI 10.1677/ERC-07-0096; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Dagher R, 1999, Oncologist, V4, P34; Dantonello TM, 2008, J CLIN ONCOL, V26, P406, DOI 10.1200/JCO.2007.12.2382; Diaconescu S, 2013, ROM J MORPHOL EMBRYO, V54, P531; Fan SJ, 1998, CLIN CANCER RES, V4, P1047; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Funhoff R, 2012, TOXICOL LETT, V211, pS113, DOI 10.1016/j.toxlet.2012.03.421; Groninger E, 2002, INT J ONCOL, V21, P1339; HARRISON SD, 1983, CANCER CHEMOTH PHARM, V11, P62; Hasinoff BB, 2008, MOL PHARMACOL, V74, P1722, DOI 10.1124/mol.108.050104; Hasinoff BB, 2010, TOXICOL APPL PHARM, V249, P132, DOI 10.1016/j.taap.2010.08.026; Jain AK, 2012, BIOORGAN MED CHEM, V20, P3378, DOI 10.1016/j.bmc.2012.03.069; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Klauber N, 1997, CANCER RES, V57, P81; Kullmann MK, 2013, CELL CYCLE, V12, P2625, DOI 10.4161/cc.25622; Kumar R, 2009, BRIT J CANCER, V101, P1717, DOI 10.1038/sj.bjc.6605366; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Morton CL, 2007, INVEST NEW DRUG, V25, P285, DOI 10.1007/s10637-007-9042-y; Moyer JD, 1997, CANCER RES, V57, P4838; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Oussenko IA, 2011, CANCER RES, V71, P4968, DOI 10.1158/0008-5472.CAN-10-1603; OWELLEN RJ, 1976, CANCER RES, V36, P1499; PARTHASARATHI G, 1994, J DRUG TARGET, V2, P173, DOI 10.3109/10611869409015907; Pellegrini F, 2005, CANCER INVEST, V23, P264, DOI 10.1081/CNV-200055970; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; RUYMANN FB, 1984, CANCER-AM CANCER SOC, V53, P368, DOI 10.1002/1097-0142(19840115)53:2<368::AID-CNCR2820530233>3.0.CO;2-3; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Wang JP, 2003, INT J PHARMACEUT, V251, P13, DOI 10.1016/S0378-5173(02)00580-X; Wong MY, 2011, NANOMED-NANOTECHNOL, V7, P834, DOI 10.1016/j.nano.2011.02.001; Zhang Q, 2013, BIOCHEM PHARMACOL, V86, P351, DOI 10.1016/j.bcp.2013.05.019; Zhou HY, 2008, J MED CHEM, V51, P1242, DOI 10.1021/jm7012024; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200	51	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121806	10.1371/journal.pone.0121806	http://dx.doi.org/10.1371/journal.pone.0121806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811876	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700141
J	Quinto, J; Marcos-Garcia, MD; Diaz-Castelazo, C; Rico-Gray, V; Galante, E; Mico, E				Quinto, Javier; de los Angeles Marcos-Garcia, Maria; Diaz-Castelazo, Cecilia; Rico-Gray, Victor; Galante, Eduardo; Mico, Estefania			Association Patterns in Saproxylic Insect Networks in Three Iberian Mediterranean Woodlands and Their Resistance to Microhabitat Loss	PLOS ONE			English	Article							ECOLOGICAL NETWORKS; BEETLE ASSEMBLAGES; DIVERSITY; NESTEDNESS; STABILITY; BIODIVERSITY; COMMUNITIES; ROBUSTNESS; FOREST; FACILITATION	The assessment of the relationship between species diversity, species interactions and environmental characteristics is indispensable for understanding network architecture and ecological distribution in complex networks. Saproxylic insect communities inhabiting tree hollow microhabitats within Mediterranean woodlands are highly dependent on woodland configuration and on microhabitat supply they harbor, so can be studied under the network analysis perspective. We assessed the differences in interacting patterns according to woodland site, and analysed the importance of functional species in modelling network architecture. We then evaluated their implications for saproxylic assemblages' persistence, through simulations of three possible scenarios of loss of tree hollow microhabitat. Tree hollow-saproxylic insect networks per woodland site presented a significant nested pattern. Those woodlands with higher complexity of tree individuals and tree hollow microhabitats also housed higher species/interactions diversity and complexity of saproxylic networks, and exhibited a higher degree of nestedness, suggesting that a higher woodland complexity positively influences saproxylic diversity and interaction complexity, thus determining higher degree of nestedness. Moreover, the number of insects acting as key interconnectors (nodes falling into the core region, using core/periphery tests) was similar among woodland sites, but the species identity varied on each. Such differences in insect core composition among woodland sites suggest the functional role they depict at woodland scale. Tree hollows acting as core corresponded with large tree hollows near the ground and simultaneously housing various breeding microsites, whereas core insects were species mediating relevant ecological interactions within saproxylic communities, e.g. predation, competitive or facilitation interactions. Differences in network patterns and tree hollow characteristics among woodland sites clearly defined different sensitivity to microhabitat loss, and higher saproxylic diversity and woodland complexity showed positive relation with robustness. These results highlight that woodland complexity goes hand in hand with biotic and ecological complexity of saproxylic networks, and together exhibited positive effects on network robustness.	[Quinto, Javier; de los Angeles Marcos-Garcia, Maria; Galante, Eduardo; Mico, Estefania] Univ Alicante, Ctr Iberoamer Biodiversidad CIBIO, E-03080 Alicante, Spain; [Diaz-Castelazo, Cecilia; Rico-Gray, Victor] Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico	Universitat d'Alacant; Instituto de Ecologia - Mexico	Quinto, J (corresponding author), Univ Alicante, Ctr Iberoamer Biodiversidad CIBIO, E-03080 Alicante, Spain.	javier.qnt@gmail.com	Díaz Castelazo, Cecilia/Q-8973-2018; Micó, Estefanía/H-1983-2015; Quinto, Javier/AAU-5098-2021; Galante, Eduardo/B-8619-2015; Marcos-Garcia, M. Angeles/H-7925-2015	Díaz Castelazo, Cecilia/0000-0002-0185-6607; Micó, Estefanía/0000-0002-7361-4770; Quinto, Javier/0000-0002-0774-5852; Galante, Eduardo/0000-0001-7935-6584; Marcos-Garcia, M. Angeles/0000-0002-2439-2630	 [I+D CGL2011-23658];  [CGL2012-31669]	; 	The research Projects I+D CGL2011-23658 y CGL2012-31669 of the Spanish Minister of Science provided economic support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KNA, 2008, REV ECOL-TERRE VIE, P9; Allesina S, 2009, PHILOS T R SOC B, V364, P1701, DOI 10.1098/rstb.2008.0214; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Borgatti S., 2002, UCINET WINDOWS SOFTW; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Bouget C, 2008, REV ECOL-TERRE VIE, P33; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Buse J, 2008, ZOOL MIDDLE EAST, V45, P55, DOI 10.1080/09397140.2008.10638307; Canseco V. Garcia, 1997, PARQUE NACL CABANERO, P95; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Carstensen DW, 2012, J BIOGEOGR, V39, P739, DOI 10.1111/j.1365-2699.2011.02628.x; Carstensen DW, 2009, J BIOGEOGR, V36, P1540, DOI 10.1111/j.1365-2699.2009.02098.x; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Marquitti FMD, 2014, ECOGRAPHY, V37, P221, DOI 10.1111/j.1600-0587.2013.00506.x; Dormann C.F., 2008, R NEWS, V8, P8; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dunne JA, 2009, PHILOS T R SOC B, V364, P1711, DOI 10.1098/rstb.2008.0219; Eklof A, 2006, J ANIM ECOL, V75, P239, DOI 10.1111/j.1365-2656.2006.01041.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Fortuna MA, 2009, ECOLOGY, V90, P934, DOI 10.1890/08-0174.1; Gouix N, 2012, BIODIVERS CONSERV, V21, P421, DOI 10.1007/s10531-011-0190-1; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2010, ECOLOGY, V91, P2941, DOI 10.1890/09-1175.1; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; Jiang L, 2009, AM NAT, V174, P651, DOI 10.1086/605961; Jonsson N., 2004, Animal Biodiversity and Conservation, V27, P79; Joppa LN, 2010, EVOL ECOL RES, V12, P35; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Marcos-Garcia M.A., 2013, INSECTOS SAPROX LICO, P123; Medan D, 2007, J THEOR BIOL, V246, P510, DOI 10.1016/j.jtbi.2006.12.033; Melian CJ, 2009, OIKOS, V118, P122, DOI 10.1111/j.1600-0706.2008.16751.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Mico E, 2011, J NAT HIST, V45, P2527, DOI 10.1080/00222933.2011.596953; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Piazzon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019637; Quinto J, 2014, J INSECT CONSERV, V18, P981, DOI 10.1007/s10841-014-9705-x; Quinto J, 2013, J INSECT CONSERV, V17, P765, DOI 10.1007/s10841-013-9559-7; Quinto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045062; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Sanchez-Galvan IR, 2014, ENVIRON ENTOMOL, V43, P336, DOI 10.1603/EN13075; Sirami C, 2008, REV ECOL-TERRE VIE, P101; Speight M.C.D., 1989, Council of Europe Nature and Environment Series, P1; Speight M.C.D., 2010, SYRPH NET DATABASE E, V61, P1; Stenbacka F, 2010, INSECT CONSERV DIVER, V3, P114, DOI 10.1111/j.1752-4598.2010.00082.x; Stokland JN, 2012, ECOL BIODIVERS CONS, P1; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Thebault E, 2013, J BIOGEOGR, V40, P759, DOI 10.1111/jbi.12015; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tylianakis JM, 2006, ECOLOGY, V87, P3047, DOI 10.1890/0012-9658(2006)87[3047:DEFASO]2.0.CO;2; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; Vacher C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001740; Verdu M, 2008, AM NAT, V172, P751, DOI 10.1086/593003; Winter S, 2008, FOREST ECOL MANAG, V255, P1251, DOI 10.1016/j.foreco.2007.10.029; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003	67	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122141	10.1371/journal.pone.0122141	http://dx.doi.org/10.1371/journal.pone.0122141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811197	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700171
J	Rancourt, RC; Schellong, K; Ott, R; Bogatyrev, S; Tzschentke, B; Plagemann, A				Rancourt, Rebecca C.; Schellong, Karen; Ott, Raffael; Bogatyrev, Semen; Tzschentke, Barbara; Plagemann, Andreas			Acquired Alterations of Hypothalamic Gene Expression of Insulin and Leptin Receptors and Glucose Transporters in Prenatally High-Glucose Exposed Three-Week Old Chickens Do Not Coincide with Aberrant Promoter DNA Methylation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NEUROPEPTIDE-Y; FOOD-INTAKE; ARCUATE NEURONS; PLASMA-GLUCOSE; OBESITY; NUCLEI; HYPERINSULINISM; MODEL; PROOPIOMELANOCORTIN	Background Prenatal exposures may have a distinct impact for long-term health, one example being exposure to maternal 'diabesity' during pregnancy increasing offspring 'diabesity' risk. Malprogramming of the central nervous regulation of body weight, food intake and metabolism has been identified as a critical mechanism. While concrete disrupting factors still remain unclear, growing focus on acquired epigenomic alterations have been proposed. Due to the independent development from the mother, the chicken embryo provides a valuable model to distinctively establish causal factors and mechanisms. Aim The aim of this study was to determine the effects of prenatal hyperglycemia on postnatal hypothalamic gene expression and promoter DNA methylation in the chicken. Methods and Findings To temporarily induce high-glucose exposure in chicken embryos, 0.5 ml glucose solution (30 mmol/l) were administered daily via catheter into a vessel of the chorioallantoic egg membrane from days 14 to 17 of incubation. At three weeks of postnatal age, body weight, total body fat, blood glucose, mRNA expression (INSR, LEPR, GLUT1, GLUT3) as well as corresponding promoter DNA methylation were determined in mediobasal hypothalamic brain slices (Nucleus infundibuli hypothalami). Although no significant changes in morphometric and metabolic parameters were detected, strongly decreased mRNA expression occurred in all candidate genes. Surprisingly, however, no relevant alterations were observed in respective promoter methylation. Conclusion Prenatal hyperglycemia induces strong changes in later hypothalamic expression of INSR, LEPR, GLUT1, and GLUT3 mRNA. While the chicken provides an interesting approach for developmental malprogramming, the classical expression regulation via promoter methylation was not observed here. This may be due to alternative/interacting brain mechanisms or the thus far under-explored bird epigenome.	[Rancourt, Rebecca C.; Schellong, Karen; Ott, Raffael; Plagemann, Andreas] Charite, Campus Virchow Klinikum, Div Expt Obstet, Clin Obstet, D-13353 Berlin, Germany; [Bogatyrev, Semen; Tzschentke, Barbara] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Plagemann, A (corresponding author), Charite, Campus Virchow Klinikum, Div Expt Obstet, Clin Obstet, D-13353 Berlin, Germany.	andreas.plagemann@charite.de		Ott, Raffael/0000-0002-5178-1033; Rancourt, Rebecca/0000-0003-2696-7220	German Research Foundation (DFG) [PL 241/6-1, TZ 6/17-1, GRK 1208]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by grants from the German Research Foundation (DFG: PL 241/6-1, TZ 6/17-1, and GRK 1208). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS L, 1990, DIABETES METAB REV, V6, P147, DOI 10.1002/dmr.5610060303; Boswell Tim, 2005, Journal of Poultry Science, V42, P161, DOI 10.2141/jpsa.42.161; BUYSE J, 1990, REPROD NUTR DEV, V30, P683, DOI 10.1051/rnd:19900605; Byerly MS, 2010, PHYSIOL GENOMICS, V42, P157, DOI 10.1152/physiolgenomics.00029.2010; Cassy S, 2004, DOMEST ANIM ENDOCRIN, V27, P51, DOI 10.1016/j.domaniend.2004.01.004; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Contreras C, 2014, CELL REP, V9, P366, DOI 10.1016/j.celrep.2014.08.057; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Davey MG, 2007, CYTOGENET GENOME RES, V117, P231, DOI 10.1159/000103184; Davidowa H, 2000, NEUROREPORT, V11, P2795, DOI 10.1097/00001756-200008210-00037; Davidowa H, 2006, EUR J NEUROSCI, V23, P1248, DOI 10.1111/j.1460-9568.2006.04636.x; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; De Groef B, 2008, MOL CELL ENDOCRINOL, V293, P17, DOI 10.1016/j.mce.2008.06.002; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; Derks NM, 2008, NEUROSCIENCE, V156, P305, DOI 10.1016/j.neuroscience.2008.07.047; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; Franke K, 2005, BRAIN RES, V1031, P276, DOI 10.1016/j.brainres.2004.11.006; Fresard L, 2014, NUCLEIC ACIDS RES, V42, P3768, DOI 10.1093/nar/gkt1390; Fresard L, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-16; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Hazelwood Robert L., 2000, P539, DOI 10.1016/B978-012747605-6/50021-3; Head JA, 2014, MOL ECOL RESOUR, V14, P943, DOI 10.1111/1755-0998.12244; Head JA, 2014, INTEGR COMP BIOL, V54, P77, DOI 10.1093/icb/icu025; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056411; Hutchinson DS, 2008, BRAIN RES BULL, V76, P224, DOI 10.1016/j.brainresbull.2008.02.019; Ka S, 2011, NEUROGENETICS, V12, P211, DOI 10.1007/s10048-011-0290-9; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kato H, 2000, BIOSCI BIOTECH BIOCH, V64, P903, DOI 10.1271/bbb.64.903; Kono T, 2005, BRIT POULTRY SCI, V46, P510, DOI 10.1080/00071660500181289; Kozlenkov A, 2014, NUCLEIC ACIDS RES, V42, P109, DOI 10.1093/nar/gkt838; KUENZEL WJ, 1982, J COMP NEUROL, V206, P293, DOI 10.1002/cne.902060309; Kuenzel WJ, 1998, STEREOTAXIC ATLAS BR; Landmann EM, 2012, NEUROSCI LETT, V515, P87, DOI 10.1016/j.neulet.2012.03.025; Levin BE, 2010, FRONT NEUROENDOCRIN, V31, P270, DOI 10.1016/j.yfrne.2010.02.005; Linder K, 2014, DIABETOLOGIA, V57, P1192, DOI 10.1007/s00125-014-3217-9; Liu XJ, 2007, DOMEST ANIM ENDOCRIN, V32, P155, DOI 10.1016/j.domaniend.2006.02.001; Lopez M, 2005, DIABETOLOGIA, V48, P140, DOI 10.1007/s00125-004-1596-z; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; McCrimmon RJ, 2004, DIABETES, V53, P1953, DOI 10.2337/diabetes.53.8.1953; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; METZGER BE, 1980, DIABETES CARE, V3, P402, DOI 10.2337/diacare.3.3.402; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Miller RR, 2005, COMP BIOCHEM PHYS B, V141, P323, DOI 10.1016/j.cbpc.2005.04.008; Natt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096376; Newmyer BA, 2013, BEHAV BRAIN RES, V236, P327, DOI 10.1016/j.bbr.2012.08.015; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ohkubo T, 2008, J POULT SCI, V45, P233, DOI 10.2141/jpsa.45.233; Phillipps HR, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.162; Plagemann A, 1997, INT J OBESITY, V21, P451, DOI 10.1038/sj.ijo.0800429; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Plagemann A, 1998, NEUROREPORT, V9, P4069, DOI 10.1097/00001756-199812210-00012; Plagemann A, 1999, NEUROREPORT, V10, P3211, DOI 10.1097/00001756-199910190-00016; Plagemann A, 1999, DEV NEUROSCI-BASEL, V21, P58, DOI 10.1159/000017367; Plagemann A, 1999, INT J DEV NEUROSCI, V17, P37, DOI 10.1016/S0736-5748(98)00064-1; Plagemann A, 2011, EARLY HUM DEV, V87, P743, DOI 10.1016/j.earlhumdev.2011.08.018; Plagemann A, 2012, PERINATAL PROGRAMMING: THE STATE OF THE ART, P243; Plagemann A, 2012, BEST PRACT RES CL EN, V26, P641, DOI 10.1016/j.beem.2012.03.008; Plagemann A, 2010, J PERINAT MED, V38, P393, DOI [10.1515/JPM.2010.051, 10.1515/jpm.2010.051]; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Schellong K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078799; Schmidt I, 2000, PHYSIOL GENOMICS, V3, P113, DOI 10.1152/physiolgenomics.2000.3.2.113; Seki Y, 2003, GEN COMP ENDOCR, V133, P80, DOI 10.1016/S0016-6480(03)00145-X; Shiraishi JI, 2008, DOMEST ANIM ENDOCRIN, V34, P223, DOI 10.1016/j.domaniend.2007.05.002; Shiraishi J, 2011, NEUROSCI LETT, V491, P177, DOI 10.1016/j.neulet.2011.01.031; SILVERMAN BL, 1991, DIABETES, V40, P121, DOI 10.2337/diab.40.2.S121; SILVERMAN BL, 1993, ANN NY ACAD SCI, V699, P36, DOI 10.1111/j.1749-6632.1993.tb18835.x; Simon J., 1988, Leanness in domestic birds: genetic, metabolic and hormonal aspects., P258; SIMON J, 1982, J NUTR, V112, P1961, DOI 10.1093/jn/112.10.1961; SINSIGALLI NA, 1987, J NUTR, V117, P941, DOI 10.1093/jn/117.5.941; Smith ML, 2011, BEHAV BRAIN RES, V216, P719, DOI 10.1016/j.bbr.2010.08.021; Stevens A, 2010, ENDOCRINOLOGY, V151, P3652, DOI 10.1210/en.2010-0094; Sweazea KL, 2006, COMP BIOCHEM PHYS B, V144, P263, DOI 10.1016/j.cbpb.2005.12.027; TAOUIS M, 1993, GEN COMP ENDOCR, V89, P167, DOI 10.1006/gcen.1993.1020; Tzschentke B, 2006, WORLD POULTRY SCI J, V62, P626, DOI 10.1079/WPS2006117; Verberne AJM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00038; Woods SC, 2000, ANNU REV PSYCHOL, V51, P255, DOI 10.1146/annurev.psych.51.1.255; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817; Yossifoff M, 2008, EUR J NEUROSCI, V28, P2267, DOI 10.1111/j.1460-9568.2008.06532.x; Zhang W, 2013, PHYSIOL GENOMICS, V45, P1084, DOI 10.1152/physiolgenomics.00102.2013	82	6	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119213	10.1371/journal.pone.0119213	http://dx.doi.org/10.1371/journal.pone.0119213			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811618	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700012
J	Telford, WG; Shcherbakova, DM; Buschke, D; Hawley, TS; Verkhusha, VV				Telford, William G.; Shcherbakova, Daria M.; Buschke, David; Hawley, Teresa S.; Verkhusha, Vladislav V.			Multiparametric Flow Cytometry Using Near-Infrared Fluorescent Proteins Engineered from Bacterial Phytochromes	PLOS ONE			English	Article							IN-VIVO; RED; LASERS; YELLOW; ORANGE; GREEN	Engineering of fluorescent proteins (FPs) has followed a trend of achieving longer fluorescence wavelengths, with the ultimate goal of producing proteins with both excitation and emission in the near-infrared (NIR) region of the spectrum. Flow cytometers are now almost universally equipped with red lasers, and can now be equipped with NIR lasers as well. Most red-shifted FPs of the GFP-like family are maximally excited by orange lasers (590 to 610 nm) not commonly found on cytometers. This has changed with the development of the iRFP series of NIR FPs from the protein family of bacterial phytochromes. The shortest wavelength variants of this series, iRFP670 and iRFP682 showed maximal excitation with visible red lasers. The longer wavelength variants iRFP702, iRFP713 and iRFP720 could be optimally excited by NIR lasers ranging from 685 to 730 nm. Pairs of iRFPs could be detected simultaneously by using red and NIR lasers. Moreover, a novel spectral cytometry technique, which relies on spectral deconvolution rather than optical filters, allowed spectra of all five iRFPs to be analyzed simultaneously with no spectral overlap. Together, the combination of iRFPs with the advanced flow cytometry will allow to first image tissues expressing iRFPs deep in live animals and then quantify individual cell intensities and sort out the distinct primary cell subpopulations ex vivo.	[Telford, William G.] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Shcherbakova, Daria M.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Buschke, David] Sony Biotechnol Inc, San Jose, CA USA; [Hawley, Teresa S.] George Washington Univ, Flow Cytometry Core Facil, Washington, DC USA; [Verkhusha, Vladislav V.] Univ Helsinki, Fac Med, Dept Biochem & Dev Biol, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; George Washington University; University of Helsinki	Telford, WG (corresponding author), NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA.	telfordw@mail.nih.gov; vladislav.verkhusha@einstein.yu.edu	Verkhusha, Vladislav/AAU-7784-2020	Verkhusha, Vladislav/0000-0002-2083-8121	National Cancer Institute, National Institutes of Health; National Institutes of Health [GM073913, GM108579]; European Union [ERC-2013-ADG-340233]; Sony Biotechnology Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108579, R01GM073913] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Sony Biotechnology Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by intramural research funds from the National Cancer Institute, National Institutes of Health (WGT) and by grants GM073913 and GM108579 from the National Institutes of Health and ERC-2013-ADG-340233 from the European Union's FP7 program (VVV). Sony Biotechnology Inc. provided support in the form of salary for author DB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Filonov GS, 2013, CHEM BIOL, V20, P1078, DOI 10.1016/j.chembiol.2013.06.009; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Hawley TS, 2001, BIOTECHNIQUES, V30, P1028, DOI 10.2144/01305rr01; Hawley TS, 2001, STEM CELLS, V19, P118, DOI 10.1634/stemcells.19-2-118; Hoffman RA, 1987, CYTOMETRY SUPPL 1, V8, P103; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Kapoor V, 2008, CYTOM PART A, V73A, P570, DOI 10.1002/cyto.a.20563; Kapoor V, 2007, NAT METHODS, V4, P678, DOI 10.1038/nmeth0907-678; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Morozova KS, 2010, BIOPHYS J, V99, pL13, DOI 10.1016/j.bpj.2010.04.025; Piatkevich KD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3153; Piatkevich KD, 2013, SCI REP-UK, V3, DOI 10.1038/srep01847; Piatkevich KD, 2011, METHOD CELL BIOL, V102, P431, DOI 10.1016/B978-0-12-374912-3.00017-1; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHAPIRO HM, 1993, ANN NY ACAD SCI, V677, P155, DOI 10.1111/j.1749-6632.1993.tb38774.x; Shapiro HM, 2009, CURR PROTOCOL CYTOM, V49; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; Shcherbakova DM, 2012, ANGEW CHEM INT EDIT, V51, P10724, DOI 10.1002/anie.201200408; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Telford WG, 2009, CYTOM PART A, V75A, P1031, DOI 10.1002/cyto.a.20790	24	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122342	10.1371/journal.pone.0122342	http://dx.doi.org/10.1371/journal.pone.0122342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811854	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700185
J	Ding, XC; Wu, LY; Yan, C; Du, H				Ding, Xinchun; Wu, Lingyan; Yan, Cong; Du, Hong			Establishment of lal-/- Myeloid Lineage Cell Line That Resembles Myeloid-Derived Suppressive Cells	PLOS ONE			English	Article							LYSOSOMAL ACID LIPASE; LAL(-/-) MICE; INFLAMMATION; EXPRESSION; CANCER; MTOR; METABOLISM; OXIDATION; FISSION; FUSION	Myeloid-derived suppressor cells (MDSCs) in mouse are inflammatory cells that play critical roles in promoting cancer growth and metastasis by directly stimulating cancer cell proliferation and suppressing immune surveillance. In order to facilitate characterization of biochemical and cellular mechanisms of MDSCs, it is urgent to establish an "MDSC-like" cell line. By cross breeding of immortomouse (simian virus 40 large T antigen transgenic mice) with wild type and lysosomal acid lipase (LAL) knock-out (lal-/-) mice, we have established a wild type (HD1A) and a lal-/- (HD1B) myeloid cell lines. Compared with HD1 A cells, HD1B cells demonstrated many characteristics similar to lal-/- MDSCs. HD1B cells exhibited increased lysosomes around perinuclear areas, dysfunction of mitochondria skewing toward fission structure, damaged membrane potential, and increased ROS production. HD1B cells showed increased glycolytic metabolism during blockage of fatty acid metabolism to fuel the energy need. Similar to lal-/- MDSCs, the mTOR signal pathway in HD1B cells is overly activated. Rapamycin treatment of HD1B cells reduced ROS production and restored the mitochondrial membrane potential. HD1B cells showed much stronger immunosuppression on CD4(+) T cell proliferation and function in vitro, and enhanced cancer cells proliferation. Knockdown of mTOR with siRNA reduced the HD1B cell ability to immunosuppress T cells and stimulate cancer cell proliferation. Therefore, the HD1B myeloid cell line is an "MDSC-like" cell line that can be used as an alternative in vitro system to study how LAL controls various myeloid cell functions.	[Ding, Xinchun; Wu, Lingyan; Yan, Cong; Du, Hong] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Ding, Xinchun; Wu, Lingyan; Yan, Cong; Du, Hong] Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN 46202 USA; [Ding, Xinchun; Wu, Lingyan; Yan, Cong] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Yan, C (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	coyan@iupui.edu; hongdu@iupui.edu	Wu, Ling/GZN-2235-2022; ding, xinchun/P-5490-2017		National Institutes of Health [HL087001, CA138759, CA152099]; NATIONAL CANCER INSTITUTE [R01CA138759, P30CA082709, R01CA152099] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL087001 (to H.D.), and CA138759, CA152099 (to C.Y.).	Barbato DL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.404; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354; Ding XC, 2014, AM J PATHOL, V184, P397, DOI 10.1016/j.ajpath.2013.10.015; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2001, J LIPID RES, V42, P489; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kita T, 2009, J BIOCHEM, V146, P787, DOI 10.1093/jb/mvp124; Lian XM, 2005, AM J PATHOL, V167, P813, DOI 10.1016/S0002-9440(10)62053-6; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Poulain-Godefroy O, 2013, INT J TRYPTOPHAN RES, P29, DOI 10.4137/IJTR.S11717; Qu P, 2011, J IMMUNOL, V187, P3854, DOI 10.4049/jimmunol.1003358; Qu P, 2010, AM J PATHOL, V176, P2394, DOI 10.2353/ajpath.2010.091063; Qu P, 2009, AM J PATHOL, V174, P944, DOI 10.2353/ajpath.2009.080562; Qu P, 2009, J IMMUNOL, V182, P1648, DOI 10.4049/jimmunol.182.3.1648; Rothe G, 1997, ATHEROSCLEROSIS, V130, P215, DOI 10.1016/S0021-9150(97)06065-6; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yan C, 2014, WORLD J IMMUNOL, V27, P42; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327; Yan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030701; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu JP, 2013, J IMMUNOL, V190, P3783, DOI 10.4049/jimmunol.1201449; Zhao T, 2014, ONCOGENE; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121001	10.1371/journal.pone.0121001	http://dx.doi.org/10.1371/journal.pone.0121001			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807535	Green Published, gold			2022-12-26	WOS:000351880000122
J	Longwe, H; Jambo, KC; Phiri, KS; Mbeye, N; Gondwe, T; Hall, T; Tetteh, KKA; Drakeley, C; Mandala, WL				Longwe, Herbert; Jambo, Kondwani C.; Phiri, Kamija S.; Mbeye, Nyanyiwe; Gondwe, Thandile; Hall, Tom; Tetteh, Kevin K. A.; Drakeley, Chris; Mandala, Wilson L.			The Effect of Daily Co-Trimoxazole Prophylaxis on Natural Development of Antibody-Mediated Immunity against P. falciparum Malaria Infection in HIV-Exposed Uninfected Malawian Children	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PROTECTION; RESPONSES; TRANSMISSION; SALMONELLA; MORTALITY; ANTIGENS; MORBIDITY; EBA-175; BREADTH	Background and Objectives Cotrimoxazole prophylaxis, currently recommended in HIVexposed, uninfected (HEU) children as protection against opportunistic infections, also has some antimalarial efficacy. We determined whether daily cotrimoxazole prophylaxis affects the natural development of antibodymediated immunity to bloodstage Plasmodium falciparum malaria infection. Methods Using an enzymelinked immunosorbent assay, we measured antibodies to 8Plasmodium falciparum antigens (AMA1, MSP1(19), MSP3, PfSE, EBA175RII, GLURP R0, GLURP R2 and CSP) in serum samples from 33 HEU children and 31 HIVunexposed, uninfected (HUU) children, collected at 6, 12 and 18 months of age. Results Compared to HIVuninfected children, HEU children had significantly lower levels of specific IgG against AMA1 at 6 months (p = 0.001), MSP1(19) at 12 months (p = 0.041) and PfSE at 6 months (p = 0.038), 12 months (p = 0.0012) and 18 months (p = 0.0097). No differences in the IgG antibody responses against the rest of the antigens were observed between the two groups at all time points. The breadth of specificity of IgG response was reduced in HEU children compared to HUU children during the follow up period. Conclusions Co-trimoxazole prophylaxis seems to reduce IgG antibody responses to P. falciparum blood stage antigens, which could be as a result of a reduction in exposure of those children under this regime. Although antibody responses were regarded as markers of exposure in this study, further studies are required to establish whether these responses are correlated in any way to clinical immunity to malaria.	[Longwe, Herbert; Mandala, Wilson L.] Univ Malawi, Coll Med, Dept Basic Med Sci, Blantyre, Malawi; [Jambo, Kondwani C.; Mandala, Wilson L.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Phiri, Kamija S.] Univ Malawi, Coll Med, Trop Haematol Res Unit, Blantyre, Malawi; [Mbeye, Nyanyiwe; Gondwe, Thandile] Univ Malawi, Coll Med, Dept Publ Hlth, Blantyre, Malawi; [Hall, Tom; Tetteh, Kevin K. A.; Drakeley, Chris] London Sch Hyg & Trop Med, London WC1, England	University of Malawi; University of Malawi; University of Malawi; University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Mandala, WL (corresponding author), Univ Malawi, Coll Med, Dept Basic Med Sci, Blantyre, Malawi.	wmandala2002@gmail.com	Mbeye, Nyanyiwe/ABB-5991-2021; Tetteh, Kevin/GYQ-9704-2022	Tetteh, Kevin/0000-0003-2733-0037; Jambo, Kondwani/0000-0002-3195-2210; Mandala, Wilson/0000-0001-9386-9239; Phiri, Kamija/0000-0003-1753-2727; Hall, Tom/0000-0002-9001-6684	Malawi Health Research Capacity Strengthening Initiative (HRCSI); DFID; Wellcome Trust funded programme; HIV Research Trust UK; Consortium for Advanced Research Training in Africa (CARTA); Southern Africa Consortium for Research Excellence (SACORE); Wellcome Trust (UK) [087547/Z/08/Z]; Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York [B8606]; Ford Foundation [1100-0399]; Sida [54100029]; Bill and Melinda Gates Foundation [51228];  [191994]	Malawi Health Research Capacity Strengthening Initiative (HRCSI); DFID; Wellcome Trust funded programme(Wellcome Trust); HIV Research Trust UK; Consortium for Advanced Research Training in Africa (CARTA); Southern Africa Consortium for Research Excellence (SACORE); Wellcome Trust (UK)(Wellcome Trust); Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York; Ford Foundation; Sida; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); 	The study was funded by the Malawi Health Research Capacity Strengthening Initiative (HRCSI), a DFID and Wellcome Trust funded programme and the HIV Research Trust UK. Partially funded by Fellowship awards provided by the Consortium for Advanced Research Training in Africa (CARTA) and Southern Africa Consortium for Research Excellence (SACORE). CARTA has been funded by the Wellcome Trust (UK) (Grant No: 087547/Z/08/Z), the Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE), the Carnegie Corporation of New York (Grant No: B8606), the Ford Foundation (Grant No: 1100-0399), Google.org (Grant No: 191994), Sida (Grant No: 54100029) and the Bill and Melinda Gates Foundation (Grant No: 51228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Boulanger D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-363; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V64, P165, DOI 10.1016/0166-6851(94)90144-9; Bwakura-Dangarembizi M, 2014, NEW ENGL J MED, V370, P41, DOI 10.1056/NEJMoa1214901; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Dobano C, 2012, CLIN VACCINE IMMUNOL, V19, P157, DOI 10.1128/CVI.05523-11; Dodoo D, 1999, INFECT IMMUN, V67, P2131, DOI 10.1128/IAI.67.5.2131-2137.1999; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-108; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2008, J INFECT DEV COUNTR, V2, P438, DOI 10.3855/jidc.158; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Haeusler GM, 2013, ADV EXP MED BIOL, V764, P13, DOI 10.1007/978-1-4614-4726-9_2; Hamel MJ, 2005, AM J TROP MED HYG, V73, P609, DOI 10.4269/ajtmh.2005.73.609; HOLDER AA, 1982, J EXP MED, V156, P1528, DOI 10.1084/jem.156.5.1528; Ibison F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052939; Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100; Kastenmuller K, 2013, INFECT IMMUN, V81, P789, DOI 10.1128/IAI.01108-12; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Kusi KA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-103; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mbeye NM, 2014, TROP MED INT HEALTH, V19, P1057, DOI 10.1111/tmi.12352; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073624; Mugyenyi CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068304; Mulenga V, 2007, AIDS, V21, P77, DOI 10.1097/QAD.0b013e3280114ed7; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; Nyirenda TS, 2014, J INFECT DIS, V210, P56, DOI 10.1093/infdis/jiu045; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Okenu DMN, 2000, INFECT IMMUN, V68, P5559, DOI 10.1128/IAI.68.10.5559-5566.2000; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Persson KEM, 2010, ACTA TROP, V114, P138, DOI 10.1016/j.actatropica.2009.05.017; Proietti C, 2013, PARASITE IMMUNOL, V35, P164, DOI 10.1111/pim.12031; Rantala AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-269; Riley EM, 1999, IMMUNOL TODAY, V20, P228, DOI 10.1016/S0167-5699(99)01456-5; Rono J, 2013, CLIN INFECT DIS, V57, P1409, DOI 10.1093/cid/cit556; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; Tsai CW, 2009, MOL BIOCHEM PARASIT, V164, P45, DOI 10.1016/j.molbiopara.2008.11.006; WHO, 2012, WORLD MALARIA REPORT 2012, P1; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Wright GJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003943	53	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121643	10.1371/journal.pone.0121643	http://dx.doi.org/10.1371/journal.pone.0121643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807475	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000351880000169
J	Patterson, SD; Rossi, JM; Paweletz, KL; Fitzpatrick, VD; Begley, CG; Busse, L; Elliott, S; McCaffery, I				Patterson, Scott D.; Rossi, John M.; Paweletz, Katherine L.; Fitzpatrick, V. Dan; Begley, C. Glenn; Busse, Leigh; Elliott, Steve; McCaffery, Ian			Functional EpoR Pathway Utilization Is Not Detected in Primary Tumor Cells Isolated from Human Breast, Non-Small Cell Lung, Colorectal, and Ovarian Tumor Tissues	PLOS ONE			English	Article							ERYTHROPOIETIN RECEPTOR EXPRESSION; ACUTE KIDNEY INJURY; ELEVATION MYOCARDIAL-INFARCTION; PATIENTS RECEIVING CHEMOTHERAPY; CANCER-RELATED ANEMIA; QUALITY-OF-LIFE; DOUBLE-BLIND; DARBEPOETIN-ALPHA; PHASE-III; STIMULATING AGENTS	Several clinical trials in oncology have reported increased mortality or disease progression associated with erythropoiesis-stimulating agents. One hypothesis proposes that erythropoiesis-stimulating agents directly stimulate tumor proliferation and/or survival through cell-surface receptors. To test this hypothesis and examine if human tumors utilize the erythropoietin receptor pathway, the response of tumor cells to human recombinant erythropoietin was investigated in disaggregated tumor cells obtained from 186 patients with colorectal, breast, lung, ovarian, head and neck, and other tumors. A cocktail of well characterized tumor growth factors (EGF, HGF, and IGF-1) were analyzed in parallel as a positive control to determine whether freshly-isolated tumor cells were able to respond to growth factor activation ex vivo. Exposing tumor cells to the growth factor cocktail resulted in stimulation of survival and proliferation pathways as measured by an increase in phosphorylation of the downstream signaling proteins AKT and ERK. In contrast, no activation by human recombinant erythropoietin was observed in isolated tumor cells. Though tumor samples exhibited a broad range of cell-surface expression of EGFR, c-Met, and IGF-1R, no cell-surface erythropoietin receptor was detected in tumor cells from the 186 tumors examined (by flow cytometry or Western blot). Erythropoiesis-stimulating agents did not act directly upon isolated tumor cells to stimulate pathways known to promote proliferation or survival of human tumor cells isolated from primary and metastatic tumor tissues.	[Patterson, Scott D.] Amgen Inc, Dept Med Sci, Thousand Oaks, CA 91320 USA; [Rossi, John M.; Paweletz, Katherine L.; Fitzpatrick, V. Dan; Busse, Leigh; McCaffery, Ian] Amgen Inc, Dept Mol Sci, Thousand Oaks, CA 91320 USA; [Begley, C. Glenn; Elliott, Steve] Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen	Patterson, SD (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	scott.patterson@gilead.com		Patterson, Scott Donald/0000-0002-9840-4964				Abdelrahman M, 2004, SHOCK, V22, P63, DOI 10.1097/01.shk.00001276869.21260.9d; Acs G, 2001, CANCER RES, V61, P3561; [Anonymous], 2010, AR DARB ALF PACK INS; Arcasoy MO, 2002, LAB INVEST, V82, P911, DOI 10.1097/01.LAB.0000020415.72863.40; Bahlmann FH, 2009, CURR OPIN NEPHROL HY, V18, P15, DOI 10.1097/MNH.0b013e32831a9dde; Baker JE, 2007, J CARDIOVASC PHARM, V49, P337, DOI 10.1097/FJC.0b013e318040cf81; Binbrek AS, 2009, AM J CARDIOL, V104, P1035, DOI 10.1016/j.amjcard.2009.05.050; Blohmer J-U, 2004, ANN ONCOL, P15; Bohlius J, 2006, JNCI-J NATL CANCER I, V98, P708, DOI 10.1093/jnci/djj189; Brendt P, 2009, SHOCK, V31, P50, DOI 10.1097/SHK.0b013e31817c0188; BROUDY VC, 1991, BLOOD, V77, P2583, DOI 10.1182/blood.V77.12.2583.2583; Brown WM, 2007, STEM CELLS, V25, P718, DOI 10.1634/stemcells.2006-0687; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Cella D, 2003, ANN ONCOL, V14, P511, DOI 10.1093/annonc/mdg167; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Elliott S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068083; Elliott S, 2012, BIOL-TARGETS THER, V6, P163, DOI 10.2147/BTT.S32281; Elliott S, 2012, NEPHROL DIAL TRANSPL, V27, P2733, DOI 10.1093/ndt/gfr698; Elliott S, 2010, J IMMUNOL METHODS, V352, P126, DOI 10.1016/j.jim.2009.10.006; Endre ZH, 2010, KIDNEY INT, V77, P1020, DOI 10.1038/ki.2010.25; Ferrario M, 2011, INT J CARDIOL, V147, P124, DOI 10.1016/j.ijcard.2009.10.028; Glaspy J, 2010, BRIT J CANCER, V102, P301, DOI 10.1038/sj.bjc.6605498; Glaspy John A, 2008, J Natl Compr Canc Netw, V6, P565; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Groopman JE, 1999, JNCI-J NATL CANCER I, V91, P1616, DOI 10.1093/jnci/91.19.1616; Hadland BK, 2009, J CLIN ONCOL, V27, P4217, DOI 10.1200/JCO.2008.21.6945; Hardee ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000549; Hedenus M, 2003, BRIT J HAEMATOL, V122, P394, DOI 10.1046/j.1365-2141.2003.04448.x; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Jelkmann W, 2008, CRIT REV ONCOL HEMAT, V67, P39, DOI 10.1016/j.critrevonc.2008.03.006; Jeong JY, 2008, INT J CANCER, V122, P274, DOI 10.1002/ijc.23068; Kamar N, 2010, TRANSPL INT, V23, P277, DOI 10.1111/j.1432-2277.2009.00982.x; Katavetin P, 2007, KIDNEY INT, V72, pS10, DOI 10.1038/sj.ki.5002482; Kirkeby A, 2007, J NEUROSCI METH, V164, P50, DOI 10.1016/j.jneumeth.2007.03.026; KOMATSU N, 1993, BLOOD, V82, P456; Lai SY, 2005, ONCOGENE, V24, P4442, DOI 10.1038/sj.onc.1208635; Laugsch M, 2008, INT J CANCER, V122, P1005, DOI 10.1002/ijc.23201; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; Littlewood TJ, 2001, J CLIN ONCOL, V19, P2865, DOI 10.1200/JCO.2001.19.11.2865; Ludwig H, 2004, EUR J CANCER, V40, P2293, DOI 10.1016/j.ejca.2004.06.019; Miller CP, 2009, STEM CELLS, V27, P2353, DOI 10.1002/stem.156; Moebus V, 2007, J CLIN ONCOL, P25; Moon C, 2003, P NATL ACAD SCI USA, V100, P11612, DOI 10.1073/pnas.1930406100; Najjar SS, 2011, JAMA-J AM MED ASSOC, V305, P1863, DOI 10.1001/jama.2011.592; Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe; Ortho, 2010, PROCR EP ALF PACK IN; Osterborg A, 2007, EUR J CANCER, V43, P510, DOI 10.1016/j.ejca.2006.10.012; Park J, 2005, AM J KIDNEY DIS, V46, P791, DOI 10.1053/j.ajkd.2005.07.034; Parsa CJ, 2004, J BIOL CHEM, V279, P20655, DOI 10.1074/jbc.M314099200; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Salahudeen AK, 2008, AM J PHYSIOL-RENAL, V294, pF1354, DOI 10.1152/ajprenal.00131.2008; Satoh K, 2006, CIRCULATION, V113, P1442, DOI 10.1161/CIRCULATIONAHA.105.583732; SAWADA K, 1988, J CELL PHYSIOL, V137, P337, DOI 10.1002/jcp.1041370218; Sinclair AM, 2008, BRIT J CANCER, V98, P1059, DOI 10.1038/sj.bjc.6604220; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Song YR, 2009, AM J NEPHROL, V30, P253, DOI 10.1159/000223229; Spreer A, 2007, PEDIATR RES, V62, P680, DOI 10.1203/PDR.0b013e318159af7a; Springborg JB, 2007, ACTA NEUROCHIR, V149, P1089, DOI 10.1007/s00701-007-1284-z; Sturiale A, 2007, NEPHROL DIAL TRANSPL, V22, P1484, DOI 10.1093/ndt/gfl769; Swift S, 2010, BLOOD, V115, P4254, DOI 10.1182/blood-2009-10-248674; Takeshita A, 2000, BRIT J HAEMATOL, V108, P55, DOI 10.1046/j.1365-2141.2000.01828.x; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; THOMA SJ, 1994, BLOOD, V83, P2103; Vansteenkiste J, 2002, J NATL CANCER I, V94, P1211; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Voors AA, 2010, EUR HEART J, V31, P2593, DOI 10.1093/eurheartj/ehq304; Westphal G, 2002, TUMORI, V88, P150, DOI 10.1177/030089160208800214; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; Witzig TE, 2005, J CLIN ONCOL, V23, P2606, DOI 10.1200/JCO.2004.10.020; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060	75	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122149	10.1371/journal.pone.0122149	http://dx.doi.org/10.1371/journal.pone.0122149			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807104	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000206
J	Stockham, S; Stamford, JE; Roberts, CT; Fitzsimmons, TR; Marchant, C; Bartold, PM; Zilm, PS				Stockham, Sara; Stamford, Justine E.; Roberts, Claire T.; Fitzsimmons, Tracy R.; Marchant, Ceilidh; Bartold, P. Mark; Zilm, Peter S.			Abnormal Pregnancy Outcomes in Mice Using an Induced Periodontitis Model and the Haematogenous Migration of Fusobacterium nucleatum Sub-Species to the Murine Placenta	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PORPHYROMONAS-GINGIVALIS INFECTION; RANDOMIZED-CONTROLLED-TRIAL; PRETERM BIRTH; ORAL BACTERIA; BONE LOSS; GENOME SEQUENCE; HOST RESPONSE; RISK-FACTOR; GROWTH PH	Objectives To investigate if there is subspecies specific migration to the placenta by Fusobacterium nucleatum (Fn) and to determine whether experimentally induced periodontitis results in adverse pregnancy outcomes (APO) in mice. Methods Periodontitis was induced in pregnant mice using an inoculum of Fn and Porphyromonas gingivalis. In parallel, four sub-species of Fn were individually injected into the circulatory system. At day 18 of gestation, the placenta, liver, spleen and blood were harvested and litter size, number of viable fetuses and resorptions, maternal, fetal and placenta weights were recorded. For the direct inoculation group, some mice were allowed to deliver for assessment of length of gestation, litter size, maternal, placental and pup weight. The presence of Fn was assessed by PCR and inflammatory mediators were measured by ELISA or multiplex analysis. Results Mice with alveolar bone loss, a marker of periodontitis, demonstrated significantly higher fetal weights (p = 0.015) and fetal/placental weight ratios (p = 0.030). PCR analysis of maternal organs did not identify Fn in any extracted tissues. In mice that received direct injection of Fn subspecies, varying degrees of APO were observed including preterm birth, intrauterine growth restriction, and fetal loss. Haematogenous spread of only Fn subsp. nucleatum to the placenta was confirmed. Litter size was significantly smaller (p = 0.023) and the number of resorptions was higher in inoculated versus control groups. Mice injected with subsp. nucleatum had significantly increased circulating CRP levels (p = 0.020) compared to controls while the mice with induced periodontitis had increased levels of IL-6 (p = 0.047) and IL-8 (p = 0.105). Conclusions Periodontitis in mice elevated fetal weight and the fetal weight/placental weight ratio. This study found that subsp. nucleatum migrated haematogenously to the placenta, leading to APO in mice. The study supports the potential role of Fn in the association between periodontitis and APO.	[Stockham, Sara; Stamford, Justine E.; Zilm, Peter S.] Univ Adelaide, Sch Dent, Oral Microbiol, Adelaide, SA, Australia; [Roberts, Claire T.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Fitzsimmons, Tracy R.; Marchant, Ceilidh; Bartold, P. Mark] Univ Adelaide, Sch Dent, Colgate Australian Clin Dent Res Ctr, Adelaide, SA, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide	Zilm, PS (corresponding author), Univ Adelaide, Sch Dent, Oral Microbiol, Adelaide, SA, Australia.	peter.zilm@adelaide.edu.au	Bartold, Mark/H-8122-2019	Marchant, Ceilidh/0000-0001-6615-8669; Zilm, Peter/0000-0001-7554-9717; Roberts, Claire/0000-0002-9250-2192; Bartold, Peter/0000-0002-5695-3877	Australian Dental Research Foundation	Australian Dental Research Foundation	Funding provided by Australian Dental Research Foundation, http://www.ada.org.au/about/adrf.aspx, PZ JS CR received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa CWJ, 2011, VIRULENCE, V2, P498, DOI 10.4161/viru.2.6.17719; Amano A, 2010, PERIODONTOL 2000, V52, P7, DOI 10.1111/j.1600-0757.2009.00328.x; Arce RM, 2009, PLACENTA, V30, P156, DOI 10.1016/j.placenta.2008.11.017; Australian Res Ctr Population Oral, 2009, AUST DENT J, V54, P390, DOI 10.1111/j.1834-7819.2009.01167.x; Baker PJ, 2000, INFECT IMMUN, V68, P5864, DOI 10.1128/IAI.68.10.5864-5868.2000; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman RE, 2007, PRETERM BIRTH CAUSES; Bendyk A, 2009, J PERIODONTAL RES, V44, P211, DOI 10.1111/j.1600-0765.2008.01108.x; Bobetsis YA, 2006, J AM DENT ASSOC, V137, p7S, DOI 10.14219/jada.archive.2006.0403; Carta G, 2004, Clin Exp Obstet Gynecol, V31, P47; Casey BM, 1997, OBSTET GYNECOL, V90, P869, DOI 10.1016/S0029-7844(97)00542-5; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chang PC, 2012, J DENT SCI, V7, P272, DOI 10.1016/j.jds.2012.02.002; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; COLLINS JG, 1994, INFECT IMMUN, V62, P4356, DOI 10.1128/IAI.62.10.4356-4361.1994; de Molon RS, 2014, J PERIODONTOL, V85, P465, DOI 10.1902/jop.2013.130225; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; DZINK JL, 1990, INT J SYST BACTERIOL, V40, P74, DOI 10.1099/00207713-40-1-74; Ebersole JL, 2010, CLIN EXP IMMUNOL, V162, P550, DOI 10.1111/j.1365-2249.2010.04202.x; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Fardini Y, 2010, INFECT IMMUN, V78, P1789, DOI 10.1128/IAI.01395-09; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; GHARBIA SE, 1992, INT J SYST BACTERIOL, V42, P296, DOI 10.1099/00207713-42-2-296; GHARBIA SE, 1990, ORAL MICROBIOL IMMUN, V5, P324, DOI 10.1111/j.1399-302X.1990.tb00434.x; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Gonzales-Mann C, 2012, J MED MICROBIOL; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Han YW, 2013, J DENT RES, V92, P485, DOI 10.1177/0022034513487559; Han YW, 2011, J DENT RES, V90, P289, DOI 10.1177/0022034510381905; Han YPW, 2010, OBSTET GYNECOL, V115, P442, DOI 10.1097/AOG.0b013e3181cb9955; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hill G B, 1998, Ann Periodontol, V3, P222, DOI 10.1902/annals.1998.3.1.222; Imada S, 2012, J OBSTET GYNAECOL RE, V38, P122, DOI 10.1111/j.1447-0756.2011.01641.x; Jeffcoat M, 2011, BJOG-INT J OBSTET GY, V118, P250, DOI 10.1111/j.1471-0528.2010.02713.x; Jeffcoat MK, 2001, J AM DENT ASSOC, V132, P875, DOI 10.14219/jada.archive.2001.0299; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Karpathy SE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000659; Keelan JA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.031; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kwik M, 2007, DIABETES RES CLIN PR, V77, P263, DOI 10.1016/j.diabres.2006.12.004; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085280; Lopez NJ, 2002, J PERIODONTOL, V73, P911, DOI 10.1902/jop.2002.73.8.911; Lopez NJ, 2002, J DENT RES, V81, P58, DOI 10.1177/154405910208100113; Macones GA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.892; Madianos PN, 2013, J CLIN PERIODONTOL, V40, pS170, DOI [10.1902/jop.2013.1340015, 10.1111/jcpe.12082]; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; Michelin MCAN, 2012, ORAL DIS, V18, P648, DOI 10.1111/j.1601-0825.2012.01917.x; Newnham JP, 2009, OBSTET GYNECOL, V114, P1239, DOI 10.1097/AOG.0b013e3181c15b40; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Offenbacher S, 2006, J PERIODONTOL, V77, P2011, DOI 10.1902/jop.2006.060047; Pitiphat W, 2005, AM J EPIDEMIOL, V162, P1108, DOI 10.1093/aje/kwi323; Polak D, 2009, J CLIN PERIODONTOL, V36, P406, DOI 10.1111/j.1600-051X.2009.01393.x; Prince AL, 2014, SEMIN REPROD MED, V32, P14, DOI 10.1055/s-0033-1361818; ROGERS AH, 1991, ORAL MICROBIOL IMMUN, V6, P250, DOI 10.1111/j.1399-302X.1991.tb00486.x; Oliveira AMSD, 2011, CLIN ORAL INVEST, V15, P609, DOI 10.1007/s00784-010-0424-8; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SPELLACY WN, 1985, OBSTET GYNECOL, V66, P158; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Tarannum F, 2007, J PERIODONTOL, V78, P2095, DOI 10.1902/jop.2007.060388; Temoin S, 2012, JCR-J CLIN RHEUMATOL, V18, P117, DOI 10.1097/RHU.0b013e3182500c95; Wang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056131; Xiong X, 2001, INT J GYNECOL OBSTET, V75, P221, DOI 10.1016/S0020-7292(01)00496-9; Xu MH, 2007, J BIOL CHEM, V282, P25000, DOI 10.1074/jbc.M611567200; Yeo A, 2005, J PERIODONTOL, V76, P551, DOI 10.1902/jop.2005.76.4.551; Zilm PS, 2007, ANAEROBE, V13, P146, DOI 10.1016/j.anaerobe.2007.04.005; Zilm PS, 2010, MICROBIOL-SGM, V156, P1783, DOI 10.1099/mic.0.035881-0	71	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120050	10.1371/journal.pone.0120050	http://dx.doi.org/10.1371/journal.pone.0120050			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806806	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000060
J	Singh, M; Shin, YK; Yang, XQ; Zehr, B; Chakrabarti, P; Kandror, KV				Singh, Maneet; Shin, Yu-Kyong; Yang, Xiaoqing; Zehr, Brad; Chakrabarti, Partha; Kandror, Konstantin V.			4E-BPs Control Fat Storage by Regulating the Expression of Egr1 and ATGL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; MAMMALIAN TARGET; TRANSLATION INITIATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS; LIPID HOMEOSTASIS; GENE-EXPRESSION; RESPONSE GENES	Early growth response transcription factor Egr1 controls multiple aspects of cell physiology and metabolism. In particular, Egr1 suppresses lipolysis and promotes fat accumulation in adipocytes by inhibiting the expression of adipose triglyceride lipase. According to current dogma, regulation of the Egr1 expression takes place primarily at the level of transcription. Correspondingly, treatment of cultured adipocytes with insulin stimulates expression of Egr1 mRNA and protein. Unexpectedly, the MEK inhibitor PD98059 completely blocks insulin-stimulated increase in the Egr1 mRNA but has only a moderate effect on the Egr1 protein. At the same time, mTORC1 inhibitors rapamycin and PP242 suppress expression of the Egr1 protein and have an opposite effect on the Egr1 mRNA. Mouse embryonic fibroblasts with genetic ablations of TSC2 or 4E-BP1/2 express less Egr1 mRNA but more Egr1 protein than wild type controls. S-35-labeling has confirmed that translation of the Egr1 mRNA is much more effective in 4E-BP1/2-null cells than in control. A selective agonist of the CB1 receptors, ACEA, up-regulates Egr1 mRNA, but does not activate mTORC1 and does not increase Egr1 protein in adipocytes. These data suggest that although insulin activates both the Erk and the mTORC1 signaling pathways in adipocytes, regulation of the Egr1 expression takes place predominantly via the mTORC1/4E-BP-mediated axis. In confirmation of this model, we show that 4E-BP1/2-null MEFs express less ATGL and accumulate more fat than control cells, while knock down of Egr1 in 4E-BP1/2-null MEFs increases ATGL expression and decreases fat storage.	[Singh, Maneet; Shin, Yu-Kyong; Yang, Xiaoqing; Zehr, Brad; Chakrabarti, Partha; Kandror, Konstantin V.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, K123D,715 Albany St, Boston, MA 02118 USA.	kkandror@bu.edu	Regan, Clinton/E-6250-2012	Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health [DK52057, AG039612]; American Diabetes Association [7-11-BS-76]; NIH [2T32DK007201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R56DK052057, T32DK007201, R01DK052057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Research Grants DK52057 and AG039612 from the National Institutes of Health, and Research Grant 7-11-BS-76 from the American Diabetes Association (to K. V. K.).; Supported by the institutional training grant 2T32DK007201 from the NIH.	ALEXANDERBRIDGES M, 1992, MOL CELL BIOCHEM, V109, P99; Aramburu J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005326; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Brand E, 2000, J MOL MED-JMM, V78, P81, DOI 10.1007/s001090000074; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Chakrabarti P, 2013, MOL CELL BIOL, V33, P3659, DOI 10.1128/MCB.01584-12; Chakrabarti P, 2010, DIABETES, V59, P775, DOI 10.2337/db09-1602; Csibi A, 2014, CURR BIOL, V24, P2274, DOI 10.1016/j.cub.2014.08.007; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Ge YJ, 2011, J BIOL CHEM, V286, P35675, DOI 10.1074/jbc.M111.262881; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gokey NG, 2011, J BIOL CHEM, V286, P29501, DOI 10.1074/jbc.M111.263509; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Muller I, 2012, ENDOCRINOLOGY, V153, P3040, DOI 10.1210/en.2012-1064; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Sartipy P, 2003, J BIOL CHEM, V278, P52298, DOI 10.1074/jbc.M306922200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Takeuchi K, 2001, J BIOL CHEM, V276, P26077, DOI 10.1074/jbc.M102704200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	19	19	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17331	17338		10.1074/jbc.M114.631895	http://dx.doi.org/10.1074/jbc.M114.631895			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25814662	Green Published, hybrid			2022-12-26	WOS:000357730900028
J	Gherasim, C; Ruetz, M; Li, Z; Hudolin, S; Banerjee, R				Gherasim, Carmen; Ruetz, Markus; Li, Zhu; Hudolin, Stephanie; Banerjee, Ruma			Pathogenic Mutations Differentially Affect the Catalytic Activities of the Human B-12-processing Chaperone CblC and Increase Futile Redox Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINED METHYLMALONIC ACIDURIA; B-12 TRAFFICKING CHAPERONE; GLUTATHIONE TRANSFERASES; VITAMIN-B-12 METABOLISM; DIRECTED MUTAGENESIS; HOMOCYSTINURIA CBLC; ARGININE RESIDUES; STRUCTURAL BASIS; COBALAMIN; MMACHC	Human CblC catalyzes the elimination of the upper axial ligand in cobalamin or B-12 derivatives entering the cell from circulation. This processing step is critical for assimilation of dietary cobalamin into the active cofactor forms that support the B-12-dependent enzymes, methionine synthase and methylmalonyl-CoA mutase. Using a modified nitroreductase scaffold tailored to bind cobalamin and glutathione, CblC exhibits versatility in the mechanism by which it removes cyano versus alkyl ligands in cobalamin. In this study, we have characterized the effects of two pathogenic missense mutations at the same residue, R161G and R161Q, which are associated with early and late onset of the CblC disorder, respectively. Wefind that the R161Q and R161G CblC mutants display lower protein stability and decreased dealkylation but not decyanation activity, suggesting that cyanocobalamin might be therapeutically useful for patients carrying mutations at Arg-161. The mutant proteins also exhibit impaired glutathione binding. In the presence of physiologically relevant glutathione concentrations, stabilization of the cob(II) alamin derivative is observed, which occurs at the expense of increased oxidation of glutathione. Futile redox cycling, which is suppressed in wild-type human CblC, explains the reported increase in oxidative stress levels associated with the CblC disorder.	[Gherasim, Carmen; Ruetz, Markus; Li, Zhu; Hudolin, Stephanie; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Regan, Clinton/E-6250-2012	Li, Zhu/0000-0003-1536-9401	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK45776 (to R. B.).	Andersson HC, 1998, J PEDIATR-US, V132, P121, DOI 10.1016/S0022-3476(98)70496-2; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; ARONOVITCH J, 1962, BIOCHEM BIOPH RES CO, V8, P416, DOI 10.1016/0006-291X(62)90288-7; Balagopalakrishna C, 1998, BIOCHEMISTRY-US, V37, P13194, DOI 10.1021/bi980941c; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2001, BIOCHEMISTRY-US, V40, P6191, DOI 10.1021/bi0104423; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BARTHOLOMEW DW, 1988, J PEDIATR-US, V112, P32, DOI 10.1016/S0022-3476(88)80114-8; Bommer M, 2014, SCIENCE, V346, P455, DOI 10.1126/science.1258118; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Froese DS, 2010, MOL GENET METAB, V100, P29, DOI 10.1016/j.ymgme.2010.02.005; Froese DS, 2009, MOL GENET METAB, V98, P338, DOI 10.1016/j.ymgme.2009.07.014; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gunduz M, 2014, EUR J PEDIATR, V173, P1707, DOI 10.1007/s00431-014-2330-6; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Jeong J, 2014, BIOCHEM BIOPH RES CO, V443, P173, DOI 10.1016/j.bbrc.2013.11.075; Jeong J, 2011, BMB REP, V44, P170, DOI 10.5483/BMBRep.2011.44.3.170; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; Li Z, 2014, J BIOL CHEM, V289, P16487, DOI 10.1074/jbc.M114.567339; Liu MY, 2010, J HUM GENET, V55, P621, DOI 10.1038/jhg.2010.81; Madej E, 2007, ARCH BIOCHEM BIOPHYS, V462, P94, DOI 10.1016/j.abb.2007.03.002; Mc Guire PJ, 2009, MOL GENET METAB, V98, P173, DOI 10.1016/j.ymgme.2009.06.007; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Pal A, 2001, CARCINOGENESIS, V22, P1301, DOI 10.1093/carcin/22.8.1301; Pastore A, 2014, J INHERIT METAB DIS, V37, P125, DOI 10.1007/s10545-013-9605-3; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; PEEL JL, 1962, J BIOL CHEM, V237, pP263; Ramasamy S, 2012, J PORPHYR PHTHALOCYA, V16, P25, DOI 10.1142/S1088424611004051; Richard E, 2009, HUM MUTAT, V30, P1558, DOI 10.1002/humu.21107; Rosenblatt DS, 1997, J INHERIT METAB DIS, V20, P528, DOI 10.1023/A:1005353530303; Ruetz M, 2013, ANGEW CHEM INT EDIT, V52, P2606, DOI 10.1002/anie.201209651; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; SCHRAUZER GN, 1969, ARCH BIOCHEM BIOPHYS, V130, P257, DOI 10.1016/0003-9861(69)90032-0; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; STENBERG G, 1991, BIOCHEM J, V274, P549, DOI 10.1042/bj2740549; Suarez-Moreira E, 2009, J AM CHEM SOC, V131, P15078, DOI 10.1021/ja904670x; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; WANG RW, 1993, J BIOL CHEM, V268, P23981; Watkins D, 2012, J INHERIT METAB DIS, V35, P665, DOI 10.1007/s10545-011-9418-1; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Yamanishi M, 2005, J AM CHEM SOC, V127, P526, DOI 10.1021/ja044365l; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022	50	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11393	11402		10.1074/jbc.M115.637132	http://dx.doi.org/10.1074/jbc.M115.637132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25809485	Green Published, hybrid			2022-12-26	WOS:000353719400016
J	Figeac, F; Dagouassat, M; Mahrouf-Yorgov, M; Le Gouvello, S; Trebeau, C; Sayed, A; Stern, JB; Validire, P; Dubois-Rande, JL; Boczkowski, J; Mus-Veteau, I; Rodriguez, AM				Figeac, Florence; Dagouassat, Maylis; Mahrouf-Yorgov, Meriem; Le Gouvello, Sabine; Trebeau, Celine; Sayed, Angeliqua; Stern, Jean-Baptiste; Validire, Pierre; Dubois-Rande, Jean-Luc; Boczkowski, Jorge; Mus-Veteau, Isabelle; Rodriguez, Anne-Marie			Lung Fibroblasts Share Mesenchymal Stem Cell Features Which Are Altered in Chronic Obstructive Pulmonary Disease via the Overactivation of the Hedgehog Signaling Pathway	PLOS ONE			English	Article							SONIC HEDGEHOG; CIGARETTE-SMOKE; STROMAL CELLS; BONE-MARROW; IN-VITRO; CHONDROGENIC DIFFERENTIATION; ADIPOGENIC DIFFERENTIATION; ENDOTHELIAL-CELLS; PROGENITOR CELLS; HUMAN SKIN	Background Alteration of functional regenerative properties of parenchymal lung fibroblasts is widely proposed as a pathogenic mechanism for chronic obstructive pulmonary disease (COPD). However, what these functions are and how they are impaired in COPD remain poorly understood. Apart from the role of fibroblasts in producing extracellular matrix, recent studies in organs different from the lung suggest that such cells might contribute to repair processes by acting like mesenchymal stem cells. In addition, several reports sustain that the Hedgehog pathway is altered in COPD patients thus aggravating the disease. Nevertheless, whether this pathway is dysregulated in COPD fibroblasts remains unknown. Objectives and Methods We investigated the stem cell features and the expression of Hedgehog components in human lung fibroblasts isolated from histologically-normal parenchymal tissue from 25 patients-8 non-smokers/ non-COPD, 8 smokers-non COPD and 9 smokers with COPD-who were undergoing surgery for lung tumor resection. Results We found that lung fibroblasts resemble mesenchymal stem cells in terms of cell surface marker expression, differentiation ability and immunosuppressive potential and that these properties were altered in lung fibroblasts from smokers and even more in COPD patients. Furthermore, we showed that some of these phenotypic changes can be explained by an over activation of the Hedgehog signaling in smoker and COPD fibroblasts. Conclusions Our study reveals that lung fibroblasts possess mesenchymal stem cell-features which are impaired in COPD via the contribution of an abnormal Hedgehog signaling. These processes should constitute a novel pathomechanism accounting for disease occurrence and progression.	[Figeac, Florence; Mahrouf-Yorgov, Meriem; Trebeau, Celine; Sayed, Angeliqua; Rodriguez, Anne-Marie] INSERM, Equipe 12, U955, F-94000 Creteil, France; [Dagouassat, Maylis; Le Gouvello, Sabine; Boczkowski, Jorge] INSERM, Equipe 4, U955, F-94000 Creteil, France; [Figeac, Florence; Dagouassat, Maylis; Mahrouf-Yorgov, Meriem; Le Gouvello, Sabine; Trebeau, Celine; Sayed, Angeliqua; Dubois-Rande, Jean-Luc; Boczkowski, Jorge; Rodriguez, Anne-Marie] Univ Paris Est, Fac Med, F-94000 Creteil, France; [Le Gouvello, Sabine] Hop Henri Mondor Chenevier, AP HP, Dept Hematol & Immunol Biol, F-94000 Creteil, France; [Stern, Jean-Baptiste] Inst Mutualiste Montsouris, Dept Thorac, Paris, France; [Validire, Pierre] Inst Mutualiste Montsouris, Dept Anatomopathol, Paris, France; [Dubois-Rande, Jean-Luc] Hop Henri Mondor Chenevier, AP HP, Serv Physiol Explorat Fonct, F-94000 Creteil, France; [Dubois-Rande, Jean-Luc] INSERM, U955, Equipe 3, F-94000 Creteil, France; [Boczkowski, Jorge] Hop Intercommunal Creteil, Serv Pneumol & Pathol Profess, F-94000 Creteil, France; [Mus-Veteau, Isabelle] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Mus-Veteau, Isabelle] Univ Nice Sophia Antipolis, F-06108 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Rodriguez, AM (corresponding author), INSERM, Equipe 12, U955, F-94000 Creteil, France.	anne-marie.rodriguez@inserm.fr	Dagouassat, Maylis/R-1837-2018; Rodriguez, Anne-Marie/M-1190-2018; Mus-veteau, Isabelle/M-8875-2016; Boczkowski, Jorge/S-7474-2018	Rodriguez, Anne-Marie/0000-0001-5557-8975; Mus-veteau, Isabelle/0000-0001-5739-7684; Boczkowski, Jorge/0000-0001-6619-5785; dagouassat, maylis/0000-0002-0903-9505; le gouvello, sabine/0000-0001-8147-2322; TREBEAU, Celine/0000-0001-6795-5379	CARESEN foundation; Association pour la Recherche et l'Etude des Maladies Cardiovasculaires (AREMCAR); Institut National de la Sante et de la Recherche (INSERM); Assistance Publique Hopitaux de Paris (Contrat Hospitalier de Recherche Translationnelle)	CARESEN foundation; Association pour la Recherche et l'Etude des Maladies Cardiovasculaires (AREMCAR); Institut National de la Sante et de la Recherche (INSERM); Assistance Publique Hopitaux de Paris (Contrat Hospitalier de Recherche Translationnelle)	This study was supported by grants from the CARESEN foundation, the Association pour la Recherche et l'Etude des Maladies Cardiovasculaires (AREMCAR for Anne-Marie Rodriguez), the Institut National de la Sante et de la Recherche (INSERM for Jorge Boczkowski and Anne-Marie Rodriguez) and the Assistance Publique Hopitaux de Paris (Contrat Hospitalier de Recherche Translationnelle for Jorge Boczkowski).	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Alt E, 2011, BIOL CELL, V103, P197, DOI 10.1042/BC20100117; Bermudez O, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063226, DOI 10.1371/J0URNAL.P0NE.0063226]; Bidet M, 2012, MOL CANCER RES, V10, P1496, DOI 10.1158/1541-7786.MCR-11-0578; Bidet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023834; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; Breslin L, 2014, CELL CYCLE, V13, P2773, DOI 10.4161/15384101.2015.945868; Cai JQ, 2012, CELL BIOL INT, V36, P349, DOI 10.1042/CBI20110284; Campioni D, 2009, CYTOM PART B-CLIN CY, V76B, P225, DOI 10.1002/cyto.b.20461; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303; Dagouassat M, 2013, AM J RESP CRIT CARE, V187, P703, DOI 10.1164/rccm.201208-1361OC; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Deslee G, 2010, AM J RESP CELL MOL, V43, P576, DOI 10.1165/rcmb.2009-0221OC; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Domenech M, 2012, INTEGR BIOL-UK, V4, P142, DOI 10.1039/c1ib00104c; Furmanski AL, 2013, J IMMUNOL, V190, P2641, DOI 10.4049/jimmunol.1202541; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Hennrick KT, 2007, AM J RESP CRIT CARE, V175, P1158, DOI 10.1164/rccm.200607-941OC; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Horn A, 2012, ARTHRITIS RHEUM-US, V64, P2724, DOI 10.1002/art.34444; Hu B, 2014, AM J RESP CELL MOL B; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jaager K, 2011, STEM CELLS DEV, V20, P1327, DOI 10.1089/scd.2010.0258; James AW, 2010, TISSUE ENG PT A, V16, P2605, DOI [10.1089/ten.tea.2010.0048, 10.1089/ten.TEA.2010.0048]; James AW, 2012, STEM CELLS DEV, V21, P2170, DOI 10.1089/scd.2011.0461; Jiang QS, 2013, MOL CELL BIOCHEM, V383, P85, DOI 10.1007/s11010-013-1757-9; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Li XC, 2012, BIOL PHARM BULL, V35, P1328, DOI 10.1248/bpb.b12-00265; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Lugli A, 2010, BRIT J CANCER, V103, P382, DOI 10.1038/sj.bjc.6605762; Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839; Myers BR, 2013, DEV CELL, V26, P346, DOI 10.1016/j.devcel.2013.07.015; NAKAMURA Y, 1995, AM J RESP CRIT CARE, V151, P1497, DOI 10.1164/ajrccm.151.5.7735606; Nicola T, 2011, AM J PHYSIOL-LUNG C, V301, pL125, DOI 10.1152/ajplung.00074.2011; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; PHIPPS RP, 1989, AM J RESP CELL MOL, V1, P65, DOI 10.1165/ajrcmb/1.1.65; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Plaisant M, 2009, STEM CELLS, V27, P703, DOI 10.1634/stemcells.2008-0888; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC; Serobyan N, 2005, BRIT J HAEMATOL, V129, P257, DOI 10.1111/j.1365-2141.2005.05446.x; Serobyan N, 2005, STEM CELLS DEV, V14, P81, DOI 10.1089/scd.2005.14.81; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Tokuhara T, 2006, CLIN CANCER RES, V12, P3971, DOI 10.1158/1078-0432.CCR-06-0338; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang HJ, 2003, AM J PHYSIOL-LUNG C, V284, pL205, DOI 10.1152/ajplung.00042.2002; Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006	60	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121579	10.1371/journal.pone.0121579	http://dx.doi.org/10.1371/journal.pone.0121579			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815884	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600106
J	Pang, XH; Luo, HJ; Chai, YC; Wang, XW; Sun, LH; He, LX; Chen, PH; Wu, H; Yang, T				Pang, Xiuhong; Luo, Huajie; Chai, Yongchuan; Wang, Xiaowen; Sun, Lianhua; He, Longxia; Chen, Penghui; Wu, Hao; Yang, Tao			A 1.6-Mb Microdeletion in Chromosome 17q22 Leads to NOG-Related Symphalangism Spectrum Disorder without Intellectual Disability	PLOS ONE			English	Article							DELETION DEL(17) Q21.3Q23; CONDUCTIVE HEARING-LOSS; SPEMANN ORGANIZER; EXPRESSION; MUTATIONS; GENE; PHENOTYPE; CELLS; DGKE; MICE	Microdeletions in chromosome 17q22, where the NOG gene resides, have been reported leading to the NOG-related symphalangism spectrum disorder (NOG-SSD), intellectual disability and other developmental abnormalities. In this study we reported a dominant Chinese Han family segregating with typical NOG-SSD symptoms including proximal symphalangism, conductive hearing loss, amblyopia and strabismus, but not intellectual disability. Sanger sequencing identified no pathogenic mutation in the coding regions of candidate genes NOG, GDF5 and FGF9. SNP genotyping in the genomic region surrounding NOG identified loss of heterozygosity in the affected family members. By array comparative genomic hybridization and quantitative real-time polymerase chain reaction, we identified and mapped the breakpoints of a novel 1.6-Mb microdeletion in chromosome 17q22 that included NOG and twelve other genes. It is the first microdeletion reported in chromosome 17q22 that is associated with NOG-SSD only but not with intellectual disability. Our results may help identifying the dosage sensitive genes for intellectual disability and other developmental abnormalities in chromosome 17q22. Our study also suggested that genomic deletions in chromosome 17q22 should be screened in the NOG-SSD patients in which no pathogenic mutation is identified by conventional sequencing methods.	[Pang, Xiuhong; Chai, Yongchuan; Wang, Xiaowen; Sun, Lianhua; He, Longxia; Chen, Penghui; Wu, Hao; Yang, Tao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Pang, Xiuhong; Chai, Yongchuan; Wang, Xiaowen; Sun, Lianhua; He, Longxia; Chen, Penghui; Wu, Hao; Yang, Tao] Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai, Peoples R China; [Pang, Xiuhong; Chai, Yongchuan; Wang, Xiaowen; Sun, Lianhua; He, Longxia; Chen, Penghui; Wu, Hao; Yang, Tao] Shanghai Key Lab Translat Med Ear & Nose Dis, Shanghai, Peoples R China; [Pang, Xiuhong] Taizhou Peoples Hosp, Dept Otorhinolaryngol Head & Neck Surg, Nanjing, Jiangsu, Peoples R China; [Luo, Huajie] Shanghai Jiao Tong Univ, Renji Hosp, Dept Otolaryngol, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wu, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.	wuhao622@sina.cn; yangtfxl@sina.com	Pang, Xiuhong/ABE-2751-2021	Yang, Tao/0000-0001-6011-987X	National Science Foundation of China [81222010, 81371101]; National Basic Research Program of China [2011CB504501]; Minister of Science and Technology of China [2012BAI09B02]; Shanghai Municipal Science and Technology Commission [14DZ2260300, 14DJ1400201, 15YF1407600]; Specialized Research Fund for the Doctoral Program of Higher Education [20130073110011]; Program for New Century Excellent Talents in University [NCET-13-0376]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Minister of Science and Technology of China; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by grants from National Science Foundation of China (81222010 and 81371101 to TY), National Basic Research Program of China (2011CB504501 to HW), Minister of Science and Technology of China (2012BAI09B02 to HW), Shanghai Municipal Science and Technology Commission (14DZ2260300 and 14DJ1400201 to HW, 15YF1407600 to YC), Specialized Research Fund for the Doctoral Program of Higher Education (20130073110011 to TY) and Program for New Century Excellent Talents in University (NCET-13-0376 to TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DALLAPICCOLA B, 1993, CLIN GENET, V43, P54, DOI 10.1111/j.1399-0004.1993.tb04452.x; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Hitzler JK, 1999, BRAIN RES, V820, P1, DOI 10.1016/S0006-8993(98)00999-8; Hwang CH, 2008, HUM MOL GENET, V17, P844, DOI 10.1093/hmg/ddm356; KHALIFA MM, 1993, CLIN GENET, V44, P258; Laurell T, 2013, EUR J HUM GENET, V21, P1085, DOI 10.1038/ejhg.2012.306; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; PARK JP, 1992, CLIN GENET, V41, P54; Puusepp H, 2009, EUR J MED GENET, V52, P71, DOI 10.1016/j.ejmg.2008.09.006; Quaggin SE, 2013, NAT GENET, V45, P475, DOI 10.1038/ng.2622; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Shimizu R, 2008, AM J MED GENET A, V146A, P1458, DOI 10.1002/ajmg.a.32319; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Usami S, 2012, CLIN GENET, V82, P514, DOI 10.1111/j.1399-0004.2011.01831.x; Wu XL, 2009, AM J HUM GENET, V85, P53, DOI 10.1016/j.ajhg.2009.06.007; Yang W, 2008, J HUM GENET, V53, P368, DOI 10.1007/s10038-008-0253-7; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	18	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120816	10.1371/journal.pone.0120816	http://dx.doi.org/10.1371/journal.pone.0120816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815513	Green Submitted, gold, Green Published			2022-12-26	WOS:000352133600048
J	Srikanthan, A; Ethier, JL; Ocana, A; Seruga, B; Krzyzanowska, MK; Amir, E				Srikanthan, Amirrtha; Ethier, Josee-Lyne; Ocana, Alberto; Seruga, Bostjan; Krzyzanowska, Monika K.; Amir, Eitan			Cardiovascular Toxicity of Multi-Tyrosine Kinase Inhibitors in Advanced Solid Tumors: A Population-Based Observational Study	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMOR; RANDOMIZED CONTROLLED-TRIALS; RENAL-CELL CARCINOMA; ADMINISTRATIVE DATA; BREAST-CANCER; SOCIOECONOMIC DISPARITIES; ANTICANCER DRUGS; HEART-FAILURE; MANAGEMENT; THERAPY	Background Treatment with small molecule tyrosine kinase inhibitors (TKIs) has improved survival in many cancers, yet has been associated with an increased risk of adverse events. Warnings of cardiovascular events are common in drug labels of many TKIs. Despite these warnings, cardiovascular toxicity of patients treated with TKIs remains unclear. Here, we evaluate the cardiovascular outcomes of advanced cancer patients treated with small molecule tyrosine kinase inhibitors. Methods A population based cohort study was undertaken involving adults aged >18 years in Ontario, Canada, diagnosed with any advanced malignancy between 2006 and 2012. Data were extracted from linked administrative governmental databases. Adults with advanced cancer receiving TKIs were identified and followed throughout the time period. The main outcomes of interest were rates of hospitalization for ischemic heart disease (acute myocardial infarction and angina) or cerebrovascular accidents and death. Results 1642 patients with a mean age of 62.5 years were studied; 1046 were treated with erlotinib, 166 with sorafenib and 430 with sunitinib. Over the 380 day median follow-up period (range 6-1970 days), 1.1% of all patients had ischemic heart events, 0.7% had cerebrovascular accidents and 72.1% died. Rates of cardiovascular events were similar to age and gender-matched individuals without cancer. In a subgroup analysis of treatment patients with a prior history of ischemic heart disease, 3.3% had ischemic heart events while 1.2% had cerebrovascular accidents. Conclusions TKIs do not appear to increase the cause-specific hazard of ischemic heart disease and cerebrovascular accidents compared to age and gender-matched individuals without advanced cancer.	[Srikanthan, Amirrtha; Ethier, Josee-Lyne; Krzyzanowska, Monika K.; Amir, Eitan] Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada; [Srikanthan, Amirrtha; Ethier, Josee-Lyne; Krzyzanowska, Monika K.; Amir, Eitan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Srikanthan, Amirrtha; Amir, Eitan] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Ocana, Alberto] Albacete Univ Hosp, Dept Med Oncol, Albacete, Spain; [Ocana, Alberto] Albacete Univ Hosp, Translat Res Unit, Albacete, Spain; [Seruga, Bostjan] Inst Oncol Ljubljana, Dept Med Oncol, Ljubljana, Slovenia	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Institute of Oncology - Slovenia	Amir, E (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada.	eitan.amir@uhn.ca	Amir, Eitan/L-6052-2019; Krzyzanowska, Monika K./ABG-3505-2020	Krzyzanowska, Monika K./0000-0001-5533-7418; Ocana, Alberto/0000-0002-1067-9630; Amir, Eitan/0000-0002-3706-525X	Cancer Care Ontario Systemic Therapy Program	Cancer Care Ontario Systemic Therapy Program	Funding was provided by the Cancer Care Ontario Systemic Therapy Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy APK, 2014, J CLIN ONCOLOGY OF S, V32; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Bayer HealthCare Pharmaceuticals Inc, 2013, NEX HIGHL PRESCR INF; Bertoluci MC, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-58; Broekman F, 2011, WORLD J CLIN ONCOL, V2, P80, DOI 10.5306/wjco.v2.i2.80; Cancer Care Ontario, 2014, CANC DRUGS FREQ ASK; Carver JR, 2007, J CLIN ONCOL, V25, P3991, DOI 10.1200/JCO.2007.10.9777; Chen Ming Hui, 2009, Curr Cardiol Rep, V11, P167; Cheng AYY, 2013, CAN J DIABETES, V37, pS1, DOI 10.1016/j.jcjd.2013.01.009; Clarke E A, 1991, IARC Sci Publ, P246; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Dienstmann R, 2011, ONCOLOGIST, V16, P1729, DOI 10.1634/theoncologist.2011-0163; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dy GK, 2013, CA-CANCER J CLIN, V63, P249, DOI 10.3322/caac.21184; Eschenhagen T, 2011, EUR J HEART FAIL, V13, P1, DOI 10.1093/eurjhf/hfq213; Genentech USA Inc, 2014, TARC HIGHL PRESCR IN; George S, 2012, ANN ONCOL, V23, P3180, DOI 10.1093/annonc/mds179; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Government of Canada, 2013, POP YEAR PROV TERR 2; Heart and Stroke Foundation, 2014, STAT HEART DIS 2014; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Khakoo AY, 2008, NAT CLIN PRACT ONCOL, V5, P655, DOI 10.1038/ncponc1225; Kim TD, 2012, HAEMATOL-HEMATOL J, V97, P883, DOI 10.3324/haematol.2011.058776; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lenihan DJ, 2008, J CLIN ONCOL, V26, P5154, DOI 10.1200/JCO.2008.18.5439; Lenihan DJ, 2013, ONCOLOGIST, V18, P900, DOI 10.1634/theoncologist.2012-0466; Levitzki A, 2013, ANNU REV PHARMACOL, V53, P161, DOI 10.1146/annurev-pharmtox-011112-140341; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; London G, 2011, KIDNEY INT SUPPL, V1, P10, DOI 10.1038/kisup.2011.5; Maitland ML, 2010, JNCI-J NATL CANCER I, V102, P596, DOI 10.1093/jnci/djq091; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Niraula S, 2012, J CLIN ONCOL, V30, P3012, DOI 10.1200/JCO.2011.40.3824; Ocana A, 2011, J CLIN ONCOL, V29, P1099, DOI 10.1200/JCO.2010.33.1462; Ontario Ministry of Health and Long-Term Care, 2013, ONT PUBL DRUG PROGR; Pfizer Inc, 2013, SUT HIGHL PRESCR INF; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Reames BN, 2014, JAMA SURG, V149, P475, DOI 10.1001/jamasurg.2013.5076; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; Schmidinger M, 2008, J CLIN ONCOL, V26, P5204, DOI 10.1200/JCO.2007.15.6331; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; Shariff-Marco S, 2014, CANCER EPIDEM BIOMAR, V23, P793, DOI 10.1158/1055-9965.EPI-13-0924; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sherbenou DW, 2007, J CLIN INVEST, V117, P2067, DOI 10.1172/JCI31988; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Steeghs N, 2007, ANN SURG ONCOL, V14, P942, DOI 10.1245/s10434-006-9227-1; Steingart RM, 2013, SEMIN ONCOL, V40, P690, DOI 10.1053/j.seminoncol.2013.09.010; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Strevel EL, 2007, J CLIN ONCOL, V25, P3362, DOI 10.1200/JCO.2006.09.6925; Suter TM, 2013, EUR HEART J, V34, P1102, DOI 10.1093/eurheartj/ehs181; Tao L, 2014, BLOOD, V123, P3553, DOI 10.1182/blood-2013-07-517110; Templeton AJ, 2013, ANN ONCOL, V24, P2972, DOI 10.1093/annonc/mdt397; Tu K, 2010, CAN J CARDIOL, V26, pE225, DOI 10.1016/S0828-282X(10)70412-8; Tu Karen, 2007, Open Med, V1, pe18; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Zee Y.K., 2010, J CLIN ONCOL, V28, pe13580, DOI [10.1200/jco.2010.28.15_suppl.e13580, DOI 10.1200/JCO.2010.28.15_SUPPL.E13580]	59	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122735	10.1371/journal.pone.0122735	http://dx.doi.org/10.1371/journal.pone.0122735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815472	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600192
J	Zhou, JS; Yao, NL; Fairchild, G; Zhang, YD; Wang, XP				Zhou, Jiansong; Yao, Nailin; Fairchild, Graeme; Zhang, Yingdong; Wang, Xiaoping			Altered Hemodynamic Activity in Conduct Disorder: A Resting-State fMRI Investigation	PLOS ONE			English	Article							CALLOUS-UNEMOTIONAL TRAITS; POSITRON-EMISSION-TOMOGRAPHY; K-SADS-PL; FUNCTIONAL CONNECTIVITY; NEURAL RESPONSES; HUMAN BRAIN; ANTISOCIAL-BEHAVIOR; MALE-ADOLESCENTS; EARLY-ONSET; PERSONALITY-DISORDER	Background Youth with conduct disorder (CD) not only inflict serious physical and psychological harm on others, but are also at greatly increased risk of sustaining injuries, developing depression or substance abuse, and engaging in criminal behaviors. The underlying neurobiological basis of CD remains unclear. Objective The present study investigated whether participants with CD have altered hemodynamic activity under resting-state conditions. Methods Eighteen medication-naive boys with CD and 18 age-and sex-matched typically developing (TD) controls underwent functional magnetic resonance imaging (MRI) scans in the resting state. The amplitude of low-frequency fluctuations (ALFF) was measured and compared between the CD and TD groups. Results Compared with the TD participants, the CD participants showed lower ALFF in the bilateral amygdala/parahippocampus, right lingual gyrus, left cuneus and right insula. Higher ALFF was observed in the right fusiform gyrus and right thalamus in the CD participants compared to the TD group. Conclusions Youth with CD displayed widespread functional abnormalities in emotion-related and visual cortical regions in the resting state. These results suggest that deficits in the intrinsic activity of resting state networks may contribute to the etiology of CD.	[Zhou, Jiansong; Zhang, Yingdong; Wang, Xiaoping] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Zhou, Jiansong; Zhang, Yingdong; Wang, Xiaoping] Hunan Prov Technol Inst Psychiat, Changsha, Hunan, Peoples R China; [Zhou, Jiansong; Zhang, Yingdong; Wang, Xiaoping] Key Lab Psychiat & Mental Hlth Hunan Prov, Changsha, Hunan, Peoples R China; [Yao, Nailin] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Fairchild, Graeme] Univ Southampton, Acad Unit Psychol, Southampton, Hants, England	Central South University; University of Hong Kong; University of Southampton	Zhou, JS (corresponding author), Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China.	zhoujs2003@aliyun.com; xyjw6@aliyun.com	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	Key Projects in the National Science & Technology Pillar Program [2012BAK16B00]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [13YJC190033]; National Natural Science Foundation of China (NSFC) [30800368, 81371500]; Science and Technology Committee of Shanghai Municipality for Shanghai Key Lab of Forensic Medicine [12DZ2271500: KF1006]	Key Projects in the National Science & Technology Pillar Program; MOE (Ministry of Education in China) Project of Humanities and Social Sciences; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shanghai Municipality for Shanghai Key Lab of Forensic Medicine	This work was supported by Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (2012BAK16B00), MOE (Ministry of Education in China) Project of Humanities and Social Sciences (Project No. 13YJC190033), the National Natural Science Foundation of China (NSFC, 30800368, 81371500), and the Science and Technology Committee of Shanghai Municipality for Shanghai Key Lab of Forensic Medicine (12DZ2271500: KF1006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banich MT, 2007, DRUG ALCOHOL DEPEN, V90, P175, DOI 10.1016/j.drugalcdep.2007.03.009; Barry CT, 2000, J ABNORM PSYCHOL, V109, P335, DOI [10.1037/0021-843X.109.2.335, 10.1037//0021-843X.109.2.335]; BIRLESON P, 1987, J CHILD PSYCHOL PSYC, V28, P43, DOI 10.1111/j.1469-7610.1987.tb00651.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bowen KL, 2014, J PSYCHOPATHOL BEHAV, V36, P60, DOI 10.1007/s10862-013-9368-z; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dadds MR, 2006, BRIT J PSYCHIAT, V189, P280, DOI 10.1192/bjp.bp.105.018150; Dadds MR, 2005, J CONSULT CLIN PSYCH, V73, P400, DOI 10.1037/0022-006X.73.3.400; Dalwani MS, 2014, DRUG ALCOHOL DEPEN, V134, P242, DOI 10.1016/j.drugalcdep.2013.10.009; Deeley Q, 2006, BRIT J PSYCHIAT, V189, P533, DOI 10.1192/bjp.bp.106.021410; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fairchild G, 2014, J AM ACAD CHILD PSY, V53, P677, DOI 10.1016/j.jaac.2014.02.009; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Fairchild G, 2009, J CHILD PSYCHOL PSYC, V50, P627, DOI 10.1111/j.1469-7610.2008.02020.x; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Golay X, 2012, MAGN RESON MATER PHY, V25, P79, DOI 10.1007/s10334-012-0308-9; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Herpertz SC, 2008, J CHILD PSYCHOL PSYC, V49, P781, DOI 10.1111/j.1469-7610.2008.01905.x; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Hyatt CJ, 2012, BIOL PSYCHIAT, V72, P207, DOI 10.1016/j.biopsych.2011.11.017; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kublbock M, 2014, NEUROIMAGE, V103, P249, DOI 10.1016/j.neuroimage.2014.09.038; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lahey BB, 2005, J CONSULT CLIN PSYCH, V73, P389, DOI 10.1037/0022-006X.73.3.389; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Lui S, 2015, PSYCHOL MED, V45, P97, DOI 10.1017/S003329171400110X; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marsh AA, 2013, J CHILD PSYCHOL PSYC, V54, P900, DOI 10.1111/jcpp.12063; Moffitt T. E., 2001, SEX DIFFERENCES ANTI; MOFFITT TE, 1990, CHILD DEV, V61, P893, DOI 10.1111/j.1467-8624.1990.tb02830.x; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nie N. H., 1975, SPSS STAT PACKAGE SO, V227; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Osuch EA, 2008, BIOL PSYCHIAT, V64, P327, DOI 10.1016/j.biopsych.2008.03.010; Passamonti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048789; Passamonti L, 2010, ARCH GEN PSYCHIAT, V67, P729, DOI 10.1001/archgenpsychiatry.2010.75; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Qiao Y, 2012, EUR CHILD ADOLES PSY, V21, P193, DOI 10.1007/s00787-012-0252-2; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robinson JL, 2010, HUM BRAIN MAPP, V31, P173, DOI 10.1002/hbm.20854; ROLAND PE, 1995, CEREB CORTEX, V5, P79, DOI 10.1093/cercor/5.1.79; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Rubia K, 2009, J CHILD PSYCHOL PSYC, V50, P669, DOI 10.1111/j.1469-7610.2008.02022.x; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Said CP, 2011, PHILOS T R SOC B, V366, P1660, DOI 10.1098/rstb.2010.0351; Sarinopoulos I, 2010, CEREB CORTEX, V20, P929, DOI 10.1093/cercor/bhp155; Sasayama D, 2010, PSYCHIAT CLIN NEUROS, V64, P394, DOI 10.1111/j.1440-1819.2010.02102.x; Scherpiet S, 2014, EUR ARCH PSY CLIN N, V264, P45, DOI 10.1007/s00406-013-0444-x; Schiffer B, 2014, PSYCHIAT RES-NEUROIM, V222, P43, DOI 10.1016/j.pscychresns.2014.01.008; Schneider S, 2011, NEUROIMAGE, V56, P1847, DOI 10.1016/j.neuroimage.2011.02.019; Schutter DJLG, 2011, J ABNORM CHILD PSYCH, V39, P333, DOI 10.1007/s10802-010-9475-1; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Shanee N, 1997, ISRAEL J PSYCHIAT, V34, P179; Silverthorn P, 1999, DEV PSYCHOPATHOL, V11, P101, DOI 10.1017/S0954579499001972; Steinmetz KRM, 2010, NEUROIMAGE, V53, P318, DOI 10.1016/j.neuroimage.2010.06.015; Sterzer P, 2005, BIOL PSYCHIAT, V57, P7, DOI 10.1016/j.biopsych.2004.10.008; Stillova K, 2013, J NEURAL TRANSM, V120, P391, DOI 10.1007/s00702-012-0890-z; Su LY, 2008, J ANXIETY DISORD, V22, P612, DOI 10.1016/j.janxdis.2007.05.011; Takeuchi H, 2013, NEUROIMAGE, V83, P318, DOI 10.1016/j.neuroimage.2013.06.044; Tiet QQ, 2001, J CHILD FAM STUD, V10, P181; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; van Goozen SHM, 2007, PSYCHOL BULL, V133, P149, DOI 10.1037/0033-2909.133.1.149; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Wallace GL, 2014, J AM ACAD CHILD PSY, V53, P456, DOI 10.1016/j.jaac.2013.12.008; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Yao NL, 2016, BRAIN STRUCT FUNCT, V221, P287, DOI 10.1007/s00429-014-0907-5; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhou JS, 2014, COMPR PSYCHIAT, V55, P1157, DOI 10.1016/j.comppsych.2014.03.022; Zhou JS, 2014, PSYCHIAT RES, V216, P379, DOI 10.1016/j.psychres.2014.01.024; Zhou JS, 2012, J FORENSIC PSYCHI PS, V23, P664, DOI 10.1080/14789949.2012.727452; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	79	19	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122750	10.1371/journal.pone.0122750	http://dx.doi.org/10.1371/journal.pone.0122750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816069	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600195
J	Braukmann, M; Methner, U; Berndt, A				Braukmann, Maria; Methner, Ulrich; Berndt, Angela			Immune Reaction and Survivability of Salmonella Typhimurium and Salmonella Infantis after Infection of Primary Avian Macrophages	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; III SECRETION SYSTEM; GENE-EXPRESSION; NITRIC-OXIDE; HOST-CELLS; CHICKEN; VIRULENCE; OXYGEN; HETEROGENEITY; INVASIVENESS	4 Salmonella serovars are differentially able to infect chickens. The underlying causes are not yet fully understood. Aim of the present study was to elucidate the importance of Salmonella Pathogenicity Island 1 and 2 (SPI-1 and -2) for the virulence of two non-host-specific, but in-vivo differently invasive, Salmonella serovars in conjunction with the immune reaction of the host. Primary avian splenic macrophages were inoculated with Salmonella enterica subspecies enterica serovar (S.) Typhimurium and S. Infantis. The number and viability of intracellular bacteria and transcription of SPI-1 and -2 genes by the pathogens, as well as transcription of immune-related proteins, surface antigen expression and nitric oxide production by the macrophages, were compared at different times post inoculation. After infection, both of the Salmonella serovars were found inside the primary macrophages. Invasion-associated SPI-1 genes were significantly higher transcribed in S. Infantis-than S. Typhimurium-infected macrophages. The macrophages counteracted the S. Infantis and S. Typhimurium infection with elevated mRNA expression of inducible nitric oxide synthase (iNOS), interleukin (IL)-12, IL-18 and lipopolysaccharide-induced tumor necrosis factor alpha factor (LITAF) as well as with an increased synthesis of nitric oxide. Despite these host cell attacks, S. Typhimurium was better able than S. Infantis to survive within the macrophages and transcribed higher rates of the SPI-2 genes spiC, ssaV, sifA, and sseA. The results showed similar immune reactions of primary macrophages after infection with both of the Salmonella strains. The more rapid and stronger transcription of SPI-2-related genes by intracellular S. Typhimurium compared to S. Infantis might be responsible for its better survival in avian primary macrophages.	[Braukmann, Maria; Berndt, Angela] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany; [Methner, Ulrich] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Bacterial Infect & Zoonoses, Jena, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Berndt, A (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany.	angela.berndt@fli.bund.de						Babu US, 2006, DEV COMP IMMUNOL, V30, P942, DOI 10.1016/j.dci.2005.12.001; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Berndt A, 2009, VET MICROBIOL, V133, P123, DOI 10.1016/j.vetmic.2008.06.025; Braukmann M, 2012, INFECT IMMUN, V80, P2976, DOI 10.1128/IAI.00437-12; Carvajal BG, 2008, VACCINE, V26, P5423, DOI 10.1016/j.vaccine.2008.07.088; Chakravortty D, 2003, MICROBES INFECT, V5, P621, DOI 10.1016/S1286-4579(03)00096-0; Chappell L, 2009, VET IMMUNOL IMMUNOP, V128, P53, DOI 10.1016/j.vetimm.2008.10.295; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Dieye Y, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-3; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; He HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058873; He HQ, 2012, FOODBORNE PATHOG DIS, V9, P1104, DOI 10.1089/fpd.2012.1233; He HQ, 2011, CYTOKINE, V53, P363, DOI 10.1016/j.cyto.2010.12.009; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Imre A, 2013, VET MICROBIOL, V167, P675, DOI 10.1016/j.vetmic.2013.07.034; Jones MA, 2001, INFECT IMMUN, V69, P5471, DOI 10.1128/IAI.69.9.5471-5476.2001; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Methner U, 2011, ZOONOSES PUBLIC HLTH, V58, P540, DOI 10.1111/j.1863-2378.2011.01400.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Okamura M, 2005, VET IMMUNOL IMMUNOP, V107, P327, DOI 10.1016/j.vetimm.2005.05.009; Pavlova B, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-16; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pieper J, 2008, VET IMMUNOL IMMUNOP, V124, P241, DOI 10.1016/j.vetimm.2008.03.008; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Rychlik I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-268; Setta A, 2012, VET IMMUNOL IMMUNOP, V146, P212, DOI 10.1016/j.vetimm.2012.03.008; SOKOL RJ, 1987, J ANAT, V151, P27; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Varmuzova K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096116; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Volf J, 2010, VET MICROBIOL, V146, P105, DOI 10.1016/j.vetmic.2010.04.031; Wigley P, 2002, MICROBES INFECT, V4, P1111, DOI 10.1016/S1286-4579(02)01635-0; Wisner ALS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029787; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	37	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122540	10.1371/journal.pone.0122540	http://dx.doi.org/10.1371/journal.pone.0122540			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811871	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700195
J	Moreno, LO; Salvemini, L; Mendonca, C; Copetti, M; De Bonis, C; De Cosmo, S; Doria, A; Trischitta, V; Menzaghi, C				Moreno, Lorena Ortega; Salvemini, Lucia; Mendonca, Christine; Copetti, Massimiliano; De Bonis, Concetta; De Cosmo, Salvatore; Doria, Alessandro; Trischitta, Vincenzo; Menzaghi, Claudia			Serum Resistin and Glomerular Filtration Rate in Patients with Type 2 Diabetes	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GENERAL JAPANESE POPULATION; CIRCULATING ADIPONECTIN; INSULIN-RESISTANCE; ALL-CAUSE; RISK; ASSOCIATION; BIOMARKERS; PLASMA; METAANALYSIS	Background High serum levels of the pro-inflammatory adipokine resistin have been associated with decreased renal function in the general population. The goal of this study was to investigate whether such association is also present among diabetic subjects, who are at increased risk of renal function loss. Methods The cross-sectional association between serum resistin levels and estimated glomerular filtration rate (eGFR) was investigated in 1,560 type 2 diabetic (T2D) patients of European ancestry comprised in two different cohorts: 762 patients from San Giovanni Rotondo (SGR; Italy) and 798 patients from Boston (US). Results Serum resistin was inversely associated with eGFR in SGR [beta (SE) for one SD of resistin increment = -1.01 (0.70) ml/min/1.73m(2), p = 0.019] and in Boston [beta (SE) = -5.31 (0.74) ml/min/1.73m(2), p < 0.001] samples, as well as in the two studies combined [beta (SE) = -3.42 (0.52) ml/min/1.73m(2), p < 0.001]. The association was unaffected by adjustment for smoking habits, BMI, waist circumference, diabetes duration, HbA1c, insulin treatment, hypertension and lipid-lowering therapy: beta (SE) for one SD of resistin increment = -1.07 (0.70), p = 0.02; -5.50 (0.88), p < 0.001; and -2.81 (0.55) ml/min/1.73m(2), p <.001, in SGR, Boston and the two studies combined, respectively. The association was significantly stronger in men than in women (p for resistin-by-gender interaction = 0.003). For each resistin SD increment, the odds of having eGFR < 0 ml/min/1.73m(2) increased by 22% (OR = 1.22; 95% CI 1.02-1.44; p = 0.025) in SGR sample, 69% (OR = 1.69; 95% CI 1.38-2.07; p < 0.001) in Boston sample, and 47% (OR = 1.47; 95% CI 1.29-1.68; p < 0.001) in the two studies considered together. Similar associations were observed in the adjusted model: OR 95% CI for each SD resistin increment being 1.23 (1.03-1.46), p = 0.021; 1.52 (1.20-1.92), p < 0.001; 1.33 (1.16-1.53), p < 0.001, in SGR, Boston and the two studies combined, respectively. Conclusions This is the first report of an association between high serum resistin and low eGFR in patients with T2D of European ancestry.	[Moreno, Lorena Ortega; Salvemini, Lucia; De Bonis, Concetta; Trischitta, Vincenzo; Menzaghi, Claudia] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Mendonca, Christine; Doria, Alessandro] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Biostat Unit, San Giovanni Rotondo, Italy; [De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Div Internal Med, Dept Med Sci, San Giovanni Rotondo, Italy; [Doria, Alessandro] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; Harvard University; Joslin Diabetes Center, Inc.; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Harvard University; Harvard Medical School; Sapienza University Rome	Trischitta, V (corresponding author), IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy.	vincenzo.trischitta@uniroma1.it; c.menzaghi@operapadrepio.it	Ortega Moreno, Lorena/ABI-5355-2020; De Cosmo, Salvatore/J-7420-2016; Copetti, Massimiliano/K-3186-2016; Trischitta, Vincenzo/K-1487-2016; DE BONIS, CONCETTA/AAM-8146-2020; COPETTI, MASSIMILIANO/AAG-1473-2021; Salvemini, Lucia/K-2121-2016; Doria, Alessandro/H-9157-2018; Menzaghi, Claudia/J-7210-2016	Ortega Moreno, Lorena/0000-0001-6008-8559; De Cosmo, Salvatore/0000-0001-8787-8286; Copetti, Massimiliano/0000-0002-7960-5947; Trischitta, Vincenzo/0000-0003-1174-127X; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Salvemini, Lucia/0000-0001-8776-9477; Doria, Alessandro/0000-0002-3830-4304; Menzaghi, Claudia/0000-0002-7438-8955	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PO Puglia FESR; Italian Ministry of Health [RC2014, RC2015]; European Foundation for the Study of Diabetes/Pfizer; Societa Italiana di Diabetologia-Fondazione Diabete Ricerca; National Institutes of Health [R01 DK073168, DK110400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168] Funding Source: NIH RePORTER	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PO Puglia FESR; Italian Ministry of Health(Ministry of Health, Italy); European Foundation for the Study of Diabetes/Pfizer; Societa Italiana di Diabetologia-Fondazione Diabete Ricerca; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST 2006 and PO Puglia FESR 2007-2013, Italian Ministry of Health grants RC2014 and RC2015, European Foundation for the Study of Diabetes/Pfizer grant and Societa Italiana di Diabetologia-Fondazione Diabete Ricerca (CM) and National Institutes of Health grants R01 DK073168 and DK110400 (AD). Dr. Ortega Moreno is supported by grant Societa Italiana di Diabetologia-Fondazione Diabete Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calabro P, 2011, J VASC RES, V48, P59, DOI 10.1159/000318775; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; De Cosmo S, 2013, NEPHROL DIAL TRANSPL, V28, P29, DOI 10.1093/ndt/gfs290; De Cosmo S, 2013, DIABETES CARE, V36, P2830, DOI 10.2337/dc12-1906; Dimitriadis K, 2009, J HUM HYPERTENS, V23, P668, DOI 10.1038/jhh.2009.12; Doria A, 2008, JAMA-J AM MED ASSOC, V300, P2389, DOI 10.1001/jama.2008.649; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Ellington AA, 2007, HYPERTENSION, V50, P708, DOI 10.1161/HYPERTENSIONAHA.107.095257; Hsu WY, 2011, J CELL PHYSIOL, V226, P2181, DOI 10.1002/jcp.22555; Jung HS, 2006, CARDIOVASC RES, V69, P76, DOI 10.1016/j.cardiores.2005.09.015; Kaplan RC, 2007, CANCER EPIDEM BIOMAR, V16, P1291, DOI 10.1158/1055-9965.EPI-06-1089; Kawamura R, 2010, NEPHROL DIAL TRANSPL, V25, P3236, DOI 10.1093/ndt/gfq155; Kollerits B, 2007, KIDNEY INT, V71, P1279, DOI 10.1038/sj.ki.5002191; Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; Lee SA, 2007, CANCER EPIDEM BIOMAR, V16, P2464, DOI 10.1158/1055-9965.EPI-07-0374; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Melone M, 2012, J AM COLL CARDIOL, V59, P1697, DOI 10.1016/j.jacc.2011.11.064; Menzaghi C, 2010, DIABETOLOGIA, V53, P226, DOI 10.1007/s00125-009-1589-z; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Menzaghi C, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0130-y; Menzaghi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064729; Menzaghi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038414; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Olkin I, 1998, BIOMETRICS, V54, P317, DOI 10.2307/2534018; Osawa H, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-60; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Qiu WB, 2014, DIABETES VASC DIS RE, V11, P121, DOI 10.1177/1479164113513912; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shetty GK, 2004, DIABETES CARE, V27, P2450, DOI 10.2337/diacare.27.10.2450; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; von Eynatten M, 2005, DIABETES CARE, V28, P754, DOI 10.2337/diacare.28.3.754; Yamauchi J, 2008, METABOLISM, V57, P149, DOI 10.1016/j.metabol.2007.08.018	37	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119529	10.1371/journal.pone.0119529	http://dx.doi.org/10.1371/journal.pone.0119529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811174	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700018
J	Renoz, F; Noel, C; Errachid, A; Foray, V; Hance, T				Renoz, Francois; Noel, Christine; Errachid, Abdelmounaim; Foray, Vincent; Hance, Thierry			Infection Dynamic of Symbiotic Bacteria in the Pea Aphid Acyrthosiphon pisum Gut and Host Immune Response at the Early Steps in the Infection Process	PLOS ONE			English	Article							HORIZONTAL TRANSFER; GENOME EVOLUTION; GENE-EXPRESSION; INSECT; ENDOSYMBIONTS; SERRATIA; IDENTIFICATION; VIRULENCE; DEFENSE; CELL	In addition to its obligatory symbiont Buchnera aphidicola, the pea aphid Acyrthosiphon pisum can harbor several facultative bacterial symbionts which can be mutualistic in the context of various ecological interactions. Belonging to a genus where many members have been described as pathogen in invertebrates, Serratia symbiotica is one of the most common facultative partners found in aphids. The recent discovery of strains able to grow outside their host allowed us to simulate environmental acquisition of symbiotic bacteria by aphids. Here, we performed an experiment to characterize the A. pisum response to the ingestion of the free-living S. symbiotica CWBI-2.3(T) in comparison to the ingestion of the pathogenic Serratia marcescens Db11 at the early steps in the infection process. We found that, while S. marcescens Db11 killed the aphids within a few days, S. symbiotica CWBI-2.3(T) did not affect host survival and colonized the whole digestive tract within a few days. Gene expression analysis of immune genes suggests that S. symbiotica CWBI-2.3(T) did not trigger an immune reaction, while S. marcescens Db11 did, and supports the hypothesis of a fine-tuning of the host immune response set-up for fighting pathogens while maintaining mutualistic partners. Our results also suggest that the lysosomal system and the JNK pathway are possibly involved in the regulation of invasive bacteria in aphids and that the activation of the JNK pathway is IMD-independent in the pea aphid.	[Renoz, Francois; Noel, Christine; Foray, Vincent; Hance, Thierry] Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, Louvain, Belgium; [Errachid, Abdelmounaim] Catholic Univ Louvain, Inst Sci Vie, Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Renoz, F (corresponding author), Catholic Univ Louvain, Biodivers Res Ctr, Earth & Life Inst, Louvain, Belgium.	francois.renoz@uclouvain.be	Foray, Vincent/J-3095-2019	Foray, Vincent/0000-0002-1561-1934	Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)	Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS)	Research was funded by the Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) (http://www.fnrs.be) (FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Altincicek B, 2008, INSECT MOL BIOL, V17, P711, DOI 10.1111/j.1365-2583.2008.00835.x; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Altincicek B, 2007, INSECT BIOCHEM MOLEC, V37, P726, DOI 10.1016/j.ibmb.2007.03.012; Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Burke GR, 2011, INSECT MOL BIOL, V20, P357, DOI 10.1111/j.1365-2583.2011.01070.x; Burke G, 2010, ISME J, V4, P242, DOI 10.1038/ismej.2009.114; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Chevalier F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S1; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Clayton AL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002990; Crawley M.J., 2007, R BOOK; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; de-Morais GS, 2005, BIOCHEM BIOPH RES CO, V328, P106, DOI DOI 10.1016/J.BBRC.2004.12.135; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Dubreuil G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-762; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Foray V, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00767-14; Fukatsu T, 2000, APPL ENVIRON MICROB, V66, P2748, DOI 10.1128/AEM.66.7.2748-2758.2000; Futahashi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064557; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gosalbes MJ, 2008, J BACTERIOL, V190, P6026, DOI 10.1128/JB.00525-08; Gunduz EA, 2009, P ROY SOC B-BIOL SCI, V276, P987, DOI 10.1098/rspb.2008.1476; He H, 2011, ENVIRON ENTOMOL, V40, P1405, DOI 10.1603/EN11157; Hultmark D., 1996, Experientia Supplementum (Basel), V75, P87; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Jousselin E, 2013, MOL ECOL, V22, P260, DOI 10.1111/mec.12092; Kaiwa N, 2010, APPL ENVIRON MICROB, V76, P3486, DOI 10.1128/AEM.00421-10; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2009, MICROBES ENVIRON, V24, P195, DOI 10.1264/jsme2.ME09140S; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; Kremer N, 2013, CELL HOST MICROBE, V14, P183, DOI 10.1016/j.chom.2013.07.006; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li XP, 2012, CURR MICROBIOL, V65, P610, DOI 10.1007/s00284-012-0197-1; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nishikori K, 2009, J INSECT PHYSIOL, V55, P351, DOI 10.1016/j.jinsphys.2009.01.001; Oakeson KF, 2014, GENOME BIOL EVOL, V6, P76, DOI 10.1093/gbe/evt210; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Petersen LM, 2013, CAN J MICROBIOL, V59, P627, DOI 10.1139/cjm-2013-0343; Petersen LM, 2012, APPL ENVIRON MICROB, V78, P8840, DOI 10.1128/AEM.02580-12; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; Sabri A, 2011, INT J SYST EVOL MICR, V61, P2081, DOI 10.1099/ijs.0.024133-0; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Sapountzis P, 2014, INSECT BIOCHEM MOLEC, V51, P20, DOI 10.1016/j.ibmb.2014.05.005; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042114; Sirvio A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-335; Snyder AK, 2010, P ROY SOC B-BIOL SCI, V277, P2389, DOI 10.1098/rspb.2010.0364; Tryselius Y, 1997, INSECT MOL BIOL, V6, P173, DOI 10.1111/j.1365-2583.1997.tb00085.x; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Vigneron A, 2014, CURR BIOL, V24, P2267, DOI 10.1016/j.cub.2014.07.065; Wang LF, 2010, INSECT MOL BIOL, V19, P99, DOI 10.1111/j.1365-2583.2009.00952.x	77	30	32	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122099	10.1371/journal.pone.0122099	http://dx.doi.org/10.1371/journal.pone.0122099			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811863	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700168
J	Suabjakyong, P; Saiki, R; Van Griensven, LJLD; Higashi, K; Nishimura, K; Igarashi, K; Toida, T				Suabjakyong, Papawee; Saiki, Ryotaro; Van Griensven, Leo J. L. D.; Higashi, Kyohei; Nishimura, Kazuhiro; Igarashi, Kazuei; Toida, Toshihiko			Polyphenol Extract from Phellinus igniarius Protects against Acrolein Toxicity In Vitro and Provides Protection in a Mouse Stroke Model	PLOS ONE			English	Article							ANTIOXIDANT PROPERTIES; OXIDASE; CELLS	The basidiomycetous mushroom Phellinus igniarius (L.) Quel. has been used as traditional medicine in various Asian countries for many years. Although many reports exist on its anti-oxidative and anti-inflammatory activities and therapeutic effects against various diseases, our current knowledge of its effect on stroke is very limited. Stroke is a neurodegenerative disorder in which oxidative stress is a key hallmark. Following the 2005 discovery by Igarashi's group that acrolein produced from polyamines in vivo is a major cause of cell damage by oxidative stress, we now describe the effects of anti-oxidative extracts from P. igniarius on symptoms of experimentally induced stroke in mice. The toxicity of acrolein was compared with that of hydrogen peroxide in a mouse mammary carcinoma cell line (FM3A). We found that the complete inhibition of FM3A cell growth by 5 mu M acrolein could be prevented by crude ethanol extract of P. igniarius at 0.5 mu g/ml. Seven polyphenol compounds named 3,4-dihydroxybenzaldehyde, 4-(3,4-dihydroxyphenyl-3-buten-2one, inonoblin C, phelligridin D, inoscavin C, phelligridin C and interfungin B were identified from this ethanolic extract by LCMS and H-1 NMR. Polyphenol-containing extracts of P. igniarius were then used to prevent acrolein toxicity in a mouse neuroblastoma (Neuro-2a) cell line. The results suggested that Neuro-2a cells were protected from acrolein toxicity at 2 and 5 mu M by this polyphenol extract at 0.5 and 2 mu g/ml, respectively. Furthermore, in mice with experimentally induced stroke, intraperitoneal treatment with P. igniarius polyphenol extract at 20 mu g/kg caused a reduction of the infarction volume by 62.2% compared to untreated mice. These observations suggest that the polyphenol extract of P. igniarius could serve to prevent ischemic stroke.	[Suabjakyong, Papawee; Saiki, Ryotaro; Higashi, Kyohei; Nishimura, Kazuhiro; Igarashi, Kazuei; Toida, Toshihiko] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin & Analyt Biochem, Chiba, Japan; [Saiki, Ryotaro; Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chiba, Japan; [Van Griensven, Leo J. L. D.] Univ Wageningen & Res Ctr, Plant Res Int, NL-6700 AP Wageningen, Netherlands	Chiba University; Chiba University; Wageningen University & Research	Toida, T (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Clin & Analyt Biochem, 1-8-1 Inohana, Chiba, Japan.	toida@faculty.chiba-u.jp	Saiki, Papawee/L-6529-2018	Saiki, Papawee/0000-0002-9028-2640; Higashi, Kyohei/0000-0002-2622-4825; Igarashi, Kazuei/0000-0003-3751-3187; Nishimura, Kazuhiro/0000-0002-6209-5522				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Atawodi SE, 2010, ADV BIOL RES, V4, P314; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng YC, 2009, J NEUROCHEM, V110, P947, DOI 10.1111/j.1471-4159.2009.06186.x; FUJII S, 1981, BIOCHIM BIOPHYS ACTA, V661, P342, DOI 10.1016/0005-2744(81)90023-1; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Iwata H, 2011, INT J ONCOL, V38, P1653, DOI 10.3892/ijo.2011.999; KIMES BW, 1971, BIOCHIM BIOPHYS ACTA, V228, P223, DOI 10.1016/0005-2787(71)90562-4; Kuo MC, 2006, J ETHNOPHARMACOL, V103, P217, DOI 10.1016/j.jep.2005.08.010; Lee CL, 2006, ENZYME MICROB TECH, V38, P14, DOI 10.1016/j.enzmictec.2004.10.009; Lee IH, 2002, FEMS MICROBIOL LETT, V209, P63, DOI 10.1111/j.1574-6968.2002.tb11110.x; Liu F, 2014, FASEB J, V28, P830; Lung MY, 2010, J FOOD SCI, V75, pE18, DOI 10.1111/j.1750-3841.2009.01384.x; Maher P, 2007, BRAIN RES, V1173, P117, DOI 10.1016/j.brainres.2007.07.061; Mathew J, 2008, INT J MED MUSHROOMS, V10, P139, DOI 10.1615/IntJMedMushr.v10.i2.40; Mau JL, 2002, J AGR FOOD CHEM, V50, P6072, DOI 10.1021/jf0201273; Mau JL, 2002, FOOD RES INT, V35, P519, DOI 10.1016/S0963-9969(01)00150-8; Mizuno T., 1999, International Journal of Medicinal Mushrooms, V1, P9; Monro JA, 2003, ARCH ENVIRON HEALTH, V58, P533, DOI 10.3200/AEOH.58.8.533-537; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; Rahman MM, 2007, CURR VASC PHARMACOL, V5, P276, DOI 10.2174/157016107782023406; Saiki R, 2011, BIOCHEM BIOPH RES CO, V404, P1044, DOI 10.1016/j.bbrc.2010.12.107; Saiki R, 2009, STROKE, V40, P3356, DOI 10.1161/STROKEAHA.109.553248; Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2; Sanchez C, 2004, APPL MICROBIOL BIOT, V64, P756, DOI 10.1007/s00253-004-1569-7; Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569; Sigalov E, 2000, J MOL NEUROSCI, V15, P147, DOI 10.1385/JMN:15:3:147; Sperling O, 2003, NEUROSCI LETT, V351, P137, DOI 10.1016/S0304-3940(03)00858-9; Tanaka S, 2014, J PROTEOME RES, V13, P3846, DOI 10.1021/pr500155z; Tanaka Y, 2007, LIFE SCI, V81, P1381, DOI 10.1016/j.lfs.2007.09.011; Tomitori H, 2005, STROKE, V36, P2609, DOI 10.1161/01.STR.0000190004.36793.2d; Tsai SY, 2008, INT J MED MUSHROOMS, V10, P279; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Wang Y, 2005, ORG LETT, V7, P4733, DOI 10.1021/ol0520875; Wang Y, 2005, ORG LETT, V7, P1675, DOI 10.1021/ol0475764; Wang Y, 2012, FOOD CHEM, V131, P206, DOI 10.1016/j.foodchem.2011.08.061; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Weesepoel Y, 2009, THESIS U WAGENINGEN; Wei S, 2008, INT J MED MUSHROOMS, V10, P315, DOI 10.1615/IntJMedMushr.v10.i4.30; Wei S, 2008, INT J MED MUSHROOMS, V10, P1, DOI 10.1615/IntJMedMushr.v10.i1.20; Winkler BS, 2003, EXP EYE RES, V76, P715, DOI 10.1016/S0014-4835(03)00052-6; Yoshida M, 2009, BIOCHEM BIOPH RES CO, V378, P313, DOI 10.1016/j.bbrc.2008.11.054; [Zheng Weifa 郑维发], 2010, [菌物学报, Mygosystema], V29, P897; Zheng WF, 2011, PHYTOCHEM ANALYSIS, V22, P95, DOI 10.1002/pca.1225	46	30	30	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122733	10.1371/journal.pone.0122733	http://dx.doi.org/10.1371/journal.pone.0122733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811373	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700199
J	Brar, V; Gill, S; Cardillo, C; Tesauro, M; Panza, JA; Campia, U				Brar, Vijaywant; Gill, Sartaj; Cardillo, Carmine; Tesauro, Manfredi; Panza, Julio A.; Campia, Umberto			Sex-Specific Effects of Cardiovascular Risk Factors on Endothelium-Dependent Dilation and Endothelin Activity in Middle-Aged Women and Men	PLOS ONE			English	Article							HEART-DISEASE; VASCULAR-TONE; DYSFUNCTION; VASODILATION; DISPARITIES; BLOCKADE	Background Healthy middle-aged postmenopausal women have higher endothelium-dependent dilation and lower vasoconstrictor activity of endothelin-1 than men. Whether these sex-specific differences extend to patients with cardiovascular risk factors has not been investigated. The current study aimed to determine whether, in patients with cardiovascular risk factors, sex-specific differences exist in endothelium-dependent dilation and endothelin-1 activity. Methods Forearm blood flow responses were measured by strain-gauge plethysmography during the intra-arterial infusion of acetylcholine, sodium nitroprusside, and the selective endothelin type A receptor blocker BQ-123 in 50 women and 64 men with cardiovascular risk factors. Results Acetylcholine and sodium nitroprusside induced a significant vasodilation in women and men alike (p < 0.01 for both). Also BQ-123 caused a significant vasodilation (p < 0.001) in both groups. The vasodilator response to acetylcholine was greater in women compared to men; however there were no differences in the response to sodium nitroprusside and BQ-123 (p = NS for both) between the two sex groups. Conclusions Middle-aged women with cardiovascular risk factors have significantly higher endothelium-dependent dilation than middle-aged men; however, vascular endothelin 1 activity is similar in the two groups. These findings suggest that the presence of cardiovascular risk factors is associated with sex-specific effects on endothelium-dependent dilation but not on endothelin 1 activity. Further study is needed to confirm our findings and to characterize the mechanisms underlying this sex-specific regulation of endothelial function.	[Brar, Vijaywant; Campia, Umberto] MedStar Cardiovasc Res Network, Washington, DC 20010 USA; [Brar, Vijaywant; Campia, Umberto] MedStar Washington Hosp Ctr, Washington, DC USA; [Gill, Sartaj] Prince Georges Gen Hosp & Med Ctr, Cheverly, MD USA; [Cardillo, Carmine] Catholic Univ, Internal Med, Rome, Italy; [Tesauro, Manfredi] Univ Roma Tor Vergata, Med Syst, Rome, Italy; [Panza, Julio A.] Westchester Med Ctr, Valhalla, NY USA	MedStar Washington Hospital Center; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Westchester Medical Center	Campia, U (corresponding author), MedStar Cardiovasc Res Network, Washington, DC 20010 USA.	umberto.campia@medstar.net	brar, vijaywant/AAR-5875-2020	brar, vijaywant/0000-0002-3528-327X; Cardillo, Carmine/0000-0001-5182-3005				Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Bohm F, 2002, CLIN SCI, V102, P321; Campia U, 2006, CIRCULATION, V113, P867, DOI 10.1161/CIRCULATIONAHA.105.549618; Campia U, 2002, AM J CARDIOL, V89, P286, DOI 10.1016/S0002-9149(01)02229-9; Cardillo C, 1999, HYPERTENSION, V33, P753, DOI 10.1161/01.HYP.33.2.753; Cardillo C, 2002, CIRCULATION, V105, P452, DOI 10.1161/hc0402.102989; Cardillo C, 2002, CIRCULATION, V106, P1783, DOI 10.1161/01.CIR.0000032260.01569.64; CARDILLO C, J AM COLL CARDIOLOGY, V36, P1483; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Gouni-Berthold I, 2008, DIABETES CARE, V31, P1389, DOI 10.2337/dc08-0194; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Moreau KL, 2001, J CLIN ENDOCRINOLOGY, V97, P4692; Natarajan S, 2003, ARCH INTERN MED, V163, P1735, DOI 10.1001/archinte.163.14.1735; PANZA JA, 1994, J AM COLL CARDIOL, V23, P1610, DOI 10.1016/0735-1097(94)90664-5; Perticone F, 2001, DIABETES, V50, P159, DOI 10.2337/diabetes.50.1.159; Schnabel RB, 2013, J HYPERTENS, V31, P1437, DOI 10.1097/HJH.0b013e328360f755; Stauffer BL, 2010, AM J PHYSIOL-REG I, V298, pR261, DOI 10.1152/ajpregu.00626.2009; Wexler DJ, 2005, DIABETES CARE, V28, P514, DOI 10.2337/diacare.28.3.514	21	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121810	10.1371/journal.pone.0121810	http://dx.doi.org/10.1371/journal.pone.0121810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807234	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000183
J	Chan, EKF; Hardie, RA; Petersen, DC; Beeson, K; Bornman, RMS; Smith, AB; Hayes, VM				Chan, Eva K. F.; Hardie, Rae-Anne; Petersen, Desiree C.; Beeson, Karen; Bornman, Riana M. S.; Smith, Andrew B.; Hayes, Vanessa M.			Revised Timeline and Distribution of the Earliest Diverged Human Maternal Lineages in Southern Africa	PLOS ONE			English	Article							MTDNA VARIATION; ANCIENT MITOCHONDRIAL; BLOMBOS CAVE; GENOME; POPULATIONS; SUBSTRUCTURE; DIVERSITY; EVOLUTION; INFERENCE; REVEALS	The oldest extant human maternal lineages include mitochondrial haplogroups L0d and L0k found in the southern African click-speaking forager peoples broadly classified as Khoesan. Profiling these early mitochondrial lineages allows for better understanding of modern human evolution. In this study, we profile 77 new early-diverged complete mitochondrial genomes and sub-classify another 105 L0d/L0k individuals from southern Africa. We use this data to refine basal phylogenetic divergence, coalescence times and Khoesan prehistory. Our results confirm L0d as the earliest diverged lineage (similar to 172 kya, 95% CI: 149-199 kya), followed by L0k (similar to 159 kya, 95% CI: 136-183 kya) and a new lineage we name L0g (similar to 94 kya, 95% CI: 72-116 kya). We identify two new L0d1 subclades we name L0d1d and L0d1c4/L0d1e, and estimate L0d2 and L0d1 divergence at similar to 93 kya (95% CI: 76-112 kya). We concur the earliest emerging L0d1'2 sublineage L0d1b (similar to 49 kya, 95% CI: 37-58 kya) is widely distributed across southern Africa. Concomitantly, we find the most recent sublineage L0d2a (similar to 172 kya, 95% CI: 10-27 kya) to be equally common. While we agree that lineages L0d1c and L0k1a are restricted to contemporary inland Khoesan populations, our observed predominance of L0d2a and L0d1a in non-Khoesan populations suggests a once independent coastal Khoesan prehistory. The distribution of early-diverged human maternal lineages within contemporary southern Africans suggests a rich history of human existence prior to any archaeological evidence of migration into the region. For the first time, we provide a genetic-based evidence for significant modern human evolution in southern Africa at the time of the Last Glacial Maximum at between similar to 21-17 kya, coinciding with the emergence of major lineages L0d1a, L0d2b, L0d2d and L0d2a.	[Chan, Eva K. F.; Hardie, Rae-Anne; Petersen, Desiree C.; Hayes, Vanessa M.] Garvan Inst Med Res, Lab Human Comparat & Prostate Canc Genom, Darlinghurst, NSW 2010, Australia; [Chan, Eva K. F.; Hardie, Rae-Anne; Petersen, Desiree C.; Hayes, Vanessa M.] Univ New South Wales Australia, Fac Med, Randwick, NSW, Australia; [Petersen, Desiree C.; Beeson, Karen; Hayes, Vanessa M.] Craig Venter Inst, La Jolla, CA 92037 USA; [Bornman, Riana M. S.; Hayes, Vanessa M.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Hatfield, Herts, England; [Smith, Andrew B.] Univ Cape Town, Dept Archaeol, ZA-7700 Rondebosch, South Africa; [Hayes, Vanessa M.] Univ Sydney, Cent Clin Sch, Camperdown, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; J. Craig Venter Institute; University of Cape Town; University of Sydney	Hayes, VM (corresponding author), Garvan Inst Med Res, Lab Human Comparat & Prostate Canc Genom, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	v.hayes@garvan.org.au	Hayes, Vanessa M/GPP-2807-2022; Hayes, Vanessa/W-3728-2019	Hayes, Vanessa M/0000-0002-4524-7280; Chan, Eva/0000-0002-6104-3763; , Riana/0000-0003-3975-2333; Petersen, Desiree/0000-0002-0817-2574; Hardie, Rae-Anne/0000-0003-4868-4045	Petre Foundation, Australia; J. Craig Venter Family Fund, La Jolla, CA, U.S.A	Petre Foundation, Australia; J. Craig Venter Family Fund, La Jolla, CA, U.S.A	VMH is supported via the Petre Foundation, Australia, and previously via the J. Craig Venter Family Fund, La Jolla, CA, U.S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Barbieri C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099117; Barbieri C, 2013, AM J HUM GENET, V92, P285, DOI 10.1016/j.ajhg.2012.12.010; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Friederich R, 2009, DIE HAILLOM UND DAS, DOI [10.1586/erp.0953, DOI 10.1586/ERP.09.53]; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Guldemann T, 2008, SOUTH AFR HUMANIT, V20, P93; Haacke WHG, 2002, LINGUISTIC EVIDENCE; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Henshilwood C, 1996, ANTIQUITY, V70, P945, DOI 10.1017/S0003598X00084210; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Huffman TN, 1988, HEINEMANN EDUCATIONA, DOI DOI 10.1016/S2214-109X(13)70069-X; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; Meyer S, 1999, GENETICS, V152, P1103; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mithen S, 2006, AFTER THE ICE A GLOB; Morris AG, 2002, HUM EVOL, V17, P231, DOI DOI 10.1007/BF02436374; Morris AG, 2014, GENOME BIOL EVOL, V6, P2647, DOI 10.1093/gbe/evu202; Pages H, BIOSTRINGS STRING OB; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pleurdeau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040340; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price TD, 2011, CURR ANTHROPOL, V52, pS163, DOI 10.1086/659964; Quintana-Murci L, 2010, AM J HUM GENET, V86, P611, DOI 10.1016/j.ajhg.2010.02.014; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robbins LH, 2005, CURR ANTHROPOL, V46, P671, DOI 10.1086/432748; Rosa A, 2011, J ANTHROPOL SCI, V89, P25, DOI 10.4436/jass.89006; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Sandelowsky B. H., 1979, S AFRICAN ARCHAEOLOG, V3, P52; Schlebusch CM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-56; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schlebusch CM, 2011, J HUM GENET, V56, P623, DOI 10.1038/jhg.2011.71; Schlebusch CM, 2009, ELECTROPHORESIS, V30, P3657, DOI 10.1002/elps.200900197; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Smith A.B., 1995, S AFRICAN ARCHAEOLOG, V50, P3, DOI [10.2307/3889270, DOI 10.2307/3889270]; Smith AB, 2005, AFRICAN HERDERS EMER; Smith AB, 2006, EXCAVATIONS AT KASTE; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Van der Ross RE, 2005, UP FROM SLAVERY SLAV; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; [No title captured], DOI DOI 10.1371/JOURNALPGEN.1003309	54	61	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121223	10.1371/journal.pone.0121223	http://dx.doi.org/10.1371/journal.pone.0121223			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807545	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000138
J	Chirault, M; Lucas, C; Goubault, M; Chevrier, C; Bressac, C; Lecureuil, C				Chirault, Marlene; Lucas, Christophe; Goubault, Marlene; Chevrier, Claude; Bressac, Christophe; Lecureuil, Charlotte			A Combined Approach to Heat Stress Effect on Male Fertility in Nasonia vitripennis: From the Physiological Consequences on Spermatogenesis to the Reproductive Adjustment of Females Mated with Stressed Males	PLOS ONE			English	Article							DINARMUS-BASALIS HYMENOPTERA; MALE SEX-PHEROMONE; WASP NASONIA; PARASITIC WASP; EXTREME TEMPERATURES; MATING-BEHAVIOR; MALE-STERILITY; COURTSHIP; RATIO; MORPHOLOGY	In recent years, several studies have shown a decline in reproductive success in males in both humans and wildlife. Research on male fertility has largely focused on vertebrates, although invertebrates constitute the vast majority of terrestrial biodiversity. The reduction of their reproductive capacities due to environmental stresses can have strong negative ecological impacts, and also dramatic consequences on world food production if it affects the reproductive success of biological control agents, such as parasitic wasps used to control crop pests. Here Nasonia vitripennis, a parasitic wasp of various fly species, was studied to test the effects of 24h-heat stress applied during the first pupal stage on male fertility. Results showed that only primary spermatocytes were present at the first pupal stage in all cysts of the testes. Heat stress caused a delay in spermatogenesis during development and a significant decrease in sperm stock at emergence. Females mated with these heat-stressed males showed a reduce sperm count stored in their spermatheca. Females did not appear to distinguish heat-stressed from control males and did not remate more frequently to compensate for the lack of sperm transferred. As a result, females mated with heat-stressed males produced a suboptimal lifetime offspring sex ratio compared to those mated with control males. This could further impact the population dynamics of this species. N. vitripennis appears to be an interesting biological model to study the mechanisms of subfertility and its consequence on female reproductive strategies and provides new research perspectives in both invertebrates and vertebrates.	[Chirault, Marlene; Lucas, Christophe; Goubault, Marlene; Chevrier, Claude; Bressac, Christophe; Lecureuil, Charlotte] Univ Tours, UFR Sci & Tech, Inst Rech Biol Insecte, CNRS,UMR 7261, Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours	Lecureuil, C (corresponding author), Univ Tours, UFR Sci & Tech, Inst Rech Biol Insecte, CNRS,UMR 7261, Parc Grandmont, Tours, France.	charlotte.lecureuil@univ-tours.fr	Bressac, Christophe/AAF-9183-2021; Lucas, Christophe/A-4186-2011; Lécureuil, Charlotte/B-4841-2016; Goubault, Marlène/B-4771-2016	Lucas, Christophe/0000-0003-2839-7583; Lécureuil, Charlotte/0000-0002-7339-9185; Goubault, Marlène/0000-0002-9452-7668; bressac, christophe/0000-0001-7609-8970	Press Val de Loire Universite (APR-IA) [GDR3658]	Press Val de Loire Universite (APR-IA)	This work was supported by Press Val de Loire Universite (APR-IA2012), GDR3658. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, P NATL ACAD SCI USA, V105, P8914, DOI 10.1073/pnas.0801559105; Arora A, 2000, J BIOL CHEM, V275, P1594, DOI 10.1074/jbc.275.3.1594; Beukeboom LW, 2001, BEHAV GENET, V31, P167, DOI 10.1023/A:1010201427204; Blaul B, 2011, P ROY SOC B-BIOL SCI, V278, P3286, DOI 10.1098/rspb.2011.0001; Bressac C, 1998, J INSECT PHYSIOL, V44, P351, DOI 10.1016/S0022-1910(97)00119-4; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Chevrier C, 2002, J INSECT BEHAV, V15, P385, DOI 10.1023/A:1016269210140; CHIHRANE J, 1994, ENTOMOPHAGA, V39, P11, DOI 10.1007/BF02373490; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Eeva T, 2009, ENVIRON POLLUT, V157, P3126, DOI 10.1016/j.envpol.2009.05.040; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; GODFRAY HCJ, 1990, J EVOLUTION BIOL, V3, P3, DOI 10.1046/j.1420-9101.1990.3010003.x; Grassberger M, 2003, MED VET ENTOMOL, V17, P257, DOI 10.1046/j.1365-2915.2003.00439.x; GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; HOAGE TR, 1968, J ULTRA MOL STRUCT R, V24, P6, DOI 10.1016/S0022-5320(68)80014-0; Hogge M, 1975, J SUB MICROCYTOL; Insausti TC, 2008, J EXP BIOL, V211, P780, DOI 10.1242/jeb.014043; Jorgensen KT, 2006, J THERM BIOL, V31, P280, DOI 10.1016/j.jtherbio.2005.11.026; Kehrli P, 2005, BIOL CONTROL, V32, P191, DOI 10.1016/j.biocontrol.2004.09.012; Kitana N, 2007, BIOL REPROD, V76, P346, DOI 10.1095/biolreprod.106.053736; KRAINACKER DA, 1988, EXP APPL ACAROL, V5, P151, DOI 10.1007/BF02053824; Kus-Liskiewicz M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-456; Lacoume S, 2006, J INSECT PHYSIOL, V52, P249, DOI 10.1016/j.jinsphys.2005.11.003; Lacoume S, 2007, J INSECT PHYSIOL, V53, P1008, DOI 10.1016/j.jinsphys.2007.05.006; Lacoume S, 2009, BIOL CONTROL, V49, P214, DOI 10.1016/j.biocontrol.2009.02.002; Larsson M, 2000, EUR J CELL BIOL, V79, P718, DOI 10.1078/0171-9335-00097; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Mironidis GK, 2010, J THERM BIOL, V35, P59, DOI 10.1016/j.jtherbio.2009.11.001; Nelson D.R., 1978, Advances in Insect Physiology, V13, P1, DOI 10.1016/S0065-2806(08)60263-5; Niedermayer S, 2013, J APPL ENTOMOL, V137, P146, DOI 10.1111/j.1439-0418.2012.01726.x; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; PENNYPACKER MIRIAM I., 1958, ARCH BIOL, V69, P483; POMONIS JG, 1980, J CHEM ECOL, V6, P965, DOI 10.1007/BF00994653; Pultz MA, 2003, GENESIS, V35, P185, DOI 10.1002/gene.10189; Ratte H.T., 1985, P33; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; Ruther J, 2007, J EXP BIOL, V210, P2163, DOI 10.1242/jeb.02789; Ruther J, 2011, J CHEM ECOL, V37, P161, DOI 10.1007/s10886-010-9898-8; Ruther J, 2009, P ROY SOC B-BIOL SCI, V276, P3303, DOI 10.1098/rspb.2009.0738; Stearns S.C., 1992, pi; Steiner S, 2009, J CHEM ECOL, V35, P416, DOI 10.1007/s10886-009-9624-6; Nguyen TM, 2013, J INSECT PHYSIOL, V59, P248, DOI 10.1016/j.jinsphys.2012.12.001; Toft G, 2005, ECOTOX ENVIRON SAFE, V60, P15, DOI 10.1016/j.ecoenv.2004.07.010; Toft G, 2003, ENVIRON HEALTH PERSP, V111, P695, DOI 10.1289/ehp.6022; Van Den Assem J, 2004, REV NASONIA CHALCIDO, P123; VANDENASSEM J, 1994, J INSECT BEHAV, V7, P53, DOI 10.1007/BF01989827; VANDENASSEM J, 1984, J COMP PHYSIOL, V155, P233, DOI 10.1007/BF00612640; VdA J, 1986, MATING BEHAV PARASIT; Visser B, 2010, P NATL ACAD SCI USA, V107, P8677, DOI 10.1073/pnas.1001744107; WERREN JH, 1980, SCIENCE, V208, P1157, DOI 10.1126/science.208.4448.1157; Werren JH, 2009, CSH PROT, V10, P134; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; WHITING AR, 1967, Q REV BIOL, V42, P333, DOI 10.1086/405402; Xie Q, 2008, J ECON ENTOMOL, V101, P736, DOI 10.1603/0022-0493(2008)101[736:TROOFF]2.0.CO;2	62	23	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120656	10.1371/journal.pone.0120656	http://dx.doi.org/10.1371/journal.pone.0120656			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807005	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000093
J	Hecht, SS; Koh, WP; Wang, RW; Chen, ML; Carmella, SG; Murphy, SE; Yuan, JM				Hecht, Stephen S.; Koh, Woon-Puay; Wang, Renwei; Chen, Menglan; Carmella, Steven G.; Murphy, Sharon E.; Yuan, Jian-Min			Elevated Levels of Mercapturic Acids of Acrolein and Crotonaldehyde in the Urine of Chinese Women in Singapore Who Regularly Cook at Home	PLOS ONE			English	Article							LUNG-CANCER RISK; INDOOR AIR-POLLUTION; TOXICANT BIOMARKERS; CARBONYL-COMPOUNDS; THERMAL-OXIDATION; NONSMOKING WOMEN; FUMES; EMISSIONS; DNA; CARCINOGEN	Lung cancer is unusually common among non-smoking women in Southeastern Asia but the causes of this frequently fatal disease are not well understood. Several epidemiology studies indicate that inhalation of fumes from high temperature Chinese style cooking with a wok may be a cause. Only one previous study investigated uptake of potential toxicants and carcinogens by women who cook with a wok. We enrolled three-hundred twenty-eight non-smoking women from Singapore for this study. Each provided a spot urine sample and answered a questionnaire concerning their cooking habits and other factors. The urine samples were analyzed by liquid chromatography-tandem mass spectrometry for mercapturic acid metabolites of acrolein (3-hydroxypropylmercapturic acid), crotonaldehyde (3-hydroxy-1-methylpropylmercapturic acid), and benzene (S-phenylmercapturic acid), accepted biomarkers of uptake of these toxic and carcinogenic compounds. We observed statistically significant effects of wok cooking frequency on levels of 3-hydroxypropylmercapturic acid and 3-hydroxy-1-methylpropylmercapturic acid, but not S-phenylmercapturic acid. Women who cooked greater than 7 times per week had a geometric mean of 2600 (95% CI, 2189-3090) pmol/mg creatinine 3-hydroxypropylmercapturic acid compared to 1901 (95% CI, 1510-2395) pmol/mg creatinine when cooking less than once per week (P for trend 0.018). The corresponding values for 3-hydroxy-1-methylpropylmercapturic acid were 1167 (95% CI, 1022-1332) and 894 (95% CI, 749-1067) pmol/mg creatinine (P for trend 0.008). We conclude that frequent wok cooking leads to elevated exposure to the toxicants acrolein and crotonaldehyde, but not benzene. Kitchens should be properly ventilated to decrease exposure to potentially toxic and carcinogenic fumes produced during Chinese style wok cooking.	[Hecht, Stephen S.; Chen, Menglan; Carmella, Steven G.; Murphy, Sharon E.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Koh, Woon-Puay] Duke NUS Grad Med Sch, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hecht, SS (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	hecht002@umn.edu		Hecht, Stephen/0000-0001-7228-1356; Yuan, Jian-Min/0000-0002-4620-3108	National Cancer Institute [R01 CA144034, CA-77598]; NATIONAL CANCER INSTITUTE [P30CA077598, R01CA144034, UM1CA182876] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grant R01 CA144034 from the National Cancer Institute. Mass spectrometry was carried out in the core facilities of the Masonic Cancer Center, University of Minnesota, supported in part by National Cancer Institute grant CA-77598. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, IARC Monogr Eval Carcinog Risks Hum, V63, P337; Burcham PC, 2010, CHEM-BIOL INTERACT, V183, P416, DOI 10.1016/j.cbi.2009.12.006; Butler LM, 2013, CARCINOGENESIS, V34, P1794, DOI 10.1093/carcin/bgt113; Carmella SG, 2013, J CHROMATOGR B, V935, P36, DOI 10.1016/j.jchromb.2013.07.004; Cheah EY, 2014, BIOCHEM PHARMACOL, V89, P148, DOI 10.1016/j.bcp.2014.02.009; Chiu YL, 2010, CANCER CAUSE CONTROL, V21, P777, DOI 10.1007/s10552-010-9506-9; CHUNG FL, 1986, CANCER RES, V46, P1285; CHUNG FL, 1984, CANCER RES, V44, P990; Da Silva TO, 2008, J AGR FOOD CHEM, V56, P3129, DOI 10.1021/jf0734525; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Fullana A, 2004, J AGR FOOD CHEM, V52, P5207, DOI 10.1021/jf035241f; GAO YT, 1987, INT J CANCER, V40, P604, DOI 10.1002/ijc.2910400505; Hecht SS, 2010, CHEM RES TOXICOL, V23, P1001, DOI 10.1021/tx100056m; Hecht SS, 2010, CANCER EPIDEM BIOMAR, V19, P1185, DOI 10.1158/1055-9965.EPI-09-1291; Ho SSH, 2006, J AIR WASTE MANAGE, V56, P1091, DOI 10.1080/10473289.2006.10464532; International Agency for Research on Cancer, 2010, IARC MONOGRAPHS EVAL, V95, P392; International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100F, P249; International Agency for Research on Cancer, 1995, IARC MON EV CARC RIS, V63, P373; Katragadda HR, 2010, FOOD CHEM, V120, P59, DOI 10.1016/j.foodchem.2009.09.070; Ko YC, 1997, INT J EPIDEMIOL, V26, P24, DOI 10.1093/ije/26.1.24; Lin JM, 2000, B ENVIRON CONTAM TOX, V64, P817; Lin Y, 2012, NUTR CANCER, V64, P508, DOI 10.1080/01635581.2012.668743; Mathias PI, 2014, J CHROMATOGR B, V964, P136, DOI 10.1016/j.jchromb.2014.02.057; Metayer C, 2002, LUNG CANCER, V35, P111, DOI 10.1016/S0169-5002(01)00412-3; Minko IG, 2009, CHEM RES TOXICOL, V22, P759, DOI 10.1021/tx9000489; Mu LN, 2013, CANCER CAUSE CONTROL, V24, P439, DOI 10.1007/s10552-012-0130-8; National Registry of Diseases Office Health Promotion Board, 2013, SING CANC REG INT AN, DOI [10.1136/bjophthalmol-2012-302032, DOI 10.1136/BJOPHTHALMOL-2012-302032]; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PELLIZZARI ED, 1995, J EXPO ANAL ENV EPID, V5, P77; Schauer JJ, 2002, ENVIRON SCI TECHNOL, V36, P567, DOI 10.1021/es002053m; Seaman VY, 2009, ATMOS ENVIRON, V43, P6199, DOI 10.1016/j.atmosenv.2009.08.043; Seow A, 2000, CANCER EPIDEM BIOMAR, V9, P1215; SHIELDS PG, 1995, J NATL CANCER I, V87, P836, DOI 10.1093/jnci/87.11.836; Bastos LCS, 2010, J AGR FOOD CHEM, V58, P12777, DOI 10.1021/jf1028575; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Stewart BW, 2014, WORLD CANC REPORT 20, P16, DOI DOI 10.1136/oemed-2019-106012; Tang L, 2010, ENVIRON HEALTH PERSP, V118, P1257, DOI 10.1289/ehp.0901587; UMANO K, 1987, J AGR FOOD CHEM, V35, P909, DOI 10.1021/jf00078a014; Wang XR, 2009, ANN ONCOL, V20, P746, DOI 10.1093/annonc/mdn699; Yu ITS, 2006, CANCER RES, V66, P4961, DOI 10.1158/0008-5472.CAN-05-2932; Zhong LJ, 1999, EPIDEMIOLOGY, V10, P488, DOI 10.1097/00001648-199909000-00005	41	13	13	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120023	10.1371/journal.pone.0120023	http://dx.doi.org/10.1371/journal.pone.0120023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807518	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000351880000057
J	Lapa, C; Linsenmann, T; Luckerath, K; Samnick, S; Herrmann, K; Stoffer, C; Ernestus, RI; Buck, AK; Lohr, M; Monoranu, CM				Lapa, Constantin; Linsenmann, Thomas; Lueckerath, Katharina; Samnick, Samuel; Herrmann, Ken; Stoffer, Carolin; Ernestus, Ralf-Ingo; Buck, Andreas K.; Loehr, Mario; Monoranu, Camelia-Maria			Tumor-Associated Macrophages in Glioblastoma Multiforme-A Suitable Target for Somatostatin Receptor-Based Imaging and Therapy?	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN-BRAIN-TUMORS; HUMAN GLIOMAS; ADJUVANT TEMOZOLOMIDE; CELL INFILTRATION; EXPRESSION; ACTIVATION; SUBTYPES; GROWTH; CANCER	Background Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults. Tumor-associated macrophages (TAM) have been shown to promote malignant growth and to correlate with poor prognosis. [1,4,7,10-tetraazacyclododecane-NN', N '', N'''-tetraacetic acid]-d-Phe1, Tyr3-octreotate (DOTATATE) labeled with Gallium-68 selectively binds to somatostatin receptor 2A (SSTR2A) which is specifically expressed and up-regulated in activated macrophages. On the other hand, the role of SSTR2A expression on the cell surface of glioma cells has not been fully elucidated yet. The aim of this study was to non-invasively assess SSTR2A expression of both glioma cells as well as macrophages in GBM. Methods 15 samples of patient-derived GBM were stained immunohistochemically for macrophage infiltration (CD68), proliferative activity (Ki67) as well as expression of SSTR2A. Anti-CD45 staining was performed to distinguish between resident microglia and tumor-infiltrating macrophages. In a subcohort, positron emission tomography (PET) imaging using Ga-68-DOTATATE was performed and the semiquantitatively evaluated tracer uptake was compared to the results of immunohistochemistry. Results The amount of microglia/macrophages ranged from < 10% to > 50% in the tumor samples with the vast majority being resident microglial cells. A strong SSTR2A immunostaining was observed in endothelial cells of proliferating vessels, in neurons and neuropile. Only faint immunostaining was identified on isolated microglial and tumor cells. Somatostatin receptor imaging revealed areas of increased tracer accumulation in every patient. However, retention of the tracer did not correlate with immunohistochemical staining patterns. Conclusion SSTR2A seems not to be overexpressed in GBM samples tested, neither on the cell surface of resident microglia or infiltrating macrophages, nor on the surface of tumor cells. These data suggest that somatostatin receptor directed imaging and treatment strategies are less promising in GBM.	[Lapa, Constantin; Lueckerath, Katharina; Samnick, Samuel; Herrmann, Ken; Buck, Andreas K.] Univ Hosp Wurzburg, Dept Nucl Med, Wurzburg, Germany; [Linsenmann, Thomas; Ernestus, Ralf-Ingo; Loehr, Mario] Univ Hosp Wurzburg, Dept Neurosurg, Wurzburg, Germany; [Stoffer, Carolin; Monoranu, Camelia-Maria] Univ Wurzburg, Inst Pathol, Dept Neuropathol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Lapa, C (corresponding author), Univ Hosp Wurzburg, Dept Nucl Med, Wurzburg, Germany.	Lapa_c@ukw.de	Linsenmann, Thomas/AAE-3678-2019; Lueckerath, Katharina/S-5882-2018; Herrmann, Ken/E-8956-2015; Lapa, Constantin/GLV-0441-2022; Löhr, Mario/AAD-4542-2019; Herrmann, Ken/GOH-1465-2022; Lueckerath, Katharina/AAF-8598-2019	Linsenmann, Thomas/0000-0001-6763-8680; Lueckerath, Katharina/0000-0001-6109-2066; Lapa, Constantin/0000-0001-7536-2207; Lueckerath, Katharina/0000-0001-6109-2066; Buck, Andreas/0000-0002-6447-0613				Ambrosini V, 2011, J NUCL MED, V52, p42S, DOI 10.2967/jnumed.110.085753; Antunes P, 2007, EUR J NUCL MED MOL I, V34, P982, DOI 10.1007/s00259-006-0317-x; Armani C, 2007, J LEUKOCYTE BIOL, V81, P845, DOI 10.1189/jlb.0606417; Bourdier T, 2011, NUCL MED BIOL, V38, P645, DOI 10.1016/j.nucmedbio.2011.01.001; Breeman WAP, 2011, SEMIN NUCL MED, V41, P314, DOI 10.1053/j.semnuclmed.2011.02.001; Cervera P, 2002, J NEUROENDOCRINOL, V14, P458, DOI 10.1046/j.1365-2826.2002.00801.x; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Dalm VASH, 2003, AM J PHYSIOL-ENDOC M, V285, pE344, DOI 10.1152/ajpendo.00048.2003; DAVIDSON SE, 1992, INT J CANCER, V50, P10, DOI 10.1002/ijc.2910500104; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Dutour A, 1998, INT J CANCER, V76, P620, DOI 10.1002/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.3.CO;2-X; FEINDT J, 1995, J NEUROCHEM, V65, P1997; FLAMM J, 1986, UROL INT, V41, P187, DOI 10.1159/000281194; Fueger BJ, 2010, J NUCL MED, V51, P1532, DOI 10.2967/jnumed.110.078592; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hanscheid H, 2012, EUR J NUCL MED MOL I, V39, P1284, DOI 10.1007/s00259-012-2124-x; Heute D, 2010, J NUCL MED, V51, P397, DOI 10.2967/jnumed.109.072819; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Huysentruyt LC, 2008, INT J CANCER, V123, P73, DOI 10.1002/ijc.23492; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Komohara Y, 2012, CANCER SCI, V103, P2165, DOI 10.1111/cas.12015; Kostianovsky AM, 2008, J IMMUNOL, V181, P5425, DOI 10.4049/jimmunol.181.8.5425; Krantic S, PEPTIDES, V200, P1941; Kreissl MC, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-99; Langen KJ, 2011, NUKLEARMED-NUCL MED, V50, P167, DOI 10.3413/nuk-2011041; LEENSTRA S, 1995, J NEUROIMMUNOL, V56, P17, DOI 10.1016/0165-5728(94)00128-B; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Mawrin C, 2004, J NEUROPATH EXP NEUR, V63, P13, DOI 10.1093/jnen/63.1.13; MORANTZ RA, 1979, J NEUROSURG, V50, P305, DOI 10.3171/jns.1979.50.3.0305; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nishie A, 1999, CLIN CANCER RES, V5, P1107; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; REISINE T, 1995, ENDOCR REV, V16, P427, DOI 10.1210/er.16.4.427; Reubi JC, 2000, EUR J NUCL MED, V27, P273, DOI 10.1007/s002590050034; REUBI JC, 1987, CANCER RES, V47, P5758; Shimura S, 2000, CANCER RES, V60, P5857; Strojnik T, 2009, ANTICANCER RES, V29, P3269; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tsutsui S, 2005, ONCOL REP, V14, P425; Wagner S, 1999, INT J CANCER, V82, P12, DOI 10.1002/(SICI)1097-0215(19990702)82:1<12::AID-IJC3>3.0.CO;2-O; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Zhai HY, 2011, GLIA, V59, P472, DOI 10.1002/glia.21117	46	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122269	10.1371/journal.pone.0122269	http://dx.doi.org/10.1371/journal.pone.0122269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807228	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000215
J	Lee, YA; Kang, SG; Song, SW; Rho, JS; Kim, EK				Lee, Yun-Ah; Kang, Sung-Goo; Song, Sang-Wook; Rho, Jun-Seung; Kim, Eun-Kyung			Association between Metabolic Syndrome, Smoking Status and Coronary Artery Calcification	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SUBCLINICAL ATHEROSCLEROSIS; INSULIN-RESISTANCE; HEART-DISEASE; OBESITY; PREVALENCE; MORTALITY; ADULTS; WOMEN	Coronary artery calcification (CAC), an indicator of coronary artery stenosis, is an independent risk factor of ischemic heart disease. Smoking increases the risk of metabolic syndrome (MS) and cardiovascular disease. Almost no previous studies have evaluated the combined effect of MS and smoking status on CAC. Therefore, in this study we examined the relationships between CAC, MS, and smoking. This study included 775 adult males without histories of cardiovascular disease who visited the Health Promotion Center at the University Hospital in Gyeonggi-do, Republic of Korea from January 2, 2010 to December 31, 2012. All subjects were screened for CAC by multi-detector computed tomography (MDCT). CAC increased significantly with age and body mass index (BMI). Among MS components, abdominal obesity and elevated fasting blood glucose were correlated with CAC. After adjusting for age and BMI, MS was associated with a 1.46-fold increase in CAC (95% CI: 1.02-2.09), abdominal obesity was associated with a 1.45-fold increase (95% CI: 1.04-2.04), elevated fasting blood glucose was associated with a 2-fold increase (95% CI: 1.36-2.94), and MS and smoking combined were associated with 2.44-fold increase in CAC. Thus, the combination of smoking and MS had a greater impact on CAC than any single factor alone. MS is correlated with an increased risk of CAC, and a combination of MS and smoking is associated with even greater risk. These findings can be used to prevent cardiovascular disease in adults.	[Lee, Yun-Ah; Kang, Sung-Goo; Song, Sang-Wook; Rho, Jun-Seung] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Family Med, Suwon, South Korea; [Song, Sang-Wook; Kim, Eun-Kyung] Catholic Univ Korea, St Vincents Hosp, Coll Med, Hlth Promot Ctr, Suwon, South Korea	Catholic University of Korea; Catholic University of Korea	Kang, SG (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Family Med, Suwon, South Korea.	hippo94@naver.com		Kang, Sung-Goo/0000-0003-4627-291X; Lee, Yun-Ah/0000-0001-8910-7143				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Bonora E, 2004, DIABETIC MED, V21, P52, DOI 10.1046/j.1464-5491.2003.01068.x; Budoff MJ, 2008, VASC HEALTH RISK MAN, V4, P315, DOI 10.2147/VHRM.S1160; Budoff MJ, 2003, PROG CARDIOVASC DIS, V46, P135, DOI 10.1016/S0033-0620(03)00083-5; Cao HL, 2013, CHINESE MED J-PEKING, V126, P4618, DOI 10.3760/cma.j.issn.0366-6999.20131083; Choe KO, 1997, KOREAN CIRC J, V27, P566; 김동희, 2008, Korean Circulation Journal, V38, P29; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Folsom AR, 2004, ANGIOLOGY, V55, P613, DOI 10.1177/000331970405500602; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Golden SH, 2002, DIABETES, V51, P3069, DOI 10.2337/diabetes.51.10.3069; GORDON T, 1977, ANN INTERN MED, V87, P393, DOI 10.7326/0003-4819-87-4-393; GORDON T, 1982, AM HEART J, V103, P1031, DOI 10.1016/0002-8703(82)90567-1; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Ishizaka N, 2005, ATHEROSCLEROSIS, V181, P381, DOI 10.1016/j.atherosclerosis.2005.01.026; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jockel KH, 2009, ATHEROSCLEROSIS, V203, P221, DOI 10.1016/j.atherosclerosis.2008.05.041; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Klein BEK, 2002, DIABETES CARE, V25, P1790, DOI 10.2337/diacare.25.10.1790; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lehmann N, 2014, ATHEROSCLEROSIS, V232, P339, DOI 10.1016/j.atherosclerosis.2013.11.045; Liu SM, 2001, CURR OPIN LIPIDOL, V12, P395, DOI 10.1097/00041433-200108000-00005; Meigs JB, 2002, AM J MANAG CARE, V8, pS283; MJOS OD, 1988, AM HEART J, V115, P272, DOI 10.1016/0002-8703(88)90649-7; Onat A, 2002, ATHEROSCLEROSIS, V165, P285, DOI 10.1016/S0021-9150(02)00236-8; Park HS, 2006, DIABETES CARE, V29, P933, DOI 10.2337/diacare.29.04.06.dc06-0069; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Ramos JJ, 2007, AM J MED SCI, V334, P350, DOI 10.1097/MAJ.0b013e3181379f2d; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Wong ND, 2012, JACC-CARDIOVASC IMAG, V5, P358, DOI 10.1016/j.jcmg.2011.12.015; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6; Wong ND, 2003, J AM COLL CARDIOL, V41, P1547, DOI 10.1016/S0735-1097(03)00193-1	44	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122430	10.1371/journal.pone.0122430	http://dx.doi.org/10.1371/journal.pone.0122430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816100	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600179
J	Pinheiro, NM; Miranda, CJCP; Perini, A; Camara, NOS; Costa, SKP; Alonso-Vale, MIC; Caperuto, LC; Tiberio, IFLC; Prado, MAM; Martins, MA; Prado, VF; Prado, CM				Pinheiro, Nathalia M.; Miranda, Claudia J. C. P.; Perini, Adenir; Camara, Niels O. S.; Costa, Soraia K. P.; Alonso-Vale, Maria Isabel C.; Caperuto, Luciana C.; Tiberio, Iolanda F. L. C.; Prado, Marco Antonio M.; Martins, Milton A.; Prado, Vania F.; Prado, Carla M.			Pulmonary Inflammation Is Regulated by the Levels of the Vesicular Acetylcholine Transporter	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ALLERGIC AIRWAY INFLAMMATION; NONNEURONAL ACETYLCHOLINE; LUNG INFLAMMATION; MICE; RELEASE; EXPRESSION; SYSTEM; ASTHMA; CELLS	Acetylcholine (ACh) plays a crucial role in physiological responses of both the central and the peripheral nervous system. Moreover, ACh was described as an anti-inflammatory mediator involved in the suppression of exacerbated innate response and cytokine release in various organs. However, the specific contributions of endogenous release ACh for inflammatory responses in the lung are not well understood. To address this question we have used mice with reduced levels of the vesicular acetylcholine transporter (VAChT), a protein required for ACh storage in secretory vesicles. VAChT deficiency induced airway inflammation with enhanced TNF-alpha and IL-4 content, but not IL-6, IL-13 and IL-10 quantified by ELISA. Mice with decreased levels of VAChT presented increased collagen and elastic fibers deposition in airway walls which was consistent with an increase in inflammatory cells positive to MMP-9 and TIMP-1 in the lung. In vivo lung function evaluation showed airway hyperresponsiveness to methacholine in mutant mice. The expression of nuclear factor-kappa B (p65-NF-kappa B) in lung of VAChT-deficient mice were higher than in wild-type mice, whereas a decreased expression of janus-kinase 2 (JAK2) was observed in the lung of mutant animals. Our findings show the first evidence that cholinergic deficiency impaired lung function and produce local inflammation. Our data supports the notion that cholinergic system modulates airway inflammation by modulation of JAK2 and NF-kappa B pathway. We proposed that intact cholinergic pathway is necessary to maintain the lung homeostasis.	[Pinheiro, Nathalia M.; Miranda, Claudia J. C. P.; Perini, Adenir; Tiberio, Iolanda F. L. C.; Martins, Milton A.; Prado, Carla M.] Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, Brazil; [Alonso-Vale, Maria Isabel C.; Caperuto, Luciana C.; Prado, Carla M.] Univ Fed Sao Paulo, Dept Biol Sci, Diadema, Brazil; [Camara, Niels O. S.] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil; [Costa, Soraia K. P.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil; [Prado, Marco Antonio M.; Prado, Vania F.] Univ Western Ontario, Dept Physiol & Pharmacol, Robarts Res Inst, Mol Med Grp, London, ON, Canada; [Prado, Marco Antonio M.; Prado, Vania F.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Western University (University of Western Ontario); Western University (University of Western Ontario)	Prado, CM (corresponding author), Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, Brazil.	carla.prado@unifesp.br	Tibério, Iolanda FLC/C-6461-2012; Pinheiro, Nathalia M/F-1422-2016; COSTA, SORAIA K P/X-6388-2019; Alonso-Vale, Maria Isabel C/C-6108-2012; Costa, Soraia KP/K-7227-2012; Prado, Marco Antonio Maximo/K-7638-2013; Prado, Carla M/G-3327-2012; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011; Prado, Vania Ferreira/K-7630-2013; Caperuto, Luciana/K-2489-2012	Tibério, Iolanda FLC/0000-0002-5662-7895; COSTA, SORAIA K P/0000-0002-2574-4490; Costa, Soraia KP/0000-0002-2574-4490; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Prado, Carla M/0000-0003-1160-0442; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Prado, Vania Ferreira/0000-0003-4994-6393; ALONSO-VALE, MARIA ISABEL/0000-0001-5847-8080	Sao Paulo State Research Foundation [FAPESP-2008/55359-5]; National Council for Technologic and Development (CNPq), Brazil [471224/2009-0]	Sao Paulo State Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Technologic and Development (CNPq), Brazil	Funding: This study was supported by Sao Paulo State Research Foundation (FAPESP-2008/55359-5) and National Council for Technologic and Development (CNPq) (471224/2009-0), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Caperuto LC, 2008, ENDOCRINOLOGY, V149, P6326, DOI 10.1210/en.2008-0655; Catal F, 2015, ALLERGOL IMMUNOPATH, V43, P14, DOI 10.1016/j.aller.2013.11.002; Chetta A, 1997, CHEST, V111, P852, DOI 10.1378/chest.111.4.852; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Ganesan S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-131; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Guzman MS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001194; Hantos Z, 2008, J APPL PHYSIOL, V105, P1864, DOI 10.1152/japplphysiol.90924.2008; Hofer S, 2008, CRIT CARE MED, V36, P404, DOI 10.1097/01.CCM.0B013E31816208B3; Ishii M, 2006, CURR PHARM DESIGN, V12, P3573, DOI 10.2174/138161206778522056; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Kawashima K, 2004, FRONT BIOSCI-LANDMRK, V9, P2063, DOI 10.2741/1390; Kawashima K, 2012, LIFE SCI, V91, P1027, DOI 10.1016/j.lfs.2012.05.006; Kox M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034431; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Kummer W, 2014, CURR OPIN PHARMACOL, V16, P43, DOI 10.1016/j.coph.2014.03.001; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lima RD, 2010, J NEUROCHEM, V113, P943, DOI 10.1111/j.1471-4159.2010.06657.x; Lips KS, 2007, LIFE SCI, V80, P2263, DOI 10.1016/j.lfs.2007.01.026; Lips KS, 2005, AM J RESP CELL MOL, V33, P79, DOI 10.1165/rcmb.2004-0363OC; Mazzon E, 2008, CLIN EXP IMMUNOL, V153, P136, DOI 10.1111/j.1365-2249.2008.03669.x; Moldoveanu B, 2009, J INFLAMM RES, V2, P1; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Parrish WR, 2008, ANN NY ACAD SCI, V1144, P210, DOI 10.1196/annals.1418.011; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Pena G, 2010, J MOL MED, V88, P851, DOI 10.1007/s00109-010-0628-z; Phipps S, 2004, AM J RESP CELL MOL, V31, P626, DOI 10.1165/rcmb.2004-0193OC; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Prado CM, 2006, AM J RESP CELL MOL, V35, P457, DOI 10.1165/rcmb.2005-0391OC; Prado MAM, 2002, NEUROCHEM INT, V41, P291, DOI 10.1016/S0197-0186(02)00044-X; Prado VF, 2013, BIOCHEM J, V450, P265, DOI 10.1042/BJ20121662; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Proskocil BJ, 2004, ENDOCRINOLOGY, V145, P2498, DOI 10.1210/en.2003-1728; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Racke K, 2006, EUR J PHARMACOL, V533, P57, DOI 10.1016/j.ejphar.2005.12.050; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Roy A, 2013, FASEB J, V27, P5072, DOI 10.1096/fj.13-238279; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Schelegle ES, 2012, RESP PHYSIOL NEUROBI, V181, P277, DOI 10.1016/j.resp.2012.04.003; Song XM, 2008, SHOCK, V30, P468, DOI 10.1097/SHK.0b013e31816d5e49; Su X, 2007, AM J RESP CELL MOL, V37, P186, DOI 10.1165/rcmb.2006-0240OC; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Toledo AC, 2013, BRIT J PHARMACOL, V168, P1736, DOI 10.1111/bph.12062; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Verbout NG, 2007, AM J PHYSIOL-LUNG C, V292, pL1126, DOI 10.1152/ajplung.00455.2006; Vieira RP, 2007, AM J RESP CRIT CARE, V176, P871, DOI 10.1164/rccm.200610-1567OC; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wessler I, 2003, LIFE SCI, V72, P2055, DOI 10.1016/S0024-3205(03)00083-3; Wessler I, 2007, LIFE SCI, V80, P2253, DOI 10.1016/j.lfs.2007.01.042; Yang X, 2014, QJM-INT J MED, V107, P789, DOI 10.1093/qjmed/hcu005	55	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120441	10.1371/journal.pone.0120441	http://dx.doi.org/10.1371/journal.pone.0120441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816137	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600036
J	Hamad, IAY; Fei, Y; Kalea, AZ; Yin, D; Smith, AJP; Palmen, J; Humphries, SE; Talmud, PJ; Walker, AP				Hamad, Ibrahim A. Y.; Fei, Yue; Kalea, Anastasia Z.; Yin, Dan; Smith, Andrew J. P.; Palmen, Jutta; Humphries, Steve E.; Talmud, Philippa J.; Walker, Ann P.			Demonstration of the Presence of the "Deleted" MIR122 Gene in HepG2 Cells	PLOS ONE			English	Article							C VIRUS-RNA; HEPATOCELLULAR-CARCINOMA; HUMAN GENOME; REGULATORY ELEMENTS; MICRORNA; EXPRESSION; DNA; FAIRE; LINE	MicroRNA 122 (miR-122) is highly expressed in the liver where it influences diverse biological processes and pathways, including hepatitis C virus replication and metabolism of iron and cholesterol. It is processed from a long non-coding primary transcript (similar to 7.5 kb) and the gene has two evolutionarily-conserved regions containing the pri-mir-122 promoter and pre-mir-122 hairpin region. Several groups reported that the widely-used hepatocytic cell line HepG2 had deficient expression of miR-122, previously ascribed to deletion of the pre-mir-122 stem-loop region. We aimed to characterise this deletion by direct sequencing of 6078 bp containing the pri-mir-122 promoter and pre-mir-122 stem-loop region in HepG2 and Huh-7, a control hepatocytic cell line reported to express miR-122, supported by sequence analysis of cloned genomic DNA. In contrast to previous findings, the entire sequence was present in both cell lines. Ten SNPs were heterozygous in HepG2 indicating that DNA was present in two copies. Three validation isolates of HepG2 were sequenced, showing identical genotype to the original in two, whereas the third was different. Investigation of promoter chromatin status by FAIRE showed that Huh-7 cells had 6.2 +/- 0.19- and 2.7 +/- 0.01-fold more accessible chromatin at the proximal (HNF4 alpha-binding) and distal DR1 transcription factor sites, compared to HepG2 cells (p=0.03 and 0.001, respectively). This was substantiated by ENCODE genome annotations, which showed a DNAse I hypersensitive site in the pri-mir-122 promoter in Huh-7 that was absent in HepG2 cells. While the origin of the reported deletion is unclear, cell lines should be obtained from a reputable source and used at low passage number to avoid discrepant results. Deficiency of miR-122 expression in HepG2 cells may be related to a relative deficiency of accessible promoter chromatin in HepG2 versus Huh-7 cells.	[Hamad, Ibrahim A. Y.; Fei, Yue; Kalea, Anastasia Z.; Yin, Dan; Smith, Andrew J. P.; Palmen, Jutta; Humphries, Steve E.; Talmud, Philippa J.; Walker, Ann P.] UCL, Inst Cardiovasc Sci, BHF Labs, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Hamad, Ibrahim A. Y.] Al Azhar Univ, Dept Med Biochem, Dumyat 34511, Egypt; [Yin, Dan] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Coll Life Sci & Technol, Minist Educ,Key Lab Mol Bioohys, Wuhan 430074, Peoples R China	University of London; University College London; Egyptian Knowledge Bank (EKB); Al Azhar University; Huazhong University of Science & Technology	Walker, AP (corresponding author), UCL, Inst Cardiovasc Sci, BHF Labs, Ctr Cardiovasc Genet, London WC1E 6JF, England.	ann.walker@ucl.ac.uk	Kalea, Anastasia Z./G-4053-2010; FEI, YUE/AAN-6934-2020; Walker, Ann P/C-1628-2008	FEI, YUE/0000-0002-4622-6377; Hamad, Ibrahim/0000-0002-3443-761X; Humphries, Stephen E/0000-0002-8221-6547; Kalea, Anastasia Z./0000-0001-5775-3984; Talmud, Philippa/0000-0002-5560-1933; YIN, DAN/0000-0003-1268-5345; Smith, Andrew/0000-0003-1141-2978	Egyptian Cultural and Educational Bureau; National Institute for Health Research University College London Hospitals Biomedical Research Centre; BHF [FS/13/6/29977, PG 008/08]; British Heart Foundation [FS/13/6/29977, RG/08/008/25291] Funding Source: researchfish	Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); BHF(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This study was supported by: a channel scheme studentship from the Egyptian Cultural and Educational Bureau (IAYH, APW), http://www.mohe-casm.edu.eg/; A National Institute for Health Research University College London Hospitals Biomedical Research Centre #HZHD (AZK), (http://www.uclhospitals.brc.nihr.ac.uk/); A BHF Intermediate Basic Science Research Fellowship FS/13/6/29977 (AJPS) and a BHF Programme Grant PG 008/08 (SEH, PJT), (www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Basu S, 2014, NUCLEIC ACIDS RES, V42, P7170, DOI 10.1093/nar/gku346; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cheng D, 1993, Prog Clin Biol Res, V382, P149; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; HARBERS M., 2012, TAG BASED NEXT GENER; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Selden C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082312; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Smith AJP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002908; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vecchi C, 2010, HEPATOLOGY, V51, P654, DOI 10.1002/hep.23410; Wong N, 2000, HEPATOLOGY, V32, P1060, DOI 10.1053/jhep.2000.19349; Wu X, 2009, SCAND J GASTROENTERO, V44, P1332, DOI 10.3109/00365520903215305	35	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122471	10.1371/journal.pone.0122471	http://dx.doi.org/10.1371/journal.pone.0122471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811611	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700192
J	Kaur, J; Duan, SY; Vaas, LAI; Penesyan, A; Meyer, W; Paulsen, IT; Nevalainen, H				Kaur, Jashanpreet; Duan, Shu Yao; Vaas, Lea A. I.; Penesyan, Anahit; Meyer, Wieland; Paulsen, Ian T.; Nevalainen, Helena			Phenotypic Profiling of Scedosporium aurantiacum, an Opportunistic Pathogen Colonizing Human Lungs	PLOS ONE			English	Article							CARBON UTILIZATION PROFILES; CYSTIC-FIBROSIS; PSEUDALLESCHERIA-BOYDII; CRYPTOCOCCUS-NEOFORMANS; MOLECULAR PHYLOGENY; FUNGI; VIRULENCE; MODEL; IDENTIFICATION; TRICHODERMA	Genotyping studies of Australian Scedosporium isolates have revealed the strong prevalence of a recently described species: Scedosporium aurantiacum. In addition to occurring in the environment, this fungus is also known to colonise the respiratory tracts of cystic fibrosis (CF) patients. A high throughput Phenotype Microarray (PM) analysis using 94 assorted substrates (sugars, amino acids, hexose-acids and carboxylic acids) was carried out for four isolates exhibiting different levels of virulence, determined using a Galleria mellonella infection model. A significant difference was observed in the substrate utilisation patterns of strains displaying differential virulence. For example, certain sugars such as sucrose (saccharose) were utilised only by low virulence strains whereas some sugar derivatives such as D-turanose promoted respiration only in the more virulent strains. Strains with a higher level of virulence also displayed flexibility and metabolic adaptability at two different temperature conditions tested (28 and 37 degrees C). Phenotype microarray data were integrated with the whole-genome sequence data of S. aurantiacum to reconstruct a pathway map for the metabolism of selected substrates to further elucidate differences between the strains.	[Kaur, Jashanpreet; Penesyan, Anahit; Paulsen, Ian T.; Nevalainen, Helena] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Kaur, Jashanpreet; Penesyan, Anahit; Paulsen, Ian T.; Nevalainen, Helena] Macquarie Univ, Biomol Frontiers Res Ctr, Sydney, NSW 2109, Australia; [Duan, Shu Yao; Vaas, Lea A. I.; Meyer, Wieland] Univ Sydney, Westmead Millennium Inst, Westmead Hosp,Ctr Infect Dis & Microbiol,Mol Myco, Sydney Med School,Marie Bashir Inst Infect Dis &, Sydney, NSW 2006, Australia; [Vaas, Lea A. I.] Fungal Biodivers Ctr, Cent bur Schimmelculturen, Bioinformat Grp, Utrecht, Netherlands	Macquarie University; Macquarie University; University of Sydney; Westmead Institute for Medical Research; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Nevalainen, H (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	helena.nevalainen@mq.edu.au	Penesyan, Anahit/Y-6884-2019; Penesyan, Anahit/A-9442-2012; Meyer, Wieland/G-1204-2015; Paulsen, Ian/K-3832-2012	Penesyan, Anahit/0000-0002-2502-0740; Penesyan, Anahit/0000-0002-2502-0740; Meyer, Wieland/0000-0001-9933-8340; Paulsen, Ian/0000-0001-9015-9418; Nevalainen, Helena/0000-0003-0083-4630	Australian Research Council-Super Science Fellowship (ARC-SSF)	Australian Research Council-Super Science Fellowship (ARC-SSF)(Australian Research Council)	Australian Research Council-Super Science Fellowship (ARC-SSF) was awarded to N.H. Packer, M.P. Molloy, H.K. Nevalainen, I.T. Paulsen and P.A. Haynes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2010, J CLIN MICROBIOL, V48, P4410, DOI 10.1128/JCM.01646-10; Atanasova L, 2010, J ZHEJIANG UNIV-SC B, V11, P151, DOI 10.1631/jzus.B1000007; Bercoff AP, 2015, GENOME ANNOUNC, V3, DOI [10.1128/genomeA.01526-14, DOI 10.1128/GENOMEA.01526-14]; Blyth CC, 2010, J CLIN MICROBIOL, V48, P314, DOI 10.1128/JCM.01470-09; Blyth CC, 2010, MED MYCOL, V48, pS37, DOI 10.3109/13693786.2010.500627; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; CADDICK MX, 1994, ANTON LEEUW INT J G, V65, P169, DOI 10.1007/BF00871943; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Delhaes L, 2008, EMERG INFECT DIS, V14, P282, DOI 10.3201/eid1402.070920; Druzhinina IS, 2006, APPL ENVIRON MICROB, V72, P2126, DOI 10.1128/AEM.72.3.2126-2133.2006; Firacative C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105076; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; Gilgado F, 2009, MED MYCOL, V47, P371, DOI 10.1080/13693780802256539; Guarro J, 2006, MED MYCOL, V44, P295, DOI 10.1080/13693780600752507; Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235; Harun A, 2010, MED MYCOL, V48, pS70, DOI 10.3109/13693786.2010.515254; Harun A, 2010, MED MYCOL, V48, pS45, DOI 10.3109/13693786.2010.517224; Harun A, 2009, MED MYCOL, V47, P406, DOI 10.1080/13693780802510240; Heath CH, 2009, CLIN MICROBIOL INFEC, V15, P689, DOI 10.1111/j.1469-0691.2009.02802.x; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Jun H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-68; Kaltseis J, 2009, MED MYCOL, V47, P398, DOI 10.1080/13693780802585317; Khalil Sammar, 2009, Open Microbiol J, V3, P9, DOI 10.2174/1874285800903010009; Kraus PR, 2004, EUKARYOT CELL, V3, P1249, DOI 10.1128/EC.3.5.1249-1260.2004; Lackner M, 2012, ANTIMICROB AGENTS CH, V56, P2635, DOI 10.1128/AAC.05910-11; Lan CY, 2002, P NATL ACAD SCI USA, V99, P14907, DOI 10.1073/pnas.232566499; Llorens A, 2006, INT J FOOD MICROBIOL, V106, P297, DOI 10.1016/j.ijfoodmicro.2005.09.005; Loesch A, 2010, J INVERTEBR PATHOL, V104, P58, DOI 10.1016/j.jip.2010.01.007; Loira N, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-35; MANDELS GR, 1954, PLANT PHYSIOL, V29, P18, DOI 10.1104/pp.29.1.18; Morales CA, 2005, APPL ENVIRON MICROB, V71, P4388, DOI 10.1128/AEM.71.8.4388-4399.2005; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Santos ALS, 2009, MED MYCOL, V47, P375, DOI 10.1080/13693780802610305; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Smedsgaard J, 2005, J EXP BOT, V56, P273, DOI 10.1093/jxb/eri068; Steen BR, 2002, GENOME RES, V12, P1386, DOI 10.1101/gr.80202; Tang E, 2010, CAN J MICROBIOL, V56, P979, DOI 10.1139/W10-085; Tanzer Matthew M., 2003, Functional & Integrative Genomics, V3, P160, DOI 10.1007/s10142-003-0089-3; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222	48	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122354	10.1371/journal.pone.0122354	http://dx.doi.org/10.1371/journal.pone.0122354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811884	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700186
J	Li, YH; Tao, ML; Ma, FP; Pan, GQ; Zhou, ZY; Wu, ZL				Li, Yanhong; Tao, Meiling; Ma, Fuping; Pan, Guoqing; Zhou, Zeyang; Wu, Zhengli			A Monoclonal Antibody That Tracks Endospore Formation in the Microsporidium Nosema bombycis	PLOS ONE			English	Article							SPORE WALL PROTEIN; ENCEPHALITOZOON-CUNICULI; DEVELOPMENTAL EXPRESSION; PHYLOGENETIC ANALYSIS; PROTEOMIC ANALYSIS; GENOME SEQUENCE; IDENTIFICATION; INTESTINALIS; DIAGNOSIS; PATHOGEN	Nosema bombycis, the first identified microsporidium, is a destructive pathogen of the silkworm Bombyx mori and causes severe worldwide economic losses in sericulture. Major microsporidian structural proteins, such as the spore wall protein (SWP), are known to be involved in host invasion. In this study, the reactivity of the monoclonal antibody 2B10 was tested against an endospore protein of N. bombycis with a molecular weight size at 50-kDa, using Western blotting. The antigen was purified after immunoprecipitation and was further identified as EOB13320 according to MALDI-TOF MS assay. We found that EOB13320 locates to the surface of the different developmental stages of the parasite, mostly the sporoblast stage and the mature spore after immunoelectron microscopy examination. EOB13320 was also widely distributed in the developing endospore, especially at the sporoblast stage. This endospore protein also accumulated in the cytoplasm of both the merogony and sporoblast stages. These results imply that EOB13320 detected by monoclonal antibody 2B10 is expressed throughout the life cycle of the parasite, notably during the stage when the endospore is formed, and that this protein is important for spore-coat formation and parasite maintenance. Our study could be instrumental in the understanding of spore wall formation and will help to gain greater insight into the biology of this parasite.	[Li, Yanhong; Pan, Guoqing; Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Li, Yanhong; Ma, Fuping; Wu, Zhengli] Southwest Univ, Coll Anim Sci & Technol, Chongqing 400715, Peoples R China; [Tao, Meiling] Jiangsu Univ Sci & Technol, Sericultural Res Inst, Zhenjiang 212018, Jiangsu, Peoples R China; [Zhou, Zeyang] Chongqing Normal Univ, Lab Anim Biol, Chongqing 400047, Peoples R China; [Wu, Zhengli] Southwest Univ, Fisheries Ecol & Environm Lab, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China; Jiangsu University of Science & Technology; Chongqing Normal University; Southwest University - China	Zhou, ZY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	zyzhou@swu.edu.cn; zh20140202@swu.edu.cn	li, yan/GTI-4638-2022		Foundation for the Author of National Excellent Doctoral Dissertation of PR China [FANEDD 201473]; Fundamental Research Funds for the Central Universities [SWU114011, SWU114015, XDJK2015C012]	Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD 201473) and the Fundamental Research Funds for the Central Universities (Grant number: SWU114011, SWU114015, and XDJK2015C012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers PJA, 1996, J CLIN MICROBIOL, V34, P282, DOI 10.1128/JCM.34.2.282-285.1996; Bohne W, 2000, INFECT IMMUN, V68, P2268, DOI 10.1128/IAI.68.4.2268-2275.2000; Brosson D, 2005, FEMS MICROBIOL LETT, V247, P81, DOI 10.1016/j.femsle.2005.04.031; Brosson D, 2006, PROTEOMICS, V6, P3625, DOI 10.1002/pmic.200500796; Cai SF, 2011, PARASITOLOGY, V138, P1102, DOI 10.1017/S0031182011000801; CALI A, 1993, J EUKARYOT MICROBIOL, V40, P101, DOI 10.1111/j.1550-7408.1993.tb04889.x; Cali Ann, 1999, P85; Capella-Gutierrez S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-47; Chen J, 2013, PARASITOLOGY, V140, P1394, DOI 10.1017/S0031182013000875; Corradi N, 2008, GENOMICS, V91, P388, DOI 10.1016/j.ygeno.2007.12.006; Corradi Nicolas, 2009, Fungal Biology Reviews, V23, P1, DOI 10.1016/j.fbr.2009.05.001; Delbac F, 1998, J EUKARYOT MICROBIOL, V45, P224, DOI 10.1111/j.1550-7408.1998.tb04529.x; Enriquez FJ, 1997, J CLIN MICROBIOL, V35, P724, DOI 10.1128/JCM.35.3.724-729.1997; Gill EE, 2006, GENE, V375, P103, DOI 10.1016/j.gene.2006.02.023; Hayman JR, 2001, INFECT IMMUN, V69, P7057, DOI 10.1128/IAI.69.11.7057-7066.2001; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Keohane EM, 1996, J EUKARYOT MICROBIOL, V43, P26, DOI 10.1111/j.1550-7408.1996.tb02468.x; Li YH, 2009, INT J PARASITOL, V39, P391, DOI 10.1016/j.ijpara.2008.08.011; Li YanHong, 2007, Acta Sericologica Sinica, V33, P138; Li Z, 2012, EUKARYOT CELL, V11, P229, DOI 10.1128/EC.05127-11; Lujan HD, 1998, HYBRIDOMA, V17, P237, DOI 10.1089/hyb.1998.17.237; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Peuvel-Fanget I, 2006, INT J PARASITOL, V36, P309, DOI 10.1016/j.ijpara.2005.10.005; Polonais V, 2010, INFECT IMMUN, V78, P2221, DOI 10.1128/IAI.01225-09; Prigneau O, 2000, J EUKARYOT MICROBIOL, V47, P48, DOI 10.1111/j.1550-7408.2000.tb00010.x; Schottelius J, 2000, MICROBES INFECT, V2, P1401, DOI 10.1016/S1286-4579(00)01293-4; Southern TR, 2007, EUKARYOT CELL, V6, P1354, DOI 10.1128/EC.00113-07; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Vavra Jiri, 1999, P7; Wang JY, 2007, PROTEOMICS, V7, P1461, DOI 10.1002/pmic.200600825; Wasson K, 2000, VET PATHOL, V37, P113, DOI 10.1354/vp.37-2-113; Wu ZL, 2008, PROTEOMICS, V8, P2447, DOI 10.1002/pmic.200700584; Wu ZL, 2009, J EUKARYOT MICROBIOL, V56, P113, DOI 10.1111/j.1550-7408.2008.00375.x; Xu YJ, 2006, INFECT IMMUN, V74, P239, DOI 10.1128/IAI.74.1.239-247.2006; Zhang F, 2007, PARASITOLOGY, V134, P1551, DOI 10.1017/S0031182007002934	38	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121884	10.1371/journal.pone.0121884	http://dx.doi.org/10.1371/journal.pone.0121884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811182	Green Submitted, gold, Green Published			2022-12-26	WOS:000356353700153
J	Lin, J; Han, ZH; Li, HX; Chen, SY; Li, XY; Liu, P; Wang, YL; Tang, CS; Du, JB; Jin, HF				Lin, Jing; Han, Zhenhui; Li, Hongxia; Chen, Selena Ying; Li, Xueying; Liu, Ping; Wang, Yuli; Tang, Chaoshu; Du, Junbao; Jin, Hongfang			Plasma C-Type Natriuretic Peptide as a Predictor for Therapeutic Response to Metoprolol in Children with Postural Tachycardia Syndrome	PLOS ONE			English	Article							NEURALLY-MEDIATED SYNCOPE; CHRONIC HEART-FAILURE; MIDODRINE HYDROCHLORIDE; ORTHOSTATIC INTOLERANCE; DIAGNOSTIC MANAGEMENT; INCREASE; CNP; ADOLESCENTS; RECEPTORS; BIOMARKER	POTS is a global public-health disease, but predictor for therapeutic response to metoprolol in children with POTS is lacking. This study was designed to investigate predictive value of plasma C-type natriuretic peptide (CNP) in the therapeutic efficacy of metoprolol on postural tachycardia syndrome (POTS) in children. Totally 34 children with POTS and 27 healthy children were included in the study. The head-up test or head-up tilt test was used to check heart rate and blood pressure from supine to upright in subjects. A double antibody (competitive) sandwich immunoluminometric assay was used to detect plasma CNP. Metoprolol was used to treat children with POTS. The difference in plasma concentrations of CNP between responders and non-responders was compared. An ROC curve was used to analyze plasma CNP to predict efficacy of metoprolol on POTS in children. Plasma CNP in children with POTS was significantly higher than that of healthy children [(51.9 +/- 31.4) vs. (25.1 +/- 19.1) pg/ml, P < 0.001]. Plasma CNP in responders to metoprolol was significantly higher than non-responders [(59.1 +/- 33.5) vs. (34.8 +/- 16.7) pg/ml, P = 0.037] before treatment. The ROC curve showed that area under the curve was 0.821 (95% CI 0.642-0.999). The cut-off value of plasma CNP > 32.55 pg/ml yielded a sensitivity of 95.8% and specificity of 70% in predicting therapeutic efficacy of metoprolol on POTS children. Plasma CNP might serve as a useful predictor for the therapeutic efficacy of metoprolol on POTS in children.	[Lin, Jing; Li, Hongxia; Liu, Ping; Wang, Yuli; Du, Junbao; Jin, Hongfang] Peking Univ, Dept Pediat, Hosp 1, Beijing 100871, Peoples R China; [Han, Zhenhui] Kaifeng Childrens Hosp, Dept Pediat, Kaifeng, Henan, Peoples R China; [Chen, Selena Ying] Univ Calif San Diego, La Jolla, CA 92093 USA; [Li, Xueying] Peking Univ, Hosp 1, Dept Med Stat, Beijing 100871, Peoples R China; [Tang, Chaoshu] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Tang, Chaoshu] Minist Educ, Key Lab Mol Cardiol, Beijing, Peoples R China	Peking University; University of California System; University of California San Diego; Peking University; Peking University	Jin, HF (corresponding author), Peking Univ, Dept Pediat, Hosp 1, Beijing 100871, Peoples R China.	jinhongfang51@126.com		Chen, Selena/0000-0001-5147-9507; Jin, Hongfang/0000-0002-1606-8988	National Twelfth Five-Year Plan for Science & Technology Support [2012BAI03B03]; Major Basic Research Project [2012CB517806]	National Twelfth Five-Year Plan for Science & Technology Support; Major Basic Research Project	The work was supported by grants from the National Twelfth Five-Year Plan for Science & Technology Support [2012BAI03B03] and Major Basic Research Project [2012CB517806]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr CS, 1996, PEPTIDES, V17, P1243, DOI 10.1016/S0196-9781(96)00110-6; Chen L, 2011, CIRC J, V75, P927, DOI 10.1253/circj.CJ-10-0514; Del Ry S, 2008, PEPTIDES, V29, P79, DOI 10.1016/j.peptides.2007.10.022; Del Ry S, 2005, EUR J HEART FAIL, V7, P1145, DOI 10.1016/j.ejheart.2004.12.009; Del Ry S, 2005, CLIN CHEM LAB MED, V43, P641, DOI 10.1515/CCLM.2005.110; Del Ry S, 2007, PEPTIDES, V28, P1068, DOI 10.1016/j.peptides.2007.03.002; Del Ry S, 2006, J CARDIOVASC MED, V7, P397, DOI 10.2459/01.JCM.0000228688.94709.5a; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Jarjour IT, 2013, SEMIN PEDIATR NEUROL, V20, P18, DOI 10.1016/j.spen.2013.01.001; Johnson JN, 2010, PEDIATR NEUROL, V42, P77, DOI 10.1016/j.pediatrneurol.2009.07.002; Lai CC, 2009, PACE, V32, P234, DOI 10.1111/j.1540-8159.2008.02207.x; Liao Y, 2013, AM J CARDIOL, V112, P816, DOI 10.1016/j.amjcard.2013.05.008; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; MosquedaGarcia R, 1997, J CLIN INVEST, V99, P2736, DOI 10.1172/JCI119463; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Prickett TCR, 2012, PEPTIDES, V36, P54, DOI 10.1016/j.peptides.2012.04.017; Qvigstad E, 2010, CARDIOVASC RES, V85, P763, DOI 10.1093/cvr/cvp364; Springer J, 2012, J MOL CELL CARDIOL, V52, P1122, DOI 10.1016/j.yjmcc.2012.01.018; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; Takekoshi K, 2000, LIFE SCI, V66, pPL303, DOI 10.1016/S0024-3205(00)00549-X; Takida S, 1999, HYPERTENSION, V33, P124, DOI 10.1161/01.HYP.33.1.124; Winker R, 2004, WIEN KLIN WOCHENSCHR, V116, P40; Winker R, 2003, INT ARCH OCC ENV HEA, V76, P143, DOI 10.1007/s00420-002-0395-4; Yang JY, 2013, J PEDIATR-US, V163, P1169, DOI 10.1016/j.jpeds.2013.04.039; Zhang Feng-wen, 2011, Zhonghua Er Ke Za Zhi, V49, P428; Zhang FW, 2012, J AM COLL CARDIOL, V60, P315, DOI 10.1016/j.jacc.2012.04.025; Zhang QY, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0249-3; Zhao J, 2014, AM J CARDIOL, V114, P601, DOI 10.1016/j.amjcard.2014.05.039	29	23	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121913	10.1371/journal.pone.0121913	http://dx.doi.org/10.1371/journal.pone.0121913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811760	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700157
J	Schilling, JS; Kaffenberger, JT; Liew, FJ; Song, ZW				Schilling, Jonathan S.; Kaffenberger, Justin T.; Liew, Feng Jin; Song, Zewei			Signature Wood Modifications Reveal Decomposer Community History	PLOS ONE			English	Article							ROT FUNGI; BROWN-ROT; DECAY; FORESTS; DEBRIS; GENOMES; MATTER; RATES	Correlating plant litter decay rates with initial tissue traits (e.g. C, N contents) is common practice, but in woody litter, predictive relationships are often weak. Variability in predicting wood decomposition is partially due to territorial competition among fungal decomposers that, in turn, have a range of nutritional strategies (rot types) and consequences on residues. Given this biotic influence, researchers are increasingly using culture-independent tools in an attempt to link variability more directly to decomposer groups. Our goal was to complement these tools by using certain wood modifications as 'signatures' that provide more functional information about decomposer dominance than density loss. Specifically, we used dilute alkali solubility (DAS; higher for brown rot) and lignin: density loss (L:D; higher for white rot) to infer rot type (binary) and fungal nutritional mode (gradient), respectively. We first determined strength of pattern among 29 fungi of known rot type by correlating DAS and L: D with mass loss in birch and pine. Having shown robust relationships for both techniques above a density loss threshold, we then demonstrated and resolved two issues relevant to species consortia and field trials, 1) spatial patchiness creating gravimetric bias (density bias), and 2) brown rot imprints prior or subsequent to white rot replacement (legacy effects). Finally, we field-tested our methods in a New Zealand Pinus radiata plantation in a paired-plot comparison. Overall, results validate these low-cost techniques that measure the collective histories of decomposer dominance in wood. The L: D measure also showed clear potential in classifying 'rot type' along a spectrum rather than as a traditional binary type (brown versus white rot), as it places the nutritional strategies of wood-degrading fungi on a scale (L:D=0-5, in this case). These information-rich measures of consequence can provide insight into their biological causes, strengthening the links between traits, structure, and function during wood decomposition.	[Schilling, Jonathan S.; Kaffenberger, Justin T.; Liew, Feng Jin] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA; [Schilling, Jonathan S.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Song, Zewei] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Schilling, JS (corresponding author), Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA.	schillin@umn.edu			University of Minnesota; Andrew W. Mellon Foundation (New York, NY)	University of Minnesota(University of Minnesota System); Andrew W. Mellon Foundation (New York, NY)	Fieldwork in New Zealand was possible thanks to sabbatical funding (for JSS) from the University of Minnesota, and in Alaska (for JSS, JTK, FL, ZS) thanks to a Jr. Faculty grant from the Andrew W. Mellon Foundation (New York, NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; [Anonymous], 1983, WOOD CHEM ULTRASTRUC; ASTM, 2007, D141307 ASTM INT; ASTM, 2001, E172101 ASTM INT; Berg B., 2003, DECOMPOSITION PROCES; Blanchette RA, 2004, APPL ENVIRON MICROB, V70, P1328, DOI 10.1128/AEM.70.3.1328-1335.2004; Boddy L, 2001, ECOL B, V49, P43, DOI DOI 10.2307/20113263; Bradford MA, 2014, NAT CLIM CHANGE, V4, P625, DOI [10.1038/NCLIMATE2251, 10.1038/nclimate2251]; Bray MW, 1924, IND ENG CHEM, V16, P137, DOI 10.1021/ie50170a012; Brischke C, 2014, CONSTR BUILD MATER, V66, P384, DOI 10.1016/j.conbuildmat.2014.05.087; Campbell W. G., 1952, WOOD CHEM, V2, P1061; Cowling E.B., 1961, USDA TECH B, V1258; Dickie IA, 2012, ECOL LETT, V15, P133, DOI 10.1111/j.1461-0248.2011.01722.x; Eriksson K.-E., 1990, MICROBIAL ENZYMATIC; Filley TR, 2002, ORG GEOCHEM, V33, P111, DOI 10.1016/S0146-6380(01)00144-9; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Fraver S, 2013, ECOSYSTEMS, V16, P1262, DOI 10.1007/s10021-013-9682-z; Freschet GT, 2012, J ECOL, V100, P161, DOI 10.1111/j.1365-2745.2011.01896.x; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; GILBERTSON RL, 1980, MYCOLOGIA, V72, P1, DOI 10.2307/3759417; Harmon ME, 2013, FOREST ECOL MANAG, V291, P259, DOI 10.1016/j.foreco.2012.11.046; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Harmon ME, 2008, NRS29 USDA NO RES ST; Heilmann-Clausen J, 2004, FOREST ECOL MANAG, V201, P105, DOI 10.1016/j.foreco.2004.07.010; Henningsson B., 1967, STUDIA FORESTALIA SU, V41, P1; Hibbett DS, 2001, SYST BIOL, V50, P215, DOI 10.1080/10635150151125879; Jackson BG, 2013, OIKOS, V122, P1131, DOI 10.1111/j.1600-0706.2012.00056.x; Jurgensen MF, 1997, FOREST SCI, V43, P234; Kahl T, 2009, EUR J FOREST RES, V128, P467, DOI 10.1007/s10342-009-0294-2; Kubartova A, 2012, MOL ECOL, V21, P4514, DOI 10.1111/j.1365-294X.2012.05723.x; Li GY, 2011, CARBOHYD POLYM, V85, P560, DOI 10.1016/j.carbpol.2011.03.014; MANSOR H, 1989, Pertanika, V12, P405; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parfitt D, 2010, FUNGAL ECOL, V3, P338, DOI 10.1016/j.funeco.2010.02.001; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Rodriguez J, 2011, FOR SCI, V80, P81, DOI 10.1007/978-94-007-1599-8_5; RYPACEK V, 1975, BIOL PLANTARUM, V17, P452, DOI 10.1007/BF02921059; Salvachua D, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-115; Scheffer T. C., 1971, Forest Products Journal, V21, P25; Shortle WC, 2010, HOLZFORSCHUNG, V64, P529, DOI 10.1515/HF.2010.051; Sluiter A, 2008, NRELTP51042618, DOI [10.1186/1754-6834-6-162.A, DOI 10.1186/1754-6834-6-162.A]; SOLLINS P, 1982, CAN J FOREST RES, V12, P18, DOI 10.1139/x82-003; Song Z, MICROBIAL E IN PRESS; Song ZW, 2012, FEMS MICROBIOL ECOL, V79, P109, DOI 10.1111/j.1574-6941.2011.01201.x; Swales A, 2005, 200536 ENV WAIK; Technical Association of the Pulp and Paper Industry - TAPPI, 2000, T235CM00 TAPPI; van der Wal A, 2014, ECOLOGY; van Geffen KG, 2010, ECOLOGY, V91, P3686, DOI 10.1890/09-2224.1; Viitanen H, 2010, EUR J WOOD WOOD PROD, V68, P303, DOI 10.1007/s00107-010-0450-x; Westfall JA, 2007, FOREST ECOL MANAG, V253, P171, DOI 10.1016/j.foreco.2007.07.014; Worrall JJ, 1997, MYCOLOGIA, V89, P199, DOI 10.2307/3761073; Zabel RA., 1992, WOOD MICROBIOLOGY DE	54	31	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120679	10.1371/journal.pone.0120679	http://dx.doi.org/10.1371/journal.pone.0120679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811364	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700055
J	Zhu, YP; Peng, ZG; Wu, ZY; Li, JR; Huang, MH; Si, SY; Jiang, JD				Zhu, Yan-Ping; Peng, Zong-Gen; Wu, Zhou-Yi; Li, Jian-Rui; Huang, Meng-Hao; Si, Shu-Yi; Jiang, Jian-Dong			Host APOBEC3G Protein Inhibits HCV Replication through Direct Binding at NS3	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DRUG-RESISTANCE; MESSENGER-RNA; B-VIRUS; THERAPY; CHROMATOGRAPHY; PERSPECTIVES; EXPRESSION; CHALLENGES; HELICASE	Human APOBEC3G (hA3G) is a cytidine deaminase that restricts replication of certain viruses. We have previously reported that hA3G was a host restriction factor against hepatitis C virus (HCV) replication, and hA3G stabilizers showed a significant inhibitory activity against HCV. However, the molecular mechanism of hA3G against HCV remains unknown. We show in this study that hA3G's C-terminal directly binds HCV non-structural protein NS3 at its C-terminus, which is responsible for NS3's helicase and NTPase activity. Binding of hA3G to the C-terminus of NS3 reduced helicase activity, and therefore inhibited HCV replication. The anti-HCV mechanism of hA3G appeared to be independent of its deamination activity. Although early stage HCV infection resulted in an increase in host hA3G as an intracellular response against HCV replication, hA3G was gradually diminished after a long-term incubation, suggesting an unknown mechanism(s) that protects HCV NS3 from inactivation by hA3G. The process represents, at least partially, a cellular defensive mechanism against HCV and the action is mediated through a direct interaction between host hA3G and HCV NS3. We believe that understanding of the antiviral mechanism of hA3G against HCV might open an interesting avenue to explore hA3G stabilizers as a new class of anti-HCV agents.	[Zhu, Yan-Ping; Peng, Zong-Gen; Wu, Zhou-Yi; Li, Jian-Rui; Huang, Meng-Hao; Si, Shu-Yi; Jiang, Jian-Dong] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Biotechnol, Lab Antiviral Res, Beijing 100050, Peoples R China; [Jiang, Jian-Dong] Chinese Acad Med Sci, Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College	Peng, ZG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Biotechnol, Lab Antiviral Res, Beijing 100050, Peoples R China.	pumcpzg@126.com; jiang.jdong@163.com	Peng, Zong-Gen/GVU-2327-2022; Huang, Menghao/I-3104-2019	Huang, Menghao/0000-0002-2389-8680; Peng, Zong-Gen/0000-0001-7662-6892	National Natural Science Foundation, China [81321004, 81322050, 81173101]; National Mega-Project for "R&D for Innovative drugs"; Ministry of Science and Technology, China [2012ZX09301-002-001]; Ministry of Education, China [NCET-12-0072]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); National Mega-Project for "R&D for Innovative drugs"; Ministry of Science and Technology, China(Ministry of Science and Technology, China); Ministry of Education, China(Ministry of Education, China)	The work was supported by the National Natural Science Foundation, China (81321004, JD Jiang; 81322050, ZG Peng; 81173101, ZG Peng), National Mega-Project for "R&D for Innovative drugs", Ministry of Science and Technology, China (2012ZX09301-002-001, JD Jiang), Ministry of Education, China (NCET-12-0072, ZG Peng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casey LC, 2013, CURR OPIN GASTROEN, V29, P243, DOI 10.1097/MOG.0b013e32835ff972; Cen S, 2010, J BIOL CHEM, V285, P16546, DOI 10.1074/jbc.M109.085308; Ejima T, 2011, INT J MOL MED, V28, P613, DOI 10.3892/ijmm.2011.737; Fehrholz M, 2012, J GEN VIROL, V93, P565, DOI 10.1099/vir.0.038919-0; Friew YN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-56; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Izumi T, 2008, MINI-REV MED CHEM, V8, P231; Kawaoka T, 2011, J VIRAL HEPATITIS, V18, pE550, DOI 10.1111/j.1365-2893.2011.01468.x; Komohara Y, 2006, J MOL HISTOL, V37, P327, DOI 10.1007/s10735-006-9059-0; Krawczyk M, 2010, METHODS MOL BIOL, V587, P211, DOI 10.1007/978-1-60327-355-8_15; Lange CM, 2013, J HEPATOL, V58, P583, DOI 10.1016/j.jhep.2012.10.019; Mohammed I, 2012, ACS MED CHEM LETT, V3, P465, DOI 10.1021/ml300037k; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Peng ZG, 2011, HEPATOLOGY, V53, P1080, DOI 10.1002/hep.24160; Peng ZG, 2010, HEPATOLOGY, V52, P845, DOI 10.1002/hep.23766; Ploss A, 2012, GUT, V61, P25, DOI 10.1136/gutjnl-2012-302048; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sudo K, 1996, ANTIVIR RES, V32, P9, DOI 10.1016/0166-3542(95)00969-8; Sudo Kenji, 2005, Antiviral Chemistry & Chemotherapy, V16, P385; Takaori-Kondo A, 2006, INT J HEMATOL, V83, P213, DOI 10.1532/IJH97.05187; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wang YP, 2010, ANTIMICROB AGENTS CH, V54, P2070, DOI 10.1128/AAC.01764-09; Wardell AD, 1999, J GEN VIROL, V80, P701, DOI 10.1099/0022-1317-80-3-701; Welsch C, 2012, CURR OPIN VIROL, V2, P651, DOI 10.1016/j.coviro.2012.08.008; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	30	92	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121608	10.1371/journal.pone.0121608	http://dx.doi.org/10.1371/journal.pone.0121608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811715	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700121
J	Gremmel, T; Perkmann, T; Kopp, CW; Seidinger, D; Eichelberger, B; Koppensteiner, R; Steiner, S; Panzer, S				Gremmel, Thomas; Perkmann, Thomas; Kopp, Christoph W.; Seidinger, Daniela; Eichelberger, Beate; Koppensteiner, Renate; Steiner, Sabine; Panzer, Simon			Interleukin-6 and Asymmetric Dimethylarginine Are Associated with Platelet Activation after Percutaneous Angioplasty with Stent Implantation	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; DUAL ANTIPLATELET THERAPY; CHRONIC KIDNEY-DISEASE; DIABETES-MELLITUS; POOR RESPONSE; P-SELECTIN; CLOPIDOGREL; THROMBOSIS; IMPACT; INTERVENTION	Data linking in vivo platelet activation with inflammation and cardiovascular risk factors are scarce. Moreover, the interrelation between endothelial dysfunction as early marker of atherosclerosis and platelet activation has not been studied, so far. We therefore sought to investigate the associations of inflammation, endothelial dysfunction and cardiovascular risk factors with platelet activation and monocyte-platelet aggregate (MPA) formation in 330 patients undergoing angioplasty with stent implantation for atherosclerotic cardiovascular disease. P-selectin expression, activation of glycoprotein IIb/IIIa and MPA formation were determined by flow cytometry. Interleukin (IL)-6, high sensitivity C-reactive protein and asymmetric dimethylarginine (ADMA) were measured by commercially available assays. IL-6 was the only parameter which was independently associated with platelet P-selectin expression and activated GPIIb/IIIa as well as with leukocyte-platelet interaction in multivariate regression analysis (all p<0.05). ADMA was independently associated with GPIIb/IIIa activation (p<0.05). Patients with high IL-6 exhibited a significantly higher expression of P-selectin than patients with low IL-6 (p=0.001), whereas patients with high ADMA levels showed a more pronounced activation of GPIIb/IIIa than patients with low ADMA (p=0.003). In conclusion, IL-6 and ADMA are associated with platelet activation after percutaneous angioplasty with stent implantation. It remains to be established whether they act prothrombotic and atherogenic themselves or are just surrogate markers for atherosclerosis with concomitant platelet activation.	[Gremmel, Thomas; Kopp, Christoph W.; Seidinger, Daniela; Koppensteiner, Renate] Med Univ Vienna, Dept Internal Med 2, Div Angiol, Vienna, Austria; [Perkmann, Thomas] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Eichelberger, Beate; Panzer, Simon] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria; [Steiner, Sabine] Pk Hosp Leipzig, Ctr Vasc Med Angiol Cardiol & Vasc Surg, Leipzig, Germany	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Gremmel, T (corresponding author), Med Univ Vienna, Dept Internal Med 2, Div Angiol, Vienna, Austria.	thomas.gremmel@meduniwien.ac.at	Perkmann, Thomas/F-3074-2012; Steiner, Sabine/AAG-5804-2021	Steiner, Sabine/0000-0002-5680-1072; Gremmel, Thomas/0000-0001-9554-7292; Perkmann, Thomas/0000-0002-7976-0285				Angiolillo DJ, 2006, J AM COLL CARDIOL, V48, P298, DOI 10.1016/j.jacc.2006.03.038; Angiolillo DJ, 2010, J AM COLL CARDIOL, V55, P1139, DOI 10.1016/j.jacc.2009.10.043; Bernlochner I, 2010, THROMB HAEMOSTASIS, V104, P1193, DOI 10.1160/TH10-05-0266; Bonello-Palot N, 2009, AM J CARDIOL, V104, P1511, DOI 10.1016/j.amjcard.2009.07.015; Bugert P, 2006, PLATELETS, V17, P503, DOI 10.1080/09537100600901491; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Erlinge D, 2008, J AM COLL CARDIOL, V52, P1968, DOI 10.1016/j.jacc.2008.07.068; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gremmel T, 2010, J THROMB HAEMOST, V8, P37, DOI 10.1111/j.1538-7836.2009.03644.x; Gremmel T, 2014, THROMB HAEMOSTASIS, V111, P474, DOI 10.1160/TH13-07-0558; Gremmel T, 2013, NEPHROL DIAL TRANSPL, V28, P2116, DOI 10.1093/ndt/gft103; Gremmel T, 2013, J ATHEROSCLER THROMB, V20, P630, DOI 10.5551/jat.17665; Gremmel T, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13800; Gremmel T, 2013, TRANSL RES, V161, P421, DOI 10.1016/j.trsl.2012.12.015; Gremmel T, 2009, ATHEROSCLEROSIS, V207, P608, DOI 10.1016/j.atherosclerosis.2009.05.037; Gremmel T, 2009, THROMB HAEMOSTASIS, V101, P333, DOI 10.1160/TH08-09-0577; Hwang SJ, 2011, CIRC J, V75, P1350, DOI 10.1253/circj.CJ-10-0488; Marino M, 2013, J BIOL REG HOMEOS AG, V27, P841; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Muller K, 2010, ATHEROSCLEROSIS, V213, P256, DOI 10.1016/j.atherosclerosis.2010.07.023; OLEKSOWICZ L, 1995, AM J HEMATOL, V48, P92, DOI 10.1002/ajh.2830480205; OLEKSOWICZ L, 1994, THROMB HAEMOSTASIS, V72, P302; PENG JP, 1994, BLOOD, V83, P398; SHATTIL SJ, 1987, BLOOD, V70, P307; Siller-Matula JM, 2013, INT J CARDIOL, V167, P430, DOI 10.1016/j.ijcard.2012.01.016; Soslau G, 1997, CYTOKINE, V9, P405, DOI 10.1006/cyto.1996.0182; Vandendries ER, 2004, THROMB HAEMOSTASIS, V92, P459, DOI 10.1160/TH04-05-0306; Yan SL, 2014, INFLAMM BOWEL DIS, V20, P353, DOI 10.1097/01.MIB.0000440614.83703.84	29	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122586	10.1371/journal.pone.0122586	http://dx.doi.org/10.1371/journal.pone.0122586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807315	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000223
J	Han, XZ; Pozo, FM; Wisotsky, JN; Wang, BL; Jacobberger, JW; Zhang, YW				Han, Xiangzi; Pozo, Franklin Mayca; Wisotsky, Jacob N.; Wang, Benlian; Jacobberger, James W.; Zhang, Youwei			Phosphorylation of Minichromosome Maintenance 3 (MCM3) by Checkpoint Kinase 1 (Chk1) Negatively Regulates DNA Replication and Checkpoint Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; DNA Damage; DNA Replication; Phosphorylation; Signal Transduction	CELL-CYCLE CHECKPOINT; S-PHASE; DAMAGE CHECKPOINT; COMPLEX; PROTEIN; ATR; INITIATION; STRESS; HELICASE; PROMOTES	Background: Chk1 and the MCM complex play important roles in DNA replication and replication checkpoint. Results: Chk1 phosphorylates MCM3. Conclusion: Phosphorylation of MCM3 by Chk1 regulates normal DNA replication and checkpoint. Significance: These results provide insights into our understanding of DNA replication control and replication checkpoint activation. Mechanisms controlling DNA replication and replication checkpoint are critical for the maintenance of genome stability and the prevention or treatment of human cancers. Checkpoint kinase 1 (Chk1) is a key effector protein kinase that regulates the DNA damage response and replication checkpoint. The heterohexameric minichromosome maintenance (MCM) complex is the core component of mammalian DNA helicase and has been implicated in replication checkpoint activation. Here we report that Chk1 phosphorylates the MCM3 subunit of the MCM complex at Ser-205 under normal growth conditions. Mutating the Ser-205 of MCM3 to Ala increased the length of DNA replication track and shortened the S phase duration, indicating that Ser-205 phosphorylation negatively controls normal DNA replication. Upon replicative stress treatment, the inhibitory phosphorylation of MCM3 at Ser-205 was reduced, and this reduction was accompanied with the generation of single strand DNA, the key platform for ataxia telangiectasia mutated and Rad3-related (ATR) activation. As a result, the replication checkpoint is activated. Together, these data provide significant insights into the regulation of both normal DNA replication and replication checkpoint activation through the novel phosphorylation of MCM3 by Chk1.	[Han, Xiangzi; Pozo, Franklin Mayca; Zhang, Youwei] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Wisotsky, Jacob N.; Zhang, Youwei] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA; [Jacobberger, James W.; Zhang, Youwei] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Sch Med, Cleveland, OH 44106 USA; [Jacobberger, James W.] Case Western Reserve Univ, Div Gen Med Sci, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Zhang, YW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Case Comprehens Canc Ctr, 2123 Adelbert Rd,Wood Bldg W343A, Cleveland, OH 44106 USA.	yxz169@case.edu	Regan, Clinton/E-6250-2012; Jacobberger, James/P-9183-2014	Jacobberger, James/0000-0002-3092-5157	National Institutes of Health [R00 CA126173]; NCI; NCI [R01 CA163214]; American Cancer Society Pilot Grant ACS [IRG-91-022-15]; NATIONAL CANCER INSTITUTE [R00CA126173, R01CA163214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Pilot Grant ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R00 CA126173, a career development award from the NCI, and R01 CA163214 from the NCI (to Y. Z.). This work was also supported by American Cancer Society Pilot Grant ACS IRG-91-022-15 (to Y. Z.).	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bialik S, 2008, MOL CELL PROTEOMICS, V7, P1089, DOI 10.1074/mcp.M700579-MCP200; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Han XZ, 2014, J BIOL CHEM, V289, P24716, DOI 10.1074/jbc.M114.575035; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ilves I, 2012, P NATL ACAD SCI USA, V109, P13163, DOI 10.1073/pnas.1211525109; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Liu QH, 2000, GENE DEV, V14, P1448; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Pereverzeva I, 2000, MOL CELL BIOL, V20, P3667, DOI 10.1128/MCB.20.10.3667-3676.2000; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Scorah J, 2008, J BIOL CHEM, V283, P17250, DOI 10.1074/jbc.M800369200; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shi YL, 2007, J BIOL CHEM, V282, P9236, DOI 10.1074/jbc.M609256200; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Taricani L, 2009, CELL CYCLE, V8, P482, DOI 10.4161/cc.8.3.7661; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wang JN, 2011, CELL CYCLE, V10, P500, DOI 10.4161/cc.10.3.14753; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Zachos G, 2005, MOL CELL BIOL, V25, P563, DOI 10.1128/MCB.25.2.563-574.2005; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	41	22	24	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12370	12378		10.1074/jbc.M114.621532	http://dx.doi.org/10.1074/jbc.M114.621532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809478	hybrid, Green Published			2022-12-26	WOS:000354388600045
J	Breen, CJ; Martin, DS; Ma, H; McQuaid, K; O'Kennedy, R; Findlay, JBC				Breen, Conor J.; Martin, Darren S.; Ma, Hui; McQuaid, Kate; O'Kennedy, Richard; Findlay, John B. C.			Production of Functional Human Vitamin A Transporter/RBP Receptor (STRA6) for Structure Determination	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; MATTHEW-WOOD-SYNDROME; INTEGRAL MEMBRANE-PROTEINS; PICHIA-PASTORIS; INSULIN-RESISTANCE; ESCHERICHIA-COLI; PLASMA; CRYSTALLIZATION; MUTATIONS; OVEREXPRESSION	STRA6 is a plasma membrane protein that mediates the transport of vitamin A, or retinol, from plasma retinol binding protein (RBP) into the cell. Mutations in human STRA6 are associated with Matthew-Wood syndrome, which is characterized by severe developmental defects. Despite the obvious importance of this protein to human health, little is known about its structure and mechanism of action. To overcome the difficulties frequently encountered with the production of membrane proteins for structural determination, STRA6 has been expressed in Pichia pastoris as a fusion to green fluorescent protein (GFP), a strategy which has been a critical first step in solving the crystal structures of several membrane proteins. STRA6-GFP was correctly targeted to the cell surface where it bound RBP. Here we report the large-scale expression, purification and characterisation of STRA6-GFP. One litre of culture, corresponding to 175 g cells, yielded about 1.5 mg of pure protein. The interaction between purified STRA6 and its ligand RBP was studied by surface plasmon resonance-based binding analysis. The interaction between STRA6 and RBP was not retinol-dependent and the binding data were consistent with a transient interaction of 1 mole RBP/mole STRA6.	[Breen, Conor J.; Martin, Darren S.; McQuaid, Kate; Findlay, John B. C.] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland; [Ma, Hui; O'Kennedy, Richard] Dublin City Univ, Biomed Diagnost Inst, Natl Ctr Sensor Res, Dublin 9, Ireland	Maynooth University; Dublin City University	Findlay, JBC (corresponding author), Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland.	john.findlay@nuim.ie	McQuaid, Kate/G-2621-2015	Mc Quaid, Kate/0000-0002-2075-1894; Breen, Conor/0000-0003-4737-7350	Science Foundation Ireland [08/IN.1/B1900]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland (www.sfi.ie), grant number 08/IN.1/B1900. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Albalat R, 2011, GENOME BIOL EVOL, V3, P985, DOI 10.1093/gbe/evr084; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Burke BJ, 2006, LIPOCALINS; Casey J, 2011, HUM MUTAT, V32, P1417, DOI 10.1002/humu.21590; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; Cukras C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050205; Day ES, 2013, ANAL BIOCHEM, V440, P96, DOI 10.1016/j.ab.2013.05.012; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Fischer M, 2010, TRENDS MICROBIOL, V18, P471, DOI 10.1016/j.tim.2010.06.009; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hays FA, 2010, METHOD ENZYMOL, V470, P695, DOI 10.1016/S0076-6879(10)70029-X; Hedfalk K, 2013, BIOENGINEERED, V4, P363, DOI 10.4161/bioe.23886; HELLER J, 1975, J BIOL CHEM, V250, P3613; Hjelm A, 2013, METHODS MOL BIOL, V1033, P381, DOI 10.1007/978-1-62703-487-6_24; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Kawaguchi R, 2008, J BIOL CHEM, V283, P15160, DOI 10.1074/jbc.M801060200; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2012, J MEMBRANE BIOL, V245, P731, DOI 10.1007/s00232-012-9463-1; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Low C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038244; Michel H, 2001, INT TABLES CRYSTALLO; Mistrik P, 2004, ANAL BIOCHEM, V327, P271, DOI 10.1016/j.ab.2004.01.022; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Newstead S, 2008, PROTEIN SCI, V17, P466, DOI 10.1110/ps.073263108; PETERSON PA, 1971, J BIOL CHEM, V246, P44; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Rabus R, 1999, MICROBIOL-SGM, V145, P3431, DOI 10.1099/00221287-145-12-3431; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P561; SIVAPRASADARAO A, 1994, BIOCHEM J, V300, P437, DOI 10.1042/bj3000437; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; Sunga AJ, 2008, FEMS YEAST RES, V8, P870, DOI 10.1111/j.1567-1364.2008.00410.x; Terra R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082808; Wysocka-Kapcinska M, 2010, PROTEIN EXPRES PURIF, V71, P28, DOI 10.1016/j.pep.2010.01.015	47	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122293	10.1371/journal.pone.0122293	http://dx.doi.org/10.1371/journal.pone.0122293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816144	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000352133600164
J	Yu, LH; Xie, LQ; Dai, C; Xie, B; Liang, ML; Zhao, L; Yin, XT; Wang, J				Yu, Longhua; Xie, Liqi; Dai, Chao; Xie, Bing; Liang, Minglong; Zhao, Lu; Yin, Xuntao; Wang, Jian			Progressive Thinning of Visual Cortex in Primary Open-Angle Glaucoma of Varying Severity	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; VOXEL-BASED MORPHOMETRY; MAGNETIC-RESONANCE IMAGES; OPTIC-NERVE; PARVOCELLULAR LAYERS; NEURAL DEGENERATION; CLINICAL SEVERITY; COORDINATE SYSTEM; GLOBAL MOTION; AREA V4	The aim of this study was to investigate possible changes of cortical thickness in the visual cortex in primary open-angle glaucoma (POAG) of varying severity. Twenty normal controls (NC), 20 mild (MP) and 17 severe (SP) POAG patients were recruited and scanned using magnetic resonance imaging. Cortical thickness analyses with regions of interest (V1, V2, ventral V3, V4 and V5/MT+) were used to assess the cortical changes among the three groups. Furthermore, the associations of cortical thickness with retinal nerve fiber layer (RNFL) thickness and mean deviation of visual field were analyzed. Compared with the NC group, decreased cortical thickness was detected in the bilateral V5/MT+ areas in the MP group and the left V1, bilateral V2 and V5/MT+ areas in the SP group. Cortical thinning of the bilateral V2 areas was detected in the SP group compared with the MP group. In addition, cortical thinning of these visual areas was related to the ophthalmologic measurements. In conclusion, POAG patients exhibit cortical thinning in the bilateral V5/MT+ in the early stage of disease. The cortical degeneration in visual areas is discrepant with disease progressing and the dorsal pathway might be selectively damaged in POAG. Therefore, the cortical thinning of these visual areas may play a key role in the progression of POAG and can serve as a novel biomarker for accurately evaluating the severity of POAG.	[Yu, Longhua; Xie, Bing; Liang, Minglong; Yin, Xuntao; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Yu, Longhua; Xie, Liqi] Peoples Liberat Army, Hosp 401, Dept Radiol, Qingdao, Shandong, Peoples R China; [Dai, Chao] Third Mil Med Univ, Southwest Hosp, Ophthalmol Res Ctr, Chongqing, Peoples R China; [Zhao, Lu; Yin, Xuntao] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada	Army Medical University; Army Medical University; McGill University	Yin, XT (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	xuntaoyin@gmail.com; wangjian811@gmail.com		Yin, Xuntao/0000-0002-8228-6908	Natural Science Foundation of China [30870697]; Natural Science Foundation of China for Young Scholars [81301205]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China for Young Scholars	This study was supported by the Natural Science Foundation of China (no. 30870697) and the Natural Science Foundation of China for Young Scholars (No. 81301205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai A, 2011, J NEUROSCI, V31, P10270, DOI 10.1523/JNEUROSCI.5956-10.2011; Bogorodzki P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093682; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; CHATURVEDI N, 1993, AM J OPHTHALMOL, V116, P182, DOI 10.1016/S0002-9394(14)71283-8; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Chen ZQ, 2013, CLIN EXP OPHTHALMOL, V41, P43, DOI 10.1111/j.1442-9071.2012.02832.x; Cowey A, 2006, EXP BRAIN RES, V171, P558, DOI 10.1007/s00221-006-0479-6; El-Shamayleh Y, 2013, J NEUROSCI, V33, P16594, DOI 10.1523/JNEUROSCI.2753-13.2013; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; FITZPATRICK D, 1985, J NEUROSCI, V5, P3329; Fornito A, 2008, HUM BRAIN MAPP, V29, P478, DOI 10.1002/hbm.20412; Ghose GM, 1997, J NEUROPHYSIOL, V77, P2191, DOI 10.1152/jn.1997.77.4.2191; Giaschi DE, 1996, J OPT SOC AM A, V13, P707, DOI 10.1364/JOSAA.13.000707; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Joffe KM, 1997, VISION RES, V37, P955, DOI 10.1016/S0042-6989(96)00221-0; Johansson Barbro B., 2004, Keio Journal of Medicine, V53, P231, DOI 10.2302/kjm.53.231; Karwatsky P, 2006, OPTOMETRY VISION SCI, V83, P466, DOI 10.1097/01.opx.0000225107.38719.0d; Krug K, 2013, CURR BIOL, V23, P1454, DOI 10.1016/j.cub.2013.06.023; Lam D, 2009, MOL VIS, V15, P2217; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Li M, 2014, J NEUROSCI, V34, P202, DOI 10.1523/JNEUROSCI.4549-12.2014; Lu HDD, 2010, NEURON, V68, P1002, DOI 10.1016/j.neuron.2010.11.020; LUND JS, 1988, ANNU REV NEUROSCI, V11, P253, DOI 10.1146/annurev.ne.11.030188.001345; Luthra A, 2005, EXP EYE RES, V80, P43, DOI 10.1016/j.exer.2004.08.016; Malikovic A, 2007, CEREB CORTEX, V17, P562, DOI 10.1093/cercor/bhj181; McKendrick AM, 2005, INVEST OPHTH VIS SCI, V46, P3693, DOI 10.1167/iovs.04-1406; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Michelson G, 2013, GRAEF ARCH CLIN EXP, V251, P243, DOI 10.1007/s00417-011-1887-2; Mills RP, 2006, AM J OPHTHALMOL, V141, P24, DOI 10.1016/j.ajo.2005.07.044; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; ROE AW, 1995, J NEUROSCI, V15, P3689; Rottschy C, 2007, HUM BRAIN MAPP, V28, P1045, DOI 10.1002/hbm.20348; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shimazawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030526; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wang MY, 2013, NEURORADIOLOGY, V55, P493, DOI 10.1007/s00234-013-1133-1; Weber AJ, 2000, INVEST OPHTH VIS SCI, V41, P1370; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073208; Yucel YH, 2001, INVEST OPHTH VIS SCI, V42, P3216; Yucel YH, 2000, ARCH OPHTHALMOL-CHIC, V118, P378; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	56	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121960	10.1371/journal.pone.0121960	http://dx.doi.org/10.1371/journal.pone.0121960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816070	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600131
J	Yu, ZL; Wang, J; Lin, JX; Zhao, MY; Qiu, JP				Yu, Zhiliang; Wang, Ju; Lin, Jianxun; Zhao, Minyan; Qiu, Juanping			Exploring Regulation Genes Involved in the Expression of L-Amino Acid Oxidase in Pseudoalteromonas sp Rf-1	PLOS ONE			English	Article							MARINOMONAS-MEDITERRANEA; LYSINE OXIDASE; NEUROSPORA-CRASSA; MARINE BACTERIUM; PROTEIN; VENOM; N-4-ACETYLCYTIDINE; CLONING; PCR	Bacterial L-amino acid oxidase (LAAO) is believed to play important biological and ecological roles in marine niches, thus attracting increasing attention to understand the regulation mechanisms underlying its production. In this study, we investigated genes involved in LAAO production in marine bacterium Pseudoalteromonas sp. Rf-1 using transposon mutagenesis. Of more than 4,000 mutants screened, 15 mutants showed significant changes in LAAO activity. Desired transposon insertion was confirmed in 12 mutants, in which disrupted genes and corresponding functions were identified. Analysis of LAAO activity and lao gene expression revealed that GntR family transcriptional regulator, methylase, non-ribosomal peptide synthetase, TonB-dependent heme-receptor family, Na+/H+ antiporter and related arsenite permease, N-acetyltransferase GCN5, Ketol-acid reductoisomerase and SAM-dependent methytransferase, and their coding genes may be involved in either upregulation or downregulation pathway at transcriptional, posttranscriptional, translational and/or posttranslational level. The nhaD and sdmT genes were separately complemented into the corresponding mutants with abolished LAAO-activity. The complementation of either gene can restore LAAO activity and lao gene expression, demonstrating their regulatory role in LAAO biosynthesis. This study provides, for the first time, insights into the molecular mechanisms regulating LAAO production in Pseudoalteromonas sp. Rf-1, which is important to better understand biological and ecological roles of LAAO.	[Yu, Zhiliang; Wang, Ju; Zhao, Minyan; Qiu, Juanping] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou 310014, Zhejiang, Peoples R China; [Lin, Jianxun] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	Zhejiang University of Technology; Columbia University	Yu, ZL (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou 310014, Zhejiang, Peoples R China.	zlyu@zjut.edu.cn; qiujping@zjut.edu.cn			Regional Demonstration of Marine Economy Innovative Development Project, China [12PYY001SF08]; Natural Science Foundation of Zhejiang Province, China [Y5100153]; Graduate Students' Science and Technology Innovation Program (Youth Talent Plan) of Zhejiang Province, China [2014R403103]	Regional Demonstration of Marine Economy Innovative Development Project, China; Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Graduate Students' Science and Technology Innovation Program (Youth Talent Plan) of Zhejiang Province, China	This work was supported by Regional Demonstration of Marine Economy Innovative Development Project, China (No. 12PYY001SF08) (http://www.soa.gov.cn/), Natural Science Foundation of Zhejiang Province, China (No. Y5100153) (http://www.zjnsf.gov.cn/index.aspx) and Graduate Students' Science and Technology Innovation Program (Youth Talent Plan) of Zhejiang Province, China (No. 2014R403103) (http://www.zjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman JP, 2007, MAR DRUGS, V5, P220, DOI 10.3390/md20070017; Calderon J, 1997, MICROBIOL-SGM, V143, P1969, DOI 10.1099/00221287-143-6-1969; Chen WM, 2010, ENZYME MICROB TECH, V47, P52, DOI 10.1016/j.enzmictec.2010.03.008; Das G, 2008, EMBO J, V27, P840, DOI 10.1038/emboj.2008.20; DEBUSK RM, 1984, J BACTERIOL, V159, P583, DOI 10.1128/JB.159.2.583-589.1984; DEBUSK RM, 1984, J BACTERIOL, V160, P493, DOI 10.1128/JB.160.2.493-498.1984; DEBUSK RM, 1984, J BACTERIOL, V160, P656, DOI 10.1128/JB.160.2.656-661.1984; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gomez D, 2010, MOL MICROBIOL, V75, P462, DOI 10.1111/j.1365-2958.2009.07000.x; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hoskisson Paul A, 2009, Adv Appl Microbiol, V69, P1, DOI 10.1016/S0065-2164(09)69001-8; Huang YL, 2011, BIOFOULING, V27, P287, DOI 10.1080/08927014.2011.562978; Hyeon JE, 2012, J BACTERIOL, V194, P2181, DOI 10.1128/JB.06562-11; Ikeuchi Y, 2008, EMBO J, V27, P2194, DOI 10.1038/emboj.2008.154; Isnansetyo A, 2003, INT J SYST EVOL MICR, V53, P583, DOI 10.1099/ijs.0.02431-0; James SG, 1996, APPL ENVIRON MICROB, V62, P2783, DOI 10.1128/AEM.62.8.2783-2788.1996; Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee ML, 2014, INT J MED SCI, V11, P593, DOI 10.7150/ijms.8096; Letoffe S, 2005, J BACTERIOL, V187, P4637, DOI 10.1128/JB.187.13.4637-4645.2005; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Lu QM, 2002, J NAT TOXINS, V11, P25; Lucas-Elio P, 2006, J BACTERIOL, V188, P2493, DOI 10.1128/JB.188.7.2493-2501.2006; Mai-Prochnow A, 2008, J BACTERIOL, V190, P5493, DOI 10.1128/JB.00549-08; Molina-Quintero LR, 2010, APPL ENVIRON MICROB, V76, P6141, DOI 10.1128/AEM.00690-10; NAKANO M, 1966, J BIOL CHEM, V241, P2075; Naumann GB, 2011, BBA-GEN SUBJECTS, V1810, P683, DOI 10.1016/j.bbagen.2011.04.003; NIEDERMANN DM, 1991, FEMS MICROBIOL LETT, V79, P309; Okubo BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033639; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ana CDS, 2008, COMP BIOCHEM PHYS A, V151, P443, DOI 10.1016/j.cbpa.2007.02.036; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Skovhus TL, 2007, FEMS MICROBIOL ECOL, V61, P348, DOI 10.1111/j.1574-6941.2007.00339.x; Solano F, 2000, J BACTERIOL, V182, P3754, DOI 10.1128/JB.182.13.3754-3760.2000; STERN L, 1978, J BIOL CHEM, V253, P6132; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Yu ZZ, 2014, J APPL MATH, DOI 10.1155/2014/928051; Yu ZL, 2014, APPL BIOCHEM BIOTECH, V174, P13, DOI 10.1007/s12010-014-1005-0; Yu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082483; Yu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055548; Yu ZL, 2012, APPL BIOCHEM BIOTECH, V167, P1, DOI 10.1007/s12010-012-9611-1; Zuliani JP, 2009, PROTEIN PEPTIDE LETT, V16, P908, DOI 10.2174/092986609788923347	42	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122741	10.1371/journal.pone.0122741	http://dx.doi.org/10.1371/journal.pone.0122741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815733	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600193
J	Zanardo, V; Straface, G				Zanardo, Vincenzo; Straface, Gianluca			The Higher Temperature in the Areola Supports the Natural Progression of the Birth to Breastfeeding Continuum	PLOS ONE			English	Article							NEWBORN-INFANTS; MATERNAL-BEHAVIOR; NIPPLE; STIMULATION; OXYTOCIN; STIMULUS; RELEASE; ODOR	Numerous functional features that promote the natural progression of the birth to breast-feeding continuum are concentrated in the human female's areolar region. The aim of this study was to look more closely into the thermal characteristics of areola, which are said to regulate the local evaporation rate of odors and chemical signals that are uniquely important for the neonate's 'breast crawl'. A dermatological study of the areolae and corresponding intern breast quadrants was undertaken on the mothers of 70 consecutive, healthy, full-term breastfed infants. The study took place just after the births at the Policlinico Abano Terme, in Italy from January to February 2014. Temperature, pH and elasticity were assessed one day postpartum using the Soft Plus 5.5 (Callegari S.P.A., Parma, Italy). The mean areolar temperature was found to be significantly higher than the corresponding breast quadrant (34.60 +/- 1.40 degrees C vs. 34.04 +/- 2.00 degrees C, p<0.001) and the pH was also significantly higher (4.60 +/- 0.59 vs. 4.17 +/- 0.59, p< 0.001). In contrast, the elasticity of the areolar was significantly lower (23.52 +/- 7.83 vs. 29.02 +/- 8.44%, p<0.003). Our findings show, for the first time, that the areolar region has a higher temperature than the surrounding breast skin, together with higher pH values and lower elasticity. We believe that the higher temperature of the areolar region may act as a thermal signal to guide the infant directly to the nipple and to the natural progression of the birth to breastfeeding continuum.	[Zanardo, Vincenzo; Straface, Gianluca] Policlin Abano Terme, Div Perinatal Med, I-35031 Abano Terme, Italy		Zanardo, V (corresponding author), Policlin Abano Terme, Div Perinatal Med, Piazza Colombo 1, I-35031 Abano Terme, Italy.	vincenzo.zanardo@libero.it						ALEXANDER G, 1982, APPL ANIM ETHOL, V9, P165, DOI 10.1016/0304-3762(82)90192-4; Allam MDE, 2006, INFANT BEHAV DEV, V29, P308, DOI 10.1016/j.infbeh.2005.12.008; Bartocci M, 2000, PEDIATR RES, V48, P18, DOI 10.1203/00006450-200007000-00006; Bergquist LL, 2009, J PERINATOL, V29, P1, DOI [10.1038/jp.2008.130, DOI 10.1038/JP.2008.130]; Cruz A, 2000, NATURE, V403, P889, DOI 10.1038/35002581; EPSTEIN AN, 1970, PHYSIOL BEHAV, V5, P1395, DOI 10.1016/0031-9384(70)90125-3; IGGO A, 1969, J PHYSIOL-LONDON, V200, P403, DOI 10.1113/jphysiol.1969.sp008701; Jacobs R, 2002, J ORAL REHABIL, V29, P923, DOI 10.1046/j.1365-2842.2002.00960.x; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; Kendrick KM, 2000, EXP PHYSIOL, V85, p111S, DOI 10.1111/j.1469-445X.2000.tb00014.x; KENDRICK KM, 1992, BRAIN RES, V569, P199, DOI 10.1016/0006-8993(92)90631-I; Klaus M, 1998, Pediatrics, V102, P1244; Landers MS, 2012, DEV NEUROSCI-BASEL, V34, P101, DOI 10.1159/000336732; Macfarlane A, 1975, Ciba Found Symp, P103; Matthiesen AS, 2001, BIRTH-ISS PERINAT C, V28, P13, DOI 10.1046/j.1523-536x.2001.00013.x; Mitz V, 1997, SENOLOGIA, V2, P33; MONTAGNA W, 1974, J INVEST DERMATOL, V63, P10, DOI 10.1111/1523-1747.ep12677284; Nishitani S, 2014, CHEM SENSES, V39, P195, DOI 10.1093/chemse/bjt068; Perkins OC, 1926, AM J OBSTET GYNECOL, V11, P789, DOI 10.1016/S0002-9378(26)90186-5; Porter RH, 1999, NEUROSCI BIOBEHAV R, V23, P439, DOI 10.1016/S0149-7634(98)00044-X; RIGHARD L, 1990, LANCET, V336, P1105, DOI 10.1016/0140-6736(90)92579-7; RUSSELL MJ, 1976, NATURE, V260, P520, DOI 10.1038/260520a0; Schaal B, 2006, DEV PSYCHOBIOL, V48, P100, DOI 10.1002/dev.20122; VARENDI H, 1994, LANCET, V344, P989, DOI 10.1016/S0140-6736(94)91645-4; Varendi H, 2001, ACTA PAEDIATR, V90, P372, DOI 10.1080/080352501750126131; VUORENKO V, 1969, EXPERIENTIA, V25, P1286, DOI 10.1007/BF01897502; Weisz-Carrington P., 1987, HORMONES IMMUNITY, P172; WHO/UNICEF, 1989, PROT PROM SUPP BREAS; WIDSTROM AM, 1990, EARLY HUM DEV, V21, P153, DOI 10.1016/0378-3782(90)90114-X; WIDSTROM AM, 1987, ACTA PAEDIATR SCAND, V76, P566, DOI 10.1111/j.1651-2227.1987.tb10522.x	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0118774	10.1371/journal.pone.0118774	http://dx.doi.org/10.1371/journal.pone.0118774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815834	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600010
J	Bhakuni, T; Sharma, A; Rashid, Q; Kapil, C; Saxena, R; Mahapatra, M; Jairajpuri, MA				Bhakuni, Teena; Sharma, Amit; Rashid, Qudsia; Kapil, Charu; Saxena, Renu; Mahapatra, Manoranjan; Jairajpuri, Mohamad Aman			Antithrombin III Deficiency in Indian Patients with Deep Vein Thrombosis: Identification of First India Based AT Variants Including a Novel Point Mutation (T280A) that Leads to Aggregation	PLOS ONE			English	Article							PROTEIN; POLYMERIZATION; SEQUENCE; REGION; SERVER	Antithrombin III (AT) is the main inhibitor of blood coagulation proteases like thrombin and factor Xa. In this study we report the identification and characterization of several variants of AT for the first time in Indian population. We screened 1950 deep vein thrombosis (DVT) patients for AT activity and antigen levels. DNA sequencing was further carried out in patients with low AT activity and/or antigen levels to identify variations in the AT gene. Two families, one with type I and the other with type II AT deficiency were identified. Three members of family I showed an increase in the coagulation rates and recurrent thrombosis in this family was solely attributed to the rs2227589 polymorphism. Four members of family II spanning two generations had normal antigen levels and decreased AT activity. A novel single nucleotide insertion, g.13362_13363insA in this family in addition to g.2603T>C (p.R47C) mutation were identified. AT purified from patient's plasma on hi-trap heparin column showed a marked decrease in heparin affinity and thrombin inhibition rates. Western blot analysis showed the presence of aggregated AT. We also report a novel point mutation at position g.7549A>G (p.T280A), that is highly conserved in serpin family. Variant protein isolated from patient plasma indicated loss of regulatory function due to in-vivo polymerization. In conclusion this is the first report of AT mutations in SERPINC1 gene in Indo-Aryan population where a novel point mutation p.T280A and a novel single nucleotide insertion g.13362_13363insA are reported in addition to known variants like p.R47C, p.C4-X and polymorphisms of rs2227598, PstI and DdeI.	[Bhakuni, Teena; Rashid, Qudsia; Kapil, Charu; Jairajpuri, Mohamad Aman] Jamia Millia Islamia, Dept Biosci, Prot Conformat & Enzymol Lab, New Delhi 110025, India; [Sharma, Amit; Saxena, Renu; Mahapatra, Manoranjan] All India Inst Med Sci, Dept Haematol, New Delhi, India	Jamia Millia Islamia; All India Institute of Medical Sciences (AIIMS) New Delhi	Jairajpuri, MA (corresponding author), Jamia Millia Islamia, Dept Biosci, Prot Conformat & Enzymol Lab, New Delhi 110025, India.	mjairajpuri@jmi.ac.in	Jairajpuri, Mohamad/AAS-2556-2020	Kapil, Charu/0000-0002-8750-5006	Indian Council of Medical Research [52/2/2009-BMS]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The project was funded by the Indian Council of Medical Research (52/2/2009-BMS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Angchaisuksiri P, 2011, THROMB HAEMOSTASIS, V106, P585, DOI 10.1160/TH11-03-0184; Anton AI, 2009, HAEMATOL-HEMATOL J, V94, P589, DOI 10.3324/haematol.2008.000604; Austin H, 2011, J THROMB HAEMOST, V9, P489, DOI 10.1111/j.1538-7836.2011.04185.x; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; BORG JY, 1990, FEBS LETT, V266, P163, DOI 10.1016/0014-5793(90)81530-2; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Caspers M, 2012, THROMB HAEMOSTASIS, V108, P247, DOI 10.1160/TH11-12-0875; Chiou A, 2009, BIOPHYS J, V97, P2306, DOI 10.1016/j.bpj.2009.07.057; Corral J, 2005, HAEMATOLOGICA, V90, P238; Corral J, 2004, J THROMB HAEMOST, V2, P931, DOI 10.1111/j.1538-7836.2004.00749.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng HY, 2012, J THROMB THROMBOLYS, V34, P244, DOI 10.1007/s11239-012-0733-7; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; de la Morena-Barrio ME, 2012, THROMB HAEMOSTASIS, V107, P430, DOI 10.1160/TH11-10-0701; Franco RF, 2001, HUM GENET, V109, P369, DOI 10.1007/s004390100593; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Jairajpuri MA, 2002, J BIOL CHEM, V277, P24460, DOI 10.1074/jbc.M203127200; KOIDE T, 1984, P NATL ACAD SCI-BIOL, V81, P289, DOI 10.1073/pnas.81.2.289; KUBOTA S, 1986, BIOPOLYMERS, V25, P1493, DOI 10.1002/bip.360250808; Lane DA, 1997, THROMB HAEMOSTASIS, V77, P197; LANE DA, 1992, J CLIN INVEST, V90, P2422, DOI 10.1172/JCI116133; Martinez-Martinez I, 2012, J THROMB HAEMOST, V10, P1859, DOI 10.1111/j.1538-7836.2012.04839.x; Martinez-Martinez I, 2010, HAEMATOL-HEMATOL J, V95, P1358, DOI 10.3324/haematol.2009.015487; MOHANTY D, 1982, THROMB RES, V27, P763, DOI 10.1016/0049-3848(82)90015-9; Mushunje A, 2004, J THROMB HAEMOST, V2, P2170, DOI 10.1111/j.1538-7836.2004.01047.x; OKAJIMA K, 1993, BLOOD, V81, P1300; OLDS RJ, 1992, BLOOD, V79, P1206, DOI 10.1182/blood.V79.5.1206.bloodjournal7951206; Picard V, 2003, BLOOD, V102, P919, DOI 10.1182/blood-2002-11-3391; PROCHOWNIK EV, 1983, NEW ENGL J MED, V308, P1549, DOI 10.1056/NEJM198306303082601; Raja SM, 2003, J BIOL CHEM, V278, P13688, DOI 10.1074/jbc.M300062200; Reitsma PH, 2007, J THROMB HAEMOST, V5, P264, DOI 10.1111/j.1538-7836.2007.02502.x; Sekiya A, 2011, INT J HEMATOL, V93, P216, DOI 10.1007/s12185-010-0763-x; Singh P, 2014, PROTEIN PEPTIDE LETT, V21, P714; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yamazaki T, 1996, THROMB RES, V82, P275, DOI 10.1016/0049-3848(96)00074-6; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	42	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121889	10.1371/journal.pone.0121889	http://dx.doi.org/10.1371/journal.pone.0121889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811371	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700154
J	Ni, CP; Chow, MCM; Jiang, XL; Li, SJ; Pang, SMC				Ni, Cuiping; Chow, Meyrick Chum Ming; Jiang, Xiaolian; Li, Sijian; Pang, Samantha Mei Che			Factors Associated with Resilience of Adult Survivors Five Years after the 2008 Sichuan Earthquake in China	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; SCALE CD-RISC; SOCIAL SUPPORT; MEDIATING ROLE; MENTAL-HEALTH; TRAUMA; EXPERIENCE; RESOURCES; CHILDREN	Given the paucity of quantitative empirical research on survivors' resilience and its predictors in the context of long-term recovery after disasters, we examined how resilience predictors differed by gender among adult survivors five years after the Sichuan earthquake. This was a cross-sectional survey study of adult survivors (N = 495; aged 18-60) living in reconstructed communities five years into the recovery process after the Wenchuan earthquake. The instruments we used included assessments of sociodemographic characteristics and earthquake exposure level, the Connor-Davidson Resilience Scale, and the Social Support Rating Scale. Support-seeking behaviors emerged as a significant predictor of male survivors' resilience, while subjective support and marital status were found to be predictors of female survivors' resilience. Annual household income and chronic disease were predictors for both male and female groups. The findings of this study can be used in devising methods to boost survivors' resilience by promoting their satisfaction with social support and their ability to obtain effective support. Additionally, the results suggest how to assist survivors who may have relatively poor resilience.	[Ni, Cuiping] Sichuan Univ, Hong Kong Polytech Univ, Inst Disaster Management & Reconstruct, Chengdu 610064, Sichuan, Peoples R China; [Ni, Cuiping; Li, Sijian; Pang, Samantha Mei Che] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Chow, Meyrick Chum Ming] Tung Wah Coll, Dept Nursing & Hlth Sci, Hong Kong, Peoples R China; [Jiang, Xiaolian] Sichuan Univ, West China Hosp, West China Sch Nursing, Chengdu 610064, Sichuan, Peoples R China	Hong Kong Polytechnic University; Sichuan University; Hong Kong Polytechnic University; Sichuan University	Jiang, XL (corresponding author), Sichuan Univ, West China Hosp, West China Sch Nursing, Chengdu 610064, Sichuan, Peoples R China.	jiang_xiaolian@126.com	Chow, Meyrick/AAW-4751-2021	Chow, Meyrick/0000-0001-6826-1539				Ablett JR, 2007, PSYCHO-ONCOL, V16, P733, DOI 10.1002/pon.1130; American Psychology Association, 2010, ROAD RES WHAT IS RES; [Anonymous], 2012, INT J POPUL RES; Ardalan A, 2010, AGEING SOC, V31, P179; Arnberg FK, 2012, J TRAUMA STRESS, V25, P721, DOI 10.1002/jts.21758; Betancourt TS, 2008, INT REV PSYCHIATR, V20, P317, DOI 10.1080/09540260802090363; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Catalano D, 2011, REHABIL PSYCHOL, V56, P200, DOI 10.1037/a0024571; Cheng SF, 2012, KAOHSIUNG J MED SCI, V28, P105, DOI 10.1016/j.kjms.2011.10.015; Connor KM, 2006, J CLIN PSYCHIAT, V67, P46; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Crabtree A, 2013, SOC INDIC RES, V113, P711, DOI 10.1007/s11205-013-0297-8; Davidson J, 2008, INT CLIN PSYCHOPHARM, V23, P299, DOI 10.1097/YIC.0b013e32830c202d; Fava GA, 2009, J PERS, V77, P1903, DOI 10.1111/j.1467-6494.2009.00604.x; Frankenberg E, 2013, ECOL SOC, V18, DOI 10.5751/ES-05377-180216; Gucciardi DF, 2011, PSYCHOL SPORT EXERC, V12, P423, DOI 10.1016/j.psychsport.2011.02.005; Gutierrez Lombana W., 2012, COLOMB J ANESTESIOL, V40, P207, DOI [10.1016/j.rcae.2012.05.006, DOI 10.1016/J.RCAE.2012.05.006]; Harrison KE, 2010, INT PSYCHOGERIATR, V22, P445, DOI 10.1017/S1041610209991463; Hjemdal O, 2006, MEAS EVAL COUNS DEV, V39, P84, DOI 10.1080/07481756.2006.11909791; Hooberman J, 2010, AM J ORTHOPSYCHIAT, V80, P557, DOI 10.1111/j.1939-0025.2010.01060.x; Huang XL, 2009, ALM BEICH QIANG AUT, P191; Kaniasty K., 2004, BIOTERRORISM PSYCHOL, V3, P200; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Ke X, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-573; Kimerling R., 2009, MENTAL HLTH DISASTER, P203, DOI [10.1017/CBO9780511730030.012, DOI 10.1017/CBO9780511730030.012]; Kjellstrand E. K., 2012, J DIVORCE REMARRIAGE, V53, P311, DOI DOI 10.1080/10502556.2012.671677; Knight BG, 2000, PSYCHOL AGING, V15, P627, DOI 10.1037/0882-7974.15.4.627; Li M, 2012, J COMMUNITY PSYCHOL, V40, P860, DOI 10.1002/jcop.21496; Liu J, 2008, J XINJIANG MED U, V31, P1, DOI DOI 10.3969/J.ISSN.1009-5551.2008.01.001; Madsen MD, 2010, RES SOCIAL WORK PRAC, V20, P223, DOI 10.1177/1049731509347853; Migerode F, 2012, J DEV PHYS DISABIL, V24, P487, DOI 10.1007/s10882-012-9285-1; Molyneux M, 2002, DEV CHANGE, V33, P167, DOI 10.1111/1467-7660.00246; Peng L, 2012, PSYCHIAT RES, V196, P138, DOI 10.1016/j.psychres.2011.12.006; Pietrzak RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038964; Rajkumar AP, 2008, SOC SCI MED, V67, P844, DOI 10.1016/j.socscimed.2008.05.014; Ramirez-Maestre C, 2014, J PAIN, V15, P608, DOI 10.1016/j.jpain.2014.02.006; Ruiz-Robledillo N, 2014, RES DEV DISABIL, V35, P686, DOI 10.1016/j.ridd.2013.12.007; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Scali J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039879; Seery MD, 2011, CURR DIR PSYCHOL SCI, V20, P390, DOI 10.1177/0963721411424740; SHUMAKER SA, 1984, J SOC ISSUES, V40, P11, DOI 10.1111/j.1540-4560.1984.tb01105.x; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Ungar M, 2013, J CHILD PSYCHOL PSYC, V54, P348, DOI 10.1111/jcpp.12025; van der Velden PG, 2013, PSYCHIAT CLIN NEUROS, V67, P110, DOI 10.1111/pcn.12022; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wang L, 2010, PSYCHIAT CLIN NEUROS, V64, P499, DOI 10.1111/j.1440-1819.2010.02130.x; Wills T. A., 2000, SOCIAL SUPPORT MEASU, P86, DOI DOI 10.1093/MED:PSYCH/9780195126709.003.0004; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; Xiao S, 1999, CHINESE MENT HLTH J, V12, P127; Xinhua News Agency, 2008, JUN 9 THER WER 69 14; Xu JP, 2011, J AFFECT DISORDERS, V133, P274, DOI 10.1016/j.jad.2011.03.034; Yu XN, 2011, COMPR PSYCHIAT, V52, P218, DOI 10.1016/j.comppsych.2010.05.010; Yu XN, 2007, SOC BEHAV PERSONAL, V35, P19, DOI 10.2224/sbp.2007.35.1.19; Yu YJ, 2014, PSYCHIAT RES, V215, P401, DOI 10.1016/j.psychres.2013.10.032; Zhao CY, 2013, QUAL LIFE RES, V22, P733, DOI 10.1007/s11136-012-0197-4	55	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121033	10.1371/journal.pone.0121033	http://dx.doi.org/10.1371/journal.pone.0121033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811775	Green Published, gold			2022-12-26	WOS:000356353700076
J	Zhang, Q; Wu, JP; Sun, YX; Zhang, M; Mai, BX; Mo, L; Lee, TM; Zou, FS				Zhang, Qiang; Wu, Jiangping; Sun, Yuxin; Zhang, Min; Mai, Bixian; Mo, Ling; Lee, Tien Ming; Zou, Fasheng			Do Bird Assemblages Predict Susceptibility by E-Waste Pollution? A Comparative Study Based on Species- and Guild-Dependent Responses in China Agroecosystems	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; BROMINATED FLAME RETARDANTS; PERSISTENT HALOGENATED COMPOUNDS; TERRESTRIAL PASSERINE BIRDS; KINGFISHERS ALCEDO-ATTHIS; AGRICULTURAL INTENSIFICATION; FARMLAND BIODIVERSITY; GEOGRAPHICAL PATTERN; INSECTIVOROUS BIRDS; RECYCLING REGION	Indirect effects of electronic waste (e-waste) have been proposed as a causal factor in the decline of bird populations, but analyses of the severity impacts on community assembly are currently lacking. To explore how population abundance/species diversity are influenced, and which functional traits are important in determining e-waste susceptibility, here we surveyed breeding and overwintering birds with a hierarchically nested sampling design, and used linear mixed models to analyze changes in bird assemblages along an exposure gradient in South China. Total bird abundance and species diversity decreased with e-waste severity (exposed < surrounding < reference), reflecting the decreasing discharge and consequent side effects. Twenty-five breeding species exclusively used natural farmland, and nine species decreased significantly in relative abundance at e-waste polluted sites. A high pairwise similarity between exposed and surrounding sites indicates a diffuse effect of pollutants on the species assembly at local scale. We show that sensitivity to e-waste severity varies substantially across functional guild, with the prevalence of woodland insectivorous and grassland specialists declining, while some open farmland generalists such as arboreal frugivores, and terrestrial granivores were also rare. By contrast, the response of waterbirds, omnivorous and non-breeding visitors seem to be tolerable to a wide range of pollution so far. These findings underscore that improper e-waste dismantling results in a severe decline of bird diversity, and the different bird assemblages on polluted and natural farmlands imply species-and guild-dependent susceptibility with functional traits. Moreover, a better understanding of the impact of e-waste with different pollution levels, combined multiple pollutants, and in a food-web context on bird is required in future.	[Zhang, Qiang; Zhang, Min; Zou, Fasheng] South China Inst Endangered Anim, Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Jiangping; Sun, Yuxin; Mai, Bixian; Mo, Ling] Chinese Acad Sci, Guangzhou Inst Geochem, Guangzhou, Guangdong, Peoples R China; [Lee, Tien Ming] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Lee, Tien Ming] Columbia Univ, Earth Inst, New York, NY USA	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Geochemistry, CAS; Columbia University; Columbia University	Zou, FS (corresponding author), South China Inst Endangered Anim, Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	zoufs@gdei.gd.cn	Sun, Yuxin/E-4770-2013	Sun, Yuxin/0000-0003-0674-8709; Zhang, Min/0000-0002-6918-6726	National Natural Science Foundation of China [31200327, 31172067, 41230639]; Science and Technology Planning Project of Guangdong Province, China [2011B0311000004]; Wildlife Survey in Nanling National Nature Reserve [RYCG12-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Wildlife Survey in Nanling National Nature Reserve	This study was funded by National Natural Science Foundation of China (31200327, 31172067 and 41230639), Science and Technology Planning Project of Guangdong Province, China (2011B0311000004) and Wildlife Survey in Nanling National Nature Reserve (RYCG12-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bi XH, 2007, ENVIRON SCI TECHNOL, V41, P5647, DOI 10.1021/es070346a; BirdLifeInternational, 2001, THREAT BIRDS AS BIRD; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Browne SJ, 2004, IBIS, V146, P125, DOI 10.1111/j.1474-919X.2004.00235.x; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Eeva T, 2009, ENVIRON POLLUT, V157, P3126, DOI 10.1016/j.envpol.2009.05.040; Eeva T, 2012, BIOL CONSERV, V150, P33, DOI 10.1016/j.biocon.2012.03.004; Field RH, 2004, IBIS, V146, P60, DOI 10.1111/j.1474-919X.2004.00356.x; Fuller RJ, 2004, IBIS, V146, P22, DOI 10.1111/j.1474-919X.2004.00357.x; Fuller RJ, 2000, ECOLOGY AND CONSERVATION OF LOWLAND FARMLAND BIRDS, P5; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hart JD, 2006, J APPL ECOL, V43, P81, DOI 10.1111/j.1365-2664.2005.01103.x; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Liu JA, 2010, ARCH ENVIRON CON TOX, V59, P492, DOI 10.1007/s00244-010-9487-4; Luo XJ, 2009, ENVIRON SCI TECHNOL, V43, P306, DOI 10.1021/es8018644; McCune B., 2011, PC ORD MULTIVARIATE; Meng XZ, 2007, ENVIRON SCI TECHNOL, V41, P1821, DOI 10.1021/es062251z; Mo L, 2013, ENVIRON POLLUT, V174, P57, DOI 10.1016/j.envpol.2012.11.007; Mo L, 2012, ENVIRON TOXICOL CHEM, V31, P2153, DOI 10.1002/etc.1929; Moorcroft D, 2006, BIRD STUDY, V53, P156, DOI 10.1080/00063650609461428; Moradi Hossein Varasteh, 2009, International Journal of Zoological Research, V5, P27, DOI 10.3923/ijzr.2009.27.41; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Ni HG, 2010, ENVIRON TOXICOL CHEM, V29, P1237, DOI 10.1002/etc.160; Peach WJ, 1999, J APPL ECOL, V36, P798, DOI 10.1046/j.1365-2664.1999.00445.x; Reif J, 2008, IBIS, V150, P596, DOI 10.1111/j.1474-919X.2008.00829.x; Robinson BH, 2009, SCI TOTAL ENVIRON, V408, P183, DOI 10.1016/j.scitotenv.2009.09.044; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Siriwardena GM, 2008, IBIS, V150, P585, DOI 10.1111/j.1474-919X.2008.00828.x; Smucker KM, 2005, ECOL APPL, V15, P1535, DOI 10.1890/04-1353; Stephens SE, 2004, BIOL CONSERV, V115, P101, DOI 10.1016/S0006-3207(03)00098-3; Stone R, 2009, SCIENCE, V325, P1055, DOI 10.1126/science.325_1055; STOUFFER PC, 1995, ECOLOGY, V76, P2429, DOI 10.2307/2265818; Sun YX, 2014, SCI TOTAL ENVIRON, V490, P815, DOI 10.1016/j.scitotenv.2014.05.066; Sun YX, 2012, ENVIRON POLLUT, V171, P191, DOI 10.1016/j.envpol.2012.07.026; Sun YX, 2012, ENVIRON POLLUT, V162, P381, DOI 10.1016/j.envpol.2011.12.013; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tomy GT, 2007, ENVIRON SCI TECHNOL, V41, P2249, DOI 10.1021/es062781v; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Waltert M, 2005, ECOL APPL, V15, P1351, DOI 10.1890/04-1002; Waltert M, 2004, CONSERV BIOL, V18, P1339, DOI 10.1111/j.1523-1739.2004.00127.x; Widmer R, 2005, ENVIRON IMPACT ASSES, V25, P436, DOI 10.1016/j.eiar.2005.04.001; Wu JP, 2009, ENVIRON SCI TECHNOL, V43, P5212, DOI 10.1021/es901103y; Wu JP, 2012, J ENVIRON SCI-CHINA, V24, P183, DOI 10.1016/S1001-0742(11)60758-4; Zhang Q, 2011, FOREST ECOL MANAG, V261, P1738, DOI 10.1016/j.foreco.2011.01.025; Zhang Y, 2010, ENVIRON TOXICOL CHEM, V29, P852, DOI 10.1002/etc.122; Zhao Z., 2001, HDB BIRDS CHINA	50	10	10	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122264	10.1371/journal.pone.0122264	http://dx.doi.org/10.1371/journal.pone.0122264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811881	Green Submitted, gold, Green Published			2022-12-26	WOS:000356353700177
J	Zhivov, A; Peschel, S; Schober, HC; Stachs, O; Baltrusch, S; Bambi, MT; Kilangalanga, J; Winter, K; Kundt, G; Guthoff, RF				Zhivov, Andrey; Peschel, Sabine; Schober, Hans-Christof; Stachs, Oliver; Baltrusch, Simone; Bambi, Marie Therese; Kilangalanga, Janvier; Winter, Karsten; Kundt, Guenther; Guthoff, Rudolf F.			Diabetic Foot Syndrome and Corneal Subbasal Nerve Plexus Changes in Congolese Patients with Type 2 Diabetes	PLOS ONE			English	Article							MEDIAL ARTERIAL CALCIFICATION; SUB-SAHARAN AFRICA; SMALL FIBER DAMAGE; PERIPHERAL NEUROPATHY; CONFOCAL MICROSCOPY; RETINOPATHY; DISEASE; SEVERITY; MELLITUS; RISK	Background To study the severity of diabetic neuropathy, diabetic retinopathy and grades of diabetic foot syndrome for correlations with corneal subbasal nerve plexus (SBP) changes in Congolese patients with type 2 diabetes. Methodology/Principal Findings Twenty-eight type 2 diabetes patients with diabetes-related foot ulceration were recruited in a diabetic care unit in Kinshasa, Democratic Republic of Congo. Corneal SBP was investigated by confocal laser-scanning microscopy to analyse nerve fibre density (NFD) [mu m/mu m(2)], number of branches [n] and number of connectivity points [n]. Foot ulceration was graded using the Wagner ulcer classification. Corneal sensitivity (Cochet-Bonnet), Neuropathy Symptom Score (NSS), Neuropathy Disability Score (NDS), ankle-brachial index (ABI) and ophthalmological status were evaluated. Foot ulceration was ranked as mild (Wagner 0-1: 13 patients/46.4%), moderate (Wagner 2-3: 10 patients/35.7%) and severe (Wagner 4-5: 5 patients/17.9%). The correlation between Wagner Score and NFD (p=0.017, r =-0,454), NDS and NFD (p=0,039, r =-0.400) as well as Wagner Score and HbA1c (p=0,007, r =-0.477) was stated. Significant differences in confocal SBP parameters were observed between Wagner 0-1 and Wagner 4 5 (number of branches (p=0.012), number of connectivity points (p=0.001), nerve fibre density (p=0.033)) and ABI (p=0.030), and between Wagner 2-3 and Wagner 4-5 (number of branches (p=0.003), number of connectivity points (p=0.005) and nerve fibre density (p=0.014)). Differences in NDS (p=0.001) and corneal sensation (p=0.032) were significant between Wagner 0-1 and Wagner 2-3. Patients with diabetic retinopathy had significantly longer diabetes duration (p= 0.03) and higher NDS (p= 0.01), but showed no differences in SBP morphology or corneal sensation. Conclusions/Significance While confirming the diabetic aetiology of foot ulceration due to medial arterial calcification, this study indicates that the grade of diabetic foot syndrome correlates with corneal SBP changes and corneal sensation in patients in sub- Saharan Africa.	[Zhivov, Andrey; Peschel, Sabine; Stachs, Oliver; Guthoff, Rudolf F.] Univ Rostock, Dept Ophthalmol, D-18055 Rostock, Germany; [Schober, Hans-Christof] Klinikum Sudstadt, Clin Internal Med 1, Rostock, Germany; [Baltrusch, Simone] Univ Rostock, Inst Med Biochem & Mol Biol, D-18055 Rostock, Germany; [Bambi, Marie Therese; Kilangalanga, Janvier] St Joseph Hosp, Dept Ophthalmol, Kinshasa, DEM REP CONGO; [Winter, Karsten] Univ Leipzig, Translat Ctr Regenerat Med TRM, D-04109 Leipzig, Germany; [Kundt, Guenther] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany	University of Rostock; University of Rostock; Leipzig University; University of Rostock	Zhivov, A (corresponding author), Univ Rostock, Dept Ophthalmol, D-18055 Rostock, Germany.	andyzhyvov@yahoo.com						Adler AI, 2002, DIABETES CARE, V25, P894, DOI 10.2337/diacare.25.5.894; [Anonymous], 1988, DIABETES CARE, V11, P592, DOI 10.2337/diacare.11.7.592; [Anonymous], 2013, Diabetes Care, V36 Suppl 1, pS3, DOI 10.2337/dc13-S003; Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855; Barr ELM, 2006, DIABETES CARE, V29, P1114, DOI 10.2337/dc05-2464; Boulton A J, 2000, J Fam Pract, V49, pS3; Boulton AJM, 2004, NEW ENGL J MED, V351, P48, DOI 10.1056/NEJMcp032966; Carrington AL, 2002, DIABETES CARE, V25, P2010, DOI 10.2337/diacare.25.11.2010; Chadli A, 2000, DIABETES METAB, V26, P497; EVERHART JE, 1988, DIABETOLOGIA, V31, P16; International Diabetes Federation, 2012, DIAB GLANC; Jude EB, 2001, DIABETES CARE, V24, P1433, DOI 10.2337/diacare.24.8.1433; Knappe S, 2010, KLIN MONBL AUGENHEIL, V230, P64; Kumar Anil R, 2009, J Clin Res Pediatr Endocrinol, V1, P227, DOI 10.4274/jcrpe.v1i5.227; LESTER FT, 1995, ETHIOPIAN MED J, V33, P15; LESTER FT, 1993, DIABETES CARE, V16, P187, DOI 10.2337/diacare.16.1.187; Longo-Mbenza B, 2011, DIABETES METAB SYND, V5, P17, DOI 10.1016/j.dsx.2010.05.009; MASER R E, 1991, Journal of Diabetic Complications, V5, P6, DOI 10.1016/0891-6632(91)90003-8; Mbanya JC, 2003, J CARDIOVASC RISK, V10, P191, DOI 10.1097/00043798-200306000-00006; Messmer EM, 2010, GRAEF ARCH CLIN EXP, V248, P1307, DOI 10.1007/s00417-010-1396-8; Papanas N, 2013, CURR DIABETES REP, V13, P488, DOI 10.1007/s11892-013-0390-z; Potier L, 2011, EUR J VASC ENDOVASC, V41, P110, DOI 10.1016/j.ejvs.2010.09.020; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Unwin N, 1999, PUBLIC HEALTH, V113, P141, DOI 10.1016/S0033-3506(99)00139-0; WAGNER FW, 1987, ORTHOPEDICS, V10, P163; White Richard O, 2009, Clin Diabetes, V27, P105; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Winter Karsten, 2010, Biomedizinische Technik, V55, P252, DOI 10.1515/BMT.2010.562; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; YOUNG MJ, 1993, DIABETOLOGIA, V36, P615, DOI 10.1007/BF00404070; Zhivov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052157	32	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119842	10.1371/journal.pone.0119842	http://dx.doi.org/10.1371/journal.pone.0119842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811186	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700027
J	Cork, AJ; Ericsson, DJ; Law, RHP; Casey, LW; Valkov, E; Bertozzi, C; Stamp, A; Jovcevski, B; Aquilina, A; Whisstock, JC; Walker, MJ; Kobe, B				Cork, Amanda J.; Ericsson, Daniel J.; Law, Ruby H. P.; Casey, Lachlan W.; Valkov, Eugene; Bertozzi, Carlo; Stamp, Anna; Jovcevski, Blagojce; Aquilina, Andrew; Whisstock, James C.; Walker, Mark J.; Kobe, Bostjan			Stability of the Octameric Structure Affects Plasminogen-Binding Capacity of Streptococcal Enolase	PLOS ONE			English	Article							FAST INTERACTION REFINEMENT; ALPHA-ENOLASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; VIRULENCE FACTORS; GLU-PLASMINOGEN; YEAST ENOLASE; PROTEIN; SURFACE; PYOGENES	Group A Streptococcus (GAS) is a human pathogen that has the potential to cause invasive disease by binding and activating human plasmin(ogen). Streptococcal surface enolase (SEN) is an octameric alpha-enolase that is localized at the GAS cell surface. In addition to its glycolytic role inside the cell, SEN functions as a receptor for plasmin(ogen) on the bacterial surface, but the understanding of the molecular basis of plasmin(ogen) binding is limited. In this study, we determined the crystal and solution structures of GAS SEN and characterized the increased plasminogen binding by two SEN mutants. The plasminogen binding ability of SENK312A and SENK362A is similar to 2- and similar to 3.4-fold greater than for the wild-type protein. A combination of thermal stability assays, native mass spectrometry and X-ray crystallography approaches shows that increased plasminogen binding ability correlates with decreased stability of the octamer. We propose that decreased stability of the octameric structure facilitates the access of plasmin(ogen) to its binding sites, leading to more efficient plasmin (ogen) binding and activation.	[Cork, Amanda J.; Ericsson, Daniel J.; Casey, Lachlan W.; Valkov, Eugene; Bertozzi, Carlo; Stamp, Anna; Walker, Mark J.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Cork, Amanda J.; Ericsson, Daniel J.; Casey, Lachlan W.; Valkov, Eugene; Bertozzi, Carlo; Stamp, Anna; Walker, Mark J.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Cork, Amanda J.; Ericsson, Daniel J.; Walker, Mark J.; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Law, Ruby H. P.; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Law, Ruby H. P.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3800, Australia; [Jovcevski, Blagojce; Aquilina, Andrew] Univ Wollongong, Sch Biol Sci & Illawarra Hlth & Med Res, Wollongong, NSW 2522, Australia	University of Queensland; University of Queensland; University of Queensland; Monash University; Monash University; University of Wollongong	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	mark.walker@uq.edu.au; b.kobe@uq.edu.au	Kobe, Bostjan/D-1292-2009; Casey, Lachlan/N-3396-2015; Ericsson, Daniel/F-7458-2011; Valkov, Eugene/AAA-1735-2020; Jovcevski, Blagojce/AAD-3651-2020	Kobe, Bostjan/0000-0001-9413-9166; Casey, Lachlan/0000-0002-4458-0137; Ericsson, Daniel/0000-0001-5101-9244; Valkov, Eugene/0000-0002-3721-1739; Walker, Mark/0000-0001-7423-2769; law, ruby/0000-0001-5432-5781; Jovcevski, Blagojce/0000-0001-7999-1385; Whisstock, James/0000-0003-4200-5611	National Health and Medical Research Council (NHMRC) [APP565526]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by the National Health and Medical Research Council (NHMRC; APP565526). BK and MJW are NHMRC Research Fellows. JCW is an ARC Federation Fellow and Honorary NHMRC Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andronicos NM, 2000, FIBRINOLYSIS PROTEOL, V14, P327, DOI 10.1054/fipr.2000.0090; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Balhara V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088395; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Evran S, 2012, PROTEIN ENG DES SEL, V25, P285, DOI 10.1093/protein/gzs015; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Glenting J, 2013, MICROBIOL RES, V168, P245, DOI 10.1016/j.micres.2013.01.003; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Jin H, 2011, MBIO, V2, DOI 10.1128/mBio.00068-11; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang HJ, 2008, ACTA CRYSTALLOGR D, V64, P651, DOI 10.1107/S0907444908008561; Karbassi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008810; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kornblatt MJ, 1998, EUR J BIOCHEM, V251, P775, DOI 10.1046/j.1432-1327.1998.2510775.x; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhnel K, 2001, J MOL BIOL, V313, P583, DOI 10.1006/jmbi.2001.5065; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; LEBIODA L, 1989, J BIOL CHEM, V264, P3685; LOTTENBERG R, 1992, J BACTERIOL, V174, P5204, DOI 10.1128/JB.174.16.5204-5210.1992; Lu Q, 2012, PROTEIN CELL, V3, P769, DOI 10.1007/s13238-012-2040-7; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Morris AM, 2008, FEBS J, V275, P5885, DOI 10.1111/j.1742-4658.2008.06719.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pal-Bhowmick I, 2007, FEBS J, V274, P1932, DOI 10.1111/j.1742-4658.2007.05738.x; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuck P, 1996, ANAL BIOCHEM, V240, P262, DOI 10.1006/abio.1996.0356; SCHURIG H, 1995, PROTEIN SCI, V4, P228; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thomas CL, 2012, CURR DRUG TARGETS, V13, P308; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOLD F, 1957, J BIOL CHEM, V227, P301; WYNN R, 1993, PROTEIN SCI, V2, P395	62	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121764	10.1371/journal.pone.0121764	http://dx.doi.org/10.1371/journal.pone.0121764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807546	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000178
J	Pinheiro, MMG; Miltojevic, AB; Radulovic, NS; Abdul-Wahab, IR; Boylan, F; Fernandes, PD				Gomes Pinheiro, Mariana Martins; Miltojevic, Ana B.; Radulovic, Niko S.; Abdul-Wahab, Ikarastika Rahayu; Boylan, Fabio; Fernandes, Patricia Dias			Anti-Inflammatory Activity of Choisya ternata Kunth Essential Oil, Ternanthranin, and Its Two Synthetic Analogs (Methyl and Propyl N-Methylanthranilates)	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; FORMALIN TEST; LEUKOCYTE RECRUITMENT; ACUTE-INFLAMMATION; MODEL; RAT; MECHANISMS; RUTACEAE; RELEASE; CARRAGEENAN	Choisya ternata Kunth (Rutaceae) is native to North America where it is popularly known as "Mexican orange". In this study, the anti-inflammatory effects of the essential oil (EO) obtained from the leaves of C. ternata, one of its minor components (ternanthranin-ISOAN) and its two synthetic analogues (methyl and propyl N-methylanthranilate - MAN and PAN) were evaluated. Mice pretreated with the EO (EO) obtained from C. ternata leaves (3-100 mg/kg, p.o.), ISOAN, MAN or PAN (1-30 mg/kg, p.o.) and the reference drugs, morphine (1 mg/kg, p.o.) and acetylsalicylic acid (ASA, 100 mg/kg, p.o.), were evaluated in inflammation models such as formalin and subcutaneous air pouch models, with measurement of cell migration, exudate volume, protein extravasation, nitric oxide and pro-inflammatory cytokines. The EO from C. ternata significantly inhibited the time that the animals spent licking the formalin-injected paw in the second phase of the model at their higher doses (30 and 100 mg/kg, respectively). An inhibition of the inflammatory reaction induced after subcutaneous carrageenan injection into air pouch was also observed. In this model, the EO significantly reduced cell migration, exudate volume, protein extravased, and the increase in levels of inflammatory mediators (nitric oxide, TNF-alpha and IL-1 beta). ISOAN, MAN and PAN behaved in the same fashion at much smaller doses. Also, these molecules were able to show significant effects in the reduction of paw edema (at all tested doses) when the phlogistic agent was carrageenan, bradykinin, 5-HT, PGE2, C48/80 or 12-O-tetradecanoyl-phorbol-acetate (TPA). None of the tested doses had any effect in reducing histamine-induced edema. Our results indicate that the EO from C. ternata and anthranilate derivatives demonstrates an anti-inflammatory effect.	[Gomes Pinheiro, Mariana Martins; Fernandes, Patricia Dias] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil; [Miltojevic, Ana B.; Radulovic, Niko S.] Univ Nis, Fac Sci & Math, Dept Chem, Nish 18000, Serbia; [Abdul-Wahab, Ikarastika Rahayu; Boylan, Fabio] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Trinity Biomed Sci Inst, Dublin 2, Ireland	Universidade Federal do Rio de Janeiro; University of Nis; Trinity College Dublin	Fernandes, PD (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil.	patricia.dias@icb.ufrj.br	Boylan, Fabio/K-9707-2015; Fernandes, Patricia Dias/C-4489-2013; Fernandes, Patricia Dias/W-1565-2019; Abdul Wahab, Ikarastika Rahayu/D-8571-2013	Boylan, Fabio/0000-0001-5531-1787; Fernandes, Patricia Dias/0000-0001-6870-6745; Fernandes, Patricia Dias/0000-0001-6870-6745; Abdul Wahab, Ikarastika Rahayu/0000-0003-1329-5322; Radulovic, Niko/0000-0003-1342-7567; Miltojevic, Ana/0000-0002-8073-1641	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [401683/2013-3, 473106/2012-4]; Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro [E-26/010.001643/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (#401683/2013-3 and 473106/2012-4); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (E-26/010.001643/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro EJ, 2009, QUIM NOVA, V32, P679, DOI 10.1590/S0100-40422009000300012; Beninca JP, 2011, FOOD CHEM, V124, P468, DOI 10.1016/j.foodchem.2010.06.056; Butchar JP, 2006, CURR PHARM DESIGN, V12, P4143, DOI 10.2174/138161206778743574; Chavan MJ, 2010, PHYTOMEDICINE, V17, P149, DOI 10.1016/j.phymed.2009.05.016; CRECHE J, 1987, PHYTOCHEMISTRY, V26, P1947, DOI 10.1016/S0031-9422(00)81735-5; Creche J, 1993, BIOTECHNOLOGY AGR FO, P107; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Dal Secco D, 2003, NITRIC OXIDE-BIOL CH, V9, P153, DOI 10.1016/j.niox.2003.11.001; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Ding Y, 2010, BIOORG MED CHEM LETT, V20, P1528, DOI 10.1016/j.bmcl.2010.01.096; DIROSA M, 1972, J PHARM PHARMACOL, V24, P89, DOI 10.1111/j.2042-7158.1972.tb08940.x; DREYER DL, 1980, PHYTOCHEMISTRY, V19, P935, DOI 10.1016/0031-9422(80)85141-7; FERREIRA S H, 1979, Journal of Pharmacy and Pharmacology, V31, P648; Ferro VA, 2007, METHODS, V42, P313, DOI 10.1016/j.ymeth.2007.05.005; FIELD L, 1978, J CHEM SOC CHEM COMM, P249, DOI 10.1039/c39780000249; FOSTER SJ, 1986, BIOCHEM PHARMACOL, V35, P1709, DOI 10.1016/0006-2952(86)90328-X; Vigil SV, 2008, TRANSPL IMMUNOL, V19, P25, DOI 10.1016/j.trim.2008.01.003; Pinheiro MMG, 2014, EUR J PHARMACOL, V727, P106, DOI 10.1016/j.ejphar.2013.12.042; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guerra ASHD, 2011, INT IMMUNOPHARMACOL, V11, P1816, DOI 10.1016/j.intimp.2011.07.010; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; LEVINE JD, 1984, SCIENCE, V225, P743, DOI 10.1126/science.6087456; Lima DF, 2012, J PHARM PHARMACOL, V64, P283, DOI 10.1111/j.2042-7158.2011.01401.x; MALMBERG AB, 1995, BRIT J PHARMACOL, V114, P1069, DOI 10.1111/j.1476-5381.1995.tb13315.x; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; MARTIN SW, 1994, J PHARMACOL TOX MET, V32, P139, DOI 10.1016/1056-8719(94)90067-1; Martinez V, 1999, PAIN, V81, P179, DOI 10.1016/S0304-3959(99)00008-1; Matheus ME, 2007, EUR J PHARMACOL, V556, P200, DOI 10.1016/j.ejphar.2006.10.057; McRoberts JA, 2011, NEUROSCIENCE, V172, P474, DOI 10.1016/j.neuroscience.2010.10.045; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Omote K, 1998, BRAIN RES, V787, P161, DOI 10.1016/S0006-8993(97)01568-0; Parada CA, 2001, NEUROSCIENCE, V102, P937, DOI 10.1016/S0306-4522(00)00523-6; Radulovic N.S., 2013, FU PHYS CHEM TECH, V11, P67, DOI [10.2298/FUPCT1301067R, DOI 10.2298/FUPCT1301067R]; Radulovic NS, 2013, LIFE SCI, V93, P840, DOI 10.1016/j.lfs.2013.10.002; Radulovic NS, 2013, PHYTOTHER RES, V27, P1334, DOI 10.1002/ptr.4877; Radulovic NS, 2011, J ETHNOPHARMACOL, V135, P610, DOI 10.1016/j.jep.2011.03.035; RAO VSN, 1990, J PHARM PHARMACOL, V42, P877, DOI 10.1111/j.2042-7158.1990.tb07046.x; Raymundo LJRP, 2011, J ETHNOPHARMACOL, V134, P725, DOI 10.1016/j.jep.2011.01.027; RIDEAU M, 1979, PHYTOCHEMISTRY, V18, P155, DOI 10.1016/S0031-9422(00)90936-1; Romano M, 1997, MEDIAT INFLAMM, V6, P32, DOI 10.1080/09629359791901; ROSLAND JH, 1990, PAIN, V42, P235, DOI 10.1016/0304-3959(90)91167-H; Santos ARS, 1997, NEUROPEPTIDES, V31, P381, DOI 10.1016/S0143-4179(97)90075-5; Schmid-Schonbein GW, 2006, ANNU REV BIOMED ENG, V8, P93, DOI 10.1146/annurev.bioeng.8.061505.095708; Schmidt N, 2010, BIOCHEM PHARMACOL, V79, P722, DOI 10.1016/j.bcp.2009.10.012; SEJOURNE M, 1981, PHYTOCHEMISTRY, V20, P353, DOI 10.1016/0031-9422(81)85129-1; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Smiderle FR, 2008, EUR J PHARMACOL, V597, P86, DOI 10.1016/j.ejphar.2008.08.028; TEA K N, 1975, Plantes Medicinales et Phytotherapie, V9, P187; Tjolsen A, 1992, PAIN, V30, P103; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wahab IRA, 2012, PLANTA MED, V78, P1597, DOI 10.1055/s-0032-1315044; Waterman P. G., 1973, Biochemical Systematics, V1, P153, DOI 10.1016/0305-1978(73)90006-9; Yashpal K, 1998, EUR J PAIN-LONDON, V2, P63, DOI 10.1016/S1090-3801(98)90047-7; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje	56	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121063	10.1371/journal.pone.0121063	http://dx.doi.org/10.1371/journal.pone.0121063			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807367	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000128
J	Li, J; Xiao, H; Zhu, QG; Zhou, Y; Li, CQ; Liu, H; Huang, ZP; Shang, J				Li, Jie; Xiao, Hong; Zhu, Qingan; Zhou, Yue; Li, Changqing; Liu, Huan; Huang, Zhiping; Shang, Jin			Novel Pedicle Screw and Plate System Provides Superior Stability in Unilateral Fixation for Minimally Invasive Transforaminal Lumbar Interbody Fusion: An In Vitro Biomechanical Study	PLOS ONE			English	Article							POSTERIOR; SPINES	Purpose This study aims to compare the biomechanical properties of the novel pedicle screw and plate system with the traditional rod system in asymmetrical posterior stabilization for minimally invasive transforaminal lumbar interbody fusion (MI-TLIF). We compared the immediate stabilizing effects of fusion segment and the strain distribution on the vertebral body. Methods Seven fresh calf lumbar spines (L3-L6) were tested. Flexion/extension, lateral bending, and axial rotation were induced by pure moments of +/- 5.0 Nm and the range of motion (ROM) was recorded. Strain gauges were instrumented at L4 and L5 vertebral body to record the strain distribution under flexion and lateral bending (LB). After intact kinematic analysis, a right sided TLIF was performed at L4-L5. Then each specimen was tested for the following constructs: unilateral pedicle screw and rod (UR); unilateral pedicle screw and plate (UP); UR and transfacet pedicle screw (TFS); UP and TFS; UP and UR. Results All instrumented constructs significantly reduced ROM in all motion compared with the intact specimen, except the UR construct in axial rotation. Unilateral fixation (UR or UP) reduced ROM less compared with the bilateral fixation (UP/UR+TFS, UP+UR). The plate system resulted in more reduction in ROM compared with the rod system, especially in axial rotation. UP construct provided more stability in axial rotation compared with UR construct. The strain distribution on the left and right side of L4 vertebral body was significantly different from UR and UR+TFS construct under flexion motion. The strain distribution on L4 vertebral body was significantly influenced by different fixation constructs. Conclusions The novel plate could provide sufficient segmental stability in axial rotation. The UR construct exhibits weak stability and asymmetrical strain distribution in fusion segment, while the UP construct is a good alternative choice for unilateral posterior fixation of MI-TLIF.	[Li, Jie; Xiao, Hong; Zhou, Yue; Li, Changqing; Liu, Huan; Shang, Jin] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Zhu, Qingan; Huang, Zhiping] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Spinal Surg, Guangzhou, Guangdong, Peoples R China	Army Medical University; Southern Medical University - China	Zhou, Y (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	xqzhouyue@163.com	Liu, Huan/AGD-0339-2022	Liu, Huan/0000-0002-5519-7336	fund of the Chinese National Science and Technology Support Program [2012BAI14B00]; Major Project of Chongqing Municipal Science and Technology Commission [cstc2012gg-yyjsB10012]	fund of the Chinese National Science and Technology Support Program; Major Project of Chongqing Municipal Science and Technology Commission	This work was supported by fund of the Chinese National Science and Technology Support Program (2012BAI14B00) and the Major Project of Chongqing Municipal Science and Technology Commission (cstc2012gg-yyjsB10012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao J, 2009, J S MED U, V29, P965; Ao Jun, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P959; Choi UY, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.2.FOCUS12398; Crawford Neil R, 2010, Neurosurgery, V66, pE404, DOI 10.1227/01.NEU.0000363701.76835.BF; Cristofolini L, 2013, SPINE J, V13, P1281, DOI 10.1016/j.spinee.2013.06.014; Dahdaleh NS, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.5.FOCUS13171; Deguchi M, 1998, J SPINAL DISORD, V11, P459; Deutsch Harel, 2006, Neurosurg Focus, V20, pE10; Farshad M1, 2004, ACTA NEUROCHIR WIEN, V156, P2147; Gaines RW, 2000, J BONE JOINT SURG AM, V82A, P1458, DOI 10.2106/00004623-200010000-00013; GOEL VK, 1991, SPINE, V16, pS155, DOI 10.1097/00007632-199103001-00023; Harris BM, 2004, SPINE, V29, pE65, DOI 10.1097/01.BRS.0000113034.74567.86; Kettler A, 2007, EUR SPINE J, V16, P2186, DOI 10.1007/s00586-007-0485-9; Lin ZS, 2013, CHIN J PRATICAL MED, V29, P1; Patwardhan AG, 2003, J ORTHOPAED RES, V21, P540, DOI 10.1016/S0736-0266(02)00202-4; Patwardhan AG, 1999, SPINE, V24, P1003, DOI 10.1097/00007632-199905150-00014; Ross SM, 2003, J ENG TECHNOL, V20, P38; Sethi A, 2011, SPINE J, V11, P863, DOI 10.1016/j.spinee.2011.06.015; Sheng SR, 2010, EUR SPINE J, V19, P46, DOI 10.1007/s00586-009-1192-5; Sim HB, 2010, J NEUROSURG-SPINE, V12, P700, DOI 10.3171/2009.12.SPINE09123; Slucky Andrew V, 2006, Spine J, V6, P78, DOI 10.1016/j.spinee.2005.08.003; THALGOTT J, 1991, SPINE, V16, pS170, DOI 10.1097/00007632-199103001-00025; Tuttle Jonathan, 2006, Neurosurg Focus, V20, pE5; VICECONTI M, 1992, CLIN ASP B, V3, P177; Wetzel FT, 1999, SPINE, V24, P1138, DOI 10.1097/00007632-199906010-00014; WHITECLOUD TS, 1989, SPINE, V14, P472, DOI 10.1097/00007632-198904000-00027; Wilke HJ, 2011, EUR SPINE J, V20, P1859, DOI 10.1007/s00586-011-1822-6; Xue HM, 2012, SPINE J, V12, P209, DOI 10.1016/j.spinee.2012.01.010; Yucesoy K, 2008, J NEUROSURG-SPINE, V8, P44, DOI 10.3171/SPI-08/01/044	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0123134	10.1371/journal.pone.0123134	http://dx.doi.org/10.1371/journal.pone.0123134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807513	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000233
J	Nunes, KZ; Nunes, DO; Silveira, EA; Pereira, CAC; Broseghini, GB; Vassallo, DV; Fioresi, M				Nunes, Karolini Zuqui; Nunes, Dieli Oliveira; Silveira, Edna Aparecida; Cruz Pereira, Camila Almenara; Broseghini Filho, Gilson Bras; Vassallo, Dalton Valentim; Fioresi, Mirian			Chronic Lead Exposure Decreases the Vascular Reactivity of Rat Aortas: The Role of Hydrogen Peroxide	PLOS ONE			English	Article							NITRIC-OXIDE; INDUCED HYPERTENSION; CYCLOOXYGENASE PATHWAYS; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; POTASSIUM CHANNELS; ACTIVATION; PRESSURE; CATALASE	We investigated whether exposure to small concentrations of lead alters blood pressure and vascular reactivity. Male Wistar rats were sorted randomly into the following two groups: control (Ct) and treatment with 100 ppm of lead (Pb), which was added to drinking water, for 30 days. Systolic blood pressure (BP) was measured weekly. Following treatment, aortic ring vascular reactivity was assessed. Tissue samples were properly stored for further biochemical investigation. The lead concentration in the blood reached approximately 8 mu g/dL. Treatment increased blood pressure and decreased the contractile responses of the aortic rings to phenylephrine (1 nM-100 mM). Following N-nitro-L arginine methyl ester (L-NAME) administration, contractile responses increased in both groups but did not differ significantly between them. Lead effects on R-max were decreased compared to control subjects following superoxide dismutase (SOD) administration. Catalase, diethyldithiocarbamic acid (DETCA), and apocynin increased the vasoconstrictor response induced by phenylephrine in the aortas of lead-treated rats but did not increase the vasoconstrictor response in the aortas of untreated rats. Tetraethylammonium (TEA) potentiated the vasoconstrictor response induced by phenylephrine in aortic segments in both groups, but these effects were greater in lead-treated rats. The co-incubation of TEA and catalase abolished the vasodilatory effect noted in the lead group. The present study is the first to demonstrate that blood lead concentrations well below the values established by international legislation increased blood pressure and decreased phenylephrine-induced vascular reactivity. The latter effect was associated with oxidative stress, specifically oxidative stress induced via increases in hydrogen peroxide levels and the subsequent effects of hydrogen peroxide on potassium channels.	[Nunes, Karolini Zuqui; Nunes, Dieli Oliveira; Silveira, Edna Aparecida; Cruz Pereira, Camila Almenara; Broseghini Filho, Gilson Bras; Vassallo, Dalton Valentim; Fioresi, Mirian] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Fioresi, Mirian] Univ Fed Espirito Santo, Dept Nursing, Vitoria, ES, Brazil; [Vassallo, Dalton Valentim] Hlth Sci Ctr Vitoria EMESCAM, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria	Nunes, KZ (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	karol-zuqui@hotmail.com	Fioresi, Mirian/O-6625-2019; Vassallo, Dalton/K-8289-2016	Nunes, Karolini Zuqui/0000-0003-3433-4925; Vassallo, Dalton/0000-0002-4463-4174	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/FAPES - Fundacao de Amparo a Pesquisa do Espirito Santo	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/FAPES - Fundacao de Amparo a Pesquisa do Espirito Santo	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br/) to DVV, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/FAPES - Fundacao de Amparo a Pesquisa do Espirito Santo (www.fapes.es.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlonsoGalicia M, 1997, HYPERTENSION, V29, P320, DOI 10.1161/01.HYP.29.1.320; BOSCOLO P, 1988, ENVIRON HEALTH PERSP, V78, P101, DOI 10.2307/3430508; Carmignani M, 2002, LIFE SCI, V68, P401; Costa CA, 1997, CLIN CHEM, V43, P1196; Den Hond E, 2002, J HUM HYPERTENS, V16, P563, DOI 10.1038/sj.jhh.1001452; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ding YX, 1998, ENVIRON RES, V76, P107, DOI 10.1006/enrs.1997.3796; Dong DL, 2008, CELL PHYSIOL BIOCHEM, V22, P119, DOI 10.1159/000149789; Ellis A, 2003, CAN J PHYSIOL PHARM, V81, P1013, DOI 10.1139/Y03-106; Farmand F, 2005, ENVIRON RES, V98, P33, DOI 10.1016/j.envres.2004.05.016; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Fioresi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096900; Fiorim J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017117; Gottesfeld P, 2011, J OCCUP ENVIRON HYG, V8, P520, DOI 10.1080/15459624.2011.601710; Grizzo LT, 2008, TOXICOL SCI, V103, P207, DOI 10.1093/toxsci/kfn018; Gurer-Orhan H, 2004, TOXICOLOGY, V195, P147, DOI 10.1016/j.tox.2003.09.009; Heydari A, 2006, TOXICOL LETT, V166, P88, DOI 10.1016/j.toxlet.2006.05.014; Karimi G, 2002, PHARMACOL RES, V46, P31, DOI 10.1016/S1043-6618(02)00035-X; KHALILMANESH F, 1993, AM J HYPERTENS, V6, P723, DOI 10.1093/ajh/6.9.723; Kosnett MJ, 2007, ENVIRON HEALTH PERSP, V115, P463, DOI 10.1289/ehp.9784; Kozlowska Hanna, 2007, Postepy Hig Med Dosw (Online), V61, P555; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Ni ZM, 2004, KIDNEY INT, V66, P2329, DOI 10.1111/j.1523-1755.2004.66032.x; Park SW, 2015, PFLUG ARCH EUR J PHY, V467, P285, DOI 10.1007/s00424-014-1513-3; Patrick L, 2006, ALTERN MED REV, V11, P2; Silveira EA, 2010, BRAZ J MED BIOL RES, V43, P492, DOI 10.1590/S0100-879X2010007500027; Silveira EA, 2014, FREE RADICAL BIO MED, V67, P366, DOI 10.1016/j.freeradbiomed.2013.11.021; Sun CW, 1998, CIRC RES, V83, P1069, DOI 10.1161/01.RES.83.11.1069; Thakali K, 2006, HYPERTENSION, V47, P482, DOI 10.1161/01.HYP.0000201540.91234.8f; Vassallo DV, 2011, BRAZ J MED BIOL RES, V44, P939, DOI 10.1590/S0100-879X2011000900016; Vaziri ND, 2007, CLIN EXP PHARMACOL P, V34, P920, DOI 10.1111/j.1440-1681.2007.04644.x; Vaziri ND, 1997, KIDNEY INT, V52, P1042, DOI 10.1038/ki.1997.426; Vaziri ND, 1999, KIDNEY INT, V56, P1492, DOI 10.1046/j.1523-1755.1999.00670.x; Vaziri ND, 2003, KIDNEY INT, V63, P186, DOI 10.1046/j.1523-1755.2003.00711.x; Weseler AR, 2010, CURR HYPERTENS REP, V12, P154, DOI 10.1007/s11906-010-0103-9; Zhang DX, 2012, CIRC RES, V110, P471, DOI 10.1161/CIRCRESAHA.111.258871	38	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120965	10.1371/journal.pone.0120965	http://dx.doi.org/10.1371/journal.pone.0120965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807237	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000119
J	Rickabaugh, TM; Baxter, RM; Sehl, M; Sinsheimer, JS; Hultin, PM; Hultin, LE; Quach, A; Martnez-Maza, O; Horvath, S; Vilain, E; Jamieson, BD				Rickabaugh, Tammy M.; Baxter, Ruth M.; Sehl, Mary; Sinsheimer, Janet S.; Hultin, Patricia M.; Hultin, Lance E.; Quach, Austin; Martnez-Maza, Otoniel; Horvath, Steve; Vilain, Eric; Jamieson, Beth D.			Acceleration of Age-Associated Methylation Patterns in HIV-1-Infected Adults	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; MULTICENTER AIDS COHORT; POLYCOMB GROUP PROTEINS; DNA METHYLATION; HIV-INFECTION; STEM-CELLS; REPLICATIVE SENESCENCE; MORTALITY-RATES; CANCER	Patients with treated HIV-1-infection experience earlier occurrence of aging-associated diseases, raising speculation that HIV-1-infection, or antiretroviral treatment, may accelerate aging. We recently described an age-related co-methylation module comprised of hundreds of CpGs; however, it is unknown whether aging and HIV-1-infection exert negative health effects through similar, or disparate, mechanisms. We investigated whether HIV-1-infection would induce age-associated methylation changes. We evaluated DNA methylation levels at >450,000 CpG sites in peripheral blood mononuclear cells (PBMC) of young (20-35) and older (36-56) adults in two separate groups of participants. Each age group for each data set consisted of 12 HIV-1-infected and 12 age-matched HIV-1-uninfected samples for a total of 96 samples. The effects of age and HIV-1 infection on methylation at each CpG revealed a strong correlation of 0.49, p<1 x 10(-200) and 0.47, p<1 x 10(-200). Weighted gene correlation network analysis (WGCNA) identified 17 co-methylation modules; module 3 (ME3) was significantly correlated with age (cor=0.70) and HIV-1 status (cor=0.31). Older HIV-1(+) individuals had a greater number of hypermethylated CpGs across ME3 (p=0.015). In a multivariate model, ME3 was significantly associated with age and HIV status (Data set 1: beta(age)= 0.007088, p=2.08 x 10(-9); beta(HIV)= 0.099574, p=0.0011; Data set 2: beta(age) = 0.008762, p=1.27x 10(-5); beta(HIV) = 0.128649, p= 0.0001). Using this model, we estimate that HIV-1 infection accelerates age-related methylation by approximately 13.7 years in data set 1 and 14.7 years in data set 2. The genes related to CpGs in ME3 are enriched for polycomb group target genes known to be involved in cell renewal and aging. The overlap between ME3 and an aging methylation module found in solid tissues is also highly significant (Fisher-exact p=5.6 x 10(-6), odds ratio=1.91). These data demonstrate that HIV-1 infection is associated with methylation patterns that are similar to age-associated patterns and suggest that general aging and HIV-1 related aging work through some common cellular and molecular mechanisms. These results are an important first step for finding potential therapeutic targets and novel clinical approaches to mitigate the detrimental effects of both HIV-1-infection and aging.	[Rickabaugh, Tammy M.; Sehl, Mary; Hultin, Lance E.; Jamieson, Beth D.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, AIDS Inst, Los Angeles, CA 90024 USA; [Baxter, Ruth M.; Sinsheimer, Janet S.; Quach, Austin; Horvath, Steve; Vilain, Eric] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Sehl, Mary; Sinsheimer, Janet S.] Univ Calif Los Angeles, David Geffen Sch Med, Biomath, Los Angeles, CA 90095 USA; [Sinsheimer, Janet S.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Hultin, Patricia M.; Martnez-Maza, Otoniel] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Martnez-Maza, Otoniel] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA; [Martnez-Maza, Otoniel] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jamieson, BD (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, AIDS Inst, Los Angeles, CA 90024 USA.	jamieson@mednet.ucla.edu	Martinez-Maza, Otoniel/B-2667-2009	Martinez-Maza, Otoniel/0000-0003-1364-0675	NIA [1RO1-AG-030327]; UCLA AIDS Institute/CFAR Seed Grant from the National Institutes of Health [AI-28697]; NIH T032 training grant [5T32GM008243-25]; NSF [DMS-1264153]; Johns Hopkins University Bloomberg School of Public Health [U01-AI35042]; Northwestern University [U01-AI35039]; University of California, Los Angeles [U01-AI35040]; University of Pittsburgh [U01-AI35041]; Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health [UM1-AI35043]; National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Deafness and Communication Disorders (NIDCD); National Institutes of Health through the National Cancer Institute [P30 CA016042]; National Institutes of Health through the National Institute of Allergy and Infectious Diseases, Center for AIDS Research [5P30 AI028697]; David Geffen School of Medicine;  [UL1-TR000424]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035041, P30AI028697, UM1AI035043, U01AI035040, U01AI035042, U01AI035039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030327] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UCLA AIDS Institute/CFAR Seed Grant from the National Institutes of Health; NIH T032 training grant; NSF(National Science Foundation (NSF)); Johns Hopkins University Bloomberg School of Public Health; Northwestern University; University of California, Los Angeles(University of California System); University of Pittsburgh(University of Pittsburgh); Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Deafness and Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health through the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health through the National Institute of Allergy and Infectious Diseases, Center for AIDS Research; David Geffen School of Medicine(University of California System); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIA Grant 1RO1-AG-030327 awarded to B.D. Jamieson, P.I., and by a UCLA AIDS Institute/CFAR Seed Grant from the National Institutes of Health award AI-28697 given to Dr. Eric Vilain, P.I. Ruth Baxter was supported by a NIH T032 training grant #5T32GM008243-25. Janet Sinsheimer is partially funded by NSF grant DMS-1264153. Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS) and/or the Women's Interagency HIV Study (WIHS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). MACS Principal Investigators are funded by the following sources: Johns Hopkins University Bloomberg School of Public Health (Joseph Margolick), U01-AI35042; Northwestern University (Steven Wolinsky), U01-AI35039; University of California, Los Angeles (Roger Detels), U01-AI35040; University of Pittsburgh (Charles Rinaldo), U01-AI35041; the Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health (Lisa Jacobson), UM1-AI35043. The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the National Cancer Institute (NCI). Targeted supplemental funding for specific projects was also provided by the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Deafness and Communication Disorders (NIDCD). MACS data collection is also supported by UL1-TR000424 (JHU CTSA). Research supported in this publication included work performed in the Flow Cytometry Core Facility supported by the National Institutes of Health through the National Cancer Institute under award number P30 CA016042, and through the National Institute of Allergy and Infectious Diseases, Center for AIDS Research award number 5P30 AI028697. Additional support was provided by various donor funds awarded by the David Geffen School of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or donors to the David Geffen School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Arnold DM, 2006, BLOOD, V108, P460, DOI 10.1182/blood-2005-11-4407; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Blanco JR, 2010, AIDS REV, V12, P218; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Deeks SG, 2012, CURR OPIN IMMUNOL; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Dock JN, 2011, AGING DIS, V2, P382; Dorrucci M, 2001, J ACQ IMMUN DEF SYND, V26, P377, DOI 10.1097/00126334-200104010-00016; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Effros RB, 2000, MICROBES INFECT, V2, P69, DOI 10.1016/S1286-4579(00)00283-5; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Engels EA, 2010, JAIDS-J ACQ IMM DEF, V54, P78, DOI 10.1097/01.qai.0000371677.48743.8d; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; Guaraldi G, 2009, CLIN INFECT DIS, V49, P1756, DOI 10.1086/648080; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; High KP, 2010, J AM GERIATR SOC, V58, P765, DOI 10.1111/j.1532-5415.2010.02772.x; Hooshyar D, 2007, AIDS, V21, P2093, DOI 10.1097/QAD.0b013e3282e9a664; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Hsue PY, 2008, AIDS, V22, P825, DOI 10.1097/QAD.0b013e3282f7cd42; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lucas GM, 2007, AIDS, V21, P2435, DOI 10.1097/QAD.0b013e32827038ad; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Rickabaugh TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016459; Rodriguez-Rodero S, 2010, DISCOV MED, V10, P225; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shibata D, 2006, INT J CANCER, V119, P801, DOI 10.1002/ijc.21912; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Thomas J, 2003, JAIDS-J ACQ IMM DEF, V33, P281, DOI 10.1097/00126334-200307010-00001; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Tsai PC, 2012, EPIGENOMICS-UK, V4, P511, DOI [10.2217/EPI.12.45, 10.2217/epi.12.45]; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22	61	70	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119201	10.1371/journal.pone.0119201	http://dx.doi.org/10.1371/journal.pone.0119201			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807146	gold, Green Published			2022-12-26	WOS:000351880000022
J	Xu, MJ; Cooke, M; Steinmetz, D; Karakousis, G; Saxena, D; Bartlett, E; Xu, XW; Hahn, SM; Dorsey, JF; Kao, GD				Xu, Melody J.; Cooke, Mariana; Steinmetz, David; Karakousis, Giorgos; Saxena, Deeksha; Bartlett, Edmund; Xu, Xiaowei; Hahn, Stephen M.; Dorsey, Jay F.; Kao, Gary D.			A Novel Approach for the Detection and Genetic Analysis of Live Melanoma Circulating Tumor Cells	PLOS ONE			English	Article							TELOMERASE ACTIVITY; BRAF; SURVIVAL; ASSOCIATION; MUTATIONS; ASSAY	Background Circulating tumor cell (CTC) detection and genetic analysis may complement currently available disease assessments in patients with melanoma to improve risk stratification and monitoring. We therefore sought to establish the feasibility of a telomerase-based assay for detecting and isolating live melanoma CTCs. Methods The telomerase-based CTC assay utilizes an adenoviral vector that, in the presence of elevated human telomerase activity, drives the amplification of green fluorescent protein. Tumor cells are then identified via an image processing system. The protocol was tested on melanoma cells in culture or spiked into control blood, and on samples from patients with metastatic melanoma. Genetic analysis of the isolated melanoma CTCs was then performed for BRAF mutation status. Results The adenoviral vector was effective for all melanoma cell lines tested with sensitivity of 88.7% (95%CI85.6-90.4%) and specificity of 99.9% (95%CI99.8-99.9%). In a pilot trial of patients with metastatic disease, CTCs were identified in 9 of 10 patients, with a mean of 6.0 CTCs/mL. At a cutoff of 1.1 CTCs/mL, the telomerase-based assay exhibits test performance of 90.0% sensitivity and 91.7% specificity. BRAF mutation analysis of melanoma cells isolated from culture or spiked control blood, or from pilot patient samples was found to match the known BRAF mutation status of the cell lines and primary tumors. Conclusions To our knowledge, this is the first report of a telomerase-based assay effective for detecting and isolating live melanoma CTCs. These promising findings support further studies, including towards integrating into the management of patients with melanoma receiving multimodality therapy.	[Xu, Melody J.; Cooke, Mariana; Steinmetz, David; Saxena, Deeksha; Hahn, Stephen M.; Dorsey, Jay F.; Kao, Gary D.] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Karakousis, Giorgos; Bartlett, Edmund] Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA; [Xu, Xiaowei] Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Kao, GD (corresponding author), Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA.	GaryKao@uphs.upenn.edu	Cooke, Mariana/V-1375-2019; Cooke, Mariana/ABD-5051-2021	Bartlett, Edmund/0000-0002-0923-153X; Cooke, Mariana/0000-0001-9300-8447; /0000-0001-5459-5730	National Center for Research Resources [UL1TR000003, TL1TR000138]; National Center for Advancing Translational Sciences of the National Institutes of Health; Burroughs Wellcome Career Award for Medical Scientists [1006792]; National Institute of Neurological Disorders and Stroke [K08 NS076548-01]; NATIONAL CANCER INSTITUTE [P30CA016520, P50CA174523, P01CA114046] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000138, UL1TR000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS076548] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MJX was supported by Grant Number UL1TR000003 and TL1TR000138 from the National Center for Research Resources (http://www.nih.gov/about/almanac/organization/NCRR.htm) and National Center for Advancing Translational Sciences (www.ncats.nih.gov/) of the National Institutes of Health. JFD was supported on a Burroughs Wellcome Career Award for Medical Scientists (1006792, http://www.bwfund.org/) and National Institute of Neurological Disorders and Stroke (K08 NS076548-01, http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, WHAT AR SURV RAT MEL; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chiu CG, 2014, CLIN CHEM, V60, P873, DOI 10.1373/clinchem.2013.213611; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dorsey JF, 2015, CANCER-AM CANCER SOC, V121, P139, DOI 10.1002/cncr.28975; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Hoshimoto S, 2012, J CLIN ONCOL, V30, P3819, DOI 10.1200/JCO.2011.40.0887; Hoshimoto S, 2012, ANN SURG, V255, P357, DOI 10.1097/SLA.0b013e3182380f56; Jarkowski A, 2014, ANN PHARMACOTHER, V48, P1456, DOI 10.1177/1060028014544165; Ju M, 2014, CANCER BIOL THER, V15, P683, DOI 10.4161/cbt.28412; Kang SY, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-121; Karakousis G, 2013, J INVEST DERMATOL, V133, P1460, DOI 10.1038/jid.2013.34; Khoja L, 2013, J INVEST DERMATOL, V133, P1582, DOI 10.1038/jid.2012.468; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kojima T, 2009, J CLIN INVEST, V119, P3172, DOI 10.1172/JCI38609; Kudo LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041564; Lin J, 2011, BRIT J CANCER, V104, P464, DOI 10.1038/sj.bjc.6606072; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Luo X, 2014, CELL REP, V7, P645, DOI 10.1016/j.celrep.2014.03.039; MacArthur KM, 2014, CANCER RES, V74, P2152, DOI 10.1158/0008-5472.CAN-13-0813; Maida Y, 2009, INT J ONCOL, V34, P1549, DOI 10.3892/ijo_00000284; Mocellin S, 2006, CLIN CANCER RES, V12, P4605, DOI 10.1158/1078-0432.CCR-06-0823; Nicholl MB, 2011, ANN SURG, V253, P116, DOI 10.1097/SLA.0b013e3181fca894; Okwan-Duodu D, 2015, AM J CLIN ONCOL-CANC, V38, P119, DOI 10.1097/COC.0b013e3182940dc3; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Rao C, 2011, INT J ONCOL, V38, P755, DOI 10.3892/ijo.2011.896; Sakaizawa K, 2012, BRIT J CANCER, V106, P939, DOI 10.1038/bjc.2012.12; Scoggins CR, 2006, J CLIN ONCOL, V24, P2849, DOI 10.1200/JCO.2005.03.2342; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Stamell EF, 2013, INT J RADIAT ONCOL, V85, P293, DOI 10.1016/j.ijrobp.2012.03.017; Steen S, 2008, P BAYL U MED CENT, V21, P127; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; US Cancer Statistics Working Group, 2013, US CANC STAT 1999 20; Yu X, 2014, PIGMENT CELL MELANOM; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	38	22	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0123376	10.1371/journal.pone.0123376	http://dx.doi.org/10.1371/journal.pone.0123376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807549	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000234
J	Zhou, XJ; Yan, SW; Sun, C; Li, SZ; Li, J; Xu, MY; Liu, XQ; Zhang, SJ; Zhao, QQ; Li, Y; Fan, YL; Chen, RM; Wang, L				Zhou, Xiaojin; Yan, Shengwei; Sun, Cheng; Li, Suzhen; Li, Jie; Xu, Miaoyun; Liu, Xiaoqing; Zhang, Shaojun; Zhao, Qianqian; Li, Ye; Fan, Yunliu; Chen, Rumei; Wang, Lei			A Maize Jasmonate Zim-Domain Protein, ZmJAZ14, Associates with the JA, ABA, and GA Signaling Pathways in Transgenic Arabidopsis	PLOS ONE			English	Article							VEGETATIVE STORAGE PROTEIN; BHLH TRANSCRIPTION FACTORS; STAMEN DEVELOPMENT; DEFENSE RESPONSES; REGULATED DEFENSE; GENE-EXPRESSION; ABSCISIC-ACID; GIBBERELLIN; ETHYLENE; RESISTANCE	Jasmonate (JA) is an important signaling molecule involved in the regulation of many physiological and stress-related processes in plants. Jasmonate ZIM-domain (JAZ) proteins have been implicated in regulating JA signaling pathways and the cross talk between various phytohormones. Maize is not only an important cereal crop, but also a model plant for monocotyledon studies. Although many JAZ proteins have been characterized in Arabidopsis and rice, few reports have examined the function of JAZ proteins in maize. In this report, we examined the phylogenetic relationship and expression pattern of JAZ family genes in maize. In addition, a tassel and endosperm-specific JAZ gene, ZmJAZ14, was identified using microarray data analysis and real-time RT-PCR, and its expression was induced by polyethylene glycol (PEG), jasmonate (JA), abscisic acid (ABA), and gibberellins (GAs). ZmJAZ14 was shown to be localized in the nucleus and possessed no transcriptional activating activity, suggesting that it functions as a transcriptional regulator. We found that overexpression of ZmJAZ14 in Arabidopsis enhanced plant tolerance to JA and ABA treatment, as well as PEG stress, while it promoted growth under GA stimulus. Moreover, ZmJAZ14 interacted with a subset of transcription factors in Arabidopsis, and the accumulation of several marker genes involved in JA, ABA, and GA signaling pathways were altered in the overexpression lines. These results suggest that ZmJAZ14 may serve as a hub for the cross talk among the JA, ABA, and GA signaling pathways. Our results can be used to further characterize the function of JAZ family proteins in maize, and the gene cloned in this study may serve as a candidate for drought tolerance and growth promotion regulation in maize.	[Zhou, Xiaojin; Yan, Shengwei; Sun, Cheng; Xu, Miaoyun; Liu, Xiaoqing; Zhang, Shaojun; Zhao, Qianqian; Li, Ye; Fan, Yunliu; Chen, Rumei; Wang, Lei] Chinese Acad Agr Sci, Biotechnol Res Inst, Dept Crop Genom & Genet Improvement, Beijing 100193, Peoples R China; [Zhou, Xiaojin; Yan, Shengwei; Sun, Cheng; Xu, Miaoyun; Liu, Xiaoqing; Zhang, Shaojun; Zhao, Qianqian; Li, Ye; Fan, Yunliu; Chen, Rumei; Wang, Lei] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Li, Suzhen] Agr Univ Hebei, Hebei Subctr Chinese Natl Maize Improvement Ctr, Dept Agron, Baoding, Peoples R China; [Li, Jie] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Hebei Agricultural University; Beijing Normal University	Chen, RM (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Dept Crop Genom & Genet Improvement, Beijing 100193, Peoples R China.	chenrumei@caas.cn	Zhang, Shaojun/GLQ-9920-2022; xu, miaoyun/AAF-3676-2021		National High-Tech RD Program [2012AA10A306]; National Key Basic Research Program [2014CB138200]; National Special Program for Transgenic Research [2014ZX08003-002]	National High-Tech RD Program(National High Technology Research and Development Program of China); National Key Basic Research Program(National Basic Research Program of China); National Special Program for Transgenic Research	This work was supported by the National High-Tech R&D Program (grant number 2012AA10A306), the National Key Basic Research Program (Grant No. 2014CB138200) and the National Special Program for Transgenic Research (2014ZX08003-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; BERGER S, 1995, PLANT MOL BIOL, V27, P933, DOI 10.1007/BF00037021; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Cheng ZW, 2011, MOL PLANT, V4, P279, DOI 10.1093/mp/ssq073; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Engelberth J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034855; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Gao XH, 2011, MOL PLANT, V4, P601, DOI 10.1093/mp/ssr046; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Liu XQ, 2014, PLANT BIOTECHNOL J, V12, P1286, DOI 10.1111/pbi.12227; Liu YL, 2005, PLANT PHYSIOL, V139, P1545, DOI 10.1104/pp.105.066837; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Mandaokar A, 2006, PLANT J, V46, P984, DOI 10.1111/j.1365-313X.2006.02756.x; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Niu YJ, 2011, J EXP BOT, V62, P2143, DOI 10.1093/jxb/erq408; Oh Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057868; Oh Y, 2012, PLANT PHYSIOL, V159, P769, DOI 10.1104/pp.112.193771; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 1998, PLANT CELL, V10, P1571, DOI 10.1105/tpc.10.9.1571; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Rojo E, 2003, J PLANT GROWTH REGUL, V22, P82, DOI 10.1007/s00344-003-0027-6; Song SS, 2011, PLANT CELL, V23, P1000, DOI 10.1105/tpc.111.083089; Staswick PE, 1998, PLANT J, V15, P747, DOI 10.1046/j.1365-313X.1998.00265.x; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Ueguchi-Tanaka M, 2007, ANNU REV PLANT BIOL, V58, P183, DOI 10.1146/annurev.arplant.58.032806.103830; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vicient CM, 2000, J EXP BOT, V51, P1211, DOI 10.1093/jexbot/51.348.1211; Wager A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00041; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; XU YL, 1995, P NATL ACAD SCI USA, V92, P6640, DOI 10.1073/pnas.92.14.6640; Xu YL, 1999, PLANT CELL, V11, P927, DOI 10.1105/tpc.11.5.927; Yamada S, 2012, PLANT CELL PHYSIOL, V53, P2060, DOI 10.1093/pcp/pcs145; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zhao Y, 2011, PLANT CELL TISS ORG, V105, P159, DOI 10.1007/s11240-010-9848-8; Zhou XJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-238; Zhu D, 2012, BIOCHEM BIOPH RES CO, V426, P273, DOI 10.1016/j.bbrc.2012.08.086; Zhu D, 2011, PLANT MOL BIOL, V77, P285, DOI 10.1007/s11103-011-9810-0; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	66	27	36	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121824	10.1371/journal.pone.0121824	http://dx.doi.org/10.1371/journal.pone.0121824			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807368	gold, Green Published			2022-12-26	WOS:000351880000184
J	Visa, M; Alcarraz-Vizan, G; Montane, J; Cadavez, L; Castano, C; Villanueva-Penacarrillo, ML; Servitja, JM; Novials, A				Visa, Montse; Alcarraz-Vizan, Gema; Montane, Joel; Cadavez, Lisa; Castano, Carlos; Luisa Villanueva-Penacarrillo, Maria; Servitja, Joan-Marc; Novials, Anna			Islet amyloid polypeptide exerts a novel autocrine action in beta-cell signaling and proliferation	FASEB JOURNAL			English	Article						type 2 diabetes; amylin; pancreatic islets; Erk1/2; Akt	STIMULATED INSULIN-SECRETION; COMPENSATORY GROWTH; AMYLIN; TYPE-2; EXPRESSION; RECEPTORS; APOPTOSIS; PHOSPHORYLATION; ADRENOMEDULLIN; HOMEOSTASIS	The toxic effects of human islet amyloid polypeptide (IAPP) on pancreatic islets have been widely studied. However, much less attention has been paid to the physiologic actions of IAPP on pancreatic beta cells, which secrete this peptide together with insulin upon glucose stimulation. Here, we aimed to explore the signaling pathways and mitogenic actions of IAPP on beta cells. We show that IAPP activated Erk1/2 and v-akt murine thymoma viral oncogene homolog 1 (Akt) at the picomolar range (10-100 pM) in mouse pancreatic islets and MIN6 beta cells cultured at low glucose concentrations. In contrast, IAPP decreased the induction of these pathways by high glucose levels. Consistently, IAPP induced a 1.7-fold increase of beta-cell proliferation at low-glucose conditions, whereas it reduced beta-cell proliferation at high glucose levels. Strikingly, the specific antagonist of the IAPP receptor AC187 (100 nM) decreased the activation of Erk1/2 and Akt and reduced beta-cell proliferation by 24% in glucose-stimulated b cells, uncovering a key role of endogenously released IAPP in beta-cell responses to glucose. We conclude that exogenously added IAPP exerts a dual effect on beta-cell mitogenic signaling and proliferation, depending on the glucose concentration. Importantly, secreted IAPP contributes to the signaling and mitogenic response of beta cells to glucose through an autocrine mechanism.	[Visa, Montse; Alcarraz-Vizan, Gema; Montane, Joel; Cadavez, Lisa; Castano, Carlos; Servitja, Joan-Marc; Novials, Anna] Inst Invest Biomed August Pi I Sunyer, Diabet & Obes Res Lab, Barcelona 08036, Spain; [Visa, Montse; Alcarraz-Vizan, Gema; Montane, Joel; Cadavez, Lisa; Castano, Carlos; Luisa Villanueva-Penacarrillo, Maria; Servitja, Joan-Marc; Novials, Anna] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Luisa Villanueva-Penacarrillo, Maria] Fdn Jimenez Diaz, Inst Invest Sanitaria, Dept Metab Nutr & Hormones, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Fundacion Jimenez Diaz	Servitja, JM (corresponding author), Inst Invest Biomed August Pi I Sunyer, Diabet & Obes Res Lab, C Rossello 149-153,5th Floor, Barcelona 08036, Spain.	servitja@clinic.ub.es; anovials@clinic.ub.es	Montane, Joel/ABE-6021-2021; Castaño, Carlos/AAS-3591-2021; Visa, Montse/AAQ-8529-2021	Castaño, Carlos/0000-0003-1671-7826; Novials, Anna/0000-0003-0465-2949; Montane, Joel/0000-0001-9531-9580; Alcarraz-Vizan, Gema/0000-0002-2429-0597; SERVITJA, JOAN-MARC/0000-0002-1241-8004	Intituto de Salud Carlos III; Ministerio de Economia y Competitividad [PI11/00679, PI14/00447, BFU2010-17639]; Fondo Europeo de Desarrollo Regional, Union Europea, Una Manera de Hacer Europa; Centro de Investigacion Biomedica en Red (Proyecto Integrado de Excelencia) [PIE1400061]; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas; Institut d'Investigacions Biomediques August Pi i Sunyer Predoctoral Fellowship; Sarda Farriol Research Programme	Intituto de Salud Carlos III; Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional, Union Europea, Una Manera de Hacer Europa; Centro de Investigacion Biomedica en Red (Proyecto Integrado de Excelencia); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas; Institut d'Investigacions Biomediques August Pi i Sunyer Predoctoral Fellowship; Sarda Farriol Research Programme	The authors thank Kimberly Katte of Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas for technical manuscript correction. This work was funded by grants from the Intituto de Salud Carlos III and Ministerio de Economia y Competitividad (PI11/00679 and PI14/00447 to A.N.; BFU2010-17639 to J.-M.S.), cofunded by Fondo Europeo de Desarrollo Regional, Union Europea, Una Manera de Hacer Europa, the Centro de Investigacion Biomedica en Red (Proyecto Integrado de Excelencia PIE1400061), and the Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas. M.V. is a recipient of an Institut d'Investigacions Biomediques August Pi i Sunyer Predoctoral Fellowship. The Diabetes and Obesity Research Laboratory at the Institut d'Investigacions Biomediques August Pi i Sunyer is supported by the Sarda Farriol Research Programme. This work was developed at the Centre Esther Koplowitz, Barcelona, Spain.	Akesson B, 2003, REGUL PEPTIDES, V111, P55, DOI 10.1016/S0167-0115(02)00252-5; Alcarraz-Vizan G, 2015, FASEB J, V29, P95, DOI 10.1096/fj.14-255489; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; BENNET WM, 1994, DIABETOLOGIA, V37, P436; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; BRODERICK CL, 1991, BIOCHEM BIOPH RES CO, V177, P932, DOI 10.1016/0006-291X(91)90628-K; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; CIARALDI TP, 1992, DIABETES, V41, P975, DOI 10.2337/diabetes.41.8.975; COOPER GJS, 1988, P NATL ACAD SCI USA, V85, P7763, DOI 10.1073/pnas.85.20.7763; Cornish J, 2004, BIOCHEM BIOPH RES CO, V318, P240, DOI 10.1016/j.bbrc.2004.04.020; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; DATTA H, 1990, BIOCHEM SOC T, V18, P1276, DOI 10.1042/bst0181276; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Fucini RV, 1999, J BIOL CHEM, V274, P18651, DOI 10.1074/jbc.274.26.18651; Gebre-Medhin S, 1998, BIOCHEM BIOPH RES CO, V250, P271, DOI 10.1006/bbrc.1998.9308; Gedulin BR, 2006, REGUL PEPTIDES, V137, P121, DOI 10.1016/j.regpep.2006.06.004; GILL AM, 1991, LIFE SCI, V48, P703, DOI 10.1016/0024-3205(91)90546-N; Harris PJ, 1997, AM J PHYSIOL-RENAL, V272, pF13; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Hay DL, 2004, BIOCHEM SOC T, V32, P865, DOI 10.1042/BST0320865; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; HUANG HJS, 1992, HYPERTENSION, V19, pI101, DOI 10.1161/01.HYP.19.1_Suppl.I101; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Karlsson E, 2001, DIABETOLOGIA, V44, P1015, DOI 10.1007/s001250100601; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Leckstrom A, 1999, PANCREAS, V18, P266, DOI 10.1097/00006676-199904000-00008; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Lutz TA, 2012, CELL MOL LIFE SCI, V69, P1947, DOI 10.1007/s00018-011-0905-1; Mather KJ, 2002, DIABETES-METAB RES, V18, P118, DOI 10.1002/dmrr.263; MOORE CX, 1991, BIOCHEM BIOPH RES CO, V179, P1, DOI 10.1016/0006-291X(91)91325-7; Moreno P, 2011, PEPTIDES, V32, P2077, DOI 10.1016/j.peptides.2011.09.007; Moreno-Asso A, 2013, DIABETOLOGIA, V56, P1761, DOI 10.1007/s00125-013-2930-0; Mulder H, 2000, AM J PHYSIOL-ENDOC M, V278, pE684, DOI 10.1152/ajpendo.2000.278.4.E684; NAGAMATSU S, 1990, DIABETES, V39, P871, DOI 10.2337/diabetes.39.7.871; OHSAWA H, 1989, BIOCHEM BIOPH RES CO, V160, P961, DOI 10.1016/0006-291X(89)92529-1; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Reidelberger RD, 2001, AM J PHYSIOL-REG I, V280, pR605, DOI 10.1152/ajpregu.2001.280.3.R605; SALAS M, 1995, DIABETES METAB, V21, P269; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; WANG ZL, 1993, DIABETES, V42, P330, DOI 10.2337/diabetes.42.2.330; Westwell-Roper CY, 2014, DIABETES, V63, P1698, DOI 10.2337/db13-0863; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Wookey PJ, 2006, THESCIENTIFICWORLDJO, V6, P1642, DOI 10.1100/tsw.2006.263; Wookey Peter J, 2003, ScientificWorldJournal, V3, P163; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x	51	21	22	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2970	2979		10.1096/fj.15-270553	http://dx.doi.org/10.1096/fj.15-270553			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25808537				2022-12-26	WOS:000356859100025
J	Fan, YJ; Chen, H; Li, AF; Shi, YS; Zhang, YC; Feng, QC; Sun, Y; Zheng, H; He, Y				Fan, Yujia; Chen, Hui; Li, Aifan; Shi, Yunshu; Zhang, Yuchao; Feng, Qingchuan; Sun, Yan; Zheng, Hong; He, Ying			A Promoter Polymorphism (rs17222919,-1316T/G) of ALOX5AP Gene Is Associated with Decreased Risk of Ischemic Stroke in Two Independent Chinese Populations	PLOS ONE			English	Article							5-LIPOXYGENASE ACTIVATING PROTEIN; INTRACEREBRAL HEMORRHAGE; MYOCARDIAL-INFARCTION; PHOSPHODIESTERASE 4D; HAPLOTYPE; VARIANTS; DISEASE	No coding sequence variants of the gene encoding 5-lipoxygenase-activating protein (ALOX5AP) leading to amino acid substitutions have been identified. Therefore, variants in the ALOX5AP promoter region have received attention recently. The purpose of this study was to explore whether the promoter polymorphism rs17222919 is involved in the etiology of ischemic stroke (IS) in the Chinese Han population. We investigated the rs17222919 polymorphism by TaqMan genotyping in two independent Chinese Han samples: the first comprised 910 IS patients and 925 healthy inhabitants from the northern Henan Province, while the second included 1003 IS patients and 889 healthy controls from the southern Henan Province. Functional characterization of rs17222919 was performed by an in vitro luciferase assay. After adjusting for conventional risk factors, the G allele frequencies in the IS groups were significantly lower than that in the control groups of the two independent Chinese cohorts (19.0% vs. 22.9%, P = 0.004, odds ratio (OR) = 0.792, 95% confidence interval (CI) = 0.675-0.929; 18.8% vs. 22.9%, P = 0.002, OR = 0.782, 95% CI = 0.668-0.915, respectively). This was also observed in the large-artery atherosclerosis (LAA) and stroke of other undetermined etiology (SUE) subtypes (P = 0.019, OR = 0.815, 95% CI = 0.687-0.967; P = 0.021, OR = 0.815, 95% CI = 0.685-0.970, respectively). Additionally, the TG genotype and G allele frequencies were significantly lower in the IS compared with the control group in two female cohorts (P<0.05). Finally, the in vitro luciferase assay demonstrated that the G allele has a significantly lower transcription activity than the T allele (P = 0.031). Our study provides evidence that the promoter single nucleotide polymorphism (SNP) rs17222919 is a potential genetic protective factor for IS in the Chinese Han population.	[Fan, Yujia; Chen, Hui; Shi, Yunshu; Zhang, Yuchao; Feng, Qingchuan; Sun, Yan; Zheng, Hong; He, Ying] Zhengzhou Univ, Basic Med Coll, Dept Cell Biol & Med Genet, Zhengzhou 450052, Peoples R China; [Li, Aifan] First People Hosp Zhengzhou, Dept Neurol, Zhengzhou, Peoples R China	Zhengzhou University	Zheng, H (corresponding author), Zhengzhou Univ, Basic Med Coll, Dept Cell Biol & Med Genet, Zhengzhou 450052, Peoples R China.	hzheng@zzu.edu.cn; heying39@163.com			Zhengzhou city science and technology bureau [131PLJRC679]; Zhengzhou University [ZDGD13001]	Zhengzhou city science and technology bureau; Zhengzhou University	This study was supported by grants from the leading talent project of Zhengzhou city science and technology bureau (project number 131PLJRC679) and by the support of the high-end talent plan of Zhengzhou University (project number ZDGD13001). The high-end talent plan of Zhengzhou University is a project provided by Zhengzhou University in order to cultivate talent. The source of this funding is governmental finances. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bisoendial RJ, 2012, ATHEROSCLEROSIS, V220, P425, DOI 10.1016/j.atherosclerosis.2011.10.040; Domingues-Montanari S, 2010, CEREBROVASC DIS, V29, P528, DOI 10.1159/000302738; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Ji RJ, 2011, CEREBROVASC DIS, V32, P261, DOI 10.1159/000330341; Kim DH, 2011, PROSTAG LEUKOTR ESS, V85, P115, DOI 10.1016/j.plefa.2011.07.004; Lapenna A, 2012, PROSTAG LEUKOTR ESS, V86, P135, DOI 10.1016/j.plefa.2012.01.001; Mirzaei M, 2012, J NEUROL NEUROSUR PS, V83, P138, DOI 10.1136/jnnp-2011-300408; Quarta G, 2009, EUR J HUM GENET, V17, P1448, DOI 10.1038/ejhg.2009.71; Raitoharju E, 2011, ATHEROSCLEROSIS, V218, P127, DOI 10.1016/j.atherosclerosis.2011.05.005; Saleheen D, 2005, STROKE, V36, P2275, DOI 10.1161/01.STR.0000182242.59466.ee; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Wang GN, 2014, GENE, V533, P461, DOI 10.1016/j.gene.2013.10.018; Wang Y, 2012, WORLD J EMERG MED, V3, P108, DOI [10.5847/wjem.j.1920-8642.2012.02.005, 10.5847/wjem.j.issn.1920-8642.2012.02.005]; Yang DZ, 2014, J MOL NEUROSCI, V53, P493, DOI 10.1007/s12031-013-0147-9; Yocum GT, 2009, STROKE, V40, P1597, DOI 10.1161/STROKEAHA.108.541177; Zhang Wei-Li, 2006, Acta Genetica Sinica, V33, P678, DOI 10.1016/S0379-4172(06)60099-1; Zintzaras E, 2009, AM J EPIDEMIOL, V169, P523, DOI 10.1093/aje/kwn368	20	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122393	10.1371/journal.pone.0122393	http://dx.doi.org/10.1371/journal.pone.0122393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815512	gold, Green Submitted, Green Published			2022-12-26	WOS:000352133600176
J	Harris, MA; Van, AN; Malik, BH; Jabbour, JM; Maitland, KC				Harris, Meagan A.; Van, Andrew N.; Malik, Bilal H.; Jabbour, Joey M.; Maitland, Kristen C.			A Pulse Coupled Neural Network Segmentation Algorithm for Reflectance Confocal Images of Epithelial Tissue	PLOS ONE			English	Article							IN-VIVO; AMELANOTIC TISSUE; MICROSCOPY; MODEL	Automatic segmentation of nuclei in reflectance confocal microscopy images is critical for visualization and rapid quantification of nuclear-to-cytoplasmic ratio, a useful indicator of epithelial precancer. Reflectance confocal microscopy can provide three-dimensional imaging of epithelial tissue in vivo with sub-cellular resolution. Changes in nuclear density or nuclear-to-cytoplasmic ratio as a function of depth obtained from confocal images can be used to determine the presence or stage of epithelial cancers. However, low nuclear to background contrast, low resolution at greater imaging depths, and significant variation in reflectance signal of nuclei complicate segmentation required for quantification of nuclear-to-cytoplasmic ratio. Here, we present an automated segmentation method to segment nuclei in reflectance confocal images using a pulse coupled neural network algorithm, specifically a spiking cortical model, and an artificial neural network classifier. The segmentation algorithm was applied to an image model of nuclei with varying nuclear to background contrast. Greater than 90% of simulated nuclei were detected for contrast of 2.0 or greater. Confocal images of porcine and human oral mucosa were used to evaluate application to epithelial tissue. Segmentation accuracy was assessed using manual segmentation of nuclei as the gold standard.	[Harris, Meagan A.; Van, Andrew N.; Malik, Bilal H.; Jabbour, Joey M.; Maitland, Kristen C.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Maitland, KC (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.	kmaitland@tamu.edu	Maitland, Kristen/D-6961-2011; Maitland, Kristen/N-9171-2019	Maitland, Kristen/0000-0003-0931-0622; Maitland, Kristen/0000-0003-0931-0622; Malik, Bilal/0000-0003-4824-9684; Van, Andrew/0000-0002-8787-0943	National Cancer Institute [R01 CA138653]; NATIONAL CANCER INSTITUTE [R01CA138653] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute under award number R01 CA138653. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeytunge S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3582335; Anuthama K, 2010, ORAL ONCOL, V46, P232, DOI 10.1016/j.oraloncology.2009.12.008; Belien JAM, 2002, CYTOMETRY, V49, P12, DOI 10.1002/cyto.10138; Boudoux C, 2009, J VOICE, V23, P269, DOI 10.1016/j.jvoice.2007.10.003; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Carlson K, 2005, GYNECOL ONCOL, V99, pS84, DOI 10.1016/j.ygyno.2005.07.049; Chen Y, 2011, IEEE T NEURAL NETWOR, V22, P880, DOI 10.1109/TNN.2011.2128880; Collier T, 2002, ACAD RADIOL, V9, P504, DOI 10.1016/S1076-6332(03)80326-4; Collier T, 2000, OPT EXPRESS, V6, P40, DOI 10.1364/OE.6.000040; Drezek RA, 2000, AM J OBSTET GYNECOL, V182, P1135, DOI 10.1067/mob.2000.104844; Dunn AK, 1996, APPL OPTICS, V35, P3441, DOI 10.1364/AO.35.003441; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Ekblad U, 2004, SIGNAL PROCESS, V84, P1131, DOI 10.1016/j.sigpro.2004.03.012; Franco E. L., 2002, CANC PRECURSORS EPID; Fuchs FS, 2013, EUR RESPIR J, V41, P1401, DOI 10.1183/09031936.00062512; Gorodnichev E. E., 1995, Journal of Experimental and Theoretical Physics, V80, P112; Guitera P, 2012, J INVEST DERMATOL, V132, P2386, DOI 10.1038/jid.2012.172; Guns R, 2012, INFORM PROCESS MANAG, V48, P1171, DOI 10.1016/j.ipm.2012.02.009; Hu JX, 2003, IEEE T VIS COMPUT GR, V9, P320, DOI 10.1109/TVCG.2003.1207440; Jabbour JM, 2011, ANN BIOMED ENG; Jabbour JM, 2014, BIOMED OPT EXPRESS, V5, P645, DOI 10.1364/BOE.5.000645; Jabbour JM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong JW, 2012, J MICROELECTROMECH S, V21, P308, DOI 10.1109/JMEMS.2011.2175368; Kester RT, 2007, OPT EXPRESS, V15, P2409, DOI 10.1364/OE.15.002409; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Lindblad T, 2005, IMAGE PROCESSING USI, pxi; Luck BL, 2005, IEEE T IMAGE PROCESS, V14, P1265, DOI 10.1109/TIP.2005.852460; Ma Z, 2010, COMPUT METHOD BIOMEC, V13, P235, DOI 10.1080/10255840903131878; Maitland KC, 2008, ORAL ONCOL; Meining A, 2007, CLIN GASTROENTEROL H, V5, P1261, DOI 10.1016/j.cgh.2007.05.019; Nehal KS, 2008, SEMIN CUTAN MED SURG, V27, P37, DOI 10.1016/j.sder.2008.01.006; Otsu N, 1975, AUTOMATICA, V11, P23, DOI [DOI 10.1109/TSMC.1979.4310076, 10.1109/TSMC.1979.4310076, 10.1109/tsmc.1979.4310076]; PAWLEY J B, 2006, HDB BIOL CONFOCAL MI, V3, DOI [10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Prewitt J. M. S., 1970, PICTURE PROCESSING P, P75, DOI DOI 10.4236/AD.2014.22003; Ragazzi M, 2014, MODERN PATHOL, V27, P460, DOI 10.1038/modpathol.2013.158; Saldua MA, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016006; Sarti A, 2000, IEEE T BIO-MED ENG, V47, P1600, DOI 10.1109/10.887941; Sobel I., 1968, STANFORD ARTIFICIAL, P271; Tabatabaei N, 2014, BIOMED OPT EXPRESS, V5, P197, DOI 10.1364/BOE.5.000197; Tanbakuchi AA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.027; Van AN, 2014, PULSE COUPLED NEURAL, DOI [10.5281/zenodo.12804, DOI 10.5281/ZENODO.12804]; Wang JH, 2003, IEEE T SYST MAN CY B, V33, P572, DOI 10.1109/TSMCB.2003.814306; White WM, 1999, LARYNGOSCOPE, V109, P1709, DOI 10.1097/00005537-199910000-00029; Wu K, 2011, UROLOGY, V78, P225, DOI 10.1016/j.urology.2011.02.057; Zhan K, 2009, IEEE T NEURAL NETWOR, V20, P1980, DOI 10.1109/TNN.2009.2030585; Ziou D., 1998, Pattern Recognition and Image Analysis, V8, P537	48	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122368	10.1371/journal.pone.0122368	http://dx.doi.org/10.1371/journal.pone.0122368			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816131	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600172
J	Staffa, L; Echterdiek, F; Nelius, N; Benner, A; Werft, W; Lahrmann, B; Grabe, N; Schneider, M; Tariverdian, M; Doeberitz, MV; Blaker, H; Kloor, M				Staffa, Laura; Echterdiek, Fabian; Nelius, Nina; Benner, Axel; Werft, Wiebke; Lahrmann, Bernd; Grabe, Niels; Schneider, Martin; Tariverdian, Mirjam; Doeberitz, Magnus von Knebel; Blaeker, Hendrik; Kloor, Matthias			Mismatch Repair-Deficient Crypt Foci in Lynch Syndrome - Molecular Alterations and Association with Clinical Parameters	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; FRAMESHIFT MUTATIONS; GENETIC ALTERATIONS; COLON CANCERS; HEREDITARY; EVOLUTION; TUMORS; HNPCC; RISK	Lynch syndrome is caused by germline mutations of DNA mismatch repair (MMR) genes, most frequently MLH1 and MSH2. Recently, MMR-deficient crypt foci (MMR-DCF) have been identified as a novel lesion which occurs at high frequency in the intestinal mucosa from Lynch syndrome mutation carriers, but very rarely progress to cancer. To shed light on molecular alterations and clinical associations of MMR-DCF, we systematically searched the intestinal mucosa from Lynch syndrome patients for MMR-DCF by immunohistochemistry. The identified lesions were characterised for alterations in microsatellite-bearing genes with proven or suspected role in malignant transformation. We demonstrate that the prevalence of MMR-DCF (mean 0.84 MMR-DCF per 1 cm(2) mucosa in the colorectum of Lynch syndrome patients) was significantly associated with patients' age, but not with patients' gender. No MMR-DCF were detectable in the mucosa of patients with sporadic MSI-H colorectal cancer (n = 12). Microsatellite instability of at least one tested marker was detected in 89% of the MMR-DCF examined, indicating an immediate onset of microsatellite instability after MMR gene inactivation. Coding microsatellite mutations were most frequent in the genes HT001 (ASTE1) with 33%, followed by AIM2 (17%) and BAX (10%). Though MMR deficiency alone appears to be insufficient for malignant transformation, it leads to measurable microsatellite instability even in single MMR-deficient crypts. Our data indicate for the first time that the frequency of MMR-DCF increases with patients' age. Similar patterns of coding microsatellite instability in MMR-DCF and MMR-deficient cancers suggest that certain combinations of coding microsatellite mutations, including mutations of the HT001, AIM2 and BAX gene, may contribute to the progression of MMR-deficient lesions into MMR-deficient cancers.	[Staffa, Laura; Echterdiek, Fabian; Nelius, Nina; Doeberitz, Magnus von Knebel; Kloor, Matthias] Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumour Biol, D-69120 Heidelberg, Germany; [Staffa, Laura; Echterdiek, Fabian; Nelius, Nina; Doeberitz, Magnus von Knebel] DKFZ German Canc Res Ctr Heidelberg, Clin Cooperat Unit Appl Tumour Biol, Heidelberg, Germany; [Benner, Axel; Werft, Wiebke] DKFZ German Canc Res Ctr Heidelberg, Dept Biostat, Heidelberg, Germany; [Lahrmann, Bernd; Grabe, Niels] Bioquant, Hamamatsu Tissue Imaging & Anal TIGA Ctr, Heidelberg, Germany; [Schneider, Martin; Tariverdian, Mirjam] Univ Heidelberg Hosp, Dept Gen Visceral & Accid Surg, D-69120 Heidelberg, Germany; [Blaeker, Hendrik] Univ Hosp Charite, Dept Gen Pathol, Berlin, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kloor, M (corresponding author), Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumour Biol, Neuenheimer Feld 224, D-69120 Heidelberg, Germany.	matthias.kloor@med.uni-heidelberg.de	Echterdiek, Fabian/AAK-7013-2020; Grabe, Niels/I-6214-2016; Grabe, Niels/AAP-6493-2020	Echterdiek, Fabian/0000-0001-7239-4959; Grabe, Niels/0000-0003-1732-3706	Deutsche Krebshilfe [70-2369]; Deutsche Forschungsgemeinschaft [BL-554/3, DFG-KFO 227]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded partly by grants of the Deutsche Krebshilfe (grant number 70-2369, MvKD) and the Deutsche Forschungsgemeinschaft (grant numbers BL-554/3, HB; and DFG-KFO 227, MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland CR, 2013, GASTROENTEROLOGY, V144, P868, DOI 10.1053/j.gastro.2013.03.014; Boland CR, 2005, FAM CANCER, V4, P211, DOI 10.1007/s10689-004-4489-x; Calabrese P, 2004, AM J PATHOL, V164, P1447, DOI 10.1016/S0002-9440(10)63231-2; Carethers JM, 2014, GASTROENTEROLOGY, V146, P602, DOI 10.1053/j.gastro.2014.01.041; De Jong AE, 2004, GASTROENTEROLOGY, V126, P42, DOI 10.1053/j.gastro.2003.10.043; de la Chapelle A, 2003, NEW ENGL J MED, V349, P209, DOI 10.1056/NEJMp038099; Duval A, 2001, HUM MOL GENET, V10, P513, DOI 10.1093/hmg/10.5.513; Engel C, 2010, CLIN GASTROENTEROL H, V8, P174, DOI 10.1016/j.cgh.2009.10.003; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Kloor M, 2012, LANCET ONCOL, V13, P598, DOI 10.1016/S1470-2045(12)70109-2; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Liljegren A, 2008, J CLIN ONCOL, V26, P3434, DOI 10.1200/JCO.2007.13.2795; Lindgren G, 2002, GUT, V50, P228, DOI 10.1136/gut.50.2.228; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Mensenkamp AR, 2014, GASTROENTEROLOGY, V146, P643, DOI 10.1053/j.gastro.2013.12.002; PARSONS R, 1995, SCIENCE, V268, P738, DOI 10.1126/science.7632227; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Rodriguez-Soler M, 2013, GASTROENTEROLOGY, V144, P926, DOI 10.1053/j.gastro.2013.01.044; Roy HK, 2003, GUT, V52, P1665, DOI 10.1136/gut.52.12.1665; Saeterdal I, 2001, P NATL ACAD SCI USA, V98, P13255, DOI 10.1073/pnas.231326898; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Schwitalle Yvette, 2004, Cancer Immun, V4, P14; Shia J, 2014, FAM CANC; Shibata Darryl, 2006, Cancer Biomarkers, V2, P29; Simpkins SB, 1999, HUM MOL GENET, V8, P661, DOI 10.1093/hmg/8.4.661; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Thibodeau SN, 1996, CANCER RES, V56, P4836; Tougeron D, 2009, MODERN PATHOL, V22, P1186, DOI 10.1038/modpathol.2009.80; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Woerner SM, 2007, GENE CHROMOSOME CANC, V46, P1080, DOI 10.1002/gcc.20493; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; Wojciechowicz K, 2014, GASTROENTEROLOGY	38	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121980	10.1371/journal.pone.0121980	http://dx.doi.org/10.1371/journal.pone.0121980			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816162	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600132
J	Yoshida, A; Niki, M; Yamamoto, Y; Yasunaga, A; Ansai, T				Yoshida, Akihiro; Niki, Mamiko; Yamamoto, Yuji; Yasunaga, Ai; Ansai, Toshihiro			Proteome Analysis Identifies the Dpr Protein of Streptococcus mutans as an Important Factor in the Presence of Early Streptococcal Colonizers of Tooth Surfaces	PLOS ONE			English	Article							IRON-BINDING PROTEIN; OXYGEN TOLERANCE; BACTERIOCIN PRODUCTION; NADH OXIDASES; SANGUINIS; COLONIZATION; COEXISTENCE; MICROFLORA; RESISTANCE; SEQUENCE	Oral streptococci are primary colonizers of tooth surfaces and Streptococcus mutans is the principal causative agent of dental caries in humans. A number of proteins are involved in the formation of monospecies biofilms by S. mutans. This study analyzed the protein expression profiles of S. mutans biofilms formed in the presence or absence of S. gordonii, a pioneer colonizer of the tooth surface, by two-dimensional gel electrophoresis (2-DE). After identifying S. mutans proteins by Mass spectrometric analysis, their expression in the presence of S. gordonii was analyzed. S. mutans was inoculated with or without S. gordonii DL1. The two species were compartmentalized using 0.2-mu l Anopore membranes. The biofilms on polystyrene plates were harvested, and the solubilized proteins were separated by 2-DE. When S. mutans biofilms were formed in the presence of S. gordonii, the peroxide resistance protein Dpr of the former showed 4.3-fold increased expression compared to biofilms that developed in the absence of the pioneer colonizer. In addition, we performed a competition assay using S. mutans antioxidant protein mutants together with S. gordonii and other initial colonizers. Growth of the dpr-knockout S. mutans mutant was significantly inhibited by S. gordonii, as well as by S. sanguinis. Furthermore, a cell viability assay revealed that the viability of the dpr-defective mutant was significantly attenuated compared to the wild-type strain when co-cultured with S. gordonii. Therefore, these results suggest that Dpr might be one of the essential proteins for S. mutans survival on teeth in the presence of early colonizing oral streptococci.	[Yoshida, Akihiro] Matsumoto Dent Univ, Dept Oral Microbiol, Shiojiri, Japan; [Yoshida, Akihiro; Yasunaga, Ai; Ansai, Toshihiro] Kyushu Dent Univ, Div Community Oral Hlth Sci, Dept Oral Hlth Promot, Kitakyushu, Fukuoka, Japan; [Niki, Mamiko] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 558, Japan; [Yamamoto, Yuji] Kitasato Univ, Sch Vet Med, Dept Anim Sci, Towada, Aomori, Japan	Matsumoto Dental University; Kyushu Dental University; Osaka Metropolitan University; Kitasato University	Yoshida, A (corresponding author), Matsumoto Dent Univ, Dept Oral Microbiol, Shiojiri, Japan.	aki@po.mdu.ac.jp	Ansai, Toshihiro/AAM-2203-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [23463257]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid (C) 23463257 (to A.Yo.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; BREHM J, 1987, NUCLEIC ACIDS RES, V15, P3177, DOI 10.1093/nar/15.7.3177; Colella AD, 2012, ANAL BIOCHEM, V430, P108, DOI 10.1016/j.ab.2012.08.015; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Fujishima K, 2013, APPL ENVIRON MICROB, V79, P1436, DOI 10.1128/AEM.03306-12; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; Heng NCK, 2007, J BACTERIOL, V189, P1468, DOI 10.1128/JB.01174-06; Higuchi M, 1999, J BACTERIOL, V181, P5940, DOI 10.1128/JB.181.19.5940-5947.1999; Higuchi M, 2000, J BIOSCI BIOENG, V90, P484, DOI 10.1016/S1389-1723(01)80028-1; Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kreth J, 2005, J BACTERIOL, V187, P7193, DOI 10.1128/JB.187.21.7193-7203.2005; Kreth J, 2005, MOL MICROBIOL, V57, P392, DOI 10.1111/j.1365-2958.2005.04695.x; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Liu JM, 2011, MICROBIOL-SGM, V157, P2433, DOI 10.1099/mic.0.048314-0; NAKAYAMA K, 1992, J BACTERIOL, V174, P4928, DOI 10.1128/JB.174.15.4928-4934.1992; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Perry JA, 2011, ORAL MICROBIAL COMMUNITIES: GENOMIC INQUIRY AND INTERSPECIES COMMUNICATION, P247; Petersen FC, 2010, METHODS MOL BIOL, V666, P167, DOI 10.1007/978-1-60761-820-1_12; Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SHIROZA T, 1993, INFECT IMMUN, V61, P3745, DOI 10.1128/IAI.61.9.3745-3755.1993; SUTTON HC, 1984, ARCH BIOCHEM BIOPHYS, V235, P106, DOI 10.1016/0003-9861(84)90259-5; Tsou CC, 2008, INFECT IMMUN, V76, P4038, DOI 10.1128/IAI.00477-08; Wang BY, 2011, J DENT RES, V90, P501, DOI 10.1177/0022034510388808; Wang BY, 2005, APPL ENVIRON MICROB, V71, P354, DOI 10.1128/AEM.71.1.354-362.2005; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Yamamoto Y, 2000, J BACTERIOL, V182, P3740, DOI 10.1128/JB.182.13.3740-3747.2000; Yamamoto Y, 2004, J BACTERIOL, V186, P5997, DOI 10.1128/JB.186.18.5997-6002.2004; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005; Yoshida A, 2002, MICROBIOL-SGM, V148, P3385, DOI 10.1099/00221287-148-11-3385	41	10	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121176	10.1371/journal.pone.0121176	http://dx.doi.org/10.1371/journal.pone.0121176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816242	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600069
J	De la Vega-Ruiz, G; Dominguez-Ramirez, L; Riveros-Rosas, H; Guerrero-Mendiola, C; Torres-Larios, A; Hernandez-Alcantara, G; Garcia-Trejo, JJ; Ramirez-Silva, L				De la Vega-Ruiz, Gustavo; Dominguez-Ramirez, Lenin; Riveros-Rosas, Hector; Guerrero-Mendiola, Carlos; Torres-Larios, Alfredo; Hernandez-Alcantara, Gloria; Garcia-Trejo, Jose J.; Ramirez-Silva, Leticia			New Insights on the Mechanism of the K+-Independent Activity of Crenarchaeota Pyruvate Kinases	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; RABBIT MUSCLE; BINDING; METAL; COMPLEXES; PHOSPHOENOLPYRUVATE; MONOVALENT; RESOLUTION; ENZYME; MODEL	Eukarya pyruvate kinases have glutamate at position 117 (numbered according to the rabbit muscle enzyme), whereas in Bacteria have either glutamate or lysine and in Archaea have other residues. Glutamate at this position makes pyruvate kinases K+-dependent, whereas lysine confers K+-independence because the positively charged residue substitutes for the monovalent cation charge. Interestingly, pyruvate kinases from two characterized Crenarchaeota exhibit K+-independent activity, despite having serine at the equivalent position. To better understand pyruvate kinase catalytic activity in the absence of K+ or an internal positive charge, the Thermofilum pendens pyruvate kinase (valine at the equivalent position) was characterized. The enzyme activity was K+-independent. The kinetic mechanism was random order with a rapid equilibrium, which is equal to the mechanism of the rabbit muscle enzyme in the presence of K+ or the mutant E117K in the absence of K+. Thus, the substrate binding order of the T. pendens enzyme was independent despite lacking an internal positive charge. Thermal stability studies of this enzyme showed two calorimetric transitions, one attributable to the A and C domains (T-m of 99.2 degrees C), and the other (T-m of 105.2 degrees C) associated with the B domain. In contrast, the rabbit muscle enzyme exhibits a single calorimetric transition (T-m of 65.2 degrees C). The calorimetric and kinetic data indicate that the B domain of this hyperthermophilic enzyme is more stable than the rest of the protein with a conformation that induces the catalytic readiness of the enzyme. B domain interactions of pyruvate kinases that have been determined in Pyrobaculum aerophilum and modeled in T. pendens were compared with those of the rabbit muscle enzyme. The results show that intra- and interdomain interactions of the Crenarchaeota enzymes may account for their higher B domain stability. Thus the structural arrangement of the T. pendens pyruvate kinase could allow charge-independent catalysis.	[De la Vega-Ruiz, Gustavo; Riveros-Rosas, Hector; Guerrero-Mendiola, Carlos; Hernandez-Alcantara, Gloria; Ramirez-Silva, Leticia] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Dominguez-Ramirez, Lenin] Univ Americas Puebla, Dept Ciencias Quim Biol, Cholula 72820, Puebla, Mexico; [Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Mexico City 04510, DF, Mexico; [Garcia-Trejo, Jose J.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Americas Puebla (UDLAP); Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ramirez-Silva, L (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico.	lramirez@bq.unam.mx	Dominguez-Ramirez, Lenin/AAG-9864-2020; Riveros-Rosas, Hector/ABD-6638-2020; Riveros-Rosas, Hector/B-6607-2008	Dominguez-Ramirez, Lenin/0000-0002-3483-4658; Riveros-Rosas, Hector/0000-0003-0194-2537; Riveros-Rosas, Hector/0000-0003-0194-2537; Hernandez-Alcantara, Gloria/0000-0002-7029-6033; Torres-Larios, Alfredo/0000-0002-0702-350X; GUERRERO MENDIOLA, CARLOS/0000-0002-9427-4090	Direccion General de Apoyo al Personal Academico-Universidad Nacional Autonoma de Mexico [IN215912, IN216513, IN201213]; Consejo Nacional de Ciencia y Tecnologia [CB2011-164838]	Direccion General de Apoyo al Personal Academico-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Direccion General de Apoyo al Personal Academico-Universidad Nacional Autonoma de Mexico, Grants IN215912 (to L.R.-S.), IN216513 (to H. R.-R.), and Grant IN201213 (to A.T.-L.) and by Consejo Nacional de Ciencia y Tecnologia Grant CB2011-164838 (to A.T.-L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH S, 1973, BIOCHEM J, V131, P223, DOI 10.1042/bj1310223; Allen SC, 1996, ACTA CRYSTALLOGR D, V52, P499, DOI 10.1107/S0907444995016040; [Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; BUCHER T, 1955, METHOD ENZYMOL, V1, P435, DOI 10.1016/0076-6879(55)01071-9; BUSTO F, 1988, BIOCHEM CELL BIOL, V66, P148, DOI 10.1139/o88-020; Case D, 2012, AMBER 12; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cleland W. W, 1970, ENZYMES, V2, P1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; DOUGHERTY TM, 1985, BIOCHEMISTRY-US, V24, P5875, DOI 10.1021/bi00342a028; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; GUPTA RK, 1978, J BIOL CHEM, V253, P8878; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7; JETTEN MSM, 1994, APPL ENVIRON MICROB, V60, P2501, DOI 10.1128/AEM.60.7.2501-2507.1994; Johnsen U, 2003, J BIOL CHEM, V278, P25417, DOI 10.1074/jbc.M210288200; KACHMAR JF, 1953, J BIOL CHEM, V200, P669; KAPOOR R, 1981, BIOCHEM J, V193, P435, DOI 10.1042/bj1930435; KASAHARA M, 1978, J BIOL CHEM, V253, P4180; KAYNE FJ, 1970, J AM CHEM SOC, V92, P220, DOI 10.1021/ja00704a048; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; Larsen TM, 1997, ARCH BIOCHEM BIOPHYS, V345, P199, DOI 10.1006/abbi.1997.0257; Laughlin LT, 1997, ARCH BIOCHEM BIOPHYS, V348, P262, DOI 10.1006/abbi.1997.0448; LIAO CL, 1971, J BACTERIOL, V106, P37, DOI 10.1128/JB.106.1.37-44.1971; Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; MILDVAN AS, 1965, J BIOL CHEM, V240, P238; MILDVAN AS, 1966, J BIOL CHEM, V241, P1178; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Nikolova PV, 1997, BIOCHEMISTRY-US, V36, P1381, DOI 10.1021/bi962367f; NOWAK T, 1972, BIOCHEMISTRY-US, V11, P2819, DOI 10.1021/bi00765a014; ONUCHIC JN, 1995, P NATL ACAD SCI USA, V92, P3626, DOI 10.1073/pnas.92.8.3626; Oria-Hernandez J, 2005, J BIOL CHEM, V280, P37924, DOI 10.1074/jbc.M508490200; Oria-Hernandez J, 2006, J BIOL CHEM, V281, P30717, DOI 10.1074/jbc.M605310200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Ramirez-Silva L, 2003, EUR J BIOCHEM, V270, P2377, DOI 10.1046/j.1432-1033.2003.03605.x; Ramirez-Silva L, 2001, EUR J BIOCHEM, V268, P3267, DOI 10.1046/j.1432-1327.2001.02222.x; RAMIREZSILVA L, 1993, BIOCHEMISTRY-US, V32, P5332, DOI 10.1021/bi00071a008; RAUSHEL FM, 1980, BIOCHEMISTRY-US, V19, P5481, DOI 10.1021/bi00565a003; REED GH, 1974, BIOCHEMISTRY-US, V13, P3537, DOI 10.1021/bi00714a020; REUBEN J, 1971, J BIOL CHEM, V246, P6227; REYNARD AM, 1961, J BIOL CHEM, V236, P2277; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; RUIZARRIBAS A, 1994, BIOCHEMISTRY-US, V33, P13787, DOI 10.1021/bi00250a032; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Schramm A, 2000, J BACTERIOL, V182, P2001, DOI 10.1128/JB.182.7.2001-2009.2000; SMART JB, 1979, ARCH MICROBIOL, V122, P281, DOI 10.1007/BF00411292; Solomons JTG, 2013, BIOCHEMISTRY-US, V52, P5865, DOI 10.1021/bi400761b; Steiner P, 1998, GENE, V220, P31, DOI 10.1016/S0378-1119(98)00418-1; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Susan-Resiga D, 2004, BIOCHEMISTRY-US, V43, P15230, DOI 10.1021/bi049864d; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	62	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119233	10.1371/journal.pone.0119233	http://dx.doi.org/10.1371/journal.pone.0119233			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811853	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700014
J	Karanovic, I				Karanovic, Ivana			Barcoding of Ancient Lake Ostracods (Crustacea) Reveals Cryptic Speciation with Extremely Low Distances	PLOS ONE			English	Article							WESTERN-AUSTRALIA; PHYLOGENIES; DIVERGENCE; INFERENCE; ALIGNMENT; TAXONOMY; MRBAYES; RATES; MODEL	Ostracods are drastically reduced crustaceans, with never more than eight appendages enclosed between two valves, leaving only a limited number of morphological characters for species delineation. Conservative morphology of characters used to define genera, along with high variability of characters used to define species are creating problems in applying a morphospecies concept. A high intraspecific variability in a Lake Biwa (Japan) endemic, Physocypria biwaensis (Okubo, 1990), has been observed previously but was never studied in detail. Two sympatric forms, differing in pigmentation and size, suggest a presence of reproductive isolation. The aim of this study is to employ molecular and morphometric tools to aid in species delineation within P. biwaensis complex and reconstruct their phylogenetic relationships. A fragment of the mtCOI gene was amplified from 30 specimens, and an additional 37 specimens were studied for morphological characters. Resulting phylogenies showed that each morphologically distinct form is associated with a distinct phylogenetic group based on mtDNA. The average pairwise distance is very low (5%), indicating a recent divergence time. I speculate that there is a possibility that one of them originated in the lake, while the other probably colonized it afterwards. This seems to be supported with an apparent niche partitioning at different depths. In spite of the fact that traditionally used sexual characters are highly variable in these two species, the morphometric analysis of shell and soft part related characters clearly delineates them and suggests that such characters may be useful for future detection of seemingly cryptic ostracod species.	[Karanovic, Ivana] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Karanovic, Ivana] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	Hanyang University; University of Tasmania	Karanovic, I (corresponding author), Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea.	ivana@hanyang.ac.kr			NIBR (National Institute of Biological Resources), Korea [2013-02-001]; Lake Biwa Museum Comprehensive Research Project, Japan [11-01]	NIBR (National Institute of Biological Resources), Korea; Lake Biwa Museum Comprehensive Research Project, Japan	Financial support for sequencing and SEM work to the author came from NIBR (National Institute of Biological Resources) grant (NIBR No. 2013-02-001), Korea, while the necessary facilities were provided by the Hanyang University and Eulji University, both in Seoul. Collecting from the Lake Biwa was supported by the Lake Biwa Museum Comprehensive Research Project 11-01, Japan. The funders had no role in study design and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Birky CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052544; Bode SNS, 2010, MOL PHYLOGENET EVOL, V54, P542, DOI 10.1016/j.ympev.2009.08.022; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; Danielopol DL, 1978, SITZUNGSBERICHTE OST, V187, P1, DOI [10.1007/s10329-008-0116-z, DOI 10.1007/S10329-008-0116-Z]; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Higashi R, 2011, J CRUSTACEAN BIOL, V31, P142, DOI 10.1651/09-3234.1; Higuti Janet, 2012, European Journal of Taxonomy, V33, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jeffery NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018364; Karanovic I, 2007, CRUSTACEANA MONOGR, V7, P1, DOI 10.1163/ej.9789004156937.i-434; Karanovic I, 2012, RECENT FRESHWATER OS, DOI 10.1007/978-3-642-21810-1; Karanovic T, 2012, INVERTEBR SYST, V26, P115, DOI 10.1071/IS11027; Keyser D, 2005, HYDROBIOLOGIA, V538, P95, DOI 10.1007/s10750-004-4940-x; Keyser Dietmar, 2004, Studia Quaternaria, V21, P19; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Koenders A, 2012, BIOL INVASIONS, V14, P2187, DOI 10.1007/s10530-012-0224-y; Kornicker L.S., 1975, Smithsonian Contributions to Zoology, VNo. 163, P1; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Martens K., 1994, Advances in Limnology, V44, P75; Martens K, 2008, HYDROBIOLOGIA, V595, P185, DOI 10.1007/s10750-007-9245-4; Martens K, 2013, EUR J TAXON, V66, P1, DOI 10.5852/ejt.2013.66; Meisch C, 2000, FRESHWATER OSTRACODA; Okubo I., 1990, RES CRUSTACEA, V19, P1, DOI DOI 10.18353/RCUSTACEA.19.0_1; Patarnello T, 2003, MOL PHYLOGENET EVOL, V28, P420, DOI 10.1016/S1055-7903(03)00124-6; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satoguchi Y., 2012, LAKE BIWA INTERACTIO, P9; Schon I, 2014, HYDROBIOLOGIA, V739, P119, DOI 10.1007/s10750-013-1581-y; Schon I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039844; Smith RJ, 2012, LAKE BIWA INTERACTIO, P99; Smith RJ, 2008, J NAT HIST, V42, P2865, DOI 10.1080/00222930802361030; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	44	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121133	10.1371/journal.pone.0121133	http://dx.doi.org/10.1371/journal.pone.0121133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811597	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700084
J	Klein, RC; Fabres-Klein, MH; de Oliveira, LL; Feio, RN; Malouin, F; Ribon, ADB				Klein, Raphael Contelli; Fabres-Klein, Mary Hellen; de Oliveira, Leandro Licursi; Feio, Renato Neves; Malouin, Francois; Barros Ribon, Andrea de Oliveira			A C-Type Lectin from Bothrops jararacussu Venom Disrupts Staphylococcal Biofilms	PLOS ONE			English	Article							PLANT-LECTINS; VIRULENCE FACTORS; PROTEINS; MASTITIS; AUREUS; ADHESION; COW; PURIFICATION; INHIBITION; IMPACT	Bovine mastitis is a major threat to animal health and the dairy industry. Staphylococcus aureus is a contagious pathogen that is usually associated with persistent intramammary infections, and biofilm formation is a relevant aspect of the outcome of these infections. Several biological activities have been described for snake venoms, which led us to screen secretions of Bothrops jararacussu for antibiofilm activity against S. aureus NRS155. Crude venom was fractionated by size-exclusion chromatography, and the fractions were tested against S. aureus. Biofilm growth, but not bacterial growth, was affected by several fractions. Two fractions (15 and 16) showed the best activities and were also assayed against S. epidermidis NRS101. Fraction 15 was identified by TripleTOF mass spectrometry as a galactose-binding C-type lectin with a molecular weight of 15 kDa. The lectin was purified from the crude venom by D-galactose affinity chromatography, and only one peak was observed. This pure lectin was able to inhibit 75% and 80% of S. aureus and S. epidermidis biofilms, respectively, without affecting bacterial cell viability. The lectin also exhibited a dose-dependent inhibitory effect on both bacterial biofilms. The antibiofilm activity was confirmed using scanning electron microscopy. A pre-formed S. epidermidis biofilm was significantly disrupted by the C-type lectin in a time-dependent manner. Additionally, the lectin demonstrated the ability to inhibit biofilm formation by several mastitis pathogens, including different field strains of S. aureus, S. hyicus, S. chromogenes, Streptococcus agalactiae, and Escherichia coli. These findings reveal a new activity for C-type lectins. Studies are underway to evaluate the biological activity of these lectins in a mouse mastitis model.	[Klein, Raphael Contelli; Fabres-Klein, Mary Hellen; Barros Ribon, Andrea de Oliveira] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Lab Biotecnol Mol, BR-36570000 Vicosa, MG, Brazil; [de Oliveira, Leandro Licursi] Univ Fed Vicosa, Dept Biol Geral, Lab Glicobiol, BR-36570000 Vicosa, MG, Brazil; [Feio, Renato Neves] Univ Fed Vicosa, Dept Biol Anim, Museu Zool, BR-36570000 Vicosa, MG, Brazil; [Malouin, Francois] Univ Sherbrooke, Fac Sci, Dept Biol, CEVDM, Sherbrooke, PQ J1K 2R1, Canada	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa; University of Sherbrooke	Malouin, F (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, CEVDM, Sherbrooke, PQ J1K 2R1, Canada.	francois.malouin@usherbrooke.ca; abribon@ufv.br	de Oliveira, Leandro Licursi/D-3616-2009; Ribon, Andrea O. B./C-8318-2017; Feio, Renato/AAD-8127-2020	de Oliveira, Leandro Licursi/0000-0003-4353-7011; Ribon, Andrea O. B./0000-0001-8485-3075; Feio, Renato/0000-0002-3607-2896; Malouin, Francois/0000-0001-5031-345X; Assis, Clodoaldo/0000-0001-5009-2706	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig) [CBB-APQ-01054-10]; Natural Sciences and Engineering Research Council of Canada [89758-2010]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	AOBR was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Fapemig) CBB-APQ-01054-10. http://www.fapemig.br/. FM was supported by Natural Sciences and Engineering Research Council of Canada. Grant 89758-2010. http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar M., 2007, THESIS U AGR FAISALA; Bales PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067950; Barkema HW, 2009, J DAIRY SCI, V92, P4717, DOI 10.3168/jds.2009-2347; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Beenken KE, 2012, INFECT IMMUN, V80, P1634, DOI 10.1128/IAI.06134-11; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217; Clutterbuck AL, 2007, VET MICROBIOL, V121, P1, DOI 10.1016/j.vetmic.2006.12.029; Deluyker HA, 2005, J DAIRY SCI, V88, P604, DOI 10.3168/jds.S0022-0302(05)72724-7; Dhanawade NB, 2010, VET RES COMMUN, V34, P81, DOI 10.1007/s11259-009-9326-0; Almeida FBD, 2010, YEAST, V27, P67, DOI 10.1002/yea.1731; Elifio-Esposito SL, 2007, J VENOM ANIM TOXINS, V13, P782, DOI 10.1590/S1678-91992007000400009; Fox JW, 2008, PROTEOMICS, V8, P909, DOI 10.1002/pmic.200700777; Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667; Gundelach Y, 2011, J VET SCI, V12, P227, DOI 10.4142/jvs.2011.12.3.227; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamilton MA, 2002, J AOAC INT, V85, P479; Hasan I, 2014, INDIAN J BIOCHEM BIO, V51, P142; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Hillerton JE, 2005, J APPL MICROBIOL, V98, P1250, DOI 10.1111/j.1365-2672.2005.02649.x; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Islam B, 2009, J APPL MICROBIOL, V106, P1682, DOI 10.1111/j.1365-2672.2008.04135.x; Jabbouri S, 2010, FEMS IMMUNOL MED MIC, V59, P280, DOI 10.1111/j.1574-695X.2010.00695.x; Koh DCI, 2006, CELL MOL LIFE SCI, V63, P3030, DOI 10.1007/s00018-006-6315-0; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu JH, 2002, BBA-GEN SUBJECTS, V1572, P387, DOI 10.1016/S0304-4165(02)00320-3; Marcato-Romain CE, 2012, BIOFOULING, V28, P305, DOI 10.1080/08927014.2012.673122; McCleary RJR, 2013, TOXICON, V62, P56, DOI 10.1016/j.toxicon.2012.09.008; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006; MOREIRA RD, 1991, MEM I OSWALDO CRUZ, V86, P211; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Papa R, 2013, MICROB PATHOGENESIS, V63, P44, DOI 10.1016/j.micpath.2013.05.003; Parra-Ruiz J, 2012, REV ESP QUIM, V25, P10; Peumans WJ, 1998, BIOTECHNOL GENET ENG, V15, P199, DOI 10.1080/02648725.1998.10647956; Raza A, 2013, MOL MICROBIOL RES, V33, P1; Reyher KK, 2011, J DAIRY SCI, V94, P1616, DOI 10.3168/jds.2010-3180; Sakakura M, 2008, J BIOL CHEM, V283, P33665, DOI 10.1074/jbc.M804067200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; SUTRA L, 1994, J MED MICROBIOL, V40, P79, DOI 10.1099/00222615-40-2-79; Taraszkiewicz A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/150653; Tateda Kazuhiro, 2007, Journal of Infection and Chemotherapy, V13, pCP7, DOI 10.1007/s10156-007-0555-2; Vasconcelos MA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/365272; Vasudevan P, 2003, VET MICROBIOL, V92, P179, DOI 10.1016/S0378-1135(02)00360-7; Veh KA, 2015, J DAIRY SCI, V98, P155, DOI 10.3168/jds.2014-8044; Wang R, 2012, BIOTECHNOL BIOENG, V109, P336, DOI 10.1002/bit.23342; Zadoks RN, 2009, IRISH VET J, V62, P59, DOI 10.1186/2046-0481-62-S4-S59	50	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120514	10.1371/journal.pone.0120514	http://dx.doi.org/10.1371/journal.pone.0120514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811661	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700049
J	Le Flohic, G; Motsch, P; DeNys, H; Childs, S; Courage, A; King, T				Le Flohic, Guillaume; Motsch, Peggy; DeNys, Helene; Childs, Simon; Courage, Amos; King, Tony			Behavioural Ecology and Group Cohesion of Juvenile Western Lowland Gorillas (Gorilla g. gorilla) during Rehabilitation in the Bateke Plateaux National Park, Gabon	PLOS ONE			English	Article							AFRICAN SANCTUARY ALLIANCE; LONG-LIVED PRIMATES; CO-INERTIA ANALYSIS; BAI-HOKOU; LOPE RESERVE; REINTRODUCTION SUCCESS; FRUIT SCARCITY; DIET; RELEASE; DECLINE	Rehabilitation of animals followed by reintroduction into the wild can benefit conservation by supplementing depleted wild populations or reintroducing a species in an area where it has been extirpated or become extinct. The western lowland gorilla (WLG, Gorilla g. gorilla) is persistently poached; infants are often illegally traded and used as pets. Some are confiscated and rehabilitated, then kept in sanctuaries or reintroduced into the wild. Prior to reintroduction, the ability of the orphans to survive independently in their environment needs to be assessed. Here, we performed a multivariate analysis, including diet composition, activity-budget, and pattern of strata using of a group of five juvenile WLG in the process of rehabilitation and distinguished three sub-periods of ecological significance: the high furgivory period, the Dialium fruits consumption period, and the high folivory period. The consequences of these variations on their well-being (play behaviour) and the group cohesion (spatial proximity and social interactions) were examined. Like wild WLGs, diets shifted seasonally from frugivorous to folivorous, while the same staple foods were consumed and large amounts of Dialium fruits were seasonally gathered high in trees. When succulent fruit intake was the highest, thus providing high energy from sugar, juveniles spent less time feeding, more time playing and group cohesion was the highest. Conversely, the cohesion decreased with increasing folivory, individuals spent more time feeding and less time playing together. Nonetheless, the group cohesion also decreased after the death of one highly social, wild-born orphan. This may underscore the importance of skilled individuals in the cohesion and well-being of the entire group and, ultimately, to rehabilitation success. This study evaluates the rehabilitation success with regards to the methods used and highlights the need to consider a set of individual and environmental factors for enhancing rehabilitation while preserving the local biodiversity and individual well-being.	[Le Flohic, Guillaume; DeNys, Helene; Childs, Simon] Aspinall Fdn, Projet Protect Gorilles, Franceville, Gabon; [Le Flohic, Guillaume] African Pk Network, Unite Gest, Brazzaville, Rep Congo; [Motsch, Peggy] Ctr Int Rech Med Franceville, Franceville, Gabon; [Courage, Amos; King, Tony] Aspinall Fdn, Hythe, Kent, England		Le Flohic, G (corresponding author), Aspinall Fdn, Projet Protect Gorilles, Franceville, Gabon.	guillaumelf@african-parks.org	De Nys, Helene/P-6384-2016	De Nys, Helene/0000-0002-2942-4531; King, Tony/0000-0003-4597-0134	Ministry of Water and Forests; National Agency for National Parks of the government of Gabon; The Aspinall Foundation of UK	Ministry of Water and Forests; National Agency for National Parks of the government of Gabon; The Aspinall Foundation of UK	We thank the Ministry of Water and Forests and the National Agency for National Parks of the government of Gabon, and The Aspinall Foundation of UK for their long-term commitment to and funding of the reintroduction and protected area management projects. We thank Celine Bret who helped in social networks visualization and analysis, Valerie Dufour and Alain Butet for their revision of the manuscript, and their wise advice and comments. We are grateful to the reviewers, in particular Shelly Masi, for their very useful and appreciated comments, and to Valerie Durand-Hernandez for English editing. Special thanks to the project staff: Anathole Atsouomaloula, Alain Bikita, Jemael Djoungou Leck, Chinaud-Payeri Kakaka, and Laurent Kantouna.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ashraf NVK, 2005, BACK WILD STUDIES WI, P34; Bady P, 2004, CR BIOL, V327, P29, DOI 10.1016/j.crvi.2003.10.007; Baker Lynne R., 2002, Re-introduction News, V21, P29; BARRETT L, 1992, ANIM BEHAV, V44, P111, DOI 10.1016/S0003-3472(05)80760-2; Bateson Patrick, 2005, P13; Beck B, 2007, BEST PRACTICE GUIDEL, DOI [10.1007/s10329-013-0386-yPMID: 24132600, DOI 10.1007/S10329-013-0386-Y]; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brugiere D, 2002, INT J PRIMATOL, V23, P999, DOI 10.1023/A:1019693814988; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chapman CA, 2006, AFR J ECOL, V44, P116, DOI 10.1111/j.1365-2028.2006.00636.x; Chessel D., 1996, REV STAT APPL, V44, P35; Chessel D., 2004, R NEWS, V4, P5; Cheyne S. M., 2012, International Zoo Yearbook, V46, P265, DOI 10.1111/j.1748-1090.2011.00149.x; Cheyne Susan M., 2006, BMC Ecology, V6, P5, DOI 10.1186/1472-6785-6-5; Cipolletta C, 2007, INT J PRIMATOL, V28, P457, DOI 10.1007/s10764-007-9129-5; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Doran DM, 2002, AM J PRIMATOL, V58, P91, DOI 10.1002/ajp.10053; Doran DM, 1998, EVOL ANTHROPOL, V6, P120; Dray S, 2003, ECOSCIENCE, V10, P110, DOI 10.1080/11956860.2003.11682757; Dray S., 2007, R NEWS, V7, P47; Farmer Kay H., 2008, P79, DOI 10.1007/978-0-387-70721-1_3; Farmer KH, 2002, AM J PRIMATOL, V58, P117, DOI 10.1002/ajp.10054; Ferrie GM, 2014, BIODIVERS CONSERV, V23, P187, DOI 10.1007/s10531-013-0592-3; Goldberg TL, 2008, AM J PRIMATOL, V70, P716, DOI 10.1002/ajp.20562; Goldsmith ML, 1999, INT J PRIMATOL, V20, P1, DOI 10.1023/A:1020528115829; Guy AJ, 2013, BIODIVERS CONSERV, V22, P825, DOI 10.1007/s10531-013-0452-1; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Heo MS, 1998, COMMUN STAT-SIMUL C, V27, P843, DOI 10.1080/03610919808813512; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Hladik A, 1978, ECOLOGY ARBOREAL FOL, P51; Hladik C. M., 1977, P481; Houser A, 2011, S AFR J WILDL RES, V41, P11, DOI 10.3957/056.041.0111; Huijbregts B, 2003, ORYX, V37, P437, DOI 10.1017/S0030605303000802; IUCN, 2000, 2000 IUCN RED LIST T; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; King Tony, 2005, IZN International Zoo News, V52, P198; King T, 2014, ORYX, V48, P294, DOI 10.1017/S0030605312001391; King T, 2012, INT J PRIMATOL, V33, P134, DOI 10.1007/s10764-011-9563-2; King Tony, 2009, IZN International Zoo News, V56, P342; King Tony, 2008, P217; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; Moore M, 2007, MAR MAMMAL SCI, V23, P731, DOI 10.1111/j.1748-7692.2007.00146.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ongman Lissa, 2013, Animals, V3, P109, DOI 10.3390/ani3010109; Pearson L, 2008, ORYX, V42, P14; POIRIER FE, 1974, AM ZOOL, V14, P275; R Core Team, 2021, R LANGUAGE ENV STAT; Remis MJ, 1999, PRIMATES, V40, P383, DOI 10.1007/BF02557560; Remis MJ, 1997, AM J PRIMATOL, V43, P87; Remis MJ, 2001, INT J PRIMATOL, V22, P807, DOI 10.1023/A:1012021617737; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; Russon Anne E., 2009, P327; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Schaumburg F, 2012, AM J PRIMATOL, V74, P1071, DOI 10.1002/ajp.22067; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Stiles D, 2013, STOLEN APES LLLICIT; Stoinski TS, 2004, AM J PRIMATOL, V62, P1, DOI 10.1002/ajp.20002; Taborsky B, 2012, TRENDS ECOL EVOL, V27, P679, DOI 10.1016/j.tree.2012.09.003; Tutin C.E.G., 1988, Primate Report, P25; Tutin CEG, 1997, AM J PRIMATOL, V42, P1, DOI 10.1002/(SICI)1098-2345(1997)42:1<1::AID-AJP1>3.0.CO;2-0; TUTIN CEG, 1992, AM J PRIMATOL, V28, P29, DOI 10.1002/ajp.1350280103; United Nations Environmental Programme (UNEP), 2013, LLLEG TRAD ROBS WILD; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; WHITE LJT, 1995, AFR J ECOL, V33, P124, DOI 10.1111/j.1365-2028.1995.tb00788.x; WHITE LJT, 1994, J TROP ECOL, V10, P289, DOI 10.1017/S0266467400007975; White TH, 2005, CONDOR, V107, P424, DOI 10.1650/7672; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; WILLIAMSON EA, 1990, AM J PRIMATOL, V21, P265, DOI 10.1002/ajp.1350210403; Williamson EA, 1988, BEHAV ECOLOGY W LOWL; Wolfaardt AC, 2009, AFR J MAR SCI, V31, P31, DOI 10.2989/AJMS.2009.31.1.3.774	79	6	6	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119609	10.1371/journal.pone.0119609	http://dx.doi.org/10.1371/journal.pone.0119609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811467	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700020
J	Nakamura, DS; Edwards, AK; Ahn, SH; Thomas, R; Tayade, C				Nakamura, Diane S.; Edwards, Andrew K.; Ahn, Soo Hyun; Thomas, Richard; Tayade, Chandrakant			Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis	PLOS ONE			English	Article							MIMETIC PEPTIDE; ANGIOGENESIS; MECHANISMS; THERAPIES; ABT-898; DISEASE	Endometriosis is a gynecological disease defined by the growth of endometrium outside of the uterus. Although endometriosis contributes to 50% of female infertility cases, medical treatments are incompatible with pregnancy. Angiogenesis, the growth of blood vessels from existing vasculature, plays a crucial role in endometriotic lesion growth and survival. Previously, we demonstrated the effectiveness of thrombospondin-1 analog, ABT-898 (Abbott Laboratories) to inhibit endometriotic lesion vascularization in mice. We have now evaluated the trans-generational implications of ABT-898 treatment before and during mouse pregnancy. We hypothesized that ABT-898 would target lesion vasculature without affecting pregnancy, offspring development, or ovarian and uterine vascularity in mice. Endometriosis was induced using human endometrium in a-estradiol-primed BALB/c-Rag-2(-/-)Il2r gamma(-/-) mice receiving intraperitoneal injections of ABT-898 (25 mg/kg) or 5% dextrose control for 21 days. Ultrasound assessment of lesion vascularization revealed a reduction in blood flow supplying treated lesions. Excised ABT-898 treated lesions stained for CD31(+) endothelial cells exhibited a decrease in microvessel density. Following confirmation of estrous cycling, mice were bred and treated with ABT-898 on gestation days 7, 9, 11, 13, 15, 17, and 19. ABT-898 did not affect estrous cycling or pregnancy parameters including litter size across generations and offspring weight gain. Quantification of angiogenic cytokine plasma levels revealed no significant differences between treatment groups. Vimentin staining of the uterus and ovary revealed no observable effects of ABT-898. Similarly, no obvious histological anomalies were observed in the kidney, liver, ovary, or uterus following ABT-898 treatment. These results suggest that ABT-898 effectively inhibit endometriotic lesion vascularization without affecting trans-generational pregnancy outcomes in mice.	[Nakamura, Diane S.; Edwards, Andrew K.; Ahn, Soo Hyun; Tayade, Chandrakant] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Thomas, Richard] Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Tayade, C (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	tayadec@queensu.ca			Canadian Institutes of Health Research; Principals Development Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Principals Development Fund	This research was supported by funding from Canadian Institutes of Health Research and the Principals Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson GD, 2010, J ENDOMETR PELVIC PA, V2, P3, DOI 10.1177/228402651000200102; Bedaiwy MA, 2010, SRM, V8, P10; Bulletti C, 2010, J ASSIST REPROD GEN, V27, P441, DOI 10.1007/s10815-010-9436-1; Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Garside SA, 2010, ENDOCRINOLOGY, V151, P5905, DOI 10.1210/en.2010-0283; Giudice LC, 2013, NEW ENGL J MED, V362, P2389; Groothuis P. G., 2005, Angiogenesis, V8, P147, DOI 10.1007/s10456-005-9005-x; Henkin J, 2011, EXPERT OPIN THER TAR, V15, P1369, DOI 10.1517/14728222.2011.640319; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Kitawaki J, 2002, J STEROID BIOCHEM, V83, P149, DOI 10.1016/S0960-0760(02)00260-1; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lessey BA, 2000, FERTIL STERIL, V73, P1089, DOI 10.1016/S0015-0282(00)00519-7; Levy AR, 2011, J OBSTET GYNAECOL CA, V33, P830, DOI 10.1016/S1701-2163(16)34986-6; MCBRIDE WG, 1961, LANCET, V2, P1358; Nakamura DS, 2012, AM J PATHOL, V181, P570, DOI 10.1016/j.ajpath.2012.05.010; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Senapati S, 2011, CLIN OBSTET GYNECOL, V54, P720, DOI 10.1097/GRF.0b013e3182353e06; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Soares SR, 2012, FERTIL STERIL, V98, P529, DOI 10.1016/j.fertnstert.2012.07.1120; Taylor RN, 2009, REPROD SCI, V16, P140, DOI 10.1177/1933719108324893; Zaslavsky A, 2010, BLOOD, V115, P4605, DOI 10.1182/blood-2009-09-242065	28	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121545	10.1371/journal.pone.0121545	http://dx.doi.org/10.1371/journal.pone.0121545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811892	Green Submitted, gold, Green Published			2022-12-26	WOS:000356353700114
J	Perez-Padilla, R; Wehrmeister, FC; de Oca, MM; Lopez, MV; Jardim, JR; Muino, A; Valdivia, G; Pertuze, J; Menezes, AMB				Perez-Padilla, Rogelio; Wehrmeister, Fernando C.; Montes de Oca, Maria; Victorina Lopez, Maria; Jardim, Jose R.; Muino, Adriana; Valdivia, Gonzalo; Pertuze, Julio; Menezes, Ana Maria B.		PLATINO Grp	Instability in the COPD Diagnosis upon Repeat Testing Vary with the Definition of COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LATIN-AMERICAN CITIES; PREVALENCE; SPIROMETRY; PLATINO; BOLD	Background A low FEV1/FVC from post-bronchodilator spirometry is required to diagnose COPD. Both the FEV1 and the FVC can vary over time; therefore, individuals can be given a diagnosis of mild COPD at one visit, but have normal spirometry during the next appointment, even without an intervention. Methods We analyzed two population-based surveys of adults with spirometry carried out for the same individuals 5-9 years after their baseline examination. We determined the factors associated with a change in the spirometry interpretation from one exam to the next utilizing different criteria commonly used to diagnose COPD. Results The rate of an inconsistent diagnosis of mild COPD was 11.7% using FEV1/FVC <0.70, 5.9% using FEV1/FEV6 < the lower limit of the normal range, LLN and 4.1% using the GOLD stage 2-4 criterion. The most important factor associated with diagnostic inconsistency was the closeness of the ratio to the LLN during the first examination. Inconsistency decreased with a lower FEV1. Conclusions Using FEV1/FEV6 < LLN or GOLD stage 2-4 as the criterion for airflow obstruction reduces inconsistencies in the diagnosis of mild COPD. Further improvement could be obtained by defining a borderline zone around the LLN (e.g. plus or minus 0.6 SD), or repeating the test in patients with borderline results.	[Perez-Padilla, Rogelio] Natl Inst Resp Dis, Sleep Clin, Mexico City, DF, Mexico; [Victorina Lopez, Maria; Muino, Adriana] Univ Republica, Fac Med, Montevideo, Uruguay; [Montes de Oca, Maria] Cent Univ Venezuela, Hosp Univ Caracas, Div Pulm, Caracas, Venezuela; [Wehrmeister, Fernando C.; Menezes, Ana Maria B.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Valdivia, Gonzalo; Pertuze, Julio] Pontificia Univ Catolica Chile, Santiago, Chile; [Jardim, Jose R.] Univ Fed Sao Paulo, Sao Paulo, Brazil	Universidad de la Republica, Uruguay; University of Central Venezuela; Universidade Federal de Pelotas; Pontificia Universidad Catolica de Chile; Universidade Federal de Sao Paulo (UNIFESP)	Perez-Padilla, R (corresponding author), Natl Inst Resp Dis, Sleep Clin, Mexico City, DF, Mexico.	perezpad@unam.mx	Jardim, Jose R/E-3205-2016; de, Maria Montes/AAP-7687-2021; Menezes, Ana MB/G-7266-2012; Wehrmeister, Fernando/A-3006-2014; Nascimento, Oliver A./B-3039-2011	Menezes, Ana MB/0000-0002-2996-9427; Wehrmeister, Fernando/0000-0001-7137-1747; Nascimento, Oliver A./0000-0003-3138-2219; Valdivia, Gonzalo/0000-0001-5368-6745; Moreno, Dolores/0000-0002-6481-1377	Asociacion Latinoamericana de Torax (ALAT); Boehringer Ingelheim GmbH; GlaxoSmithKline; Novartis	Asociacion Latinoamericana de Torax (ALAT); Boehringer Ingelheim GmbH(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis)	The PLATINO study has been sponsored by The Asociacion Latinoamericana de Torax (ALAT), Boehringer Ingelheim GmbH, GlaxoSmithKline and Novartis for the collection of the data during the field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Menezes Ana M B, 2004, BMC Med Res Methodol, V4, P15, DOI 10.1186/1471-2288-4-15; Menezes AMB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109732; Menezes AMB, 2014, ARCH BRONCONEUMOL, V50, P10, DOI 10.1016/j.arbres.2013.07.014; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Perez-Padilla Rogelio, 2007, COPD, V4, P113, DOI 10.1080/15412550701341012; Perez-Padilla R, 2006, ARCH BRONCONEUMOL, V42, P317, DOI 10.1157/13090581; Perez-Padilla R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067960; Reddel HK, 2014, LACK CONSISTENCY OVE; Standardization of Spirometry, 1994, AM J RESP CRIT CARE, V152, P1107; Vollmer WM, 2009, EUR RESPIR J, V34, P588, DOI 10.1183/09031936.00164608; WATSON RDS, 1987, J HYPERTENS, V5, P207, DOI 10.1097/00004872-198704000-00012	16	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121832	10.1371/journal.pone.0121832	http://dx.doi.org/10.1371/journal.pone.0121832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811461	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700146
J	Redaelli, M; Ricatti, MJ; Simonetto, M; Claus, M; Ballabio, M; Caretta, A; Mucignat-Caretta, C				Redaelli, Marco; Ricatti, Mara Jimena; Simonetto, Marialaura; Claus, Mirko; Ballabio, Maurizio; Caretta, Antonio; Mucignat-Caretta, Carla			Serotonin and Noradrenaline Reuptake Inhibitors Improve Micturition Control in Mice	PLOS ONE			English	Article							URINARY-INCONTINENCE; OVERACTIVE BLADDER; NEURAL-CONTROL; DULOXETINE; IMIPRAMINE; MANAGEMENT; URGENCY; OPTIONS; MODELS; SWITCH	Poor micturition control may cause profound distress, because proper voiding is mandatory for an active social life. Micturition results from the subtle interplay of central and peripheral components. It involves the coordination of autonomic and neuromuscular activity at the brainstem level, under the executive control of the prefrontal cortex. We tested the hypothesis that administration of molecules acting as reuptake inhibitors of serotonin, noradrenaline or both may exert a strong effect on the control of urine release, in a mouse model of overactive bladder. Mice were injected with cyclophosphamide (40 mg/kg), to increase micturition acts. Mice were then given one of four molecules: the serotonin reuptake inhibitor imipramine, its metabolite desipramine that acts on noradrenaline reuptake, the serotonin and noradrenaline reuptake inhibitor duloxetine or its active metabolite 4-hydroxy-duloxetine. Cyclophosphamide increased urine release without inducing overt toxicity or inflammation, except for increase in urothelium thickness. All the antidepressants were able to decrease the cyclophosphamide effects, as apparent from longer latency to the first micturition act, decreased number of urine spots and volume of released urine. These results suggest that serotonin and noradrenaline reuptake inhibitors exert a strong and effective modulatory effect on the control of urine release and prompt to additional studies on their central effects on brain areas involved in the social and behavioral control of micturition.	[Redaelli, Marco; Ricatti, Mara Jimena; Simonetto, Marialaura; Claus, Mirko; Mucignat-Caretta, Carla] Univ Padua, Dept Mol Med, Padua, Italy; [Redaelli, Marco; Caretta, Antonio; Mucignat-Caretta, Carla] Natl Inst Biostruct & Biosyst, Rome, Italy; [Ricatti, Mara Jimena] Univ Buenos Aires Natl Sci & Tech Council UBA CON, Cell Biol & Neurosci Inst, Buenos Aires, DF, Argentina; [Ballabio, Maurizio] Ronzoni Villa Fdn, Seregno, Italy; [Caretta, Antonio] Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy	University of Padua; University of Parma	Mucignat-Caretta, C (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	carla.mucignat@unipd.it	Redaelli, Marco/J-6821-2017; Caretta, Antonio/L-5851-2017; Simonetto, Marialaura/AGV-5257-2022; Mucignat, Carla/N-6299-2017	Redaelli, Marco/0000-0001-9738-9080; Mucignat, Carla/0000-0001-5307-0414; Claus, Mirko/0000-0002-4099-9838	Ronzoni-Villa Foundation; University of Padova; Italian Ministry of Research [PRIN 2011]	Ronzoni-Villa Foundation; University of Padova; Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ronzoni-Villa Foundation (http://www.dongnocchi.it/i-centri/centro-ronzoni-villa-don-gnocchi): a private foundation that funds researches related to elderly persons, grant 2011 to MR; the University of Padova (www.unipd.it): grant "ex-60%" 2011 to CMC; and the Italian Ministry of Research (www.istruzione.it): grant PRIN 2011 to CMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2003, DRUGS, V63, P2595, DOI 10.2165/00003495-200363230-00003; Beckel Jonathan M, 2011, Handb Exp Pharmacol, P149, DOI 10.1007/978-3-642-16499-6_8; Boudes M, 2011, NEUROUROL URODYNAM, V30, P1659, DOI 10.1002/nau.21180; Burgard EC, 2003, UROLOGY, V62, P10, DOI 10.1016/S0090-4295(03)00590-9; Cavaggioni A, 2008, CHEM SENSES, V33, P655, DOI 10.1093/chemse/bjn035; Cottingham C, 2012, NEUROPHARMACOLOGY, V62, P2354, DOI 10.1016/j.neuropharm.2012.02.011; Coyne KS, 2013, INT J CLIN PRACT, V67, P1015, DOI 10.1111/ijcp.12164; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; de Groat WC, 1998, EUR UROL, V34, P2, DOI 10.1159/000052265; Di Rezze S, 2012, CLIN NEUROPHARMACOL, V35, P231, DOI 10.1097/WNF.0b013e3182613dce; Drake MJ, 2010, NEUROUROL URODYNAM, V29, P119, DOI 10.1002/nau.20841; Dugan SE, 2004, ANN PHARMACOTHER, V38, P2078, DOI 10.1345/aph.1E084; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Golubeva AV, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.260; Griffiths D, 2005, J UROLOGY, V174, P1862, DOI 10.1097/01.ju.0000177450.34451.97; Griffiths DJ, 2013, ACTA PHYSIOL, V207, P93, DOI 10.1111/apha.12019; Griffiths D, 2008, NEUROUROL URODYNAM, V27, P466, DOI 10.1002/nau.20549; Hunsballe JM, 2001, UROL RES, V29, P118, DOI 10.1007/s002400100175; Ricatti MJ, 2009, SYNAPSE, V63, P291, DOI 10.1002/syn.20605; Jost WH, 2013, J NEURAL TRANSM, V120, P587, DOI 10.1007/s00702-012-0914-8; Jost Wolfgang H, 2005, Ther Clin Risk Manag, V1, P259; Kakizaki H, 2011, NEUROUROL URODYNAM, V30, P653, DOI 10.1002/nau.21138; Kuo F, 2004, BIOORG MED CHEM LETT, V14, P3481, DOI 10.1016/j.bmcl.2004.04.066; Lamin E, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0280-3; Lantz RJ, 2003, DRUG METAB DISPOS, V31, P1142, DOI 10.1124/dmd.31.9.1142; MAGGI CA, 1989, J PHARMACOL EXP THER, V248, P278; Marlatt MW, 2010, BRAIN RES, V1341, P93, DOI 10.1016/j.brainres.2010.03.086; Miller KL, 2005, J WOMENS HEALTH, V14, P595, DOI 10.1089/jwh.2005.14.595; Mogi K, 2012, PSYCHOPHARMACOLOGY, V224, P201, DOI 10.1007/s00213-012-2821-y; Mucignat-Caretta C, 2004, HORM BEHAV, V46, P11, DOI 10.1016/j.yhbeh.2004.02.004; Mucignat-Caretta C, 2004, NEUROBIOL DIS, V16, P386, DOI 10.1016/j.nbd.2004.03.007; Muller Norbert, 2008, Expert Rev Neurother, V8, P527, DOI 10.1586/14737175.8.4.527; Schuessler B, 2006, BJOG-INT J OBSTET GY, V113, P5, DOI 10.1111/j.1471-0528.2006.00877.x; Seth Jai H, 2013, Handb Clin Neurol, V117, P111, DOI 10.1016/B978-0-444-53491-0.00010-9; Smith AL, 2011, ANN MED, V43, P461, DOI 10.3109/07853890.2011.564203; Szigeti GP, 2005, J MUSCLE RES CELL M, V26, P23, DOI 10.1007/s10974-005-9003-z; Tai CF, 2009, J NEUROPHYSIOL, V102, P2719, DOI 10.1152/jn.00700.2009; Thor KB, 2010, AM J PHYSIOL-REG I, V299, pR416, DOI 10.1152/ajpregu.00111.2010; Thor KB, 2004, INT J GYNECOL OBSTET, V86, pS38, DOI 10.1016/j.ijgo.2004.04.028; Verhamme KMC, 2008, DRUG SAFETY, V31, P373, DOI 10.2165/00002018-200831050-00002; Wade AG, 2010, CURR MED RES OPIN, V26, P1031, DOI 10.1185/03007991003661877; Wein AJ, 1998, UROLOGY, V51, P43, DOI 10.1016/S0090-4295(98)90009-7	42	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121883	10.1371/journal.pone.0121883	http://dx.doi.org/10.1371/journal.pone.0121883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812116	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700152
J	Ribas, TFA; Rodrigues, LRR; Nagamachi, CY; Gomes, AJB; Rissino, JD; O'Brien, PCM; Yang, FT; Ferguson-Smith, MA; Pieczarka, JC				Augusto Ribas, Talita Fernanda; Ribeiro Rodrigues, Luis Reginaldo; Nagamachi, Cleusa Yoshiko; Baia Gomes, Anderson Jose; Rissino, Jorge das Dores; O'Brien, Patricia Caroline Mary; Yang, Fengtang; Ferguson-Smith, Malcolm Andrew; Pieczarka, Julio Cesar			Phylogenetic Reconstruction by Cross-Species Chromosome Painting and G-Banding in Four Species of Phyllostomini Tribe (Chiroptera, Phyllostomidae) in the Brazilian Amazon: An Independent Evidence for Monophyly	PLOS ONE			English	Article							BATS; EVOLUTION; PLATYRRHINI; FISH; CYTOGENETICS; KARYOTYPE; PRIMATES; NUCLEAR; TONATIA; FAMILY	The subfamily Phyllostominae comprises taxa with a variety of feeding strategies. From the cytogenetic point of view, Phyllostominae shows different rates of chromosomal evolution between genera, with Phyllostomus hastatus probably retaining the ancestral karyotype for the subfamily. Since chromosomal rearrangements occur rarely in the genome and have great value as phylogenetic markers and in taxonomic characterization, we analyzed three species: Lophostoma silvicola (LSI), Phyllostomus discolor (PDI) and Tonatia saurophila (TSA), representing the tribe Phyllostomini, collected in the Amazon region, by classic and molecular cytogenetic techniques in order to reconstruct the phylogenetic relationships within this tribe. LSA has a karyotype of 2n=34 and FN=60, PDI has 2n=32 and FN=60 and TSA has 2n=16 and FN=20. Comparative analysis using G-banding and chromosome painting show that the karyotypic complement of TSA is highly rearranged relative to LSI and PHA, while LSI, PHA and PDI have similar karyotypes, differing by only three chromosome pairs. Nearly all chromosomes of PDI and PHA were conserved in toto, except for chromosome 15 that was changed by a pericentric inversion. A strongly supported phylogeny (bootstrap=100 and Bremer=10 steps), confirms the monophyly of Phyllostomini. In agreement with molecular topologies, TSA was in the basal position, while PHA and LSI formed sister taxa. A few ancestral syntenies are conserved without rearrangements and most associations are autapomorphic traits for Tonatia or plesiomorphic for the three genera analyzed here. The karyotype of TSA is highly derived in relation to that of other phyllostomid bats, differing from the supposed ancestral karyotype of Phyllostomidae by multiple rearrangements. Phylogenies based on chromosomal data are independent evidence for the monophyly of tribe Phyllostomini as determined by molecular topologies and provide additional support for the paraphyly of the genus Tonatia by the exclusion of the genus Lophostoma.	[Augusto Ribas, Talita Fernanda; Nagamachi, Cleusa Yoshiko; Baia Gomes, Anderson Jose; Rissino, Jorge das Dores; Pieczarka, Julio Cesar] Fed Univ Para, ICB, Lab Citogenet, BR-66059 Belem, Para, Brazil; [Ribeiro Rodrigues, Luis Reginaldo] Univ Fed Oeste Para, ICED, Lab Genet & Biodiversidade, Santarem, Para, Brazil; [Nagamachi, Cleusa Yoshiko; Pieczarka, Julio Cesar] CNPq, Belem, Para, Brazil; [O'Brien, Patricia Caroline Mary; Ferguson-Smith, Malcolm Andrew] Univ Cambridge, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Yang, Fengtang] Wellcome Trust Sanger Inst, Cytogenet Facil, Cambridge, England	Universidade Federal do Para; Universidade Federal do Oeste do Para; University of Cambridge; Wellcome Trust Sanger Institute	Pieczarka, JC (corresponding author), Fed Univ Para, ICB, Lab Citogenet, BR-66059 Belem, Para, Brazil.	juliopieczarka@gmail.com	Yang, Fan/GYU-4249-2022; Pieczarka, Julio C/E-7585-2016; Gomes, anderson/AFO-4296-2022; Rodrigues, Luis Reginaldo Ribeiro/AAE-4847-2021; Nagamachi, Cleusa/AAV-8985-2021; ribas, talita/AAN-1096-2021	Pieczarka, Julio C/0000-0003-2951-8877; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734; Gomes, Anderson/0000-0002-3887-3283; Yang, Fengtang/0000-0002-3573-2354; RIBAS, TALITA/0000-0002-1564-8956	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [479824/2012-6, 552032,2010-7]; FAPESPA Fundacao Amazonia Paraense [064/20122, 007/2011]; CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [047/2012]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA Fundacao Amazonia Paraense(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Author: JCP Grant Number: 479824/2012-6, Author: CYN Grant Number: 552032,2010-7, http://www.cnpq.br/. FAPESPA Fundacao Amazonia Paraense http://www.fapespa.pa.gov.br/, Author: JCP Grant Number: 064/20122, Author: CYN Grant Number: 007/2011. CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Author: CYN Grant Number: 047/2012, http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD ML, 1983, BIOCHEM SYST ECOL, V11, P295, DOI 10.1016/0305-1978(83)90067-4; Gomes AJB, 2012, COMP CYTOGENET, V6, P213, DOI 10.3897/CompCytogen.v6i2.1679; Baker R.J., 1982, Pymatuning Laboratory of Ecology Special Publications, V6, P303; Baker R.J., 1979, Texas Tech University Museum Special Publications, P107; BAKER RJ, 1989, SYST ZOOL, V38, P228, DOI 10.2307/2992284; BAKER RJ, 1980, SYST ZOOL, V29, P239, DOI 10.2307/2412660; BAKER RJ, 2006, ATLAS MAMMALIAN CHRO, P378; Baker RJ, 2003, OCCAS PAP MUS TEXAS, V230, P1; BAKER RJ, 1970, CYTOGENETICS, V9, P131; Baker Robert J., 2004, Occasional Papers Museum of Texas Tech University, V232, P1; Baker Robert J., 2003, Occasional Papers Museum of Texas Tech University, V228, P1; Baker RJ, 2012, CAM STUD MORPHOL MOL, P385; Baker Robert J., 2000, Occasional Papers Museum of Texas Tech University, V202, P1; Bell DM, 2001, J MAMMAL, V82, P81, DOI 10.1644/1545-1542(2001)082<0081:POKMIR>2.0.CO;2; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; de Oliveira EHC, 2005, CYTOGENET GENOME RES, V108, P183, DOI 10.1159/000080814; de Oliveira EHC, 2002, CHROMOSOME RES, V10, P669, DOI 10.1023/A:1021520529952; DeBry RW, 2001, SYST BIOL, V50, P742, DOI 10.1080/106351501753328866; Dobigny G, 2004, SYST BIOL, V53, P470, DOI 10.1080/10635150490445698; Dumas F, 2012, CYTOGENET GENOME RES, V136, P175, DOI 10.1159/000336976; Ferreri GC, 2005, J HERED, V96, P217, DOI 10.1093/jhered/esi029; Gardner A.L., 2007, MAMMALS S AM; GARDNER AL, 1977, SYST ZOOL, V26, P300, DOI 10.2307/2412677; Genoways H, 1984, ANN CARNEGIE MUS, V49, P203; Goloboff P, 2008, CLADISTICS, V24, P91; Goodwin George G., 1942, JOUR MAMMAL, V23, P204, DOI 10.2307/1375074; Graphodatsky AS, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-22; Hatanaka T, 2004, GENETICA, V122, P239, DOI 10.1007/s10709-004-2039-y; Hoffmann FG, 2008, MOL PHYLOGENET EVOL, V49, P653, DOI 10.1016/j.ympev.2008.08.002; HONEYCUTT R L, 1980, Annals of Carnegie Museum, V49, P237; HONEYCUTT RL, 1987, J MAMMAL, V68, P518, DOI 10.2307/1381588; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; KOOP BF, 1984, GENETICA, V64, P199, DOI 10.1007/BF00115344; Koopman KF, 1994, HDB ZOOLOGY 60; Lee TE, 2002, J MAMMAL, V83, P49, DOI 10.1093/jmammal/83.1.49; Mao XG, 2008, CHROMOSOME RES, V16, P155, DOI 10.1007/s10577-007-1206-2; McKenna M, 1987, CLASSIFICATION MAMMA; Moratelli Ricardo, 2002, Genetics and Molecular Research, V1, P128; MORIELLE E, 1988, REV BRAS GENET, V11, P853; Nagamachi CY, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-28; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; Nagamachi CY, 1999, AM J PRIMATOL, V49, P133, DOI 10.1002/(SICI)1098-2345(199910)49:2<133::AID-AJP5>3.3.CO;2-Y; Neusser M, 2001, CYTOGENET CELL GENET, V94, P206, DOI 10.1159/000048818; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; PATTON JC, 1978, SYST ZOOL, V27, P449, DOI 10.2307/2412927; Pieczarka JC, 2013, CHROMOSOME RES, V21, P383, DOI 10.1007/s10577-013-9365-9; Pieczarka JC, 2005, CHROMOSOME RES, V13, P339, DOI 10.1007/s10577-005-2886-0; Porter CA, 2003, J MAMMAL, V84, P791, DOI 10.1644/BME-010; Ribas TFA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-119; Robinson TJ, 2008, CHROMOSOME RES, V16, P1133, DOI 10.1007/s10577-008-1264-0; Rodrigues LRR, 2011, CYTOGENET GENOME RES, V133, P1, DOI 10.1159/000323956; Rodrigues LRR, 2000, GENET MOL BIOL, V23, P595, DOI 10.1590/S1415-47572000000300016; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; SEABRIGH.M, 1971, LANCET, V2, P971; Silva A, 2005, GENET MOL BIOL, V2, P248; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V237, P1; Sotero-Caio CG, 2011, CYTOGENET GENOME RES, V132, P156, DOI 10.1159/000321574; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; VARELLAGARCIA M, 1989, REV BRAS GENET, V12, P761; Verma RS., 1995, HUMAN CHROMOSOMES PR, V2; Volleth M, 1999, CHROMOSOME RES, V7, P57, DOI 10.1023/A:1009227428727; Volleth M, 2012, CYTOGENET GENOME RES, V137, P165, DOI 10.1159/000338929; Wetterer AL, 2000, B AM MUS NAT HIST, P4, DOI 10.1206/0003-0090(2000)248<0001:POPBMC>2.0.CO;2; Yang F, 1997, CHROMOSOMA, V106, P37, DOI 10.1007/s004120050222; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691	70	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122845	10.1371/journal.pone.0122845	http://dx.doi.org/10.1371/journal.pone.0122845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806812	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000228
J	Desai, IK; Kurpad, AV; Chomitz, VR; Thomas, T				Desai, Ishaan K.; Kurpad, Anura V.; Chomitz, Virginia R.; Thomas, Tinku			Aerobic Fitness, Micronutrient Status, and Academic Achievement in Indian School-Aged Children	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SOCIOECONOMIC-STATUS; STUDENT PERFORMANCE; SELF-ESTEEM; EXERCISE; URBAN; OVERWEIGHT; PATTERNS; DISEASE; YOUTH	Aerobic fitness has been shown to have several beneficial effects on child health. However, research on its relationship with academic performance has been limited, particularly in developing countries and among undernourished populations. This study examined the association between aerobic fitness and academic achievement in clinically healthy but nutritionally compromised Indian school-aged children and assessed whether micronutrient status affects this association. 273 participants, aged 7 to 10.5 years, were enrolled from three primary schools in Bangalore, India. Data on participants' aerobic fitness (20-m shuttle test), demographics, anthropometry, diet, physical activity, and micronutrient status were abstracted. School-wide exam scores in mathematics and Kannada language served as indicators of academic performance and were standardized by grade level. The strength of the fitness/achievement association was analyzed using Spearman's rank correlation, multiple variable logistic regression, and multi-level models. Significant positive correlations between aerobic capacity (VO2 peak) and academic scores in math and Kannada were observed (P < 0.05). After standardizing scores across grade levels and adjusting for school, gender, socioeconomic status, and weight status (BMI Z-score), children with greater aerobic capacities (mL * kg-1 * min-1) had greater odds of scoring above average on math and Kannada exams (OR= 1.08, 95% CI: 1.02 to 1.15 and OR= 1.11, 95% CI: 1.04 to 1.18, respectively). This association remained significant after adjusting for micronutrient deficiencies. These findings provide preliminary evidence of a fitness/achievement association in Indian children. While the mechanisms by which aerobic fitness may be linked to academic achievement require further investigation, the results suggest that educators and policymakers should consider the adequacy of opportunities for physical activity and fitness in schools for both their physical and potential academic benefits.	[Desai, Ishaan K.] Harvard Univ, Fac Arts & Sci, Cambridge, MA 02138 USA; [Kurpad, Anura V.] St Johns Natl Acad Hlth Sci, St Johns Res Inst, Div Nutr, Bangalore, Karnataka, India; [Chomitz, Virginia R.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Thomas, Tinku] St Johns Natl Acad Hlth Sci, St Johns Res Inst, Div Epidemiol & Biostat, Bangalore, Karnataka, India	Harvard University; St. John's National Academy of Health Sciences; St. John's Research Institute; Massachusetts Department of Public Health; Tufts University; St. John's National Academy of Health Sciences; St. John's Research Institute	Thomas, T (corresponding author), St Johns Natl Acad Hlth Sci, St Johns Res Inst, Div Epidemiol & Biostat, Bangalore, Karnataka, India.	tinku.sarah@sjri.res.in		Desai, Ishaan/0000-0002-5945-3077	Harvard Global Health Institute; GlaxoSmithKline Consumer Healthcare Ltd, Gurgaon, India	Harvard Global Health Institute; GlaxoSmithKline Consumer Healthcare Ltd, Gurgaon, India(GlaxoSmithKline)	IKD received funding from the Harvard Global Health Institute to engage in research at St. John's Research Institute during the summer of 2013. The funding for the original intervention study was provided by GlaxoSmithKline Consumer Healthcare Ltd, Gurgaon, India. The funders had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. All authors are independent from the funders.	Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; [Anonymous], 2008, FITNESSGRAM ACTIVITY; Bass RW, 2013, ACTA PAEDIATR, V102, P832, DOI 10.1111/apa.12278; Bharathi AV, 2008, ASIA PAC J CLIN NUTR, V17, P178; Boreham C, 2001, J SPORT SCI, V19, P915, DOI 10.1080/026404101317108426; Castelli DM, 2007, J SPORT EXERCISE PSY, V29, P239, DOI 10.1123/jsep.29.2.239; Chomitz VR, 2009, J SCHOOL HEALTH, V79, P30, DOI 10.1111/j.1746-1561.2008.00371.x; Coe DP, 2013, J SCHOOL HEALTH, V83, P500, DOI 10.1111/josh.12058; Datar A, 2004, OBES RES, V12, P58, DOI 10.1038/oby.2004.9; Davis CL, 2007, RES Q EXERCISE SPORT, V78, P510, DOI 10.5641/193250307X13082512817660; Ekeland E, 2005, BRIT J SPORT MED, V39, P792, DOI 10.1136/bjsm.2004.017707; Eveland-Sayers BM, 2009, J PHYS ACT HEALTH, V6, P99, DOI 10.1123/jpah.6.1.99; FAO/WHO/UNU, 2004, HUM EN REQ REP JOINT; Grissom JB., 2005, JEP J ENV PSYCHOL, V8, P11, DOI DOI 10.5297/SER.1403.010; Hardman K, 2008, KINESIOLOGY, V40, P5; Hillman CH, 2005, MED SCI SPORT EXER, V37, P1967, DOI 10.1249/01.mss.0000176680.79702.ce; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Jacob Arpitha, 2011, Int J Biomed Sci, V7, P51; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kannan R, 2013, HINDU; Karkera A, 2013, INDIAN J PEDIAT; Kumar N, 2007, INDIAN J PEDIATR, V74, P1131; Kwak L, 2009, J PEDIATR-US, V155, P914, DOI 10.1016/j.jpeds.2009.06.019; Liao PA, 2013, HEALTH EDUC RES, V28, P512, DOI 10.1093/her/cyt041; London RA, 2011, J SCHOOL HEALTH, V81, P400, DOI 10.1111/j.1746-1561.2011.00608.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Matton L, 2006, MED SCI SPORT EXER, V38, P1114, DOI 10.1249/01.mss.0000222840.58767.40; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Council for Educational Research and Training, 2006, 3 NCERT PUBL DEP; Ohtake PJ, 2005, CARDIOPULM PHYS THER, V16, P5; Rauner RR, 2013, J PEDIATR-US, V163, P344, DOI 10.1016/j.jpeds.2013.01.006; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Roberts CK, 2010, J PEDIATR-US, V156, P711, DOI 10.1016/j.jpeds.2009.11.039; Salmon J, 2007, EPIDEMIOL REV, V29, P144, DOI 10.1093/epirev/mxm010; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Swaminathan S, 2013, EUR J CLIN NUTR, V67, P467, DOI 10.1038/ejcn.2013.14; Swaminathan S, 2007, INDIAN PEDIATR, V44, P593; Swaminathan S, 2013, INDIAN J PEDIATR, V80, pS63, DOI 10.1007/s12098-012-0846-1; Swaminathan S, 2011, INDIAN J MED RES, V134, P174; Taras H, 2005, J SCHOOL HEALTH, V75, P291, DOI 10.1111/j.1746-1561.2005.00040.x; Taras H, 2005, J SCHOOL HEALTH, V75, P214, DOI 10.1111/j.1746-1561.2005.00026.x; Tremblay MS, 2000, PEDIATR EXERC SCI, V12, P312, DOI 10.1123/pes.12.3.312; Vail K, 2006, AM SCH BOARD J, P30; Vaz M, 2011, J NUTR, V141, P2017, DOI 10.3945/jn.110.135012; Welk GJ, 2010, RES Q EXERCISE SPORT, V81; Welk GJ, 2010, RES Q EXERCISE SPORT, V81, pS16, DOI 10.1080/02701367.2010.10599690; Wittberg RA, 2009, AM J HEALTH EDUC, V40, P30, DOI 10.1080/19325037.2009.10599076; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR	51	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122487	10.1371/journal.pone.0122487	http://dx.doi.org/10.1371/journal.pone.0122487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806824	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000220
J	Murphy, PA; Begum, S; Hynes, RO				Murphy, Patrick A.; Begum, Shahinoor; Hynes, Richard O.			Tumor Angiogenesis in the Absence of Fibronectin or Its Cognate Integrin Receptors	PLOS ONE			English	Article							ALPHA-V INTEGRINS; IN-VIVO; EXTRACELLULAR-MATRIX; VASCULAR DEVELOPMENT; EMBRYOID BODIES; MOUSE EMBRYOS; GROWTH; LYMPHANGIOGENESIS; ALPHA-5-BETA-1; TUMORIGENESIS	Binding of alpha 5 beta 1 and alpha v beta 3/beta 5 integrin receptors on the endothelium to their fibronectin substrate in the extracellular matrix has been targeted as a possible means of blocking tumor angiogenesis and tumor growth. However, clinical trials of blocking antibodies and peptides have been disappointing despite promising preclinical results, leading to questions about the mechanism of the inhibitors and the reasons for their failure. Here, using tissue-specific and inducible genetics to delete the alpha 5 and alpha v receptors in the endothelium or their fibronectin substrate, either in the endothelium or globally, we show that both are dispensable for tumor growth, in transplanted tumors as well as spontaneous and angiogenesis-dependent RIP-Tag-driven pancreatic adenocarcinomas. In the nearly complete absence of fibronectin, no differences in vascular density or the deposition of basement membrane laminins, ColIV, Nid1, Nid2, or the TGF beta binding matrix proteins, fibrillin-1 and -2, could be observed. Our results reveal that fibronectin and the endothelial fibronectin receptor subunits, alpha 5 and av, are dispensable for tumor angiogenesis, suggesting that the inhibition of angiogenesis induced by antibodies or small molecules may occur through a dominant negative effect, rather than a simple functional block.	[Murphy, Patrick A.; Begum, Shahinoor; Hynes, Richard O.] MIT, Howard Hughes Med Inst, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Hynes, RO (corresponding author), MIT, Howard Hughes Med Inst, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	rohynes@mit.edu			National Institute of Health [5F32HL110484, PO1-HL66105]; Howard Hughes Medical Institute; Koch Institute from the National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105, F32HL110484] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Koch Institute from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health grants to PAM (5F32HL110484) and to ROH (PO1-HL66105 (PI Monty Krieger) and by the Howard Hughes Medical Institute of which ROH is an Investigator) and was supported in part by the Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TE, 1987, NATURE, V325, P223, DOI 10.1038/325223a0; Astrof S, 2004, MOL CELL BIOL, V24, P8662, DOI 10.1128/MCB.24.19.8662-8670.2004; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bhaskar V, 2008, INVEST NEW DRUG, V26, P7, DOI 10.1007/s10637-007-9078-z; Bhaskar V, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-61; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Goh KL, 1997, DEVELOPMENT, V124, P4309; Hager JH, 2004, CANCER RES, V64, P2406, DOI 10.1158/0008-5472.CAN-03-3522; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Mateo J, 2014, CANCER CHEMOTH PHARM; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Murphy PA, 2014, ARTERIOSCLEROSIS THR; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Naba A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-518; Naba A, 2014, ELIFE, V3, DOI 10.7554/eLife.01308; Naba A, 2012, MATRIX BIOL, V31, P371, DOI 10.1016/j.matbio.2012.11.008; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Schaffner F, 2014, CANC CHEMOTHERAPY PH; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Taverna D, 1998, CANCER RES, V58, P848; Taverna D, 2001, CANCER RES, V61, P5255; Turner CJ, 2014, DEV BIOL, V392, P381, DOI 10.1016/j.ydbio.2014.05.006; van der Flier A, 2010, DEVELOPMENT, V137, P2439, DOI 10.1242/dev.049551; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; von Au A, 2013, NEOPLASIA, V15, P925, DOI 10.1593/neo.13762; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Xie L, 2011, P NATL ACAD SCI USA, V108, P9939, DOI 10.1073/pnas.1105041108; Yang JT, 1999, DEV BIOL, V215, P264, DOI 10.1006/dbio.1999.9451; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	46	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120872	10.1371/journal.pone.0120872	http://dx.doi.org/10.1371/journal.pone.0120872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807551	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000106
J	Zhang, SQ; Manor, B; Li, L				Zhang, Shuqi; Manor, Brad; Li, Li			H-Index Is Important for Postural Control for People with Impaired Foot Sole Sensation	PLOS ONE			English	Article							ANKLE JOINT PROPRIOCEPTION; SPINDLE AFFERENT-FIBERS; PERIPHERAL NEUROPATHY; PLANTAR PRESSURE; BALANCE CONTROL; STRETCH REFLEX; OLDER-ADULTS; FUNCTIONAL INSTABILITY; PHYSICAL PERFORMANCE; MUSCLE-ACTIVITY	Introduction People with Peripheral Neuropathy (PN), especially those with impaired sensory inputs through the small-afferent fiber (type II afferent fibers) reflex loop (SAF), might depend more on the large-afferent fiber (type I afferent fibers) reflex loop (LAF) for postural control. Purpose To examine whether the function of the LAF reflex loop, reflected by the H-reflex and ankle joint proprioception, influences postural control when the SAF reflex loop is impaired, as indicated by reduced foot sole cutaneous sensation. Methods Thirteen participants (8 women, 5 men) diagnosed with PN and 12 age-matched controls (7 women, 5 men) completed the testing protocol. Measures of interest included the H-index, active (AAP) and passive (PAP) ankle proprioception, plantar pressure sensitivity (PPS), average sway velocity (V-AVG) and area (A(95)) during 30 seconds eyes-closed standing, 6-minute walk distance (6MWD) and timed up-and-go duration (TUG). Results Statistically significant group-dependent regression was observed between V-AVG and H-index. Compared to the control group, the PN group demonstrated reduced PPS (2.0 +/- 1.9 vs. 4.2 +/- 1.2, P <.05) and H-index (63.6 +/- 10.9 vs. 76.4 +/- 16.0, P <.05), greater V-AVG (3.5 +/- 2.1 vs. 1.6 +/- 0.6cm/s, P <.05) and A(95) (10.0 +/- 10.1 vs. 2.5 +/- 1.5cm(2), P <.05), shorter 6MWD (442.2 +/- 93.0 vs. 525.3 +/- 68.2m, P <.05), and longer TUG (9.4 +/- 1.6 vs. 6.5 +/- 1.3s, P <.05). Within the PN group, but not the control group, the H-index was correlated with V-AVG (r = -.56, P <.05). Moreover, within the PN group only, PAP scores were correlated with 6MWD (r = -.68, P <.05) and TUG (r = -.59, P <.05) performance. No other statistically significant group difference, correlation or group-dependent regression was observed. Conclusion V-AVG, 6MWD, and TUG correlated with LAF reflex loop function observed among those with impaired functioning of the SAF reflex loop. This observation suggests that the LAF reflex loop may be critical to the control of balance in those individuals suffering from small-fiber PN.	[Zhang, Shuqi] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Zhang, Shuqi; Li, Li] Georgia So Univ, Statesboro, GA 30460 USA; [Manor, Brad] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA; [Manor, Brad] Harvard Univ, Sch Med, Boston, MA USA; [Manor, Brad] Hebrew SeniorLife, Inst Aging Res, Roslindale, MA USA; [Li, Li] Shanghai Univ Sport, Minist Educ, Key Lab Exercise & Hlth Sci, Shanghai, Peoples R China	Louisiana State University System; Louisiana State University; University System of Georgia; Georgia Southern University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Hebrew SeniorLife; Shanghai University of Sport	Li, L (corresponding author), Georgia So Univ, Statesboro, GA 30460 USA.	lili@georgiasouthern.edu	Li, Li/AAJ-2868-2020	/0000-0001-5902-9762				Billot M, 2013, NEUROSCI LETT, V535, P40, DOI 10.1016/j.neulet.2012.11.022; Birmingham TB, 2000, CLIN J SPORT MED, V10, P264, DOI 10.1097/00042752-200010000-00007; CAPADAY C, 1986, J NEUROSCI, V6, P1308; Caselli A, 2002, DIABETES CARE, V25, P1066, DOI 10.2337/diacare.25.6.1066; CHEN H, 1995, CLIN BIOMECH, V10, P271, DOI 10.1016/0268-0033(95)99806-D; Curthoys IS, 1995, J VESTIBULAR RES EQU, DOI [10.3233/VES-130497, DOI 10.3233/VES-130497]; De Carlo M S, 1986, J Orthop Sports Phys Ther, V8, P70; DIENER HC, 1984, BRAIN RES, V296, P103, DOI 10.1016/0006-8993(84)90515-8; Eils E, 2004, GAIT POSTURE, V20, P54, DOI 10.1016/S0966-6362(03)00095-X; Eils E, 2002, J BIOMECH, V35, P1307, DOI 10.1016/S0021-9290(02)00168-9; Era Pertti, 2002, Aging Clin Exp Res, V14, P37; FEUERBACH JW, 1994, AM J SPORT MED, V22, P223, DOI 10.1177/036354659402200212; Freeman M A, 1965, J Bone Joint Surg Br, V47, P669; Fu ASN, 2005, AM J SPORT MED, V33, P1174, DOI 10.1177/0363546504271976; GLENCROSS D, 1981, J SPORT MED PHYS FIT, V21, P23; Grey MJ, 2001, J PHYSIOL-LONDON, V534, P925, DOI 10.1111/j.1469-7793.2001.00925.x; HERTEL JN, 1996, J SPORT REHABIL, V5, P111; HOFFER JA, 1981, J NEUROPHYSIOL, V45, P267, DOI 10.1152/jn.1981.45.2.267; Horak FB, 2001, J NEUROPHYSIOL, V86, P575, DOI 10.1152/jn.2001.86.2.575; Jerosch J, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P171; Kavounoudias A, 2001, J PHYSIOL-LONDON, V532, P869, DOI 10.1111/j.1469-7793.2001.0869e.x; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; KONRADSEN L, 1993, J BONE JOINT SURG BR, V75, P433, DOI 10.1302/0301-620X.75B3.8496215; Lee AJY, 2008, CLIN BIOMECH, V23, P1065, DOI 10.1016/j.clinbiomech.2008.04.013; LENTELL G, 1995, J ORTHOP SPORT PHYS, V21, P206, DOI 10.2519/jospt.1995.21.4.206; Lephart SM, 1998, SPORTS MED, V25, P149, DOI 10.2165/00007256-199825030-00002; Li L, 2010, AM J CHINESE MED, V38, P449, DOI 10.1142/S0192415X1000797X; MANCHESTER D, 1989, J GERONTOL, V44, pM118; Manor B, 2008, GAIT POSTURE, V28, P343, DOI 10.1016/j.gaitpost.2008.01.004; Manor B, 2012, DIABETES CARE, V35, P1907, DOI 10.2337/dc11-2463; Manor B, 2009, GAIT POSTURE, V30, P253, DOI 10.1016/j.gaitpost.2009.04.011; Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310; MATTHEWS PBC, 1991, TRENDS NEUROSCI, V14, P87, DOI 10.1016/0166-2236(91)90064-2; Mazzaro N, 2006, EXP BRAIN RES, V173, P713, DOI 10.1007/s00221-006-0451-5; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Meyer PF, 2004, EXP BRAIN RES, V156, P505, DOI 10.1007/s00221-003-1804-y; Nardone A, 2000, EXP BRAIN RES, V135, P155, DOI 10.1007/s002210000513; Nardone A, 2006, GAIT POSTURE, V23, P364, DOI 10.1016/j.gaitpost.2005.04.002; Nardone A, 2007, CLIN NEUROPHYSIOL, V118, P538, DOI 10.1016/j.clinph.2006.11.012; Nashner L.M., 1981, HDB BEHAVIORAL NEURO, V5, P527; Nurse MA, 1999, CLIN BIOMECH, V14, P667, DOI 10.1016/S0268-0033(99)00020-0; Nurse MA, 2001, CLIN BIOMECH, V16, P719, DOI 10.1016/S0268-0033(01)00090-0; Padua L, 2005, J PERIPHER NERV SYST, V10, P3, DOI 10.1111/j.1085-9489.2005.10103.x; Paillard J, 1968, NEUROPSYCHOLOGY SPAT, P37; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Perry SD, 2000, BRAIN RES, V877, P401, DOI 10.1016/S0006-8993(00)02712-8; Prieto-Marquez A, 2007, J VERTEBR PALEONTOL, V27, P603, DOI 10.1671/0272-4634(2007)27[603:NEOPSA]2.0.CO;2; RICHARDSON JK, 1995, J GERONTOL A-BIOL, V50, pM211, DOI 10.1093/gerona/50A.4.M211; Richardson JK, 2002, J AM GERIATR SOC, V50, P1767, DOI 10.1046/j.1532-5415.2002.50503.x; Rooney J, 2002, ECOL ENTOMOL, V27, P373, DOI 10.1046/j.1365-2311.2002.00420.x; Scaglioni G, 2002, J APPL PHYSIOL, V92, P2292, DOI 10.1152/japplphysiol.00367.2001; Schieppati M, 1997, J PHYSIOL-LONDON, V503, P691, DOI 10.1111/j.1469-7793.1997.691bg.x; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Simoneau GG, 1996, ARCH PHYS MED REHAB, V77, P453, DOI 10.1016/S0003-9993(96)90033-7; Sinkj&AELIG T, 2004, J PHYSL, V523, P817; Sinkjaer T, 1996, J NEUROPHYSIOL, V76, P1112, DOI 10.1152/jn.1996.76.2.1112; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; TAYLOR J, 1985, J NEUROPHYSIOL, V53, P341, DOI 10.1152/jn.1985.53.2.341; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; VANDENBOSCH CG, 1995, ARCH PHYS MED REHAB, V76, P850, DOI 10.1016/S0003-9993(95)80551-6; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5; Zhang Shuying, 2014, Int Psychogeriatr, P1	62	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121847	10.1371/journal.pone.0121847	http://dx.doi.org/10.1371/journal.pone.0121847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807534	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000186
J	Bastiaansen, KC; van Ulsen, P; Wijtmans, M; Bitter, W; Llamas, MA				Bastiaansen, Karlijn C.; van Ulsen, Peter; Wijtmans, Maikel; Bitter, Wilbert; Llamas, Maria A.			Self-cleavage of the Pseudomonas aeruginosa Cell-surface Signaling Anti-sigma Factor FoxR Occurs through an N-O Acyl Rearrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Gene Regulation; Iron; Post-translational Modification (PTM); Proteolysis; Pseudomonas aeruginosa (P; aeruginosa); Siderophore; Signal Transduction	CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; IRON TRANSPORT; PROTEIN; SIDEROPHORES; GLYCOSYLASPARAGINASE; FRAMEWORK; RESPONSES; RECEPTOR	Background: Many transmembrane anti-sigma factors, including P. aeruginosa FoxR, undergo periplasmic self-cleavage by an unknown mechanism. Results: Presence of an OH or SH group at +1 of the cleavage site is essential for FoxR self-cleavage. Conclusion: FoxR self-cleavage is mediated by an N-O acyl rearrangement. Significance: The complex proteolytic network that modulates alternative sigma factor activity in Gram-negative bacteria also includes an enzyme-independent step. The Fox system of Pseudomonas aeruginosa is a cell-surface signaling (CSS) pathway employed by the bacterium to sense and respond to the presence of the heterologous siderophore ferrioxamine in the environment. This regulatory pathway controls the transcription of the foxA ferrioxamine receptor gene through the extracytoplasmic function sigma factor sigma(FoxI). In the absence of ferrioxamine, the activity of sigma(FoxI) is inhibited by the transmembrane anti-sigma factor FoxR. Upon binding of ferrioxamine by the FoxA receptor, FoxR is processed by a complex proteolytic cascade leading to the release and activation of sigma(FoxI). Interestingly, we have recently shown that FoxR undergoes self-cleavage between the periplasmic Gly-191 and Thr-192 residues independent of the perception of ferrioxamine. This autoproteolytic event, which is widespread among CSS anti-sigma factors, produces two distinct domains that interact and function together to transduce the presence of the signal. In this work, we provide evidence that the self-cleavage of FoxR is not an enzyme-dependent process but is induced by an N-O acyl rearrangement. Mutation analysis showed that the nucleophilic side chain of the Thr-192 residue at +1 of the cleavage site is required for an attack on the preceding Gly-191, after which the resulting ester bond is likely hydrolyzed. Because the cleavage site is well preserved and the hydrolysis of periplasmic CSS anti-sigma factors is widely observed, we hypothesize that cleavage via an N-O acyl rearrangement is a conserved feature of these proteins.	[Bastiaansen, Karlijn C.; Llamas, Maria A.] CSIC, Environm Protect Dept, Estn Expt Zaidin, E-18008 Granada, Spain; [Bastiaansen, Karlijn C.; van Ulsen, Peter; Bitter, Wilbert] Vrije Univ, Sect Mol Microbiol, Dept Mol Cell Biol, NL-1081 HV Amsterdam, Netherlands; [Wijtmans, Maikel] Vrije Univ, Div Med Chem, Dept Chem & Pharmaceut Sci, NL-1081 HV Amsterdam, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Llamas, MA (corresponding author), CSIC, Environm Protect Dept, Estn Expt Zaidin, C Prof Albareda 1, E-18008 Granada, Spain.	marian.llamas@eez.csic.es	Bitter, Wilbert/AAA-6872-2019; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/ABG-3726-2020; Llamas, María A/M-1669-2014	Bitter, Wilbert/0000-0001-8347-6511; Llamas, María A/0000-0002-9499-0492; van Ulsen, Peter/0000-0002-2164-1611	Netherlands Organization for Scientific Research through ECHO [2951201]; European Union [3038130]; Spanish Ministry of Economy [RYC2011-08874, SAF2012-31919]	Netherlands Organization for Scientific Research through ECHO; European Union(European Commission); Spanish Ministry of Economy(Spanish Government)	This work was supported by Netherlands Organization for Scientific Research through ECHO Grant 2951201 (to K. C. B.), Marie Curie Career Integration Grant (CIG) 3038130 from the European Union, and Ramon&Cajal Grant RYC2011-08874 and Plan Nacional Grant SAF2012-31919 from the Spanish Ministry of Economy (to M. A. L.).	Bastiaansen KC, 2015, ENVIRON MICROBIOL, V17, P3263, DOI 10.1111/1462-2920.12776; Bastiaansen KC, 2014, ENVIRON MICROBIOL, V16, P2433, DOI 10.1111/1462-2920.12371; Bastiaansen KC, 2012, BACTERIAL REGULATORY NETWORKS, P59; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Braun V, 2006, BIOMETALS, V19, P103, DOI 10.1007/s10534-005-8253-y; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Campbell EA, 2007, MOL CELL, V27, P793, DOI 10.1016/j.molcel.2007.07.009; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Dembek M, 2012, J BIOL CHEM, V287, P1538, DOI 10.1074/jbc.M111.302463; Ditzel L, 1998, J MOL BIOL, V279, P1187, DOI 10.1006/jmbi.1998.1818; Draper RC, 2011, MOL MICROBIOL, V82, P1444, DOI 10.1111/j.1365-2958.2011.07901.x; Du ZM, 2009, J AM CHEM SOC, V131, P11581, DOI 10.1021/ja904318w; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; FINNEN RL, 1992, J BACTERIOL, V174, P4977, DOI 10.1128/JB.174.15.4977-4985.1992; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garcia-Herrero A, 2005, MOL MICROBIOL, V58, P1226, DOI 10.1111/j.1365-2958.2005.04889.x; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Johansson DGA, 2009, J AM CHEM SOC, V131, P9475, DOI 10.1021/ja9010817; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; KOSTER M, 1993, MOL MICROBIOL, V8, P591, DOI 10.1111/j.1365-2958.1993.tb01603.x; Llamas MA, 2006, J BACTERIOL, V188, P1882, DOI 10.1128/JB.188.5.1882-1891.2006; Llamas MA, 2014, FEMS MICROBIOL REV, V38, P569, DOI 10.1111/1574-6976.12078; Maillard AP, 2014, J MOL BIOL, V426, P2313, DOI 10.1016/j.jmb.2014.04.003; Malki I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089502; Mettrick KA, 2009, MOL MICROBIOL, V74, P1257, DOI 10.1111/j.1365-2958.2009.06932.x; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; Paulus H, 1998, CHEM SOC REV, V27, P375, DOI 10.1039/a827375z; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Poole K, 2003, FRONT BIOSCI-LANDMRK, V8, pD661, DOI 10.2741/1051; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schalk IJ, 2004, MOL MICROBIOL, V54, P14, DOI 10.1111/j.1365-2958.2004.04241.x; Schalk IJ, 2009, BIOMETALS, V22, P671, DOI 10.1007/s10534-008-9203-2; Shao Y, 1996, BIOCHEMISTRY-US, V35, P3810, DOI 10.1021/bi952592h; Shukla J, 2014, ACTA CRYSTALLOGR D, V70, P1026, DOI 10.1107/S1399004714000121; Starokadomskyy PL, 2007, MOL BIOL+, V41, P278, DOI 10.1134/S0026893307020094; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	53	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12237	12246		10.1074/jbc.M115.643098	http://dx.doi.org/10.1074/jbc.M115.643098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809487	Green Published, hybrid			2022-12-26	WOS:000354388600034
J	Hsieh, LS; Su, WM; Han, GS; Carman, GM				Hsieh, Lu-Sheng; Su, Wen-Min; Han, Gil-Soo; Carman, George M.			Phosphorylation Regulates the Ubiquitin-independent Degradation of Yeast Pah1 Phosphatidate Phosphatase by the 20S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDP-DIACYLGLYCEROL SYNTHASE; NUCLEAR-MEMBRANE GROWTH; PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; LIPID-METABOLISM; MEDIATED REGULATION; ORTHOLOGUE PAH1P; ACID; BIOSYNTHESIS	Saccharomyces cerevisiae Pah1 phosphatidate phosphatase, which catalyzes the conversion of phosphatidate to diacylglycerol for triacylglycerol synthesis and simultaneously controls phosphatidate levels for phospholipid synthesis, is subject to the proteasome-mediated degradation in the stationary phase of growth. In this study, we examined the mechanism for its degradation using purified Pah1 and isolated proteasomes. Pah1 expressed in S. cerevisiae or Escherichia coli was not degraded by the 26S proteasome, but by its catalytic 20S core particle, indicating that its degradation is ubiquitin-independent. The degradation of Pah1 by the 20S proteasome was dependent on time and proteasome concentration at the pH optimum of 7.0. The 20S proteasomal degradation was conserved for human lipin 1 phosphatidate phosphatase. The degradation analysis using Pah1 truncations and its fusion with GFP indicated that proteolysis initiates at the N- and C-terminal unfolded regions. The folded region of Pah1, in particular the haloacid dehalogenase-like domain containing the DIDGT catalytic sequence, was resistant to the proteasomal degradation. The structural change of Pah1, as reflected by electrophoretic mobility shift, occurs through its phosphorylation by Pho85-Pho80, and the phosphorylation sites are located within its N-and C-terminal unfolded regions. Phosphorylation of Pah1 by Pho85-Pho80 inhibited its degradation, extending its half-life by similar to 2-fold. The dephosphorylation of endogenously phosphorylated Pah1 by the Nem1-Spo7 protein phosphatase, which is highly specific for the sites phosphorylated by Pho85-Pho80, stimulated the 20S proteasomal degradation and reduced its half-life by 2.6-fold. These results indicate that the proteolysis of Pah1 by the 20S proteasome is controlled by its phosphorylation state.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Lu-Sheng, Hsieh/AAZ-9188-2020; Regan, Clinton/E-6250-2012	Lu-Sheng, Hsieh/0000-0001-7555-759X; Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health [GM028140, GM050679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R01GM050679, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM028140 and GM050679.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; CARTER JR, 1966, J LIPID RES, V7, P678; CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; CHIRALA SS, 1994, NUCLEIC ACIDS RES, V22, P412, DOI 10.1093/nar/22.3.412; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; HAID A, 1983, METHOD ENZYMOL, V96, P192; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2009, CHEM REV, V109, P1479, DOI 10.1021/cr900054t; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Laporte D, 2011, J CELL BIOL, V192, P949, DOI 10.1083/jcb.201009028; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lussier M, 1997, GENETICS, V147, P435; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peters LZ, 2013, J CELL BIOL, V201, P663, DOI 10.1083/jcb.201211146; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Ruiz C, 1999, YEAST, V15, P1001; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Shen HF, 1996, J BIOL CHEM, V271, P789, DOI 10.1074/jbc.271.2.789; Siniossoglou S, 2000, J BIOL CHEM, V275, P19352, DOI 10.1074/jbc.M001314200; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; TANAKA K, 1986, J BIOL CHEM, V261, P5197; Tar K, 2014, J BIOL CHEM, V289, P12145, DOI 10.1074/jbc.M114.554105; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003	101	41	43	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11467	11478		10.1074/jbc.M115.648659	http://dx.doi.org/10.1074/jbc.M115.648659			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25809482	hybrid, Green Published			2022-12-26	WOS:000353719400023
J	Christophe, C; Muller, S; Rodrigues, M; Petit, AE; Cattiaux, P; Dupre, L; Gadat, S; Valitutti, S				Christophe, Claire; Mueller, Sabina; Rodrigues, Magda; Petit, Anne-Elisabeth; Cattiaux, Patrick; Dupre, Loic; Gadat, Sebastien; Valitutti, Salvatore			A Biased Competition Theory of Cytotoxic T Lymphocyte Interaction with Tumor Nodules	PLOS ONE			English	Article							CANCER-IMMUNOTHERAPY; CELLS; ACTIVATION; BARRIERS; FAILURE; MODEL	The dynamics of the interaction between Cytotoxic T Lymphocytes (CTL) and tumor cells has been addressed in depth, in particular using numerical simulations. However, stochastic mathematical models that take into account the competitive interaction between CTL and tumors undergoing immunoediting, a process of tumor cell escape from immunesurveillance, are presently missing. Here, we introduce a stochastic dynamical particle interaction model based on experimentally measured parameters that allows to describe CTL function during immunoediting. The model describes the competitive interaction between CTL and melanoma cell nodules and allows temporal and two-dimensional spatial progression. The model is designed to provide probabilistic estimates of tumor eradication through numerical simulations in which tunable parameters influencing CTL efficacy against a tumor nodule undergoing immunoediting are tested. Our model shows that the rate of CTL/tumor nodule productive collisions during the initial time of interaction determines the success of CTL in tumor eradication. It allows efficient cytotoxic function before the tumor cells acquire a substantial resistance to CTL attack, due to mutations stochastically occurring during cell division. Interestingly, a bias in CTL motility inducing a progressive attraction towards a few scout CTL, which have detected the nodule enhances early productive collisions and tumor eradication. Taken together, our results are compatible with a biased competition theory of CTL function in which CTL efficacy against a tumor nodule undergoing immunoediting is strongly dependent on guidance of CTL trajectories by scout siblings. They highlight unprecedented aspects of immune cell behavior that might inspire new CTL-based therapeutic strategies against tumors.	[Christophe, Claire; Cattiaux, Patrick; Gadat, Sebastien] CNRS, Inst Math Toulouse, UMR 5219, Toulouse, France; [Christophe, Claire; Mueller, Sabina; Rodrigues, Magda; Dupre, Loic; Valitutti, Salvatore] Fac Med Toulouse, INSERM, Ctr Physiopathol Toulouse Purpan, UMR 1043,Sect Dynam Mol Interact Lymphocytaires, F-31073 Toulouse, France; [Christophe, Claire; Mueller, Sabina; Rodrigues, Magda; Cattiaux, Patrick; Dupre, Loic; Valitutti, Salvatore] Univ Toulouse 3, F-31062 Toulouse, France; [Petit, Anne-Elisabeth] Univ Libre Bruxelles, Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium; [Gadat, Sebastien] Univ Toulouse 1, Toulouse Sch Econ, F-31042 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Toulouse; Universite Toulouse 1 Capitole; Universite Toulouse III - Paul Sabatier; Universite de Toulouse - Jean Jaures; Institut National des Sciences Appliquees de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Ludwig Institute for Cancer Research; Universite Libre de Bruxelles; Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics	Gadat, S (corresponding author), CNRS, Inst Math Toulouse, UMR 5219, Toulouse, France.	sebastien.gadat@math.univ-toulouse.fr; salvatore.valitutti@inserm.fr	Valitutti, Salvatore/M-2999-2014; dupre, loic/L-8174-2014	Valitutti, Salvatore/0000-0002-6432-4421; dupre, loic/0000-0002-7278-6503; Muller, Sabina/0000-0002-4580-2758	Association pour la Recherche sur le Cancer [SL220100601347]; Institut National du Cancer [2012-054]; Agence Nationale de la Recherche (Laboratoire d'Excellence Toulouse Cancer)	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (Laboratoire d'Excellence Toulouse Cancer)(French National Research Agency (ANR))	Funding: This work was supported by grants from the Association pour la Recherche sur le Cancer (SL220100601347), from the Institut National du Cancer (no 2012-054) and from the Agence Nationale de la Recherche (Laboratoire d'Excellence Toulouse Cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel H, 2013, CURR OPIN IMMUNOL, V25, P261, DOI 10.1016/j.coi.2013.03.004; Babbs CF, 2012, AM J CANCER RES, V2, P204; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Caramalho I, 2009, J CELL MOL MED, V13, P3834, DOI 10.1111/j.1582-4934.2008.00586.x; Catalfamo M, 2004, IMMUNITY, V20, P219, DOI 10.1016/S1074-7613(04)00027-5; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Cockburn IA, 2013, P NATL ACAD SCI USA, V110, P9090, DOI 10.1073/pnas.1303858110; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Gajewski TF, 2007, CLIN CANCER RES, V13, P5256, DOI 10.1158/1078-0432.CCR-07-0892; Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009; Ganusov VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015959; Graw F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000466; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Mallet DG, 2006, J THEOR BIOL, V239, P334, DOI 10.1016/j.jtbi.2005.08.002; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; Yukalov VI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083225	30	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120053	10.1371/journal.pone.0120053	http://dx.doi.org/10.1371/journal.pone.0120053			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815811	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600026
J	Diaz, I; Hubbard, A; Decker, A; Cohen, M				Diaz, Ivan; Hubbard, Alan; Decker, Anna; Cohen, Mitchell			Variable Importance and Prediction Methods for Longitudinal Problems with Missing Variables	PLOS ONE			English	Article							MASSIVE TRANSFUSION; TRAUMA; INFERENCE; INJURY; BOX	We present prediction and variable importance (VIM) methods for longitudinal data sets containing continuous and binary exposures subject to missingness. We demonstrate the use of these methods for prognosis of medical outcomes of severe trauma patients, a field in which current medical practice involves rules of thumb and scoring methods that only use a few variables and ignore the dynamic and high-dimensional nature of trauma recovery. Well-principled prediction and VIM methods can provide a tool to make care decisions informed by the high-dimensional patient's physiological and clinical history. Our VIM parameters are analogous to slope coefficients in adjusted regressions, but are not dependent on a specific statistical model, nor require a certain functional form of the prediction regression to be estimated. In addition, they can be causally interpreted under causal and statistical assumptions as the expected outcome under time-specific clinical interventions, related to changes in the mean of the outcome if each individual experiences a specified change in the variable (keeping other variables in the model fixed). Better yet, the targeted MLE used is doubly robust and locally efficient. Because the proposed VIM does not constrain the prediction model fit, we use a very flexible ensemble learner (the SuperLearner), which returns a linear combination of a list of user-given algorithms. Not only is such a prediction algorithm intuitive appealing, it has theoretical justification as being asymptotically equivalent to the oracle selector. The results of the analysis show effects whose size and significance would have been not been found using a parametric approach (such as stepwise regression or LASSO). In addition, the procedure is even more compelling as the predictor on which it is based showed significant improvements in cross-validated fit, for instance area under the curve (AUC) for a receiver-operator curve (ROC). Thus, given that 1) our VIM applies to any model fitting procedure, 2) under assumptions has meaningful clinical (causal) interpretations and 3) has asymptotic (influence-curve) based robust inference, it provides a compelling alternative to existing methods for estimating variable importance in high-dimensional clinical (or other) data.	[Diaz, Ivan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Hubbard, Alan; Decker, Anna] Univ Calif Berkeley, Div Biostat, Berkeley, CA 94720 USA; [Cohen, Mitchell] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Diaz, I (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.	idiaz@jhu.edu			PROMMTT Prospective Observational Multi-Center Transfusion Study (UCSF)	PROMMTT Prospective Observational Multi-Center Transfusion Study (UCSF)	Funding: Funding provided by PROMMTT Prospective Observational Multi-Center Transfusion Study (UCSF). http://cetir-tmc.org/research/prommtt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickel PJ, 1997, E CIENT ADAPTIVE EST; Bir N, 2011, AM J RESP CELL MOL, V45, P632, DOI 10.1165/rcmb.2010-0397OC; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buchman TG, 2010, CRIT CARE, V14, DOI 10.1186/cc8868; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Cohen MJ, 2009, J TRAUMA, V67, P1176, DOI 10.1097/TA.0b013e3181c1c1bc; Dawid AP, 2010, CORR; Diaz I, 2011, BIOMETRICS IN PRESS; Didelez V, 2006, UAI; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Hastie T., 1986, STAT SCI, V1986, P297, DOI [DOI 10.1214/SS/1177013604, 10.1214/ss/1177013604]; Hess JR, 2006, TRANSFUSION, V46, P685, DOI 10.1111/j.1537-2995.2006.00816.x; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; Korb KB, 2004, LECT NOTES ARTIF INT, V3157, P322; Krumrei NJ, 2012, J TRAUMA ACUTE CARE, V72, P211, DOI 10.1097/TA.0b013e318240507b; Lesko MM, 2012, J NEUROTRAUMA; MacFadden LN, 2012, J TRAUMA ACUTE CARE; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; Olden JD, 2004, ECOL MODEL, V178, P389, DOI 10.1016/j.ecolmodel.2004.03.013; Olden JD, 2002, ECOL MODEL, V154, P135, DOI 10.1016/S0304-3800(02)00064-9; ROBINS J, 1986, MATH MODELLING, V7, P1393, DOI 10.1016/0270-0255(86)90088-6; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; RUBIN DB, 1978, ANN STAT, V6, P34, DOI 10.1214/aos/1176344064; Schochl H, 2011, CRIT CARE, V15, DOI 10.1186/cc10539; Stitelman O., 2010, UC BERKELEY DIVISION; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tuglus C., 2011, TARGETED LEARNING CA, P367; van de Geer S., 2000, CAMBRIDGE SERIES STA; van der Laan M.J., 2003, SPR S STAT; van der Laan M.J., 2006, INT J BIOSTAT, V2, P11, DOI 10.2202/1557-4679.1043; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; van der Laan MJ, 2006, INT J BIOSTAT, V2, P11, DOI [10.2202/1557-4679.1043, DOI 10.2202/1557-4679.1043]; van der Laan MJ., 2004, STAT APPL GENET MOL, V3, pArticl	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120031	10.1371/journal.pone.0120031	http://dx.doi.org/10.1371/journal.pone.0120031			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815719	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600025
J	Khandanlou, R; Ahmad, MB; Masoumi, HRF; Shameli, K; Basri, M; Kalantari, K				Khandanlou, Roshanak; Ahmad, Mansor B.; Masoumi, Hamid Reza Fard; Shameli, Kamyar; Basri, Mahiran; Kalantari, Katayoon			Rapid Adsorption of Copper(II) and Lead(II) by Rice Straw/Fe3O4 Nanocomposite: Optimization, Equilibrium Isotherms, and Adsorption Kinetics Study	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; AQUEOUS-SOLUTION; HEAVY-METAL; DYE REMOVAL; BIOSORPTION; CELLULOSE; CU2+; IONS; PB2+; OIL	Rice straw/magnetic nanocomposites (RS/Fe3O4-NCs) were prepared via co-precipitation method for removal of Pb(II) and Cu(II) from aqueous solutions. Response surface methodology (RSM) was utilized to find the optimum conditions for removal of ions. The effects of three independent variables including initial ion concentration, removal time, and adsorbent dosage were investigated on the maximum adsorption of Pb (II) and Cu (II). The optimum conditions for the adsorption of Pb(II) and Cu(II) were obtained (100 and 60 mg/L) of initial ion concentration, (41.96 and 59.35 s) of removal time and 0.13 g of adsorbent for both ions, respectively. The maximum removal efficiencies of Pb(II) and Cu(II) were obtained 96.25% and 75.54%, respectively. In the equilibrium isotherm study, the adsorption data fitted well with the Langmuir isotherm model. The adsorption kinetics was best depicted by the pseudo-second order model. Desorption experiments showed adsorbent can be reused successfully for three adsorption-desorption cycles.	[Khandanlou, Roshanak; Ahmad, Mansor B.; Masoumi, Hamid Reza Fard; Basri, Mahiran; Kalantari, Katayoon] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia; [Shameli, Kamyar] Univ Teknol Malaysia, MJIIT, Kuala Lumpur 54100, Malaysia	Universiti Putra Malaysia; Universiti Teknologi Malaysia	Khandanlou, R (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia.	roshanak_bch@yahoo.com; mansorahmad@upm.edu.my	Kalantari, Katayoon/Y-9256-2019	Kalantari, Katayoon/0000-0001-8814-3863	University Putra Malaysia (UPM)	University Putra Malaysia (UPM)	The authors thank University Putra Malaysia (UPM) for its financial support. The authors are also grateful to the staff of the Department of Chemistry UPM for their help in this research, and to the Institute of Bioscience (IBS/UPM) for technical assistance.	Abdullah AZ, 2009, DESALINATION, V244, P227, DOI 10.1016/j.desal.2008.06.004; Amini M, 2008, J HAZARD MATER, V154, P694, DOI 10.1016/j.jhazmat.2007.10.114; Atia AA, 2005, SEP PURIF TECHNOL, V46, P208, DOI 10.1016/j.seppur.2005.05.009; Bhaumik M, 2011, J HAZARD MATER, V190, P381, DOI 10.1016/j.jhazmat.2011.03.062; Chang YP, 2012, APPL SURF SCI, V261, P504, DOI 10.1016/j.apsusc.2012.08.045; Chen H, 2009, ADSORPTION, V15, P381, DOI 10.1007/s10450-009-9155-z; Chen SB, 2010, GEOCHEM J, V44, P233, DOI 10.2343/geochemj.1.0065; Chuah TG, 2005, DESALINATION, V175, P305, DOI 10.1016/j.desal.2004.10.014; Ding Y, 2012, BIORESOURCE TECHNOL, V114, P20, DOI 10.1016/j.biortech.2012.01.110; Donia AM, 2012, CHEM ENG J, V191, P22, DOI 10.1016/j.cej.2011.08.034; El-Ashtoukhy ESZ, 2008, DESALINATION, V223, P162, DOI 10.1016/j.desal.2007.01.206; Farooq U, 2010, BIORESOURCE TECHNOL, V101, P5043, DOI 10.1016/j.biortech.2010.02.030; Feng QG, 2004, J COLLOID INTERF SCI, V278, P1, DOI 10.1016/j.jcis.2004.05.030; Gao H, 2008, J HAZARD MATER, V150, P446, DOI 10.1016/j.jhazmat.2007.04.126; Ge F, 2012, J HAZARD MATER, V211, P366, DOI 10.1016/j.jhazmat.2011.12.013; Halim SFA, 2009, BIORESOURCE TECHNOL, V100, P710, DOI 10.1016/j.biortech.2008.07.031; Hillel D, 1998, ENVIRONMENTAL SOIL P; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Jin X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106991; Khandanlou R, 2014, BIORESOURCES, V9, P642; Khandanlou R, 2013, MOLECULES, V18, P6597, DOI 10.3390/molecules18066597; Larous S, 2005, DESALINATION, V185, P483, DOI 10.1016/j.desal.2005.03.090; Lu P, 2012, CARBOHYD POLYM, V87, P2546, DOI 10.1016/j.carbpol.2011.11.023; Lu P, 2012, CARBOHYD POLYM, V87, P564, DOI 10.1016/j.carbpol.2011.08.022; Masoumi HRF, 2013, SCI WORLD J, DOI 10.1155/2013/962083; Mishra YK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345606; Musa SH, 2013, COLLOID SURFACE B, V112, P113, DOI 10.1016/j.colsurfb.2013.07.043; Pehlivan E, 2009, J HAZARD MATER, V164, P982, DOI 10.1016/j.jhazmat.2008.08.115; Ramana DKV, 2013, CHEM ENG J, V223, P806, DOI 10.1016/j.cej.2013.03.001; Rocha CG, 2009, J HAZARD MATER, V166, P383, DOI 10.1016/j.jhazmat.2008.11.074; Savina IN, 2011, J HAZARD MATER, V192, P1002, DOI 10.1016/j.jhazmat.2011.06.003; Shen YF, 2009, SEP PURIF TECHNOL, V68, P312, DOI 10.1016/j.seppur.2009.05.020; Shin KY, 2011, J HAZARD MATER, V190, P36, DOI 10.1016/j.jhazmat.2010.12.102; Sohrabi MR, 2014, J IND ENG CHEM, V20, P2535, DOI 10.1016/j.jiec.2013.10.037; Wojnarovits L, 2010, RADIAT PHYS CHEM, V79, P848, DOI 10.1016/j.radphyschem.2010.02.006; Xiarchos I, 2008, J MEMBRANE SCI, V321, P222, DOI 10.1016/j.memsci.2008.04.065; Yadav AK, 2013, ECOL ENG, V52, P211, DOI 10.1016/j.ecoleng.2012.12.069; Zhao DL, 2010, J ALLOY COMPD, V502, P392, DOI 10.1016/j.jallcom.2010.04.177; Zhao XD, 2011, J MOL STRUCT, V986, P68, DOI 10.1016/j.molstruc.2010.11.049	39	40	40	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120264	10.1371/journal.pone.0120264	http://dx.doi.org/10.1371/journal.pone.0120264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815470	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000352133600032
J	Xu, FF; Sun, X; Chen, YL; Huang, Y; Tong, C; Bao, JS				Xu, Feifei; Sun, Xiao; Chen, Yaling; Huang, Yan; Tong, Chuan; Bao, Jinsong			Rapid Identification of Major QTLs Associated with Rice Grain Weight and Their Utilization	PLOS ONE			English	Article							NATURAL VARIATION; DRAFT SEQUENCE; SIZE; YIELD; GENE; LENGTH; TRAIT; WIDTH; ENCODES; SHAPE	To uncover the genetics of rice grain weight, we constructed an RIL population derived from a cross between a large grain accession M201 and a small size variety JY293. Specific Locus Amplified Fragment Sequencing (SLAF-Seq) technology was used to genotype two bulked DNA pools made from individual DNA of the heaviest 30 lines and the lightest 30 lines according to the 1000 grain weight (TGW). Bulked segregant analysis (BSA) was used to identify SLAFs strongly associated with TGW. Two marker-intensive regions at 24,600,000-24,850,000 bp and 25,000,000-25,350,000 bp on chromosome 3 were identified tightly related to the TGW. Then a linkage map of chromosome 3 was constructed with SSR markers and some SLAF derived single nucleotide polymorphisms (SNPs). Quantitative trait locus (QTL) mapping for TGW, grain length, grain width, and grain thickness revealed one major QTL in the second hot-region and two other minor QTLs for grain weight. These three QTLs displayed hierarchical effects on grain length and grain weight in order of qTGW3.2 (qGL3) qTGW3.1 (GS3) qTGW3.3. Multiple comparisons of means among the eight combinations of 3 QTLs revealed that the lines with two of three QTLs deriving from M201 displayed a large grain weight phenotype (TGW 40.2g, average data of three years) and lines with both qTGW3.1 and qTGW3.3 alleles from M201 (42.5g) had similar grain weight to the qTGW3.2 (40.8g) alone. Two strategies with similar effectiveness were proposed to improve grain weight by marker-assisted selection (MAS). One is to introduce the novel qTGW3.2 allele alone, and the other is to pyramid qTGW3.1 and qTGW3.3 alleles together. One new allele of GS3 (39 bp deletion in intron 1) and two SNPs in coding sequence of qGL3 identified in this study from M201 are useful in pyramiding elite alleles for molecular breeding for improvement of rice yield.	[Xu, Feifei; Sun, Xiao; Chen, Yaling; Huang, Yan; Tong, Chuan; Bao, Jinsong] Zhejiang Univ, Inst Nucl Agr Sci, Coll Agr & Biotechnol, Hangzhou 310029, Zhejiang, Peoples R China	Zhejiang University	Bao, JS (corresponding author), Zhejiang Univ, Inst Nucl Agr Sci, Coll Agr & Biotechnol, Huajiachi Campus, Hangzhou 310029, Zhejiang, Peoples R China.	jsbao@zju.edu.cn	Bao, Jinsong/A-7413-2008; Tong, Chuan/AAG-1666-2020	Bao, Jinsong/0000-0002-9606-6615; Tong, Chuan/0000-0003-1383-5042	Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture [201103007]; Fundamental Research Funds for the Central Universities [2011FZA6011]	Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The Special Fund for Agro-scientific Research in the Public Interest (201103007) from the Ministry of Agriculture and the Fundamental Research Funds for the Central Universities (2011FZA6011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Holmes RS, 2010, COMP BIOCHEM PHYS D, V5, P45, DOI 10.1016/j.cbd.2009.09.004; Hu ZJ, 2012, J INTEGR PLANT BIOL, V54, P979, DOI 10.1111/jipb.12008; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lu L, 2013, NEW PHYTOL, V200, P1269, DOI 10.1111/nph.12430; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Shao-Qing T, 2013, GENE, V527, P201, DOI 10.1016/j.gene.2013.05.063; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sun LJ, 2013, J INTEGR PLANT BIOL, V55, P938, DOI 10.1111/jipb.12062; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141	34	46	52	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122206	10.1371/journal.pone.0122206	http://dx.doi.org/10.1371/journal.pone.0122206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815721	gold, Green Submitted, Green Published			2022-12-26	WOS:000352133600153
J	Haddad, LB; Feldacker, C; Jamieson, DJ; Tweya, H; Cwiak, C; Chaweza, T; Mlundira, L; Chiwoko, J; Samala, B; Kachale, F; Bryant, AG; Hosseinipour, MC; Stuart, GS; Hoffman, I; Phiri, S				Haddad, Lisa B.; Feldacker, Caryl; Jamieson, Denise J.; Tweya, Hannock; Cwiak, Carrie; Chaweza, Thomas; Mlundira, Linly; Chiwoko, Jane; Samala, Bernadette; Kachale, Fanny; Bryant, Amy G.; Hosseinipour, Mina C.; Stuart, Gretchen S.; Hoffman, Irving; Phiri, Sam			Pregnancy Prevention and Condom Use Practices among HIV-Infected Women on Antiretroviral Therapy Seeking Family Planning in Lilongwe, Malawi	PLOS ONE			English	Article							FERTILITY DESIRES; GENITOURINARY MEDICINE; UNINTENDED PREGNANCY; INTRAUTERINE-DEVICE; DISCORDANT COUPLES; CONTRACEPTIVE USE; RURAL UGANDA; INTENTIONS; SERVICES; RWANDA	Background Programs for integration of family planning into HIV care must recognize current practices and desires among clients to appropriately target and tailor interventions. We sought to evaluate fertility intentions, unintended pregnancy, contraceptive and condom use among a cohort of HIV-infected women seeking family planning services within an antiretroviral therapy (ART) clinic. Methods 200 women completed an interviewer-administered questionnaire during enrollment into a prospective contraceptive study at the Lighthouse Clinic, an HIV/ART clinic in Lilongwe, Malawi, between August and December 2010. Results Most women (95%) did not desire future pregnancy. Prior reported unintended pregnancy rates were high (69% unplanned and 61% unhappy with timing of last pregnancy). Condom use was inconsistent, even among couples with discordant HIV status, with lack of use often attributed to partner's refusal. Higher education, older age, lower parity and having an HIV negative partner were factors associated with consistent condom usage. Discussion High rates of unintended pregnancy among these women underscore the need for integ rating family planning, sexually transmitted infection (STI) prevention, and HIV services. Contraceptive access and use, including condoms, must be improved with specific efforts to enlist partner support. Messages regarding the importance of condom usage in conjunction with more effective modern contraceptive methods for both infection and pregnancy prevention must continue to be reinforced over the course of ongoing ART treatment.	[Haddad, Lisa B.; Jamieson, Denise J.; Cwiak, Carrie] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Feldacker, Caryl; Tweya, Hannock; Chaweza, Thomas; Mlundira, Linly; Chiwoko, Jane; Samala, Bernadette; Phiri, Sam] Lighthouse Trust, Lilongwe, Malawi; [Feldacker, Caryl] Univ Washington, Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA; [Bryant, Amy G.; Hosseinipour, Mina C.; Stuart, Gretchen S.; Hoffman, Irving] Univ N Carolina, Chapel Hill, NC USA; [Hosseinipour, Mina C.] Univ N Carolina, Project Malawi, Lilongwe, Malawi; [Kachale, Fanny] Minist Hlth, Reprod Hlth Serv, Lilongwe, Malawi	Emory University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Haddad, LB (corresponding author), Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.	lbhadda@emory.edu	D'Albuquerque, Luiz A Carneiro/I-4011-2012	D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168; Feldacker, Caryl/0000-0002-8152-6754; Jamieson, Denise/0000-0003-2597-1201; Haddad, Lisa/0000-0002-7631-6760	center for AIDS research at Emory University [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	center for AIDS research at Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study received financial support from an anonymous foundation and from the center for AIDS research at Emory University (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ICF MACRO; [Anonymous], 2004, DEMOGRAPHIC AND HEAL; Balkus J, 2007, SEX TRANSM DIS, V34, P25, DOI 10.1097/01.olq.0000218880.88179.36; Bongaarts J, 2013, POPUL DEV REV, V38, P153, DOI 10.1111/j.1728-4457.2013.00557.x; CARLIN EM, 1995, GENITOURIN MED, V71, P106; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Cook R, 2014, CULT HEALTH SEX, V16, P741, DOI 10.1080/13691058.2014.902103; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Cooper ML, 1999, HEALTH PSYCHOL, V18, P464; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Gallo MF, 2011, SEX TRANSM DIS, V38, P909, DOI 10.1097/OLQ.0b013e318223be4b; Goldstein RL, 2013, J ADOLESCENT HEALTH, V52, P77, DOI 10.1016/j.jadohealth.2012.08.001; Grabbe K, 2009, J WOMENS HEALTH, V18, P1449, DOI 10.1089/jwh.2008.1160; Haddad LB, 2014, INT J GYNECOL OBSTET, V126, P213, DOI 10.1016/j.ijgo.2014.03.026; Haddad LB, 2013, CONTRACEPTION, V88, P737, DOI 10.1016/j.contraception.2013.08.006; Hamid S, 2006, INT FAM PLAN PERSPEC, V32, P71, DOI 10.1363/3207106; Heys J, 2009, AIDS, V23, pS37, DOI 10.1097/01.aids.0000363776.76129.fd; Hoffman IF, 2008, JAIDS-J ACQ IMM DEF, V47, P477, DOI 10.1097/QAI.0b013e318165dc52; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2004, MAKING CONDOMS WORK; Kassa N, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-1; KELL PD, 1992, GENITOURIN MED, V68, P233; Khu NH, 2013, CONTRACEPTION, V88, P74, DOI 10.1016/j.contraception.2012.10.004; Kikuchi K, 2011, BIOSCI TRENDS, V5, P255, DOI 10.5582/bst.2011.v5.6.255; KING R, 1995, AIDS, V9, pS45; Leslie J, 2009, WITHOUT STRONG INTEG; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; MCCARTHY GA, 1992, GENITOURIN MED, V68, P386; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Nakakeeto ON, 2009, AIDS, V23, P987, DOI 10.1097/QAD.0b013e32832a17e9; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Ngure K, 2012, AIDS, V26, P513, DOI 10.1097/QAD.0b013e32834f981c; Panozzo L, 2003, SWISS MED WKLY, V133, P124; Patel R, 2014, AIDS PATIENT CARE ST, V28, P418, DOI 10.1089/apc.2014.0046; Peterman TA, 1996, J ACQ IMMUN DEF SYND, V12, P69, DOI 10.1097/00042560-199605010-00010; Petruney T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010781; Polis CB, 2011, CONTRACEPTION, V83, P549, DOI 10.1016/j.contraception.2010.10.002; Reynolds HW, 2008, SEX TRANSM INFECT, V84, pII49, DOI 10.1136/sti.2008.030049; Ross A, 2004, AIDS, V18, P799, DOI 10.1097/00002030-200403260-00012; Rutenberg N, 2005, STUD FAMILY PLANN, V36, P235, DOI 10.1111/j.1728-4465.2005.00064.x; Sangi-Haghpeykar H, 2005, PERSPECT SEX REPRO H, V37, P184, DOI 10.1363/3718405; Sherr L, 2004, HIV MED, V5, P258, DOI 10.1111/j.1468-1293.2004.00218.x; Stephenson JM, 1996, AIDS, V10, P1683, DOI 10.1097/00002030-199612000-00013; Stover J, 1996, FUTURES GROUP INTERN; Sweeney C, 1992, Popline, V14, P1; Thackway SV, 1997, AIDS, V11, P663, DOI 10.1097/00002030-199705000-00014; Wall KM, 2012, JOURNAL OF ACQUIRED; World Health Organization, 2009, MEDICAL ELIGIBILITY; Yalew E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-308; Zuehlke Eric, 2009, REDUCING UNINTENDED	52	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121039	10.1371/journal.pone.0121039	http://dx.doi.org/10.1371/journal.pone.0121039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811849	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700077
J	Morton, JS; Andersson, IJ; Cheung, PY; Baker, P; Davidge, ST				Morton, Jude S.; Andersson, Irene J.; Cheung, Po-Yin; Baker, Philip; Davidge, Sandra T.			The Vascular Effects of Sodium Tanshinone IIA Sulphonate in Rodent and Human Pregnancy	PLOS ONE			English	Article							DANSHEN SALVIA-MILTIORRHIZA; PORCINE CORONARY-ARTERY; ISOLATED FEMORAL-ARTERY; SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE; DOWN-REGULATION; FETAL-GROWTH; MOUSE MODEL; IN-UTERO; MICE	Danshen, in particular its derivative tanshinone IIA (TS), is a promising compound in the treatment of cardiovascular diseases and has been used for many years in traditional Chinese medicine. Although many actions of TS have been researched, its vasodilator effects in pregnancy remain unknown. There have been a few studies that have shown the ability of TS to reduce blood pressure in women with hypertensive pregnancies; however, there are no studies which have examined the vascular effects of TS in the pregnant state in either normal or complicated pregnancies. Our aim was to determine the vasoactive role of TS in multiple arteries during pregnancy including: rat resistance (mesenteric and uterine) and conduit (carotid) arteries. Further, we aimed to assess the ability of TS to improve uterine blood flow in a rodent model of intrauterine growth restriction. Wire myography was used to assess vascular responses to the water-soluble derivative, sodium tanshinone IIA sulphonate (STS) or to the endothelium-dependent vasodilator, methylcholine. At mid-pregnancy, STS caused direct vasodilation of rat resistance (pEC(50) mesenteric: 4.47 +/- 0.05 and uterine: 3.65 +/- 0.10) but not conduit (carotid) arteries. In late pregnancy, human myometrial arteries responded with a similar sensitivity to STS (pEC50 myometrial: 3.26 +/- 0.13). STS treatment for the last third of pregnancy in eNOS(-/-) mice increased uterine artery responses to methylcholine (E-max eNOS(-/-): 55.2 +/- 9.2% vs. eNOS(-/-) treated: 75.7 +/- 8.9%, p<0.0001). The promising vascular effects, however, did not lead to improved uterine or umbilical blood flow in vivo, nor to improved fetal biometrics; body weight and crown-rump length. Further, STS treatment increased the uterine artery resistance index and decreased offspring body weight in control mice. Further research would be required to determine the safety and efficacy of use of STS in pregnancy.	[Morton, Jude S.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynaecol, Edmonton, AB, Canada; [Morton, Jude S.; Andersson, Irene J.; Cheung, Po-Yin; Davidge, Sandra T.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Morton, Jude S.; Andersson, Irene J.; Cheung, Po-Yin; Davidge, Sandra T.] Cardiovasc Res Ctr, Edmonton, AB, Canada; [Andersson, Irene J.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Baker, Philip] Univ Auckland, Liggins Inst, Natl Res Ctr Growth & Dev, Gravida, Auckland 1, New Zealand	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Auckland	Davidge, ST (corresponding author), Univ Alberta, Dept Obstet & Gynaecol, Edmonton, AB, Canada.	sandra.davidge@ualberta.ca	Cheung, Po-Yin/C-2804-2013	Cheung, Po-Yin/0000-0002-7141-1523; Davidge, Sandra/0000-0002-5559-4905	Canadian Institutes of Health Research (CIHR) [118160540, 0020054]; Women and Children's Health Research Institute through the Stollery Children's Hospital Foundation; Women and Children's Health Research Institute through the Royal Alexandra Hospital Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute through the Stollery Children's Hospital Foundation; Women and Children's Health Research Institute through the Royal Alexandra Hospital Foundation	S. T. Davidge is a Canada Research Chair (CRC) in Maternal and Perinatal Cardiovascular Health. The Davidge laboratory receives funding from the Canadian Institutes of Health Research (CIHR, Grant numbers: 118160540; 0020054) and the Women and Children's Health Research Institute through the generous support of the Stollery Children's Hospital Foundation and the Royal Alexandra Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCTOR AM, 1986, PROSTAG LEUKOTR ESS, V23, P229, DOI 10.1016/0262-1746(86)90190-3; Carbillon L, 2012, J MATERN-FETAL NEO M, V25, P877, DOI 10.3109/14767058.2011.601364; Chen J, 2003, CHINESE MEDICAL HERB; Fan GW, 2011, J CARDIOVASC PHARM, V57, P340, DOI 10.1097/FJC.0b013e31820a0da1; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Hefler LA, 2001, AM J PHYSIOL-REG I, V280, pR174, DOI 10.1152/ajpregu.2001.280.1.R174; Hsieh YC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P410, DOI 10.1161/CIRCEP.111.000152; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kulandavelu S, 2006, HYPERTENSION, V47, P1175, DOI 10.1161/01.HYP.0000218440.71846.db; Kulandavelu S, 2012, HYPERTENSION, V60, P231, DOI 10.1161/HYPERTENSIONAHA.111.187559; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; Lam FFY, 2006, J CARDIOVASC PHARM, V47, P139, DOI 10.1097/01.fjc.0000197540.12685.ce; Lam FFY, 2005, J CARDIOVASC PHARM, V46, P361, DOI 10.1097/01.fjc.0000175439.94906.e9; Li Chun-fang, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P68; Lin JH, 2010, CHINESE MED J-PEKING, V123, P2548, DOI 10.3760/cma.j.issn.0366-6999.2010.18.010; Liu JQ, 2009, AM J PHYSIOL-HEART C, V297, pH1217, DOI 10.1152/ajpheart.00477.2009; Liu S Y, 1994, Zhonghua Fu Chan Ke Za Zhi, V29, P648; Mao CP, 2009, AM J CHINESE MED, V37, P1031, DOI 10.1142/S0192415X09007478; Pan Chunshui, 2011, Ther Adv Cardiovasc Dis, V5, P99, DOI 10.1177/1753944710396538; Poudel R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064401; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Rueda-Clausen CF, 2014, REPROD SCI, V21, P492, DOI 10.1177/1933719113503401; Saleem T, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-41; Stanley JL, 2012, HYPERTENSION, V59, P1021, DOI 10.1161/HYPERTENSIONAHA.111.186270; Tan XQ, 2011, EUR J PHARMACOL, V656, P27, DOI 10.1016/j.ejphar.2011.01.028; Tang FT, 2011, EUR J PHARMACOL, V650, P275, DOI 10.1016/j.ejphar.2010.07.038; Visentin S, 2014, ATHEROSCLEROSIS, V237, P391, DOI 10.1016/j.atherosclerosis.2014.09.027; Wan AKS, 2008, J NAT PROD, V71, P1825, DOI 10.1021/np800119k; Wang J, 2010, EUR J PHARMACOL, V640, P129, DOI 10.1016/j.ejphar.2010.04.047; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Wang Xue-feng, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P969; Wu GB, 2009, EUR J PHARMACOL, V617, P102, DOI 10.1016/j.ejphar.2009.06.046; Wu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094957; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Xu SW, 2014, INT J CARDIOL, V174, P878, DOI 10.1016/j.ijcard.2014.04.226; Xu SW, 2011, ARCH BIOCHEM BIOPHYS, V515, P72, DOI 10.1016/j.abb.2011.08.006; Xu Y, 2008, J CLIN IMMUNOL, V28, P512, DOI 10.1007/s10875-008-9206-3; Yang Y, 2008, EUR J PHARMACOL, V598, P9, DOI 10.1016/j.ejphar.2008.09.013; Zhang YF, 2009, DRUG CHEM TOXICOL, V32, P362, DOI 10.1080/01480540903176594; Zhou LH, 2012, ASIAN PAC J CANCER P, V13, P4453, DOI 10.7314/APJCP.2012.13.9.4453; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	43	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121897	10.1371/journal.pone.0121897	http://dx.doi.org/10.1371/journal.pone.0121897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811628	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700156
J	Myers, TA; Maibach, E; Peters, E; Leiserowitz, A				Myers, Teresa A.; Maibach, Edward; Peters, Ellen; Leiserowitz, Anthony			Simple Messages Help Set the Record Straight about Scientific Agreement on Human-Caused Climate Change: The Results of Two Experiments	PLOS ONE			English	Article							RISK; COMMUNICATION; NUMERACY; SCIENCE; BENEFIT; INFORMATION; SUPPORT; CONTEXT; POLICY; TRIAL	Human-caused climate change is happening; nearly all climate scientists are convinced of this basic fact according to surveys of experts and reviews of the peer-reviewed literature. Yet, among the American public, there is widespread misunderstanding of this scientific consensus. In this paper, we report results from two experiments, conducted with national samples of American adults, that tested messages designed to convey the high level of agreement in the climate science community about human-caused climate change. The first experiment tested hypotheses about providing numeric versus non-numeric assertions concerning the level of scientific agreement. We found that numeric statements resulted in higher estimates of the scientific agreement. The second experiment tested the effect of eliciting respondents' estimates of scientific agreement prior to presenting them with a statement about the level of scientific agreement. Participants who estimated the level of agreement prior to being shown the corrective statement gave higher estimates of the scientific consensus than respondents who were not asked to estimate in advance, indicating that incorporating an "estimation and reveal" technique into public communication about scientific consensus may be effective. The interaction of messages with political ideology was also tested, and demonstrated that messages were approximately equally effective among liberals and conservatives. Implications for theory and practice are discussed.	[Myers, Teresa A.; Maibach, Edward] George Mason Univ, Ctr Climate Change Commun, Dept Commun, Fairfax, VA 22030 USA; [Peters, Ellen] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Leiserowitz, Anthony] Yale Univ, Sch Forestry & Environm Studies, Yale Project Climate Change Commun, New Haven, CT 06511 USA	George Mason University; University System of Ohio; Ohio State University; Yale University	Maibach, E (corresponding author), George Mason Univ, Ctr Climate Change Commun, Dept Commun, Fairfax, VA 22030 USA.	emaibach@gmu.edu	Leiserowitz, Anthony/HGB-4208-2022; Leiserowitz, Anthony/ABE-6529-2020; Maibach, Edward/A-7102-2009	Leiserowitz, Anthony/0000-0001-5349-409X; Maibach, Edward/0000-0003-3409-9187	Grantham Foundation for the Protection of the Environment; Rockefeller Family Fund (RFF)	Grantham Foundation for the Protection of the Environment; Rockefeller Family Fund (RFF)	This research was funded by the Grantham Foundation for the Protection of the Environment, the Rockefeller Family Fund (RFF), as well as by Lawrence Linden, Robert Litterman and Henry Paulson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolsen T, 2014, AM POLIT RES, V42, P65, DOI 10.1177/1532673X13484173; Boykoff MT, 2004, GLOBAL ENVIRON CHANG, V14, P125, DOI 10.1016/j.gloenvcha.2003.10.001; BRUN W, 1988, ORGAN BEHAV HUM DEC, V41, P390, DOI 10.1016/0749-5978(88)90036-2; Budescu DV, 2009, PSYCHOL SCI, V20, P299, DOI 10.1111/j.1467-9280.2009.02284.x; BUDESCU DV, 1988, J EXP PSYCHOL HUMAN, V14, P281, DOI 10.1037/0096-1523.14.2.281; Burkell J, 2004, J MED LIBR ASSOC, V92, P200; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Dunlap R.E., 2011, OXFORD HDB CLIMATE C, P144; Dunlap RE, 2008, ENVIRONMENT, V50, P26, DOI 10.3200/ENVT.50.5.26-35; Environmental Protection Agency, CLIM CHANG FACTS ANS; Fagerlin A, 2005, PATIENT EDUC COUNS, V57, P294, DOI 10.1016/j.pec.2004.08.007; Farnsworth SJ, 2012, SCI COMMUN, V34, P435, DOI 10.1177/1075547011422957; FETTING JH, 1990, J CLIN ONCOL, V8, P1476, DOI 10.1200/JCO.1990.8.9.1476; Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1; FRIESTAD M, 1994, J CONSUM RES, V21, P1, DOI 10.1086/209380; Gurmankin AD, 2004, MED DECIS MAKING, V24, P265, DOI 10.1177/0272989X04265482; Hallowell N, 1997, J Genet Couns, V6, P269, DOI 10.1023/A:1025624221369; Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646; INGLIS S, 1993, ANAESTH INTENS CARE, V21, P799, DOI 10.1177/0310057X9302100609; JACKSON S, 1988, HUM COMMUN RES, V15, P127, DOI 10.1111/j.1468-2958.1988.tb00174.x; Janiszewski C, 2008, PSYCHOL SCI, V19, P121, DOI 10.1111/j.1467-9280.2008.02057.x; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kahan DM, ADV POL PSY IN PRESS; Krosnick JA, 2006, CLIMATIC CHANGE, V77, P7, DOI 10.1007/s10584-006-9068-8; Leiserowitz A., 2013, CLIMATE CHANGE AM MI; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271; LOEWENSTEIN G, 1994, PSYCHOL BULL, V116, P75, DOI 10.1037/0033-2909.116.1.75; Maibach E, 2012, PSYCHOL SCI PUBL INT, V13, P105, DOI 10.1177/1529100612457647; Marteau TM, 2000, PRENATAL DIAG, V20, P714, DOI 10.1002/1097-0223(200009)20:9<714::AID-PD906>3.0.CO;2-4; McCright AM, 2013, CLIMATIC CHANGE, V119, P511, DOI 10.1007/s10584-013-0704-9; McCright AM, 2011, GLOBAL ENVIRON CHANG, V21, P1163, DOI 10.1016/j.gloenvcha.2011.06.003; McCright AM, 2010, THEOR CULT SOC, V27, P100, DOI 10.1177/0263276409356001; Myers TA, 2011, COMMUN METHODS MEAS, V5, P297, DOI 10.1080/19312458.2011.624490; National Research Council, 2012, CLIM CHANG EV IMP CH; Olson MJ, 1997, J BEHAV DECIS MAKING, V10, P117, DOI 10.1002/(SICI)1099-0771(199706)10:2<117::AID-BDM251>3.0.CO;2-7; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Oreskes N., 2010, MERCHANTS DOUBT; Peters E, 2007, HEALTH AFFAIR, V26, P741, DOI 10.1377/hlthaff.26.3.741; Peters E, 2014, MED DECIS MAKING, V34, P430, DOI 10.1177/0272989X13511705; Pooley E., 2010, CLIMATE WAR TRUE BEL, P55; Powell J. L., 2012, INQUISITION CLIMATE; Powell JL, 2014, WHY CLIMATE DENIERS; Schwartz PH, 2011, HASTINGS CENT REP, V41, P30, DOI 10.1353/hcr.2011.0029; SLATER MD, 1991, JOURNALISM QUART, V68, P412, DOI 10.1177/107769909106800312; Slovic P, 2017, BEHAV PUBLIC POL, V1, P54, DOI [10.1017/bpp.2016.2, DOI 10.1017/BPP.2016.2]; Van der Linden S, PLOS ONE IN PRESS; WALLSTEN TS, 1986, J EXP PSYCHOL GEN, V115, P348, DOI 10.1037/0096-3445.115.4.348; Windschitl PD, 1999, J EXP PSYCHOL LEARN, V25, P1514, DOI 10.1037/0278-7393.25.6.1514; Zimmer, 1983, DECISION MAKING UNCE, V16, P159, DOI [DOI 10.1016/S0166-4115(08)62198-6, 10.1016/S0166-4115(08)62198-6]; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	56	51	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120985	10.1371/journal.pone.0120985	http://dx.doi.org/10.1371/journal.pone.0120985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25812121	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700071
J	Salado-Rasmussen, K; Theilgaard, ZP; Chiduo, MG; Bygbjerg, IC; Gerstoft, J; Luneborg-Nielsen, M; Lemnge, M; Katzenstein, TL				Salado-Rasmussen, Kirsten; Theilgaard, Zahra P.; Chiduo, Mercy G.; Bygbjerg, Ib C.; Gerstoft, Jan; Luneborg-Nielsen, Margrethe; Lemnge, Martha; Katzenstein, Terese L.			Nevirapine, Sodium Concentration and HIV-1 RNA in Breast Milk and Plasma among HIV-Infected Women Receiving Short-Course Antiretroviral Prophylaxis	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RANDOMIZED CLINICAL-TRIAL; HUMAN LACTATION; VIRAL LOAD; TRANSMISSION; INFANT; MASTITIS	Introduction Risk factors for breast milk transmission of HIV-1 from mother to child include high plasma and breast milk viral load, low maternal CD4 count and breast pathology such as mastitis. Objective To determine the impact of nevirapine and subclinical mastitis on HIV-1 RNA in maternal plasma and breast milk after intrapartum single-dose nevirapine combined with either 1-week tail of Combivir (zidovudine/lamivudine) or single-dose Truvada (tenofovir/emtricitabine). Methods Maternal plasma and bilateral breast milk samples were collected between April 2008 and April 2011 at 1, 4 and 6 weeks postpartum from HIV-infected Tanzanian women. Moreover, plasma samples were collected at delivery from mother and infant. Results HIV-1 RNA was quantified in 1,212 breast milk samples from 273 women. At delivery, 96% of the women and 99% of the infants had detectable nevirapine in plasma with a median (inter-quartile range, IQR) of 1.5 mu g/mL (0.75-2.20 mu g/mL) and 1.04 mu g/mL (0.39-1.71 mu g/mL), respectively (P < 0.001). At 1 week postpartum, 93% and 98% of the women had detectable nevirapine in plasma and breast milk, with a median (IQR) of 0.13 mu g/mL (0.13-0.39 mu g/mL) and 0.22 mu g/mL (0.13-0.34 mu g/mL), respectively. Maternal plasma and breast milk HIV-1 RNA correlated at all visits (R = 0.48, R = 0.7, R = 0.59; all P = 0.01). Subclinical mastitis was detected in 67% of the women at some time during 6 weeks, and in 38% of the breast milk samples. Breast milk samples with subclinical mastitis had significantly higher HIV-1 RNA at 1, 4 and 6 weeks (all P < 0.05). Conclusion After short-course antiretroviral prophylaxis, nevirapine was detectable in most infant cord blood samples and the concentration in maternal plasma and breast milk was high through week 1 accompanied by suppressed HIV-1 RNA in plasma and breast milk.	[Salado-Rasmussen, Kirsten; Theilgaard, Zahra P.; Gerstoft, Jan; Luneborg-Nielsen, Margrethe; Katzenstein, Terese L.] Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Chiduo, Mercy G.; Lemnge, Martha] Natl Inst Med Res, Tanga, Tanzania; [Bygbjerg, Ib C.] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Salado-Rasmussen, K (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	ksalado@hotmail.com		Bygbjerg, Ib/0000-0001-9100-2754; Katzenstein, Terese L/0000-0002-2233-500X	European & Developing Countries Clinical Trials Partnership; Laege Agnethe Lovgreens Legat; Bjorn Astrups Foundation	European & Developing Countries Clinical Trials Partnership; Laege Agnethe Lovgreens Legat; Bjorn Astrups Foundation	This research was supported by the European & Developing Countries Clinical Trials Partnership (http://www.edctp.org). KS received research funding for this study from Laege Agnethe Lovgreens Legat and Bjorn Astrups Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizire J, 2012, JAIDS-J ACQ IMM DEF, V60, P483, DOI 10.1097/QAI.0b013e318246bf9e; Becquet R, 2013, CLIN INFECT DIS, V56, P140, DOI 10.1093/cid/cis813; CONNER AE, 1979, PEDIATRICS, V63, P910; EREMAN RR, 1987, J NUTR, V117, P1154, DOI 10.1093/jn/117.6.1154; Filteau SM, 1999, AM J CLIN NUTR, V69, P953; Filteau SM, 1999, IMMUNOLOGY, V97, P595, DOI 10.1046/j.1365-2567.1999.00834.x; Gantt S, 2007, J INFECT DIS, V196, P570, DOI 10.1086/519843; Holland DT, 2005, ICCAC, pA34; Hudgens MG, 2013, CLIN INFECT DIS, V56, P131, DOI 10.1093/cid/cis808; Lunney KM, 2010, CLIN INFECT DIS, V50, P762, DOI 10.1086/650535; Mirochnick M, 1998, J INFECT DIS, V178, P368, DOI 10.1086/515641; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; NEVILLE MC, 1991, AM J CLIN NUTR, V54, P81, DOI 10.1093/ajcn/54.1.81; NEVILLE MC, 1984, AM J CLIN NUTR, V40, P635, DOI 10.1093/ajcn/40.3.635; Phiri W, 2006, AIDS RES HUM RETROV, V22, P607, DOI 10.1089/aid.2006.22.607; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Salado-Rasmussen K, 2011, CLIN CHEM LAB MED, V49, P1171, DOI 10.1515/CCLM.2011.184; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; Semba R D, 1999, J Hum Lact, V15, P301, DOI 10.1177/089033449901500407; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Semrau K, 2012, J ACQ IMMUN DEF SYND, V62, P346; Semrau K, 2008, JAIDS-J ACQ IMM DEF, V47, P320, DOI 10.1097/QAI.0b013e31815e7436; Shapiro RL, 2009, J INFECT DIS, V199, P414, DOI 10.1086/596034; Slyker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029777; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 2013, GLOB UPD HIV TREATM; Willumsen JF, 2003, AIDS, V17, P407, DOI 10.1097/00002030-200302140-00015; World Health Organization, 2008, 10 FACTS BREASTF; World Health Organization, 2013, CLIN GUID CONT CAR A; World Health Organization, 2000, MAST CAUS MAN	31	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121111	10.1371/journal.pone.0121111	http://dx.doi.org/10.1371/journal.pone.0121111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812161	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700080
J	Wong, MS; Huang, P; Li, WY; Li, Y; Zhang, SS; Zhang, C				Wong, ManSin; Huang, Ping; Li, Weiyi; Li, Ying; Zhang, Samuel S.; Zhang, Chun			T-Helper1/T-Helper2 Cytokine Imbalance in the Iris of Patients with Glaucoma	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; NORMAL-PRESSURE GLAUCOMA; NORMAL-TENSION GLAUCOMA; AQUEOUS-HUMOR; INTRAOCULAR-PRESSURE; TRABECULAR MESHWORK	The mechanistic study of glaucoma pathogenesis has shifted to seeking to understand the effects of immune responses on retinal ganglion cell damage and protection. Cytokines mediate the biological effects of the immune system, and our previous study revealed an imbalance of T-helper (Th) 1-derived and Th2-derived cytokines in the serum of patients with glaucoma. In this study, we collected irises from normal individuals and patients with primary open-angle closure (POAG) or chronic angle-closure glaucoma (CACG). We used real-time polymerase chain reaction (PCR) to measure the expression of Th1 (interleukin (IL)-2, interferon-gamma (IFN-gamma)), Th2 (IL-4, IL-6, IL-10), and Th3 (transforming growth factor-beta (TGF-beta)) cytokines. We then performed immunohistochemical staining to characterize the localization of the upregulated cytokines in iris cryosections. We observed an upward trend in the expression of IL-2 and IFN-gamma and a downward trend in IL-6 expression in the iris of POAG and CACG patients. Expression of TGF-beta also increased. Immunohistochemistry revealed that IL-2 expression in POAG and CACG patients was localized in the anterior surface of the blood vessel wall in the stroma of the iris, in the cytoplasm of some cells, in the anterior epithelium, and in the posterior pigment epithelium. These findings indicate that immune status differed between the iris tissues of POAG and CACG patients and those of normal individuals. A T-helper cytokine imbalance may modulate the immune microenvironment in glaucomatous eyes and thus influence optic neuropathy.	[Wong, ManSin; Huang, Ping; Li, Weiyi; Li, Ying; Zhang, Chun] Peking Univ, Ctr Eye, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China; [Li, Weiyi] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhang, Samuel S.] Penn State Univ, Dept Neural & Behav Sci, Hershey, PA USA	Peking University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Huang, P (corresponding author), Peking Univ, Ctr Eye, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China.	huangping512@hotmail.com			Chinese State Natural and Science Foundation [81300756]; Beijing Natural Science Foundation [7132219]	Chinese State Natural and Science Foundation; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from Chinese State Natural and Science Foundation (grant no. 81300756) and Beijing Natural Science Foundation (grant no. 7132219). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2011, CLIN EXP ALLERGY, V41, P1729, DOI 10.1111/j.1365-2222.2011.03827.x; Akira S, 1997, INT J BIOCHEM CELL B, V29, P1401, DOI 10.1016/S1357-2725(97)00063-0; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Balaiya S, 2011, CLIN OPHTHALMOL, V5, P553, DOI 10.2147/OPTH.S19453; BECKER B, 1962, ARCH OPHTHALMOL-CHIC, V68, P643; Berger S, 2008, INVEST OPHTH VIS SCI, V49, P3605, DOI 10.1167/iovs.07-0817; Bhattacharya SK, 2009, INVEST OPHTH VIS SCI, V50, P551, DOI 10.1167/iovs.08-2632; Birke MT, 2011, INVEST OPHTH VIS SCI, V52, P468, DOI 10.1167/iovs.10-5990; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Borkenstein A, 2013, MOL VIS, V19, P2306; CARTWRIGHT MJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P500, DOI 10.1001/archopht.1992.01080160078035; Chen JZ, 2003, AM J MED, V114, P697, DOI 10.1016/S0002-9343(03)00199-2; Chua J, 2012, MOL VIS, V18, P431; Chudgar SM, 2006, MOL VIS, V12, P1117; CLERICI M, 1994, IMMUNOL TODAY, V15, P575, DOI 10.1016/0167-5699(94)90220-8; Cui XH, 2008, EYE RES, V26, P108; Deboy CA, 2006, EXP NEUROL, V201, P212, DOI 10.1016/j.expneurol.2006.04.028; Drance SM, 1999, CAN J OPHTHALMOL, V34, P1; Fernandez-Durango R, 2008, INVEST OPHTH VIS SCI, V49, P2506, DOI 10.1167/iovs.07-1363; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Fu QL, 2008, CELL MOL NEUROBIOL, V28, P317, DOI 10.1007/s10571-007-9155-z; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; Fukuchi T, 2001, JPN J OPHTHALMOL, V45, P592, DOI 10.1016/S0021-5155(01)00414-2; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Gramlich OW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057557; Gramlich OW, 2013, CURR OPIN PHARMACOL, V13, P90, DOI 10.1016/j.coph.2012.09.005; Grieshaber MC, 2007, SURV OPHTHALMOL, V52, pS115, DOI 10.1016/j.survophthal.2007.08.005; Gupta N, 1997, Curr Opin Ophthalmol, V8, P38, DOI 10.1097/00055735-199704000-00007; HAMARD P, 1994, BRIT J OPHTHALMOL, V78, P449, DOI 10.1136/bjo.78.6.449; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Hautala N, 2012, ACTA OPHTHALMOL, V90, pe246, DOI 10.1111/j.1755-3768.2011.02219.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hong S, 2008, BIOCELL, V32, P201; Huang P, 2007, EYE RES, V25, P454; Huang P, 2005, RES ADV OPHTHALMOL, V25, P41; Huang P, 2010, J GLAUCOMA, V19, P324, DOI 10.1097/IJG.0b013e3181b4cac7; Huang Ping, 2009, J Ocul Biol Dis Infor, V2, P78; Husain S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089392; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Kennedy KJ, 1999, J CLIN IMMUNOL, V19, P273, DOI 10.1023/A:1020535423465; Kirwan RP, 2004, J GLAUCOMA, V13, P327, DOI 10.1097/00061198-200408000-00011; Kitaoka Y, 2006, INVEST OPHTH VIS SCI, V47, P1448, DOI 10.1167/iovs.05-0299; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Koeberle PD, 2004, NEUROSCIENCE, V125, P903, DOI 10.1016/S0306-4522(03)00398-1; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; Liang Jia-Kai, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P322; Liang Y, 2012, J CLIN IMMUNOL, V32, P1048, DOI 10.1007/s10875-012-9690-3; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; Min Seong Hee, 2006, Korean J Ophthalmol, V20, P162; NAGASUBRAMANIAN S, 1978, T OPHTHAL SOC UK, V98, P22; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Neufeld AH, 2004, BRAIN RES BULL, V62, P455, DOI 10.1016/j.brainresbull.2003.07.005; Ochi H, 2001, J NEUROIMMUNOL, V119, P297, DOI 10.1016/S0165-5728(01)00393-9; Ochiai Y, 2002, JPN J OPHTHALMOL, V46, P249, DOI 10.1016/S0021-5155(01)00523-8; Ozcan Altan Atakan, 2004, International Ophthalmology, V25, P19, DOI 10.1023/B:INTE.0000018524.48581.79; Pena JDO, 1999, BRIT J OPHTHALMOL, V83, P209, DOI 10.1136/bjo.83.2.209; Picht G, 2001, GRAEF ARCH CLIN EXP, V239, P199, DOI 10.1007/s004170000252; Prasanna G, 2003, MOL CELL BIOCHEM, V253, P71, DOI 10.1023/A:1026005418874; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; RATAN RR, 1994, J NEUROCHEM, V62, P376; Robertson JV, 2010, INVEST OPHTH VIS SCI, V51, P308, DOI 10.1167/iovs.09-3380; Rodriguez-Sainz MD, 2002, EUR CYTOKINE NETW, V13, P110; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Sanchez RN, 2003, INVEST OPHTH VIS SCI, V44, P4006, DOI 10.1167/iovs.03-0040; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Shi Jun, 2012, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V26, P1073; Siu AW, 2002, EXP EYE RES, V75, P401, DOI 10.1006/exer.2002.2029; SOMMER A, 1989, AM J OPHTHALMOL, V107, P186, DOI 10.1016/0002-9394(89)90221-3; Sredni-Kenigsbuch D, 2002, INT J NEUROSCI, V112, P665, DOI 10.1080/00207450290025725; Stefan C, 2008, Oftalmologia, V52, P110; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Tezel Gulgun, 2004, Curr Opin Ophthalmol, V15, P80, DOI 10.1097/00055735-200404000-00003; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Trivedi RH, 2011, J OCUL PHARMACOL TH, V27, P477, DOI 10.1089/jop.2010.0100; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Wax MB, 2011, EXP EYE RES, V93, P187, DOI 10.1016/j.exer.2010.08.016; Wax MB, 1998, ARCH OPHTHALMOL-CHIC, V116, P993, DOI 10.1001/archopht.116.8.993; Wax MB, 1998, AM J OPHTHALMOL, V125, P145, DOI 10.1016/S0002-9394(99)80084-1; Wax MB, 2002, MOL NEUROBIOL, V26, P45, DOI 10.1385/MN:26:1:045; Welge-Lussen U, 2010, KLIN MONATSBL AUGENH, V227, P99, DOI 10.1055/s-0029-1245171; Welge-Lussen U, 1999, INVEST OPHTH VIS SCI, V40, P2235; Yamamoto N, 2005, OPHTHALMIC RES, V37, P29, DOI 10.1159/000083019; Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666, DOI 10.1001/archopht.118.5.666; Yang JJ, 2001, AM J OPHTHALMOL, V131, P421, DOI 10.1016/S0002-9394(00)00862-X; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Yoneda K, 2007, GROWTH FACTORS, V25, P160, DOI 10.1080/08977190701723505; Yu XB, 2007, OPHTHAL SURG LAS IM, V38, P6, DOI 10.3928/15428877-20070101-01; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Zanon-Moreno V, 2008, J GLAUCOMA, V17, P263, DOI 10.1097/IJG.0b013e31815c3a7f; Zhang C, 2008, EXP EYE RES, V86, P991, DOI 10.1016/j.exer.2008.03.020; Zhang GX, 2000, MULT SCLER J, V6, P3, DOI 10.1191/135245800678827446; Zhao SW, 2005, STUDY IMMUNE BALANCE, P5; Zhong L, 1999, Zhonghua Yan Ke Za Zhi, V35, P383; Zhou X, 2011, INT J OPHTHALMOL-CHI, V4, P594, DOI 10.3980/j.issn.2222-3959.2011.06.04	101	28	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122184	10.1371/journal.pone.0122184	http://dx.doi.org/10.1371/journal.pone.0122184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811482	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700173
J	Yukl, SA; Shergill, AK; Girling, V; Li, QS; Killian, M; Epling, L; Li, PL; Kaiser, P; Haase, A; Havlir, DV; McQuaid, K; Sinclair, E; Wong, JK				Yukl, Steven A.; Shergill, Amandeep K.; Girling, Valerie; Li, Qingsheng; Killian, Maudi; Epling, Lorrie; Li, Peilin; Kaiser, Philipp; Haase, Ashley; Havlir, Diane V.; McQuaid, Kenneth; Sinclair, Elizabeth; Wong, Joseph K.			Site-Specific Differences in T Cell Frequencies and Phenotypes in the Blood and Gut of HIV-Uninfected and ART-Treated HIV plus Adults	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; MUCOSAL IMMUNE RECONSTITUTION; PERIPHERAL-BLOOD; LYMPHOID-TISSUE; GASTROINTESTINAL-TRACT; COLLAGEN DEPOSITION; DISEASE PROGRESSION; POSITIVE PATIENTS; SIV INFECTION	Gastrointestinal T lymphocytes are critical for mucosal immunity and HIV pathogenesis, yet little is known about normal T cell numbers and phenotypes in different regions of the gut, or the degree to which ART can restore levels to those of HIV-uninfected individuals. To investigate these questions, we measured T cell frequencies and markers of memory, activation, anergy, and homing in the blood, ileum, and rectum of HIV- and ART-suppressed HIV+ adults. In HIV-individuals, T cell frequencies and phenotypes differed significantly between sites. Compared to HIV-adults, HIV+ adults had lower absolute CD4+T cell counts in the ileal lamina propria and lower relative CD4+T cell counts in the blood and ileum. In the gut, HIV+ adults had a higher proportion of CD38+CD4+ T cells, a lower proportion of terminally-differentiated effector cells, and, in the rectum, a higher proportion of CTLA-4+ CD4+T cells. In HIV+ individuals, relative CD4+T cell numbers in the ileum correlated with the proportion of CTLA-4+ CD4+T cells, whereas in the rectum, they tended to correlate with the proportion of circulating CD4+T cells expressing alpha 4 beta 7 or CCR6. Mechanisms of T cell reconstitution may differ throughout the gut, with homing contributing more in the rectum while ileal reconstitution is associated with mucosal CD4+T cell anergy.	[Yukl, Steven A.; Shergill, Amandeep K.; Li, Peilin; Kaiser, Philipp; McQuaid, Kenneth; Wong, Joseph K.] San Francisco VA Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Yukl, Steven A.; Shergill, Amandeep K.; Girling, Valerie; Killian, Maudi; Epling, Lorrie; Li, Peilin; Kaiser, Philipp; Havlir, Diane V.; McQuaid, Kenneth; Sinclair, Elizabeth; Wong, Joseph K.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Li, Qingsheng] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Haase, Ashley] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of Nebraska System; University of Nebraska Lincoln; University of Minnesota System; University of Minnesota Twin Cities	Yukl, SA (corresponding author), San Francisco VA Med Ctr, Dept Med, San Francisco, CA 94121 USA.	steven.yukl@ucsf.edu	Li, Peilin/CAG-5411-2022		U.S. Department of Veterans Affairs [1 IK2 CX000520-01, I01 BX000192]; UCSF-Gladstone Center for AIDS Research (CFAR) [P30-AI027763]; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [R56AI091573, U19AI096109, 1R21AI104445-01A1]; Swiss National Science Foundation [PBZHP3_147260]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R21AI104445, R56AI091573, U19AI096109] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000520] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); UCSF-Gladstone Center for AIDS Research (CFAR); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the U.S. Department of Veterans Affairs [1 IK2 CX000520-01 (SY), I01 BX000192 (JW)]; the UCSF-Gladstone Center for AIDS Research (CFAR) [P30-AI027763 (SY)]; the National Institute of Allergy and Infectious Diseases at the National Institutes of Health [R56AI091573 (JW, SY, AS, DH), U19AI096109 (JW), 1R21AI104445-01A1 (PL)]; and the Swiss National Science Foundation [PBZHP3_147260 (PK)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Andrew DP, 1996, EUR J IMMUNOL, V26, P897, DOI 10.1002/eji.1830260427; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cassol E, 2013, J INFECT DIS, V208, P1113, DOI 10.1093/infdis/jit249; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2004, P NATL ACAD SCI USA, V101, P2464, DOI 10.1073/pnas.0307328101; Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129; Costiniuk CT, 2012, MUCOSAL IMMUNOL, V5, P596, DOI 10.1038/mi.2012.82; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Estes J, 2008, J INFECT DIS, V198, P456, DOI 10.1086/590112; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Gordon SN, 2010, J IMMUNOL, V185, P5169, DOI 10.4049/jimmunol.1001801; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Hayes TL, 2013, AIDS, V27, P867, DOI 10.1097/QAD.0b013e32835d85b4; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kader M, 2009, J MED PRIMATOL, V38, P32, DOI 10.1111/j.1600-0684.2009.00373.x; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kewenig S, 1999, GASTROENTEROLOGY, V116, P1115, DOI 10.1016/S0016-5085(99)70014-4; Krzysiek R, 2001, BLOOD, V98, P3169, DOI 10.1182/blood.V98.10.3169; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Rueda CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030307; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read SW, 2011, JAIDS-J ACQ IMM DEF, V56, P340, DOI 10.1097/QAI.0b013e31820bf84c; Schacker TW, 2005, AIDS, V19, P2169, DOI 10.1097/01.aids.0000194801.51422.03; Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]; SCHNEIDER T, 1995, GUT, V37, P524, DOI 10.1136/gut.37.4.524; Sheth PM, 2008, MUCOSAL IMMUNOL, V1, P382, DOI 10.1038/mi.2008.23; Smit-McBride Z, 1998, J VIROL, V72, P6646, DOI 10.1128/JVI.72.8.6646-6656.1998; Talal AH, 2001, J ACQ IMMUN DEF SYND, V26, P1, DOI 10.1097/00126334-200101010-00001; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; Wang LX, 2014, P NATL ACAD SCI USA, V111, P3146, DOI 10.1073/pnas.1318175111; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104; Wolff MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041373; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zeitz M, 1998, PATHOBIOLOGY, V66, P151, DOI 10.1159/000028013	49	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121290	10.1371/journal.pone.0121290	http://dx.doi.org/10.1371/journal.pone.0121290			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811360	Green Published, gold			2022-12-26	WOS:000356353700091
J	Chien, KL; Hsu, HC; Chen, PC; Lin, HJ; Su, TC; Chen, MF; Lee, YT				Chien, Kuo-Liong; Hsu, Hsiu-Ching; Chen, Pei-Chun; Lin, Hung-Ju; Su, Ta-Chen; Chen, Ming-Fong; Lee, Yuan-Teh			Total 25-Hydroxyvitamin D Concentration as a Predictor for All-Cause Death and Cardiovascular Event Risk among Ethnic Chinese Adults: A Cohort Study in a Taiwan Community	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; OPERATING CHARACTERISTIC CURVES; SERUM; DISEASE; MORTALITY; MODELS; ASSOCIATION; POPULATION; DENSITY; HEALTH	Background Evidence of an inverse association between serum 25-hydoroxyvitamin D [25(OH) D] and the risk of all-cause death and cardiovascular disease from prospective studies is inconsistent. We tested the relationship between 25(OH) D and the risk among adult ethnic Chinese in Taiwan. Methods We conducted a community-based cohort study of 1816 participants (age 60.2 +/- 10.2 yrs, 45.0% women) in the Chin-Shan Community Cardiovascular Cohort Study who were free of cardiovascular diseases at baseline and provided 25(OH) D measurements. Results During a median 9.6 (interquartile range, 8.8-10.5) years' follow-up period, totally 263 cases developed cardiovascular death events and 559 participants were documented to death from any cause. As 25(OH) D concentration increased, the incidence rates of cardiovascular events and all-cause death decreased progressively. 25(OH) D was inversely associated with all-cause death: the adjusted hazard ratio was 0.49 (95% confidence interval [CI], 0.25-0.97) for the third quartile and a significant J-shape relationship was found. The performance measures by integrated discriminative improvement showed significant improvement after adding 25(OH) D information (0.14%, 95% CI, 0.03-0.31, P=0.050, for all-cause death and 0.32%, 95% CI, 0.02-0.62, P=0.018 for cardiovascular events). Conclusion These findings suggested a modest inverse association between 25(OH)D and the risk of all-cause death among diabetic participants and a good predictive factor in the community. Further studies to investigate the mechanism of vitamin D role on health effect are warranted.	[Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chien, Kuo-Liong; Hsu, Hsiu-Ching; Lin, Hung-Ju; Su, Ta-Chen; Chen, Ming-Fong; Lee, Yuan-Teh] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Pei-Chun] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuang, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chang Gung University	Chien, KL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	klchien@ntu.edu.tw	Chen, Ming/GVU-8412-2022	Chen, Pei-Chun/0000-0002-8713-8816; CHIEN, KUO-LIONG/0000-0003-4979-8351; SU, TA-CHEN/0000-0001-7523-7166	National Science Council [NSC 102-2314-B-002 -080 -MY2, NSC 100-2314-B-002 -113 -MY3, NSC 100-2923-I-002-001-MY2]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was partly supported by National Science Council (NSC 102-2314-B-002 -080 -MY2, NSC 100-2314-B-002 -113 -MY3, and NSC 100-2923-I-002-001-MY2).	Brandenburg VM, 2012, ATHEROSCLEROSIS, V225, P253, DOI 10.1016/j.atherosclerosis.2012.08.005; Chien KL, 2005, ATHEROSCLEROSIS, V183, P147, DOI 10.1016/j.atherosclerosis.2005.01.018; Chien KL, 1999, CLIN CHEM, V45, P838; Chien KL, 2012, INT J CARDIOL, V157, P263, DOI 10.1016/j.ijcard.2012.03.017; Chien KL, 2010, STROKE, V41, P1858, DOI 10.1161/STROKEAHA.110.586222; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Formiga F, 2013, GERONTOLOGY; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Govindarajulu US, 2007, STAT MED, V26, P3735, DOI 10.1002/sim.2848; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HERNDON JE, 1995, STAT MED, V14, P2119, DOI 10.1002/sim.4780141906; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2005, NEW ENGL J MED, V352, P515; Hosmer DW, 1989, APPL LOG REGRESS, V1, P25; Jassal SK, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2010.07.013; Judd SE, 2008, AM J CLIN NUTR, V87, P136, DOI 10.1093/ajcn/87.1.136; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lee MS, 2008, ASIA PAC J CLIN NUTR, V17, P397; Lee YT, 2000, J CLIN EPIDEMIOL, V53, P838, DOI 10.1016/S0895-4356(00)00198-0; Liu LJ, 2012, AM J CARDIOL, V110, P834, DOI 10.1016/j.amjcard.2012.05.013; McGeechan K, 2008, ARCH INTERN MED, V168, P2304, DOI 10.1001/archinte.168.21.2304; Muscogiuri G, 2012, NUTR METAB CARDIOVAS, V22, P81, DOI 10.1016/j.numecd.2011.11.001; Nimptsch K, 2012, CLIN ENDOCRINOL, V77, P106, DOI 10.1111/j.1365-2265.2012.04332.x; Norman AW, 2008, AM J CLIN NUTR, V88, P1455, DOI 10.3945/ajcn.2008.27049; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Riek AE, 2010, J STEROID BIOCHEM, V121, P430, DOI 10.1016/j.jsbmb.2010.03.018; Rohrmann S, 2013, NUTR METAB CARDIOVAS; Schierbeck LL, 2012, EUR J ENDOCRINOL, V167, P553, DOI 10.1530/EJE-12-0283; Tsai KS, 1997, BONE, V20, P371, DOI 10.1016/S8756-3282(97)00010-0; WIELAND H, 1983, J LIPID RES, V24, P904; Wielders JPM, 2009, CLIN CHEM, V55, P1584, DOI 10.1373/clinchem.2008.117366; Zhao GX, 2012, J HYPERTENS, V30, P284, DOI 10.1097/HJH.0b013e32834e1f0a; Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	39	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0123097	10.1371/journal.pone.0123097	http://dx.doi.org/10.1371/journal.pone.0123097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807387	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000232
J	Duinhouwer, LE; Tuysuz, N; Rombouts, EWJC; ter Borg, MND; Mastrobattista, E; Spanholtz, J; Cornelissen, JJ; ten Berge, D; Braakman, E				Duinhouwer, Lucia E.; Tuysuz, Nesrin; Rombouts, Elwin W. J. C.; ter Borg, Mariette N. D.; Mastrobattista, Enrico; Spanholtz, Jan; Cornelissen, Jan J.; ten Berge, Derk; Braakman, Eric			Wnt3a Protein Reduces Growth Factor-Driven Expansion of Human Hematopoietic Stem and Progenitor Cells in Serum-Free Cultures	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; ARYL-HYDROCARBON RECEPTOR; IN-VIVO; SELF-RENEWAL; WNT/BETA-CATENIN; UNRELATED DONORS; CD34(+) CELLS; BONE-MARROW; TRANSPLANTATION; REPOPULATION	Ex vivo expansion of hematopoietic stem and progenitor cells (HSPC) is a promising approach to improve insufficient engraftment after umbilical cord blood stem cell transplantation (UCB-SCT). Although culturing HSPC with hematopoietic cytokines results in robust proliferation, it is accompanied with extensive differentiation and loss of self-renewal capacity. Wnt signaling has been implicated in regulating HSPC fate decisions in vivo and in promoting HSPC self-renewal by inhibition of differentiation, but the effects of Wnt on the ex vivo expansion of HSPC are controversial. Here, we demonstrate that exogenous Wnt3a protein suppresses rather than promotes the expansion of UCB-derived CD34(+) cells in serum free expansion cultures. The reduced expansion was also observed in cultures initiated with Lin(-)CD34(+)CD38(low)CD45RA(-)CD90(+) cells which are highly enriched in HSC and was also observed in response to activation of beta-catenin signaling by GSK3 inhibition. The presence of Wnt3a protein during the culture reduced the frequency of multilineage CFU-GEMM and the long-term repopulation ability of the expanded HSPC. These data suggest that Wnt signaling reduces expansion of human HSPC in growth factor-driven expansion cultures by promoting differentiation of HSPC.	[Duinhouwer, Lucia E.; Rombouts, Elwin W. J. C.; ter Borg, Mariette N. D.; Cornelissen, Jan J.; Braakman, Eric] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [Tuysuz, Nesrin; ten Berge, Derk] Erasmus Univ, Med Ctr, Erasmus MC Stem Cell Inst, Rotterdam, Netherlands; [Mastrobattista, Enrico] Univ Utrecht, Inst Pharmaceut Sci, Utrecht, Netherlands; [Spanholtz, Jan] Glycostem, Oss, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Utrecht University	Braakman, E (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands.	e.braakman@erasmusmc.nl	Berge, Derk ten/ABF-2591-2020; Berge, Derk ten/C-1967-2012; Mastrobattista, Enrico/O-6670-2016	Berge, Derk ten/0000-0002-5863-0860; Mastrobattista, Enrico/0000-0002-6745-2015; Spanholtz, Jan/0000-0001-7152-6956	TI Pharma [D5-402]	TI Pharma	This work was supported by a grant from TI Pharma and performed within the framework of the TIPharma Project D5-402: The Prograft Study: optimizing the applicability of stem cell therapy The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; de Lima M, 2012, NEW ENGL J MED, V367, P2305, DOI 10.1056/NEJMoa1207285; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Duchez P, 2012, CELL TRANSPLANT, V21, P2517, DOI 10.3727/096368911X637425; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Fuerer C, 2010, DEV DYNAM, V239, P184, DOI 10.1002/dvdy.22067; Gasiewicz TA, 2010, CHEM-BIOL INTERACT, V184, P246, DOI 10.1016/j.cbi.2009.10.019; Glimm H, 1999, BLOOD, V94, P2161, DOI 10.1182/blood.V94.7.2161.419k32_2161_2168; Goff JP, 1998, BLOOD, V92, P4098, DOI 10.1182/blood.V92.11.4098.423k28_4098_4107; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Iscove NN, 1997, CURR BIOL, V7, P805, DOI 10.1016/S0960-9822(06)00341-1; Ivanovic Z, 2011, CELL TRANSPLANT, V20, P1453, DOI 10.3727/096368910X552853; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Ming M, 2012, J BIOL CHEM, V287, P22683, DOI 10.1074/jbc.M112.342089; Morrell NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002930; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Ng YY, 2004, J LEUKOCYTE BIOL, V75, P314, DOI 10.1189/jlb.0603287; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Sato MM, 2009, GENES CELLS, V14, P141, DOI 10.1111/j.1365-2443.2008.01258.x; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Singh KP, 2009, CARCINOGENESIS, V30, P11, DOI 10.1093/carcin/bgn224; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Wagner JE, 2013, 55 ASH ANN M EXP DEC; Walasek MA, 2012, ANN NY ACAD SCI, V1266, P138, DOI 10.1111/j.1749-6632.2012.06549.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao L, 2009, METHOD ENZYMOL, V465, P331, DOI 10.1016/S0076-6879(09)65017-5	44	11	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119086	10.1371/journal.pone.0119086	http://dx.doi.org/10.1371/journal.pone.0119086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807521	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000017
J	Essa, MM; Subash, S; Akbar, M; Al-Adawi, S; Guillemin, GJ				Essa, Musthafa Mohamed; Subash, Selvaraju; Akbar, Mohammed; Al-Adawi, Samir; Guillemin, Gilles J.			Long-Term Dietary Supplementation of Pomegranates, Figs and Dates Alleviate Neuroinflammation in a Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							PHOENIX-DACTYLIFERA L.; FICUS-CARICA L.; ANTIOXIDANT ACTIVITY; IN-VITRO; COGNITIVE DECLINE; HEPATOPROTECTIVE ACTIVITY; ANTIINFLAMMATORY DRUGS; INFLAMMATORY PROTEINS; OXIDATIVE STRESS; LEAF EXTRACT	Alzheimer's disease (AD) is a devastating age-related neurodegenerative disease with no specific treatment at present. The APPsw/Tg2576 mice exhibit age-related deterioration in memory and learning as well as amyloid-beta (AP) accumulation, and this mouse strain is considered an effective model for studying the mechanism of accelerated brain aging and senescence. The present study was aimed to investigate the beneficial effects of dietary supplements pomegranate, figs, or the dates on suppressing inflammatory cytokines in APP5w/Tg2576 mice. Changes in the plasma cytokines and A beta, ATP, and inflammatory cytokines were investigated in the brain of transgenic mice. Significantly enhanced levels of inflammatory cytokines IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, TNF-alpha and Eotaxin activity were decreased by administration of the diet supplements containing pomegranates, figs, or dates. In addition, putative delays in the formation of senile plaques, as indicated by a decreasing tendency of brain A beta 1-40 and A beta 1-42 contents, were observed. Thus, novel results mediated by reducing inflammatory cytokines during aging may represent one mechanism by which these supplements exert their beneficial effects against neurodegenerative diseases such as AD.	[Essa, Musthafa Mohamed; Subash, Selvaraju] Sultan Qaboos Univ, Dept Food Sci & Nutr, Coll Agr & Marine Sci, Muscat, Oman; [Essa, Musthafa Mohamed; Subash, Selvaraju; Al-Adawi, Samir] Sultan Qaboos Univ, Ageing & Dementia Res Grp, Muscat, Oman; [Essa, Musthafa Mohamed; Guillemin, Gilles J.] Macquarie Univ, Neuropharmacol Grp, MND & Neurodegenerat Dis Res Ctr, Sydney, NSW 2109, Australia; [Akbar, Mohammed] NIAAA, Sect Mol Pharmacol & Toxicol, Lab Membrane Biochem & Biophys, NIH, Rockville, MD 20852 USA; [Al-Adawi, Samir] Sultan Qaboos Univ, Coll Med & Hlth Sci, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University; Macquarie University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Sultan Qaboos University	Essa, MM (corresponding author), Sultan Qaboos Univ, Dept Food Sci & Nutr, Coll Agr & Marine Sci, Muscat, Oman.	drmdessa@squ.edu.om	Al-Adawi, Samir/A-9663-2016; Essa, Mohamed/AAX-2596-2020; Guillemin, Gilles J/C-3878-2015; Selvaraju, Subash/GVS-0905-2022	Al-Adawi, Samir/0000-0002-9858-5582; Guillemin, Gilles J/0000-0001-8105-4470; Selvaraju, Subash/0000-0003-1691-1581; Musthafa Mohamed, Essa/0000-0001-7505-9785	Research Council of Oman [RC/AGR/FOOD/11/01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a Research grant from the Research Council of Oman (RC/AGR/FOOD/11/01) to MME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Farsi M, 2005, J AGR FOOD CHEM, V53, P7586, DOI 10.1021/jf050578y; Al-Farsi M, 2006, 3 INT DAT PALM C, P19; Al-Qarawi AA, 2008, PHARM BIOL, V46, P227, DOI 10.1080/13880200701739322; ALJANE F, 2009, JORDAN J AGR SCI, V5, P1; Allaith AAA, 2008, INT J FOOD SCI TECH, V43, P1033, DOI 10.1111/j.1365-2621.2007.01558.x; Alturki Saleh M., 2013, Asian Journal of Plant Sciences, V12, P119, DOI 10.3923/ajps.2013.119.127; Aref HL, 2010, PAK J PHARM SCI, V23, P53; Asgary S, 2014, PHYTOTHER RES, V28, P193, DOI 10.1002/ptr.4977; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Biglari F, 2008, FOOD CHEM, V107, P1636, DOI 10.1016/j.foodchem.2007.10.033; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; Braidy N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/685909; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Canal J. R., 2000, Acta Physiologica Hungarica, V87, P71, DOI 10.1556/APhysiol.87.2000.1.8; Celik F, 2013, EUR REV MED PHARMACO, V17, P2988; Cosentino SA, 2010, ARCH NEUROL-CHICAGO, V67, P1485, DOI 10.1001/archneurol.2010.189; de Oliveira JFF, 2013, INFLAMM RES, V62, P971, DOI 10.1007/s00011-013-0659-3; Dik MG, 2005, NEUROLOGY, V64, P1371, DOI 10.1212/01.WNL.0000158281.08946.68; Dillard CJ, 2000, J SCI FOOD AGR, V80, P1744, DOI [10.1002/1097-0010(20000915)80:12<1744::AID-JSFA725>3.0.CO;2-W, 10.1002/1097-0010(20000915)80:12&lt;1744::AID-JSFA725&gt;3.0.CO;2-W]; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; El-Mougy S.A., 1991, ALEX J PHARM SCI, V5, P156; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Essa MM, 2010, ANTIAMYLOIDOGENIC EF, P397; Essa MM, 2012, NEUROCHEM RES, V37, P1829, DOI 10.1007/s11064-012-0799-9; Fagarasan MO, 1996, BRAIN RES, V723, P231, DOI 10.1016/0006-8993(96)00259-4; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Funakoshi-Tago M, ANTIINFLAMMATORY ACT; Gamil-Abdel-Hafez M, 1980, 4 S BIOL ASP SAUD AR, P89; Gilani AH, 2008, J ETHNOPHARMACOL, V119, P1, DOI 10.1016/j.jep.2008.05.040; Gond NY, 2008, INDIAN J PHARM SCI, V70, P364, DOI 10.4103/0250-474X.43003; Gonzalez-Molina E, 2009, FOOD CHEM, V115, P1364, DOI 10.1016/j.foodchem.2009.01.056; GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276; Haas HS, 1997, PROG NEUROBIOL, V51, P195, DOI 10.1016/S0301-0082(96)00055-X; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; HUELL M, 1995, ACTA NEUROPATHOL, V89, P544; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Ishurd O, 2005, CARBOHYD POLYM, V59, P531, DOI 10.1016/j.carbpol.2004.11.004; Jbir R, 2008, SCI HORTIC-AMSTERDAM, V115, P231, DOI 10.1016/j.scienta.2007.09.002; Jing P, 2012, FOOD CHEM, V132, P1457, DOI 10.1016/j.foodchem.2011.12.002; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kelawala NS, 2004, INT J FOOD SCI NUTR, V55, P511, DOI 10.1080/09637480400015794; Khadabadi SS., 2007, INDIAN DRUGS, V44, P54; Kislev ME, 2006, SCIENCE, V312, P1372, DOI 10.1126/science.1125910; Krishna Mohan G, 2007, DARU, V15, P162; Kritikar K. D., 1986, INDIAN MED PLANTS, P2329; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Laske C, 2010, J ALZHEIMERS DIS, V21, P1263, DOI 10.3233/JAD-2010-100510; Loren DJ, 2005, PEDIATR RES, V57, P858, DOI 10.1203/01.PDR.0000157722.07810.15; Mansouri A, 2005, FOOD CHEM, V89, P411, DOI 10.1016/j.foodchem.2004.02.051; Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Melgarejo P, 2009, SCI HORTIC-AMSTERDAM, V120, P500, DOI 10.1016/j.scienta.2008.12.013; Mohamad S, 2011, J ETHNOPHARMACOL, V133, P1021, DOI 10.1016/j.jep.2010.11.037; Murray CA, 1998, J NEUROSCI, V18, P2974; Muthaiyah B, 2011, NEUROCHEM RES, V36, P2096, DOI 10.1007/s11064-011-0533-z; Neyrinck AM, 2013, BRIT J NUTR, V109, P802, DOI 10.1017/S0007114512002206; Patel D, APIGENIN CANC CHEMOP; Patil VV, 2010, INT J PHARM SCI REV, V2; Patil VV., 2010, INT J PHARM SCI REV, V2, P48; PATTERSON PH, 1995, CURR OPIN NEUROBIOL, V5, P642, DOI 10.1016/0959-4388(95)80070-0; Perez C, 1999, PHYTOTHER RES, V13, P188, DOI 10.1002/(SICI)1099-1573(199905)13:3&lt;188::AID-PTR411&gt;3.0.CO;2-P; Puri A, 2000, J ETHNOPHARMACOL, V71, P89, DOI 10.1016/S0378-8741(99)00181-6; Rainero I, 2004, NEUROBIOL AGING, V25, P1293, DOI 10.1016/j.neurobiolaging.2004.02.011; Richter G, 2002, BRIT J HAEMATOL, V119, P1042, DOI 10.1046/j.1365-2141.2002.03954.x; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Rojanathammanee L, 2013, J NUTR, V143, P597, DOI 10.3945/jn.112.169516; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Rubnov S, 2001, J NAT PROD, V64, P993, DOI 10.1021/np000592z; Saafi EB, 2011, EXP TOXICOL PATHOL, V63, P433, DOI 10.1016/j.etp.2010.03.002; Salah A., 2005, J KING SAUD U, V17, P117; SALLAL AKJ, 1989, MICROBIOS, V59, P203; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Shraideh ZA, 1998, MYCOPATHOLOGIA, V142, P119, DOI 10.1023/A:1006901019786; Shukla M, 2008, NUTRITION, V24, P733, DOI 10.1016/j.nut.2008.03.013; Solomon A, 2006, J AGR FOOD CHEM, V54, P7717, DOI 10.1021/jf060497h; Solomon A, 2010, J AGR FOOD CHEM, V58, P7158, DOI 10.1021/jf100153z; Solomon A, 2010, J AGR FOOD CHEM, V58, P6660, DOI 10.1021/jf100122a; STRAUSS S, 1992, LAB INVEST, V66, P223; Subash M, 2014, NUTR NEUROSCIENCE; Subash S, 2014, NUTR NEUROS IN PRESS; Subash S., 2014, NUTR NEUROSCIENCE; Subash S, 2014, FASEB J, V28, P845; Subash S, 2013, FASEB J S, V28; Subash Selvaraju, 2014, J Tradit Complement Med, V4, P232, DOI 10.4103/2225-4110.139107; Subash S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/546357; Tezcan F, 2009, FOOD CHEM, V115, P873, DOI 10.1016/j.foodchem.2008.12.103; Tota S, 2010, BEHAV BRAIN RES, V209, P73, DOI 10.1016/j.bbr.2010.01.017; van Gool WA, 2003, J NEUROL, V250, P788, DOI 10.1007/s00415-003-1146-5; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Vayalil PK, 2002, J AGR FOOD CHEM, V50, P610, DOI 10.1021/jf010716t; Veberic R, 2008, FOOD CHEM, V106, P153, DOI 10.1016/j.foodchem.2007.05.061; Vinson JA, 1998, J AGR FOOD CHEM, V46, P3630, DOI 10.1021/jf980295o; Vinson JA, 2005, J AM COLL NUTR, V24, P44, DOI 10.1080/07315724.2005.10719442; Vinson JA, 1999, CEREAL FOOD WORLD, V44, P82; Wang Guiting, 2004, Zhong Yao Cai, V27, P754; Wang LJ, 2003, ACTA HORTIC, P191; Weiss E, 2006, SCIENCE, V312, P1608, DOI 10.1126/science.1127235; Winand J, 2014, FOOD FUNCT, V5, P310, DOI 10.1039/c3fo60443h; Xu Jing, 2005, Zhonghua Yufang Yixue Zazhi, V39, P80; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yancheva SD, 2005, PLANT SCI, V168, P1433, DOI 10.1016/j.plantsci.2004.12.007; Zhang LH, 2011, FOOD CHEM, V127, P1444, DOI 10.1016/j.foodchem.2011.01.077; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	109	57	60	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120964	10.1371/journal.pone.0120964	http://dx.doi.org/10.1371/journal.pone.0120964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807081	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000118
J	Gupta, N; Christiansen, CS; Hallman, DM; Korshoj, M; Carneiro, IG; Holtermann, A				Gupta, Nidhi; Christiansen, Caroline Stordal; Hallman, David M.; Korshoj, Mette; Carneiro, Isabella Gomes; Holtermann, Andreas			Is Objectively Measured Sitting Time Associated with Low Back Pain? A Cross-Sectional Investigation in the NOMAD study	PLOS ONE			English	Article							PHYSICAL RISK-FACTORS; WORK-ENVIRONMENT; LEISURE-TIME; LIFE-STYLE; PSYCHOSOCIAL FACTORS; SEDENTARY BEHAVIOR; UNITED-STATES; POPULATION; VALIDITY; PREVALENCE	Background Studies on the association between sitting time and low back pain (LBP) have found contrasting results. This may be due to the lack of objectively measured sitting time or because socioeconomic confounders were not considered in the analysis. Objectives To investigate the association between objectively measured sitting time (daily total, and occupational and leisure-time periods) and LBP among blue-collar workers. Methods Two-hundred-and-one blue-collar workers wore two accelerometers (GT3X+ Actigraph) for up to four consecutive working days to obtain objective measures of sitting time, estimated via Acti4 software. Workers reported their LBP intensity the past month on a scale from 0 (no pain) to 9 (worst imaginable pain) and were categorized into either low (<= 5) or high (>5) LBP intensity groups. In the multivariate-adjusted binary logistic regression analysis, total sitting time, and occupational and leisure-time sitting were both modeled as continuous (hours/day) and categorical variables (i.e. low, moderate and high sitting time). Results The multivariate logistic regression analysis showed a significant positive association between total sitting time (per hour) and high LBP intensity (odds ratio; OR=1.43, 95% CI=1.15-1.77, P=0.01). Similar results were obtained for leisure-time sitting (OR=1.45, 95% CI=1.10-1.91, P=0.01), and a similar but non-significant trend was obtained for occupational sitting time (OR=1.34, 95% CI 0.99-1.82, P= 0.06). In the analysis on categorized sitting time, high sitting time was positively associated with high LBP for total (OR=3.31, 95% CI=1.18-9.28, P=0.03), leisure (OR=5.31, 95% CI=1.57-17.90, P=0.01), and occupational (OR=3.26, 95% CI=0.89-11.98, P=0.08) periods, referencing those with low sitting time. Conclusion Sitting time is positively associated with LBP intensity among blue-collar workers. Future studies using a prospective design with objective measures of sitting time are recommended.	[Gupta, Nidhi; Christiansen, Caroline Stordal; Korshoj, Mette; Carneiro, Isabella Gomes; Holtermann, Andreas] Natl Res Ctr Working Environm, Dept Musculoskeletal Disorders, Copenhagen, Denmark; [Hallman, David M.] Univ Gavle, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden	National Research Centre for the Working Environment; University of Gavle	Gupta, N (corresponding author), Natl Res Ctr Working Environm, Dept Musculoskeletal Disorders, Copenhagen, Denmark.	ngu@nrcwe.dk			internal funding from Federal Institute for Occupational Safety and Health (BAuA), Berlin, Germany; National Research Centre for the Working Environment (NRCWE), Copenhagen, Denmark	internal funding from Federal Institute for Occupational Safety and Health (BAuA), Berlin, Germany; National Research Centre for the Working Environment (NRCWE), Copenhagen, Denmark	This study was supported by the internal funding from Federal Institute for Occupational Safety and Health (BAuA), Berlin, Germany and The National Research Centre for the Working Environment (NRCWE), Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affuso O, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-2; Andersen LL, 2012, INT ARCH OCC ENV HEA, V85, P615, DOI 10.1007/s00420-011-0709-5; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Balogh I, 2004, APPL ERGON, V35, P49, DOI 10.1016/j.apergo.2003.06.001; Beach Tyson A C, 2005, Spine J, V5, P145, DOI 10.1016/j.spinee.2004.07.036; Bennie JA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-107; Bjorck-van Dijken C, 2008, J REHABIL MED, V40, P864, DOI 10.2340/16501977-0273; Burdorf A, 1997, SCAND J WORK ENV HEA, V23, P243, DOI 10.5271/sjweh.217; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Chen SM, 2009, INT ARCH OCC ENV HEA, V82, P797, DOI 10.1007/s00420-009-0410-0; Clark BK, 2011, MED SCI SPORT EXER, V43, P1907, DOI 10.1249/MSS.0b013e31821820a2; Clemes SA, 2012, J PHYS ACT HEALTH, V9, P533, DOI 10.1123/jpah.9.4.533; Corlett EN, 2006, ERGONOMICS, V49, P1538, DOI 10.1080/00140130600766261; COSTE J, 1994, BRIT MED J, V308, P577, DOI 10.1136/bmj.308.6928.577; Croft PR, 1999, SPINE, V24, P1556, DOI 10.1097/00007632-199908010-00009; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; DAMKOT DK, 1984, SPINE, V9, P395, DOI 10.1097/00007632-198405000-00012; Eatough EM, 2012, APPL ERGON, V43, P554, DOI 10.1016/j.apergo.2011.08.009; Ekholm O, 2006, SUNDHED SYGELIGHED D; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Hamberg-van Reenen HH, 2007, PAIN, V130, P93, DOI 10.1016/j.pain.2006.11.004; Hartvigsen J, 2004, OCCUP ENVIRON MED, V61; Hartvigsen J, 2000, SCAND J PUBLIC HEALT, V28, P230, DOI 10.1177/14034948000280030201; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2010, REV ESP CARDIOL, V63, P261, DOI 10.1016/S0300-8932(10)70083-X; Hesketh KR, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-1; Hildebrandt VH, 2000, INT ARCH OCC ENV HEA, V73, P507, DOI 10.1007/s004200000167; Hooftman WE, 2004, SCAND J WORK ENV HEA, V30, P261, DOI 10.5271/sjweh.794; Hoogendoorn WE, 2002, OCCUP ENVIRON MED, V59, P323, DOI 10.1136/oem.59.5.323; Jansen JP, 2004, OCCUP ENVIRON MED, V61, P972, DOI 10.1136/oem.2003.012245; Jones GT, 2003, PEDIATRICS, V111, P822, DOI 10.1542/peds.111.4.822; Jorgensen MB, 2013, SPINE, V38, pE359, DOI 10.1097/BRS.0b013e31828435d4; Juul-Kristensen B, 2004, SCAND J WORK ENV HEA, V30, P390, DOI 10.5271/sjweh.827; Kong PW, 2010, IFMBE P, V31; Korshoj M, 2014, ERGONOMICS, V57, P247, DOI 10.1080/00140139.2013.869358; Krapac L., 1994, Arhiv za Higijenu Rada i Toksikologiju, V45, P341; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Lagersted-Olsen J, 2014, INT J SPORTS MED, V35, P534, DOI 10.1055/s-0033-1358467; Leboeuf-Yde C, 2004, J ELECTROMYOGR KINES, V14, P129, DOI 10.1016/j.jelekin.2003.09.019; LEE YH, 1994, J SAFETY RES, V25, P135, DOI 10.1016/0022-4375(94)90070-1; Levangie PK, 1999, PHYS THER, V79, P757, DOI 10.1093/ptj/79.8.757; LINTON SJ, 1990, WORK STRESS, V4, P41, DOI 10.1080/02678379008256963; Linton SJ, 2001, J OCCUP REHABIL, V11, P53, DOI 10.1023/A:1016656225318; Lis AM, 2007, EUR SPINE J, V16, P283, DOI 10.1007/s00586-006-0143-7; Lunde LK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1075; Macfarlane GJ, 1997, SPINE, V22, P1143, DOI 10.1097/00007632-199705150-00015; MAGORA A, 1975, SCAND J REHABIL MED, V7, P146; MASSET D, 1994, SPINE, V19, P143, DOI 10.1097/00007632-199401001-00004; Mathiassen SE, 2006, APPL ERGON, V37, P419, DOI 10.1016/j.apergo.2006.04.006; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; McGill SM, 2000, ERGONOMICS, V43, P486, DOI 10.1080/001401300184369; Merrill RM, 2011, PRINCIPLES EPIDEMIOL; Meucci RD, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-155; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Nourbakhsh MR, 2001, J SPINAL DISORD, V14, P283, DOI 10.1097/00002517-200108000-00002; Omokhodion FO, 2003, OCCUP MED-OXFORD, V53, P287, DOI 10.1093/occmed/kqg063; Ozguler A, 2000, J EPIDEMIOL COMMUN H, V54, P215, DOI 10.1136/jech.54.3.215; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Petersen CB, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-13; PIETRI F, 1992, SCAND J WORK ENV HEA, V18, P52, DOI 10.5271/sjweh.1614; Pincus T, 2008, ARTHRIT RHEUM-ARTHR, V59, P14, DOI 10.1002/art.23251; Pope MH, 2002, ANNU REV BIOMED ENG, V4, P49, DOI 10.1146/annurev.bioeng.4.092101.122107; RIIHIMAKI H, 1991, SCAND J WORK ENV HEA, V17, P81, DOI 10.5271/sjweh.1728; Roffey DM, 2010, SPINE J, V10, P89, DOI 10.1016/j.spinee.2009.09.003; ROTGOLTZ J, 1992, ISRAEL J MED SCI, V28, P615; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Schuna JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-126; Sjolie AN, 2004, SPINE, V29, P2452, DOI 10.1097/01.brs.0000143666.58758.8b; Skotte J, 2014, J PHYS ACT HEALTH, V11, P76, DOI 10.1123/jpah.2011-0347; Skov T, 1996, OCCUP ENVIRON MED, V53, P351, DOI 10.1136/oem.53.5.351; Spittaels H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-149; Spyropoulos Panagiotis, 2007, Pain Physician, V10, P651; Strijk JE, 2012, J EPIDEMIOL COMMUN H, V66, P1071, DOI 10.1136/jech-2011-200626; SVENSSON HO, 1989, SPINE, V14, P517, DOI 10.1097/00007632-198905000-00008; Szpalski M, 2002, EUR SPINE J, V11, P459, DOI 10.1007/s00586-002-0385-y; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; Vandelanotte C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1110; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Vingard E, 2000, SPINE, V25, P493, DOI 10.1097/00007632-200002150-00017; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wai EK, 2008, SPINE J, V8, P195, DOI 10.1016/j.spinee.2007.10.024; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; WALSH K, 1989, SCAND J WORK ENV HEA, V15, P54, DOI 10.5271/sjweh.1891; Xu Y, 1997, OCCUP ENVIRON MED, V54, P741, DOI 10.1136/oem.54.10.741; Yip VYB, 2004, J ADV NURS, V46, P430, DOI 10.1111/j.1365-2648.2004.03009.x; Yue Pengying, 2012, BMC Public Health, V12, P789, DOI 10.1186/1471-2458-12-789	87	64	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121159	10.1371/journal.pone.0121159	http://dx.doi.org/10.1371/journal.pone.0121159			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806808	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000132
J	van der Starre, WE; van Nieuwkoop, C; Thomson, U; Zijderveld-Voshart, MSM; Koopman, JPR; van der Reijden, TJK; van Dissel, JT; van de Vosse, E				van der Starre, Willize E.; van Nieuwkoop, Cees; Thomson, Uginia; Zijderveld-Voshart, Marleen S. M.; Koopman, Jan Pieter R.; van der Reijden, Tanny J. K.; van Dissel, Jaap T.; van de Vosse, Esther			Urinary Proteins, Vitamin D and Genetic Polymorphisms as Risk Factors for Febrile Urinary Tract Infection and Relation with Bacteremia: A Case Control Study	PLOS ONE			English	Article							PARATHYROID-HORMONE LEVELS; TAMM-HORSFALL PROTEIN; ACUTE PYELONEPHRITIS; ESCHERICHIA-COLI; BACTERIAL-INFECTION; CHILDREN; INTERLEUKIN-6; SUSCEPTIBILITY; ASSOCIATION; WOMEN	Objective/Purpose Febrile urinary tract infection (UTI) is a common bacterial disease that may lead to substantial morbidity and mortality especially among the elderly. Little is known about biomarkers that predict a complicated course. Our aim was to determine the role of certain urinary cytokines or antimicrobial proteins, plasma vitamin D level, and genetic variation in host defense of febrile UTI and its relation with bacteremia. Methods A case-control study. Out of a cohort of consecutive adults with febrile UTI (n = 787) included in a multi-center observational cohort study, 46 cases with bacteremic E. coli UTI and 45 cases with non-bacteremic E. coli UTI were randomly selected and compared to 46 controls. Urinary IL-6, IL-8, LL37, beta-defensin 2 and uromodulin as well as plasma 25-hydroxyvitamin D were measured. In 440 controls and 707 UTI patients polymorphisms were genotyped in the genes CXCR1, DEFA4, DEFB1, IL6, IL8, MYD88, UMOD, TIRAP, TLR1, TLR2, TLR5 and TNF. Results IL-6, IL-8, and LL37 are different between controls and UTI patients, although these proteins do not distinguish between patients with and without bacteremia. While uromodulin did not differ between groups, inability to produce uromodulin is more common in patients with bacteremia. Most participants in the study, including the controls, had insufficient vitamin D and, at least in winter, UTI patients have lower vitamin D than controls. Associations were found between the CC genotype of IL6 SNP rs1800795 and occurrence of bacteremia and between TLR5 SNP rs5744168 and protection from UTI. The rare GG genotype of IL6 SNP rs1800795 was associated with higher beta-defensin 2 production. Conclusion Although no biomarker was able to distinguish between UTI with or without bacteremia, two risk factors for bacteremia were identified. These were inability to produce uromodulin and an IL6 rs1800795 genotype.	[van der Starre, Willize E.; van Nieuwkoop, Cees; Thomson, Uginia; Zijderveld-Voshart, Marleen S. M.; Koopman, Jan Pieter R.; van der Reijden, Tanny J. K.; van Dissel, Jaap T.; van de Vosse, Esther] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [van Nieuwkoop, Cees] Haga Hosp, Dept Internal Med, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital	van de Vosse, E (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	E.van_de_Vosse@LUMC.nl	van de Vosse, Esther/HDO-0723-2022; van de Vosse, Esther/B-7285-2009	van de Vosse, Esther/0000-0001-5199-3426; van Nieuwkoop, Cees/0000-0003-0734-0844; Koopman, Jan Pieter/0000-0003-1335-9402	Bronovo research fund; Stichting Franje 1 fonds	Bronovo research fund; Stichting Franje 1 fonds	Support was provided by Bronovo research fund (no grant number), [www.bronovo.nl/vrienden-van-bronovo/projecten/onderzoek] to JD and Stichting Franje 1 fonds (no grant number) to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan S, 2012, PEDIATR NEPHROL, V27, P417, DOI 10.1007/s00467-011-2000-0; Borella E, 2014, ANN NY ACAD SCI, V1317, P76, DOI 10.1111/nyas.12321; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Chromek M, 2008, J MOL MED, V86, P37, DOI 10.1007/s00109-007-0256-4; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Hawn TR, 2009, PLOS ONE, V4, pe5990, DOI DOI 10.1371/J0U; HEDGES S, 1992, J INFECT DIS, V166, P653, DOI 10.1093/infdis/166.3.653; Hertting O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015580; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Javor J, 2014, FOLIA MICROBIOL, V59, P307, DOI 10.1007/s12223-014-0303-9; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; KO YC, 1993, INFECT IMMUN, V61, P1307, DOI 10.1128/IAI.61.4.1307-1314.1993; Kunin CM, 2003, ARCH INTERN MED, V163, P2393, DOI 10.1001/archinte.163.19.2393-b; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Nielsen K, 2014, NORD PSYCHOL, V66, P1, DOI 10.1080/19012276.2014.885764; Nitschke M, 2002, EXP NEPHROL, V10, P332, DOI 10.1159/000065296; Nseir W, 2013, INT J INFECT DIS, V17, pE1121, DOI 10.1016/j.ijid.2013.06.007; Otto G, 1999, J INFECT DIS, V179, P172, DOI 10.1086/314534; Ragnarsdottir B, 2011, NAT REV UROL, V8, P449, DOI 10.1038/nrurol.2011.100; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; REINHART H, 1990, J UROLOGY, V144, P1185, DOI 10.1016/S0022-5347(17)39687-8; Renata Y, 2013, EUR J PEDIATR, V172, P769, DOI 10.1007/s00431-012-1914-2; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Sambrook, 2001, MOL CLONING LAB MANU, V3rd; Scholes D, 2010, J UROLOGY, V184, P564, DOI 10.1016/j.juro.2010.03.139; Sheu JN, 2006, CYTOKINE, V36, P276, DOI 10.1016/j.cyto.2007.02.006; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Tabel Y, 2007, INT J IMMUNOGENET, V34, P399, DOI 10.1111/j.1744-313X.2007.00709.x; Tan CK, 2012, INFECT IMMUN, V80, P3145, DOI 10.1128/IAI.00023-12; TULLUS K, 1994, PEDIATR NEPHROL, V8, P280, DOI 10.1007/BF00866334; Ulett GC, 2013, CURR OPIN MICROBIOL, V16, P100, DOI 10.1016/j.mib.2013.01.005; van Nieuwkoop C, 2010, J INFECTION, V60, P114, DOI 10.1016/j.jinf.2009.11.008; van Nieuwkoop C, 2010, CRIT CARE, V14, DOI 10.1186/cc9328; van Nieuwkoop C, 2010, CLIN INFECT DIS, V50, pE69, DOI 10.1086/652657; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Zakharyan R, 2012, TISSUE ANTIGENS, V80, P136, DOI 10.1111/j.1399-0039.2012.01886.x	41	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121302	10.1371/journal.pone.0121302	http://dx.doi.org/10.1371/journal.pone.0121302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807366	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000144
J	Patel, AX; Burdakov, D				Patel, Ameera X.; Burdakov, Denis			Mechanisms of Gain Control by Voltage-Gated Channels in Intrinsically-Firing Neurons	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SHUNTING INHIBITION; ELECTROPHYSIOLOGICAL PROPERTIES; PYRAMIDAL NEURONS; DOWN-REGULATION; DYNAMIC-CLAMP; CA2+ CHANNELS; K+ CHANNELS; IN-VIVO; RAT	Gain modulation is a key feature of neural information processing, but underlying mechanisms remain unclear. In single neurons, gain can be measured as the slope of the current-frequency (input-output) relationship over any given range of inputs. While much work has focused on the control of basal firing rates and spike rate adaptation, gain control has been relatively unstudied. Of the limited studies on gain control, some have examined the roles of synaptic noise and passive somatic currents, but the roles of voltage-gated channels present ubiquitously in neurons have been less explored. Here, we systematically examined the relationship between gain and voltage-gated ion channels in a conductance-based, tonically-active, model neuron. Changes in expression (conductance density) of voltage-gated channels increased (Ca2+ channel), reduced (K+ channels), or produced little effect (h-type channel) on gain. We found that the gain-controlling ability of channels increased exponentially with the steepness of their activation within the dynamic voltage window (voltage range associated with firing). For depolarization-activated channels, this produced a greater channel current per action potential at higher firing rates. This allowed these channels to modulate gain by contributing to firing preferentially at states of higher excitation. A finer analysis of the current-voltage relationship during tonic firing identified narrow voltage windows at which the gain-modulating channels exerted their effects. As a proof of concept, we show that h-type channels can be tuned to modulate gain by changing the steepness of their activation within the dynamic voltage window. These results show how the impact of an ion channel on gain can be predicted from the relationship between channel kinetics and the membrane potential during firing. This is potentially relevant to understanding input-output scaling in a wide class of neurons found throughout the brain and other nervous systems.	[Patel, Ameera X.] Univ Cambridge, Brain Mapping Unit, Cambridge, England; [Burdakov, Denis] Natl Inst Med Res, MRC, London NW7 1AA, England; [Burdakov, Denis] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England	University of Cambridge; MRC National Institute for Medical Research; University of London; King's College London	Patel, AX (corresponding author), Univ Cambridge, Brain Mapping Unit, Cambridge, England.	ap531@cam.ac.uk		Burdakov, Denis/0000-0002-9134-9165; Patel, Ameera/0000-0002-4157-2705	Wellcome Trust; GSK [085686/Z/08/C]; University of Cambridge MB/PhD Programme; European Research Council; UK Medical Research Council [MC\_UP\_1202/2]; MRC [MC_UP_1202/2] Funding Source: UKRI; Medical Research Council [MC_UP_1202/2] Funding Source: researchfish; The Francis Crick Institute [10055] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); GSK(GlaxoSmithKline); University of Cambridge MB/PhD Programme; European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	Funding: This work was supported by the Wellcome Trust- and GSK-funded TMAT programme (085686/Z/08/C, AXP), the University of Cambridge MB/PhD Programme (AXP), the European Research Council (FP7 starting grant to DB) and the UK Medical Research Council (DB, ref: MC\_UP\_1202/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bowden SEH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0006.2001; Brizzi L, 2004, J PHYSIOL-LONDON, V558, P671, DOI 10.1113/jphysiol.2003.059964; Brown RE, 2002, J NEUROSCI, V22, P8850; Burdakov D, 2005, NEURAL COMPUT, V17, P991, DOI 10.1162/0899766053491841; Burdakov D, 2002, J NEUROSCI, V22, P6380; CETINER M, 1993, BRIT J PHARMACOL, V110, P995, DOI 10.1111/j.1476-5381.1993.tb13912.x; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Davies PJ, 1996, J PHYSIOL-LONDON, V495, P353, DOI 10.1113/jphysiol.1996.sp021599; Deng P, 2005, NEUROSCIENCE, V131, P135, DOI 10.1016/j.neuroscience.2004.11.004; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Fernandez FR, 2010, J NEUROSCI, V30, P230, DOI 10.1523/JNEUROSCI.3995-09.2010; Golowasch J, 2009, J NEUROPHYSIOL, V102, P2161, DOI 10.1152/jn.00160.2009; Graham Lyle J., 2009, V1, P141, DOI 10.1007/978-0-387-89279-5_7; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Holt GR, 1997, NEURAL COMPUT, V9, P1001, DOI 10.1162/neco.1997.9.5.1001; Karnani MM, 2013, J PHYSIOL-LONDON, V591, P933, DOI 10.1113/jphysiol.2012.243493; Kispersky TJ, 2012, J NEUROSCI, V32, P10995, DOI 10.1523/JNEUROSCI.2045-12.2012; Koch Christof, 1999, P1; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Le Bon-Jegoa M, 2007, FRONT NEUROSCI-SWITZ, V1, P123, DOI 10.3389/neuro.01.1.1.009.2007; Li XM, 2007, J NEUROSCI, V27, P5249, DOI 10.1523/JNEUROSCI.0802-07.2007; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; MULLE C, 1986, J NEUROSCI, V6, P2134; Patel AX, 2012, NEURAL COMPUT, V24, P3181, DOI 10.1162/NECO_a_00373; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Prinz AA, 2003, J NEUROSCI, V23, P943; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schweitzer P, 2003, J NEUROSCI, V23, P10884; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shu YS, 2003, J NEUROSCI, V23, P10388; Solsona C, 1998, BIOPHYS J, V74, P1061, DOI 10.1016/S0006-3495(98)74030-5; Sperelakis N, 2011, CELL PHYSL SOURCE BO; Stevens DR, 2001, BEHAV BRAIN RES, V124, P105, DOI 10.1016/S0166-4328(01)00219-4; TRAUB RD, 1977, NEUROSCIENCE, V2, P829, DOI 10.1016/0306-4522(77)90110-5; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; Ulrich D, 2003, EUR J NEUROSCI, V18, P2159, DOI 10.1046/j.1460-9568.2003.02942.x; VANDERMAELEN CP, 1983, BRAIN RES, V289, P109, DOI 10.1016/0006-8993(83)90011-2; Williams RH, 2008, P NATL ACAD SCI USA, V105, P11975, DOI 10.1073/pnas.0802687105; WISGIRDA ME, 1994, P NATL ACAD SCI USA, V91, P2858, DOI 10.1073/pnas.91.7.2858; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Zhang ZW, 2003, J NEUROSCI, V23, P3373	52	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0115431	10.1371/journal.pone.0115431	http://dx.doi.org/10.1371/journal.pone.0115431			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816008	Green Published, gold			2022-12-26	WOS:000352133600003
J	Chen, S; Zhang, M; Xing, LL; Wang, Y; Xiao, YT; Wu, YM				Chen, Sheng; Zhang, Min; Xing, Lili; Wang, Yue; Xiao, Yongtao; Wu, Yeming			HIF-1 alpha Contributes to Proliferation and Invasiveness of Neuroblastoma Cells via SHH Signaling	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; SONIC HEDGEHOG PATHWAY; GROWTH IN-VITRO; BREAST-CANCER; PANCREATIC-CANCER; THERAPEUTIC TARGET; LUNG-CANCER; EXPRESSION; HIF-1; OVEREXPRESSION	The aim of this study was to investigate the effects of hypoxia-inducible factor-1 alpha (HIF-1 alpha) on the proliferation, migration and invasion of neuroblastoma (NB) cells and the mechanisms involved. We here initially used the real-time polymerase chain reaction (real-time PCR), Western blotting and immunohistochemistry (IHC) to detect the expression of HIF-1 alpha and components of the sonic hedgehog (SHH) signaling pathway in NB cells and human specimens. Subsequently, cell proliferation, migration and invasion were analyzed using the cell counting assay, wound healing assay and Transwell system in two types of human NB cell lines, SH-SY5Y and IMR32. In addition, the role of HIF-1 alpha in NB cells growth was determined in a xenograft nude mouse model. We found that the level of HIF-1 alpha was significantly upregulated during NB progression and was associated with the expression of two components of SHH signaling, SHH and GLI1. We next indicated that the proliferation, migration and invasiveness of SH-SY5Y and IMR32 cells were significantly inhibited by HIF-1 alpha knockdown, which was mediated by small interfering RNAs (siRNAs) targeting against its mRNA. Furthermore, the growth of NB cells in vivo was also suppressed by HIF-1 alpha inhibition. Finally, the pro-migration and proliferative effects of HIF-1 alpha could be reversed by disrupting SHH signaling. In conclusion, our results demonstrated that upregulation of HIF-1 alpha in NB promotes proliferation, migration and invasiveness via SHH signaling.	[Chen, Sheng; Zhang, Min; Xing, Lili; Wang, Yue; Wu, Yeming] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Surg, Shanghai 200030, Peoples R China; [Xiao, Yongtao] Shanghai Inst Pediat Res, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wu, YM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Surg, Shanghai 200030, Peoples R China.	wuymsh@163.com			National Natural Science Foundation of China [81272803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by a grant from National Natural Science Foundation of China (81272803). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker T, 2004, CANC TREAT, V117, P219; Bernhart E, 2013, EXP CELL RES, V319, P2037, DOI 10.1016/j.yexcr.2013.03.029; Bijlsma MF, 2009, J CELL MOL MED, V13, P2053, DOI 10.1111/j.1582-4934.2008.00491.x; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Chen JW, 2014, DIS MARKERS, V2014, P1, DOI 10.1155/2014/786543; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Choi JY, 2011, J BREAST CANCER, V14, P88, DOI 10.4048/jbc.2011.14.2.88; Choy SW, 2012, VITAM HORM, V88, P1, DOI 10.1016/B978-0-12-394622-5.00001-8; Efroni S, 2013, IET SYST BIOL, V7, P243, DOI 10.1049/iet-syb.2010.0078; Ghattass K, 2013, CURR CANCER DRUG TAR, V13, P670, DOI 10.2174/15680096113139990004; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/fon.13.92, 10.2217/FON.13.92]; Gleason JM, 2014, THER ADV UROL, V6, P165, DOI 10.1177/1756287214528023; Guo MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090518; Hong Soon-Sun, 2004, Cancer Res Treat, V36, P343, DOI 10.4143/crt.2004.36.6.343; Huang LL, 2014, CLIN CANCER RES, V20, P1566, DOI 10.1158/1078-0432.CCR-13-2195; Isobe T, 2013, INT J CLIN ONCOL, V18, P293, DOI 10.1007/s10147-012-0378-8; Ji RC, 2014, CANCER LETT, V346, P6, DOI 10.1016/j.canlet.2013.12.001; Jing SW, 2013, DIS ESOPHAGUS, V26, P75, DOI 10.1111/j.1442-2050.2011.01321.x; Kumar R, 2007, MOL CANCER THER, V6, P2012, DOI 10.1158/1535-7163.MCT-07-0193; Lal BC, 2005, CLIN CANCER RES, V11, P4479, DOI 10.1158/1078-0432.CCR-05-0166; Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139; Li W, 2013, INT J MOL MED, V32, P271, DOI 10.3892/ijmm.2013.1405; Malek MM, 2010, SURGERY, V148, P778, DOI 10.1016/j.surg.2010.07.021; Mao L, 2009, CANCER SCI, V100, P1848, DOI 10.1111/j.1349-7006.2009.01262.x; Marton I, 2012, ANTICANCER RES, V32, P5227; Matsushita S, 2014, CANCER SCI, V105, P272, DOI 10.1111/cas.12354; Onishi H, 2014, WORLD J GASTROENTERO, V20, P2335, DOI 10.3748/wjg.v20.i9.2335; Ren WW, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13855; Schiapparelli P, 2011, CANCER LETT, V310, P222, DOI 10.1016/j.canlet.2011.07.005; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shahi MH, 2011, TUMOR BIOL, V32, P113, DOI 10.1007/s13277-010-0105-x; Spivak-Kroizman TR, 2013, CANCER RES, V73, P3235, DOI 10.1158/0008-5472.CAN-11-1433; Sun GG, 2014, BREAST J, V20, P213, DOI 10.1111/tbj.12238; Vora Ajay, 2002, Paediatr Drugs, V4, P405; Wang Q, 2014, GENE, V541, P69, DOI 10.1016/j.gene.2014.03.025; Wickstrom M, 2013, INT J CANCER, V132, P1516, DOI 10.1002/ijc.27820	38	34	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121115	10.1371/journal.pone.0121115	http://dx.doi.org/10.1371/journal.pone.0121115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811359	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700082
J	Hermsen, R; Toonen, P; Kuijk, E; Youssef, SA; Kuiper, R; van Heesch, S; de Bruin, A; Cuppen, E; Simonis, M				Hermsen, Roel; Toonen, Pim; Kuijk, Ewart; Youssef, Sameh A.; Kuiper, Raoul; van Heesch, Sebastiaan; de Bruin, Alain; Cuppen, Edwin; Simonis, Marieke			Lack of Major Genome Instability in Tumors of p53 Null Rats	PLOS ONE			English	Article							MUTATIONS; CANCER; MICE; TELOMERES; SARCOMAS; BREAST; GENES; CELLS	Tumorigenesis is often associated with loss of tumor suppressor genes (such as TP53), genomic instability and telomere lengthening. Previously, we generated and characterized a rat p53 knockout model in which the homozygous rats predominantly develop hemangiosarcomas whereas the heterozygous rats mainly develop osteosarcomas. Using genome-wide analyses, we find that the tumors that arise in the heterozygous and homozygous Tp53(C273X) mutant animals are also different in their genomic instability profiles. While p53 was fully inactivated in both heterozygous and homozygous knockout rats, tumors from homozygous animals show very limited aneuploidy and low degrees of somatic copy number variation as compared to the tumors from heterozygous animals. In addition, complex structural rearrangements such as chromothripsis and breakage-fusion-bridge cycles were never found in tumors from homozygous animals, while these were readily detectable in tumors from heterozygous animals. Finally, we measured telomere length and telomere lengthening pathway activity and found that tumors of homozygous animals have longer telomeres but do not show clear telomerase or alternative lengthening of telomeres (ALT) activity differences as compared to the tumors from heterozygous animals. Taken together, our results demonstrate that host p53 status in this rat p53 knockout model has a large effect on both tumor type and genomic instability characteristics, where full loss of functional p53 is not the main driver of large-scale structural variations. Our results also suggest that chromothripsis primarily occurs under p53 heterozygous rather than p53 null conditions.	[Hermsen, Roel; Toonen, Pim; Kuijk, Ewart; van Heesch, Sebastiaan; Cuppen, Edwin; Simonis, Marieke] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Hermsen, Roel; Toonen, Pim; Kuijk, Ewart; van Heesch, Sebastiaan; Cuppen, Edwin; Simonis, Marieke] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Youssef, Sameh A.; Kuiper, Raoul; de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Dutch Mol Pathol Ctr, NL-3584 CL Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University	Cuppen, E (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	e.cuppen@hubrecht.eu	Cuppen, Edwin/F-5696-2011; de Bruin, Alain/AAL-9195-2020; van Heesch, Sebastiaan/AAT-6595-2020; Kuijk, Ewart/I-2569-2019; Cuppen, Edwin/H-2389-2016	Cuppen, Edwin/0000-0002-0400-9542; van Heesch, Sebastiaan/0000-0001-9593-1980; Kuijk, Ewart/0000-0002-1385-6516; Cuppen, Edwin/0000-0002-0400-9542; Kuiper, Raoul/0000-0001-5645-2389; de Bruin, Alain/0000-0001-8579-2649	European Community [HEALTH-F4-2010-241504]; NWO-CW TOP [700.58.303]; NWO [863.10.007]	European Community(European Commission); NWO-CW TOP; NWO(Netherlands Organization for Scientific Research (NWO))	Research in the laboratory of EC is financially supported by the European Community's Seventh Framework Programme (FP7/2007-2013; ec.europa.eu/research/fp7/) under grant agreement No. HEALTH-F4-2010-241504 (EURATRANS) and the NWO-CW TOP grant 700.58.303 (http://www.nwo.nl/onderzoek-en-resultaten/programmas/top-subsidies/top-subsidies+aard-en+levenswetenschappen). MS acknowledges funding from the NWO Vernieuwingsimpuls program 863.10.007 (http://www.nwo.nl/financiering/onzefinancieringsinstrumenten/nwo/vernieuwingsimpuls/veni/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Baumhoer D, 2005, GYNECOL ONCOL, V97, P348, DOI 10.1016/j.ygyno.2004.12.046; CHANG F, 1993, BRIT J CANCER, V68, P653, DOI 10.1038/bjc.1993.404; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Gorden BH, 2014, AM J PATHOL; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Kitada K, 2013, CYTOGENET GENOME RES, V139, P1, DOI 10.1159/000342885; Lamerato-Kozicki AR, 2006, EXP HEMATOL, V34, P870, DOI 10.1016/j.exphem.2006.04.013; Lau LMS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks781; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu LP, 2013, HUM PATHOL, V44, P2302, DOI 10.1016/j.humpath.2013.05.012; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Overholtzer M, 2003, P NATL ACAD SCI USA, V100, P11547, DOI 10.1073/pnas.1934852100; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Senturk S, 2014, P NATL ACAD SCI USA, V111, pE3287, DOI 10.1073/pnas.1321640111; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; van Boxtel R, 2011, AM J PATHOL, V179, P1616, DOI 10.1016/j.ajpath.2011.06.036; van Boxtel R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-460; van Heesch S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r33; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087	27	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122066	10.1371/journal.pone.0122066	http://dx.doi.org/10.1371/journal.pone.0122066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811670	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700166
J	Meng, ZB; Kang, JC; Wen, TC; Lei, BX; Hyde, KD				Meng, Zebin; Kang, Jichuan; Wen, Tingchi; Lei, Bangxing; Hyde, Kevin David			Cordycepin and N-6-(2-Hydroxyethyl)Adenosine from Cordyceps pruinosa and Their Interaction with Human Serum Albumin	PLOS ONE			English	Article							BINDING-SITE; IN-VITRO; MILITARIS; IDENTIFICATION; MECHANISM; APOPTOSIS; STRESS; ACID	Cordyceps pruinosa (CP) is often used as Traditional Chinese Medicine, but the substance basis of its medicinal properties is unclear. In this study, two compounds were isolated from CP cultures by column chromatography, and identified as cordycepin and N-6-(2-hydroxyethyl)-adenosine (HEA) by Nuclear Magnetic Resonance. In order to understand the efficacy of these two substances as potential therapeutic agents, it is necessary to explore their binding with proteins. The molecular mechanisms of interaction between cordycepin, HEA and human serum albumin (HSA) were studied using UV and fluorescence spectroscopy. The bingding constants between HSA and cordycepin were 4.227, 3.573 and 3.076 x 10(3).at 17, 27 and 37 degrees C respectively, and that of HSA and HEA were 27.102, 19.409 and 13.002 x 10(3).at the three tempretures respectively. Both cordycepin and HEA can quench the intrinsic fluorescence of HSA via static quenching, and they can bind with HSA to form complexes with a single binding site. The interaction forces between cordycepin and HSA were determined as electrostatic and hydrophobic, and those of HEA and HSA were hydrogen bonding and van der Waals forces. Using Foster's equation, the distance between fluorophores of cordycepin and HSA, and HEA and HSA are estimated to be 5.31 nm and 4.98 nm, respectively. In this study, cordycepin was isolated for the first time from CP, and will provide a new source of cordycepin and expand the use of this taxon. The interaction mechanisms between cordycepin and HSA was studied for the first time, which will provide a useful guide for the clinical application of cordycepin. The pharmacological importance of this study is to understand the interaction of HSA with cordycepin and HEA, which will be essential for the future designing of drugs based on the two compounds.	[Meng, Zebin; Kang, Jichuan; Wen, Tingchi; Lei, Bangxing] Guizhou Univ, Natl Educ Minist China, Engn & Res Ctr Southwest Biopharmaceut Resources, Guiyang 550003, Guizhou Provinc, Peoples R China; [Meng, Zebin] Guizhou Normal Coll, Guizhou Bioresource Dev & Utilizat Key Lab, Guiyang, Guizhou Provinc, Peoples R China; [Hyde, Kevin David] Mae Fah Luang Univ, Sch Sci, Inst Excellence Fungal Res, Chiang Rai, Thailand	Guizhou University; Guizhou Education University; Mae Fah Luang University	Kang, JC (corresponding author), Guizhou Univ, Natl Educ Minist China, Engn & Res Ctr Southwest Biopharmaceut Resources, Guiyang 550003, Guizhou Provinc, Peoples R China.	bcec.jckang@gzu.edu.cn	Wen, Ting-Chi/X-4696-2019	Wen, Ting-chi/0000-0003-1744-5869	National Natural Science Foundation of China (NSFC) [30660002, 31200016]; international collaboration plan of Guizhou province [G[2012]7006]; innovation team construction for science and technology of Guizhou province [[2012]4007]; Agricultural Science and Technology Foundation of Guizhou province [[2011]3054]; Modernization of Traditional Chinese Medicine Program of Guizhou Province from the Science and Technology Department of Guizhou province, China [[2012]5008]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); international collaboration plan of Guizhou province; innovation team construction for science and technology of Guizhou province; Agricultural Science and Technology Foundation of Guizhou province; Modernization of Traditional Chinese Medicine Program of Guizhou Province from the Science and Technology Department of Guizhou province, China	This work was supported by the grants from the National Natural Science Foundation of China (NSFC Nos. 30660002 & 31200016), the international collaboration plan of Guizhou province (No. G[2012]7006), the innovation team construction for science and technology of Guizhou province (No. [2012]4007), the Agricultural Science and Technology Foundation of Guizhou province (No. [2011]3054) and the Modernization of Traditional Chinese Medicine Program of Guizhou Province (No. [2012]5008) from the Science and Technology Department of Guizhou province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043814; Ahn YJ, 2000, J AGR FOOD CHEM, V48, P2744, DOI 10.1021/jf990862n; Belatik A, 2012, EUR J MED CHEM, V48, P114, DOI 10.1016/j.ejmech.2011.12.002; Bijari N, 2013, J LUMIN, V143, P328, DOI 10.1016/j.jlumin.2013.04.045; Cai ZL, 2013, EUR J PHARMACOL, V714, P249, DOI 10.1016/j.ejphar.2013.05.049; Chai YQ, 2006, China patent, Patent No. [ZL200410094511, 200410094511]; Choi S, 2011, TOXICOL APPL PHARM, V257, P165, DOI 10.1016/j.taap.2011.08.030; Cui D., 2009, IRANIAN J MED HYPOTH, V3, P23, DOI DOI 10.5455/AIM.2014.22.255-258; Cui FL, 2007, LUMINESCENCE, V22, P546, DOI 10.1002/bio.999; Ding F, 2009, DYES PIGMENTS, V83, P249, DOI 10.1016/j.dyepig.2009.05.003; DURCAN MJ, 1989, EUR J PHARMACOL, V168, P285, DOI 10.1016/0014-2999(89)90789-9; FURUYA T, 1983, PHYTOCHEMISTRY, V22, P2509, DOI 10.1016/0031-9422(83)80150-2; Gokoglu E, 2014, LUMINESCENCE, V29, P872, DOI 10.1002/bio.2635; He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; He YT, 2013, ADV MATER RES-SWITZ, V750-752, P1593, DOI 10.4028/www.scientific.net/AMR.750-752.1593; Hebia C, 2014, J PHOTOCH PHOTOBIO B, V130, P254, DOI 10.1016/j.jphotobiol.2013.11.025; Hong IP, 2003, KOREAN J SERICULTURA, V45; Hu YJ, 2009, BIOMACROMOLECULES, V10, P517, DOI 10.1021/bm801120k; Hywel-Jones N. L., 2001, BIODIVERSITY TROPICA, P107; Jeong JW, 2011, TOXICOL IN VITRO, V25, P817, DOI 10.1016/j.tiv.2011.02.001; Jin ML, 2014, NEUROTOXICOLOGY, V41, P102, DOI 10.1016/j.neuro.2014.01.005; Ju-Hyon L, 2011, J CANC THERAPY, V2, DOI [10.4236/jct.2011.22029, DOI 10.4236/JCT.2011.22029]; KACZKA EA, 1964, BIOCHEM BIOPH RES CO, V14, P456, DOI 10.1016/0006-291X(64)90086-5; Kim HG, 2010, J ETHNOPHARMACOL, V128, P342, DOI 10.1016/j.jep.2010.01.049; Kim KM, 2003, TOXICOL APPL PHARM, V190, P1, DOI 10.1016/S0041-008X(03)00152-2; Kodama EN, 2000, BIOCHEM PHARMACOL, V59, P273, DOI 10.1016/S0006-2952(99)00325-1; Kratz F, 2012, J CONTROL RELEASE, V161, P429, DOI 10.1016/j.jconrel.2011.11.028; Liang ZQ, 2007, FUNGI IN CHINA; Liu J., 2001, THE J, V17, P189; LOVINGER GG, 1973, VIROLOGY, V55, P524, DOI 10.1016/0042-6822(73)90195-5; Lv Zi-Ming, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2914; Meng ZB, 2014, ARCH BIOL SCI, V66, P1411, DOI 10.2298/ABS1404411M; Noh EM, 2009, RHEUMATOLOGY, V48, P45, DOI 10.1093/rheumatology/ken417; Ramesh T, 2012, EXP GERONTOL, V47, P979, DOI 10.1016/j.exger.2012.09.003; Ren ZH, 2012, INT IMMUNOPHARMACOL, V14, P698, DOI 10.1016/j.intimp.2012.10.008; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Sattar Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084045; Sohn SH, 2012, PLANTA MED, V78, P1620, DOI 10.1055/s-0032-1315212; Vodnala SK, 2009, PLOS NEGLECT TROP D, V3, P1; Wang Dong-mei, 2013, Yaoxue Xuebao, V48, P881; Wang J, 2013, J LUMIN, V136, P422, DOI 10.1016/j.jlumin.2012.12.004; Xu L, 2008, J ANHUI AGR U, V1; Yan ZY, 2006, SPECTROSC SPECT ANAL, V26, P1494; Yang Tao, 2011, Mycosystema, V30, P180; Zhang GW, 2009, SPECTROSC SPECT ANAL, V29, P184, DOI 10.3964/j.issn.1000-0593(2009)01-0184-04; Zhou XX, 2008, AM J CHINESE MED, V36, P967, DOI 10.1142/S0192415X08006387; Zhu LiNa, 2013, Acta Edulis Fungi, V20, P62	48	12	17	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121669	10.1371/journal.pone.0121669	http://dx.doi.org/10.1371/journal.pone.0121669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811172	Green Submitted, gold, Green Published			2022-12-26	WOS:000356353700126
J	Song, QH; Mao, BB; Cheng, JB; Gao, YH; Jiang, K; Chen, J; Yuan, ZQ; Meng, SS				Song, Qinghe; Mao, Beibei; Cheng, Jinbo; Gao, Yuhao; Jiang, Ke; Chen, Jun; Yuan, Zengqiang; Meng, Songshu			YAP Enhances Autophagic Flux to Promote Breast Cancer Cell Survival in Response to Nutrient Deprivation	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; INHIBITS AUTOPHAGY; HETEROZYGOSITY; APOPTOSIS; PROTEIN; PROLIFERATION; DEATH; LC3; IDENTIFICATION; TUMORIGENESIS	The Yes-associated protein (YAP), a transcriptional coactivator inactivated by the Hippo tumor suppressor pathway, functions as an oncoprotein in a variety of cancers. However, its contribution to breast cancer remains controversial. This study investigated the role of YAP in breast cancer cells under nutrient deprivation (ND). Here, we show that YAP knockdown sensitized MCF7 breast cancer cells to nutrient deprivation-induced apoptosis. Furthermore, in response to ND, YAP increased the autolysosome degradation, thereby enhancing the cellular autophagic flux in breast cancer cells. Of note, autophagy is crucial for YAP to protect MCF7 cells from apoptosis under ND conditions. In addition, the TEA domain (TEAD) family of growth-promoting transcription factors was indispensable for YAP-mediated regulation of autophagy. Collectively, our data reveal a role for YAP in promoting breast cancer cell survival upon ND stress and uncover an unappreciated function of YAP/TEAD in the regulation of autophagy.	[Song, Qinghe; Mao, Beibei; Cheng, Jinbo; Gao, Yuhao; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Song, Qinghe; Gao, Yuhao; Yuan, Zengqiang] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Jiang, Ke; Meng, Songshu] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Dalian, Liaoning, Peoples R China; [Chen, Jun] Sichuan Univ, Coll Life Sci, Ctr Growth Metab & Aging, Chengdu, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Dalian Medical University; Sichuan University	Yuan, ZQ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	zqyuan@ibp.ac.cn; ssmeng@dlmedu.edu.cn	Yuan, Zengqiang/G-5245-2017	Yuan, Zengqiang/0000-0001-5739-2867; , Yuhao/0000-0001-9005-3154	Ministry of Science and Technology of China [973-2012CB910701]; National Science Foundation of China [81125010, 81030025, 81372471]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (973-2012CB910701 to ZY; http://www.most.gov.cn/eng/); and the National Science Foundation of China (81125010 and 81030025 to ZY, 81372471 to SM; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Bian JC, 2011, ARCH VIROL, V156, P1335, DOI 10.1007/s00705-011-0987-y; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; CARTER SL, 1994, CANCER RES, V54, P6270; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Gong C, 2013, ONCOGENE, V32, P2261, DOI 10.1038/onc.2012.252; GUDMUNDSSON J, 1995, BRIT J CANCER, V72, P696, DOI 10.1038/bjc.1995.396; HAMPTON GM, 1994, CANCER RES, V54, P4586; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Karantza-Wadsworth V, 2007, AUTOPHAGY, V3, P610, DOI 10.4161/auto.4867; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; McLeland CB, 2011, METHODS MOL BIOL, V697, P199, DOI 10.1007/978-1-60327-198-1_21; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; TOMLINSON IPM, 1995, J CLIN PATHOL, V48, P424, DOI 10.1136/jcp.48.5.424; Tufail R, 2012, BREAST CANCER RES TR, V131, P743, DOI 10.1007/s10549-011-1435-0; Veldhoen RA, 2013, ONCOGENE, V32, P736, DOI 10.1038/onc.2012.92; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; WINQVIST R, 1995, CANCER RES, V55, P2660; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xiao L, 2011, J NEUROSCI, V31, P9611, DOI 10.1523/JNEUROSCI.0035-11.2011; Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Yue W, 2013, AUTOPHAGY, V9, P714, DOI 10.4161/auto.23997; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025	46	43	46	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120790	10.1371/journal.pone.0120790	http://dx.doi.org/10.1371/journal.pone.0120790			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811979	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700061
J	Ting, PY; Damoiseaux, R; Titz, B; Bradley, KA; Graeber, TG; Fernandez-Vega, V; Bannister, TD; Chase, P; Nair, R; Scampavia, L; Hodder, P; Spicer, TP; Colicelli, J				Ting, Pamela Y.; Damoiseaux, Robert; Titz, Bjoern; Bradley, Kenneth A.; Graeber, Thomas G.; Fernandez-Vega, Virneliz; Bannister, Thomas D.; Chase, Peter; Nair, Reji; Scampavia, Louis; Hodder, Peter; Spicer, Timothy P.; Colicelli, John			Identification of Small Molecules that Disrupt Signaling between ABL and Its Positive Regulator RIN1	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITOR; K562 CELL-LINE; BCR-ABL; CHRONIC PHASE; CLINICAL RESISTANCE; IMATINIB RESISTANCE; C-ABL; DOMAIN	Constitutively active BCR-ABL kinase fusions are causative mutations in the pathogenesis of hematopoietic neoplasias including chronic myelogenous leukemia (CML). Although these fusions have been successfully targeted with kinase inhibitors, drug-resistance and relapse continue to limit long-term survival, highlighting the need for continued innovative drug discovery. We developed a time-resolved Forster resonance energy transfer (TR-FRET) -based assay to identify compounds that disrupt stimulation of the ABL kinase by blocking its ability to bind the positive regulator RIN1. This assay was used in a high throughput screen (HTS) of two small molecule libraries totaling 444,743 compounds. 708 confirmed hits were counter-screened to eliminate off-target inhibitors and reanalyzed to prioritize compounds with IC50 values below 10 mu M. The CML cell line K562 was then used to identify five compounds that decrease MAPK1/3 phosphorylation, which we determined to be an indicator of RIN1-dependent ABL signaling. One of these compounds is a thiadiazole, and the other four are structurally related acyl piperidine amides. Notably, these five compounds lower cellular BCR-ABL1 kinase activity by blocking a positive regulatory interaction rather than directly inhibiting ABL catalytic function.	[Ting, Pamela Y.; Colicelli, John] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Mol Biol Inst,Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Damoiseaux, Robert; Bradley, Kenneth A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Titz, Bjoern; Graeber, Thomas G.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging, Metabol & Prote Ctr,Calif NanoSyst Inst, Los Angeles, CA USA; [Titz, Bjoern; Graeber, Thomas G.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Bradley, Kenneth A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Fernandez-Vega, Virneliz; Chase, Peter; Scampavia, Louis; Hodder, Peter; Spicer, Timothy P.] Scripps Res Inst FL, Translat Res Inst, Jupiter, FL USA; [Bannister, Thomas D.; Nair, Reji] Scripps Res Inst FL, Dept Chem, Translat Res Inst, Jupiter, FL USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Colicelli, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Mol Biol Inst,Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	colicelli@mednet.ucla.edu	Damoiseaux, Robert/S-6712-2019; Titz, Bjoern/G-6317-2017; Damoiseaux, Robert/F-1086-2011	Damoiseaux, Robert/0000-0002-7611-7534; Titz, Bjoern/0000-0003-4414-4105; Damoiseaux, Robert/0000-0002-7611-7534; Graeber, Thomas/0000-0001-8574-9181	National Institutes of Health [CA136699, P01 CA168585, R21 CA169993]; Ruth L. Kirschstein National Research Service Award [GM007185]; Whitcome Training Fellowship; UCLA Jonsson Comprehensive Cancer Center; National Cancer Institute [P01 CA168585, R21 CA169993]; American Cancer Society [RSG-12-257-01-TBE]; Melanoma Research Alliance Established Investigator Award [20120279]; National Center for Advancing Translational Sciences UCLA CTSI [UL1TR000124]; National Institute of Health's Roadmap Initiative [U54MH084512]; NATIONAL CANCER INSTITUTE [R01CA136699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome Training Fellowship; UCLA Jonsson Comprehensive Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Melanoma Research Alliance Established Investigator Award; National Center for Advancing Translational Sciences UCLA CTSI; National Institute of Health's Roadmap Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [grant number CA136699 to JC]; the Ruth L. Kirschstein National Research Service Award [grant number GM007185 to PT]; the Whitcome Training Fellowship (to PT); funds from the UCLA Jonsson Comprehensive Cancer Center; the National Cancer Institute and National Institutes of Health [grant number P01 CA168585, R21 CA169993 to TGG]; the American Cancer Society Research Scholar Award [grant number RSG-12-257-01-TBE to TGG]; the Melanoma Research Alliance Established Investigator Award [grant number 20120279 to TGG]; the National Center for Advancing Translational Sciences UCLA CTSI [grant number UL1TR000124 to TGG]; and the National Institute of Health's Roadmap Initiative [grant number U54MH084512 to VFV, TB, PC, RN, LS, PH and TS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Afar DEH, 1997, IMMUNITY, V6, P773, DOI 10.1016/S1074-7613(00)80452-5; Balaji K, 2012, J CELL SCI, V125, P5887, DOI 10.1242/jcs.113688; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Cao XQ, 2008, J BIOL CHEM, V283, P31401, DOI 10.1074/jbc.M804002200; Charlton AJ, 1996, FEBS LETT, V382, P289, DOI 10.1016/0014-5793(96)00186-X; Cortes JE, 2013, NEW ENGL J MED, V369, P1783, DOI 10.1056/NEJMoa1306494; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Dixon AS, 2012, PHARM RES-DORDR, V29, P1098, DOI 10.1007/s11095-011-0654-8; Druker BJ, 2006, J CLIN ONCOL, V24, p338S; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hibasami H, 1998, INT J MOL MED, V1, P725; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Jin LY, 2014, ANNU REV PHARMACOL, V54, P435, DOI 10.1146/annurev-pharmtox-011613-140028; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Kawabata T, 2011, J CHEM INF MODEL, V51, P1775, DOI 10.1021/ci2001023; Kawano T, 2004, MOL CELL BIOCHEM, V258, P25, DOI 10.1023/B:MCBI.0000012830.96393.b9; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Liang YC, 1999, CARCINOGENESIS, V20, P733, DOI 10.1093/carcin/20.4.733; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Miller NJ, 1996, FEBS LETT, V392, P40, DOI 10.1016/0014-5793(96)00780-6; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Prakash A, 2006, MOL CELL PROTEOMICS, V5, P423, DOI 10.1074/mcp.M500133-MCP200; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Thai M, 2011, LEUKEMIA, V25, P290, DOI 10.1038/leu.2010.268; Yuan JL, 2005, J FLUORESC, V15, P559, DOI 10.1007/s10895-005-2829-3; Zabriskie MS, 2014, CANCER CELL, V26, P428, DOI 10.1016/j.ccr.2014.07.006; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x	41	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121833	10.1371/journal.pone.0121833	http://dx.doi.org/10.1371/journal.pone.0121833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811598	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700147
J	Yu, X; Luo, YX; Liu, J; Liu, YH; Sun, QN				Yu, Xin; Luo, Yixin; Liu, Jie; Liu, Yuehua; Sun, Qiuning			TOX Acts an Oncological Role in Mycosis Fungoides	PLOS ONE			English	Article							T-CELL LYMPHOMA; CUTANEOUS-LYMPHOMAS; THYMOCYTE SELECTION; SEZARY-SYNDROME; CANCER; CLASSIFICATION; IDENTIFICATION; MARKERS; SYSTEM; EORTC	Mycosis fungoides (MF) is a low-grade lymphoma characterized by clonal expansion of atypical CD4+ skin-homing T lymphocytes. Herein, we examined the role of thymocytes selection associated HMG-box (TOX), a gene previously found to be unregulated in MF skin biopsies, in MF pathogenesis. TOX encodes a high-mobility group family (HMG) domain DNA binding nuclear protein, which regulates the differentiation of developing T-cells. First, we confirmed that TOX expression levels in MF were increased compared with those in benign inflammatory dermatitis (BID) and normal skin. In addition, TOX level increased with the progression MF from patch stage to tumor stage. Overexpression of TOX accelerated the proliferation and migration of MF cell lines in vitro, which were blocked by AKT inhibitors. In conclusion, our study confirmed that TOX was highly expressed in MF lesions and accelerates the proliferation and migration of MF. TOX is a diagnostic marker for MF and may play a pathogenic role in disease progression.	[Liu, Jie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Dermatol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Dermatol, Beijing 100730, Peoples R China.	liujie04672@pumch.cn	LUO, YIXIN/AAT-1733-2020; Sun, Qiuning/AAJ-3692-2021	LUO, YIXIN/0000-0002-5592-162X; Sun, Qiuning/0000-0002-1912-341X	Beijing Natural Science Foundation [7142136]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by a grant from Beijing Natural Science Foundation (No. 7142136). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aliahmad P, 2012, CURR OPIN IMMUNOL, V24, P173, DOI 10.1016/j.coi.2011.12.001; Aliahmad P, 2011, J IMMUNOL, V187, P5931, DOI 10.4049/jimmunol.1101474; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; ARAI E, 1991, PATHOL RES PRACT, V187, P451, DOI 10.1016/S0344-0338(11)80006-3; Bardet V, 2002, GENE CHROMOSOME CANC, V33, P178, DOI 10.1002/gcc.10014; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Girardi M, 2004, NEW ENGL J MED, V350, P1978, DOI 10.1056/NEJMra032810; Gonzalez-Aguilar A, 2012, CLIN CANCER RES, V18, P5203, DOI 10.1158/1078-0432.CCR-12-0845; Groves FD, 2000, JNCI-J NATL CANCER I, V92, P1240, DOI 10.1093/jnci/92.15.1240; Huang YS, 2014, ONCOTARGET, V5, P4418, DOI 10.18632/oncotarget.2031; Manfe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029541; McGirt LY, 2014, J INVEST DERMATOL, V134, P1101, DOI 10.1038/jid.2013.461; Morimura S, 2014, ARCH DERMATOL RES; Morimura S, 2014, J DERMATOL, V41, P57, DOI 10.1111/1346-8138.12351; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; Tessema M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034850; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Yang J, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-51; Zhang YH, 2012, J INVEST DERMATOL, V132, P1698, DOI 10.1038/jid.2012.13	22	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0117479	10.1371/journal.pone.0117479	http://dx.doi.org/10.1371/journal.pone.0117479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811617	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700003
J	Yurkov, A; Guerreiro, MA; Sharma, L; Carvalho, C; Fonseca, A				Yurkov, Andrey; Guerreiro, Marco A.; Sharma, Lav; Carvalho, Claudia; Fonseca, Alvaro			Multigene Assessment of the Species Boundaries and Sexual Status of the Basidiomycetous Yeasts Cryptococcus flavescens and C. terrestris (Tremellales)	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MULTIPLE SEQUENCE ALIGNMENT; GENETIC-EVIDENCE; NUCLEAR LARGE; MATING-TYPE; SP NOV.; PHYLOGENY; EVOLUTION; RDNA; RECOMBINATION	Cryptococcus flavescens and C. terrestris are phenotypically indistinguishable sister species that belong to the order Tremellales (Tremellomycetes, Basidiomycota) and which may be mistaken for C. laurentii based on phenotype. Phylogenetic separation between C. flavescens and C. terrestris was based on rDNA sequence analyses, but very little is known on their intraspecific genetic variability or propensity for sexual reproduction. We studied 59 strains from different substrates and geographic locations, and used a multilocus sequencing (MLS) approach complemented with the sequencing of mating type (MAT) genes to assess genetic variation and reexamine the boundaries of the two species, as well as their sexual status. The following five loci were chosen for MLS: the rDNA ITS-LSU region, the rDNA IGS1 spacer, and fragments of the genes encoding the largest subunit of RNA polymerase II (RPB1), the translation elongation factor 1 alpha (TEF1) and the p21-activated protein kinase (STE20). Phylogenetic network analyses confirmed the genetic separation of the two species and revealed two additional cryptic species, for which the names Cryptococcus baii and C. ruineniae are proposed. Further analyses of the data revealed a high degree of genetic heterogeneity within C. flavescens as well as evidence for recombination between lineages detected for this species. Strains of C. terrestris displayed higher levels of similarity in all analysed genes and appear to make up a single recombining group. The two MAT genes (STE3 and SXI1/SXI2) sequenced for C. flavescens strains confirmed the potential for sexual reproduction and suggest the presence of a tetrapolar mating system with a biallelic pheromone/receptor locus and a multiallelic HD locus. In C. terrestris we could only sequence STE3, which revealed a biallelic P/R locus. In spite of the strong evidence for sexual recombination in the two species, attempts at mating compatible strains of both species on culture media were unsuccessful.	[Yurkov, Andrey] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany; [Guerreiro, Marco A.; Sharma, Lav; Carvalho, Claudia; Fonseca, Alvaro] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, Ctr Recursos Microbiol, Caparica, Portugal	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Universidade Nova de Lisboa	Yurkov, A (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany.	andrey.yurkov@dsmz.de	Yurkov, Andrey M./E-7854-2011; Carvalho, Cláudia/T-5588-2017; Guerreiro, Marco Alexandre/M-1679-2016	Yurkov, Andrey M./0000-0002-1072-5166; Carvalho, Cláudia/0000-0002-3890-2259; Guerreiro, Marco Alexandre/0000-0002-5133-8779; Sharma, Lav/0000-0001-6615-2478	FCT-Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/BIA-MIC/113051/2009]	FCT-Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by funds from FCT-Fundacao para a Ciencia e a Tecnologia, Portugal (www.fct.pt), project PTDC/BIA-MIC/113051/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime MC, 2006, MYCOLOGIA, V98, P896, DOI 10.3852/mycologia.98.6.896; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bandoni RJ, 1995, STUD MYCOL, P13; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Begerow D, 2006, MYCOLOGIA, V98, P906, DOI 10.3852/mycologia.98.6.906; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1339, DOI 10.1016/B978-0-444-52149-1.00100-2; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Crestani J, 2009, INT J SYST EVOL MICR, V59, P631, DOI 10.1099/ijs.0.001800-0; Croll D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-13; De Beeck MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097629; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; DeGiorgio M, 2009, MOL BIOL EVOL, V26, P501, DOI 10.1093/molbev/msn254; Diaz MR, 2005, FEMS YEAST RES, V5, P1129, DOI 10.1016/j.femsyr.2005.05.005; Dodgson AR, 2005, FUNGAL GENET BIOL, V42, P233, DOI 10.1016/j.fgb.2004.11.010; Dunlap CA, 2007, FEMS YEAST RES, V7, P449, DOI 10.1111/j.1567-1364.2006.00193.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; Findley K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002528; Fonseca A, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1661, DOI 10.1016/B978-0-444-52149-1.00138-5; Guerreiro MA, 2013, EUKARYOT CELL, V12, P746, DOI 10.1128/EC.00065-13; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Henk DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002851; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Hsueh YP, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P139; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ikeda R, 2004, CARBOHYD RES, V339, P503, DOI 10.1016/j.carres.2003.11.015; Kano R, 2012, MYCOPATHOLOGIA, V173, P179, DOI 10.1007/s11046-011-9479-6; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kues U, 2011, MYCOTA, V14, P97; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; KURTZMAN CP, 1973, MYCOLOGIA, V65, P388, DOI 10.2307/3758110; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; KWONCHUNG KJ, 1975, MYCOLOGIA, V67, P1197, DOI 10.2307/3758842; Lachance MA, 2011, FEMS YEAST RES, V11, P324, DOI 10.1111/j.1567-1364.2011.00718.x; Lachance MA, 2010, ANTON LEEUW INT J G, V97, P155, DOI 10.1007/s10482-009-9399-3; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Metin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000961; METZLER B, 1989, SYST APPL MICROBIOL, V12, P280, DOI 10.1016/S0723-2020(89)80075-X; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Rong XQ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00762-13; Sampaio JP, 2002, MYCOLOGIA, V94, P873, DOI 10.2307/3761703; Satoh K, 2013, ANTON LEEUW INT J G, V104, P83, DOI 10.1007/s10482-013-9928-y; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Statzell-Tallman A, 2008, FEMS YEAST RES, V8, P103, DOI 10.1111/j.1567-1364.2007.00314.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Takashima M, 2003, INT J SYST EVOL MICR, V53, P1187, DOI 10.1099/ijs.0.02498-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavanti A, 2004, FUNGAL GENET BIOL, V41, P553, DOI 10.1016/j.fgb.2003.12.008; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Tsui CKM, 2008, FEMS YEAST RES, V8, P651, DOI 10.1111/j.1567-1364.2007.00342.x; Wang P, 2002, EUKARYOT CELL, V1, P257, DOI 10.1128/EC.1.2.257-272.2002; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913; Wu Q, 2008, FEMS YEAST RES, V8, P641, DOI 10.1111/j.1567-1364.2008.00362.x; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004	70	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120400	10.1371/journal.pone.0120400	http://dx.doi.org/10.1371/journal.pone.0120400			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811603	Green Published, gold			2022-12-26	WOS:000356353700048
J	Fautrelle, L; Mareschal, D; French, R; Addyman, C; Thomas, E				Fautrelle, Lilian; Mareschal, Denis; French, Robert; Addyman, Caspar; Thomas, Elizabeth			Motor Activity Improves Temporal Expectancy	PLOS ONE			English	Article							TIME PERCEPTION; INTERNAL CLOCK; MODELS; ATTENTION; DURATION; IMAGERY; DISCRIMINATION; DISSOCIATION; PERFORMANCE; ACTIVATION	Certain brain areas involved in interval timing are also important in motor activity. This raises the possibility that motor activity might influence interval timing. To test this hypothesis, we assessed interval timing in healthy adults following different types of training. The pre- and post-training tasks consisted of a button press in response to the presentation of a rhythmic visual stimulus. Alterations in temporal expectancy were evaluated by measuring response times. Training consisted of responding to the visual presentation of regularly appearing stimuli by either: (1) pointing with a whole-body movement, (2) pointing only with the arm, (3) imagining pointing with a whole-body movement, (4) simply watching the stimulus presentation, (5) pointing with a whole-body movement in response to a target that appeared at irregular intervals (6) reading a newspaper. Participants performing a motor activity in response to the regular target showed significant improvements in judgment times compared to individuals with no associated motor activity. Individuals who only imagined pointing with a whole-body movement also showed significant improvements. No improvements were observed in the group that trained with a motor response to an irregular stimulus, hence eliminating the explanation that the improved temporal expectations of the other motor training groups was purely due to an improved motor capacity to press the response button. All groups performed a secondary task equally well, hence indicating that our results could not simply be attributed to differences in attention between the groups. Our results show that motor activity, even when it does not play a causal or corrective role, can lead to improved interval timing judgments.	[Fautrelle, Lilian] Univ Paris Quest, Unite Format & Rech Sci & Tech Activites Phys & S, Ctr Rech Sport & Mouvement EA2931, Nanterre La Def, France; [Mareschal, Denis; Addyman, Caspar] Birkbeck Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England; [Thomas, Elizabeth] Univ Bourgogne, INSERM, Unite Format & Rech Sci & Tech Activites Phys & S, U1093,Cognit Act & Plast Sensori Motrice, Dijon, France; [French, Robert] CNRS, UMR 5022, Lab Etud Apprentissage & Dev, Dijon, France	University of London; Birkbeck University London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bourgogne	Thomas, E (corresponding author), Univ Bourgogne, INSERM, Unite Format & Rech Sci & Tech Activites Phys & S, U1093,Cognit Act & Plast Sensori Motrice, Campus Univ, Dijon, France.	Elizabeth.Thomas@u-bourgogne.fr	Mareschal, Denis/ABE-4342-2020; Mareschal, Denis/C-4671-2008	Mareschal, Denis/0000-0002-9828-9548; Mareschal, Denis/0000-0002-9828-9548; Fautrelle, Lilian/0000-0002-4044-8614; Addyman, Caspar/0000-0003-0001-9548	Economic and Social Research Council (UK) [RES-062-23-0819]; Agence National de la Recherche as part of the ORA international collaboration initiative [-10-ORAR-006-03]; Royal Society Wolfson research merit award; Economic and Social Research Council [ES/I014802/1] Funding Source: researchfish; ESRC [ES/I014802/1] Funding Source: UKRI	Economic and Social Research Council (UK)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Agence National de la Recherche as part of the ORA international collaboration initiative; Royal Society Wolfson research merit award(Royal Society of London); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by Economic and Social Research Council (UK) grant RES-062-23-0819 and Agence National de la Recherche grant -10-ORAR-006-03 as part of the ORA international collaboration initiative. DM is supported in part by a Royal Society Wolfson research merit award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002771; Addyman C., 2011, P ANN M COGN SCI SOC, V33, P354; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Avanzino L, 2013, BRAIN, V136, P444, DOI 10.1093/brain/aws328; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Bausenhart K, 2013, EXPERIMENTAL PSYCHOL, V18, P1; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Brown SW, 2002, J EXP PSYCHOL HUMAN, V28, P600, DOI 10.1037//0096-1523.28.3.600; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P204, DOI 10.1162/jocn.2008.20017; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2010, TRENDS COGN SCI, V14, P520, DOI 10.1016/j.tics.2010.09.002; Burle B, 2001, J EXP PSYCHOL HUMAN, V27, P195, DOI 10.1037/0096-1523.27.1.195; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Correa A, 2004, PERCEPT PSYCHOPHYS, V66, P264, DOI 10.3758/BF03194878; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Coull JT, 1998, J NEUROSCI, V18, P7426; Droit-Volet S, 1998, J EXP CHILD PSYCHOL, V68, P236, DOI 10.1006/jecp.1997.2430; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Gavazzi G, 2013, SCIENTIFIC REPORTS, V3, P1; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hodinott-Hill I, 2002, CURR BIOL, V12, P1779, DOI 10.1016/S0960-9822(02)01219-8; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Kanai R, 2006, PERCEPT PSYCHOPHYS, V68, P1113, DOI 10.3758/BF03193714; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Latash M, 2008, NEUROPHYSIOLOGICAL B, P53; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; Meck WH, 2005, BRAIN COGNITION, V58, P1, DOI 10.1016/j.bandc.2004.09.004; Meegan DV, 2000, NAT NEUROSCI, V3, P860, DOI 10.1038/78757; Michon JA, 1989, GUYAU AND THE IDEA O; Mita A, 2009, NAT NEUROSCI, V12, P502, DOI 10.1038/nn.2272; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papaxanthis C, 2002, BEHAV BRAIN RES, V134, P209, DOI 10.1016/S0166-4328(02)00030-X; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Penfield W, 1952, THE CEREBRAL CORTEX; Porro CA, 1996, J NEUROSCI, V16, P7688; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rammsayer T, 2001, PSYCHON B REV, V8, P270, DOI 10.3758/BF03196161; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Schwartze M, 2012, NEUROIMAGE, V60, P290, DOI 10.1016/j.neuroimage.2011.11.089; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Stetson C, 2006, NEURON, V51, P651, DOI 10.1016/j.neuron.2006.08.006; Szameitat AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038506; Thomas E., 2014, TIMING TIME PERCEPTI, V1, P1, DOI [10.1163/24054496-00101002, DOI 10.1163/24054496-00101002]; Tomassini A, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00051; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; Vicario CM, 2011, PERCEPT MOTOR SKILL, V113, P3, DOI 10.2466/04.22.PMS.113.4.3-10; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wearden JH, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P21; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Wurtz RH, 2011, PHILOS T R SOC B, V366, P492, DOI 10.1098/rstb.2010.0186; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	68	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119187	10.1371/journal.pone.0119187	http://dx.doi.org/10.1371/journal.pone.0119187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806813	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000351880000020
J	Jones, MJ; Donegan, NP; Mikheyeva, IV; Cheung, AL				Jones, Mary Janice; Donegan, Niles P.; Mikheyeva, Irina V.; Cheung, Ambrose L.			Improving Transformation of Staphylococcus aureus Belonging to the CC1, CC5 and CC8 Clonal Complexes	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEM; HORIZONTAL GENE-TRANSFER; GENOME; ENDONUCLEASES; ENZYMES; ELECTROPORATION; EPIDEMIOLOGY; EVOLUTION; SEQUENCE; STRAINS	Methicillin resistant Staphylococcus aureus (MRSA) is an opportunistic pathogen found in hospital and community environments that can cause serious infections. A major barrier to genetic manipulations of clinical isolates has been the considerable difficulty in transforming these strains with foreign plasmids, such as those from E. coli, in part due to the type I and IV Restriction Modification (R-M) barriers. Here we combine a Plasmid Artificial Modification (PAM) system with DC10B E. coli cells (dcm mutants) to bypass the barriers of both type I and IV R-M of S. aureus, thus allowing E. coli plasmid DNA to be transformed directly into clinical MRSA strains MW2, N315 and LAC, representing three of the most common clonal complexes. Successful transformation of clinical S. aureus isolates with E. coli-derived plasmids should greatly increase the ability to genetically modify relevant S. aureus strains and advance our understanding of S. aureus pathogenesis.	[Jones, Mary Janice; Donegan, Niles P.; Cheung, Ambrose L.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Mikheyeva, Irina V.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH USA	Dartmouth College; Dartmouth College	Cheung, AL (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	ambrose.cheung@dartmouth.edu		Donegan, Niles/0000-0002-8328-2044	NIH [AI106937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007519, R01AI106937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI106937 to ALC. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2003, MMWR MORBIDITY MORTA; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Galdzicki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017005; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; LACKS S, 1977, J MOL BIOL, V114, P153, DOI 10.1016/0022-2836(77)90289-3; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; MAHMOOD R, 1990, J BIOL CHEM, V265, P4652; MASLOW JN, 1995, EUR J CLIN MICROBIOL, V14, P282, DOI 10.1007/BF02116520; Monk IR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00049; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Mucke M, 2001, J MOL BIOL, V312, P687, DOI 10.1006/jmbi.2001.4998; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; PALMER BR, 1994, GENE, V143, P1, DOI 10.1016/0378-1119(94)90597-5; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Rao DN, 2014, NUCLEIC ACIDS RES, V42, P45, DOI 10.1093/nar/gkt616; Roberts GA, 2013, NUCLEIC ACIDS RES, V41, P7472, DOI 10.1093/nar/gkt535; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; STOBBERINGH EE, 1977, J BACTERIOL, V131, P645, DOI 10.1128/JB.131.2.645-649.1977; SUSSENBACH JS, 1978, NUCLEIC ACIDS RES, V5, P1153, DOI 10.1093/nar/5.4.1153; SZILAK L, 1990, NUCLEIC ACIDS RES, V18, P4659, DOI 10.1093/nar/18.16.4659; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Veiga H, 2009, APPL ENVIRON MICROB, V75, P3034, DOI 10.1128/AEM.01862-08; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Xu SY, 2011, NUCLEIC ACIDS RES, V39, P5597, DOI 10.1093/nar/gkr098; Yasui K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn884	36	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119487	10.1371/journal.pone.0119487	http://dx.doi.org/10.1371/journal.pone.0119487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807379	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000032
J	Niavarani, A; Currie, E; Reyal, Y; Anjos-Afonso, F; Horswell, S; Griessinger, E; Sardina, JL; Bonnet, D				Niavarani, Ahmadreza; Currie, Erin; Reyal, Yasmin; Anjos-Afonso, Fernando; Horswell, Stuart; Griessinger, Emmanuel; Luis Sardina, Jose; Bonnet, Dominique			APOBEC3A Is Implicated in alpha Novel Class of G-to-A mRNA Editing in WT1 Transcripts	PLOS ONE			English	Article							DNA-SEQUENCE DIFFERENCES; WILMS-TUMOR SUPPRESSOR; CELL-LINE; CYTIDINE DEAMINASES; WIDESPREAD RNA; FOREIGN DNA; LEUKEMIA; ENZYME; RESTRICTION; GENE	Classic deamination mRNA changes, including cytidine to uridine (C-to-U) and adenosine to inosine (A-to-I), are important exceptions to the central dogma and lead to significant alterations in gene transcripts and products. Although there are a few reports of non-classic mRNA alterations, as yet there is no molecular explanation for these alternative changes. Wilms Tumor 1 (WT1) mutations and variants are implicated in several diseases, including Wilms tumor and acute myeloid leukemia (AML). We observed two alternative G-to-A changes, namely c.1303G>A and c.1586G>A in cDNA clones and found them to be recurrent in a series of 21 umbilical cord blood mononuclear cell (CBMC) samples studied. Two less conserved U-to-C changes were also observed. These alternative changes were found to be significantly higher in non-progenitor as compared to progenitor CBMCs, while they were found to be absent in a series of AML samples studied, indicating they are targeted, cell type-specific mRNA editing modifications. Since APOBEC/ADAR family members are implicated in RNA/DNA editing, we screened them by RNA-interference (RNAi) for WT1-mRNA changes and observed near complete reversal of WT1 c.1303G>A alteration upon APOBEC3A (A3A) knockdown. The role of A3A in mediating this change was confirmed by A3A overexpression in Fujioka cells, which led to a significant increase in WT1 c.1303G>A mRNA editing. Non-progenitor CBMCs showed correspondingly higher levels of A3A-mRNA and protein as compared to the progenitor ones. To our knowledge, this is the first report of mRNA modifying activity for an APOBEC3 protein and implicates A3A in a novel G-to-A form of editing. These findings open the way to further investigations into the mechanisms of other potential mRNA changes, which will help to redefine the RNA editing paradigm in both health and disease.	[Niavarani, Ahmadreza; Currie, Erin; Anjos-Afonso, Fernando; Bonnet, Dominique] Canc Res UK London Res Inst, Haematopoiet Stem Cell Lab, London WC2A 3PX, England; [Niavarani, Ahmadreza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Tehran, Iran; [Reyal, Yasmin] Univ Coll London Hosp NHS Trust, Dept Haematol, London, England; [Horswell, Stuart] Canc Res UK London Res Inst, Dept Bioinformat, London WC2A 3PX, England; [Griessinger, Emmanuel] Univ Nice Sophia Antipolis, INSERM U1065, Mediterranean Ctr Mol Med C3M, F-06189 Nice, France; [Luis Sardina, Jose] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain	Cancer Research UK; Tehran University of Medical Sciences; University College London Hospitals NHS Foundation Trust; University of London; University College London; Cancer Research UK; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Bonnet, D (corresponding author), Canc Res UK London Res Inst, Haematopoiet Stem Cell Lab, London WC2A 3PX, England.	Dominique.Bonnet@cancer.org.uk	Niavarani, Ahmadreza/B-9946-2017; Sardina, José Luis/H-7047-2015; Griessinger, Emmanuel/G-5574-2018; Niavarani, Ahmadreza/O-1814-2019	Niavarani, Ahmadreza/0000-0001-7773-6778; Sardina, José Luis/0000-0002-8493-3937; Niavarani, Ahmadreza/0000-0001-7773-6778; Horswell, Stuart/0000-0003-2787-1933; GRIESSINGER, Emmanuel/0000-0001-7529-4187; Anjos-Afonso, Fernando/0000-0003-4392-488X	Cancer Research UK; Leukaemia Lymphoma Research Clinical Research Fellowship; The Francis Crick Institute [10045, 10002] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Leukaemia Lymphoma Research Clinical Research Fellowship; The Francis Crick Institute	This work was supported by Cancer Research UK (D.B.). Y.R. was funded by a Leukaemia Lymphoma Research Clinical Research Fellowship and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2012, NUCL ACIDS RES; Ariyaratana Suzie, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000336; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Castandet B, 2011, BIOCHEMISTRY-MOSCOW+, V76, P924, DOI 10.1134/S0006297911080086; CHEONG C, 1988, NUCLEIC ACIDS RES, V16, P5115, DOI 10.1093/nar/16.11.5115; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; DRUMMOND IA, 1994, MOL CELL BIOL, V14, P3800, DOI 10.1128/MCB.14.6.3800; GALLAGHER R, 1979, BLOOD, V54, P713; Garcia GA, 2005, BIOORG CHEM, V33, P229, DOI 10.1016/j.bioorg.2005.01.001; Grohmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008956; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; HIROSE M, 1982, GANN, V73, P735; Ho PA, 2011, J CLIN ONCOL, V29, P704, DOI 10.1200/JCO.2010.31.9327; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Klimek-Tomczak K, 2006, BRIT J CANCER, V94, P586, DOI 10.1038/sj.bjc.6602938; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Lin W, 2012, SCIENCE, V335, DOI 10.1126/science.1210624; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Nakamuta M, 1996, J BIOL CHEM, V271, P25981, DOI 10.1074/jbc.271.42.25981; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Storck S, 2011, CURR OPIN IMMUNOL, V23, P337, DOI 10.1016/j.coi.2011.02.002; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Virappane P, 2008, J CLIN ONCOL, V26, P5429, DOI 10.1200/JCO.2008.16.0333; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Zhu YJ, 2014, GENETICS, V196, P1047, DOI 10.1534/genetics.114.161414	47	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120089	10.1371/journal.pone.0120089	http://dx.doi.org/10.1371/journal.pone.0120089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807502	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000351880000065
J	Wu, JF; Peng, DH; Li, ZP; Zhao, L; Ling, HZ				Wu, Jianfa; Peng, Dahao; Li, Zhuping; Zhao, Li; Ling, Huanzhang			Network Intrusion Detection Based on a General Regression Neural Network Optimized by an Improved Artificial Immune Algorithm	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; HIGH-DIMENSION; CLASSIFICATION; SYSTEM; PERFORMANCE; BP; GA	To effectively and accurately detect and classify network intrusion data, this paper introduces a general regression neural network (GRNN) based on the artificial immune algorithm with elitist strategies (AIAE). The elitist archive and elitist crossover were combined with the artificial immune algorithm (AIA) to produce the AIAE-GRNN algorithm, with the aim of improving its adaptivity and accuracy. In this paper, the mean square errors (MSEs) were considered the affinity function. The AIAE was used to optimize the smooth factors of the GRNN; then, the optimal smooth factor was solved and substituted into the trained GRNN. Thus, the intrusive data were classified. The paper selected a GRNN that was separately optimized using a genetic algorithm (GA), particle swarm optimization (PSO), and fuzzy C-mean clustering (FCM) to enable a comparison of these approaches. As shown in the results, the AIAE-GRNN achieves a higher classification accuracy than PSO-GRNN, but the running time of AIAE-GRNN is long, which was proved first. FCM and GA-GRNN were eliminated because of their deficiencies in terms of accuracy and convergence. To improve the running speed, the paper adopted principal component analysis (PCA) to reduce the dimensions of the intrusive data. With the reduction in dimensionality, the PCA-AIAE-GRNN decreases in accuracy less and has better convergence than the PCA-PSO-GRNN, and the running speed of the PCA-AIAE-GRNN was relatively improved. The experimental results show that the AIAE-GRNN has a higher robustness and accuracy than the other algorithms considered and can thus be used to classify the intrusive data.	[Wu, Jianfa] Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China; [Peng, Dahao; Li, Zhuping] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Zhao, Li] Harbin Engn Univ, Coll Natl Secrecy, Harbin, Heilongjiang, Peoples R China; [Ling, Huanzhang] Harbin Engn Univ, Coll Sci, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University; Harbin Engineering University; Harbin Engineering University; Harbin Engineering University	Ling, HZ (corresponding author), Harbin Engn Univ, Coll Sci, Harbin, Heilongjiang, Peoples R China.	linghuanzhang@hrbeu.edu.cn			National Natural Science Foundation of China [51309068]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors was sponsored by National Natural Science Foundation of China (Grant No: 51309068) and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghdad R, 2008, COMPUT SECUR, V27, P168, DOI 10.1016/j.cose.2008.06.001; Cao JC, 2006, ENERGY, V31, P3435, DOI 10.1016/j.energy.2006.04.001; Chen JY, 2013, APPL MATH INFORM SCI, V7, P149; Choubey NS, 2013, APPL SOFT COMPUT, V13, P2923, DOI 10.1016/j.asoc.2012.03.069; Choudhary AK, 2009, INT J COMPUT SCI NET, V9, P219; Cigizoglu HK, 2006, ADV ENG SOFTW, V37, P63, DOI 10.1016/j.advengsoft.2005.05.002; Dasgupta D, 2011, APPL SOFT COMPUT, V11, P1574, DOI 10.1016/j.asoc.2010.08.024; Erkmen B, 2008, EXPERT SYST APPL, V35, P472, DOI 10.1016/j.eswa.2007.07.021; Forrest S, 1996, SEC PRIV 1996 P 1996, P120; Freitas AA, 2007, IEEE T EVOLUT COMPUT, V11, P521, DOI 10.1109/TEVC.2006.884042; Gao F, 2014, J SYST ENG ELECTRON, P25573; Gao Wei, 2003, Systems Engineering and Electronics, V25, P1427; Ge H, 1999, THESIS S CHINA U TEC; Guo HX, 2011, APPL SOFT COMPUT, V11, P1144, DOI 10.1016/j.asoc.2010.02.014; Hajiaghaei-Keshteli M, 2011, APPL SOFT COMPUT, V11, P2069, DOI 10.1016/j.asoc.2010.07.004; He J, 2001, ARTIF INTELL, V127, P57, DOI 10.1016/S0004-3702(01)00058-3; He Jun, 2004, Natural Computing, V3, P21, DOI 10.1023/B:NACO.0000023417.31393.c7; Hua JP, 2009, PATTERN RECOGN, V42, P409, DOI 10.1016/j.patcog.2008.08.001; ILGUN K, 1995, IEEE T SOFTWARE ENG, V21, P181, DOI 10.1109/32.372146; Jawhar MMT, 2012, ADV MATER RES-SWITZ, V403-408, P3519, DOI 10.4028/www.scientific.net/AMR.403-408.3519; KDD CUP, 1999, UCI MACHINE LEARNING; Kim S, 2014, WATER RESOUR MANAG, V28, P185, DOI 10.1007/s11269-013-0479-9; Lee CM, 2009, NEUROCOMPUTING, V73, P449, DOI 10.1016/j.neucom.2009.07.005; Liang Y, 2006, CONTROL DECIS, V21; Liang Ying, 2006, Control and Decision, V21, P453; Lin SM, 2013, NEURAL COMPUT APPL, V22, P783, DOI 10.1007/s00521-011-0769-1; Lindqvist U, 1999, P IEEE S SECUR PRIV, P146, DOI 10.1109/SECPRI.1999.766911; Lippmann R, 2000, COMPUT NETW, V34, P579, DOI 10.1016/S1389-1286(00)00139-0; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Lu HY, 2010, INT J ELEC POWER, V32, P921, DOI 10.1016/j.ijepes.2010.03.001; Marengo E, 2003, J CHROMATOGR A, V1004, P13, DOI 10.1016/S0021-9673(03)00852-5; Rank E, 2003, SIGNAL PROCESS, V83, P1393, DOI 10.1016/S0165-1684(03)00088-4; Rojas I, 2002, NEUROCOMPUTING, V42, P267, DOI 10.1016/S0925-2312(01)00338-1; Sarbu C, 2005, TALANTA, V65, P1215, DOI 10.1016/j.talanta.2004.08.047; Tan GZ, 2008, J CENT SOUTH UNIV T, V15, P845, DOI 10.1007/s11771-008-0156-y; Tian DX, 2009, INT J INF SECUR, V8, P25, DOI 10.1007/s10207-008-0061-2; Timmis J, 2008, THEOR COMPUT SCI, V403, P11, DOI 10.1016/j.tcs.2008.02.011; Tong XJ, 2009, COMPUT PHYS COMMUN, V180, P1795, DOI 10.1016/j.cpc.2009.05.004; Wang J, 2014, ATMOS RES, V137, P245, DOI 10.1016/j.atmosres.2013.10.014; Wang Q, 2008, STUDIES S OCEAN, P1; Wang YN, 2010, SOFT COMPUT, V14, P193, DOI 10.1007/s00500-008-0394-9; Warrender C, 1999, P IEEE S SECUR PRIV, P133, DOI 10.1109/SECPRI.1999.766910; Wei Yu-Xin, 2006, Journal of Software, V17, P2384, DOI 10.1360/jos172384; Xiao YQ, 2011, NEUROCOMPUTING, V74, P1102, DOI 10.1016/j.neucom.2010.12.003; Yang JX, 2013, INTELL AUTOM SOFT CO, V19, P305, DOI 10.1080/10798587.2013.824161; Yao SB, 2012, SCI CHINA TECHNOL SC, V55, P3118, DOI 10.1007/s11431-012-4934-2; Yap KS, 2008, IEEE T NEURAL NETWOR, V19, P1641, DOI 10.1109/TNN.2008.2000992; Ye HT, 2010, J S CHINA U T NAT SC, V2, P28; Yu J, 2004, IEEE T SYST MAN CY B, V34, P634, DOI 10.1109/TSMCB.2003.810951; Zheng Ri-rong, 2005, Control and Decision, V20, P161; Zheng RR, 2005, CONTROL DECISION, V20	52	14	15	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120976	10.1371/journal.pone.0120976	http://dx.doi.org/10.1371/journal.pone.0120976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807466	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000121
J	Chang, YJ; Hsu, SL; Liu, YT; Lin, YH; Lin, MH; Huang, SJ; Ho, JAA; Wu, LC				Chang, Ya Ju; Hsu, Shih Lan; Liu, Yi Ting; Lin, Yu Hsuan; Lin, Ming Hui; Huang, Shu Jung; Ho, Ja-an Annie; Wu, Li-Chen			Gallic Acid Induces Necroptosis via TNF-alpha Signaling Pathway in Activated Hepatic Stellate Cells	PLOS ONE			English	Article							CATALASE GENE-EXPRESSION; OXIDATIVE STRESS; PROGRAMMED NECROSIS; NEGATIVE REGULATION; DEATH; APOPTOSIS; ANTIOXIDANT; CARCINOMA; NETWORK	Gallic acid (3, 4, 5-trihydroxybenzoic acid, GA), a natural phenolic acid widely found in gallnuts, tea leaves and various fruits, possesses several bioactivities against inflammation, oxidation, and carcinogenicity. The beneficial effect of GA on the reduction of animal hepatofibrosis has been indicated due to its antioxidative property. However, the cytotoxicity of GA autoxidation causing cell death has also been reported. Herein, we postulated that GA might target activated hepatic stellate cells (aHSCs), the cell type responsible for hepatofibrosis, to mitigate the process of fibrosis. The molecular cytotoxic mechanisms that GA exerted on aHSCs were then analyzed. The results indicated that GA elicited aHSC programmed cell death through TNF-alpha-mediated necroptosis. GA induced significant oxidative stress through the suppression of catalase activity and the depletion of glutathione (GSH). Elevated oxidative stress triggered the production of TNF-alpha facilitating the undergoing of necroptosis through the up-regulation of key necroptotic regulatory proteins TRADD and receptor-interacting protein 3 (RIP3), and the inactivation of caspase-8. Calmodulin and calpain-1 activation were engaged, which promoted subsequent lysosomal membrane permeabilization (LMP). The TNF-alpha antagonist (SPD-304) and the RIP1 inhibitor (necrostatin-1, Nec-1) confirmed GA-induced TNFR1-mediated necroptosis. The inhibition of RIP1 by Nec-1 diverted the cell death from necroptosis to apoptosis, as the activation of caspase 3 and the increase of cytochrome c. Collectively, this is the first report indicating that GA induces TNF signaling-triggered necroptosis in aHSCs, which may offer an alternative strategy for the amelioration of liver fibrosis.	[Chang, Ya Ju; Ho, Ja-an Annie] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Hsu, Shih Lan] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Liu, Yi Ting; Lin, Yu Hsuan; Lin, Ming Hui; Huang, Shu Jung; Wu, Li-Chen] Natl Chi Nan Univ, Dept Appl Chem, Puli, Taiwan	National Taiwan University; Taichung Veterans General Hospital; National Chi Nan University	Wu, LC (corresponding author), Natl Chi Nan Univ, Dept Appl Chem, Puli, Taiwan.	lw25@ncnu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	Ho, Annie/0000-0001-6684-1118	Taichung Veterans General Hospital (TCVGH)-National Chi Nan University (NCNU) [1027902, 1017901]; National Science Council of Taiwan (NSC) [101-2627-M-260-001, 101-2113-M-260-002-MY2]; National Chi Nan University; Taichung Veterans General Hospital; National Science Council Taiwan	Taichung Veterans General Hospital (TCVGH)-National Chi Nan University (NCNU); National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); National Chi Nan University; Taichung Veterans General Hospital; National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Taichung Veterans General Hospital (TCVGH)-National Chi Nan University (NCNU) 1027902, National Science Council of Taiwan (NSC) 101-2627-M-260-001, National Science Council of Taiwan (NSC) 101-2113-M-260-002-MY2, and Taichung Veterans General Hospital (TCVGH)-National Chi Nan University (NCNU)-1017901. National Chi Nan University, http://www.ncnu.edu.tw/ncnuweb/; Taichung Veterans General Hospital, http://www.vghtc.gov.tw/home/index.html; National Science Council Taiwan, http://www.most.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bors W, 2000, ARCH BIOCHEM BIOPHYS, V374, P347, DOI 10.1006/abbi.1999.1606; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chia YC, 2010, MOLECULES, V15, P8377, DOI 10.3390/molecules15118377; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Chuang CY, 2010, J AGR FOOD CHEM, V58, P2943, DOI 10.1021/jf9043265; Georgiadis Vassilis, 2012, JAKSTAT, V1, P200, DOI 10.4161/jkst.20968; Guimaraes ELM, 2006, LIVER INT, V26, P477, DOI 10.1111/j.1478-3231.2006.01245.x; Han WD, 2009, APOPTOSIS, V14, P674, DOI 10.1007/s10495-009-0334-x; Hentze H, 2002, J BIOL CHEM, V277, P5588, DOI 10.1074/jbc.M110766200; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hynes MJ, 2001, J INORG BIOCHEM, V85, P131, DOI 10.1016/S0162-0134(01)00205-7; Inoue M, 2000, BIOL PHARM BULL, V23, P1153, DOI 10.1248/bpb.23.1153; INOUE M, 1994, BIOCHEM BIOPH RES CO, V204, P898, DOI 10.1006/bbrc.1994.2544; Kawada N, 1998, HEPATOLOGY, V27, P1265, DOI 10.1002/hep.510270512; Kennedy CL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000516; Lee KW, 2005, J AGR FOOD CHEM, V53, P1990, DOI 10.1021/jf0486040; Li D, 1999, J GASTROEN HEPATOL, V14, P618, DOI 10.1046/j.1440-1746.1999.01928.x; Marra M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-171; Min JY, 2010, FEBS LETT, V584, P2427, DOI 10.1016/j.febslet.2010.04.048; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Moujalled DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.201; Nabavi SM, 2013, MOL CELL BIOCHEM, V372, P233, DOI 10.1007/s11010-012-1464-y; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Ohno Y, 1999, ANTI-CANCER DRUG, V10, P845, DOI 10.1097/00001813-199910000-00008; Pourahmad J, 2012, TOXICOL IN VITRO, V26, P545, DOI 10.1016/j.tiv.2012.01.020; Qiu XB, 2000, HEART VESSELS, V15, P90, DOI 10.1007/s003800070038; Quan X, 2011, FEBS LETT, V585, P3436, DOI 10.1016/j.febslet.2011.09.035; Rasool MK, 2010, J PHARM PHARMACOL, V62, P638, DOI 10.1211/jpp.62.05.0012; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; Russell LH, 2012, ANTICANCER RES, V32, P1595; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; SATO K, 1992, MOL CELL BIOL, V12, P2525, DOI 10.1128/MCB.12.6.2525; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Takeuchi T, 2000, J BIOCHEM-TOKYO, V128, P1025, DOI 10.1093/oxfordjournals.jbchem.a022830; Traister A, 2005, SCAND J GASTROENTERO, V40, P1226, DOI 10.1080/00365520510023341; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Yanez J, 2004, NUTR CANCER, V49, P191, DOI 10.1207/s15327914nc4902_11; You BR, 2011, MOL CELL BIOCHEM, V357, P295, DOI 10.1007/s11010-011-0900-8; You BR, 2011, DRUG CHEM TOXICOL, V34, P38, DOI 10.3109/01480545.2010.494182; Zhang YF, 2014, TOXICOL LETT, V225, P445, DOI 10.1016/j.toxlet.2014.01.005	42	34	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120713	10.1371/journal.pone.0120713	http://dx.doi.org/10.1371/journal.pone.0120713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816210	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600044
J	Flores, CL; Gancedo, C				Flores, Carmen-Lisset; Gancedo, Carlos			The Gene YALI0E20207g from Yarrowia lipolytica Encodes an N-Acetylglucosamine Kinase Implicated in the Regulated Expression of the Genes from the N-Acetylglucosamine Assimilatory Pathway	PLOS ONE			English	Article							GLUCOSE-PHOSPHORYLATING ENZYMES; BROAD-SUBSTRATE-SPECIFICITY; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; TRANSCRIPTIONAL REGULATION; MOLECULAR-CLONING; ESCHERICHIA-COLI; HEXOKINASE; IDENTIFICATION; GLUCOKINASE	The non-conventional yeast Yarrowia lipolyticapossesses an ORF, YALI0E20207g, which encodes a protein with an amino acid sequence similar to hexokinases from different organisms. We have cloned that gene and determined several enzymatic properties of its encoded protein showing that it is an N-acetylglucosamine (NAGA) kinase. This conclusion was supported by the lack of growth in NAGA of a strain carrying a YALI0E20207g deletion. We named this gene YlNAG5. Expression of YlNAG5 as well as that of the genes encoding the enzymes of the NAGA catabolic pathway-identified by a BLAST search-was induced by this sugar. Deletion of YlNAG5 rendered that expression independent of the presence of NAGA in the medium and reintroduction of the gene restored the inducibility, indicating that YlNag5 participates in the transcriptional regulation of the NAGA assimilatory pathway genes. Expression of YlNAG5 was increased during sporulation and homozygous Ylnag5/Ylnag5 diploid strains sporulated very poorly as compared with a wild type isogenic control strain pointing to a participation of the protein in the process. Overexpression of YlNAG5 allowed growth in glucose of an Ylhxk1glk1 double mutant and produced, in a wild type background, aberrant morphologies in different media. Expression of the gene in a Saccharomyces cerevisiae hxk1 hxk2 glk1 triple mutant restored ability to grow in glucose.	[Flores, Carmen-Lisset; Gancedo, Carlos] UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Metab & Cell Signalling, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Flores, CL (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Metab & Cell Signalling, Madrid, Spain.	clflores@iib.uam.es	Gancedo, Carlos/E-9831-2016; Flores, Carmen-Lisset/F-9598-2017	Gancedo, Carlos/0000-0002-6278-3667; Flores, Carmen-Lisset/0000-0002-2439-5030	Spanish Ministry for Science and Innovation (MICINN) [BFU2010-19628-C02-02]	Spanish Ministry for Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grant BFU2010-19628-C02-02 from the Spanish Ministry for Science and Innovation (MICINN, now MINECO; URL: http://www.mineco.gob.es/portal/site/mineco/) to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abghari A, 2014, FRONT ENERGY RES, DOI 10.3389/fenrg.2014.00021; ALLEN MB, 1980, BIOCHIM BIOPHYS ACTA, V614, P357, DOI 10.1016/0005-2744(80)90225-9; Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Alvarez-Anorve LI, 2011, BBA-PROTEINS PROTEOM, V1814, P1846, DOI 10.1016/j.bbapap.2011.07.010; Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; Barth G, 1996, YARROWIA LIPOLYTICA; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; BERNHEIM NJ, 1970, J BACTERIOL, V101, P384, DOI 10.1128/JB.101.2.384-391.1970; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Breidenbach MA, 2010, P NATL ACAD SCI USA, V107, P3988, DOI 10.1073/pnas.0911247107; Brigham CJ, 2005, J BACTERIOL, V187, P890, DOI 10.1128/JB.187.3.890-901.2005; BROWN DH, 1951, BIOCHIM BIOPHYS ACTA, V7, P487, DOI 10.1016/0006-3002(51)90063-7; CALCAGNO M, 1984, BIOCHIM BIOPHYS ACTA, V787, P165, DOI 10.1016/0167-4838(84)90076-1; Cho JI, 2009, PLANT SIGNAL BEHAV, V4, P908, DOI 10.4161/psb.4.9.9533; Curtin CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033840; Curtin CD, 2014, FEMS YEAST RES, V14, P997, DOI 10.1111/1567-1364.12198; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DAVAGNINO J, 1980, J BIOL CHEM, V255, P2633; Lopez MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010654; Delic M, 2013, FEMS MICROBIOL REV, V37, P872, DOI 10.1111/1574-6976.12020; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Durrens P, 2005, YEAST, V22, P337, DOI 10.1002/yea.1214; Eberhardt I, 1999, EUR J BIOCHEM, V262, P191, DOI 10.1046/j.1432-1327.1999.00370.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flores CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023695; Flores CL, 2005, MICROBIOL-SGM, V151, P1465, DOI 10.1099/mic.0.27856-0; Flores CL, 2005, EUKARYOT CELL, V4, P356, DOI 10.1128/EC.4.2.356-364.2005; GAILLARDIN C, 1987, CURR GENET, V11, P369, DOI 10.1007/BF00378179; Gaillardin C, 2012, FEMS YEAST RES, V12, P317, DOI 10.1111/j.1567-1364.2011.00782.x; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; GANCEDO JM, 1977, J BIOL CHEM, V252, P4443; Gilmore SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003799; GINDZIEN.A, 1974, EUR J BIOCHEM, V43, P155, DOI 10.1111/j.1432-1033.1974.tb03395.x; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Guo T, 2003, J CELL BIOL, V162, P1255, DOI 10.1083/jcb.200305055; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HEREDIA CF, 1968, EUR J BIOCHEM, V5, P321, DOI 10.1111/j.1432-1033.1968.tb00373.x; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; HIRAI M, 1975, BIOCHIM BIOPHYS ACTA, V391, P282, DOI 10.1016/0005-2744(75)90252-1; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jardon R, 2008, EUKARYOT CELL, V7, P1742, DOI 10.1128/EC.00169-08; Kettner K, 2007, FEMS YEAST RES, V7, P683, DOI 10.1111/j.1567-1364.2007.00259.x; Konopka JB, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/489208; KOTYK A, 1989, FOLIA MICROBIOL, V34, P1, DOI 10.1007/BF02821317; Kramarenko T, 2000, FOLIA MICROBIOL, V45, P521, DOI 10.1007/BF02818721; Kumar MJ, 2000, P NATL ACAD SCI USA, V97, P14218, DOI 10.1073/pnas.250452997; Kurtzman CP, 1999, YEASTS TAXONOMIC STU; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee H, 2014, MOL CELLS, V37, P322, DOI 10.14348/molcells.2014.2377; Lee H, 2014, MOL CELLS, V37, P248, DOI 10.14348/molcells.2014.2354; Levinson WE, 2007, ENZYME MICROB TECH, V41, P292, DOI 10.1016/j.enzmictec.2007.02.005; LOBO Z, 1977, ARCH BIOCHEM BIOPHYS, V182, P639, DOI 10.1016/0003-9861(77)90544-6; Lue NF, 2010, TRENDS BIOCHEM SCI, V35, P8, DOI 10.1016/j.tibs.2009.08.006; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; MAENPAA PH, 1968, SCIENCE, V161, P1253, DOI 10.1126/science.161.3847.1253; MAITRA PK, 1970, J BIOL CHEM, V245, P2423; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Naseem S, 2011, J BIOL CHEM, V286, P28671, DOI 10.1074/jbc.M111.249854; Nishimasu H, 2006, J BACTERIOL, V188, P2014, DOI 10.1128/JB.188.5.2014-2019.2006; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; Ottaviano D, 2014, MICROBIOL-SGM, V160, P1369, DOI 10.1099/mic.0.078543-0; Pelaez R, 2010, BIOCHEM J, V432, P181, DOI 10.1042/BJ20100663; Petit T, 1999, YEAST, V15, P1573, DOI 10.1002/(SICI)1097-0061(199911)15:15<1573::AID-YEA478>3.3.CO;2-V; Petit T, 1996, FEBS LETT, V378, P185, DOI 10.1016/0014-5793(95)01451-9; PRIOR C, 1993, MOL CELL BIOL, V13, P3882, DOI 10.1128/MCB.13.7.3882; Rao KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053638; Reith J, 2011, J BACTERIOL, V193, P5386, DOI 10.1128/JB.05514-11; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Scarcelli JJ, 2012, FEMS YEAST RES, V12, P305, DOI 10.1111/j.1567-1364.2011.00778.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Morales-Vargas AT, 2012, RES MICROBIOL, V163, P378, DOI 10.1016/j.resmic.2012.03.002; Uehara T, 2004, J BACTERIOL, V186, P7273, DOI 10.1128/JB.186.21.7273-7279.2004; VERA ML, 1984, ARCH BIOCHEM BIOPHYS, V229, P237, DOI 10.1016/0003-9861(84)90149-8; WALSH RB, 1991, GENETICS, V128, P521; Wendland J, 2009, APPL ENVIRON MICROB, V75, P5840, DOI 10.1128/AEM.00053-09; Whiteway M, 2004, CURR OPIN MICROBIOL, V7, P350, DOI 10.1016/j.mib.2004.06.005; Yamada-Okabe T, 2001, EUR J BIOCHEM, V268, P2498, DOI 10.1046/j.1432-1327.2001.02135.x; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; Young E, 2011, APPL ENVIRON MICROB, V77, P3311, DOI 10.1128/AEM.02651-10; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662	84	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122135	10.1371/journal.pone.0122135	http://dx.doi.org/10.1371/journal.pone.0122135			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816199	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600148
J	Kirichek, O; Soper, A; Dzyuba, B; Callear, S; Fuller, B				Kirichek, Oleg; Soper, Alan; Dzyuba, Boris; Callear, Sam; Fuller, Barry			Strong Isotope Effects on Melting Dynamics and Ice Crystallisation Processes in Cryo Vitrification Solutions	PLOS ONE			English	Article							KINETIC-ENERGY; MOUSE EMBRYOS; WATER	The nucleation and growth of crystalline ice during cooling, and further crystallization processes during re-warming are considered to be key processes determining the success of low temperature storage of biological objects, as used in medical, agricultural and nature conservation applications. To avoid these problems a method, termed vitrification, is being developed to inhibit ice formation by use of high concentration of cryoprotectants and ultra-rapid cooling, but this is only successful across a limited number of biological objects and in small volume applications. This study explores physical processes of ice crystal formation in a model cryoprotective solution used previously in trials on vitrification of complex biological systems, to improve our understanding of the process and identify limiting biophysical factors. Here we present results of neutron scattering experiments which show that even if ice crystal formation has been suppressed during quench cooling, the water molecules, mobilised during warming, can crystallise as detectable ice. The crystallisation happens right after melting of the glass phase formed during quench cooling, whilst the sample is still transiting deep cryogenic temperatures. We also observe strong water isotope effects on ice crystallisation processes in the cryoprotectant mixture. In the neutron scattering experiment with a fully protiated water component, we observe ready crystallisation occurring just after the glass melting transition. On the contrary with a fully deuteriated water component, the process of crystallisation is either completely or substantially supressed. This behaviour might be explained by nuclear quantum effects in water. The strong isotope effect, observed here, may play an important role in development of new cryopreservation strategies.	[Kirichek, Oleg; Soper, Alan; Callear, Sam] Rutherford Appleton Lab, ISIS Facil, STFC, Didcot OX11 0QX, Oxon, England; [Dzyuba, Boris] Univ South Bohemia Ceske Budejovice, South Bohemian Res Ctr Aquaculture & Hydrocenoses, Zatisi, Vodnany, Czech Republic; [Fuller, Barry] UCL, Dept Surg, London, England; [Fuller, Barry] UCL, Liver Transplant Unit, London, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of South Bohemia Ceske Budejovice; University of London; University College London; University of London; University College London	Kirichek, O (corresponding author), Rutherford Appleton Lab, ISIS Facil, STFC, Harwell Oxford Campus, Didcot OX11 0QX, Oxon, England.	oleg.kirichek@stfc.ac.uk	Dzyuba, Borys B/F-8997-2015	Dzyuba, Borys B/0000-0003-2083-3010; Soper, Alan/0000-0002-7903-8356	project "Strengthening of excellence scientific teams in University of South Bohemia, Faculty of Fisheries & Protection of Waters, Czech Republic" [1.07/2.3.00/20.0024]	project "Strengthening of excellence scientific teams in University of South Bohemia, Faculty of Fisheries & Protection of Waters, Czech Republic"	BD participation is supported by project "Strengthening of excellence scientific teams in University of South Bohemia, Faculty of Fisheries & Protection of Waters, Czech Republic. 1.07/2.3.00/20.0024" (http://www.frov.jcu.cz/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi J, 2010, CRYOBIOLOGY, V60, P52, DOI 10.1016/j.cryobiol.2009.11.004; Dzyuba B, 2010, CRYOBIOLOGY, V61, P404, DOI DOI 10.1016/J.CRYOBIOL.2010.10.142; Evans B, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/3/034018; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; Fuller B, 2004, LIFE IN THE FROZEN STATE, P505, DOI 10.1201/9780203647073.ch18; Habershon S, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3167790; Li XZ, 2011, P NATL ACAD SCI USA, V108, P6369, DOI 10.1073/pnas.1016653108; Markland TE, 2011, NAT PHYS, V7, P134, DOI 10.1038/NPHYS1865; Miller TF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2074967; Novikov VN, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.065701; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; RALL WF, 1987, CRYOBIOLOGY, V24, P387, DOI 10.1016/0011-2240(87)90042-3; Romanelli G, 2013, J PHYS CHEM LETT, V4, P3251, DOI 10.1021/jz401538r; Senesi R, 2013, CHEM PHYS, V427, P111, DOI 10.1016/j.chemphys.2013.09.010; Soper A., 1990, P 11 M INT COLL ADV; Soper AK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.065502; Wowk B, 2010, CRYOBIOLOGY, V60, P11, DOI 10.1016/j.cryobiol.2009.05.007; Zeidler A, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/28/284126; Zhang Tiantian, 2007, P411, DOI 10.1007/978-1-4020-6235-3_14	19	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120611	10.1371/journal.pone.0120611	http://dx.doi.org/10.1371/journal.pone.0120611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815751	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600041
J	Xu, MY; Chen, XH; Yin, H; Yin, LQ; Liu, F; Fu, YC; Yao, JW; Deng, XL				Xu, Mingyan; Chen, Xihe; Yin, Hao; Yin, Liqin; Liu, Fan; Fu, Yucai; Yao, Jiangwu; Deng, Xiaoling			Cloning and Characterization of the Human Integrin beta 6 Gene Promoter	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; EXPRESSION; ALPHA-V-BETA-6; ACTIVATION; MOTILITY; CANCER; CELLS; STAT3	The integrin beta 6 (ITGB6) gene, which encodes the limiting subunit of the integrin av beta 6 heterodimer, plays an important role in wound healing and carcinogenesis. The mechanism underlying ITGB6 regulation, including the identification of DNA elements and cognate transcription factors responsible for basic transcription of human ITGB6 gene, remains unknown. This report describes the cloning and characterization of the human ITGB6 promoter. Using 50-RACE (rapid amplification of cDNA ends) analysis, the transcriptional initiation site was identified. Promoter deletion analysis identified and functionally validated a TATA box located in the region -24 to -18 base pairs upstream of the ITGB6 promoter. The regulatory elements for transcription of the ITGB6 gene were predominantly located -289 to -150 from the ITGB6 promoter and contained putative binding sites for transcription factors such as STAT3 and C/EBP alpha. Using chromatin immunoprecipitation assays, this study has demonstrated, for the first time, that transcription factors STAT3 and C/EBP alpha are involved in the positive regulation of ITGB6 transcription in oral squamous cell carcinoma cells. These findings have important implications for unraveling the mechanism of abnormal ITGB6 activation in tissue remodeling and tumorigenesis.	[Xu, Mingyan; Yao, Jiangwu] Xiamen Stomatol Hosp, Xiamen Stomatol Res Inst, Dept Oral Biol & Biomat, Xiamen, Fujian, Peoples R China; [Xu, Mingyan; Liu, Fan; Deng, Xiaoling] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Fujian, Peoples R China; [Chen, Xihe; Yin, Hao; Yin, Liqin; Fu, Yucai] Shantou Univ, Coll Med, Lab Cell Senescence, Shantou, Guangdong, Peoples R China	Xiamen University; Shantou University	Yao, JW (corresponding author), Xiamen Stomatol Hosp, Xiamen Stomatol Res Inst, Dept Oral Biol & Biomat, Xiamen, Fujian, Peoples R China.	dentyjw@126.com; xiaolingdeng@xmu.edu.cn			National Natural Sciences Foundation of China [81072208, 30900661, 81370160]; Medical Innovation Project of Fujian Province [2014CXB-47]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Innovation Project of Fujian Province	This work was supported by the National Natural Sciences Foundation of China (81072208 to MX, 30900661 and 81370160 to XD) and Medical Innovation Project of Fujian Province (2014CXB-47 to MX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko Y, 1997, CANCER LETT, V118, P101, DOI 10.1016/S0304-3835(97)00234-6; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Bandyopadhyay A, 2009, CURR DRUG TARGETS, V10, P645, DOI 10.2174/138945009788680374; Bansal M, 2014, CURR OPIN STRUC BIOL, V25, P77, DOI 10.1016/j.sbi.2014.01.007; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Breous E, 2005, MOL CELL ENDOCRINOL, V245, P169, DOI 10.1016/j.mce.2005.11.009; BREUSS JM, 1995, J CELL SCI, V108, P2241; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Deng XL, 2013, INT J BIOCHEM CELL B, V45, P1366, DOI 10.1016/j.biocel.2013.04.003; Duran EM, 2005, FRONT BIOSCI-LANDMRK, V10, P2955, DOI 10.2741/1751; Ganguly KK, 2013, CELL ADH MIGR, V7; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Kumar M, 2013, INT J CANCER, V132, P2032, DOI 10.1002/ijc.27880; Li DR, 2012, BIOTECHNIQUES, V52, P173, DOI 10.2144/000113821; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059473; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; LopezRodriguez C, 1997, J BIOL CHEM, V272, P29120, DOI 10.1074/jbc.272.46.29120; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; STARR DB, 1995, J MOL BIOL, V250, P434; Sullivan BP, 2011, J PHARMACOL EXP THER, V337, P471, DOI 10.1124/jpet.110.177337; Thomas GJ, 2006, J ORAL PATHOL MED, V35, P1, DOI 10.1111/j.1600-0714.2005.00374.x; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zaragoza K, 2010, MOL CELL BIOL, V30, P2293, DOI 10.1128/MCB.01619-09; Zhao Y, 2012, CELL BIOCHEM FUNCT, V30, P340, DOI 10.1002/cbf.2810	33	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121439	10.1371/journal.pone.0121439	http://dx.doi.org/10.1371/journal.pone.0121439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816241	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600093
J	Zhang, L; Pan, P; Sappington, TW; Lu, WX; Luo, LZ; Jiang, XF				Zhang, Lei; Pan, Pan; Sappington, Thomas W.; Lu, Weixiang; Luo, Lizhi; Jiang, Xingfu			Accelerated and Synchronized Oviposition Induced by Flight of Young Females May Intensify Larval Outbreaks of the Rice Leaf Roller	PLOS ONE			English	Article							LONG-DURATION FLIGHT; CNAPHALOCROCIS-MEDINALIS; TRADE-OFFS; CYDIA-POMONELLA; LEPIDOPTERA; REPRODUCTION; MIGRATION; FECUNDITY; BEHAVIOR; GRASSHOPPER	Physiological management of migration-reproduction trade-offs in energy allocation often includes a package of adaptions referred to as the oogenesis-flight syndrome. In some species, this trade-off may be overestimated, because factors like flight behavior and environmental conditions may mitigate it. In this study, we examined the reproductive consequences induced by different flight scenarios in an economically-important Asian migrant insect, Cnaphalocrocis medinalis. We found that the influences of flight on reproduction are not absolutely positive or negative, but instead depend on the age at which the moth begins flight, flight duration, and how many consecutive nights they are flown. Adult flight on the 1st or 2nd night after emergence, flight for 6 h or 12 h nightly, and flight on the first two consecutive nights after emergence significantly accelerated onset of oviposition or enhanced synchrony of egg-laying. The latter can contribute to subsequent larval outbreaks. However, flight after the 3rd night, flight for 18 h at any age, or flight on more than 3 consecutive nights after adult emergence did not promote reproductive development, and in some scenarios even constrained adult reproduction. These results indicate that there is a migration/reproduction trade-off in C. medinalis, but that it is mitigated or eliminated by flight under appropriate conditions. The strategy of advanced and synchronized oviposition triggered by migratory flight of young females may be common in other migratory insect pests.	[Zhang, Lei; Pan, Pan; Lu, Weixiang; Luo, Lizhi; Jiang, Xingfu] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pest, Beijing 100193, Peoples R China; [Sappington, Thomas W.] Iowa State Univ, USDA ARS, Corn Insects & Crop Genet Res Unit, Genet Lab, Ames, IA USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Iowa State University; United States Department of Agriculture (USDA)	Jiang, XF (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pest, Beijing 100193, Peoples R China.	xfjiang@ippcaas.cn		Sappington, Thomas/0000-0002-4083-4101	Special Fund for Agro-scientific Research in the Public Interest [201403031, 200903057]; National Natural Science Foundation of China [31000850, 31071641, 31371947]; Beijing Natural Science Foundation [6142017]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was funded by projects under the Special Fund for Agro-scientific Research in the Public Interest (201403031, 200903057), the National Natural Science Foundation of China (No. 31000850, 31071641, 31371947) and the Beijing Natural Science Foundation (6142017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; BAUTISTA RC, 1984, ENVIRON ENTOMOL, V13, P439, DOI 10.1093/ee/13.2.439; CHANG SS, 1980, ACTA ENTOMOL SINICA, V23, P130; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Cheng YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031562; Colvin J., 1993, PHYSIOL ENTOMOL, V97, P828; Dale D., 1994, P363; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Elliott CG, 2012, PHYSIOL ENTOMOL, V37, P219, DOI 10.1111/j.1365-3032.2012.00835.x; [高月波 GAO YueBo], 2008, [生态学报, Acta Ecologica Sinica], V28, P5238; Gibbs M, 2010, OECOLOGIA, V163, P341, DOI 10.1007/s00442-010-1613-5; Gu HN, 2006, ECOL ENTOMOL, V31, P68, DOI 10.1111/j.0307-6946.2006.00761.x; Guerra PA, 2007, J INSECT BEHAV, V20, P377, DOI 10.1007/s10905-007-9084-1; Guerra PA, 2009, BIOL LETTERS, V5, P229, DOI 10.1098/rsbl.2008.0570; GUNN A, 1989, PHYSIOL ENTOMOL, V14, P419, DOI 10.1111/j.1365-3032.1989.tb01111.x; [韩志民 Han Zhimin], 2012, [植物保护, Plant Protection], V38, P44; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; HIGHNAM KC, 1964, J INSECT PHYSIOL, V10, P849, DOI 10.1016/0022-1910(64)90077-0; Huang Xue-fei, 2010, Nanjing Nongye Daxue Xuebao, V33, P23; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; Jiang XF, 2010, J INSECT PHYSIOL, V56, P1631, DOI 10.1016/j.jinsphys.2010.06.006; Jiang XF, 2011, ENVIRON ENTOMOL, V40, P516, DOI 10.1603/EN10199; Johnson C.G., 1969, MIGRATION DISPERSAL; Karlsson B, 2008, P ROY SOC B-BIOL SCI, V275, P2131, DOI 10.1098/rspb.2008.0404; Keil S, 2001, ECOL ENTOMOL, V26, P495, DOI 10.1046/j.1365-2311.2001.00346.x; KENNEDY JS, 1951, PHILOS T ROY SOC B, V235, P163, DOI 10.1098/rstb.1951.0003; Khan ZR, 1996, CROP PROT, V15, P121, DOI 10.1016/0261-2194(95)00066-6; Kong HL, 2010, ENVIRON ENTOMOL, V39, P1579, DOI 10.1603/EN09314; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Liao Huai-Jian, 2012, Chinese Journal of Applied Entomology, V49, P1078; Lorenz MW, 2007, J INSECT PHYSIOL, V53, P819, DOI 10.1016/j.jinsphys.2007.03.011; Luo Lizhi, 1999, Acta Entomologica Sinica, V42, P150; MASON LJ, 1989, ENVIRON ENTOMOL, V18, P980, DOI 10.1093/ee/18.6.980; MCANELLY ML, 1986, BIOL BULL, V170, P378, DOI 10.2307/1541849; Min KJ, 2004, J INSECT PHYSIOL, V50, P531, DOI 10.1016/j.jinsphys.2004.03.009; National Coordinated Research Team on Rice Leaf Roller, 1981, SCI AGR SINICA, V14, P1; Pan Pan, 2013, Chinese Journal of Applied Entomology, V50, P583, DOI 10.7679/j.issn.2095-1353.2013.083; Rankin M.A., 1986, P27; RANKIN MA, 1992, ANNU REV ENTOMOL, V37, P533, DOI 10.1146/annurev.en.37.010192.002533; RILEY JR, 1995, B ENTOMOL RES, V85, P397, DOI 10.1017/S0007485300036130; Rose DJW, 2000, AFRICAN ARMYWORM HDB; RYGG TD, 1966, ENTOMOL EXP APPL, V9, P74, DOI 10.1007/BF00341160; SAPPINGTON TW, 1992, ENVIRON ENTOMOL, V21, P677, DOI 10.1093/ee/21.4.677; Senthil N.S., 2004, PHYTOPARASITICA, V32, P433; SHEPARD BM, 1991, HDB PEST MANAGEMENT, P225; SLANSKY F, 1980, ENTOMOL EXP APPL, V28, P277, DOI 10.1007/BF00366314; Socha R, 2013, EUR J ENTOMOL, V110, P115, DOI 10.14411/eje.2013.016; Sun BB, 2013, ARCH INSECT BIOCHEM, V82, P1, DOI 10.1002/arch.21067; WALDBAUER GP, 1980, B ENTOMOL RES, V70, P65, DOI 10.1017/S0007485300009780; WILLERS JL, 1987, J INSECT PHYSIOL, V33, P803, DOI 10.1016/0022-1910(87)90027-8; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zhang X.X., 1981, J NANJING AGR UNIVER, V4, P40; Zhang XX, 1980, ENTOMOL KNOWLEDGE, V6, P241; Zhang XX, 1991, STRATEGY TECHNOLOGY, P48; Zhang Y, 2009, J ECON ENTOMOL, V102, P133, DOI 10.1603/029.102.0119; Zhao XC, 2009, J INSECT PHYSIOL, V55, P1039, DOI 10.1016/j.jinsphys.2009.07.007	56	20	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121821	10.1371/journal.pone.0121821	http://dx.doi.org/10.1371/journal.pone.0121821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815767	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600121
J	Jadaun, A; Sudhakar, DR; Subbarao, N; Dixit, A				Jadaun, Alka; Sudhakar, Raja D.; Subbarao, N.; Dixit, Aparna			In Silico Screening for Novel Inhibitors of DNA Polymerase III Alpha Subunit of Mycobacterium tuberculosis (MtbDnaE2, H37R(v))	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN MODELS; MECHANISM; PLATFORM; ANALOGS; BIOLOGY; DESIGN	Tuberculosis, a pandemic disease is caused by Mycobacterium tuberculosis (Mtb). DNA polymerase III encoded by DnaE2 of Mtb is specifically required for its survival in vivo, and hence can be considered to be a potential drug target. Amino acid sequence analysis of the MtbDnaE2 and its human counterpart does not show any significant similarity. Therefore, a 3D model of the MtbDnaE2 was generated using Modeller 9v10 with the template structure of E. Coli DNA polymerase III alpha subunit (2HNH_A). The generated models were validated using a number of programmes such as RAMPAGE/PROCHECK, VERIFY_3D, and ProSA. MtbDnaE2 has few conserved residues and four conserved domains similar to that present in DNA polymerase III of E. coli. In silico screening was performed with bioactive anti-tuberculosis compounds and 6-AU (a known inhibitor of DNA polymerase III of Bacillus subtilis) and its analogues against the modeled MtbDnaE2 structure. Docking was performed using GOLD v5.2 software which resulted in the identification of top ten compounds with high GOLD fitness scores and binding affinity (X-Score). To further evaluate the efficacy of these compounds, in silico ADMET analysis was performed using MedChem Designer v3. Given their high binding affinity to the targeted MtbDnaE2, which is essential for DNA replication in the Mtb and good ADMET properties, these compounds are promising candidates for further evaluation and development as anti-tubercular agents.	[Jadaun, Alka; Dixit, Aparna] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Sudhakar, Raja D.; Subbarao, N.] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Subbarao, N (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	nsrao.jnu@gmail.com; adixit7@gmail.com	Subbarao, Prof Naidu/AAZ-1832-2020	Subbarao, Prof Naidu/0000-0002-1720-2165	Department of Biotechnology (DBT), Government of India, New Delhi at the Centre of Excellence in Bioinformatics at SCIS and SBT, JNU, New Delhi	Department of Biotechnology (DBT), Government of India, New Delhi at the Centre of Excellence in Bioinformatics at SCIS and SBT, JNU, New Delhi	Used infrastructure supported by the Department of Biotechnology (DBT), Government of India, New Delhi at the Centre of Excellence in Bioinformatics at SCIS and SBT, JNU, New Delhi and financial support provided to JNU, New Delhi, under the DBT-BUILDER programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Anishetty S, 2005, COMPUT BIOL CHEM, V29, P368, DOI 10.1016/j.compbiolchem.2005.07.001; [Anonymous], 2010, Drug Discov Today Technol, V7, pe203, DOI 10.1016/j.ddtec.2010.10.003; [Anonymous], 1994, Espacenet Patent search Bibliographic data, Patent No. [EP0589201(A1), 0589201]; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Bailey S, 2006, CELL, V126, P893, DOI 10.1016/j.cell.2006.07.027; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Barnes MH, 1998, BIOCHEMISTRY-US, V37, P15254, DOI 10.1021/bi981113m; Barros T, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-8; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Bethesda MD, 2013, NCBI HDB; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BROWN NC, 1986, DRUG EXP CLIN RES, V12, P555; BROWN NC, 1977, J MED CHEM, V20, P1186, DOI 10.1021/jm00219a015; Brown NC, 1999, CURR OPIN ANTIINFECT, V1, P45; Clark DE, 1999, J PHARM SCI-US, V88, P807, DOI 10.1021/js9804011; CLEMENTS JE, 1975, J BIOL CHEM, V250, P522; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cook WJ, 2010, ACTA CRYSTALLOGR D, V66, P190, DOI 10.1107/S0907444909049051; COZZARELLI NR, 1977, ANNU REV BIOCHEM, V46, P641, DOI 10.1146/annurev.bi.46.070177.003233; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gobec S, 2004, BIOORG MED CHEM LETT, V14, P3559, DOI 10.1016/j.bmcl.2004.04.052; Goswami T, 2013, ARCH ORAL BIOL, V58, P545, DOI 10.1016/j.archoralbio.2012.09.020; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Lamers MH, 2006, CELL, V126, P881, DOI 10.1016/j.cell.2006.07.028; Levchenko I, 2009, STRUCTURE RSSB CLPX, DOI [10.2210/pdb3eod/pdb, DOI 10.2210/PDB3EOD/PDB]; Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; McKinney JD, 1998, BIOMED RES REP, P51; Meyer EF, 1997, PROTEIN SCI, V6, P1591, DOI 10.1002/pro.5560060724; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Parniak MA, 2003, ANAL BIOCHEM, V322, P33, DOI 10.1016/j.ab.2003.06.001; Pathak AK, 2004, J MED CHEM, V47, P273, DOI 10.1021/jm030389b; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Simon CL, 2003, STRUCTURE FUNCTION G, V50, P437; Sriram D, 2004, BIOORG MED CHEM LETT, V14, P1085, DOI 10.1016/j.bmcl.2004.01.007; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Suenderhauf C, 2014, PHARM RES; Tarantino PM, 1999, J MED CHEM, V42, P2035, DOI 10.1021/jm980693i; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todeschini R., 2008, HDB MOL DESCRIPTORS; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; WHO (World Health Organization), 2004, WHO IUATLD GLOB PROJ; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WRIGHT GE, 1984, J MED CHEM, V27, P181, DOI 10.1021/jm00368a013; WRIGHT GE, 1990, PHARMACOL THERAPEUT, V47, P447, DOI 10.1016/0163-7258(90)90066-B	51	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119760	10.1371/journal.pone.0119760	http://dx.doi.org/10.1371/journal.pone.0119760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811866	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700024
J	Wang, CH; Huang, SB; Yang, MC; Lin, YT; Chu, IH; Shen, YN; Chiu, YH; Hung, SH; Kang, L; Hong, YR; Chen, CH				Wang, Chihuei; Huang, Shih-Bo; Yang, Min-Chi; Lin, Yi-Tsen; Chu, I-Hung; Shen, Ya-Ni; Chiu, Yueh-Ho; Hung, Shao-Hung; Kang, Lin; Hong, Yi-Ren; Chen, Chung-Hwan			Combining Paclitaxel with ABT-263 Has a Synergistic Effect on Paclitaxel Resistant Prostate Cancer Cells	PLOS ONE			English	Article							PROMOTES SURVIVAL; BH3-ONLY PROTEINS; BCL-2; APOPTOSIS; ABT-737; INHIBITOR; DEATH; MCL-1; MITOCHONDRIA; ANTAGONIST	We assessed the capability of paclitaxel, one of the taxanes, to induce death in two prostate cancer lines, LNCaP and PC3. Paclitaxel drove an apoptotic pathway in LNCaP, but not in PC3 cells, in response to G2/M arrest. An examination of the levels of anti-apoptotic proteins revealed that Bcl-xl was much higher in PC3 cells than in LNCaP cells and Bcl2 could be detected only in PC3 cells, not in LNCaP cells. Knocking down Bcl-xl enhanced paclitaxel-induced apoptosis in LNCaP cells, while we were unable to knock down Bcl-xl efficiently in PC3 cells. Significantly, a comparison of ABT-263, a specific inhibitor of Bcl2 and Bcl-xl, with ABT-199, a Bcl2 selective inhibitor, disclosed that only ABT-263, not ABT-199, could induce apoptosis in LNCaP and PC3 cells. The results indicate that Bcl-xl has a protective role against paclitaxel-induced apoptosis in LNCaP and PC3 cells, and its overexpression causes the paclitaxel resistance seen in PC3 cells. Interestingly, combined paclitaxel with ABT-263 to treat LNCaP and PC3 cells demonstrated synergistic apoptosis activation, indicating that ABT-263 could enhance paclitaxel-induced apoptosis in LNCaP cells and overcome Bcl-xl overexpression to trigger paclitaxel-induced apoptosis in PC3 cells. We also observed that the activation of apoptosis in LNCaP cells was more efficient than in PC3 cells in response to paclitaxel plus ABT-263 or to ABT-263 alone, suggesting that the apoptosis pathway in PC3 cells might have further differences from that in LNCaP cells even after Bcl-xl overexpression is accounted for.	[Wang, Chihuei; Huang, Shih-Bo; Yang, Min-Chi; Lin, Yi-Tsen; Chu, I-Hung; Shen, Ya-Ni; Chiu, Yueh-Ho] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Hung, Shao-Hung] Fooyin Univ Hosp, Dept Orthoped Surg, Pinutung, Taiwan; [Kang, Lin] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan 70101, Taiwan; [Kang, Lin] Natl Cheng Kung Univ Hosp, Dept Obstet & Gynecol, Tainan 70428, Taiwan; [Hong, Yi-Ren] Kaohsiung Med Univ, Dept Biochem, Kaohsiung, Taiwan; [Chen, Chung-Hwan] Kaohsiung Med Univ, Dept Orthoped, Kaohsiung, Taiwan; [Chen, Chung-Hwan] Kaohsiung Med Univ Hosp, Dept Orthoped, Kaohsiung, Taiwan	Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wang, CH (corresponding author), Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan.	chwang@kmu.edu.tw; hwan@cc.kmu.edu.tw	Chen, Chung-Hwan/D-4036-2009; Huang, Shih-Bo/AAO-9699-2021	Chen, Chung-Hwan/0000-0001-8941-4792; Huang, Shih-Bo/0000-0002-1048-2344; Hong, Yi-Ren/0000-0001-5470-6090	National Health Research Institutes of Taiwan [EX99-9935EI]; Kaohsiung medical University [KMU-M103005]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Kaohsiung medical University	This research was supported by Grant EX99-9935EI (to CHC) from the National Health Research Institutes of Taiwan; Grant KMU-M103005 (to CW) from Kaohsiung medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billard C, 2013, MOL CANCER THER, V12, P1691, DOI 10.1158/1535-7163.MCT-13-0058; Boiani M, 2013, J BIOL CHEM, V288, P6980, DOI 10.1074/jbc.M112.414177; Castilla C, 2006, ENDOCRINOLOGY, V147, P4960, DOI 10.1210/en.2006-0502; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Fojo AT, 2005, SEMIN ONCOL, V32, pS3, DOI 10.1053/j.seminoncol.2005.09.010; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Gogada R, 2012, J BIOL CHEM; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Happo L, 2012, J CELL SCI, V125, P1081, DOI 10.1242/jcs.090514; Hari M, 2006, MOL CANCER THER, V5, P270, DOI 10.1158/1535-7163.MCT-05-0190; Janssen K, 2007, BLOOD, V110, P3662, DOI 10.1182/blood-2007-02-073213; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kutuk O, 2010, CELL DEATH DIFFER, V17, P1624, DOI 10.1038/cdd.2010.41; Kutuk O, 2008, CANCER RES, V68, P7985, DOI 10.1158/0008-5472.CAN-08-1418; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Ni ZH, 2014, FREE RADICAL BIO MED, V70, P194, DOI 10.1016/j.freeradbiomed.2014.02.012; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Parrondo R, 2013, PEERJ, V1, DOI 10.7717/peerj.144; Ranganathan S, 1998, BRIT J CANCER, V77, P562, DOI 10.1038/bjc.1998.91; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vo TT, 2010, ADV EXP MED BIOL, V687, P49; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304	34	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120913	10.1371/journal.pone.0120913	http://dx.doi.org/10.1371/journal.pone.0120913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811469	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700065
J	Baronian, G; Ginda, K; Berry, L; Cohen-Gonsaud, M; Zakrzewska-Czerwinska, J; Jakimowicz, D; Molle, V				Baronian, Gregory; Ginda, Katarzyna; Berry, Laurence; Cohen-Gonsaud, Martin; Zakrzewska-Czerwinska, Jolanta; Jakimowicz, Dagmara; Molle, Virginie			Phosphorylation of Mycobacterium tuberculosis ParB Participates in Regulating the ParABS Chromosome Segregation System	PLOS ONE			English	Article							SER/THR PROTEIN-KINASES; STREPTOMYCES-COELICOLOR A3(2); BACILLUS-SUBTILIS CHROMOSOME; FATTY-ACID SYNTHASE; CAULOBACTER-CRESCENTUS; BIPOLAR LOCALIZATION; PARTITIONING PROTEIN; REPLICATION ORIGIN; LINEAR CHROMOSOME; ESCHERICHIA-COLI	Here, we present for the first time that Mycobacterium tuberculosis ParB is phosphorylated by several mycobacterial Ser/Thr protein kinases in vitro. ParB and ParA are the key components of bacterial chromosome segregation apparatus. ParB is a cytosolic conserved protein that binds specifically to centromere-like DNA parS sequences and interacts with ParA, a weak ATPase required for its proper localization. Mass spectrometry identified the presence of ten phosphate groups, thus indicating that ParB is phosphorylated on eight threonines, Thr32, Thr41, Thr53, Thr110, Thr195, and Thr254, Thr300, Thr303 as well as on two serines, Ser5 and Ser239. The phosphorylation sites were further substituted either by alanine to prevent phosphorylation or aspartate to mimic constitutive phosphorylation. Electrophoretic mobility shift assays revealed a drastic inhibition of DNA-binding by ParB phosphomimetic mutant compared to wild type. In addition, bacterial two-hybrid experiments showed a loss of ParA-ParB interaction with the phosphomimetic mutant, indicating that phosphorylation is regulating the recruitment of the partitioning complex. Moreover, fluorescence microscopy experiments performed in the surrogate Mycobacterium smegmatis Delta parB strain revealed that in contrast to wild type Mtb ParB, which formed subpolar foci similar to M. smegmatis ParB, phoshomimetic Mtb ParB was delocalized. Thus, our findings highlight a novel regulatory role of the different isoforms of ParB representing a molecular switch in localization and functioning of partitioning protein in Mycobacterium tuberculosis.	[Baronian, Gregory; Berry, Laurence; Molle, Virginie] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Montpellier, France; [Baronian, Gregory; Berry, Laurence; Molle, Virginie] Univ Montpellier I, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Montpellier, France; [Ginda, Katarzyna; Zakrzewska-Czerwinska, Jolanta; Jakimowicz, Dagmara] Univ Wroclaw, Fac Biotechnol, Dept Mol Microbiol, PL-50138 Wroclaw, Poland; [Cohen-Gonsaud, Martin] Univ Montpellier 2, Ctr Biochim Struct, CNRS, UMR 5048, Montpellier, France; [Cohen-Gonsaud, Martin] Univ Montpellier I, Ctr Biochim Struct, CNRS, UMR 5048, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Wroclaw; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Molle, V (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Montpellier, France.	virginie.molle@univ-montp2.fr	MOLLE, Virginie/D-4050-2019; Jakimowicz, Dagmara/AAK-1908-2021	MOLLE, Virginie/0000-0002-6573-3411; Jakimowicz, Dagmara/0000-0002-7857-064X; Berry, laurence/0000-0002-8150-7860; Cohen-Gonsaud, Martin/0000-0002-0150-9912	National Research Agency [ANR-09-MIEN-004]; ATIP/AVENIR Program; Region Languedoc-Roussilon; Wroclaw Research Center EIT+ under the project Biotechnologies and advanced medical technologies-BioMed - European Regional Development Fund (Operational Program Innovative Economy) [POIG 1.1., Project 3.1., 1.1.2]	National Research Agency(French National Research Agency (ANR)); ATIP/AVENIR Program; Region Languedoc-Roussilon; Wroclaw Research Center EIT+ under the project Biotechnologies and advanced medical technologies-BioMed - European Regional Development Fund (Operational Program Innovative Economy)	This work was supported by grants from the National Research Agency (ANR-09-MIEN-004) and the ATIP/AVENIR Program for V.M., and the Region Languedoc-Roussilon for G.B. and from the Wroclaw Research Center EIT+ under the project Biotechnologies and advanced medical technologies -BioMed (POIG 1.1. Project 3.1.) financed from the European Regional Development Fund (Operational Program Innovative Economy, 1.1.2) for KG, JZ-C and DJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barthe P, 2009, STRUCTURE, V17, P568, DOI 10.1016/j.str.2009.02.012; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Casart Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-51; Chaudhuri BN, 2011, J MOL BIOL, V413, P901, DOI 10.1016/j.jmb.2011.08.002; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Donovan C, 2010, J BACTERIOL, V192, P3441, DOI 10.1128/JB.00214-10; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; Ginda K, 2013, MOL MICROBIOL, V87, P998, DOI 10.1111/mmi.12146; Godfrin-Estevenon AM, 2002, MOL MICROBIOL, V43, P39, DOI 10.1046/j.1365-2958.2002.02735.x; Harms A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003802; Huang Q, 2007, CURR TOP MED CHEM, V7, P527, DOI 10.2174/156802607780059790; Iniesta AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086897; Ireton K, 1998, CURR OPIN CELL BIOL, V10, P276, DOI 10.1016/S0955-0674(98)80151-8; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jakimowicz D, 2002, MOL MICROBIOL, V45, P1365, DOI 10.1046/j.1365-2958.2002.03102.x; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Leiba J, 2013, J BIOL CHEM, V288, P16546, DOI 10.1074/jbc.M112.398503; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Lewis PJ, 1997, MOL MICROBIOL, V25, P945, DOI 10.1111/j.1365-2958.1997.mmi530.x; Lewis RA, 2002, MICROBIOL-SGM, V148, P537, DOI 10.1099/00221287-148-2-537; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Madiraju MVVS, 2006, MOL MICROBIOL, V59, P1876, DOI 10.1111/j.1365-2958.2006.05068.x; Maloney E, 2009, TUBERCULOSIS, V89, pS65, DOI 10.1016/S1472-9792(09)70015-0; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Plocinska R, 2014, J BACTERIOL, V196, P4120, DOI 10.1128/JB.01795-14; Qin MH, 1999, GENE, V233, P121, DOI 10.1016/S0378-1119(99)00148-1; RAJAGOPALAN M, 1995, J BACTERIOL, V177, P6527, DOI 10.1128/jb.177.22.6527-6535.1995; Rajagopalan M, 2005, FEMS MICROBIOL LETT, V250, P9, DOI 10.1016/j.femsle.2005.06.043; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shiloh MU, 2010, CURR OPIN MICROBIOL, V13, P86, DOI 10.1016/j.mib.2009.11.006; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Zawilak A, 2004, BIOCHEM J, V382, P247, DOI 10.1042/BJ20040338	56	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119907	10.1371/journal.pone.0119907	http://dx.doi.org/10.1371/journal.pone.0119907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807382	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000048
J	Edward, DP; Alkatan, H; Rafiq, Q; Eberhart, C; Al Mesfer, S; Ghazi, N; Al Safieh, L; Kondkar, AA; Abu Amero, KK				Edward, Deepak P.; Alkatan, Hind; Rafiq, Qundeel; Eberhart, Charles; Al Mesfer, Saleh; Ghazi, Nicola; Al Safieh, Leen; Kondkar, Altaf A.; Abu Amero, Khaled K.			MicroRNA Profiling in Intraocular Medulloepitheliomas	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; TOLL-LIKE RECEPTORS; CILIARY BODY; ANTICANCER CHEMOTHERAPY; EXPRESSION; CANCER; DISEASES; TUMOR; RADIOTHERAPY; SUPPRESSION	Purpose To study the differential expression of microRNA (miRNA) profiles between intraocular medulloepithelioma (ME) and normal control tissue (CT). Material and Methods Total RNA was extracted from formalin fixed paraffin embedded (FFPE) intraocular ME (n=7) and from age matched ciliary body controls (n=8). The clinical history and phenotype was recorded. MiRNA profiles were determined using the Affymetrix GeneChip miRNA Arrays analyzed using expression console 1.3 software. Validation of significantly dysregulated miRNA was confimed by quantitaive real-time PCR. The web-based DNA Intelligent Analysis (DIANA)-miRPath v2.0 was used to perform enrichment analysis of differentially expressed (DE) miRNA gene targets in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. Results The pathologic evaluation revealed one benign (benign non-teratoid, n=1) and six malignant tumors (malignant teratoid, n=2; malignant non-teratoid, n = 4). A total of 88 miRNAs were upregulated and 43 miRNAs were downregulated significantly (P<0.05) in the tumor specimens. Many of these significantly dysregulated miRNAs were known to play various roles in carcinogenesis and tumor behavior. RT-PCR validated three significantly upregulated miRNAs and three significantly downregulated miRNAs namely miR-217, miR-216a, miR-216b, miR-146a, miR-509-3p and miR-211. Many DE miRNAs that were significant in ME tumors showed dysregulation in retinoblastoma, glioblastoma, and precursor, normal and reactive human cartilage. Enriched pathway analysis suggested a significant association of upregulated miRNAs with 15 pathways involved in prion disease and several types of cancer. The pathways involving significantly downregulated miRNAs included the toll-like receptor (TLR) (p<4.36E-16) and Nuclear Factor kappa B (NF-kappa B) signaling pathways (p<9.00E-06). Conclusions We report significantly dysregulated miRNAs in intraocular ME tumors, which exhibited abnormal profiles in other cancers as well such as retinoblastoma and glioblastoma. Pathway analysis of all dysregulated miRNAs shared commonalities with other cancer pathways.	[Edward, Deepak P.; Alkatan, Hind; Al Mesfer, Saleh; Ghazi, Nicola; Al Safieh, Leen] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Edward, Deepak P.; Rafiq, Qundeel; Eberhart, Charles] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD USA; [Kondkar, Altaf A.; Abu Amero, Khaled K.] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [Abu Amero, Khaled K.] Univ Florida, Coll Med, Dept Ophthalmol, Jacksonville, FL USA	King Khaled Eye Specialist Hospital; Johns Hopkins University; Johns Hopkins Medicine; King Saud University; State University System of Florida; University of Florida	Edward, DP (corresponding author), King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia.	dedwar39@jhmi.edu	Ghazi, Nicola/AAH-4169-2020; Kondkar, Altaf/ACU-8038-2022; ALKATAN, HIND M/AAU-3752-2021	Ghazi, Nicola/0000-0001-9255-8025; Kondkar, Altaf/0000-0002-5516-6951; ALKATAN, HIND M/0000-0002-9968-4099	KKESH-JHU collaborative grant [KKESHJHU/02-04]	KKESH-JHU collaborative grant	This study was funded by the KKESH-JHU collaborative grant KKESHJHU/02-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalaei-Andabili SH, 2013, IMMUNOTHERAPY-UK, V5, P1127, DOI 10.2217/imt.13.112; Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Ali S, 2012, J CELL PHYSIOL, V227, P3373, DOI 10.1002/jcp.24036; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bradley BS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-21; BROUGHTON WL, 1978, AM J OPHTHALMOL, V85, P407, DOI 10.1016/S0002-9394(14)77739-6; CANNING CR, 1988, BRIT J OPHTHALMOL, V72, P764, DOI 10.1136/bjo.72.10.764; Chen SD, 2014, GENE DEV, V28, P1054, DOI 10.1101/gad.239681.114; Chu TH, 2013, CANCER LETT, V337, P115, DOI 10.1016/j.canlet.2013.05.032; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; de Yebenes VG, 2014, BLOOD, V124, P229, DOI 10.1182/blood-2013-12-543611; Dungwa JV, 2012, HISTOPATHOLOGY, V61, P417, DOI 10.1111/j.1365-2559.2012.04227.x; Dunmire JJ, 2013, EXP EYE RES, V108, P68, DOI 10.1016/j.exer.2012.10.016; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Foulkes WD, 2014, NAT REV CANCER, V14, P662, DOI 10.1038/nrc3802; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Garcia-Feijoo J, 2005, J ULTRAS MED, V24, P247, DOI 10.7863/jum.2005.24.2.247; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang KM, 2008, MAMM GENOME, V19, P510, DOI 10.1007/s00335-008-9127-8; Iida K, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-21; Janssens S, 2003, CLIN MICROBIOL REV, V16, P637, DOI 10.1128/CMR.16.4.637-646.2003; Jeong BH, 2014, J KOREAN MED SCI, V29, P623, DOI 10.3346/jkms.2014.29.5.623; Kaliki S, 2013, OPHTHALMOLOGY, V120, P2552, DOI 10.1016/j.ophtha.2013.05.015; Korshunov A, 2014, ACTA NEUROPATHOL, V128, P279, DOI 10.1007/s00401-013-1228-0; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Krutilina R, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3693; Kunz M, 2013, ADV EXP MED BIOL, V774, P103, DOI 10.1007/978-94-007-5590-1_6; Li H, 2013, NEOPLASMA, V60, P511, DOI 10.4149/neo_2013_066; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; McAlinden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075012; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; McLendon Roger E, 2002, Brain Tumor Pathol, V19, P51, DOI 10.1007/BF02478927; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murray MJ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.1; Peng CH, 2012, BRIT J OPHTHALMOL, V96, P747, DOI 10.1136/bjophthalmol-2011-300585; Ragusa M, 2013, MOL VIS, V19, P430; Saunders T, 2012, ARCH PATHOL LAB MED, V136, P212, DOI 10.5858/arpa.2010-0669-RS; Seok JK, 2014, NUCLEIC ACIDS RES, V42, P8062, DOI 10.1093/nar/gku515; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Shields JA, 1996, OPHTHALMOLOGY, V103, P1998, DOI 10.1016/S0161-6420(96)30394-1; Slade I, 2011, J MED GENET, V48, P273, DOI 10.1136/jmg.2010.083790; Su J, 2014, MOL CELL BIOCHEM, V392, P289, DOI 10.1007/s11010-014-2039-x; Takei H, 2007, PATHOL INT, V57, P91, DOI 10.1111/j.1440-1827.2006.02062.x; Theriault BL, 2014, CLIN EXP OPHTHALMOL, V42, P33, DOI 10.1111/ceo.12132; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; To KH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-69; Vajaranant TS, 2005, NEUROIMAG CLIN N AM, V15, P69, DOI 10.1016/j.nic.2005.02.008; Vimalraj S, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/451248; Vinnakota K, 2013, NEURO-ONCOLOGY, V15, P1457, DOI 10.1093/neuonc/not115; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wu CR, 2012, INVEST OPHTH VIS SCI, V53, P3906, DOI 10.1167/iovs.11-9178; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369; Xue Y, 2013, CANCER GENET-NY, V206, P217, DOI 10.1016/j.cancergen.2013.05.020; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; ZIMMERMAN LE, 1971, AM J OPHTHALMOL, V72, P1039	62	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121706	10.1371/journal.pone.0121706	http://dx.doi.org/10.1371/journal.pone.0121706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807141	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000174
J	Groves, RA; Hagel, JM; Zhang, Y; Kilpatrick, K; Levy, A; Marsolais, F; Lewinsohn, E; Sensen, CW; Facchini, PJ				Groves, Ryan A.; Hagel, Jillian M.; Zhang, Ye; Kilpatrick, Korey; Levy, Asaf; Marsolais, Frederic; Lewinsohn, Efraim; Sensen, Christoph W.; Facchini, Peter J.			Transcriptome Profiling of Khat (Catha edulis) and Ephedra sinica Reveals Gene Candidates Potentially Involved in Amphetamine-Type Alkaloid Biosynthesis	PLOS ONE			English	Article							PHENYLPROPYLAMINO ALKALOIDS; EXPRESSION; AMINOTRANSFERASE; BENZALDEHYDE; ARABIDOPSIS; CLONING; ENZYME; ACCUMULATION; METABOLISM; CATABOLISM	Amphetamine analogues are produced by plants in the genus Ephedra and by khat (Catha edulis), and include the widely used decongestants and appetite suppressants (1S,2S)-pseudoephedrine and (1R,2S)-ephedrine. The production of these metabolites, which derive from L-phenylalanine, involves a multi-step pathway partially mapped out at the biochemical level using knowledge of benzoic acid metabolism established in other plants, and direct evidence using khat and Ephedra species as model systems. Despite the commercial importance of amphetamine-type alkaloids, only a single step in their biosynthesis has been elucidated at the molecular level. We have employed Illumina next-generation sequencing technology, paired with Trinity and Velvet-Oases assembly platforms, to establish data-mining frameworks for Ephedra sinica and khat plants. Sequence libraries representing a combined 200,000 unigenes were subjected to an annotation pipeline involving direct searches against public databases. Annotations included the assignment of Gene Ontology (GO) terms used to allocate unigenes to functional categories. As part of our functional genomics program aimed at novel gene discovery, the databases were mined for enzyme candidates putatively involved in alkaloid biosynthesis. Queries used for mining included enzymes with established roles in benzoic acid metabolism, as well as enzymes catalyzing reactions similar to those predicted for amphetamine alkaloid metabolism. Gene candidates were evaluated based on phylogenetic relationships, FPKM-based expression data, and mechanistic considerations. Establishment of expansive sequence resources is a critical step toward pathway characterization, a goal with both academic and industrial implications.	[Groves, Ryan A.; Hagel, Jillian M.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Zhang, Ye; Sensen, Christoph W.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Kilpatrick, Korey; Marsolais, Frederic] Univ Western Ontario, Dept Biol, London, ON, Canada; [Levy, Asaf] Agr & Agrifood, Southern Crop Protect & Food Res Ctr, London, ON, Canada; [Levy, Asaf] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Levy, Asaf; Lewinsohn, Efraim] Agr Res Org, Newe Yaar Res Ctr, Dept Aromat Med & Spice Crops, IL-30095 Ramat Yishay, Israel	University of Calgary; University of Calgary; Western University (University of Western Ontario); Hebrew University of Jerusalem	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca	Sensen, Christoph W./C-1798-2013	Sensen, Christoph W./0000-0001-9604-8962; Marsolais, Frederic/0000-0003-3914-141X	Binational Agricultural Research and Development Fund [CA-9117-09]; Israel Science Foundation [814/06]; Biorefining Conversions Network - Alberta Innovates Bio Solutions	Binational Agricultural Research and Development Fund; Israel Science Foundation(Israel Science Foundation); Biorefining Conversions Network - Alberta Innovates Bio Solutions	This work was supported through grants from the Binational Agricultural Research and Development Fund (CA-9117-09), the Israel Science Foundation (814/06), and the Biorefining Conversions Network funded by Alberta Innovates Bio Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Balint EE, 2009, WIEN KLIN WOCHENSCHR, V121, P604, DOI 10.1007/s00508-009-1259-7; Biastoff S, 2009, PHYTOCHEMISTRY, V70, P1708, DOI 10.1016/j.phytochem.2009.06.012; Chang AK, 1997, BIOCHEM J, V327, P161, DOI 10.1042/bj3270161; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Davis EM, 2005, PLANT PHYSIOL, V137, P873, DOI 10.1104/pp.104.053306; de la Torre F, 2006, PLANT J, V46, P414, DOI 10.1111/j.1365-313X.2006.02713.x; Drew DP, 2013, INT J MOL SCI, V14, P9080, DOI 10.3390/ijms14059080; Engel S, 2003, BIOTECHNOL BIOENG, V83, P833, DOI 10.1002/bit.10728; Finet C, 2010, CURR BIOL, V20, P2217, DOI 10.1016/j.cub.2010.11.035; Gaasterland T, 1996, TRENDS GENET, V12, P76, DOI 10.1016/0168-9525(96)81406-5; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gonda I, 2010, J EXP BOT, V61, P1111, DOI 10.1093/jxb/erp390; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Groot MNN, 1999, APPL ENVIRON MICROB, V65, P5590; GRUESORENSEN G, 1994, J AM CHEM SOC, V116, P6195, DOI 10.1021/ja00093a019; GRUESORENSEN G, 1989, CAN J CHEM, V67, P998, DOI 10.1139/v89-152; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2012, TRENDS PLANT SCI, V17, P404, DOI 10.1016/j.tplants.2012.03.004; Hagel JM, 2011, GENET MOL BIOL, V34, P640, DOI 10.1590/S1415-47572011000400017; Ibdah M, 2009, PLANT PHYSIOL, V150, P416, DOI 10.1104/pp.109.135848; Ingram CU, 2007, BIOTECHNOL BIOENG, V96, P559, DOI 10.1002/bit.21125; Iversen L., 2006, SPEED ECSTASY RITALI; Klein A, 2009, INT J DRUG POLICY, V20, P509, DOI 10.1016/j.drugpo.2009.05.002; KLEIN RR, 1995, PLANT MOL BIOL, V27, P249, DOI 10.1007/BF00020181; Krizevski R, 2007, J ETHNOPHARMACOL, V114, P432, DOI 10.1016/j.jep.2007.08.042; Krizevski R, 2012, PHYTOCHEMISTRY, V81, P71, DOI 10.1016/j.phytochem.2012.05.018; Krizevski R, 2010, PHYTOCHEMISTRY, V71, P895, DOI 10.1016/j.phytochem.2010.03.019; Krizevski R, 2008, ISR J PLANT SCI, V56, P207, DOI 10.1560/IJPS.56.3.207; Kursteiner O, 2003, PLANT PHYSIOL, V132, P968, DOI 10.1104/pp.102.016907; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee EJ, 2011, PLANT PHYSIOL, V157, P1067, DOI 10.1104/pp.111.185512; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liu L., 2009, ESSENTIALS CHINESE M; Long MC, 2009, PLANT J, V59, P256, DOI 10.1111/j.1365-313X.2009.03864.x; Maeda H, 2011, NAT CHEM BIOL, V7, P19, DOI [10.1038/nchembio.485, 10.1038/NCHEMBIO.485]; McGettigan PA, 2013, CURR OPIN CHEM BIOL, V17, P4, DOI 10.1016/j.cbpa.2012.12.008; Meyer D, 2011, J AM CHEM SOC, V133, P3609, DOI 10.1021/ja110236w; NAKAJIMA K, 1993, P NATL ACAD SCI USA, V90, P9591, DOI 10.1073/pnas.90.20.9591; Okada T, 2008, BIOL PHARM BULL, V31, P2194, DOI 10.1248/bpb.31.2194; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; PORTSTEFFEN A, 1994, PHYTOCHEMISTRY, V37, P391, DOI 10.1016/0031-9422(94)85066-6; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qualley AV, 2012, P NATL ACAD SCI USA, V109, P16383, DOI 10.1073/pnas.1211001109; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Vogel M, 2010, J BIOL CHEM, V285, P18397, DOI 10.1074/jbc.M109.088989; Ward J, 2010, CURR ORG CHEM, V14, P1914, DOI 10.2174/138527210792927546; Xiao M, 2013, J BIOTECHNOL, V166, P122, DOI 10.1016/j.jbiotec.2013.04.004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	50	14	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119701	10.1371/journal.pone.0119701	http://dx.doi.org/10.1371/journal.pone.0119701			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806807	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000036
J	Helsen, K; Vlaeyen, JWS; Goubert, L				Helsen, Kim; Vlaeyen, Johan W. S.; Goubert, Liesbet			Indirect Acquisition of Pain-Related Fear: An Experimental Study of Observational Learning Using Coloured Cold Metal Bars	PLOS ONE			English	Article							CHRONIC MUSCULOSKELETAL PAIN; SELECTIVE ATTENTIONAL BIAS; LOW-BACK-PAIN; CATASTROPHIZING SCALE; AVOIDANCE; THREAT; OTHERS; RELIABILITY; ASSOCIATION; AWARENESS	Background Previous research has demonstrated that pain-related fear can be acquired through observation of another's pain behaviour during an encounter with a painful stimulus. The results of two experimental studies were presented, each with a different pain stimulus, of which the aim was to investigate the effect of observational learning on pain expectancies, avoidance behaviour, and physiological responding. Additionally, the study investigated whether certain individuals are at heightened risk to develop pain-related fear through observation. Finally, changes in pain-related fear and pain intensity after exposure to the feared stimulus were examined. Methods During observational acquisition, healthy female participants watched a video showing coloured cold metal bars being placed against the neck of several models. In a differential fear conditioning paradigm, one colour was paired with painful facial expressions, and another colour was paired with neutral facial expressions of the video models. During exposure, both metal bars with equal temperatures (-25 degrees or + 8 degrees Celsius) were placed repeatedly against participants' own neck. Results Results showed that pain-related beliefs can be acquired by observing pain in others, but do not necessarily cause behavioural changes. Additionally, dispositional empathy might play a role in the acquisition of these beliefs. Furthermore, skin conductance responses were higher when exposed to the pain-associated bar, but only in one of two experiments. Differential pain-related beliefs rapidly disappeared after first-hand exposure to the stimuli. Conclusions This study enhances our understanding of pain-related fear acquisition and subsequent exposure to the feared stimulus, providing leads for pain prevention and management strategies.	[Helsen, Kim; Vlaeyen, Johan W. S.] Univ Leuven, KU Leuven, Res Grp Hlth Psychol, Leuven, Belgium; [Helsen, Kim; Goubert, Liesbet] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Vlaeyen, Johan W. S.] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands	KU Leuven; Ghent University; Maastricht University	Vlaeyen, JWS (corresponding author), Univ Leuven, KU Leuven, Res Grp Hlth Psychol, Tiensestr 102, Leuven, Belgium.	Johannes.Vlaeyen@ppw.kuleuven.be	Vlaeyen, Johan/P-9070-2019; Goubert, Liesbet/J-9607-2012	Vlaeyen, Johan/0000-0003-0437-6665; Goubert, Liesbet/0000-0002-7657-5148; Helsen, Kim/0000-0002-2938-316X	Odysseus Grant "the Psychology of Pain and Disability Research Program" - Research Foundation - Flanders (FWO Vlaanderen, Belgium)	Odysseus Grant "the Psychology of Pain and Disability Research Program" - Research Foundation - Flanders (FWO Vlaanderen, Belgium)	The contribution of Kim Helsen and Johan Vlaeyen was supported by the Odysseus Grant "the Psychology of Pain and Disability Research Program" funded by the Research Foundation - Flanders (FWO Vlaanderen, Belgium). http://www.fwo.be/Default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaudova I., 2013, FRONT PSYCHOL, V4, P1, DOI DOI 10.3389/FPSYG.2013.00001; Arntz A, 2004, PAIN, V109, P20, DOI 10.1016/j.pain.2003.12.030; ASHFORD SJ, 1985, J OCCUP PSYCHOL, V58, P67, DOI 10.1111/j.2044-8325.1985.tb00181.x; Askew C, 2008, CLIN PSYCHOL REV, V28, P1249, DOI 10.1016/j.cpr.2008.05.003; Askew C, 2007, BEHAV RES THER, V45, P2616, DOI 10.1016/j.brat.2007.06.008; Asmundson GJ, 2004, UNDERSTANDING TREATI, V3-24; Asmundson GJG, 2007, J PAIN, V8, P11, DOI 10.1016/j.jpain.2006.05.008; Bandura A., 1986, SOCIAL FDN THOUGHT A; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Braaksma MAH, 2002, J EDUC PSYCHOL, V94, P405, DOI 10.1037//0022-0663.94.2.405; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Britton JC, 2011, DEPRESS ANXIETY, V28, P5, DOI 10.1002/da.20733; Carroll EMA, 2011, J PAIN SYMPTOM MANAG, V41, P975, DOI 10.1016/j.jpainsymman.2010.08.011; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRAIG KD, 1978, J PERS SOC PSYCHOL, V36, P805, DOI 10.1037/0022-3514.36.8.805; CRAIG KD, 1971, J PERS SOC PSYCHOL, V19, P53, DOI 10.1037/h0031097; Crombez G, 1998, PAIN, V75, P187, DOI 10.1016/S0304-3959(97)00219-4; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Darlow B, 2012, EUR J PAIN, V16, P3, DOI 10.1016/j.ejpain.2011.06.006; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Clercq A, 2006, BEHAV RES METHODS, V38, P504, DOI 10.3758/BF03192805; De Corte K, 2007, PSYCHOL BELG, V47, P235, DOI 10.5334/pb-47-4-235; De Houwer J, 2003, PSYCHOLOGY OF EVALUATION, P219; De Houwer J, 2009, LEARN BEHAV, V37, P1, DOI 10.3758/LB.37.1.1; Egliston KA, 2007, BEHAV RES THER, V45, P1871, DOI 10.1016/j.brat.2007.02.007; Field AP, 2008, COGNITION EMOTION, V22, P459, DOI 10.1080/02699930801886532; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gerull FC, 2002, BEHAV RES THER, V40, P279, DOI 10.1016/S0005-7967(01)00013-4; Gheldof ELM, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2010.01.003; Goubert L, 2005, PAIN, V118, P285, DOI 10.1016/j.pain.2005.10.025; Goubert L, 2013, ENCY PAIN; Goubert L, 2011, J PAIN, V12, P167, DOI 10.1016/j.jpain.2010.10.001; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Helsen K, 2013, ENCY PAIN; Helsen K, 2013, J PAIN, V14, P676, DOI 10.1016/j.jpain.2013.01.771; Helsen K, 2011, J PAIN, V12, P1230, DOI 10.1016/j.jpain.2011.07.002; Hirsh AT, 2008, J PAIN, V9, P806, DOI 10.1016/j.jpain.2008.03.012; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kelly MM, 2007, EMOTION, V7, P324, DOI 10.1037/1528-3542.7.2.324; Kenny D. A., 2006, DYADIC DATA ANAL; Keogh E, 2003, PAIN, V104, P85, DOI 10.1016/S0304-3959(02)00468-2; Keogh E, 2001, PAIN, V91, P91, DOI 10.1016/S0304-3959(00)00422-X; Koch MD, 2002, J ANXIETY DISORD, V16, P511, DOI 10.1016/S0887-6185(02)00170-6; Koutantji M, 1998, PAIN, V77, P25, DOI 10.1016/S0304-3959(98)00075-X; Kronborg C, 2009, EUR J HEALTH ECON, V10, P5, DOI 10.1007/s10198-008-0096-3; Linton SJ, 1999, PSYCHOL HEALTH, V14, P1051, DOI 10.1080/08870440008407366; Mailhot JP, 2012, EUR J NEUROSCI, V35, P271, DOI 10.1111/j.1460-9568.2011.07953.x; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Meulders A, 2013, PAIN, V154, P272, DOI 10.1016/j.pain.2012.10.025; Meulders A, 2011, PAIN, V152, P2460, DOI 10.1016/j.pain.2011.05.015; Mineka S, 2002, BIOL PSYCHIAT, V52, P927, DOI 10.1016/S0006-3223(02)01669-4; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Olsson A, 2007, SOC COGN AFFECT NEUR, V2, P3, DOI 10.1093/scan/nsm005; Osman A, 2002, J BEHAV MED, V25, P155, DOI 10.1023/A:1014884704974; Ostelo RWJG, 2008, PAIN, V135, P3, DOI 10.1016/j.pain.2007.12.003; Peeters F.P.M.L., 1996, TIJDSCHR PSYCHIAT, V38, P240; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; RACHMAN S, 1977, BEHAV RES THER, V15, P375, DOI 10.1016/0005-7967(77)90041-9; RACHMAN S, 1991, CLIN PSYCHOL REV, V11, P155, DOI 10.1016/0272-7358(91)90093-A; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Roelofs J, 2005, PAIN, V116, P339, DOI 10.1016/j.pain.2005.05.003; Rosen NO, 2009, HEALTH COMMUN, V24, P228, DOI 10.1080/10410230902804125; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Spruyt A, 2010, EXP PSYCHOL, V57, P36, DOI 10.1027/1618-3169/a000005; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tabbert K, 2011, SOC COGN AFFECT NEUR, V6, P495, DOI 10.1093/scan/nsq070; Turk DC, 2010, CURR PAIN HEADACHE R, V14, P88, DOI 10.1007/s11916-010-0094-x; Vachon-Presseau E, 2011, PAIN, V152, P1525, DOI 10.1016/j.pain.2011.02.039; Valeriani M, 2008, NEUROIMAGE, V40, P1419, DOI 10.1016/j.neuroimage.2007.12.056; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Vlaeyen JWS, 1999, MANUAL THER, V4, P187, DOI 10.1054/math.1999.0199; Von Korff M, 2005, PAIN, V113, P331, DOI 10.1016/j.pain.2004.11.010; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x	79	8	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0117236	10.1371/journal.pone.0117236	http://dx.doi.org/10.1371/journal.pone.0117236			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806969	Green Published, gold			2022-12-26	WOS:000351880000005
J	Jackson, HW; Hojilla, CV; Weiss, A; Sanchez, OH; Wood, GA; Khokha, R				Jackson, Hartland W.; Hojilla, Carlo V.; Weiss, Ashley; Sanchez, Otto H.; Wood, Geoffrey A.; Khokha, Rama			Timp3 Deficient Mice Show Resistance to Developing Breast Cancer	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TISSUE INHIBITOR; CELL-DEATH; METALLOPROTEINASES; GROWTH; INFLAMMATION; PROGRESSION; EXPRESSION; ALPHA; METHYLATION	Timp3 is commonly silenced in breast cancer, but mechanistic studies have identified both tumor promotion and suppression effects of this gene. We have taken a genetic approach to determine the impact of Timp3 loss on two mouse models of breast cancer. Interestingly, MMTV-PyMT Timp3(-/-) mice have delayed tumor onset and 36% of MMTV-Neu Timp3(-/-) mice remain tumor free. TIMP3 is a regulator of TNF signaling and similar to Timp3, Tnf or Tnfr1 loss delays early tumorigenesis. The tumor suppression in Timp3 null mice requires Tnfr1, but does not result in alterations in the local immune compartment. In the mammary gland, Timps are highly expressed in the stroma and through the transplantation of tumor cells we observe that Timp3 deficiency in the host is sufficient to delay the growth of early, but not advanced tumor cells. Together our data is the first to identify a tumor promoting role of endogenous Timp3 in vivo, the spatial and temporal windows of this effect, and its dependence on Tnfr1.	[Jackson, Hartland W.; Hojilla, Carlo V.; Weiss, Ashley; Sanchez, Otto H.; Wood, Geoffrey A.; Khokha, Rama] Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Khokha, R (corresponding author), Univ Toronto, Ontario Canc Inst, 500 Sherbourne St, Toronto, ON M5S 1A1, Canada.	rkhokha@uhnres.utoronto.ca	Jackson, Hartland/AAL-7751-2020; Wood, Geoffrey/ABB-2052-2021	Jackson, Hartland/0000-0001-6423-2415; Wood, Geoffrey/0000-0003-1756-8607; Khokha, Rama/0000-0002-6028-1524	Canadian Breast Cancer Research Alliance [16411]; Canadian Breast Cancer Foundation; National Cancer Institute of Canada	Canadian Breast Cancer Research Alliance; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was funded by the Canadian Breast Cancer Research Alliance (grant #16411) and the Canadian Breast Cancer Foundation. HWJ was supported by a Canadian Breast Cancer Foundation PhD Fellowship and CVH was supported by a National Cancer Institute of Canada PhD Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Bachman KE, 1999, CANCER RES, V59, P798; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bian JH, 1996, CARCINOGENESIS, V17, P1805, DOI 10.1093/carcin/17.9.1805; Bond M, 2002, J BIOL CHEM, V277, P13787, DOI 10.1074/jbc.M111507200; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Celebiler A, 2009, CANCER SCI, V100, P2341, DOI 10.1111/j.1349-7006.2009.01333.x; Cruz-Munoz W, 2006, ONCOGENE, V25, P650, DOI 10.1038/sj.onc.1209104; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gu P, 2008, NEOPLASIA, V10, P563, DOI 10.1593/neo.08208; Hojilla CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026718; Hoque MO, 2008, J UROLOGY, V179, P743, DOI 10.1016/j.juro.2007.09.019; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kassiri Z, 2009, J BIOL CHEM, V284, P29893, DOI 10.1074/jbc.M109.028449; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lin H, 2012, CANCER GENE THER, V19, P845, DOI 10.1038/cgt.2012.70; Lu YZ, 2011, J BIOL CHEM, V286, P42292, DOI 10.1074/jbc.M111.270926; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Murthy A, 2012, J IMMUNOL, V188, P2876, DOI 10.4049/jimmunol.1102199; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Nakamura M, 2005, LAB INVEST, V85, P165, DOI 10.1038/labinvest.3700223; Panda H, 2012, J CLIN ENDOCR METAB, V97, pE1316, DOI 10.1210/jc.2012-1018; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Sangaletti S, 2010, CANCER RES, V70, P7764, DOI 10.1158/0008-5472.CAN-10-0471; Smith MR, 1997, CYTOKINE, V9, P770, DOI 10.1006/cyto.1997.0233; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Span PN, 2004, J PATHOL, V202, P395, DOI 10.1002/path.1528; Varela LM, 1996, ENDOCRINOLOGY, V137, P4915, DOI 10.1210/en.137.11.4915; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Warren MA, 2009, MOL CANCER THER, V8, P2655, DOI 10.1158/1535-7163.MCT-09-0358; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435; YANG TT, 1992, P NATL ACAD SCI USA, V89, P10676, DOI 10.1073/pnas.89.22.10676; Zhang L, 2010, CANCER GENE THER, V17, P171, DOI 10.1038/cgt.2009.59	40	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120107	10.1371/journal.pone.0120107	http://dx.doi.org/10.1371/journal.pone.0120107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807548	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000066
J	Poyraz, O; Brunner, K; Lohkamp, B; Axelsson, H; Hammarstrom, LGJ; Schnell, R; Schneider, G				Poyraz, Omer; Brunner, Katharina; Lohkamp, Bernhard; Axelsson, Hanna; Hammarstrom, Lars G. J.; Schnell, Robert; Schneider, Gunter			Crystal Structures of the Kinase Domain of the Sulfate-Activating Complex in Mycobacterium tuberculosis	PLOS ONE			English	Article							ADENOSINE 5'-PHOSPHOSULFATE KINASE; HUMAN PAPS SYNTHETASE-1; APS-KINASE; ATP-SULFURYLASE; MACROMOLECULAR STRUCTURES; PENICILLIUM-CHRYSOGENUM; STATIONARY-PHASE; GENE-EXPRESSION; SOFTWARE; SULFOTRANSFERASES	In Mycobacterium tuberculosis the sulfate activating complex provides a key branching point in sulfate assimilation. The complex consists of two polypeptide chains, CysD and CysN. CysD is an ATP sulfurylase that, with the energy provided by the GTPase activity of CysN, forms adenosine-5'-phosphosulfate (APS) which can then enter the reductive branch of sulfate assimilation leading to the biosynthesis of cysteine. The CysN polypeptide chain also contains an APS kinase domain (CysC) that phosphorylates APS leading to 3'-phosphoadenosine-5'-phosphosulfate, the sulfate donor in the synthesis of sulfolipids. We have determined the crystal structures of CysC from M. tuberculosis as a binary complex with ADP, and as ternary complexes with ADP and APS and the ATP mimic AMP-PNP and APS, respectively, to resolutions of 1.5 angstrom, 2.1 angstrom and 1.7 angstrom, respectively. CysC shows the typical APS kinase fold, and the structures provide comprehensive views of the catalytic machinery, conserved in this enzyme family. Comparison to the structure of the human homolog show highly conserved APS and ATP binding sites, questioning the feasibility of the design of specific inhibitors of mycobacterial CysC. Residue Cys556 is part of the flexible lid region that closes off the active site upon substrate binding. Mutational analysis revealed this residue as one of the determinants controlling lid closure and hence binding of the nucleotide substrate.	[Poyraz, Omer; Brunner, Katharina; Lohkamp, Bernhard; Schnell, Robert; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Axelsson, Hanna; Hammarstrom, Lars G. J.] Karolinska Inst, Dept Med Biochem & Biophys, Sci Life Lab Stockholm, Chem Biol Consortium Sweden, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Schneider, G (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	gunter.schneider@ki.se	Axelsson, Hanna/AGG-7882-2022	Axelsson, Hanna/0000-0003-2365-1749; SCHNELL, ROBERT/0000-0001-7530-3629; Hammarstrom, Lars/0000-0002-3903-7746	Swedish Governmental Agency for Innovation Systems (VINNOVA); Swedish Science Council (VR)	Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova); Swedish Science Council (VR)(Swedish Research Council)	This work was supported by the Swedish Governmental Agency for Innovation Systems (VINNOVA) and the Swedish Science Council (VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Bowman KG, 1999, CHEM BIOL, V6, pR9, DOI 10.1016/S1074-5521(99)80014-3; Carroll KS, 2005, PLOS BIOL, V3, P1418, DOI 10.1371/journal.pbio.0030250; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fuda H, 2002, BIOCHEM J, V365, P497, DOI 10.1042/BJ20020044; Gay SC, 2009, ACTA CRYSTALLOGR D, V65, P1021, DOI 10.1107/S0907444909026547; GOREN MB, 1974, INFECT IMMUN, V9, P142, DOI 10.1128/IAI.9.1.142-149.1974; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; Lansdon EB, 2002, BIOCHEMISTRY-US, V41, P13672, DOI 10.1021/bi026556b; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; LIU CX, 1994, BIOCHEMISTRY-US, V33, P7309, DOI 10.1021/bi00189a036; MacRae IJ, 2000, BIOCHEMISTRY-US, V39, P1613, DOI 10.1021/bi9924157; MacRae IJ, 1999, ARCH BIOCHEM BIOPHYS, V361, P277, DOI 10.1006/abbi.1998.0993; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mougous JD, 2002, CHEM BIOL, V9, P767, DOI 10.1016/S1074-5521(02)00175-8; Mougous JD, 2006, MOL CELL, V21, P109, DOI 10.1016/j.molcel.2005.10.034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pinto R, 2004, MICROBIOL-SGM, V150, P1681, DOI 10.1099/mic.0.26894-0; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; Schelle MW, 2006, CHEMBIOCHEM, V7, P1516, DOI 10.1002/cbic.200600224; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Singh B, 2003, J BIOL CHEM, V278, P71, DOI 10.1074/jbc.M206688200; Sun MH, 2005, J BIOL CHEM, V280, P7861, DOI 10.1074/jbc.M409613200; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Williams SJ, 2002, J BIOL CHEM, V277, P32606, DOI 10.1074/jbc.M204613200; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035	41	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121494	10.1371/journal.pone.0121494	http://dx.doi.org/10.1371/journal.pone.0121494			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807013	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000157
J	Stewart, LM; Holman, CDJ; Semmens, JB; Preen, D; Mai, Q; Hart, R				Stewart, Louise M.; Holman, C. D'Arcy J.; Semmens, James B.; Preen, David; Mai, Qun; Hart, Roger			Hospital Mental Health Admissions in Women after Unsuccessful Infertility Treatment and In Vitro Fertilization: An Australian Population-Based Cohort Study	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; IVF; ADJUSTMENT; MORTALITY; CANCER; BIRTH	Objective To examine the association between in vitro fertilization (IVF) and later admission to hospital with a mental health diagnosis in women who remained childless after infertility treatment. Methods This was a population-based cohort study using linked administrative hospital and registry data. The study population included all women commencing hospital treatment for infertility in Western Australia between the years 1982 and 2002 aged 20-44 years at treatment commencement who did not have a recorded birth by the end of follow-up (15 August 2010) and did not have a hospital mental health admission prior to the first infertility admission (n=6,567). Of these, 2,623 women had IVF and 3,944 did not. We used multivariate Cox regression modeling of mental health admissions and compared women undergoing IVF treatment with women having infertility treatment but not IVF. Results Over an average of 17 years of follow-up, 411 women in the cohort were admitted to hospital with a mental health diagnosis; 93 who had IVF and 318 who did not. The unadjusted hazard ratio (HR) for a hospital mental health admission comparing women who had IVF with those receiving other infertility treatment was 0.50 (95% confidence interval [CI] 0.40-0.63). After adjustment for age, calendar year and socio-economic status the HR was 0.56 (95% CI 0.44-0.71). Conclusions IVF treatment is associated with a reduced risk of hospital mental health admissions in women after unsuccessful infertility treatment. This may be explained by the healthy cohort effect.	[Stewart, Louise M.; Semmens, James B.] Curtin Univ, Fac Hlth Sci, Ctr Populat Hlth Res, Bentley, WA, Australia; [Holman, C. D'Arcy J.; Preen, David; Mai, Qun] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Hart, Roger] Univ Western Australia, King Edward Mem Hosp, Sch Womens & Infants Hlth, Subiaco, WA, Australia; [Hart, Roger] Bethesda Hosp, Fertil Specialists Western Australia, Claremont, CA, Australia	Curtin University; University of Western Australia; King Edward Memorial Hospital; University of Western Australia	Stewart, LM (corresponding author), Curtin Univ, Fac Hlth Sci, Ctr Populat Hlth Res, Bentley, WA, Australia.	louise.m.stewart@curtin.edu.au	Stewart, Louise M/I-3753-2013; Preen, David/H-5663-2014	Stewart, Louise M/0000-0003-2015-6320; Preen, David/0000-0002-2982-2169	Lotterywest Data Linkage Infrastructure Funding; NHMRC Capacity Building Grant [573122]	Lotterywest Data Linkage Infrastructure Funding; NHMRC Capacity Building Grant(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by Lotterywest Data Linkage Infrastructure Funding and NHMRC Capacity Building Grant project no 573122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Ansari Z, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-475; Australia Bureau of Statistics, 2008, INF PAP INTR SOC IND; Australian Institute of Health and Welfare, 2013, CHILD WELF SER, V60; BARAM D, 1988, J PSYCHOSOM OBST GYN, V9, P181, DOI 10.3109/01674828809016800; Bryson Caroline A., 2000, Hum Fertil (Camb), V3, P214, DOI 10.1080/1464727002000199011; Data Linkage Western Australia, EN HLTH MED RES W AU; Ferland P, 2013, FAM J, V21, P180, DOI 10.1177/1066480712466813; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; HYNES GJ, 1992, BRIT J MED PSYCHOL, V65, P269, DOI 10.1111/j.2044-8341.1992.tb01707.x; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Kee BS, 2000, J ASSIST REPROD GEN, V17, P445; Klemetti R, 2005, HUM REPROD, V20, P3293, DOI 10.1093/humrep/dei253; Kristiansson P, 2007, HUM REPROD, V22, P421, DOI 10.1093/humrep/del411; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; Pasch LA, 2012, FERTIL STERIL, V98, P459, DOI 10.1016/j.fertnstert.2012.05.023; POSTHUMA WFM, 1994, BRIT MED J, V308, P1268; Sejbaek CS, 2013, HUM REPROD, V28, P1100, DOI 10.1093/humrep/des442; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Stewart LM, 2013, MELANOMA RES, V23, P489, DOI 10.1097/CMR.0000000000000019; Stewart LM, 2013, GYNECOL ONCOL, V129, P372, DOI 10.1016/j.ygyno.2013.01.027; Stewart LM, 2013, GYNECOL ONCOL, V128, P260, DOI 10.1016/j.ygyno.2012.10.023; Stewart LM, 2012, FERTIL STERIL, V98, P334, DOI 10.1016/j.fertnstert.2012.04.019; Venn A, 2001, HUM REPROD, V16, P2691, DOI 10.1093/humrep/16.12.2691; Verhaak CM, 2007, HUM REPROD, V22, P305, DOI 10.1093/humrep/del355; Verhaak CM, 2005, HUM REPROD, V20, P2253, DOI 10.1093/humrep/dei015; Yli-Kuha AN, 2010, HUM REPROD, V25, P2018, DOI 10.1093/humrep/deq164	27	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120076	10.1371/journal.pone.0120076	http://dx.doi.org/10.1371/journal.pone.0120076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25807258	Green Published, gold			2022-12-26	WOS:000351880000063
J	Zhao, YL; Zhong, R; Sun, LG; Jia, J; Ma, SM; Liu, XD				Zhao, Yinlong; Zhong, Rui; Sun, Liguang; Jia, Jie; Ma, Shumei; Liu, Xiaodong			Ionizing Radiation-Induced Adaptive Response in Fibroblasts under Both Monolayer and 3-Dimensional Conditions	PLOS ONE			English	Article							DNA-DAMAGE; RADIOADAPTIVE RESPONSE; CHROMOSOMAL DAMAGE; PROTEIN EXPRESSION; CELLS; IRRADIATION; CULTURE; INDUCTION; P53; LYMPHOCYTES	To observe the adaptive response (AR) induced by ionizing radiation in human fibroblasts under monolayer and 3-dimensional (3-D) condition. Three kinds of fibroblasts were cultured under both monolayer and 3-D condition. Immunofluorescent staining was used to detect the gamma-H2AX foci and the morphological texture. Trypan blue staining was used to detect the cell death. Western blot was used to detect the expressions of gamma-H2AX, p53 and CDKN1A/p21 (p21). We found that DNA damage increased in a dose-dependent and time-dependent manner after high doses of radiation. When cells were pretreated with a priming low dose of radiation followed by high dose radiation, DNA damage was attenuated under both monolayer and 3-D condition, and the adaptive response (AR) was induced. Additionally, the morphology of cells under monolayer and 3-D conditions were different, and radiation also induced AR according to morphological texture analysis. Priming low dose radiation induced AR both under monolayer and 3-D condition. Interestingly, 3-D microenvironment made cells more sensitive to radiation. The expression of p53 and p21 was changed and indicated that they might participate in the regulation of AR.	[Zhao, Yinlong; Zhong, Rui; Ma, Shumei; Liu, Xiaodong] Jilin Univ, Sch Publ Hlth, Key Lab Radiobiol, Minist Hlth, Changchun 130023, Peoples R China; [Zhao, Yinlong] Jilin Univ, Hosp 2, Dept Nucl Med, Changchun, Peoples R China; [Sun, Liguang] Jilin Univ, Hosp 1, Dept Translat Med, Changchun, Peoples R China; [Jia, Jie] China Japan Union Hosp, Dept Ultrasound, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University	Ma, SM (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.	shmm2001@yahoo.com.cn; liuxiaod@jlu.edu.cn	Liu, Xiaodong/R-5861-2019		NSFC grant [30770649, 30970682]; Research Fund for the Doctoral Program of Higher Education of China [20100061110070]; Program for New Century Excellent Talents in University	NSFC grant(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was supported by NSFC grant (30770649, 30970682), Research Fund for the Doctoral Program of Higher Education of China (20100061110070), Program for New Century Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, RADIAT ENVIRON BIOPH; Barilla J, 2013, AUSTRALAS PHYS ENG S, V36, P11, DOI 10.1007/s13246-012-0179-4; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Bodnarchuk I A, 2003, Radiats Biol Radioecol, V43, P19; Bonner WM, 2004, MUTAT RES-FUND MOL M, V568, P33, DOI 10.1016/j.mrfmmm.2004.06.044; CAI L, 1995, MUTAGENESIS, V10, P95, DOI 10.1093/mutage/10.2.95; Chen SL, 2000, TOXICOL SCI, V55, P97, DOI 10.1093/toxsci/55.1.97; Cheng GH, 2010, BIOMED ENVIRON SCI, V23, P487, DOI 10.1016/S0895-3988(11)60012-3; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Coleman MA, 2005, RADIAT RES, V164, P369, DOI 10.1667/RR3356.1; Cramers P, 2005, RADIAT RES, V164, P383, DOI 10.1667/RR3430.1; Esposito G, 2011, RADIAT PROT DOSIM, V143, P320, DOI 10.1093/rpd/ncq474; Feinendegen Ludwig E, 2004, Nonlinearity Biol Toxicol Med, V2, P143, DOI 10.1080/15401420490507431; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Han W, 2011, MUTAT RES-FUND MOL M, V709-10, P1, DOI 10.1016/j.mrfmmm.2011.02.011; Ishii K, 1996, PHYSIOL CHEM PHYS ME, V28, P83; Kalantari H, 2014, MUTAT RES-GEN TOX EN, V761, P44, DOI 10.1016/j.mrgentox.2014.01.002; Lanza V, 2005, J RADIAT RES, V46, P265, DOI 10.1269/jrr.46.265; Lee KB, 2009, ANN SURG ONCOL, V16, P2882, DOI 10.1245/s10434-009-0535-0; Lee SJ, 2000, CELL BIOL TOXICOL, V16, P175, DOI 10.1023/A:1007658905639; Liu SZ, 2010, HUM EXP TOXICOL, V29, P275, DOI 10.1177/0960327109363967; Liu X, 2013, ANAL CHEM, V85, P6295, DOI 10.1021/ac400519c; Matsusaki M, 2014, ADV DRUG DELIVER REV, V74, P95, DOI 10.1016/j.addr.2014.01.003; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; PRASAD AV, 1995, RADIAT RES, V143, P263, DOI 10.2307/3579212; Preston R Julian, 2005, Toxicol Appl Pharmacol, V207, P550, DOI 10.1016/j.taap.2004.12.024; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sakamoto-Hojo ET, 2003, MUTAT RES-REV MUTAT, V544, P403, DOI 10.1016/j.mrrev.2003.07.004; Sannino A, 2013, J RADIAT RES; Sasaki MS, 2002, MUTAT RES-FUND MOL M, V504, P101, DOI 10.1016/S0027-5107(02)00084-2; Sasiadek Maria, 2002, Journal of Applied Genetics, V43, P525; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Stoilov LM, 2007, MUTAGENESIS, V22, P117, DOI 10.1093/mutage/gel061; Tanaka Toshiki, 2009, V523, P161, DOI 10.1007/978-1-59745-190-1_11; Tang FR, 2014, INT J RADIAT BIOL, P1, DOI [10.3109/09553002.2013.836617, DOI 10.3109/09553002.2013.836617]; Tas F, 2000, AM J CLIN ONCOL-CANC, V23, P546, DOI 10.1097/00000421-200012000-00002; Tsai KKC, 2005, CANCER RES, V65, P6734, DOI 10.1158/0008-5472.CAN-05-0703	37	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121289	10.1371/journal.pone.0121289	http://dx.doi.org/10.1371/journal.pone.0121289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807079	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000142
J	Greenough, L; Kelman, Z; Gardner, AF				Greenough, Lucia; Kelman, Zvi; Gardner, Andrew F.			The Roles of Family B and D DNA Polymerases in Thermococcus Species 9 degrees N Okazaki Fragment Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION; ARCHAEON; PCNA	During replication, Okazaki fragment maturation is a fundamental process that joins discontinuously synthesized DNA fragments into a contiguous lagging strand. Efficient maturation prevents repeat sequence expansions, small duplications, and generation of double-stranded DNA breaks. To address the components required for the process in Thermococcus, Okazaki fragment maturation was reconstituted in vitro using purified proteins from Thermococcus species 9 degrees N or cell extracts. A dual color fluorescence assay was developed to monitor reaction substrates, intermediates, and products. DNA polymerase D (polD) was proposed to function as the replicative polymerase in Thermococcus replicating both the leading and the lagging strands. It is shown here, however, that it stops before the previous Okazaki fragments, failing to rapidly process them. Instead, Family B DNA polymerase (polB) was observed to rapidly fill the gaps left by polD and displaces the downstream Okazaki fragment to create a flap structure. This flap structure was cleaved by flap endonuclease 1 (Fen1) and the resultant nick was ligated by DNA ligase to form a mature lagging strand. The similarities to both bacterial and eukaryotic systems and evolutionary implications of archaeal Okazaki fragment maturation are discussed.	[Greenough, Lucia; Gardner, Andrew F.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Kelman, Zvi] NIST, Rockville, MD 20850 USA	New England Biolabs; National Institute of Standards & Technology (NIST) - USA	Gardner, AF (corresponding author), 240 Cty Rd, Ipswich, MA 01938 USA.	gardner@neb.com			New England Biolabs, Inc.	New England Biolabs, Inc.	This work was supported by New England Biolabs, Inc.	Balakrishnan L, 2010, METHODS, V51, P347, DOI 10.1016/j.ymeth.2010.02.017; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Beattie TR, 2012, EMBO J, V31, P1556, DOI 10.1038/emboj.2012.12; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Cubonova L, 2013, J BACTERIOL, V195, P2322, DOI 10.1128/JB.02037-12; Greenough L, 2014, EXTREMOPHILES, V18, P653, DOI 10.1007/s00792-014-0646-9; Henneke G, 2005, J MOL BIOL, V350, P53, DOI 10.1016/j.jmb.2005.04.042; Henneke G, 2012, BIOCHEM J, V447, P271, DOI 10.1042/BJ20120959; Jozwiakowski SK, 2014, NUCLEIC ACIDS RES, V42, P9949, DOI 10.1093/nar/gku683; Kelman LM, 2014, ANNU REV GENET, V48, P71, DOI 10.1146/annurev-genet-120213-092148; KORNBERG A, 1988, J BIOL CHEM, V263, P1; Kurth I, 2013, TRENDS BIOCHEM SCI, V38, P195, DOI 10.1016/j.tibs.2012.10.003; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; Makarova KS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00354; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; Prokhorova TA, 2003, P NATL ACAD SCI USA, V100, P13241, DOI 10.1073/pnas.2336104100; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Rouillon C, 2007, J MOL BIOL, V369, P343, DOI 10.1016/j.jmb.2007.03.054; Sarmiento F, 2013, P NATL ACAD SCI USA, V110, P4726, DOI 10.1073/pnas.1220225110	20	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12514	12522		10.1074/jbc.M115.638130	http://dx.doi.org/10.1074/jbc.M115.638130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25814667	Green Published, hybrid			2022-12-26	WOS:000354569000008
J	Dong, SZ; Lin, JY; Held, NL; Clem, RJ; Passarelli, AL; Franz, AWE				Dong, Shengzhang; Lin, Jingyi; Held, Nicole L.; Clem, Rollie J.; Passarelli, A. Lorena; Franz, Alexander W. E.			Heritable CRISPR/Cas9-Mediated Genome Editing in the Yellow Fever Mosquito, Aedes aegypti	PLOS ONE			English	Article							TARGETED MUTAGENESIS; RNA INTERFERENCE; EFFICIENT; GENE; DROSOPHILA; NUCLEASE; RESISTANCE; VIRUS	In vivo targeted gene disruption is a powerful tool to study gene function. Thus far, two tools for genome editing in Aedes aegypti have been applied, zinc-finger nucleases (ZFN) and transcription activator-like effector nucleases (TALEN). As a promising alternative to ZFN and TALEN, which are difficult to produce and validate using standard molecular biological techniques, the clustered regularly interspaced short palindromic repeats/CRISPR-associated sequence 9 (CRISPR/Cas9) system has recently been discovered as a "do-it-yourself" genome editing tool. Here, we describe the use of CRISPR/Cas9 in the mosquito vector, Aedes aegypti. In a transgenic mosquito line expressing both Dsred and enhanced cyan fluorescent protein (ECFP) from the eye tissue-specific 3xP3 promoter in separated but tightly linked expression cassettes, we targeted the ECFP nucleotide sequence for disruption. When supplying the Cas9 enzyme and two sgRNAs targeting different regions of the ECFP gene as in vitro transcribed mRNAs for germline transformation, we recovered four different G1 pools (5.5% knockout efficiency) where individuals still expressed DsRed but no longer ECFP. PCR amplification, cloning, and sequencing of PCR amplicons revealed indels in the ECFP target gene ranging from 2-27 nucleotides. These results show for the first time that CRISPR/Cas9 mediated gene editing is achievable in Ae. aegypti, paving the way for further functional genomics related studies in this mosquito species.	[Dong, Shengzhang; Lin, Jingyi; Held, Nicole L.; Franz, Alexander W. E.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Clem, Rollie J.; Passarelli, A. Lorena] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	University of Missouri System; University of Missouri Columbia; Kansas State University	Franz, AWE (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.	franza@missouri.edu		Dong, Shengzhang/0000-0002-8218-4688; Clem, Rollie/0000-0002-2368-720X	NIAID-NIH [R01AI091972]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091972] Funding Source: NIH RePORTER	NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIAID-NIH grant R01AI091972. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2007, P NATL ACAD SCI USA, V104, P9970, DOI 10.1073/pnas.0701515104; Arpino JAJ, 2014, ACTA CRYSTALLOGR D, V70, P2152, DOI 10.1107/S139900471401267X; Aryan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060082; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bozas A, 2009, GENETICS, V182, P641, DOI 10.1534/genetics.109.101329; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Franz AWE, 2011, INSECT MOL BIOL, V20, P587, DOI 10.1111/j.1365-2583.2011.01089.x; Franz Alexander W E, 2014, Curr Trop Med Rep, V1, P21; Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833; Gokcezade J, 2014, G3-GENES GENOM GENET, V4, P2279, DOI 10.1534/g3.114.014126; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khoo CCH, 2013, INSECT MOL BIOL, V22, P104, DOI 10.1111/imb.12008; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Konet DS, 2007, INSECT MOL BIOL, V16, P199, DOI 10.1111/j.1365-2583.2006.00714.x; Liesch J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002486; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Liu YY, 2014, INSECT BIOCHEM MOLEC, V49, P35, DOI 10.1016/j.ibmb.2014.03.010; Ma SY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04489; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; MOJICA FJM, 1993, MOL MICROBIOL, V9, P613, DOI 10.1111/j.1365-2958.1993.tb01721.x; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Rong YS, 2001, GENETICS, V157, P1307; Sebo ZL, 2014, FLY, V8, P52, DOI 10.4161/fly.26828; Shao YJ, 2014, NAT PROTOC, V9, P2493, DOI 10.1038/nprot.2014.171; Smidler AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074511; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Takasu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073458; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101210; Wendell MD, 2000, INSECT MOL BIOL, V9, P119, DOI 10.1046/j.1365-2583.2000.00166.x; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Xue ZY, 2014, G3-GENES GENOM GENET, V4, P2167, DOI 10.1534/g3.114.014159; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825	47	73	79	7	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122353	10.1371/journal.pone.0122353	http://dx.doi.org/10.1371/journal.pone.0122353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815482	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600168
J	Kacprzak, K; Jurka, P; Dolka, I; Czopowicz, M; Ruszczak, A; Duszewska, A				Kacprzak, Kamil; Jurka, Piotr; Dolka, Izabella; Czopowicz, Michal; Ruszczak, Anna; Duszewska, Anna			Changes in Ovaries and Uterus after Aglepristone Administration in the Third Week of Luteal Phase of Non-Pregnant Bitches	PLOS ONE			English	Article							STEROID-RECEPTORS; PREGNANCY; PROGESTERONE; TERMINATION; DOG	Objective The mechanism of aglepristone action in the placentation time in the bitch remains unclear. The aim of this study was to describe the mechanism by which aglepristone influences ovaries and uterus and to measure the levels of steroid sex hormones in nonpregnant bitches. Materials and Methods Fourteen bitches assigned to a study (n=9) and control (n=5) group were given aglepristone and saline solution, respectively, on the 19th and 20th day after LH peak. On the 26th day after LH peak an ovariohysterectomy was performed. Blood samples were screened for estradiol and progesterone concentrations. Ovaries and uterine horns and bodies were isolated for histological and morphometrical diagnosis and immunohistochemistry analysis of a-estrogen and progesterone receptor expression. Results A decrease of progesterone (p<0.01) and no differences in total estrogen level in the study group were observed. There were no significant differences either in the histomorphometry or a-estrogen and progesterone receptors expression in ovaries. Increase in expression of progesterone receptors in endometrium without surface epithelium of horns (p<0.05), endometrial surface epithelium (p<0.05), myometrium of uterine body (p<0.01) and estrogen receptors in endometrium without surface epithelium of horns (p<0.05) was observed. Elevated estrogen receptors probably increased sensitivity of tissues to estrogens in the bloodstream and led to notable inflammation, haemorrhages, and hyperplasia in endometrium with mononuclear immune cell infiltration. The myometrium of horns and endometrium of uterine body of study bitches were significantly thicker than in the control group (p<0.05 and p<0.01). Furthermore myometrium of uterine body was thicker than myometrium of horns (p<0.001) and expression of progesterone receptors was higher in uterine body (p<0.01). No differences were observed between endometrium of horns and body within groups. Conclusion To the knowledge of the authors this is the first study, which describes the inflammatory effect developing in uterus in response to aglepristone administration, and attempts to elucidate its mechanisms.	[Kacprzak, Kamil; Jurka, Piotr; Ruszczak, Anna] Warsaw Univ Life Sci, Dept Small Anim Dis Clin, Fac Vet Med, Warsaw, Poland; [Dolka, Izabella] Warsaw Univ Life Sci, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland; [Czopowicz, Michal] Warsaw Univ Life Sci, Fac Vet Med, Lab Vet Epidemiol & Econ, Warsaw, Poland; [Duszewska, Anna] Warsaw Univ Life Sci, Fac Vet Med, Dept Morphol Sci, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Kacprzak, K (corresponding author), Warsaw Univ Life Sci, Dept Small Anim Dis Clin, Fac Vet Med, Warsaw, Poland.	kamil_kacprzak@sggw.pl	Czopowicz, Michał/U-5452-2018	Czopowicz, Michał/0000-0002-4238-8360; /0000-0002-6904-0700; Duszewska, Anna/0000-0003-3336-9667; Jurka, Piotr/0000-0002-3321-4844; Kacprzak, Kamil/0000-0003-1906-6061	National Science Centre, Poland [N N308 566940]	National Science Centre, Poland(National Science Centre, Poland)	This research was supported by the National Science Centre, Poland grant No. N N308 566940. PJ and KK received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dhaliwal GK, 1999, ANIM REPROD SCI, V56, P259, DOI 10.1016/S0378-4320(99)00042-1; Galac S, 2000, THERIOGENOLOGY, V53, P941, DOI 10.1016/S0093-691X(00)00241-7; Hoffmann B, 1999, REPROD DOMEST ANIM, V34, P219, DOI 10.1111/j.1439-0531.1999.tb01244.x; Jurka P, 2010, REPROD DOMEST ANIM, V45, P525, DOI 10.1111/j.1439-0531.2008.01288.x; Kanca H, 2008, THERIOGENOLOGY, V70, P1439, DOI 10.1016/j.theriogenology.2008.04.045; LINDEFORSBERG C, 1992, J SMALL ANIM PRACT, V33, P331, DOI 10.1111/j.1748-5827.1992.tb01159.x; Parillo F, 2013, ANIM REPROD SCI, V138, P118, DOI 10.1016/j.anireprosci.2013.02.001; Polisca A, 2010, THERIOGENOLOGY, V74, P672, DOI 10.1016/j.theriogenology.2010.03.021	8	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121597	10.1371/journal.pone.0121597	http://dx.doi.org/10.1371/journal.pone.0121597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816198	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600108
J	Smith, GA; Rocha, EM; Rooney, T; Barneoud, P; McLean, JR; Beagan, J; Osborn, T; Coimbra, M; Luo, YY; Hallett, PJ; Isacson, O				Smith, Gaynor A.; Rocha, Emily M.; Rooney, Thomas; Barneoud, Pascal; McLean, Jesse R.; Beagan, Jonathan; Osborn, Teresia; Coimbra, Madeleine; Luo, Yongyi; Hallett, Penelope J.; Isacson, Ole			A Nurr1 Agonist Causes Neuroprotection in a Parkinson's Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C)	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; ALPHA-SYNUCLEIN; TRANSCRIPTION FACTOR; GENE-EXPRESSION; RET EXPRESSION; RAT MODEL; NEUROINFLAMMATION; MUTATION; BRAIN; LIPOPOLYSACCHARIDE	Dopaminergic neurons in the substantia nigra pars compacta (SNpc) are characterized by the expression of genes required for dopamine synthesis, handling and reuptake and the expression of these genes is largely controlled by nuclear receptor related 1 (Nurr1). Nurr1 is also expressed in astrocytes and microglia where it functions to mitigate the release of proinflammatory cytokines and neurotoxic factors. Given that Parkinson's disease (PD) pathogenesis has been linked to both loss of Nurr1 expression in the SNpc and inflammation, increasing levels of Nurr1 maybe a promising therapeutic strategy. In this study a novel Nurr1 agonist, SA00025, was tested for both its efficiency to induce the transcription of dopaminergic target genes in vivo and prevent dopaminergic neuron degeneration in an inflammation exacerbated 6-OHDA-lesion model of PD. SA00025 (30mg/kg p.o.) entered the brain and modulated the expression of the dopaminergic phenotype genes TH, VMAT, DAT, AADC and the GDNF receptor gene c-Ret in the SN of naive rats. Daily gavage treatment with SA00025 (30mg/kg) for 32 days also induced partial neuroprotection of dopaminergic neurons and fibers in rats administered a priming injection of polyinosinic-polycytidylic acid (poly (I:C) and subsequent injection of 6-OHDA. The neuroprotective effects of SA00025 in this dopamine neuron degeneration model were associated with changes in microglial morphology indicative of a resting state and a decrease in microglial specific IBA-1 staining intensity in the SNpc. Astrocyte specific GFAP staining intensity and IL-6 levels were also reduced. We conclude that Nurr1 agonist treatment causes neuroprotective and anti-inflammatory effects in an inflammation exacerbated 6-OHDA lesion model of PD.	[Smith, Gaynor A.; Rocha, Emily M.; McLean, Jesse R.; Beagan, Jonathan; Osborn, Teresia; Hallett, Penelope J.; Isacson, Ole] Harvard Univ, McLean Hosp, Sch Med, Neuroregenerat Res Inst, Belmont, MA 02474 USA; [Rooney, Thomas; Barneoud, Pascal] Sanofi, Neurodegenerat & Pain Unit, Chilly Mazarin, France; [Coimbra, Madeleine] Sanofi, Disposit Safety & Anim Res, Dept 1, Chilly Mazarin, France; [Luo, Yongyi] Sanofi, Genzyme Drug Metab & Pharmacokinet Dept, Waltham, MA USA	Harvard University; McLean Hospital; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Genzyme Corporation	Hallett, PJ (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Neuroregenerat Res Inst, Belmont, MA 02474 USA.	PHallett@mclean.harvard.edu; Isacson@hms.harvard.edu		Hallett, Penelope/0000-0002-8858-9096; Smith, Gaynor/0000-0003-4332-8383; Rocha, Emily/0000-0003-2171-5104; Isacson, Ole/0000-0001-8091-8302	McLean Hospital/Harvard Medical School; Sanofi; Sanofi-Genzyme	McLean Hospital/Harvard Medical School; Sanofi; Sanofi-Genzyme	MJFF was the sole provider of support in the form of salaries for authors listed under McLean Hospital/Harvard Medical School. Sanofi and Sanofi-Genzyme provided support in the form of salaries for authors (TR, PB, MC and YL), but did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. Sanofi and Sanofi-Genzyme did collect PK data and reviewed the final completed manuscript. No changes were made to the manuscript by Sanofi and Sanofi-Genzyme to the data or interpretation.	Alavian KN, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-27; Baffi JS, 1999, NEUROSCIENCE, V93, P631, DOI 10.1016/S0306-4522(99)00124-4; Cao JP, 2010, BRAIN RES BULL, V83, P321, DOI 10.1016/j.brainresbull.2010.09.009; Chu YP, 2006, J COMP NEUROL, V494, P495, DOI 10.1002/cne.20828; Chu YP, 2002, J COMP NEUROL, V450, P203, DOI 10.1002/cne.10261; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Couch Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-166; Daher JPL, 2014, P NATL ACAD SCI USA, V111, P9289, DOI 10.1073/pnas.1403215111; Decressac M, 2013, NAT REV NEUROL, V9, P629, DOI 10.1038/nrneurol.2013.209; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Deleidi M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003492; Deleidi M, 2010, J NEUROSCI, V30, P16091, DOI 10.1523/JNEUROSCI.2400-10.2010; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Galleguillos D, 2010, J NEUROCHEM, V114, P1158, DOI 10.1111/j.1471-4159.2010.06841.x; Gandhi R, 2007, BRAIN BEHAV IMMUN, V21, P477, DOI 10.1016/j.bbi.2006.12.005; Gao HM, 2003, J NEUROSCI, V23, P1228, DOI 10.1523/JNEUROSCI.23-04-01228.2003; Gillardon F, 2012, NEUROSCIENCE, V208, P41, DOI 10.1016/j.neuroscience.2012.02.001; Grimes DA, 2006, MOVEMENT DISORD, V21, P906, DOI 10.1002/mds.20820; Hayley S, 2004, J NEUROSCI, V24, P2045, DOI 10.1523/JNEUROSCI.4564-03.2004; Helmy AA, 2012, NEURODEGENER DIS, V9, P81, DOI 10.1159/000329568; Hering R, 2004, NEUROLOGY, V62, P1231, DOI 10.1212/01.WNL.0000118285.18383.90; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Kadkhodaei B, 2013, P NATL ACAD SCI USA, V110, P2360, DOI 10.1073/pnas.1221077110; Konat GW, 2009, J NEUROSCI RES, V87, P1381, DOI 10.1002/jnr.21958; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Luo Y, 2012, INT REV NEUROBIOL, V102, P1, DOI 10.1016/B978-0-12-386986-9.00001-6; Mangano EN, 2009, NEUROBIOL AGING, V30, P1361, DOI 10.1016/j.neurobiolaging.2007.11.020; Moran LB, 2007, ACTA NEUROPATHOL, V113, P253, DOI 10.1007/s00401-006-0181-6; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Nguyen TA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-50; Pan J, 2007, NEUROSCI LETT, V428, P82, DOI 10.1016/j.neulet.2007.09.032; Pratt L, 2013, PEDIATR RES, V74, P393, DOI 10.1038/pr.2013.126; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Silvestroni A, 2009, NEUROREPORT, V20, P1098, DOI 10.1097/WNR.0b013e32832e34ee; Sonntag KC, 2004, EUR J NEUROSCI, V19, P1141, DOI 10.1111/j.1460-9568.2004.03204.x; Tan EK, 2004, MOVEMENT DISORD, V19, P1503, DOI 10.1002/mds.20246; Tan EK, 2003, NEUROSCI LETT, V347, P139, DOI 10.1016/S0304-3940(03)00539-1; Volpicelli F, 2007, J NEUROCHEM, V102, P441, DOI 10.1111/j.1471-4159.2007.04494.x; Wallen A, 2001, MOL CELL NEUROSCI, V18, P649, DOI 10.1006/mcne.2001.1057; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yi SH, 2014, DEVELOPMENT, V141, P761, DOI 10.1242/dev.095802; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang LF, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.022	46	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121072	10.1371/journal.pone.0121072	http://dx.doi.org/10.1371/journal.pone.0121072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815475	Green Published, gold			2022-12-26	WOS:000352133600064
J	Uehara, K; Coxon, JP; Byblow, WD				Uehara, Kazumasa; Coxon, James P.; Byblow, Winston D.			Transcranial Direct Current Stimulation Improves Ipsilateral Selective Muscle Activation in a Frequency Dependent Manner	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; ANTAGONIST MUSCLES; MAGNETIC STIMULATION; EXCITABILITY; INHIBITION; MOVEMENTS; SUPPRESSION; SYNERGIES; FACILITATION; MODULATION	Failure to suppress antagonist muscles can lead to movement dysfunction, such as the abnormal muscle synergies often seen in the upper limb after stroke. A neurophysiological surrogate of upper limb synergies, the selectivity ratio (SR), can be determined from the ratio of biceps brachii (BB) motor evoked potentials to transcranial magnetic stimulation prior to forearm pronation versus elbow flexion. Surprisingly, cathodal transcranial direct current stimulation (c-TDCS) over ipsilateral primary motor cortex (M1) reduces (i.e. improves) the SR in healthy adults, and chronic stroke patients. The ability to suppress antagonist muscles may be exacerbated at high movement rates. The aim of the present study was to investigate whether the selective muscle activation of the biceps brachii (BB) is dependent on altering frequency demands, and whether the c-tDCS improvement of SR is dependent on task frequency. Seventeen healthy participants performed repetitive isometric elbow flexion and forearm pronation at three rates, before and after c-tDCS or sham delivered to ipsilateral left M1. Ipsilateral c-tDCS improved the SR in a frequency dependent manner by selectively suppressing BB antagonist excitability. Our findings confirm that c-tDCS is an effective tool for improving selective muscle activation, and provide novel evidence for its efficacy at rates of movement where it is most likely to benefit task performance.	[Uehara, Kazumasa; Coxon, James P.; Byblow, Winston D.] Univ Auckland, Dept Sport & Exercise Sci, Movement Neurosci Lab, Auckland 1, New Zealand; [Uehara, Kazumasa; Coxon, James P.; Byblow, Winston D.] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [Uehara, Kazumasa] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Div Human Sci, Human Motor Control Lab, Higashihiroshima, Hiroshima 724, Japan	University of Auckland; University of Auckland; Hiroshima University	Byblow, WD (corresponding author), Univ Auckland, Dept Sport & Exercise Sci, Movement Neurosci Lab, Auckland 1, New Zealand.	w.byblow@auckland.ac.nz	Byblow, Winston/D-3579-2009; Coxon, James/S-1286-2019	Byblow, Winston/0000-0001-8347-6730; Coxon, James/0000-0003-2351-8489; Uehara, Kazumasa/0000-0003-2350-8694	Aotearoa Foundation of New Zealand [9133-3627269]; Faculty Research Development Fund (FRDF) grant [3704166]; Japan Society for the Promotion of Science [24-393]	Aotearoa Foundation of New Zealand; Faculty Research Development Fund (FRDF) grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	KU is supported by a postdoctoral fellow from Japan Society for the Promotion of Science (24-393). JPC is supported by a postdoctoral fellowship from the Aotearoa Foundation of New Zealand (9133-3627269). This study was financially supported by a Faculty Research Development Fund (FRDF) grant awarded to WDB (3704166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Bradnam LV, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00184; Bradnam LV, 2012, CEREB CORTEX, V22, P2662, DOI 10.1093/cercor/bhr344; Bradnam LV, 2011, J NEUROPHYSIOL, V105, P2582, DOI 10.1152/jn.01084.2010; Bradnam LV, 2010, J NEUROPHYSIOL, V104, P2594, DOI 10.1152/jn.00365.2010; Bradnam LV, 2010, J NEUROPHYSIOL, V103, P2382, DOI 10.1152/jn.01046.2009; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; CHENEY PD, 1985, J NEUROPHYSIOL, V53, P805, DOI 10.1152/jn.1985.53.3.805; d'Avella A, 2008, J NEUROPHYSIOL, V100, P1433, DOI 10.1152/jn.01377.2007; DE LUCA CJ, 1987, J NEUROPHYSIOL, V58, P525, DOI 10.1152/jn.1987.58.3.525; Furuya S, 2012, HUM MOVEMENT SCI, V31, P26, DOI 10.1016/j.humov.2011.01.002; Gerachshenko T, 2008, CLIN NEUROPHYSIOL, V119, P683, DOI 10.1016/j.clinph.2007.11.004; Gerachshenko T, 2007, EXP BRAIN RES, V183, P531, DOI 10.1007/s00221-007-1071-4; Gerard MJ, 2002, HUM FACTORS, V44, P51, DOI 10.1518/0018720024494757; GOWLAND C, 1992, PHYS THER, V72, P624, DOI 10.1093/ptj/72.9.624; Harris-Love ML, 2007, J NEUROPHYSIOL, V97, P2511, DOI 10.1152/jn.01331.2006; Hayashi MJ, 2008, CEREB CORTEX, V18, P2932, DOI 10.1093/cercor/bhn053; Hortobagyi T, 2006, EXP BRAIN RES, V171, P322, DOI 10.1007/s00221-005-0274-9; Kaneko K, 1996, ELECTROMYOGR MOTOR C, V101, P478, DOI 10.1016/S0921-884X(96)96021-X; Kuxhaus L, 2014, J BIOMECH, V47, P1234, DOI 10.1016/j.jbiomech.2013.12.008; Levin MF, 2000, BRAIN RES, V853, P352, DOI 10.1016/S0006-8993(99)02298-2; MARSDEN CD, 1983, J PHYSIOL-LONDON, V335, P1; McCambridge AB, 2011, J NEUROPHYSIOL, V105, P2937, DOI 10.1152/jn.00171.2011; Monte-Silva K, 2010, J NEUROPHYSIOL, V103, P1735, DOI 10.1152/jn.00924.2009; Nakamura H, 1997, J PHYSIOL-LONDON, V498, P817, DOI 10.1113/jphysiol.1997.sp021905; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ROM DM, 1990, BIOMETRIKA, V77, P663, DOI 10.2307/2337008; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Simkins M, 2013, EXP BRAIN RES, V229, P517, DOI 10.1007/s00221-013-3613-2; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Taylor JL, 2001, MUSCLE NERVE, V24, P18, DOI 10.1002/1097-4598(200101)24:1<18::AID-MUS2>3.3.CO;2-4; Uehara K, 2013, BEHAV BRAIN RES, V240, P33, DOI 10.1016/j.bbr.2012.10.053; Uehara K, 2011, NEUROSCI LETT, V488, P22, DOI 10.1016/j.neulet.2010.10.073; van den Berg FE, 2011, J COGNITIVE NEUROSCI, V23, P3456, DOI 10.1162/jocn_a_00018; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Welmer AK, 2006, AM J PHYS MED REHAB, V85, P112, DOI 10.1097/01.phm.0000197587.78140.17; WIERZBICKA MM, 1986, EXP BRAIN RES, V63, P331	40	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122434	10.1371/journal.pone.0122434	http://dx.doi.org/10.1371/journal.pone.0122434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816204	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600180
J	Zhang, JH; Chen, SL; Hou, ZQ; Cai, J; Dong, MM; Shi, XR				Zhang, Jinhui; Chen, Songlin; Hou, Zhiqiang; Cai, Jing; Dong, Mingmin; Shi, Xiaorui			Lipopolysaccharide-Induced Middle Ear Inflammation Disrupts the cochlear Intra-Strial Fluid-Blood Barrier through Down-Regulation of Tight Junction Proteins	PLOS ONE			English	Article							MACROPHAGE-LIKE MELANOCYTES; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL GROWTH-FACTOR; OTITIS-MEDIA; BRAIN-BARRIER; PERICYTE MIGRATION; GUINEA-PIG; INNER-EAR; IN-VITRO; MICROVASCULAR PERICYTES	Middle ear infection (or inflammation) is the most common pathological condition that causes fluid to accumulate in the middle ear, disrupting cochlear homeostasis. Lipopolysaccharide, a product of bacteriolysis, activates macrophages and causes release of inflammatory cytokines. Many studies have shown that lipopolysaccharides cause functional and structural changes in the inner ear similar to that of inflammation. However, it is specifically not known how lipopolysaccharides affect the blood-labyrinth barrier in the stria vascularis (intra-strial fluid-blood barrier), nor what the underlying mechanisms are. In this study, we used a cell culture-based in vitro model and animal-based in vivo model, combined with immunohistochemistry and a vascular leakage assay, to investigate lipopolysaccharide effects on the integrity of the mouse intra-strial fluid-blood barrier. Our results show lipopolysaccharide-induced local infection significantly affects intra-strial fluid-blood barrier component cells. Pericytes and perivascular-resident macrophage-like melanocytes are particularly affected, and the morphological and functional changes in these cells are accompanied by substantial changes in barrier integrity. Significant vascular leakage is found in the lipopolysaccharide treated-animals. Consistent with the findings from the in vivo animal model, the permeability of the endothelial cell monolayer to FITC-albumin was significantly higher in the lipopolysaccharide-treated monolayer than in an untreated endothelial cell monolayer. Further study has shown the lipopolysaccharide-induced inflammation to have a major effect on the expression of tight junctions in the blood barrier. Lipopolysaccharide was also shown to cause high frequency hearing loss, corroborated by previous reports from other laboratories. Our findings show lipopolysaccharide-evoked middle ear infection disrupts inner ear fluid balance, and its particular effects on the intra-strial fluid-blood barrier, essential for cochlear homeostasis. The barrier is degraded as the expression of tight junction-associated proteins such as zona occludens 1, occludin, and vascular endothelial cadherin are down-regulated.	[Zhang, Jinhui; Dong, Mingmin] Zhengzhou Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Zhengzhou, Henan, Peoples R China; [Zhang, Jinhui; Chen, Songlin; Hou, Zhiqiang; Cai, Jing; Shi, Xiaorui] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA	Zhengzhou University; Oregon Health & Science University	Shi, XR (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Zhengzhou, Henan, Peoples R China.	shix@ohsu.edu	zhang, jinhui/GXF-6528-2022; zhang, jin/GXV-9154-2022	Hou, Zhiqiang/0000-0002-5154-7474	National Institute of Health [NIH NIDCD R01-DC010844, DC R21DC1239801, NIHP30-DC005983]; National Key Basic Research Program of China [2014CB943001]; National Natural Science Foundation of China [81120108009]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R01DC010844, R21DC012398] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by National Institute of Health grants NIH NIDCD R01-DC010844 (XS), DC R21DC1239801 (XS), NIHP30-DC005983, as well as by grants from the National Key Basic Research Program of China, No. 2014CB943001, and National Natural Science Foundation of China, No. 81120108009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera KY, 2014, CELL MOL LIFE SCI, V71, P299, DOI 10.1007/s00018-013-1432-z; Axelsson A, 1968, ACTA OTOLARYNGOL S, V243, P3; Buckiova D, 2012, NANOMEDICINE-UK, V7, P1339, DOI 10.2217/NNM.12.5; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Cho JG, 2007, INT J PEDIATR OTORHI, V71, P101, DOI 10.1016/j.ijporl.2006.09.010; Choi CH, 2012, INT J PEDIATR OTORHI, V76, P544, DOI 10.1016/j.ijporl.2012.01.013; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Dai M, 2010, AM J PATHOL, V177, P3089, DOI 10.2353/ajpath.2010.100340; DARROW DH, 1992, LARYNGOSCOPE, V102, P683, DOI 10.1288/00005537-199206000-00015; Date I, 2006, NEUROSCI LETT, V407, P141, DOI 10.1016/j.neulet.2006.08.050; Dohgu S, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-23; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Dore-Duffy P, 2011, METHODS MOL BIOL, V686, P49, DOI 10.1007/978-1-60761-938-3_2; Edelman DA, 2007, J TRAUMA, V62, P89, DOI 10.1097/TA.0b013e31802dd712; Erickson MA, 2012, BRAIN BEHAV IMMUN, V26, P1085, DOI 10.1016/j.bbi.2012.07.003; Florea A, 2006, ACTA OTO-LARYNGOL, V126, P910, DOI 10.1080/00016480600606699; Gratton M A, 1996, Hear Res, V102, P181, DOI 10.1016/S0378-5955(96)90017-9; GRATTON MA, 1992, PIGM CELL RES, V5, P30, DOI 10.1111/j.1600-0749.1992.tb00779.x; Greenhalgh S.N., 2013, F1000PRIME REP, P5; GUO YC, 1994, J LARYNGOL OTOL, V108, P310, DOI 10.1017/S0022215100126623; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hamidi A, 2012, J BIOL CHEM, V287, P123, DOI 10.1074/jbc.M111.285122; Hess A, 1998, BRAIN RES, V813, P97, DOI 10.1016/S0006-8993(98)00997-4; Hirose K, 2014, JARO-J ASSOC RES OTO, V15, P707, DOI 10.1007/s10162-014-0476-6; Hirose K, 2014, JARO-J ASSOC RES OTO, V15, P555, DOI 10.1007/s10162-014-0458-8; [黄丽华 Huang Lihua], 2013, [细胞与分子免疫学杂志, Chinese Journal of Cellular and Molecular Immunology], V29, P1012; HUNTER CA, 1992, LAB INVEST, V67, P635; Hurtado-Alvarado G, 2014, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00080; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Jang CH, 2014, INT J PEDIATR OTORHI, V78, P465, DOI 10.1016/j.ijporl.2013.12.022; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Juhn S K, 2001, Int Tinnitus J, V7, P72; JUHN SK, 1981, ACTA OTO-LARYNGOL, V91, P529, DOI 10.3109/00016488109138538; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Khoramrooz SS, 2012, AURIS NASUS LARYNX, V39, P369, DOI 10.1016/j.anl.2011.07.002; Kim TH, 2010, FOOD CHEM TOXICOL, V48, P1682, DOI 10.1016/j.fct.2010.03.045; Kobayashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062187; KRAUSE D, 1993, ADV EXP MED BIOL, V331, P149; Lei S, 2014, EUR J CELL BIOL, V93, P299, DOI 10.1016/j.ejcb.2014.05.003; Monaghan-Benson E, 2011, METHODS MOL BIOL, V763, P281, DOI 10.1007/978-1-61779-191-8_19; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Neng LL, 2013, NAT PROTOC, V8, P709, DOI 10.1038/nprot.2013.033; Neng LL, 2013, JARO-J ASSOC RES OTO, V14, P175, DOI 10.1007/s10162-012-0365-9; Ohlemiller KK, 2008, HEARING RES, V244, P85, DOI 10.1016/j.heares.2008.08.001; Park CW, 2004, J KOREAN MED SCI, V19, P735, DOI 10.3346/jkms.2004.19.5.735; Peppi M, 2004, J ANAT, V205, P257, DOI 10.1111/j.0021-8782.2004.00332.x; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Pieper C, 2014, BRAIN RES, V1550, P1, DOI 10.1016/j.brainres.2014.01.004; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Quaegebeur A, 2010, NEURON, V68, P321, DOI 10.1016/j.neuron.2010.10.024; Quintanilla-Dieck L, 2013, OTOLARYNG HEAD NECK, V149, P301, DOI 10.1177/0194599813491712; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; Rodriguez A, 2013, AM J PATHOL, V182, P2132, DOI 10.1016/j.ajpath.2013.01.054; SAKAGAMI M, 1982, CELL TISSUE RES, V226, P511; SALT AN, 1987, LARYNGOSCOPE, V97, P984; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Scaini G, 2014, MOL NEUROBIOL, V50, P358, DOI 10.1007/s12035-013-8618-0; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Shi XR, 2008, MICROCIRCULATION, V15, P515, DOI 10.1080/10739680802047445; Shi XR, 2014, HEARING RES, V313, P38, DOI 10.1016/j.heares.2014.04.006; Shi XR, 2011, HEARING RES, V282, P10, DOI 10.1016/j.heares.2011.08.006; Shi XR, 2010, CELL TISSUE RES, V342, P21, DOI 10.1007/s00441-010-1040-2; Shi XR, 2009, AM J PATHOL, V174, P1692, DOI 10.2353/ajpath.2009.080739; Shi XR, 2003, HEARING RES, V177, P43, DOI 10.1016/S0378-5955(02)00796-7; Shimizu F, 2013, NEUROBIOL AGING, V34, P1902, DOI 10.1016/j.neurobiolaging.2013.01.012; Song JJ, 2012, ACTA OTO-LARYNGOL, V132, P1145, DOI 10.3109/00016489.2012.697640; Spicer SS, 2002, HEARING RES, V172, P172, DOI 10.1016/S0378-5955(02)00581-6; Steinbach WJ, 2002, PEDIATRICS, V109, P993, DOI 10.1542/peds.109.6.993; TABOR DR, 1989, J LEUKOCYTE BIOL, V45, P452, DOI 10.1002/jlb.45.5.452; TAKACS B, 1987, J IMMUNOL, V138, P1999; TARLOW MJ, 1991, ARCH DIS CHILD, V66, P181, DOI 10.1136/adc.66.2.181; van Well GTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035837; van Zon A, 2012, COCHRANE DB SYST REV, V9, pCD009163, DOI DOI 10.1002/14651858.CD009163.PUB3; Vandenhaute E, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-11; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wangemann P, 2002, ADV OTO-RHINO-LARYNG, V59, P51; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Watanabe K, 2001, EUR ARCH OTO-RHINO-L, V258, P164, DOI 10.1007/s004050100335; Watanabe KI, 2000, FREE RADICAL RES, V32, P363, DOI 10.1080/10715760000300361; Wu TT, 2009, TOXICOL LETT, V191, P195, DOI 10.1016/j.toxlet.2009.08.025; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016547; Yi X, 2000, INVEST OPHTH VIS SCI, V41, P4093; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279; Zhang F, 2013, JARO-J ASSOC RES OTO, V14, P635, DOI 10.1007/s10162-013-0403-2; Zhang F, 2013, FASEB J, V27, P3730, DOI 10.1096/fj.13-232892; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P10388, DOI 10.1073/pnas.1205210109	88	37	40	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122572	10.1371/journal.pone.0122572	http://dx.doi.org/10.1371/journal.pone.0122572			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815897	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600186
J	Lee, JM; Park, SJ; Lee, SP; Park, E; Chang, SA; Kim, HK; Lee, W; Kim, YJ; Lee, SC; Park, SW; Sohn, DW; Choe, YH				Lee, Joo Myung; Park, Sung-Ji; Lee, Seung-Pyo; Park, Eunah; Chang, Sung-A; Kim, Hyung-Kwan; Lee, Whal; Kim, Yong-Jin; Lee, Sang-Chol; Park, Seung Woo; Sohn, Dae-Won; Choe, Yeon Hyeon			Gender Difference in Ventricular Response to Aortic Stenosis: Insight from Cardiovascular Magnetic Resonance	PLOS ONE			English	Article							VALVE-REPLACEMENT; PAPILLARY-MUSCLES; CLINICAL PRESENTATION; SEX-DIFFERENCES; IMPACT; TRANSCATHETER; HYPERTROPHY; TRABECULAE; ECHOCARDIOGRAPHY; PROGRESSION	Background Although left ventricular hypertrophy (LVH) and remodeling is associated with cardiac mortality and morbidity, little is known about the impact of gender on the ventricular response in aortic stenosis (AS) patients. This study aimed to analyze the differential effect of gender on ventricular remodeling in moderate to severe AS patients. Methods and Results A total of 118 consecutive patients (67 +/- 9 years; 63 males) with moderate or severe AS (severe 81.4%) underwent transthoracic echocardiography and cardiovascular magnetic resonance (CMR) within a 1-month period in this two-center prospective registry. The pattern of LV remodeling was assessed using the LV mass index (LVMI) and LV remodeling index (LVRI; LV mass/LV end-diastolic volume) by CMR. Although there were no differences in AS severity parameters nor baseline characteristics between genders, males showed a significantly higher LVMI (102.6 +/- 29.1g/m(2) vs. 86.1 +/- 29.2g/m(2), p=0.003) and LVRI (1.1 +/- 0.2 vs. 1.0 +/- 0.3, p=0.018), regardless of AS severity. The LVMI was significantly associated with aortic valve area (AVA) index and valvuloarterial impedance in females, whereas it was not in males, resulting in significant interaction between genders (PInteraction=0.007/0.014 for AVA index/valvuloarterial impedance, respectively). Similarly, the LVRI also showed a significantly different association between male and female subjects with the change in AS severity parameters (PInteraction=0.033/<0.001/0.029 for AVA index/transaortic mean pressure gradient/valvuloarterial impedance, respectively). Conclusion Males are associated with greater degree of LVH and higher LVRI compared to females at moderate to severe AS. However, females showed a more exaggerated LV remodeling response, with increased severity of AS and hemodynamic loads, than males.	[Lee, Joo Myung; Lee, Seung-Pyo; Kim, Hyung-Kwan; Kim, Yong-Jin; Sohn, Dae-Won] Sungkyunkwan Univ, Sch Med, Cardiovasc Ctr, Seoul, South Korea; [Lee, Joo Myung; Lee, Seung-Pyo; Kim, Hyung-Kwan; Kim, Yong-Jin; Sohn, Dae-Won] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Park, Eunah; Lee, Whal] Sungkyunkwan Univ, Sch Med, Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Park, Sung-Ji; Chang, Sung-A; Lee, Sang-Chol; Park, Seung Woo; Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiovasc Imaging Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, SP (corresponding author), Sungkyunkwan Univ, Sch Med, Cardiovasc Ctr, Seoul, South Korea.	splee0624@gmail.com		Kim, Hyung-Kwan/0000-0001-7950-2131; Chang, Sung-A/0000-0001-5124-605X; Lee, Joo Myung/0000-0002-2178-4014	Korean Health Technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [A120753]	Korean Health Technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project (A120753), Ministry of Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AURIGEMMA GP, 1994, AM J CARDIOL, V74, P794, DOI 10.1016/0002-9149(94)90437-5; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Briand M, 2005, J AM COLL CARDIOL, V46, P291, DOI 10.1016/j.jacc.2004.10.081; Chuang ML, 2012, JACC-CARDIOVASC IMAG, V5, P1115, DOI 10.1016/j.jcmg.2012.05.015; De Castro S, 2007, HEART, V93, P205, DOI 10.1136/hrt.2006.093997; Dweck MR, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-50; FAGGIANO P, 1992, AM J CARDIOL, V70, P229, DOI 10.1016/0002-9149(92)91280-H; Fuchs C, 2010, HEART, V96, P539, DOI 10.1136/hrt.2009.186650; Hayashida K, 2012, J AM COLL CARDIOL, V59, P566, DOI 10.1016/j.jacc.2011.10.877; Humphries KH, 2012, J AM COLL CARDIOL, V60, P882, DOI 10.1016/j.jacc.2012.05.009; Janik M, 2008, J HYPERTENS, V26, P1677, DOI 10.1097/HJH.0b013e328302ca14; Lee SP, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-72; Legget ME, 1996, AM HEART J, V131, P94, DOI 10.1016/S0002-8703(96)90056-3; Mark PB, 2007, NEPHROL DIAL TRANSPL, V22, P1815, DOI 10.1093/ndt/gfm224; Milavetz DL, 2000, CHEST, V117, P1094, DOI 10.1378/chest.117.4.1094; Myerson SG, 2002, HYPERTENSION, V39, P750, DOI 10.1161/hy0302.104674; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764; Rider OJ, 2013, EUR HEART J, V34, P292, DOI 10.1093/eurheartj/ehs341; ROGER VL, 1990, AM HEART J, V119, P331, DOI 10.1016/S0002-8703(05)80024-9; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stamou SC, 2012, J THORAC CARDIOV SUR, V144, P486, DOI 10.1016/j.jtcvs.2011.11.023; Vahanian A, 2010, EUR HEART J, V31, P416, DOI 10.1093/eurheartj/ehp575; Villa Emmanuel, 2006, Cardiovasc Ultrasound, V4, P25, DOI 10.1186/1476-7120-4-25; Weinsaft JW, 2008, INT J CARDIOL, V126, P359, DOI 10.1016/j.ijcard.2007.04.179	25	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121684	10.1371/journal.pone.0121684	http://dx.doi.org/10.1371/journal.pone.0121684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811358	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700127
J	Rajaganapathy, BR; Chancellor, MB; Nirmal, J; Dang, L; Tyagi, P				Rajaganapathy, Bharathi Raja; Chancellor, Michael B.; Nirmal, Jayabalan; Dang, Loan; Tyagi, Pradeep			Bladder Uptake of Liposomes after Intravesical Administration Occurs by Endocytosis	PLOS ONE			English	Article							DIMETHYL-SULFOXIDE; DNA RELEASE; CYSTITIS; CHOLESTEROL; THERAPY; CELLS	Liposomes have been used therapeutically and as a local drug delivery system in the bladder. However, the exact mechanism for the uptake of liposomes by bladder cells is unclear. In the present study, we investigated the role of endocytosis in the uptake of liposomes by cultured human UROtsa cells of urothelium and rat bladder. UROtsa cells were incubated in serum-free media with liposomes containing colloidal gold particles for 2 h either at 37 degrees C or at 4 degrees C. Transmission Electron Microscopy (TEM) images of cells incubated at 37 degrees C found endocytic vesicles containing gold inside the cells. In contrast, only extracellular binding was noticed in cells incubated with liposomes at 4 degrees C. Absence of liposome internalization at 4 degrees C indicates the need of energy dependent endocytosis as the primary mechanism of entry of liposomes into the urothelium. Flow cytometry analysis revealed that the uptake of liposomes at 37 degrees C occurs via clathrin mediated endocytosis. Based on these observations, we propose that clathrin mediated endocytosis is the main route of entry for liposomes into the urothelial layer of the bladder and the findings here support the usefulness of liposomes in intravesical drug delivery.	[Rajaganapathy, Bharathi Raja; Chancellor, Michael B.; Nirmal, Jayabalan] Oakland Univ, William Beaumont Sch Med, William Beaumont Hosp Res Inst, Dept Urol, Royal Oak, MI 48067 USA; [Tyagi, Pradeep] Univ Pittsburgh, Dept Urol, Pittsburgh, PA USA; [Dang, Loan] Oakland Univ, Eye Res Inst, Rochester, MI 48063 USA	Oakland University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oakland University	Chancellor, MB (corresponding author), Oakland Univ, William Beaumont Sch Med, William Beaumont Hosp Res Inst, Dept Urol, Royal Oak, MI 48067 USA.	chancellormb@gmail.com	J, Nirmal/AAO-5138-2020	J, Nirmal/0000-0001-7864-6053	National Institute of Health [DK083323]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083323] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Health (Grant number-DK083323). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Celano M, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-63; Chuang YC, 2009, J UROLOGY, V182, P1393, DOI 10.1016/j.juro.2009.06.024; Chuang YC, 2009, J UROLOGY, V182, P786, DOI 10.1016/j.juro.2009.03.083; Cosco D, 2012, INT J NANOMED, V7, P2535, DOI [10.2147/IJN.S28114, 10.2147/IJN.S34025]; Dellis A, 2014, EXPERT OPIN INV DRUG, V23, P751, DOI 10.1517/13543784.2014.909406; Dowson C, 2012, EUR UROL, V61, P834, DOI 10.1016/j.eururo.2011.12.011; Giannantoni A, 2006, EUR UROL, V50, P1183, DOI 10.1016/j.eururo.2006.08.025; Gregoriadis G, 2005, INT J PHARM, V300, P125, DOI 10.1016/j.ijpharm.2005.06.007; Gregoriadis G, 1995, TRENDS BIOTECHNOL, V13, P527, DOI 10.1016/S0167-7799(00)89017-4; GREGORIADIS G, 1976, BIOCHEM SOC T, V4, P256, DOI 10.1042/bst0040256; Kaufman J, 2010, REV UROL, V12, P181; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Lai MC, 2013, INT J UROL, V20, P203, DOI 10.1111/j.1442-2042.2012.03135.x; Nirmal J, 2012, UROL SCI, V23, P70, DOI 10.1016/j.urols.2012.07.005; Nirmal J, 2013, J UROLOGY, V189, P1553, DOI 10.1016/j.juro.2012.10.123; Parkin J, 1997, UROLOGY, V49, P105, DOI 10.1016/S0090-4295(97)00181-7; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Sapra Puja, 2005, Current Drug Delivery, V2, P369, DOI 10.2174/156720105774370159; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Tyagi P, 2006, MOL PHARMACEUT, V3, P369, DOI 10.1021/mp060001j; Tyagi P, 2009, BJU INT, V104, P1689, DOI 10.1111/j.1464-410X.2009.08673.x; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; Zhou ZX, 2011, INT J TOXICOL, V30, P174, DOI 10.1177/1091581810394548; Zuhorn IS, 2002, J BIOL CHEM, V277, P18021, DOI 10.1074/jbc.M111257200	27	26	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122766	10.1371/journal.pone.0122766	http://dx.doi.org/10.1371/journal.pone.0122766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811468	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000356353700200
J	Nguyen, VS; Logger, L; Spinelli, S; Desmyter, A; Le, TTH; Kellenberger, C; Douzi, B; Durand, E; Roussel, A; Cascales, E; Cambillau, C				Van Son Nguyen; Logger, Laureen; Spinelli, Silvia; Desmyter, Aline; Thi Thu Hang Le; Kellenberger, Christine; Douzi, Badreddine; Durand, Eric; Roussel, Alain; Cascales, Eric; Cambillau, Christian			Inhibition of Type VI Secretion by an Anti-TssM Llama Nanobody	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODIES; BACTERIAL TYPE VI; CRYSTAL-STRUCTURE; SYSTEM; PROTEIN; FRAGMENTS	The type VI secretion system (T6SS) is a secretion pathway widespread in Gram-negative bacteria that targets toxins in both prokaryotic and eukaryotic cells. Although most T6SSs identified so far are involved in inter-bacterial competition, a few are directly required for full virulence of pathogens. The T6SS comprises 13 core proteins that assemble a large complex structurally and functionally similar to a phage contractile tail structure anchored to the cell envelope by a trans-membrane spanning stator. The central part of this stator, TssM, is a 1129-amino-acid protein anchored in the inner membrane that binds to the TssJ outer membrane lipoprotein. In this study, we have raised camelid antibodies against the purified TssM periplasmic domain. We report the crystal structure of two specific nanobodies that bind to TssM in the nanomolar range. Interestingly, the most potent nanobody, nb25, competes with the TssJ lipoprotein for TssM binding in vitro suggesting that TssJ and the nb25 CDR3 loop share the same TssM binding site or causes a steric hindrance preventing TssM-TssJ complex formation. Indeed, periplasmic production of the nanobodies displacing the TssM-TssJ interaction inhibits the T6SS function in vivo. This study illustrates the power of nanobodies to specifically target and inhibit bacterial secretion systems.	[Van Son Nguyen; Spinelli, Silvia; Desmyter, Aline; Thi Thu Hang Le; Kellenberger, Christine; Douzi, Badreddine; Durand, Eric; Roussel, Alain; Cambillau, Christian] CNRS, UMR 7257, Architecture & Fonct Macromol Biol, Marseille, France; [Van Son Nguyen; Spinelli, Silvia; Desmyter, Aline; Thi Thu Hang Le; Kellenberger, Christine; Douzi, Badreddine; Durand, Eric; Roussel, Alain; Cambillau, Christian] Aix Marseille Univ, Architecture & Fonct Macromol Biol, Marseille, France; [Logger, Laureen; Cascales, Eric] Aix Marseille Univ, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, CNRS,UMR 7255, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Cascales, E (corresponding author), Aix Marseille Univ, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, CNRS,UMR 7255, 31 Chemin Joseph Aiguier, Marseille, France.	cascales@imm.cnrs.fr; ccambillau@gmail.com	Douzi, Badreddine/ABA-4540-2021; Durand, Eric/E-6739-2017; CASCALES, ERIC/G-7420-2011; douzi, Badreddine/Z-5707-2019; kellenberger, christine/AAV-9304-2020	Douzi, Badreddine/0000-0003-3140-4713; Durand, Eric/0000-0002-0577-8220; CASCALES, ERIC/0000-0003-0611-9179; nguyen, van-son/0000-0002-3079-2016	Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]; Fondation pour la Recherche Medicale (FRM) [DEQ2011-0421282]; French Embassy in Vietnam; University of Sciences and Techniques of 1 Hanoi (USTH); French Ministry of Research; FRM [FRM-SPF20101221116]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Embassy in Vietnam; University of Sciences and Techniques of 1 Hanoi (USTH); French Ministry of Research(Ministry of Research, FranceEuropean Commission); FRM(Fondation pour la Recherche Medicale)	This work was supported by grants from the Agence Nationale de la Recherche to EC (ANR-10-JCJC-1303-03) and from the Fondation pour la Recherche Medicale (FRM) to CC (DEQ2011-0421282). VSN is supported by a PhD grant from the French Embassy in Vietnam, and TTHL is supported by a PhD grant from the University of Sciences and Techniques of 1 Hanoi (USTH). LL is supported by a doctoral fellowship from the French Ministry of Research. ED was supported by a FRM post-doctoral fellowship (FRM-SPF20101221116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams H, 2014, J BIOTECHNOL, V186, P66, DOI 10.1016/j.jbiotec.2014.06.029; Alzogaray V, 2011, FASEB J, V25, P526, DOI 10.1096/fj.10-162958; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Conrath K, 2009, PROTEIN SCI, V18, P619, DOI 10.1002/pro.69; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2015, CURR OPIN STRUC BIOL, V32, P1, DOI 10.1016/j.sbi.2015.01.001; Desmyter A, 2013, P NATL ACAD SCI USA, V110, pE1371, DOI 10.1073/pnas.1301336110; Durand E, 2014, TRENDS MICROBIOL, V22, P498, DOI 10.1016/j.tim.2014.06.004; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gueguen E, 2013, APPL ENVIRON MICROB, V79, P32, DOI 10.1128/AEM.02504-12; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Hussack G, 2014, PROTEIN ENG DES SEL, V27, P191, DOI 10.1093/protein/gzu011; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nguyen VS, 2015, ACTA CRYSTALLOGR F I, P71; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Steyaert J, 2011, EUR BIOPHYS J BIOPHY, V40, P223; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zoued A, 2014, BBA-MOL CELL RES, V1843, P1664, DOI 10.1016/j.bbamcr.2014.03.018; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	43	13	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122187	10.1371/journal.pone.0122187	http://dx.doi.org/10.1371/journal.pone.0122187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811612	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700174
J	Beluzi, M; Peres, SB; Henriques, FS; Sertie, RAL; Franco, FO; Santos, KB; Knobl, P; Andreotti, S; Shida, CS; Neves, RX; Farmer, SR; Seelaender, M; Lima, FB; Batista, ML				Beluzi, Mercia; Peres, Sidney B.; Henriques, Felipe S.; Sertie, Rogerio A. L.; Franco, Felipe O.; Santos, Kaltinaitis B.; Knobl, Pamela; Andreotti, Sandra; Shida, Claudio S.; Neves, Rodrigo X.; Farmer, Stephen R.; Seelaender, Marilia; Lima, Fabio B.; Batista, Miguel L., Jr.			Pioglitazone Treatment Increases Survival and Prevents Body Weight Loss in Tumor-Bearing Animals: Possible Anti-Cachectic Effect	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; ADIPOSE-TISSUE; PPAR-GAMMA; INSULIN-RESISTANCE; DIABETIC-PATIENTS; INDUCED CACHEXIA; CANCER CACHEXIA; METABOLISM; THIAZOLIDINEDIONES; CELLS	Cachexia is a multifactorial syndrome characterized by profound involuntary weight loss, fat depletion, skeletal muscle wasting, and asthenia; all symptoms are not entirely attributable to inadequate nutritional intake. Adipose tissue and skeletal muscle loss during cancer cachexia development has been described systematically. The former was proposed to precede and be more rapid than the latter, which presents a means for the early detection of cachexia in cancer patients. Recently, pioglitazone (PGZ) was proposed to exhibit anticancer properties, including a reduction in insulin resistance and adipose tissue loss; nevertheless, few studies have evaluated its effect on survival. For greater insight into a potential anti-cachectic effect due to PGZ, 8-week-old male Wistar rats were subcutaneously inoculated with 1 mL (2x10(7)) of Walker 256 tumor cells. The animals were randomly assigned to two experimental groups: TC (tumor + saline-control) and TP5 (tumor + PGZ/5 mg). Body weight, food ingestion and tumor growth were measured at baseline and after removal of tumor on days 7, 14 and 26. Samples from different visceral adipose tissue (AT) depots were collected on days 7 and 14 and stored at -80oC (5 to 7 animals per day/group). The PGZ treatment showed an increase in the survival average of 27.3%(P<0.01) when compared to TC. It was also associated with enhanced body mass preservation (40.7 and 56.3%, p<0.01) on day 14 and 26 compared with the TC group. The treatment also reduced the final tumor mass (53.4%, p<0.05) and anorexia compared with the TC group during late-stage cachexia. The retroperitoneal AT (RPAT) mass was preserved on day 7 compared with the TC group during the same experimental period. Such effect also demonstrates inverse relationship with tumor growth, on day 14. Gene expression of PPAR-gamma, adiponectin, LPL and C/EBP-alpha from cachectic rats was upregulated after PGZ. Glucose uptake from adipocyte cells (RPAT) was entirely re-established due to PGZ treatment. Taken together, the results demonstrate beneficial effects of PGZ treatment at both the early and final stages of cachexia.	[Beluzi, Mercia; Henriques, Felipe S.; Sertie, Rogerio A. L.; Franco, Felipe O.; Santos, Kaltinaitis B.; Knobl, Pamela; Shida, Claudio S.; Neves, Rodrigo X.; Batista, Miguel L., Jr.] Univ Mogi das Cruzes, Integrated Grp Biotechnol, Lab Adipose Tissue Biol, Mogi Das Cruzes, Brazil; [Neves, Rodrigo X.; Seelaender, Marilia; Batista, Miguel L., Jr.] Univ Sao Paulo, Inst Biomed Sci, Canc Metab Res Grp, Sao Paulo, Brazil; [Sertie, Rogerio A. L.; Andreotti, Sandra; Lima, Fabio B.] Univ Sao Paulo, Inst Biomed Sci, Physiol Lab, Sao Paulo, Brazil; [Peres, Sidney B.] Univ Estadual Maringa, Dept Physiol Sci, Maringa, Parana, Brazil; [Shida, Claudio S.] Univ Fed Sao Paulo, Dept Biomed Engn, Sao Jose Dos Campos, Brazil; [Farmer, Stephen R.] Boston Sch Med, Dept Biochem, Boston, MA USA	Universidade de Mogi das Cruzes; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Maringa; Universidade Federal de Sao Paulo (UNIFESP)	Batista, ML (corresponding author), Univ Mogi das Cruzes, Integrated Grp Biotechnol, Lab Adipose Tissue Biol, Mogi Das Cruzes, Brazil.	migueljr4@me.com	de Oliveira Franco, Felipe/AAP-3905-2020; Peres, Sidney Barnabé/J-1780-2012; Batista Jr., Miguel Luiz/E-7748-2015; Lima, Fabio/L-5634-2019; Knoebl, Paul/G-2787-2010; Seelaender, Marilia Cerqueira Leite/B-9101-2011; Henriques, Felipe/I-6312-2015	Peres, Sidney Barnabé/0000-0001-7954-9546; Batista Jr., Miguel Luiz/0000-0001-7022-5131; Knoebl, Paul/0000-0002-7909-7225; Seelaender, Marilia Cerqueira Leite/0000-0002-9999-8020; Franco, Felipe/0000-0002-4185-223X; Lima, Fabio/0000-0003-0573-9544; Henriques, Felipe/0000-0002-9245-7141; Farmer, Stephen/0000-0003-2483-2795	FAPESP [2010/51078-1, 2008/54091-9, 2012/51094-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported FAPESP Grant Number 2010/51078-1 (Miguel L. Batista Jr.) and 2008/54091-9 and 2012/51094-1 (Marilia Seelaender). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles JM, 2010, J AM MED DIR ASSOC, V11, P229, DOI 10.1016/j.jamda.2010.02.004; Arner P, 2011, SCIENCE, V333, P163, DOI 10.1126/science.1209418; Asp ML, 2011, CANCER BIOL THER, V12, P957, DOI 10.4161/cbt.12.11.18134; Asp ML, 2010, INT J CANCER, V126, P756, DOI 10.1002/ijc.24784; Batista ML, 2013, CYTOKINE, V61, P532, DOI 10.1016/j.cyto.2012.10.023; Batista ML, 2012, J ENDOCRINOL, V215, P363, DOI 10.1530/JOE-12-0307; Bennani-Baiti N, 2011, SUPPORT CARE CANCER, V19, P1451, DOI 10.1007/s00520-010-0972-0; Bing C, 2006, BRIT J CANCER, V95, P1028, DOI 10.1038/sj.bjc.6603360; Burkey BF, 2000, METABOLISM, V49, P1301, DOI 10.1053/meta.2000.9524; Cassolla P, 2012, CELL BIOCHEM FUNCT, V30, P265, DOI 10.1002/cbf.2792; Chalasani N, 2005, AM J GASTROENTEROL, V100, P1317, DOI 10.1111/j.1572-0241.2005.41690.x; Chilcott J, 2001, CLIN THER, V23, P1792, DOI 10.1016/S0149-2918(00)80078-8; Dahlman I, 2010, BRIT J CANCER, V102, P1541, DOI 10.1038/sj.bjc.6605665; Das SK, 2013, TRENDS MOL MED, V19, P292, DOI 10.1016/j.molmed.2013.02.006; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Day C, 1999, DIABETIC MED, V16, P179, DOI 10.1046/j.1464-5491.1999.00023.x; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; DiGirolamo M, 2001, METHOD MOL BIOL, V155, P65; Dubuisson O, 2011, ENDOCRINOLOGY, V152, P3648, DOI 10.1210/en.2011-0225; ELKEBBI IM, 1994, METABOLISM, V43, P953, DOI 10.1016/0026-0495(94)90173-2; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; FERNANDES LC, 1990, AM J PHYSIOL, V258, pE1033, DOI 10.1152/ajpendo.1990.258.6.E1033; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Govindarajan R, 2007, J CLIN ONCOL, V25, P1476, DOI 10.1200/JCO.2006.07.2777; Gurnell M, 2007, PPAR RES, V2007, DOI 10.1155/2007/83593; Honors MA, 2012, J CACHEXIA SARCOPENI, V3, P5, DOI 10.1007/s13539-011-0051-5; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lima FB, 1998, AM J PHYSIOL-ENDOC M, V275, pE934; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Machado AP, 2004, CELL TISSUE RES, V318, P503, DOI 10.1007/s00441-004-0987-2; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Palesty JA, 2003, DIGEST DIS, V21, P198, DOI 10.1159/000073337; Parsons HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029330; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; Saha S, 2012, EUR J PHARMACOL, V697, P13, DOI 10.1016/j.ejphar.2012.09.021; Seelaender MCL, 1996, BIOCHEM MOL BIOL INT, V39, P1037; Sharma S, 2006, LIFE SCI, V80, P235, DOI 10.1016/j.lfs.2006.09.009; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Tang WHW, 2003, J AM COLL CARDIOL, V41, P1394, DOI 10.1016/S0735-1097(03)00159-1; TAYEK JA, 1992, J AM COLL NUTR, V11, P445; Tisdale MJ, 2010, CURR OPIN GASTROEN, V26, P146, DOI 10.1097/MOG.0b013e3283347e77; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; Vaupel P, 1989, Adv Exp Med Biol, V248, P835; Yang KJ, 2010, LIFE SCI, V87, P405, DOI 10.1016/j.lfs.2010.08.002	48	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122660	10.1371/journal.pone.0122660	http://dx.doi.org/10.1371/journal.pone.0122660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807446	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000224
J	Crossin, GT; Sundstrom, LF; Vandersteen, WE; Devlin, RH				Crossin, Glenn T.; Sundstrom, L. Fredrik; Vandersteen, Wendy E.; Devlin, Robert H.			Early Life-History Consequences of Growth-Hormone Transgenesis in Rainbow Trout Reared in Stream Ecosystem Mesocosms	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-KISUTCH; COHO SALMON; DISEASE RESISTANCE; WILD-TYPE; GENOTYPE; SURVIVAL; FISH; PREDATION; RATES; RISK	There is persistent commercial interest in the use of growth modified fishes for shortening production cycles and increasing overall food production, but there is concern over the potential impact that transgenic fishes might have if ever released into nature. To explore the ecological consequences of transgenic fish, we performed two experiments in which the early growth and survival of growth-hormone transgenic rainbow trout (Oncorhynchus mykiss) were assessed in naturalized stream mesocosms that either contained predators or were predator-free. We paid special attention to the survival bottleneck that occurs during the early life-history of salmonids, and conducted experiments at two age classes (first-feeding fry and 60 days post-first-feeding) that lie on either side of the bottleneck. In the late summer, the first-feeding transgenic trout could not match the growth potential of their wildtype siblings when reared in a hydrodynamically complex and oligotrophic environment, irrespective of predation pressure. Furthermore, overall survival of transgenic fry was lower than in wild-type (transgenic = 30% without predators, 8% with predators; wild-type = 81% without predators, 31% with predators). In the experiment with 60-day old fry, we explored the effects of the transgene in different genetic backgrounds (wild versus domesticated). We found no difference in overwinter survival but significantly higher growth by transgenic trout, irrespective of genetic background. We conclude that the high mortality of GH-transgenic trout during first-feeding reflects an inability to sustain the basic metabolic requirements necessary for life in complex, stream environments. However, when older, GH-transgenic fish display a competitive advantage over wild-type fry, and show greater growth and equal survival as wild-type. These results demonstrate how developmental age and time of year can influence the response of genotypes to environmental conditions. We therefore urge caution when extrapolating the results of GH-transgenesis risk assessment studies across multiple life-history or developmental stages.	[Crossin, Glenn T.; Sundstrom, L. Fredrik; Vandersteen, Wendy E.; Devlin, Robert H.] Fisheries & Oceans Canada, W Vancouver Lab, Ctr Aquaculture & Environm Res, W Vancouver, BC V7V 1N6, Canada; [Crossin, Glenn T.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Sundstrom, L. Fredrik] Uppsala Univ, Dept Ecol & Genet Anim Ecol, SE-75236 Uppsala, Sweden	Fisheries & Oceans Canada; Dalhousie University; Uppsala University	Crossin, GT (corresponding author), Fisheries & Oceans Canada, W Vancouver Lab, Ctr Aquaculture & Environm Res, 4160 Marine Dr, W Vancouver, BC V7V 1N6, Canada.	gtc@dal.ca	Sundstrom, Fred/E-6736-2011	Sundstrom, Fred/0000-0002-3157-7289; Crossin, Glenn/0000-0003-1080-1189	Canadian Regulatory System for Biotechnology grant [61740]; National Science and Engineering Research Council of Canada; European Community [MOIF-CT-2005-8141]	Canadian Regulatory System for Biotechnology grant; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Community(European Commission)	Canadian Regulatory System for Biotechnology grant 61740 to RHD. National Science and Engineering Research Council of Canada Visiting Fellowship to GTC. Marie Curie Outgoing International Fellowship contract MOIF-CT-2005-8141 from the European Community's Sixth Framework Programme to LFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MV, 1999, ANIM BEHAV, V58, P933, DOI 10.1006/anbe.1999.1229; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Arnesen AM, 2003, AQUACULTURE, V222, P167, DOI 10.1016/S0044-8486(03)00109-1; Biro PA, 2004, P ROY SOC B-BIOL SCI, V271, P2233, DOI 10.1098/rspb.2004.2861; Bohlin T, 1996, J FISH BIOL, V49, P157; Conover DO, 1997, EARLY LIFE HIST RECR, P307; Devlin RH, 2013, J ANIM SCI, V91, P5247, DOI 10.2527/jas.2013-6612; Devlin RH, 2007, ENV RISK ASSESS GENE, V3, P151, DOI 10.1079/9781845932961.0151; Devlin RH, 2006, TRENDS BIOTECHNOL, V24, P89, DOI 10.1016/j.tibtech.2005.12.008; Devlin RH, 2004, P NATL ACAD SCI USA, V101, P9303, DOI 10.1073/pnas.0400023101; Devlin RH, 2004, AQUACULTURE, V236, P607, DOI 10.1016/j.aquaculture.2004.02.026; DEVLIN RH, 1994, NATURE, V371, P209, DOI 10.1038/371209a0; Devlin RH, 2001, NATURE, V409, P781, DOI 10.1038/35057314; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Duan M, 2011, AQUACULTURE, V317, P175, DOI 10.1016/j.aquaculture.2011.04.013; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; FLEMING IA, 1990, ECOLOGY, V71, P1, DOI 10.2307/1940241; Fraser DJ, 2010, ECOL APPL, V20, P935, DOI 10.1890/09-0694.1; Fraser DJ, 2008, EVOL APPL, V1, P501, DOI 10.1111/j.1752-4571.2008.00037.x; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Gluckman, 2011, PLASTICITY ROBUSTNES; HERSHBERGER WK, 1990, AQUACULTURE, V85, P187, DOI 10.1016/0044-8486(90)90018-I; Houde ALS, 2010, ICES J MAR SCI, V67, P657, DOI 10.1093/icesjms/fsp272; Hutchings JA, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P154; Jhingan E, 2003, J FISH BIOL, V63, P806, DOI 10.1046/j.1095-8649.2003.00194.x; Johnsson JI, 1999, FUNCT ECOL, V13, P514, DOI 10.1046/j.1365-2435.1999.00341.x; Kapuscinski AR, 2007, METHODOLOGIES TRANSG, V3; Kennedy BP, 2008, ECOLOGY, V89, P2529, DOI 10.1890/06-1353.1; Kim JH, 2013, FISH SHELLFISH IMMUN, V34, P1553, DOI 10.1016/j.fsi.2013.03.365; Lee CG, 2003, J FISH BIOL, V62, P753, DOI 10.1046/j.1095-8649.2003.00057.x; Leggatt RA, 2012, AQUACULTURE, V356, P193, DOI 10.1016/j.aquaculture.2012.05.016; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lohmus M, 2008, HORM BEHAV, V54, P506, DOI 10.1016/j.yhbeh.2008.02.010; Lohmus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009980; Milner NJ, 2003, FISH RES, V62, P111, DOI 10.1016/S0165-7836(02)00157-1; Moreau DTR, 2011, J FISH BIOL, V78, P726, DOI 10.1111/j.1095-8649.2010.02888.x; Moreau DTR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095853; Muir WM, 2002, TRANSGENIC RES, V11, P101, DOI 10.1023/A:1015203812200; Sundstrom LF, 2007, P NATL ACAD SCI USA, V104, P3889, DOI 10.1073/pnas.0608767104; Sundstrom LF, 2011, EVOL ECOL, V25, P447, DOI 10.1007/s10682-010-9406-1; Sundstrom LF, 2009, J APPL ECOL, V46, P762, DOI 10.1111/j.1365-2664.2009.01668.x; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; Sundstrom LF, 2005, EVOLUTION, V59, P1560, DOI 10.1111/j.0014-3820.2005.tb01805.x; Tymchuk WE, 2005, AQUACULTURE, V245, P295, DOI 10.1016/j.aquaculture.2004.11.007; Tymchuk WE, 2007, EVOLUTION, V61, P1225, DOI 10.1111/j.1558-5646.2007.00102.x; Tymchuk WE, 2006, T AM FISH SOC, V135, P442, DOI 10.1577/T05-181.1; Vandersteen W, 2012, EVOL APPL, V5, P76, DOI 10.1111/j.1752-4571.2011.00210.x	48	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120173	10.1371/journal.pone.0120173	http://dx.doi.org/10.1371/journal.pone.0120173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807001	gold, Green Published			2022-12-26	WOS:000351880000069
J	Lu, CL; Qin, LL; Liu, HC; Candas, D; Fan, M; Li, JJ				Lu, Chung-Ling; Qin, Lili; Liu, Hsin-Chen; Candas, Demet; Fan, Ming; Li, Jian Jian			Tumor Cells Switch to Mitochondrial Oxidative Phosphorylation under Radiation via mTOR-Mediated Hexokinase II Inhibition - A Warburg-Reversing Effect	PLOS ONE			English	Article							MAMMALIAN TARGET; CANCER-CELLS; UP-REGULATION; RAPAMYCIN; PATHWAY; GROWTH; METABOLISM; NVP-BEZ235; AUTOPHAGY; STRESS	A unique feature of cancer cells is to convert glucose into lactate to produce cellular energy, even under the presence of oxygen. Called aerobic glycolysis [The Warburg Effect] it has been extensively studied and the concept of aerobic glycolysis in tumor cells is generally accepted. However, it is not clear if aerobic glycolysis in tumor cells is fixed, or can be reversed, especially under therapeutic stress conditions. Here, we report that mTOR, a critical regulator in cell proliferation, can be relocated to mitochondria, and as a result, enhances oxidative phosphorylation and reduces glycolysis. Three tumor cell lines (breast cancer MCF-7, colon cancer HCT116 and glioblastoma U87) showed a quick relocation of mTOR to mitochondria after irradiation with a single dose 5 Gy, which was companied with decreased lactate production, increased mitochondrial ATP generation and oxygen consumption. Inhibition of mTOR by rapamycin blocked radiation-induced mTOR mitochondrial relocation and the shift of glycolysis to mitochondrial respiration, and reduced the clonogenic survival. In irradiated cells, mTOR formed a complex with Hexokinase II [HK II], a key mitochondrial protein in regulation of glycolysis, causing reduced HK II enzymatic activity. These results support a novel mechanism by which tumor cells can quickly adapt to genotoxic conditions via mTOR-mediated reprogramming of bioenergetics from predominantly aerobic glycolysis to mitochondrial oxidative phosphorylation. Such a "waking-up" pathway for mitochondrial bioenergetics demonstrates a flexible feature in the energy metabolism of cancer cells, and may be required for additional cellular energy consumption for damage repair and survival. Thus, the reversible cellular energy metabolisms should be considered in blocking tumor metabolism and may be targeted to sensitize them in anti-cancer therapy.	[Lu, Chung-Ling; Qin, Lili; Liu, Hsin-Chen; Candas, Demet; Fan, Ming; Li, Jian Jian] Univ Calif Davis, Sch Med, Dept Radiat Oncol, Sacramento, CA 95817 USA	University of California System; University of California Davis	Li, JJ (corresponding author), Univ Calif Davis, Sch Med, Dept Radiat Oncol, Sacramento, CA 95817 USA.	jijli@ucdavis.edu	Qin, Lili/J-7481-2016	Li, Jian Jian/0000-0003-3694-9675	National Institutes of Health RO1 [CA133402, CA152313]; NATIONAL CANCER INSTITUTE [R01CA133402, P30CA093373, R01CA152313] Funding Source: NIH RePORTER	National Institutes of Health RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health RO1 Grants CA133402 and CA152313 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2008, ONCOGENE, V27, P6738, DOI 10.1038/onc.2008.265; Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; Bartoletti-Stella A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.187; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Blagosklonny MV, 2010, PLOS ONE, V5, DOI [10.1371/ lournaLpone.0012341, DOI 10.1371/L0URNALP0NE.0012341]; Candas D, 2014, ANTIOXID REDOX SIGN, V20, P1599, DOI 10.1089/ars.2013.5305; Cao P, 2009, BRIT J CANCER, V100, P1267, DOI 10.1038/sj.bjc.6604995; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Chen LY, 2012, MOL CELL, V47, P839, DOI 10.1016/j.molcel.2012.07.002; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Crowder RJ, 2005, BREAST CANCER RES, V7, P212, DOI 10.1186/bcr1307; Cunningham JT, 2007, NATURE, P450; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Eldridge A, 2012, FREE RADICAL BIO MED, V53, P1838, DOI 10.1016/j.freeradbiomed.2012.08.589; Fang R, 2012, J BIOL CHEM, V287, P23227, DOI 10.1074/jbc.M112.373084; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Hu ZY, 2014, J MOL MED, V92, P837, DOI 10.1007/s00109-014-1174-x; Khacho M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4550; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JH, 2014, RADIAT ONCOL J, V32, P103, DOI 10.3857/roj.2014.32.3.103; Kim Kwang Woon, 2014, Genes Cancer, V5, P293; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P4208, DOI 10.4161/cc.10.24.18487; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Oruganty-Das A, 2012, CELL METAB, V16, P789, DOI 10.1016/j.cmet.2012.11.002; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Pollak M, 2013, CANCER CELL, V23, P263, DOI 10.1016/j.ccr.2013.02.015; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Roberts DJ, 2014, MOL CELL, V53, P521, DOI 10.1016/j.molcel.2013.12.019; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Wang PY, 2013, NEW ENGL J MED, V368, P1027, DOI 10.1056/NEJMoa1214091; Wang T, 2005, J BIOL CHEM, V280, P12593, DOI 10.1074/jbc.M410982200; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wittwer JA, 2011, CANCER PREV RES, V4, P1476, DOI 10.1158/1940-6207.CAPR-11-0028; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	58	99	101	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121046	10.1371/journal.pone.0121046	http://dx.doi.org/10.1371/journal.pone.0121046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807077	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000126
J	Aguilar-Martinez, E; Morrisroe, C; Sharrocks, AD				Aguilar-Martinez, Elisa; Morrisroe, Claire; Sharrocks, Andrew D.			The Ubiquitin Ligase UBE3A Dampens ERK Pathway Signalling in HPV E6 Transformed HeLa Cells	PLOS ONE			English	Article							PROTEIN-KINASE CASCADE; MOUSE MODEL; SUSTAINED ACTIVATION; ANGELMAN SYNDROME; P53; TRANSCRIPTION; CANCER; SUMO	Signalling through the ERK MAP kinase pathway plays an important role in many biological processes and it is often deregulated in disease states such as cancer. One major effect of MAP kinase signalling is to promote gene expression through the phosphorylation and activation of transcription factors like ELK1. ELK1 in turn controls the activity of immediate-early genes such as FOS. Here we have used ELK1 activation in HeLa cells as a read out to conduct a genome-wide siRNA screen to identify negative regulators of ERK-mediated immediate-early gene activation. One of the candidates that we identified was the E3 ubiquitin ligase UBE3A/E6-AP. Reductions in UBE3A levels cause increased basal levels of ERK activity, a loss of growth factor-mediated ERK activation and concomitant defects in immediate-early gene expression. Thus, UBE3A acts to dampen down basal level ERK activation and to prime the pathway for growth factor-mediated activation. Mechanistically, we demonstrate that UBE3A functions in HeLa cells through its binding partner, HPV18 E6 protein and the E6 target protein p53. Loss of either E6 or p53 blocks the effect of UBE3A depletion on ERK pathway signalling, indicating that in the context of oncogenic viral protein expression, UBE3A plays an important role in negating the consequences of p53 activation on ERK pathway signalling.	[Aguilar-Martinez, Elisa; Morrisroe, Claire; Sharrocks, Andrew D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Sharrocks, AD (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	a.d.sharrocks@manchester.ac.uk		Aguilar-Martinez, Elisa/0000-0002-0046-2104	Wellcome Trust [093052]; Royal Society-Wolfson award	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society-Wolfson award(Royal Society of London)	Funding: This work was supported by the Wellcome Trust (093052) and a Royal Society-Wolfson award to ADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BeerRomero P, 1997, ONCOGENE, V14, P595, DOI 10.1038/sj.onc.1200872; Bird LM, 2014, APPL CLIN GENET, V7, P93, DOI 10.2147/TACG.S57386; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Filonova I, 2014, LEARN MEMORY, V21, P98, DOI 10.1101/lm.032375.113; Gossan NC, 2014, NUCLEIC ACIDS RES, V42, P5765, DOI 10.1093/nar/gku225; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kukushkin AN, 2002, ONCOGENE, V21, P719, DOI 10.1038/sj.onc.1205118; Lee SW, 2000, P NATL ACAD SCI USA, V97, P8302, DOI 10.1073/pnas.150024397; Mardirossian S, 2009, EXP NEUROL, V220, P341, DOI 10.1016/j.expneurol.2009.08.035; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Plotnikov A, 2011, MOL CELL BIOL, V31, P3515, DOI 10.1128/MCB.05424-11; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033	22	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119366	10.1371/journal.pone.0119366	http://dx.doi.org/10.1371/journal.pone.0119366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815718	gold, Green Submitted, Green Published			2022-12-26	WOS:000352133600017
J	Hruschka, DJ; Hadley, C; Brewis, AA; Stojanowski, CM				Hruschka, Daniel J.; Hadley, Craig; Brewis, Alexandra A.; Stojanowski, Christopher M.			Genetic Population Structure Accounts for Contemporary Ecogeographic Patterns in Tropic and Subtropic-Dwelling Humans	PLOS ONE			English	Article							BODY-SURFACE AREA; WEIGHT; SIZE; MASS; PROPORTIONS; CLIMATE; HEIGHT; BIRTH; SELECTION; CHILDREN	Contemporary human populations conform to ecogeographic predictions that animals will become more compact in cooler climates and less compact in warmer ones. However, it remains unclear to what extent this pattern reflects plastic responses to current environments or genetic differences among populations. Analyzing anthropometric surveys of 232,684 children and adults from across 80 ethnolinguistic groups in sub-Saharan Africa, Asia and the Americas, we confirm that body surface-to-volume correlates with contemporary temperature at magnitudes found in more latitudinally diverse samples (Adj. R-2 = 0.14-0.28). However, far more variation in body surface-to-volume is attributable to genetic population structure (Adj. R-2 = 0.50-0.74). Moreover, genetic population structure accounts for nearly all of the observed relationship between contemporary temperature and body surface-to-volume among children and adults. Indeed, after controlling for population structure, contemporary temperature accounts for no more than 4% of the variance in body form in these groups. This effect of genetic affinity on body form is also independent of other ecological variables, such as dominant mode of subsistence and household wealth per capita. These findings suggest that the observed fit of human body surface-to-volume with current climate in this sample reflects relatively large effects of existing genetic population structure of contemporary humans compared to plastic response to current environments.	[Hruschka, Daniel J.; Brewis, Alexandra A.; Stojanowski, Christopher M.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Hadley, Craig] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	Arizona State University; Arizona State University-Tempe; Emory University	Hruschka, DJ (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.	Daniel.Hruschka@asu.edu						Auerbach BM, 2012, AM J PHYS ANTHROPOL, V149, P525, DOI 10.1002/ajpa.22154; Beall CM, 2012, HUMAN BIOL EVOLUTION, P177; Betti L, 2012, HUM BIOL, V84, P139, DOI 10.3378/027.084.0203; Bogin B, 2003, COMP BIOCHEM PHYS A, V136, P71, DOI 10.1016/S1095-6433(02)00294-5; Bogin B, 2002, AM J HUM BIOL, V14, P753, DOI 10.1002/ajhb.10092; Cowgill LW, 2012, AM J PHYS ANTHROPOL, V148, P557, DOI 10.1002/ajpa.22072; CROGNIER E, 1981, ANN HUM BIOL, V8, P99, DOI 10.1080/03014468100004841; Davies JB, 2011, ECON J, V121, P223, DOI 10.1111/j.1468-0297.2010.02391.x; Foster F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072269; Gardner JL, 2009, P ROY SOC B-BIOL SCI, V276, P3845, DOI 10.1098/rspb.2009.1011; Hadley C, 2014, AM J PHYS ANTHROPOL, V154, P232, DOI 10.1002/ajpa.22496; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hayes A. F., 2013, INTRODUCTION TO MEDI; Higgins RW, 2011, AM J PHYS ANTHROPOL, V146, P336, DOI 10.1002/ajpa.21575; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holliday TW, 1997, J HUM EVOL, V32, P423, DOI 10.1006/jhev.1996.0111; Hruschka DJ, 2014, AM J PHYS ANTHROPOL, V153, P542, DOI 10.1002/ajpa.22452; Hruschka DJ, 2013, ECON HUM BIOL, V11, P337, DOI 10.1016/j.ehb.2012.01.001; Hruschka DJ, 2013, AM J PHYS ANTHROPOL, V151, P68, DOI 10.1002/ajpa.22258; Hruschka DJ, ESTIMATING ABSOLUTE; IBM Corp, 2011, IBM SPSS STATISTICS; ICF Macro, DEMOGRAPHIC AND HEAL; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Leonard W.R., 2010, HUMAN EVOLUTIONARY B, P157; Lewin R., 1998, PRINCIPLES OF HUMAN; Long JC, 2009, AM J PHYS ANTHROPOL, V139, P23, DOI 10.1002/ajpa.21011; MALINA RM, 1975, AM J CLIN NUTR, V28, P1061, DOI 10.1093/ajcn/28.9.1061; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Roberts DF, 1953, AM J PHYS ANTHROP-NE, V11, P533, DOI 10.1002/ajpa.1330110404; ROBERTS DF, 1969, J BIOSOC SCI, VS, P43, DOI 10.1017/S002193200002321X; Roberts DF, 1978, CLIMATE AND HUMAN VA; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Ruff C, 2005, J HUM EVOL, V48, P381, DOI 10.1016/j.jhevol.2004.11.009; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Serrat MA, 2008, P NATL ACAD SCI USA, V105, P19348, DOI 10.1073/pnas.0803319105; Singhal A, 2003, AM J CLIN NUTR, V77, P726, DOI 10.1093/ajcn/77.3.726; Stock JT, 2006, AM J PHYS ANTHROPOL, V131, P194, DOI 10.1002/ajpa.20398; Stone GN, 2011, PHILOS T R SOC B, V366, P1410, DOI 10.1098/rstb.2010.0311; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Ulijaszek SJ, 1993, NUTRITIONAL ANTHROPO; Verbraecken J, 2006, METABOLISM, V55, P515, DOI 10.1016/j.metabol.2005.11.004; von Cramon-Taubadel N, 2013, PROCEEDINGS OF THE R, V280, DOI [10.1098/rspb.2013.1629, DOI 10.1098/RSPB.2013.1629]; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; Wells JCK, 2002, J THEOR BIOL, V214, P413, DOI 10.1006/jtbi.2001.2465; Wells JCK, 2012, AM J PHYS ANTHROPOL, V147, P169, DOI 10.1002/ajpa.21591	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122301	10.1371/journal.pone.0122301	http://dx.doi.org/10.1371/journal.pone.0122301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816235	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600165
J	Grube, MM; von der Lippe, E; Schlaud, M; Brettschneider, AK				Grube, Maike Miriam; von der Lippe, Elena; Schlaud, Martin; Brettschneider, Anna-Kristin			Does Breastfeeding Help to Reduce the Risk of Childhood Overweight and Obesity? A Propensity Score Analysis of Data from the KiGGS Study	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL RECALL; GERMAN CHILDREN; BLOOD-PRESSURE; UNITED-STATES; DURATION; PREVALENCE; ADIPOSITY; HEALTH; ADOLESCENTS	Background Current studies suggest that the beneficial effect of breastfeeding on overweight and obesity may have been largely overestimated. We examined the relationship between >4 months of full breastfeeding and overweight/obesity in children living in Germany. Methods We analyzed retrospectively collected data on breastfeeding from children aged 3-17 years who participated in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS baseline study) between 2003 and 2006 (n = 13163). To minimize confounding, we applied propensity score matching and multivariate logistic regression analyses to estimate the effect of breastfeeding on childhood overweight and obesity. Results Adjusted analyses of the matched dataset (n = 8034) indicated that children who were breastfed for <4 months had a significant reduction in the odds of overweight (OR 0.81 [95% CI 0.71-0.92]) and obesity (OR 0.75 [95% CI 0.61-0.92]) compared to children who were not breastfed or who were breastfed for a shorter duration. Further analyses stratified by age group showed that the association was strongest in children aged 7-10 years (OR 0.67 [95% CI 0.53-0.84] for overweight and OR 0.56 [95% CI 0.39-0.81] for obesity), while no significant effect could be seen in other age groups. Discussion Our findings support the hypothesis that breastfeeding does have a beneficial effect on childhood overweight and obesity, although the effect seems to be strongest in children of primary school age.	[Grube, Maike Miriam; von der Lippe, Elena; Schlaud, Martin; Brettschneider, Anna-Kristin] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany	Robert Koch Institute	Grube, MM (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.	maike.grube@posteo.de		Brettschneider, Anna-Kristin/0000-0002-2805-5105	German Federal Ministry of Health; Ministry of Education and Research; Federal Ministry of Food, Agriculture and Consumer Protection	German Federal Ministry of Health; Ministry of Education and Research; Federal Ministry of Food, Agriculture and Consumer Protection	The KiGGS study was funded by the German Federal Ministry of Health (http://www.bmg.bund.de/), the Ministry of Education and Research (http://www.bmbf.de) and the Federal Ministry of Food, Agriculture and Consumer Protection (http://www.bmelv.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2007, STAT MED, V26, P3078, DOI 10.1002/sim.2781; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; Boutwell BB, 2012, J PAEDIATR CHILD H, V48, P840, DOI 10.1111/j.1440-1754.2012.02547.x; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; Bundesinstitut fur Risikobewertung, 2004, STILLD EMPF NAT STIL; Colen CG, 2014, SOC SCI MED, V109, P55, DOI 10.1016/j.socscimed.2014.01.027; Dietz WH, 2001, JAMA-J AM MED ASSOC, V285, P2506, DOI 10.1001/jama.285.19.2506; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Evenhouse E, 2005, HEALTH SERV RES, V40, P1781, DOI 10.1111/j.1475-6773.2005.00453.x; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fisk CM, 2011, MATERN CHILD NUTR, V7, P61, DOI 10.1111/j.1740-8709.2010.00241.x; Gillman MW, 2011, INT J EPIDEMIOL, V40, P681, DOI 10.1093/ije/dyr085; Gillman MW, 2006, EPIDEMIOLOGY, V17, P112, DOI 10.1097/01.ede.0000181629.59452.95; Global Health Observatory (GHO), 2013, OBESITY 2008; Hoffmann SW, 2012, OBESITY, V20, P2151, DOI 10.1038/oby.2012.172; Horta B.L., 2013, LONG TERM EFFECTS BR; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Ito J, 2014, ANN EPIDEMIOL, V24, P267, DOI 10.1016/j.annepidem.2013.11.007; Jenkins JM, 2014, AM J PUBLIC HEALTH, V104, pS128, DOI 10.2105/AJPH.2013.301713; Jiang M, 2013, HEALTH SERV RES, V48, P628, DOI 10.1111/j.1475-6773.2012.01456.x; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kersting M, 2013, EMPFEHLUNGEN ERNAHRU; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kristiansen AL, 2010, PUBLIC HEALTH NUTR, V13, P2087, DOI 10.1017/S1368980010002156; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Lampert T, 2014, BUNDESGESUNDHEITSBLA, V57, P762, DOI 10.1007/s00103-014-1974-8; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Martin RM, 2013, JAMA-J AM MED ASSOC, V309, P1005, DOI 10.1001/jama.2013.167; Metzger MW, 2010, AM J HUM BIOL, V22, P291, DOI 10.1002/ajhb.20982; Moss A, 2012, EUR J PEDIATR, V171, P289, DOI 10.1007/s00431-011-1531-5; Natland ST, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-179; Nelson MC, 2005, EPIDEMIOLOGY, V16, P247, DOI 10.1097/01.ede.0000152900.81355.00; Nwaru BI, 2013, CLIN EXP ALLERGY, V43, P1263, DOI 10.1111/cea.12180; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Promislow JHE, 2005, AM J EPIDEMIOL, V161, P289, DOI 10.1093/aje/kwi044; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Savino F, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/327505; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Thoemmes F., 2012, PSMATCHING 3 03; Thoemmes FJ, 2011, MULTIVAR BEHAV RES, V46, P90, DOI 10.1080/00273171.2011.540475; [United Nations Childrens Fund World Health Organization], 2001, GLOBAL STRATEGY FOR; von der Lippe E, 2014, BUNDESGESUNDHEITSBLA, V57, P849, DOI 10.1007/s00103-014-1985-5; Wabitsch M, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-17	49	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122534	10.1371/journal.pone.0122534	http://dx.doi.org/10.1371/journal.pone.0122534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811831	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700194
J	Lighthall, JG; Kempton, JB; Hausman, F; MacArthur, CJ; Trune, DR				Lighthall, Jessyka G.; Kempton, J. Beth; Hausman, Frances; MacArthur, Carol J.; Trune, Dennis R.			Control of Middle Ear Inflammatory and Ion Homeostasis Genes by Transtympanic Glucocorticoid and Mineralocorticoid Treatments	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; OTITIS-MEDIA; FLUID ABSORPTION; MOUSE MODEL; EXPRESSION; CYTOKINE	Hypothesis Transtympanic steroid treatment will induce changes in ion homeostasis and inflammatory gene expression to decrease middle ear inflammation due to bacterial inoculation. Background Otitis media is common, but treatment options are limited to systemic antibiotic therapy or surgical intervention. Systemic glucocorticoid treatment of mice decreases inflammation and improves fluid clearance. However, transtympanic delivery of glucocorticoids or mineralocorticoid has not been explored to determine if direct steroid application is beneficial. Methods Balb/c mice received transtympanic inoculation of heat-killed Haemophilus influenzae (H flu), followed by transtympanic treatment with either prednisolone or aldosterone. Mice given PBS instead of steroid and untreated mice were used as controls. Four hours after steroid treatment, middle ears were harvested for mRNA extraction and 24 hours after inoculation middle ears were harvested and examined for measures of inflammation. Results H flu inoculation caused the increased expression of nearly all inflammatory cytokine genes and induced changes in expression of several genes related to cellular junctions and transport channels. Both steroids generally reversed the expression of inflammatory genes and caused ion and water regulatory genes to return to normal or near normal levels. Histologic evaluation of middle ears showed improved fluid and inflammatory cell clearance. Conclusion Improvement in middle ear inflammation was noted with both the glucocorticoid prednisolone and the mineralocorticoid aldosterone. This was due to reversal of inflammation-induced changes in middle ear cytokine genes, as well as those involved in ion and water homeostasis. Because glucocorticoids bind to the mineralocorticoid receptor, but not the reverse, it is concluded that much of the reduction of fluid and other inflammation measures was due to these steroids impact on ion and water transport channels. Further research is necessary to determine if this alternative mineralocorticoid treatment for otitis media will be clinically effective with fewer side effects than glucocorticoids.	[Lighthall, Jessyka G.; Kempton, J. Beth; Hausman, Frances; MacArthur, Carol J.; Trune, Dennis R.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97239 USA	Oregon Health & Science University	Trune, DR (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97239 USA.	truned@ohsu.edu	Lighthall, Jessyka/Y-6813-2019		NIH-NIDCD [R01 DC009455, P30 DC005983]	NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by NIH-NIDCD R01 DC009455 (DRT) and NIH-NIDCD P30 DC005983 (DRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JY, 2007, EUR J PHARMACOL, V567, P19, DOI 10.1016/j.ejphar.2007.04.026; Choi JY, 2006, EUR J PHARMACOL, V536, P12, DOI 10.1016/j.ejphar.2006.02.031; Couloigner V, 2006, PFLUG ARCH EUR J PHY, V453, P11, DOI 10.1007/s00424-006-0103-4; Ghaheri BA, 2007, OTOLARYNG HEAD NECK, V137, P332, DOI 10.1016/j.otohns.2007.03.020; Ghaheri BA, 2007, LARYNGOSCOPE, V117, P22, DOI 10.1097/01.mlg.0000240170.48584.73; JUHN SK, 1992, ACTA OTO-LARYNGOL, P37; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Kim SJ, 2007, J CELL BIOCHEM, V101, P576, DOI 10.1002/jcb.21216; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; Li HS, 2002, ACTA OTO-LARYNGOL, V122, P488, DOI 10.1080/00016480260092273; Li JP, 2005, HEARING RES, V210, P1, DOI 10.1016/j.heares.2005.04.011; MacArthur CJ, 2008, OTOLARYNG HEAD NECK, V139, P646, DOI 10.1016/j.otohns.2008.07.029; MacArthur CJ, 2006, HEARING RES, V219, P12, DOI 10.1016/j.heares.2006.05.012; MacArthur CJ, 2006, LARYNGOSCOPE, V116, P1071, DOI 10.1097/01.mlg.0000224527.41288.c4; MacArthur CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075213; MacArthur CJ, 2011, OTOL NEUROTOL, V32, P508, DOI 10.1097/MAO.0b013e31820e6de4; MacArthur CJ, 2009, ARCH OTOLARYNGOL, V135, P453, DOI 10.1001/archoto.2009.23; Morris LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039004; Ondrey FG, 1998, OTOLARYNG HEAD NECK, V119, P342, DOI 10.1016/S0194-5998(98)70075-0; Rosenfeld RM, 2004, PEDIATRICS, V113, P1412, DOI 10.1542/peds.113.5.1412; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; Sato K, 1999, ANN OTO RHINOL LARYN, V108, P559, DOI 10.1177/000348949910800606; Sato K, 1999, INFECT IMMUN, V67, P1943; Son EJ, 2009, EUR J PHARMACOL, V602, P383, DOI 10.1016/j.ejphar.2008.11.012; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; TEELE DW, 1990, J INFECT DIS, V162, P685, DOI 10.1093/infdis/162.3.685; Trune DR, 2012, ANAT REC, V295, P1928, DOI 10.1002/ar.22576; Trune DR, 2010, CURR OPIN OTOLARYNGO, V18, P413, DOI 10.1097/MOO.0b013e32833d9597; Trune DR, 2009, BRAIN RES, V1277, P90, DOI 10.1016/j.brainres.2009.02.047; Tsuprun V, 2008, OTOL NEUROTOL, V29, P1056, DOI 10.1097/MAO.0b013e31818af3ad	31	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119228	10.1371/journal.pone.0119228	http://dx.doi.org/10.1371/journal.pone.0119228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811752	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700013
J	Nie, SJ; Yue, HY; Zhou, J; Xing, D				Nie, Shengjun; Yue, Haiyun; Zhou, Jun; Xing, Da			Mitochondrial-Derived Reactive Oxygen Species Play a Vital Role in the Salicylic Acid Signaling Pathway in Arabidopsis thaliana	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ALTERNATIVE OXIDASE; OXIDATIVE STRESS; ELECTRON-TRANSPORT; NITRIC-OXIDE; PERMEABILITY TRANSITION; HYPERSENSITIVE RESPONSE; PATHOGEN ATTACK; DISEASE; RESPIRATION	Plant mitochondria constitute a major source of ROS and are proposed to act as signaling organelles in the orchestration of defense response. At present, the signals generated and then integrated by mitochondria are still limited. Here, fluorescence techniques were used to monitor the events of mitochondria in vivo, as well as the induction of mitochondrial signaling by a natural defensive signal chemical salicylic acid (SA). An inhibition of respiration was observed in isolated mitochondria subjected to SA. The cytochrome reductase activity analysis in isolated mitochondria demonstrated that SA might act directly on the complex III in the respiration chain by inhibiting the activity. With this alteration, a quick burst of mitochondrial ROS (mtROS) was stimulated. SA-induced mtROS caused mitochondrial morphology transition in leaf tissue or protoplasts expressing mitochondria-GFP (43C5) and depolarization of membrane potential. However, the application of AsA, an H2O2 scavenger, significantly prevented both events, indicating that both of them are attributable to ROS accumulation. In parallel, SA-induced mtROS up-regulated AOX1a transcript abundance and this induction was correlated with the disease resistance, whereas AsA-pretreatment interdicted this effect. It is concluded that mitochondria play an essential role in the signaling pathway of SA-induced ROS generation, which possibly provided new insight into the SA-mediated biological processes, including plant defense response.	[Xing, Da] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; S China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Xing, D (corresponding author), S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China.	xingda@scnu.edu.cn			Program for Changjiang Scholars and Innovative Research Team in University [IRT0829]; Key Program of NSFC-Guangdong Joint Funds of China [U0931005]; National High Technology Research and Development Program of China (863 Program) [2007AA10Z204]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Key Program of NSFC-Guangdong Joint Funds of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0829), the Key Program of NSFC-Guangdong Joint Funds of China (U0931005) and the National High Technology Research and Development Program of China (863 Program) (2007AA10Z204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Alvarez ME, 2000, PLANT MOL BIOL, V44, P429, DOI 10.1023/A:1026561029533; Amirsadeghi S, 2007, PHYSIOL PLANTARUM, V129, P253, DOI 10.1111/j.1399-3054.2006.00775.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Beers EP, 2001, CURR OPIN PLANT BIOL, V4, P561, DOI 10.1016/S1369-5266(00)00216-8; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; Braidot E, 1999, FEBS LETT, V451, P347, DOI 10.1016/S0014-5793(99)00616-X; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Clarke SM, 2004, PLANT J, V38, P432, DOI 10.1111/j.1365-313X.2004.02054.x; Colombatti F, 2014, MITOCHONDRION, V19, P238, DOI 10.1016/j.mito.2014.03.006; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Cvetkovska M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22749; Cvetkovska M, 2013, PLANT CELL ENVIRON, V36, P721, DOI 10.1111/pce.12009; Cvetkovska M, 2012, PLANT CELL ENVIRON, V35, P1121, DOI 10.1111/j.1365-3040.2011.02477.x; Dat JF, 1998, PLANT PHYSIOL, V118, P1455, DOI 10.1104/pp.118.4.1455; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Finnegan PM, 2004, ADV PHOTO RESPIRAT, V17, P163; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gao CJ, 2008, PLANTA, V227, P755, DOI 10.1007/s00425-007-0654-4; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Gilliland A, 2003, PLANT PHYSIOL, V132, P1518, DOI 10.1104/pp.102.017640; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HE P, 2006, METHOD MOL BIOL, V354, P1; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Jones A, 2000, TRENDS PLANT SCI, V5, P225, DOI 10.1016/S1360-1385(00)01605-8; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Lam E, 2008, CRIT REV PLANT SCI, V27, P413, DOI 10.1080/07352680802467744; Larkindale J, 2002, PLANT PHYSIOL, V128, P682, DOI 10.1104/pp.010320; Latifi A, 2005, J BACTERIOL, V187, P6596, DOI 10.1128/JB.187.18.6596-6598.2005; Lee S, 2010, NEW PHYTOL, V188, P626, DOI 10.1111/j.1469-8137.2010.03378.x; Logan DC, 2000, J EXP BOT, V51, P865, DOI 10.1093/jexbot/51.346.865; Maxwell DP, 2002, PLANT J, V29, P269, DOI 10.1046/j.1365-313X.2002.01216.x; Millenaar FF, 2003, PLANT BIOLOGY, V5, P2, DOI 10.1055/s-2003-37974; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; MOORE AL, 1988, FEBS LETT, V235, P76, DOI 10.1016/0014-5793(88)81237-7; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; NEUBURGER M, 1982, ARCH BIOCHEM BIOPHYS, V217, P312, DOI 10.1016/0003-9861(82)90507-0; Noctor G, 2007, TRENDS PLANT SCI, V12, P125, DOI 10.1016/j.tplants.2007.01.005; Norman C, 2004, PLANT PHYSIOL, V134, P492, DOI 10.1104/pp.103.031039; Ordog SH, 2002, PLANT PHYSIOL, V129, P1858, DOI 10.1104/pp.003855; Orozco-Cardenas ML, 2002, PLANT PHYSIOL, V130, P487, DOI 10.1104/pp.008375; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Pastorino JG, 1999, BIOCHEM BIOPH RES CO, V265, P405, DOI 10.1006/bbrc.1999.1696; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Rao MV, 2002, PLANT J, V32, P447, DOI 10.1046/j.1365-313X.2002.01434.x; Rao MV, 1999, PLANT J, V17, P603, DOI 10.1046/j.1365-313X.1999.00400.x; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; RHOADS DM, 1993, PLANT PHYSIOL, V103, P877, DOI 10.1104/pp.103.3.877; Robson CA, 2002, PLANT PHYSIOL, V129, P1908, DOI 10.1104/pp.004853; Scott I, 2008, NEW PHYTOL, V177, P90, DOI 10.1111/j.1469-8137.2007.02255.x; Senthil-Kumar M, 2012, PLANT CELL ENVIRON, V35, P1329, DOI 10.1111/j.1365-3040.2012.02492.x; Sun AZ, 2012, PLANT PHYSIOL, V160, P1081, DOI 10.1104/pp.112.201798; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Umbach AL, 2005, PLANT PHYSIOL, V139, P1806, DOI 10.1104/pp.105.070763; Vacca RA, 2006, PLANT PHYSIOL, V141, P208, DOI 10.1104/pp.106.078683; Vanlerberghe GC, 2002, PLANT PHYSIOL, V129, P1829, DOI 10.1104/pp.002691; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Vanlerberghe GC, 2009, PHYSIOL PLANTARUM, V137, P392, DOI 10.1111/j.1399-3054.2009.01254.x; Vellosillo T, 2013, PLANT PHYSIOL, V161, P617, DOI 10.1104/pp.112.207514; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wagner AM, 1997, PLANT PHYSIOL, V115, P617, DOI 10.1104/pp.115.2.617; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Xie ZX, 1999, PLANT PHYSIOL, V120, P217, DOI 10.1104/pp.120.1.217; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yip JYH, 2001, PHYSIOL PLANTARUM, V112, P327, DOI 10.1034/j.1399-3054.2001.1120305.x; Zhang LR, 2008, PLANT CELL PHYSIOL, V49, P1092, DOI 10.1093/pcp/pcn086; Zmijewski JW, 2009, AM J PHYSIOL-LUNG C, V296, pL624, DOI DOI 10.1152/ajplung.90522.2008	81	51	52	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119853	10.1371/journal.pone.0119853	http://dx.doi.org/10.1371/journal.pone.0119853			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811367	Green Submitted, gold, Green Published			2022-12-26	WOS:000356353700028
J	Pandit, R; van der Zwaal, EM; Luijendijk, MCM; Brans, MAD; van Rozen, AJ; Ophuis, RJAO; Vanderschuren, LJMJ; Adan, RAH; la Fleur, SE				Pandit, Rahul; van der Zwaal, Esther M.; Luijendijk, Mieneke C. M.; Brans, Maike A. D.; van Rozen, Andrea J.; Ophuis, Ralph J. A. Oude; Vanderschuren, Louk J. M. J.; Adan, Roger A. H.; la Fleur, Susanne E.			Central Melanocortins Regulate the Motivation for Sucrose Reward	PLOS ONE			English	Article							AGOUTI-RELATED PROTEIN; RECEPTOR EXPRESSION; DOPAMINE; BEHAVIOR; BRAIN; AGRP; FAT; ANTAGONIST; ACTIVATION; SCHEDULES	The role of the melanocortin (MC) system in feeding behavior is well established. Food intake is potently suppressed by central infusion of the MC 3/4 receptor agonist alpha-melanocyte stimulating hormone (alpha-MSH), whereas the MC 3/4 receptor inverse-agonist Agouti Related Peptide (AGRP) has the opposite effect. MC receptors are widely expressed in both hypothalamic and extra-hypothalamic brain regions, including nuclei involved in food reward and motivation, such as the nucleus accumbens (NAc) and the ventral tegmental area. This suggests that MCs modulate motivational aspects of food intake. To test this hypothesis, rats were injected intracerebroventricularly with alpha-MSH or AGRP and their motivation for sucrose was tested under a progressive ratio schedule of reinforcement. Food motivated behavior was dose-dependently decreased by alpha-MSH. Conversely, AGRP increased responding for sucrose, an effect that was blocked by pretreatment with the dopamine receptor antagonist alpha-flupenthixol. In contrast to progressive ratio responding, free intake of sucrose remained unaltered upon alpha-MSH or AGRP infusion. In addition, we investigated whether the effects of alpha-MSH and AGRP on food motivation were mediated by the NAc shell. In situ hybridization of MC3 and MC4 receptor expression confirmed that the MC4 receptor was expressed throughout the NAc, and injection of alpha-MSH and AGRP into the NAc shell caused a decrease and an increase in motivation for sucrose, respectively. These data show that the motivation for palatable food is modulated by MC4 receptors in the NAc shell, and demonstrate cross-talk between the MC and dopamine system in the modulation of food motivation.	[Pandit, Rahul; van der Zwaal, Esther M.; Luijendijk, Mieneke C. M.; Brans, Maike A. D.; van Rozen, Andrea J.; Ophuis, Ralph J. A. Oude; Vanderschuren, Louk J. M. J.; Adan, Roger A. H.; la Fleur, Susanne E.] Univ Med Ctr Utrecht, Dept Translat Neurosci, Utrecht, Netherlands; [Vanderschuren, Louk J. M. J.] Univ Utrecht, Fac Vet Med, Dept Anim Sci & Soc, Div Behav Neurosci, Utrecht, Netherlands; [la Fleur, Susanne E.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam	Pandit, R (corresponding author), Univ Med Ctr Utrecht, Dept Translat Neurosci, Utrecht, Netherlands.	r.pandit@umcutrecht.nl	Vanderschuren, Louk/AAS-4391-2020	Vanderschuren, Louk/0000-0002-5379-0363; Oude Ophuis, Ralph/0000-0001-6316-2638	European Community [245009]; ZonMw-VIDI grant [917.96.331]	European Community(European Commission); ZonMw-VIDI grant	The work was supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013 under grant agreement no 245009). SL was supported by a ZonMw-VIDI grant (917.96.331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro JD, 1996, MOL PHARMACOL, V50, P583; Bagnol D, 1999, J NEUROSCI, V19; Begriche K, 2013, PROG MOL BIOL TRANSL, V114, P109, DOI 10.1016/B978-0-12-386933-3.00004-2; Benoit SC, 2001, PHARMACOL BIOCHEM BE, V69, P603, DOI 10.1016/S0091-3057(01)00558-5; BERGENDAHL M, 1992, NEUROENDOCRINOLOGY, V56, P913, DOI 10.1159/000126324; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Chandra R, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00013; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cui HX, 2012, J COMP NEUROL, V520, P4168, DOI 10.1002/cne.23145; Davis JF, 2011, PHYSIOL BEHAV, V102, P491, DOI 10.1016/j.physbeh.2010.12.017; de Backer MWA, 2011, INT J OBESITY, V35, P629, DOI 10.1038/ijo.2010.169; de Vaca SC, 1998, J NEUROSCI, V18, P7502; Dietrich MO, 2012, NAT NEUROSCI, V15, P1108, DOI 10.1038/nn.3147; Duan J, 2007, OBESITY, V15, P2624, DOI 10.1038/oby.2007.314; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Figlewicz DP, 2013, APPETITE, V61, P19, DOI 10.1016/j.appet.2012.09.021; Figlewicz DP, 2011, AM J PHYSIOL-REG I, V300, pR876, DOI 10.1152/ajpregu.00655.2010; Grimm JW, 2011, PSYCHOPHARMACOLOGY, V216, P219, DOI 10.1007/s00213-011-2210-y; Grueter BA, 2013, P NATL ACAD SCI USA, V110, P1923, DOI 10.1073/pnas.1221742110; Hagan MM, 2001, ENDOCRINOLOGY, V142, P1050, DOI 10.1210/en.142.3.1050; Hagan MM, 1999, J NEUROSCI, V19, P2362; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hajnal A, 2001, BRAIN RES, V904, P76, DOI 10.1016/S0006-8993(01)02451-9; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hsu R, 2005, EUR J NEUROSCI, V21, P2233, DOI 10.1111/j.1460-9568.2005.04038.x; King CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025864; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; la Fleur SE, 2010, INT J OBESITY, V34, P537, DOI 10.1038/ijo.2009.257; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lindblom J, 2002, PHARMACOL RES, V45, P119, DOI 10.1006/phrs.2001.0913; Mountjoy KG, 2010, ADV EXP MED BIOL, V681, P29, DOI 10.1007/978-1-4419-6354-3_3; Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Ophuis RJAO, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00014; Pandit R, 2013, EUR J PHARMACOL, V719, P208, DOI 10.1016/j.ejphar.2013.04.059; Pecina S, 2003, J NEUROSCI, V23, P9395; POGGIOLI R, 1986, PEPTIDES, V7, P843, DOI 10.1016/0196-9781(86)90104-X; Randall PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047934; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Salamone JD, 2001, NEUROSCIENCE, V105, P863, DOI 10.1016/S0306-4522(01)00249-4; Sokolowski JD, 1998, NEUROSCIENCE, V86, P1001, DOI 10.1016/S0306-4522(98)00066-9; Tracy AL, 2008, PHARMACOL BIOCHEM BE, V89, P263, DOI 10.1016/j.pbb.2007.12.018; Vaughan C, 2006, PEPTIDES, V27, P2829, DOI 10.1016/j.peptides.2006.07.008; Veeneman MMJ, 2012, PSYCHOPHARMACOLOGY, V220, P771, DOI 10.1007/s00213-011-2525-8; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854	46	24	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121768	10.1371/journal.pone.0121768	http://dx.doi.org/10.1371/journal.pone.0121768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811380	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700136
J	Power, C; Pereira, SMP; Li, L				Power, Chris; Pereira, Snehal M. Pinto; Li, Leah			Childhood Maltreatment and BMI Trajectories to Mid-Adult Life: Follow-Up to Age 50y in a British Birth Cohort	PLOS ONE			English	Article							BODY-MASS INDEX; HOUSEHOLD DYSFUNCTION; OBESITY; ABUSE; RISK; HEALTH; EPIDEMIOLOGY; ASSOCIATIONS; ADIPOSITY; MORBIDITY	Background Childhood maltreatment including abuse and neglect has been associated with adult obesity, but evidence on life-course development of obesity or BMI gain is unclear. We aim to establish whether childhood maltreatments are related to obesity or BMI at different life-stages 7y-50y and to identify possible explanations for associations. Methods Childhood physical, psychological and sexual abuse, neglect and BMI at seven ages were recorded in the 1958 birth cohort (n similar to 15,000). Associations of child maltreatments with BMI at separate ages were tested using linear regression or logistic regression for obesity, and with rate of child-to-adult BMI gain using multilevel models. We adjusted for potential covariates. Results Abuse was reported in similar to 12% of the population. Abuse was not associated with elevated childhood BMI, but adult associations were observed: i.e. the abused had faster child-adult BMI gain than the non-abused; associations were independent of adult covariates. For physical abuse in both genders there was a positive linear association of similar to 0.006/y zBMI gain with age after adjustment for all covariates. Similarly, there was a linear association of physical abuse with obesity risk: e.g. among females from a low ORadjusted of 0.34 (0.16,0.71) at 7y to 1.67 (1.25,2.24) at 50y. In females faster zBMI gains with age of similar to 0.0034/y were observed for sexual abuse and increases in obesity risk were faster: from a low ORadjusted of 0.23 (0.06,0.84) at 7y to 1.34 (0.86,2.10) at 50y. Psychological abuse and neglect associations were less consistent. Conclusions Childhood maltreatment associations with BMI or obesity varied across life: physical and, in females, sexual abuse were associated with faster lifetime BMI gains, which may have detrimental long-term health consequences.	[Power, Chris; Pereira, Snehal M. Pinto; Li, Leah] UCL, UCL Inst Child Hlth, Populat Policy & Practice, London WC1N 1EH, England	University of London; University College London	Power, C (corresponding author), UCL, UCL Inst Child Hlth, Populat Policy & Practice, London WC1N 1EH, England.	christine.power@ucl.ac.uk		Pinto Pereira, Snehal/0000-0002-0876-8757	Department of Health Policy Research Programme through the Public Health Research Consortium (PHRC); Department of Health's NIHR Biomedical Research Centre	Department of Health Policy Research Programme through the Public Health Research Consortium (PHRC); Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by the Department of Health Policy Research Programme through the Public Health Research Consortium (PHRC). The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Information about the wider programme of the PHRC is available from http://phrc.lshtm.ac.uk. The GOSH/UCL Institute of Child Health was supported in part by the Department of Health's NIHR Biomedical Research Centre. The funders had no input into in study design; data collection, analysis, and interpretation; in the writing of the report; and in the decision to submit the article for publication. Researchers were independent of influence from study funders.	ABRAHAM S, 1971, HSMHA HEALTH REP, V86, P273, DOI 10.2307/4594149; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Bentley T, 2009, OBESITY, V17, P1900, DOI 10.1038/oby.2009.160; Brown RE, 2013, J AGING HEALTH, V25, P803, DOI 10.1177/0898264313492823; Chartier MJ, 2009, AM J PUBLIC HEALTH, V99, P847, DOI 10.2105/AJPH.2007.122408; Clark C, 2010, ANN EPIDEMIOL, V20, P385, DOI 10.1016/j.annepidem.2010.02.008; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Danese A, 2014, MOL PSYCHIATR, V19, P544, DOI 10.1038/mp.2013.54; Denholm R, 2013, CHILD ABUSE REV, V22, P340, DOI 10.1002/car.2235; Denholm R, 2013, INT J EPIDEMIOL, V42, P1399, DOI 10.1093/ije/dyt169; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Fergusson DM, 2000, PSYCHOL MED, V30, P529, DOI 10.1017/S0033291799002111; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; Geoffroy MC, 2014, PSYCHOL MED, V44, P2641, DOI 10.1017/S0033291714000142; Gilbert R, 2009, LANCET, V378, P68, DOI [10.1016/j.bbrc.2008.10.176, DOI 10.1016/J.BBRC.2008.10.176]; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kendall-Tackett K, 2004, CHILD ABUSE NEGLECT, V28, P723, DOI 10.1016/j.chiabu.2004.02.002; Li L, 2007, J HYPERTENS, V25, P1215, DOI 10.1097/HJH.0b013e3280f3c01a; Li L, 2014, INT J EPIDEMIOL, V43, P1163, DOI 10.1093/ije/dyu071; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Mamun AA, 2007, INT J OBESITY, V31, P578, DOI 10.1038/sj.ijo.0803571; Matthews KA, 2014, BRAIN BEHAV IMMUN, V36, P29, DOI 10.1016/j.bbi.2013.09.013; Noll JG, 2007, PEDIATRICS, V120, pE61, DOI 10.1542/peds.2006-3058; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; PARKER G, 1979, BRIT J PSYCHIAT, V134, P138, DOI 10.1192/bjp.134.2.138; Pereira SMP, 2013, EUR HEART J, V34, P1215, DOI 10.1093/eurheartj/ehs333; Power C, 2003, INT J OBESITY, V27, P1081, DOI 10.1038/sj.ijo.0802323; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Rich-Edwards JW, 2010, AM J PREV MED, V39, P529, DOI 10.1016/j.amepre.2010.09.007; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Riso LP, 2002, J AFFECT DISORDERS, V70, P103, DOI 10.1016/S0165-0327(01)00376-7; Rodgers B, 1996, PSYCHOL MED, V26, P51, DOI 10.1017/S0033291700033717; Rodgers B, 1999, SOC PSYCH PSYCH EPID, V34, P333, DOI 10.1007/s001270050153; Rosenman S, 2004, SOC PSYCH PSYCH EPID, V39, P695, DOI 10.1007/s00127-004-0802-0; Shin SH, 2012, CHILD ABUSE NEGLECT, V36, P84, DOI 10.1016/j.chiabu.2011.08.007; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Suderman M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-13; Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403; van Dijk SJ, 2015, INT J OBESITY, V39, P85, DOI 10.1038/ijo.2014.34; Vatten LJ, 2006, EUR J CARDIOV PREV R, V13, P909, DOI 10.1097/01.hjr.0000239463.80390.52; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wright CM, 2001, BMJ-BRIT MED J, V323, P1280, DOI 10.1136/bmj.323.7324.1280	45	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119985	10.1371/journal.pone.0119985	http://dx.doi.org/10.1371/journal.pone.0119985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811782	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700032
J	Privitera, GJ; McGrath, HK; Windus, BA; Doraiswamy, PM				Privitera, Gregory J.; McGrath, Hannah K.; Windus, Brittany A.; Doraiswamy, P. Murali			Eat Now or Later: Self-Control as an Overlapping Cognitive Mechanism of Depression and Obesity	PLOS ONE			English	Article							MAJOR DEPRESSION; LATE-LIFE; IMPULSIVITY; DELAY; ADULTS; OVERWEIGHT; SYMPTOMS; BEHAVIOR; REWARDS; SMOKERS	While overlapping neurobiological mechanisms are known, relatively little is known about how "self-control" and cognitive affective processing of rewards may also influence the bidirectional risk between obesity and depression. The objective of this study was to identify the extent to which "self-control," measured using a delay discounting task is co-related to BMI and Depression diagnostic thresholds. A within-subjects counterbalanced design was used in which 92 participants (Mean +/- SD: BMI = 27.9 +/- 3.5, HAMD = 14.7 +/- 7.7) completed a series of clinical diagnostic, survey, and demographic questionnaires in a behavioral health laboratory setting. For the delay discounting task, participants chose between one large delayed reward and one successively smaller immediate reward for four food types (dessert, fried food, fruit, and vegetable). Results showed that delay discounting scores were predictive of BMI and depression with lower delay discounting scores associated with higher BMI and HAMD for the dessert (HAMD scores (beta = -.197, p =.013), BMI (beta = -. 239, p <.001)) and fried food (HAMD scores (beta = -. 328, p =.001), BMI (beta = -. 166, p =.027)). Clinical significance was further evident when HAMD and BMI scores were converted to diagnostic thresholds. Only depression and/or atypical depressive symptoms were related to delay discounting scores with the fruit and vegetable. Thus, reduced cognitive affective self-control for impulsive food choices-particularly for "comfort foods" high in fat and sugar-appears to be a shared cognitive mechanism for both conditions perhaps contributing to the high prevalence of co-morbid mood disorders and weight gain.	[Privitera, Gregory J.; McGrath, Hannah K.; Windus, Brittany A.] St Bonaventure Univ, Dept Psychol, St Bonaventure, NY 14778 USA; [Doraiswamy, P. Murali] Duke Univ, Dept Psychiat & Behav Sci, Duke Inst Brain Sci, Durham, England; [Doraiswamy, P. Murali] Duke Univ, Duke Brain & Soc program, Durham, England		Privitera, GJ (corresponding author), St Bonaventure Univ, Dept Psychol, St Bonaventure, NY 14778 USA.	gprivite@sbu.edu						Aguayo G A, 2012, Bull Soc Sci Med Grand Duche Luxemb, P7; AINSLIE GW, 1974, J EXP ANAL BEHAV, V21, P485, DOI 10.1901/jeab.1974.21-485; Arterburn DE, 2004, J AM GERIATR SOC, V52, P1907, DOI 10.1111/j.1532-5415.2004.52517.x; Bickel WK, 1999, PSYCHOPHARMACOLOGY, V146, P447, DOI 10.1007/PL00005490; Blanco C, 2012, J CLIN PSYCHIAT, V73, P224, DOI 10.4088/JCP.10m06227; Blazer DG, 2003, J GERONTOL A-BIOL, V58, P249; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Chou KL, 2013, DEPRESS ANXIETY, V30, P574, DOI 10.1002/da.22098; Crean JP, 2000, EXP CLIN PSYCHOPHARM, V8, P155, DOI 10.1037/1064-1297.8.2.155; Dave DM, 2011, J MENT HEALTH POLICY, V14, P165; Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x; Dombrovski AY, 2013, JAMA PSYCHIAT, V70, P1020, DOI 10.1001/jamapsychiatry.2013.75; Dube L, 2005, PHYSIOL BEHAV, V86, P559, DOI 10.1016/j.physbeh.2005.08.023; Eisenberg DTA, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-2; Epstein LH, 2010, PHYSIOL BEHAV, V100, P438, DOI 10.1016/j.physbeh.2010.04.029; Faith M. S., 1997, Overweight and weight management: the health professional's guide to understanding and practice., P439; FEDORCHAK PM, 1987, J EXP PSYCHOL ANIM B, V13, P73, DOI 10.1037/0097-7403.13.1.73; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Goldschmidt AB, 2008, INT J EAT DISORDER, V41, P153, DOI 10.1002/eat.20481; Goldschmidt AB, 2014, INT J EAT DISORDER, V47, P281, DOI 10.1002/eat.22188; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122; Imhoff S, 2014, DRUG ALCOHOL DEPEN, V135, P152, DOI 10.1016/j.drugalcdep.2013.11.014; Jasinska AJ, 2012, APPETITE, V59, P738, DOI 10.1016/j.appet.2012.08.001; Kampov-Polevoy Alexey B, 2006, Eat Behav, V7, P181, DOI 10.1016/j.eatbeh.2005.09.005; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kuo SY, 2011, PSYCHOL MED, V41, P1665, DOI 10.1017/S0033291710002473; Li ZB, 2004, INT J GERIATR PSYCH, V19, P68, DOI 10.1002/gps.1040; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Macht M, 2000, APPETITE, V35, P65, DOI 10.1006/appe.2000.0325; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Nestler EJ, 2012, NATURE, V490, P171, DOI 10.1038/490171a; Odum AL, 2011, J EXP ANAL BEHAV, V96, P427, DOI 10.1901/jeab.2011.96-423; Privitera, 2017, STAT BEHAV SCI; Privitera G. J., 2008, PSYCHOL DIETER ITS N; Privitera G. J., 2013, J BEHAV BRAIN SCI, V3, P1, DOI [10.4236/jbbs.2013.31001, DOI 10.4236/JBBS.2013.31001]; Privitera G. J., 2013, J BEHAV BRAIN SCI, V3, P163, DOI [DOI 10.4236/JBBS.2013.32016, 10.4236/jbbs.2013.32016]; Privitera GJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00873; Roberts RE, 2000, AM J EPIDEMIOL, V152, P163, DOI 10.1093/aje/152.2.163; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; Sanderson SC, 2010, ISSUES CLIN CHILD PS, P329, DOI 10.1007/978-1-4419-5800-6_14; Schlam TR, 2013, J PEDIATR-US, V162, P90, DOI 10.1016/j.jpeds.2012.06.049; Tindell AJ, 2009, J NEUROSCI, V29, P12220, DOI 10.1523/JNEUROSCI.2499-09.2009; United States Department of Agriculture (USDA), 2010, PROF FOOD CONS AM; Yeomans MR, 2006, FRONT NUTR SCI, P93, DOI 10.1079/9780851990323.0093; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005	47	20	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0123136	10.1371/journal.pone.0123136	http://dx.doi.org/10.1371/journal.pone.0123136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811652	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700211
J	Xian, L; Wang, F; Luo, X; Feng, YL; Feng, JX				Xian, Liang; Wang, Fei; Luo, Xiang; Feng, Yu-Liang; Feng, Jia-Xun			Purification and Characterization of a Highly Efficient Calcium-Independent alpha-Amylase from Talaromyces pinophilus 1-95	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; SIMULTANEOUS SACCHARIFICATION; BIOETHANOL PRODUCTION; SEPARATE HYDROLYSIS; ASPERGILLUS-NIGER; FUEL ETHANOL; LOW PH; STARCH; FERMENTATION; GLUCOAMYLASE	Alpha-amylase is a very important enzyme in the starch conversion process. Most of the alpha-amylases are calcium-dependent and exhibit poor performance in the simultaneous saccharification and fermentation process of industrial bioethanol production that uses starch as feedstock. In this study, an extracellular amylolytic enzyme was purified from the culture broth of newly isolated Talaromyces pinophilus strain 1-95. The purified amylolytic enzyme, with an apparent molecular weight of 58 kDa on SDS-PAGE, hydrolyzed maltopentaose, maltohexaose, and maltoheptaose into mainly maltose and maltotriose and minor amount of glucose, confirming the endo-acting mode of the enzyme, and hence, was named Talaromyces pinophilus alpha-amylase (TpAA). TpAA was most active at pH 4.0-5.0 (with the temperature held at 37 degrees C) and 55 degrees C (at pH 5.0), and stable within the pH range of 5.0-9.5 (at 4 degrees C) and below 45 degrees C (at pH 5.0). Interestingly, the Ca2+ did not improve its enzymatic activity, optimal temperature, or thermostability of the enzyme, indicating that the TpAA was Ca2+-independent. TpAA displayed higher enzyme activity toward malto-oligosaccharides and dextrin than other previously reported alpha-amylases. This highly active Ca2+-independent alpha-amylase may have potential applications in starch-to-ethanol conversion process.	[Xian, Liang; Wang, Fei; Luo, Xiang; Feng, Yu-Liang; Feng, Jia-Xun] Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China	Guangxi University	Feng, JX (corresponding author), Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.	jiaxunfeng@sohu.com			Guangxi Natural Science Foundation [2012GXNSFGA060005]; Guangxi BaGui Scholars Program Foundation [2011A001]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi BaGui Scholars Program Foundation	This work was financially supported by grants from the Guangxi Natural Science Foundation (grant number 2012GXNSFGA060005, Prof. Jia-Xun Feng) and the Guangxi BaGui Scholars Program Foundation (grant number 2011A001, Prof. Jia-Xun Feng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2007, PROG ENERG COMBUST, V33, P233, DOI 10.1016/j.pecs.2006.08.003; Asoodeh A, 2013, EXTREMOPHILES, V17, P339, DOI 10.1007/s00792-013-0520-1; Asoodeh A, 2010, INT J BIOL MACROMOL, V46, P289, DOI 10.1016/j.ijbiomac.2010.01.013; Bagheri A, 2014, FOOD CHEM, V161, P270, DOI 10.1016/j.foodchem.2014.03.095; Bao YL, 2011, ANTON LEEUW INT J G, V99, P329, DOI 10.1007/s10482-010-9494-5; Bozic N, 2011, BIOCHEM ENG J, V53, P203, DOI 10.1016/j.bej.2010.10.014; Buchholz K, 2008, CARBOHYD RES, V343, P1966, DOI 10.1016/j.carres.2008.02.007; Cardona CA, 2007, BIORESOURCE TECHNOL, V98, P2415, DOI 10.1016/j.biortech.2007.01.002; Cho HY, 2000, BBA-PROTEIN STRUCT M, V1478, P333, DOI 10.1016/S0167-4838(00)00037-6; Crabb WD, 1997, TRENDS BIOTECHNOL, V15, P349, DOI 10.1016/S0167-7799(97)01082-2; Currie JN, 1915, J BIOL CHEM, V22, P287; de Souza PM, 2010, BRAZ J MICROBIOL, V41, P850, DOI 10.1590/S1517-83822010000400004; Demirbas A, 2009, APPL ENERG, V86, pS108, DOI 10.1016/j.apenergy.2009.04.036; DOYLE EM, 1989, APPL MICROBIOL BIOT, V30, P492, DOI 10.1007/BF00263854; Ezeji TC, 2007, J IND MICROBIOL BIOT, V34, P771, DOI 10.1007/s10295-007-0253-1; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Fujii T, 2014, FEMS MICROBIOL LETT, V351, P32, DOI 10.1111/1574-6968.12352; Galante YA, 2003, CURR ORG CHEM, V7, P1399, DOI 10.2174/1385272033486468; Ghollasi M, 2013, ENZYME MICROB TECH, V53, P406, DOI 10.1016/j.enzmictec.2013.09.001; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; Haki GD, 2008, WORLD J MICROB BIOT, V24, P2517, DOI 10.1007/s11274-008-9775-6; Han P, 2013, APPL BIOCHEM BIOTECH, V170, P420, DOI 10.1007/s12010-013-0198-y; Hira A, 2009, ENERG POLICY, V37, P2450, DOI 10.1016/j.enpol.2009.02.037; Hmidet N, 2008, PROCESS BIOCHEM, V43, P499, DOI 10.1016/j.procbio.2008.01.017; Hong SB, 2006, INT J SYST EVOL MICR, V56, P477, DOI 10.1099/ijs.0.63980-0; IVANOVA VN, 1993, J BIOTECHNOL, V28, P277, DOI 10.1016/0168-1656(93)90176-N; James JA, 1997, CURR MICROBIOL, V34, P186, DOI 10.1007/s002849900166; Kelly RM, 2009, J BIOTECHNOL, V140, P184, DOI 10.1016/j.jbiotec.2009.01.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li X, 2012, FOLIA MICROBIOL, V57, P447, DOI 10.1007/s12223-012-0160-3; Lin HJ, 2011, J IND MICROBIOL BIOT, V38, P733, DOI 10.1007/s10295-010-0910-7; MANNERS DJ, 1989, CARBOHYD POLYM, V11, P87, DOI 10.1016/0144-8617(89)90018-0; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moon SK, 2012, J BIOTECHNOL, V157, P584, DOI 10.1016/j.jbiotec.2011.06.009; Moreira FG, 2004, J BASIC MICROB, V44, P29, DOI 10.1002/jobm.200310302; Ohgren K, 2007, PROCESS BIOCHEM, V42, P834, DOI 10.1016/j.procbio.2007.02.003; Okolo BN, 2001, J SCI FOOD AGR, V81, P329, DOI [10.1002/1097-0010(200102)81:3&lt;329::AID-JSFA815&gt;3.0.CO;2-3, 10.1002/1097-0010(200102)81:3<329::AID-JSFA815>3.0.CO;2-3]; Onodera M, 2013, BIOSCI BIOTECH BIOCH, V77, P281, DOI 10.1271/bbb.120693; Ozturk MT, 2013, APPL BIOCHEM BIOTECH, V171, P263, DOI 10.1007/s12010-013-0331-y; Presecki AV, 2013, BIOPROC BIOSYST ENG, V36, P1555, DOI 10.1007/s00449-013-0926-2; Qiu HG, 2010, APPL ENERG, V87, P76, DOI 10.1016/j.apenergy.2009.07.015; Riaz M, 2012, FOOD CHEM, V130, P24, DOI 10.1016/j.foodchem.2011.06.037; Richardson TH, 2002, J BIOL CHEM, V277, P26501, DOI 10.1074/jbc.M203183200; Sahnoun M, 2012, PROCESS BIOCHEM, V47, P18, DOI 10.1016/j.procbio.2011.09.016; Sajedi RH, 2005, ENZYME MICROB TECH, V36, P666, DOI 10.1016/j.enzmictec.2004.11.003; Sajedi RH, 2004, APPL BIOCHEM BIOTECH, V119, P41, DOI 10.1385/ABAB:119:1:41; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Sanchez OJ, 2008, BIORESOURCE TECHNOL, V99, P5270, DOI 10.1016/j.biortech.2007.11.013; Silva TM, 2013, FOLIA MICROBIOL, V58, P495, DOI 10.1007/s12223-013-0230-1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soleimani M, 2012, J MOL CATAL B-ENZYM, V74, P1, DOI 10.1016/j.molcatb.2011.07.011; Soni SK, 2003, PROCESS BIOCHEM, V39, P185, DOI 10.1016/S0032-9592(03)00058-X; STEYN AJC, 1995, CURR GENET, V28, P526, DOI 10.1007/BF00518165; Thang VH, 2010, APPL BIOCHEM BIOTECH, V161, P157, DOI 10.1007/s12010-009-8770-1; Thom C, 1910, USDA BUREAU OF ANIMA, V118, P37; Tsao CY, 2004, FISHERIES SCI, V70, P174, DOI 10.1111/j.1444-2906.2003.00786.x; van der Kaaij RM, 2007, MICROBIOL-SGM, V153, P4003, DOI 10.1099/mic.0.2007/008607-0; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; VIHINEN M, 1989, CRIT REV BIOCHEM MOL, V24, P329, DOI 10.3109/10409238909082556; Wang SJ, 2008, APPL MICROBIOL BIOT, V80, P605, DOI 10.1007/s00253-008-1561-8; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zheng DQ, 2013, APPL MICROBIOL BIOT, V97, P2067, DOI 10.1007/s00253-013-4698-z; Zhu MJ, 2012, BIOSCI BIOTECH BIOCH, V76, P671, DOI 10.1271/bbb.110750	64	48	51	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121531	10.1371/journal.pone.0121531	http://dx.doi.org/10.1371/journal.pone.0121531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811759	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700112
J	Chynoweth, MW; Lepczyk, CA; Litton, CM; Hess, SC; Kellner, JR; Cordell, S				Chynoweth, Mark W.; Lepczyk, Christopher A.; Litton, Creighton M.; Hess, Steven C.; Kellner, James R.; Cordell, Susan			Home Range Use and Movement Patterns of Non-Native Feral Goats in a Tropical Island Montane Dry Landscape	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; CAPRA-HIRCUS; SOCIAL SEGREGATION; ECOLOGY; UNGULATE; DYNAMICS; RAINFALL; HABITAT; LOCATIONS; IMPACTS	Advances in wildlife telemetry and remote sensing technology facilitate studies of broad-scale movements of ungulates in relation to phenological shifts in vegetation. In tropical island dry landscapes, home range use and movements of non-native feral goats (Capra hircus) are largely unknown, yet this information is important to help guide the conservation and restoration of some of the world's most critically endangered ecosystems. We hypothesized that feral goats would respond to resource pulses in vegetation by traveling to areas of recent green-up. To address this hypothesis, we fitted six male and seven female feral goats with Global Positioning System (GPS) collars equipped with an Argos satellite upload link to examine goat movements in relation to the plant phenology using the Normalized Difference Vegetation Index (NDVI). Movement patterns of 50% of males and 40% of females suggested conditional movement between non-overlapping home ranges throughout the year. A shift in NDVI values corresponded with movement between primary and secondary ranges of goats that exhibited long-distance movement, suggesting that vegetation phenology as captured by NDVI is a good indicator of the habitat and movement patterns of feral goats in tropical island dry landscapes. In the context of conservation and restoration of tropical island landscapes, the results of our study identify how non-native feral goats use resources across a broad landscape to sustain their populations and facilitate invasion of native plant communities.	[Chynoweth, Mark W.; Lepczyk, Christopher A.; Litton, Creighton M.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Hess, Steven C.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawail Natl Pk, HI USA; [Kellner, James R.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Cordell, Susan] US Forest Serv, USDA, Inst Pacific Islands Forestry, Hilo, HI USA	University of Hawaii System; University of Hawaii Manoa; United States Department of the Interior; United States Geological Survey; Brown University; United States Department of Agriculture (USDA); United States Forest Service	Chynoweth, MW (corresponding author), Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA.	chynoweth.mark@gmail.com		Hess, Steven/0000-0001-6403-9922	National Science Foundation Graduate Research Fellowship [2010094953]; USDA Forest Service, Pacific Southwest Research Station, Institute of Pacific Islands Forestry Research Joint Venture [08-JV-11272177-074]; Strategic Environmental Research and Development Program [RC-1645]; W. T. Yoshimoto Foundation Endowed Fellowship in Animal Wildlife Conservation Biology; Invasive Species Program of USGS	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); USDA Forest Service, Pacific Southwest Research Station, Institute of Pacific Islands Forestry Research Joint Venture; Strategic Environmental Research and Development Program; W. T. Yoshimoto Foundation Endowed Fellowship in Animal Wildlife Conservation Biology; Invasive Species Program of USGS	Funding was provided by the National Science Foundation Graduate Research Fellowship under Grant #2010094953 to MWC; USDA Forest Service, Pacific Southwest Research Station, Institute of Pacific Islands Forestry Research Joint Venture 08-JV-11272177-074 to CML; Strategic Environmental Research and Development Program RC-1645 to SC; W. T. Yoshimoto Foundation Endowed Fellowship in Animal Wildlife Conservation Biology to MWC. Support for SH was provided by the Invasive Species Program of USGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], RAINFALL ATLAS HAWAI; Baker R. R., 1978, EVOLUTIONARY ECOLOGY; Beck PSA, 2008, INT J REMOTE SENS, V29, P4277, DOI 10.1080/01431160802104942; Bischof R, 2012, AM NAT, V180, P407, DOI 10.1086/667590; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brinkman TJ, 2005, J WILDLIFE MANAGE, V69, P1099, DOI 10.2193/0022-541X(2005)069[1099:MOFWDE]2.0.CO;2; BURKE MG, 1988, NATL GEOGR RES, V4, P272; Cabin RJ, 2000, CONSERV BIOL, V14, P439, DOI 10.1046/j.1523-1739.2000.99006.x; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Calhim S, 2006, ANIM BEHAV, V72, P31, DOI 10.1016/j.anbehav.2005.08.013; Chynoweth MW, 2013, PAC SCI, V67, P141, DOI 10.2984/67.2.1; CIHLAR J, 1991, REMOTE SENS ENVIRON, V35, P279, DOI 10.1016/0034-4257(91)90018-2; COBLENTZ BE, 1978, BIOL CONSERV, V13, P279, DOI 10.1016/0006-3207(78)90038-1; COBLENTZ BE, 1980, J WILDLIFE MANAGE, V44, P929, DOI 10.2307/3808328; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; DAVENPORT ML, 1993, INT J REMOTE SENS, V14, P2369, DOI 10.1080/01431169308954042; DIXON KR, 1980, ECOLOGY, V61, P1040, DOI 10.2307/1936821; Elmore AJ, 2005, EARTH INTERACT, V9; Frank DA, 1998, BIOSCIENCE, V48, P513, DOI 10.2307/1313313; Harris NR, 2007, RANGELAND ECOL MANAG, V60, P339, DOI 10.2111/1551-5028(2007)60[339:SAADOI]2.0.CO;2; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Holyoak M, 2008, P NATL ACAD SCI USA, V105, P19060, DOI 10.1073/pnas.0800483105; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Ito TY, 2006, J ZOOL, V269, P291, DOI 10.1111/j.1469-7998.2006.00077.x; Kellner JR, 2011, ECOL APPL, V21, P2094, DOI 10.1890/10-0859.1; King D, 1992, HOME RANGES FERAL GO; Leimgruber P, 2001, BIOL CONSERV, V102, P205, DOI 10.1016/S0006-3207(01)00041-6; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Loope LL, 1985, HAWAIIS TERRESTRIAL, P377; Michelena P, 2004, ANIM BEHAV, V68, P1371, DOI 10.1016/j.anbehav.2004.04.008; Moorcroft PR, 2012, J MAMMAL, V93, P903, DOI 10.1644/11-MAMM-S-254.1; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; OBRIEN PH, 1988, APPL ANIM BEHAV SCI, V21, P209, DOI 10.1016/0168-1591(88)90110-4; OBRIEN PH, 1984, APPL ANIM BEHAV SCI, V12, P373, DOI 10.1016/0168-1591(84)90129-1; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Rodgers AR., 1998, HRE HOME RANGE EXTEN; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Shaw R. B., 1997, PLANT COMMUNITIES PO; Shi JB, 2005, MAMMALIA, V69, P185, DOI 10.1515/mamm.2005.016; Stenseth N.C., 1992, P5; Svoray T, 2011, ECOHYDROLOGY, V4, P56, DOI 10.1002/eco.123; The R Project for Statistical Computing, 2011, R LANG ENV STAT COMP; WATTS T, 1984, J WILDLIFE MANAGE, V48, P814, DOI 10.2307/3801428; Weber KT, 2001, J RANGE MANAGE, V54, P21, DOI 10.2307/4003522; Weise DR, 2010, PAC SCI, V64, P199, DOI 10.2984/64.2.199; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; YOCOM CF, 1967, AM MIDL NAT, V77, P418, DOI 10.2307/2423350	55	8	10	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119231	10.1371/journal.pone.0119231	http://dx.doi.org/10.1371/journal.pone.0119231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807275	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000023
J	Coura, CO; Souza, RB; Rodrigues, JAG; Vanderlei, EDO; de Arajo, IWF; Ribeiro, NA; Frota, AF; Ribeiro, KA; Chaves, HV; Pereira, KMA; da Cunha, RMS; Bezerra, MM; Benevides, NMB				Coura, Chistiane Oliveira; Souza, Ricardo Basto; Gurgel Rodrigues, Jose Arievilo; Oliveira Vanderlei, Edfranck de Sousa; Fernandes de Arajo, Ianna Wivianne; Ribeiro, Natassia Albuquerque; Frota, Annyta Fernandes; Ribeiro, Katia Alves; Chaves, Helliada Vasconcelos; Alves Pereira, Karuza Maria; Silva da Cunha, Rodrigo Maranguape; Bezerra, Mirna Marques; Barros Benevides, Norma Maria			Mechanisms Involved in the Anti-Inflammatory Action of a Polysulfated Fraction from Gracilaria cornea in Rats	PLOS ONE			English	Article							SULFATED-POLYSACCHARIDE FRACTION; MONOXIDE-BILIVERDIN PATHWAY; HO-1 PATHWAY; PAW EDEMA; CARRAGEENAN; MIGRATION; GALACTAN	The anti-inflammatory mechanisms of the sulfated polysaccharidic fraction obtained from red marine alga Gracilaria cornea (Gc-Fl) were investigated using a paw edema model induced in rats by different inflammatory agents (carrageenan, dextran, serotonin, bradykinin, compound 48/80 or L-arginine). Gc-Fl at the doses of 3, 9 or 27 mg/kg, subcutaneously s.c., significantly inhibited rat paw edema induced by carrageenan and dextran, as confirmed by myeloperoxidase and Evans' blue assessments, respectively. Gc-Fl (9 mg/kg, s.c.) inhibited rat paw edema induced by histamine, compound 48/80 and L-arginine. Additionally, Gc-Fl (9 mg/kg, s.c.) inhibited Cg-induced edema in animals with intact mast cells but did not inhibit that with degranulated mast cells by compound 48/80, revealing a protective role on mast cell membranes. Gc-Fl down-regulated the IL-1 beta, TNF-alpha and COX-2 mRNA and protein levels compared with those of the carrageenan group, based on qRT-PCR and immunohistochemistry analyses. After inhibition with ZnPP IX, a specific heme oxygenase-1 (HO-1) inhibitor, the anti-inflammatory effect of Gc-Fl was not observed in Cg-induced paw edema, suggesting that the anti-inflammatory effect of Gc-Fl is, in part, dependent on the integrity of the HO-1 pathway. Gc-Fl can target a combination of multiple points involved in inflammatory phenomena.	[Coura, Chistiane Oliveira; Souza, Ricardo Basto; Gurgel Rodrigues, Jose Arievilo; Oliveira Vanderlei, Edfranck de Sousa; Fernandes de Arajo, Ianna Wivianne; Ribeiro, Natassia Albuquerque; Barros Benevides, Norma Maria] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil; [Frota, Annyta Fernandes; Ribeiro, Katia Alves; Bezerra, Mirna Marques] Univ Fed Ceara, Fac Med, Sobral, Ceara, Brazil; [Chaves, Helliada Vasconcelos; Alves Pereira, Karuza Maria] Univ Fed Ceara, Fac Dent, Sobral, Ceara, Brazil; [Silva da Cunha, Rodrigo Maranguape] Biotechnol Nucleus Sobral, Sobral, Ceara, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Ceara	Benevides, NMB (corresponding author), Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil.	nmbb@ufc.br	da Cunha, Rodrigo M. S./O-9958-2014; Benevides, Norma/K-5647-2015; Souza, Ricardo Basto/G-5292-2015; Frota, Annyta Fernandes/AAH-4082-2019; da Silva Cunha, Rodrigo/GWZ-3902-2022	da Cunha, Rodrigo M. S./0000-0002-4467-3018; Souza, Ricardo Basto/0000-0003-1930-9975; Frota, Annyta Fernandes/0000-0002-4550-0266; Barros Benevides, Norma Maria/0000-0001-5067-2110	Conselho Nacional de Desenvolvimento Cientifico e tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P179; Bang JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2662; BRADLEY PP, 1982, BLOOD, V60, P618; Chaves HV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/707985; Chaves LD, 2013, IMMUNOPHARM IMMUNOT, V35, P93, DOI 10.3109/08923973.2012.707211; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Coura CO, 2012, BASIC CLIN PHARMACOL, V110, P335, DOI 10.1111/j.1742-7843.2011.00811.x; de Brito TV, 2013, J PHARM PHARMACOL, V65, P724, DOI 10.1111/jphp.12024; de Sousa AAS, 2013, FUND CLIN PHARMACOL, V27, P173, DOI 10.1111/j.1472-8206.2011.01001.x; DIETRICH CP, 1976, ANAL BIOCHEM, V70, P645, DOI 10.1016/0003-2697(76)90496-6; DIROSA M, 1971, J PATHOL, V104, P15, DOI 10.1002/path.1711040103; Esteves CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075874; Farias WRL, 2000, J BIOL CHEM, V275, P29299, DOI 10.1074/jbc.M002422200; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Feitosa RFG, 2002, MEDIAT INFLAMM, V11, P155, DOI 10.1080/09622935020138000; de Araujo IWF, 2011, CARBOHYD POLYM, V86, P1207, DOI 10.1016/j.carbpol.2011.06.016; Fernandes JC, 2010, MAR DRUGS, V8, P1763, DOI 10.3390/md8061763; Fosslien E, 2005, ANN CLIN LAB SCI, V35, P347; Freitas A, 2006, BRIT J PHARMACOL, V149, P345, DOI 10.1038/sj.bjp.0706882; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Grangeiro NMG, 2011, PHARMACOL REP, V63, P112, DOI 10.1016/S1734-1140(11)70405-4; Rodrigues JAG, 2011, CIENC RURAL, V41, P634, DOI 10.1590/S0103-84782011000400014; Haddad JJ, 2002, BIOCHEM BIOPH RES CO, V297, P700, DOI 10.1016/S0006-291X(02)02287-8; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P1349, DOI 10.1177/29.11.6172466; [Кулинский В.И. Kulinsky V.I.], 2007, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V72, P733; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LO TN, 1982, J PHARMACOL EXP THER, V221, P261; Melo MRS, 2002, CARBOHYD POLYM, V49, P491, DOI 10.1016/S0144-8617(02)00006-1; Ndisang JF., 2010, MED INFLAMM, V2010, P359; Vanderlei EDO, 2011, INFLAMM RES, V60, P1121, DOI 10.1007/s00011-011-0376-8; Pae Hyun-Ock, 2009, Immune Netw, V9, P12, DOI 10.4110/in.2009.9.1.12; Pereira LD, 2012, J ETHNOPHARMACOL, V139, P642, DOI 10.1016/j.jep.2011.12.012; Pomin VH, 2012, BBA-GEN SUBJECTS, V1820, P1971, DOI 10.1016/j.bbagen.2012.08.022; Pomin VH, 2008, GLYCOBIOLOGY, V18, P1016, DOI 10.1093/glycob/cwn085; Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650; Quindere ALG, 2013, PHARMACOL REP, V65, P600, DOI 10.1016/S1734-1140(13)71037-5; Ribeiro NA, 2014, INFLAMM RES, V63, P569, DOI 10.1007/s00011-014-0728-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Silva RO, 2012, MAR DRUGS, V10, P2618, DOI 10.3390/md10122618; Siqueira RCL, 2011, PHARM BIOL, V49, P167, DOI 10.3109/13880209.2010.505605; Souza BWS, 2012, FOOD HYDROCOLLOID, V27, P287, DOI 10.1016/j.foodhyd.2011.10.005; Thorlacius H, 1997, AM J PHYSIOL-HEART C, V272, pH1725, DOI 10.1152/ajpheart.1997.272.4.H1725; VINEGAR R, 1969, J PHARMACOL EXP THER, V166, P96; WILHELM DL, 1962, PHARMACOL REV, V14, P251; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544	45	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119319	10.1371/journal.pone.0119319	http://dx.doi.org/10.1371/journal.pone.0119319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807556	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000026
J	Domingo, L; Barroso-Barcenilla, F; Cambra-Moo, O				Domingo, Laura; Barroso-Barcenilla, Fernando; Cambra-Moo, Oscar			Seasonality and Paleoecology of the Late Cretaceous Multi-Taxa Vertebrate Assemblage of "Lo Hueco" (Central Eastern Spain)	PLOS ONE			English	Article							OXYGEN-ISOTOPE FRACTIONATION; DINOSAUR BODY TEMPERATURES; SOUTH-CENTRAL PYRENEES; CARBON-ISOTOPE; BIOGENIC PHOSPHATE; THERMAL MAXIMUM; STABLE-ISOTOPES; CLIMATE-CHANGE; RECORD; WATER	Isotopic studies of multi-taxa terrestrial vertebrate assemblages allow determination of paleoclimatic and paleoecological aspects on account of the different information supplied by each taxon. The late Campanian-early Maastrichtian "Lo Hueco" Fossil-Lagersatte (central eastern Spain), located at a subtropical paleolatitude of similar to 31 degrees N, constitutes an ideal setting to carry out this task due to its abundant and diverse vertebrate assemblage. Local delta O-18(PO4) values estimated from delta O-18(PO4) values of theropods, sauropods, crocodyliforms, and turtles are close to delta O-18(H2O) values observed at modern subtropical latitudes. Theropod delta O-18(H2O) values are lower than those shown by crocodyliforms and turtles, indicating that terrestrial endothermic taxa record delta O-18(H2O) values throughout the year, whereas semiaquatic ectothermic taxa delta O-18(H2O) values represent local meteoric waters over a shorter time period when conditions are favorable for bioapatite synthesis (warm season). Temperatures calculated by combining theropod, crocodyliform, and turtle delta O-18(H2O) values and gar delta O-18(PO4) have enabled us to estimate seasonal variability as the difference between mean annual temperature (MAT, yielded by theropods) and temperature of the warmest months (TWMs, provided by crocodyliforms and turtles). Delta TWMs-MAT value does not point to a significantly different seasonal thermal variability when compared to modern coastal subtropical meteorological stations and Late Cretaceous rudists from eastern Tethys. Bioapatite and bulk organic matter delta C-13 values point to a C-3 environment in the "Lo Hueco" area. The estimated fractionation between sauropod enamel and diet is similar to 15 parts per thousand. While waiting for paleoecological information yielded by the ongoing morphological study of the "Lo Hueco" crocodyliforms, delta C-13 and delta O-18(CO3) results point to incorporation of food items with brackish influence, but preferential ingestion of freshwater. "Lo Hueco" turtles showed the lowest delta C-13 and delta O-18(CO3) values of the vertebrate assemblage, likely indicating a diet based on a mixture of aquatic and terrestrial C-3 vegetation and/or invertebrates and ingestion of freshwater.	[Domingo, Laura] Inst Geociencias IGEO CSIC UCM, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain; [Domingo, Laura; Barroso-Barcenilla, Fernando] Univ Complutense Madrid, Dept Paleontol, Madrid, Spain; [Domingo, Laura] Univ Calif Santa Cruz, Earth & Planetary Sci Dept, Santa Cruz, CA 95064 USA; [Barroso-Barcenilla, Fernando] Univ Alcala de Henares, Dept Geol & Geog, Grp Invest IberCreta, E-28871 Alcala De Henares, Spain; [Cambra-Moo, Oscar] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, Lab Poblaciones Pasado, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); Complutense University of Madrid; University of California System; University of California Santa Cruz; Universidad de Alcala; Autonomous University of Madrid	Domingo, L (corresponding author), Inst Geociencias IGEO CSIC UCM, Dept Geol Sedimentaria & Cambio Medioambiental, Madrid, Spain.	laudomingo@gmail.com	Barroso-Barcenilla, Fernando/M-5578-2014; Cambra-Moo, Oscar/L-2378-2013; Domingo, Laura/J-6549-2012	Barroso-Barcenilla, Fernando/0000-0002-7938-7230; Cambra-Moo, Oscar/0000-0001-7730-3294; Domingo, Laura/0000-0002-9062-0881	Spanish Ministry of Economy and Competitivity [CGL2009-09000, CGL2009-10766, CGL2011-25894, CGL2012-35199]; University of California Santa Cruz; PICATA program (UCM-UPM Moncloa Campus of International Excellence, Spain); Juan de la Cierva program (Spanish Ministry of Economy and Competitivity)	Spanish Ministry of Economy and Competitivity(Spanish Government); University of California Santa Cruz(University of California System); PICATA program (UCM-UPM Moncloa Campus of International Excellence, Spain); Juan de la Cierva program (Spanish Ministry of Economy and Competitivity)	This study was supported by research projects CGL2009-09000 and CGL2009-10766 (Spanish Ministry of Economy and Competitivity). LD acknowledges postdoctoral fellowships of the University of California Santa Cruz, PICATA program (UCM-UPM Moncloa Campus of International Excellence, Spain), and Juan de la Cierva program (Spanish Ministry of Economy and Competitivity). Part of this research was carried out within projects CGL2011-25894 and CGL2012-35199 (Spanish Ministry of Economy and Competitivity). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot R, 2004, EARTH PLANET SC LETT, V226, P255, DOI 10.1016/j.epsl.2004.07.015; Amiot R, 2007, PALAEOGEOGR PALAEOCL, V243, P412, DOI 10.1016/j.palaeo.2006.08.013; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; Amiot R, 2011, P NATL ACAD SCI USA, V108, P5179, DOI 10.1073/pnas.1011369108; Amiot R, 2010, GEOLOGY, V38, P139, DOI 10.1130/G30402.1; Angst D, 2014, NATURWISSENSCHAFTEN, V101, P313, DOI 10.1007/s00114-014-1158-2; Barrick RE, 1999, PALAIOS, V14, P186, DOI 10.2307/3515374; Barrick RE, 1996, PALAIOS, V11, P295, DOI 10.2307/3515240; Barroso-Barcenilla F, 2009, CRETACEOUS RES, V30, P1268, DOI 10.1016/j.cretres.2009.07.010; Bassett D, 2007, PALAIOS, V22, P98, DOI 10.2110/palo.2005.p05-089r; Biasatti DM, 2004, PALAEOGEOGR PALAEOCL, V206, P203, DOI 10.1016/j.palaeo.2004.01.004; Bryant JD, 1996, GEOCHIM COSMOCHIM AC, V60, P5145; Bush ABG, 1997, PALEOCEANOGRAPHY, V12, P495, DOI 10.1029/97PA00721; Calvo Jorge O., 1994, Gaia, V10, P183; Cambra-Moo O, 2013, LETHAIA, V46, P127, DOI 10.1111/j.1502-3931.2012.00331.x; Cambra-Moo O, 2012, GEOBIOS-LYON, V45, P157, DOI 10.1016/j.geobios.2011.04.002; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Clarke A, 2013, AM NAT, V182, P283, DOI 10.1086/671259; Clementz MT, 2009, GEOL J, V44, P605, DOI 10.1002/gj.1173; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; Coulson AB, 2008, PALAEOGEOGR PALAEOCL, V264, P78, DOI 10.1016/j.palaeo.2008.04.008; Coulson AB, 2011, NAT GEOSCI, V4, P852, DOI [10.1038/NGEO1312, 10.1038/ngeo1312]; DeConto R. M., 2000, WARM CLIMATES EARTH, P275, DOI DOI 10.1017/CBO9780511564512.010; DeConto RM, 1999, GEOLOGICAL SOC AM SP, V332, P391, DOI DOI 10.1130/0-8137-2332-9.391; Diez Diaz V, 2013, J VERTEBR PALEONTOL, P116; Domingo L, 2013, PALAIOS, V28, P195, DOI 10.2110/palo.2012.p12-097r; Domingo L, 2009, EARTH PLANET SC LETT, V281, P226, DOI 10.1016/j.epsl.2009.02.025; Domingo L, 2009, PALAEOGEOGR PALAEOCL, V274, P204, DOI 10.1016/j.palaeo.2009.02.004; Domingo L, 2009, PALAEOGEOGR PALAEOCL, V272, P53, DOI 10.1016/j.palaeo.2008.11.006; Domingo MS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2138; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Forster A, 2007, GEOLOGY, V35, P919, DOI 10.1130/G23874A.1; Fox-Dobbs K, 2008, PALAEOGEOGR PALAEOCL, V261, P30, DOI 10.1016/j.palaeo.2007.12.011; Frakes L. A, 1992, CLIMATE MODES PHANER; Fricke HC, 1998, EARTH PLANET SC LETT, V160, P193, DOI 10.1016/S0012-821X(98)00088-0; Fricke HC, 2000, GEOLOGY, V28, P799, DOI 10.1130/0091-7613(2000)028<0799:MTMLAT>2.3.CO;2; Fricke HC, 2008, PALEOBIOLOGY, V34, P534, DOI 10.1666/08020.1; Fricke HC, 2008, PALAEOGEOGR PALAEOCL, V266, P13, DOI 10.1016/j.palaeo.2008.03.030; Fricke HC, 2009, PALEOBIOLOGY, V35, P270, DOI 10.1666/08025.1; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; Friedrich O, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001654; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Golovneva LB, 2000, GEOL SOC SPEC PUBL, V181, P43, DOI 10.1144/GSL.SP.2000.181.01.05; Gonzalez-Acebron L, 2014, FACIES, V60, P755, DOI 10.1007/s10347-014-0402-8; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Grimes ST, 2003, GEOCHIM COSMOCHIM AC, V67, P4033, DOI 10.1016/S0016-7037(03)00173-X; Gutierrez G, 1979, CUADERNOS GEOLOGIA I, V5, P127; Hay WW, 1999, GEOL S AM S, P1; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Huber BT, 2002, GEOLOGY, V30, P123, DOI 10.1130/0091-7613(2002)030<0123:DSPROE>2.0.CO;2; HUBER BT, 1995, GEOL SOC AM BULL, V107, P1164, DOI 10.1130/0016-7606(1995)107<1164:MLCCOT>2.3.CO;2; Hummel Juergen, 2011, P11; Hunter S.J., 2008, CLIM PAST DISCUSS, V4, P981, DOI DOI 10.5194/CPD-4-981-2008; Iacumin P, 1996, EARTH PLANET SC LETT, V142, P1, DOI 10.1016/0012-821X(96)00093-3; Jackson K, 1996, BIOL J LINN SOC, V58, P371; JENKYNS HC, 1994, GEOL MAG, V131, P1, DOI 10.1017/S0016756800010451; Jenkyns HC, 2004, NATURE, V432, P888, DOI 10.1038/nature03143; Johnson BJ, 1998, GEOCHIM COSMOCHIM AC, V62, P2451, DOI 10.1016/S0016-7037(98)00175-6; Knoll F, 2013, J VERTEBR PALEONTOL, P155; Knoll F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054991; Koch PL, 2007, ECOL METHOD CONCEPT, P99, DOI 10.1002/9780470691854.ch5; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; KOLODNY Y, 1983, EARTH PLANET SC LETT, V64, P398, DOI 10.1016/0012-821X(83)90100-0; Lecuyer C, 2003, PALAEOGEOGR PALAEOCL, V193, P457, DOI 10.1016/S0031-0182(03)00261-X; Lecuyer C, 2013, CHEM GEOL, V347, P217, DOI 10.1016/j.chemgeo.2013.03.008; MacLeod KG, 2005, GEOLOGY, V33, P437, DOI 10.1130/G21466.1; MARINO BD, 1991, NATURE, V349, P127, DOI 10.1038/349127a0; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; Markwick PJ, 1998, SEPM SPECIAL PUBLICA, V58, P17; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; Narvaez I., 2013, 6 JORN INT PAL DIN E, P96; Nordt L., 2003, GSA TODAY, V13, P4, DOI DOI 10.1130/1052-5173(2003)0132.0.CO;2; O'Connor MP, 1999, PALEOBIOLOGY, V25, P341, DOI 10.1017/S0094837300021321; Ortega Francisco, 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P119; PARRISH JT, 1988, GEOLOGY, V16, P22, DOI 10.1130/0091-7613(1988)016<0022:LCTVAN>2.3.CO;2; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Perez-Garcia Adan, 2013, P251; Perez-Garcia A, 2012, GEOBIOS-LYON, V45, P219, DOI 10.1016/j.geobios.2011.03.001; Peyrot D, 2013, PALAEOGEOGR PALAEOCL, V387, P27, DOI 10.1016/j.palaeo.2013.07.005; Pontzer H, 2009, PLOS ONE, V4, pA127, DOI 10.1371/journal.pone.0007783; Pough FH, 2002, VERTEBRATE LIFE; Poulsen CJ, 2003, GEOLOGY, V31, P115, DOI 10.1130/0091-7613(2003)031<0115:DTROTA>2.0.CO;2; Puceat E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000823; Puceat E, 2010, EARTH PLANET SC LETT, V298, P135, DOI 10.1016/j.epsl.2010.07.034; Puceat E, 2007, GEOLOGY, V35, P107, DOI 10.1130/G23103A.1; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; ROZANSKI K, 1993, CLIMATE CHANGE CONTI; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; SLOAN LC, 1990, GEOLOGY, V18, P489, DOI 10.1130/0091-7613(1990)018<0489:ECDEH>2.3.CO;2; Steuber T, 2005, NATURE, V437, P1341, DOI 10.1038/nature04096; Steuber T, 1999, INT J EARTH SCI, V88, P551, DOI 10.1007/s005310050284; Straight WH, 2004, PALAEOGEOGR PALAEOCL, V206, P239, DOI 10.1016/j.palaeo.2004.01.006; Suarez CA, 2012, PALAEOGEOGR PALAEOCL, V313, P78, DOI 10.1016/j.palaeo.2011.10.011; Thomas KJS, 2004, PALAEOGEOGR PALAEOCL, V206, P257, DOI 10.1016/j.palaeo.2004.01.007; Tutken T, 2006, PALAEOGEOGR PALAEOCL, V241, P457, DOI 10.1016/j.palaeo.2006.04.007; Tutken T, 2004, PALAEOGEOGR PALAEOCL, V206, P217, DOI 10.1016/j.palaeo.2004.01.005; Tutken T., 2011, BIOL SAUROPOD DINOSA, P57; Vennemann TW, 2001, GEOCHIM COSMOCHIM AC, V65, P1583, DOI 10.1016/S0016-7037(00)00629-3; WEAVER JC, 1983, PALEOBIOLOGY, V9, P173, DOI 10.1017/S0094837300007557; Wheatley PV, 2012, MAR ECOL PROG SER, V447, P211, DOI 10.3354/meps09503; Yeakel JD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0239; Yeakel JD, 2012, J R SOC INTERFACE, V9, P3219, DOI 10.1098/rsif.2012.0481	109	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119968	10.1371/journal.pone.0119968	http://dx.doi.org/10.1371/journal.pone.0119968			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806819	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000351880000052
J	Rerkasem, K; Rattanatanyong, P; Rerkasem, A; Wongthanee, A; Rungruengthanakit, K; Mangklabruks, A; Mutirangura, A				Rerkasem, Kittipan; Rattanatanyong, Prakasit; Rerkasem, Amaraporn; Wongthanee, Antika; Rungruengthanakit, Kittipong; Mangklabruks, Ampica; Mutirangura, Apiwat			Higher Alu Methylation Levels in Catch-Up Growth in Twenty-Year-Old Offsprings	PLOS ONE			English	Article							GLOBAL DNA METHYLATION; CORONARY-HEART-DISEASE; BLOOD-CELL DNA; LINE-1 METHYLATION; PERIPHERAL-BLOOD; HIGH-RISK; CANCER; HYPOMETHYLATION; HYPERMETHYLATION; ASSOCIATION	Alu elements and long interspersed element-1 (LINE-1 or L1) are two major human intersperse repetitive sequences. Lower Alu methylation, but not LINE-1, has been observed in blood cells of people in old age, and in menopausal women having lower bone mass and osteoporosis. Nevertheless, Alu methylation levels also vary among young individuals. Here, we explored phenotypes at birth that are associated with Alu methylation levels in young people. In 2010, 249 twenty-years-old volunteers whose mothers had participated in a study association between birth weight (BW) and nutrition during pregnancy in 1990, were invited to take part in our present study. In this study, the LINE-1 and Alu methylation levels and patterns were measured in peripheral mononuclear cells and correlated with various nutritional parameters during intrauterine and postnatal period of offspring. This included the amount of maternal intake during pregnancy, the mother's weight gain during pregnancy, birth weight, birth length, and the rate of weight gain in the first year of life. Catch-up growth (CUG) was defined when weight during the first year was >0.67 of the standard score, according to WHO data. No association with LINE-1 methylation was identified. The mean level of Alu methylation in the CUG group was significantly higher than those non-CUG (39.61% and 33.66 % respectively, P < 0.0001). The positive correlation between the history of CUG in the first year and higher Alu methylation indicates the role of Alu methylation, not only in aging cells, but also in the human growth process. Moreover, here is the first study that demonstrated the association between a phenotype during the newborn period and intersperse repetitive sequences methylation during young adulthood.	[Rerkasem, Kittipan; Rerkasem, Amaraporn] Chiang Mai Univ, Fac Med, Dept Surg, Chiang Mai 50000, Thailand; [Rerkasem, Kittipan; Wongthanee, Antika; Rungruengthanakit, Kittipong; Mangklabruks, Ampica] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Rattanatanyong, Prakasit; Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Dept Anat, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok 10330, Thailand; [Mangklabruks, Ampica] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50000, Thailand	Chiang Mai University; Chiang Mai University; Chulalongkorn University; Chiang Mai University	Rerkasem, K (corresponding author), Chiang Mai Univ, Fac Med, Dept Surg, Chiang Mai 50000, Thailand.	rerkase@gmail.com			Thailand Research Fund [MRG 5280229]; National Research University Project under Thailand's office of The Commission of Higher Education; Endocrine Unit of Maharaj Nakorn Chiang Mai Hospital; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; National Science and Technology Development Agency (NSTDA), Thailand	Thailand Research Fund(Thailand Research Fund (TRF)); National Research University Project under Thailand's office of The Commission of Higher Education; Endocrine Unit of Maharaj Nakorn Chiang Mai Hospital; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; National Science and Technology Development Agency (NSTDA), Thailand	This work was supported by joint funding from the Thailand Research Fund (MRG 5280229) and the National Research University Project under Thailand's office of The Commission of Higher Education. This research was also funded by the Endocrine Unit of Maharaj Nakorn Chiang Mai Hospital and the Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. The methylation analysis was funded by Research Chair Grant 2011 from the National Science and Technology Development Agency (NSTDA), Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Bansal N, 2008, J HYPERTENS, V26, P412, DOI 10.1097/HJH.0b013e3282f3168e; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Chiowanich Pien, 2012, Journal of the Medical Association of Thailand, V95, P358; Dulloo AG, 2009, DIABETES, V58, P1037, DOI 10.2337/db09-0290; Dunger DB, 2007, P NUTR SOC, V66, P451, DOI 10.1017/S0029665107005721; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Fabris S, 2011, EPIGENETICS-US, V6, P188, DOI 10.4161/epi.6.2.13528; Guenard F, 2013, J OBES, V2013, DOI 10.1155/2013/492170; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Hyland PL, 2013, MELANOMA RES, V23, P55, DOI 10.1097/CMR.0b013e32835adc51; Intarasunanont P, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-31; Jintaridth P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070386; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Kile ML, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-47; Kile ML, 2012, ENVIRON HEALTH PERSP, V120, P1061, DOI 10.1289/ehp.1104173; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kitkumthorn N, 2012, CLIN CHIM ACTA, V413, P869, DOI 10.1016/j.cca.2012.01.024; Koletzko B, 2013, NESTLE NUTR WORKS SE, V71, P11, DOI 10.1159/000342533; Kongruttanachok N, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-70; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; Nakkuntod J, 2011, CLIN CHIM ACTA, V412, P1457, DOI 10.1016/j.cca.2011.04.002; Nielsen SS, 2012, J PARKINSON DIS, V2, P303, DOI 10.3233/JPD-012129; Nobili Valerio, 2008, Pediatr Endocrinol Rev, V6, P241; Nutrition Division Department of Health, 1992, NUTR VAL THAI FOOD; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Peluso M, 2012, INT J EPIDEMIOL, V41, P1753, DOI 10.1093/ije/dys129; Perng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062587; Phillips DIW, 2011, WORLD J DIABETES, V2, P211, DOI 10.4239/wjd.v2.i12.211; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Pobsook T, 2011, CLIN CHIM ACTA, V412, P314, DOI 10.1016/j.cca.2010.10.030; Rerkasem K, 2012, ASIA PAC J CLIN NUTR, V21, P247; Sirivanichsuntorn P, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-10; Toschke AM, 2004, ARCH PEDIAT ADOL MED, V158, P449, DOI 10.1001/archpedi.158.5.449; Walters RJ, 2013, EPIGENETICS-US, V8, P748, DOI 10.4161/epi.25178; Wangsri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045292; Wanichnopparat W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-205; Wongpaiboonwattana W, 2013, ASIAN PAC J CANCER P, V14, P3773, DOI 10.7314/APJCP.2013.14.6.3773; Wu HC, 2012, CARCINOGENESIS, V33, P1946, DOI 10.1093/carcin/bgs201; Wu HC, 2011, EPIGENETICS-US, V6, P29, DOI 10.4161/epi.6.1.13393; Zhao JY, 2012, DIABETES, V61, P542, DOI 10.2337/db11-1048	45	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120032	10.1371/journal.pone.0120032	http://dx.doi.org/10.1371/journal.pone.0120032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807557	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000058
J	Richards, VP; Lefebure, T; Bitar, PDP; Dogan, B; Simpson, KW; Schukken, YH; Stanhope, MJ				Richards, Vincent P.; Lefebure, Tristan; Bitar, Paulina D. Pavinski; Dogan, Belgin; Simpson, Kenneth W.; Schukken, Ynte H.; Stanhope, Michael J.			Genome Based Phylogeny and Comparative Genomic Analysis of Intra-Mammary Pathogenic Escherichia coli	PLOS ONE			English	Article							BOVINE MASTITIS; VIRULENCE FACTORS; SECRETION SYSTEM; SPECIES TREES; J5 BACTERIN; DAIRY-COWS; GENE TREES; EFFICACY; STRAINS; DNA	Escherichia coli is an important cause of bovine mastitis and can cause both severe inflammation with a short-term transient infection, as well as less severe, but more chronic inflammation and infection persistence. E. coli is a highly diverse organism that has been classified into a number of different pathotypes or pathovars, and mammary pathogenic E. coli (MPEC) has been proposed as a new such pathotype. The purpose of this study was to use genome sequence data derived from both transient and persistent MPEC isolates (two isolates of each phenotype) to construct a genome-based phylogeny that places MPEC in its phylogenetic context with other E. coli pathovars. A subsidiary goal was to conduct comparative genomic analyses of these MPEC isolates with other E. coli pathovars to provide a preliminary perspective on loci that might be correlated with the MPEC phenotype. Both concatenated and consensus tree phylogenies did not support MPEC monophyly or the monophyly of either transient or persistent phenotypes. Three of the MPEC isolates (ECA-727, ECC-Z, and ECA-O157) originated from within the predominately commensal clade of E. coli, referred to as phylogroup A. The fourth MPEC isolate, of the persistent phenotype (ECC-1470), was sister group to an isolate of ETEC, falling within the E. coli B1 clade. This suggests that the MPEC phenotype has arisen on numerous independent occasions and that this has often, although not invariably, occurred from commensal ancestry. Examination of the genes present in the MPEC strains relative to the commensal strains identified a consistent presence of the type VI secretion system (T6SS) in the MPEC strains, with only occasional representation in commensal strains, suggesting that T6SS may be associated with MPEC pathogenesis and/or as an inter-bacterial competitive attribute and therefore could represent a useful target to explore for the development of MPEC specific inhibitors.	[Richards, Vincent P.; Lefebure, Tristan; Bitar, Paulina D. Pavinski; Schukken, Ynte H.; Stanhope, Michael J.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Dogan, Belgin; Simpson, Kenneth W.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stanhope, MJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	mjs297@cornell.edu	Richards, Vince/AAO-4261-2020; Richards, Vincent/AAV-1816-2021; Lefebure, Tristan/A-6489-2009; Schukken, Ynte H/C-3405-2008; Schukken, Ynte/ABD-3352-2021	Lefebure, Tristan/0000-0003-3923-8166; Schukken, Ynte H/0000-0002-8250-4194; Schukken, Ynte/0000-0002-8250-4194; Richards, Vincent/0000-0002-9309-6595	New York State Foundation for Science, Technology and Innovation [C040124]	New York State Foundation for Science, Technology and Innovation	This work was financially supported by The New York State Foundation for Science, Technology and Innovation (grant C040124) http://esd.ny.gov/nystar/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RA, 2011, VET RES COMMUN, V35, P89, DOI 10.1007/s11259-010-9455-5; Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; Bluthgen Nils, 2005, Genome Inform, V16, P106; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2009, SYST BIOL, V58, P35, DOI 10.1093/sysbio/syp008; DESJARDINS P, 1995, J MOL EVOL, V41, P440, DOI 10.1007/BF00160315; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dogan B, 2012, VET MICROBIOL, V159, P163, DOI 10.1016/j.vetmic.2012.03.033; Dopfer D, 2000, VET MICROBIOL, V74, P331, DOI 10.1016/S0378-1135(00)00191-7; Dopfer D, 1999, J DAIRY SCI, V82, P80, DOI 10.3168/jds.S0022-0302(99)75211-2; Ewing GB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-118; Ghanbarpour R, 2010, RES VET SCI, V88, P6, DOI 10.1016/j.rvsc.2009.06.003; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Hogan JS, 2005, J DAIRY SCI, V88, P534, DOI 10.3168/jds.S0022-0302(05)72715-6; Hogan JS, 1999, J DAIRY SCI, V82, P939, DOI 10.3168/jds.S0022-0302(99)75312-9; Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577; Katholm J, 2010, MAST RES PRACT P 5 I; Ke YC, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00106; Keefe GP, 1997, CAN VET J, V38, P429; Liu YX, 2014, RES MICROBIOL, V165, P273, DOI 10.1016/j.resmic.2014.03.007; LOHUIS JACM, 1990, J DAIRY SCI, V73, P333, DOI 10.3168/jds.S0022-0302(90)78678-X; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Shpigel NY, 2008, CURR OPIN MICROBIOL, V11, P60, DOI 10.1016/j.mib.2008.01.004; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Suojala L, 2011, VET MICROBIOL, V147, P383, DOI 10.1016/j.vetmic.2010.07.011; Van Dongen S, 2000, THESIS U UTRECHT NET; Wilson DJ, 2007, CLIN VACCINE IMMUNOL, V14, P693, DOI 10.1128/CVI.00104-07; Wilson DJ, 1999, J DAIRY SCI, V82, P1664, DOI 10.3168/jds.S0022-0302(99)75395-6; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	44	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119799	10.1371/journal.pone.0119799	http://dx.doi.org/10.1371/journal.pone.0119799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807497	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000041
J	Robertson, DJ; Kramer, RSS; Burton, AM				Robertson, David J.; Kramer, Robin S. S.; Burton, A. Mike			Face Averages Enhance User Recognition for Smartphone Security	PLOS ONE			English	Article							PHOTOGRAPHS; FAMILIARITY; PERFORMANCE	Our recognition of familiar faces is excellent, and generalises across viewing conditions. However, unfamiliar face recognition is much poorer. For this reason, automatic face recognition systems might benefit from incorporating the advantages of familiarity. Here we put this to the test using the face verification system available on a popular smartphone ( the Samsung Galaxy). In two experiments we tested the recognition performance of the smartphone when it was encoded with an individual's 'face-average' - a representation derived from theories of human face perception. This technique significantly improved performance for both unconstrained celebrity images ( Experiment 1) and for real faces ( Experiment 2): users could unlock their phones more reliably when the device stored an average of the user's face than when they stored a single image. This advantage was consistent across a wide variety of everyday viewing conditions. Furthermore, the benefit did not reduce the rejection of imposter faces. This benefit is brought about solely by consideration of suitable representations for automatic face recognition, and we argue that this is just as important as development of matching algorithms themselves. We propose that this representation could significantly improve recognition rates in everyday settings.	[Robertson, David J.; Kramer, Robin S. S.; Burton, A. Mike] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland; [Robertson, David J.; Kramer, Robin S. S.; Burton, A. Mike] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of Aberdeen; University of York - UK	Robertson, DJ (corresponding author), Univ Aberdeen, Sch Psychol, Aberdeen, Scotland.	david.robertson@york.ac.uk	Burton, Mike/A-9491-2008; Robertson, David/H-6515-2017	Burton, Mike/0000-0002-2035-2084; Kramer, Robin/0000-0001-8339-8832; Robertson, David/0000-0002-8393-951X	Economic and Social Research Council, UK; European Research Council [ES/J022950/1, ERC-ADG 323262]; Economic and Social Research Council [ES/J022950/1, ES/J022950/2] Funding Source: researchfish; ESRC [ES/J022950/1, ES/J022950/2] Funding Source: UKRI	Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council(European Research Council (ERC)European Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by awards from the Economic and Social Research Council, UK, and the European Research Council to Burton (ES/J022950/1; ERC-ADG 323262). http://www.esrc.ac.uk/; http://erc.europa.eu/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini Y, 1997, IEEE T PATTERN ANAL, V19, P721, DOI 10.1109/34.598229; Aviv A.J., 2010, P 4 USENIX C OFF TEC; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; BRUCE V, 1986, PERCEPTION, V15, P387, DOI 10.1068/p150387; Burton AM, 2013, Q J EXP PSYCHOL, V66, P1467, DOI 10.1080/17470218.2013.800125; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Burton AM, 2005, COGNITIVE PSYCHOL, V51, P256, DOI 10.1016/j.cogpsych.2005.06.003; Calder A., 2011, OXFORD HDB FACE PERC; Glisson WB, 2011, INT J INF SECUR, V10, P337, DOI 10.1007/s10207-011-0144-3; Jenkins R, 2008, SCIENCE, V319, P435, DOI 10.1126/science.1149656; Jenkins R, 2011, COGNITION, V121, P313, DOI 10.1016/j.cognition.2011.08.001; Jenkins R, 2011, PHILOS T R SOC B, V366, P1671, DOI 10.1098/rstb.2010.0379; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; KLATZKY RL, 1984, MEM COGNITION, V12, P60, DOI 10.3758/BF03196998; Longmore CA, 2008, J EXP PSYCHOL HUMAN, V34, P77, DOI 10.1037/0096-1523.34.1.77; Megreya AM, 2007, PERCEPT PSYCHOPHYS, V69, P1175, DOI 10.3758/BF03193954; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Megreya AM, 2008, J EXP PSYCHOL-APPL, V14, P364, DOI 10.1037/a0013464; O'Toole AJ, 2012, ACM T APPL PERCEPT, V9, DOI 10.1145/2355598.2355599; Phillips PJ, 2014, IMAGE VISION COMPUT, V32, P74, DOI 10.1016/j.imavis.2013.12.002; Phillips PJ, 2010, IEEE T PATTERN ANAL, V32, P831, DOI 10.1109/TPAMI.2009.59; Taigman Y, 2014, PROC CVPR IEEE, P1701, DOI 10.1109/CVPR.2014.220; Tari F, 2006, P 2 S USABLE PRIVACY, P56, DOI DOI 10.1145/1143120.1143128; Young AW, 2011, BRIT J PSYCHOL, V102, P959, DOI 10.1111/j.2044-8295.2011.02045.x; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342	25	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119460	10.1371/journal.pone.0119460	http://dx.doi.org/10.1371/journal.pone.0119460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25807251	Green Published, gold, Green Accepted			2022-12-26	WOS:000351880000031
J	Chen, ZG; Tong, YQ; Li, Y; Gao, QP; Wang, QY; Fu, CH; Xia, ZN				Chen, Zhanguo; Tong, Yongqing; Li, Yan; Gao, Qingping; Wang, Qiongyu; Fu, Chaohong; Xia, Zunen			Development and Validation of a 3-Plex RT-qPCR Assay for the Simultaneous Detection and Quantitation of the Three PML-RARa Fusion Transcripts in Acute Promyelocytic Leukemia	PLOS ONE			English	Article							MINIMAL-RESIDUAL-DISEASE; POLYMERASE-CHAIN-REACTION; TRANS-RETINOIC ACID; REAL-TIME PCR; ARSENIC TRIOXIDE; T(15-17) TRANSLOCATION; GENE TRANSCRIPTS; MESSENGER-RNA; ALPHA; BREAKPOINT	Rapid diagnosis of acute promyelocytic leukemia (APL) with promyelocytic leukemia-retinoic acid receptor alpha (PML-RARa) contributes to a highly effective therapy with all-trans retinoic acid (ATRA). Real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) is a valuable tool to diagnose APL with PML-RARa. However, a single RT-qPCR analysis, which is laborious and costly, has to be performed in three reactions to determine whether one of the three PML-RARa transcripts is present and to quantify the involved transcript. This paper describes a novel TaqMan MGB probe-based 3-plex RT-qPCR assay in a single reaction to detect simultaneously the three PML-RARa transcripts. Specific primers and probe were designed, and the results were further normalized to the Abelson gene. The detection results for the serially diluted plasmid indicate that the analytical sensitivity was 10 copies per reaction for PML-RARa bcr1, bcr2, and bcr3. A relatively high sensitivity of 10(-4) was achieved with this assay when analyzing the bcr1 transcripts obtained from the NB4 cell line. The reproducibility was satisfactory because the coefficients of variation of cycle threshold values were less than 3% for both inter-and intra-assays. After testing 319 newly diagnosed patients with leukemia (including 61 APL cases), the results of the 3-plex RT-qPCR assay completely agreed with the traditional methods used for the detection of PML-RARa. The quantitative results of the 3-plex RT-qPCR were highly correlated with the single RT-qPCR and showed similar assay sensitivity for 60 PML-RARa positive APL samples at diagnosis and 199 samples from 57 patients during follow-up. Interestingly, one PML-RARa bcr2 case at diagnosis with breakpoint at 1579, which was not detected by the single RT-q-PCR, was detected by the 3-plex RT-qPCR assay. The 3-plex RT-qPCR assay is a specific, sensitive, stable, and cost-effective method that can be used for the rapid diagnosis and treatment monitoring of APL with PML-RARa.	[Chen, Zhanguo; Tong, Yongqing; Li, Yan; Fu, Chaohong; Xia, Zunen] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan 430072, Hubei, Peoples R China; [Gao, Qingping; Wang, Qiongyu] Wuhan Univ, Renmin Hosp, Dept Hematol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Li, Y (corresponding author), Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan 430072, Hubei, Peoples R China.	yanlitf1120@163.com			National Natural Science Foundation of China [81000771]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grants 81000771). YQT is the Grant Recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cassinat B, 2000, LEUKEMIA, V14, P324, DOI 10.1038/sj.leu.2401652; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Choppa PC, 2003, AM J CLIN PATHOL, V119, P137, DOI 10.1092/0M99TW738UDCGYW1; Chui L, 2010, J MOL DIAGN, V12, P469, DOI 10.2353/jmoldx.2010.090221; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Esteve J, 2007, LEUKEMIA, V21, P446, DOI 10.1038/sj.leu.2404501; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; GALLAGHER RE, 1995, BLOOD, V86, P1540, DOI 10.1182/blood.V86.4.1540.bloodjournal8641540; Gallagher RE, 2003, BLOOD, V101, P2521, DOI 10.1182/blood-2002-05-1357; Grimwade D, 2014, BEST PRACT RES CL HA, V27, P53, DOI 10.1016/j.beha.2014.04.002; Grimwade D, 2009, J CLIN ONCOL, V27, P3650, DOI 10.1200/JCO.2008.20.1533; Gu B W, 2001, Hematol J, V2, P330, DOI 10.1038/sj.thj.6200128; Hasan SK, 2010, GENE CHROMOSOME CANC, V49, P726, DOI 10.1002/gcc.20783; Ismail S, 2007, ACTA HAEMATOL-BASEL, V118, P183, DOI 10.1159/000109471; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Lanotte M, 1991, BLOOD; Lo-Coco E, 2007, CURR TOP MICROBIOL, V313, P145; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lou YJ, 2013, LEUKEMIA RES, V37, P37, DOI 10.1016/j.leukres.2012.09.004; Pallisgaard N, 1998, BLOOD, V92, P574, DOI 10.1182/blood.V92.2.574; PANDOLFI PP, 1992, EMBO J, V11, P1397, DOI 10.1002/j.1460-2075.1992.tb05185.x; Ravandi F, 2009, J CLIN ONCOL, V27, P504, DOI 10.1200/JCO.2008.18.6130; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Schnittger S, 2003, BLOOD, V102, P2746, DOI 10.1182/blood-2003-03-0880; Stein E, 2009, BEST PRACT RES CL HA, V22, P153, DOI 10.1016/j.beha.2008.12.007; Takenokuchi M, 2009, J CLIN LAB ANAL, V23, P223, DOI 10.1002/jcla.20306; Tallman MS, 2009, BLOOD, V114, P5126, DOI 10.1182/blood-2009-07-216457; Tallman MS, 1997, NEW ENGL J MED, V337, P1021, DOI 10.1056/NEJM199710093371501; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262	34	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122530	10.1371/journal.pone.0122530	http://dx.doi.org/10.1371/journal.pone.0122530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815789	gold, Green Submitted, Green Published			2022-12-26	WOS:000352133600185
J	Dong, HN; Liu, YF; Zu, X; Li, N; Li, FR; Zhang, DW				Dong, Huina; Liu, Yongfei; Zu, Xin; Li, Ning; Li, Feiran; Zhang, Dawei			An Enzymatic Assay for High-Throughput Screening of Cytidine-Producing Microbial Strains	PLOS ONE			English	Article							BACILLUS-SUBTILIS; GLUTAMATE-DEHYDROGENASE; AMMONIA; INDOPHENOL; BERTHELOT; DEAMINASE; SYNTHETASE; MUTANTS; SERUM	Cytidine is an industrially useful precursor for the production of antiviral compounds and a variety of industrial compounds. Interest in the microbial production of cytidine has grown recently and high-throughput screening of cytidine over-producers is an important approach in large-scale industrial production using microorganisms. An enzymatic assay for cytidine was developed combining cytidine deaminase (CDA) and indophenol method. CDA catalyzes the cleavage of cytidine to uridine and NH3, the latter of which can be accurately determined using the indophenol method. The assay was performed in 96-well plates and had a linear detection range of cytidine of 0.058 - 10 mM. This assay was used to determine the amount of cytidine in fermentation flasks and the results were compared with that of High Perfomance Liquid Chromatography (HPLC) method. The detection range of the CDA method is not as wide as that of the HPLC, furthermore the correlation factor of CDA method is not as high as that of HPLC. However, it was suitable for the detection of large numbers of crude samples and was applied to high-throughput screening for high cytidine-producing strains using 96-well deep-hole culture plates. This assay was proved to be simple, accurate, specific and suitable for cytidine detection and high-throughput screening of cytidine-producing strains in large numbers of samples (96 well or more).	[Dong, Huina; Liu, Yongfei; Zu, Xin; Li, Ning; Li, Feiran; Zhang, Dawei] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China; [Dong, Huina; Liu, Yongfei; Zhang, Dawei] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Zhang, Dawei] Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China; [Zu, Xin] Dalian Polytech Univ, Sch Biol Engn, Light Ind Technol & Engn, Dalian 116034, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Dalian Polytechnic University	Zhang, DW (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.	zhang_dw@tib.cas.cn	Li, Feiran/GNP-2168-2022	Li, Feiran/0000-0001-9155-5260	State Key Development Program for Basic Research of China (973 Program) [2013CB733600]; National Nature Science Foundation of China [31200036, 31370089]	State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from State Key Development Program for Basic Research of China (973 Program, 2013CB733600), National Nature Science Foundation of China (31200036, 31370089).	Asahi S, 1996, BIOSCI BIOTECH BIOCH, V60, P353, DOI 10.1271/bbb.60.353; ASAHI S, 1995, BIOSCI BIOTECH BIOCH, V59, P915, DOI 10.1271/bbb.59.915; ASAHI S, 1994, BIOSCI BIOTECH BIOCH, V58, P1399, DOI 10.1271/bbb.58.1399; Baumgartner M, 2002, ACTA VET HUNG, V50, P263, DOI 10.1556/AVet.50.2002.3.2; BOLLETER WT, 1961, ANAL CHEM, V33, P592, DOI 10.1021/ac60172a034; Carlow DC, 1999, BIOCHEMISTRY-US, V38, P12258, DOI 10.1021/bi990819t; CARTER CW, 1995, BIOCHIMIE, V77, P92, DOI 10.1016/0300-9084(96)88110-7; DAFONSECAWOLLHEIM F, 1992, EUR J CLIN CHEM CLIN, V30, P537; DIAZ J, 1995, CLIN CHEM, V41, P1048; DIENST SG, 1961, J LAB CLIN MED, V58, P149; Fang HT, 2013, BIOTECHNOL LETT, V35, P245, DOI 10.1007/s10529-012-1068-3; HALL A, 1993, APPL GEOCHEM, V8, P101, DOI 10.1016/0883-2927(93)90059-P; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; IOSEFSOHN M, 1985, CLIN CHEM, V31, P2012; Johansson E, 2004, BIOCHEMISTRY-US, V43, P6020, DOI 10.1021/bi035893x; Kameya M, 2014, ANAL BIOCHEM, V447, P33, DOI 10.1016/j.ab.2013.11.002; Kashyap Rajpal S, 2006, Cerebrospinal Fluid Res, V3, P5, DOI 10.1186/1743-8454-3-5; KILLEEN GF, 1993, ANAL BIOCHEM, V215, P284, DOI 10.1006/abio.1993.1588; Lee YB, 2011, J MICROBIOL, V49, P53, DOI 10.1007/s12275-011-0195-1; Liu YF, 2014, ENZYME MICROB TECH, V67, P1, DOI 10.1016/j.enzmictec.2014.08.008; MROZ EA, 1982, KIDNEY INT, V21, P524, DOI 10.1038/ki.1982.56; NGO TT, 1982, ANAL CHEM, V54, P46, DOI 10.1021/ac00238a015; PARK JM, 1994, KOREAN J MICROBIOL, V32, P545; POTVIN BW, 1975, J BACTERIOL, V123, P604, DOI 10.1128/JB.123.2.604-615.1975; Rao Z, 2013, FINE CHEM INTERMEDIA, V43, P29; Richards D A, 1987, Biomed Chromatogr, V2, P148, DOI 10.1002/bmc.1130020404; ROLAND KL, 1985, J BACTERIOL, V163, P991, DOI 10.1128/JB.163.3.991-999.1985; SEARLE PL, 1984, ANALYST, V109, P549, DOI 10.1039/an9840900549; TALKE H, 1965, KLIN WOCHENSCHR, V43, P174, DOI 10.1007/BF01484513; TANGANELLI E, 1982, CLIN CHEM, V28, P1461; TAYLOR S, 1974, ANAL BIOCHEM, V60, P153, DOI 10.1016/0003-2697(74)90140-7; Thomas DH, 2002, J CHROMATOGR A, V956, P181, DOI 10.1016/S0021-9673(02)00141-3; THOMPSON PW, 1986, ANN RHEUM DIS, V45, P9, DOI 10.1136/ard.45.1.9; Uezer A, 2008, ANAL CHIM ACTA, V612, P53, DOI 10.1016/j.aca.2008.02.015; WAKISAKA S, 1987, ANAL BIOCHEM, V163, P117, DOI 10.1016/0003-2697(87)90101-1; Yamaguchi F, 2005, CLIN CHIM ACTA, V352, P165, DOI 10.1016/j.cccn.2004.09.011	36	6	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121612	10.1371/journal.pone.0121612	http://dx.doi.org/10.1371/journal.pone.0121612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816248	Green Submitted, gold, Green Published			2022-12-26	WOS:000352133600109
J	Harris, JL; Balci, Y				Harris, Jordan Lee; Balci, Yilmaz			Population Structure of the Bacterial Pathogen Xylella fastidiosa among Street Trees in Washington DC	PLOS ONE			English	Article							LEAF SCORCH DISEASE; CITRUS VARIEGATED CHLOROSIS; PIERCES-DISEASE; UNITED-STATES; INTERSUBSPECIFIC RECOMBINATION; GENETIC DIVERSITY; CLONAL DIVERSITY; GENOME SEQUENCES; STRAINS; SYCAMORE	Bacterial leaf scorch, associated with the bacterial pathogen Xylella fastidiosa, is a widely established and problematic disease of landscape ornamentals in Washington D.C. A multilocus sequence typing analysis was performed using 10 housekeeping loci for X. fastidiosa strains in order to better understand the epidemiology of leaf scorch disease in this municipal environment. Samples were collected from 7 different tree species located throughout the District of Columbia, consisting of 101 samples of symptomatic and asymptomatic foliage from 84 different trees. Five strains of the bacteria were identified. Consistent with prior data, these strains were host specific, with only one strain associated with members of the red oak family, one strain associated with American elm, one strain associated with American sycamore, and two strains associated with mulberry. Strains found for asymptomatic foliage were the same as strains from the symptomatic foliage on individual trees. Cross transmission of the strains was not observed at sites with multiple species of infected trees within an approx. 25 m radius of one another. X. fastidiosa strain specificity observed for each genus of tree suggests a highly specialized host-pathogen relationship.	[Harris, Jordan Lee; Balci, Yilmaz] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Balci, Y (corresponding author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	ybalci@umd.edu			District Department of Transportation, Urban Forestry Administration (DDOT UFA) [11DG11420004355]	District Department of Transportation, Urban Forestry Administration (DDOT UFA)	Financial support for this research was provided by the District Department of Transportation, Urban Forestry Administration (DDOT UFA) through funds provided by the USDA Forest Service, Northeastern Area Cooperative Forest Health Program (11DG11420004355) (http://www.na.fs.fed.us). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2008, APPL ENVIRON MICROB, V74, P3690, DOI 10.1128/AEM.02388-07; Almeida RPP, 2003, APPL ENVIRON MICROB, V69, P7447, DOI 10.1128/AEM.69.12.7447-7452.2003; BLAKE JH, 1993, PLANT DIS, V77, P1262, DOI 10.1094/PD-77-1262B; Brody JR, 2004, BIOTECHNIQUES, V36, P214, DOI 10.2144/04362BM02; Castle SJ, 2005, PEST MANAG SCI, V61, P75, DOI 10.1002/ps.949; CHANG CJ, 1993, CURR MICROBIOL, V27, P137, DOI 10.1007/BF01576010; Chen J, 2005, PHYTOPATHOLOGY, V95, P708, DOI 10.1094/PHYTO-95-0708; Chen J, 2010, J BACTERIOL, V192, P4534, DOI 10.1128/JB.00651-10; DAVIS MJ, 1978, SCIENCE, V199, P75, DOI 10.1126/science.199.4324.75; DeStefano Darren A., 2007, Arboriculture & Urban Forestry, V33, P246; Harris JL, 2014, PLANT DIS, V98, P1611, DOI 10.1094/PDIS-02-14-0158-SR; HARTMAN JR, 1991, PLANT DIS, V75, P862, DOI 10.1094/PD-75-0862D; HAYGOOD RA, 1988, PHYTOPATHOLOGY, V78, P628; HAYGOOD RA, 1988, PLANT DIS, V72, P644, DOI 10.1094/PD-72-0644C; HEARON SS, 1980, CAN J BOT, V58, P1986, DOI 10.1139/b80-228; Hernandez-Martinez R, 2007, PHYTOPATHOLOGY, V97, P857, DOI 10.1094/PHYTO-97-7-0857; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kishi LT, 2008, REV BRAS FRUTIC, V30, P202, DOI 10.1590/S0100-29452008000100037; Kostka S. J., 1985, Journal of Arboriculture, V11, P54; KOSTKA SJ, 1986, PLANT DIS, V70, P690, DOI 10.1094/PD-70-690; Lashomb J, 2002, BACTERIAL LEAF SCORC, P1; McElrone Andrew J., 1999, Journal of Arboriculture, V25, P258; Nunney L, 2013, XYLELLA FASTIDIOSA S; Nunney L, 2014, APPL ENVIRON MICROB, V80, P3025, DOI 10.1128/AEM.04112-13; Nunney L, 2013, APPL ENVIRON MICROB, V79, P2189, DOI 10.1128/AEM.03208-12; Nunney L, 2012, APPL ENVIRON MICROB, V78, P4702, DOI 10.1128/AEM.01126-12; Pierce B, 2011, J PLANT PATHOL MICRO, V2, P111; Purcell AH, 1999, PHYTOPATHOLOGY, V89, P53, DOI 10.1094/PHYTO.1999.89.1.53; Randall JJ, 2009, APPL ENVIRON MICROB, V75, P5631, DOI 10.1128/AEM.00609-09; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Schaad NW, 2004, SYST APPL MICROBIOL, V27, P290, DOI 10.1078/0723-2020-00263; Schreiber HL, 2010, SOUTHWEST ENTOMOL, V35, P479, DOI 10.3958/059.035.0336; Schuenzel EL, 2005, APPL ENVIRON MICROB, V71, P3832, DOI 10.1128/AEM.71.7.3832-3839.2005; Sherald J. L., 1994, Journal of Arboriculture, V20, P18; Sherald James L., 2007, Arboriculture & Urban Forestry, V33, P376; SHERALD JL, 1987, PLANT DIS, V71, P930, DOI 10.1094/PD-71-0930; SHERALD JL, 1993, PLANT DIS, V77, P190, DOI 10.1094/PD-77-0190; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Tubajika KM, 2007, CROP PROT, V26, P92, DOI 10.1016/j.cropro.2006.04.006; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; WELLS JM, 1987, INT J SYST BACTERIOL, V37, P136, DOI 10.1099/00207713-37-2-136; WELLS JM, 1983, PHYTOPATHOLOGY, V73, P859, DOI 10.1094/Phyto-73-859; WESTER HORACE V., 1959, PLANT DIS REPORTER, V43, P519; Wickert E, 2007, PHYTOPATHOLOGY, V97, P1543, DOI 10.1094/PHYTO-97-12-1543; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601	46	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121297	10.1371/journal.pone.0121297	http://dx.doi.org/10.1371/journal.pone.0121297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815838	Green Published, gold			2022-12-26	WOS:000352133600082
J	Szaz, D; Horvath, G; Barta, A; Robertson, BA; Farkas, A; Egri, A; Tarjanyi, N; Racz, G; Kriska, G				Szaz, Denes; Horvath, Gabor; Barta, Andras; Robertson, Bruce A.; Farkas, Alexandra; Egri, Adam; Tarjanyi, Nikolett; Racz, Gergely; Kriska, Gyorgy			Lamp-Lit Bridges as Dual Light-Traps for the Night-Swarming Mayfly, Ephoron virgo: Interaction of Polarized and Unpolarized Light Pollution	PLOS ONE			English	Article							AQUATIC INSECTS; ARTIFICIAL-LIGHT; 1791 EPHEMEROPTERA; ECOLOGICAL TRAPS; WATER DETECTION; RIVER; POLYMITARCYIDAE; CONSEQUENCES; POLAROTAXIS; ATTRACTION	Ecological photopollution created by artificial night lighting can alter animal behavior and lead to population declines and biodiversity loss. Polarized light pollution is a second type of photopollution that triggers water-seeking insects to ovisposit on smooth and dark man-made objects, because they simulate the polarization signatures of natural water bodies. We document a case study of the interaction of these two forms of photopollution by conducting observations and experiments near a lamp-lit bridge over the river Danube that attracts mass swarms of the mayfly Ephoron virgo away from the river to oviposit on the asphalt road of the bridge. Millions of mayflies swarmed near bridge-lights for two weeks. We found these swarms to be composed of 99% adult females performing their upstream compensatory flight and were attracted upward toward unpolarized bridge-lamp light, and away from the horizontally polarized light trail of the river. Imaging polarimetry confirmed that the asphalt surface of the bridge was strongly and horizontally polarized, providing a supernormal ovipositional cue to Ephoron virgo, while other parts of the bridge were poor polarizers of lamplight. Collectively, we confirm that Ephoron virgo is independently attracted to both unpolarized and polarized light sources, that both types of photopollution are being produced at the bridge, and that spatial patterns of swarming and oviposition are consistent with evolved behaviors being triggered maladaptively by these two types of light pollution. We suggest solutions to bridge and lighting design that should prevent or mitigate the impacts of such scenarios in the future. The detrimental impacts of such scenarios may extend beyond Ephoron virgo.	[Szaz, Denes; Horvath, Gabor; Barta, Andras; Farkas, Alexandra; Egri, Adam; Racz, Gergely] Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary; [Robertson, Bruce A.] Bard Coll, Div Sci Math & Comp, Annandale on Hudson, NY 12504 USA; [Farkas, Alexandra; Egri, Adam; Tarjanyi, Nikolett; Kriska, Gyorgy] Hungarian Acad Sci, Danube Res Inst, Ctr Ecol Res, Budapest, Hungary; [Kriska, Gyorgy] Eotvos Lorand Univ, Inst Biol, Grp Methodol Biol Teaching, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand University	Horvath, G (corresponding author), Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary.	gh@arago.elte.hu	Kriska, György/B-5723-2019	Kriska, Gyorgy/0000-0003-4271-3167	Lendulet Project from the Hungarian Academy of Sciences; Center for Innovation and Grant Affairs, Eotvos University, Budapest	Lendulet Project from the Hungarian Academy of Sciences; Center for Innovation and Grant Affairs, Eotvos University, Budapest	Gabor Horvath thanks the German Alexander von Humboldt Foundation for an equipment donation. The financial support from the Lendulet Project received by Andras Baldi (supervisor of Gyorgy Kriska) from the Hungarian Academy of Sciences is also acknowledged. The authors thank also the organisational and financial support obtained from Gyorgyi Antoni (director, Center for Innovation and Grant Affairs, Eotvos University, Budapest), Miklos Tamas and Csaba Meszaros (EvoGreen Ltd., member of the EvoPro Group, Budapest). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bij de Vaate A, 1992, HYDROBIOL B, V25, P237; Boda P, 2014, NATURWISSENSCHAFTEN, V101, P385, DOI 10.1007/s00114-014-1166-2; BOWDEN J, 1982, B ENTOMOL RES, V72, P535, DOI 10.1017/S0007485300008579; BOWDEN J, 1981, B ENTOMOL RES, V71, P621, DOI 10.1017/S0007485300010142; Cid N, 2008, AQUAT INSECT, V30, P163, DOI 10.1080/01650420802010356; Csabai Z, 2006, FRESHWATER BIOL, V51, P1341, DOI 10.1111/j.1365-2427.2006.01576.x; Davies TW, 2013, GLOBAL CHANGE BIOL, V19, P1417, DOI 10.1111/gcb.12166; Davies TW, 2012, BIOL LETTERS, V8, P764, DOI 10.1098/rsbl.2012.0216; Egri A, 2012, NATURWISSENSCHAFTEN, V99, P407, DOI 10.1007/s00114-012-0916-2; Eisenbeis Gerhard, 2006, P281; Eisenbeis Gerhard, 2001, Schriftenreihe fuer Landschaftspflege und Naturschutz, V67, P75; ELLIOTT JM, 1967, ARCH HYDROBIOL, V63, P204; Fletcher RJ, 2012, P ROY SOC B-BIOL SCI, V279, P2546, DOI 10.1098/rspb.2012.0139; FRANK K D, 1988, Journal of the Lepidopterists' Society, V42, P63; Gal J, 2001, REMOTE SENS ENVIRON, V76, P103, DOI 10.1016/S0034-4257(00)00196-6; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; HORRIDGE GA, 1982, PROC R SOC SER B-BIO, V216, P25, DOI 10.1098/rspb.1982.0059; Horvath G., 2008, Aquatic insects: challenges to populations, P204, DOI 10.1079/9781845933968.0204; Horvath G, 1997, J EXP BIOL, V200, P1155; Horvath G., 2004, POLARIZED LIGHT ANIM; Horvath G, 2014, SPRINGER SERRIES VIS, V2; Horvath G, 2010, SERIES ENV REMEDIATI; Horvath G, 2009, FRONT ECOL ENVIRON, V7, P317, DOI 10.1890/080129; Ibanez C., 1991, P483; Kazanci Nilgun, 2013, Review of Hydrobiology, V6, P69; Kokko H, 2001, EVOL ECOL RES, V3, P537; Kriska G, 1998, J EXP BIOL, V201, P2273; Kriska G, 2008, NATURWISSENSCHAFTEN, V95, P461, DOI 10.1007/s00114-008-0345-4; Kriska G, 2009, J INSECT PHYSIOL, V55, P1167, DOI 10.1016/j.jinsphys.2009.08.013; Kriska G, 2007, NATURWISSENSCHAFTEN, V94, P148, DOI 10.1007/s00114-006-0180-4; Kriska G, 2006, VISION RES, V46, P4382, DOI 10.1016/j.visres.2006.08.020; Kriska G, 2006, P ROY SOC B-BIOL SCI, V273, P1667, DOI 10.1098/rspb.2006.3500; Kureck A., 1996, Archiv fuer Hydrobiologie Supplement, V113, P319; Kureck A., 1992, Natur und Landschaft, V67, P407; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; MADSEN BL, 1973, LIMNOL OCEANOGR, V18, P678, DOI 10.4319/lo.1973.18.4.0678; MADSEN BL, 1977, ARCH HYDROBIOL, V81, P119; Malnas K, 2011, J INSECT CONSERV, V15, P823, DOI 10.1007/s10841-011-9380-0; Menzel R., 1979, HDB SENSORY PHYSL, V7 / 6 / 6, P503, DOI DOI 10.1007/978-3-642-66999-6_9; Metcalfe NB, 1997, J ANIM ECOL, V66, P866, DOI 10.2307/6002; Moore Marianne V., 2006, P365; Perkin EK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00241.1; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Robertson BA, 2012, AVIAN CONSERV ECOL, V7, DOI 10.5751/ACE-00533-070202; ROOS TAGE, 1957, REPT INST FRESHWATER RES DROTTNINGHOLM, V38, P167; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schoenemund E, 1930, TIERWELT DEUTSCHLAND, V19, P1; SCHWIND R, 1995, J COMP PHYSIOL A, V177, P439; SCHWIND R, 1991, J COMP PHYSIOL A, V169, P531; SUZUKI S, 1985, COMPUT VISION GRAPH, V30, P32, DOI 10.1016/0734-189X(85)90016-7; TEAGUE MR, 1980, J OPT SOC AM, V70, P920, DOI 10.1364/JOSA.70.000920; Tobias Wolfgang, 1996, Natur und Museum (Frankfurt am Main), V126, P37; van Langevelde F, 2011, BIOL CONSERV, V144, P2274, DOI 10.1016/j.biocon.2011.06.004; Young S, 1996, FRESHWATER BIOL, V36, P17, DOI 10.1046/j.1365-2427.1996.00055.x	56	39	41	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121194	10.1371/journal.pone.0121194	http://dx.doi.org/10.1371/journal.pone.0121194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815748	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600073
J	Won, S; Sayeed, I; Peterson, BL; Wali, B; Kahn, JS; Stein, DG				Won, Soonmi; Sayeed, Iqbal; Peterson, Bethany L.; Wali, Bushra; Kahn, Jared S.; Stein, Donald G.			Vitamin D Prevents Hypoxia/Reoxygenation-Induced Blood-Brain Barrier Disruption via Vitamin D Receptor-Mediated NF-kB Signaling Pathways	PLOS ONE			English	Article							MICROVESSEL ENDOTHELIAL-CELLS; FACTOR-KAPPA-B; PYRIDOXAL 5'-PHOSPHATE; EXPERIMENTAL STROKE; ISCHEMIC-STROKE; MOUSE-BRAIN; HYPOXIA; PERMEABILITY; EXPRESSION; INJURY	Maintaining blood-brain barrier integrity and minimizing neuronal injury are critical components of any therapeutic intervention following ischemic stroke. However, a low level of vitamin D hormone is a risk factor for many vascular diseases including stroke. The neuroprotective effects of 1,25(OH)2D3 (vitamin D) after ischemic stroke have been studied, but it is not known whether it prevents ischemic injury to brain endothelial cells, a key component of the neurovascular unit. We analyzed the effect of 1,25(OH)(2)D-3 on brain endothelial cell barrier integrity and tight junction proteins after hypoxia/reoxygenation in a mouse brain endothelial cell culture model that closely mimics many of the features of the blood-brain barrier in vitro. Following hypoxic injury in bEnd. 3 cells, 1,25(OH)(2)D-3 treatment prevented the decrease in barrier function as measured by transendothelial electrical resistance and permeability of FITC-dextran (40 kDa), the decrease in the expression of the tight junction proteins zonula occludin-1, claudin-5, and occludin, the activation of NF-kB, and the increase in matrix metalloproteinase-9 expression. These responses were blocked when the interaction of 1,25(OH))(2)D-3 with the vitamin D receptor (VDR) was inhibited by pyridoxal 5'-phosphate treatment. Our findings show a direct, VDR-mediated, protective effect of 1,25(OH))(2)D-3 against ischemic injury-induced blood-brain barrier dysfunction in cerebral endothelial cells.	[Won, Soonmi; Sayeed, Iqbal; Peterson, Bethany L.; Wali, Bushra; Kahn, Jared S.; Stein, Donald G.] Emory Univ, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA	Emory University	Sayeed, I (corresponding author), Emory Univ, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA.	isayeed@emory.edu	Stein, Donald/AAJ-5139-2020		American Heart Association SDG grant [11SDG5430002]; National Health Institute [R01HD061971]; Marcus Foundation of Atlanta; BHR Pharma; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061971] Funding Source: NIH RePORTER	American Heart Association SDG grant(American Heart Association); National Health Institute; Marcus Foundation of Atlanta; BHR Pharma; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by American Heart Association SDG grant 11SDG5430002 to IS and National Health Institute R01HD061971 to DGS. Partial funding for some of the assays used in this project was provided by the Marcus Foundation of Atlanta and BHR Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ahmad A, 2012, MICROVASC RES, V84, P222, DOI 10.1016/j.mvr.2012.05.008; Balden R, 2012, ENDOCRINOLOGY, V153, P2420, DOI 10.1210/en.2011-1783; Beer TM, 2003, J CLIN ONCOL, V21, P123, DOI 10.1200/jco.2003.05.117; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Eelen G, 2004, J BONE MINER RES, V19, P133, DOI 10.1359/JBMR.0301204; Engelhardt S, 2014, BRIT J PHARMACOL, V171, P1210, DOI 10.1111/bph.12489; Fatma N, 2008, BRAIN RES, V1233, P63, DOI 10.1016/j.brainres.2008.07.076; Fatma N, 2009, J BIOL CHEM, V284, P22758, DOI 10.1074/jbc.M109.016071; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hwang IK, 2007, EXP NEUROL, V206, P114, DOI 10.1016/j.expneurol.2007.04.005; Itoh Y, 2006, CLIN HEMORHEOL MICRO, V34, P163; Janjetovic Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005988; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Kandzari DE, 2005, EXPERT OPIN INV DRUG, V14, P1435, DOI 10.1517/13543784.14.11.1435; Kastrup A, 2008, STROKE, V39, P2385, DOI 10.1161/STROKEAHA.107.505420; KOONG AC, 1994, CANCER RES, V54, P1425; Kuckleburg CJ, 2008, THROMB HAEMOSTASIS, V99, P363, DOI 10.1160/TH07-07-0474; Kuhlmann CRW, 2009, NEUROSCI LETT, V449, P168, DOI 10.1016/j.neulet.2008.10.096; Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; Naik P, 2012, J PHARM SCI-US, V101, P1337, DOI 10.1002/jps.23022; Nakagawa K, 2005, CARCINOGENESIS, V26, P1044, DOI 10.1093/carcin/bgi049; Navaratna D, 2009, CELL ADHES MIGR, V3, P216, DOI 10.4161/cam.3.2.8396; Nicolazzo JA, 2006, J PHARM PHARMACOL, V58, P281, DOI 10.1211/jpp.58.3.0001; PATEL SR, 1995, J CLIN INVEST, V96, P50, DOI 10.1172/JCI118061; Peterlik M, 2009, EUR J CLIN NUTR, V63, P1377, DOI 10.1038/ejcn.2009.105; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sen CK, 1996, FASEB J, V10, P709; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Takata F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055166; Tse AKW, 2010, MOL IMMUNOL, V47, P1728, DOI 10.1016/j.molimm.2010.03.004; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Wang LF, 2014, MOL NEUROBIOL; Watson PMD, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-59; Won S, 2014, J CEREBR BLOOD F MET, V34, P72, DOI 10.1038/jcbfm.2013.163; Yang MZ, 2007, NEUROL RES, V29, P749, DOI 10.1179/016164107X208103; Yuan W, 2010, ANN BIOMED ENG, V38, P1463, DOI 10.1007/s10439-010-9920-x; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	54	77	81	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122821	10.1371/journal.pone.0122821	http://dx.doi.org/10.1371/journal.pone.0122821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815722	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600201
J	Hapuarachchi, HC; Chua, RCR; Shi, Y; Thein, TL; Lee, LK; Lee, KS; Lye, DC; Ng, LC; Leo, YS				Hapuarachchi, Hapuarachchige Chanditha; Chua, Rachel Choon Rong; Shi, Yuan; Thein, Tun Lin; Lee, Linda Kay; Lee, Kim Sung; Lye, David Chien; Ng, Lee Ching; Leo, Yee Sin			Clinical Outcome and Genetic Differences within a Monophyletic Dengue Virus Type 2 Population	PLOS ONE			English	Article							T-CELL RESPONSES; NONSTRUCTURAL PROTEIN NS2A; ORIGINAL ANTIGENIC SIN; ENVELOPE PROTEIN; DOMAIN-III; CYCLIZATION SEQUENCES; ANTIBODY-RESPONSES; HEMORRHAGIC-FEVER; CRYSTAL-STRUCTURE; GLYCOPROTEIN NS1	The exact mechanisms of interplay between host and viral factors leading to severe dengue are yet to be fully understood. Even though previous studies have implicated specific genetic differences of Dengue virus (DENV) in clinical severity and virus attenuation, similar studies with large-scale, whole genome screening of monophyletic virus populations are limited. Therefore, in the present study, we compared 89 whole genomes of DENV-2 cosmopolitan clade III isolates obtained from patients diagnosed with dengue fever (DF, n = 58), dengue hemorrhagic fever (DHF, n = 30) and dengue shock syndrome (DSS, n = 1) in Singapore between July 2010 and January 2013, in order to determine the correlation of observed viral genetic differences with clinical outcomes. Our findings showed no significant difference between the number of primary and secondary infections that progressed to DHF and DSS (p>0.05) in our study cohort. Despite being highly homogenous, study isolates possessed 39 amino acid substitutions of which 10 substitutions were fixed in three main groups of virus isolates. None of those substitutions were specifically associated with DHF and DSS. Notably, two evolutionarily unique virus groups possessing C-P43T+NS1-S103T+NS2A-V83I+NS3-R337K+NS3-I600T+NS5-P136S and NS2A-T119N mutations were exclusively found in patients with DF, the benign form of DENV infections. Those mutants were significantly associated with mild disease outcome. These observations indicated that disease progression into DHF and DSS within our patient population was more likely to be due to host than virus factors. We hypothesize that selection for potentially less virulent groups of DENV-2 in our study cohort may be an evolutionary adaptation of viral strains to extend their survival in the human-mosquito transmission cycle.	[Hapuarachchi, Hapuarachchige Chanditha; Chua, Rachel Choon Rong; Shi, Yuan; Ng, Lee Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore 138667, Singapore; [Thein, Tun Lin; Lee, Linda Kay; Lye, David Chien; Leo, Yee Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore 308433, Singapore; [Lee, Kim Sung] Ngee Ann Polytech, Sch Life Sci & Chem Technol, Singapore 599489, Singapore	Tan Tock Seng Hospital	Ng, LC (corresponding author), Natl Environm Agcy, Environm Hlth Inst, 11 Biopolis Way,06-05-08, Singapore 138667, Singapore.	ng_lee_ching@nea.gov.sg	Lye, David/ABF-4402-2021	Hapuarachchi, Hapuarachchige Chanditha/0000-0001-7079-8538; Lye, David/0000-0003-0324-0205	Singapore National Research Foundation under the STOP TCR Flagship Program [NMRC/TCR/005]	Singapore National Research Foundation under the STOP TCR Flagship Program	The study was funded by the Singapore National Research Foundation under the STOP TCR Flagship Program (NMRC/TCR/005) administered by the National Medical Research Council (NMRC), Ministry of Health, Singapore. The funding sources of this study had no role in the study design, data collection, data analysis, data interpretation, writing of the report, or in the decision to submit the paper for publication.	Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; Amin N, 2009, MALAYS J MED SCI, V16, P4; AnandaRao R, 2005, VIRUS RES, V112, P60, DOI 10.1016/j.virusres.2005.03.022; Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; Audsley M, 2011, VIROLOGY, V414, P63, DOI 10.1016/j.virol.2011.03.008; Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bernardo L, 2005, CLIN DIAGN LAB IMMUN, V12, P361, DOI 10.1128/CDLI.12.2.361-362.2005; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Cedillo-Barron L, 2014, MICROBES INFECT, V16, P711, DOI 10.1016/j.micinf.2014.07.011; CHAMBERS TJ, 1989, VIROLOGY, V169, P100, DOI 10.1016/0042-6822(89)90045-7; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chan AHY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033451; Chen HL, 2008, AM J TROP MED HYG, V79, P495, DOI 10.4269/ajtmh.2008.79.495; Chen Y, 2010, VIROLOGY, V398, P290, DOI 10.1016/j.virol.2009.12.010; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; de Borba L, 2015, J VIROL; Hernandez SID, 2014, J CLIN VIROL, V60, P196, DOI 10.1016/j.jcv.2014.04.002; Descloux E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000493; Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; FALCONAR AKI, 1994, ARCH VIROL, V137, P315, DOI 10.1007/BF01309478; Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646; Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10; Gagnon SJ, 1996, J VIROL, V70, P141, DOI 10.1128/JVI.70.1.141-147.1996; Gan VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090037; Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; GUZMAN MG, 1995, AM J TROP MED HYG, V52, P241, DOI 10.4269/ajtmh.1995.52.241; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Han HK, 2012, EPIDEMIOLOGICAL NEWS; Health Mo, 2012, WEEKL INF DIS B, P1; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; Huang JH, 1999, J MED VIROL, V57, P1, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;1::AID-JMV1&gt;3.0.CO;2-T; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Koo C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-275; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; Leo YS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-498; Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08; LIN B, 1994, VIROLOGY, V202, P885, DOI 10.1006/viro.1994.1410; Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006; LIVINGSTON PG, 1994, J VIROL, V68, P3283, DOI 10.1128/JVI.68.5.3283-3288.1994; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307; Malavige GN, 2013, J CLIN VIROL, V58, P605, DOI 10.1016/j.jcv.2013.10.023; Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608; Mathew A, 1996, J CLIN INVEST, V98, P1684, DOI 10.1172/JCI118964; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; MORENS DM, 1987, J MED VIROL, V22, P169, DOI 10.1002/jmv.1890220208; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pandey BD, 2000, MICROBIOL IMMUNOL, V44, P179, DOI 10.1111/j.1348-0421.2000.tb02480.x; Parameswaran P, 2012, J VIROL, V86, P8546, DOI 10.1128/JVI.00736-12; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; RCoreTeam, 2013, R A LANGUAGE AND ENV; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; Rossi SL, 2007, VIROLOGY, V364, P184, DOI 10.1016/j.virol.2007.02.009; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; Tajima S, 2007, J GEN VIROL, V88, P2214, DOI 10.1099/vir.0.82661-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tay MY, 2014, J BIOL CHEM; Thai KTD, 2012, J VIROL, V86, P835, DOI 10.1128/JVI.05985-11; Tuiskunen A, 2011, ARCH VIROL, V156, P2023, DOI 10.1007/s00705-011-1100-2; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004; Whitehead SS, 2003, VACCINE, V21, P4307, DOI 10.1016/S0264-410X(03)00488-2; Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022; WHO, 2009, DENGUE GUIDELINES FO; WHO, 1997, DENG HAEM FEV DIAGN; Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06; Zhu W, 2007, VIRUS RES, V126, P226, DOI 10.1016/j.virusres.2007.03.004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	117	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121696	10.1371/journal.pone.0121696	http://dx.doi.org/10.1371/journal.pone.0121696			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811657	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700129
J	Karunakaran, C; Christensen, CR; Gaillard, C; Lahlali, R; Blair, LM; Perumal, V; Miller, SS; Hitchcock, AP				Karunakaran, Chithra; Christensen, Colleen R.; Gaillard, Cedric; Lahlali, Rachid; Blair, Lisa M.; Perumal, Vijayan; Miller, Shea S.; Hitchcock, Adam P.			Introduction of Soft X-Ray Spectromicroscopy as an Advanced Technique for Plant Biopolymers Research	PLOS ONE			English	Article							CELL-WALL POLYSACCHARIDES; INFRARED-SPECTROSCOPY; QUANTITATIVE-ANALYSIS; DIFFUSE-REFLECTANCE; XANES SPECTROSCOPY; WHEAT ENDOSPERM; MICROSCOPY; WOOD; POLYMERS; MICROSPECTROSCOPY	Soft X-ray absorption spectroscopy coupled with nano-scale microscopy has been widely used in material science, environmental science, and physical sciences. In this work, the advantages of soft X-ray absorption spectromicroscopy for plant biopolymer research were demonstrated by determining the chemical sensitivity of the technique to identify common plant biopolymers and to map the distributions of biopolymers in plant samples. The chemical sensitivity of soft X-ray spectroscopy to study biopolymers was determined by recording the spectra of common plant biopolymers using soft X-ray and Fourier Transform mid Infrared (FT-IR) spectroscopy techniques. The soft X-ray spectra of lignin, cellulose, and polygalacturonic acid have distinct spectral features. However, there were no distinct differences between cellulose and hemicellulose spectra. Mid infrared spectra of all biopolymers were unique and there were differences between the spectra of water soluble and insoluble xylans. The advantage of nano-scale spatial resolution exploited using soft X-ray spectromicroscopy for plant biopolymer research was demonstrated by mapping plant cell wall biopolymers in a lentil stem section and compared with the FT-IR spectromicroscopy data from the same sample. The soft X-ray spectromicroscopy enables mapping of biopolymers at the sub-cellular (similar to 30 nm) resolution whereas, the limited spatial resolution in the micron scale range in the FT-IR spectromicroscopy made it difficult to identify the localized distribution of biopolymers. The advantages and limitations of soft X-ray and FT-IR spectromicroscopy techniques for biopolymer research are also discussed.	[Karunakaran, Chithra; Lahlali, Rachid; Blair, Lisa M.; Perumal, Vijayan] Canadian Light Source Inc, Saskatoon, SK, Canada; [Christensen, Colleen R.] Natl Res Council Canada, Ind Res Assistance Program, Saskatoon, SK, Canada; [Gaillard, Cedric] INRA Biopolymers, Interact, Assemblies Unit BIA, Nantes, France; [Blair, Lisa M.] Canadian Food Inspect Agcy, Saskatoon, SK, Canada; [Miller, Shea S.] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Hitchcock, Adam P.] McMaster Univ, Brockhouse Inst Mat Res, Hamilton, ON, Canada	University of Saskatchewan; National Research Council Canada; INRAE; Canadian Food Inspection Agency; Agriculture & Agri Food Canada; McMaster University	Karunakaran, C (corresponding author), Canadian Light Source Inc, 44 Innovation Blvd, Saskatoon, SK, Canada.	Chithra.Karunakaran@lightsource.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council Canada (NRC); Canadian Institutes of Health Research (CIHR); University of Saskatchewan; Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy [DE-AC03-76SF00098]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada (NRC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy(United States Department of Energy (DOE))	The research described in this paper was performed at the Canadian Light Source Inc., and the Advanced Light Source. The Canadian Light Source Inc. is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), National Research Council Canada (NRC), Canadian Institutes of Health Research (CIHR), and the University of Saskatchewan. The Advanced Light Source is supported by the Director, Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy, under Contract No. DE-AC03-76SF00098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade H, 1997, J ELECTRON SPECTROSC, V84, P53, DOI 10.1016/S0368-2048(97)00013-3; ADE H, 1992, SCIENCE, V258, P972, DOI 10.1126/science.1439809; Ade H., 2002, CHEM APPL SYNCHROTRO, P285; Ade H, 2008, POLYMER, V49, P643, DOI 10.1016/j.polymer.2007.10.030; Agarwal UP, 2006, PLANTA, V224, P1141, DOI 10.1007/s00425-006-0295-z; Aspinall GO, 1970, POLYSACCHARIDES, P104; Beetz T, 2003, J SYNCHROTRON RADIAT, V10, P280, DOI 10.1107/S0909049503003261; BELTON PS, 1987, ANALYST, V112, P1117, DOI 10.1039/an9871201117; Boese J, 1997, J ELECTRON SPECTROSC, V85, P9, DOI 10.1016/S0368-2048(97)00032-7; Boyce CK, 2004, P NATL ACAD SCI USA, V101, P17555, DOI 10.1073/pnas.0408024101; Boyce CK, 2003, INT J PLANT SCI, V164, P691, DOI 10.1086/377113; Boyce CK, 2002, GEOLOGY, V30, P1039; Brandes J., 2009, BIOPHYSICOCHEMICAL P, P729, DOI DOI 10.1002/9780470494950.CH17; Buckley CJ, 1997, J PHYS IV, V7, P83, DOI 10.1051/jp4/1997011; Budevska BO, 2002, HDB VIBRATIONAL SPEC, P1; Chao W, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009777; Coates J., 2000, ENCY ANAL CHEM, DOI DOI 10.1002/9780470027318.A5606; Cody GD, 2000, AIP CONF PROC, V507, P307; Cody GD, 2009, J ELECTRON SPECTROSC, V170, P57, DOI 10.1016/j.elspec.2008.09.007; Colthup N.B., 1990, INTRO INFRARED RAMAN, P547, DOI [10.1016/b978-0-08-091740-5.50009-0, DOI 10.1016/B978-0-08-091740-5.50009-0]; Cruz DH, 2006, BIOMACROMOLECULES, V7, P836, DOI 10.1021/bm050943u; Cyran MR, 2007, J AGR FOOD CHEM, V55, P2329, DOI 10.1021/jf062473g; Dynes JJ, 2006, ENVIRON SCI TECHNOL, V40, P1556, DOI 10.1021/es0513638; Goda K, 2006, COMPOS PART A-APPL S, V37, P2213, DOI 10.1016/j.compositesa.2005.12.014; Goff KL, 2009, ANALYST, V134, P2216, DOI 10.1039/b915810c; Guillon F, 2011, J EXP BOT, V62, P1001, DOI 10.1093/jxb/erq332; Hettrich K, 2006, MACROMOL SYMP, V232, P37, DOI 10.1002/masy.200551405; Himmelsbach DS, 1999, VIB SPECTROSC, V19, P361, DOI 10.1016/S0924-2031(98)00065-4; Hitchcock AP, 2012, ENVIRON SCI TECHNOL, V46, P2821, DOI 10.1021/es202238k; Hitchcock AP, 2005, J ELECTRON SPECTROSC, V144, P259, DOI 10.1016/j.elspec.2005.01.279; Hitchcock AP, 2002, J BIOMAT SCI-POLYM E, V13, P919, DOI 10.1163/156856202320401960; Hitchcock AP, 2001, ULTRAMICROSCOPY, V88, P33, DOI 10.1016/S0304-3991(00)00113-3; Hsu C. P. S., 1997, HDB INSTRUMENTAL TEC; JACOBSEN C, 1993, J MICROSC-OXFORD, V172, P121, DOI 10.1111/j.1365-2818.1993.tb03403.x; Jeremic D, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0176-9; Jones PD, 2006, WOOD SCI TECHNOL, V40, P709, DOI 10.1007/s00226-006-0085-6; Karunakaran C, 2009, CHARACTERIZATION INT, P116; Karunakaran C, 2010, CHARACTERIZATION WHE, P50; Kaznacheyev K, 2002, J PHYS CHEM A, V106, P3153, DOI 10.1021/jp013385w; Koprinarov I, 2001, MACROMOLECULES, V34, P4424, DOI 10.1021/ma001626c; Koprinarov IN, 2002, J PHYS CHEM B, V106, P5358, DOI 10.1021/jp0132811; Lawrence JR, 2011, WILEY-IUPAC SER BIOP, P341; Lawrence JR, 2003, APPL ENVIRON MICROB, V69, P5543, DOI 10.1128/AEM.69.9.5543-5554.2003; MA Y, 1991, PHYS REV A, V44, P1848, DOI 10.1103/PhysRevA.44.1848; Miller LM, 2003, J BIOL PHYS, V29, P219, DOI 10.1023/A:1024401027599; MILLER SS, 1995, CEREAL CHEM, V72, P421; Miller SS, 1999, ANN BOT-LONDON, V84, P297, DOI 10.1006/anbo.1999.0915; MILLER SS, 1994, CEREAL CHEM, V71, P64; Moronne MM, 1999, ULTRAMICROSCOPY, V77, P23, DOI 10.1016/S0304-3991(99)00002-9; Opanowicz M, 2011, J EXP BOT, V62, P735, DOI 10.1093/jxb/erq309; Oraji R, 2013, XRAY SPECTROMICROSCO, P118; Pandey KK, 1999, J APPL POLYM SCI, V71, P1969, DOI 10.1002/(SICI)1097-4628(19990321)71:12<1969::AID-APP6>3.0.CO;2-D; Park P, 2008, J GEN PLANT PATHOL, V74, P2, DOI 10.1007/s10327-007-0042-8; Philippe S, 2006, J AGR FOOD CHEM, V54, P2303, DOI 10.1021/jf052922x; Philippe S, 2006, J AGR FOOD CHEM, V54, P5113, DOI 10.1021/jf060466m; Philippe S, 2006, PLANTA, V224, P449, DOI 10.1007/s00425-005-0209-5; Quaroni L, 2015, ANGEW CHEM INT EDIT, V54, P318, DOI 10.1002/anie.201407728; Robert P, 2005, J AGR FOOD CHEM, V53, P7014, DOI 10.1021/jf051145y; Robert P, 2011, PLANTA, V233, P393, DOI 10.1007/s00425-010-1306-7; Signorell R., 2010, SCANNING TRANSMISSIO; Stewart-Ornstein J, 2007, J PHYS CHEM B, V111, P7691, DOI 10.1021/jp0720993; Stohr J., 1992, NEXAFS SPECTROSCOPY; Urquhart SG, 1999, J ELECTRON SPECTROSC, V100, P119, DOI 10.1016/S0368-2048(99)00043-2; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Wang J, 2011, AIP CONF PROC, V1365, P215, DOI 10.1063/1.3625342; Wetzel DL, 2003, VIB SPECTROSC, V31, P109, DOI 10.1016/S0924-2031(02)00100-5; WILLIAMS S, 1993, J MICROSC-OXFORD, V170, P155, DOI 10.1111/j.1365-2818.1993.tb03335.x; Xu F, 2007, CARBOHYD POLYM, V67, P56, DOI 10.1016/j.carbpol.2006.04.014; YANG CQ, 1995, FUEL, V74, P543, DOI 10.1016/0016-2361(95)98357-K; Yangquanwei Z, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-463; Yu PQ, 2007, J SYNCHROTRON RADIAT, V14, P382, DOI 10.1107/S0909049507014264; Zubavichus Y, 2004, J ELECTRON SPECTROSC, V134, P25, DOI 10.1016/j.elspec.2003.09.006	72	32	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122959	10.1371/journal.pone.0122959	http://dx.doi.org/10.1371/journal.pone.0122959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811457	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700209
J	Pirila, E; Vayrynen, O; Sundquist, E; Pakkila, K; Nyberg, P; Nurmenniemi, S; Paakkonen, V; Pesonen, P; Dayan, D; Vered, M; Uhlin-Hansen, L; Salo, T				Pirila, Emma; Vayrynen, Otto; Sundquist, Elias; Pakkila, Kaisa; Nyberg, Pia; Nurmenniemi, Sini; Paakkonen, Virve; Pesonen, Paula; Dayan, Dan; Vered, Marilena; Uhlin-Hansen, Lars; Salo, Tuula			Macrophages Modulate Migration and Invasion of Human Tongue Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ALTERNATIVE ACTIVATION; INHIBITORY FACTOR; CANCER; MICROENVIRONMENT; M1; PROLIFERATION; METASTASIS; EXPRESSION; PROGRESSION	Oral tongue squamous cell carcinoma (OTSCC) has a high mortality rate and the incidence is rising worldwide. Despite advances in treatment, the disease lacks specific prognostic markers and treatment modality. The spreading of OTSCC is dependent on the tumor microenvironment and involves tumor-associated macrophages (TAMs). Although the presence of TAMs is associated with poor prognosis in OTSCC, the specific mechanisms underlying this are still unknown. The aim here was to investigate the effect of macrophages (Mfs) on HSC-3 tongue carcinoma cells and NF-kappaB activity. We polarized THP-1 cells to M1 (inflammatory), M2 (TAM-like) and R848 (imidazoquinoline-treated) type Mfs. We then investigated the effect of Mfs on HSC-3 cell migration and NF-kappaB activity, cytokine production and invasion using several different in vitro migration models, a human 3D tissue invasion model, antibody arrays, confocal microscopy, immunohistochemistry and a mouse invasion model. We found that in co-culture studies all types of Mfs fused with HSC-3 cells, a process which was partially due to efferocytosis. HSC-3 cells induced expression of epidermal growth factor and transforming growth factor-beta in co-cultures with M2 Mfs. Direct cell-cell contact between M2 Mfs and HSC-3 cells induced migration and invasion of HSC-3 cells while M1 Mfs reduced HSC-3 cell invasion. M2 Mfs had an excess of NF-kappaB p50 subunit and a lack of p65 subunits both in the presence and absence of HSC-3 cells, indicating dysregulation and pro-tumorigenic NF-kappaB activation. TAM-like cells were abundantly present in close vicinity to carcinoma cells in OTSCC patient samples. We conclude that M2 Mfs/TAMs have an important role in OTSCC regulating adhesion, migration, invasion and cytokine production of carcinoma cells favouring tumor growth. These results demonstrate that OTSCC patients could benefit from therapies targeting TAMs, polarizing TAM-like M2 Mfs to inflammatory macrophages and modulating NF-kappaB activity.	[Pirila, Emma; Vayrynen, Otto; Sundquist, Elias; Pakkila, Kaisa; Nyberg, Pia; Nurmenniemi, Sini; Salo, Tuula] Univ Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland; [Pirila, Emma; Vayrynen, Otto; Sundquist, Elias; Pakkila, Kaisa; Nyberg, Pia; Nurmenniemi, Sini; Salo, Tuula] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Pirila, Emma; Vayrynen, Otto; Sundquist, Elias; Pakkila, Kaisa; Nyberg, Pia; Nurmenniemi, Sini; Salo, Tuula] Univ Oulu, Oulu Med Res Ctr, Oulu, Finland; [Pirila, Emma; Vayrynen, Otto; Sundquist, Elias; Pakkila, Kaisa; Nyberg, Pia; Nurmenniemi, Sini; Salo, Tuula] Oulu Univ Hosp, Oulu, Finland; [Pesonen, Paula] Univ Oulu, Inst Dent, Dept Community Dent, Oulu, Finland; [Dayan, Dan; Vered, Marilena] Tel Aviv Univ, Sch Dent Med, Dept Oral Pathol & Oral Med, IL-69978 Tel Aviv, Israel; [Vered, Marilena] Chaim Sheba Med Ctr, Inst Pathol, Tel Aviv, Israel; [Uhlin-Hansen, Lars] Univ Tromso, Fac Hlth Sci, Inst Med Biol, Tromso, Norway; [Uhlin-Hansen, Lars] Univ Hosp Northern Norway, Dept Pathol, Tromso, Norway; [Paakkonen, Virve] Univ Oulu, Dept Pedodont Cariol & Endodontol, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Tel Aviv University; Chaim Sheba Medical Center; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oulu	Pirila, E (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland.	emma.pirila@oulu.fi	, tuula/ABG-2051-2021; Xia, Bo/P-9380-2016	Paakkonen, Virve/0000-0001-9770-8598	Finnish Dental Society Apollonia; Finnish Cultural Foundation; Northern Finland Cancer Foundation; Academy of Finland [130140]	Finnish Dental Society Apollonia; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Northern Finland Cancer Foundation; Academy of Finland(Academy of Finland)	This work was partially funded with grants from the Finnish Dental Society Apollonia (E. Pirila, P. Nyberg), the Finnish Cultural Foundation (E. Pirila), Northern Finland Cancer Foundation (E. Pirila) and Academy of Finland grant number 130140 (T. Salo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas O, 2011, HISTOPATHOLOGY, V58, P643, DOI 10.1111/j.1365-2559.2010.03617.x; Abiko Y, 2003, ARCH ORAL BIOL, V48, P171, DOI 10.1016/S0003-9969(02)00167-X; Adams DL, 2014, P NATL ACAD SCI USA, V111, P3514, DOI 10.1073/pnas.1320198111; Annertz K, 2012, ACTA OTO-LARYNGOL, V132, P552, DOI 10.3109/00016489.2011.649146; Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Chakraborty K, 2012, HUM IMMUNOL, V73, P38, DOI 10.1016/j.humimm.2011.10.015; Chengye Zhan, 2013, Biochem Biophys Res Commun, V439, P121, DOI 10.1016/j.bbrc.2013.08.015; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Clawson GA, 2013, SCIENCE, V342, P699, DOI 10.1126/science.1244270; Connelly L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2935; Cook J, 2013, CURR OPIN PHARMACOL, V13, P595, DOI 10.1016/j.coph.2013.05.017; Costea DE, 2013, CANCER RES, V73, P3888, DOI 10.1158/0008-5472.CAN-12-4150; Dayan D, 2012, CANCER MED-US, V1, P128, DOI 10.1002/cam4.24; De Palma M, 2011, NATURE, V472, P303, DOI 10.1038/472303a; Dittmar T, 2013, CURR MOL MED, V13, P735, DOI 10.2174/1566524011313050005; Drobits B, 2012, J CLIN INVEST, V122, P575, DOI 10.1172/JCI61034; Dumitru CA, 2011, INT J CANCER, V129, P859, DOI 10.1002/ijc.25991; Engstrom A, 2014, INT J ONCOL, V44, P385, DOI 10.3892/ijo.2013.2203; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Franca CM, 2013, J ORAL PATHOL MED, V42, P368, DOI 10.1111/jop.12011; Fujii N, 2012, J ORAL PATHOL MED, V41, P444, DOI 10.1111/j.1600-0714.2012.01127.x; Hadler-Olsen E, 2010, VIRCHOWS ARCH, V457, P677, DOI 10.1007/s00428-010-0980-y; Hagemann T, 2009, BLOOD, V113, P3139, DOI 10.1182/blood-2008-12-172825; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; KELLER R, 1990, INT J CANCER, V46, P682, DOI 10.1002/ijc.2910460422; Kindt N, 2013, INT J ONCOL, V43, P185, DOI 10.3892/ijo.2013.1944; Koontongkaew S, 2013, J CANCER, V4, P66, DOI 10.7150/jca.5112; Koontongkaew S, 2012, MED ONCOL, V29, P690, DOI 10.1007/s12032-011-9871-6; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; Kylmaniemi M, 1996, J DENT RES, V75, P919, DOI 10.1177/00220345960750030901; Li CN, 2002, ONCOL REP, V9, P1219; Liu SY, 2008, ORAL ONCOL, V44, P277, DOI 10.1016/j.oraloncology.2007.02.007; Maniecki MB, 2012, INT J CANCER, V131, P2320, DOI 10.1002/ijc.27506; Marcus B, 2004, CANCER-AM CANCER SOC, V101, P2779, DOI 10.1002/cncr.20701; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Mashhadiabbas F, 2012, OR SURG OR MED OR PA, V114, P240, DOI 10.1016/j.oooo.2012.04.009; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Garcia MPS, 2012, CANCER LETT, V323, P11, DOI 10.1016/j.canlet.2012.03.040; Ramineni SK, 2013, J PHARM SCI-US, V102, P593, DOI 10.1002/jps.23386; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Salo T, 2014, EXP CELL RES, V325, P58, DOI 10.1016/j.yexcr.2013.12.029; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smith KJ, 2004, CLIN EXP DERMATOL, V29, P505, DOI 10.1111/j.1365-2230.2004.01593.x; Tanaka T, 2012, CANCER SCI, V103, P836, DOI 10.1111/j.1349-7006.2012.02255.x; Teppo S, 2013, EXP CELL RES, V319, P376, DOI 10.1016/j.yexcr.2012.12.010; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Udagawa T, 2010, CURR OPIN PHARMACOL, V10, P369, DOI 10.1016/j.coph.2010.06.010; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; Vered M, 2011, NAT REV CANCER, V11, P382, DOI 10.1038/nrc2982-c1; Weber M, 2014, J CRANIOMAXILLOFAC S, pS1010; Wolff HA, 2011, RADIAT ENVIRON BIOPH, V50, P145, DOI 10.1007/s00411-010-0341-x; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; Yang YJ, 2014, CANCER BIOL THER, V15, P99, DOI 10.4161/cbt.26718; Zajac E, 2013, BLOOD, V122, P4054, DOI 10.1182/blood-2013-05-501494	63	33	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120895	10.1371/journal.pone.0120895	http://dx.doi.org/10.1371/journal.pone.0120895			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811194	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700063
J	Velez-Carrasco, W; Green, CE; Catz, P; Furimsky, A; O'Loughlin, K; Eterovic, VA; Ferchmin, PA				Velez-Carrasco, Wanda; Green, Carol E.; Catz, Paul; Furimsky, Anna; O'Loughlin, Kathleen; Eterovic, Vesna A.; Ferchmin, P. A.			Pharmacokinetics and Metabolism of 4R-Cembranoid	PLOS ONE			English	Article							ACUTE HIPPOCAMPAL SLICES; TOBACCO CEMBRANOIDS; NICOTINIC RECEPTORS; SPECIES-DIFFERENCES; EXPRESSION; NEUROTOXICITY; INHIBITION; INDUCTION; MECHANISM; PROTECTS	4R-cembranoid (4R) is a natural cyclic diterpenoid found in tobacco leaves that displays neuroprotective activity. 4R protects against NMDA, paraoxon (POX), and diisopropylfluorophosphate (DFP) damage in rat hippocampal slices and against DFP in rats in vivo. The purpose of this study was to examine the metabolism and pharmacokinetics of 4R as part of its preclinical development as a neuroprotective drug. 10 mu M 4R was found to be very stable in plasma for up to 1 hr incubation. 4R metabolism in human microsomes was faster than in the rat. Ten metabolites of 4R were detected in the microsomal samples; 6 dihydroxy and 4 monohydroxy forms of 4R. Male rats received a single dose of 4R at 6 mg/kg i.v., i.m., or s.c. The i.v. group had the highest plasma concentration of 1017 ng/mL. The t(1/2) was 36 min and reached the brain within 10 min. The brain peak concentration was 6516 ng/g. The peak plasma concentration in the i.m. group was 163 ng/mL compared to 138 ng/mL in the s.c. group. The t1/2 of 4R after i.m. and s.c. administration was approximately 1.5 hr. The brain peak concentration was 329 ng/g in the i.m. group and 323 ng/g for the s.c. group. The brain to plasma ratio in the i.v. group was 6.4, reached 10 min after dose, whereas in the i.m. and s.c. groups was 2.49 and 2.48, respectively, at 90 min after dose. Our data show that 4R crosses the BBB and concentrates in the brain where it exerts its neuroprotective effect.	[Velez-Carrasco, Wanda; Eterovic, Vesna A.; Ferchmin, P. A.] Univ Cent del Caribe, Dept Biochem, Bayamon, PR 00621 USA; [Green, Carol E.; Catz, Paul; Furimsky, Anna; O'Loughlin, Kathleen] SRI Int, Biosci Div, Menlo Pk, CA 94025 USA	SRI International	Ferchmin, PA (corresponding author), Univ Cent del Caribe, Dept Biochem, Bayamon, PR 00621 USA.	ferchmin@gmail.com			National Institutes of Health National Institute of Neurological Disorders and Stroke [CounterACT UO1 NS063555, HHSN271200623691C]; Specialized Neuroscience Research Program [1U54NS083924-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS063555, U54NS083924] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Specialized Neuroscience Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health National Institute of Neurological Disorders and Stroke [Grants CounterACT UO1 NS063555, HHSN271200623691C] and the Specialized Neuroscience Research Program [Grant 1U54NS083924-01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuznait AH, 2011, FOOD CHEM TOXICOL, V49, P2765, DOI 10.1016/j.fct.2011.08.004; DeBusk BC, 2008, FISH PHYSIOL BIOCHEM, V34, P483, DOI 10.1007/s10695-008-9225-2; EKLUND AM, 1992, ACTA CHEM SCAND, V46, P367, DOI 10.3891/acta.chem.scand.46-0367; El Sayed KA, 2008, BIOORGAN MED CHEM, V16, P2886, DOI 10.1016/j.bmc.2007.12.056; Eterovic VA, 2013, BIOORGAN MED CHEM, V21, P4678, DOI 10.1016/j.bmc.2013.05.018; Eterovic VA, 2011, TOXICOL IN VITRO, V25, P1468, DOI 10.1016/j.tiv.2011.04.021; Ferchmin PA, 2014, NEUROTOXICOLOGY, V44, P80, DOI 10.1016/j.neuro.2014.06.001; Ferchmin PA, 2013, J NEUROSCI RES, V91, P416, DOI 10.1002/jnr.23155; Ferchmin PA, 2009, TOXICON, V54, P1174, DOI 10.1016/j.toxicon.2009.02.033; Ferchmin PA, 2005, J NEUROSCI RES, V82, P631, DOI 10.1002/jnr.20666; Ferchmin PA, 2001, J NEUROSCI RES, V64, P18, DOI 10.1002/jnr.1049; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; MCLEAN S, 1993, J CHEM ECOL, V19, P1625, DOI 10.1007/BF00982297; Pagan OR, 2009, EUR J PHARMACOL, V615, P118, DOI 10.1016/j.ejphar.2009.05.022; Patki KC, 2003, DRUG METAB DISPOS, V31, P938, DOI 10.1124/dmd.31.7.938; ROBERTS DL, 1962, J ORG CHEM, V27, P3989, DOI 10.1021/jo01058a056; Shipley LA, 2012, J CHEM ECOL, V38, P1178, DOI 10.1007/s10886-012-0192-9; Smith DJ, 2004, J BACTERIOL, V186, P3631, DOI 10.1128/JB.186.11.3631-3639.2004; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]	21	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121540	10.1371/journal.pone.0121540	http://dx.doi.org/10.1371/journal.pone.0121540			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811857	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700113
J	Wei, CH; Ren, HX; Xu, LY; Li, L; Liu, RZ; Zhang, L; Zhao, FP; Lu, J; Zhang, XN; Du, LX				Wei, Caihong; Ren, Hangxing; Xu, Lingyang; Li, Li; Liu, Ruizao; Zhang, Li; Zhao, Fuping; Lu, Jian; Zhang, Xiaoning; Du, Lixin			Signals of Ezh2, Src, and Akt Involve in Myostatin-Pax7 Pathways Regulating the Myogenic Fate Determination during the Sheep Myoblast Proliferation and Differentiation	PLOS ONE			English	Article							SATELLITE CELL-PROLIFERATION; SKELETAL-MUSCLE; TERMINAL DIFFERENTIATION; SELF-RENEWAL; PAX7; EXPRESSION; PROTEIN; GROWTH; ACTIVATION; INHIBITION	Myostatin and Pax7 have been well documented individually, however, the mechanism by which Myostatin regulates Pax7 is seldom reported. Here, based on muscle transcriptome analysis in Texel (Myostatin mutant) and Ujumqin (wild type) sheep across the five fetal stages, we constructed and examined the Myostatin-Pax7 pathways in muscle. Then we validated the signals by RNAi in the proliferating and differentiating sheep myoblasts in vitro at mRNA, protein, and cell morphological levels. We reveal that Myostatin signals to Pax7 at least through Ezh2, Src, and Akt during the sheep myoblast proliferation and differentiation. Other signals such as p38MAPK, mTOR, Erk1/2, Wnt, Bmp2, Smad, Tgfb1, and p21 are most probably involved in the Myostatin-affected myogenic events. Myostatin knockdown significantly reduces the counts of nucleus and myotube, but not the fusion index of myoblasts during cell differentiation. In addition, findings also indicate that Myostatin is required for normal myogenic differentiation of the sheep myoblasts, which is different from the C2C12 myoblasts. We expand the regulatory network of Myostatin-Pax7 pathways and first illustrate that Myostatin as a global regulator participates in the epigenetic events involved in myogenesis, which contributes to understand the molecular mechanism of Myostatin in regulation of myogenesis.	[Wei, Caihong; Xu, Lingyang; Liu, Ruizao; Zhang, Li; Zhao, Fuping; Lu, Jian; Zhang, Xiaoning; Du, Lixin] Chinese Acad Agr Sci, Natl Ctr Mol Genet & Breeding Anim, Inst Anim Sci, Beijing 100193, Peoples R China; [Ren, Hangxing] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Li, Li] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Chengdu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Sichuan Agricultural University	Du, LX (corresponding author), Chinese Acad Agr Sci, Natl Ctr Mol Genet & Breeding Anim, Inst Anim Sci, Beijing 100193, Peoples R China.	lxdu@263.net	Li, Li/T-4353-2017; Xu, Lingyang/W-8664-2019	Li, Li/0000-0003-2459-3499; 	National Key Technology R&D Program of China [2011BAD28B05-2]; National Meat Sheep System Specialist Program	National Key Technology R&D Program of China(National Key Technology R&D Program); National Meat Sheep System Specialist Program	The research was supported by the National Key Technology R&D Program of China (2011BAD28B05-2), and the National Meat Sheep System Specialist Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chou RH, 2011, AM J TRANSL RES, V3, P243; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Diao YR, 2012, CELL STEM CELL, V11, P231, DOI 10.1016/j.stem.2012.05.022; FALCONE G, 1985, P NATL ACAD SCI USA, V82, P426, DOI 10.1073/pnas.82.2.426; Garikipati DK, 2012, J ENDOCRINOL, V215, P177, DOI 10.1530/JOE-12-0260; Gilson H, 2009, AM J PHYSIOL-ENDOC M, V297, pE157, DOI 10.1152/ajpendo.00193.2009; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE41, DOI 10.1152/ajpendo.00389.2012; Ji M, 2008, CELL SIGNAL, V20, P1452, DOI 10.1016/j.cellsig.2008.03.013; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kawabe YI, 2012, CELL STEM CELL, V11, P333, DOI 10.1016/j.stem.2012.07.001; Lagha M, 2008, COLD SH Q B, V73, P307, DOI 10.1101/sqb.2008.73.006; Langley B, 2004, ONCOGENE, V23, P524, DOI 10.1038/sj.onc.1207144; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Lim MJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P197, DOI 10.1016/j.abb.2007.06.004; Liu CX, 2012, BIOCHEM BIOPH RES CO, V422, P381, DOI 10.1016/j.bbrc.2012.04.151; Lu HG, 2002, J BIOL CHEM, V277, P46687, DOI 10.1074/jbc.M209643200; Lu J, 2012, J CELL BIOCHEM, V113, P2652, DOI 10.1002/jcb.24140; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meikrantz W, 1996, J BIOL CHEM, V271, P10205, DOI 10.1074/jbc.271.17.10205; Meng Xiang-Ren, 2008, Yichuan, V30, P1585, DOI 10.3724/SP.J.1005.2008.01585; Miyake M, 2012, CELL TISSUE RES, V349, P615, DOI 10.1007/s00441-012-1422-8; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Mozzetta C, 2011, CELL CYCLE, V10, P191, DOI 10.4161/cc.10.2.14441; Niu AR, 2013, J CELL SCI, V126, P4349, DOI 10.1242/jcs.125328; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Olguin HC, 2012, J CELL MOL MED, V16, P1013, DOI 10.1111/j.1582-4934.2011.01348.x; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Philip B, 2005, CELL SIGNAL, V17, P365, DOI 10.1016/j.cellsig.2004.08.003; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Ren HX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-411; Ricaud S, 2003, ONCOGENE, V22, P8221, DOI 10.1038/sj.onc.1207177; Rios R, 2004, ENDOCRINOLOGY, V145, P2795, DOI 10.1210/en.2003-1166; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Ronda AC, 2010, J STEROID BIOCHEM, V122, P287, DOI 10.1016/j.jsbmb.2010.05.002; Rosoff WJ, 2002, J CELL PHYSIOL, V193, P328, DOI 10.1002/jcp.10182; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sato F, 2006, AM J PHYSIOL-CELL PH, V291, pC538, DOI 10.1152/ajpcell.00543.2005; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tsao J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt152; Wei CH, 2014, PHYSIOL GENOMICS, V46, P429, DOI 10.1152/physiolgenomics.00184.2013; Wei CaiHong, 2012, Journal of Agricultural Biotechnology, V20, P283; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Yang W, 2006, CANCER RES, V66, P1320, DOI 10.1158/0008-5472.CAN-05-3060; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; YOON HY, 1994, ONCOGENE, V9, P801; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007	66	7	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120956	10.1371/journal.pone.0120956	http://dx.doi.org/10.1371/journal.pone.0120956			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811841	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700068
J	Klein, W; Westendorf, C; Schmidt, A; Conill-Cortes, M; Rutz, C; Blohs, M; Beyermann, M; Protze, J; Krause, G; Krause, E; Schulein, R				Klein, Wolfgang; Westendorf, Carolin; Schmidt, Antje; Conill-Cortes, Merce; Rutz, Claudia; Blohs, Marcus; Beyermann, Michael; Protze, Jonas; Krause, Gerd; Krause, Eberhard; Schuelein, Ralf			Defining a Conformational Consensus Motif in Cotransin-Sensitive Signal Sequences: A Proteomic and Site-Directed Mutagenesis Study	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; PHASE PEPTIDE-SYNTHESIS; COTRANSLATIONAL TRANSLOCATION; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; MAMMALIAN-CELLS; IDENTIFICATION; INHIBITION; PROTEINS; RECEPTOR	The cyclodepsipeptide cotransin was described to inhibit the biosynthesis of a small subset of proteins by a signal sequence-discriminatory mechanism at the Sec61 protein-conducting channel. However, it was not clear how selective cotransin is, i.e. how many proteins are sensitive. Moreover, a consensus motif in signal sequences mediating cotransin sensitivity has yet not been described. To address these questions, we performed a proteomic study using cotransin-treated human hepatocellular carcinoma cells and the stable isotope labelling by amino acids in cell culture technique in combination with quantitative mass spectrometry. We used a saturating concentration of cotransin (30 micromolar) to identify also less-sensitive proteins and to discriminate the latter from completely resistant proteins. We found that the biosynthesis of almost all secreted proteins was cotransin-sensitive under these conditions. In contrast, biosynthesis of the majority of the integral membrane proteins was cotransin-resistant. Cotransin sensitivity of signal sequences was neither related to their length nor to their hydrophobicity. Instead, in the case of signal anchor sequences, we identified for the first time a conformational consensus motif mediating cotransin sensitivity.	[Klein, Wolfgang; Westendorf, Carolin; Schmidt, Antje; Conill-Cortes, Merce; Rutz, Claudia; Blohs, Marcus; Beyermann, Michael; Protze, Jonas; Krause, Gerd; Krause, Eberhard; Schuelein, Ralf] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Schulein, R (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany.	schuelein@fmp-berlin.de	Protze, Jonas/ABB-9737-2020	Protze, Jonas/0000-0002-1506-9831; Klussmann, Jens Peter/0000-0002-8223-7954	Deutsche Forschungsgemeinschaft [1116/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Our work was funded by the Deutsche Forschungsgemeinschaft Grant 1116/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2008, J PROTEOME RES, V7, P3900, DOI 10.1021/pr800198w; AUDIGIER Y, 1987, P NATL ACAD SCI USA, V84, P5783, DOI 10.1073/pnas.84.16.5783; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Coin I, 2008, ORG LETT, V10, P3857, DOI 10.1021/ol800855p; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; Coin I, 2009, ADV EXP MED BIOL, V611, P127, DOI 10.1007/978-0-387-73657-0_56; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Harant H, 2007, MOL PHARMACOL, V71, P1657, DOI 10.1124/mol.107.034249; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Iwaki T, 2012, BRIT J HAEMATOL, V157, P291, DOI 10.1111/j.1365-2141.2012.09074.x; Kelly CJ, 2011, HUM REPROD UPDATE, V17, P4, DOI 10.1093/humupd/dmq027; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; MacKinnon AL, 2014, ELIFE, V3, DOI 10.7554/eLife.01483; Maifeld SV, 2011, CHEM BIOL, V18, P1082, DOI 10.1016/j.chembiol.2011.06.015; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sahoo SK, 2010, BMB REP, V43, P158, DOI 10.5483/BMBRep.2010.43.3.158; Schulz K, 2010, J BIOL CHEM, V285, P32878, DOI 10.1074/jbc.M110.129627; Tjarnlund-Wolf A, 2012, STROKE, V43, P2833, DOI 10.1161/STROKEAHA.111.622217; von Heijne G, 1990, CURR OPIN CELL BIOL, V2, P604, DOI 10.1016/0955-0674(90)90100-S; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Westendorf C, 2011, J BIOL CHEM, V286, P35588, DOI 10.1074/jbc.M111.239244; Zhang G, 2008, J PROTEOME RES, V7, P4715, DOI 10.1021/pr800255a; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	34	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120886	10.1371/journal.pone.0120886	http://dx.doi.org/10.1371/journal.pone.0120886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806945	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000109
J	Tang, MC; Wu, MY; Hwang, MH; Chang, YT; Huang, HJ; Lin, AMY; Yang, JCH				Tang, Mei-Chuan; Wu, Mei-Yi; Hwang, Ming-Hung; Chang, Ya-Ting; Huang, Hui-Ju; Lin, Anya Maan-Yuh; Yang, James Chih-Hsin			Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; INDUCED APOPTOSIS; INDUCED AUTOPHAGY; GROWTH; ADENOCARCINOMA; INHIBITION; MUTATIONS; THERAPY; AFATINIB; DEATH	Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), including gefitinib, are effective for non-small cell lung cancer (NSCLC) patients with EGFR mutations. However, these patients eventually develop resistance to EGFR-TKI. The goal of the present study was to investigate the involvement of autophagy in gefitinib resistance. We developed gefitinib-resistant cells (PC-9/gef) from PC-9 cells (containing exon 19 deletion EGFR) after long-term exposure in gefitinib. PC-9/gef cells (B4 and E3) were 200-fold more resistant to gefitinib than PC-9/wt cells. Compared with PC-9/wt cells, both PC-9/gefB4 and PC-9/gefE3 cells demonstrated higher basal LC3-II levels which were inhibited by 3-methyladenine (3-MA, an autophagy inhibitor) and potentiated by chloroquine (CQ, an inhibitor of autophagolysosomes formation), indicating elevated autophagy in PC-9/gef cells. 3-MA and CO concentration-dependently inhibited cell survival of both PC-9wt and PC-9/gef cells, suggesting that autophagy may be pro-survival. Furthermore, gefitinib increased LC3-II levels and autolysosome formation in both PC-9/wt cells and PC-9/gef cells. In PC-9/wt cells, CO potentiated the cytotoxicity by low gefitinib (3nM). Moreover, CO overcame the acquired gefitinib resistance in PC-9/gef cells by enhancing gefitinib-induced cytotoxicity, activation of caspase 3 and poly (ADP-ribose) polymerase cleavage. Using an in vivo model xenografting with PC-9/wt and PC-9/gefB4 cells, oral administration of gefitinib (50 mg/kg) completely inhibited the tumor growth of PC-9/wt but not PC-9/gefB4cells. Combination of CO (75 mg/kg, i.p.) and gefitinib was more effective than gefitinib alone in reducing the tumor growth of PC-9/gefB4. Our data suggest that inhibition of autophagy may be a therapeutic strategy to overcome acquired resistance of gefitinib in EGFR mutation NSCLC patients.	[Tang, Mei-Chuan; Yang, James Chih-Hsin] Natl Taiwan Univ, Natl Ctr Excellence Clin Trial & Res, Taipei 10764, Taiwan; [Wu, Mei-Yi; Chang, Ya-Ting; Lin, Anya Maan-Yuh] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Hwang, Ming-Hung; Yang, James Chih-Hsin] Natl Taiwan Univ, Grad Inst Oncol, Taipei 10764, Taiwan; [Huang, Hui-Ju; Lin, Anya Maan-Yuh] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Yang, James Chih-Hsin] Natl Taiwan Univ, Grad Inst Oncol, Taipei 10764, Taiwan; [Yang, James Chih-Hsin] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lin, AMY (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan.	myalin@ym.edu.tw; chihyang@NTU.edu.tw	Yang, James Chih-Hsin/W-1587-2019	Yang, James Chih-Hsin/0000-0002-5586-5138	Ministry of Science and Technology, Taiwan [NSC 101-2314-B-002 -090 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	NSC 101-2314-B-002 -090 -MY3 by Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Arcella A, 2013, BRAIN RES, V1495, P37, DOI 10.1016/j.brainres.2012.11.044; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Cufi S, 2012, ONCOTARGET, V3, P1600; Fan CD, 2006, BIOORGAN MED CHEM, V14, P3218, DOI 10.1016/j.bmc.2005.12.035; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Fung C, 2012, CANCER BIOL THER, V13, P1417, DOI 10.4161/cbt.22002; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Huang MH, 2013, MOL ONCOL, V7, P112, DOI 10.1016/j.molonc.2012.09.002; Ji C, 2014, CANC BIOL THER, V15; Kim JY, 2012, ARCH ORAL BIOL, V57, P1018, DOI 10.1016/j.archoralbio.2012.04.005; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Li H, 2011, ADV MED SCI-POLAND, V56, P275, DOI 10.2478/v10039-011-0043-x; Li HY, 2013, CANCER BIOTHER RADIO, V28, P115, DOI 10.1089/cbr.2012.1268; Li ZX, 2011, MED ONCOL, V28, P572, DOI 10.1007/s12032-010-9470-y; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mijaljica D, 2012, AUTOPHAGY, V8, P1701, DOI 10.4161/auto.21332; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; Okamoto K, 2010, CANCER RES, V70, P10402, DOI 10.1158/0008-5472.CAN-10-2438; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Park JH, 2014, ONCOL REP, V10, P3892; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang Yao, 2011, Chin J Cancer, V30, P690, DOI 10.5732/cjc.011.10056; Wu G, 2014, BIOTECHNOL LETT; Xu Y, 2012, CANCER LETT, V314, P232, DOI 10.1016/j.canlet.2011.09.034; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; Yang JCH, 2012, LANCET ONCOL, V13, P539, DOI 10.1016/S1470-2045(12)70086-4	39	40	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119135	10.1371/journal.pone.0119135	http://dx.doi.org/10.1371/journal.pone.0119135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807554	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000018
J	Hyldahl, RD; Nelson, B; Xin, L; Welling, T; Groscost, L; Hubal, MJ; Chipkin, S; Clarkson, PM; Parcell, AC				Hyldahl, Robert D.; Nelson, Brad; Xin, Ling; Welling, Tyson; Groscost, Logan; Hubal, Monica J.; Chipkin, Stuart; Clarkson, Priscilla M.; Parcell, Allen C.			Extracellular matrix remodeling and its contribution to protective adaptation following lengthening contractions in human muscle	FASEB JOURNAL			English	Article						eccentric exercise; satellite cell; repeated-bout effect; muscle damage	SKELETAL-MUSCLE; ECCENTRIC EXERCISE; SATELLITE CELLS; SINGLE BOUT; CONNECTIVE-TISSUE; SYSTEMS-ANALYSIS; GROWTH-FACTORS; RAT TENDON; COLLAGEN; DAMAGE	This study determined the contribution of extracellular matrix (ECM) remodeling to the protective adaptation of human skeletal muscle known as the repeated-bout effect (RBE). Muscle biopsies were obtained 3 hours, 2 days, and 27 days following an initial bout (B1) of lengthening contractions (LCs) and 2 days following a repeated bout (B2) in 2 separate studies. Biopsies from the nonexercised legs served as controls. In the first study, global transcriptomic analysis indicated widespread changes in ECM structural, deadhesive, and signaling transcripts, 3 hours following LC. To determine if ECM remodeling is involved in the RBE, we conducted a second study by use of a repeated-bout paradigm. TNC immunoreactivity increased 10.8-fold following B1, was attenuated following B2, and positively correlated with LC-induced strength loss (r(2) = 0.45; P = 0.009). Expression of collagen I, III, and IV (COL1A1, COL3A1, COL4A1) transcripts was unchanged early but increased 5.7 +/- 2.5-, 3.2 +/- 0.9-, and 2.1 +/- 0.4-fold (P < 0.05), respectively, 27 days post-B1 and were unaffected by B2. Likewise, TGF-beta signaling demonstrated a delayed response following LC. Satellite cell content increased 80% (P < 0.05) 2 days post-B1 (P < 0.05), remained elevated 27 days post-B1, and was unaffected by B2. Collectively, the data suggest sequential ECM remodeling characterized by early deadhesion and delayed reconstructive activity that appear to contribute to the RBE.	[Hyldahl, Robert D.; Welling, Tyson; Groscost, Logan; Parcell, Allen C.] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA; [Nelson, Brad] Ohio Dominican Univ, Dept Nat Sci, Columbus, OH USA; [Xin, Ling; Chipkin, Stuart; Clarkson, Priscilla M.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Hubal, Monica J.] George Washington Univ, Dept Integrat Syst Biol, Washington, DC USA	Brigham Young University; Ohio Dominican University; University of Massachusetts System; University of Massachusetts Amherst; George Washington University	Hyldahl, RD (corresponding author), Brigham Young Univ, Dept Exercise Sci, 106 SFH, Provo, UT 84602 USA.	robhyldahl@byu.edu	Nelson, Brad/P-8771-2016; Hyldahl, Robert/AAZ-3960-2020	Nelson, Brad/0000-0003-0793-2006; Hubal, Monica/0000-0001-6579-6036				Beaton LJ, 2002, J PHYSIOL-LONDON, V544, P849, DOI 10.1113/jphysiol.2002.022350; Boppart MD, 2008, AM J PHYSIOL-REG I, V295, pR1623, DOI 10.1152/ajpregu.00089.2008; Boppart MD, 2006, AM J PHYSIOL-CELL PH, V290, pC1660, DOI 10.1152/ajpcell.00317.2005; Breen EC, 1996, J APPL PHYSIOL, V81, P355, DOI 10.1152/jappl.1996.81.1.355; Cao Y, 2003, MOL CELL BIOL, V23, P6725, DOI 10.1128/MCB.23.19.6725-6738.2003; Crameri RM, 2004, MATRIX BIOL, V23, P259, DOI 10.1016/j.matbio.2004.05.009; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Gavin TP, 2001, J APPL PHYSIOL, V90, P1219, DOI 10.1152/jappl.2001.90.4.1219; Grounds MD, 2005, SCAND J MED SCI SPOR, V15, P381, DOI 10.1111/j.1600-0838.2005.00467.x; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2013, SCAND J MED SCI SPOR, V23, pe150, DOI 10.1111/j.1600-0838.2011.01414.x; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Hubal MJ, 2008, AM J PHYSIOL-REG I, V294, pR1628, DOI 10.1152/ajpregu.00853.2007; Hyldahl RD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00485; Hyldahl RD, 2014, MUSCLE NERVE, V49, P155, DOI 10.1002/mus.24077; Hyldahl RD, 2011, FASEB J, V25, P2956, DOI 10.1096/fj.10-177105; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; LAPIER TK, 1995, J APPL PHYSIOL, V78, P1065, DOI 10.1152/jappl.1995.78.3.1065; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Macaluso F, 2013, MUSCLE NERVE, V48, P109, DOI 10.1002/mus.23721; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; Mackey AL, 2004, J APPL PHYSIOL, V97, P197, DOI 10.1152/japplphysiol.01174.2003; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; McHugh MP, 2003, SCAND J MED SCI SPOR, V13, P88, DOI 10.1034/j.1600-0838.2003.02477.x; McKay BR, 2010, J PHYSIOL-LONDON, V588, P3307, DOI 10.1113/jphysiol.2010.190876; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Mukund K, 2014, MUSCLE NERVE, V50, P744, DOI 10.1002/mus.24211; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; NOSAKA K, 1995, MED SCI SPORT EXER, V27, P1263; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Paulsen G, 2012, EXERC IMMUNOL REV, V18, P42; Paulsen G, 2010, MED SCI SPORT EXER, V42, P75, DOI 10.1249/MSS.0b013e3181ac7adb; Raastad T, 2010, MED SCI SPORT EXER, V42, P86, DOI 10.1249/MSS.0b013e3181ac7afa; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Smith LR, 2013, WIRES SYST BIOL MED, V5, P55, DOI 10.1002/wsbm.1197; Stupka N, 2001, J APPL PHYSIOL, V91, P1669, DOI 10.1152/jappl.2001.91.4.1669; Thomas K, 2015, CONNECT TISSUE RES, V56, P1, DOI 10.3109/03008207.2014.947369; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang Y, 2012, J APPL PHYSIOL, V113, P1884, DOI 10.1152/japplphysiol.01514.2011; WATT DJ, 1987, ANAT EMBRYOL, V175, P527, DOI 10.1007/BF00309688	43	81	83	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2894	2904		10.1096/fj.14-266668	http://dx.doi.org/10.1096/fj.14-266668			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25808538				2022-12-26	WOS:000356859100019
J	Chi, X; Shetty, SK; Shows, HW; Hjelmaas, AJ; Malcolm, EK; Davies, BSJ				Chi, Xun; Shetty, Shwetha K.; Shows, Hannah W.; Hjelmaas, Alexander J.; Malcolm, Emily K.; Davies, Brandon S. J.			Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Lipase; Lipolysis; Lipoprotein Metabolism; Triglyceride	ACTIVATED RECEPTOR-GAMMA; ADIPOSE-TISSUE; IN-VIVO; RICH LIPOPROTEINS; TARGET GENE; PROTEINS 3; ANGPTL4; PLASMA; CHYLOMICRONEMIA; INCREASES	Background: Lipoprotein lipase (LPL) function is modified by interactions with its transporter GPIHBP1 and the inhibitor angiopoietin-like 4 (ANGPTL4). Results: ANGPTL4 inactivated GPIHBP1-bound LPL. Inactivated LPL could not bind GPIHBP1. Conclusion: ANGPTL4 inactivation of LPL reduces the affinity of LPL for GPIHBP1 causing dissociation. Significance: Understanding ANGPTL4's interactions with LPL in a physiological context is vital to clarifying ANGPTL4's role in triglyceride metabolism. The release of fatty acids from plasma triglycerides for tissue uptake is critically dependent on the enzyme lipoprotein lipase (LPL). Hydrolysis of plasma triglycerides by LPL can be disrupted by the protein angiopoietin-like 4 (ANGPTL4), and ANGPTL4 has been shown to inactivate LPL in vitro. However, in vivo LPL is often complexed to glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) on the surface of capillary endothelial cells. GPIHBP1 is responsible for trafficking LPL across capillary endothelial cells and anchors LPL to the capillary wall during lipolysis. How ANGPTL4 interacts with LPL in this context is not known. In this study, we investigated the interactions of ANGPTL4 with LPL-GPIHBP1 complexes on the surface of endothelial cells. We show that ANGPTL4 was capable of binding and inactivating LPL complexed to GPIHBP1 on the surface of endothelial cells. Once inactivated, LPL dissociated from GPIHBP1. We also show that ANGPTL4-inactivated LPL was incapable of binding GPIHBP1. ANGPTL4 was capable of binding, but not inactivating, LPL at 4 degrees C, suggesting that binding alone was not sufficient for ANGPTL4's inhibitory activity. We observed that although the N-terminal coiled-coil domain of ANGPTL4 by itself and full-length ANGPTL4 both bound with similar affinities to LPL, the N-terminal fragment was more potent in inactivating both free and GPIHBP1-bound LPL. These results led us to conclude that ANGPTL4 can both bind and inactivate LPL complexed to GPIHBP1 and that inactivation of LPL by ANGPTL4 greatly reduces the affinity of LPL for GPIHBP1.	Univ Iowa, Dept Biochem, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; Univ Iowa, Obes Res & Educ Initiat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Davies, BSJ (corresponding author), Univ Iowa, Dept Biochem, 169 Newton Rd,PBDB 3326, Iowa City, IA 52242 USA.	Brandon-davies@uiowa.edu		Shetty, Shwetha Kumari/0000-0003-1762-8040; Davies, Brandon/0000-0002-7168-8522; Cushing, Emily/0000-0002-9495-802X	American Heart Association	American Heart Association(American Heart Association)	This work was supported by a grant from the American Heart Association Scientist Development (to B. S. J. D.).	Adhikary T, 2013, ONCOGENE, V32, P5241, DOI 10.1038/onc.2012.549; Basu D, 2011, J LIPID RES, V52, P826, DOI 10.1194/jlr.D010744; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Charriere S, 2011, J CLIN ENDOCR METAB, V96, pE1675, DOI 10.1210/jc.2011-1444; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Coca-Prieto I, 2011, J INTERN MED, V270, P224, DOI 10.1111/j.1365-2796.2011.02361.x; Davies BSJ, 2008, MOL ENDOCRINOL, V22, P2496, DOI 10.1210/me.2008-0146; Davies BSJ, 2012, J LIPID RES, V53, P2690, DOI 10.1194/jlr.M031559; Davies BSJ, 2012, CURR OPIN LIPIDOL, V23, P35, DOI 10.1097/MOL.0b013e32834d0b33; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Dijk W, 2014, TRENDS ENDOCRIN MET, V25, P146, DOI 10.1016/j.tem.2013.12.005; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Gin P, 2011, ARTERIOSCL THROM VAS, V31, P176, DOI 10.1161/ATVBAHA.110.214718; Goulbourne CN, 2014, CELL METAB, V19, P849, DOI 10.1016/j.cmet.2014.01.017; Jonker JT, 2013, AM J CLIN NUTR, V97, P255, DOI 10.3945/ajcn.112.043687; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lafferty MJ, 2013, J BIOL CHEM, V288, P28524, DOI 10.1074/jbc.M113.497602; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Mehta N, 2014, ARTERIOSCL THROM VAS, V34, P1057, DOI 10.1161/ATVBAHA.113.302802; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Merkel M, 2002, J BIOL CHEM, V277, P7405, DOI 10.1074/jbc.M107914200; Mitrou P, 2010, INT J OBESITY, V34, P770, DOI 10.1038/ijo.2009.293; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; OLIVECRONA G, 1995, CURR OPIN LIPIDOL, V6, P291, DOI 10.1097/00041433-199510000-00009; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Olivecrona T, 2009, CELLULAR LIPID METABOLISM, P315, DOI 10.1007/978-3-642-00300-4_13; REINA M, 1992, J LIPID RES, V33, P1823; Rios JJ, 2012, J INHERIT METAB DIS, V35, P531, DOI 10.1007/s10545-011-9406-5; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Smart-Halajko MC, 2010, ARTERIOSCL THROM VAS, V30, P2277, DOI 10.1161/ATVBAHA.110.212209; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; TAYLOR KG, 1979, DIABETOLOGIA, V16, P313, DOI 10.1007/BF01223620; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang Y, 2011, DIABETES, V60, P2041, DOI 10.2337/db11-0042; Weinstein MM, 2010, ARTERIOSCL THROM VAS, V30, P2106, DOI 10.1161/ATVBAHA.110.214403; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	50	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11865	11877		10.1074/jbc.M114.623769	http://dx.doi.org/10.1074/jbc.M114.623769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809481	Green Published, hybrid			2022-12-26	WOS:000354388600006
J	Choi, WS; Noh, JY; Baek, JH; Seo, YB; Lee, J; Song, JY; Park, DW; Lee, JS; Cheong, HJ; Kim, WJ				Choi, Won Suk; Noh, Ji Yun; Baek, Ji Hyeon; Seo, Yu Bin; Lee, Jacob; Song, Joon Young; Park, Dae Won; Lee, Jin Soo; Cheong, Hee Jin; Kim, Woo Joo			Suboptimal Effectiveness of the 2011-2012 Seasonal Influenza Vaccine in Adult Korean Populations	PLOS ONE			English	Article							UNITED-STATES; ANTIGEN; INFECTION; DIAGNOSIS; VIRUS	Background The effectiveness of the 2011-2012 seasonal influenza vaccine was evaluated in adult Korean populations with regard to how well it could prevent laboratory-confirmed influenza and influenza-related complications. Materials and Methods A retrospective case-control and retrospective cohort study was conducted among patients who visited four selected hospitals from September 2011 to May 2012. The analysis included 1,130 laboratory-confirmed influenza patients. For each influenza case, one control patient was chosen at a ratio of 1:1. A control was defined as an age group-matched patient who visited the same hospital with influenza-like illness within 48 hours of symptom onset but for whom laboratory tests were negative for influenza. Age group and visit date were matched between the cases and controls. Vaccine effectiveness (VE) was defined as [100 x (1-odds ratio for influenza in vaccinated versus non-vaccinated persons)]. The patients with laboratory-confirmed influenza were followed for at least one month through reviewing the medical records and conducting a telephone interview. Results The VE of the 2011-2012 seasonal influenza vaccine was 3.8% [95% confidence interval (CI), -16.5% to 20.6%] for preventing laboratory-confirmed influenza, -16.1% (95% CI, -48.3 to 9.1) for influenza A and 26.2%(95% CI, -2.6 to 46.2) for influenza B. The age-specific adjusted VE was 0.3% (95% CI, -29.4 to 23.1) among participants aged 19 to 49 years, 11.9% (95% CI, -34.3 to 42.2) among those aged 50 to 64 years and -3.9% (-60.1 to 32.5) among those aged >= 65 years. The adjusted VE for preventing any influenza-related complications was -10.7% (95% CI, -41.1% to 42.2%). Conclusions The 2011-2012 seasonal influenza vaccine was not effective in preventing laboratory-confirmed influenza or influenza-related complications in adult Korean populations.	[Choi, Won Suk; Noh, Ji Yun; Song, Joon Young; Park, Dae Won; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea; [Baek, Ji Hyeon; Lee, Jin Soo] Inha Univ, Div Infect Dis, Dept Internal Med, Coll Med, Inchon, South Korea; [Seo, Yu Bin; Lee, Jacob] Hallym Univ, Div Infect Dis, Dept Internal Med, Coll Med, Chunchon, South Korea; [Kim, Woo Joo] Transgovt Enterprise Pandem Influenza Korea, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Inha University; Hallym University	Cheong, HJ (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 136705, South Korea.	heejinmd@korea.ac.kr	Choi, Won Suk/V-2730-2017; Kim, Woo Joo/D-2733-2015	Choi, Won Suk/0000-0001-5874-4764; Kim, Woo Joo/0000-0002-4546-3880; Park, Dae Won/0000-0002-7653-686X; Song, Joon Young/0000-0002-0148-7194; Cheong, Hee Jin/0000-0002-2532-1463	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A103001]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	Funding: This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant No.: A103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, HLTH SECTION SECRETA, V87, P83; Biggs C, 2010, EMERG MED J, V27, P5, DOI 10.1136/emj.2009.078683; Cao WP, 2011, EXPERT REV VACCINES, V10, P1529, DOI [10.1586/ERV.11.137, 10.1586/erv.11.137]; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Choi WS, 2013, CLIN VACCINE IMMUNOL, V20, P877, DOI 10.1128/CVI.00009-13; Choi WS, 2011, YONSEI MED J, V52, P683, DOI 10.3349/ymj.2011.52.4.683; Dhankhar P, 2010, CLIN THER, V32, P1501, DOI 10.1016/j.clinthera.2010.07.019; Fedson DS, 2005, VACCINE, V23, P5133, DOI 10.1016/j.vaccine.2005.06.010; KCDC, 2012, INFL SENT SURV REP; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; Legrand J, 2006, VACCINE, V24, P6605, DOI 10.1016/j.vaccine.2006.05.063; Louie JK, 2010, EMERG INFECT DIS, V16, P824, DOI [10.3201/eid1605.091794, 10.3201/eid1605.091797]; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Noh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064295; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Rondy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059681; Sambhara S, 2009, CURR TOP MICROBIOL, V333, P413, DOI 10.1007/978-3-540-92165-3_20; Seo YB, 2013, VACCINE, V31, P1426, DOI 10.1016/j.vaccine.2012.10.024; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; Song JY, 2011, VACCINE, V29, P1395, DOI 10.1016/j.vaccine.2010.12.050; Talbot HK, 2013, CLIN INFECT DIS, V56, P1774, DOI 10.1093/cid/cit124; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Valenciano M, 2013, EUROSURVEILLANCE, V18, P12; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743	24	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0098716	10.1371/journal.pone.0098716	http://dx.doi.org/10.1371/journal.pone.0098716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815717	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600001
J	De Baets, S; Verhelst, J; Van den Hoecke, S; Smet, A; Schotsaert, M; Job, ER; Roose, K; Schepens, B; Fiers, W; Saelens, X				De Baets, Sarah; Verhelst, Judith; Van den Hoecke, Silvie; Smet, Anouk; Schotsaert, Michael; Job, Emma R.; Roose, Kenny; Schepens, Bert; Fiers, Walter; Saelens, Xavier			A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody	PLOS ONE			English	Article							NS1 PROTEIN; RECEPTOR SPECIFICITY; INFECTION; REPLICATION; GENERATION; CLEAVAGE; BINDING; MACROPHAGES; MORTALITY; DYNAMICS	The severity of influenza-related illness is mediated by many factors, including in vivo cell tropism, timing and magnitude of the immune response, and presence of pre-existing immunity. A direct way to study cell tropism and virus spread in vivo is with an influenza virus expressing a reporter gene. However, reporter gene-expressing influenza viruses are often attenuated in vivo and may be genetically unstable. Here, we describe the generation of an influenza A virus expressing GFP from a tri-cistronic NS segment. To reduce the size of this engineered gene segment, we used a truncated NS1 protein of 73 amino acids combined with a heterologous dimerization domain to increase protein stability. GFP and nuclear export protein coding information were fused in frame with the truncated NS1 open reading frame and separated from each other by 2A self-processing sites. The resulting PR8-NS1 (1-73) GFP virus was successfully rescued and replicated as efficiently as the parental PR8 virus in vitro and was slightly attenuated in vivo. Flow cytometry-based monitoring of cells isolated from PR8-NS1(1-73) GFP virus infected BALB/c mice revealed that GFP expression peaked on day two in all cell types tested. In particular respiratory epithelial cells and myeloid cells known to be involved in antigen presentation, including dendritic cells (CD11c(+)) and inflammatory monocytes (CD11b(+) GR1(+)), became GFP positive following infection. Prophylactic treatment with anti-M2e monoclonal antibody or oseltamivir reduced GFP expression in all cell types studied, demonstrating the usefulness of this reporter virus to analyze the efficacy of antiviral treatments in vivo. Finally, deep sequencing analysis, serial in vitro passages and ex vivo analysis of PR8-NS1(1-73) GFP virus, indicate that this virus is genetically and phenotypically stable.	[De Baets, Sarah; Verhelst, Judith; Van den Hoecke, Silvie; Smet, Anouk; Schotsaert, Michael; Job, Emma R.; Roose, Kenny; Schepens, Bert; Fiers, Walter; Saelens, Xavier] VIB, Dept Med Prot Res, Ghent, Belgium; [De Baets, Sarah; Verhelst, Judith; Van den Hoecke, Silvie; Smet, Anouk; Schotsaert, Michael; Job, Emma R.; Roose, Kenny; Schepens, Bert; Fiers, Walter; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Saelens, X (corresponding author), VIB, Dept Med Prot Res, Ghent, Belgium.	xavier.saelens@irc.vib-ugent.be	Saelens, Xavier/N-5728-2015; Schotsaert, Michael/AAA-9960-2020	Schotsaert, Michael/0000-0003-3156-3132; De Baets, Sarah/0000-0002-3094-4526; , Xavier/0000-0002-3861-6965	Agentschap voor innovatie door wetenschap en techniek (IWT) [81050, 83050]; Fonds wetenschappelijk onderzoek Vlaanderen (FWO-Vlaanderen); IUAP BELVIR [p7/45]; Ghent University Special Research Grant [BOF12/GOA/014]; EC FP7 project FLUNIVAC; Methusalem grant from Ghent University [BOF09/01M00709];  [FWO14/KAN/042]	Agentschap voor innovatie door wetenschap en techniek (IWT); Fonds wetenschappelijk onderzoek Vlaanderen (FWO-Vlaanderen)(FWO); IUAP BELVIR; Ghent University Special Research Grant; EC FP7 project FLUNIVAC; Methusalem grant from Ghent University; 	This work was supported by Agentschap voor innovatie door wetenschap en techniek (IWT) grants 81050 and 83050 to SDB, by Fonds wetenschappelijk onderzoek Vlaanderen (FWO-Vlaanderen) grants to BS and SVdH, by a FWO14/KAN/042 grant to BS, by IUAP BELVIR project p7/45 and by Ghent University Special Research Grant BOF12/GOA/014 to JV. KR is currently supported by EC FP7 project FLUNIVAC. The Flow Cytometer core facility at IRC is supported by a Methusalem grant (BOF09/01M00709) from Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Bender A, 1998, IMMUNOBIOLOGY, V198, P552, DOI 10.1016/S0171-2985(98)80078-8; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Chua MA, 2013, CELL REP, V3, P23, DOI 10.1016/j.celrep.2012.12.010; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; De Baets S, 2013, J VIROL, V87, P3314, DOI 10.1128/JVI.03019-12; de Graaf M, 2014, EMBO J, V33, P823, DOI 10.1002/embj.201387442; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Dougan SK, 2013, NATURE, V503, P406, DOI 10.1038/nature12637; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fujii K, 2005, J VIROL, V79, P3766, DOI 10.1128/JVI.79.6.3766-3774.2005; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Hartmann BM, 2013, J VIROL, V87, P1916, DOI 10.1128/JVI.02980-12; Hashimoto K, 2002, J VIROL, V76, P6743, DOI 10.1128/JVI.76.13.6743-6749.2002; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Hertz T, 2013, P NATL ACAD SCI USA, V110, P13492, DOI 10.1073/pnas.1221555110; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Katz JM, 2004, IMMUNOL RES, V29, P113, DOI 10.1385/IR:29:1-3:113; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; Kittel C, 2005, J VIROL, V79, P10672, DOI 10.1128/JVI.79.16.10672-10677.2005; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; Lakdawala SS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003971; Lakdawala SS, 2013, VIROLOGY, V446, P349, DOI 10.1016/j.virol.2013.08.011; Li F, 2010, J VIROL, V84, P12075, DOI 10.1128/JVI.00046-10; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Michiels B, 2011, VACCINE, V29, P9159, DOI 10.1016/j.vaccine.2011.08.008; Mueller SN, 2010, J VIROL, V84, P1847, DOI 10.1128/JVI.01317-09; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Pan WQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3369; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; Pena L, 2013, J VIROL, V87, P5118, DOI 10.1128/JVI.02490-12; PERCY N, 1994, J VIROL, V68, P4486, DOI 10.1128/JVI.68.7.4486-4492.1994; Poehling KA, 2013, PEDIATRICS, V131, P207, DOI 10.1542/peds.2012-1255; Qian XY, 1995, RNA, V1, P948; REED L. J., 1938, AMER JOUR HYG, V27, P493; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Schotsaert M, 2013, MUCOSAL IMMUNOL, V6, P276, DOI 10.1038/mi.2012.69; Short KR, 2012, J GEN VIROL, V93, P2315, DOI 10.1099/vir.0.045021-0; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Tran V, 2013, J VIROL, V87, P13321, DOI 10.1128/JVI.02381-13; Van den Hoecke S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1284-z; Wang XY, 2002, J VIROL, V76, P12951, DOI 10.1128/JVI.76.24.12951-12962.2002; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; Wolschek M, 2011, J VIROL, V85, P2469, DOI 10.1128/JVI.01650-10; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Young DF, 2003, J VIROL, V77, P2174, DOI 10.1128/JVI.77.3.2174-2181.2003	60	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121491	10.1371/journal.pone.0121491	http://dx.doi.org/10.1371/journal.pone.0121491			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816132	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600100
J	Karabanov, AN; Paine, R; Chao, CC; Schulze, K; Scott, B; Hallett, M; Mishkin, M				Karabanov, Anke Ninija; Paine, Rainer; Chao, Chi Chao; Schulze, Katrin; Scott, Brian; Hallett, Mark; Mishkin, Mortimer			Participation of the Classical Speech Areas in Auditory Long-Term Memory	PLOS ONE			English	Article							WORKING-MEMORY; IRRELEVANT SPEECH; WORD-LENGTH; RECOGNITION MEMORY; CORTEX; FMRI; INTERFERENCE; INFORMATION; SUPPRESSION; INTEGRATION	Accumulating evidence suggests that storing speech sounds requires transposing rapidly fluctuating sound waves into more easily encoded oromotor sequences. If so, then the classical speech areas in the caudalmost portion of the temporal gyrus (pSTG) and in the inferior frontal gyrus (IFG) may be critical for performing this acoustic-oromotor transposition. We tested this proposal by applying repetitive transcranial magnetic stimulation (rTMS) to each of these left-hemisphere loci, as well as to a nonspeech locus, while participants listened to pseudowords. After 5 minutes these stimuli were re-presented together with new ones in a recognition test. Compared to control-site stimulation, pSTG stimulation produced a highly significant increase in recognition error rate, without affecting reaction time. By contrast, IFG stimulation led only to a weak, non-significant, trend toward recognition memory impairment. Importantly, the impairment after pSTG stimulation was not due to interference with perception, since the same stimulation failed to affect pseudoword discrimination examined with short interstimulus intervals. Our findings suggest that pSTG is essential for transforming speech sounds into stored motor plans for reproducing the sound. Whether or not the IFG also plays a role in speech-sound recognition could not be determined from the present results.	[Karabanov, Anke Ninija; Scott, Brian; Mishkin, Mortimer] NIMH, Bethesda, MD 20892 USA; [Karabanov, Anke Ninija] Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Karabanov, Anke Ninija; Paine, Rainer; Chao, Chi Chao; Hallett, Mark] Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA; [Schulze, Katrin] UCL, Inst Child Hlth, London, England; [Chao, Chi Chao] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of London; University College London; National Taiwan University; National Taiwan University Hospital	Karabanov, AN (corresponding author), NIMH, Bethesda, MD 20892 USA.	ankenk@drcmr.dk	Scott, Brian H/G-7932-2012	Chao, Chi-Chao/0000-0001-6499-5789; Karabanov, Anke Ninija/0000-0003-1874-393X	NIH; Lundbeck Foundation [R59-2010-5399] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH001101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002669] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: Funding from a NIH intramural grants to Drs. Mortimer Mishkin and Mark Hallett. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DJ, 2011, J COGNITIVE NEUROSCI, V23, P1358, DOI 10.1162/jocn.2010.21519; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2002, Q J EXP PSYCHOL-A, V55, P353, DOI 10.1080/02724980143000523; Baddeley A.D., 1974, PSYCHOL LEARNING MOT; BADDELEY AD, 1975, J VERB LEARN VERB BE, V14, P575, DOI 10.1016/S0022-5371(75)80045-4; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Benjamin AS, 2004, J MEM LANG, V51, P159, DOI 10.1016/j.jml.2004.04.001; Buchsbaum BR, 2005, NEURON, V48, P687, DOI 10.1016/j.neuron.2005.09.029; Buchsbaum BR, 2011, BRAIN LANG, V119, P119, DOI 10.1016/j.bandl.2010.12.001; Buchsbaum BR, 2011, J COGNITIVE NEUROSCI, V23, P978, DOI 10.1162/jocn.2010.21496; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Di Lazzaro V, 2002, EXP BRAIN RES, V147, P108, DOI 10.1007/s00221-002-1223-5; Fiez JA, 1996, J NEUROSCI, V16, P808; Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002; Fritz J, 2005, P NATL ACAD SCI USA, V102, P9359, DOI 10.1073/pnas.0503998102; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Hall D, 2011, Q J EXP PSYCHOL, V64, P1580, DOI 10.1080/17470218.2011.564636; Henson R, 2003, Q J EXP PSYCHOL-A, V56, P1307, DOI 10.1080/02724980244000747; Herwig U, 2003, NEUROIMAGE, V20, P1032, DOI 10.1016/S1053-8119(03)00368-9; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; HIRSHMAN E, 1995, J EXP PSYCHOL LEARN, V21, P302; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Koelsch S, 2009, HUM BRAIN MAPP, V30, P859, DOI 10.1002/hbm.20550; Kowalska DM, 2001, NEUROSCIENCE, V104, P965, DOI 10.1016/S0306-4522(01)00140-3; Larsen JD, 2003, Q J EXP PSYCHOL-A, V56, P1249, DOI 10.1080/02724980244000765; Neath I, 1998, MEM COGNITION, V26, P343, DOI 10.3758/BF03201145; Nixon P, 2004, J COGNITIVE NEUROSCI, V16, P289, DOI 10.1162/089892904322984571; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Petrides M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000170; RATCLIFF R, 1990, J EXP PSYCHOL LEARN, V16, P163, DOI 10.1037/0278-7393.16.2.163; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Rogalsky C, 2011, J COGNITIVE NEUROSCI, V23, P1664, DOI 10.1162/jocn.2010.21530; Romero L, 2006, J COGNITIVE NEUROSCI, V18, P1147, DOI 10.1162/jocn.2006.18.7.1147; Sack AT, 2009, J COGNITIVE NEUROSCI, V21, P207, DOI 10.1162/jocn.2009.21126; Schendel ZA, 2007, MEM COGNITION, V35, P640, DOI 10.3758/BF03193302; Schulze K, 2012, P NATL ACAD SCI USA, V109, P7121, DOI 10.1073/pnas.1204717109; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Scott BH, 2012, P NATL ACAD SCI USA, V109, P12237, DOI 10.1073/pnas.1209685109; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Surprenant AM, 1999, MEMORY, V7, P405, DOI 10.1080/741944920; Takano B, 2004, NEUROIMAGE, V23, P849, DOI 10.1016/j.neuroimage.2004.06.032; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P3, DOI 10.3758/BF03194023; Yates Frances A., 1966, ART MEMORY	47	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119472	10.1371/journal.pone.0119472	http://dx.doi.org/10.1371/journal.pone.0119472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25815813	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600018
J	Radin, JM; Hawksworth, AW; Ortiguerra, RG; Brice, GT				Radin, Jennifer M.; Hawksworth, Anthony W.; Ortiguerra, Ryan G.; Brice, Gary T.			Seroprotective Antibodies to 2011 Variant Influenza A(H3N2v) and Seasonal Influenza A(H3N2) among Three Age Groups of US Department of Defense Service Members	PLOS ONE			English	Article							LONG-TERM IMMUNOGENICITY; UNITED-STATES; HUMAN INFECTIONS; IMMUNE-RESPONSE; H1N1 2009; VACCINE; VIRUS; ADULTS; EFFICACY; H3N2V	Background In 2011, a new variant of influenza A(H3N2) emerged that contained a recombination of genes from swine H3N2 viruses and the matrix (M) gene of influenza A(H1N1)pdm09 virus. New combinations and variants of pre-existing influenza viruses are worrisome if there is low or nonexistent immunity in a population, which increases chances for an outbreak or pandemic. Methods Sera collected in 2011 were obtained from US Department of Defense service members in three age groups: 19-21 years, 32-33 years, and 47-48 years. Pre- and post-vaccination samples were available for the youngest age group, and postvaccination samples for the two older groups. Specimens were tested using microneutralization assays for antibody titers against H3N2v (A/Indiana/10/2011) and seasonal H3N2 virus (A/Perth/16/2009). Results The youngest age group had significantly (p<0.05) higher geometric mean titers for H3N2v with 165 (95% confidence interval [CI]: 105-225) compared with the two older groups, aged 32-33 and 47-48 years, who had geometric mean titers of 68 (95% CI: 55-82) and 46 (95% CI: 24-65), respectively. Similarly, the youngest age group also had the highest geometric mean titers for seasonal H3N2. In the youngest age group, the proportion of patients who seroconverted after vaccination was 12% for H3N2v and 27% for seasonal H3N2. Discussion Our results were similar to previous studies that found highest seroprotection among young adults and decreasing titers among older adults. The proportion of 19- to 21-year-olds who seroconverted after seasonal vaccination was low and similar to previous findings. Improving our understanding of H3N2v immunity among different age groups in the United States can help inform vaccination plans if H3N2v becomes more transmissible in the future.	[Radin, Jennifer M.; Hawksworth, Anthony W.; Ortiguerra, Ryan G.; Brice, Gary T.] Naval Hlth Res Ctr, Operat Infect Dis Dept, San Diego, CA 92106 USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Radin, JM (corresponding author), Naval Hlth Res Ctr, Operat Infect Dis Dept, San Diego, CA 92106 USA.	jennifer.radin@med.navy.mil		Radin, Jennifer/0000-0003-3843-0842	Department of Defense Global Emerging Infections Surveillance and Response System under Work Unit [60805]; US Government	Department of Defense Global Emerging Infections Surveillance and Response System under Work Unit; US Government	Report number 14-29, supported by Department of Defense Global Emerging Infections Surveillance and Response System under Work Unit No. 60805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Jennifer Radin, Mr. Anthony Hawksworth, and Mr. Ryan Ortiguerra are employed by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and are funded to do this work by the US Government. CDR Gary Brice is a military service member. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the US Government. Approved for public release; distribution is unlimited. US Government Work (17 USC 105). Not copyrighted in the US. This research has been conducted in compliance with all applicable federal regulations governing the protection of human subjects in research (Protocol NHRC.2013.0025).	Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Barria MI, 2013, J INFECT DIS, V207, P115, DOI 10.1093/infdis/jis641; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; Biggerstaff M, 2013, CLIN INFECT DIS, V57, pS12, DOI 10.1093/cid/cit273; BLACK SC, 2011, AM POETRY REV, V40, P30, DOI DOI 10.1097/INF.0B013E3182367662; Centers for Disease Control and Prevention (CDC), 2012, MMWR-MORBID MORTAL W, V16, P237; Chan KH, 2011, CLIN VACCINE IMMUNOL, V18, P867, DOI 10.1128/CVI.00555-10; Epperson S, 2013, CLIN INFECT DIS, V57, pS4, DOI 10.1093/cid/cit272; Faix DJ, 2012, PLOS ONE, V7, pe3481; Houser KV, 2013, J VIROL, V87, P1261, DOI 10.1128/JVI.02625-12; Huijskens E, 2011, CLIN VACCINE IMMUNOL, V18, P1401, DOI 10.1128/CVI.05046-11; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; Kelly H, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0UMAL.P0NE.0021828; Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; Phillips CJ, 2013, CLIN INFECT DIS, V56, P11, DOI 10.1093/cid/cis860; Richards S., 2011, Morbidity and Mortality Weekly Report, V60, P1741; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Skowronski DM, 2012, EUROSURVEILLANCE, V17, P2; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Song JY, 2013, CLIN VACCINE IMMUNOL, V20, P513, DOI 10.1128/CVI.00725-12; Song JY, 2010, VACCINE, V28, P3929, DOI 10.1016/j.vaccine.2010.03.067; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; Waalen K, 2012, EUROSURVEILLANCE, V17, P5; Word Health Organization, 2010, REC VIR INFL VACC US	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121037	10.1371/journal.pone.0121037	http://dx.doi.org/10.1371/journal.pone.0121037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816244	Green Submitted, gold, Green Published			2022-12-26	WOS:000352133600061
J	Nguyen, TKA; Reinink, P; El Messlaki, C; Im, JS; Ercan, A; Porcelli, SA; Van Rhijn, I				Thi Kim Anh Nguyen; Reinink, Peter; El Messlaki, Chema; Im, Jin S.; Ercan, Altan; Porcelli, Steven A.; Van Rhijn, Ildiko			Expression Patterns of Bovine CD1 In Vivo and Assessment of the Specificities of the Anti-Bovine CD1 Antibodies	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; CELLS; PROTEINS; MOLECULES; RESPONSES; CLUSTER; FAMILY; GENES	Research addressing the in vivo effects of T cell activation by lipids, glycolipids, and lipopeptides is hampered by the absence of a suitable animal model. Mice and rats do not express CD1a, CD1b, and CD1c molecules that present pathogen-derived lipid antigens in humans. In cattle, two CD1A and three CD1B genes are transcribed. The proteins encoded by these genes differ in their antigen binding domains and in their cytoplasmic tails, suggesting that they may traffic differently in the cell and thus have access to different antigens. In the current study, we describe the genomic organization of the bovine CD1 locus and transcription of bovine CD1 genes in freshly isolated dendritic cells and B cells from different tissues. After determining the specificity of previously only partly characterized anti-CD1 antibodies by testing recombinant single chain bovine CD1 proteins and CD1-transfected cells, we were able to determine cell surface protein expression on freshly isolated cells. Our study suggests that CD1b1 and CD1b3 are more broadly expressed than CD1b5, and CD1a2 is more broadly expressed than CD1a1. Pseudoafferent lymph dendritic cells express CD1B genes, but no transcription is detected in lymph nodes. Even though B cells transcribe CD1B genes, there is no evidence of protein expression at the cell surface. Thus, patterns of CD1 protein expression are largely conserved among species.	[Thi Kim Anh Nguyen; Reinink, Peter; El Messlaki, Chema; Van Rhijn, Ildiko] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Im, Jin S.] Univ Texas MD Anderson Canc Ctr, Sect Transplant Immunol, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Ercan, Altan; Van Rhijn, Ildiko] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Utrecht University; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Van Rhijn, I (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands.	i.vanrhijn@uu.nl	Ercan, Altan/AGO-4238-2022	Van Rhijn, Ildiko/0000-0002-1446-5701; Reinink, Peter/0000-0002-9836-1335; Nguyen, Thi Kim-Anh/0000-0002-2202-8659	Nederlands Wetenschappelijk Onderzoek [824.02.002, 836.08.001]	Nederlands Wetenschappelijk Onderzoek	This work was supported by Nederlands Wetenschappelijk Onderzoek, grant 824.02.002 and 836.08.001 to IVR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dascher CC, 1999, J IMMUNOL, V163, P5478; de Jong A, 2014, NAT IMMUNOL, V15, P177, DOI 10.1038/ni.2790; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; DUTIA BM, 1991, VET IMMUNOL IMMUNOP, V27, P189, DOI 10.1016/0165-2427(91)90099-X; Girardi E, 2010, J IMMUNOL, V185, P376, DOI 10.4049/jimmunol.1000042; Hayes SM, 2001, J IMMUNOL, V166, P403, DOI 10.4049/jimmunol.166.1.403; Hiromatsu K, 2002, J IMMUNOL, V169, P330, DOI 10.4049/jimmunol.169.1.330; Hope JC, 2003, VET IMMUNOL IMMUNOP, V95, P21, DOI 10.1016/S0165-2427(03)00104-1; Hopkins J, 2000, VET IMMUNOL IMMUNOP, V73, P3, DOI 10.1016/S0165-2427(99)00159-2; HOWARD CJ, 1993, VET IMMUNOL IMMUNOP, V39, P25, DOI 10.1016/0165-2427(93)90161-V; Im JS, 2004, J BIOL CHEM, V279, P299, DOI 10.1074/jbc.M308803200; MACHUGH ND, 1988, SCAND J IMMUNOL, V27, P541, DOI 10.1111/j.1365-3083.1988.tb02381.x; MACKAY CR, 1985, IMMUNOLOGY, V55, P729; Nguyen TKA, 2009, VACCINE, V27, P4818, DOI 10.1016/j.vaccine.2009.05.078; OREILLY KL, 1989, IMMUNOLOGY, V67, P176; PARSONS KR, 1991, VET IMMUNOL IMMUNOP, V27, P201, DOI [10.1016/0165-2427(91)90076-O, 10.1016/0165-2427(91)90101-H]; Rhind SM, 1999, IMMUNOGENETICS, V49, P225, DOI 10.1007/s002510050483; Rhind SM, 1996, VET IMMUNOL IMMUNOP, V52, P265, DOI 10.1016/0165-2427(96)05576-6; Thi KAN, 2013, INT IMMUNOL, V25, P91, DOI 10.1093/intimm/dxs092; Thi KAN, 2011, VET IMMUNOL IMMUNOP, V142, P265, DOI 10.1016/j.vetimm.2011.05.016; van Beeck FAL, 2008, IMMUNOGENETICS, V60, P315, DOI 10.1007/s00251-008-0297-z; Van Rhijn I, 2007, J LEUKOCYTE BIOL, V81, P968, DOI 10.1189/jlb.0506331; Van Rhijn I, 2006, J IMMUNOL, V176, P4888, DOI 10.4049/jimmunol.176.8.4888; Van Rhijn I, 2009, EUR J IMMUNOL, V39, P3031, DOI 10.1002/eji.200939619; Wang JK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037647, 10.1371/journal.pone.0030209, 10.1371/journal.pone.0047127, 10.1371/journal.pone.0051808]; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121923	10.1371/journal.pone.0121923	http://dx.doi.org/10.1371/journal.pone.0121923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815476	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600128
J	Zhou, AF; He, YX; Wu, D; Zhang, XN; Zhang, C; Liu, ZH; Yu, JQ				Zhou, Aifeng; He, Yuxin; Wu, Duo; Zhang, Xiaonan; Zhang, Can; Liu, Zhonghui; Yu, Junqing			Changes in the Radiocarbon Reservoir Age in Lake Xingyun, Southwestern China during the Holocene	PLOS ONE			English	Article							ASIAN MONSOON; PLANT MACROFOSSILS; BULK-SEDIMENT; N-ALKANES; BLACK-SEA; EVOLUTION; VARIABILITY; CALIBRATION; GRADIENT; RECORDS	Chronology is a necessary component of paleoclimatology. Radiocarbon dating plays a central role in determining the ages of geological samples younger than ca. 50 ka BP. However, there are many limitations for its application, including radiocarbon reservoir effects, which may cause incorrect chronology in many lakes. Here we demonstrate temporal changes in the radiocarbon reservoir age of Lake Xingyun, Southwestern China, where radiocarbon ages based on bulk organic matter have been reported in previous studies. Our new radiocarbon ages, determined from terrestrial plant macrofossils suggest that the radiocarbon reservoir age changed from 960 to 2200 years during the last 8500 cal a BP years. These changes to the reservoir effect were associated with inputs from either pre-aged organic carbon or C-14-depleted hard water in Lake Xingyun caused by hydrological change in the lake system. The radiocarbon reservoir age may in return be a good indicator for the carbon source in lake ecosystems and depositional environment.	[Zhou, Aifeng; Wu, Duo; Zhang, Xiaonan; Zhang, Can] Lanzhou Univ, Collaborat Innovat Ctr Arid Environm & Climate Ch, MOE Key Lab Western Chinas Environm Syst, Lanzhou 730000, Peoples R China; [He, Yuxin] Zhejiang Univ, Dept Earth Sci, Hangzhou 310003, Zhejiang, Peoples R China; [He, Yuxin; Liu, Zhonghui] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Junqing] Chinese Acad Sci, Qinghai Inst Salt Lakes, Xining, Peoples R China	Lanzhou University; Zhejiang University; University of Hong Kong; Chinese Academy of Sciences; Qinghai Institute of Salt Lakes, CAS	Zhou, AF (corresponding author), Lanzhou Univ, Collaborat Innovat Ctr Arid Environm & Climate Ch, MOE Key Lab Western Chinas Environm Syst, Lanzhou 730000, Peoples R China.	zhouaf@lzu.edu.cn	Wu, Duo/ACI-5090-2022; Liu, Zhonghui/D-3163-2009	Liu, Zhonghui/0000-0002-2168-8305; Zhou, Aifeng/0000-0001-8349-8585	National Basic Research Program of China [2010CB950202]; National Natural Science Foundation of China [41271221, 41201203, 40571173]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China (No. 2010CB950202), the National Natural Science Foundation of China (Grant Nos. 41271221, 41201203, and 40571173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MB, 1996, QUATERNARY RES, V45, P300, DOI 10.1006/qres.1996.0031; An ZS, 2011, SCIENCE, V333, P719, DOI 10.1126/science.1203752; ANDREE M, 1986, RADIOCARBON, V28, P411, DOI 10.1017/S0033822200007529; Arnold L. D., 1995, DATING METHODS QUATE, V2, P107; Ascough PL, 2011, HOLOCENE, V21, P1073, DOI 10.1177/0959683611400466; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; Barnekow L, 1998, GFF, V120, P59, DOI 10.1080/11035899801201059; Bennike O, 2000, PALAEOGEOGR PALAEOCL, V155, P285, DOI 10.1016/S0031-0182(99)00121-2; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Bi XH, 2005, ORG GEOCHEM, V36, P1405, DOI 10.1016/j.orggeochem.2005.06.001; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Bondevik S, 2006, SCIENCE, V312, P1514, DOI 10.1126/science.1123300; Boyle JF, 2002, DEV PALEOENVIRON RES, V2, P83; BROWN TA, 1989, QUATERNARY RES, V32, P205, DOI 10.1016/0033-5894(89)90076-8; Chen FH, 2008, QUATERNARY SCI REV, V27, P351, DOI 10.1016/j.quascirev.2007.10.017; Chen FH, 2014, J QUATERNARY SCI, V29, P661, DOI 10.1002/jqs.2735; Child JK, 1999, GEOGR PHYS QUATERN, V53, P407, DOI 10.7202/004780ar; Colman SM, 1996, QUATERNARY SCI REV, V15, P669, DOI 10.1016/0277-3791(96)00027-3; Cook CG, 2013, BOREAS, V42, P224, DOI 10.1111/j.1502-3885.2012.00287.x; CRANWELL PA, 1987, ORG GEOCHEM, V11, P513, DOI 10.1016/0146-6380(87)90007-6; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Ficken KJ, 2000, ORG GEOCHEM, V31, P745, DOI 10.1016/S0146-6380(00)00081-4; Geyh MA, 1998, RADIOCARBON, V40, P475; GODWIN H, 1951, AM J SCI, V249, P301, DOI 10.2475/ajs.249.4.301; Grimm EC, 2009, QUATERNARY RES, V72, P301, DOI 10.1016/j.yqres.2009.05.006; Hall BL, 2001, EARTH PLANET SC LETT, V193, P565, DOI 10.1016/S0012-821X(01)00524-6; HAN J, 1969, P NATL ACAD SCI USA, V64, P436, DOI 10.1073/pnas.64.2.436; He YX, 2014, HOLOCENE, V24, P405, DOI 10.1177/0959683613519689; Heegaard E, 2005, HOLOCENE, V15, P612, DOI 10.1191/0959683605hl836rr; Henderson ACG, 2010, QUATERNARY SCI REV, V29, P2215, DOI 10.1016/j.quascirev.2010.05.019; Hodell DA, 1999, QUATERNARY RES, V52, P369, DOI 10.1006/qres.1999.2072; Hou JZ, 2012, QUATERNARY SCI REV, V48, P67, DOI 10.1016/j.quascirev.2012.06.008; Howarth JD, 2013, QUAT GEOCHRONOL, V17, P68, DOI 10.1016/j.quageo.2013.02.001; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Kwiecien O, 2008, RADIOCARBON, V50, P99, DOI 10.1017/S0033822200043393; Liu XQ, 2008, QUATERNARY SCI REV, V27, P867, DOI 10.1016/j.quascirev.2007.12.006; MACDONALD GM, 1991, ECOLOGY, V72, P1150, DOI 10.2307/1940612; MACDONALD GM, 1987, GEOLOGY, V15, P837, DOI 10.1130/0091-7613(1987)15<837:CRDOTP>2.0.CO;2; MANGERUD J, 1972, Boreas (Oslo), V1, P143; Mischke S, 2010, CHEM GEOL, V276, P95, DOI 10.1016/j.chemgeo.2010.06.003; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Sachse D, 2006, ORG GEOCHEM, V37, P469, DOI 10.1016/j.orggeochem.2005.12.003; Siani G, 2001, SCIENCE, V294, P1917, DOI 10.1126/science.1063649; Snyder J.A., 1994, SVALBARD HOLOCENE, V4, P413, DOI DOI 10.1177/095968369400400409; Song XL, 1994, PALEOLIMNOLOGICAL ST; Soulet G, 2011, QUATERNARY SCI REV, V30, P1019, DOI 10.1016/j.quascirev.2011.03.001; Stein M, 2004, RADIOCARBON, V46, P649, DOI 10.1017/S0033822200035700; Sutherland DG, 1980, STUDIES LATEGLACIAL, P139; WALKER D, 1986, J BIOGEOGR, V13, P477, DOI 10.2307/2844968; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Weete J.D., 1976, CHEM BIOCH NATURAL W, P349; WEI K, 1994, GEOCHIMICA, V23, P33; Yu SY, 2007, RADIOCARBON, V49, P1241, DOI 10.1017/S0033822200043150; Yu SY, 2014, RADIOCARBON, V56, P127, DOI 10.2458/56.16922; Zhou AF, 2009, RADIOCARBON, V51, P529, DOI 10.1017/S0033822200055909	58	23	25	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121532	10.1371/journal.pone.0121532	http://dx.doi.org/10.1371/journal.pone.0121532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815508	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600104
J	Hertel, R; Rodriguez, DP; Hollensteiner, J; Dietrich, S; Leimbach, A; Hoppert, M; Liesegang, H; Volland, S				Hertel, Robert; Rodriguez, David Pintor; Hollensteiner, Jacqueline; Dietrich, Sascha; Leimbach, Andreas; Hoppert, Michael; Liesegang, Heiko; Volland, Sonja			Genome-Based Identification of Active Prophage Regions by Next Generation Sequencing in Bacillus licheniformis DSM13	PLOS ONE			English	Article							DEFECTIVE PROPHAGE; SKIN ELEMENT; SUBTILIS; PBSX; BACTERIOPHAGES; SYSTEM; INDUCTION	Prophages are viruses, which have integrated their genomes into the genome of a bacterial host. The status of the prophage genome can vary from fully intact with the potential to form infective particles to a remnant state where only a few phage genes persist. Prophages have impact on the properties of their host and are therefore of great interest for genomic research and strain design. Here we present a genome-and next generation sequencing (NGS)-based approach for identification and activity evaluation of prophage regions. Seven prophage or prophage-like regions were identified in the genome of Bacillus licheniformis DSM13. Six of these regions show similarity to members of the Siphoviridae phage family. The remaining region encodes the B. licheniformis orthologue of the PBSX prophage from Bacillus subtilis. Analysis of isolated phage particles (induced by mitomycin C) from the wild-type strain and prophage deletion mutant strains revealed activity of the prophage regions BLi_Pp2 (PBSX-like), BLi_Pp3 and BLi_Pp6. In contrast to BLi_Pp2 and BLi_Pp3, neither phage DNA nor phage particles of BLi_Pp6 could be visualized. However, the ability of prophage BLi_Pp6 to generate particles could be confirmed by sequencing of particle-protected DNA mapping to prophage locus BLi_Pp6. The introduced NGS-based approach allows the investigation of prophage regions and their ability to form particles. Our results show that this approach increases the sensitivity of prophage activity analysis and can complement more conventional approaches such as transmission electron microscopy (TEM).	[Hertel, Robert; Rodriguez, David Pintor; Hollensteiner, Jacqueline; Dietrich, Sascha; Leimbach, Andreas; Hoppert, Michael; Liesegang, Heiko; Volland, Sonja] Univ Gottingen, Inst Microbiol & Genet, Dept Genom & Appl Microbiol, D-37073 Gottingen, Germany	University of Gottingen	Liesegang, H (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Genom & Appl Microbiol, D-37073 Gottingen, Germany.	hlieseg@gwdg.de; svollan@gwdg.de		Liesegang, Heiko/0000-0003-1792-2047; Hertel, Robert/0000-0003-4982-6084; Leimbach, Andreas/0000-0001-9077-1041; Hoppert, Dr., Michael/0000-0001-5277-3513	German Ministry of Education and Research (BMBF); Open Access Publication Funds of the Gottingen University	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Open Access Publication Funds of the Gottingen University	This work was funded by the German Ministry of Education and Research (BMBF, http://www.bmbf.de/) and publication was supported by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2012, ARCH VIROL, V157, P1843, DOI 10.1007/s00705-012-1383-y; Ackermann Hans-W, 2011, Bacteriophage, V1, P138; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Baumgart M, 2013, APPL ENVIRON MICROB, V79, P6006, DOI 10.1128/AEM.01634-13; Bondy-Denomy J, 2014, J MICROBIOL, V52, P235, DOI 10.1007/s12275-014-4083-3; Bose M., 2006, In Silico Biology, V6, P223; Briggs GS, 2012, J BACTERIOL, V194, P5162, DOI 10.1128/JB.00865-12; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; Casjens SR, 2005, CURR OPIN MICROBIOL, V8, P451, DOI 10.1016/j.mib.2005.06.014; Dawyndt P, 2005, IEEE T KNOWL DATA EN, V17, P1111, DOI 10.1109/TKDE.2005.131; DHAESE P, 1985, MOL GEN GENET, V200, P490, DOI 10.1007/BF00425736; Dietrich S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093677; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; HAAS M, 1969, J VIROL, V3, P233, DOI 10.1128/JVI.3.2.233-247.1969; Holzenburg A, 1998, ROYAL MICROSCOPICAL, P112; HUANG WM, 1970, J VIROL, V5, P237, DOI 10.1128/JVI.5.2.237-246.1970; Jin TT, 2014, ARCH VIROL, V159, P739, DOI 10.1007/s00705-013-1898-x; Kawasaki T, 2007, J BACTERIOL, V189, P5792, DOI 10.1128/JB.00540-07; Kimura T, 2010, J BACTERIOL, V192, P6209, DOI 10.1128/JB.00625-10; Krogh S, 1996, MICROBIOL-UK, V142, P2031, DOI 10.1099/13500872-142-8-2031; Krogh S, 1998, J BACTERIOL, V180, P2110, DOI 10.1128/JB.180.8.2110-2117.1998; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence JG, 2001, TRENDS MICROBIOL, V9, P535, DOI 10.1016/S0966-842X(01)02198-9; MCDONNELL GE, 1994, J BACTERIOL, V176, P5820, DOI 10.1128/JB.176.18.5820-5830.1994; MEYER BJ, 1975, P NATL ACAD SCI USA, V72, P4785, DOI 10.1073/pnas.72.12.4785; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Panis G, 2012, VIRUSES-BASEL, V4, P2417, DOI 10.3390/v4112417; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Pope WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069273; Rachinger M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00525-13; Rachinger M, 2013, J BIOTECHNOL, V167, P365, DOI 10.1016/j.jbiotec.2013.07.026; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAFER A, 1994, J BACTERIOL, V176, P7309; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sozhamannan S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-34; STEENSMA HY, 1978, A VAN LEEUW J MICROB, V44, P353, DOI 10.1007/BF00394312; STEENSMA HY, 1978, FEMS MICROBIOL LETT, V3, P313, DOI 10.1016/0378-1097(78)90016-2; Utter B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100502; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Waschkau B, 2008, APPL MICROBIOL BIOT, V78, P181, DOI 10.1007/s00253-007-1278-0; Wiegand S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-667; WOOD HE, 1990, J BACTERIOL, V172, P2667, DOI 10.1128/jb.172.5.2667-2674.1990; WUNSCHE L, 1989, ACTA BIOTECHNOL, V9, P395, DOI 10.1002/abio.370090502	52	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120759	10.1371/journal.pone.0120759	http://dx.doi.org/10.1371/journal.pone.0120759			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811873	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700060
J	Lin, HM; Kou, BQ; Li, XT; Wang, YJ; Ding, B; Shi, C; Liu, HH; Tang, RB; Sun, JQ; Yan, FH; Zhang, H				Lin, Huimin; Kou, Binquan; Li, Xiangting; Wang, Yujie; Ding, Bei; Shi, Chen; Liu, Huanhuan; Tang, Rongbiao; Sun, Jianqi; Yan, Fuhua; Zhang, Huan			Grating-Based Phase-Contrast Imaging of Tumor Angiogenesis in Lung Metastases	PLOS ONE			English	Article							SYNCHROTRON-RADIATION; AGENTS; INTERFEROMETER; CT; ANGIOGRAPHY; TOMOGRAPHY; SIGNATURES; CARCINOMA; MOUSE; RAT	Purpose To assess the feasibility of the grating-based phase-contrast imaging (GPI) technique for studying tumor angiogenesis in nude BALB/c mice, without contrast agents. Methods We established lung metastatic models of human gastric cancer by injecting the moderately differentiated SGC-7901 gastric cancer cell line into the tail vein of nude mice. Samples were embedded in a 10% formalin suspension and dried before imaging. Grating-based Xray phase-contrast images were obtained at the BL13W beamline of the Shanghai Synchrotron Radiation Facility (SSRF) and compared with histological sections. Results Without contrast agents, grating-based X-ray phase-contrast imaging still differentiated angiogenesis within metastatic tumors with high spatial resolution. Vessels, down to tens of microns, showed gray values that were distinctive from those of the surrounding tumors, which made them easily identifiable. The vessels depicted in the imaging study were similar to those identified on histopathology, both in size and shape. Conclusions Our preliminary study demonstrates that grating-based X-ray phase-contrast imaging has the potential to depict angiogenesis in lung metastases.	[Lin, Huimin; Ding, Bei; Shi, Chen; Liu, Huanhuan; Tang, Rongbiao; Yan, Fuhua; Zhang, Huan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200025, Peoples R China; [Kou, Binquan; Li, Xiangting; Wang, Yujie] Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200240, Peoples R China; [Sun, Jianqi] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, YJ (corresponding author), Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200240, Peoples R China.	yujiewang@sjtu.edu.cn; huanzhangy@126.com	wang, yujie/C-2582-2015; Kou, Binquan/O-8302-2016		Chinese National Science Foundation [11175121]; NSFC [81171312]; National Basic Research Program of China (973 Program) [2010CB834301]; Shanghai science and technology development fund [134119a5900]; Shanghai Jiao Tong University Biomedical Engineering Project [YG2011MS49, YG2012MS48]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai science and technology development fund; Shanghai Jiao Tong University Biomedical Engineering Project	The study was supported by the Chinese National Science Foundation no. 11175121, NSFC (No. 81171312) and the National Basic Research Program of China (973 Program; 2010CB834301). Shanghai science and technology development fund (No. 134119a5900), Shanghai Jiao Tong University Biomedical Engineering Project (No. YG2011MS49, YG2012MS48). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2013, ABDOM IMAGING, V38, P763, DOI 10.1007/s00261-012-9934-y; Badea CT, 2008, PHYS MED BIOL, V53, pR319, DOI 10.1088/0031-9155/53/19/R01; BONSE U, 1965, APPL PHYS LETT, V7, P99, DOI 10.1063/1.1754330; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang Y, 2013, CURR TOP MED CHEM, V13, P434; Chien CC, 2010, ANAL BIOANAL CHEM, V397, P2109, DOI 10.1007/s00216-010-3775-8; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Dillman JR, 2008, AM J ROENTGENOL, V190, P187, DOI 10.2214/AJR.07.2718; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Ford NL, 2003, MED PHYS, V30, P2869, DOI 10.1118/1.1617353; Gaass T, 2013, EPL, V102; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Itoh H, 2011, OPT EXPRESS, V19, P3339, DOI 10.1364/OE.19.003339; Jun HY, 2014, MICROSC RES TECH; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Laperle CM, 2008, PHYS MED BIOL, V53, P6911, DOI 10.1088/0031-9155/53/23/017; Li A, 2006, BRIT J RADIOL, V79, P368, DOI 10.1259/bjr/88469693; Li Bei-lei, 2013, Zhonghua Gan Zang Bing Za Zhi, V21, P684, DOI 10.3760/cma.j.issn.1007-3418.2013.09.009; Lusic H, 2013, CHEM REV, V113, P1641, DOI 10.1021/cr200358s; McDonald SA, 2009, J SYNCHROTRON RADIAT, V16, P562, DOI 10.1107/S0909049509017920; Missbach-Guentner J, 2011, INT J DEV BIOL, V55, P535, DOI 10.1387/ijdb.103229jm; Momose A, 2000, RADIOLOGY, V217, P593, DOI 10.1148/radiology.217.2.r00oc14593; Momose A, 1999, P SOC PHOTO-OPT INS, V3772, P188, DOI 10.1117/12.363720; MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Munch B, 2009, OPT EXPRESS, V17, P8567, DOI 10.1364/OE.17.008567; Ollila D W, 1998, Chest Surg Clin N Am, V8, P183; Patel N, 2012, FUTURE ONCOL, V8, P1443, DOI [10.2217/FON.12.136, 10.2217/fon.12.136]; Pfeiffer F, 2007, PHYS MED BIOL, V52, P6923, DOI 10.1088/0031-9155/52/23/010; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Richter CP, 2009, MICROSC RES TECHNIQ, V72, P902, DOI 10.1002/jemt.20728; Rubin R, 1996, US News World Rep, V120, P54; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; STARKEY JR, 1988, INT J CANCER, V42, P48, DOI 10.1002/ijc.2910420110; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; Takeda T, 2002, CIRCULATION, V105, P1708, DOI 10.1161/01.CIR.0000012752.35225.6C; Takeda T, 2000, RADIOLOGY, V214, P298, DOI 10.1148/radiology.214.1.r00ja08298; Takeda T, 2012, J SYNCHROTRON RADIAT, V19, P252, DOI 10.1107/S0909049511056226; Tang RB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02313; Tang RB, 2011, PHYS MED BIOL, V56, P3503, DOI 10.1088/0031-9155/56/12/004; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Turkbey B, 2009, AM J ROENTGENOL, V193, P304, DOI 10.2214/AJR.09.2869; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Wu J, 2013, DALTON T, V42, P7032, DOI 10.1039/c3dt50143d; Wu XM, 2011, ACTA PHARMACOL SIN, V32, P259, DOI 10.1038/aps.2010.204; Xi Y, 2012, J SYNCHROTRON RADIAT, V19, P821, DOI 10.1107/S0909049512029354; Zanette I, 2012, P NATL ACAD SCI USA, V109, P10199, DOI 10.1073/pnas.1117861109; Zhang X, 2008, PHYS MED BIOL, V53, P5735, DOI 10.1088/0031-9155/53/20/011; Zhu PP, 2010, P NATL ACAD SCI USA, V107, P13576, DOI 10.1073/pnas.1003198107	56	8	8	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121438	10.1371/journal.pone.0121438	http://dx.doi.org/10.1371/journal.pone.0121438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811626	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700102
J	Malik, SA; Qureshi, IM; Amir, M; Malik, AN; Haq, I				Malik, Suheel Abdullah; Qureshi, Ijaz Mansoor; Amir, Muhammad; Malik, Aqdas Naveed; Haq, Ihsanul			Numerical Solution to Generalized Burgers'-Fisher Equation Using Exp-Function Method Hybridized with Heuristic Computation	PLOS ONE			English	Article							DIFFERENTIAL QUADRATURE METHOD; SIMULATION; HUXLEY	In this paper, a new heuristic scheme for the approximate solution of the generalized Burgers'-Fisher equation is proposed. The scheme is based on the hybridization of Exp-function method with nature inspired algorithm. The given nonlinear partial differential equation (NPDE) through substitution is converted into a nonlinear ordinary differential equation (NODE). The travelling wave solution is approximated by the Exp-function method with unknown parameters. The unknown parameters are estimated by transforming the NODE into an equivalent global error minimization problem by using a fitness function. The popular genetic algorithm (GA) is used to solve the minimization problem, and to achieve the unknown parameters. The proposed scheme is successfully implemented to solve the generalized Burgers'-Fisher equation. The comparison of numerical results with the exact solutions, and the solutions obtained using some traditional methods, including adomian decomposition method (ADM), homotopy perturbation method (HPM), and optimal homotopy asymptotic method (OHAM), show that the suggested scheme is fairly accurate and viable for solving such problems.	[Malik, Suheel Abdullah; Amir, Muhammad; Malik, Aqdas Naveed; Haq, Ihsanul] Int Islamic Univ, Fac Engn & Technol, Dept Elect Engn, Islamabad, Pakistan; [Qureshi, Ijaz Mansoor] Air Univ, Dept Elect Engn, Islamabad, Pakistan	International Islamic University, Pakistan; Air University Islamabad	Malik, SA (corresponding author), Int Islamic Univ, Fac Engn & Technol, Dept Elect Engn, Islamabad, Pakistan.	suheel.abdullah@iiu.edu.pk		Haq, Ihsanul/0000-0002-5692-1250				Abu Arqub O, 2012, ABSTR APPL ANAL, DOI 10.1155/2012/205391; Assas LMB, 2009, J COMPUT APPL MATH, V233, P97, DOI 10.1016/j.cam.2009.07.016; Behrang MA., 2011, WORLD ACAD SCI ENG T, V49, P1098; Behzadi SS, 2011, MATH COMPUTATIONAL A, V6, P443; Caetano C, 2011, INT J QUANTUM CHEM, V111, P2732, DOI 10.1002/qua.22572; Chun C, 2008, J PHYS CONF SER, V96, DOI 10.1088/1742-6596/96/1/012217; Ebaid AEH, 2009, Z NATURFORSCH A, V64, P604, DOI 10.1515/zna-2009-9-1010; Ebaid A, 2012, J MATH ANAL APPL, V392, P1, DOI 10.1016/j.jmaa.2011.04.025; He JH, 2006, CHAOS SOLITON FRACT, V30, P700, DOI 10.1016/j.chaos.2006.03.020; Hu MS, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/252168; Ismail HNA, 2004, APPL MATH COMPUT, V159, P291, DOI 10.1016/j.amc.2003.10.050; Javidi M, 2006, INT MATH FORUM, V1, P1555, DOI DOI 10.12988/IMF.2006.06132; Jiwari R, 2013, APPL MATH COMPUT, V219, P6680, DOI 10.1016/j.amc.2012.12.035; Jiwari R, 2012, COMPUT PHYS COMMUN, V183, P2413, DOI 10.1016/j.cpc.2012.06.009; Jiwari R, 2012, COMPUT PHYS COMMUN, V183, P600, DOI 10.1016/j.cpc.2011.12.004; Khan JA, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/11/110205; Khattak AJ, 2009, APPL MATH MODEL, V33, P3718, DOI 10.1016/j.apm.2008.12.010; Kheiri H, 2010, ACTA U APULENSIS, V24, P35; Malek A, 2006, APPL MATH COMPUT, V183, P260, DOI 10.1016/j.amc.2006.05.068; Malik SA, 2013, RES J RECENT SCI, V2, P1; Malik SA., 2014, ADV STUD BIOL, V6, P99, DOI 10.12988/asb.2014.4520; Malik SA, 2013, J BASIC APPL SCI RES, V3, P10; Malik SA, 2012, J BASIC APPL SCI RES, V2, P11136; Malik SA, 2014, SCI WORLD J, DOI 10.1155/2014/837021; Mitchell M., 1995, Complexity, V1, P31; Mittal R., 2009, J APPL MATH MECH, V5, P1; Mittal RC, 2013, ENG COMPUTATION, V30, P117, DOI 10.1108/02644401311286071; Mittal RC, 2012, INT J NUMER METHOD H, V22, P880, DOI 10.1108/09615531211255761; Mittal RC, 2009, INT J COMPUT METH EN, V10, P450, DOI 10.1080/15502280903111424; Mittal RC, 2014, INT J COMPUTER MATH; Moghimi M, 2007, CHAOS SOLITON FRACT, V33, P1756, DOI 10.1016/j.chaos.2006.03.031; Nawaz R, 2013, J APPL MATH, DOI 10.1155/2013/387478; Ozis T, 2008, PHYS LETT A, V372, P3836, DOI 10.1016/j.physleta.2008.02.074; Raja MAZ, 2010, ANN MATH ARTIF INTEL, V60, P229, DOI 10.1007/s10472-010-9222-x; Rashidi MM, 2009, NUMER METH PART D E, V25, P409, DOI 10.1002/num.20350; Sari Murat, 2011, Mathematical & Computational Applications, V16, P477; Xu ZH, 2010, ACTA MATH APPL SIN-E, V26, P669, DOI 10.1007/s10255-010-0031-0	37	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121728	10.1371/journal.pone.0121728	http://dx.doi.org/10.1371/journal.pone.0121728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811858	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700131
J	Oliveira, KN; Coley, PD; Kursar, TA; Kaminski, LA; Moreira, MZ; Campos, RI				Oliveira, Karla N.; Coley, Phyllis D.; Kursar, Thomas A.; Kaminski, Lucas A.; Moreira, Marcelo Z.; Campos, Ricardo I.			The Effect of Symbiotic Ant Colonies on Plant Growth: A Test Using an Azteca-Cecropia System	PLOS ONE			English	Article							RAIN-FOREST; HERBIVORY; PROTECTION; MUTUALISM; BENEFITS; DEFENSE; AVAILABILITY; ONTOGENY; BEHAVIOR; FOOD	In studies of ant-plant mutualisms, the role that ants play in increasing the growth rates of their plant partners is potentially a key beneficial service. In the field, we measured the growth of Cecropia glaziovii saplings and compared individuals that were naturally colonized by Azteca muelleri ants with uncolonized plants in different seasons (wet and dry). We also measured light availability as well as attributes that could be influenced by the presence of Azteca colonies, such as herbivory, leaf nutrients (total nitrogen and delta N-15), and investments in defense (total phenolics and leaf mass per area). We found that colonized plants grew faster than uncolonized plants and experienced a lower level of herbivory in both the wet and dry seasons. Colonized plants had higher nitrogen content than uncolonized plants, although the d15N, light environment, total phenolics and leaf mass per area, did not differ between colonized and uncolonized plants. Since colonized and uncolonized plants did not differ in the direct defenses that we evaluated, yet herbivory was lower in colonized plants, we conclude that biotic defenses were the most effective protection against herbivores in our system. This result supports the hypothesis that protection provided by ants is an important factor promoting plant growth. Since C. glaziovii is widely distributed among a variety of forests and ecotones, and since we demonstrated a strong relationship with their ant partners, this system can be useful for comparative studies of ant-plant interactions in different habitats. Also, given this study was carried out near the transition to the subtropics, these results help generalize the geographic distribution of this mutualism and may shed light on the persistence of the interactions in the face of climate change.	[Oliveira, Karla N.; Campos, Ricardo I.] Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil; [Coley, Phyllis D.; Kursar, Thomas A.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Coley, Phyllis D.; Kursar, Thomas A.] Smithsonian Trop Res Inst, Panama City, Panama; [Kaminski, Lucas A.] Inst Biol Evolut CSIC UPF, Barcelona, Spain; [Moreira, Marcelo Z.] Univ Sao Paulo, CENA, Lab Ecol Isotop, Sao Paulo, Brazil	Universidade Federal de Vicosa; Utah System of Higher Education; University of Utah; Smithsonian Institution; Smithsonian Tropical Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Universidade de Sao Paulo	Campos, RI (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil.	ricardo.campos@ufv.br	Campos, Ricardo I/K-2395-2015; Moreira, Marcelo Z/D-4622-2013; Kaminski, Lucas A/J-9036-2012	Moreira, Marcelo Z/0000-0001-6769-5570; 	Brazilian National Council for Scientific and Technological Development (CNPq) [479576/2011-4]; Foundation of Support to the Research of Minas Gerais (FAPEMIG); CAPES [99999.000258/2014-08]; NSF [DEB-0444590]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation of Support to the Research of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NSF(National Science Foundation (NSF))	Financial support was provided by a grant from the Brazilian National Council for Scientific and Technological Development (CNPq - proc. #479576/2011-4) coordinated by RIC. KNO was supported by a national PhD fellowship from Foundation of Support to the Research of Minas Gerais (FAPEMIG) and an international PhD sandwich fellowship from CAPES-Processo no 99999.000258/2014-08. PDC and TAK's participation in this research was supported by NSF DEB-0444590.	[Anonymous], 2014, R LANG ENV STAT COMP; Barrie A., 1996, MASS SPECTROM SOILS, P1; Benson WW, 1985, AMAZONIA, P239; Berg C. C., 2005, FLORA NEOTROPICA MON, V94; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Close DC, 2002, OIKOS, V99, P166, DOI 10.1034/j.1600-0706.2002.990117.x; COLE RJ, 1973, SCIENCE, V179, P1324, DOI 10.1126/science.179.4080.1324; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLEY PD, 1986, OECOLOGIA, V70, P238, DOI 10.1007/BF00379246; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Crawley M. J, 2002, STAT COMPUTING INTRO; Davidson DW., 2005, FLORA NEOTROPICA MON, P214; Defossez E, 2011, P ROY SOC B-BIOL SCI, V278, P1419, DOI 10.1098/rspb.2010.1884; Defossez E, 2009, NEW PHYTOL, V182, P942, DOI 10.1111/j.1469-8137.2009.02793.x; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Dejean A, 2012, CR BIOL, V335, P214, DOI 10.1016/j.crvi.2012.01.002; Del Val E, 2003, PLANT ECOL, V169, P35, DOI 10.1023/A:1026227811685; Faveri SB, 2004, BIOTROPICA, V36, P641, DOI 10.1111/j.1744-7429.2004.tb00359.x; Fischer RC, 2003, J ECOL, V91, P126, DOI 10.1046/j.1365-2745.2003.00747.x; FOLGARAIT PJ, 1994, FUNCT ECOL, V8, P22, DOI 10.2307/2390107; Frederickson ME, 2005, OECOLOGIA, V143, P387, DOI 10.1007/s00442-004-1817-7; Freitas AVL, 1996, J ANIM ECOL, V65, P205, DOI 10.2307/5723; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Heil M, 2001, OECOLOGIA, V126, P404, DOI 10.1007/s004420000534; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hothorn T., 2008, MULTCOMP SIMULTANEOU; HUNTLY N, 1991, ANNU REV ECOL SYST, V22, P477, DOI 10.1146/annurev.ecolsys.22.1.477; IPCC, 2007, CONTRIBUTION WORKING; Janzen D.H., 1979, HERBIVORES THEIR INT, P331; JANZEN DH, 1969, ECOLOGY, V50, P147, DOI 10.2307/1934677; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Lamarre GPA, 2012, ECOLOGY, V93, pS195, DOI 10.1890/11-0397.1; LETOURNEAU DK, 1990, SCIENCE, V248, P215, DOI 10.1126/science.248.4952.215; LONGINO JT, 1989, BIOTROPICA, V21, P126, DOI 10.2307/2388703; LONGINO JT, 1991, ANT - PLANT INTERACTIONS, P271; Machado G, 2001, ECOL ENTOMOL, V26, P436, DOI 10.1046/j.1365-2311.2001.00328.x; MARQUIS RJ, 1984, SCIENCE, V226, P537, DOI 10.1126/science.226.4674.537; MARQUIS RJ, 1992, ECOLOGY, V73, P143, DOI 10.2307/1938727; Massad TJ, 2011, ARTHROPOD-PLANT INTE, V5, P125, DOI 10.1007/s11829-011-9121-z; Moraes SC, 2009, ECOLOGY, V90, P2375, DOI 10.1890/08-1274.1; Nishi AH, 2008, SOCIOBIOLOGY, V52, P367; Novotny V, 1998, OECOLOGIA, V115, P514, DOI 10.1007/s004420050549; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Poorter L, 2001, FUNCT ECOL, V15, P113, DOI 10.1046/j.1365-2435.2001.00503.x; Pringle EG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001705; RICKSON FR, 1976, AM J BOT, V63, P1266, DOI 10.2307/2441742; ROCHA CFD, 1992, OECOLOGIA, V91, P249, DOI 10.1007/BF00317792; Roux O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020538; Sagers CL, 2000, OECOLOGIA, V123, P582, DOI 10.1007/PL00008863; Santos Flavio A. M., 2000, Revista Brasileira de Botanica, V23, P133; SCHUPP EW, 1986, OECOLOGIA, V70, P379, DOI 10.1007/BF00379500; Silva Celice Alexandre, 2010, Braz. J. Bot., V33, P207, DOI 10.1590/S0100-84042010000200002; Silveira RD, 2002, REV BIOL TROP, V50, P117; Sposito TC, 2001, AM J BOT, V88, P939, DOI 10.2307/2657047; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Trager MD, 2006, J ECOL, V94, P1156, DOI 10.1111/j.1365-2745.2006.01165.x; Trager MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014308; Trimble ST, 2004, OECOLOGIA, V138, P74, DOI 10.1007/s00442-003-1406-1; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; Yu DW, 1997, ECOL MONOGR, V67, P273, DOI 10.1890/0012-9615(1997)067[0273:ESOSSI]2.0.CO;2	62	9	9	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120351	10.1371/journal.pone.0120351	http://dx.doi.org/10.1371/journal.pone.0120351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811369	Green Published, gold			2022-12-26	WOS:000356353700046
J	Shimizu, F; Nishihara, H; Sano, Y; Takeshita, Y; Takahashi, S; Maeda, T; Takahashi, T; Abe, M; Koga, M; Kanda, T				Shimizu, Fumitaka; Nishihara, Hideaki; Sano, Yasuteru; Takeshita, Yukio; Takahashi, Shiori; Maeda, Toshihiko; Takahashi, Toshiyuki; Abe, Masaaki; Koga, Michiaki; Kanda, Takashi			Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LESIONS; INTERLEUKIN-6; PERMEABILITY; DISTINCTION; AQUAPORIN-4; ACTIVATION; CHEMOKINES; ASTROCYTE; PROFILES	Objective Severe damage to the blood-brain barrier (BBB) allows anti-aquaporin 4 (AQP4) antibodies to access the astrocytic endfeet in neuromyelitis optica (NMO). In the current study, we identified the pathogenic cytokines/chemokines that are responsible for the BBB malfunction induced by NMO sera. Methods We measured the levels of 27 cytokines/chemokines in human brain microvascular endothelial cells (BMECs) after exposure to sera obtained from patients with the acute and stable phases of anti-AQP4 antibody-positive NMO spectrum disorder (NMOSD), multiple sclerosis (MS) patients and healthy controls (HC) using a multiplexed fluorescent bead-based immunoassay system. Results The induced protein (IP)-10 level in the cells was markedly increased following exposure to acute phase NMOSD sera. Other cytokines/chemokines including interleukin (IL)-6 and monocyte chemotactic protein (MCP)-1 were also significantly increased in the acute NMOSD group compared to both the MS and HC groups. The up-regulation of the IP-10 levels in the cells after exposure to the acute-phase NMOSD sera was also observed using another specified ELISA, and this effect was significantly decreased during the remission phase in the individual NMOSD patients. Furthermore, the increase in the level of IP-10 after exposure to the sera was significantly correlated with the cerebrospinal fluid/serum albumin ratio. Conclusions Sera from the acute phase of NMO markedly increased the autocrine secretion of IP-10 by BMECs. The over-production of IP-10 in BMECs may play an important role in the pathogenesis of NMO and may therefore help to mediate the trafficking of T cells expressing its receptor across the BBB.	[Shimizu, Fumitaka; Nishihara, Hideaki; Sano, Yasuteru; Takeshita, Yukio; Takahashi, Shiori; Maeda, Toshihiko; Abe, Masaaki; Koga, Michiaki; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan; [Takahashi, Toshiyuki] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan	Yamaguchi University; Tohoku University	Kanda, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan.	tkanda@yamaguchi-u.ac.jp	Koga, Michiaki/L-4825-2019; Nishihara, Hideaki/AAJ-7563-2021	Koga, Michiaki/0000-0002-1356-955X; Nishihara, Hideaki/0000-0002-2990-835X	Japan Society for the Promotion of Science, Tokyo, Japan [24790886, 22790821]; Ministry of Health, Labor and Welfare of Japan [K2002528]; Yamaguchi University Hospital; Grants-in-Aid for Scientific Research [26461271] Funding Source: KAKEN	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Yamaguchi University Hospital; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants (Nos. 24790886 and Nos. 22790821) from the Japan Society for the Promotion of Science, Tokyo, Japan and also by research grant (K2002528) from Health and Labor Sciences Research Grants for research on intractable diseases (Neuroimmunological Disease Research Committee) from the Ministry of Health, Labor and Welfare of Japan and also by the Translational Research Promotion Grant from Yamaguchi University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Ayzenberg I, 2013, JAMA NEUROL, V70, P394, DOI 10.1001/jamaneurol.2013.1246; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Fife BT, 2001, J IMMUNOL, V166, P7617, DOI 10.4049/jimmunol.166.12.7617; Haruki H, 2013, J NEUROL SCI, V331, P136, DOI 10.1016/j.jns.2013.05.035; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Icoz S, 2010, INT J NEUROSCI, V120, P71, DOI 10.3109/00207450903428970; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Kaplin AI, 2005, J CLIN INVEST, V115, P2731, DOI 10.1172/JCI25141; Kieseier BC, 2013, JAMA NEUROL, V70, P390, DOI 10.1001/jamaneurol.2013.668; Kitic Maja, 2013, Acta Neuropathol Commun, V1, P5, DOI 10.1186/2051-5960-1-5; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lucchinetti CF, 2014, BRAIN PATHOL, V24, P83, DOI 10.1111/bpa.12099; Matsushita T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061835; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Narikawa K, 2004, J NEUROIMMUNOL, V149, P182, DOI 10.1016/j.jneuroim.2003.12.010; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Pohl M, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-85; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Sharma R, 2010, ACTA NEUROPATHOL, V120, P223, DOI 10.1007/s00401-010-0704-z; Shimizu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092872; Shimizu F, 2013, ADV NEUROBIOL, V7, P157, DOI 10.1007/978-1-4614-8313-7_10; Shimizu F, 2012, J NEUROL NEUROSUR PS, V83, P288, DOI 10.1136/jnnp-2011-300434; Szczucinski A, 2007, ACTA NEUROL SCAND, V115, P137, DOI 10.1111/j.1600-0404.2006.00749.x; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Tasaki A, 2014, J NEUROL NEUROSUR PS, V85, P419, DOI 10.1136/jnnp-2013-305907; Thompson CD, 2013, J NEUROTRAUM, V30, P1311, DOI 10.1089/neu.2012.2651; Uzawa A, 2014, BRAIN PATHOL, V24, P67, DOI 10.1111/bpa.12097; Uzawa A, 2013, CLIN CHIM ACTA, V421, P181, DOI 10.1016/j.cca.2013.03.020; Uzawa A, 2011, ARCH NEUROL-CHICAGO, V68, P913, DOI 10.1001/archneurol.2011.148; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Yanagawa K, 2009, NEUROLOGY, V73, P1628, DOI 10.1212/WNL.0b013e3181c1deb9	37	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122000	10.1371/journal.pone.0122000	http://dx.doi.org/10.1371/journal.pone.0122000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811465	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700164
J	Amaral, CP; Simoes, MA; Castelo-Branco, MS				Amaral, Carlos P.; Simoes, Marco A.; Castelo-Branco, Miguel S.			Neural Signals Evoked by Stimuli of Increasing Social Scene Complexity Are Detectable at the Single-Trial Level and Right Lateralized	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; EVENT-RELATED POTENTIALS; FACIAL EXPRESSIONS; YOUNG-CHILDREN; GAZE; PERCEPTION; P300; EYE; FACES; ATTENTION	Classification of neural signals at the single-trial level and the study of their relevance in affective and cognitive neuroscience are still in their infancy. Here we investigated the neurophysiological correlates of conditions of increasing social scene complexity using 3D human models as targets of attention, which may also be important in autism research. Challenging single-trial statistical classification of EEG neural signals was attempted for detection of oddball stimuli with increasing social scene complexity. Stimuli had an oddball structure and were as follows: 1) flashed schematic eyes, 2) simple 3D faces flashed between averted and non-averted gaze (only eye position changing), 3) simple 3D faces flashed between averted and non-averted gaze (head and eye position changing), 4) animated avatar alternated its gaze direction to the left and to the right (head and eye position), 5) environment with 4 animated avatars all of which change gaze and one of which is the target of attention. We found a late (> 300 ms) neurophysiological oddball correlate for all conditions irrespective of their complexity as assessed by repeated measures ANOVA. We attempted single-trial detection of this signal with automatic classifiers and obtained a significant balanced accuracy classification of around 79%, which is noteworthy given the amount of scene complexity. Lateralization analysis showed a specific right lateralization only for more complex realistic social scenes. In sum, complex ecological animations with social content elicit neurophysiological events which can be characterized even at the single-trial level. These signals are right lateralized. These finding paves the way for neuroscientific studies in affective neuroscience based on complex social scenes, and given the detectability at the single trial level this suggests the feasibility of brain computer interfaces that can be applied to social cognition disorders such as autism.	[Amaral, Carlos P.; Simoes, Marco A.; Castelo-Branco, Miguel S.] Univ Coimbra, Fac Med, IBILI Inst Biomed Imaging Life Sci, Coimbra, Portugal; [Castelo-Branco, Miguel S.] Brain Imaging Network Portugal, ICNAS, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Castelo-Branco, MS (corresponding author), Univ Coimbra, Fac Med, IBILI Inst Biomed Imaging Life Sci, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Simões, Marco/U-3815-2019; Amaral, Carlos/J-4282-2019; Castelo-Branco, Miguel/F-3866-2019	Simões, Marco/0000-0003-3713-2464; Amaral, Carlos/0000-0002-0493-9192; Castelo-Branco, Miguel/0000-0003-4364-6373	 [CENTRO-07-5T24-FEDER-00205];  [1176470];  [59 Euros 20132015];  [FP7-HEALTH-2013-INNOVATION-1 - 602186 - BRAINTRAIN];  [FCT-UID/NEU/04539/2013]	; ; ; ; 	This work was supported by the following: CENTRO-07-5T24-FEDER-00205 From molecules to man: novel diagnostic imaging tools in neurological and psychiatric disorders 1176470, 59 Euros 20132015; FP7-HEALTH-2013-INNOVATION-1 - 602186 - BRAINTRAIN- Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders, Overall budget 6 million euros, UC budget 850.000 Euros; Hometec QREN -Assisted Living Autism 811417,85; Bial 133/2012 A direct test of the binding by synchrony hypothesis in humans: the neural correlates of coherent object perception, Bial Foundation, 2013, 44.000 Euros; and Bial 133/2012 The role of the core and extended face networks in visual perception and high level social cognition, Bial Foundation, 2013, 46.000 Euros; and grant FCT-UID/NEU/04539/2013, which covers the publication costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Bartels A, 2004, HUM BRAIN MAPP, V21, P75, DOI 10.1002/hbm.10153; Bayliss JD, 2000, NEUROCOMPUTING, V32, P637, DOI 10.1016/S0925-2312(00)00226-5; Bobes MA, 2004, COGN NEUROPSYCHOL, V21, P691, DOI 10.1080/02643290342000258; Bonda E, 1996, J NEUROSCI, V16, P3737; Brancucci A, 2009, PHILOS T R SOC B, V364, P895, DOI 10.1098/rstb.2008.0279; Campanella S, 2002, BIOL PSYCHOL, V59, P171, DOI 10.1016/S0301-0511(02)00005-4; Campbell R, 2001, COGNITIVE BRAIN RES, V12, P233, DOI 10.1016/S0926-6410(01)00054-4; Carlin JD, 2013, CURR OPIN NEUROBIOL, V23, P450, DOI 10.1016/j.conb.2012.11.014; Carlin JD, 2012, CEREB CORTEX, V22, P735, DOI 10.1093/cercor/bhr061; Chai H, 2012, NEUROPHYSIOL CLIN, V42, P369, DOI 10.1016/j.neucli.2012.04.087; Conty L, 2007, NEUROPSYCHOLOGIA, V45, P3024, DOI 10.1016/j.neuropsychologia.2007.05.017; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Donnerer M, 2010, PRESENCE-TELEOP VIRT, V19, P12, DOI 10.1162/pres.19.1.12; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fishman I, 2011, COGN NEUROSCI-UK, V2, P67, DOI 10.1080/17588928.2010.527434; Friesen CK, 2003, NEUROREPORT, V14, P489, DOI 10.1097/01.wnr.0000058776.36017.5d; Graewe B, 2013, CEREB CORTEX, V23, P2489, DOI 10.1093/cercor/bhs246; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Gunji A, 2013, BRAIN DEV-JPN, V35, P293, DOI 10.1016/j.braindev.2012.12.008; Hall DA, 2005, J COGNITIVE NEUROSCI, V17, P939, DOI 10.1162/0898929054021175; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; HENNIGHAUSEN E, 1993, ELECTROEN CLIN NEURO, V86, P199, DOI 10.1016/0013-4694(93)90008-J; Jones EA, 2006, BEHAV MODIF, V30, P782, DOI 10.1177/0145445506289392; Kaspar Kai, 2013, ISRN Neurosci, V2013, P868491, DOI 10.1155/2013/868491; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; Kleih SC, 2011, PROG BRAIN RES, V194, P27, DOI 10.1016/B978-0-444-53815-4.00019-4; Koegel RL, 2009, J AUTISM DEV DISORD, V39, P1240, DOI 10.1007/s10803-009-0732-5; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; Lahnakoski JM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00233; Laube I, 2011, NEUROIMAGE, V54, P1643, DOI 10.1016/j.neuroimage.2010.08.074; Mak JN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025003; Mason SG., 2012, BRAIN COMPUTER INTER, P190, DOI [DOI 10.1093/ACPROF:OSO/9780195388855.001.0001, 10.1093/acprof:oso/9780195388855.001.0001]; Mattout J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00114; Mosconi MW, 2005, NEUROIMAGE, V27, P247, DOI 10.1016/j.neuroimage.2005.03.027; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; Ojala M, 2009, IEEE DATA MINING, P908, DOI 10.1109/ICDM.2009.108; Onishi A., 2011, P 5 INT BRAIN COMP I, P192; Patel Salil H, 2005, Int J Med Sci, V2, P147; Pelphrey KA, 2004, PSYCHOL SCI, V15, P598, DOI 10.1111/j.0956-7976.2004.00726.x; Pelphrey KA, 2007, SOC COGN AFFECT NEUR, V2, P140, DOI 10.1093/scan/nsm010; Piccione F, 2008, PSYCHNOLOGY J, V6, P99; Pires G, 2012, CLIN NEUROPHYSIOL, V123, P1168, DOI 10.1016/j.clinph.2011.10.040; Pires G, 2011, J NEUROSCI METH, V195, P270, DOI 10.1016/j.jneumeth.2010.11.016; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Puce A, 1998, J NEUROSCI, V18, P2188; Rebola J, 2012, NEUROPSYCHOLOGIA, V50, P3693, DOI 10.1016/j.neuropsychologia.2012.06.020; Ricciardelli P, 2002, NEUROPSYCHOLOGIA, V40, P769, DOI 10.1016/S0028-3932(01)00190-7; Rice K, 2012, J AM ACAD CHILD PSY, V51, P238, DOI 10.1016/j.jaac.2011.12.017; Sachs G, 2004, PSYCHIAT RES-NEUROIM, V131, P249, DOI 10.1016/j.pscychresns.2004.05.005; Salva OR, 2007, BEHAV BRAIN RES, V177, P15, DOI 10.1016/j.bbr.2006.11.020; Salva OR, 2012, COMP COGN BEHAV REV, V7, P110, DOI 10.3819/ccbr.2012.70006; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Semrud-Clikeman M, 2011, NEUROPSYCHOBIOLOGY, V64, P47, DOI 10.1159/000325075; Senju A, 2005, NEUROPSYCHOLOGIA, V43, P1297, DOI 10.1016/j.neuropsychologia.2004.12.002; Siniscalchi M, 2013, BIOL BEHAV BRAIN ASY, P1, DOI [10.1080/1357650X.2013.833214, DOI 10.1080/1357650X.2013.833214]; Stoesz BM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00193; Susac A, 2004, BRAIN TOPOGR, V16, P265; Tangermann M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00055; Teixeira M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086201; van der Heijden F, 2004, JOURNAL OF TIME SERI; Wainer AL, 2011, RES AUTISM SPECT DIS, V5, P96, DOI 10.1016/j.rasd.2010.08.002; Wang PT, 2012, ARXIV PREPR ARXIV121, P1; Whalen C, 2006, J AUTISM DEV DISORD, V36, P655, DOI 10.1007/s10803-006-0108-z; Zhang Y, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026018	74	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121970	10.1371/journal.pone.0121970	http://dx.doi.org/10.1371/journal.pone.0121970			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807525	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000193
J	Battaile, BC; Sakamoto, KQ; Nordstrom, CA; Rosen, DAS; Trites, AW				Battaile, Brian C.; Sakamoto, Kentaro Q.; Nordstrom, Chad A.; Rosen, David A. S.; Trites, Andrew W.			Accelerometers Identify New Behaviors and Show Little Difference in the Activity Budgets of Lactating Northern Fur Seals (Callorhinus ursinus) between Breeding Islands and Foraging Habitats in the Eastern Bering Sea	PLOS ONE			English	Article							ACCELERATION DATA; TACTICS	We tagged 82 lactating northern fur seals (Callorhinus ursinus) with tri-axial accelerometers and magnetometers on two eastern Bering Sea islands (Bogoslof and St. Paul) with contrasting population trajectories. Using depth data, accelerometer data and spectral analysis we classified time spent diving (30%), resting (similar to 7%), shaking and grooming their pelage (9%), swimming in the prone position (similar to 10%) and two types of previously undocumented rolling behavior (29%), with the remaining time (similar to 15%) unspecified. The reason for the extensive rolling behavior is not known. We ground-truthed the accelerometry signals for shaking and grooming and rolling behaviors and identified the acceleration signal for porpoising by filming tagged northern fur seals in captivity. Speeds from GPS interpolated data indicated that animals traveled fastest while in the prone position, suggesting that this behavior is indicative of destination-based swimming. Very little difference was found in the percentages of time spent in the categorical behaviors with respect to breeding islands (Bogoslof or St. Paul Island), forager type (cathemeral or nocturnal), and the region where the animals foraged (primarily on-shelf <200m, or off-shelf > 200m). The lack of significant differences between islands, regions and forager type may indicate that behaviors summarized over a trip are somewhat hardwired even though foraging trip length and when and where animals dive are known to vary with island, forager type and region.	[Battaile, Brian C.; Nordstrom, Chad A.; Rosen, David A. S.; Trites, Andrew W.] Univ British Columbia, Fisheries Ctr, Marine Mammal Res Unit, Aquat Ecosyst Res Lab, Vancouver, BC V5Z 1M9, Canada; [Sakamoto, Kentaro Q.] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan	University of British Columbia; Hokkaido University	Battaile, BC (corresponding author), Univ British Columbia, Fisheries Ctr, Marine Mammal Res Unit, Aquat Ecosyst Res Lab, Vancouver, BC V5Z 1M9, Canada.	bbattaile@usgs.gov	Sakamoto, Kentaro/N-7424-2019; Sakamoto, Kentaro/A-4843-2012	Sakamoto, Kentaro/0000-0002-8499-799X; Sakamoto, Kentaro/0000-0002-8499-799X; Trites, Andrew/0000-0003-0342-5322	U.S. National Science Foundation; North Pacific Research Board	U.S. National Science Foundation(National Science Foundation (NSF)); North Pacific Research Board	This work was conducted as part of the Bering Sea Integrated Research Program (BSIERP) patch dynamics project, funded jointly by the U.S. National Science Foundation and the North Pacific Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Boogaart KG, 2013, ANAL COMPOSITIONAL D; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Call KA, 2008, DEEP-SEA RES PT II, V55, P1883, DOI 10.1016/j.dsr2.2008.04.022; Dowd M, 2011, ECOLOGY, V92, P568, DOI 10.1890/10-0611.1; Fossette S, 2010, J EXP BIOL, V213, P4074, DOI 10.1242/jeb.048207; Gentry R. L., 1986, FUR SEALS MATERNAL S, P61; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gleiss AC, 2009, REV-METHODS TECHNOL, V9, P211, DOI 10.1007/978-1-4020-9640-2_13; GOEBEL ME, 1991, FISH B-NOAA, V89, P171; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Insley S. J., 2008, Endangered Species Research, V4, P147, DOI 10.3354/esr00050; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kuhn CE, 2014, J ANIM ECOL, V83, P1169, DOI 10.1111/1365-2656.12202; LOUGHLIN TR, 1987, CAN J ZOOL, V65, P2079, DOI 10.1139/z87-318; Naito Yasuhiko, 2007, Polar Science, V1, P101, DOI 10.1016/j.polar.2007.10.001; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nordstrom CA, 2013, DEEP-SEA RES PT II, V88-89, P78, DOI 10.1016/j.dsr2.2012.07.010; Paredes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092520; R Core Team, 2021, R LANGUAGE ENV STAT; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Skinner John P., 2010, Endangered Species Research, V10, P61, DOI 10.3354/esr00236; Springer AM, 2008, SEASONAL FORAGING ST; Sterling JT, 2004, CAN J ZOOL, V82, P1621, DOI 10.1139/Z04-136; Towell RG, 2011, 2011 NO FUR SEAL PUP; Towell RG, 2010, 2010 NO FUR SEAL PUP; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Zeppelin TK, 2010, MAR ECOL PROG SER, V409, P241, DOI 10.3354/meps08624	33	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0118761	10.1371/journal.pone.0118761	http://dx.doi.org/10.1371/journal.pone.0118761			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807552	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000010
J	Battipaglia, G; Zalloni, E; Castaldi, S; Marzaioli, F; Cazzolla-Gatti, R; Lasserre, B; Tognetti, R; Marchetti, M; Valentini, R				Battipaglia, Giovanna; Zalloni, Enrica; Castaldi, Simona; Marzaioli, Fabio; Cazzolla-Gatti, Roberto; Lasserre, Bruno; Tognetti, Roberto; Marchetti, Marco; Valentini, Riccardo			Long Tree-Ring Chronologies Provide Evidence of Recent Tree Growth Decrease in a Central African Tropical Forest	PLOS ONE			English	Article							AIR CO2 ENRICHMENT; ATMOSPHERIC CO2; ELEVATED CO2; BRACHYSTEGIA-SPICIFORMIS; WOOD PRODUCTION; RISING CO2; CLIMATE; CARBON; TEMPERATURE; RESPONSES	It is still unclear whether the exponential rise of atmospheric CO2 concentration has produced a fertilization effect on tropical forests, thus incrementing their growth rate, in the last two centuries. As many factors affect tree growth patterns, short -term studies might be influenced by the confounding effect of several interacting environmental variables on plant growth. Long-term analyses of tree growth can elucidate long-term trends of plant growth response to dominant drivers. The study of annual rings, applied to long tree-ring chronologies in tropical forest trees enables such analysis. Long-term tree-ring chronologies of three widespread African species were measured in Central Africa to analyze the growth of trees over the last two centuries. Growth trends were correlated to changes in global atmospheric CO2 concentration and local variations in the main climatic drivers, temperature and rainfall. Our results provided no evidence for a fertilization effect of CO2 on tree growth. On the contrary, an overall growth decline was observed for all three species in the last century, which appears to be significantly correlated to the increase in local temperature. These findings provide additional support to the global observations of a slowing down of C sequestration in the trunks of forest trees in recent decades. Data indicate that the CO2 increase alone has not been sufficient to obtain a tree growth increase in tropical trees. The effect of other changing environmental factors, like temperature, may have overridden the fertilization effect of CO2.	[Battipaglia, Giovanna; Zalloni, Enrica; Castaldi, Simona] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Battipaglia, Giovanna] Univ Montpellier 2, Ecole Prat Hautes Etud, Inst Bot, Ctr Bioarchaeol & Ecol, Montpellier, France; [Marzaioli, Fabio] Univ Naples 2, Dept Math & Phys, Caserta, Italy; [Cazzolla-Gatti, Roberto; Valentini, Riccardo] Univ Tuscia DIBAF, Dept Innovat Biol Agrofood & Forest Syst, Viterbo, Italy; [Lasserre, Bruno; Tognetti, Roberto; Marchetti, Marco] Univ Molise, Dept Biosci & Terr, Pesche, Italy; [Tognetti, Roberto] EFI Project Ctr Mt Forests MOUNTFOR, San Michele All Adige, Italy	Universita della Campania Vanvitelli; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Universita della Campania Vanvitelli; Tuscia University; University of Molise	Battipaglia, G (corresponding author), Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy.	giovanna.battipaglia@unina2.it	Marchetti, Marco/D-9277-2012; Gatti, Roberto Cazzolla/G-5462-2015; Cazzolla Gatti, Roberto/ABD-7380-2021; Castaldi, Simona/B-1699-2012; Tognetti, Roberto/C-4962-2008; Marzaioli, Fabio/AAA-7550-2019; lasserre, bruno/G-1409-2011; Valentini, Riccardo/D-1226-2010	Marchetti, Marco/0000-0002-5275-5769; Gatti, Roberto Cazzolla/0000-0001-5130-8492; Cazzolla Gatti, Roberto/0000-0001-5130-8492; Castaldi, Simona/0000-0003-3937-8169; Tognetti, Roberto/0000-0002-7771-6176; lasserre, bruno/0000-0003-1150-8064; Valentini, Riccardo/0000-0002-6756-5634; Marzaioli, Fabio/0000-0002-2676-4055; Battipaglia, Giovanna/0000-0003-1741-3509	ERC grant GHG Africa [247349]	ERC grant GHG Africa	The present work was supported by the ERC grant GHG Africa no. 247349. This research is linked to activities conducted within the COST FP1106 'STReESS network. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004247; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; AMTHOR JS, 1995, GLOBAL CHANGE BIOL, V1, P243, DOI 10.1111/j.1365-2486.1995.tb00025.x; Baker TR, 2004, PHILOS T R SOC B, V359, P353, DOI 10.1098/rstb.2003.1422; Battipaglia G, 2013, NEW PHYTOL, V197, P544, DOI 10.1111/nph.12044; Biondi F, 1999, ECOL APPL, V9, P216, DOI 10.1890/1051-0761(1999)009[0216:CTRCAR]2.0.CO;2; Biondi F, 2008, TREE-RING RES, V64, P81, DOI 10.3959/2008-6.1; BREITSPRECHER A, 1990, ECOLOGY, V71, P1156, DOI 10.2307/1937383; Brienen RJW, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004143; CEULEMANS R, 1994, NEW PHYTOL, V127, P425, DOI 10.1111/j.1469-8137.1994.tb03961.x; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clark DA, 2004, PHILOS T R SOC B, V359, P477, DOI 10.1098/rstb.2003.1426; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Cook E. R., 1984, PROGRAM ARSTAN USERS; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; Couralet C, 2010, BIOTROPICA, V42, P503, DOI 10.1111/j.1744-7429.2009.00613.x; De Ridder M, 2013, TREES-STRUCT FUNCT, V27, P1225, DOI 10.1007/s00468-013-0871-3; Detienne P., 1977, BOIS FOR TROP, V175, P52; Detienne P., 1976, BOIS FOR TROP, V169, P29; Domec JC, 2009, PLANT CELL ENVIRON, V32, P1500, DOI 10.1111/j.1365-3040.2009.02014.x; Dong SX, 2012, P ROY SOC B-BIOL SCI, V279, P3923, DOI 10.1098/rspb.2012.1124; Durrieu de Madron B., 1998, SERIE FORAFRI; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Esper J, 2003, TREE-RING RES, V59, P81; FAO, 2007, STAT WORLDS FOR 2007; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Fichtler E, 2004, TREES-STRUCT FUNCT, V18, P442, DOI 10.1007/s00468-004-0324-0; Gebrekirstos A, 2008, TREES-STRUCT FUNCT, V22, P631, DOI 10.1007/s00468-008-0221-z; Gourlay ID, 1995, IAWA J, V16, P353, DOI 10.1163/22941932-90001425; Hattenschwiler S, 1997, GLOB CHANGE BIOL, V3, P463, DOI 10.1046/j.1365-2486.1997.00105.x; HOGAN KP, 1991, PLANT CELL ENVIRON, V14, P763, DOI 10.1111/j.1365-3040.1991.tb01441.x; Holmes R.L., 1993, TREE RING B, V43, P69; Idso SB, 1999, GLOBAL CHANGE BIOL, V5, P493, DOI 10.1046/j.1365-2486.1999.00240.x; Jell B, 2002, NOMADIC PEOPLES, V6, P180; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Korner C, 2009, ANNU REV ECOL EVOL S, V40, P61, DOI 10.1146/annurev.ecolsys.110308.120217; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Laurance WF, 2004, NATURE, V428, P171, DOI 10.1038/nature02383; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Nehrbass-Ahles C, 2014, GLOBAL CHANGE BIOL, V20, P2867, DOI 10.1111/gcb.12599; Nicholson SE, 2000, HYDROLOG SCI J, V45, P75, DOI 10.1080/02626660009492307; Nicholson SE, 2001, CLIMATIC CHANGE, V50, P317, DOI 10.1023/A:1010674724320; Nicholson SE, 2001, CLIMATIC CHANGE, V48, P387, DOI 10.1023/A:1010736008362; Nicholson SE, 2012, QUATERNARY RES, V78, P13, DOI 10.1016/j.yqres.2012.03.012; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Norby RJ, 2011, NEW PHYTOL, V189, P893, DOI 10.1111/j.1469-8137.2010.03641.x; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; PREGITZER KS, 1995, NEW PHYTOL, V129, P579, DOI 10.1111/j.1469-8137.1995.tb03025.x; REEKIE EG, 1989, OECOLOGIA, V79, P212, DOI 10.1007/BF00388481; ROGERS HH, 1983, SCIENCE, V220, P428, DOI 10.1126/science.220.4595.428; Rowland L, 2014, OECOLOGIA, V174, P295, DOI 10.1007/s00442-013-2766-9; Sass-Klaassen U, 2008, INT J PLANT SCI, V169, P1057, DOI 10.1086/590473; Schongart J, 2006, GLOBAL CHANGE BIOL, V12, P1139, DOI 10.1111/j.1365-2486.2006.01154.x; Schweingruber F.H., 2007, TREE RINGS ENV DENDR; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Soule PT, 2006, NEW PHYTOL, V171, P379, DOI 10.1111/j.1469-8137.2006.01746.x; Stinziano JR, 2014, BOTANY, V92, P425, DOI 10.1139/cjb-2013-0314; Tandoh JB, 2013, RADIOCARBON, V55, P885, DOI 10.1017/S0033822200058045; Therrell MD, 2006, CLIM DYNAM, V26, P677, DOI 10.1007/s00382-005-0108-2; Tognetti R, 2000, NEW PHYTOL, V146, P59, DOI 10.1046/j.1469-8137.2000.00620.x; Trouet V, 2006, BIOTROPICA, V38, P375, DOI 10.1111/j.1744-7429.2006.00155.x; Trouet V, 2001, IAWA J, V22, P385, DOI 10.1163/22941932-90000384; Trouet V, 2010, DENDROCHRONOLOGIA, V28, P161, DOI 10.1016/j.dendro.2009.10.002; van der Sleen P, 2015, NAT GEOSCI, V8, P24, DOI [10.1038/ngeo2313, 10.1038/NGEO2313]; Wagner F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092337; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Weiner J, 2001, OIKOS, V94, P374, DOI 10.1034/j.1600-0706.2001.940219.x; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Wils THG, 2011, TREES-STRUCT FUNCT, V25, P345, DOI 10.1007/s00468-010-0521-y; Worbes M, 1995, IAWA J, V16, P337, DOI 10.1163/22941932-90001424; Worbes M, 2003, FOREST ECOL MANAG, V173, P105, DOI 10.1016/S0378-1127(01)00814-3; Worbes Martin, 2002, Dendrochronologia, V20, P217, DOI 10.1078/1125-7865-00018; Yamori W, 2014, PHOTOSYNTH RES, V119, P101, DOI 10.1007/s11120-013-9874-6; Zhou LM, 2014, NATURE, V509, P86, DOI 10.1038/nature13265; Zuidema PA, 2013, TRENDS PLANT SCI, V18, P413, DOI 10.1016/j.tplants.2013.05.006	80	39	40	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120962	10.1371/journal.pone.0120962	http://dx.doi.org/10.1371/journal.pone.0120962			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806946	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000117
J	Bimolata, W; Kumar, A; Reddy, MSK; Sundaram, RM; Laha, GS; Qureshi, IA; Ghazi, IA				Bimolata, Waikhom; Kumar, Anirudh; Reddy, Sai Kiran M.; Sundaram, Raman Meenakshi; Laha, Gouri Sankar; Qureshi, Insaf Ahmed; Ghazi, Irfan Ahmad			Nucleotide Diversity Analysis of Three Major Bacterial Blight Resistance Genes in Rice	PLOS ONE			English	Article							ORYZAE PV. ORYZAE; TRIGGERS DISEASE RESISTANCE; KINASE-LIKE PROTEIN; CONFERRING RESISTANCE; MOLECULAR DIVERSITY; DNA POLYMORPHISM; EXPRESSION; SATIVA; DOMESTICATION; TRANSCRIPTION	Nucleotide sequence polymorphisms among R gene alleles influence the process of co-evolutionary interaction between host and pathogen by shaping the response of host plants towards invading pathogens. Here, we present the DNA sequence polymorphisms and diversities present among natural alleles of three rice bacterial blight resistance genes, Xa21, Xa26 and xa5. The diversity was examined across different wild relatives and cultivars of Oryza species. Functional significance of selected alleles was evaluated through semi-quantitative reverse transcription polymerase chain reaction and real time PCR. The greatest nucleotide diversity and singleton variable sites (SVS) were present in Xa26 (pi = 0.01958; SVS = 182) followed by xa5 and Xa21 alleles. The highest frequency of single nucleotide polymorphisms were observed in Xa21 alleles and least in xa5. Transition bias was observed in all the genes and 'G' to 'A' transitions were more favored than other form of transitions. Neutrality tests failed to show the presence of selection at these loci, though negative Tajima's D values indicate the presence of a rare form of polymorphisms. At the interspecies level, O. nivara exhibited more diversity than O. sativa. We have also identified two nearly identical resistant alleles of xa5 and two sequentially identical alleles of Xa21. The alleles of xa5 showed basal levels of expression while Xa21 alleles were functionally not expressed.	[Bimolata, Waikhom; Kumar, Anirudh; Reddy, Sai Kiran M.; Ghazi, Irfan Ahmad] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500046, Andhra Pradesh, India; [Sundaram, Raman Meenakshi] Directorate Rice Res, Crop Improvement Sect, Hyderabad 500030, Andhra Pradesh, India; [Laha, Gouri Sankar] Directorate Rice Res, Crop Protect Sect, Hyderabad 500030, Andhra Pradesh, India; [Qureshi, Insaf Ahmed] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research; University of Hyderabad	Ghazi, IA (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India.	irfan@uohyd.ernet.in	Qureshi, Insaf Ahmed/W-1957-2019; Sundaram, Raman/L-5294-2019; Kumar, Anirudh/AAR-3265-2021	Qureshi, Insaf Ahmed/0000-0001-7720-7067; Kumar, Anirudh/0000-0002-9672-901X	Department of Science & Technology, New Delhi, India [SR/SO/PS-21/09]; CSIR [09/414/(0832)/2008- EMR-I]	Department of Science & Technology, New Delhi, India(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This research work is supported by grants from Department of Science & Technology, New Delhi, India (grant no. SR/SO/PS-21/09). WB is also grateful to CSIR for the fellowship (award no. 09/414/(0832)/2008- EMR-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHIKARI TB, 1994, PLANT DIS, V78, P73, DOI 10.1094/PD-78-0073; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anirudh Kumar, 2013, Australian Journal of Crop Science, V7, P32; Bimolata W, 2013, PLANTA, V238, P293, DOI 10.1007/s00425-013-1891-3; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Bustamam M, 1996, P 3 AS PAC C AGR BIO, P107; Chen S, 2008, MOL BREEDING, V22, P433, DOI 10.1007/s11032-008-9187-1; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Doyle JJ, 1989, FOCUS, V12, P13; DRR, 2001, DIR RIC RES PROGR RE, V2; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; FU YX, 1993, GENETICS, V133, P693; Goel RK., 1998, RICE GENET NEWSL, V15, P131; Gu KY, 2009, MOL PLANT PATHOL, V10, P829, DOI 10.1111/j.1364-3703.2009.00567.x; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Haseneyer G, 2008, THEOR APPL GENET, V117, P321, DOI 10.1007/s00122-008-0777-4; Huang CL, 2008, GENETICS, V179, P1527, DOI 10.1534/genetics.108.089805; IRRI, 2002, STAND EV SUYST SES; Iyer AS, 2004, MOL PLANT MICROBE IN, V17, P1348, DOI 10.1094/MPMI.2004.17.12.1348; Iyer-Pascuzzi A.S., 2007, RICE FUNCTIONAL GENO, P113; Iyer-Pascuzzi AS, 2007, MOL BREEDING, V19, P291, DOI 10.1007/s11032-006-9055-9; Jiang GH, 2006, MOL GENET GENOMICS, V275, P354, DOI 10.1007/s00438-005-0091-7; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khush GS, 1991, RICE GENET NEWSL, Vl7, P121; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Kowalczuk Maria, 2001, Journal of Applied Genetics, V42, P553; Kumar PN, 2012, PHYTOPATHOLOGY, V102, P222, DOI 10.1094/PHYTO-03-11-0075; Lavanya B, 1998, P 7 NAT RIC BIOT NET, P21; Lee S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026260; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mauricio R, 2003, GENETICS, V163, P735; May R.M., 1983, P186; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ochiai H, 2000, PHYTOPATHOLOGY, V90, P415, DOI 10.1094/PHYTO.2000.90.4.415; Olmstead R. G., 1998, MOL SYSTEMATICS PLAN, P164; Petrov DA, 1999, P NATL ACAD SCI USA, V96, P1475, DOI 10.1073/pnas.96.4.1475; Reddy A., P INT WORKSH BACT RI, P79; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; Rose LE, 2007, GENETICS, V175, P1307, DOI 10.1534/genetics.106.063602; Rose LE, 2004, GENETICS, V166, P1517, DOI 10.1534/genetics.166.3.1517; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Small RL, 2000, GENETICS, V155, P1913; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xiang Y, 2006, THEOR APPL GENET, V113, P1347, DOI 10.1007/s00122-006-0388-x; Xu SJ, 2007, J INTEGR PLANT BIOL, V49, P852, DOI 10.1111/j.1744-7909.2007.00494.x; Yoshida K, 2009, GENES GENET SYST, V84, P121, DOI 10.1266/ggs.84.121; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	60	9	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120186	10.1371/journal.pone.0120186	http://dx.doi.org/10.1371/journal.pone.0120186			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807168	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000070
J	Chouvenc, T; Helmick, EE; Su, NY				Chouvenc, Thomas; Helmick, Ericka E.; Su, Nan-Yao			Hybridization of Two Major Termite Invaders as a Consequence of Human Activity	PLOS ONE			English	Article							FORMOSAN SUBTERRANEAN TERMITE; COPTOTERMES-GESTROI ISOPTERA; CLIMATE-CHANGE; INVASIVE TERMITES; GENE FLOW; RHINOTERMITIDAE; COLONY; EVOLUTION; IMPACT; POPULATION	While hybridization of an invasive species with a native species is a common occurrence, hybridization between two invasive species is rare. Formosan subterranean termites (Coptotermes formosanus) and Asian subterranean termites (C. gestroi) are both ecologically successful and are the two most economically important termite pests in the world. Both species have spread throughout many areas of the world due to human activity; however, their distributions overlap in only three narrow areas because of distinct ecological requirements. In south Florida, where C. formosanus and C. gestroi are both invasive, the dispersal flight seasons of both species overlapped for the first time on record in 2013 and 2014. Pairings of heterospecific individuals were readily observed in the field and C. gestroi males preferentially engaged in mating behavior with C. formosanus females rather than females from their own species. In the laboratory, heterospecific and conspecific pairings had an equal colony establishment rate, but heterospecific incipient colonies had twice the growth rate of conspecific incipient colonies, suggesting a potential case of hybrid vigor. As all prezygotic barriers were lifted between the two species in the field, the apparent absence of post-zygotic barriers in the laboratory raises the possibility for introgressive hybridization in south Florida. While laboratory observations remain to be confirmed in the field, and the alate hybrid fertility is currently unknown, our results raise a tangible concern about the hybridization of two major destructive pest species. Such hybridization would likely be associated with a new economic impact.	[Chouvenc, Thomas; Su, Nan-Yao] Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Dept Entomol & Nematol, Ft Lauderdale, FL 33314 USA; [Helmick, Ericka E.] Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Dept Plant Pathol, Ft Lauderdale, FL 33314 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chouvenc, T (corresponding author), Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Dept Entomol & Nematol, Ft Lauderdale, FL 33314 USA.	tomchouv@ufl.edu	su, nan/GRS-5213-2022					Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Aldrich BT, 2009, INSECT SOC, V56, P439, DOI 10.1007/s00040-009-0041-1; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chouvenc T, 2014, INSECT SOC, V61, P171, DOI 10.1007/s00040-014-0343-9; Chouvenc T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113949; Chunco AJ, 2014, ECOL EVOL, V4, P2019, DOI 10.1002/ece3.1052; Coenen D, 2010, THESIS U FLORIDA; Connetable S, 2012, INSECT SOC, V59, P269, DOI 10.1007/s00040-011-0216-4; Corn ML, 2013, R43258 US C; Costa-Leonardo AM, 2005, SOCIOBIOLOGY, V45, P137; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Evans TA, 2013, ANNU REV ENTOMOL, V58, P455, DOI 10.1146/annurev-ento-120811-153554; Fitzpatrick BM, 2010, P NATL ACAD SCI USA, V107, P3606, DOI 10.1073/pnas.0911802107; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Grace JK, 2014, P 10 PAC RIM TERM RE, V1, P1; Hartke TR, 2011, NATURWISSENSCHAFTEN, V98, P745, DOI 10.1007/s00114-011-0823-y; Higa SY, 1981, THESIS U HAWAII HONO; Hochmair HH, 2010, J ECON ENTOMOL, V103, P1338, DOI 10.1603/EC09428; HUANG LW, 1987, ACTA ENTOMOL SINICA, V30, P393; Husseneder C, 2012, BIOL INVASIONS, V14, P419, DOI 10.1007/s10530-011-0087-7; Huxel GR, 1999, BIOL CONSERV, V89, P143, DOI 10.1016/S0006-3207(98)00153-0; Innis MA, PCR PROTOCOLS GUIDE, P19903; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; KING E. G. JR., 1969, Annals of the Entomological Society of America, V62, P536, DOI 10.1093/aesa/62.3.536; Lefebvre T, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-38; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Li HF, 2013, J ECON ENTOMOL, V106, P311, DOI 10.1603/EC12309; Li Hou-Feng, 2010, American Entomologist, V56, P222; Li HF, 2010, ENVIRON ENTOMOL, V39, P1601, DOI 10.1603/EN09262; Li HF, 2009, ANN ENTOMOL SOC AM, V102, P684, DOI 10.1603/008.102.0413; Matsuura K, 2004, INSECT SOC, V51, P325, DOI 10.1007/s00040-004-0746-0; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Nutting W. L., 1969, P233; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Paul J, 2010, BIOL INVASIONS, V12, P2967, DOI 10.1007/s10530-010-9699-6; Peppuy A., 1999, THESIS U P M CURIE P; Primack RB, 2009, BIOL CONSERV, V142, P1943, DOI 10.1016/j.biocon.2009.03.016; R Core Team, 2021, R LANGUAGE ENV STAT; Raina AK, 2003, J INSECT BEHAV, V16, P233, DOI 10.1023/A:1023967818906; Raina A, 2007, ANN ENTOMOL SOC AM, V100, P418, DOI 10.1603/0013-8746(2007)100[418:SOSSDA]2.0.CO;2; Riley SPD, 2003, ECOL APPL, V13, P1263, DOI 10.1890/02-5023; Ross KG, 2005, MOL ECOL, V14, P3419, DOI 10.1111/j.1365-294X.2005.02661.x; Rust MK, 2012, ANNU REV ENTOMOL, V57, P355, DOI 10.1146/annurev-ento-120710-100634; Ryan ME, 2009, P NATL ACAD SCI USA, V106, P11166, DOI 10.1073/pnas.0902252106; Scheffrahn RH, 2005, FLA ENTOMOL, V88, P201, DOI 10.1653/0015-4040(2005)088[0201:DOTTGC]2.0.CO;2; Scheffrahn RH, 2013, FLA ENTOMOL, V96, P781, DOI 10.1653/024.096.0311; Schierenbeck KA, 2009, BIOL INVASIONS, V11, P1093, DOI 10.1007/s10530-008-9388-x; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Senn HV, 2009, MOL ECOL, V18, P862, DOI 10.1111/j.1365-294X.2008.04051.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Shoemaker DD, 1996, EVOLUTION, V50, P1958, DOI 10.1111/j.1558-5646.1996.tb03583.x; Su NY, 2013, FLA ENTOMOL, V96, P765, DOI 10.1653/024.096.0309; Su Nan-Yao, 1998, Integrated Pest Management Reviews, V3, P1, DOI 10.1023/A:1009684821954; SU NY, 1988, SOCIOBIOLOGY, V14, P353; Su NY, 1997, FLA ENTOMOL, V80, P408, DOI 10.2307/3495774; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson GJ, 2000, MOL PHYLOGENET EVOL, V17, P419, DOI 10.1006/mpev.2000.0852; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; VANDERMEER RK, 1985, FLA ENTOMOL, V68, P501, DOI 10.2307/3495147; Vargo EL, 2000, MOL ECOL, V9, P1935, DOI 10.1046/j.1365-294x.2000.0090111935.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winkler KA, 2011, MOL ECOL, V20, P456, DOI 10.1111/j.1365-294X.2010.04961.x; Woodrow RJ, 2001, SOCIOBIOLOGY, V38, P667; Yeap BK, 2011, ENVIRON ENTOMOL, V40, P470, DOI 10.1603/EN10108	69	43	43	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120745	10.1371/journal.pone.0120745	http://dx.doi.org/10.1371/journal.pone.0120745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806968	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000101
J	Kotepui, M; Piwkham, D; PhunPhuech, B; Phiwklam, N; Chupeerach, C; Duangmano, S				Kotepui, Manas; Piwkham, Duangjai; PhunPhuech, Bhukdee; Phiwklam, Nuoil; Chupeerach, Chaowanee; Duangmano, Suwit			Effects of Malaria Parasite Density on Blood Cell Parameters	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; PLASMODIUM-FALCIPARUM; NITRIC-OXIDE; CHILDREN; ANEMIA; PLATELETS; VIETNAM; DISEASE; IMMUNE; ADULTS	Changes in blood cell parameters are already a well-known feature of malarial infections. To add to this information, the objective of this study was to investigate the varying effects that different levels of parasite density have on blood cell parameters. Patients diagnosed with malaria at Phobphra Hospital, Tak Province, Thailand between January 1st 2009 and January 1st 2012 were recruited as subjects for data collection. Blood cell parameters of 2,024 malaria-infected patients were evaluated and statistically analyzed. Neutrophil and platelet counts were significantly higher, however, RBC count was significantly lower in patients with P. falciparum infection compared to those with P. vivax infection (p<0.0001). Leukocyte counts were also significantly higher in patients with high parasitemia compared to those with low and moderate parasitemia. In terms of differential leukocyte count, neutrophil count was significantly higher in patients with high parasitemia compared to those with low and moderate parasitemia (p<0.0001). On the other hand, both lymphocyte and monocyte counts were significantly lower in patients with high parasitemia (p<0.0001). RBC count and Hb concentration, as well as platelet count were also significantly reduced (p<0.05) and (p<0.0001), respectively. To summarize, patients infected with different malaria parasites exhibited important distinctive hematological parameters, with neutrophil and eosinophil counts being the two hematological parameters most affected. In addition, patients infected with different malarial densities also exhibited important changes in leukocyte count, platelet count and hemoglobin concentration during the infection. These findings offer the opportunity to recognize and diagnose malaria related anemia, help support the treatment thereof, as well as relieve symptoms of severe malaria in endemic regions.	[Kotepui, Manas; Piwkham, Duangjai] Walailak Univ, Sch Allied Hlth Sci & Publ Hlth, Med Technol Program, Nakhon Si Thammarat, Thailand; [Chupeerach, Chaowanee] Mahidol Univ, Inst Nutr, Nakhon Pathom, Thailand; [Duangmano, Suwit] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiang Mai 50000, Thailand	Walailak University; Mahidol University; Chiang Mai University	Kotepui, M (corresponding author), Walailak Univ, Sch Allied Hlth Sci & Publ Hlth, Med Technol Program, Nakhon Si Thammarat, Thailand.	manas.ko@wu.ac.th		Chupeerach, Chaowanee/0000-0002-1093-1621				Ali H, 2008, JCPSP-J COLL PHYSICI, V18, P362, DOI 06.2008/JCPSP.362368; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Bashawri LAM, 2002, ANN SAUDI MED, V22, P372, DOI 10.5144/0256-4947.2002.372; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BORDESSOULE D, 1990, J CLIN PATHOL, V43, P461, DOI 10.1136/jcp.43.6.461; DALE DC, 1973, BLOOD, V41, P197, DOI 10.1182/blood.V41.2.197.197; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; FISHER GU, 1970, AM J TROP MED HYG, V19, P27, DOI 10.4269/ajtmh.1970.19.27; GOLDSTEIN E, 1968, MIL MED, V133, P991, DOI 10.1093/milmed/133.12.991; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Haldar Kasturi, 2009, Hematology Am Soc Hematol Educ Program, P87, DOI 10.1182/asheducation-2009.1.87; Hviid L, 2000, INFECT IMMUN, V68, P6087, DOI 10.1128/IAI.68.10.6087-6089.2000; Kakoma Ibulaimu, 1992, Korean Journal of Parasitology, V30, P177, DOI 10.3347/kjp.1992.30.3.177; Kitua AY, 1997, TROP MED INT HEALTH, V2, P325; Kochar D. K., 2006, Journal of Vector Borne Diseases, V43, P104; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; McKenzie FE, 2005, J INFECT DIS, V192, P323, DOI 10.1086/431152; Mohapatra M K, 2006, J Assoc Physicians India, V54, P848; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; MURRAY CJL, 1990, T ROY SOC TROP MED H, V84, P1, DOI 10.1016/0035-9203(90)90364-K; Murthy G L, 2000, J Indian Med Assoc, V98, P160; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Phillips A, 2009, CLIN INFECT DIS, V48, P871, DOI 10.1086/597258; PHILLIPS RE, 1992, BAILLIERE CLIN HAEM, V5, P315, DOI 10.1016/S0950-3536(11)80022-3; Prasad R, 2009, J TROP PEDIATRICS, V55, P374, DOI 10.1093/tropej/fmp028; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Richards MW, 1998, AM J TROP MED HYG, V59, P859, DOI 10.4269/ajtmh.1998.59.859; Rojanasthien Sophark, 1992, Journal of the Medical Association of Thailand, V75, P190; Saravu K, 2011, ANN TROP MED PARASIT, V105, P593, DOI 10.1179/2047773211Y.0000000013; Shanks G. Dennis, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P795; Suwanarusk R, 2004, J INFECT DIS, V189, P190, DOI 10.1086/380468; Tangpukdee N, 2012, INT J LAB HEMATOL, V34, P320, DOI 10.1111/j.1751-553X.2011.01398.x; Weatherall D., 1988, ANAEMIA MALARIA; Wickramasinghe SN, 2000, BEST PRACT RES CL HA, V13, P277, DOI 10.1053/beha.1999.0072; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819	37	68	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121057	10.1371/journal.pone.0121057	http://dx.doi.org/10.1371/journal.pone.0121057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807235	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000127
J	Rosenberg, Y; Sack, M; Montefiori, D; Labranche, C; Lewis, M; Urban, L; Mao, LJ; Fischer, R; Jiang, XM				Rosenberg, Yvonne; Sack, Markus; Montefiori, David; Labranche, Celia; Lewis, Mark; Urban, Lori; Mao, Lingjun; Fischer, Rainer; Jiang, Xiaoming			Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques	PLOS ONE			English	Article							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; MUCOSAL SHIV CHALLENGE; POTENT NEUTRALIZATION; PASSIVE TRANSFER; PROTECTION; THERAPY	The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and success in preventing SHIV infection following their passive administration, have increased the likelihood that immunotherapeutic strategies can be adopted to prevent and treat HIV-1 infection. However, while broad and potent neutralizing activity is an essential prerequisite, in vivo properties such as good circulatory stability and non-immunogenicity are equally critical for developing a human treatment. In the present study, glycoforms of the bnAbs 10-1074, NIH45-46(G54W), 10E8, PGT121, PGT128, PGT145, PGT135, PG9, PG16, VRC01 and b12 were produced by Agrobacterium-mediated transient transfection of Nicotiana benthamiana and assessed following administration in rhesus macaques. The results indicate that (i) N-glycans within the VL domain impair plasma stability of plant-derived bnAbs and (ii) while PGT121 and b12 exhibit no immunogenicity in rhesus macaques after multiple injections, VRC01, 10-1074 and NIH45-46(G54W) elicit high titer anti-idiotypic antibodies following a second injection. These anti-idiotypic antibodies specifically bind the administered bnAb or a close family member, and inhibit the bnAb in neutralization assays. These findings suggest that specific mutations in certain bnAbs contribute to their immunogenicity and call attention to the prospect that these mutated bnAbs will be immunogenic in humans, potentially compromising their value for prophylaxis and therapy of HIV-1.	[Rosenberg, Yvonne; Urban, Lori; Mao, Lingjun; Jiang, Xiaoming] PlantVax Corp, Rockville, MD 20850 USA; [Sack, Markus; Fischer, Rainer] RTWH Aachen Univ, Inst Mol Biotechnol, Aachen, Germany; [Montefiori, David; Labranche, Celia] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Lewis, Mark] Bioqual Inc, Rockville, MD USA	RWTH Aachen University; Duke University; BIOQUAL Inc.	Rosenberg, Y (corresponding author), PlantVax Corp, Rockville, MD 20850 USA.	yjr@plantvax.com	Sack, Markus/AAP-9252-2021; Sack, Markus/K-6681-2013	Sack, Markus/0000-0002-7380-9228	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) [R44AI081621, R43AI070123]; European Research Council Advanced Grant ''Future-Pharma'' [269110]	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Research Council Advanced Grant ''Future-Pharma''	This work has been funded by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) grants #R44AI081621 and #R43AI070123 and in part by the European Research Council Advanced Grant ''Future-Pharma'', proposal number 269110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Gomord W, 2005, TRENDS BIOTECHNOL, V23, P559, DOI 10.1016/j.tibtech.2005.09.003; Gorny MK, 2006, PLOS MED, V3, P966, DOI 10.1371/journal.pmed.0030259; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kwong PD, 2009, CELL HOST MICROBE, V6, P292, DOI 10.1016/j.chom.2009.09.008; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Matucci A, 2014, INT TRENDS IMMUNITY, V2, P11; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Ramessar K, 2008, P NATL ACAD SCI USA, V105, P3727, DOI 10.1073/pnas.0708841104; Rosenberg Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058724; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2013, PLOS PATHOG, V9, P1; Stoger E, 2014, ANNU REV PLANT BIOL, V65, P743, DOI 10.1146/annurev-arplant-050213-035850; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	36	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120451	10.1371/journal.pone.0120451	http://dx.doi.org/10.1371/journal.pone.0120451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807114	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000078
J	Xu, YT; Zhou, X; Huang, ML				Xu, Yongtao; Zhou, Xu; Huang, Meilan			StaRProtein, A Web Server for Prediction of the Stability of Repeat Proteins	PLOS ONE			English	Article							QUASI-CHEMICAL APPROXIMATION; FOLDING ENERGY LANDSCAPE; STRUCTURE SELECTION; CRYSTAL-STRUCTURE; PAIR POTENTIALS; REFERENCE STATE; MEAN FORCE; BINDING; RECOGNITION; DOMAIN	Repeat proteins have become increasingly important due to their capability to bind to almost any proteins and the potential as alternative therapy to monoclonal antibodies. In the past decade repeat proteins have been designed to mediate specific protein-protein interactions. The tetratricopeptide and ankyrin repeat proteins are two classes of helical repeat proteins that form different binding pockets to accommodate various partners. It is important to understand the factors that define folding and stability of repeat proteins in order to prioritize the most stable designed repeat proteins to further explore their potential binding affinities. Here we developed distance-dependant statistical potentials using two classes of alpha-helical repeat proteins, tetratricopeptide and ankyrin repeat proteins respectively, and evaluated their efficiency in predicting the stability of repeat proteins. We demonstrated that the repeat-specific statistical potentials based on these two classes of repeat proteins showed paramount accuracy compared with non-specific statistical potentials in: 1) discriminate correct vs. incorrect models 2) rank the stability of designed repeat proteins. In particular, the statistical scores correlate closely with the equilibrium unfolding free energies of repeat proteins and therefore would serve as a novel tool in quickly prioritizing the designed repeat proteins with high stability. StaRProtein web server was developed for predicting the stability of repeat proteins.	[Xu, Yongtao; Zhou, Xu; Huang, Meilan] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast, Antrim, North Ireland	Queens University Belfast	Huang, ML (corresponding author), Queens Univ Belfast, Sch Chem & Chem Engn, David Keir Bldg,Stranmillis Rd, Belfast, Antrim, North Ireland.	m.huang@qub.ac.uk						Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Binz HK, 2006, PROTEINS, V65, P280, DOI 10.1002/prot.20930; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Canyuk B, 2004, J MOL BIOL, V335, P905, DOI 10.1016/j.jmb.2003.11.012; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; Cortajarena AL, 2004, PROTEIN ENG DES SEL, V17, P399, DOI 10.1093/protein/gzh047; Deng HY, 2012, PROTEINS, V80, P2311, DOI 10.1002/prot.24121; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Gaspari Z, 2005, BIOINFORMATICS, V21, P3322, DOI 10.1093/bioinformatics/bti513; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Huang J, 2012, NATURE, V482, P542, DOI 10.1038/nature10806; Javadi Y, 2009, P NATL ACAD SCI USA, V106, P17383, DOI 10.1073/pnas.0907455106; Kajander T, 2005, J AM CHEM SOC, V127, P10188, DOI 10.1021/ja0524494; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Kramer MA, 2010, J MOL BIOL, V404, P381, DOI 10.1016/j.jmb.2010.09.023; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Lu H, 2001, PROTEINS, V44, P223, DOI 10.1002/prot.1087; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; Mann A, 2013, J VIROL, V87, P5868, DOI 10.1128/JVI.00152-13; Mello CC, 2004, P NATL ACAD SCI USA, V101, P14102, DOI 10.1073/pnas.0403386101; Merz T, 2008, J MOL BIOL, V376, P232, DOI 10.1016/j.jmb.2007.11.047; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Phillips JJ, 2012, PROTEIN SCI, V21, P327, DOI 10.1002/pro.2018; Rykunov D, 2007, PROTEINS, V67, P559, DOI 10.1002/prot.21279; Rykunov D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-128; Samudrala R, 2000, PROTEIN SCI, V9, P1399, DOI 10.1110/ps.9.7.1399; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Skolnick J, 1997, PROTEIN SCI, V6, P676; Suzuki F, 1998, J BIOL CHEM, V273, P29302, DOI 10.1074/jbc.273.45.29302; Teixeira C, 2011, EUR J MED CHEM, V46, P979, DOI 10.1016/j.ejmech.2011.01.046; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046; Wetzel SK, 2010, J MOL BIOL, V402, P241, DOI 10.1016/j.jmb.2010.07.031; Xu YT, 2012, PROTEINS, V80, P2154, DOI 10.1002/prot.24105; Yang YD, 2008, PROTEINS, V72, P793, DOI 10.1002/prot.21968; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, pE480, DOI 10.1073/pnas.1103367108; Zhang B, 2000, J MOL BIOL, V299, P1121, DOI 10.1006/jmbi.2000.3803; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859; Zhang J, 2010, PLOS ONE, V5; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhu HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033943; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003	56	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119417	10.1371/journal.pone.0119417	http://dx.doi.org/10.1371/journal.pone.0119417			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807112	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000030
J	Giehl, K; Keller, C; Muehlich, S; Goppelt-Struebe, M				Giehl, Klaudia; Keller, Christof; Muehlich, Susanne; Goppelt-Struebe, Margarete			Actin-Mediated Gene Expression Depends on RhoA and Rac1 Signaling in Proximal Tubular Epithelial Cells	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; SERUM RESPONSE FACTOR; TGF-BETA; FACTOR CTGF; TRANSCRIPTION; DYNAMICS; MODULATION; ACTIVATION; MECHANISMS; MIGRATION	Morphological alterations of cells can lead to modulation of gene expression. An essential link is the MKL1-dependent activation of serum response factor ( SRF), which translates changes in the ratio of G-and F-actin into mRNA transcription. SRF activation is only partially characterized in non-transformed epithelial cells. Therefore, the impact of GTPases of the Rho family and changes in F-actin structures were analyzed in renal proximal tubular epithelial cells. Activation of SRF signaling was compared to the regulation of a known MKL1/ SRF target gene, connective tissue growth factor ( CTGF). In the human proximal tubular cell line HKC-8 overexpression of two actin mutants either favoring or preventing the formation of F-actin fibers regulated SRF-mediated transcription as well as CTGF expression. Only overexpression of constitutively active RhoA activated SRF-dependent gene expression whereas no effect was detected upon overexpression of Rac1 mutants. To elucidate the functional role of Rho kinases as downstream mediators of RhoA, pharmacological inhibition and genetic inhibition by transient siRNA knock down were compared. Upon stimulation with lysophosphatidic acid ( LPA) Rho kinase inhibitors partially suppressed SRF-mediated transcription, whereas interference with Rho kinase expression by siRNA reduced activation of SRF, but barely affected CTGF expression. Together with the partial inhibition of CTGF expression by the pharmacological inhibitors Y27432 and H1154, Rho kinases seem to be less important in mediating RhoA signaling related to CTGF expression in HKC8 epithelial cells. Short term pharmacological inhibition of Rac1 activity by EHT1864 reduced SRF-dependent CTGF expression in HKC-8 cells, but was overcome by a stimulatory effect after prolonged incubation after 4-6 h. Similarly, human primary cells of proximal but not of distal tubular origin showed inhibitory as well as stimulatory effects of Rac1 inhibition. Thus, RhoA signaling activates MKL1-SRF-mediated CTGF expression in proximal tubular cells, whereas Rac1 signaling is more complex with adaptive cellular responses.	[Giehl, Klaudia] Univ Giessen, Internal Med 5, Signal Transduct Cellular Motil, D-35390 Giessen, Germany; [Keller, Christof; Goppelt-Struebe, Margarete] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany; [Muehlich, Susanne] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, Munich, Germany	Justus Liebig University Giessen; University of Erlangen Nuremberg; University of Munich	Goppelt-Struebe, M (corresponding author), Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany.	margarete.goppelt-struebe@uk-erlangen.de			Deutsche Forschungsgemeinschaft [SFB423]; Medical Clinic 4, Universitatsklinikum Erlangen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Clinic 4, Universitatsklinikum Erlangen	CK was recipient of a fellowship from the Deutsche Forschungsgemeinschaft, SFB423. This work was supported by funds of the Medical Clinic 4, Universitatsklinikum Erlangen.	Adam O, 2010, J AM COLL CARDIOL, V55, P469, DOI 10.1016/j.jacc.2009.08.064; Bakkebo M, 2012, FEBS LETT, V586, P3367, DOI 10.1016/j.febslet.2012.07.027; Blaauw E, 2013, J CARDIOVASC TRANSL, V6, P861, DOI 10.1007/s12265-013-9489-5; Black SA, 2008, J BIOL CHEM, V283, P10835, DOI 10.1074/jbc.M710363200; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Busche S, 2010, J CELL SCI, V123, P2803, DOI 10.1242/jcs.061887; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chen G, 2013, J CELL SCI, V126, P3697, DOI 10.1242/jcs.126714; Cicha I, 2014, INT J BIOCHEM CELL B, V46, P39, DOI 10.1016/j.biocel.2013.11.014; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Giehl K, 2008, AM J PHYSIOL-RENAL, V294, pF407, DOI 10.1152/ajprenal.00093.2007; Hampl V, 2013, EMBO MOL MED, V5, P1367, DOI 10.1002/emmm.201202406; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Keller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043584; Kroening S, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3126pl1; Kroening S, 2010, J CELL PHYSIOL, V223, P703, DOI 10.1002/jcp.22079; Kroening S, 2010, AM J PHYSIOL-RENAL, V298, pF796, DOI 10.1152/ajprenal.00528.2009; Kroening S, 2009, NEPHROL DIAL TRANSPL, V24, P3319, DOI 10.1093/ndt/gfp305; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morgan-Fisher M, 2013, J HISTOCHEM CYTOCHEM, V61, P185, DOI 10.1369/0022155412470834; Muehlich S, 2004, ATHEROSCLEROSIS, V175, P261, DOI 10.1016/j.atherosclerosis.2004.04.011; Muehlich S, 2012, ONCOGENE, V31, P3913, DOI 10.1038/onc.2011.560; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, pC1732, DOI 10.1152/ajpcell.00552.2006; Ott C, 2003, J BIOL CHEM, V278, P44305, DOI 10.1074/jbc.M309140200; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Rajakyla E.K., 2014, SMALL GTPASES, V6, P5; Ratheesh A, 2013, PROG MOL BIOL TRANSL, V116, P49, DOI 10.1016/B978-0-12-394311-8.00003-0; Samarakoon R, 2010, CELL SIGNAL, V22, P1413, DOI 10.1016/j.cellsig.2010.03.020; Shi-wen X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007438; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; Staus DP, 2014, AM J PHYSIOL-HEART C, V307, pH379, DOI 10.1152/ajpheart.01002.2013; Tang AT, 2012, CELL SIGNAL, V24, P1375, DOI 10.1016/j.cellsig.2012.03.005; Zuehlke J, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-25	38	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121589	10.1371/journal.pone.0121589	http://dx.doi.org/10.1371/journal.pone.0121589			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816094	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600107
J	Kim, MJ; Kim, YS; Oh, CS; Go, JH; Lee, IS; Park, WK; Cho, SM; Kim, SK; Shin, DH				Kim, Myeung Ju; Kim, Yi-Suk; Oh, Chang Seok; Go, Jai-Hyang; Lee, In Sun; Park, Won-Kyu; Cho, Seok-Min; Kim, Soon-Kwan; Shin, Dong Hoon			Anatomical Confirmation of Computed Tomography-Based Diagnosis of the Atherosclerosis Discovered in 17th Century Korean Mummy	PLOS ONE			English	Article							ANCIENT EGYPTIAN MUMMIES; MEDIEVAL CHILD MUMMY; PERUVIAN MUMMY; JOSEON DYNASTY; FEMALE MUMMY; YANGJU; WOMEN; TOMB; AGE; DNA	In the present study on a newly discovered 17th century Korean mummy, computed tomography (CT) revealed multiple aortic calcifications within the aortic wall that were indicative of ancient atherosclerosis. The CT-based findings were confirmed by our subsequent post-factum dissection, which exhibited possible signs of the disease including ulcerated plaques, ruptured hemorrhages, and intimal thickening where the necrotic core was covered by the fibrous cap. These findings are strong indicators that the mummy suffered from aortic atherosclerosis during her lifetime. The present study is a good example of how CT images of vascular calcifications can be a useful diagnostic tool in forming at least preliminary diagnoses of ancient atherosclerosis.	[Kim, Myeung Ju] Dankook Univ, Dept Anat, Coll Med, Cheonan, South Korea; [Kim, Yi-Suk] Ewha Womans Univ, Sch Med, Dept Anat, Seoul, South Korea; [Oh, Chang Seok; Shin, Dong Hoon] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Oh, Chang Seok; Shin, Dong Hoon] Seoul Natl Univ, Coll Med, Inst Forens Sci, Seoul, South Korea; [Go, Jai-Hyang] Dankook Univ, Dept Pathol, Coll Med, Cheonan, South Korea; [Lee, In Sun] Seoul Natl Univ Hosp, Dept Radiol, Bundang, South Korea; [Park, Won-Kyu] Chungbuk Natl Univ, Dept Wood & Paper Sci, Cheongju, South Korea; [Cho, Seok-Min] Gaya Natl Res Inst Cultural Heritage, Chang Won, South Korea; [Kim, Soon-Kwan] Natl Res Inst Cultural Heritage, Cultural Heritage Sci Ctr, Taejon, South Korea	Dankook University; Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU); Dankook University; Seoul National University (SNU); Seoul National University Hospital; Chungbuk National University	Shin, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea.	cuteminjae@gmail.com			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2009688]; Education and Research Encouragement Fund of Seoul National University Hospital	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education; Education and Research Encouragement Fund of Seoul National University Hospital	Funding: This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2009688) and by the Education and Research Encouragement Fund of Seoul National University Hospital (2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelfattah A, 2013, INT J CARDIOL, V167, P570, DOI 10.1016/j.ijcard.2012.01.082; Adao Luis, 2004, Rev Port Cardiol, V23, P69; Allam AH, 2011, JACC-CARDIOVASC IMAG, V4, P315, DOI 10.1016/j.jcmg.2011.02.002; Allam Adel H, 2010, Am Heart Hosp J, V8, P10; Allam AH, 2009, JAMA-J AM MED ASSOC, V302, P2091, DOI 10.1001/jama.2009.1641; Appelboom T, 1999, LANCET, V354, P2153, DOI 10.1016/S0140-6736(99)07113-5; Auer J, 2003, CLIN CARDIOL, V26, P569, DOI 10.1002/clc.4960261205; Aufderheide A.C., 2003, SCI STUDY MUMMIES; Brooks S, 1990, J HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Bruckert E, 1999, J CARDIOVASC RISK, V6, P327; Chang BS, 2006, J ANAT, V209, P671, DOI 10.1111/j.1469-7580.2006.00607.x; Charlier P, 2010, JAMA-J AM MED ASSOC, V303, P1149, DOI 10.1001/jama.2010.326; Dickson JH, 2000, PHILOS T R SOC B, V355, P1843, DOI 10.1098/rstb.2000.0739; Fornaciari G, 2013, LANCET, V382, P123, DOI 10.1016/S0140-6736(13)61554-8; Hershkovitz I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102441; HOEG JM, 1994, ARTERIOSCLER THROMB, V14, P1066, DOI 10.1161/01.ATV.14.7.1066; Kim MJ, 2008, INT J OSTEOARCHAEOL, V18, P614, DOI 10.1002/oa.962; Kim SB, 2006, J ANAT, V209, P681, DOI 10.1111/j.1469-7580.2006.00637.x; Kim YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099779; Kromgan WM, 1986, HUMAN SKELETON FOREN; LAMENDIN H, 1992, J FORENSIC SCI, V37, P1373; Lee EJ, 2009, ANTIQUITY, V83, P145, DOI 10.1017/S0003598X00098148; Lee IS, 2007, ANN ANAT, V189, P558, DOI 10.1016/j.aanat.2007.03.005; Lee IS, 2009, ANN ANAT, V191, P309, DOI 10.1016/j.aanat.2009.02.006; Lee KH, 2013, J KOREAN WOOD SCI TE, V41, P406, DOI [10.3346/jkms.2014.29.3.351, DOI 10.3346/JKMS.2014.29.3.351]; Lim DS, 2008, J ANAT, V213, P482, DOI 10.1111/j.1469-7580.2008.00955.x; Lim DS, 2010, J ANAT, V217, P67, DOI 10.1111/j.1469-7580.2010.01240.x; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P15, DOI 10.1002/ajpa.1330680103; Lynnerup N, 2007, YEARB PHYS ANTHROPOL, V50, P162, DOI 10.1002/ajpa.20728; Martin R., 1988, ANTHROPOLOGIE, V1; Martrille L, 2007, J FORENSIC SCI, V52, P302, DOI 10.1111/j.1556-4029.2006.00367.x; Nerlich AG, 1995, VIRCHOWS ARCH, V427, P423; Oh CS, 2011, ANN ANAT, V193, P544, DOI 10.1016/j.aanat.2011.02.005; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Pinto R J, 1992, Indian Heart J, V44, P99; Piombino-Mascali D, 2014, AM J HUM BIOL, V26, P676, DOI 10.1002/ajhb.22578; Pringle H., 2001, MUMMY C SCI OBSESSIO; Rollo F, 2002, P NATL ACAD SCI USA, V99, P12594, DOI 10.1073/pnas.192184599; Ruffer MA, 1911, J PATHOL BACTERIOL, V15, P453, DOI 10.1002/path.1700150403; Ruffer MA., 1921, STUDIES PALAEOPATHOL; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Schiele F, 2014, PRESSE MED, V43, P796, DOI 10.1016/j.lpm.2014.04.011; Schoen FJ, 2002, ROBBINS BASIC PATHOL; Seo M, 2008, J PARASITOL, V94, P467, DOI 10.1645/GE-1365.1; Seo M, 2007, J PARASITOL, V93, P589, DOI 10.1645/GE-905R3.1; Sheehan D.C., 1980, THEORY PRACTICE HIST; Shin DH, 2003, ANN ANAT, V185, P377, DOI 10.1016/S0940-9602(03)80065-1; Shin DH, 2003, FORENSIC SCI INT, V137, P172, DOI 10.1016/S0379-0738(03)00335-9; Shin DH, 2012, J ARCHAEOL SCI, V39, P1103, DOI 10.1016/j.jas.2011.12.011; Shin DH, 2010, J ANAT, V216, P329, DOI 10.1111/j.1469-7580.2009.01185.x; Shin DH, 2009, J PARASITOL, V95, P137, DOI 10.1645/GE-1588.1; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X; Ubaldi M, 1998, AM J PHYS ANTHROPOL, V107, P285, DOI 10.1002/(SICI)1096-8644(199811)107:3<285::AID-AJPA5>3.0.CO;2-U; Zhang YY, 2014, ARTERIOSCL THROM VAS, V34, P2128, DOI 10.1161/ATVBAHA.114.303889	54	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119474	10.1371/journal.pone.0119474	http://dx.doi.org/10.1371/journal.pone.0119474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816014	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600019
J	Koo, M; Hwang, JH				Koo, Malcolm; Hwang, Juen-Haur			Risk of Sudden Sensorineural Hearing Loss in Patients with Common Preexisting Sensorineural Hearing Impairment: A Population-Based Study in Taiwan	PLOS ONE			English	Article							SEVERITY	Objective The role of preexisting sensorineural hearing impairment on the risk for sudden sensorineural hearing loss (SSHL) is still unclear. In this study, we aimed to assess the risk of SSHL in patients with common preexisting sensorineural hearing impairment using population-based data. Methods A population-based case-control study design was used to analyze claims data between January 2001 and December 2011 obtained from the Taiwan National Health Insurance Research Database. The cases consisted of 514 patients with SSHL and the controls were frequency matched to 2,570 cases by sex, 10-year age group, and year of index date. Common sensorineural hearing impairments were retrospectively assessed in the cases and controls. Associations between sensorineural hearing impairment and risk of SSHL were evaluated using unconditional univariate and multivariate logistic regression analyses. Results The mean age for the 3,084 study subjects was 53.1 years (standard deviation, S.D. = 15.6). Of the 514 cases, 49 (9.5%) had sensorineural hearing impairment while only 44 (1.7%) of the 2,570 controls had the same condition. Univariate logistic regression analyses indicated that preexisting sensorineural hearing impairment was significantly associated with SSHL (odds ratio, OR = 6.05, p < 0.001). Other comorbidities including hypertension, diabetes mellitus, and hyperlipidemia also showed significant associations with SSHL. Similar results were obtained when the association between SSHL and sensorineural hearing impairment was adjusted with either all the covariates (adjusted OR = 6.22, p < 0.001) or with only those selected using a backward elimination procedure (adjusted OR = 6.20, p < 0.001). Conclusions Results from this population-based case-control study revealed that common sensorineural hearing impairment might be a novel risk factor for SSHL.	[Koo, Malcolm] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Res, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Hwang, Juen-Haur] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hwang, Juen-Haur] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan; [Hwang, Juen-Haur] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Sleep Ctr, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Hwang, JH (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	g120796@tzuchi.com.tw	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Chau JK, 2010, LARYNGOSCOPE, V120, P1011, DOI 10.1002/lary.20873; Chu CH, 2013, CEPHALALGIA, V33, P80, DOI 10.1177/0333102412468671; Gagnon PM, 2007, HEARING RES, V226, P79, DOI 10.1016/j.heares.2006.09.006; Gazquez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026759; Greco A, 2011, AUTOIMMUN REV, V10, P756, DOI 10.1016/j.autrev.2011.05.005; Hughes GB, 1996, OTOLARYNG CLIN N AM, V29, P393; Hwang JH, 2011, AUDIOLOGY NEUROTOL E, V1, P1, DOI 10.1159/000329795; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060730; Hwang JH, 2012, NEUROBIOL AGING, V33, P1920, DOI 10.1016/j.neurobiolaging.2011.10.012; Hwang JH, 2009, OBESITY, V17, P1796, DOI 10.1038/oby.2009.66; Lin C, 2013, JAMA OTOLARYNGOL, V139, P251, DOI 10.1001/jamaoto.2013.1709; Lin C, 2013, AUDIOL NEURO-OTOL, V18, P95, DOI 10.1159/000345512; Lin RJ, 2012, LARYNGOSCOPE, V122, P624, DOI 10.1002/lary.22480; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; National Health Insurance Administration, 2013, 2013 2014 NAT HLTH I; Roy S, 2013, J CLIN INVEST, V123, P4945, DOI 10.1172/JCI71353; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Wu ZS, 2010, TZU CHI MED J, V22, P141; Ziegler EA, 2003, LARYNGO RHINO OTOL, V82, P4, DOI 10.1055/s-2003-36904	19	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121190	10.1371/journal.pone.0121190	http://dx.doi.org/10.1371/journal.pone.0121190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815507	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600072
J	Matuschek, H; Kliegl, R; Holschneider, M				Matuschek, Hannes; Kliegl, Reinhold; Holschneider, Matthias			Smoothing Spline ANOVA Decomposition of Arbitrary Splines: An Application to Eye Movements in Reading	PLOS ONE			English	Article								The Smoothing Spline ANOVA (SS-ANOVA) requires a specialized construction of basis and penalty terms in order to incorporate prior knowledge about the data to be fitted. Typically, one resorts to the most general approach using tensor product splines. This implies severe constraints on the correlation structure, i.e. the assumption of isotropy of smoothness can not be incorporated in general. This may increase the variance of the spline fit, especially if only a relatively small set of observations are given. In this article, we propose an alternative method that allows to incorporate prior knowledge without the need to construct specialized bases and penalties, allowing the researcher to choose the spline basis and penalty according to the prior knowledge of the observations rather than choosing them according to the analysis to be done. The two approaches are compared with an artificial example and with analyses of fixation durations during reading.	[Matuschek, Hannes; Holschneider, Matthias] Univ Potsdam, Focus Area Dynam Complex Syst, D-14476 Potsdam, Germany; [Matuschek, Hannes; Kliegl, Reinhold] Univ Potsdam, Dept Psychol, D-14476 Potsdam, Germany	University of Potsdam; University of Potsdam	Matuschek, H (corresponding author), Univ Potsdam, Focus Area Dynam Complex Syst, Karl Liebknecht Str 24, D-14476 Potsdam, Germany.	hannes.matuschek@uni-potsdam.de	Kliegl, Reinhold/A-1276-2009; Kliegl, Reinhold/AAD-3463-2019	Kliegl, Reinhold/0000-0002-0180-8488; Kliegl, Reinhold/0000-0002-0180-8488; Holschneider, Matthias/0000-0003-3987-105X	CLARIN, BMBF-FKZ [01UG1120A]; Deutsche Forschungsgemeinschaft [FOR-868]	CLARIN, BMBF-FKZ; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was funded by CLARIN, BMBF-FKZ: 01UG1120A and the Deutsche Forschungsgemeinschaft FOR-868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2010, AMST STUD THEORY HIS, V311, P257; Demidenko E, 2004, MIXED MODELS THEORY, V518; Gu C, 2013, PACKAGE GSS; Gu C., 2002, SPR S STAT, DOI 10.1007/978-1-4757-3683-0; HASTIE T, 1987, J AM STAT ASSOC, V82, P371, DOI 10.2307/2289439; Heister J, 2012, VISUAL WORD RECOGNIT, V2; KIMELDOR.GS, 1970, ANN MATH STAT, V41, P495, DOI 10.1214/aoms/1177697089; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Kliegl R, 2007, J EXP PSYCHOL GEN, V136, P530, DOI 10.1037/0096-3445.136.3.530; Kosling K, 2012, PROMINENCE TRICONSTI; Lin XH, 1999, J ROY STAT SOC B, V61, P381, DOI 10.1111/1467-9868.00183; R Core Team, 2021, R LANGUAGE ENV STAT; Ruppert D., 2003, SEMIPARAMETRIC REGRE, V12; Tremblay Antoine, 2010, PERSPECTIVES FORMULA, P151; WAHBA G., 1990, SPLINE MODELS OBSERV, V59, DOI [10.1137/1.9781611970128, DOI 10.1137/1.9781611970128]; Wieling M, 2014, LANG DYN CHANG, V4, P253, DOI 10.1163/22105832-00402001; Wieling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023613; Wood S, 2012, PACKAGE GAMM4; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood S. N., 2012, PACKAGE MGCV; Wotschack C, 2013, Q J EXP PSYCHOL, V66, P548, DOI 10.1080/17470218.2011.625094	21	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119165	10.1371/journal.pone.0119165	http://dx.doi.org/10.1371/journal.pone.0119165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816246	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600013
J	Uloth, MB; Clode, PL; You, MP; Barbetti, MJ				Uloth, Margaret B.; Clode, Peta L.; You, Ming Pei; Barbetti, Martin J.			Calcium Oxalate Crystals: An Integral Component of the Sclerotinia sclerotiorum/Brassica carinata Pathosystem	PLOS ONE			English	Article							OXALIC-ACID; INFECTION; PATHOGENICITY; RESISTANCE; TISSUE; FUNGI	Oxalic acid is an important virulence factor for disease caused by the fungal necrotrophic pathogen Sclerotinia sclerotiorum, yet calcium oxalate (CaOx) crystals have not been widely reported. B. carinata stems were infected with S. sclerotiorum and observed using light microscopy. Six hours post inoculation (hpi), CaOx crystals were evident on 46% of stem sections and by 72 hpi on 100%, demonstrating that the secretion of oxalic acid by S. sclerotiorum commences before hyphal penetration. This is the first time CaOx crystals have been reported on B. carinata infected with S. sclerotiorum. The shape of crystals varied as infection progressed. Long tetragonal rods were dominant 12 hpi (68% of crystal-containing samples), but by 72 hpi, 50% of stems displayed bipyramidal crystals, and only 23% had long rods. Scanning electron microscopy from 24 hpi revealed CaOx crystals in all samples, ranging from tiny irregular crystals (< 0.5 mu m) to large (up to 40 mu m) highly organized arrangements. Crystal morphology encompassed various forms, including tetragonal prisms, oval plates, crystal sand, and druses. Large conglomerates of CaOx crystals were observed in the hyphal mass 72 hpi and these are proposed as a strategy of the fungus to hold and detoxify Ca2+ ions. The range of crystal morphologies suggests that S. sclerotiorum growth and infection controls the form taken by CaOx crystals.	[Uloth, Margaret B.; You, Ming Pei; Barbetti, Martin J.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA 6009, Australia; [Clode, Peta L.] Univ Western Australia, Fac Sci, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia; [You, Ming Pei; Barbetti, Martin J.] Univ Western Australia, Fac Sci, UWA Inst Agr, Crawley, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Barbetti, MJ (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.	martin.barbetti@uwa.edu.au	Clode, Peta L/C-4482-2011; Barbetti, Martin J/B-3455-2011	Barbetti, Martin J/0000-0002-5331-0817; you, mingpei/0000-0001-8393-229X; Clode, Peta/0000-0002-5188-4737	Australia Research Council; Department of Agriculture and Food Western Australia [LP100200113]; Australian Postgraduate Award	Australia Research Council(Australian Research Council); Department of Agriculture and Food Western Australia; Australian Postgraduate Award(Australian Government)	This work was supported by the Australia Research Council and the Department of Agriculture and Food Western Australia (Project LP100200113, "Factors responsible for host resistance to the pathogen Sclerotinia sclerotiorum for developing effective disease management in vegetable Brassicas", (http://www.arc.gov.au/)). MU gratefully acknowledges the financial assistance of an Australian Postgraduate Award. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATEMAN DF, 1965, PHYTOPATHOLOGY, V55, P204; Billon-Grand G, 2012, MOL PLANT PATHOL, V13, P568, DOI 10.1111/j.1364-3703.2011.00772.x; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bradley CA, 2006, PLANT DIS, V90, P215, DOI 10.1094/PD-90-0215; De Bary A., 1886, BOT ZTG, V44, P377; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; DUTTON MV, 1993, APPL MICROBIOL BIOT, V39, P5, DOI 10.1007/BF00166839; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Garg H, 2010, ANN BOT-LONDON, V106, P897, DOI 10.1093/aob/mcq196; Garg H, 2010, EUR J PLANT PATHOL, V126, P305, DOI 10.1007/s10658-009-9547-7; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Heller A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072292; Huang L, 2008, J PLANT DIS PROTECT, V115, P9, DOI 10.1007/BF03356233; JAMAUX I, 1995, PLANT PATHOL, V44, P22, DOI 10.1111/j.1365-3059.1995.tb02712.x; Lewis BG, 1989, PHYTOTOXINS PLANT PA, P479; Li CX, 2006, AUST J AGR RES, V57, P1131, DOI 10.1071/AR06066; Liang X, 2014, MOL PLANT PATHOL, DOI 2010.1111/mpp.12211; Marciano P, 1993, PHYSL PLANT PATHOL, V22, P339; MAXWELL DP, 1970, PHYTOPATHOLOGY, V60, P1395, DOI 10.1094/Phyto-60-1395; NOYES RD, 1981, PHYSIOL PLANT PATHOL, V18, P123; TU JC, 1985, PHYSIOL PLANT PATHOL, V26, P111, DOI 10.1016/0048-4059(85)90034-7; Uloth MB, 2015, PLANT PATHOL, V64, P1140, DOI 10.1111/ppa.12338; Uloth M, 2014, PLANT DIS, V98, P184, DOI 10.1094/PDIS-06-13-0612-RE; Uloth MB, 2013, FIELD CROP RES, V154, P40, DOI 10.1016/j.fcr.2013.07.013; Webb MA, 1999, PLANT CELL, V11, P751, DOI 10.1105/tpc.11.4.751; WHITNEY KD, 1988, MYCOLOGIA, V80, P707, DOI 10.2307/3807722; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; YANG J, 1993, MYCOL RES, V97, P1516, DOI 10.1016/S0953-7562(09)80227-X; Zhang DB, 2002, CHEM MATER, V14, P2450, DOI 10.1021/cm010768y; Zhou T, 1999, CAN J PLANT PATHOL, V21, P93, DOI 10.1080/07060661.1999.10600090; Ziman L, 1998, Z PFLANZENK PFLANZEN, V105, P283	32	19	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122362	10.1371/journal.pone.0122362	http://dx.doi.org/10.1371/journal.pone.0122362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816022	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600171
J	Bokes, P; Singh, A				Bokes, Pavol; Singh, Abhyudai			Protein Copy Number Distributions for a Self-Regulating Gene in the Presence of Decoy Binding Sites	PLOS ONE			English	Article							EXPRESSION; MODELS	A single transcription factor may interact with a multitude of targets on the genome, some of which are at gene promoters, others being part of DNA repeat elements. Being sequestered at binding sites, protein molecules can be prevented from partaking in other pathways, specifically, from regulating the expression of the very gene that encodes them. Acting as decoys at the expense of the autoregulatory loop, the binding sites can have a profound impact on protein abundance-on its mean as well as on its cell-to-cell variability. In order to quantify this impact, we study in this paper a mathematical model for pulsatile expression of a transcription factor that autoregulates its expression and interacts with decoys. We determine the exact stationary distribution for protein abundance at the single-cell level, showing that in the case of non-cooperative positive autoregulation, the distribution can be bimodal, possessing a basal expression mode and a distinct, up-regulated, mode. Bimodal protein distributions are more feasible if the rate of degradation is the same irrespective of whether protein is bound or not. Contrastingly, the presence of decoy binding sites which protect the protein from degradation reduces the availability of the bimodal scenario.	[Bokes, Pavol] Comenius Univ, Dept Appl Math & Stat, Bratislava, Slovakia; [Singh, Abhyudai] Univ Delaware, Dept Elect & Comp Engn, Newark, DE USA	Comenius University Bratislava; University of Delaware	Bokes, P (corresponding author), Comenius Univ, Dept Appl Math & Stat, Bratislava, Slovakia.	pavol.bokes@fmph.uniba.sk	Bokes, Pavol/AAP-5053-2021	Bokes, Pavol/0000-0002-8414-6933	Slovak Research and Development Agency [APVV-0134-10]; VEGA grant agency [1/0319/15]; National Science Foundation [DMS-1312926]; University of Delaware Research Foundation (UDRF); Oak Ridge Associated Universities (ORAU); Direct For Mathematical & Physical Scien [1312926] Funding Source: National Science Foundation	Slovak Research and Development Agency(Slovak Research and Development Agency); VEGA grant agency(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); National Science Foundation(National Science Foundation (NSF)); University of Delaware Research Foundation (UDRF); Oak Ridge Associated Universities (ORAU); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	PB is supported by the Slovak Research and Development Agency (contract no. APVV-0134-10) and also by the VEGA grant agency (contract no. 1/0319/15). AS is supported by the National Science Foundation Grant DMS-1312926, University of Delaware Research Foundation (UDRF), and Oak Ridge Associated Universities (ORAU).	Alon U, 2007, INTRO SYSTEMS BIOL D; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bokes P, 2012, J MATH BIOL, V65, P493, DOI 10.1007/s00285-011-0468-7; Burger A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041920; Burger A, 2010, P NATL ACAD SCI USA, V107, P4016, DOI 10.1073/pnas.0915138107; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hornos JEM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051907; Keener J., 2008, MATH PHYSL CELLULAR; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Mackey MC, 2013, SIAM J APPL MATH, V73, P1830, DOI 10.1137/12090229X; Mackey MC, 2011, J THEOR BIOL, V274, P84, DOI 10.1016/j.jtbi.2011.01.020; Marban C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026894; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Ptashne M, 2004, GENETIC SWITCH PHAGE; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Singh A, 2012, IEEE DECIS CONTR P, P4918; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Soltani M, 2014, NONSPECIC TRAN UNPUB; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Yvinec R, 2014, J MATH BIOL, V68, P1051, DOI 10.1007/s00285-013-0661-y	32	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120555	10.1371/journal.pone.0120555	http://dx.doi.org/10.1371/journal.pone.0120555			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811868	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700051
J	Mo, XB; Lu, X; Zhang, YH; Zhang, ZL; Deng, FY; Lei, SF				Mo, Xing-Bo; Lu, Xin; Zhang, Yong-Hong; Zhang, Zeng-Li; Deng, Fei-Yan; Lei, Shu-Feng			Gene-Based Association Analysis Identified Novel Genes Associated with Bone Mineral Density	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; OSTEOPOROSIS; EXPRESSION; CHINESE; RISK; LOCI; HIP	Genetic factors contribute to the variation of bone mineral density (BMD), which is a major risk factor of osteoporosis. The aim of this study was to identify more "novel" genes for BMD. Based on the publicly available SNP-based P values, we performed an initial gene-based analysis in a total of 32,961 individuals. Furthermore, we performed differential expression, pathway and protein-protein interaction analyses to find supplementary evidence to support the significance of the identified genes. About 21,695 genes for femoral neck (FN)-BMD and 21,683 genes for lumbar spine (LS)-BMD were analyzed using gene-based association analysis. A total of 35 FN-BMD associated genes and 53 LS-BMD associated genes were identified (P < 2.3x10(-6)) after Bonferroni correction. Among them, 64 genes have not been reported in previous SNP-based genome-wide association studies. Differential expression analysis further supported the significant associations of 14 genes with FN-BMD and 19 genes with LS-BMD. Especially, WNT3 and WNT9B in the Wnt signaling pathway for FN-BMD were further supported by pathway analysis and protein-protein interaction analysis. The present study took the advantage of gene-based association method to perform a supplementary analysis of the GWAS dataset and found some BMD-associated genes. The evidence taken together supported the importance of Wnt signaling pathway genes in determining osteoporosis. Our findings provided more insights into the genetic basis of osteoporosis.	[Mo, Xing-Bo; Lu, Xin; Zhang, Yong-Hong; Zhang, Zeng-Li; Deng, Fei-Yan; Lei, Shu-Feng] Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China; [Mo, Xing-Bo; Lu, Xin; Zhang, Yong-Hong; Zhang, Zeng-Li; Deng, Fei-Yan; Lei, Shu-Feng] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Jiangsu, Peoples R China; [Mo, Xing-Bo; Zhang, Yong-Hong; Lei, Shu-Feng] Soochow Univ, Sch Publ Hlth, Dept Epidemiol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Lei, SF (corresponding author), Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China.	leishufeng@yahoo.com	Mo, Xingbo/I-7112-2013	Mo, Xingbo/0000-0001-8956-4918	Natural Science Foundation of China [31401079, 81373010, 81473046, 81401343, 31271336, 31071097]; natural science foundation of Jiangsu Province [BK20130300]; Startup Fund from Soochow University [Q413900313, Q413900112, Q413900712]; China Postdoctoral Science Foundation [2014M551649]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Startup Fund from Soochow University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by Natural Science Foundation of China (31401079, 81373010, 81473046, 81401343, 31271336, and 31071097), the natural science foundation of Jiangsu Province (BK20130300), the Startup Fund from Soochow University (Q413900313, Q413900112, Q413900712), Project funded by China Postdoctoral Science Foundation (2014M551649), and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden NK, 1996, J BONE MINER RES, V11, P530; Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Cheung CL, 2012, OSTEOPOROSIS INT, V23, P131, DOI 10.1007/s00198-011-1779-7; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gennari L, 2005, AM J EPIDEMIOL, V161, P307, DOI 10.1093/aje/kwi055; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gutierrez-Berzal J, 2006, EXP CELL RES, V312, P938, DOI 10.1016/j.yexcr.2005.12.007; Hashii Y, 2004, LEUKEMIA, V18, P1546, DOI 10.1038/sj.leu.2403450; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Jian WX, 2005, J BONE MINER METAB, V23, P181, DOI 10.1007/s00774-004-0558-3; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Lei SF, 2009, BONE, V44, P1010, DOI 10.1016/j.bone.2008.05.016; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Pillas D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000856; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; TARONE RE, 1990, BIOMETRICS, V46, P515, DOI 10.2307/2531456; Xiao P, 2008, J BONE MINER RES, V23, P644, DOI [10.1359/jbmr.080105, 10.1359/JBMR.080105]	27	20	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121811	10.1371/journal.pone.0121811	http://dx.doi.org/10.1371/journal.pone.0121811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811989	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700142
J	Van der Stocken, T; Vanschoenwinkel, B; De Ryck, DJR; Bouma, TJ; Dahdouh-Guebas, F; Koedam, N				Van der Stocken, Tom; Vanschoenwinkel, Bram; De Ryck, Dennis J. R.; Bouma, Tjeerd J.; Dahdouh-Guebas, Farid; Koedam, Nico			Interaction between Water and Wind as a Driver of Passive Dispersal in Mangroves	PLOS ONE			English	Article							AVICENNIA-MARINA PROPAGULES; LONG-DISTANCE DISPERSAL; DISTURBANCE; WORLD; SEEDS	Although knowledge on dispersal patterns is essential for predicting long-term population dynamics, critical information on the modalities of passive dispersal and potential interactions between vectors is often missing. Here, we use mangrove propagules with a wide variety of morphologies to investigate the interaction between water and wind as a driver of passive dispersal. We imposed 16 combinations of wind and hydrodynamic conditions in a flume tank, using propagules of six important mangrove species (and genera), resulting in a set of dispersal morphologies that covers most variation present in mangrove propagules worldwide. Additionally, we discussed the broader implications of the outcome of this flume study on the potential of long distance dispersal for mangrove propagules in nature, applying a conceptual model to a natural mangrove system in Gazi Bay (Kenya). Overall, the effect of wind on dispersal depended on propagule density (g l(-1)). The low-density Heritiera littoralis propagules were most affected by wind, while the high-density vertically floating propagules of Ceriops tagal and Bruguiera gymnorrhiza were least affected. Avicennia marina, and horizontally floating Rhizophora mucronata and C. tagal propagules behaved similarly. Morphological propagule traits, such as the dorsal sail of H. littoralis, explained another part of the interspecific differences. Within species, differences in dispersal velocities can be explained by differences in density and for H. littoralis also by variations in the shape of the dorsal sail. Our conceptual model illustrates that different propagule types have a different likelihood of reaching the open ocean depending on prevailing water and wind currents. Results suggest that in open water, propagule traits (density, morphology, and floating orientation) appear to determine the effect of water and wind currents on dispersal dynamics. This has important implications for inter-and intraspecific variation in dispersal patterns and the likelihood of reaching suitable habitat patches within a propagule's viable period.	[Van der Stocken, Tom; Vanschoenwinkel, Bram; De Ryck, Dennis J. R.; Dahdouh-Guebas, Farid; Koedam, Nico] Vrije Univ Brussel, Lab Plant Biol & Nat Management, Brussels, Belgium; [Van der Stocken, Tom; De Ryck, Dennis J. R.; Dahdouh-Guebas, Farid] Univ Libre Bruxelles, Lab Syst Ecol & Resource Management, Brussels, Belgium; [Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res NIOZ, Dept Spatial Ecol, Yerseke, Netherlands	Vrije Universiteit Brussel; Universite Libre de Bruxelles; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Van der Stocken, T (corresponding author), Vrije Univ Brussel, Lab Plant Biol & Nat Management, Brussels, Belgium.	tvdstock@gmail.com	Vanschoenwinkel, Bram/I-9021-2019	Vanschoenwinkel, Bram/0000-0002-8973-6297; Bouma, Tjeerd/0000-0001-7824-7546; Van der Stocken, Tom/0000-0002-1820-9123	Flemish Interuniversity Council - University Development Cooperation (VLIR-UOS); VLIR PhD Scholarship (VLADOC)	Flemish Interuniversity Council - University Development Cooperation (VLIR-UOS); VLIR PhD Scholarship (VLADOC)	This research was funded by the Flemish Interuniversity Council - University Development Cooperation (VLIR-UOS; http://www.vliruos.be/). TVdS has a VLIR PhD Scholarship (VLADOC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Balke T, 2013, BIOGEOSCIENCES, V10, P5411, DOI 10.5194/bg-10-5411-2013; Balke T, 2014, J ECOL, V102, P700, DOI 10.1111/1365-2745.12241; Balke T, 2013, J APPL ECOL, V50, P740, DOI 10.1111/1365-2664.12067; Balke T, 2011, MAR ECOL PROG SER, V440, P1, DOI 10.3354/meps09364; Breitfuss MJ, 2003, ESTUAR COAST SHELF S, V56, P573, DOI 10.1016/S0272-7714(02)00207-X; Chambert S, 2009, RIVER RES APPL, V25, P48, DOI 10.1002/rra.1093; Chan H. T., 1985, Malaysian Forester, V48, P324; Chang ER, 2008, FUNCT ECOL, V22, P720, DOI 10.1111/j.1365-2435.2008.01434.x; Chave J., 2005, MEASURING WOOD DENSI; Clarke PJ, 2001, J ECOL, V89, P648, DOI 10.1046/j.0022-0477.2001.00584.x; CLARKE PJ, 1993, AQUAT BOT, V45, P195, DOI 10.1016/0304-3770(93)90021-N; Dahdouh-Guebas F., 2002, Wetlands Ecology and Management, V10, P179, DOI 10.1023/A:1020133110407; DELANGE WP, 1994, J COASTAL RES, V10, P539; Di Nitto D, 2013, BIOGEOSCIENCES, V10, P5095, DOI 10.5194/bg-10-5095-2013; Dodd RS, 2002, MOL ECOL, V11, P1327, DOI 10.1046/j.1365-294X.2002.01525.x; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FRANCIS L, 1991, J EXP BIOL, V158, P117; Gilman EL, 2008, AQUAT BOT, V89, P237, DOI 10.1016/j.aquabot.2007.12.009; Gunn CR, 1976, WORLD GUIDE TROPICAL; Higgins SI, 1999, AM NAT, V153, P464, DOI 10.1086/303193; Iosilevskii G, 2009, J R SOC INTERFACE, V6, P613, DOI 10.1098/rsif.2008.0457; Kitheka JU, 2003, ESTUAR COAST SHELF S, V56, P655, DOI 10.1016/S0272-7714(02)00217-2; Marris E, 2014, NATURE, V510, P320, DOI 10.1038/510320a; Nathan R., 2007, Seed dispersal: theory and its application in a changing world, P252, DOI 10.1079/9781845931650.0252; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; Nettel A, 2007, EVOLUTION, V61, P958, DOI 10.1111/j.1558-5646.2007.00070.x; Ozinga WA, 2004, J ECOL, V92, P767, DOI 10.1111/j.0022-0477.2004.00916.x; Randin CF, 2013, GLOBAL ECOL BIOGEOGR, V22, P913, DOI 10.1111/geb.12040; Sarneel JM, 2014, J VEG SCI, V25, P262, DOI 10.1111/jvs.12074; Steinke TD, 2003, AFR J MAR SCI, V25, P169, DOI 10.2989/18142320309504007; Stieglitz T, 2001, MAR ECOL PROG SER, V211, P131, DOI 10.3354/meps211131; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; van der Pijl L, 1982, PRINCIPAL DISPERSAL; Van der Stocken T, 2013, BIOGEOSCIENCES, V10, P3635, DOI 10.5194/bg-10-3635-2013; YAMASHIRO MORIYA, 1961, HIKOBIA, V2, P209	44	33	33	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121593	10.1371/journal.pone.0121593	http://dx.doi.org/10.1371/journal.pone.0121593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811191	Green Published, gold			2022-12-26	WOS:000356353700117
J	Zhou, Y; Guo, L; Lu, CY; Deng, JX; He, Y; Huang, JH; Huang, GL; Deng, XQ; Gao, X				Zhou, Ying; Guo, Lan; Lu, Ci-yong; Deng, Jian-xiong; He, Yuan; Huang, Jing-hui; Huang, Guo-liang; Deng, Xue-qing; Gao, Xue			Bullying as a Risk for Poor Sleep Quality among High School Students in China	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; ADOLESCENTS; CHILDREN; INSOMNIA; BEHAVIOR; HEALTH; WORK; VICTIMIZATION; DISTURBANCES; ASSOCIATION	Objective To determine whether involvement in bullying as a bully, victim, or bully-victim was associated with a higher risk of poor sleep quality among high school students in China. Methods A cross-sectional study was conducted. A total of 23,877 high school students were surveyed in six cities in Guangdong Province. All students were asked to complete the adolescent health status questionnaire, which included the Chinese version of the Pittsburgh Sleep Quality Index (PSQI) and bullying involvement. Descriptive statistics were used to evaluate sleep quality and the prevalence of school bullying. Multi-level logistic regression analyses were conducted to examine the association between being victimized and bullying others with sleep quality. Results Among the 23,877 students, 6,127 (25.66%) reported having poor sleep quality, and 10.89% reported being involved in bullying behaviors. Of the respondents, 1,410 (5.91%) were pure victims of bullying, 401 (1.68%) were bullies and 784 (3.28%) were bully-victims. Frequently being involved in bullying behaviors (being bullied or bullying others) was related to increased risks of poor sleep quality compared with adolescents who were not involved in bullying behaviors. After adjusting for age, sex, and other confounding factors, the students who were being bullied (OR=2.05, 95%CI=1.81-2.32), bullied others (OR=2.30, 95%CI=1.85-2.86) or both (OR=2.58, 95%CI=2.20-3.03) were at a higher risk for poor sleep quality. Conclusions Poor sleep quality among high school students is highly prevalent, and school bullying is prevalent among adolescents in China. The present results suggested that being involved in school bullying might be a risk factor for poor sleep quality among adolescents.	[Zhou, Ying; Guo, Lan; Lu, Ci-yong; He, Yuan; Deng, Xue-qing; Gao, Xue] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Jian-xiong; Huang, Jing-hui; Huang, Guo-liang] Ctr ADR Monitoring Guangdong, Guangzhou, Guangdong, Peoples R China; [Zhou, Ying] Ctr Dis Control & Prevent Haizhu Dist, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Lu, CY (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	luciyong@mail.sysu.edu.cn			Guangdong Food and Drug Administration	Guangdong Food and Drug Administration	This study was supported by Guangdong Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Alfano CA, 2009, DEPRESS ANXIETY, V26, P503, DOI 10.1002/da.20443; BOULTON MJ, 1992, BRIT J EDUC PSYCHOL, V62, P73, DOI 10.1111/j.2044-8279.1992.tb01000.x; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; Cook CR, 2010, SCHOOL PSYCHOL QUART, V25, P65, DOI 10.1037/a0020149; Craig W, 2009, INT J PUBLIC HEALTH, V54, P216, DOI 10.1007/s00038-009-5413-9; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Doi Y, 2003, SLEEP, V26, P467, DOI 10.1093/sleep/26.4.467; Eriksen W, 2008, INT ARCH OCC ENV HEA, V81, P301, DOI 10.1007/s00420-007-0214-z; Feng Q, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100914, 10.1371/journal.pone.0104348]; Fricke-Oerkermann L, 2007, SLEEP, V30, P1371, DOI 10.1093/sleep/30.10.1371; Gini G, 2009, PEDIATRICS, V123, P1059, DOI 10.1542/peds.2008-1215; Gladstone GL, 2006, J NERV MENT DIS, V194, P201, DOI 10.1097/01.nmd.0000202491.99719.c3; Guo QZ, 2010, BIOMED ENVIRON SCI, V23, P108, DOI 10.1016/S0895-3988(10)60039-6; Hansen AM, 2014, INT ARCH OCC ENV HEA, V87, P285, DOI 10.1007/s00420-013-0860-2; Hansen TB, 2012, AGGRESS VIOLENT BEH, V17, P383, DOI 10.1016/j.avb.2012.03.008; Harel-Fisch Y, 2011, J ADOLESCENCE, V34, P639, DOI 10.1016/j.adolescence.2010.09.008; Huang YS, 2010, SLEEP MED, V11, P1035, DOI 10.1016/j.sleep.2010.04.009; Kamphuis J, 2012, SLEEP MED, V13, P327, DOI 10.1016/j.sleep.2011.12.006; Klomek AB, 2007, J AM ACAD CHILD PSY, V46, P40, DOI 10.1097/01.chi.0000242237.84925.18; Kubiszewski V, 2014, CHRONOBIOL INT, V31, P542, DOI 10.3109/07420528.2013.877475; Lallukka T, 2011, SCAND J WORK ENV HEA, V37, P204, DOI 10.5271/sjweh.3137; Lazaratou H, 2005, EUR CHILD ADOLES PSY, V14, P237, DOI 10.1007/s00787-005-0460-0; Liu XC, 2006, CURR OPIN PSYCHIATR, V19, P288, DOI 10.1097/01.yco.0000218600.40593.18; Liu XC, 2002, PSYCHIAT RES, V111, P75, DOI 10.1016/S0165-1781(02)00131-2; Nakata A, 2004, SOC SCI MED, V59, P1719, DOI 10.1016/j.socscimed.2004.02.002; Niedhammer I, 2009, SLEEP, V32, P1211, DOI 10.1093/sleep/32.9.1211; Notelaers G, 2006, WORK STRESS, V20, P289, DOI 10.1080/02678370601071594; O'Moore M, 2011, INT J WORKPLACE HEAL, V4, P67, DOI 10.1108/17538351111118608; Ohayon M, 2000, PREVALENCE PATTERNS; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Olweus D, 2010, AM J ORTHOPSYCHIAT, V80, P124, DOI 10.1111/j.1939-0025.2010.01015.x; Peach HD, 2013, J ADOLESCENT HEALTH, V53, P293, DOI 10.1016/j.jadohealth.2013.03.012; Rodriguez-Munoz A, 2011, BEHAV PSYCHOL, V19, P453; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Vartia MAL, 2001, SCAND J WORK ENV HEA, V27, P63, DOI 10.5271/sjweh.588; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Wang J, 2009, J ADOLESCENT HEALTH, V45, P368, DOI 10.1016/j.jadohealth.2009.03.021; Williams K, 1996, BRIT MED J, V313, P17, DOI 10.1136/bmj.313.7048.17; Williams PG, 2013, ANN BEHAV MED, V46, P40, DOI 10.1007/s12160-013-9482-x; Xianchen Liu ZZCJ, 2008, SLEEP PATTERNS AND P, DOI [10.1542/peds.2007-1464, DOI 10.1542/PEDS.2007-1464]; Xu ZW, 2012, J PAEDIATR CHILD H, V48, P138, DOI 10.1111/j.1440-1754.2011.02065.x	42	36	37	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121602	10.1371/journal.pone.0121602	http://dx.doi.org/10.1371/journal.pone.0121602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811479	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700119
J	Cremers, AL; de Laat, MM; Kapata, N; Gerrets, R; Klipstein-Grobusch, K; Grobusch, MP				Cremers, Anne Lia; de laat, Myrthe Manon; Kapata, Nathan; Gerrets, Rene; Klipstein-Grobusch, Kerstin; Grobusch, Martin Peter			Assessing the Consequences of Stigma for Tuberculosis Patients in Urban Zambia	PLOS ONE			English	Article							RURAL DISTRICT; TB TREATMENT; GENDER; KNOWLEDGE; HIV; PERCEPTIONS; DISCRIMINATION; EPIDEMIOLOGY; ADHERENCE; BELIEFS	Background Stigma is one of the many factors hindering tuberculosis (TB) control by negatively affecting hospital delay and treatment compliance. In Zambia, the morbidity and mortality due to TB remains high, despite extended public health attempts to control the epidemic and to diminish stigma. Study Aim To enhance understanding of TB-related stigmatizing perceptions and to describe TB patients' experiences of stigma in order to point out recommendations to improve TB policy. Methods We conducted a mixed method study at Kanyama clinic and surrounding areas, in Lusaka, Zambia; structured interviews with 300 TB patients, multiple in-depth interviews with 30 TB patients and 10 biomedical health workers, 3 focus group discussions with TB patients and treatment supporters, complemented by participant observation and policy analysis of the TB control program. Predictors of stigma were identified by use of multivariate regression analyses; qualitative analysis of the in-depth interviews, focus group discussions and participant observation was used for triangulation of the study findings. Results We focused on the 138/300 patients that described TB-related perceptions and attitudes, of whom 113 (82%) reported stigma. Stigma provoking TB conceptions were associated with human immunodeficiency virus (HIV)-infection, alleged immoral behaviour, (perceived) incurability, and (traditional) myths about TB aetiology. Consequences of stigma prevailed both among children and adults and included low self-esteem, insults, ridicule, discrimination, social exclusion, and isolation leading to a decreased quality of life and social status, non-disclosure, and/or difficulties with treatment compliance and adherence. Women had significantly more stigma-related problems than men. Conclusions The findings illustrate that many TB patients faced stigma-related issues, often hindering effective TB control and suggesting that current efforts to reduce stigma are not yet optimal. The content and implementation of sensitization programs should be improved and more emphasis needs to be placed on women and children.	[Cremers, Anne Lia; de laat, Myrthe Manon; Kapata, Nathan; Grobusch, Martin Peter] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Cremers, Anne Lia; Gerrets, Rene] Univ Amsterdam, Dept Sociol & Anthropol, Fac Social & Behav Sci, Amsterdam, Netherlands; [Kapata, Nathan] Natl TB Leprosy Control Programme, Lusaka, Zambia; [Kapata, Nathan] Univ Zambia Univ Coll London UNZA UCL Program, Lusaka, Zambia; [Klipstein-Grobusch, Kerstin] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol, Johannesburg, South Africa	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Utrecht University; Utrecht University Medical Center; University of Witwatersrand	Grobusch, MP (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.p.grobusch@amc.uva.nl	Klipstein-Grobusch, Kerstin/F-5555-2016; Kapata, Nathan/AAW-2469-2020	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Kapata, Nathan/0000-0002-3877-8809	KNCV; Scholten-Cordes Fund	KNCV; Scholten-Cordes Fund	We are indebted to the study participants and staff of Kanyama clinic, Lusaka, Zambia. Moreover, A.L. Cremers received a travel grant of the KNCV and a grant from the Scholten-Cordes Fund to support conduct of this research.	Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Banerjee A, 2000, INT J TUBERC LUNG D, V4, P1047; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Baylies C, 2002, AIDS SEXUALITY GENDE; Bennstam AL, 2004, QUAL HEALTH RES, V14, P299, DOI 10.1177/1049732303261822; Bishop FL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/187365; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Bond V, 2006, J COMMUNITY APPL SOC, V16, P452, DOI 10.1002/casp.893; Buregyeya E, 2011, INT J TUBERC LUNG D, V15, P938, DOI 10.5588/ijtld.10.0211; Cornwall A, 2003, WORLD DEV, V31, P1325, DOI 10.1016/S0305-750X(03)00086-X; Courtwright A, 2010, PUBLIC HEALTH REP, V125, P34, DOI 10.1177/00333549101250S407; Cramm JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-72; Edginton ME, 2002, INT J TUBERC LUNG D, V6, P1075; Franck C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-426; Gelaw M, 2001, East Afr Med J, V78, P382; Getahun H, 2001, ETHIOPIAN MED J, V39, P283; Goffman E, 2009, STIGMA NOTES MANAGEM; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Heunis J C, 2007, Curationis, V30, P4; Hudelson P, 1996, TUBERCLE LUNG DIS, V77, P391, DOI 10.1016/S0962-8479(96)90110-0; Indicators WD, 2010, POV HEADC RAT NAT PO; Jittimanee SX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006360; Jurgensen M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-2; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Kapata N, 2012, J TROP PEDIATRICS; Krishnan L, 2014, TUBERC RES TREAT; Liefooghe R, 1997, TROP MED INT HEALTH, V2, P809, DOI 10.1046/j.1365-3156.1997.d01-380.x; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Macq J, 2006, Psychol Health Med, V11, P346, DOI 10.1080/13548500600595277; Marais BJ, 2010, INFECT DIS CLIN N AM, V24, P727, DOI 10.1016/j.idc.2010.04.004; Moller V, 2007, S AFR REV SOCIOL, V38, P103, DOI 10.1080/21528586.2007.10419170; Moore H. L., 1994, CUTTING TREES GENDER; Mulenga CL, 2014, LUSAKA ZAMBIA; Murray LK, 2006, J NERV MENT DIS, V194, P610, DOI 10.1097/01.nmd.0000230662.01953.bc; Needham DM, 2001, TROP MED INT HEALTH, V6, P256, DOI 10.1046/j.1365-3156.2001.00709.x; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Ngang PN, 2007, INT J TUBERC LUNG D, V11, P1108; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Scambler G, 2009, SOCIOL HEALTH ILL, V31, P441, DOI 10.1111/j.1467-9566.2009.01161.x; Smith J. A., 2007, INT J QUAL STUD HEAL, V2, P3, DOI [10.1080/17482620601016120, DOI 10.1080/17482620601016120]; Somma Daryl, 2006, Psychol Health Med, V11, P271, DOI 10.1080/13548500600594981; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; Waisbord S, 2007, SOC SCI MED, V65, P2130, DOI 10.1016/j.socscimed.2007.06.023; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P837; Weiss Mitchell G, 2006, Psychol Health Med, V11, P277; WHO, 2013, GLOB TUB REP 2013 WH; Yang Wei-Teng, 2014, Tuberc Res Treat, V2014, P461935, DOI 10.1155/2014/461935	48	68	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119861	10.1371/journal.pone.0119861	http://dx.doi.org/10.1371/journal.pone.0119861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806955	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000045
J	Lina, TT; Alzahrani, S; House, J; Yamaoka, Y; Sharpe, AH; Rampy, BA; Pinchuk, IV; Reyes, VE				Lina, Taslima T.; Alzahrani, Shatha; House, Jennifer; Yamaoka, Yoshio; Sharpe, Arlene H.; Rampy, Bill A.; Pinchuk, Irina V; Reyes, Victor E.			Helicobacter pylori cag Pathogenicity Island's Role in B7-H1 Induction and Immune Evasion	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; REGULATORY T-CELLS; PEPTIC-ULCER; B7 FAMILY; PROTEIN; INFECTION; PHOSPHORYLATION; COLONIZATION; ACTIVATION; EXPRESSION	During Helicobacter pylori (H. pylori) infection CD4(+) T cells in the gastric lamina propria are hyporesponsive and polarized by Th1/Th17 cell responses controlled by T-reg cells. We have previously shown that H. pylori upregulates B7-H1 expression on GEC, which, in turn, suppress T cell proliferation, effector function, and induce T-reg cells in vitro. In this study, we investigated the underlying mechanisms and the functional relevance of B7-H1 induction by H. pylori infection to chronic infection. Using H. pylori wild type (WT), cag pathogenicity island (cag PAI(-)) and cagA(-) isogenic mutant strains we demonstrated that H. pylori requires its type 4 secretion system (T4SS) as well as its effector protein CagA and peptidoglycan (PG) fragments for B7-H1 upregulation on GEC. Our study also showed that H. pylori uses the p38 MAPK pathway to upregulate B7-H1 expression in GEC. In vivoconfirmation was obtained when infection of C57BL/6 mice with H. pylori PMSS1 strain, which has a functional T4SS delivery system, but not with H. pylori SS1 strain lacking a functional T4SS, led to a strong upregulation of B7-H1 expression in the gastric mucosa, increased bacterial load, induction of T-reg cells in the stomach, increased IL-10 in the serum. Interestingly, B7-H1(-/-) mice showed less T-reg cells and reduced bacterial loads after infection. These studies demonstrate how H. pylori T4SS components activate the p38 MAPK pathway, upregulate B7-H1 expression by GEC, and cause T-reg cell induction; thus, contribute to establishing a persistent infection characteristic of H. pylori.	[Lina, Taslima T.; Alzahrani, Shatha; Pinchuk, Irina V; Reyes, Victor E.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [House, Jennifer; Reyes, Victor E.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA; [Yamaoka, Yoshio] Baylor Coll Med, Houston, TX 77030 USA; [Sharpe, Arlene H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Rampy, Bill A.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Pinchuk, Irina V] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Pinchuk, IV (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	ivpinchu@utmb.edu; vreyes@utmb.edu		Yamaoka, Yoshio/0000-0002-1222-5819	National Institutes of Health [AI68712, DK090090-01, CA127022]; American Gastroenterological Association Research Scholar Award; NIH [1U54RR02614]; University of Texas Medical Branch Clinical and Translational Sciences Award; Sealy Endowment and Institute for Human Infection and Immunity; UTMB Sealy Centre for Vaccine Development Pre-doctoral Fellowship; McLaughlin Pre-doctoral Fellowship; NATIONAL CANCER INSTITUTE [R21CA127022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI068712, P01AI056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK090090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association Research Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Medical Branch Clinical and Translational Sciences Award; Sealy Endowment and Institute for Human Infection and Immunity; UTMB Sealy Centre for Vaccine Development Pre-doctoral Fellowship; McLaughlin Pre-doctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AI68712, DK090090-01 and CA127022; American Gastroenterological Association Research Scholar Award, NIH 1U54RR02614; The University of Texas Medical Branch Clinical and Translational Sciences Award, Sealy Endowment and Institute for Human Infection and Immunity; UTMB Sealy Centre for Vaccine Development Pre-doctoral Fellowship; McLaughlin Pre-doctoral Fellowship. The American Cancer Society RSG-10-159-01-LIB, NIH 8UL1TR000041, The University of New Mexico clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Berstad AE, 1999, AM J PATHOL, V155, P1097, DOI 10.1016/S0002-9440(10)65212-1; Beswick EJ, 2007, INFECT IMMUN, V75, P4334, DOI 10.1128/IAI.00553-07; Beswick EJ, 2006, J IMMUNOL, V176, P6794, DOI 10.4049/jimmunol.176.11.6794; Blaser MJ, 1996, AM J CLIN PATHOL, V106, P565; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen LG, 2007, J IMMUNOL, V178, P6634, DOI 10.4049/jimmunol.178.10.6634; Cheng HH, 2012, WORLD J GASTROENTERO, V18, P34, DOI 10.3748/wjg.v18.i1.34; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; COGHLAN JG, 1987, LANCET, V2, P1109; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Crabtree JE, 2002, HELICOBACTER, V7, P139, DOI 10.1046/j.1083-4389.2002.00071.x; Das S, 2006, J IMMUNOL, V176, P3000, DOI 10.4049/jimmunol.176.5.3000; DElios MM, 1997, J IMMUNOL, V158, P962; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; FAN XJ, 1994, GUT, V35, P1379, DOI 10.1136/gut.35.10.1379; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Goll R, 2007, HELICOBACTER, V12, P185, DOI 10.1111/j.1523-5378.2007.00495.x; Groeger S, 2011, IMMUNOBIOLOGY, V216, P1302, DOI 10.1016/j.imbio.2011.05.005; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Keates S, 1999, J IMMUNOL, V163, P5552; Krupnick AS, 2005, J IMMUNOL, V175, P6265, DOI 10.4049/jimmunol.175.10.6265; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030786; Li SP, 2010, BIOMED ENVIRON SCI, V23, P273, DOI 10.1016/S0895-3988(10)60063-3; Lina TT, 2013, J IMMUNOL, V191, P3838, DOI 10.4049/jimmunol.1300524; Lucas B, 2001, INFECT IMMUN, V69, P1714, DOI 10.1128/IAI.69.3.1714-1721.2001; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; McGeachy MJ, 2005, CYTOKINE, V32, P81, DOI 10.1016/j.cyto.2005.07.012; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; Roussel Y, 2007, VACCINE, V25, P2919, DOI 10.1016/j.vaccine.2006.07.013; Suarez G, 2006, WORLD J GASTROENTERO, V12, P5593, DOI 10.3748/wjg.v12.i35.5593; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang G, 2012, MBIO, V3, DOI 10.1128/mBio.00409-12; Wang SD, 2004, CELL MOL IMMUNOL, V1, P37; Watanabe T, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/476482; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Wu XC, 2009, CANCER EPIDEMIOL, V33, P337, DOI 10.1016/j.canep.2009.09.006	64	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121841	10.1371/journal.pone.0121841	http://dx.doi.org/10.1371/journal.pone.0121841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807464	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000185
J	Perisic, L; Rodriguez, PQ; Hultenby, K; Sun, Y; Lal, M; Betsholtz, C; Uhlen, M; Wernerson, A; Hedin, U; Pikkarainen, T; Tryggvason, K; Patrakka, J				Perisic, Ljubica; Rodriguez, Patricia Q.; Hultenby, Kjell; Sun, Ying; Lal, Mark; Betsholtz, Christer; Uhlen, Mathias; Wernerson, Annika; Hedin, Ulf; Pikkarainen, Timo; Tryggvason, Karl; Patrakka, Jaakko			Schip1 Is a Novel Podocyte Foot Process Protein that Mediates Actin Cytoskeleton Rearrangements and Forms a Complex with Nherf2 and Ezrin	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FILTRATION; ZEBRAFISH; IDENTIFICATION; VISUALIZATION; PODOCALYXIN; EXPRESSION; GLOMERULI; COMPONENT; NEPHRIN	Background Podocyte foot process effacement accompanied by actin cytoskeleton rearrangements is a cardinal feature of many progressive human proteinuric diseases. Results By microarray profiling of mouse glomerulus, SCHIP1 emerged as one of the most highly enriched transcripts. We detected Schip1 protein in the kidney glomerulus, specifically in podocytes foot processes. Functionally, Schip1 inactivation in zebrafish by morpholino knock-down results in foot process disorganization and podocyte loss leading to proteinuria. In cultured podocytes Schip1 localizes to cortical actin-rich regions of lamellipodia, where it forms a complex with Nherf2 and ezrin, proteins known to participate in actin remodeling stimulated by PDGF beta signaling. Mechanistically, overexpression of Schip1 in vitro causes accumulation of cortical F-actin with dissolution of transversal stress fibers and promotes cell migration in response to PDGF-BB stimulation. Upon actin disassembly by latrunculin A treatment, Schip1 remains associated with the residual F-actin-containing structures, suggesting a functional connection with actin cytoskeleton possibly via its interaction partners. A similar assay with cytochalasin D points to stabilization of cortical actin cytoskeleton in Schip1 overexpressing cells by attenuation of actin depolymerisation. Conclusions Schip1 is a novel glomerular protein predominantly expressed in podocytes, necessary for the zebrafish pronephros development and function. Schip1 associates with the cortical actin cytoskeleton network and modulates its dynamics in response to PDGF signaling via interaction with the Nherf2/ezrin complex. Its implication in proteinuric diseases remains to be further investigated.	[Perisic, Ljubica; Rodriguez, Patricia Q.; Lal, Mark; Pikkarainen, Timo; Tryggvason, Karl; Patrakka, Jaakko] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden; [Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Clin Res Ctr, Stockholm, Sweden; [Sun, Ying; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Vasc Biol Div, Stockholm, Sweden; [Uhlen, Mathias] Royal Inst Technol, Dept Biotechnol, Stockholm, Sweden; [Wernerson, Annika] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden; [Perisic, Ljubica; Hedin, Ulf] Karolinska Inst, Div Vasc Surg, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology; Karolinska Institutet; Karolinska Institutet	Patrakka, J (corresponding author), Karolinska Inst, Dept Med, Karolinska Univ Hosp Huddinge, KI AZ Integrated CardioMetab Ctr, Stockholm, Sweden.	jaakko.patrakka@ki.se	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016; Patrakka, Jaakko/AAG-8796-2019	Uhlen, Mathias/0000-0002-4858-8056; Wernerson, Annika/0000-0003-2792-0010; Hedin, Ulf/0000-0001-9212-3945	Knut and Alice Wallenberg Foundation; Swedish Research Council; Swedish Foundation for Strategic Research	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by grants from the Knut and Alice Wallenberg Foundation (KT, CB), the Swedish Research Council (KT, CB, JP), the Swedish Foundation for Strategic Research (KT, CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Ebarasi L, 2011, CURR OPIN NEPHROL HY, V20, P416, DOI 10.1097/MNH.0b013e3283477797; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He B, 2011, J AM SOC NEPHROL, V22, P1019, DOI 10.1681/ASN.2010121291; James MF, 2004, J CELL SCI, V117, P2951, DOI 10.1242/jcs.01156; Kabgani N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034907; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Lindenmeyer MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011545; Martin PM, 2008, J NEUROSCI, V28, P6111, DOI 10.1523/JNEUROSCI.1044-08.2008; Mathieson PW, 2010, NEPHROL DIAL TRANSPL, V25, P1772, DOI 10.1093/ndt/gfq121; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Nishibori Y, 2011, J AM SOC NEPHROL, V22, P2037, DOI 10.1681/ASN.2010111147; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Perisic L, 2012, KIDNEY INT, V82, P1071, DOI 10.1038/ki.2012.252; Pierchala BA, 2010, KIDNEY INT, V78, P868, DOI 10.1038/ki.2010.212; Russo LM, 2002, AM J KIDNEY DIS, V39, P899, DOI 10.1053/ajkd.2002.32764; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Scoles DR, 2008, BBA-REV CANCER, V1785, P32, DOI 10.1016/j.bbcan.2007.10.001; Sistani L, 2011, KIDNEY INT, V80, P1045, DOI 10.1038/ki.2011.231; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Takeda Tetsuro, 2003, Clin Exp Nephrol, V7, P260, DOI 10.1007/s10157-003-0257-8; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; Uehara Goro, 2004, Clin Exp Nephrol, V8, P36, DOI 10.1007/s10157-003-0265-8; Uhlen P, 2003, ANN NY ACAD SCI, V986, P514, DOI 10.1111/j.1749-6632.2003.tb07237.x; Wasik AA, 2014, AM J PATHOL, V184, P1727, DOI 10.1016/j.ajpath.2014.03.002; Wegner B, 2010, AM J PHYSIOL-RENAL, V298, pF1492, DOI 10.1152/ajprenal.00030.2010; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	38	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122067	10.1371/journal.pone.0122067	http://dx.doi.org/10.1371/journal.pone.0122067			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807495	gold, Green Published			2022-12-26	WOS:000351880000201
J	Teixeira, RR; Diaz, MM; Santos, TVD; Bernardes, JTM; Peixoto, LG; Bocanegra, OL; Neto, MB; Espindola, FS				Teixeira, Renata Roland; Diaz, Miguel Mauricio; da Silva Santos, Tatiane Vanessa; Martins Bernardes, Jean Tofoles; Peixoto, Leonardo Gomes; Bocanegra, Olga Lucia; Neto, Morun Bernardino; Espindola, Foued Salmen			Chronic Stress Induces a Hyporeactivity of the Autonomic Nervous System in Response to Acute Mental Stressor and Impairs Cognitive Performance in Business Executives	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; PITUITARY-ADRENAL AXIS; ACUTE PSYCHOSOCIAL STRESS; EFFORT-REWARD-IMBALANCE; PSYCHOLOGICAL STRESS; LONG-TERM; NEURONAL EXCITABILITY; WORK STRESS; CORTISOL; MEMORY	The present study examined the incidence of chronic stress in business executives (109 subjects: 75 male and 34 female) and its relationship with cortisol levels, cognitive performance, and autonomic nervous system (ANS) reactivity after an acute mental stressor. Blood samples were collected from the subjects to measure cortisol concentration. After the sample collection, the subjects completed the Lipp Inventory of Stress Symptoms for Adults and the Stroop Color-Word Test to evaluate stress and cognitive performance levels, respectively. Saliva samples were collected prior to, immediately after, and five minutes after the test. The results revealed that 90.1% of the stressed subjects experienced stress phases that are considered chronic stress. At rest, the subjects with chronic stress showed higher cortisol levels, and no gender differences were observed. No differences were found between the stressed and non-stressed subjects regarding salivary amylase activity prior to test. Chronic stress also impaired performance on the Stroop test, which revealed higher rates of error and longer reaction times in the incongruent stimulus task independently of gender. For the congruent stimulus task of the Stroop test, the stressed males presented a higher rate of errors than the non-stressed males and a longer reaction time than the stressed females. After the acute mental stressor, the non-stressed male group showed an increase in salivary alpha-amylase activity, which returned to the initial values five minutes after the test; this ANS reactivity was not observed in the chronically stressed male subjects. The ANS responses of the non-stressed vs stressed female groups were not different prior to or after the Stroop test. This study is the first to demonstrate a blunted reactivity of the ANS when male subjects with chronic psychological stress were subjected to an acute mental stressor, and this change could contribute to impairments in cognitive performance.	[Teixeira, Renata Roland; Diaz, Miguel Mauricio; da Silva Santos, Tatiane Vanessa; Martins Bernardes, Jean Tofoles; Peixoto, Leonardo Gomes; Bocanegra, Olga Lucia; Espindola, Foued Salmen] Univ Fed Uberlandia, Inst Genet & Biochem, BR-38400 Uberlandia, MG, Brazil; [Neto, Morun Bernardino] Univ Sao Paulo, Dept Basic & Ambiental Sci, Lorena, SP, Brazil	Universidade Federal de Uberlandia; Universidade de Sao Paulo	Espindola, FS (corresponding author), Univ Fed Uberlandia, Inst Genet & Biochem, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	foued@ufu.br	Neto, Morun Bernardino/L-7381-2015; Espindola, Foued Salmen/C-5324-2013; Teixeira, Renata/AAE-1421-2019	Neto, Morun Bernardino/0000-0003-4292-7800; Espindola, Foued Salmen/0000-0002-6937-1411; Peixoto, Leonardo/0000-0002-4201-7076	funding agency FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais) [APQ 01347/08]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	funding agency FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from the funding agency FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - grant no. APQ 01347/08). TVSS, MMD, and OLB received graduate fellowships from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwood MA, 2011, BIOL PSYCHOL, V88, P57, DOI 10.1016/j.biopsycho.2011.06.008; Bauer AM, 2002, J DEV BEHAV PEDIATR, V23, P102, DOI 10.1097/00004703-200204000-00007; BECK SG, 1994, NEUROENDOCRINOLOGY, V60, P261, DOI 10.1159/000126758; Bellingrath S, 2008, PSYCHONEUROENDOCRINO, V33, P1335, DOI 10.1016/j.psyneuen.2008.07.008; Braunstein-Bercovitz H, 2003, ANXIETY STRESS COPIN, V16, P345, DOI 10.1080/10615800310000112560; Braunstein-Bercovitz H, 2001, EMOTION, V1, P182, DOI 10.1037//1528-3542.1.2.182; Brown ES, 2004, BIOL PSYCHIAT, V55, P538, DOI 10.1016/j.biopsych.2003.09.010; Buske-Kirschbaum A, 2002, J CLIN ENDOCR METAB, V87, P4245, DOI 10.1210/jc.2001-010872; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Camelo Silvia H. Henriques, 2004, Rev. Latino-Am. Enfermagem, V12, P14, DOI 10.1590/S0104-11692004000100003; Cavanaugh MA, 2000, J APPL PSYCHOL, V85, P65, DOI 10.1037/0021-9010.85.1.65; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chatterton RT, 1997, J CLIN ENDOCR METAB, V82, P2503, DOI 10.1210/jc.82.8.2503; Coluccia D, 2008, J NEUROSCI, V28, P3474, DOI 10.1523/JNEUROSCI.4893-07.2008; Compare Angelo, 2014, Cardiovasc Psychiatry Neurol, V2014, P324374, DOI 10.1155/2014/324374; Cornelisse S, 2011, PSYCHONEUROENDOCRINO, V36, P569, DOI 10.1016/j.psyneuen.2010.09.002; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; de Kloet ER, 2000, EUR J PHARMACOL, V405, P187, DOI 10.1016/S0014-2999(00)00552-5; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Diaz Gomez Miguel Mauricio, 2013, PLoS One, V8, pe64043, DOI 10.1371/journal.pone.0064043; Diaz MM, 2012, INT J SPORTS MED, V33, P763, DOI 10.1055/s-0032-1304638; Diaz MM, 2013, J STRENGTH COND RES, V27, P1340, DOI 10.1519/JSC.0b013e318267a612; El-Sheikh M, 2008, J ABNORM CHILD PSYCH, V36, P601, DOI 10.1007/s10802-007-9204-6; Elling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018009; Engert V, 2011, PSYCHONEUROENDOCRINO, V36, P1294, DOI 10.1016/j.psyneuen.2011.02.018; Evans BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061724; Faragher EB, 2005, OCCUP ENVIRON MED, V62, P105, DOI 10.1136/oem.2002.006734; Fortunato CK, 2008, DEV PSYCHOBIOL, V50, P807, DOI 10.1002/dev.20326; Gehrman PR, 2015, BEHAV SLEEP MED, V13, P255, DOI 10.1080/15402002.2014.880344; Gerra G, 2001, PSYCHONEUROENDOCRINO, V26, P91, DOI 10.1016/S0306-4530(00)00046-9; Goldstein DS, 2010, CELL MOL NEUROBIOL, V30, P1433, DOI 10.1007/s10571-010-9606-9; Gomez RG, 2009, PSYCHONEUROENDOCRINO, V34, P1012, DOI 10.1016/j.psyneuen.2009.01.017; Gordis EB, 2008, HORM BEHAV, V53, P96, DOI 10.1016/j.yhbeh.2007.09.002; Gordis EB, 2006, PSYCHONEUROENDOCRINO, V31, P976, DOI 10.1016/j.psyneuen.2006.05.010; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Grossman R, 2006, ANN NY ACAD SCI, V1071, P410, DOI 10.1196/annals.1364.032; Hilgert JB, 2006, J DENT RES, V85, P324, DOI 10.1177/154405910608500408; Hsu FC, 2003, PSYCHOPHARMACOLOGY, V167, P431, DOI 10.1007/s00213-003-1413-2; Imrich R, 2010, RHEUM DIS CLIN N AM, V36, P721, DOI 10.1016/j.rdc.2010.09.003; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; JOELS M, 1995, J STEROID BIOCHEM, V53, P315, DOI 10.1016/0960-0760(95)00069-C; Joels M, 2001, J NEUROENDOCRINOL, V13, P657, DOI 10.1046/j.1365-2826.2001.00688.x; Keenan PA, 1996, NEUROLOGY, V47, P1396, DOI 10.1212/WNL.47.6.1396; Kop WJ, 2011, BIOL PSYCHOL, V86, P230, DOI 10.1016/j.biopsycho.2010.12.003; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Kunz-Ebrecht SR, 2004, SOC SCI MED, V58, P1523, DOI 10.1016/s0277-9536(03)00347-2; Kushnir T, 1992, Public Health Rev, V20, P215; Lapiz-Bluhm M Danet, 2014, Curr Top Behav Neurosci, V18, P45, DOI 10.1007/7854_2014_331; Lipp MEN, 2000, MANUAL DO INVENTARIO; Loeppke R, 2009, J OCCUP ENVIRON MED, V51, P411, DOI 10.1097/JOM.0b013e3181a39180; Loerbroks A, 2010, ALLERGY, V65, P1298, DOI 10.1111/j.1398-9995.2010.02375.x; Lundberg U, 1999, J Occup Health Psychol, V4, P142, DOI 10.1037/1076-8998.4.2.142; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Lupien SJ, 2001, BEHAV BRAIN RES, V127, P137, DOI 10.1016/S0166-4328(01)00361-8; Maruyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039375; Matos-Gomes N, 2010, NEUROIMMUNOMODULAT, V17, P396, DOI 10.1159/000292064; McEwan IJ, 1997, BIOESSAYS, V19, P153, DOI 10.1002/bies.950190210; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; Monteleone P, 2011, PSYCHOL MED, V41, P1963, DOI 10.1017/S0033291711000092; Montoya ER, 2014, PSYCHONEUROENDOCRINO, V47, P31, DOI 10.1016/j.psyneuen.2014.04.022; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2010, PSYCHONEUROENDOCRINO, V35, P1565, DOI 10.1016/j.psyneuen.2010.06.002; Naumova EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051323; O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703; PAVLIDES C, 1993, HIPPOCAMPUS, V3, P183, DOI 10.1002/hipo.450030210; Reagan LP, 2008, EUR J PHARMACOL, V585, P64, DOI 10.1016/j.ejphar.2008.02.050; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schoofs D, 2013, BEHAV BRAIN RES, V241, P144, DOI 10.1016/j.bbr.2012.12.004; SELYE H, 1950, BRIT MED J, V1, P1383, DOI 10.1136/bmj.1.4667.1383; Siegrist J, 1997, ACTA PHYSIOL SCAND, V161, P112; Sotnikov S, 2014, PSYCHONEUROENDOCRINO, V48, P41, DOI 10.1016/j.psyneuen.2014.06.006; Southwick SM, 2002, AM J PSYCHIAT, V159, P1420, DOI 10.1176/appi.ajp.159.8.1420; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Tanno Ana Paula, 2002, Rev. Bras. Cienc. Farm., V38, P273, DOI 10.1590/S1516-93322002000300004; Tanno AP, 2002, LIFE SCI, V71, P2973, DOI 10.1016/S0024-3205(02)02145-8; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Vigil JM, 2010, CHILD DEV, V81, P1228, DOI 10.1111/j.1467-8624.2010.01464.x; Wirtz PH, 2008, PSYCHONEUROENDOCRINO, V33, P92, DOI 10.1016/j.psyneuen.2007.10.003; Wirtz PH, 2010, PSYCHONEUROENDOCRINO, V35, P536, DOI 10.1016/j.psyneuen.2009.09.002; Wolf JM, 2008, BIOL PSYCHOL, V78, P20, DOI 10.1016/j.biopsycho.2007.12.004; Zalonis I, 2009, ARCH CLIN NEUROPSYCH, V24, P81, DOI 10.1093/arclin/acp011	85	35	38	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119025	10.1371/journal.pone.0119025	http://dx.doi.org/10.1371/journal.pone.0119025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25807003	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000013
J	Yoon, JH; Kim, JY; Park, JK; Ko, SB				Yoon, Jin-Ha; Kim, Jang-Young; Park, Jong-Ku; Ko, Sang-Baek			Oxidative Damage Markers Are Significantly Associated with the Carotid Artery Intima-Media Thickness after Controlling for Conventional Risk Factors of Atherosclerosis in Men	PLOS ONE			English	Article							LIPID-PEROXIDATION; ENDOTHELIAL DYSFUNCTION; STRESS; ISOPROSTANES; APOPTOSIS; CALCIFICATION; DISEASE; 8-OHDG; DNA	Background This study aimed to assess the association between oxidative damage markers and carotid artery intima-media thickness (CIMT) after controlling for conventional risk factors of atherosclerosis in multiple logistic regression models. Methods and Findings Fifty-one case male participants (CIMT >= 0.9 mm) were enrolled during their visits to Korean Genomic Rural Cohort Study of Wonju centers between May 1 and August 31, 2011, along with 51 control participants (CIMT < 0.9 mm) selected using frequency matching by age group. The levels of oxidative damage markers, 8-hydroxy-20-deoxyquuanosine (8-OHdG), malondialdehyde (MDA), and 8-iso-prostaglandin F2 alpha (Isoprostane), were measured. Conditional logistic regression models were used to evaluate relative relationships between the oxidative damage markers and the risk of high CIMT. Results The markers of oxidative lipid (Isoprostane and MDA) and DNA (8-OHdG) damage were associated with CIMT after controlling for the conventional risk factors, including age, low density lipoprotein, body mass index, smoking history, alcohol consumption, and metabolic syndrome (ORs [95% CI] for Isoprostane: 3rd tertile, 8.47 [2.59-27.67]; for MDA: 3rd tertile, 8.47 [2.59-27.67]; for 8-OHdG: 3rd tertile, 5.58 [1.79-17.33]). When all the oxidative damage markers were incorporated in the same logistic regression model, only Isoprostane was significantly related to CIMT (OR [95% CI]: 4.22 [1.31-13.53] in 2nd tertile and 14.21 [3.34-60.56] in 3rd tertile). Conclusions In this nested case-control study, the oxidative damage markers of lipid and DNA were associated with CIMT even after controlling for the conventional risk factors of cardiovascular diseases.	[Yoon, Jin-Ha; Park, Jong-Ku; Ko, Sang-Baek] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea; [Kim, Jang-Young] Yonsei Univ, Wonju Coll Med, Dept Cardiol, Wonju, South Korea; [Yoon, Jin-Ha] Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea; [Park, Jong-Ku; Ko, Sang-Baek] Yonsei Univ, Inst Genom Cohort, Wonju, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University	Ko, SB (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea.	kohhj@yonsei.ac.kr		Yoon, Jin-Ha/0000-0003-4198-2955				Ari E, HEMODIALYSIS INT; Basu S, 2000, CLIN SCI, V99, P511, DOI 10.1042/cs0990511; Basu S, 2010, PROSTAG LEUKOTR ESS, V82, P219, DOI 10.1016/j.plefa.2010.02.031; Bauer J, 2014, BRIT J PHARMACOL, V171, P3115, DOI 10.1111/bph.12677; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Fam SS, 2003, CURR MED CHEM, V10, P1723, DOI 10.2174/0929867033457115; Fam SS, CURR DRUG TARGETS CA, V5, P165; Fei X, 2011, CORONARY ARTERY DIS, V22, P223, DOI 10.1097/MCA.0b013e328344b615; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Halliwell B, 2010, ANTIOXID REDOX SIGN, V13, P145, DOI 10.1089/ars.2009.2934; Harrison D, 2003, AM J CARDIOL, V91, p7A; Haschke M, 2007, CLIN CHEM, V53, P489, DOI 10.1373/clinchem.2006.078972; Helmersson J, 1999, PROSTAG LEUKOTR ESS, V61, P203; Jo M, 2011, J GASTROENTEROL, V46, P809, DOI 10.1007/s00535-011-0392-z; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Mercer J, 2007, MUTAT RES-FUND MOL M, V621, P75, DOI 10.1016/j.mrfmmm.2007.02.011; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Pylvas M, 2011, ANTICANCER RES, V31, P1411; Roob JM, 2000, J AM SOC NEPHROL, V11, P539, DOI 10.1681/ASN.V113539; Schulze P Christian, 2005, Curr Atheroscler Rep, V7, P242, DOI 10.1007/s11883-005-0013-5; Siegel G, 2014, COLLOID SURFACE A, V442, P173, DOI 10.1016/j.colsurfa.2013.05.022; Sitia S, 2010, AUTOIMMUN REV, V9, P830, DOI 10.1016/j.autrev.2010.07.016; Surh Y.J., 2005, OXIDATIVE STRESS INF; Swartz HM, 2007, ANTIOXID REDOX SIGN, V9, P1757, DOI 10.1089/ars.2007.1718; Takasu J, 2010, ATHEROSCLEROSIS, V209, P142, DOI 10.1016/j.atherosclerosis.2009.09.013; Thaiparambil JT, 2007, CHEM RES TOXICOL, V20, P1737, DOI 10.1021/tx700289g; Victor VM, 2009, CURR PHARM DESIGN, V15, P2988, DOI 10.2174/138161209789058093; Woodward M, 2009, CLIN SCI, V116, P53, DOI 10.1042/CS20070404; Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010; Yin F, 2013, ARTERIOSCL THROM VAS, V33, P1153, DOI 10.1161/ATVBAHA.112.300552; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075535; Yoon JH, 2011, ANN HUM BIOL, V38, P640, DOI 10.3109/03014460.2011.598188; Zhang ZJ, 2013, ANN CLIN BIOCHEM, V50, P108, DOI 10.1258/acb.2012.011263	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119731	10.1371/journal.pone.0119731	http://dx.doi.org/10.1371/journal.pone.0119731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806957	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000037
J	Zhu, SC; Jing, RQ; Yang, YW; Huang, YT; Wang, X; Leng, Y; Xi, JJ; Wang, GY; Jia, WW; Kang, JH				Zhu, Songcheng; Jing, Ruiqi; Yang, Yiwei; Huang, Yitong; Wang, Xin; Leng, Ye; Xi, Jiajie; Wang, Guiying; Jia, Wenwen; Kang, Jiuhong			A Motif from Lys(216) to Lys(222) in Human BUB3 Protein Is a Nuclear Localization Signal and Critical for BUB3 Function in Mitotic Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ACCURATE CHROMOSOME SEGREGATION; CENP-A; KINETOCHORE FUNCTION; AURORA-B; MOUSE OOCYTE; MPS1; PHOSPHORYLATION; RECRUITMENT; CELLS	Human BUB3 is a key mitotic checkpoint factor that recognizes centromeric components and recruits other mitotic checkpoint molecules to the unattached kinetochore. The key amino acid residues responsible for its localization are not yet defined. In this study, we identified a motif from Lys(216) to Lys(222) in BUB3 as its nuclear localization signal. A BUB3 mutant with deletion of this motif (Del216-222) was found to localize to both the cytoplasm and the nucleus, distinct from the exclusively nuclear distribution of wild-type BUB3. Further analysis revealed that residues Glu(213), Lys(216), Lys(217), Lys(218), Tyr(219), and Phe(221), but not Lys(222), contribute to nuclear localization. Interestingly, the nuclear localization signal was also critical for the kinetochore localization of BUB3. The deletion mutant Del216-222 and a subtle mutant with four residue changes in this region (E213Q/(KE)-E-216/(KE)-E-217/(KE)-E-218 (QE)) did not localize to the kinetochore efficiently or mediate mitotic checkpoint arrest. Protein interaction data suggested that the QE mutant was able to interact with BUB1, MAD2, and BubR1 but that its association with the centromeric components CENP-A and KNL1 was impaired. Amotif from Leu(61) to Leu(65) in CENP-A was found to be involved in the association of BUB3 and CENP-A in cells; however, further assays suggested that CENP-A does not physically interact with BUB3 and does not affect BUB3 localization. Our findings help to dissect the mechanisms of BUB3 in mitotic checkpoint signaling.	[Zhu, Songcheng; Jing, Ruiqi; Yang, Yiwei; Huang, Yitong; Wang, Xin; Leng, Ye; Xi, Jiajie; Wang, Guiying; Jia, Wenwen; Kang, Jiuhong] Tongji Univ, Shanghai Matern & Infant Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University	Zhu, SC (corresponding author), Tongji Univ, Shanghai Matern & Infant Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, 1239 Si Ping Rd, Shanghai 200092, Peoples R China.	zhusongcheng@tongji.edu.cn; jhkang@tongji.edu.cn			National Natural Science Foundation of China; Ministry of Science and Technology [31171432, 2011CBA01100, 91219305, 31210103905, 31371510, 31101061, 81170499, 31201107, 31301208, 81201599, 2011CB965100, 2012CB966603, 2013CB967600]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 12ZR1450900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Foundation of China and the Ministry of Science and Technology (Grants 31171432, 2011CBA01100, 91219305, 31210103905, 31371510, 31101061, 81170499, 31201107, 31301208, 81201599, 2011CB965100, 2012CB966603, and 2013CB967600) and the Science and Technology Commission of Shanghai Municipality (Grants 11ZR1438500 and 12ZR1450900).	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; da Silva SM, 2013, J CELL BIOL, V201, P385, DOI 10.1083/jcb.201210018; de Voer RM, 2013, GASTROENTEROLOGY, V145, P544, DOI 10.1053/j.gastro.2013.06.001; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Goutte-Gattat D, 2013, P NATL ACAD SCI USA, V110, P8579, DOI 10.1073/pnas.1302955110; Handyside AH, 2012, BBA-MOL BASIS DIS, V1822, P1913, DOI 10.1016/j.bbadis.2012.07.007; Hauf S, 2013, BIOCHEM SOC T, V41, P1755, DOI 10.1042/BST20130240; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Jiang H, 2014, DEV CELL, V28, P268, DOI 10.1016/j.devcel.2013.12.013; Kops GJPL, 2008, FRONT BIOSCI-LANDMRK, V13, P3606, DOI 10.2741/2953; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Larsen NA, 2004, J MOL BIOL, V344, P885, DOI 10.1016/j.jmb.2004.09.094; Lermontova I, 2011, PLANT J, V68, P40, DOI 10.1111/j.1365-313X.2011.04664.x; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017794; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McGregor M, 2014, CELL CYCLE, V13, P739, DOI 10.4161/cc.27549; Niikura Y, 2010, CELL DEATH DIFFER, V17, P1011, DOI 10.1038/cdd.2009.207; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Okaz E, 2012, CELL, V151, P603, DOI 10.1016/j.cell.2012.08.044; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Quimby BB, 2005, EUKARYOT CELL, V4, P274, DOI 10.1128/EC.4.2.274-280.2005; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Slattery SD, 2008, CELL CYCLE, V7, P787, DOI 10.4161/cc.7.6.5563; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Toledo CM, 2014, DEV CELL, V28, P282, DOI 10.1016/j.devcel.2013.12.014; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Vleugel M, 2013, J CELL BIOL, V203, P943, DOI 10.1083/jcb.201307016; Wang YC, 2014, CELL CYCLE, V13, DOI 10.4161/cc.29027; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Wilson DK, 2005, J BIOL CHEM, V280, P13944, DOI 10.1074/jbc.M412919200; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yan HL, 2012, CELL SIGNAL, V24, P961, DOI 10.1016/j.cellsig.2011.12.019; Zhang G, 2014, J CELL SCI, V127, P871, DOI 10.1242/jcs.139725; Zhang XJ, 2011, CELL CYCLE, V10, P2742, DOI 10.4161/cc.10.16.15927; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200	44	5	5	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11282	11292		10.1074/jbc.M114.598029	http://dx.doi.org/10.1074/jbc.M114.598029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25814666	hybrid, Green Published			2022-12-26	WOS:000353719400007
J	Biamonte, F; Zolea, F; Bisognin, A; Di Sanzo, M; Saccoman, C; Scumaci, D; Aversa, I; Panebianco, M; Faniello, MC; Bortoluzzi, S; Cuda, G; Costanzo, F				Biamonte, Flavia; Zolea, Fabiana; Bisognin, Andrea; Di Sanzo, Maddalena; Saccoman, Claudia; Scumaci, Domenica; Aversa, Ilenia; Panebianco, Mariafranca; Faniello, Maria Concetta; Bortoluzzi, Stefania; Cuda, Giovanni; Costanzo, Francesco			H-Ferritin-Regulated MicroRNAs Modulate Gene Expression in K562 Cells	PLOS ONE			English	Article							MYELOID-LEUKEMIA; MESSENGER-RNAS; DIFFERENTIATION; LET-7; IRON; CANCER; CHAIN; BIOGENESIS; SUPPRESSOR; MECHANISM	In a previous study, we showed that the silencing of the heavy subunit (FHC) offerritin, the central iron storage molecule in the cell, is accompanied by a modification in global gene expression. In this work, we explored whether different FHC amounts might modulate miRNA expression levels in K562 cells and studied the impact of miRNAs in gene expression profile modifications. To this aim, we performed a miRNA-mRNA integrative analysis in K562 silenced for FHC (K562(shFHC)) comparing it with K562 transduced with scrambled RNA (K562(shRNA)). Four miRNAs, namely hsa-let-7g, hsa-let-7f, hsa-let-7i and hsa-miR-125b, were significantly up-regulated in silenced cells. The remarkable down-regulation of these miRNAs, following FHC expression rescue, supports a specific relation between FHC silencing and miRNA-modulation. The integration of target predictions with miRNA and gene expression profiles led to the identification of a regulatory network which includes the miRNAs up-regulated by FHC silencing, as well as91 down-regulated putative target genes. These genes were further classified in 9 networks; the highest scoring network, "Cell Death and Survival, Hematological System Development and Function, Hematopoiesis", is composed by 18 focus molecules including RAF1 and ERK1/2. We confirmed that, following FHC silencing, ERK1/2 phosphorylation is severely impaired and that RAF1 mRNA is significantly down-regulated. Taken all together, our data indicate that, in our experimental model, FHC silencing may affect RAF1/pERK1/2 levels through the modulation of a specific set of miRNAs and add new insights in to the relationship among iron homeostasis and miRNAs.	[Biamonte, Flavia; Zolea, Fabiana; Di Sanzo, Maddalena; Scumaci, Domenica; Aversa, Ilenia; Panebianco, Mariafranca; Faniello, Maria Concetta; Cuda, Giovanni; Costanzo, Francesco] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, I-88100 Catanzaro, Italy; [Bisognin, Andrea; Saccoman, Claudia; Bortoluzzi, Stefania] Univ Padua, Dept Biol, I-35131 Padua, Italy	Magna Graecia University of Catanzaro; University of Padua	Costanzo, F (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Salvatore Venuta Campus,Viale Europa, I-88100 Catanzaro, Italy.	fsc@unicz.it	Scumaci, Domenica/AAH-1493-2019; Biamonte, Flavia/AAC-4934-2019; Bortoluzzi, Stefania/G-8211-2011; Costanzo, Francesco Saverio/K-3168-2018; Aversa, Ilenia/AAK-5501-2020; Cuda, Giovanni/AAC-2821-2019; Biamonte, Flavia/AAF-2092-2020; Cuda, Giovanni/F-5359-2012	Biamonte, Flavia/0000-0003-3248-3863; Bortoluzzi, Stefania/0000-0001-8240-3070; Costanzo, Francesco Saverio/0000-0002-3096-9416; Aversa, Ilenia/0000-0003-4721-6792; Cuda, Giovanni/0000-0001-6313-1866; Cuda, Giovanni/0000-0001-6313-1866; FANIELLO, Concetta Maria/0000-0001-6938-2754; Scumaci, Domenica/0000-0002-8117-834X	Italian Ministry of Education, University and Research [PON01_02834, 2010NYKNS7]; Fondazione Cariparo	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariparo(Fondazione Cariparo)	This work received support from Italian Ministry of Education, University and Research (PON01_02834 - Prometeo grant to GC; PRIN 2010-11, project number 2010NYKNS7 to SB; Fondazione Cariparo (Excellence Projects 2011-2012) to SB). This study was supported by the Italian Ministry of Education, University and Research (PON01_02834 - Prometeo grant to GC; PRIN 2010-11, project number 2010NYKNS7 to SB) and by Fondazione Cariparo (Excellence Projects 2011-2012) to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Alkhateeb AA, 2013, BBA-REV CANCER, V1836, P245, DOI 10.1016/j.bbcan.2013.07.002; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Banzhaf-Strathmann J, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-30; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; Bevilacqua MA, 1997, J BIOL CHEM, V272, P20736, DOI 10.1074/jbc.272.33.20736; Bevilacqua MA, 2002, ARCH BIOCHEM BIOPHYS, V407, P39, DOI 10.1016/S0003-9861(02)00436-8; BEVILACQUA MA, 1988, ITAL J BIOCHEM, V37, P1; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; COCCIA EM, 1995, BLOOD, V86, P1570, DOI 10.1182/blood.V86.4.1570.bloodjournal8641570; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; COSTANZO F, 1986, NUCLEIC ACIDS RES, V14, P721, DOI 10.1093/nar/14.2.721; Davis M, 2013, NUTRIENTS, V5, P2611, DOI 10.3390/nu5072611; Di Sanzo M, 2011, J PROTEOME RES, V10, P5444, DOI 10.1021/pr200705z; Faniello MC, 2008, INT J BIOCHEM CELL B, V40, P2110, DOI 10.1016/j.biocel.2008.02.010; Faniello MC, 2002, BIOCHEM J, V363, P53, DOI 10.1042/0264-6021:3630053; Festa M, 2000, J BIOL CHEM, V275, P36708, DOI 10.1074/jbc.M004988200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hou WH, 2012, BBA-GENE REGUL MECH, V1819, P1113, DOI 10.1016/j.bbagrm.2012.06.001; Iwasaki K, 2006, MOL CELL BIOL, V26, P2845, DOI 10.1128/MCB.26.7.2845-2856.2006; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee JH, 2009, BIOCHEM BIOPH RES CO, V389, P399, DOI 10.1016/j.bbrc.2009.08.125; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; LEVI S, 1988, J BIOL CHEM, V263, P18086; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; Manca S, 2011, EXP DERMATOL, V20, P932, DOI 10.1111/j.1600-0625.2011.01359.x; Misaggi R, 2014, GENE, V535, P327, DOI 10.1016/j.gene.2013.10.067; Montagner S, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-14; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Rashid KA, 2002, J BIOL CHEM, V277, P22010, DOI 10.1074/jbc.M112448200; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; TSUJI Y, 1991, J BIOL CHEM, V266, P7257; Wang J, 2011, J BIOSCIENCES, V36, P481, DOI 10.1007/s12038-011-9083-4; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Xiong Qian, 2014, Genomics Proteomics & Bioinformatics, V12, P79, DOI 10.1016/j.gpb.2014.02.001; Yuan XL, 2004, J MOL BIOL, V339, P131, DOI 10.1016/j.jmb.2004.03.027; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	46	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122105	10.1371/journal.pone.0122105	http://dx.doi.org/10.1371/journal.pone.0122105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815883	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600146
J	Gritti, G; Boschini, C; Rossi, A; Delaini, F; Grassi, A; Algarotti, A; Mico, C; Trezzi, R; Gianatti, A; Barbui, AM; Rambaldi, A				Gritti, Giuseppe; Boschini, Cristina; Rossi, Andrea; Delaini, Federica; Grassi, Anna; Algarotti, Alessandra; Mico, Caterina; Trezzi, Rosangela; Gianatti, Andrea; Barbui, Anna Maria; Rambaldi, Alessandro			Primary Treatment Response Rather than Front Line Stem Cell Transplantation Is Crucial for Long Term Outcome of Peripheral T-Cell Lymphomas	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; HIGH-DOSE CHEMOTHERAPY; EMISSION-TOMOGRAPHY; UP-FRONT; MACOP-B; CHOP; THERAPY; PROGNOSIS	Outcome of systemic peripheral T-cell lymphomas (PTCL) is unsatisfactory and no controlled clinical study guides the therapy. Phase II studies suggest to consolidate response achieved after front-line treatment with stem cell transplant (SCT). We retrospectively evaluate the impact of front-line SCT consolidation in a single Center cohort of 209 patients treated during the last two decades. Median age was 49 years (range 15-85) with a prevalence of male sex (61%), advanced stage (68%) while IPI was >2 in 44%. Primary treatment was MACOP-B (39%) CHO(E) P (39%), intensive regimens (18%) or others (4%). Complete response to primary treatment (i.e. before SCT) was 60% (5% partial remission). Forty-four patients further proceeded to SCT while 92 did not receive consolidation. Outcome of primary responders was good, with a 3-year overall survival of 74% (82% in ALCL ALK+ and 69% for the other histologies). By multivariate analysis a better overall survival was significantly associated with IPI <2 (P=0.001), primary response (P=0.000), and ALCL ALK+ (P=0.012). The multivariate analysis performed on responders, showed that only IPI was predictive of a better survival while ALCL ALK+ and undergoing SCT were not. Response to primary treatment rather than post-remission programs is the crucial determinant of PTCL outcome.	[Gritti, Giuseppe; Boschini, Cristina; Rossi, Andrea; Delaini, Federica; Grassi, Anna; Algarotti, Alessandra; Mico, Caterina; Barbui, Anna Maria; Rambaldi, Alessandro] Azienda Osped Papa Giovanni XXIII, Hematol Transplant Unit, Bergamo, Italy; [Gritti, Giuseppe; Boschini, Cristina; Rossi, Andrea; Delaini, Federica; Grassi, Anna; Algarotti, Alessandra; Mico, Caterina; Barbui, Anna Maria; Rambaldi, Alessandro] Azienda Osped Papa Giovanni XXIII, Bone Marrow Transplant Unit, Bergamo, Italy; [Trezzi, Rosangela; Gianatti, Andrea] Azienda Osped Papa Giovanni XXIII, Pathol Unit, Bergamo, Italy	ASST Papa Giovanni XXIII; ASST Papa Giovanni XXIII; ASST Papa Giovanni XXIII	Rambaldi, A (corresponding author), Azienda Osped Papa Giovanni XXIII, Hematol Transplant Unit, Bergamo, Italy.	arambaldi@hpg23.it	Rambaldi, Alessandro/M-6172-2019; Gritti, Giuseppe/K-7321-2019; Rambaldi, Alessandro/P-2603-2018	Rambaldi, Alessandro/0000-0002-3739-7502; Gritti, Giuseppe/0000-0002-6789-5123; Rambaldi, Alessandro/0000-0002-3739-7502; Boschini, Cristina/0000-0001-6905-7038	Associazione Matteo Riboldi; Associazione Paolo Belli - Associazione Italiana Lotta alla Leucemia (AIL) sezione di Bergamo; Associazione Italiana per la Ricerca sul Cancro - "AIRC 5 per Mille" -IIC Project, Innate Immunity in Cancer (IIC), Molecular Targeting and Cellular Therapy [9962]	Associazione Matteo Riboldi; Associazione Paolo Belli - Associazione Italiana Lotta alla Leucemia (AIL) sezione di Bergamo; Associazione Italiana per la Ricerca sul Cancro - "AIRC 5 per Mille" -IIC Project, Innate Immunity in Cancer (IIC), Molecular Targeting and Cellular Therapy(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by grants from Associazione Matteo Riboldi (www.associazionematteoriboldi.org), Associazione Paolo Belli - Associazione Italiana Lotta alla Leucemia (AIL) sezione di Bergamo (www.ailbergamo.it) and the Associazione Italiana per la Ricerca sul Cancro (www.airc.it) - "AIRC 5 per Mille" -IIC Project, Innate Immunity in Cancer (IIC), Molecular Targeting and Cellular Therapy (# 9962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NCCN CLIN PRACTICE G; Bassan R, 2009, BLOOD, V113, P4153, DOI 10.1182/blood-2008-11-185132; Cahu X, 2011, ANN ONCOL, V22, P705, DOI 10.1093/annonc/mdq415; Casulo C, 2013, LEUKEMIA LYMPHOMA, V54, P2163, DOI 10.3109/10428194.2013.767901; Chen AI, 2008, BIOL BLOOD MARROW TR, V14, P741, DOI 10.1016/j.bbmt.2008.04.004; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Corradini P, 2006, LEUKEMIA, V20, P1533, DOI 10.1038/sj.leu.2404306; Corradini P, 2014, LEUKEMIA, V28, P1885, DOI 10.1038/leu.2014.79; d'Amore F, 2012, J CLIN ONCOL, V30, P3093, DOI 10.1200/JCO.2011.40.2719; Dearden CE, 2011, BRIT J HAEMATOL, V153, P451, DOI 10.1111/j.1365-2141.2011.08651.x; Delabie J, 2011, BLOOD, V118, P148, DOI 10.1182/blood-2011-02-335216; Escalon MP, 2005, CANCER-AM CANCER SOC, V103, P2091, DOI 10.1002/cncr.20999; Gallamini A, 2004, BLOOD, V103, P2474, DOI 10.1182/blood-2003-09-3080; Gallamini A, 2007, BLOOD, V110, P2316, DOI 10.1182/blood-2007-02-074641; Gallamini A, 2012, BLOOD, V120, P4913, DOI 10.1182/blood-2012-03-403790; Gisselbrecht C, 1998, BLOOD, V92, P76; Jantunen E, 2013, BLOOD, V121, P2529, DOI 10.1182/blood-2012-11-466839; Jerkeman M, 1999, ANN ONCOL, V10, P1079, DOI 10.1023/A:1008392528248; KLIMO P, 1985, ANN INTERN MED, V102, P596, DOI 10.7326/0003-4819-102-5-596; Kluin-Nelemans HC, 2011, ANN ONCOL, V22, P1595, DOI 10.1093/annonc/mdq635; Kyriakou C, 2008, J CLIN ONCOL, V26, P218, DOI 10.1200/JCO.2007.12.6219; Lunning MA, 2013, CURR TREAT OPTION ON, V14, P212, DOI 10.1007/s11864-013-0232-x; Mercadal S, 2008, ANN ONCOL, V19, P958, DOI 10.1093/annonc/mdn022; Nickelsen M, 2009, ANN ONCOL, V20, P1977, DOI 10.1093/annonc/mdp211; Pellegrini C, 2012, ASH ANN M, V120, P2721; Reimer P, 2009, J CLIN ONCOL, V27, P106, DOI 10.1200/JCO.2008.17.4870; Rodriguez J, 2003, ANN ONCOL, V14, P1768, DOI 10.1093/annonc/mdg459; Rodriguez J, 2007, EUR J HAEMATOL, V79, P32, DOI 10.1111/j.1600-0609.2007.00856.x; Savage KJ, 2008, BLOOD, V111, P5496, DOI 10.1182/blood-2008-01-134270; Savage KJ, 2011, HEMATOL-AM SOC HEMAT, P515, DOI 10.1182/asheducation-2011.1.515; Schmitz N, 2010, BLOOD, V116, P3418, DOI 10.1182/blood-2010-02-270785; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Simon A, 2010, BRIT J HAEMATOL, V151, P159, DOI 10.1111/j.1365-2141.2010.08329.x; Smith SM, 2013, J CLIN ONCOL, V31, P3100, DOI 10.1200/JCO.2012.46.0188; Swerdlow SH, 2008, WHO CLASSIFICATION T; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Weisenburger DD, 2011, BLOOD, V117, P3402, DOI 10.1182/blood-2010-09-310342	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121822	10.1371/journal.pone.0121822	http://dx.doi.org/10.1371/journal.pone.0121822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815886	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600122
J	Lorber, B; Chew, DJ; Hauck, SM; Chong, RS; Fawcett, JW; Martin, KR				Lorber, Barbara; Chew, Daniel J.; Hauck, Stefanie M.; Chong, Rachel S.; Fawcett, James W.; Martin, Keith R.			Retinal Glia Promote Dorsal Root Ganglion Axon Regeneration	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-1; APOLIPOPROTEIN-E; NEURITE OUTGROWTH; MESANGIAL CELLS; SPINAL-CORD; IN-VITRO; SPARC; SURVIVAL; LIPOPROTEINS; OSTEONECTIN	Axon regeneration in the adult central nervous system (CNS) is limited by several factors including a lack of neurotrophic support. Recent studies have shown that glia from the adult rat CNS, specifically retinal astrocytes and Muller glia, can promote regeneration of retinal ganglion cell axons. In the present study we investigated whether retinal glia also exert a growth promoting effect outside the visual system. We found that retinal glial conditioned medium significantly enhanced neurite growth and branching of adult rat dorsal root ganglion neurons (DRG) in culture. Furthermore, transplantation of retinal glia significantly enhanced regeneration of DRG axons past the dorsal root entry zone after root crush in adult rats. To identify the factors that mediate the growth promoting effects of retinal glia, mass spectrometric analysis of retinal glial conditioned medium was performed. Apolipoprotein E and secreted protein acidic and rich in cysteine (SPARC) were found to be present in high abundance, a finding further confirmed by western blotting. Inhibition of Apolipoprotein E and SPARC significantly reduced the neuritogenic effects of retinal glial conditioned medium on DRG in culture, suggesting that Apolipoprotein E and SPARC are the major mediators of this regenerative response.	[Lorber, Barbara; Chew, Daniel J.; Chong, Rachel S.; Fawcett, James W.; Martin, Keith R.] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge CB2 0PY, England; [Hauck, Stefanie M.] German Res Ctr Environm Hlth, Res Unit Prot Sci, Helmholtz Ctr Munich, D-85764 Neuherberg, Germany; [Fawcett, James W.; Martin, Keith R.] Cambridge NIHR Biomed Res Ctr, Cambridge CB2 0PY, England; [Martin, Keith R.] Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge, England	University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lorber, B (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge CB2 0PY, England.	bl288@cam.ac.uk; krgm2@cam.ac.uk	Chong, Rachel/AAY-2015-2021; Hauck, Stefanie/B-3300-2013	Chong, Rachel/0000-0003-1339-4099; Hauck, Stefanie/0000-0002-1630-6827; Fawcett, James/0000-0002-7990-4568; Lorber, Barbara/0000-0001-9986-4543	van Geest Fight for Sight Early Career Investigator Award [1868]; MRC [G1000864] Funding Source: UKRI; Medical Research Council [G1000864] Funding Source: researchfish; Fight for Sight [1867/68] Funding Source: researchfish; International Spinal Research Trust [NRB110] Funding Source: researchfish	van Geest Fight for Sight Early Career Investigator Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; International Spinal Research Trust	Funding: This work was supported by a van Geest Fight for Sight Early Career Investigator Award, grant number 1868 [BL].	Au E, 2007, J NEUROSCI, V27, P7208, DOI 10.1523/JNEUROSCI.0509-07.2007; Bampton ETW, 2005, EUR J NEUROSCI, V21, P2611, DOI 10.1111/j.1460-9568.2005.04128.x; Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; Blesch Armin, 2012, Handb Clin Neurol, V109, P563, DOI 10.1016/B978-0-444-52137-8.00035-8; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Hauck SM, 2008, MOL CELL PROTEOMICS, V7, P1349, DOI 10.1074/mcp.M700456-MCP200; Hauck SM, 2012, J PROTEOMICS, V75, P4545, DOI 10.1016/j.jprot.2012.04.052; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Hayashi H, 2012, J BIOL CHEM, V287, P25395, DOI 10.1074/jbc.M112.370130; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Kosacka J, 2009, NEUROSCIENCE, V162, P282, DOI 10.1016/j.neuroscience.2009.04.073; Kury P, 2004, FASEB J, V18, P398, DOI 10.1096/fj.04-1777fje; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Li J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/786475; Lorber B, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015001; Lorber B, 2012, NEUROBIOL DIS, V45, P243, DOI 10.1016/j.nbd.2011.08.008; Lorber B, 2009, J NEUROSCI RES, V87, P2645, DOI 10.1002/jnr.22095; Ma CHE, 2009, BRAIN RES, V1289, P1, DOI 10.1016/j.brainres.2009.06.093; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Muller A, 2007, BRAIN, V130, P3308, DOI 10.1093/brain/awm257; Shanmugaratnam J, 1997, MOL BRAIN RES, V50, P113, DOI 10.1016/S0169-328X(97)00176-9; Smith GM, 2012, TRENDS NEUROSCI, V35, P156, DOI 10.1016/j.tins.2011.10.006; Stary M, 2005, EXP CELL RES, V310, P331, DOI 10.1016/j.yexcr.2005.07.013; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yan Q, 1998, J HISTOCHEM CYTOCHEM, V46, P3, DOI 10.1177/002215549804600102; Yoon C, 2013, J BIOL CHEM, V288, P26557, DOI 10.1074/jbc.M113.478552	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0115996	10.1371/journal.pone.0115996	http://dx.doi.org/10.1371/journal.pone.0115996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816134	Green Published, gold			2022-12-26	WOS:000352133600004
J	Lyu, XF; Yu, JB; Zhou, M; Ma, B; Wang, GM; Zhan, C; Han, GX; Guan, B; Wu, HF; Li, YZ; Wang, D				Lyu, Xiaofei; Yu, Junbao; Zhou, Mo; Ma, Bin; Wang, Guangmei; Zhan, Chao; Han, Guangxuan; Guan, Bo; Wu, Huifeng; Li, Yunzhao; Wang, De			Changes of Soil Particle Size Distribution in Tidal Flats in the Yellow River Delta	PLOS ONE			English	Article							LAND-USE TYPES; FRACTAL FEATURES; SPATIAL-PATTERNS; CHINA; SEDIMENT; WETLAND; FRAGMENTATION; VARIABILITY; ACCRETION; SALINITY	Background The tidal flat is one of the important components of coastal wetland systems in the Yellow River Delta (YRD). It can stabilize shorelines and protect coastal biodiversity. The erosion risk in tidal flats in coastal wetlands was seldom been studied. Characterizing changes of soil particle size distribution (PSD) is an important way to quantity soil erosion in tidal flats. Method/Principal findings Based on the fractal scale theory and network analysis, we determined the fractal characterizations (singular fractal dimension and multifractal dimension) soil PSD in a successional series of tidal flats in a coastal wetland in the YRD in eastern China. The results showed that the major soil texture was from silt loam to sandy loam. The values of fractal dimensions, ranging from 2.35 to 2.55, decreased from the low tidal flat to the high tidal flat. We also found that the percent of particles with size ranging between 0.4 and 126 mu m was related with fractal dimensions. Tide played a great effort on soil PSD than vegetation by increasing soil organic matter (SOM) content and salinity in the coastal wetland in the YRD. Conclusions/Significance Tidal flats in coastal wetlands in the YRD, especially low tidal flats, are facing the risk of soil erosion. This study will be essential to provide a firm basis for the coast erosion control and assessment, as well as wetland ecosystem restoration.	[Lyu, Xiaofei; Yu, Junbao; Ma, Bin; Wang, Guangmei; Zhan, Chao; Han, Guangxuan; Guan, Bo; Wu, Huifeng; Li, Yunzhao; Wang, De] Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China; [Lyu, Xiaofei; Yu, Junbao; Ma, Bin; Wang, Guangmei; Zhan, Chao; Han, Guangxuan; Guan, Bo; Wu, Huifeng; Li, Yunzhao; Wang, De] YICCAS, Shandong Prov Key Lab Coastal Environm Proc, Yantai, Shandong, Peoples R China; [Lyu, Xiaofei; Wang, Guangmei; Zhan, Chao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhou, Mo] NE Normal Univ, Environm Coll, Changchun 130024, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeast Normal University - China	Yu, JB (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China.	junbao.yu@gmail.com	wang, gm/GWV-1237-2022; Wu, Huifeng/E-4886-2016	马, 斌/0000-0001-8625-1676; Yu, Junbao/0000-0002-3433-3538; Ma, Bin/0000-0003-3666-7862	Project of National Science & Technology Pillar Program in "12th Five Year'' period [2011BAC02B01]; National Natural Science Foundation for Distinguished Young Scholar of Shandong Province [JQ201114]; National Science Foundation of China [41301333]	Project of National Science & Technology Pillar Program in "12th Five Year'' period; National Natural Science Foundation for Distinguished Young Scholar of Shandong Province; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project of National Science & Technology Pillar Program in "12th Five Year'' period (2011BAC02B01), National Natural Science Foundation for Distinguished Young Scholar of Shandong Province (No. JQ201114), and the National Science Foundation of China (41301333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martin MA, 2009, VADOSE ZONE J, V8, P202, DOI 10.2136/vzj2008.0038; Baker RC, 2013, ACTA ARITH, V157, P37, DOI 10.4064/aa157-1-3; Billingsley Patrick, 1965, ERGODIC THEORY INFOR; Biswas A, 2012, NONLINEAR PROC GEOPH, V19, P227, DOI 10.5194/npg-19-227-2012; Callaway JC, 2012, ESTUAR COAST, V35, P1163, DOI 10.1007/s12237-012-9508-9; Chen M, 2013, BIOGEOCHEMISTRY, V115, P167, DOI 10.1007/s10533-013-9826-4; Doi H, 2009, POPUL ECOL, V51, P57, DOI 10.1007/s10144-008-0127-z; Fan XM, 2011, ECOHYDROLOGY, V4, P744, DOI 10.1002/eco.164; Fu H, 2009, ARID LAND RES MANAG, V23, P137, DOI 10.1080/15324980902813658; Gao GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088559; Ghorbani N, 2012, NUTR CYCL AGROECOSYS, V93, P15, DOI 10.1007/s10705-012-9496-y; Gulser C, 2006, GEODERMA, V131, P33, DOI 10.1016/j.geoderma.2005.03.004; Nguyen HYT, 2013, J COAST CONSERV, V17, P93, DOI 10.1007/s11852-012-0221-4; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; Mavi MS, 2012, SOIL BIOL BIOCHEM, V45, P8, DOI 10.1016/j.soilbio.2011.10.003; Montero E, 2003, GEODERMA, V112, P197, DOI 10.1016/S0016-7061(02)00306-3; Peng G, 2014, J SOIL SEDIMENT, V14, P1116, DOI 10.1007/s11368-014-0876-6; Perfect E, 1997, ENG GEOL, V48, P185, DOI 10.1016/S0013-7952(97)00040-9; Pye K, 2007, FORENSIC SCI INT, V167, P30, DOI 10.1016/j.forsciint.2006.06.005; Renyi A., 1970, PROBABILITY THEORY; Salako FK, 1999, GEODERMA, V91, P103, DOI 10.1016/S0016-7061(99)00006-3; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Schulte E.E, 1995, RECOMMENDED SOIL TES, Vsecond; Setia R, 2011, SOIL BIOL BIOCHEM, V43, P1908, DOI 10.1016/j.soilbio.2011.05.013; Setia R, 2011, SOIL BIOL BIOCHEM, V43, P667, DOI 10.1016/j.soilbio.2010.12.004; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Wang D, 2008, CATENA, V72, P29, DOI 10.1016/j.catena.2007.03.019; Wissing L., 2014, Geoderma, V228/229, P90, DOI 10.1016/j.geoderma.2013.12.012; Xie XJ, 2013, J MT SCI-ENGL, V10, P437, DOI 10.1007/s11629-013-2500-3; Xu GC, 2013, CATENA, V101, P17, DOI 10.1016/j.catena.2012.09.013; Yu J, 2011, BIOGEOSCIENCES, V8, P2427, DOI 10.5194/bg-8-2427-2011; Yu JB, 2014, ENVIRON EARTH SCI, V72, P589, DOI 10.1007/s12665-013-2980-0; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092839; Zhang YN, 2013, ECOL ENG, V52, P308, DOI 10.1016/j.ecoleng.2012.10.002	36	24	25	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121368	10.1371/journal.pone.0121368	http://dx.doi.org/10.1371/journal.pone.0121368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816240	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600085
J	Mills-Lujan, K; Andrews, DL; Chou, CW; Deom, CM				Mills-Lujan, Katherine; Andrews, David L.; Chou, Chau-Wen; Deom, C. Michael			The Roles of Phosphorylation and SHAGGY-Like Protein Kinases in Geminivirus C4 Protein Induced Hyperplasia	PLOS ONE			English	Article							BRASSINOSTEROID SIGNAL-TRANSDUCTION; GENE-EXPRESSION; GSK3-LIKE KINASES; RECEPTOR KINASES; CELL-DIVISION; ARABIDOPSIS; MOVEMENT; FAMILY; LOCALIZATION; MECHANISMS	Even though plant cells are highly plastic, plants only develop hyperplasia under very specific abiotic and biotic stresses, such as when exposed to pathogens like Beet curly top virus (BCTV). The C4 protein of BCTV is sufficient to induce hyperplasia and alter Arabidopsis development. It was previously shown that C4 interacts with two Arabidopsis Shaggy-like protein kinases, AtSK21 and 23, which are negative regulators of brassinosteroid (BR) hormone signaling. Here we show that the C4 protein interacts with five additional AtSK family members. Bikinin, a competitive inhibitor of the seven AtSK family members that interact with C4, induced hyperplasia similar to that induced by the C4 protein. The Ser49 residue of C4 was found to be critical for C4 function, since: 1) mutagenesis of Ser49 to Ala abolished the C4-induced phenotype, abolished C4/AtSK interactions, and resulted in a mutant protein that failed to induce changes in the BR signaling pathway; 2) Ser49 is phosphorylated in planta; and 3) plant-encoded AtSKs must be catalytically active to interact with C4. A C4 N-myristoylation site mutant that does not localize to the plasma membrane and does not induce a phenotype, retained the ability to bind AtSKs. Taken together, these results suggest that plasma membrane associated C4 interacts with and co-opts multiple AtSKs to promote its own phosphorylation and activation to subsequently compromise cell cycle control.	[Mills-Lujan, Katherine; Andrews, David L.; Deom, C. Michael] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [Chou, Chau-Wen] Univ Georgia, Dept Chem, Prote & Mass Spectrometry Core Facil, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Deom, CM (corresponding author), Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA.	deom@uga.edu		Deom, C. Michael/0000-0002-7008-9720	Georgia Agricultural Experiment Station	Georgia Agricultural Experiment Station	This research was funded by the Georgia Agricultural Experiment Station. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; CHAPMAN S, 1992, PLANT J, V2, P549; Charrier B, 2002, PLANT PHYSIOL, V130, P577, DOI 10.1104/pp.009175; Charrier B, 2000, PLANT PHYSIOL, V130, P577; Chen MK, 2013, PLANT PHYSIOL, V162, P1978, DOI 10.1104/pp.113.218198; Cho H, 2014, NAT CELL BIOL, V16, P66, DOI 10.1038/ncb2893; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; Desvoyes B, 2006, PLANT PHYSIOL, V140, P67, DOI 10.1104/pp.105.071027; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dogra SC, 2009, PLANT MOL BIOL, V71, P25, DOI 10.1007/s11103-009-9506-x; ESAU K, 1978, AM J BOT, V65, P772, DOI 10.2307/2442153; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gudesblat GE, 2012, NAT CELL BIOL, V14, P548, DOI 10.1038/ncb2471; Gutierrez C, 2002, PHYSIOL MOL PLANT P, V60, P219, DOI 10.1006/pmpp.2002.0401; Hanley-Bowdoin L, 2004, MOL PLANT PATHOL, V5, P149, DOI [10.1111/j.1364-3703.2004.00214.x, 10.1111/J.1364-3703.2004.00214.X]; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; JUPIN I, 1994, VIROLOGY, V204, P82, DOI 10.1006/viro.1994.1512; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kondo Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4504; Latham JR, 1997, PLANT J, V11, P1273, DOI 10.1046/j.1365-313X.1997.11061273.x; LEE S, 1994, PLANT J, V6, P525, DOI 10.1046/j.1365-313X.1994.6040525.x; Li JM, 2002, SCIENCE, V295, P1299; Lozano-Duran R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022383; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; Mills-Lujan K, 2010, PROTOPLASMA, V239, P95, DOI 10.1007/s00709-009-0086-z; Ohad N, 2007, PLANT PHYSIOL, V145, P1090, DOI 10.1104/pp.107.107284; Park J, 2004, MOL CELLS, V17, P117; Park J, 2010, PLANT CELL REP, V29, P1377, DOI 10.1007/s00299-010-0923-8; Peng P, 2008, MOL PLANT, V1, P338, DOI 10.1093/mp/ssn001; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Qi XS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-143; Rojas MR, 2001, VIROLOGY, V291, P110, DOI 10.1006/viro.2001.1194; Rozhon W, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-172; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Saidi Y, 2012, TRENDS PLANT SCI, V17, P39, DOI 10.1016/j.tplants.2011.10.002; STANLEY J, 1992, VIROLOGY, V190, P506, DOI 10.1016/0042-6822(92)91243-N; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Teng KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011280; Tomas DM, 2011, MOL PLANT MICROBE IN, V24, P849, DOI 10.1094/MPMI-12-10-0291; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vanitharani R, 2005, TRENDS PLANT SCI, V10, P144, DOI 10.1016/j.tplants.2005.01.005; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Varsani A, 2014, ARCH VIROL, V159, P1873, DOI 10.1007/s00705-014-1982-x; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Yan ZY, 2009, PLANT PHYSIOL, V150, P710, DOI 10.1104/pp.109.138099; Ye HX, 2011, J INTEGR PLANT BIOL, V53, P455, DOI 10.1111/j.1744-7909.2011.01046.x; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Zhang SS, 2009, PLANT SIGNAL BEHAV, V4, P1117, DOI 10.4161/psb.4.12.9903; Zhiponova MK, 2013, NEW PHYTOL, V197, P490, DOI 10.1111/nph.12036; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	63	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122356	10.1371/journal.pone.0122356	http://dx.doi.org/10.1371/journal.pone.0122356			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815729	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600169
J	Yang, SH; Lin, JC; Wu, SY; Huang, KL; Jung, F; Ma, MC; Hsu, GSW; Jow, GM				Yang, Shih-Hsing; Lin, Jau-Chen; Wu, Shu-Yu; Huang, Kun-Lun; Jung, Fang; Ma, Ming-Chieh; Hsu, Guoo-Shyng Wang; Jow, Guey-Mei			Membrane Translocation of IL-33 Receptor in Ventilator Induced Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; SOLUBLE ST2; MECHANICAL VENTILATION; PROTECTIVE-VENTILATION; HEART-FAILURE; INFLAMMATION; MORTALITY; CYTOKINE	Ventilator-induced lung injury is associated with inflammatory mechanism and causes high mortality. The objective of this study was to discover the role of IL-33 and its ST2 receptor in acute lung injury induced by mechanical ventilator (ventilator-induced lung injury; VILI). Male Wistar rats were intubated after tracheostomy and received ventilation at 10 cm H2O of inspiratory pressure (PC10) by a G5 ventilator for 4 hours. The hemodynamic and respiratory parameters were collected and analyzed. The morphological changes of lung injury were also assessed by histological H&E stain. The dynamic changes of lung injury markers such as TNF-alpha and IL-1 beta were measured in serum, bronchoalveolar lavage fluid (BALF), and lung tissue homogenization by ELISA assay. During VILI, the IL-33 profile change was detected in BALF, peripheral serum, and lung tissue by ELISA analysis. The Il-33 and ST2 expression were analyzed by immunohistochemistry staining and western blot analysis. The consequence of VILI by H&E stain showed inducing lung congestion and increasing the expression of pro-inflammatory cytokines such as TNF-alpha and IL-1 beta in the lung tissue homogenization, serum, and BALF, respectively. In addition, rats with VILI also exhibited high expression of IL-33 in lung tissues. Interestingly, the data showed that ST2L (membrane form) was highly accumulated in the membrane fraction of lung tissue in the PC10 group, but the ST2L in cytosol was dramatically decreased in the PC10 group. Conversely, the sST2 (soluble form) was slightly decreased both in the membrane and cytosol fractions in the PC10 group compared to the control group. In conclusion, these results demonstrated that ST2L translocation from the cytosol to the cell membranes of lung tissue and the down-expression of sST2 in both fractions can function as new biomarkers of VILI. Moreover, IL33/ST2 signaling activated by mechanically responsive lung injury may potentially serve as a new therapy target.	[Yang, Shih-Hsing; Lin, Jau-Chen; Jung, Fang] Fu Jen Catholic Univ, Dept Resp Therapy, New Taipei City, Taiwan; [Yang, Shih-Hsing; Hsu, Guoo-Shyng Wang] Fu Jen Catholic Univ, PhD Program Nutr & Food Sci, New Taipei City, Taiwan; [Wu, Shu-Yu; Huang, Kun-Lun] Natl Def Med Ctr, Inst Aerosp & Undersea Med, Taipei, Taiwan; [Ma, Ming-Chieh; Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Hsu, Guoo-Shyng Wang] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei City, Taiwan	Fu Jen Catholic University; Fu Jen Catholic University; National Defense Medical Center; Fu Jen Catholic University; Fu Jen Catholic University	Jow, GM (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan.	039666@mail.fju.edu.tw			National Science Council of Taiwan [NSC 97-2320-B-030-003-MY3, NSC 101-2320-B-030-008-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants NSC 97-2320-B-030-003-MY3 and NSC 101-2320-B-030-008-MY3 from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa P, 2011, RESP CARE, V56, P1942, DOI 10.4187/respcare.01183; Amado-Rodriguez L, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-52; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Belperio JA, 2010, VENTILATOR INDUCED L, P223; Bertok S, 2012, THORAX, V67, P244, DOI 10.1136/thoraxjnl-2011-200590; Biehl M, 2013, RESP CARE, V58, P927, DOI 10.4187/respcare.02347; Broch K, 2012, EUR J HEART FAIL, V14, P268, DOI 10.1093/eurjhf/hfs006; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Dries DJ, 2007, RESPIR CARE, V52, P31; Halbertsma FJJ, 2005, NETH J MED, V63, P382; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Ho JE, 2013, J CLIN INVEST, V123, P4208, DOI 10.1172/JCI67119; Institute of Laboratory Animal Resources. Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Ky B, 2011, CIRC-HEART FAIL, V4, P180, DOI 10.1161/CIRCHEARTFAILURE.110.958223; Le Goffic R, 2011, AM J RESP CELL MOL, V45, P1125, DOI 10.1165/rcmb.2010-0516OC; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Lingel A, 2009, STRUCTURE, V17, P1398, DOI 10.1016/j.str.2009.08.009; Liu DJ, 2012, AM J PHYSIOL-LUNG C, V302, pL370, DOI 10.1152/ajplung.00349.2011; Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Needham DM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2124; Nin N, 2006, CRIT CARE MED, V34, P1093, DOI 10.1097/01.CCM.0000205663.92384.E7; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shah RV, 2009, CIRC-HEART FAIL, V2, P311, DOI 10.1161/CIRCHEARTFAILURE.108.833707; Tang SE, 2014, FREE RADICAL BIO MED, V71, P321, DOI 10.1016/j.freeradbiomed.2014.03.034; Uttman L, 2012, BRIT J ANAESTH, V109, P584, DOI 10.1093/bja/aes230; Vaporidi K, 2010, AM J PHYSIOL-LUNG C, V299, pL150, DOI 10.1152/ajplung.00341.2009; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Wu SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074742; Wu SY, 2012, CRIT CARE MED, V40, P553, DOI 10.1097/CCM.0b013e318232d776; Xia JG, 2011, CRIT CARE, V15, DOI 10.1186/cc10502; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818	40	13	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121391	10.1371/journal.pone.0121391	http://dx.doi.org/10.1371/journal.pone.0121391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815839	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600090
J	Boso, G; Somia, NV				Boso, Guney; Somia, Nikunj V.			Characterization of Resistance to Rhabdovirus and Retrovirus Infection in a Human Myeloid Cell Line	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; EFFICIENT GENE-TRANSFER; HIV-1 INFECTION; LDL RECEPTOR; LEUKEMIA-VIRUS; FAMILY-MEMBERS; PROTEIN; REVEALS; INHIBITION; SAMHD1	Viruses interact with various permissive and restrictive factors in host cells throughout their replication cycle. Cell lines that are non-permissive to viral infection have been particularly useful in discovering host cell proteins involved in viral life cycles. Here we describe the characterization of a human myeloid leukemia cell line, KG-1, that is resistant to infection by retroviruses and a Rhabdovirus. We show that KG-1 cells are resistant to infection by Vesicular Stomatits Virus as well as VSV Glycoprotein (VSVG) pseudotyped retroviruses due to a defect in binding. Moreover our results indicate that entry by xenotropic retroviral envelope glycoprotein RD114 is impaired in KG-1 cells. Finally we characterize a post-entry block in the early phase of the retroviral life cycle in KG-1 cells that renders the cell line refractory to infection. This cell line will have utility in discovering proteins involved in infection by VSV and HIV-1.	[Boso, Guney] Univ Minnesota, Mol Cellular Dev Biol & Genet Grad Program, Minneapolis, MN USA; [Somia, Nikunj V.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Somia, NV (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	somia001@umn.edu	Boso, Guney/GVS-1470-2022	Boso, Guney/0000-0002-1326-2953	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an NIH grant to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2006, P NATL ACAD SCI USA, V103, P15933, DOI 10.1073/pnas.0602674103; Amirache F, 2014, BLOOD, V123, P1422, DOI 10.1182/blood-2013-11-540641; Ammayappan A, 2013, J VIROL, V87, P13543, DOI 10.1128/JVI.02240-13; BARAK LS, 1981, J CELL BIOL, V90, P595, DOI 10.1083/jcb.90.3.595; Barrett T, 2013, NUCLEIC ACIDS RES, V41, P27; Baumann JG, 1998, J VIROL, V72, P7685, DOI 10.1128/JVI.72.9.7685-7687.1998; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; Bloor S, 2010, P NATL ACAD SCI USA, V107, P6970, DOI 10.1073/pnas.0908536107; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Clouser CL, 2010, J VIROL, V84, P9301, DOI 10.1128/JVI.01006-10; Coil DA, 2004, J VIROL, V78, P10920, DOI 10.1128/JVI.78.20.10920-10926.2004; Collins DR, 2014, PLOS PATHOG, V10, P23; COLLINS SJ, 1988, J VIROL, V62, P4346, DOI 10.1128/JVI.62.11.4346-4348.1988; Cosset FL, 2009, J VIROL, V83, P3228, DOI 10.1128/JVI.01711-08; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; FISCHINGER PJ, 1973, J VIROL, V11, P978, DOI 10.1128/JVI.11.6.978-985.1973; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kentsis A, 2012, NAT MED, V18, P1118, DOI 10.1038/nm.2819; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lech P, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-45; MASTROMARINO P, 1987, J GEN VIROL, V68, P2359, DOI 10.1099/0022-1317-68-9-2359; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Morizono K, 2006, VIROLOGY, V355, P71, DOI 10.1016/j.virol.2006.07.015; Obuchi M, 2003, J VIROL, V77, P8843, DOI 10.1128/JVI.77.16.8843-8856.2003; Panda D, 2011, P NATL ACAD SCI USA, V108, P19036, DOI 10.1073/pnas.1113643108; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Rasko JEJ, 1999, P NATL ACAD SCI USA, V96, P2129, DOI 10.1073/pnas.96.5.2129; SCHLEGEL R, 1983, CELL, V32, P639, DOI 10.1016/0092-8674(83)90483-X; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; SUPERTI F, 1986, ACTA VIROL, V30, P10; Teobald I, 2008, IMMUNOBIOLOGY, V213, P75, DOI 10.1016/j.imbio.2007.06.001; Weekes MP, 2012, J PROTEOME RES, V11, P1475, DOI 10.1021/pr201135e; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yolamanova M, 2013, NAT NANOTECHNOL, V8, P130, DOI [10.1038/nnano.2012.248, 10.1038/NNANO.2012.248]; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	46	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121455	10.1371/journal.pone.0121455	http://dx.doi.org/10.1371/journal.pone.0121455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811758	Green Submitted, gold, Green Published			2022-12-26	WOS:000356353700103
J	Huang, SJ; Tang, WM; Zhu, ZJ; Lu, HK; Tan, XL; Zhang, BY; Best, J; Yang, LG; Zheng, HP; Jiang, N; Yin, YP; Yang, B; Chen, XS				Huang, Shujie; Tang, Weiming; Zhu, Zhengjun; Lu, Hekun; Tan, Xueling; Zhang, Baoyuan; Best, John; Yang, Ligang; Zheng, Heping; Jiang, Ning; Yin, Yueping; Yang, Bin; Chen, Xiangsheng			Higher Prevalence of Sexual Transmitted Diseases and Correlates of Genital Warts among Heterosexual Males Attending Sexually Transmitted Infection Clinics (MSCs) in Jiangmen, China: Implication for the Up-Taking of STD Related Service	PLOS ONE			English	Article							HIV; MEN; SYPHILIS; WORKERS; HEALTH; IMPACT; RISK	Background Increasing burden of STDs is one of China's major public health concerns. However, only a limited number of studies have ever investigated the prevalence of these STDs, particular for genital warts and its correlates among heterosexual males attending STD clinics in China. In order to fill this gap, we conducted a cross-sectional study among MSCs in Jiangmen, China, between the years of 2009 and 2010. Method The eligible participants were recruited from several STD-clinics in public hospitals. We collected demographic information and behaviors of the participants. After HIV and syphilis testing, we further checked whether the participants had genital warts and genital herpes. In addition, urine samples were collected from part of the participants for CT and NG testing. Results Of the 533 eligible participants, over three-fifths were aged 35 or below, nearly three quarters had no college degree, over three-fifths were residence of Jiangmen. The prevalence of HIV, syphilis, genital warts, genital herpes, CT and NG were 0.19%, 7.50%, 7.32%, 5.25%, 9.73% and 6.19%, respectively. Living with family members (versus living alone), no STD-related service in past year, experiencing STDs related symptoms in past year, and sex with FSWs in last three months were positively associated with genital warts, with adjusted ORs of 5.54 (95% CI 1.94-15.81), 2.26 (95% CI 1.08-4.74), 1.99 (95% CI 1.00-3.99) and 2.01 (95% CI 1.00-4.04), respectively. Conclusion Our study indicates that the prevalence of STDs among MSCs in Jiangmen was high, which may further spread HIV among MSCs. Targeted interventions that focused on STDs related services uptake should be implemented urgently.	[Huang, Shujie; Tang, Weiming; Yang, Ligang; Zheng, Heping; Yang, Bin] Guangdong Prov Ctr Skin Dis & STI Control, Guangzhou 510095, Guangdong, Peoples R China; [Tang, Weiming] Univ North Carolina Project China, Guangzhou 510095, Guangdong, Peoples R China; [Zhu, Zhengjun; Lu, Hekun; Tan, Xueling; Zhang, Baoyuan] Jiangmen Dermatol Hosp, Jiangmen 529000, Peoples R China; [Best, John] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; [Jiang, Ning; Yin, Yueping; Chen, Xiangsheng] China CDC, Natl Ctr STD Control, Nanjing 210000, Jiangsu, Peoples R China	University of California System; University of California San Francisco	Yang, B (corresponding author), Guangdong Prov Ctr Skin Dis & STI Control, 2 Lujing Rd, Guangzhou 510095, Guangdong, Peoples R China.	yangbin101@hotmail.com; chenxs@ncstdlc.org		Tang, Weiming/0000-0002-9026-707X	National Mega Program [2008ZX10011]; National Institutes of Health program [1D43TW009532-01]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310] Funding Source: NIH RePORTER	National Mega Program; National Institutes of Health program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Mega Program (grant no. 2008ZX10011) and National Institutes of Health program (1D43TW009532-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; De Panfilis G, 2002, SEX TRANSM DIS, V29, P121, DOI 10.1097/00007435-200203000-00001; Dinh TH, 2008, SEX TRANSM DIS, V35, P357, DOI 10.1097/OLQ.0b013e3181632d61; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Giuliano AR, 2007, J INFECT DIS, V196, P1146, DOI 10.1086/521629; Goncalves MAG, 2003, TUMORI, V89, P9, DOI 10.1177/030089160308900103; GREER CE, 1995, J CLIN MICROBIOL, V33, P2058, DOI 10.1128/JCM.33.8.2058-2063.1995; HIPPELAINEN M, 1991, SEX T DIS, V18, P321; Institute S, 1996, SAS SYST WIND; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Li DM, 2014, CHINESE MED J-PEKING, V127, P707, DOI 10.3760/cma.j.issn.0366-6999.20131502; Lin L, 2014, SEX HEALTH, V11, P94, DOI 10.1071/SH13199; Liu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095289; Lowndes CM, 2000, AIDS, V14, P2523, DOI 10.1097/00002030-200011100-00015; Marra F, 2009, SEX TRANSM INFECT, V85, P111, DOI 10.1136/sti.2008.030999; Palacios R, 2007, JAIDS-J ACQ IMM DEF, V44, P356, DOI 10.1097/QAI.0b013e31802ea4c6; STRAND A, 1995, GENITOURIN MED, V71, P387; Tang WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085985; Thuy NTT, 1998, AIDS, V12, P425, DOI 10.1097/00002030-199804000-00012; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; WHO, 2012, GLOB INC PREV SEL CU; Woodhall S, 2008, SEX TRANSM INFECT, V84, P161, DOI 10.1136/sti.2007.029512; Wu Z, 2010, J ACQ IMMUN DEF SYND, V53, P1, DOI DOI 10.1097/QAI.0B013E3181C7D379; Xu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089723; Yang H-T, 2014, CLIN INFECT DIS; Zhang DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096364; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7	29	5	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121814	10.1371/journal.pone.0121814	http://dx.doi.org/10.1371/journal.pone.0121814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811185	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700144
J	Farcot, E; Lavedrine, C; Vernoux, T				Farcot, Etienne; Lavedrine, Cyril; Vernoux, Teva			A Modular Analysis of the Auxin Signalling Network	PLOS ONE			English	Article							FACTOR GENE FAMILY; BOX PROTEIN TIR1; RESPONSE FACTORS; ARABIDOPSIS-THALIANA; DNA-BINDING; TRANSCRIPTIONAL REGULATORS; STRUCTURAL BASIS; AUX/IAA PROTEIN; REPRESSION; DEGRADATION	Auxin is essential for plant development from embryogenesis onwards. Auxin acts in large part through regulation of transcription. The proteins acting in the signalling pathway regulating transcription downstream of auxin have been identified as well as the interactions between these proteins, thus identifying the topology of this network implicating 54 Auxin Response Factor (ARF) and Aux/IAA (IAA) transcriptional regulators. Here, we study the auxin signalling pathway by means of mathematical modeling at the single cell level. We proceed analytically, by considering the role played by five functional modules into which the auxin pathway can be decomposed: the sequestration of ARF by IAA, the transcriptional repression by IAA, the dimer formation amongst ARFs and IAAs, the feedback loop on IAA and the auxin induced degradation of IAA proteins. Focusing on these modules allows assessing their function within the dynamics of auxin signalling. One key outcome of this analysis is that there are both specific and overlapping functions between all the major modules of the signaling pathway. This suggests a combinatorial function of the modules in optimizing the speed and amplitude of auxin-induced transcription. Our work allows identifying potential functions for homo-and hetero-dimerization of transcriptional regulators, with ARF: IAA, IAA: IAA and ARF: ARF dimerization respectively controlling the amplitude, speed and sensitivity of the response and a synergistic effect of the interaction of IAA with transcriptional repressors on these characteristics of the signaling pathway. Finally, we also suggest experiments which might allow disentangling the structure of the auxin signaling pathway and analysing further its function in plants.	[Farcot, Etienne] Univ Nottingham, Sch Math Sci, Ctr Math Med & Biol, Nottingham NG7 2RD, England; [Farcot, Etienne] Univ Nottingham, Sch Math Sci, Ctr Plant Integrat Biol, Nottingham NG7 2RD, England; [Lavedrine, Cyril; Vernoux, Teva] Univ Lyon, UCBL, CNRS, Lab Reprod & Dev Plantes,INRA,ENS Lyon, Lyon, France	University of Nottingham; University of Nottingham; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Farcot, E (corresponding author), Univ Nottingham, Sch Math Sci, Ctr Math Med & Biol, Nottingham NG7 2RD, England.	etienne.farcot@nottingham.ac.uk; teva.vernoux@ens-lyon.fr	Vernoux, Teva/J-1695-2019	Vernoux, Teva/0000-0002-8257-4088	French Ministry of Research;  [ANR-12-BSV6-0005]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); 	CL and TV were supported by the ANR-12-BSV6-0005 grant (AuxiFlo). C.L. was supported by a predoctoral grant from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Villalobos LIAC, 2012, NAT CHEM BIOL, V8, P477, DOI [10.1038/NCHEMBIO.926, 10.1038/nchembio.926]; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Cho H, 2014, NAT CELL BIOL, V16, P66, DOI 10.1038/ncb2893; Cinquin O, 2002, J THEOR BIOL, V216, P229, DOI 10.1006/jtbi.2002.2544; Cranz S, 2004, BIOCHEMISTRY-US, V43, P718, DOI 10.1021/bi0355793; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Francois P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031908; Gouze Jean-Luc, 1998, Journal of Biological Systems, V6, P11, DOI 10.1142/S0218339098000054; Guilfoyle TJ, 2012, PLANT SCI, V190, P82, DOI 10.1016/j.plantsci.2012.04.003; Gunawardena J, 2013, MOL BIOL CELL, V24, P1827, DOI 10.1091/mbc.E12-03-0227; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Havens KA, 2012, PLANT PHYSIOL, V160, P135, DOI 10.1104/pp.112.202184; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Korasick DA, 2014, P NATL ACAD SCI USA, V111, P5427, DOI 10.1073/pnas.1400074111; Lau S, 2011, NAT CELL BIOL, V13, P611, DOI 10.1038/ncb2212; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Li JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027364; Middleton AM, 2010, B MATH BIOL, V72, P1383, DOI 10.1007/s11538-009-9497-4; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Muto H, 2007, PLANT PHYSIOL, V144, P187, DOI 10.1104/pp.107.096628; Muto H, 2006, PLANT CELL PHYSIOL, V47, P1095, DOI 10.1093/pcp/pcj080; Nanao MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4617; Narsai R, 2007, PLANT CELL, V19, P3418, DOI 10.1105/tpc.107.055046; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Paponov IA, 2008, MOL PLANT, V1, P321, DOI 10.1093/mp/ssm021; Pencik A, 2013, PLANT CELL, V25, P3858, DOI 10.1105/tpc.113.114421; Pierre-Jerome E, 2014, P NATL ACAD SCI USA, V111, P9407, DOI 10.1073/pnas.1324147111; Rademacher EH, 2012, DEV CELL, V22, P211, DOI 10.1016/j.devcel.2011.10.026; Rademacher EH, 2011, PLANT J, V68, P597, DOI 10.1111/j.1365-313X.2011.04710.x; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Salmon J, 2008, PLANT J, V54, P118, DOI 10.1111/j.1365-313X.2007.03396.x; Santillan M, 2008, MATH MODEL NAT PHENO, V3, P85, DOI 10.1051/mmnp:2008056; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Thomas R., 1990, BIOL FEEDBACK; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Vernoux T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.39; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659	49	32	36	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122231	10.1371/journal.pone.0122231	http://dx.doi.org/10.1371/journal.pone.0122231			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807071	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000214
J	McNamara, DE; Gopalakrishnan, S; Smith, MD; Murray, AB				McNamara, Dylan E.; Gopalakrishnan, Sathya; Smith, Martin D.; Murray, A. Brad			Climate Adaptation and Policy-Induced Inflation of Coastal Property Value	PLOS ONE			English	Article							SEA-LEVEL RISE; BEACH NOURISHMENT; SHORELINE; INSURANCE; HAZARD; ZONES; COST	Human population density in the coastal zone and potential impacts of climate change underscore a growing conflict between coastal development and an encroaching shoreline. Rising sea-levels and increased storminess threaten to accelerate coastal erosion, while growing demand for coastal real estate encourages more spending to hold back the sea in spite of the shrinking federal budget for beach nourishment. As climatic drivers and federal policies for beach nourishment change, the evolution of coastline mitigation and property values is uncertain. We develop an empirically grounded, stochastic dynamic model coupling coastal property markets and shoreline evolution, including beach nourishment, and show that a large share of coastal property value reflects capitalized erosion control. The model is parameterized for coastal properties and physical forcing in North Carolina, U.S.A. and we conduct sensitivity analyses using property values spanning a wide range of sandy coastlines along the U.S. East Coast. The model shows that a sudden removal of federal nourishment subsidies, as has been proposed, could trigger a dramatic downward adjustment in coastal real estate, analogous to the bursting of a bubble. We find that the policy-induced inflation of property value grows with increased erosion from sea level rise or increased storminess, but the effect of background erosion is larger due to human behavioral feedbacks. Our results suggest that if nourishment is not a long-run strategy to manage eroding coastlines, a gradual removal is more likely to smooth the transition to more climate-resilient coastal communities.	Univ N Carolina, Ctr Marine Sci, Dept Phys & Phys Oceanog, Wilmington, NC 28403 USA; [Gopalakrishnan, Sathya] Ohio State Univ, Dept Agr Environm & Dev Econ, Columbus, OH 43210 USA; [Smith, Martin D.; Murray, A. Brad] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	University of North Carolina; University of North Carolina Wilmington; University System of Ohio; Ohio State University; Duke University	McNamara, DE (corresponding author), Univ N Carolina, Ctr Marine Sci, Dept Phys & Phys Oceanog, Wilmington, NC 28403 USA.	mcnamarad@uncw.edu	Gopalakrishnan, Sathya/K-4079-2012; Smith, Martin D/D-9168-2016	Smith, Martin D/0000-0002-4714-463X; McNamara, Dylan/0000-0001-8752-1586; Gopalakrishnan, Sathya/0000-0002-3593-0297; Murray, A. Brad/0000-0002-2484-9151	National Science Foundation [EAR-0952120]	National Science Foundation(National Science Foundation (NSF))	Support for this project was provided by the National Science Foundation (EAR-0952120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, OCEAN SHORELINE MANA, DOI DOI 10.1016/0951-8312(91)90048-7; Bin O, 2008, LAND ECON, V84, P434, DOI 10.3368/le.84.3.434; BROWN GM, 1977, REV ECON STAT, V59, P272, DOI 10.2307/1925045; Cleary WJ, 2006, J COASTAL RES, P884; Culliton T.J., 1998, POPULATION DISTRIBUT; Elko NA, 2007, COAST ENG, V54, P49, DOI 10.1016/j.coastaleng.2006.08.001; Gopalakrishnan S, 2011, J ENVIRON ECON MANAG, V61, P297, DOI 10.1016/j.jeem.2010.09.003; Hapke C.J., 2011, NATL ASSESSMENT SHOR; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Keim BD, 2007, J CLIMATE, V20, P3498, DOI 10.1175/JCLI4187.1; Kunreuther H, 2006, ANN AM ACAD POLIT SS, V604, P208, DOI 10.1177/0002716205285685; Landry CE, 2011, LAND ECON, V87, P92, DOI 10.3368/le.87.1.92; Lund R, 1994, J APPL STAT, V21, P195; Michel-Kerjan E, 2011, SCIENCE, V333, P408, DOI 10.1126/science.1202616; Murray A.B., 2011, GEOPHYS RES LETT, V38; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Nicholls RJ, 2008, SUSTAIN SCI, V3, P89, DOI 10.1007/s11625-008-0050-4; NOAA, 2006, BEACH NOUR GUID LOC; Parsons GR, 2001, COAST MANAGE, V29, P91; REED WJ, 1984, J ENVIRON ECON MANAG, V11, P180, DOI 10.1016/0095-0696(84)90016-0; Reilly T, 2014, STAR NEWS       0417; Smith MD, 2009, J ENVIRON ECON MANAG, V58, P58, DOI 10.1016/j.jeem.2008.07.011; Trembanis AC, 1999, COAST MANAGE, V27, P329; Valverde HR, 1999, J COASTAL RES, V15, P1100; YOHE G, 1995, J ENVIRON ECON MANAG, V29, pS78, DOI 10.1006/jeem.1995.1062	26	45	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121278	10.1371/journal.pone.0121278	http://dx.doi.org/10.1371/journal.pone.0121278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806944	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000141
J	Nogueira, W; Litvak, LM; Saoji, AA; Buchner, A				Nogueira, Waldo; Litvak, Leonid M.; Saoji, Aniket A.; Buechner, Andreas			Design and Evaluation of a Cochlear Implant Strategy Based on a "Phantom" Channel	PLOS ONE			English	Article							ELECTRODE INSERTION DEPTH; PITCH PERCEPTION; ACOUSTIC HEARING; SPEECH RECOGNITION; MUSIC PERCEPTION; TEMPORAL PITCH; USERS; STIMULATION; REPRESENTATION; ADAPTATION	Unbalanced bipolar stimulation, delivered using charge balanced pulses, was used to produce "Phantom stimulation", stimulation beyond the most apical contact of a cochlear implant's electrode array. The Phantom channel was allocated audio frequencies below 300Hz in a speech coding strategy, conveying energy some two octaves lower than the clinical strategy and hence delivering the fundamental frequency of speech and of many musical tones. A group of 12 Advanced Bionics cochlear implant recipients took part in a chronic study investigating the fitting of the Phantom strategy and speech and music perception when using Phantom. The evaluation of speech in noise was performed immediately after fitting Phantom for the first time (Session 1) and after one month of take-home experience (Session 2). A repeated measures of analysis of variance (ANOVA) within factors strategy (Clinical, Phantom) and interaction time (Session 1, Session 2) revealed a significant effect for the interaction time and strategy. Phantom obtained a significant improvement in speech intelligibility after one month of use. Furthermore, a trend towards a better performance with Phantom (48%) with respect to F120 (37%) after 1 month of use failed to reach significance after type 1 error correction. Questionnaire results show a preference for Phantom when listening to music, likely driven by an improved balance between high and low frequencies.	[Nogueira, Waldo; Buechner, Andreas] Hannover Med Sch, Cluster Excellence Hearing4all, Dept Otolaryngol, Hannover, Germany; [Litvak, Leonid M.; Saoji, Aniket A.] Adv Bion LLC, Res & Technol Grp, Valencia, CA USA	Hannover Medical School	Nogueira, W (corresponding author), Hannover Med Sch, Cluster Excellence Hearing4all, Dept Otolaryngol, Hannover, Germany.	nogueiravazquez.waldo@mh-hannover.de	Nogueira, Waldo/O-3240-2016		DFG Cluster of Excellence [EXC 1077/1]; Advanced Bionics LLC	DFG Cluster of Excellence(German Research Foundation (DFG)); Advanced Bionics LLC	This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all". Advanced Bionics LLC, provided support in the form of salaries for authors [Leonid M. Litvak and Aniket A. Saoji], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Arnoldner C, 2007, AUDIOL NEURO-OTOL, V12, P313, DOI 10.1159/000103212; Baskent D, 2005, J ACOUST SOC AM, V117, P1405, DOI 10.1121/1.1856273; Baumann U, 2006, HEARING RES, V213, P34, DOI 10.1016/j.heares.2005.12.010; Boex C, 2006, JARO-J ASSOC RES OTO, V7, P110, DOI 10.1007/s10162-005-0027-2; Boyle PJ, 2009, INT J AUDIOL, V48, P211, DOI 10.1080/14992020802581982; Brown CA, 2009, J ACOUST SOC AM, V125, P1658, DOI 10.1121/1.3068441; Di Nardo W, 2011, EUR ARCH OTO-RHINO-L, V268, P27, DOI 10.1007/s00405-010-1335-7; Dorman MF, 1997, J ACOUST SOC AM, V102, P2993, DOI 10.1121/1.420354; Dorman MF, 2005, EAR HEARING, V26, P371, DOI 10.1097/00003446-200508000-00001; Dorman MF, 2003, EAR HEARING, V24, P457, DOI 10.1097/01.AUD.0000090438.20404.D9; Finley CC, 2008, OTOL NEUROTOL, V29, P920, DOI 10.1097/MAO.0b013e318184f492; Friesen LM, 2005, AUDIOL NEURO-OTOL, V10, P169, DOI 10.1159/000084027; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Gfeller K, 1998, J Am Acad Audiol, V9, P1; Gfeller K, 2007, EAR HEARING, V28, P412, DOI 10.1097/AUD.0b013e3180479318; HochmairDesoyer I, 1997, AM J OTOL, V18, pS83; ITU, 1988, 60 MHZ SYST STAND 2; (ITUa) ITU, 1988, ATT PERF BLUE BOOK; Koch DB, 2007, EAR HEARING, V28, p38S, DOI 10.1097/AUD.0b013e31803150de; Kong YY, 2010, J ACOUST SOC AM, V127, P3114, DOI 10.1121/1.3372713; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Looi V, 2008, EAR HEARING, V29, P421, DOI 10.1097/AUD.0b013e31816a0d0b; Macherey O, 2011, JARO-J ASSOC RES OTO, V12, P233, DOI 10.1007/s10162-010-0248-x; Magnusson L, 2011, INT J AUDIOL, V50, P279, DOI 10.3109/14992027.2010.537378; MCKAY CM, 1994, J ACOUST SOC AM, V96, P2664, DOI 10.1121/1.411377; Middlebrooks JC, 2010, J NEUROSCI AUT UNPUB, V30, P2225; Moore B C, 1991, Br J Audiol, V25, P171, DOI 10.3109/03005369109079851; Moore BCJ, 2005, SPR HDB AUD, V24, P234; Moore BCJ, 2003, J ACOUST SOC AM, V114, P408, DOI 10.1121/1.1577552; Nogueira W, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/531213; Oxenham AJ, 2004, P NATL ACAD SCI USA, V101, P1421, DOI 10.1073/pnas.0306958101; Reiss LAJ, 2007, JARO-J ASSOC RES OTO, V8, P241, DOI 10.1007/s10162-007-0077-8; Rosen S, 1999, J ACOUST SOC AM, V106, P3629, DOI 10.1121/1.428215; Rosslau K, 2012, ACTA OTO-LARYNGOL, V132, P64, DOI 10.3109/00016489.2011.619569; Saoji AA, 2013, HEARING RES, V298, P109, DOI 10.1016/j.heares.2012.12.006; Saoji AA, 2010, EAR HEARING, V31, P693, DOI 10.1097/AUD.0b013e3181e1d15e; Schatzer R, 2014, HEARING RES, V309, P26, DOI 10.1016/j.heares.2013.11.003; SHANNON RV, 1983, HEARING RES, V11, P157, DOI 10.1016/0378-5955(83)90077-1; Skinner M. W., 1995, Annals of Otology Rhinology and Laryngology, V104, P307; Skinner MW, 2007, ANN OTO RHINOL LARYN, V116, P2, DOI 10.1177/000348940711600401; Stakhovskaya O, 2007, JARO-J ASSOC RES OTO, V8, P220, DOI 10.1007/s10162-007-0076-9; TOWNSHEND B, 1987, IEEE T BIO-MED ENG, V34, P891, DOI 10.1109/TBME.1987.326102; Turner CW, 2008, HEARING RES, V242, P164, DOI 10.1016/j.heares.2007.11.008; van der Marel KS, 2014, EAR HEARING, V35, pE9, DOI 10.1097/01.aud.0000436256.06395.63; Vary P, 2006, DIGITAL SPEECH TRANS, P239; Vermeire K, 2010, ORL-J OTO-RHIN-LARYN, V72, P305, DOI 10.1159/000319748; Vermeire K, 2008, HEARING RES, V245, P98, DOI 10.1016/j.heares.2008.09.003; Wilson B.S., 1993, COCHLEAR IMPLANTS AU, P35; Witt S, 2002, ANN OTO RHINOL LARYN, V111, P349, DOI 10.1177/000348940211100412; Zeng FG, 2002, HEARING RES, V174, P101, DOI 10.1016/S0378-5955(02)00644-5	50	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120148	10.1371/journal.pone.0120148	http://dx.doi.org/10.1371/journal.pone.0120148			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806818	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000068
J	Tseng, YH; Khan, MA				Tseng, Yu-hwei; Khan, Mujibul Alam			Where Do the Poorest Go to Seek Outpatient Care in Bangladesh: Hospitals Run by Government or Microfinance Institutions?	PLOS ONE			English	Article							MICRO-CREDIT PROGRAM; HEALTH-CARE; RURAL BANGLADESH; SERVICES; EXPERIENCE; BARRIERS; BEHAVIOR; ACCESS; WOMEN; DETERMINANTS	Introduction Health programs implemented by microfinance institutions (MFIs) aim to benefit the poor, but whether these services reach the poorest remains uncertain. This study intended to investigate the socioeconomic distribution of patients in hospitals operated by microfinance institutions (i.e. MFI hospitals) in Bangladesh and compare the differences with public hospitals to determine if the programs were consistent with their pro-poor mandate. Methods In this cross-sectional study, we used the convenience sampling method to conduct an interviewer-assisted questionnaire survey among 347 female outpatients, with 170 in public hospitals and 177 in MFI hospitals. Independent variables were patient characteristics categorized into predisposing factors (age, education, marital status, family size), enabling factors (microcredit membership, household income) and need factors (self-rated health, perceived needs for care). We employed Generalized Estimating Equations (GEE) to evaluate how these factors contributed to MFI hospital use. Results Use of MFI hospitals was associated with microcredit membership over 5 years (OR=2.9, p<.01), moderately poor household (OR=4.09, p<.001), non-poor household (OR=7.34, p<.01) and need for preventive care (OR=3.4, p<.01), compared with public hospitals. Combining membership and income, we found microcredit members had a higher tendency towards utilization but membership effect pertained to the non-and moderately-poor. Compared with the group who were non-members and the poorest, microcredit members who were non-poor had the highest likelihood (OR=7.46, p<.001) to visit MFI hospitals, followed by members with moderate income (OR=6.91, p<.001) and then non-members in non-poor households (OR=4.48, p<.01). Those who were members but the poorest had a negative association (OR=0.42), though not significant. Despite a higher utilization of preventive services in MFI hospitals, expenditure there was significantly higher. Conclusion Inequity was more pronounced in MFI hospitals than public ones. MFI hospitals appeared to miss their target population. We suggest that MFIs reorganize health programs toward primary health care to make care equitable and universally accessible. This study holds practical implications for governments, development agencies and microfinance practitioners working at the grassroots level.	[Tseng, Yu-hwei] Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei 10764, Taiwan; [Khan, Mujibul Alam] RISE, Dhaka, Bangladesh	National Taiwan University	Tseng, YH (corresponding author), Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei 10764, Taiwan.	mayeeshatk@gmail.com			Research Initiative for Social Empowerment (RISE), Dhaka, Bangladesh	Research Initiative for Social Empowerment (RISE), Dhaka, Bangladesh	Research Initiative for Social Empowerment (RISE), Dhaka, Bangladesh was the primary source of funding. The College of Public Health, National Taiwan University provided YHT's Taiwan- Bangladesh airfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday L A, 1974, Health Serv Res, V9, P208; Ahmed NU, 2006, J HEALTH POPUL NUTR, V24, P456; Ahmed SM, 2005, B WORLD HEALTH ORGAN, V83, P109; Ahmed SM, 2006, SOC SCI MED, V63, P2899, DOI 10.1016/j.socscimed.2006.07.024; Ahmed SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012660; Amin R, 2001, WORLD DEV, V29, P1611, DOI 10.1016/S0305-750X(01)00055-9; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; Anand S, 2008, J ECON LIT, V46, P57, DOI 10.1257/jel.46.1.57; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andrulis DP, 1996, AM J PUBLIC HEALTH, V86, P162, DOI 10.2105/AJPH.86.2.162; [Anonymous], 2013, ASIA PAC J PUBLIC HL; [Anonymous], REP BANGL LIT SURV; [Anonymous], 2013, MILL DEV GOALS REP 2; Anwar A., 2004, BANGLADESH INEQUALIT; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; Balabanova D, 2011, GOOD HLTH LOST COST; Begum HA, 2013, ASIA-PAC J PUBLIC HE, V25, P345, DOI 10.1177/1010539511420132; Berhane G, 2011, AM J AGR ECON, V93, P43, DOI 10.1093/ajae/aaq126; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; Cull R, 2007, ECON J, V117, pF107, DOI 10.1111/j.1468-0297.2007.02017.x; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Friel S, 2011, ASIA-PAC J PUBLIC HE, V23, P246, DOI 10.1177/1010539511402053; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; Griffiths P, 2001, J BIOSOC SCI, V33, P339, DOI 10.1017/S002193200100339X; Hadi A, 2002, PUBLIC HEALTH, V116, P238, DOI 10.1038/sj.ph.1900863; Hadi A, 2001, HEALTH PROMOT INT, V16, P219, DOI 10.1093/heapro/16.3.219; Halder Amal Krishna, 2007, World Health Popul, V9, P48; Halder ShantanaR., 2004, J INT DEV, V16, P387, DOI [10.1002/jid.1084, DOI 10.1002/JID.1084]; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Haque MS, 2004, INT REV ADM SCI, V70, P271, DOI 10.1177/0020852304044255; Hermes N, 2011, WORLD DEV, V39, P875, DOI 10.1016/j.worlddev.2009.10.021; Hossain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044980; Islam A, 2011, AM J AGR ECON, V93, P843, DOI 10.1093/ajae/aar012; Kamal SMM, 2010, ASIA-PAC J PUBLIC HE, V22, P436, DOI 10.1177/1010539510370780; Kaplan R.S., 1996, BALANCED SCORECARD T; KATZ SJ, 1994, JAMA-J AM MED ASSOC, V272, P530, DOI 10.1001/jama.272.7.530; Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403; Leatherman S, 2010, 12 FREED HUNG; Leatherman S, 2012, HEALTH POLICY PLANN, V27, P85, DOI 10.1093/heapol/czr014; Maes J.P., 2012, STATE MICROCREDIT SU; Mercer A, 2004, HEALTH POLICY PLANN, V19, P187, DOI 10.1093/heapol/czh024; Microcredit Regulatory Authority, NGO MFIS BANGL; Mohammad Sohail, 2005, Bangladesh Development Studies, V31, P63; Mohindra KA., 2005, J HUM DEV, V6, P353, DOI [10.1080/14649880500287662, DOI 10.1080/14649880500287662]; Montgomery R., 1996, Journal of International Development, V8, P289, DOI 10.1002/(SICI)1099-1328(199603)8:2&lt;289::AID-JID368&gt;3.0.CO;2-2; Nanda P, 1999, HEALTH ECON, V8, P415, DOI 10.1002/(SICI)1099-1050(199908)8:5<415::AID-HEC450>3.0.CO;2-L; Nawaz Shah, 2010, J Asian Afr Stud, V45, P670, DOI 10.1177/0021909610383812; Quayyum Z, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-22; Rahman Atiur, 2000, BANGLADESH DEV STUDI, P1; Ravallion M, 2003, INT AFF, V79, P739, DOI 10.1111/1468-2346.00334; Reed L., 2014, STATE MICROCREDIT SU; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Sachs J.D., 2001, MACROECONOMICS HLTH; Saksena P, 2012, TROP MED INT HEALTH, V17, P23, DOI 10.1111/j.1365-3156.2011.02894.x; Sambamoorthi U, 2003, PREV MED, V37, P475, DOI 10.1016/S0091-7435(03)00172-5; Schurmann AT, 2009, J HEALTH POPUL NUTR, V27, P518; Somen Saha, 2011, International Journal of Medicine and Public Health, V1, P1, DOI 10.5530/ijmedph.1.2011.1; STANTON B, 1989, SOC SCI MED, V29, P1199, DOI 10.1016/0277-9536(89)90363-8; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Streefland P., 1990, Health Policy and Planning, V5, P261, DOI 10.1093/heapol/5.3.261; SUBEDI J, 1989, J HEALTH SOC BEHAV, V30, P412, DOI 10.2307/2136989; Szekely M, 1999, WORKING PAPER; Ullah AZ, 2006, HEALTH POLICY PLANN, V21, P143, DOI 10.1093/heapol/czj014; UNICEF, 2011, STAT WORLDS CHILDR 2; World Health Organization, INT C PRIM HLTH CAR INT C PRIM HLTH CAR; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yunus M., 1998, BANKER TO THE POOR; Zohir S., 2004, ECON POLIT WEEKLY, V39, P4109	70	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121733	10.1371/journal.pone.0121733	http://dx.doi.org/10.1371/journal.pone.0121733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25807500	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000177
J	Alencar, J; de Mello, CF; Guimaraes, AE; Gil-Santana, HR; Silva, JD; Santos-Mallet, JR; Gleiser, RM				Alencar, Jeronimo; de Mello, Cecilia Ferreira; Guimaraes, Anthony Erico; Gil-Santana, Helcio R.; Silva, Julia dos Santos; Santos-Mallet, Jacenir R.; Gleiser, Raquel M.			Culicidae Community Composition and Temporal Dynamics in Guapiacu Ecological Reserve, Cachoeiras de Macacu, Rio de Janeiro, Brazil	PLOS ONE			English	Article							MOSQUITOS DIPTERA-CULICIDAE; MAR CHIQUITA LAKE; ATLANTIC FOREST; SAO-PAULO; STATE; BIODIVERSITY; PERIDOMICILIARY; EXTRAPOLATION; MUNICIPALITY; OCHLEROTATUS	A temporal observational study was conducted of the Culicidae fauna in a remnant area of Atlantic Forest within a private reserve (Guapiacu Ecological Reserve-REGUA) presenting typical vegetation cover of dense rain forest, with some patches recovering a floristic composition similar to that of the original community. Research was carried out to analyze the influence of climatic factors (mean monthly temperature, rainfall, and air relative humidity) on the temporal dynamics of the mosquito communities that occur in the reserve. The completeness of the mosquito inventory was assessed with individual-based rarefaction-extrapolation curves. Differences in species composition between sites and months were tested with PERMANOVA. True diversities of orders 0, 1, and 2 (effective numbers) were estimated and compared between sites, months, and years. Multiple stepwise regressions were used to assess relationships between climatic variables, measures of diversity, and abundances of the most common species. There were significant interactive effects between year and site on measures of diversity. However, diversity estimates showed little variation among months, and these were weakly correlated with climatic variables. Abundances of the most common species were significantly related to temperature or relative humidity, but not rainfall. The presence of mosquito species known to be vectors of human diseases combined with an intermittent flow of visitors to the study area suggests there is a risk of disease transmission that warrants further monitoring.	[Alencar, Jeronimo; de Mello, Cecilia Ferreira; Guimaraes, Anthony Erico; Gil-Santana, Helcio R.] Fiocruz MS, Inst Oswaldo Cruz, Lab Diptera, BR-21045900 Rio De Janeiro, Brazil; [Silva, Julia dos Santos; Santos-Mallet, Jacenir R.] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Leishmanioses, BR-21045900 Rio De Janeiro, Brazil; [Gleiser, Raquel M.] Univ Nacl Cordoba, Fac Ciencias Agr, Ctr Relevamiento & Evaluac Recursos Agr & Nat, CONICET,Inst Multidisciplinario Biol Vegetal, RA-5000 Cordoba, Argentina; [Gleiser, Raquel M.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Catedra Ecol, RA-5000 Cordoba, Argentina	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Alencar, J (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Diptera, BR-21045900 Rio De Janeiro, Brazil.	jalencar@ioc.fiocruz.br; raquelgleiser@hotmail.com	Mallet, Jacenir Reis dos Santos/GRO-4228-2022; Mallet, Jacenir R S/F-5001-2017; Gil-Santana, Hélcio Reinaldo/AAG-2534-2021	Gil-Santana, Hélcio Reinaldo/0000-0002-0544-348X; Guimaraes, Anthony/0000-0002-9982-2471	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [112.076/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [301345/2013-9]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Support was provided by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (contract 112.076/2012) [http://www.faperj.br/] to JA; and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (301345/2013-9) [www.cnpq.br] to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar J, 2013, REV SOC BRAS MED TRO, V46, P769, DOI 10.1590/0037-8682-1670-2013; Alencar J, 2011, J MED ENTOMOL, V48, P223, DOI 10.1603/ME09214; [Anonymous], 2005, J MED ENTOMOL, V42, P511; Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608; Casanova C, 2002, B ENTOMOL RES, V92, P271, DOI 10.1079/BER2002178; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chao A, 2000, STAT SINICA, V10, P227; Chao A, 2010, PROGRAM USERS GUIDE; Chao A., 2005, ENCY STAT SCI, V12, P7907, DOI DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Colwell RK, 2013, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Correa FF, 2014, J AM MOSQUITO CONTR, V30, P83, DOI 10.2987/13-6372.1; Silva Allan Martins da, 2002, Iheringia, Sér. Zool., V92, P31, DOI 10.1590/S0073-47212002000400005; Di Rienzo J. A., 2014, INFOSTAT VERSION 201; Dorville LFM, 1996, STUD NEOTROP FAUNA E, V31, P68, DOI 10.1076/snfe.31.2.68.13331; FARAN M E, 1981, Mosquito Systematics, V13, P1; Forattini O P, 1981, Rev Saude Publica, V15, P557, DOI 10.1590/S0034-89101981000600001; Forattini OP, 2002, CULCIDOLOGIA MED; Gleiser RM, 2000, J MED ENTOMOL, V37, P21, DOI 10.1603/0022-2585-37.1.21; Gleiser RM, 1997, ANN TROP MED PARASIT, V91, P917, DOI 10.1080/00034989760301; Gotelli N, 2013, ENCY BIODIVERSITY, V5; Graham SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007873; GUIMARAES AE, 1989, MEM I OSWALDO CRUZ, V84, P243, DOI 10.1590/S0074-02761989000800044; Hammer O, 2001, PALAEONTOLOGIA ELECT; Herve JP, 1986, EVANDRO CHAGAS 50 AN, P409; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Hutchings RSG, 2005, MED VET ENTOMOL, V19, P428, DOI 10.1111/j.1365-2915.2005.00587.x; Labarthe N, 1998, MEM I OSWALDO CRUZ, V93, P145, DOI 10.1590/S0074-02761998000200002; Lane J., 1953, NEOTROPICAL CULICIDA, V2; Laporta GZ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002139; Lourenco-de-Oliveira R., 1985, Memorias do Instituto Oswaldo Cruz, V80, P195; Luz SLB, 1996, MEM I OSWALDO CRUZ, V91, P427, DOI 10.1590/S0074-02761996000400008; Marques TC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-41; Mello MCS, 2003, 6 C EC BRAS ED U FED, P133; Montes J, 2005, REV SAUDE PUBL, V39, P578, DOI 10.1590/S0034-89102005000400010; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Nimer E, 1979, CLIMATOLOGIA BRASIL; Pinheiro HSK, 2012, THESIS U FEDERAL RUR; Prochnow M, 2002, MATA ATLANTICA VOCE; Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175; Ribeiro AF, 2012, J VECTOR ECOL, V37, P316, DOI 10.1111/j.1948-7134.2012.00233.x; SHANNON RAYMOND C., 1939, AMER JOUR TROP MED, V19, P131; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; TEODORO U, 1994, REV SAUDE PUBL, V28, P107, DOI 10.1590/S0034-89101994000200003; VASCONCELOS PFD, 1991, REV INST MED TROP SP, V33, P465, DOI 10.1590/S0036-46651991000600007; Veloso HP, 1991, CLASSIFICACAO VEGETA, DOI [10.5681/joddd.2014.003, DOI 10.5681/JODDD.2014.003]; Viana LA, 2010, J MED ENTOMOL, V47, P670, DOI 10.1603/ME09260	52	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122268	10.1371/journal.pone.0122268	http://dx.doi.org/10.1371/journal.pone.0122268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815724	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600161
J	Cram, DL; Blount, JD; York, JE; Young, AJ				Cram, Dominic L.; Blount, Jonathan D.; York, Jennifer E.; Young, Andrew J.			Immune Response in a Wild Bird Is Predicted by Oxidative Status, but Does Not Cause Oxidative Stress	PLOS ONE			English	Article							URIC-ACID; TRADE-OFFS; SUPEROXIDE; PHYTOHEMAGGLUTININ; ANTIOXIDANTS; DAMAGE; COST; PATHOGENESIS; ACTIVATION; ALLANTOIN	The immune system provides vital protection against pathogens, but extensive evidence suggests that mounting immune responses can entail survival and fecundity costs. The physiological mechanisms that underpin these costs remain poorly understood, despite their potentially important role in shaping life-histories. Recent studies involving laboratory models highlight the possibility that oxidative stress could mediate these costs, as immune-activation can increase the production of reactive oxygen species leading to oxidative stress. However, this hypothesis has rarely been tested in free-ranging wild populations, where natural oxidative statuses and compensatory strategies may moderate immune responses and their impacts on oxidative status. Furthermore, the possibility that individuals scale their immune responses according to their oxidative status, conceivably to mitigate such costs, remains virtually unexplored. Here, we experimentally investigate the effects of a phytohaemagglutinin (PHA) immune-challenge on oxidative status in wild male and female white-browed sparrow weavers, Plocepasser mahali. We also establish whether baseline oxidative status prior to challenge predicts the scale of the immune responses. Contrary to previous work on captive animals, our findings suggest that PHA-induced immune-activation does not elicit oxidative stress. Compared with controls (n = 25 birds), PHA-injected birds (n = 27 birds) showed no evidence of a differential change in markers of oxidative damage or enzymatic and non-enzymatic antioxidant protection 24 hours after challenge. We did, however, find that the activity of a key antioxidant enzyme (superoxide dismutase, SOD) prior to immune-activation predicted the scale of the resulting swelling: birds with stronger initial SOD activity subsequently produced smaller swellings. Our findings (i) suggest that wild birds can mount immune responses without suffering from systemic oxidative stress, and (ii) lend support to biomedical evidence that baseline oxidative status can impact the scale of immune responses; a possibility not yet recognised in ecological studies of immunity.	[Cram, Dominic L.; Blount, Jonathan D.; York, Jennifer E.; Young, Andrew J.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Cram, Dominic L.] Univ Cambridge, Dept Zool, Cambridge, England; [York, Jennifer E.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, Gauteng, South Africa	University of Exeter; University of Cambridge; University of Pretoria	Cram, DL (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England.	dom.cram@gmail.com; a.j.young@exeter.ac.uk	Blount, Jonathan/K-7695-2012; Cram, Dom/H-5974-2019	Blount, Jonathan/0000-0002-0016-0130; Cram, Dom/0000-0002-8790-8294	BBSRC; NERC; Royal Society; University of Bristol; Biotechnology and Biological Sciences Research Council [BB/H022716/1] Funding Source: researchfish; Natural Environment Research Council [NE/E013481/1] Funding Source: researchfish; BBSRC [BB/H022716/1] Funding Source: UKRI; NERC [NE/E013481/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); University of Bristol; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by a BBSRC David Phillips Fellowship to AY and a NERC studentship to DC. JB was supported by a Royal Society University Research Fellowship. JY was supported by a University of Bristol PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JS, 2009, INTEGR COMP BIOL, V49, P202, DOI 10.1093/icb/icp028; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Aukrust P, 2000, EUR J CLIN INVEST, V30, P252, DOI 10.1046/j.1365-2362.2000.00619.x; Beaulieu M, 2013, ANIM BEHAV, V86, P17, DOI 10.1016/j.anbehav.2013.05.022; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Cohen AA, 2009, FUNCT ECOL, V23, P310, DOI 10.1111/j.1365-2435.2009.01540.x; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Costantini D, 2009, COMP BIOCHEM PHYS A, V153, P339, DOI 10.1016/j.cbpa.2009.03.010; Cram DL, 2015, FUNCT ECOL, V29, P229, DOI 10.1111/1365-2435.12317; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Gius D, 1999, TOXICOL LETT, V106, P93, DOI 10.1016/S0378-4274(99)00024-7; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harrison XA, 2013, MOL ECOL, V22, P5700, DOI 10.1111/mec.12505; Harrison X, 2013, BEHAV ECOL SOCIOBIOL, V67, P1915, DOI 10.1007/s00265-013-1599-1; Hasselquist D, 2012, ANIM BEHAV, V83, P1303, DOI 10.1016/j.anbehav.2012.03.025; HOLMES B, 1967, J CLIN INVEST, V46, P1422, DOI 10.1172/JCI105634; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Horak P, 2010, FUNCT ECOL, V24, P960, DOI 10.1111/j.1365-2435.2010.01755.x; Jin M, 2012, FRONT BIOSCI-LANDMRK, V17, P656, DOI 10.2741/3950; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Kilgas P, 2010, COMP BIOCHEM PHYS B, V157, P288, DOI 10.1016/j.cbpb.2010.07.002; Knaapen AM, 2006, MUTAGENESIS, V21, P225, DOI 10.1093/mutage/gel032; Koutsos EA, 2003, COMP BIOCHEM PHYS A, V135, P635, DOI 10.1016/S1095-6433(03)00158-2; Leitner S, 2009, OSTRICH, V80, P99, DOI 10.2989/OSTRICH.2009.80.2.6.833; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lugrin J, 2014, BIOL CHEM, V395, P203, DOI 10.1515/hsz-2013-0241; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Mougeot F, 2009, P ROY SOC B-BIOL SCI, V276, P1093, DOI 10.1098/rspb.2008.1570; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Okin D, 2012, CURR BIOL, V22, pR733, DOI 10.1016/j.cub.2012.07.029; Proctor PH, 2008, STROKE, V39, pE88, DOI 10.1161/STROKEAHA.107.513242; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Roberts RA, 2010, TOXICOLOGY, V276, P85, DOI 10.1016/j.tox.2010.07.009; ROBIN JP, 1987, J COMP PHYSIOL B, V157, P491, DOI 10.1007/BF00691834; Salaberria C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084108; Salvemini D, 2006, BIOCHEM SOC T, V34, P965, DOI 10.1042/BST0340965; Schmidt CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103286; Schneeberger K, 2013, J EXP BIOL, V216, P4514, DOI 10.1242/jeb.090837; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Simoyi MF, 2003, COMP BIOCHEM PHYS B, V135, P325, DOI 10.1016/S1096-4959(03)00086-1; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Spottiswoode CN, 2008, BEHAV ECOL SOCIOBIOL, V62, P963, DOI 10.1007/s00265-007-0521-0; Spychalowicz A, 2012, CURR PHARM BIOTECHNO, V13, P2456, DOI 10.2174/1389201011208062456; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Suliman HB, 2001, AM J PHYSIOL-LUNG C, V280, pL69, DOI 10.1152/ajplung.2001.280.1.L69; Tobler M, 2011, BIOL LETTERS, V7, P906, DOI 10.1098/rsbl.2011.0350; Torres R, 2007, J ANIM ECOL, V76, P1161, DOI 10.1111/j.1365-2656.2007.01282.x; Tsahar E, 2006, J COMP PHYSIOL B, V176, P653, DOI 10.1007/s00360-006-0088-5; Uller T, 2006, FUNCT ECOL, V20, P873, DOI 10.1111/j.1365-2435.2006.01163.x; van de Crommenacker J, 2012, P ROY SOC B-BIOL SCI, V279, P1466, DOI 10.1098/rspb.2011.1865; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; WEITZMAN SA, 1981, SCIENCE, V212, P546, DOI 10.1126/science.6259738; Winkler C, 2007, INT ARCH ALLERGY IMM, V142, P127, DOI 10.1159/000096438; York JE, 2012, EVOLUTION REGULATION; York JE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0970	69	16	17	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122421	10.1371/journal.pone.0122421	http://dx.doi.org/10.1371/journal.pone.0122421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815888	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600178
J	Shen, N; Liu, C; Li, JY; Chen, XQ; Yang, Y; Zhu, Y; Gong, YJ; Gong, J; Zhong, R; Cheng, LM; Miao, XP				Shen, Na; Liu, Cheng; Li, Jiaoyuan; Chen, Xueqin; Yang, Yang; Zhu, Ying; Gong, Yajie; Gong, Jing; Zhong, Rong; Cheng, Liming; Miao, Xiaoping			A Phosphorylation-Related Variant ADD1-rs4963 Modifies the Risk of Colorectal Cancer	PLOS ONE			English	Article							BETA SIGNALING PATHWAY; PROTEIN-PHOSPHORYLATION; CHINESE POPULATION; ALPHA-ADDUCIN; COLON-CANCER; SAMPLE-SIZE; METAANALYSIS; SITE; DIFFERENTIATION; SMOKING	It is well-established that abnormal protein phosphorylation could play an essential role in tumorgenesis by disrupting a variety of physiological processes such as cell growth, signal transduction and cell motility. Moreover, increasing numbers of phosphorylation-related variants have been identified in association with cancers. ADD1 (alpha-adducin), a versatile protein expressed ubiquitously in eukaryotes, exerts an important influence on membrane cytoskeleton, cell proliferation and cell-cell communication. Recently, a missense variant at the codon of ADD1's phosphorylation site, rs4963 (Ser586Cys), was reported to modify the risk of non-cardia gastric cancer. To explore the role of ADD1-rs4963 in colorectal cancer (CRC), we conducted a case-control study with a total of 1054 CRC cases and 1128 matched controls in a Chinese population. After adjustment for variables including age, gender, smoking and drinking, it was demonstrated that this variant significantly conferred susceptibility to CRC (G versus C: OR = 1.16, 95% CI = 1.03-1.31, P = 0.016; CG versus CC: OR = 1.25, 95% CI = 1.02-1.55, P = 0.036; GG versus CC: OR = 1.35, 95% CI = 1.06-1.72, P = 0.015). We further investigated the interaction of ADD1-rs4963 with smoking or drinking exposure, but found no significant result. This study is the first report of an association between ADD1 and CRC risk, promoting our knowledge of the genetics of CRC.	[Shen, Na; Liu, Cheng; Li, Jiaoyuan; Chen, Xueqin; Yang, Yang; Zhu, Ying; Gong, Yajie; Gong, Jing; Zhong, Rong; Miao, Xiaoping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China; [Shen, Na; Liu, Cheng; Li, Jiaoyuan; Chen, Xueqin; Yang, Yang; Zhu, Ying; Gong, Yajie; Gong, Jing; Zhong, Rong; Miao, Xiaoping] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Cheng, Liming] Huazhong Univ Sci & Technol, Dept Lab Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Cheng, LM (corresponding author), Huazhong Univ Sci & Technol, Dept Lab Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	chengliming@tjh.tjmu.edu.cn; miaoxp@mail.hust.edu.cn	Zhong, Rong/Q-1813-2019; Xiao, Hu/GMX-0258-2022; 李, 娇元/GVS-6952-2022; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722	National Program for Support of Top-notch Young Professionals, National Natural Science Foundation of China [NSFC-81001275, 81171878, 81222038]; Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China [131038]; Natural Science Foundation of Hubei [2012FFA011]	National Program for Support of Top-notch Young Professionals, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China; Natural Science Foundation of Hubei(Natural Science Foundation of Hubei Province)	This work was supported by the National Program for Support of Top-notch Young Professionals, National Natural Science Foundation of China NSFC-81001275, 81171878, 81222038; the Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China-131038 and the Natural Science Foundation of Hubei-2012FFA011 furnished support to XM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzeno S, 2006, ONCOGENE, V25, P6291, DOI 10.1038/sj.onc.1209644; Bowen SL, 2003, J PATHOL, V201, P119, DOI 10.1002/path.1389; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chan PC, 2014, J CELL BIOL, V204, P19, DOI 10.1083/jcb.201306083; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Chen CL, 2011, TRAFFIC, V12, P1327, DOI 10.1111/j.1600-0854.2011.01245.x; Cristobal I, 2014, BRIT J CANCER, V111, P756, DOI 10.1038/bjc.2014.376; Dai Zhen, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P598; Erxleben C, 2006, P NATL ACAD SCI USA, V103, P3932, DOI 10.1073/pnas.0511322103; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garcia-Closas M, 1999, AM J EPIDEMIOL, V149, P689; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; Gong J, 2014, TUMOR BIOL, V35, P4301, DOI 10.1007/s13277-013-1562-9; Herskowitz JH, 2010, J PROTEOME RES, V9, P6368, DOI 10.1021/pr100666c; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Li XX, 2005, J BIOL CHEM, V280, P24245, DOI 10.1074/jbc.M414637200; Liang PS, 2009, INT J CANCER, V124, P2406, DOI 10.1002/ijc.24191; Liu L, 2014, CANCER EPIDEMIOL, V38, P66, DOI 10.1016/j.canep.2013.12.009; LUBIN JH, 1990, AM J EPIDEMIOL, V131, P552, DOI 10.1093/oxfordjournals.aje.a115530; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Oh YT, 2007, APOPTOSIS, V12, P1339, DOI 10.1007/s10495-007-0066-8; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ren J, 2010, MOL CELL PROTEOMICS, V9, P623, DOI 10.1074/mcp.M900273-MCP200; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Ryu GM, 2009, NUCLEIC ACIDS RES, V37, P1297, DOI 10.1093/nar/gkn1008; Shen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107246; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang Meng-han, 2013, Zhonghua Zhong Liu Za Zhi, V35, P311, DOI 10.3760/cma.j.issn.0253-3766.2013.04.016; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Yang CY, 2008, BIOINFORMATICS, V24, pI14, DOI 10.1093/bioinformatics/btn297; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhu BB, 2015, MOL CARCINOGEN, V54, P761, DOI 10.1002/mc.22140; Zhu BB, 2014, CLIN GASTROENTEROL H, V12, P1991, DOI 10.1016/j.cgh.2014.03.019	37	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121485	10.1371/journal.pone.0121485	http://dx.doi.org/10.1371/journal.pone.0121485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816007	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600099
J	Yang, BH; Liu, R; Yang, T; Jiang, XL; Zhang, LQ; Wang, LJ; Wang, QH; Luo, ZX; Liu, EM; Fu, Z				Yang, Baohui; Liu, Ru; Yang, Ting; Jiang, Xiaoli; Zhang, Liqun; Wang, Lijia; Wang, Qinghong; Luo, Zhengxiu; Liu, Enmei; Fu, Zhou			Neonatal Streptococcus pneumoniae Infection May Aggravate Adulthood Allergic Airways Disease in Association with IL-17A	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; NEUTROPHIL RECRUITMENT; CHILDHOOD ASTHMA; MOUSE; HYPERRESPONSIVENESS; INFLAMMATION; CHILDREN; CELLS; MICE; SENSITIZATION	Epidemiologic studies have demonstrated that some bacteria colonization or infections in early-life increased the risk for subsequent asthma development. However, little is known about the mechanisms by which early-life bacterial infection increases this risk. The aim of this study was to investigate the effect of neonatal Streptococcus pneumoniae infection on the development of adulthood asthma, and to explore the possible mechanism. A non-lethal S. pneumoniae lung infection was established by intranasal inoculation of neonatal (1-week-old) female mice with D39. Mice were sensitized and challenged with ovalbumin in adulthood to induce allergic airways disease (AAD). Twenty-four hours later, the lungs and bronchoalveolar lavage fluid (BALF) were collected to assess AAD. Neonatal S. pneumoniae infection exacerbated adulthood hallmark features of AAD, with enhanced airway hyperresponsiveness and increased neutrophil recruitment into the airways, increased Th17 cells and interleukin (IL)-17A productions. Depletion of IL-17A by i.p. injection of a neutralizing monoclonal antibody reduced neutrophil recruitment into the airways, alleviated airway inflammation and decreased airway hyperresponsiveness. Furthermore, IL-17A depletion partially restored levels of inteferon-., but had no effect on the release of IL-5 or IL-13. Our data suggest that neonatal S. pneumoniae infection may promote the development of adulthood asthma in association with increased IL-17A production.	[Yang, Baohui; Liu, Ru; Yang, Ting; Jiang, Xiaoli; Zhang, Liqun; Wang, Lijia; Wang, Qinghong] Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing, Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China; [Yang, Ting; Luo, Zhengxiu; Liu, Enmei; Fu, Zhou] Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China; [Wang, Qinghong] Chongqing Med Univ, Cent Lab Childrens Hosp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Luo, ZX (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China.	luozhengxiu816@163.com	wang, qinghong/M-7969-2017		National Natural Science Foundation of China [81070015, 81270086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81070015, 81270086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Garawi A, 2011, MUCOSAL IMMUNOL, V4, P682, DOI 10.1038/mi.2011.35; Al-Muhsen S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-34; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Deng Y, 2011, J CLIN IMMUNOL, V31, P419, DOI 10.1007/s10875-010-9503-5; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Larsen JM, 2014, J ALLERGY CLIN IMMUN, V133, P1008, DOI 10.1016/j.jaci.2014.01.010; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Piippo-Savolainen E, 2006, ALLERGY ASTHMA PROC, V27, P341, DOI 10.2500/aap.2006.27.2912; Preston JA, 2011, EUR RESPIR J, V37, P53, DOI 10.1183/09031936.00049510; Preston JA, 2004, EUR RESPIR J, V23, P224, DOI 10.1183/09031936.03.00081403; Reibman J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004060; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Siegle JS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-14; Thorburn AN, 2012, J IMMUNOL, V188, P4611, DOI 10.4049/jimmunol.1101299; von Mutius E, 2001, THORAX, V56, P153, DOI 10.1136/thorax.56.2.153; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wang YH, 2011, CURR ALLERGY ASTHM R, V11, P388, DOI 10.1007/s11882-011-0210-y; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yang Ting, 2012, Chinese Journal of Biologicals, V25, P905; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107; Zang N, 2011, J VIROL, V85, P13061, DOI 10.1128/JVI.05869-11; Zhang LQ, 2014, VACCINE, V32, P2079, DOI 10.1016/j.vaccine.2014.02.013	33	16	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0123010	10.1371/journal.pone.0123010	http://dx.doi.org/10.1371/journal.pone.0123010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816135	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600204
J	Bolton, KJ; McCaw, JM; Brown, L; Jackson, D; Kedzierska, K; McVernon, J				Bolton, Kirsty J.; McCaw, James M.; Brown, Lorena; Jackson, David; Kedzierska, Katherine; McVernon, Jodie			Prior Population Immunity Reduces the Expected Impact of CTL-Inducing Vaccines for Pandemic Influenza Control	PLOS ONE			English	Article							T-CELL IMMUNITY; A VIRUS; EVOLUTIONARY DYNAMICS; LYMPHOCYTE RESPONSES; CROSS-REACT; WITHIN-HOST; H1N1 2009; INFECTION; PROTECTION; CHILDREN	Vaccines that trigger an influenza-specific cytotoxic T cell (CTL) response may aid pandemic control by limiting the transmission of novel influenza A viruses (IAV). We consider interventions with hypothetical CTL-inducing vaccines in a range of epidemiologically plausible pandemic scenarios. We estimate the achievable reduction in the attack rate, and, by adopting a model linking epidemic progression to the emergence of IAV variants, the opportunity for antigenic drift. We demonstrate that CTL-inducing vaccines have limited utility for modifying population-level outcomes if influenza-specific T cells found widely in adults already suppress transmission and prove difficult to enhance. Administration of CTL-inducing vaccines that are efficacious in "influenza-experienced" and "influenza-naive" hosts can likely slow transmission sufficiently to mitigate a moderate IAV pandemic. However if neutralising cross-reactive antibody to an emerging IAV are common in influenza-experienced hosts, as for the swine-variant H3N2v, boosting CTL immunity may be ineffective at reducing population spread, indicating that CTL-inducing vaccines are best used against novel subtypes such as H7N9. Unless vaccines cannot readily suppress transmission from infected hosts with naive T cell pools, targeting influenza-naive hosts is preferable. Such strategies are of enhanced benefit if naive hosts are typically intensively mixing children and when a subset of experienced hosts have pre-existing neutralising cross-reactive antibody. We show that CTL-inducing vaccination campaigns may have greater power to suppress antigenic drift than previously suggested, and targeting adults may be the optimal strategy to achieve this when the vaccination campaign does not have the power to curtail the attack rate. Our results highlight the need to design interventions based on pre-existing cellular immunity and knowledge of the host determinants of vaccine efficacy, and provide a framework for assessing the performance requirements of high-impact CTL-inducing vaccines.	[Bolton, Kirsty J.] Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England; [Bolton, Kirsty J.] Univ Nottingham, Sch Community Hlth Sci, Nottingham NG7 2RD, England; [McCaw, James M.; McVernon, Jodie] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Vaccine & Immunisat Res Grp, Melbourne, Vic, Australia; [McCaw, James M.; McVernon, Jodie] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Brown, Lorena; Jackson, David; Kedzierska, Katherine] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia	University of Nottingham; University of Nottingham; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne	Bolton, KJ (corresponding author), Univ Nottingham, Sch Math Sci, Nottingham NG7 2RD, England.	Kirsty.Bolton@nottingham.ac.uk		McCaw, James/0000-0002-2452-3098; Bolton, Kirsty/0000-0003-0487-4701; Jackson, David/0000-0001-7255-270X; Kedzierska, Katherine/0000-0001-6141-335X; Brown, Lorena/0000-0001-9342-909X	National Health and Medical Research Council of Australia (NHMRC) [100494, 567122]; University of Melbourne McKenzie Fellowship; University of Nottingham Anne McLaren Fellowship; Australian Research Council Future Fellowship; NHMRC	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne McKenzie Fellowship; University of Nottingham Anne McLaren Fellowship; Australian Research Council Future Fellowship(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia (NHMRC) through Project (100494), Program (567122) and Career Development (JMcV) grant schemes. KJB was supported by a University of Melbourne McKenzie Fellowship and a University of Nottingham Anne McLaren Fellowship. JMMcC is supported by an Australian Research Council Future Fellowship. KK is an NHMRC CDF2 Fellow. DJ receives support from the NHMRC. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Antrobus RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048322; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P3173, DOI 10.1073/pnas.1113342109; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Berkhoff EGM, 2005, J VIROL, V79, P11239, DOI 10.1128/JVI.79.17.11239-11246.2005; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Booy R, 2011, MED J AUSTRALIA, V194, P19, DOI 10.5694/j.1326-5377.2011.tb04139.x; Brown LE, 2009, IMMUNOL CELL BIOL, V87, P300, DOI 10.1038/icb.2009.16; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Cori A, 2012, EPIDEMICS-NETH, V4, P132, DOI 10.1016/j.epidem.2012.06.001; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; Deliyannis G, 2002, J VIROL, V76, P4212, DOI 10.1128/JVI.76.9.4212-4221.2002; Ducatez MF, 2008, VACCINE, V26, pD67, DOI 10.1016/j.vaccine.2008.07.064; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Ellebedy AH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00053; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Fu TM, 1997, J VIROL, V71, P2715, DOI 10.1128/JVI.71.4.2715-2721.1997; Glass K, 2012, EPIDEMIOLOGY, V23, P86, DOI 10.1097/EDE.0b013e31823a44a5; Goldstein E, 2009, J R SOC INTERFACE; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Guarnaccia T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003354; Hardelid P, 2011, EURO SURVEILL, V16; He XS, 2008, J INFECT DIS, V197, P803, DOI 10.1086/528804; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Jackson C, 2010, AM J EPIDEMIOL, V171, P465, DOI 10.1093/aje/kwp394; Kedzierska K, 2006, IMMUNOL REV, V211, P133, DOI 10.1111/j.0105-2896.2006.00386.x; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Koelle K, 2010, J R SOC INTERFACE, V7, P1257, DOI 10.1098/rsif.2010.0007; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Leung GM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000346; Levy JW, 2013, AM J EPIDEMIOL, V177, P1443, DOI 10.1093/aje/kws402; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P847, DOI 10.1098/rspb.2000.1572; Luo SS, 2012, J R SOC INTERFACE, V9, P2603, DOI 10.1098/rsif.2012.0180; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Manzoli L, 2012, HUM VACC IMMUNOTHER, V8, P851, DOI 10.4161/hv.19917; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Matrajt L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002964; Mccaw JM, 2009, SCIENCE, V325, P1071, DOI 10.1126/science.325_1071a; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MCMICHAEL AJ, 1983, LANCET, V2, P762; McVernon J, 2014, INFLUENZA OTHER RESP, V8, P194, DOI 10.1111/irv.12225; McVernon J, 2011, INFLUENZA OTHER RESP, V5, P7, DOI 10.1111/j.1750-2659.2010.00172.x; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Neuzil KM, 2006, J INFECT DIS, V194, P1032, DOI 10.1086/507309; Ng WC, 2009, INFLUENZA OTHER RESP, V3, P177, DOI 10.1111/j.1750-2659.2009.00087.x; Nguyen HH, 1999, VIROLOGY, V254, P50, DOI 10.1006/viro.1998.9521; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pepin KM, 2012, EPIDEMIOL INFECT, P1; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Scheible K, 2011, VACCINE, V29, P2159, DOI 10.1016/j.vaccine.2010.12.073; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Tan ACL, 2013, IMMUNOL CELL BIOL, V91, P96, DOI 10.1038/icb.2012.54; Tan ACL, 2012, MOL PHARMACEUT, V9, P2710, DOI 10.1021/mp300257x; Thomas PG, 2013, P NATL ACAD SCI USA, V110, P1839, DOI 10.1073/pnas.1222149110; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Valkenburg SA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002544; Valkenburg SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001039; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Volkov I, 2010, J R SOC INTERFACE, V7, P1311, DOI 10.1098/rsif.2009.0560; Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028063; Wearing H.J., 2005, PLOS MED, V2, DOI [10.1371/journal.pmed. 0020174, DOI 10.1371/journal.pmed.0020174]; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; White LF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001498; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wong KK, 2012, EMERG INFECT DIS, V18, P1937, DOI 10.3201/eid1812.121097; Yang JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028288; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	86	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120138	10.1371/journal.pone.0120138	http://dx.doi.org/10.1371/journal.pone.0120138			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811654	gold, Green Published			2022-12-26	WOS:000356353700040
J	Huang, H; Simsek, MF; Jin, WX; Pralle, A				Huang, Heng; Simsek, M. Fethullah; Jin, Weixiang; Pralle, Arnd			Effect of Receptor Dimerization on Membrane Lipid Raft Structure Continuously Quantified on Single Cells by Camera Based Fluorescence Correlation Spectroscopy	PLOS ONE			English	Article							INTERNAL-REFLECTION FLUORESCENCE; GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; LIVING CELLS; DIFFUSION; MODEL; MICROSCOPY; DOMAINS; MICRODOMAINS; ORGANIZATION	Membrane bound cell signaling is modulated by the membrane ultra-structure, which itself may be affected by signaling. However, measuring the interaction of membrane proteins with membrane structures in intact cells in real-time poses considerable challenges. In this paper we present a non-destructive fluorescence method that quantifies these interactions in single cells, and is able to monitor the same cell continuously to observe small changes. This approach combines total internal fluorescence microscopy with fluorescence correlation spectroscopy to measure the protein's diffusion and molecular concentration in different sized areas simultaneously. It correctly differentiates proteins interacting with membrane fences from proteins interacting with cholesterol-stabilized domains, or lipid rafts. This method detects small perturbations of the membrane ultra-structure or of a protein's tendency to dimerize. Through continuous monitoring of single cells, we demonstrate how dimerization of GPI-anchored proteins increases their association with the structural domains. Using a dual-color approach we study the effect of dimerization of one GPI-anchored protein on another type of GPI-anchored protein expressed in the same cell. Scans over the cell surface reveal a correlation between cholesterol stabilized domains and membrane cytoskeleton.	[Huang, Heng; Simsek, M. Fethullah; Jin, Weixiang; Pralle, Arnd] SUNY Buffalo, Dept Phys, Buffalo, NY 14260 USA; [Pralle, Arnd] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Pralle, A (corresponding author), SUNY Buffalo, Dept Phys, Buffalo, NY 14260 USA.	apralle@buffalo.edu	Pralle, Arnd/M-9832-2013; Simsek, Muhammed Fethullah/AAU-7786-2021	Pralle, Arnd/0000-0002-6079-109X; Simsek, Muhammed Fethullah/0000-0002-5873-0714	National Institute of Mental Health [R21 AI097879]; HFSP Research Grant [RGP0052/2012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097879] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HFSP Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by R21 AI097879 (National Institute of Mental Health) to AP. Further support came from HFSP Research Grant RGP0052/2012 to AP and internal sources (The Research Foundation for SUNY and CAS at SUNY in form of teaching assistant ship to MFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Bag N, 2014, BBA-BIOMEMBRANES, V1838, P802, DOI 10.1016/j.bbamem.2013.10.009; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Ehrig J, 2011, BIOPHYS J, V100, P80, DOI 10.1016/j.bpj.2010.11.002; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; Honigmann A, 2014, ELIFE, V3, DOI 10.7554/eLife.01671; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Honigmann A, 2012, BIOCHEM BIOPH RES CO, V427, P385, DOI 10.1016/j.bbrc.2012.09.069; Huang H, 2011, CONTINUOUS MONITORIN; Kannan B, 2007, ANAL CHEM, V79, P4463, DOI 10.1021/ac0624546; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Lim KH, 2012, BIOTECHNOL BIOENG; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/NCHEM.1546, 10.1038/nchem.1546]; Machta BB, 2011, BIOPHYS J, V100, P1668, DOI 10.1016/j.bpj.2011.02.029; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Mueller V, 2013, METHOD ENZYMOL, V519, P1, DOI 10.1016/B978-0-12-405539-1.00001-4; Pyenta PS, 2001, BIOPHYS J, V80, P2120, DOI 10.1016/S0006-3495(01)76185-1; Ries J, 2008, BIOPHYS J, V95, P390, DOI 10.1529/biophysj.107.126193; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Sankaran J, 2013, ANAL CHEM, V85, P3948, DOI 10.1021/ac303485t; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stefl M, 2012, BIOPHYS J, V102, P2104, DOI 10.1016/j.bpj.2012.03.054; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]; Tcherniak A, 2009, ANAL CHEM, V81, P746, DOI 10.1021/ac8013109; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Wachsmuth Malte, 2007, P183, DOI 10.1007/978-3-540-71331-9_7; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959; Wilson BS, 2011, ADV EXP MED BIOL, V716, P91, DOI 10.1007/978-1-4419-9533-9_6; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	36	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121777	10.1371/journal.pone.0121777	http://dx.doi.org/10.1371/journal.pone.0121777			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811483	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700137
J	Nagano, G; Ohno, H; Oki, K; Kobuke, K; Shiwa, T; Yoneda, M; Kohno, N				Nagano, Gaku; Ohno, Haruya; Oki, Kenji; Kobuke, Kazuhiro; Shiwa, Tsuguka; Yoneda, Masayasu; Kohno, Nobuoki			Activation of Classical Brown Adipocytes in the Adult Human Perirenal Depot Is Highly Correlated with PRDM16-EHMT1 Complex Expression	PLOS ONE			English	Article							ADIPOSE-TISSUE; FAT; WHITE; CELL; AGONISTS; OBESITY	Brown fat generates heat to protect against cold and obesity. Adrenergic stimulation activates the thermogenic program of brown adipocytes. Although the bioactivity of brown adipose tissue in adult humans had been assumed to very low, several studies using positron emission tomography-computed tomography (PET-CT) have detected bioactive brown adipose tissue in adult humans under cold exposure. In this study, we collected adipose tissues obtained from the perirenal regions of adult patients with pheochromocytoma (PHEO) or non-functioning adrenal tumors (NF). We demonstrated that perirenal brown adipocytes were activated in adult patients with PHEO. These cells had the molecular characteristics of classical brown fat rather than those of beige/brite fat. Expression of brown adipose tissue markers such as uncoupling protein 1 (UCP1) and cell death-inducing DFFA-like effector A (CIDEA) was highly correlated with the amounts of PRD1-BF-1-RIZ1 homologous domain-containing protein-16 (PRDM16) - euchromatic histone-lysine N-methyltransferase 1 (EHMT1) complex, the key transcriptional switch for brown fat development. These results provide novel insights into the reconstruction of human brown adipocytes and their therapeutic application against obesity and its complications such as type 2 diabetes.	[Nagano, Gaku; Ohno, Haruya; Oki, Kenji; Kobuke, Kazuhiro; Shiwa, Tsuguka; Yoneda, Masayasu; Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan	Hiroshima University	Nagano, G (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan.	haruyan711@gmail.com	Hiyama, Eiso/A-2013-2019	Hiyama, Eiso/0000-0001-9179-5037; Ohno, Haruya/0000-0001-5400-1162				Arch JRS, 2011, THER ADV ENDOCRINOL, V2, P59, DOI 10.1177/2042018811398517; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Di Franco A, 2014, J CLIN ENDOCR METAB, V99, pE1903, DOI 10.1210/jc.2014-1431; Dundamadappa SK, 2007, ACTA RADIOL, V48, P468, DOI 10.1080/02841850701199918; Frontini A, 2013, BBA-MOL CELL BIOL L, V1831, P950, DOI 10.1016/j.bbalip.2013.02.005; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Yamaga LYI, 2008, EUR J NUCL MED MOL I, V35, P446, DOI 10.1007/s00259-007-0538-7; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; LEAN MEJ, 1986, INT J OBESITY, V10, P219; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Oki K, 2012, EXP CLIN ENDOCR DIAB, V120, P244, DOI 10.1055/s-0032-1301896; Petrak O, 2013, J CLIN ENDOCR METAB, V98, P1651, DOI 10.1210/jc.2012-3625; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmussen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077907; RICQUIER D, 1982, J CLIN ENDOCR METAB, V54, P803; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Svensson PA, 2014, OBESITY, V22, P1830, DOI 10.1002/oby.20765; Ussar S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008490; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang QD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021006, 10.1371/journal.pone.0028114]; Weyer C, 1999, DIABETES METAB, V25, P11; Willemsen MH, 2011, MOL SYNDROMOL, V2, P202, DOI 10.1159/000335648; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	38	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122584	10.1371/journal.pone.0122584	http://dx.doi.org/10.1371/journal.pone.0122584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812118	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700197
J	Skodras, A; Marcelli, G				Skodras, Angelos; Marcelli, Gianluca			Computer-Generated Ovaries to Assist Follicle Counting Experiments	PLOS ONE			English	Article							PRIMORDIAL FOLLICLE; MOUSE OVARY; NUMBER	Precise estimation of the number of follicles in ovaries is of key importance in the field of reproductive biology, both from a developmental point of view, where follicle numbers are determined at specific time points, as well as from a therapeutic perspective, determining the adverse effects of environmental toxins and cancer chemotherapeutics on the reproductive system. The two main factors affecting follicle number estimates are the sampling method and the variation in follicle numbers within animals of the same strain, due to biological variability. This study aims at assessing the effect of these two factors, when estimating ovarian follicle numbers of neonatal mice. We developed computer algorithms, which generate models of neonatal mouse ovaries (simulated ovaries), with characteristics derived from experimental measurements already available in the published literature. The simulated ovaries are used to reproduce in-silico counting experiments based on unbiased stereological techniques; the proposed approach provides the necessary number of ovaries and sampling frequency to be used in the experiments given a specific biological variability and a desirable degree of accuracy. The simulated ovary is a novel, versatile tool which can be used in the planning phase of experiments to estimate the expected number of animals and workload, ensuring appropriate statistical power of the resulting measurements. Moreover, the idea of the simulated ovary can be applied to other organs made up of large numbers of individual functional units.	[Skodras, Angelos] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Marcelli, Gianluca] Univ Kent, Sch Engn & Digital Arts, Canterbury, Kent, England	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Kent	Marcelli, G (corresponding author), Univ Kent, Sch Engn & Digital Arts, Canterbury, Kent, England.	g.marcelli@kent.ac.uk						Ader H., 2008, ADVISING RES METHODS, P271; Canning J, 2003, ENDOCRINOLOGY, V144, P9, DOI 10.1210/en.2002-220988; Charleston JS, 2007, HUM REPROD, V22, P2103, DOI 10.1093/humrep/dem137; Coxworth JE, 2010, HUM REPROD, V25, P1796, DOI 10.1093/humrep/deq136; Da Silva-Buttkus P, 2009, P NATL ACAD SCI USA, V106, P456, DOI 10.1073/pnas.0810012106; Faddy M, 2007, NUMBERS OVARIAN FOLL, P1951; Falender AE, 2005, DEV BIOL, V288, P405, DOI 10.1016/j.ydbio.2005.09.038; Finch CE, 2010, ANN NY ACAD SCI, V1204, P82, DOI 10.1111/j.1749-6632.2010.05610.x; GOUGEON A, 1994, BIOL REPROD, V50, P653, DOI 10.1095/biolreprod50.3.653; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x; Howard V., 1998, UNBIASED STEREOLOGY; Hoyer PB, 2007, BIRTH DEFECTS RES B, V80, P113, DOI 10.1002/bdrb.20103; Kerr JB, 2006, REPRODUCTION, V132, P95, DOI 10.1530/rep.1.01128; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Picton HM, 2001, THERIOGENOLOGY, V55, P1193, DOI 10.1016/S0093-691X(01)00478-2; Sforza C, 2003, EARLY HUM DEV, V74, P27, DOI 10.1016/S0378-3782(03)00081-1; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120242	10.1371/journal.pone.0120242	http://dx.doi.org/10.1371/journal.pone.0120242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812007	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000356353700044
J	Turnbull, PC; Ramos, SV; MacPherson, REK; Roy, BD; Peters, SJ				Turnbull, Patrick C.; Ramos, Sofhia V.; MacPherson, Rebecca E. K.; Roy, Brian D.; Peters, Sandra J.			Characterization of Lipolytic Inhibitor G(0)/G (1) Switch Gene-2 Protein (G0S2) Expression in Male Sprague-Dawley Rat Skeletal Muscle Compared to Relative Content of Adipose Triglyceride Lipase (ATGL) and Comparitive Gene Identification-58 (CGI-58)	PLOS ONE			English	Article							TRIACYLGLYCEROL UTILIZATION; LIPID-METABOLISM; OXIDATION; EXERCISE	The rate-limiting enzyme in lipolysis, adipose triglyceride lipase (ATGL), is activated by comparative gene identification-58 (CGI-58) and inhibited by the G(0)/G(1) switch gene-2 (G0S2) protein. It is speculated that inhibition of ATGL is through a dose dependent manner of relative G0S2 protein content. There is little work examining G0S2 expression in lipolytic tissues, and the relative expression across oxidative tissues such as skeletal muscle has not yet been described. Three muscles, soleus (SOL), red gastrocnemius (RG), and white gastrocnemius (WG) were excised from 57-day old male Sprague-Dawley rats (n = 9). QRT-PCR was used for mRNA analysis, and western blotting was conducted to determine protein content. ATGL and G0S2 protein content were both greatest in the lipolytic SOL, with the least amount of both ATGL and G0S2 protein content found in the WG. CGI-58 protein content however did not mirror ATGL and G0S2 protein content, since the RG had the greatest CGI-58 protein content when compared to the SOL and WG. When comparing our tissues based on CGI-58-to-ATGL ratio and G0S2-to-ATGL ratio, it was discovered that contrary to oxidative demand, the glycolytic WG had the greatest activator CGI-58-to-ATGL ratio with the oxidative SOL having the least, and no differences in G0S2-to-ATGL across the three muscle types. These data suggest that the content of G0S2 relative to the lipase in skeletal muscle would not predict lipolytic potential.	[Turnbull, Patrick C.; Ramos, Sofhia V.; MacPherson, Rebecca E. K.; Roy, Brian D.; Peters, Sandra J.] Brock Univ, Dept Kinesiol, Ctr Bone & Muscle Hlth, St Catharines, ON L2S 3A1, Canada	Brock University	Peters, SJ (corresponding author), Brock Univ, Dept Kinesiol, Ctr Bone & Muscle Hlth, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	sandra.peters@brocku.ca	Ramos, Sofhia/ABB-9974-2020; Roy, Brian/V-6612-2019	Roy, Brian/0000-0003-4638-5586; MacPherson, Rebecca/0000-0002-1577-2658	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC post-graduate doctoral award (PGS-D)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC post-graduate doctoral award (PGS-D)	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) grants to S. J. Peters and B. D. Roy. REK Macpherson was supported by an NSERC post-graduate doctoral award (PGS-D). G0S2 knockout tissue was kindly donated by Dr. Jun Liu (Department of Pediatrics and the Kentucky Pediatric Research Institute; University of Kentucky; Lexington, KY USA).	Badin PM, 2012, J LIPID RES, V53, P839, DOI 10.1194/jlr.M019182; Biederman J, 2004, KIDNEY INT, V66, P2308, DOI 10.1111/j.1523-1755.2004.66016.x; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Dobrzyn P, 2013, AM J PHYSIOL ENDOCRI; Dyck DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE888, DOI 10.1152/ajpendo.1998.275.5.E888; Dyck DJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE340, DOI 10.1152/ajpendo.1997.272.3.E340; Dyck DJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE778, DOI 10.1152/ajpendo.2000.278.5.E778; Jocken JWE, 2008, HISTOCHEM CELL BIOL, V129, P535, DOI 10.1007/s00418-008-0386-y; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; LeBlanc PJ, 2008, AM J PHYSIOL-REG I, V295, pR1224, DOI 10.1152/ajpregu.90320.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louche K, 2013, J CLIN ENDOCR METAB, V98, P4863, DOI 10.1210/jc.2013-2058; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Nielsen TS, 2011, J CLIN ENDOCR METAB, V96, pE1293, DOI 10.1210/jc.2011-0149; Olfert ED, 1993, GUIDE CARE USE EXPT, V1; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Peters SJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE300, DOI 10.1152/ajpendo.1998.275.2.E300; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; SPRIET LL, 1985, CAN J PHYSIOL PHARM, V63, P614, DOI 10.1139/y85-102; Welch C, 2009, CANCER RES, V69, P6782, DOI 10.1158/0008-5472.CAN-09-0128; Yang XF, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-1; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	25	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120136	10.1371/journal.pone.0120136	http://dx.doi.org/10.1371/journal.pone.0120136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811590	Green Submitted, gold, Green Published			2022-12-26	WOS:000356353700039
J	Yan, SX; Sun, DF; Sun, GL				Yan, Songxian; Sun, Dongfa; Sun, Genlou			Genetic Divergence in Domesticated and Non-Domesticated Gene Regions of Barley Chromosomes	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; WILD BARLEY; NATURAL-SELECTION; QTL ANALYSIS; HORDEUM-SPONTANEUM; EVOLUTION CANYON; SPRING BARLEY; GROWTH HABIT; DIVERSITY; VULGARE	Little is known about the genetic divergence in the chromosomal regions with domesticated and non-domesticated genes. The objective of our study is to examine the effect of natural selection on shaping genetic diversity of chromosome region with domesticated and non-domesticated genes in barley using 110 SSR markers. Comparison of the genetic diversity loss between wild and cultivated barley for each chromosome showed that chromosome 5H had the highest divergence of 35.29%, followed by 3H, 7H, 4H, 2H, 6H. Diversity ratio was calculated as (diversity of wild type - diversity of cultivated type)/diversity of wild typex100%. It was found that diversity ratios of the domesticated regions on 5H, 1H and 7H were higher than those of non-domesticated regions. Diversity ratio of the domesticated region on 2H and 4H is similar to that of non-domesticated region. However, diversity ratio of the domesticated region on 3H is lower than that of non-domesticated region. Averaged diversity among six chromosomes in domesticated region was 33.73% difference between wild and cultivated barley, and was 27.56% difference in the non-domesticated region. The outcome of this study advances our understanding of the evolution of crop chromosomes.	[Yan, Songxian; Sun, Dongfa; Sun, Genlou] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Huazhong Agricultural University; Saint Marys University - Canada	Sun, DF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China.	sundongfa1@mail.hzau.edu.cn; genlou.sun@smu.ca			National Natural Science Foundation of China [31228017]; earmarked fund for China Agriculture Research System [CARS-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for China Agriculture Research System	This project was supported in part by the National Natural Science Foundation of China (31228017), an earmarked fund for China Agriculture Research System (CARS-5). The National Natural Science Foundation of China AND the earmarked fund for China Agriculture Research System, are two separate organizations. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Baek HJ, 2003, THEOR APPL GENET, V106, P397, DOI 10.1007/s00122-002-1029-7; Blattner FR, 2001, GENET RESOUR CROP EV, V48, P13, DOI 10.1023/A:1011299021969; Boyd WJR, 2003, AUST J AGR RES, V54, P1277, DOI 10.1071/AR03014; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Chen KF, 2007, INT J BIOL SCI, V3, P153; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Cronin JK, 2007, P NATL ACAD SCI USA, V104, P2773, DOI 10.1073/pnas.0611226104; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Darwin C, 1859, ORIGIN SPECIES MEANS, DOI [10.1007/s12064-009-0058-z, DOI 10.1007/S12064-009-0058-Z]; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang Z, 2014, G3-GENES GENOM GENET, V114; Fay JC, 2000, GENETICS, V155, P1405; Hancock JF, 2005, ANN BOT-LONDON, V96, P953, DOI 10.1093/aob/mci259; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Hori K, 2005, MOL BREEDING, V16, P295, DOI 10.1007/s11032-005-0998-z; Huang QY, 2002, GENOME, V45, P1216, DOI 10.1139/G02-073; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kashi Y, 1997, TRENDS GENET, V13, P74, DOI 10.1016/S0168-9525(97)01008-1; Kayser M, 2003, MOL BIOL EVOL, V20, P893, DOI 10.1093/molbev/msg092; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Koornneef M, 1997, NEW PHYTOL, V137, P1, DOI 10.1046/j.1469-8137.1997.00819.x; Li YC, 2000, THEOR APPL GENET, V101, P1029, DOI 10.1007/s001220051577; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lundqvist U, 2006, BARLEY GENET NEWSL, V36, P48; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mir RR, 2012, GENET RESOUR CROP EV, V59, P717, DOI 10.1007/s10722-011-9713-6; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; NEI M, 1978, GENETICS, V89, P583; Nevo E, 2005, BIOL J LINN SOC, V84, P205, DOI 10.1111/j.1095-8312.2005.00425.x; Nevo E, 1997, HEREDITY, V78, P373, DOI 10.1038/hdy.1997.60; NEVO E, 1986, BIOL J LINN SOC, V27, P355, DOI 10.1111/j.1095-8312.1986.tb01742.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Orabi J, 2007, THEOR APPL GENET, V114, P1117, DOI 10.1007/s00122-007-0505-5; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; PAN A, 1994, THEOR APPL GENET, V89, P900, DOI 10.1007/BF00224516; Payseur BA, 2002, MOL BIOL EVOL, V19, P1143, DOI 10.1093/oxfordjournals.molbev.a004172; Peighambari SA, 2005, PLANT SCI, V169, P1008, DOI 10.1016/j.plantsci.2005.05.018; Porto-Neto LR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-876; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; Prada D, 2004, THEOR APPL GENET, V109, P62, DOI 10.1007/s00122-004-1608-x; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Ramsay L, 2000, GENETICS, V156, P1997; Ren XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062700; Ren XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-89; Russell J, 2011, NEW PHYTOL, V191, P564, DOI 10.1111/j.1469-8137.2011.03704.x; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Sameri M, 2004, BREEDING SCI, V54, P327, DOI 10.1270/jsbbs.54.327; Scotti I, 2000, GENOME, V43, P41, DOI 10.1139/gen-43-1-41; Senthil N, 2005, EUPHYTICA, V145, P215, DOI 10.1007/s10681-005-1166-6; Shakhatreh Y, 2010, GENET RESOUR CROP EV, V57, P131, DOI 10.1007/s10722-009-9457-8; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Sun G, 2003, GENOME, V46, P729, DOI [10.1139/g03-052, 10.1139/G03-052]; Taketa S, 2004, THEOR APPL GENET, V108, P1236, DOI 10.1007/s00122-003-1560-1; Tiranti B, 2007, MOL ECOL, V16, P4942, DOI 10.1111/j.1365-294X.2007.03566.x; Ullrich SE., 2011, BARLEY PROD IMPROV U, P3, DOI DOI 10.1002/9780470958636.CH1; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Vaughan DA, 2007, ANN BOT-LONDON, V100, P893, DOI 10.1093/aob/mcm224; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; von Korff M, 2005, THEOR APPL GENET, V111, P583, DOI 10.1007/s00122-005-2049-x; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yeh F. C., 2000, POPGENE32 MICROSOFT; Yun SJ, 2005, CROP SCI, V45, P2563, DOI 10.2135/cropsci2005.0236	70	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121106	10.1371/journal.pone.0121106	http://dx.doi.org/10.1371/journal.pone.0121106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812037	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700079
J	Cheng, JJ; Ding, CF; Li, XG; Zhang, TL; Wang, XX				Cheng, Jinjin; Ding, Changfeng; Li, Xiaogang; Zhang, Taolin; Wang, Xingxiang			Rare Earth Element Transfer from Soil to Navel Orange Pulp (Citrus sinensis Osbeck cv. Newhall) and the Effects on Internal Fruit Quality	PLOS ONE			English	Article							FRACTIONATION; CADMIUM; MODEL; BIOAVAILABILITY; AVAILABILITY; VEGETABLES; STANDARDS; REGIONS; IMPACT; LONG	The effects of soil rare earth element (REE) on navel orange quality and safety in rare earth ore areas have gained great attention. This study investigated the transfer characteristics of REE from soil to navel orange pulp (Citrus sinensis Osbeck cv. Newhall) and examined the effects of soil REE on internal fruit quality in Xinfeng County, Jiangxi province, China. Path analysis showed that soil REE, pH, cation exchange capacity (CEC), and Fe oxide (Fe-ox) significantly affected pulp REE concentrations. A Freundlich-type prediction model for pulp REE was established: log[REEpulp] = -1.036 + 0.272 log[REEsoil] - 0.056 pH - 0.360 log [CEC] + 0.370 log[Fe-ox] (n = 114, R-2 = 0.60). From the prediction model, it was inferred that even when soil REE and Fe-ox were as high as 1038 mg kg(-1) and 96.4 g kg(-1), respectively, and pH and CEC were as low as 3.75 and 5.08 cmol kg(-1), respectively, pulp REE concentrations were much lower than the food limit standard. Additionally, soil REE levels were significantly correlated with selected fruit quality indicators, including titratable acidity (r = 0.52, P < 0.01), total soluble solids (r = 0.48, P < 0.01) and vitamin C (r = 0.56, P < 0.01). Generally, under routine methods of water and fertilization management, the cultivation of navel oranges in rare earth ore areas of south China with soil REE ranging from 38.6 to 546 mg kg(-1) had improved in internal fruit quality.	[Cheng, Jinjin; Ding, Changfeng; Li, Xiaogang; Zhang, Taolin] Chinese Acad Sci, Inst Soil Sci, Key Lab Soil Environm & Pollut Remediat, Nanjing 210008, Jiangsu, Peoples R China; [Cheng, Jinjin; Ding, Changfeng; Li, Xiaogang; Zhang, Taolin; Wang, Xingxiang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Xingxiang] Chinese Acad Sci, Ecol Expt Stn Red Soil, Jiangxi Key Lab Ecol Res Red Soil, Yingtan 335211, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Wang, XX (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	xxwang@issas.ac.cn	li, xiaogang/ABH-2977-2020; Ding, Changfeng/F-5947-2019	Ding, Changfeng/0000-0002-6730-9382	GanPo 555 Talents Program of Jiangxi Province, China; Knowledge Innovation Program of Chinese Academy of Sciences [ISSAS Y112000016]	GanPo 555 Talents Program of Jiangxi Province, China; Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the GanPo 555 Talents Program of Jiangxi Province, China, URL: http://www.jiangxi.gov.cn/ and the Knowledge Innovation Program of Chinese Academy of Sciences (ISSAS Y112000016), URL: http://www.cas.cn/, author received the funding: XXW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostopoulou MA, 2006, FOOD CHEM, V94, P19, DOI 10.1016/j.foodchem.2004.09.047; [Anonymous], 1997, 11466 DIN ISO; Bao JF, 2004, J HUAZHONG AGR U, V23, P663; BASTA NT, 1993, AGRON J, V85, P1054, DOI 10.2134/agronj1993.00021962008500050018x; Brioschi L, 2013, PLANT SOIL, V366, P143, DOI 10.1007/s11104-012-1407-0; Brus DJ, 2005, GEODERMA, V128, P301, DOI 10.1016/j.geoderma.2005.04.014; BYRNE RH, 1995, GEOCHIM COSMOCHIM AC, V59, P4575, DOI 10.1016/0016-7037(95)00303-7; Cao XD, 2001, CHEMOSPHERE, V44, P655, DOI 10.1016/S0045-6535(00)00492-6; Chaudri A, 2007, CHEMOSPHERE, V66, P1415, DOI 10.1016/j.chemosphere.2006.09.068; Chen M, 2001, SOIL SCI SOC AM J, V65, P491, DOI 10.2136/sssaj2001.652491x; Clemens S, 2002, TRENDS PLANT SCI, V7, P309, DOI 10.1016/S1360-1385(02)02295-1; Ding CF, 2013, J AGR FOOD CHEM, V61, P10273, DOI 10.1021/jf4029859; Ding SM, 2006, PEDOSPHERE, V16, P82, DOI 10.1016/S1002-0160(06)60029-5; Dong HQ, 2004, J FOOD ENG, V64, P355, DOI 10.1016/j.jfoodeng.2003.11.003; Fang J, 2007, GEODERMA, V141, P53, DOI 10.1016/j.geoderma.2007.05.014; Hu ZY, 2004, J PLANT NUTR, V27, P183, DOI 10.1081/PLN-120027555; Li FL, 1998, ENVIRON POLLUT, V102, P269, DOI 10.1016/S0269-7491(98)00063-3; Li XF, 2013, CHEMOSPHERE, V93, P1240, DOI 10.1016/j.chemosphere.2013.06.085; Loell M, 2011, J PLANT NUTR SOIL SC, V174, P644, DOI 10.1002/jpln.201000265; Lu R.K., 2000, ANAL METHODS AGR CHE; Manthey JA, 1996, J AGR FOOD CHEM, V44, P811, DOI 10.1021/jf950572g; MARKERT B, 1987, PHYTOCHEMISTRY, V26, P3167, DOI 10.1016/S0031-9422(00)82463-2; MEDLICOTT AP, 1985, J SCI FOOD AGR, V36, P561, DOI 10.1002/jsfa.2740360707; MHPRC (Ministry of Health of the People's Republic of China), 2005, 27622005 MHPRC GB; Okwu D., 2006, INT J MOL MED ADV SC, V1, P1; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Romkens PFAM, 2011, SCI TOTAL ENVIRON, V409, P3098, DOI 10.1016/j.scitotenv.2011.04.045; Stolpe B, 2013, GEOCHIM COSMOCHIM AC, V106, P446, DOI 10.1016/j.gca.2012.12.033; Turra C, 2013, J PLANT NUTR, V36, P762, DOI 10.1080/01904167.2012.754040; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; U. S. Environmental Protection Agency (USEPA), 1996, 1638 USEPA; VOLOKH AA, 1990, SCI TOTAL ENVIRON, V95, P141, DOI 10.1016/0048-9697(90)90059-4; Wang XP, 2004, CHEMOSPHERE, V55, P811, DOI 10.1016/j.chemosphere.2003.12.003; Wang Z.G., 1989, RARE EARTH ELEMENTS, P1; [汪振立 WANG Zhen-li], 2009, [中国地质, Geology of China], V36, P1382; WUTSCHER HK, 1993, COMMUN SOIL SCI PLAN, V24, P2059, DOI 10.1080/00103629309368936; Wyttenbach A, 1998, PLANT SOIL, V199, P267, DOI 10.1023/A:1004331826160; [余江 YU Jiang], 2009, [食品科学, Food Science], V30, P309; Zhang H, 2000, BIOL TRACE ELEM RES, V73, P19, DOI 10.1385/BTER:73:1:19; Zhang H, 2000, BIOL TRACE ELEM RES, V73, P1, DOI 10.1385/BTER:73:1:1; Zhu WF, 2005, BIOL TRACE ELEM RES, V104, P1, DOI 10.1385/BTER:104:1:001	41	23	25	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120618	10.1371/journal.pone.0120618	http://dx.doi.org/10.1371/journal.pone.0120618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806821	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000092
J	Kolek, J; Patakova, P; Melzoch, K; Sigler, K; Rezanka, T				Kolek, Jan; Patakova, Petra; Melzoch, Karel; Sigler, Karel; Rezanka, Tomas			Changes in Membrane Plasmalogens of Clostridium pasteurianum during Butanol Fermentation as Determined by Lipidomic Analysis	PLOS ONE			English	Article							FATTY-ACIDS; ACETOBUTYLICUM ATCC-824; STREPTOMYCES-FRADIAE; POLAR LIPIDS; FLUIDITY; GROWTH; TEMPERATURE; DIVERSITY; BACTERIA; STRAINS	Changes in membrane lipid composition of Clostridium pasteurianum NRRL B-598 were studied during butanol fermentation by lipidomic analysis, performed by high resolution electrospray ionization tandem mass spectrometry. The highest content of plasmalogen phospholipids correlated with the highest butanol productivity, which indicated a probable role of these compounds in the complex responses of cells toward butanol stress. A difference in the ratio of saturated to unsaturated fatty acids was found between the effect of butanol produced by the cells and butanol added to the medium. A decrease in the proportion of saturated fatty acids during conventional butanol production was observed while a rise in the content of these acids appeared when butanol was added to the culture. The largest change in total plasmalogen content was observed one hour after butanol addition i.e. at the 7th hour of cultivation. When butanol is produced by bacterial cells, then the cells are not subjected to severe stress and responded to it by relatively slowly changing the content of fatty acids and plasmalogens, while after a pulse addition of external butanol (to a final non-lethal concentration of 0.5% v/v) the cells reacted relatively quickly (within a time span of tens of minutes) by increasing the total plasmalogen content.	[Kolek, Jan; Patakova, Petra; Melzoch, Karel] Univ Chem & Technol Prague, Dept Biotechnol, Prague, Czech Republic; [Sigler, Karel; Rezanka, Tomas] Acad Sci Czech Republic, Inst Microbiol, Prague, Czech Republic	University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Kolek, J (corresponding author), Univ Chem & Technol Prague, Dept Biotechnol, Prague, Czech Republic.	Jan.Kolek@vscht.cz	Rezanka, Tomas/A-8399-2008; Patakova, Petra/B-6404-2018	Rezanka, Tomas/0000-0002-8704-9645; Patakova, Petra/0000-0002-9410-4454	Ministry of Education, Youth and Sports of the Czech Republic [MSM 6046137305]; Ministry of Education, Youth and Sports of the Czech Republic, Specific University Research MSMT [20/2014]; Grant Agency of Czech Republic [GACR P503/11/0215]; Institute of Microbiology, Academy of Sciences of the Czech Republic [RVO61388971]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic, Specific University Research MSMT; Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Institute of Microbiology, Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	Support was provided by: the Ministry of Education, Youth and Sports of the Czech Republic, project No. MSM 6046137305, (http://www.msmt.cz/) to KM PP (this funder had a role in data collection and preparation of the manuscript); the Ministry of Education, Youth and Sports of the Czech Republic, Specific University Research MSMT No. 20/2014, (http://www.msmt.cz/) to JK (this funder had a role in data collection); the Grant Agency of Czech Republic, GACR P503/11/0215, (http://www.gacr.cz/) to TR (this funder had a role in data collection and analysis); Institute of Microbiology, Academy of Sciences of the Czech Republic, Institutional Internal Project RVO61388971, (http://www.biomed.cas.cz/mbu) to TR (this funder had a role in publication fee payment).	BAER SH, 1987, APPL ENVIRON MICROB, V53, P2854, DOI 10.1128/AEM.53.12.2854-2861.1987; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Goldfine Howard, 2005, P297, DOI 10.1201/9780203489819.pt3; Guan ZQ, 2013, BBA-MOL CELL BIOL L, V1831, P1108, DOI 10.1016/j.bbalip.2013.02.004; Guan ZQ, 2012, MICROBIOL-SGM, V158, P2577, DOI 10.1099/mic.0.060707-0; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P186, DOI 10.1016/j.bbalip.2010.12.010; HONGO M, 1968, AGR BIOL CHEM TOKYO, V32, P27, DOI 10.1080/00021369.1968.10859021; Huffer S, 2011, APPL ENVIRON MICROB, V77, P6400, DOI 10.1128/AEM.00694-11; JOHNSTON NC, 1983, J GEN MICROBIOL, V129, P1075; Johnston NC, 2010, J LIPID RES, V51, P1953, DOI 10.1194/jlr.M004788; Juzlova P, 1996, PHYTOCHEMISTRY, V43, P151, DOI 10.1016/0031-9422(96)00236-1; Kates K, 1986, LAB TECHNIQUES BIOCH, P220; Kolek J, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00192-14; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; LEPAGE C, 1987, J GEN MICROBIOL, V133, P103; Linhova M, 2010, FOLIA MICROBIOL, V55, P340, DOI 10.1007/s12223-010-0054-1; Linhova M, 2012, FOLIA MICROBIOL, V57, P307, DOI 10.1007/s12223-012-0131-8; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Patakova P, 2011, J CHEM ENG, V5, P121; Patakova P, 2013, BIOTECHNOL ADV, V31, P58, DOI 10.1016/j.biotechadv.2012.01.010; Patakova P, 2011, BIOFUEL'S ENGINEERING PROCESS TECHNOLOGY, P243; Ruhl J, 2012, MICROB BIOTECHNOL, V5, P45, DOI 10.1111/j.1751-7915.2011.00286.x; Schwarz KM, 2012, J BIOTECHNOL, V161, P366, DOI 10.1016/j.jbiotec.2012.03.018; Tian B, 2013, BBA-MOL CELL BIOL L, V1831, P1185, DOI 10.1016/j.bbalip.2013.03.005; Tomas CA, 2004, J BACTERIOL, V186, P2006, DOI 10.1128/JB.186.7.2006-2018.2004; VANCURA A, 1987, FEMS MICROBIOL LETT, V48, P357, DOI 10.1016/0378-1097(87)90075-9; VANCURA A, 1988, FEMS MICROBIOL LETT, V49, P411, DOI 10.1016/0378-1097(88)90334-5; Venkataramanan KP, 2014, J BIOTECHNOL, V179, P8, DOI 10.1016/j.jbiotec.2014.03.017; VOLLHERBSTSCHNECK K, 1984, APPL ENVIRON MICROB, V47, P193, DOI 10.1128/AEM.47.1.193-194.1984; Wang QH, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-120; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-102; WOOD R, 1968, LIPIDS, V3, P129, DOI 10.1007/BF02531729; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhao YS, 2003, APPL ENVIRON MICROB, V69, P2831, DOI 10.1128/AEM.69.5.2831-2841.2003; Zhu XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070631	35	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122058	10.1371/journal.pone.0122058	http://dx.doi.org/10.1371/journal.pone.0122058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807381	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000200
J	Luo, J; Chen, XM; Pan, YW; Lu, S; Xia, ZG; Storm, DR				Luo, Jie; Chen, Xuanmao; Pan, Yung-Wei; Lu, Song; Xia, Zhengui; Storm, Daniel R.			The Type 3 Adenylyl Cyclase Is Required for the Survival and Maturation of Newly Generated Granule Cells in the Olfactory Bulb	PLOS ONE			English	Article							ADULT-BORN NEURONS; ELEMENT-BINDING PROTEIN; NEWBORN NEURONS; PRIMARY CILIA; MAMMALIAN BRAIN; INTERNEURON SUBTYPES; SYNAPTIC INTEGRATION; SENSORY EXPERIENCE; 5-HT6 RECEPTORS; TERM SURVIVAL	The type 3 adenylyl cyclase (AC3) is localized to olfactory cilia in the main olfactory epithelium (MOE) and primary cilia in the adult mouse brain. Although AC3 has been strongly implicated in odor perception and olfactory sensory neuron (OSN) targeting, its role in granule cells (GCs), the most abundant interneurons in the main olfactory bulb (MOB), remains largely unknown. Here, we report that the deletion of AC3 leads to a significant reduction in the size of the MOB as well as the level of adult neurogenesis. The cell proliferation and cell cycle in the subventricular zone (SVZ), however, are not suppressed in AC3-/- mice. Furthermore, AC3 deletion elevates the apoptosis of GCs and disrupts the maturation of newly formed GCs. Collectively, our results identify a fundamental role for AC3 in the development of adult-born GCs in the MOB.	[Luo, Jie; Chen, Xuanmao; Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Luo, Jie] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Pan, Yung-Wei; Lu, Song; Xia, Zhengui] Univ Washington, Dept Environm & Occupat Hlth Sci, Toxicol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Wuhan University; University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu		Luo, Jie/0000-0003-1899-3111; Chen, Xuanmao/0000-0002-0057-8510	National Institutes of Health [NS20498, MH073601, MH95840]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601, R01MH095840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NS20498 and MH073601 to DRS, MH95840 to ZX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Bagley J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-92; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Baker H, 1999, J NEUROSCI, V19, P9313; Batista-Brito R, 2008, J NEUROSCI, V28, P3966, DOI 10.1523/JNEUROSCI.5625-07.2008; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chen XM, 2012, J NEUROSCI, V32, P15769, DOI 10.1523/JNEUROSCI.2180-12.2012; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Cummings DM, 1997, J NEUROSCI, V17, P7433; Cummings DM, 1997, EXP NEUROL, V148, P360, DOI 10.1006/exnr.1997.6660; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fiske BK, 2001, J COMP NEUROL, V431, P311; FRAZIERCIERPIAL L, 1989, J COMP NEUROL, V289, P481, DOI 10.1002/cne.902890312; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Gire DH, 2013, NEURON, V78, P416, DOI 10.1016/j.neuron.2013.04.033; Guadiana SM, 2013, J NEUROSCI, V33, P2626, DOI 10.1523/JNEUROSCI.2906-12.2013; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Hamon M, 1999, NEUROPSYCHOPHARMACOL, V21, pS68, DOI 10.1038/sj.npp.1395368; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hebert JM, 2003, DEVELOPMENT, V130, P1101, DOI 10.1242/dev.00334; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Ishikawa Y, 2000, MOL CELL ENDOCRINOL, V162, P107, DOI 10.1016/S0303-7207(00)00210-0; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Lepski G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00155; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061948; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Livneh Y, 2011, J COMP NEUROL, V519, P2212, DOI 10.1002/cne.22625; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mechawar N, 2004, P NATL ACAD SCI USA, V101, P9822, DOI 10.1073/pnas.0403361101; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miwa N, 2005, J NEUROSCI, V25, P5404, DOI 10.1523/JNEUROSCI.1039-05.2005; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NAJBAUER J, 1995, BRAIN RES, V674, P245, DOI 10.1016/0006-8993(94)01448-Q; Nakagawa S, 2002, J NEUROSCI, V22, P3673; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Petreanu L, 2002, J NEUROSCI, V22, P6106; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Rochefort C, 2005, EUR J NEUROSCI, V22, P2863, DOI 10.1111/j.1460-9568.2005.04486.x; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schulz S, 2000, J PHYSIOLOGY-PARIS, V94, P259, DOI 10.1016/S0928-4257(00)00212-6; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Stenman J, 2003, J NEUROSCI, V23, P167; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sultan S, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00052; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Veyrac A, 2005, EXP NEUROL, V194, P444, DOI 10.1016/j.expneurol.2005.03.004; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; Wang ZS, 2011, NEUROPSYCHOPHARMACOL, V36, P772, DOI 10.1038/npp.2010.211; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Whitman MC, 2007, J NEUROSCI, V27, P9951, DOI 10.1523/JNEUROSCI.1633-07.2007; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; XIA ZG, 1992, NEUROSCI LETT, V144, P169, DOI 10.1016/0304-3940(92)90742-P; Xiao L, 2011, J PHARMACOL EXP THER, V338, P641, DOI 10.1124/jpet.111.179358; Xu ZX, 2013, NEUROSCI LETT, V541, P269, DOI 10.1016/j.neulet.2013.02.019; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007; Zou DJ, 2009, NAT REV NEUROSCI, V10, P611, DOI 10.1038/nrn2666	88	8	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122057	10.1371/journal.pone.0122057	http://dx.doi.org/10.1371/journal.pone.0122057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807252	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000199
J	Muthana, SM; Xia, L; Campbell, CT; Zhang, YL; Gildersleeve, JC				Muthana, Saddam M.; Xia, Li; Campbell, Christopher T.; Zhang, Yalong; Gildersleeve, Jeffrey C.			Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies	PLOS ONE			English	Article							CONJUGATE VACCINE CANDIDATE; CLASS SWITCH RECOMBINATION; CARBOHYDRATE MICROARRAY; BLOOD-GROUP; CLOSTRIDIUM-DIFFICILE; NATURAL ANTIBODIES; ALPHA-GAL; CANCER; OLIGOSACCHARIDE; BIOMARKERS	Anti-glycan antibodies are an abundant subpopulation of serum antibodies with critical functions in many immune processes. Changes in the levels of these antibodies can occur with the onset of disease, exposure to pathogens, or vaccination. As a result, there has been significant interest in exploiting anti-glycan antibodies as biomarkers for many diseases. Serum contains a mixture of anti-glycan antibodies that can recognize the same antigen, and competition for binding can potentially influence the detection of antibody subpopulations that are more relevant to disease processes. The most abundant antibody isotypes in serum are IgG, IgM, and IgA, but little is known regarding how these different isotypes compete for the same glycan antigen. In this study, we developed a multiplexed glycan microarray assay and applied it to evaluate how different isotypes of anti-glycan antibodies (IgA, IgG, and IgM) compete for printed glycan antigens. While IgG and IgA antibodies typically outcompete IgM for peptide or protein antigens, we found that IgM outcompete IgG and IgA for many glycan antigens. To illustrate the importance of this effect, we provide evidence that IgM competition can account for the unexpected observation that IgG of certain antigen specificities appear to be preferentially transported from mothers to fetuses. We demonstrate that IgM in maternal sera compete with IgG resulting in lower than expected IgG signals. Since cord blood contains very low levels of IgM, competition only affects maternal IgG signals, making it appear as though certain IgG antibodies are higher in cord blood than matched maternal blood. Taken together, the results highlight the importance of competition for studies involving anti-glycan antibodies.	[Muthana, Saddam M.; Xia, Li; Campbell, Christopher T.; Zhang, Yalong; Gildersleeve, Jeffrey C.] NCI, Biol Chem Lab, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gildersleeve, JC (corresponding author), NCI, Biol Chem Lab, NIH, 376 Boyles St, Frederick, MD 21702 USA.	gildersj@mail.nih.gov		Gildersleeve, Jeffrey/0000-0002-3744-6423	Intramural Research Program of the National Institutes of Health, NCI; Pharmacology Research Associate Program of the National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE [ZIABC011055] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI; Pharmacology Research Associate Program of the National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NCI. C.T.C. received fellowship funding from the Pharmacology Research Associate Program of the National Institute of General Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EW, 2004, CHEM BIOL, V11, P875, DOI 10.1016/j.chembiol.2004.04.010; Anish C, 2013, ACS CHEM BIOL, V8, P2412, DOI 10.1021/cb400602k; Anish C, 2013, ANGEW CHEM INT EDIT, V52, P9524, DOI 10.1002/anie.201301633; Aranzamendi C, 2011, EXP PARASITOL, V129, P221, DOI 10.1016/j.exppara.2011.08.015; Arthur CM, 2014, CURR OPIN CHEM BIOL, V18, P55, DOI 10.1016/j.cbpa.2013.12.017; Baader J, 2011, BIOSENS BIOELECTRON, V26, P1839, DOI 10.1016/j.bios.2010.01.021; Blixt O, 2009, AM J TRANSPLANT, V9, P83, DOI 10.1111/j.1600-6143.2008.02471.x; Blixt O, 2012, GLYCOBIOLOGY, V22, P529, DOI 10.1093/glycob/cwr178; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; Borgert A, 2012, ACS CHEM BIOL, V7, P1031, DOI 10.1021/cb300076s; Bovin N, 2012, BBA-GEN SUBJECTS, V1820, P1373, DOI 10.1016/j.bbagen.2012.02.005; Burford B, 2013, BRIT J CANCER, V108, P2045, DOI 10.1038/bjc.2013.214; Buzas EI, 2006, AUTOIMMUNITY, V39, P691, DOI 10.1080/08916930601061470; Campbell CT, 2014, P NATL ACAD SCI USA, V111, pE1749, DOI 10.1073/pnas.1314722111; Campbell CT, 2013, CLIN CANCER RES, V19, P1290, DOI 10.1158/1078-0432.CCR-12-2478; Campbell Christopher T, 2010, Curr Protoc Chem Biol, V2, P37, DOI 10.1002/9780470559277.ch090228; de Leoz MLA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002717; de Leoz MLA, 2008, DIS MARKERS, V25, P243, DOI 10.1155/2008/515318; de Paz JL, 2012, METHODS MOL BIOL, V808, P1, DOI 10.1007/978-1-61779-373-8_1; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; Dotan N, 2006, LUPUS, V15, P442, DOI 10.1191/0961203306lu2331oa; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; GILLARD BK, 1989, J IMMUNOL, V142, P3826; Grader-Beck T, 2011, ANN RHEUM DIS, V70, P2218, DOI 10.1136/ard.2011.153130; Hanson LA, 2003, ANN NY ACAD SCI, V987, P199, DOI 10.1111/j.1749-6632.2003.tb06049.x; Heimburg-Molinaro J, 2013, INT J PARASITOL, V43, P901, DOI 10.1016/j.ijpara.2013.05.012; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; Jacob F, 2012, INT J CANCER, V130, P138, DOI 10.1002/ijc.26002; JOLLIFF CR, 1982, CLIN CHEM, V28, P126; Kamiya K, 1999, MICROBIOL IMMUNOL, V43, P403, DOI 10.1111/j.1348-0421.1999.tb02423.x; KOHLER PF, 1966, NATURE, V210, P1070, DOI 10.1038/2101070a0; Kurtenkov O, 2005, EXP ONCOL, V27, P136; Li Q, 2010, INT J CANCER, V126, P459, DOI 10.1002/ijc.24716; Liao SF, 2013, P NATL ACAD SCI USA, V110, P13809, DOI 10.1073/pnas.1312457110; Lonardi E, 2010, EXPERT REV PROTEOMIC, V7, P761, DOI [10.1586/epr.10.41, 10.1586/EPR.10.41]; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Manimala JC, 2006, ANGEW CHEM INT EDIT, V45, P3607, DOI 10.1002/anie.200600591; Martin CE, 2013, J AM CHEM SOC, V135, P9713, DOI 10.1021/ja401410y; MEURMAN OH, 1978, J CLIN PATHOL, V31, P483, DOI 10.1136/jcp.31.5.483; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muthana SM, 2014, CANCER BIOMARK, V14, P29, DOI 10.3233/CBM-130383; Oberli MA, 2011, CHEM BIOL, V18, P580, DOI 10.1016/j.chembiol.2011.03.009; Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P406, DOI 10.1016/j.cbpa.2009.06.021; Oyelaran O, 2009, J PROTEOME RES, V8, P4301, DOI 10.1021/pr900515y; Oyelaran O, 2009, J PROTEOME RES, V8, P3529, DOI 10.1021/pr9002245; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Palma AS, 2014, CURR OPIN CHEM BIOL, V18, P87, DOI 10.1016/j.cbpa.2014.01.007; Palmeira P, 2009, PEDIAT ALLERG IMM-UK, V20, P528, DOI 10.1111/j.1399-3038.2008.00828.x; Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b; Pedersen JW, 2011, INT J CANCER, V128, P1860, DOI 10.1002/ijc.25778; Pochechueva T, 2011, ANALYST, V136, P560, DOI 10.1039/c0an00758g; Prasanphanich NS, 2014, GLYCOBIOLOGY, V24, P619, DOI 10.1093/glycob/cwu027; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Reis CA, 2011, EXPERT REV PROTEOMIC, V8, P435, DOI 10.1586/EPR.11.30; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Rudd PM, 2004, TRENDS BIOTECHNOL, V22, P524, DOI 10.1016/j.tibtech.2004.07.012; Schwarz M, 2006, J NEUROL SCI, V244, P59, DOI 10.1016/j.jns.2005.12.006; Shilova N, 2013, TOP CURR CHEM, P1; Shilova NV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P862, DOI 10.1134/S0006297911070170; Shilova N, 2012, GLYCOCONJUGATE J, V29, P87, DOI 10.1007/s10719-011-9368-8; Shoreibah MG, 2011, STEM CELLS DEV, V20, P515, DOI 10.1089/scd.2010.0172; Song XZ, 2012, METHODS MOL BIOL, V800, P163, DOI 10.1007/978-1-61779-349-3_11; Song XZ, 2011, NAT METHODS, V8, P85, DOI 10.1038/NMETH.1540; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Stevenson L, 1996, J HEPATOL, V25, P621, DOI 10.1016/S0168-8278(96)80229-7; van Diepen A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001922; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vuskovic Marko, 2013, J Proteomics Bioinform, V6, P302; Vuskovic Marko I, 2011, Int J Bioinform Res Appl, V7, P402, DOI 10.1504/IJBRA.2011.043771; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; Wang Denong, 2012, J Proteomics Bioinform, V5, P090; Wang LL, 2014, GLYCOBIOLOGY, V24, P507, DOI 10.1093/glycob/cwu019; WATKINS WM, 1966, SCIENCE, V152, P172, DOI 10.1126/science.152.3719.172; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Yin Z, 2013, ACS CHEM BIOL; Zeng Z, 2010, J CHROMATOGR A, V1217, P3307, DOI 10.1016/j.chroma.2009.09.029	80	28	31	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119298	10.1371/journal.pone.0119298	http://dx.doi.org/10.1371/journal.pone.0119298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807519	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000025
J	Shiwa, M; Yoneda, M; Nakanishi, S; Oki, K; Yamane, K; Kohno, N				Shiwa, Mami; Yoneda, Masayasu; Nakanishi, Shuhei; Oki, Kenji; Yamane, Kiminori; Kohno, Nobuoki			Japanese Lifestyle during Childhood Prevents the Future Development of Obesity among Japanese-Americans	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; BETA-CELL FUNCTION; MIDDLE-AGED WOMEN; DIABETES-MELLITUS; DIETARY PATTERNS; VISCERAL ADIPOSITY; INSULIN-RESISTANCE; NATIVE JAPANESE; LOS-ANGELES; RISK	Objective To evaluate whether a Japanese lifestyle during childhood could protect against the future development of obesity-associated metabolic diseases by comparing native Japanese with Japanese-Americans in whom genetic factors are the same. Methods Study subjects were 516 native Japanese and 781 Japanese-Americans who underwent medical examinations between 2007 and 2010. Japanese-Americans were divided into 444 first-generation immigrants (JA-1), who were born in Japan, and 337 second-or later-generation descendants (JA-2), who were born in the United States. The JA-2 group was then divided into the kibei subgroup (N = 79), who had moved to Japan before the age of 18 years and later returned to the United States, and the non-kibei subgroup (N = 258), who had never lived in Japan. Results The JA-2 group had the highest percentages of obesity, metabolic syndrome, and type 2 diabetes compared with native Japanese and JA-1. Furthermore, among JA-2, the prevalence of obesity and metabolic syndrome in the kibei subgroup was significantly lower than that in the non-kibei subgroup. The prevalence of diabetes in the kibei subgroup also tended to be lower than in the non-kibei subgroup. Conclusions The prevalence of obesity and metabolic diseases differed with residence in Japan during childhood among Japanese-Americans. These findings indicate the possibility that Japanese lifestyle during childhood could reduce the future risks for obesity-associated metabolic diseases.	[Shiwa, Mami; Yoneda, Masayasu; Nakanishi, Shuhei; Oki, Kenji; Yamane, Kiminori; Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan	Hiroshima University	Yoneda, M (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Hiroshima, Japan.	masayone17@hiroshima-u.ac.jp	Hiyama, Eiso/A-2013-2019	Hiyama, Eiso/0000-0001-9179-5037	Japan Society for the Promotion of Science KAKENHI [23590794]; West Corporation Chugoku Health Administration Center	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); West Corporation Chugoku Health Administration Center	This work was supported by grants from Japan Society for the Promotion of Science KAKENHI (Grant Number 23590794). West Corporation Chugoku Health Administration Center provided support in the form of salaries for authors [KY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Conroy MB, 2005, MED SCI SPORT EXER, V37, P1251, DOI 10.1249/01.mss.0000174882.60971.7f; EGUSA G, 1993, ATHEROSCLEROSIS, V100, P249, DOI 10.1016/0021-9150(93)90211-C; Egusa Genshi, 2002, J Atheroscler Thromb, V9, P299; Gavin JR, 1997, DIABETES CARE, V20, P1183; HANKIN JH, 1975, CANCER RES, V35, P3259; HARA H, 1994, DIABETES RES CLIN PR, V24, pS37, DOI 10.1016/0168-8227(94)90225-9; Hayashi T, 2003, DIABETES CARE, V26, P650, DOI 10.2337/diacare.26.3.650; Huang BJ, 1996, AM J EPIDEMIOL, V144, P674; International Diabetes Federation, IDF CONS WORLDW DEF; Kawate R, 1979, Diabetes Care, V2, P161, DOI 10.2337/diacare.2.2.161; Lauderdale DS, 2000, INT J OBESITY, V24, P1188, DOI 10.1038/sj.ijo.0801365; Malik VS, 2012, DIABETES CARE, V35, P12, DOI 10.2337/dc11-0386; Malik VS, 2011, AM J CLIN NUTR, V94, P854, DOI 10.3945/ajcn.110.009621; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Nakanishi S, 2004, BIOMED PHARMACOTHER, V58, P571, DOI 10.1016/j.biopha.2004.10.001; Okubo M, 2000, DIABETES RES CLIN PR, V47, P71, DOI 10.1016/S0168-8227(99)00106-0; Szoke E, 2008, DIABETES CARE, V31, P539, DOI 10.2337/dc07-1443; Wang MC, 2011, AM J CLIN NUTR, V93, p1168S, DOI 10.3945/ajcn.110.003475; Watanabe H, 2003, ATHEROSCLEROSIS, V166, P67, DOI 10.1016/S0021-9150(02)00304-0; Yoneda M, 2008, DIABETES RES CLIN PR, V79, P518, DOI 10.1016/j.diabres.2007.10.012	23	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120804	10.1371/journal.pone.0120804	http://dx.doi.org/10.1371/journal.pone.0120804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807391	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000104
J	Yeon, B; Ahn, E; Kim, KI; Kim, IW; Oh, JM; Park, T				Yeon, Bora; Ahn, Eunyong; Kim, Kyung-Im; Kim, In-Wha; Oh, Jung Mi; Park, Taesung			Analysis of Pharmacogenomic Variants Associated with Population Differentiation	PLOS ONE			English	Article							COMMON VARIANT; WNT PATHWAY; GENE; MAP; IDENTIFICATION; POLYMORPHISMS; KNOWLEDGE; SELECTION; WARFARIN; DATABASE	In the present study, we systematically investigated population differentiation of drug-related (DR) genes in order to identify common genetic features underlying population-specific responses to drugs. To do so, we used the International HapMap project release 27 Data and Pharmacogenomics Knowledge Base (PharmGKB) database. First, we compared four measures for assessing population differentiation: the chi-square test, the analysis of variance (ANOVA) F-test, F-st, and Nearest Shrunken Centroid Method (NSCM). F-st showed high sensitivity with stable specificity among varying sample sizes; thus, we selected F-st for determining population differentiation. Second, we divided DR genes from PharmGKB into two groups based on the degree of population differentiation as assessed by F-st: genes with a high level of differentiation (HD gene group) and genes with a low level of differentiation (LD gene group). Last, we conducted a gene ontology (GO) analysis and pathway analysis. Using all genes in the human genome as the background, the GO analysis and pathway analysis of the HD genes identified terms related to cell communication. "Cell communication" and "cell-cell signaling" had the lowest Benjamini-Hochberg's q-values (0.0002 and 0.0006, respectively), and "drug binding" was highly enriched (16.51) despite its relatively high q-value (0.0142). Among the 17 genes related to cell communication identified in the HD gene group, five genes (STX4, PPARD, DCK, GRIK4, and DRD3) contained single nucleotide polymorphisms with F-st values greater than 0.5. Specifically, the F-st values for rs10871454, rs6922548, rs3775289, rs1954787, and rs167771 were 0.682, 0.620, 0.573, 0.531, and 0.510, respectively. In the analysis using DR genes as the background, the HD gene group contained six significant terms. Five were related to reproduction, and one was "Wnt signaling pathway," which has been implicated in cancer. Our analysis suggests that the HD gene group from PharmGKB is associated with cell communication and drug binding.	[Yeon, Bora; Ahn, Eunyong; Park, Taesung] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kim, Kyung-Im; Kim, In-Wha; Oh, Jung Mi] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Park, Taesung] Seoul Natl Univ, Dept Stat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, T (corresponding author), Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea.	tspark@stats.snu.ac.kr			National Research Foundation of Korea (NRF) - Republic of Korea (MSIP) [2012R1A3A2026438, 2008-0062618, 2013M3A9C4078158]	National Research Foundation of Korea (NRF) - Republic of Korea (MSIP)	This study was supported by the National Research Foundation of Korea (NRF) grants funded by the Republic of Korea (MSIP) (2012R1A3A2026438, 2008-0062618, 2013M3A9C4078158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Cardoso MA, 1998, MOL ECOL, V7, P601, DOI 10.1046/j.1365-294x.1998.00363.x; Casto AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001266; Deeken JF, 2010, PHARMACOGENOMICS J, V10, P191, DOI 10.1038/tpj.2009.57; Duan SW, 2008, BIOINFORMATION, V3, P139, DOI 10.6026/97320630003139; Ferrer-Admetlla A, 2014, MOL BIOL EVOLUTION; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fukunaga AK, 2004, PHARMACOGENOMICS J, V4, P307, DOI 10.1038/sj.tpj.6500259; Gage BF, 2008, J THROMB THROMBOLYS, V25, P45, DOI 10.1007/s11239-007-0104-y; Garber K, 2009, J NATL CANCER I, V101, P548, DOI 10.1093/jnci/djp084; Gasso P, 2009, PHARMACOGENOMICS J, V9, P404, DOI 10.1038/tpj.2009.26; Han K, 2010, UNBALANCED SAMPLE SI, P347; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Joubert BR, 2010, J HUM GENET, V55, P366, DOI 10.1038/jhg.2010.41; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kewn S, 2000, BRIT J CLIN PHARMACO, V50, P597; Kim IW, 2012, PHARMACOGENET GENOM, V22, P829, DOI 10.1097/FPC.0b013e328358dd70; Kroep JR, 2002, MOL CANCER THER, V1, P371; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li Y, 2008, GENOMICS, V92, P488, DOI 10.1016/j.ygeno.2008.08.011; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Paddock S, 2007, AM J PSYCHIAT, V164, P1181, DOI 10.1176/appi.ajp.2007.06111790; Park J, 2007, NUCLEIC ACIDS RES, V35, pD711, DOI 10.1093/nar/gkl962; Pavani A, 2012, PHARMACOGENOMICS J, V12, P306, DOI 10.1038/tpj.2011.4; Pickard BS, 2008, P NATL ACAD SCI USA, V105, P14940, DOI 10.1073/pnas.0800643105; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; STRAUSS SH, 1993, THEOR APPL GENET, V86, P605, DOI 10.1007/BF00838716; Takahashi H, 2003, CLIN PHARMACOL THER, V73, P253, DOI 10.1067/mcp.2003.26a; Takahashi-Yanaga F, 2007, J PHARMACOL SCI, V104, P293, DOI 10.1254/jphs.CR0070024; Teichert M, 2011, PHARMACOGENET GENOM, V21, P26, DOI 10.1097/FPC.0b013e32834154fb; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wright S., 1978, EVOLUTION GENETICS P; Wu DD, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-16	45	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119994	10.1371/journal.pone.0119994	http://dx.doi.org/10.1371/journal.pone.0119994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807276	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000055
J	Erdembileg, A; Mirsoian, A; Enkhmaa, B; Zhang, W; Beckett, LA; Murphy, WJ; Berglund, LF				Erdembileg, Anuurad; Mirsoian, Annie; Enkhmaa, Byambaa; Zhang, Wei; Beckett, Laurel A.; Murphy, William J.; Berglund, Lars F.			Attenuated Age-Impact on Systemic Inflammatory Markers in the Presence of a Metabolic Burden	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; BODY-COMPOSITION; RISK-FACTORS; CHOLESTEROL; DIAGNOSIS; ATHEROSCLEROSIS; AMERICAN; PLASMA	Background The overall burden of chronic disease, inflammation and cardiovascular risk increases with age. Whether the relationship between age and inflammation is impacted by presence of an adverse metabolic burden is not known. Methods We determined inflammatory markers in humans (336 Caucasians and 224 African Americans) and in mice, representing a spectrum of age, weight and metabolic burden. Results In humans, levels of inflammatory markers increased significantly with age in subjects without the metabolic syndrome, (P=0.009 and P=0.037 for C-reactive protein, P<0.001 and P=0.001 for fibrinogen, P<0.001 and P=0.005 for serum amyloid-A, for Caucasians and African Americans, respectively). In contrast, trend patterns of inflammatory markers did not change significantly with age in subjects with metabolic syndrome in either ethnic group, except for fibrinogen in Caucasians. A composite z-score for systemic inflammation increased significantly with age in subjects without metabolic syndrome (P=0.004 and P<0.006 for Caucasians and African Americans, respectively) but not in subjects with metabolic syndrome (P=0.009 for difference in age trend between metabolic syndrome and non-metabolic syndrome). In contrast, no similar age trend was found in vascular inflammation. The findings in humans were paralleled by results in mice as serum amyloid-A levels increased across age (range 2-15 months, P<0.01) and were higher in ob/ob mice compared to control mice (P<0.001). Conclusions Presence of a metabolic challenge in mice and humans influences levels of inflammatory markers over a wide age range. Our results underscore that already at a young age, presence of a metabolic burden enhances inflammation to a level that appears to be similar to that of decades older people without metabolic syndrome.	[Erdembileg, Anuurad; Enkhmaa, Byambaa; Zhang, Wei; Murphy, William J.; Berglund, Lars F.] Univ Calif Davis, Dept Med, Davis, CA 95616 USA; [Mirsoian, Annie; Murphy, William J.] Univ Calif Davis, Dept Dermatol, Davis, CA 95616 USA; [Beckett, Laurel A.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Berglund, Lars F.] VA Northern Calif Hlth Care Syst, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Berglund, LF (corresponding author), Univ Calif Davis, Dept Med, Davis, CA 95616 USA.	lars.berglund@ucdmc.ucdavis.edu		Berglund, Lars/0000-0001-6705-1791	National Institutes of Health [HL62705, TR000002, CA095572, RR024144, 2K12HD051958]; American Heart Association [14CRP17930014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095572] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000002] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024144] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health HL62705, TR000002, CA095572, RR024144, 2K12HD051958; and American Heart Association 14CRP17930014. The sponsors provided funding in response to grant applications but had no role in design of the study, data collection or manuscript preparation.	Adler AI, 2005, DIABETIC MED, V22, P306, DOI 10.1111/j.1464-5491.2004.01418.x; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Anuurad E, 2006, J LIPID RES, V47, P2475, DOI 10.1194/jlr.M600288-JLR200; Anuurad E, 2011, ARTERIOSCL THROM VAS, V31, P2151, DOI 10.1161/ATVBAHA.111.232348; Anuurad E, 2010, J CLIN ENDOCR METAB, V95, P2376, DOI 10.1210/jc.2009-2498; Anuurad E, 2009, ATHEROSCLEROSIS, V205, P290, DOI 10.1016/j.atherosclerosis.2008.11.028; Beckett N, 2000, CARDIOVASC DRUG THER, V14, P397, DOI 10.1023/A:1007812232328; BORKAN GA, 1985, AM J PHYS ANTHROPOL, V66, P289, DOI 10.1002/ajpa.1330660306; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dada Nisha, 2002, Expert Rev Mol Diagn, V2, P17; Enkhmaa B, 2011, TRANSL RES, V158, P92, DOI 10.1016/j.trsl.2011.01.004; Ervin R. B., 2009, NATL HLTH STAT REPOR, P1; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; Giunta Sergio, 2006, Immun Ageing, V3, P12, DOI 10.1186/1742-4933-3-12; Goodpaster BH, 1985, J APPL PHYSIOL, V89, P104; Grundy SM, 2006, AM J CLIN NUTR, V83, P1248, DOI 10.1093/ajcn/83.6.1248; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P1586, DOI 10.1161/01.ATV.0000222983.73369.c8; Kosaka T, 2000, CLIN CHIM ACTA, V296, P151, DOI 10.1016/S0009-8981(00)00216-3; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Macy EM, 1997, CLIN CHEM, V43, P52; MCGOWAN MW, 1983, CLIN CHEM, V29, P538; Mendall MA, 1997, HEART, V78, P273, DOI 10.1136/hrt.78.3.273; Miller AM, 2011, CURR PHARM DESIGN, V17, P1; MILLER M, 1990, AM J CARDIOL, V65, P1, DOI 10.1016/0002-9149(90)90017-U; Paultre F, 2000, ARTERIOSCL THROM VAS, V20, P2619, DOI 10.1161/01.ATV.20.12.2619; Reaven GM, 2006, AM J CLIN NUTR, V83, P1237, DOI 10.1093/ajcn/83.6.1237; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; WARNICK GR, 1982, CLIN CHEM, V28, P1379	40	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121947	10.1371/journal.pone.0121947	http://dx.doi.org/10.1371/journal.pone.0121947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815855	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600130
J	Gaskin, PS; Hall, RV; Chami, P; St John, MA; Gaskin, DA; Molaodi, OR; Harding, S				Gaskin, Pamela S.; Hall, Ryan V.; Chami, Peter; St John, Margaret A.; Gaskin, David A.; Molaodi, Oarabile R.; Harding, Seeromanie			Associations of Blood Pressure with Body Composition among Afro-Caribbean Children in Barbados	PLOS ONE			English	Article							ETHNICALLY DIVERSE SAMPLE; MASS INDEX; RISK-FACTORS; UK CHILDREN; OBESITY; ADOLESCENTS; AFRICAN; HYPERTENSION; PREVALENCE; OVERWEIGHT	Despite complex presentation of adult hypertension and a concomitant obesity epidemic, little is known about overweight in relation to blood pressure among Caribbean children. We examined blood pressure in relation to body size in a cross-sectional study of 573 Barbadian children aged 9-10 years (2010-2011). The United States normative blood pressure percentiles were used to identify children with high (>= 95th percentile) or high normal blood pressure (90th - 95th percentile). The World Health Organization body mass index cut-off points were used to assess weight status. Major findings Thirty percent of children were overweight/obese. Percentage fat mass differed between girls (20.4%) and boys (17.72%) (p<0.05). Mean systolic blood pressure among girls was 106.11 (95% CI 105.05, 107.17) mmHg and 105.23 (104.09, 106.38) for boys. The percentages with high or high-normal mean systolic blood pressurewere14.38% (10.47, 18.29) for girls and 8.08% (4.74, 11.41) for boys. Height and body mass index were independent correlates of systolic and diastolic blood pressure. Mean systolic blood pressure was related to lean mass but not fat mass, while diastolic blood pressure was associated with fat mass index and overweight. Principal conclusion One third of 9-10 year old children in Barbados were overweight/obese and 12% had elevated mean systolic blood pressure. BP was related to body size. These findings signal potential adverse trends in weight gain and BP trends for children growing up in the context of a country that has recently undergone rapid economic transition.	[Gaskin, Pamela S.; Hall, Ryan V.; St John, Margaret A.; Gaskin, David A.] Univ W Indies, Fac Med Sci, Cave Hill, Barbados; [Chami, Peter] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Chami, Peter] Univ W Indies, Fac Pure & Appl Sci, Cave Hill, Barbados; [Molaodi, Oarabile R.; Harding, Seeromanie] Univ Glasgow, CSO MRC Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University West Indies Mona Jamaica; University West Indies Cave Hill Campus; Brown University; University West Indies Mona Jamaica; University West Indies Cave Hill Campus; University of Glasgow	Gaskin, PS (corresponding author), Univ W Indies, Fac Med Sci, Cave Hill, Barbados.	pamela.gaskin@cavehill.uwi.edu		Harding, Seeromanie/0000-0003-1964-6656	Department of Graduate Studies, University of the West Indies; Arnot Cato Foundation, Barbados; Medical Research Council [MC_U130015185, MC_EX_G0701943, MC_UU_12017/1] Funding Source: researchfish; MRC [MC_UU_12017/1, MC_U130015185, MC_EX_G0701943] Funding Source: UKRI	Department of Graduate Studies, University of the West Indies; Arnot Cato Foundation, Barbados; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been partially supported by The Department of Graduate Studies, University of the West Indies and The Arnot Cato Foundation, Barbados.	Agyemang C, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-19; [Anonymous], 2012, HUM DEV CHALL GLOB C; Beadnell B, 2007, J ADOLESCENT HEALTH, V41, P317, DOI 10.1016/j.jadohealth.2007.07.008; Brion MA, 2007, J HUM HYPERTENS, V21, P283, DOI 10.1038/sj.jhh.1002152; Central Intelligence Agency, 2012, CIA WORLD FACT BOOK; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chirinos JA, 2009, ARCH INTERN MED, V169, P580, DOI 10.1001/archinternmed.2008.611; Clasey JL, 2011, OBESITY, V19, P1813, DOI 10.1038/oby.2011.158; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Cooper RS, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-2; Daniels SR, 1997, PEDIATRICS, V99, P804, DOI 10.1542/peds.99.6.804; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; Dubois L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-199; Gaskin PS, 2008, PUBLIC HEALTH NUTR, V11, P41, DOI 10.1017/S1368980007000195; Gaskin PS, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/242875; Harding S, 2008, INT J OBESITY, V32, P82, DOI 10.1038/sj.ijo.0803662; Harding S, 2006, J HYPERTENS, V24, P1507, DOI 10.1097/01.hjh.0000239285.20315.4d; Harding S, 2010, HYPERTENSION, V55, P1063, DOI 10.1161/HYPERTENSIONAHA.109.142935; Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003; Landsberg L, 2013, OBESITY, V21, P8, DOI 10.1002/oby.20181; Largo-Wight E, 2013, J ENVIRON HEALTH, V76, P26; Lau JT, 2014, INT J BEHAV MED; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lum S, ACTA PAEDIA IN PRESS; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nelson DA, 1997, AM J PHYS ANTHROPOL, V103, P157, DOI 10.1002/(SICI)1096-8644(199706)103:2<157::AID-AJPA2>3.0.CO;2-R; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Ostchega Y, 2009, AM J HYPERTENS, V22, P59, DOI 10.1038/ajh.2008.312; Owen CG, 2010, DIABETOLOGIA, V53, P1620, DOI 10.1007/s00125-010-1781-1; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Perry HM, 2000, AM J HYPERTENS, V13, P724, DOI 10.1016/S0895-7061(99)00214-9; Rosner B, 2013, HYPERTENSION, V62, P247, DOI 10.1161/HYPERTENSIONAHA.111.00831; Russell-Brown P, 1997, CHILD SHIFTING SURVI, P326; Stuart S, 1996, Gend Dev, V4, P28, DOI 10.1080/741922017; Terres NG, 2006, REV SAUDE PUBL, V40, P627, DOI 10.1590/S0034-89102006000500011; Thomas C, 2012, J HYPERTENS, V30, P2090, DOI 10.1097/HJH.0b013e32835837c9; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Wilks RJ, 1999, W INDIAN MED J, V48, P61	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121107	10.1371/journal.pone.0121107	http://dx.doi.org/10.1371/journal.pone.0121107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815726	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600065
J	Cividini, F; Tozzi, MG; Galli, A; Pesi, R; Camici, M; Dumontet, C; Jordheim, LP; Allegrini, S				Cividini, Federico; Tozzi, Maria Grazia; Galli, Alvaro; Pesi, Rossana; Camici, Marcella; Dumontet, Charles; Jordheim, Lars Petter; Allegrini, Simone			Cytosolic 5 '-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf	PLOS ONE			English	Article							DEOXYCYTIDINE KINASE; SECRETION APPARATUS; EXPRESSION; CELLS; 5-NUCLEOTIDASE; ENZYME; INFLAMMASOME; RESISTANCE; NUCLEOSIDE; RECEPTORS	IMP/GMP preferring cytosolic 5'-nucleotidase II (cN-II) is a bifunctional enzyme whose activities and expression play crucial roles in nucleotide pool maintenance, nucleotide-dependent pathways and programmed cell death. Alignment of primary amino acid sequences of cN-II from human and other organisms show a strong conservation throughout the entire vertebrata taxon suggesting a fundamental role in eukaryotic cells. With the aim to investigate the potential role of this homology in protein-protein interactions, a two hybrid system screening of cN-II interactors was performed in S. cerevisiae. Among the X positive hits, the Leucin Rich Repeat (LRR) domain of Ipaf was found to interact with cN-II. Recombinant Ipaf isoform B (lacking the Nucleotide Binding Domain) was used in an in vitro affinity chromatography assay confirming the interaction obtained in the screening. Moreover, co-immunoprecipitation with proteins from wild type Human Embryonic Kidney 293 T cells demonstrated that endogenous cN-II co-immunoprecipitated both with wild type Ipaf and its LRR domain after transfection with corresponding expression vectors, but not with Ipaf lacking the LRR domain. These results suggest that the interaction takes place through the LRR domain of Ipaf. In addition, a proximity ligation assay was performed in A549 lung carcinoma cells and in MDA-MB-231 breast cancer cells and showed a positive cytosolic signal, confirming that this interaction occurs in human cells. This is the first report of a protein-protein interaction involving cN-II, suggesting either novel functions or an additional level of regulation of this complex enzyme.	[Cividini, Federico; Tozzi, Maria Grazia; Pesi, Rossana; Camici, Marcella] Univ Pisa, Dept Biol, Biochem Unit, Pisa, Italy; [Galli, Alvaro] Natl Res Counsil CNR, Inst Clin Physiol, Pisa, Italy; [Allegrini, Simone] Univ Sassari, Dept Chem & Pharmacol, I-07100 Sassari, Italy; [Dumontet, Charles; Jordheim, Lars Petter] Univ Lyon, Lyon, France; [Dumontet, Charles; Jordheim, Lars Petter] Univ Lyon 1, F-69365 Lyon, France; [Dumontet, Charles; Jordheim, Lars Petter] INSERM, U1052, Ctr Rech Cancerol Lyon, F-69008 Lyon, France; [Dumontet, Charles; Jordheim, Lars Petter] CNRS, UMR 5286, Ctr Rech Cancerol Lyon, Lyon, France	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Sassari; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard	Cividini, F (corresponding author), Univ Pisa, Dept Biol, Biochem Unit, Pisa, Italy.	f.cividini@gmail.com	Allegrini, Simone/F-9192-2010; Jordheim, Lars Petter/X-7228-2019; Pesi, Rossana/AAQ-3102-2020; Galli, Alvaro/K-3146-2018; Galli, Alvaro/AAL-7247-2020	Allegrini, Simone/0000-0002-7005-654X; Jordheim, Lars Petter/0000-0003-3948-7090; Galli, Alvaro/0000-0002-9091-5639; Dumontet, Charles/0000-0003-1875-134X; Cividini, Federico/0000-0001-6312-6514; Pesi, Rossana/0000-0003-4785-7282	ANR [11-BS07-032-01]; REGIONE AUTONOMA DELLA SARDEGNA, L. R. [07/08/2007, CRP 3360]	ANR(French National Research Agency (ANR)); REGIONE AUTONOMA DELLA SARDEGNA, L. R.(Regione Sardegna)	CD's laboratory receives funding through ANR grant 11-BS07-032-01 "cN-II Focus". MGT's laboratory was financially supported by a grant from the REGIONE AUTONOMA DELLA SARDEGNA, L. R. 07/08/2007, CRP 3360 (TITLE: Modulation of expression by inducible silencing; heterologous expression in S. cerevisiae; two-hybrid system. Three models to make clear the physiological role of cytosolic 5' nucleotidase II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz DH, 2010, INT J BIOCHEM CELL B, V42, P789, DOI 10.1016/j.biocel.2010.01.003; Allegrin S, 2001, J BIOL CHEM, V276, P33526, DOI 10.1074/jbc.M104088200; Allegrini S, 2004, EUR J BIOCHEM, V271, P4881, DOI 10.1111/j.1432-1033.2004.04457.x; Allegrini S, 1997, BIOCHEM J, V328, P483, DOI 10.1042/bj3280483; Allegrini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063914; Bretonnet AS, 2005, FEBS LETT, V579, P3363, DOI 10.1016/j.febslet.2005.05.014; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Careddu MG, 2008, BBA-MOL CELL RES, V1783, P1529, DOI 10.1016/j.bbamcr.2008.03.018; Damiano JS, 2004, J IMMUNOL, V173, P6338, DOI 10.4049/jimmunol.173.10.6338; Galmarini CM, 2007, LEUKEMIA RES, V31, P1325, DOI 10.1016/j.leukres.2007.02.006; Galmarini CM, 2003, BRIT J HAEMATOL, V122, P53, DOI 10.1046/j.1365-2141.2003.04386.x; Gazziola C, 1999, EXP CELL RES, V253, P474, DOI 10.1006/excr.1999.4681; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gray T, 2006, CANCER CHEMOTH PHARM, V58, P117, DOI 10.1007/s00280-005-0156-7; Guibinga GH, 2012, HUM MOL GENET, V21, P609, DOI 10.1093/hmg/ddr495; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Ipata PL, 2013, CURR MED CHEM, V20, P4205; ITOH R, 1981, BIOCHIM BIOPHYS ACTA, V657, P402, DOI 10.1016/0005-2744(81)90326-0; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; Jordheim LP, 2005, MOL CANCER THER, V4, P1268, DOI 10.1158/1535-7163.MCT-05-0121; Kang TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074967; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; KAWASAKI H, 1993, BLOOD, V81, P597; Kumar Y, 2008, ATLAS GENET CYTOGENE, V12, P56; Kumar Y, 2010, BIOCHEM J, V427, P91, DOI 10.1042/BJ20091349; Mastrangelo L, 2012, P NATL ACAD SCI USA, V109, P3377, DOI 10.1073/pnas.1118067109; Meyer JA, 2013, NAT GENET, V45, P290, DOI 10.1038/ng.2558; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; PESI R, 1994, ARCH BIOCHEM BIOPHYS, V312, P75, DOI 10.1006/abbi.1994.1282; Pesi R, 2000, NEUROREPORT, V11, P1827, DOI 10.1097/00001756-200006260-00006; Pesi R, 2010, FEBS J, V277, P4863, DOI 10.1111/j.1742-4658.2010.07891.x; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Rampazzo C, 1999, EUR J BIOCHEM, V261, P689, DOI 10.1046/j.1432-1327.1999.00320.x; Randitelli S, 1996, INT J BIOCHEM CELL B, V28, P711, DOI 10.1016/1357-2725(95)00171-9; Sadasivam S, 2005, ONCOGENE, V24, P627, DOI 10.1038/sj.onc.1208201; Sambrook J., 2001, MOL CLONING LAB MANU; Seve P, 2005, LUNG CANCER, V49, P363, DOI 10.1016/j.lungcan.2005.04.008; Spychala J, 1999, EUR J BIOCHEM, V259, P851, DOI 10.1046/j.1432-1327.1999.00099.x; SPYCHALA J, 1988, J BIOL CHEM, V263, P18759; Sutterwala FS, 2009, CLIN IMMUNOL, V130, P2, DOI 10.1016/j.clim.2008.08.011; Suzuki K, 2007, LEUKEMIA RES, V31, P1343, DOI 10.1016/j.leukres.2007.01.018; Tozzi MG, 2013, CURR MED CHEM, V20, P4285; TOZZI MG, 1991, ARCH BIOCHEM BIOPHYS, V291, P212, DOI 10.1016/0003-9861(91)90125-3; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Williams A, 2010, CURR OPIN IMMUNOL, V22, P34, DOI 10.1016/j.coi.2010.01.004; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	49	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121525	10.1371/journal.pone.0121525	http://dx.doi.org/10.1371/journal.pone.0121525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811392	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700109
J	Fukuhara, T				Fukuhara, Toru			Geographical Analysis of Aneurysmal Subarachnoid Hemorrhage in Japan Utilizing Publically-Accessible DPC Database	PLOS ONE			English	Article							TRENDS; HOSPITALIZATION; PREVALENCE; LENGTH; SYSTEM; CARE	Since the launch of the novel medical reimbursement system Diagnosis Procedure Combination (DPC) in 2003 in Japan, inpatient data has been accumulated over time as part of a Japanese governmental nationwide database. This is partially accessible by the public, and this study examined the adequacy of this database as epidemiological research material by extracting the data relating to aneurysmal subarachnoid hemorrhage (aSAH) with special attention given to the limitations that this involves. Datasets after 2010 are considered suitable for analysis because of the numbers of participating hospitals and the analysis term. Extracting the data by prefecture, those with a continuously high aSAH incidence were Aomori, Iwate, Akita, Yamagata, Kochi and Kumamoto Prefectures, and those with low aSAH incidence were Kanagawa, Shiga, Kyoto, Shimane and Ehime Prefectures. Although these obtained results are informative, a publically-accessible DPC database has several limitations. Some limitations have been resolved: the analyzed term each year is now 12-months and the number of participating hospitals seems to have stabilized around 1700. However, other limitations such as masking the numbers in each hospital reporting less than 10 patients still exist, so careful and critical interpretation is necessary in utilizing a publically-accessible DPC database. Considering the potential of this database as material for epidemiological research, future analysis of the entire DPC database by qualified researchers is desirable.	Natl Hosp Org Okayama Med Ctr, Dept Neurol Surg, Okayama, Japan		Fukuhara, T (corresponding author), Natl Hosp Org Okayama Med Ctr, Dept Neurol Surg, Okayama, Japan.	torufk@ninus.ocn.ne.jp						Adler-Milstein J, 2012, JAMA-J AM MED ASSOC, V307, P1695, DOI 10.1001/jama.2012.525; Bhat Abdul Rashid, 2011, Asian J Neurosurg, V6, P57, DOI 10.4103/1793-5482.92159; Currie J, 2013, PEDIATRICS, V131, pS127, DOI 10.1542/peds.2013-0252c; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Fargen KM, 2013, J NEUROSURG, V119, P966, DOI 10.3171/2013.5.JNS122378; Hamada J, 2004, NEUROSURGERY, V54, P31, DOI 10.1227/01.NEU.0000097196.55204.0B; Inagawa T, 2001, STROKE, V32, P1499, DOI 10.1161/01.STR.32.7.1499; Japanese Ministry of Health Labor and Welfare, 2014, 274 ANN C CENTR SOC; Japanese Ministry of Health Labor and Welfare, 2005, DPC C; Japanese Statistics Bureau Ministry of Internal Affairs and Communications, 2011, POP CENS; Kawai K, 2001, NEUROL MED-CHIR, V41, P229, DOI 10.2176/nmc.41.229; Kondo A, 2012, HEALTH POLICY, V107, P184, DOI 10.1016/j.healthpol.2012.08.010; Kubo Tatsuhiko, 2011, Sangyo Eiseigaku Zasshi, V53, P140; Kubo T, 2011, INTERNAL MED, V50, P405, DOI 10.2169/internalmedicine.50.4268; Kurki MI, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004134; Matsuda Shinya, 2004, Gan To Kagaku Ryoho, V31, P1152; Murata Atsuhiko, 2013, Keio Journal of Medicine, V62, P83, DOI 10.2302/kjm.2012-0015-OA; Nakamura Kenji, 2004, Rinsho Byori, V52, P906; Ohkuma H, 2002, STROKE, V33, P195, DOI 10.1161/hs0102.101891; Okamura S, 2005, HEALTH POLICY, V74, P282, DOI 10.1016/j.healthpol.2005.01.009; Ola O, 2014, OJPHI, V5, pe223; Sakai Homare, 2013, Journal of UOEH, V35, P39; Shivaraju A, 2011, AM HEART J, V162, P1062, DOI 10.1016/j.ahj.2011.09.009; Tateno T, 2009, JPN CANC CHEMOTHER, V36, P1703; Umemura K, 2008, NEUROL MED-CHIR, V48, P101, DOI 10.2176/nmc.48.101	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122467	10.1371/journal.pone.0122467	http://dx.doi.org/10.1371/journal.pone.0122467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811480	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700191
J	Korshoj, M; Lidegaard, M; Kittel, F; Van Herck, K; De Backer, G; De Bacquer, D; Holtermann, A; Clays, E				Korshoj, Mette; Lidegaard, Mark; Kittel, France; Van Herck, Koen; De Backer, Guy; De Bacquer, Dirk; Holtermann, Andreas; Clays, Els			The Relation of Ambulatory Heart Rate with All-Cause Mortality among Middle-Aged Men: A Prospective Cohort Study	PLOS ONE			English	Article							INDEPENDENT RISK-FACTOR; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; PREDICTIVE-VALUE; HEALTHY-MEN; FITNESS; WOMEN; ASSOCIATION; POPULATIONS; MARKERS	The aim of this study was to investigate the association between average 24-hour ambulatory heart rate and all-cause mortality, while adjusting for resting clinical heart rate, cardiorespiratory fitness, occupational and leisure time physical activity as well as classical risk factors. A group of 439 middle-aged male workers free of baseline coronary heart disease from the Belgian Physical Fitness Study was included in the analysis. Data were collected by questionnaires and clinical examinations from 1976 to 1978. All-cause mortality was collected from the national mortality registration with a mean follow-up period of 16.5 years, with a total of 48 events. After adjustment for all before mentioned confounders in a Cox proportional hazards regression analysis, a significant increased risk for all-cause mortality was found among the tertile of workers with highest average ambulatory heart rate compared to the tertile with lowest ambulatory heart rate (Hazard ratio = 3.21, 95% confidence interval: 1.22-8.44). No significant independent association was found between resting clinic heart rate and all-cause mortality. The study indicates that average 24-hour ambulatory heart rate is a strong predictor of all-cause mortality independent from resting clinic heart rate, cardiorespiratory fitness, occupational and leisure time physical activity and other classical risk factors among healthy middle-aged workers.	[Korshoj, Mette; Lidegaard, Mark; Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Kittel, France] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Van Herck, Koen; De Backer, Guy; De Bacquer, Dirk; Clays, Els] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	National Research Centre for the Working Environment; Universite Libre de Bruxelles; Ghent University	Clays, E (corresponding author), Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium.	els.clays@UGent.be	Van Herck, Koen/L-2549-2019; De Backer, Guy/AAI-4607-2021; Van Herck, Koen/G-5223-2013; De Bacquer, Dirk/HGU-3191-2022	Van Herck, Koen/0000-0003-0717-2406; Van Herck, Koen/0000-0003-0717-2406; De Bacquer, Dirk/0000-0002-3202-7238; Clays, Els/0000-0002-1092-945X	federal public service Health, Food Chain Safety and Environment; Ghent University; Universite Libre de Bruxelles	federal public service Health, Food Chain Safety and Environment; Ghent University(Ghent University); Universite Libre de Bruxelles	The original Belgian Physical Fitness Study was supported by the Belgium Ministry of Public Health (currently the federal public service Health, Food Chain Safety and Environment) and by internal grants from Ghent University and the Universite Libre de Bruxelles. For the analysis in the current paper, no additional funding was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Dov IZ, 2007, ARCH INTERN MED, V167, P2116, DOI 10.1001/archinte.167.19.2116; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Clays E, 2014, AM J EPIDEMIOL, V179, P559, DOI 10.1093/aje/kwt294; Cooney MT, 2010, AM HEART J, V159, P612, DOI 10.1016/j.ahj.2009.12.029; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greenland P, 1999, AM J EPIDEMIOL, V149, P853; Hansen TW, 2008, HYPERTENSION, V52, P229, DOI 10.1161/HYPERTENSIONAHA.108.113191; Hansen TW, 2007, J HYPERTENS, V25, P1554, DOI 10.1097/HJH.0b013e3281c49da5; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Holtermann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054548; Hozawa A, 2008, J HYPERTENS, V26, P1571, DOI 10.1097/HJH.0b013e3283041172; Imai Y, 2003, BLOOD PRESS MONIT, V8, P53, DOI 10.1097/00126097-200302000-00011; Jensen MT, 2012, EUR J PREV CARDIOL, V19, P102, DOI 10.1177/1741826710394274; Jensen MT, 2013, HEART, V99, P882, DOI 10.1136/heartjnl-2012-303375; Johansen CD, 2013, EUR HEART J, V34, P1732, DOI 10.1093/eurheartj/ehs449; Jouven X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021310; KANNEL WB, 1986, AM HEART J, V112, P820, DOI 10.1016/0002-8703(86)90480-1; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kittel F., 2003, Archives of Public Health, V61, P3; PAFFENBA.RS, 1970, NEW ENGL J MED, V282, P1109, DOI 10.1056/NEJM197005142822001; Palatini P, 2002, ARCH INTERN MED, V162, P2313, DOI 10.1001/archinte.162.20.2313; Palatini P, 2000, AM J HYPERTENS, V13, P92, DOI 10.1016/S0895-7061(99)00170-3; Palatini P, 2007, DRUGS, V67, P3, DOI 10.2165/00003495-200767002-00002; SOBOLSKI J, 1981, CARDIOLOGY, V67, P38, DOI 10.1159/000173227; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9	28	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121729	10.1371/journal.pone.0121729	http://dx.doi.org/10.1371/journal.pone.0121729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811891	Green Published, gold			2022-12-26	WOS:000356353700132
J	Ma, C; Spies, NP; Gong, T; Jones, CX; Chu, WM				Ma, Chi; Spies, Narrissa P.; Gong, Ting; Jones, Can Xin; Chu, Wen-Ming			Involvement of DNA-PKcs in the Type I IFN Response to CpG-ODNs in Conventional Dendritic Cells in TLR9-Dependent or -Independent Manners	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; DEPENDENT PROTEIN-KINASE; INTERFERON; ACTIVATION; OLIGODEOXYNUCLEOTIDES; MACROPHAGES; INDUCTION; PATHWAY; ALPHA; TLR9	CpG-ODNs activate dendritic cells (DCs) to produce interferon alpha (IFN alpha) and beta (IFN beta). Previous studies demonstrated that Toll-like receptor 9 (TLR9) deficient DCs exhibited a residual IFNa response to CpG-A, indicating that yet-unidentified molecules are also involved in induction of IFN alpha by CpG-A. Here, we report that the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) but not Ku70 deficient BMDCs showed defective IFN alpha and IFN beta responses to CpG-A or CpG-B. Loss of both DNA-PKcs and TLR9 further reduced the IFN alpha response to CpG-A. These DNA-PKcs and TLR9 effects were mediated by their downstream Akt/mTORC1 pathway and downstream events IRAK1 and IKK alpha. Loss of DNA-PKcs, TLR9, MyD88 or IRAK4 impaired phosphorylation of Akt(S473), S6K, S6, IRAK1, or IKK alpha in BMDCs in response to CpG-ODNs. The residual IFN alpha and IFN beta in DNA-PKcs-deficient BMDCs were partially responsible for the induction of IL-6 and IL-12 by CpG-ODNs and their stimulatory effect was blocked by IFNAR1 neutralizing antibodies. Further analysis indicated that CpG-ODN associated with DNA-PKcs and Ku70, and induced DNA-PKcs's interaction with TRAF3. Intriguingly, DNA-PKcs but not Ku70 expression level was reduced in TLR9-deficient BMDCs. Taken together, our data suggest that DNA-PKcs is an important mediator in the type I IFN response to CpG-ODNs in TLR9-dependent or -independent fashions.	[Ma, Chi; Spies, Narrissa P.; Gong, Ting; Jones, Can Xin; Chu, Wen-Ming] Univ Hawaii, Ctr Canc, Dept Canc Biol, Honolulu, HI 96813 USA	Cancer Research Center of Hawaii; University of Hawaii System	Chu, WM (corresponding author), Univ Hawaii, Ctr Canc, Dept Canc Biol, Honolulu, HI 96813 USA.	wchu@cc.hawaii.edu		Spies, Narrissa/0000-0002-4367-2099	NIH [R01AI54128]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054128] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the NIH (R01AI54128 to WMC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Jafri F, 2001, J IMMUNOL METHODS, V251, P53, DOI 10.1016/S0022-1759(01)00294-0; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Liu Z, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00306; Lye E, 2004, J BIOL CHEM, V279, P40653, DOI 10.1074/jbc.M402666200; Ma C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058072; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Sester DP, 2006, J IMMUNOL, V177, P4473, DOI 10.4049/jimmunol.177.7.4473; Smith GCM, 1999, BIOCHEM SOC SYMP, P91; Wang H, 2005, CURR PHARM DESIGN, V11, P2889, DOI 10.2174/1381612054546707; Wang ZW, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-10; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Yotsumoto S, 2008, J IMMUNOL, V180, P809, DOI 10.4049/jimmunol.180.2.809	24	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121371	10.1371/journal.pone.0121371	http://dx.doi.org/10.1371/journal.pone.0121371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812014	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700098
J	Ni, W; Chen, S; Qiao, K; Wang, N; Wu, ZY				Ni, Wang; Chen, Sheng; Qiao, Kai; Wang, Ning; Wu, Zhi-Ying			Genotype-Phenotype Correlation in Chinese Patients with Spinal and Bulbar Muscular Atrophy	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; CAG REPEAT LENGTH; ANDROGEN RECEPTOR; SPINOCEREBELLAR ATAXIA; CLINICAL-FEATURES; KENNEDY-DISEASE; SBMA; ONSET; EXPRESSION; DISORDERS	Spinal and bulbar muscular atrophy (SBMA) is an X-linked recessive motor neuron disease characterized by slowly progressive weakness and atrophy of proximal limbs and bulbar muscles. To assess the genotype-phenotype correlation in Chinese patients, we identified 155 patients with SBMA and retrospectively examined available data from laboratory tests and neurophysiological analyses. Correlations between genotype and phenotype were analyzed. There was an inverse correlation between the length of CAG repeats and age at first muscle weakness (p<0.0001). The serum creatine kinase level showed a significant inverse correlation with disease duration and the age at examination (p=0.019 and p=0.004, respectively). Unlike previous classification of motor-and sensory-dominant phenotypes, all findings of nerve conduction, except the amplitudes of median nerve compound motor action potential, were positively correlated to the length of CAG repeats. A significant decline in sensory nerve action potential amplitudes may assist differential diagnosis of SBMA.	[Ni, Wang; Chen, Sheng; Wang, Ning; Wu, Zhi-Ying] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China; [Ni, Wang; Chen, Sheng; Wang, Ning; Wu, Zhi-Ying] Fujian Med Univ, Affiliated Hosp 1, Inst Neurol, Fuzhou, Peoples R China; [Chen, Sheng; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Sheng; Wu, Zhi-Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Qiao, Kai; Wu, Zhi-Ying] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Qiao, Kai; Wu, Zhi-Ying] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China	Fujian Medical University; Fujian Medical University; Zhejiang University; Zhejiang University; Fudan University; Fudan University	Wu, ZY (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China.	zhiyingwu@zju.edu.cn		Chen, Sheng/0000-0002-7934-015X	National Natural Science Foundation (Beijing) [81125009]	National Natural Science Foundation (Beijing)(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation to WZY (81125009, Beijing), http://www.nsfc.gov.cn/. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Adachi H, 2005, BRAIN, V128, P659, DOI 10.1093/brain/awh381; Andrew SE, 1997, HUM MOL GENET, V6, P2005, DOI 10.1093/hmg/6.12.2005; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atsuta N, 2006, BRAIN, V129, P1446, DOI 10.1093/brain/awl096; Burgunder JM, 2011, EUR J NEUROL, V18, P207, DOI 10.1111/j.1468-1331.2010.03069.x; David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165; Dejager S, 2002, J CLIN ENDOCR METAB, V87, P3893, DOI 10.1210/jc.87.8.3893; DeStefano AL, 1996, AM J HUM GENET, V59, P119; Fu SC, 2013, J FORMOS MED ASSOC, V112, P326, DOI 10.1016/j.jfma.2012.03.008; Gan SR, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-47; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hama T, 2012, MUSCLE NERVE, V45, P169, DOI 10.1002/mus.22291; Hughes IA, 2006, BEST PRACT RES CL EN, V20, P577, DOI 10.1016/j.beem.2006.11.003; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Liveson JA, 1992, LAB REFERENCE CLIN N; Lu Ming, 2009, Zhonghua Nei Ke Za Zhi, V48, P284; Lund A, 2001, EUR J HUM GENET, V9, P431, DOI 10.1038/sj.ejhg.5200656; MACIEL P, 1995, AM J HUM GENET, V57, P54; Meinhardt U, 2002, SEMIN REPROD MED, V20, P277, DOI 10.1055/s-2002-35374; Parodi S, 2011, FRONT NEUROENDOCRIN, V32, P416, DOI 10.1016/j.yfrne.2011.06.003; Pulst SM, 2005, BRAIN, V128, P2297, DOI 10.1093/brain/awh586; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Rhodes LE, 2009, BRAIN, V132, P3242, DOI 10.1093/brain/awp258; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; Su SL, 2010, CLIN CHIM ACTA, V411, P626, DOI 10.1016/j.cca.2009.12.007; Suzuki K, 2008, BRAIN, V131, P229, DOI 10.1093/brain/awm289; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Tanaka F, 1996, HUM MOL GENET, V5, P1253, DOI 10.1093/hmg/5.9.1253	31	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122279	10.1371/journal.pone.0122279	http://dx.doi.org/10.1371/journal.pone.0122279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811990	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700178
J	Szermer-Olearnik, B; Boratynski, J				Szermer-Olearnik, Bozena; Boratynski, Janusz			Removal of Endotoxins from Bacteriophage Preparations by Extraction with Organic Solvents	PLOS ONE			English	Article							PHAGE THERAPY; PROTEIN SOLUTIONS; ADSORPTION; SEPARATION; BACTERIAL; AGENTS; SCALE; HOC	Lipopolysaccharide (LPS, endotoxin, pyrogen) constitutes a very troubling contaminant of crude phage lysates produced in Gram-negative bacteria. Toxicity of LPS depends on the strong innate immunity response including the cytokines. Therefore, its removal is important for bacteriophage applications. In this paper, we present a procedure for extractive removal of endotoxin from bacteriophage preparations with water immiscible solvents (1-octanol or 1-butanol). During extraction most of the phage lytic activity is retained in the aqueous phase, while endotoxin accumulates in the organic solvent. The levels of endotoxin (expressed as endotoxin units, EU) in the aqueous bacteriophage-containing fraction determined by limulus amebocyte lysate or EndoLISA assay were exceptionally low. While the initial endotoxin levels in the crude phage lysates ranged between 10(3) and 10(5) EU/ml the average level after organic extraction remaining in the aqueous fraction was 5.3 EU/ml. These values when related to phage titers decreased from 10(3)-10(5) EU/10(9) PFU (plaque forming units) down to an average of 2.8 EU/10(9) PFU. The purification procedure is scalable, efficient and applicable to all the bacteriophages tested: T4, HAP1 (E. coli) and F8 (P. aeruginosa).	[Szermer-Olearnik, Bozena; Boratynski, Janusz] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Biomed Chem Neolek, Wroclaw, Poland; [Boratynski, Janusz] Jan Dlugosz Univ, Dept Biomed Sci, Czestochowa, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Jan Dlugosz University	Boratynski, J (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Biomed Chem Neolek, Wroclaw, Poland.	borat@iitd.pan.wroc.pl		Szermer-Olearnik, Bozena/0000-0002-1451-4227; Boratynski, Janusz/0000-0001-5072-1162	National Centre for Research and Development (Poland) [13-0089-06]	National Centre for Research and Development (Poland)	This work was supported by The National Centre for Research and Development (Poland) grant No. 13-0089-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon Stephen T, 2011, Bacteriophage, V1, P66; ADAM O, 1995, ANAL BIOCHEM, V225, P321, DOI 10.1006/abio.1995.1161; Adams MH, 1959, BACTERIOPHAGES; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Antonino S, 2011, MICROB CELL FACT, V10, P57, DOI [10.1186/1475-2859-10-57, DOI 10.1186/1475-2859-10-57]; BAGGERMAN C, 1985, J PHARM PHARMACOL, V37, P521, DOI 10.1111/j.2042-7158.1985.tb03059.x; Boratynski J, 2004, CELL MOL BIOL LETT, V9, P253; Borysowski J, 2014, PHAGE THERAPY: CURRENT RESEARCH AND APPLICATIONS, P1; Bourdin G, 2014, APPL ENVIRON MICROB, V80, P1469, DOI 10.1128/AEM.03357-13; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Cooper CJ, 2014, LETT APPL MICROBIOL, V58, P118, DOI 10.1111/lam.12161; Dabrowska K, 2007, ARCH MICROBIOL, V187, P489, DOI 10.1007/s00203-007-0216-y; Daneshian M, 2006, J IMMUNOL METHODS, V313, P169, DOI 10.1016/j.jim.2006.04.009; DOFFERHOFF ASM, 1991, SCAND J INFECT DIS, V23, P745, DOI 10.3109/00365549109024303; Fiore GB, 2010, CONTRIB NEPHROL, V167, P55, DOI 10.1159/000315919; FISKE JM, 2001, J CHROMATOGR B, V753, P269; Gao JP, 2011, J ZHEJIANG UNIV-SC B, V12, P264, DOI [10.1631/jzus.B1000389, 10.1631/jzus.B1000303]; Garidel P, 2005, BBA-BIOMEMBRANES, V1715, P122, DOI 10.1016/j.bbamem.2005.07.013; Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063; Grallert H, 2011, NATURE METHODS, V8; Guo JS, 2012, MACROMOL BIOSCI, V12, P533, DOI 10.1002/mabi.201100394; Jang H, 2009, BMB REP, V42, P462, DOI 10.5483/BMBRep.2009.42.7.462; Liu CL, 1998, J CHROMATOGR B, V711, P127, DOI 10.1016/S0378-4347(98)00013-9; Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388; MARTICH GD, 1993, IMMUNOBIOLOGY, V187, P403, DOI 10.1016/S0171-2985(11)80353-0; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Miedzybrodzki R, 2012, ADV VIRUS RES, V83, P73, DOI 10.1016/B978-0-12-394438-2.00003-7; Moldovan R, 2007, BIOPHYS J, V93, P303, DOI 10.1529/biophysj.106.102962; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; MORRISON DC, 1975, J BIOL CHEM, V250, P2911; Paul VD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-195; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Petsch D, 1998, J MOL RECOGNIT, V11, P222, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<222::AID-JMR427>3.0.CO;2-O; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Robertson K, 2012, BIOCHEM BIOPH RES CO, V418, P537, DOI 10.1016/j.bbrc.2012.01.061; Rusiecka-Ziolkowska Jolanta, 2008, Pol Merkur Lekarski, V25, P260; Sato T, 2003, THER APHER DIAL, V7, P252, DOI 10.1046/j.1526-0968.2003.00006.x; Skurnik M, 2006, INT J MED MICROBIOL, V296, P5, DOI 10.1016/j.ijmm.2005.09.002; Szermer-Olearnik B, 2014, POSTEP HIG MED DOSW, V68, P1392, DOI 10.5604/17322693.1130086; Thiel K, 2004, NAT BIOTECHNOL, V22, P31, DOI 10.1038/nbt0104-31; TOMINAGA A, 1986, VIROLOGY, V155, P284, DOI 10.1016/0042-6822(86)90190-X; WESTPHAL O, 1952, Z NATURFORSCH B, V7, P148, DOI 10.1515/znb-1952-0303	42	60	63	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122672	10.1371/journal.pone.0122672	http://dx.doi.org/10.1371/journal.pone.0122672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811193	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700198
J	Twomey, MC; Wolfenbarger, SN; Woods, JL; Gent, DH				Twomey, Megan C.; Wolfenbarger, Sierra N.; Woods, Joanna L.; Gent, David H.			Development of Partial Ontogenic Resistance to Powdery Mildew in Hop Cones and Its Management Implications	PLOS ONE			English	Article							UNCINULA-NECATOR; GRAPE BERRIES; DOWNY MILDEW; INFECTION; SEVERITY; GROWTH; LEAVES	Knowledge of processes leading to crop damage is central to devising rational approaches to disease management. Multiple experiments established that infection of hop cones by Podosphaera macularis was most severe if inoculation occurred within 15 to 21 days after bloom. This period of infection was associated with the most pronounced reductions in alpha acids, cone color, and accelerated maturation of cones. Susceptibility of cones to powdery mildew decreased progressively after the transition from bloom to cone development, although complete immunity to the disease failed to develop. Maturation of cone tissues was associated with multiple significant affects on the pathogen manifested as reduced germination of conidia, diminished frequency of penetration of bracts, lengthening of the latent period, and decreased sporulation. Cones challenged with P. macularis in juvenile developmental stages also led to greater frequency of colonization by a complex of saprophytic, secondary fungi. Since no developmental stage of cones was immune to powdery mildew, the incidence of powdery mildew continued to increase over time and exceeded 86% by late summer. In field experiments with a moderately susceptible cultivar, the incidence of cones with powdery mildew was statistically similar when fungicide applications were made season-long or targeted only to the juvenile stages of cone development. These studies establish that partial ontogenic resistance develops in hop cones and may influence multiple phases of the infection process and pathogen reproduction. The results further reinforce the concept that the efficacy of a fungicide program may depend largely on timing of a small number of sprays during a relatively brief period of cone development. However in practice, targeting fungicide and other management tactics to periods of enhanced juvenile susceptibility may be complicated by a high degree of asynchrony in cone development and other factors that are situation-dependent.	[Twomey, Megan C.; Wolfenbarger, Sierra N.; Woods, Joanna L.; Gent, David H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Gent, David H.] USDA ARS, Forage Seed & Cereal Res Unit, Corvallis, OR USA	Oregon State University; United States Department of Agriculture (USDA)	Gent, DH (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	gentd@onid.orst.edu			US Department of Agriculture Agricultural Research Service Current Research Information System project [5358-21000-035-00]; Hop Research Council; US Department of Agriculture Specialty Crops Research Initiative [SC-2097531]	US Department of Agriculture Agricultural Research Service Current Research Information System project(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Hop Research Council; US Department of Agriculture Specialty Crops Research Initiative	Financial support was provided by US Department of Agriculture Agricultural Research Service Current Research Information System project 5358-21000-035-00, Hop Research Council (http://www.hopresearchcouncil.org/), and US Department of Agriculture Specialty Crops Research Initiative project number SC-2097531 (http://www.nifa.usda.gov/fo/specialtycropresearchinitiative.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Brewing Chemists, ASBC METH AN; Asalf B, 2014, PHYTOPATHOLOGY, V104, P954, DOI 10.1094/PHYTO-12-13-0345-R; BOOTE KJ, 1983, PHYTOPATHOLOGY, V73, P1581, DOI 10.1094/Phyto-73-1581; Brunner E, 2002, NONPARAMETRIC ANAL L; Burgess AH, 1964, HOPS BOT CULTIVATION; Carisse O, 2010, CROP PROT, V29, P969, DOI 10.1016/j.cropro.2010.03.008; Coley-Smith JR, 1963, HOP DOWNY MILDEW MIS, P30; Cooley DR, 1996, PLANT DIS, V80, P228, DOI 10.1094/PD-80-0228; DARBY P, 1988, T BRIT MYCOL SOC, V90, P650, DOI 10.1016/S0007-1536(88)80073-1; Develey-Riviere MP, 2007, NEW PHYTOL, V175, P405, DOI 10.1111/j.1469-8137.2007.02130.x; Esker P. D., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127052; Ficke A, 2003, PHYTOPATHOLOGY, V93, P556, DOI 10.1094/PHYTO.2003.93.5.556; Ficke A, 2002, PHYTOPATHOLOGY, V92, P671, DOI 10.1094/PHYTO.2002.92.6.671; Gadoury DM, 2007, PHYTOPATHOLOGY, V97, P1356, DOI 10.1094/PHYTO-97-10-1356; Gadoury DM, 2003, PHYTOPATHOLOGY, V93, P547, DOI 10.1094/PHYTO.2003.93.5.547; GAUNT RE, 1995, ANNU REV PHYTOPATHOL, V33, P119, DOI 10.1146/annurev.py.33.090195.001003; Gent DH, 2014, PLANT PATHOL, V63, P625, DOI 10.1111/ppa.12123; Gent DH, 2006, PLANT DIS, V90, P1433, DOI 10.1094/PD-90-1433; Gent DH, 2012, PLANT DIS, V96, P1343, DOI 10.1094/PDIS-01-12-0084-RE; Hysert D, 2009, COMPENDIUM HOP DIS P, P8; Jarvis WR, 2002, POWDERY MILDEWS: A COMPREHENSIVE TREATISE, P169; Kavalier AR, 2011, J AGR FOOD CHEM, V59, P4783, DOI 10.1021/jf1049084; Kennelly MM, 2005, PHYTOPATHOLOGY, V95, P1445, DOI 10.1094/PHYTO-95-1445; Mahaffee W. F., 2009, COMPENDIUM HOP DIS P, P25; Mahaffee WF, 2009, COMPENDIUM HOP DIS P, P73; Mahaffee WF., 2003, PLANT HLTH PROGR, DOI [10.1094/PHP-2003-1113-07-RV, DOI 10.1094/PHP-2003-1113-07-RV]; Nelson ME, 2015, PLANT DIS, V99, P632, DOI 10.1094/PDIS-04-14-0396-RE; Neve R.A., 1991, HOPS; Ocamb C. M., 1999, Plant Disease, V83, P1072, DOI 10.1094/PDIS.1999.83.11.1072A; Pethybridge SJ, 2001, PLANT DIS, V85, DOI 10.1094/PDIS.2001.85.11.1208A; REIFSCHNEIDER FJB, 1988, PHYTOPATHOLOGY, V78, P1463, DOI 10.1094/Phyto-78-1463; Rotem J., 1994, GENUS ALTERNARIA BIO; Royle DJ, 1978, POWDERY MILDEWS, P281; Savary S, 2006, ANNU REV PHYTOPATHOL, V44, P89, DOI 10.1146/annurev.phyto.44.070505.143342; Seigner E., 2003, Gesunde Pflanzen, V55, P29, DOI 10.1046/j.1439-0345.2003.02079.x; Shah DA, 2004, PHYTOPATHOLOGY, V94, P33, DOI 10.1094/PHYTO.2004.94.1.33; Srecec Sinisa, 2008, Agriculturae Conspectus Scientificus, V73, P161; Srecec Sinisa, 2004, Agriculturae Conspectus Scientificus, V69, P59; THOMAS GG, 1969, ANN BOT-LONDON, V33, P781, DOI 10.1093/oxfordjournals.aob.a084324; Turechek WW., 2001, PLANT HLTH PROGR, V2, P8, DOI [10.1094/PHP-2001-0313-01-RS, DOI 10.1094/PHP-2001-0313-01-RS]; Versluys JP, 2012, PROC 17TH CONVENTION, P93; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wolfenbarger SN, 2014, PLANT DIS, V98, P852, DOI 10.1094/PDIS-11-13-1127-PDN; YARWOOD C. E., 1952, Bull. Dep. Agric. Calif., V41, P19	45	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120987	10.1371/journal.pone.0120987	http://dx.doi.org/10.1371/journal.pone.0120987			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811173	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700072
J	Zhang, YX; Bharathi, SS; Rardin, MJ; Uppala, R; Verdin, E; Gibson, BW; Goetzman, ES				Zhang, Yuxun; Bharathi, Sivakama S.; Rardin, Matthew J.; Uppala, Radha; Verdin, Eric; Gibson, Bradford W.; Goetzman, Eric S.			SIRT3 and SIRT5 Regulate the Enzyme Activity and Cardiolipin Binding of Very Long-Chain Acyl-CoA Dehydrogenase	PLOS ONE			English	Article							FATTY-ACID OXIDATION; MITOCHONDRIAL	SIRT3 and SIRT5 have been shown to regulate mitochondrial fatty acid oxidation but the molecular mechanisms behind the regulation are lacking. Here, we demonstrate that SIRT3 and SIRT5 both target human very long-chain acyl-CoA dehydrogenase (VLCAD), a key fatty acid oxidation enzyme. SIRT3 deacetylates and SIRT5 desuccinylates K299 which serves to stabilize the essential FAD cofactor in the active site. Further, we show that VLCAD binds strongly to cardiolipin and isolated mitochondrial membranes via a domain near the C-terminus containing lysines K482, K492, and K507. Acetylation or succinylation of these residues eliminates binding of VLCAD to cardiolipin. SIRT3 deacetylates K507 while SIRT5 desuccinylates K482, K492, and K507. Sirtuin deacylation of recombinant VLCAD rescues membrane binding. Endogenous VLCAD from SIRT3 and SIRT5 knockout mouse liver shows reduced binding to cardiolipin. Thus, SIRT3 and SIRT5 promote fatty acid oxidation by converging upon VLCAD to promote its activity and membrane localization. Regulation of cardiolipin binding by reversible lysine acylation is a novel mechanism that is predicted to extrapolate to other metabolic proteins that localize to the inner mitochondrial membrane.	[Zhang, Yuxun; Bharathi, Sivakama S.; Uppala, Radha; Goetzman, Eric S.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA; [Rardin, Matthew J.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA USA; [Verdin, Eric] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Buck Institute for Research on Aging; University of California System; University of California San Francisco; The J David Gladstone Institutes	Goetzman, ES (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA.	eric.goetzman@chp.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183	National Institutes of Health [RO1 DK090242, R24 DK085610]; NIH [S10 OD016281]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK085610, P30DK026743] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants RO1 DK090242 (ESG) and R24 DK085610 (BWG and EV), and the NIH shared instrument program (S10 OD016281). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKMANN JD, 1983, J BIOL CHEM, V258, P7563; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3; Fould B, 2010, BIOCHEMISTRY-US, V49, P8608, DOI 10.1021/bi100742w; Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Holloway GP, 2012, J MEMBRANE BIOL, V245, P165, DOI 10.1007/s00232-012-9426-6; Kashfi K, 2011, BIOCHEM SOC T, V39, P833, DOI 10.1042/BST0390833; Maher AC, 2010, MOL GENET METAB, V100, P163, DOI 10.1016/j.ymgme.2010.03.011; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Munnik Teun, 2013, Methods Mol Biol, V1009, P253, DOI 10.1007/978-1-62703-401-2_23; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schrauwen-Hinderling VB, 2007, CURR OPIN CLIN NUTR, V10, P698, DOI 10.1097/MCO.0b013e3282f0eca9; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Still AJ, 2013, J BIOL CHEM; Vockley J, 2002, NEUROMUSCULAR DISORD, V12, P235, DOI 10.1016/S0960-8966(01)00308-X; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493	25	65	65	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122297	10.1371/journal.pone.0122297	http://dx.doi.org/10.1371/journal.pone.0122297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811481	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000356353700182
J	Xiao, GQ; Unger, P; Yang, Q; Kinoshita, Y; Singh, K; McMahon, L; Nastiuk, K; Sha, K; Krolewski, J; Burstein, D				Xiao, Guang-Qian; Unger, Pamela; Yang, Qi; Kinoshita, Yayoi; Singh, Kyra; McMahon, Loralee; Nastiuk, Kent; Sha, Kai; Krolewski, John; Burstein, David			Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis	PLOS ONE			English	Article							PTEN EXPRESSION; SUPPRESSOR PLZF; FISH ANALYSIS; HIGH-RISK; GENE; PROLIFERATION; PROGRESSION; PTEN/MMAC1; CELLS; SHOWS	PLZF is a transcription repressor, which plays a critical role in development, spermatogenesis and oncogenesis. Down-regulation of PLZF has been found in various tumor cell lines. There has been virtually no tissue study on the expression of PLZF in prostate cancer (PCa). PCa is a heterogeneous disease, most of which are indolent and non-lethal. Currently there are no biomarkers that distinguish indolent from aggressive PCa; therefore there is an urgent need for such markers to provide clinical decision support. This study aimed to investigate the expression of PLZF by immunohistochemistry in different grade as well as metastatic PCa and to correlate the alteration of PLZF expression with PCa aggressiveness. We studied a total of 83 primary PCa from biopsies, 43 metastatic PCa and 8 paired primary and metastatic PCa from radical prostatectomies with lymph node dissection. Our results demonstrated that PLZF was strongly expressed in almost all (similar to 100%) benign luminal cells (n=77) and low grade (Gleason pattern 3) PCa (n=70) and weak or absent (100%) in basal cells (n=70). Decreased or lost expression of PLZF was evidenced in 26% of high-grade (Gleason 4 and 5) primary PCa (n=70) and 84% metastatic PCa (n=43). The primary high grade PCa in the prostatectomies shared similar PLZF loss/decrease and histomorphology to that of paired parallel lymph node metastases. These data demonstrated that down-regulation of PLZF is an important molecular process for tumor progression and loss of PLZF expression detected by routine immunohistochemistry is a promising and valuable biomarker for PCa aggressiveness and metastasis in the personalized care of PCa.	[Xiao, Guang-Qian; Yang, Qi; Singh, Kyra; McMahon, Loralee; Nastiuk, Kent; Sha, Kai; Krolewski, John] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Kinoshita, Yayoi; Burstein, David] Mt Sinai Med Ctr, Dept Pathol, New York, NY 10029 USA; [Unger, Pamela] Lenox Hill Hosp, Dept Pathol, New York, NY 10021 USA	University of Rochester; Icahn School of Medicine at Mount Sinai; Northwell Health	Xiao, GQ (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA.	guang-qian_xiao@urmc.rochester.edu			NCATS NIH HHS [UL1 TR000042] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		American Cancer Society, 2013, CANC FACTS FIG 2013; Bedolla R, 2007, CLIN CANCER RES, V13, P3860, DOI 10.1158/1078-0432.CCR-07-0091; Bettendorf O, 2008, GENE CHROMOSOME CANC, V47, P565, DOI 10.1002/gcc.20560; Brunner G, 2008, CANCER BIOTHER RADIO, V23, P451, DOI 10.1089/cbr.2008.0473; Cairns P, 1997, CANCER RES, V57, P4997; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheung M, 2010, ONCOGENE, V29, P1633, DOI 10.1038/onc.2009.455; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Dong JT, 1998, ONCOGENE, V17, P1979, DOI 10.1038/sj.onc.1202119; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Fraser M., 2014, UROL ONCOL; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Halvorsen OJ, 2003, CLIN CANCER RES, V9, P1474; Han B, 2009, MODERN PATHOL, V22, P1083, DOI 10.1038/modpathol.2009.69; Jiang F, 2004, PROSTATE, V59, P426, DOI 10.1002/pros.20000; Kikugawa T, 2006, PROSTATE, V66, P1092, DOI 10.1002/pros.20443; Kolesnichenko M, 2011, CELL CYCLE, V10, P771, DOI 10.4161/cc.10.5.14829; Leong TYM, 2010, ADV ANAT PATHOL, V17, P404, DOI 10.1097/PAP.0b013e3181f8957c; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Loeb S, 2014, EUR UROL, V65, P1046, DOI 10.1016/j.eururo.2013.12.062; Lotan TL, 2011, CLIN CANCER RES, V17, P6563, DOI 10.1158/1078-0432.CCR-11-1244; McCall P, 2008, BRIT J CANCER, V99, P1296, DOI 10.1038/sj.bjc.6604680; McMenamin ME, 1999, CANCER RES, V59, P4291; Paavilainen L, 2010, J HISTOCHEM CYTOCHEM, V58, P237, DOI 10.1369/jhc.2009.954321; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; Pesche S, 1998, ONCOGENE, V16, P2879, DOI 10.1038/sj.onc.1202081; Pourmand Gholamreza, 2007, Urol J, V4, P95; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Rho SB, 2006, FEBS LETT, V580, P4073, DOI 10.1016/j.febslet.2006.06.047; Schmitz M, 2007, INT J CANCER, V120, P1284, DOI 10.1002/ijc.22359; Suliman Bandar Ali, 2012, Front Oncol, V2, P74, DOI 10.3389/fonc.2012.00074; Suzuki H, 1998, CANCER RES, V58, P204; Wan T., 2012, APPL CATEGORICAL COU; Wang XT, 2013, FASEB J, V27, P4194, DOI 10.1096/fj.13-229070; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Yoshimoto M, 2007, BRIT J CANCER, V97, P678, DOI 10.1038/sj.bjc.6603924; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003	40	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121318	10.1371/journal.pone.0121318	http://dx.doi.org/10.1371/journal.pone.0121318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807461	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000145
J	Kwon, T; Yoon, SH; Kim, KW; Caetano-Anolles, K; Cho, S; Kim, H				Kwon, Taehyung; Yoon, Sook Hee; Kim, Kyu-Won; Caetano-Anolles, Kelsey; Cho, Seoae; Kim, Heebal			Time-Calibrated Phylogenomics of the Classical Swine Fever Viruses: Genome-Wide Bayesian Coalescent Approach	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MOLECULAR CHARACTERIZATION; WILD BOAR; E-RNS; SEQUENCE; E2; EPIDEMIOLOGY; VIRULENCE; STRAIN; GLYCOPROTEIN	The phylogeny of classical swine fever virus (CSFV), the causative agent of classical swine fever (CSF), has been investigated extensively. However, no evolutionary research has been performed using the whole CSFV genome. In this study, we used 37 published genome sequences to investigate the time-calibrated phylogenomics of CSFV. In phylogenomic trees based on Bayesian inference (BI) and Maximum likelihood (ML), the 37 isolates were categorized into five genetic types (1.1, 1.2, 2.1, 2.3, and 3.4). Subgenotype 1.1 is divided into 3 groups and 1 unclassified isolate, 2.1 into 4 groups, 2.3 into 2 groups and 1 unclassified isolate, and subgenotype 1.2 and 3.4 consisted of one isolate each. We did not observe an apparent temporal or geographical relationship between isolates. Of the 14 genomic regions, NS4B showed the most powerful phylogenetic signal. Results of this evolutionary study using Bayesian coalescent approach indicate that CSFV has evolved at a rate of 13x.010(-4) substitutions per site per year. The most recent common ancestor of CSFV appeared 2770.2 years ago, which was about 8000 years after pig domestication. The effective population size of CSFV underwent a slow increase until the 1950s, after which it has remained constant.	[Kwon, Taehyung; Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Kwon, Taehyung; Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul 151747, South Korea; [Caetano-Anolles, Kelsey] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Cho, Seoae] C&K Genom Inc, Seoul 151919, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Illinois System; University of Illinois Urbana-Champaign	Kim, H (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	heebal@snu.ac.kr	Kim, Kyu Won/AAJ-7213-2020; Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Kwon, Taehyung/0000-0002-5668-059X; Caetano-Anolles, Kelsey/0000-0001-6310-6679	Next Generation BioGreen21 Program, Rural Development Administration, Republic of Korea [PJ009032]	Next Generation BioGreen21 Program, Rural Development Administration, Republic of Korea	This study was supported by a grant (PJ009032) from the Next Generation BioGreen21 Program, Rural Development Administration, Republic of Korea. Seoae Cho is CEO of C&K Genomics Inc. C&K Genomics Inc. provided support in the form of salary for author SC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aguero M, 2004, VET RES, V35, P551, DOI 10.1051/vetres:2004031; Barman N, 2014, TRANSBOUNDARY EMERGI; Blome S, 2010, VET MICROBIOL, V146, P276, DOI 10.1016/j.vetmic.2010.05.035; Chen N, 2008, VET MICROBIOL, V127, P286, DOI 10.1016/j.vetmic.2007.09.009; David D, 2011, Vet J, V190, pe146, DOI 10.1016/j.tvjl.2011.04.007; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Elena SF, 2005, J VIROL, V79, P11555, DOI 10.1128/JVI.79.18.11555-11558.2005; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Fan YF, 2008, VIRUS GENES, V36, P531, DOI 10.1007/s11262-008-0229-x; Fernandez-Sainz I, 2010, J VIROL, V84, P1536, DOI 10.1128/JVI.02050-09; Fletcher SP, 2002, J VIROL, V76, P5024, DOI 10.1128/JVI.76.10.5024-5033.2002; Floegel-Niesmann G, 2003, J VET MED B, V50, P214, DOI 10.1046/j.1439-0450.2003.00663.x; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gupta PK, 2011, ANIM BIOTECHNOL, V22, P111, DOI 10.1080/10495398.2011.566472; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Holland J, 1998, VIRUS GENES, V16, P13, DOI 10.1023/A:1007989407305; Ji W, 2014, VIRUS RES; Ji W, 2014, INFECT GENET EVOL, V25, P69, DOI 10.1016/j.meegid.2014.04.008; Perez LJ, 2012, INFECT GENET EVOL, V12, P1405, DOI 10.1016/j.meegid.2012.04.030; Kaden V, 2000, BERLINER MUNCHENER T, V114, P246; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KONIG M, 1995, J VIROL, V69, P6479; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Leifer I, 2013, VIROLOGY, V438, P51, DOI 10.1016/j.virol.2013.01.013; Leifer I, 2010, J GEN VIROL, V91, P2687, DOI 10.1099/vir.0.023200-0; Leslie EEC, 2012, PIG MOVEMENTS E INDO; Lin YJ, 2007, VIRUS GENES, V35, P737, DOI 10.1007/s11262-007-0154-4; Liu LH, 2009, VIROLOGY, V385, P351, DOI 10.1016/j.virol.2008.12.004; Liu SG, 2006, J VIROL METHODS, V134, P125, DOI 10.1016/j.jviromet.2005.12.008; Lowings P, 1996, J GEN VIROL, V77, P1311, DOI 10.1099/0022-1317-77-6-1311; Luo TR, 2011, VIRUS GENES, V42, P347, DOI 10.1007/s11262-011-0578-8; Meuwissen MPM, 1999, PREV VET MED, V42, P249, DOI 10.1016/S0167-5877(99)00079-3; MEYERS G, 1989, VIROLOGY, V171, P555, DOI 10.1016/0042-6822(89)90625-9; Meyers G, 1996, ADV VIRUS RES, V47, P53, DOI 10.1016/S0065-3527(08)60734-4; Mintiens K, 2001, J VET MED B, V48, P143, DOI 10.1046/j.1439-0450.2001.00429.x; Moennig V, 2000, VET MICROBIOL, V73, P93, DOI 10.1016/S0378-1135(00)00137-1; Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0; Murphy F.A., 1999, VET VIROL, V3, P293; Noremark M, 2009, PREV VET MED, V90, P1, DOI 10.1016/j.prevetmed.2009.03.008; Patil SS, 2012, VIRUS GENES, V44, P104, DOI 10.1007/s11262-011-0572-1; Patil SS, 2010, VET MICROBIOL, V141, P367, DOI 10.1016/j.vetmic.2009.09.021; Paton DJ, 2000, VET MICROBIOL, V73, P137, DOI 10.1016/S0378-1135(00)00141-3; PATON DJ, 1995, J COMP PATHOL, V112, P215, DOI 10.1016/S0021-9975(05)80076-3; POOLE TL, 1995, VIROLOGY, V206, P750, DOI 10.1016/S0042-6822(95)80003-4; Porta M., 2014, DICT EPIDEMIOLOGY, V6th ed; Posada David, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0605s00; Postel A, 2013, VET MICROBIOL, V161, P334, DOI 10.1016/j.vetmic.2012.07.045; Postel A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-50; Rambaut A, 2009, TRACER 1 5 2009 MCMC; Rambaut A, 2012, FIGTREE TREE FIGURE; Rambaut A, 2013, TREEANNOTATOR V1 7 0; Rijnbrand R, 1997, J VIROL, V71, P451, DOI 10.1128/JVI.71.1.451-457.1997; Risatti GR, 2005, J VIROL, V79, P3787, DOI 10.1128/JVI.79.6.3787-3796.2005; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saatkamp HW, 2000, VET MICROBIOL, V73, P221, DOI 10.1016/S0378-1135(00)00147-4; Sarma DK, 2011, COMP IMMUNOL MICROB, V34, P11, DOI 10.1016/j.cimid.2009.09.005; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Simon G, 2013, VET MICROBIOL, V166, P631, DOI 10.1016/j.vetmic.2013.06.032; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura T, 2012, J VIROL, V86, P8602, DOI 10.1128/JVI.00551-12; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; van Gennip HGP, 2002, VACCINE, V20, P1544, DOI 10.1016/S0264-410X(01)00497-2; Weiland F, 1999, J GEN VIROL, V80, P1157, DOI 10.1099/0022-1317-80-5-1157; Xia HY, 2011, ARCH VIROL, V156, P1041, DOI 10.1007/s00705-011-0948-5; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105	73	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121578	10.1371/journal.pone.0121578	http://dx.doi.org/10.1371/journal.pone.0121578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815768	Green Submitted, gold, Green Published			2022-12-26	WOS:000352133600105
J	Ono, C; Sato, M; Taka, H; Asano, S; Matsuura, Y; Bando, H				Ono, Chikako; Sato, Masanao; Taka, Hitomi; Asano, Shin-ichiro; Matsuura, Yoshiharu; Bando, Hisanori			Tightly Regulated Expression of Autographa californica Multicapsid Nucleopolyhedrovirus Immediate Early Genes Emerges from Their Interactions and Possible Collective Behaviors	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; BACULOVIRUS GENES; TRANSCRIPTIONAL ACTIVATION; RING FINGER; IE-1; IDENTIFICATION; IE1; MECHANISM; PROMOTER; PROTEIN	To infect their hosts, DNA viruses must successfully initiate the expression of viral genes that control subsequent viral gene expression and manipulate the host environment. Viral genes that are immediately expressed upon infection play critical roles in the early infection process. In this study, we investigated the expression and regulation of five canonical regulatory immediate-early (IE) genes of Autographa californica multicapsid nucleopolyhedrovirus: ie0, ie1, ie2, me53, and pe38. A systematic transient gene-expression analysis revealed that these IE genes are generally transactivators, suggesting the existence of a highly interactive regulatory network. A genetic analysis using gene knockout viruses demonstrated that the expression of these IE genes was tolerant to the single deletions of activator IE genes in the early stage of infection. A network graph analysis on the regulatory relationships observed in the transient expression analysis suggested that the robustness of IE gene expression is due to the organization of the IE gene regulatory network and how each IE gene is activated. However, some regulatory relationships detected by the genetic analysis were contradictory to those observed in the transient expression analysis, especially for IE0-mediated regulation. Statistical modeling, combined with genetic analysis using knockout alleles for ie0 and ie1, showed that the repressor function of ie0 was due to the interaction between ie0 and ie1, not ie0 itself. Taken together, these systematic approaches provided insight into the topology and nature of the IE gene regulatory network.	[Ono, Chikako; Taka, Hitomi; Asano, Shin-ichiro; Bando, Hisanori] Hokkaido Univ, Grad Sch Agr, Lab Appl Mol Entomol, Div Appl Biosci, Sapporo, Hokkaido, Japan; [Sato, Masanao] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448585, Japan; [Matsuura, Yoshiharu] Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Osaka, Japan	Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Osaka University	Bando, H (corresponding author), Hokkaido Univ, Grad Sch Agr, Lab Appl Mol Entomol, Div Appl Biosci, Sapporo, Hokkaido, Japan.	hban@abs.agr.hokudai.ac.jp		Sato, Masanao/0000-0003-3790-8218	Ministry of Education, Culture, Sports, Science and Technology in Japan [22248003]; Grants-in-Aid for Scientific Research [14J05845] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This work was supported in part by a Grant-in-Aid for Scientific Research A (No.22248003) from the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/english/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilen MF, 2007, VIRUS GENES, V35, P549, DOI 10.1007/s11262-007-0150-8; BLISSARD GW, 1991, J VIROL, V65, P5820, DOI 10.1128/JVI.65.11.5820-5827.1991; CARSON DD, 1988, VIROLOGY, V162, P444, DOI 10.1016/0042-6822(88)90485-0; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; CHISHOLM GE, 1988, J VIROL, V62, P3193, DOI 10.1128/JVI.62.9.3193-3200.1988; CRAWFORD AM, 1988, J VIROL, V62, P2773, DOI 10.1128/JVI.62.8.2773-2781.1988; FRIESEN PD, 1987, J VIROL, V61, P2264, DOI 10.1128/JVI.61.7.2264-2272.1987; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GUARINO LA, 1986, J VIROL, V57, P563, DOI 10.1128/JVI.57.2.563-571.1986; HOHMANN AW, 1983, VIROLOGY, V125, P432, DOI 10.1016/0042-6822(83)90214-3; Huijskens I, 2004, VIROLOGY, V323, P120, DOI 10.1016/j.virol.2004.03.001; Imai N, 2003, J VIROL, V77, P923, DOI 10.1128/JVI.77.2.923-930.2003; Jiang SS, 2006, J VIROL, V80, P8989, DOI 10.1128/JVI.01158-06; Katsuma Susumu, 2012, Journal of Insect Biotechnology and Sericology, V81, P7; Kim Y, 2014, CELL HOST MICROBE, V15, P84, DOI 10.1016/j.chom.2013.12.002; KNEBELMORSDORF D, 1993, J VIROL, V67, P753; Kojima K, 2001, ARCH VIROL, V146, P1407, DOI 10.1007/s007050170101; KOOL M, 1994, VIROLOGY, V198, P680, DOI 10.1006/viro.1994.1080; KOVACS GR, 1991, J VIROL, V65, P5281, DOI 10.1128/JVI.65.10.5281-5288.1991; KRAPPA R, 1991, J VIROL, V65, P805, DOI 10.1128/JVI.65.2.805-812.1991; Kremer A, 1998, VIROLOGY, V249, P336, DOI 10.1006/viro.1998.9288; Leisy DJ, 1997, J VIROL, V71, P5088, DOI 10.1128/JVI.71.7.5088-5094.1997; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; LU A, 1993, VIROLOGY, V195, P710, DOI 10.1006/viro.1993.1422; Lu LQ, 2005, J VIROL, V79, P10077, DOI 10.1128/JVI.79.15.10077-10082.2005; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Narayanan A, 2005, J BIOL CHEM, V280, P1369, DOI 10.1074/jbc.M410178200; Ono Chikako, 2007, Journal of Insect Biotechnology and Sericology, V76, P161; OREILLY D, BACULOVIRUS EXPRESSI; PASSARELLI AL, 1993, J VIROL, V67, P2149, DOI 10.1128/JVI.67.4.2149-2158.1993; Pearson MN, 1997, VIROLOGY, V235, P153, DOI 10.1006/viro.1997.8687; Prikhodko EA, 1998, J VIROL, V72, P684; PULLEN SS, 1995, J VIROL, V69, P156, DOI 10.1128/JVI.69.1.156-165.1995; Schultz KLW, 2009, J VIROL, V83, P11123, DOI 10.1128/JVI.01199-09; Schultz KLW, 2009, J VIROL, V83, P262, DOI 10.1128/JVI.01827-08; Slack JM, 1997, J VIROL, V71, P9579, DOI 10.1128/JVI.71.12.9579-9587.1997; Teng MW, 2012, CELL, V151, P1569, DOI 10.1016/j.cell.2012.11.051; THEILMANN DA, 1991, VIROLOGY, V180, P492, DOI 10.1016/0042-6822(91)90063-H; Theilmann DA, 2001, VIROLOGY, V290, P211, DOI 10.1006/viro.2001.1165; Todd JW, 1996, J VIROL, V70, P2307, DOI 10.1128/JVI.70.4.2307-2317.1996; TODD JW, 1995, J VIROL, V69, P968, DOI 10.1128/JVI.69.2.968-974.1995; Tsuda K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004015; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; VOLKMAN LE, 1984, VIROLOGY, V139, P295, DOI 10.1016/0042-6822(84)90375-1; VOLKMAN LE, 1984, VIROLOGY, V133, P354, DOI 10.1016/0042-6822(84)90401-X; Wang HH, NAT METHODS; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; WU XN, 1993, J VIROL, V67, P5833, DOI 10.1128/JVI.67.10.5833-5842.1993; YOO SH, 1994, VIROLOGY, V202, P746, DOI 10.1006/viro.1994.1396	51	1	1	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119580	10.1371/journal.pone.0119580	http://dx.doi.org/10.1371/journal.pone.0119580			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816136	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600020
J	van den Brom, R; Roest, HJ; de Bruin, A; Dercksen, D; Santman-Berends, I; van der Hoek, W; Dinkla, A; Vellema, J; Vellema, P				van den Brom, Rene; Roest, Hendrik-Jan; de Bruin, Arnout; Dercksen, Daan; Santman-Berends, Inge; van der Hoek, Wim; Dinkla, Annemiek; Vellema, Jelmer; Vellema, Piet			A Probably Minor Role for Land-Applied Goat Manure in the Transmission of Coxiella burnetii to Humans in the 2007-2010 Dutch Q Fever Outbreak	PLOS ONE			English	Article							DAIRY GOAT; NETHERLANDS; EPIDEMIC; PASTEURIZATION; MILK; SAMPLES; FARMS; DNA	In 2007, Q fever started to become a major public health problem in the Netherlands, with small ruminants as most probable source. In order to reduce environmental contamination, control measures for manure were implemented because of the assumption that manure was highly contaminated with Coxiella burnetii. The aims of this study were 1) to clarify the role of C. burnetii contaminated manure from dairy goat farms in the transmission of C. burnetii to humans, 2) to assess the impact of manure storage on temperature profiles in dunghills, and 3) to calculate the decimal reduction time of the Nine Mile RSA 493 reference strain of C. burnetii under experimental conditions in different matrices. For these purposes, records on distribution of manure from case and control herds were mapped and a potential relation to incidences of human Q fever was investigated. Additionally, temperatures in two dunghills were measured and related to heat resistance of C. burnetii. Results of negative binomial regression showed no significant association between the incidence of human Q fever cases and the source of manure. Temperature measurements in the core and shell of dunghills on two farms were above 40 degrees C for at least ten consecutive days which would result in a strong reduction of C. burnetii over time. Our findings indicate that there is no relationship between incidence of human Q fever and land applied manure from dairy goat farms with an abortion wave caused by C. burnetii. Temperature measurements in dunghills on two farms with C. burnetii shedding dairy goat herds further support the very limited role of goat manure as a transmission route during the Dutch human Q fever outbreak. It is very likely that the composting process within a dunghill will result in a clear reduction in the number of viable C. burnetii.	[van den Brom, Rene; Dercksen, Daan; Vellema, Piet] GD Anim Hlth, Dept Small Ruminant Hlth, Deventer, Netherlands; [Roest, Hendrik-Jan; Dinkla, Annemiek] Wageningen UR, Cent Vet Inst, Dept Bacteriol & TSEs, Lelystad, Netherlands; [de Bruin, Arnout; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Santman-Berends, Inge] GD Anim Hlth, Dept Epidemiol, Deventer, Netherlands; [Vellema, Jelmer] Delft Univ Technol, NL-2600 AA Delft, Netherlands	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Delft University of Technology	van den Brom, R (corresponding author), GD Anim Hlth, Dept Small Ruminant Hlth, Deventer, Netherlands.	r.vd.brom@gdanimalhealth.com			Dutch ministry of Economic Affairs	Dutch ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This study was financially supported by the Dutch ministry of Economic Affairs. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. GD Animal Health only provided financial support by paying the publication fee, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. GD Animal Health provided support in the form of salaries for authors RVdB, DPD, ISB and PV.	Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Bagge E, 2010, J APPL MICROBIOL, V109, P1549, DOI 10.1111/j.1365-2672.2010.04790.x; BEARNS RE, 1958, CAN J MICROBIOL, V4, P55, DOI 10.1139/m58-007; Berri M, 2003, VET REC, V153, P269, DOI 10.1136/vr.153.9.269; Cerf O, 2006, EPIDEMIOL INFECT, V134, P946, DOI 10.1017/S0950268806005978; de Bruin A, 2013, J APPL MICROBIOL, V114, P1395, DOI 10.1111/jam.12163; de Bruin A, 2012, APPL ENVIRON MICROB, V78, P1652, DOI 10.1128/AEM.07323-11; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; ENRIGHT JB, 1957, AM J PUBLIC HEALTH N, V47, P695, DOI 10.2105/AJPH.47.6.695; Georgiev M., 2013, Eurosurveillance, V18, P20407; Hermans T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096607; Klee SR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-2; Lung AJ, 2001, J FOOD PROTECT, V64, P1309, DOI 10.4315/0362-028X-64.9.1309; MARRIE TJ, 1990, CAN VET J, V31, P555; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mills A. F., 1999, BASIC HEAT MASS TRAN; REHACEK J, 1991, EUR J EPIDEMIOL, V7, P229, DOI 10.1007/BF00145671; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; SALMON MM, 1982, LANCET, V1, P1002; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sharma R, 2009, J ENVIRON QUAL, V38, P567, DOI 10.2134/jeq2007.0638; van den Brom R, 2012, VET REC, V170, P310, DOI 10.1136/vr.100304; Van den Brom R, 2009, SMALL RUMINANT RES, V86, P74, DOI 10.1016/j.smallrumres.2009.09.022; van der Hoek W, 2010, EUROSURVEILLANCE, V15, P4; van der Hoek W, 2012, GEOSPATIAL HEALTH, V7, P127, DOI 10.4081/gh.2012.111; van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270; van der Hoek W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1472-6963-11-57; Van Steenbergen J E, 2007, Ned Tijdschr Geneeskd, V151, P1998; Vellema P, 2014, SMALL RUMINANT RES, V118, P69, DOI 10.1016/j.smallrumres.2013.12.006; Wouda W, 2007, TIJDSCHR DIERGENEESK, V132, P908; Ziemer CJ, 2010, J ANIM SCI, V88, pE84, DOI 10.2527/jas.2009-2331	34	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121355	10.1371/journal.pone.0121355	http://dx.doi.org/10.1371/journal.pone.0121355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816149	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600084
J	Childers, DS; Kadosh, D				Childers, Delma S.; Kadosh, David			Filament Condition-Specific Response Elements Control the Expression of NRG1 and UME6, Key Transcriptional Regulators of Morphology and Virulence in Candida albicans	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HYPHAL MORPHOGENESIS; EFG1 REGULATOR; YEAST; GROWTH; GENE; TRANSITION; PATHOGENESIS; REPRESSION; INDUCTION	Candida albicans is the most frequently isolated human fungal pathogen and can cause a range ofmucosal and systemic infections in immunocompromised individuals. Morphogenesis, the ability to undergo a reversible transition from budding yeast to elongated filaments, is an essential virulence trait. The yeast-to-filament transition is associated with expression of genes specifically important for filamentation as well as other virulence-related processes, and is controlled, in part, by the key transcriptional regulators Nrg1 and Ume6. Both of these regulators are themselves controlled at the transcriptional level by filament-inducing environmental cues, although little is known about how this process occurs. In order to address this question and determine whether environmental signals regulate transcription of UME6 and NRG1 via distinct and/or common promoter elements, we performed promoter deletion analyses. Strains bearing promoter deletion constructs were induced to form filaments in YEPD plus 10% serum at 37 degrees C, Spidermedium(nitrogen and carbon starvation) and/or Lee's medium pH 6.8 (neutral pH) and reporter gene expression was measured. In the NRG1 promoter we identified several distinct condition-specific response elements for YEPD plus 10% serum at 37 degrees C and Spider medium. In the UME6 promoter we also identified response elements for YEPD plus 10% serum at 37 degrees C. While a few of these elements are distinct, others overlap with those which respond to Lee's pH 6.8 medium. Consistent with UME6 possessing a very long 5' UTR, many response elements in the UME6 promoter are located significantly upstream from the coding sequence. Our data indicate that certain distinct condition-specific elements can control expression of C. albicans UME6 and NRG1 in response to key filament-inducing environmental cues. Because C. albicans encounters a variety of host microenvironments during infection, our results suggest that UME6 and NRG1 expression can be differentially modulated by multiple signaling pathways to control filamentation and virulence in vivo.	[Childers, Delma S.; Kadosh, David] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Kadosh, D (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	kadosh@uthscsa.edu		Childers, Delma/0000-0003-2869-7332	COSTAR fellowship (National Institute of Dental and Craniofacial Research Grant) [T32DE014318, F31DE021930]; National Institute of Allergy and Infectious Diseases [5RO1AI083344]; Voelcker Young Investigator Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE021930, T32DE014318] Funding Source: NIH RePORTER	COSTAR fellowship (National Institute of Dental and Craniofacial Research Grant); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Voelcker Young Investigator Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	D.S.C. was supported by a COSTAR fellowship (National Institute of Dental and Craniofacial Research Grant T32DE014318) in addition to a Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (National Institute of Dental and Craniofacial Research Grant F31DE021930). D.K. was supported by Grant 5RO1AI083344 from the National Institute of Allergy and Infectious Diseases as well as a Voelcker Young Investigator Award from the Max and Minnie Tomerlin Voelcker Fund. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Bensen ES, MOL MICROBIOLOGY, V54, P1335; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bockmuhl DP, 2001, GENETICS, V157, P1523; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Brown AJP, 1999, TRENDS MICROBIOL, V7, P333, DOI 10.1016/S0966-842X(99)01556-5; Brown Alistair J. P., 2002, P87; Brown Alistair J. P., 2002, P95; Calderone R.A.C.C.J., 2012, CANDIDA CANDIDIASIS; Cannon RD, 1999, CRIT REV ORAL BIOL M, V10, P359, DOI 10.1177/10454411990100030701; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Childers DS, 2014, MOL MICROBIOL, V92, P570, DOI 10.1111/mmi.12576; Cleary IA, 2012, MOL MICROBIOL, V85, P557, DOI 10.1111/j.1365-2958.2012.08127.x; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Dongari-Bagtzoglou A, 1999, ORAL MICROBIOL IMMUN, V14, P364, DOI 10.1034/j.1399-302X.1999.140606.x; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Enjalbert B, 2005, EUKARYOT CELL, V4, P1203, DOI 10.1128/EC.4.7.1203-1210.2005; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Filler Scott G., 2002, P341; Garcia-Sanchez S, 2005, MOL BIOL CELL, V16, P2913, DOI 10.1091/mbc.E05-01-0071; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Guthrie C., 1991, METHOD ENZYMOL, V194, P933; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; KAUFMANN E, 1995, J MOL BIOL, V248, P239, DOI 10.1006/jmbi.1995.0218; Kebaara BW, 2008, EUKARYOT CELL, V7, P980, DOI 10.1128/EC.00357-07; Korting HC, 2003, J MED MICROBIOL, V52, P623, DOI 10.1099/jmm.0.05125-0; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Lackey E, 2013, EUKARYOT CELL, V12, P1356, DOI 10.1128/EC.00164-13; Lassak T, 2011, MOL MICROBIOL, V82, P602, DOI 10.1111/j.1365-2958.2011.07837.x; Lindsay AK, 2012, EUKARYOT CELL, V11, P1219, DOI 10.1128/EC.00144-12; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI DOI 10.1016/S0092-8674(00)80358-X; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lotz H, 2004, EUKARYOT CELL, V3, P776, DOI 10.1128/EC.3.3.776-784.2004; Lu Y, 2014, P NATL ACAD SCI USA, V111, P1975, DOI 10.1073/pnas.1318690111; Lu Y, 2013, CELL HOST MICROBE, V14, P499, DOI 10.1016/j.chom.2013.10.008; Lu Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002663; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; Mitchell AP, 1998, CURR OPIN MICROBIOL, V1, P687, DOI 10.1016/S1369-5274(98)80116-1; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Odds FC., 1988, CANDIDA CANDIDOSIS; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Schug J, 2003, CURRENT PROTOCOLS BI; Sellam A, 2010, EUKARYOT CELL, V9, P634, DOI 10.1128/EC.00325-09; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SOBEL JD, 1992, CLIN INFECT DIS, V14, pS148, DOI 10.1093/clinids/14.Supplement_1.S148; Tebarth B, 2003, J MOL BIOL, V329, P949, DOI 10.1016/S0022-2836(03)00505-9; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	56	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122775	10.1371/journal.pone.0122775	http://dx.doi.org/10.1371/journal.pone.0122775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811669	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700202
J	Fleury, MJJ; Nicol, JTJ; Samimi, M; Arnold, F; Cazal, R; Ballaire, R; Mercey, O; Gonneville, H; Combelas, N; Vautherot, JF; Moreau, T; Lorette, G; Coursaget, P; Touze, A				Fleury, Maxime J. J.; Nicol, Jerome T. J.; Samimi, Mahtab; Arnold, Francoise; Cazal, Raphael; Ballaire, Raphaelle; Mercey, Olivier; Gonneville, Helene; Combelas, Nicolas; Vautherot, Jean-Francois; Moreau, Thierry; Lorette, Gerard; Coursaget, Pierre; Touze, Antoine			Identification of the Neutralizing Epitopes of Merkel Cell Polyomavirus Major Capsid Protein within the BC and EF Surface Loops	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; HUMAN-PAPILLOMAVIRUS; MONOCLONAL-ANTIBODIES; CONFORMATIONAL EPITOPES; HUMAN INFECTION; UNITED-STATES; CARCINOMA; L1; SEQUENCE; VP1	Merkel cell polyomavirus (MCPyV) is the first polyomavirus clearly associated with a human cancer, i.e. the Merkel cell carcinoma (MCC). Polyomaviruses are small naked DNA viruses that induce a robust polyclonal antibody response against the major capsid protein (VP1). However, the polyomavirus VP1 capsid protein epitopes have not been identified to date. The aim of this study was to identify the neutralizing epitopes of the MCPyV capsid. For this goal, four VP1 mutants were generated by insertional mutagenesis in the BC, DE, EF and HI loops between amino acids 88-89, 150-151, 189-190, and 296-297, respectively. The reactivity of these mutants and wild-type VLPs was then investigated with anti-VP1 monoclonal antibodies and anti-MCPyV positive human sera. The findings together suggest that immunodominant conformational neutralizing epitopes are present at the surface of the MCPyV VLPs and are clustered within BC and EF loops.	[Fleury, Maxime J. J.] Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene, UPRES EA 3142, Angers, France; [Nicol, Jerome T. J.; Samimi, Mahtab; Arnold, Francoise; Cazal, Raphael; Ballaire, Raphaelle; Mercey, Olivier; Gonneville, Helene; Combelas, Nicolas; Lorette, Gerard; Touze, Antoine] Univ Tours, PRES Ctr Val de Loire Univ, Fac Pharmaceut Sci, UMR INRA Virol & Immunol Mol 1282, Tours, France; [Lorette, Gerard] CHRU Tours, Hop Trousseau, Serv Dermatol, Tours, France; [Vautherot, Jean-Francois] INRA Nouzilly, UMR INRA 1282, Biol Virus Aviaires, Nouzilly, France; [Moreau, Thierry] Univ Tours, PRES Ctr Val de Loire Univ, Fac Med, UMR INSERM 1100,Mecanismes Proteolyt Inflammat, Tours, France; Univ Tours, PRES Ctr Val de Loire Univ, Fac Pharmaceut Sci, Tours, France	Universite d'Angers; INRAE; Universite de Tours; CHU Tours; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Universite de Tours	Touze, A (corresponding author), Univ Tours, PRES Ctr Val de Loire Univ, Fac Pharmaceut Sci, UMR INRA Virol & Immunol Mol 1282, Tours, France.	antoine.touze@univ-tours.fr	samimi, mahtab/V-3038-2019	Touze, antoine/0000-0002-9856-9945	INSERM/Region Centre and Region Centre; Ligue Contre le Cancer	INSERM/Region Centre and Region Centre(Region Centre-Val de Loire); Ligue Contre le Cancer(Ligue nationale contre le cancer)	NC and JTJN were supported by a Doctoral grant from INSERM/Region Centre and Region Centre, respectively. Grants from the Ligue Contre le Cancer to PC (2009-2010) and AT (2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelli M, 2003, J AM ACAD DERMATOL, V49, P832, DOI 10.1016/S0190-9622(03)02108-X; Agelli M, 2010, CURR PROB CANCER, V34, P14, DOI 10.1016/j.currproblcancer.2010.01.001; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Bouvard V, 2012, LANCET ONCOL, V13, P339, DOI 10.1016/S1470-2045(12)70125-0; Buck CB, 2012, J VIROL, V86, P10887, DOI 10.1128/JVI.01690-12; Carpentier GS, 2005, J MED VIROL, V77, P558, DOI 10.1002/jmv.20492; Carter JJ, 2003, J VIROL, V77, P11625, DOI 10.1128/JVI.77.21.11625-11632.2003; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Chen XJS, 1998, EMBO J, V17, P3233, DOI 10.1093/emboj/17.12.3233; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Combelas N, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-28; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Day PM, 2007, J VIROL, V81, P8784, DOI 10.1128/JVI.00552-07; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Erickson KD, 2009, J VIROL, V83, P10275, DOI 10.1128/JVI.00949-09; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fleury MJJ, 2006, ARCH VIROL, V151, P1511, DOI 10.1007/s00705-006-0734-y; Fleury MJJ, 2009, PROTEIN SCI, V18, P1425, DOI 10.1002/pro.156; GARDNER SD, 1971, LANCET, V1, P1253; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gedvilaite A, 2000, VIROLOGY, V273, P21, DOI 10.1006/viro.2000.0392; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; JIN L, 1993, J MED VIROL, V39, P50, DOI 10.1002/jmv.1890390110; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Korup S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058021; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Lim ES, 2013, VIROLOGY, V436, P295, DOI 10.1016/j.virol.2012.12.005; Mishra N, 2014, J INFECT DIS, V210, P1595, DOI 10.1093/infdis/jiu250; Murata H, 2008, VIROLOGY, V381, P116, DOI 10.1016/j.virol.2008.07.032; Neu U, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002738; Nguyen NL, 2009, EMERG INFECT DIS, V15, P1199, DOI 10.3201/eid1508.090270; Nicol JTJ, 2014, J CLIN MICROBIOL, V52, P321, DOI 10.1128/JCM.02730-13; Nicol JTJ, 2013, CLIN VACCINE IMMUNOL, V20, P363, DOI 10.1128/CVI.00438-12; Nicol JTJ, 2012, EMERG INFECT DIS, V18, P1329, DOI 10.3201/eid1808.111625; Orozco JJ, 2005, J VIROL, V79, P9503, DOI 10.1128/JVI.79.15.9503-9514.2005; PADGETT BL, 1971, LANCET, V1, P1257; Pastrana DV, 2010, VIROLOGY, V405, P20, DOI 10.1016/j.virol.2010.06.022; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Randhawa P, 2009, J GEN VIROL, V90, P634, DOI 10.1099/vir.0.008391-0; Ribeiro T, 2010, NEUROL SCI, V31, P517, DOI 10.1007/s10072-010-0353-y; Sadeyen JR, 2003, VIROLOGY, V309, P32, DOI 10.1016/S0042-6822(02)00134-4; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; Thouvenin E, 1997, J MOL BIOL, V270, P238, DOI 10.1006/jmbi.1997.1095; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Touze A, 2001, J GEN VIROL, V82, P3005, DOI 10.1099/0022-1317-82-12-3005; Touze A, 2011, J CLIN ONCOL, V29, P1612, DOI 10.1200/JCO.2010.31.1704; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449; Zvirbliene A, 2006, J IMMUNOL METHODS, V311, P57, DOI 10.1016/j.jim.2006.01.007	52	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121751	10.1371/journal.pone.0121751	http://dx.doi.org/10.1371/journal.pone.0121751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812141	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700134
J	Fredrickson, BL; Grewen, KM; Algoe, SB; Firestine, AM; Arevalo, JMG; Ma, J; Cole, SW				Fredrickson, Barbara L.; Grewen, Karen M.; Algoe, Sara B.; Firestine, Ann M.; Arevalo, Jesusa M. G.; Ma, Jeffrey; Cole, Steve W.			Psychological Well-Being and the Human Conserved Transcriptional Response to Adversity	PLOS ONE			English	Article							MENTAL-HEALTH-CONTINUUM; HAPPINESS; MODEL	Research in human social genomics has identified a conserved transcriptional response to adversity (CTRA) characterized by up-regulated expression of pro-inflammatory genes and down-regulated expression of Type I interferon-and antibody-related genes. This report seeks to identify the specific aspects of positive psychological well-being that oppose such effects and predict reduced CTRA gene expression. In a new confirmation study of 122 healthy adults that replicated the approach of a previously reported discovery study, mixed effect linear model analyses identified a significant inverse association between expression of CTRA indicator genes and a summary measure of eudaimonic well-being from the Mental Health Continuum - Short Form. Analyses of a 2-representation of eudaimonia converged in finding correlated psychological and social subdomains of eudaimonic well-being to be the primary carriers of CTRA associations. Hedonic well-being showed no consistent CTRA association independent of eudaimonic well-being, and summary measures integrating hedonic and eudaimonic well-being showed less stable CTRA associations than did focal measures of eudaimonia (psychological and social well-being). Similar results emerged from analyses of pooled discovery and confirmation samples (n = 198). Similar results also emerged from analyses of a second new generalization study of 107 healthy adults that included the more detailed Ryff Scales of Psychological Well-being and found this more robust measure of eudaimonic well-being to also associate with reduced CTRA gene expression. Five of the 6 major sub-domains of psychological well-being predicted reduced CTRA gene expression when analyzed separately, and 3 remained distinctively prognostic in mutually adjusted analyses. All associations were independent of demographic characteristics, health-related confounders, and RNA indicators of leukocyte subset distribution. These results identify specific sub-dimensions of eudaimonic well-being as promising targets for future interventions to mitigate CTRA gene expression, and provide no support for any independent favorable contribution from hedonic well-being.	[Fredrickson, Barbara L.; Algoe, Sara B.; Firestine, Ann M.] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; [Grewen, Karen M.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC USA; [Arevalo, Jesusa M. G.; Ma, Jeffrey; Cole, Steve W.] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA; [Cole, Steve W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Med, Los Angeles, CA 90024 USA; [Cole, Steve W.] Univ Calif Los Angeles, Sch Med, Norman Cousins Ctr, Los Angeles, CA 90024 USA; [Cole, Steve W.] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA USA; [Cole, Steve W.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Fredrickson, BL (corresponding author), Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA.	blf@unc.edu			National Institutes of Health [R01NR012899, R01CA116778, P30AG107265]; NATIONAL CANCER INSTITUTE [R01CA116778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was funded by grants from the National Institutes of Health (http://www.nih.gov/): R01NR012899 (BF), R01CA116778 (SC), and P30AG107265 (SC). R01NR012899 is supported by the National Institutes of Health Common Fund, which is managed by the National Institutes of Health Office of the Director/Office of Strategic Coordination. The funder played no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, OXFORD HDB PSYCHONEU, DOI DOI 10.1093/OXFORDHB/9780195394399.013.0003; [Anonymous], BRIEF DESCRIPTION ME; Archontaki D, 2012, GENETIC INFLUENCES P; Brown NJL, 2014, P NATL ACAD SCI USA, V111, P12705, DOI 10.1073/pnas.1407057111; Cole SW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004601; Cole Steven W, 2014, Proc Natl Acad Sci U S A, V111, pE3581, DOI 10.1073/pnas.1413316111; Cole SW, 2013, AM J PUBLIC HEALTH, V103, P84, DOI 10.2105/AJPH.2012.301183; Cole SW, 2013, P NATL ACAD SCI USA, V110, pE4184, DOI 10.1073/pnas.1316887110; Cole SW, 2012, P NATL ACAD SCI USA, V109, P20578, DOI 10.1073/pnas.1218253109; Coyne JC, 2013, P NATL ACAD SCI USA, V110, pE4183, DOI 10.1073/pnas.1315212110; Finch CE, 2007, BIOL HUMAN LONGEVITY; Fredrickson BL, 2013, P NATL ACAD SCI USA, V110, P13684, DOI 10.1073/pnas.1305419110; Fredrickson BL, 2014, RESPONSE BROWN CRITI; Gallagher MW, 2009, J PERS, V77, P1025, DOI 10.1111/j.1467-6494.2009.00573.x; Harrington D, 2009, CONFIRMATORY FACTOR, DOI DOI 10.1093/ACPROF:OSO/9780195339888.001.0001; Illumina Inc, 2011, IMP HUM HT 12 EXPR B; Irwin MR, 2011, NAT REV IMMUNOL, V11, P625, DOI 10.1038/nri3042; Joshanloo M, 2013, PERS INDIV DIFFER, V55, P755, DOI 10.1016/j.paid.2013.06.002; Keyes C.L.M., 2005, ADOLESCENT FAMILY HL, V4, P3, DOI DOI 10.1007/S11205-005-5550-3; Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197; Keyes CLM, 1998, SOC PSYCHOL QUART, V61, P121, DOI 10.2307/2787065; Keyes CLM, 2008, CLIN PSYCHOL PSYCHOT, V15, P181, DOI 10.1002/cpp.572; Keyes CLM, 2012, AM J PUBLIC HEALTH, V102, P2164, DOI 10.2105/AJPH.2012.300918; Keyes CLM, 2010, AM J PUBLIC HEALTH, V100, P2379, DOI 10.2105/AJPH.2010.193615; Kutner M., 2004, APPL LINEAR STAT MOD; Lamers SMA, 2011, J CLIN PSYCHOL, V67, P99, DOI 10.1002/jclp.20741; MacCallum RC, 2001, MULTIVAR BEHAV RES, V36, P611, DOI 10.1207/S15327906MBR3604_06; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Preininger M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003362; Rietveld CA, 2013, P NATL ACAD SCI USA; Robitschek C, 2009, J COUNS PSYCHOL, V56, P321, DOI 10.1037/a0013954; Ryff CD, 2008, J HAPPINESS STUD, V9, P13, DOI 10.1007/s10902-006-9019-0; Ryff CD, 2014, PSYCHOTHER PSYCHOSOM, V83, P10, DOI 10.1159/000353263; Ryff CD, 2006, PSYCHOTHER PSYCHOSOM, V75, P85, DOI 10.1159/000090892; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Ryff CD, 1996, PSYCHOTHER PSYCHOSOM, V65, P14, DOI 10.1159/000289026; Ryff CD, 2004, PHILOS T R SOC B, V359, P1383, DOI 10.1098/rstb.2004.1521; Sloan EK, 2007, J NEUROSCI, V27, P8857, DOI 10.1523/JNEUROSCI.1247-07.2007; Stone AA., 2013, SUBJECTIVE WELL BEIN; Tung J, 2012, P NATL ACAD SCI USA, V109, P6490, DOI 10.1073/pnas.1202734109; WATERMAN AS, 1993, J PERS SOC PSYCHOL, V64, P678, DOI 10.1037/0022-3514.64.4.678	44	107	107	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121839	10.1371/journal.pone.0121839	http://dx.doi.org/10.1371/journal.pone.0121839			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811656	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700148
J	Kriete, T; Noelle, DC				Kriete, Trenton; Noelle, David C.			Dopamine and the Development of Executive Dysfunction in Autism Spectrum Disorders	PLOS ONE			English	Article							PREFRONTAL CORTEX; CHILDREN; PERFORMANCE; INTERFERENCE; DISSOCIATION; INDIVIDUALS; INHIBITION; MECHANISMS; BEHAVIORS; PATTERNS	Persons with autism regularly exhibit executive dysfunction (ED), including problems with deliberate goal-directed behavior, planning, and flexible responding in changing environments. Indeed, this array of deficits is sufficiently prominent to have prompted a theory that executive dysfunction is at the heart of these disorders. A more detailed examination of these behaviors reveals, however, that some aspects of executive function remain developmentaly appropriate. In particular, while people with autism often have difficulty with tasks requiring cognitive flexibility, their fundamental cognitive control capabilities, such as those involved in inhibiting an inappropriate but relatively automatic response, show no significant impairment on many tasks. In this article, an existing computational model of the prefrontal cortex and its role in executive control is shown to explain this dichotomous pattern of behavior by positing abnormalities in the dopamine-based modulation of frontal systems in individuals with autism. This model offers excellent qualitative and quantitative fits to performance on standard tests of cognitive control and cognitive flexibility in this clinical population. By simulating the development of the prefrontal cortex, the computational model also offers a potential explanation for an observed lack of executive dysfunction early in life.	[Kriete, Trenton] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Noelle, David C.] Univ Calif Merced, Cognit & Informat Sci, Merced, CA USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Merced	Kriete, T (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	Trenton.Kriete@Colorado.edu			University start-up funds	University start-up funds	Research was conducted as part of the first author's dissertation work at the University of California, Merced. Dr. David Noelle used University start-up funds to help support this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NC, 2009, J AUTISM DEV DISORD, V39, P1112, DOI 10.1007/s10803-009-0721-8; Barik S, 1996, BRAIN RES, V737, P347, DOI 10.1016/0006-8993(96)00964-X; Bennetto L, 1996, CHILD DEV, V67, P1816, DOI 10.2307/1131734; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Borta A, 2007, J NEUROCHEM, V100, P587, DOI 10.1111/j.1471-4159.2006.04241.x; Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Christ SE, 2007, J AUTISM DEV DISORD, V37, P1155, DOI 10.1007/s10803-006-0259-y; COHEN IL, 1994, BIOL PSYCHIAT, V36, P5, DOI 10.1016/0006-3223(94)90057-4; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; DUNBAR K, 1984, J EXP PSYCHOL HUMAN, V10, P622, DOI 10.1037/0096-1523.10.5.622; Fernell E, 1997, DEV MED CHILD NEUROL, V39, P313; Folsom TD, 2011, ADV NEUROBIOL, V1, P383, DOI 10.1007/978-1-4419-7104-3_13; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Graybiel AM, 2000, TRENDS NEUROSCI, V23, pS71, DOI 10.1016/S1471-1931(00)00027-6; Griffith EM, 1999, CHILD DEV, V70, P817, DOI 10.1111/1467-8624.00059; Grossberg S, 2006, PSYCHOL REV, V113, P483, DOI 10.1037/0033-295X.113.3.483; Gustafsson L, 1997, BIOL PSYCHIAT, V42, P1138, DOI 10.1016/S0006-3223(97)00141-8; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Houk J.C., 1994, MODELS INFORM PROCES, P215, DOI [10.7551/mitpress/4708.003.0018, DOI 10.7551/MITPRESS/4708.003.0018]; HUGHES C, 1994, NEUROPSYCHOLOGIA, V32, P477, DOI 10.1016/0028-3932(94)90092-2; Jackson ME, 2001, J NEUROSCI, V21, P676, DOI 10.1523/JNEUROSCI.21-02-00676.2001; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lopez BR, 2005, J AUTISM DEV DISORD, V35, P445, DOI 10.1007/s10803-005-5035-x; MARTINEAU J, 1992, DEV MED CHILD NEUROL, V34, P593; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; McClelland JL, 2000, J AUTISM DEV DISORD, V30, P497, DOI 10.1023/A:1005576229109; McGrath J, 1997, SCHIZOPHR RES, V26, P127, DOI 10.1016/S0920-9964(97)00070-4; Mehta MA, 2000, J NEUROSCI, V20; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 1996, J NEUROSCI, V16, P5154; Minshew NJ, 2002, NEUROPSYCHOLOGY, V16, P327, DOI 10.1037//0894-4105.16.3.327; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Loughlin C, 2000, MIND LANG, V15, P375; O'Reilly, 2007, EMERGENT NEURAL SIMU; O'reilly R.C., 2000, COMPUTATIONAL EXPLOR; Ozonoff S, 1999, J AUTISM DEV DISORD, V29, P171, DOI 10.1023/A:1023052913110; OZONOFF S, 1991, J CHILD PSYCHOL PSYC, V32, P1081, DOI 10.1111/j.1469-7610.1991.tb00351.x; Ozonoff S, 1997, J AUTISM DEV DISORD, V27, P59, DOI 10.1023/A:1025821222046; PRIOR M, 1990, J AUTISM DEV DISORD, V20, P581, DOI 10.1007/BF02216063; Qiu AQ, 2010, J AM ACAD CHILD PSY, V49, P539, DOI 10.1016/j.jaac.2010.02.012; Ralph RJ, 2001, J NEUROSCI, V21, P305, DOI 10.1523/JNEUROSCI.21-01-00305.2001; Ralph-Williams RJ, 2003, BIOL PSYCHIAT, V53, P352, DOI 10.1016/S0006-3223(02)01489-0; Rinehart NJ, 2006, DEV MED CHILD NEUROL, V48, P819, DOI 10.1017/S0012162206001769; Rinehart NJ, 2001, J AUTISM DEV DISORD, V31, P79, DOI 10.1023/A:1005617831035; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; Russell J, 1999, J AUTISM DEV DISORD, V29, P103, DOI 10.1023/A:1023084425406; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2003, CEREB CORTEX, V13, P1242, DOI 10.1093/cercor/bhg094; Staal WG, 2012, J AUTISM DEV DISORD, V42, P885, DOI 10.1007/s10803-011-1312-z; Starr MS, 1996, SYNAPSE, V22, P159, DOI 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1007/BF00115009; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Triesch J, 2006, DEVELOPMENTAL SCI, V9, P125, DOI 10.1111/j.1467-7687.2006.00470.x; Tsai LY, 1999, PSYCHOSOM MED, V61, P651, DOI 10.1097/00006842-199909000-00008; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Turner MA, 1999, J CHILD PSYCHOL PSYC, V40, P189, DOI 10.1111/1469-7610.00432	62	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121605	10.1371/journal.pone.0121605	http://dx.doi.org/10.1371/journal.pone.0121605			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811610	Green Published, gold			2022-12-26	WOS:000356353700120
J	Motawi, TMK; Rizk, SM; Shaker, OG; Mokhtar, OZH				Motawi, Tarek M. K.; Rizk, Sherine M.; Shaker, Olfat G.; Mokhtar, Olfat Z. H.			MicroRNAs as Predictor Markers for Response to Interferon Treatment of Chronic Hepatitis C Genotype-4 in Egyptian Patients	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; VIRUS; MIR-122; TRANSLATION; MODULATION; EXPRESSION	Background Hepatitis C virus genotype 4 (HCV-4) infection is common in the Middle East and Africa, with an extraordinarily high prevalence in Egypt. MicroRNAs (miRNAs) play an important role in various diseases, including HCV infection. The aim of the present study was to assess serum miR-122, miR-221 and miR-21 expression profiles in HCV-4 patients prior to treatment with HCV-4 combination therapy (pegylated alpha interferon and ribavirin) and to determine whether the miRNAs were associated with the drug response. Methods RNA was extracted from pretreatment serum samples, and miR-122, miR-221 and miR-21 levels were measured by quantitative PCR. The results were compared among patients with sustained virological responses (SVR) and non-responders (NR). Results The expression levels of miR-21 and miR-122 were significantly different between the SVR and NR groups. Receiver operator characteristic (ROC) analysis revealed that the sensitivity, specificity and positive predictive values of miR-21 were 82.2%, 77.3% and 88.1%, respectively, with a cut-off value of 1.7. The sensitivity, specificity and positive predictive values of miR-122 were 68.9%, 59.1% and 77.5%, respectively, with a cut-off value of 3.5. Conclusion and Significance miR-21 and miR-122 might be useful predictors for SVR in HCV-4 patients prior to the administration of combination therapy. A higher predictive response power was obtained for miR-21 than for miR-122. These results should reduce ineffective treatments.	[Motawi, Tarek M. K.; Rizk, Sherine M.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Shaker, Olfat G.] Cairo Univ, Fac Med, Dept Med Biochem, Cairo, Egypt; [Mokhtar, Olfat Z. H.] Cairo Univ, New Educ El Kasr El Aini Hosp, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Rizk, SM (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	sherine.abdelaziz@pharma.cu.edu.eg	O, Shaker/Y-6125-2019; Issa, Randa @M.T/E-7144-2019; Shaker, Olfat G/S-2010-2017	O, Shaker/0000-0002-3031-3599; Issa, Randa @M.T/0000-0003-0619-1234; Motawi, Tarek/0000-0001-8925-9702				Backus LI, 2007, HEPATOLOGY, V46, P37, DOI 10.1002/hep.21662; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Budhu A, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-37; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; El-Zayadi AR, 2005, WORLD J GASTROENTERO, V11, P5193; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Guarnieri DJ, 2008, ANN MED, V40, P197, DOI 10.1080/07853890701771823; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hezode Christophe, 2011, Clin Res Hepatol Gastroenterol, V35 Suppl 2, pS52, DOI 10.1016/S2210-7401(11)70008-0; Hoffmann TW, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-109; Johannes H, 2011, EUR J MED SCI, V141; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Males S, 2007, ANTIVIR THER, V12, P797; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Park JK, 2011, CANCER RES, V71, P7608, DOI 10.1158/0008-5472.CAN-11-1144; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Ramachandran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070744; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sharma AD, 2011, HEPATOLOGY, V53, P1651, DOI 10.1002/hep.24243; Shrivastava S, 2013, WORLD J HEPATOL, V5, P479, DOI 10.4254/wjh.v5.i9.479; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Tao H, 2011, PLOS ONE, V7; Villanueva RA, 2010, ANTIVIR RES, V88, P119, DOI 10.1016/j.antiviral.2010.07.004; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984; Zhang G, 2010, CURR GENOMICS, V11, P311, DOI 10.2174/138920210791616671; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	42	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121524	10.1371/journal.pone.0121524	http://dx.doi.org/10.1371/journal.pone.0121524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811198	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700108
J	Bandiera, FC; Anteneh, B; Le, T; Delucchi, K; Guydish, J				Bandiera, Frank C.; Anteneh, Berhanu; Le, Thao; Delucchi, Kevin; Guydish, Joseph			Tobacco-Related Mortality among Persons with Mental Health and Substance Abuse Problems	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; NICOTINE DEPENDENCE; CIGARETTE-SMOKING; DEPRESSION; ILLNESS; ALCOHOL; COCAINE; ASSOCIATION; DEATHS	The rate of cigarette smoking is greater among persons with mental health and/or substance abuse problems. There are few population-based datasets with which to study tobacco mortality in these vulnerable groups. The Oregon Health Authority identified persons who received publicly-funded mental health or substance abuse services from January 1996 through December 2005. These cases were then matched to Oregon Vital Statistics records for all deaths (N= 148,761) in the period 1999-2005. The rate of tobacco-related death rates was higher among persons with substance abuse problems only (53.6%) and those with both substance abuse and mental health problems (46.8%), as compared to the general population (30.7%). The rate of tobacco-related deaths among persons with mental health problems (30%) was similar to that in the general population. Persons receiving substance abuse treatment alone, or receiving both substance abuse and mental health treatment, were more likely to die and more likely to die prematurely of tobacco-related causes as compared to the general population. Persons receiving mental health services alone were not more likely to die of tobacco-related causes, but tobacco-related deaths occurred earlier in this population.	[Bandiera, Frank C.] Univ Texas Dallas, Sch Publ Hlth, Dallas, TX 75230 USA; [Anteneh, Berhanu] Oregon Hlth Author, Addict & Mental Hlth Div, Salem, OR USA; [Le, Thao; Delucchi, Kevin; Guydish, Joseph] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA USA	University of Texas System; University of Texas Dallas; University of California System; University of California San Francisco	Bandiera, FC (corresponding author), Univ Texas Dallas, Sch Publ Hlth, Dallas, TX 75230 USA.	Frank.Bandiera@UTSouthwestern.edu		Guydish, Joseph/0000-0003-2115-3340	FDA/NCI [P30CA082103-14S4]; San Francisco Treatment Research Center [P50 DA009253];  [5R25CA113710]; NATIONAL CANCER INSTITUTE [R25CA113710, P30CA082103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA009253] Funding Source: NIH RePORTER	FDA/NCI; San Francisco Treatment Research Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant number 5R25CA113710, by an FDA/NCI supplement to the Helen Diller Family Comprehensive Cancer Center (P30CA082103-14S4), and by the San Francisco Treatment Research Center (P50 DA009253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burling TA, 1996, J SUBST ABUSE, V8, P445, DOI 10.1016/S0899-3289(96)90005-X; Centers for Disease Control and Prevention, MED COV TOB CESS SER; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; DALACK GW, 1995, AM J PSYCHIAT, V152, P398; DREHER KF, 1967, INT J ADDICT, V2, P258; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; Gale CR, 2012, ARCH GEN PSYCHIAT, V69, P823, DOI 10.1001/archgenpsychiatry.2011.2000; Gfroerer J, 2013, MMWR-MORBID MORTAL W, V62, P81; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Guydish J, PREDICTORS TOBACCO U; Guydish Joseph, 2012, Am J Public Health, V102, pe17, DOI 10.2105/AJPH.2011.300590; Guydish J, 2011, NICOTINE TOB RES, V13, P401, DOI 10.1093/ntr/ntr048; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hiroeh U, 2008, J PSYCHOSOM RES, V64, P275, DOI 10.1016/j.jpsychores.2007.09.008; Hoang U, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5422; HSER YI, 1994, PREV MED, V23, P61, DOI 10.1006/pmed.1994.1009; Hurt RD, 1996, JAMA-J AM MED ASSOC, V275, P1097, DOI 10.1001/jama.275.14.1097; Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498; Lai SH, 2000, J ADDICT DIS, V19, P11, DOI 10.1300/J069v19n04_02; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P899, DOI 10.4088/JCP.v68n0612; Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539; McAnulty JM HD, 1994, TOBACCO CONTROL; MCCARRICK AK, 1986, HOSP COMMUNITY PSYCH, V37, P289; McGinty EE, 2012, PSYCHIAT SERV, V63, P714, DOI 10.1176/appi.ps.201100169; MECHANIC D, 1995, MILBANK Q, V73, P19, DOI 10.2307/3350312; Mino A, 1999, Crisis, V20, P28, DOI 10.1027//0227-5910.20.1.28; Oregon Department of Human Services Addiction and Mental Health Division, 2008, MEAS PREM MORT OR; Penninx BWJH, 2001, ARCH GEN PSYCHIAT, V58, P221, DOI 10.1001/archpsyc.58.3.221; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Prochaska J, 2004, PSYCHIAT SERV, V55, P1265, DOI 10.1176/appi.ps.55.11.1265; Prochaska JJ, 2011, NEW ENGL J MED, V365, P196, DOI 10.1056/NEJMp1105248; Prochaska JJ, 2010, DRUG ALCOHOL DEPEN, V110, P177, DOI 10.1016/j.drugalcdep.2010.03.002; Rohde P, 2003, NICOTINE TOB RES, V5, P85, DOI 10.1080/1462220031000070507; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; Schroeder SA, 2011, AM J PSYCHIAT, V168, P876, DOI 10.1176/appi.ajp.2011.11050708; Schroeder SA, 2010, ANNU REV PUBL HEALTH, V31, P297, DOI 10.1146/annurev.publhealth.012809.103701; Schroeder SA, 2009, JAMA-J AM MED ASSOC, V301, P522, DOI 10.1001/jama.2008.982; Sherman SE, 2008, BMJ-BRIT MED J, V336, P1016, DOI 10.1136/bmj.39510.805266.BE; Szatkowski L, 2013, ADDICTION; Thomas AR, 2001, TOB CONTROL, V10, P161, DOI 10.1136/tc.10.2.161; USDHHS, 2014, HLTH CONS SMOK 50 YE; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; Williams SC, 2009, TOB CONTROL, V18, P451, DOI 10.1136/tc.2009.030494; Wiseman EJ, 2000, ARCH GEN PSYCHIAT, V57, P512, DOI 10.1001/archpsyc.57.5.512; Wiseman EJ, 1996, AM J DRUG ALCOHOL AB, V22, P577, DOI 10.3109/00952999609001682; Zevallos JC, 2004, AM J PUBLIC HEALTH, V94, P1610, DOI 10.2105/AJPH.94.9.1610; ZIEDONIS DM, 1994, HOSP COMMUNITY PSYCH, V45, P204	50	96	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120581	10.1371/journal.pone.0120581	http://dx.doi.org/10.1371/journal.pone.0120581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807109	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000086
J	Dyson, RM; Palliser, HK; Latter, JL; Kelly, MA; Chwatko, G; Glowacki, R; Wright, IMR				Dyson, Rebecca M.; Palliser, Hannah K.; Latter, Joanna L.; Kelly, Megan A.; Chwatko, Grazyna; Glowacki, Rafal; Wright, Ian M. R.			Interactions of the Gasotransmitters Contribute to Microvascular Tone (Dys) regulation in the Preterm Neonate	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GLUCOCORTICOID-MEDIATED HYPERTENSION; INDUCED CEREBROVASCULAR DILATION; RESPIRATORY-DISTRESS-SYNDROME; CYSTATHIONINE BETA-SYNTHASE; OXYGENASE-1 GENE-EXPRESSION; VASCULAR ENDOTHELIAL-CELLS; CARBON-MONOXIDE PRODUCTION; SMOOTH-MUSCLE RELAXANT; 1A RECEPTOR GENE	Background & Aims Hydrogen sulphide (H2S), nitric oxide (NO), and carbon monoxide (CO) are involved in transitional microvascular tone dysregulation in the preterm infant; however there is conflicting evidence on the interaction of these gasotransmitters, and their overall contribution to the microcirculation in newborns is not known. The aim of this study was to measure the levels of all 3 gasotransmitters, characterise their interrelationships and elucidate their combined effects on microvascular blood flow. Methods 90 preterm neonates were studied at 24h postnatal age. Microvascular studies were performed by laser Doppler. Arterial COHb levels (a measure of CO) were determined through co-oximetry. NO was measured as nitrate and nitrite in urine. H2S was measured as thiosulphate by liquid chromatography. Relationships between levels of the gasotransmitters and microvascular blood flow were assessed through partial correlation controlling for the influence of gestational age. Structural equation modelling was used to examine the combination of these effects on microvascular blood flow and derive a theoretical model of their interactions. Results No relationship was observed between NO and CO (p = 0.18, r = 0.18). A positive relationship between NO and H2S (p = 0.008, r = 0.28) and an inverse relationship between CO and H2S (p = 0.01, r = -0.33) exists. Structural equation modelling was used to examine the combination of these effects on microvascular blood flow. The model with the best fit is presented. Conclusions The relationships between NO and H2S, and CO and H2S may be of importance in the preterm newborn, particularly as NO levels in males are associated with higher H2S levels and higher microvascular blood flow and CO in females appears to convey protection against vascular dysregulation. Here we present a theoretical model of these interactions and their overall effects on microvascular flow in the preterm newborn, upon which future mechanistic studies may be based.	[Dyson, Rebecca M.; Palliser, Hannah K.; Latter, Joanna L.; Wright, Ian M. R.] Hunter Med Res Inst, Mothers & Babies Res Ctr, New Lambton Hts, NSW 2305, Australia; [Dyson, Rebecca M.; Latter, Joanna L.; Wright, Ian M. R.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Dyson, Rebecca M.; Kelly, Megan A.; Wright, Ian M. R.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Dyson, Rebecca M.; Kelly, Megan A.; Wright, Ian M. R.] Univ Wollongong, Grad Sch Med, Wollongong, NSW 2522, Australia; [Palliser, Hannah K.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Chwatko, Grazyna; Glowacki, Rafal] Univ Lodz, Fac Chem, Dept Environm Chem, PL-90236 Lodz, Poland; [Wright, Ian M. R.] John Hunter Childrens Hosp, Kaleidoscope Neonatal Intens Care Unit, New Lambton Hts, NSW 2305, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Wollongong; University of Wollongong; University of Newcastle; University of Lodz	Wright, IMR (corresponding author), Hunter Med Res Inst, Mothers & Babies Res Ctr, New Lambton Hts, NSW 2305, Australia.	iwright@uow.edu.au	Chwatko, Grażyna/R-8757-2016; Kelly, Megan/D-6686-2014	Glowacki, Rafal/0000-0003-0071-1470; Chwatko, Grazyna/0000-0001-9247-5131; Kelly, Megan/0000-0002-0877-126X; Dyson, Rebecca/0000-0003-2319-6897; Latter, Joanna/0000-0002-8499-0069; Palliser, Hannah/0000-0001-5783-9737; Wright, Ian/0000-0001-5337-0134	National Health and Medical Research Council [569285]; John Hunter Hospital Charitable Trust; Hunter Children's Research Foundation; University of Lodz	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); John Hunter Hospital Charitable Trust; Hunter Children's Research Foundation; University of Lodz	This study was funded by a National Health and Medical Research Council Project Grant awarded to IMRW (ID#569285; https://www.nhmrc.gov.au/) and John Hunter Hospital Charitable Trust Project Grants awarded to IMRW, HKP and RMD. RMD was supported by the Hunter Children's Research Foundation. The HPLC work performed by GC and RG was supported by the University of Lodz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz MJ, 2001, BBA-GEN SUBJECTS, V1526, P13, DOI 10.1016/S0304-4165(01)00112-X; Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906; Altaany Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005478; Amey M, 2008, PEDIATR CRIT CARE ME, V9, P76, DOI 10.1097/01.PCC.0000298550.29453.7D; APPLEGARTH DA, 1975, CLIN CHIM ACTA, V64, P83, DOI 10.1016/0009-8981(75)90148-5; APPLEGARTH DA, 1968, CLIN CHIM ACTA, V22, P131, DOI 10.1016/0009-8981(68)90348-3; Baum M, 2008, J AM SOC NEPHROL, V19, P1251, DOI 10.1681/ASN.2008040410; Bentler P M, 1992, Stat Methods Med Res, V1, P159, DOI 10.1177/096228029200100203; Beran Tanya N, 2010, BMC Res Notes, V3, P267, DOI 10.1186/1756-0500-3-267; Blecharz KG, 2014, BIOL CELL, V106, DOI 10.1111/boc.201300083; Bouton C, 2000, J BIOL CHEM, V275, P32688, DOI 10.1074/jbc.275.42.32688; Carson RJ, 2004, SIGNAL TRANSDUCTION; Chen KJ, 2006, FREE RADICAL BIO MED, V41, P668, DOI 10.1016/j.freeradbiomed.2006.05.009; Chwatko G, 2009, TALANTA, V79, P229, DOI 10.1016/j.talanta.2009.03.040; Datta PK, 1999, KIDNEY INT, V55, P1734, DOI 10.1046/j.1523-1755.1999.00429.x; Ding Y, 1999, EUR J BIOCHEM, V264, P854, DOI 10.1046/j.1432-1327.1999.00677.x; Durante W, 1997, CIRC RES, V80, P557, DOI 10.1161/01.RES.80.4.557; Dyson RM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12145; Dyson RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105085; Dyson RM, 2012, PEDIATR RES, V71, P20, DOI 10.1038/pr.2011.9; Dyson RM, 2014, J PEDIAT CHILD HLTH, V50, P40; Eiby YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068763; Farkas I, 2008, EUR J PEDIATR, V167, P1379, DOI 10.1007/s00431-008-0673-6; Foresti R, 2003, BIOCHEM J, V372, P381, DOI 10.1042/BJ20021516; GRUNFELD JP, 1990, HORM RES, V34, P111, DOI 10.1159/000181807; HANDA M, 1984, HYPERTENSION, V6, P236, DOI 10.1161/01.HYP.6.2_Pt_1.236; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ingi T, 1996, NEURON, V16, P835, DOI 10.1016/S0896-6273(00)80103-8; Jin HF, 2006, ACTA PHARMACOL SIN, V27, P1561, DOI 10.1111/j.1745-7254.2006.00425.x; Kavdia M, 2004, J APPL PHYSIOL, V97, P293, DOI 10.1152/japplphysiol.00049.2004; Kleinert H, 1996, MOL PHARMACOL, V49, P15; Knecht KR, 2010, AM J PHYSIOL-HEART C, V299, pH70, DOI 10.1152/ajpheart.00258.2010; Krediet TG, 2002, BIOL NEONATE, V82, P150, DOI 10.1159/000063609; Kubo A, 2007, TOXICOLOGY, V241, P92, DOI 10.1016/j.tox.2007.08.087; Kubo S, 2007, TOXICOLOGY, V232, P138, DOI 10.1016/j.tox.2006.12.023; Leffler CW, 2005, AM J PHYSIOL-HEART C, V289, pH1442, DOI 10.1152/ajpheart.00464.2005; Leffler CW, 2005, AM J PHYSIOL-HEART C, V289, pH432, DOI 10.1152/ajpheart.01195.2004; Leffler CW, 2001, AM J PHYSIOL-HEART C, V280, pH1490, DOI 10.1152/ajpheart.2001.280.4.H1490; Liang MY, 2000, AM J PHYSIOL-RENAL, V279, pF728, DOI 10.1152/ajprenal.2000.279.4.F728; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Motterlini R, 1996, AM J PHYSIOL-HEART C, V270, pH107, DOI 10.1152/ajpheart.1996.270.1.H107; Oh GS, 2006, FREE RADICAL BIO MED, V41, P106, DOI 10.1016/j.freeradbiomed.2006.03.021; Ondrias K, 2008, PFLUG ARCH EUR J PHY, V457, P271, DOI 10.1007/s00424-008-0519-0; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Polglase GR, 2012, REPROD FERT DEVELOP, V24, P510, DOI 10.1071/RD11121; Pong WW, 2009, J NEUROSCI RES, V87, P2356, DOI 10.1002/jnr.22042; SATO A, 1994, J HYPERTENS, V12, P511; Sheng WS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-51; Simmons WW, 1996, J BIOL CHEM, V271, P23928, DOI 10.1074/jbc.271.39.23928; SINGH K, 1995, J BIOL CHEM, V270, P28471; Soriano RN, 2013, CAN J PHYSIOL PHARM, V91, P861, DOI 10.1139/cjpp-2013-0028; Stark MJ, 2011, J MATERN-FETAL NEO M, V24, P1215, DOI 10.3109/14767058.2011.569618; Stark MJ, 2009, PEDIATRICS, V124, P277, DOI 10.1542/peds.2008-0877; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Thom SR, 1997, CHEM RES TOXICOL, V10, P1023, DOI 10.1021/tx970041h; Thorup C, 1999, AM J PHYSIOL-RENAL, V277, pF882, DOI 10.1152/ajprenal.1999.277.6.F882; UNO S, 1994, BIOCHEM BIOPH RES CO, V204, P210, DOI 10.1006/bbrc.1994.2446; Wallerath T, 1999, P NATL ACAD SCI USA, V96, P13357, DOI 10.1073/pnas.96.23.13357; Wallerath T, 2004, NITRIC OXIDE-BIOL CH, V10, P36, DOI 10.1016/j.niox.2004.01.008; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2014, TRENDS BIOCHEM SCI, V39, P227, DOI 10.1016/j.tibs.2014.03.003; Wen C, 2000, CLIN EXP PHARMACOL P, V27, P887, DOI 10.1046/j.1440-1681.2000.03354.x; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; Whitworth JA, 2002, J HYPERTENS, V20, P1035, DOI 10.1097/00004872-200206000-00003; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Zhang QY, 2004, BIOCHEM BIOPH RES CO, V317, P30, DOI 10.1016/j.bbrc.2004.02.176; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu XY, 2010, CELL MOL LIFE SCI, V67, P1119, DOI 10.1007/s00018-009-0250-9	77	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121621	10.1371/journal.pone.0121621	http://dx.doi.org/10.1371/journal.pone.0121621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807236	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000167
J	Gauthier, JP; Outreman, Y; Mieuzet, L; Simon, JC				Gauthier, Jean-Pierre; Outreman, Yannick; Mieuzet, Lucie; Simon, Jean-Christophe			Bacterial Communities Associated with Host-Adapted Populations of Pea Aphids Revealed by Deep Sequencing of 16S Ribosomal DNA	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM; GUT MICROBIOTA; FACULTATIVE SYMBIONT; SECONDARY SYMBIONTS; ERWINIA APHIDICOLA; PLANT USE; INSECT; DIVERSITY; DIVERGENCE; INFECTION	Associations between microbes and animals are ubiquitous and hosts may benefit from harbouring microbial communities through improved resource exploitation or resistance to environmental stress. The pea aphid, Acyrthosiphon pisum, is the host of heritable bacterial symbionts, including the obligate endosymbiont Buchnera aphidicola and several facultative symbionts. While obligate symbionts supply aphids with key nutrients, facultative symbionts influence their hosts in many ways such as protection against natural enemies, heat tolerance, color change and reproduction alteration. The pea aphid also encompasses multiple plant-specialized biotypes, each adapted to one or a few legume species. Facultative symbiont communities differ strongly between biotypes, although bacterial involvement in plant specialization is uncertain. Here, we analyse the diversity of bacterial communities associated with nine biotypes of the pea aphid complex using amplicon pyrosequencing of 16S rRNA genes. Combined clustering and phylogenetic analyses of 16S sequences allowed identifying 21 bacterial OTUs (Operational Taxonomic Unit). More than 98% of the sequencing reads were assigned to known pea aphid symbionts. The presence of Wolbachia was confirmed in A. pisum while Erwinia and Pantoea, two gut associates, were detected in multiple samples. The diversity of bacterial communities harboured by pea aphid biotypes was very low, ranging from 3 to 11 OTUs across samples. Bacterial communities differed more between than within biotypes but this difference did not correlate with the genetic divergence between biotypes. Altogether, these results confirm that the aphid microbiota is dominated by a few heritable symbionts and that plant specialization is an important structuring factor of bacterial communities associated with the pea aphid complex. However, since we examined the microbiota of aphid samples kept a few generations in controlled conditions, it may be that bacterial diversity was underestimated due to the possible loss of environmental or transient taxa.	[Gauthier, Jean-Pierre; Mieuzet, Lucie] INRA, IGEPP, UMR 1349, F-35653 Le Rheu, France; [Outreman, Yannick; Simon, Jean-Christophe] Agrocampus Ouest, IGEPP, UMR 1349, F-35042 Rennes, France	INRAE; Institut Agro; Agrocampus Ouest	Simon, JC (corresponding author), Agrocampus Ouest, IGEPP, UMR 1349, F-35042 Rennes, France.	jean-christophe.simon@rennes.inra.fr	Yannick, OUTREMAN/B-9309-2012	Yannick, OUTREMAN/0000-0002-7337-3049	French Research Agency [ANR-11-BSV7-005-01]; INRA Departement Sante des Plantes et Environnement; Universite Rennes 1	French Research Agency(French National Research Agency (ANR)); INRA Departement Sante des Plantes et Environnement; Universite Rennes 1	This work was supported by funds from the French Research Agency under the ANR-11-BSV7-005-01 "Speciaphid" to JCS, and from the INRA Departement Sante des Plantes et Environnement and Universite Rennes 1 to JCS and YO.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Augustinos AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028695; Bilodeau E, 2013, EVOL ECOL, V27, P165, DOI 10.1007/s10682-012-9577-z; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Brady CM, 2013, ECOL ENTOMOL, V38, P433, DOI 10.1111/een.12020; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chen DQ, 1996, CURR MICROBIOL, V33, P123, DOI 10.1007/s002849900086; Clark EL, 2012, ENVIRON ENTOMOL, V41, P1386, DOI 10.1603/EN12152; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Costechareyre D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030702; de Vries EJ, 2004, P ROY SOC B-BIOL SCI, V271, P2171, DOI 10.1098/rspb.2004.2817; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Douglas AE, 2013, J CHEM ECOL, V39, P952, DOI 10.1007/s10886-013-0308-x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Ferrari J, 2007, OECOLOGIA, V153, P323, DOI 10.1007/s00442-007-0730-2; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Frago E, 2012, TRENDS ECOL EVOL, V27, P705, DOI 10.1016/j.tree.2012.08.013; Frantz A, 2009, BIOL J LINN SOC, V97, P718, DOI 10.1111/j.1095-8312.2009.01221.x; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; Hansen AK, 2014, MOL ECOL, V23, P1473, DOI 10.1111/mec.12421; Harada H, 1996, J GEN APPL MICROBIOL, V42, P17, DOI 10.2323/jgam.42.17; Harada H, 1997, J GEN APPL MICROBIOL, V43, P349, DOI 10.2323/jgam.43.349; Harada H, 1997, J GEN APPL MICROBIOL, V43, P363, DOI 10.2323/jgam.43.363; Henry LM, 2013, CURR BIOL, V23, P1713, DOI 10.1016/j.cub.2013.07.029; Jaquiery J, 2012, MOL ECOL, V21, P5251, DOI 10.1111/mec.12048; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jing XF, 2014, MOL ECOL, V23, P1433, DOI 10.1111/mec.12637; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonardo TE, 2004, ECOL LETT, V7, P461, DOI 10.1111/j.1461-0248.2004.00602.x; McLean AHC, 2011, P ROY SOC B-BIOL SCI, V278, P760, DOI 10.1098/rspb.2010.1654; Medina RF, 2011, J EVOLUTION BIOL, V24, P761, DOI 10.1111/j.1420-9101.2010.02215.x; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nouhaud P, 2014, J EVOLUTION BIOL, V27, P2013, DOI 10.1111/jeb.12441; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Oliver KM, ANN REV ENTOMOLOGY, P247; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Sabri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074656; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi WB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003131; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Stavrinides J, 2010, ENVIRON MICROBIOL, V12, P147, DOI 10.1111/j.1462-2920.2009.02056.x; Stavrinides J, 2009, APPL ENVIRON MICROB, V75, P2230, DOI 10.1128/AEM.02860-08; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; Tsuchida T, 2014, APPL ENVIRON MICROB, V80, P525, DOI 10.1128/AEM.03049-13; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Vorwerk S, 2007, AGR FOREST ENTOMOL, V9, P57, DOI 10.1111/j.1461-9563.2006.000319.x; Wang Z, 2014, INSECT SCI, V21, P313, DOI 10.1111/1744-7917.12102	59	28	31	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120664	10.1371/journal.pone.0120664	http://dx.doi.org/10.1371/journal.pone.0120664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807173	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000094
J	Sepulveda-Varas, P; Weary, DM; Noro, M; von Keyserlingk, MAG				Sepulveda-Varas, Pilar; Weary, Daniel M.; Noro, Mirela; von Keyserlingk, Marina A. G.			Transition Diseases in Grazing Dairy Cows Are Related to Serum Cholesterol and Other Analytes	PLOS ONE			English	Article							NONESTERIFIED FATTY-ACIDS; POSTPARTUM HEALTH-STATUS; NEGATIVE-ENERGY BALANCE; SUBCLINICAL KETOSIS; REPRODUCTIVE-PERFORMANCE; PERIPARTURIENT DISEASES; FEEDING-BEHAVIOR; MILK-PRODUCTION; BODY CONDITION; BETA-HYDROXYBUTYRATE	The objectives of this study were to describe the incidence of postpartum disease and to evaluate the association with serum cholesterol concentrations during the first 3 weeks after calving in grazing dairy cows. The association between non-esterified fatty acids (NEFA), beta-hydroxybutyrate (BHBA), calcium and postpartum diseases was also evaluated. A total of 307 Holstein dairy cows from 6 commercial grazing herds in Osorno, Chile, were monitored from calving until 21 days in milk. Cases of retained placenta, clinical hypocalcemia and clinical mastitis were recorded by the farmer using established definitions. Twice weekly, cows were evaluated for metritis by the same veterinarian based on vaginal discharge and body temperature. Postpartum blood samples were collected weekly and analyzed for serum concentrations of cholesterol, NEFA, BHBA and calcium. Cows were considered as having subclinical ketosis if BHBA > 1.2 mmol/L, and subclinical hypocalcemia if calcium < 2.0 mmol/L in any of the 3 weekly samples. Overall, 56% of the cows studied developed at least one clinical or subclinical disease after calving. Incidence of individual diseases was 8.8% for retained placenta, 4.2% for clinical hypocalcemia, 11.7% for clinical mastitis, 41.1% for metritis, 19.9% for subclinical hypocalcemia and 16.6% for subclinical ketosis. Lower postpartum cholesterol in cows was associated with developing severe metritis or having more than one clinical disease after calving. For every 0.4 mmol/L decrease in serum cholesterol cows were nearly twice as likely to be diagnosed with multiple clinical diseases after calving. Higher BHBA concentrations and lower calcium concentrations during week 1 were associated with severe cases of metritis. Low serum calcium concentration during week 1 was also associated with developing more than one clinical disorder after calving. In conclusion, the incidence of postpartum diseases can be high even in grazing herds and lower serum cholesterol concentrations were associated with occurrence of clinical postpatum disorders.	[Sepulveda-Varas, Pilar; Weary, Daniel M.; von Keyserlingk, Marina A. G.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada; [Sepulveda-Varas, Pilar] Univ Austral Chile, Programa Doctorado Ciencias Vet, Valdivia, Chile; [Noro, Mirela] Univ Fed Pampa, Hosp Vet, Uruguaiana, Brazil	University of British Columbia; Universidad Austral de Chile; Universidade Federal do Pampa	von Keyserlingk, MAG (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	nina@mail.ubc.ca	Noro, Mirela/I-1394-2012; von Keyserlingk, Marina/AAB-6353-2019; Weary, Daniel M/A-8868-2010	Noro, Mirela/0000-0003-1208-3889; von Keyserlingk, Marina/0000-0002-1427-3152; Weary, Daniel M/0000-0002-0917-3982	Emerging Leaders of the Americas Program; Government of Chile's MECE Educacion Superior Program; Canada's Natural Sciences and Engineering Research Council (NSERC, Ottawa, ON, Canada)	Emerging Leaders of the Americas Program; Government of Chile's MECE Educacion Superior Program; Canada's Natural Sciences and Engineering Research Council (NSERC, Ottawa, ON, Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors are grateful for the financial support provided to PSV by the Emerging Leaders of the Americas Program and the Government of Chile's MECE Educacion Superior Program that provided the funding for her work in Canada. This project was funded in part by a Discovery grant to MVK from Canada's Natural Sciences and Engineering Research Council (NSERC, Ottawa, ON, Canada). The authors also thank Best-Fed (Osorno, Chile) for their in kind support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; BUTLER WR, 1989, J DAIRY SCI, V72, P767, DOI 10.3168/jds.S0022-0302(89)79169-4; Cavestany D, 2005, J VET MED A, V52, P1, DOI 10.1111/j.1439-0442.2004.00679.x; Chapinal N, 2011, J DAIRY SCI, V94, P4897, DOI 10.3168/jds.2010-4075; DeGaris PJ, 2008, VET J, V176, P58, DOI 10.1016/j.tvjl.2007.12.029; DOHOO IR, 1984, CAN J COMP MED, V48, P1; Dubuc J, 2010, J DAIRY SCI, V93, P5764, DOI 10.3168/jds.2010-3429; Duffield TF, 2009, J DAIRY SCI, V92, P571, DOI 10.3168/jds.2008-1507; Duffield TF, 1998, J DAIRY SCI, V81, P2866, DOI 10.3168/jds.S0022-0302(98)75846-1; EMERY RS, 1992, J NUTR, V122, P832, DOI 10.1093/jn/122.suppl_3.832; Esposito G, 2014, ANIM REPROD SCI, V144, P60, DOI 10.1016/j.anireprosci.2013.11.007; Galvao KN, 2010, J DAIRY SCI, V93, P2926, DOI 10.3168/jds.2009-2551; Gautam G, 2009, ANIM REPROD SCI, V116, P175, DOI 10.1016/j.anireprosci.2009.02.001; Goff JP, 2008, VET J, V176, P50, DOI 10.1016/j.tvjl.2007.12.020; Goff JP, 1999, VET CLIN N AM-FOOD A, V15, P619, DOI 10.1016/S0749-0720(15)30167-5; Goldhawk C, 2009, J DAIRY SCI, V92, P4971, DOI 10.3168/jds.2009-2242; Gonzalez LA, 2008, J DAIRY SCI, V91, P1017, DOI 10.3168/jds.2007-0530; Guretzky NAJ, 2006, J DAIRY SCI, V89, P188, DOI 10.3168/jds.S0022-0302(06)72083-5; Hammon DS, 2006, VET IMMUNOL IMMUNOP, V113, P21, DOI 10.1016/j.vetimm.2006.03.022; Herdt TH, 2000, VET CLIN N AM-FOOD A, V16, P215, DOI 10.1016/S0749-0720(15)30102-X; HORST RL, 1994, J DAIRY SCI, V77, P1936, DOI 10.3168/jds.S0022-0302(94)77140-X; Huzzey JM, 2007, J DAIRY SCI, V90, P3220, DOI 10.3168/jds.2006-807; Huzzey JM, 2011, J DAIRY SCI, V94, P5878, DOI 10.3168/jds.2010-3391; Ingvartsen KL, 2003, LIVEST PROD SCI, V83, P277, DOI 10.1016/S0301-6226(03)00110-6; Kaneene JB, 1997, PREV VET MED, V31, P59, DOI 10.1016/S0167-5877(96)01141-5; Kim IH, 2003, THERIOGENOLOGY, V60, P1445, DOI 10.1016/S0093-691X(03)00135-3; LeBlanc SJ, 2005, J DAIRY SCI, V88, P159, DOI 10.3168/jds.S0022-0302(05)72674-6; LIEPA GU, 1978, J NUTR, V108, P535, DOI 10.1093/jn/108.3.535; Mammalogical Society of Japan, 2009, GUID CAR US FARM AN; Martinez N, 2012, J DAIRY SCI, V95, P7158, DOI 10.3168/jds.2012-5812; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; McDougall S, 2001, NEW ZEAL VET J, V49, P60, DOI 10.1080/00480169.2001.36204; Melendez P, 2009, THERIOGENOLOGY, V72, P826, DOI 10.1016/j.theriogenology.2009.06.001; Mulligan FJ, 2008, VET J, V176, P3, DOI 10.1016/j.tvjl.2007.12.018; Oetzel GR, 2004, VET CLIN N AM-FOOD A, V20, P651, DOI 10.1016/j.cvfa.2004.06.006; Ospina PA, 2010, J DAIRY SCI, V93, P546, DOI 10.3168/jds.2009-2277; Quiroz-Rocha GF, 2009, JAVMA-J AM VET MED A, V234, P790, DOI 10.2460/javma.234.6.790; RAMBERG CF, 1984, AM J PHYSIOL, V246, pR698, DOI 10.1152/ajpregu.1984.246.5.R698; Reinhardt TA, 2011, VET J, V188, P122, DOI 10.1016/j.tvjl.2010.03.025; Ribeiro ES, 2013, J DAIRY SCI, V96, P5682, DOI 10.3168/jds.2012-6335; RUEGG PL, 1992, AM J VET RES, V53, P10; Runciman DJ, 2008, AUST VET J, V86, P205, DOI 10.1111/j.1751-0813.2008.00301.x; Santos JEP, 2010, SOC REPROD FERTIL, V67, P387; Sepulveda-Varas P, 2014, J DAIRY SCI, V97, P6334, DOI 10.3168/jds.2014-8357; Sepulveda-Varas P, 2016, APPL ANIM BEHAV SCI, V175, P8, DOI 10.1016/j.applanim.2014.09.022; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Stevenson MA, 2000, PREV VET MED, V43, P1, DOI 10.1016/S0167-5877(99)00082-3; Suthar VS, 2013, J DAIRY SCI, V96, P2925, DOI 10.3168/jds.2012-6035; THURMOND MC, 1993, J AM VET MED ASSOC, V203, P1576; Urton G, 2005, J DAIRY SCI, V88, P2843, DOI 10.3168/jds.S0022-0302(05)72965-9; Van Saun RJ, 2008, CURRENT VET THERAPY, V5th, P153; von Keyserlingk MAG, 2009, J DAIRY SCI, V92, P4101, DOI 10.3168/jds.2009-2326; Wagemann C, 2014, ARCH MED VET, V46, P121, DOI 10.4067/S0301-732X2014000100016; Washburn SP, 2002, J DAIRY SCI, V85, P105, DOI 10.3168/jds.S0022-0302(02)74058-7; Wittrock JM, 2011, J DAIRY SCI, V94, P2408, DOI 10.3168/jds.2010-3697	56	37	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122317	10.1371/journal.pone.0122317	http://dx.doi.org/10.1371/journal.pone.0122317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807462	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000217
J	Nanduri, R; Mahajan, S; Bhagyaraj, E; Sethi, K; Kalra, R; Chandra, V; Gupta, P				Nanduri, Ravikanth; Mahajan, Sahil; Bhagyaraj, Ella; Sethi, Kanupriya; Kalra, Rashi; Chandra, Vemika; Gupta, Pawan			The Active Form of Vitamin D Transcriptionally Represses Smad7 Signaling and Activates Extracellular Signal-regulated Kinase (ERK) to Inhibit the Differentiation of a Inflammatory T Helper Cell Subset and Suppress Experimental Autoimmune Encephalomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Disease; Nuclear Receptor; Phosphorylation; T Helper Cells; Transcription Target Gene; VDR; Smad7; Gene Repression; ERK; EAE	GROWTH-FACTOR-BETA; TGF-BETA; 1,25-DIHYDROXYVITAMIN D-3; D-RECEPTOR; FOXP3 EXPRESSION; RETINOIC ACID; MULTIPLE-SCLEROSIS; PROTEIN-KINASES; TH17 CELLS; CROSS-TALK	Background: Transcriptional regulation of Smads that modulate T helper (Th) cell differentiation is not well understood. Results: Active form of vitamin D (1,25(OH)(2)D-3) leads to VDR-RXR-Smad3-HDAC2 repressive complex on VDRE-Smad7 promoter. 1,25(OH)(2)D-3 activates ERK. Conclusion: 1,25(OH)(2)D-3-VDR represses Smad7 and activates ERK leading to inhibition of inflammatory T cells and EAE. Significance: TGF Smad and non-Smad MAPK are involved in 1,25(OH)(2)D-3-VDR mediated inhibition of EAE. The ability of the active form of vitamin D, 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), to transcriptionally modulate Smads to inhibit Th17 differentiation and experimental autoimmune encephalomyelitis (EAE) has not been adequately studied. This study reports modulation of Smad signaling by the specific binding of the VDR along with its heterodimeric partner RXR to the negative vitamin D response element on the promoter of Smad7, which leads to Smad7 gene repression. The vitamin D receptor-mediated increase in Smad3 expression partially explains the IL10 augmentation seen in Th17 cells. Furthermore, the VDR axis also modulates non-Smad signaling by activating ERK during differentiation of Th17 cells, which inhibits the Th17-specific genes il17a, il17f, il22, and il23r. In vivo EAE experiments revealed that, 1,25(OH)(2)D-3 suppression of EAE correlates with the Smad7 expression in the spleen and lymph nodes. Furthermore, Smad7 expression also correlates well with IL17 and IFN expression in CNS infiltered inflammatory T cells. We also observed similar gene repression of Smad7 in in vitro differentiated Th1 cells when cultured in presence of 1,25(OH)(2)D-3. The above canonical and non-canonical pathways in part address the ability of 1,25(OH)(2)D-3-VDR to inhibit EAE.	[Nanduri, Ravikanth; Mahajan, Sahil; Bhagyaraj, Ella; Sethi, Kanupriya; Kalra, Rashi; Chandra, Vemika; Gupta, Pawan] CSIR, Dept Prot Sci & Mol Biol, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Gupta, P (corresponding author), CSIR, Dept Prot Sci & Mol Biol, Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India.	pawan@imtech.res.in	NANDURI, RAVIKANTH/Q-9729-2018; Chandra, Vemika/AAK-6997-2020	NANDURI, RAVIKANTH/0000-0002-0031-2333; Chandra, Vemika/0000-0001-5360-7875; Ella, Bhagyaraj/0000-0002-5887-9228	Institute of Microbial Technology (IMTECH; a constituent laboratory of the Council of Scientific and Industrial Research)	Institute of Microbial Technology (IMTECH; a constituent laboratory of the Council of Scientific and Industrial Research)	We thank Dr. Girish Sahni for help and effort. We also thank Institute of Microbial Technology (IMTECH; a constituent laboratory of the Council of Scientific and Industrial Research) for facilities and financial support.	Aoki CA, 2005, AUTOIMMUN REV, V4, P450, DOI 10.1016/j.autrev.2005.03.006; Bruce D, 2011, INT IMMUNOL, V23, P519, DOI 10.1093/intimm/dxr045; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cantorna MT, 1998, J NUTR, V128, P68, DOI 10.1093/jn/128.1.68; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; Cao ZH, 2003, BLOOD, V101, P498, DOI 10.1182/blood-2002-05-1549; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Dkhar HK, 2014, J IMMUNOL, V193, P295, DOI 10.4049/jimmunol.1400092; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Eloranta JJ, 2012, MOL PHARMACOL, V82, P37, DOI 10.1124/mol.112.077909; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frey RS, 1997, CANCER LETT, V117, P41, DOI 10.1016/S0304-3835(97)00211-5; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Grishkan IV, 2013, P NATL ACAD SCI USA, V110, P21101, DOI 10.1073/pnas.1306072110; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Kang SW, 2012, J IMMUNOL, V188, P5276, DOI 10.4049/jimmunol.1101211; Kleiter I, 2010, BRAIN, V133, P1067, DOI 10.1093/brain/awq039; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Lambert Jr, 2001, METH MOL B, V176, P273; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Luwor RB, 2013, ONCOGENE, V32, P2433, DOI 10.1038/onc.2012.260; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Mizobucbi T, 2003, J IMMUNOL, V171, P1140, DOI 10.4049/jimmunol.171.3.1140; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Moustakas A, 2001, J CELL SCI, V114, P4359; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Narayanan R, 2004, J BIOL CHEM, V279, P47298, DOI 10.1074/jbc.M404101200; Nonn L, 2006, CANCER RES, V66, P4516, DOI 10.1158/0008-5472.CAN-05-3796; Palmer MT, 2011, J BIOL CHEM, V286, P997, DOI 10.1074/jbc.M110.163790; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Ravid A, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730525; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rizzo A, 2014, CARCINOGENESIS, V35, P1536, DOI 10.1093/carcin/bgu027; Rizzo A, 2011, CANCER RES, V71, P7423, DOI 10.1158/0008-5472.CAN-11-1895; Russell J, 1999, J BONE MINER RES, V14, P1828, DOI 10.1359/jbmr.1999.14.11.1828; Schlenner SM, 2012, J EXP MED, V209, P1529, DOI 10.1084/jem.20112646; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Spach KM, 2006, J IMMUNOL, V177, P6030, DOI 10.4049/jimmunol.177.9.6030; Spanier JA, 2012, J IMMUNOL, V189, P3188, DOI 10.4049/jimmunol.1102925; Sporici R, 2010, EUR J IMMUNOL, V40, P2751, DOI 10.1002/eji.200939975; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tan AHM, 2010, J IMMUNOL, V184, P1849, DOI 10.4049/jimmunol.0901509; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Wu W, 2007, CANCER LETT, V254, P75, DOI 10.1016/j.canlet.2007.02.013; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	70	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12222	12236		10.1074/jbc.M114.621839	http://dx.doi.org/10.1074/jbc.M114.621839			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809484	hybrid, Green Published			2022-12-26	WOS:000354388600033
J	Beydoun, MA; Dore, GA; Canas, JA; Beydoun, HA; Zonderman, AB				Beydoun, May A.; Dore, Greg A.; Canas, Jose A.; Beydoun, Hind A.; Zonderman, Alan B.			Helicobacter pylori Seropositivity's Association with Markers of Iron, 1-Carbon Metabolism, and Antioxidant Status among US Adults: A Structural Equations Modeling Approach	PLOS ONE			English	Article							TRANSFERRIN SATURATION LEVELS; MICRONUTRIENT LEVELS; DEFICIENCY ANEMIA; OXIDATIVE STRESS; PLASMA HOMOCYST(E)INE; METHYLMALONIC ACID; ATROPHIC GASTRITIS; VITAMIN-E; INFECTION; HOMOCYSTEINE	Objectives We tested a model in which Helicobacter pylori seropositivity (Hp(s)) predicted iron status, which in turn acted as a predictor for markers of 1-C metabolism that were then allowed to predict antioxidant status. Methods National Health and Nutrition Examination Surveys (NHANES 1999-2000) cross-sectional data among adults aged 20-85 y were analyzed (n = 3,055). Markers of Hp(s), iron status (serum ferritin and transferrin saturation (TS)); 1-C metabolism (serum folate (FOLserum), B-12, total homocysteine (tHcy), methylmalonic acid (MMA)) and antioxidant status (vitamins A and E) were entered into a structural equations model (SEM). Results Predictors of Hp(s) included older age, lower education and income, racial/ethnic groups (lowest among Non-HispanicWhites), and lifetime cigarette smoking. SEM modeling indicated that Hp(s) had a direct inverse relationship with iron status (combining serum ferritin and TS) which in turn was positively related to 1-C metabolites (higher serum folate, B-12 or lower tHcy/MMA) that were positively associated with antioxidant status (combining serum vitamins A and E). Another pathway that was found bypassed 1-C metabolites (Hps -> Iron_st -> Antiox). The sum of all indirect effects from Hp(s) combining both pathways and the other indirect pathways in the model (Hps -> Iron_ st -> OneCarbon; Hps -> OneCarbon -> Antiox) was estimated at beta = -0.006 +/- 0.003, p<0.05. Conclusions In sum, of the total effect of H. pylori seropositivity on antioxidant status, two significant indirect pathways through Iron status and 1-Carbon metabolites were found. Randomized controlled trials should be conducted to uncover the concomitant causal effect of H. pylori eradication on improving iron status, folate, B-12 and antioxidant status among H. pylori seropositive individuals.	[Beydoun, May A.; Dore, Greg A.; Zonderman, Alan B.] NIA, NIA NIH IRP, Baltimore, MD 21224 USA; [Canas, Jose A.] Diabet & Metab Nemours Childrens Clin, Pediat Endocrinol, Jacksonville, FL USA; [Beydoun, Hind A.] Eastern Virginia Med Sch, Grad Program Publ Hlth, Norfolk, VA 23501 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Eastern Virginia Medical School	Beydoun, MA (corresponding author), NIA, NIA NIH IRP, Baltimore, MD 21224 USA.	baydounm@mail.nih.gov	Canas, Jose Atilio/Y-8500-2019; Zonderman, Alan B/A-5807-2013	Canas, Jose Atilio/0000-0003-4788-8820; Zonderman, Alan B/0000-0003-3530-2319; Zonderman, Alan B/0000-0002-6523-4778	Intramural Research Program of the NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000199] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported entirely by the Intramural Research Program of the NIH, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acock A. C., 2013, DISCOVERING STRUCTUR, DOI DOI 10.1080/10538712.2011.607753; Annibale B, 1999, ANN INTERN MED, V131, P668, DOI 10.7326/0003-4819-131-9-199911020-00006; BAYERDORFFER E, 1995, LANCET, V345, P1591, DOI 10.1016/S0140-6736(95)90113-2; Beydoun MA, 2013, PSYCHOSOM MED, V75, P486, DOI 10.1097/PSY.0b013e31829108c3; Beydoun MA, 2011, J NUTR, V141, P903, DOI 10.3945/jn.110.136580; Bottiglieri T, 2005, PROG NEURO-PSYCHOPH, V29, P1103, DOI 10.1016/j.pnpbp.2005.06.021; (CDC) CfDCaP, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, LAB PROC MAN FOL VIT; Centers for Disease Control and Prevention NCfHS, 2010, 1999 2000 DAT DOC CO; Centers for Disease Control and Prevention NCfHS, 2008, HEL PYL IGG ANT SER; Cheng HL, 2012, OBES REV, V13, P150, DOI 10.1111/j.1467-789X.2011.00938.x; Choe YH, 1999, HELICOBACTER, V4, P135, DOI 10.1046/j.1523-5378.1999.98066.x; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; DiGirolamo AM, 2007, PEDIATR INFECT DIS J, V26, P927, DOI 10.1097/INF.0b013e31812e52cd; Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07; DUFOUR C, 1993, J PEDIATR GASTR NUTR, V17, P225, DOI 10.1097/00005176-199308000-00018; Ellervik C, 2012, J INTERN MED, V271, P51, DOI 10.1111/j.1365-2796.2011.02404.x; Ellervik C, 2011, DIABETES CARE, V34, P2256, DOI 10.2337/dc11-0416; Ellervik C, 2011, CLIN CHEM, V57, P459, DOI 10.1373/clinchem.2010.156802; Epplein M, 2011, CANCER PREV RES, V4, P871, DOI 10.1158/1940-6207.CAPR-10-0398; HAENSZEL W, 1985, INT J CANCER, V36, P43, DOI 10.1002/ijc.2910360108; Hasan N, 2012, BRIT J CLIN PHARMACO, V74, P230, DOI 10.1111/j.1365-2125.2012.04212.x; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hershko C, 2006, BLOOD, V107, P1673, DOI 10.1182/blood-2005-09-3534; Howden CW, 2000, J CLIN GASTROENTEROL, V30, P29, DOI 10.1097/00004836-200001000-00006; Instruction Manual, 1993, INSTR MAN BIOR QUANT; JASKIEWICZ K, 1990, ANTICANCER RES, V10, P833; Kate V, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/425840; Kim Ki-Su, 2012, J Prev Med Public Health, V45, P196, DOI 10.3961/jpmph.2012.45.3.196; Klee GG, 2000, CLIN CHEM, V46, P1277; KNEKT P, 1991, AM J CLIN NUTR, V53, pS283, DOI 10.1093/ajcn/53.1.283S; Kountouras J, 2006, NEUROLOGY, V66, P938, DOI 10.1212/01.wnl.0000203644.68059.5f; Kudo M, 1995, J CLIN GASTROENTEROL, V21, pS174; Lacy BE, 2001, J NUTR, V131, p2789S, DOI 10.1093/jn/131.10.2789S; Lahner E, 2012, HELICOBACTER, V17, P1, DOI 10.1111/j.1523-5378.2011.00892.x; LOHR SHARON L., 2010, SAMPLING DESIGN AND; Manolescu BN, 2010, ACTA BIOCHIM POL, V57, P467; MARSHALL BJ, 1984, LANCET, V1, P1311; McCallum R, 2004, FACTOR ANAL PSYC 236; Mueller C, 1978, FACTOR ANAL STAT MET; Ozer B, 2005, WORLD J GASTROENTERO, V11, P2764, DOI 10.3748/wjg.v11.i18.2764; Paiva AD, 2003, CLIN CHIM ACTA, V334, P197, DOI 10.1016/S0009-8981(03)00237-7; Pandey R, 2010, ASIAN PAC J CANCER P, V11, P583; Papatheodorou L, 2007, ANTIOXID REDOX SIGN, V9, P1941, DOI 10.1089/ars.2007.1750; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Rasool Shahid, 2012, BMC Res Notes, V5, P206, DOI 10.1186/1756-0500-5-206; Salgueiro J, 2004, ALIMENT PHARM THER, V20, P1029, DOI 10.1111/j.1365-2036.2004.02265.x; Santarelli L, 2004, ALIMENT PHARM THERAP, V19, P107, DOI 10.1046/j.1365-2036.2003.01820.x; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Sawayama Y, 2005, ATHEROSCLEROSIS, V178, P303, DOI 10.1016/j.atherosclerosis.2004.08.025; Sempos CT, 2000, ANN EPIDEMIOL, V10, P441, DOI 10.1016/S1047-2797(00)00068-5; Sezikli M, 2009, HELICOBACTER, V14, P280, DOI 10.1111/j.1523-5378.2009.00686.x; Sharma S., 1996, APPL MULTIVARIATE TE; SHIPCHANDLER MT, 1995, CLIN CHEM, V41, P991; Singh U, 2005, ANNU REV NUTR, V25, P151, DOI 10.1146/annurev.nutr.24.012003.132446; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; STATA, 2013, STAT DAT AN REL 13 0; Stettin D, 2008, ADV MED SCI-POLAND, V53, P205, DOI 10.2478/v10039-008-0050-8; Szoke D, 2012, CLIN CHIM ACTA, V413, P1184, DOI 10.1016/j.cca.2012.04.021; Tchantchou F, 2006, J ALZHEIMERS DIS, V9, P421; Tomkins A, 2003, J NUTR, V133, p1649S, DOI 10.1093/jn/133.5.1649S; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; Yuan WZ, 2010, SCAND J GASTROENTERO, V45, P665, DOI 10.3109/00365521003663670	64	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121390	10.1371/journal.pone.0121390	http://dx.doi.org/10.1371/journal.pone.0121390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815731	gold, Green Submitted, Green Published			2022-12-26	WOS:000352133600089
J	Palma, J; Maebe, K; Guedes, JVC; Smagghe, G				Palma, Janine; Maebe, Kevin; Carus Guedes, Jerson Vanderlei; Smagghe, Guy			Molecular Variability and Genetic Structure of Chrysodeixis includens (Lepidoptera: Noctuidae), an Important Soybean Defoliator in Brazil	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; LOOPER LEPIDOPTERA; ANTICARSIA-GEMMATALIS; PYRETHROID RESISTANCE; POPULATION-STRUCTURE; ISSR; FLOW; DIVERSITY; EVOLUTION; SOFTWARE	This study provides the first genetic characterization of the soybean looper, Chrysodeixis includens (Walker, 1857), an important defoliating pest species of soybean crops in Brazil. Population genetic variability and the genetic structure of C. includens populations were evaluated by using ISSR markers with samples from the major soybean producing regions in Brazil in the growing seasons 2011/2012. Seven different primers were applied for population characterization of the molecular variability and genetic structure of 8 soybean looper populations from 8 states of Brazil. The seven ISSR loci generated 247 bands in 246 individuals of C. includens sampled. The expected heterozygosity (H-E) in the populations varied between 0.093 and 0.106, while the overall H-E was 0.099, indicating low genetic diversity. The analysis of molecular variance indicated that 98% of the variability was expressed among individuals within populations (F-ST = 0.021, p = 0.001). The low level of polymorphism over all populations, the high levels of gene flow, and the low genetic structure are indicatives of the exchange of genetic information between the different sampled regions. Population structuring suggests the presence of two major groups which do not correlate with their geographic sampling location in Brazil. These results may indicate recent recolonization of C. includens in Brazil or migration patterns following source-sink dynamics. Furthermore, the presence of two groups within C. includens suggests that a study on development of resistance or any other genetic-based trait needs to be evaluated on both groups, and pest management in soybean fields should be aware that differences may come to the control strategies they use.	[Palma, Janine; Carus Guedes, Jerson Vanderlei] Univ Fed Santa Maria, Dept Crop Protect, Lab Integrated Pest Management, BR-97119900 Santa Maria, RS, Brazil; [Palma, Janine; Maebe, Kevin; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium	Universidade Federal de Santa Maria (UFSM); Ghent University	Palma, J (corresponding author), Univ Fed Santa Maria, Dept Crop Protect, Lab Integrated Pest Management, BR-97119900 Santa Maria, RS, Brazil.	janine.palma@gmail.com; jerson.guedes@gmail.com	Guedes, Jerson/AAD-2483-2020; Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; Maebe, Kevin/0000-0002-3741-2143	Graduate Program in Agronomy, Federal University of Santa Maria [030086]; University of Ghent through a PhD sandwich; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Graduate Program in Agronomy, Federal University of Santa Maria; University of Ghent through a PhD sandwich; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Graduate Program in Agronomy, Federal University of Santa Maria (Project 030086), and by University of Ghent through a PhD sandwich. The scholarship was provided by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albernaz KC, 2012, B ENTOMOL RES, V102, P333, DOI 10.1017/S0007485311000678; Andow DA., 2008, COLLECT BIOSAF REV, V4, P142; Angulo AO, 1975, ESTADOS INMADUROS LE; Arias RS, 2011, ANN ENTOMOL SOC AM, V104, P576, DOI 10.1603/AN10135; Barbosa NCCP, 2014, REV BRAS ENTOMOL, V58, P203, DOI 10.1590/S0085-56262014000200012; Bernardi O, 2012, PEST MANAG SCI, V68, P1083, DOI 10.1002/ps.3271; Beroiz B, 2012, SPAN J AGRIC RES, V10, P815, DOI 10.5424/sjar/2012103-694-11; CAB International, 2014, CROP PROT COMP; CAPRIO MA, 1992, J ECON ENTOMOL, V85, P611, DOI 10.1093/jee/85.3.611; Chen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073017; Clark PL, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0501; Czepak C, 2014, CULTIV GD CULT, V178, P20; Domingues FA, 2012, J ECON ENTOMOL, V105, P2136, DOI 10.1603/EC12123; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eichlin T. D., 1975, GUIDE ADULT LARVAL P; Eichlin TD, 1978, PLUSIINAE LEPIDOPTER, DOI 10.22004/ag.econ.158098; Embrapa, 2003, TECN PROD SOJ REG CE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Ferreira ME, 1998, INTRO AO USO MARCADO; GUEDES J.V.C., 2010, CULTIVAR GRANDES CUL, V12, P24; Hendrichs J., 2007, P3; Herzog D.C., 1980, Springer Series in Experimental Entomology, P141; Hundsdoerfer AK, 2005, Z NATURFORSCH C, V60, P618; Barrionuevo MJ, 2012, FLA ENTOMOL, V95, P944, DOI 10.1653/024.095.0419; Jost DJ, 2002, J ECON ENTOMOL, V95, P286, DOI 10.1603/0022-0493-95.2.286; KOGAN M, 1974, ANN ENTOMOL SOC AM, V67, P66, DOI 10.1093/aesa/67.1.66; Liu D, 2006, ENTOMOL EXP APPL, V118, P177, DOI 10.1111/j.1570-7458.2006.00383.x; Luque C, 2002, HEREDITAS, V136, P251, DOI 10.1034/j.1601-5223.2002.1360312.x; MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8; Marsaro Junior A. L., 2010, Revista Academica Ciencias Agrarias e Ambientais, V8, P71; MARTIN PB, 1976, ENVIRON ENTOMOL, V5, P878, DOI 10.1093/ee/5.5.878; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Mendki MJ, 2011, ASIAN PAC J TROP MED, V4, P357, DOI 10.1016/S1995-7645(11)60103-X; Moscardi F., 2012, SOJA MANEJO INTEGRAD, P214; Papa G, 2007, LAGARTAS NA SOJA; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Portillo HE, 1997, J AGR ENTOMOL, V14, P9; Pritchard JK, 2000, GENETICS, V155, P945; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Roux O, 2007, MOL PHYLOGENET EVOL, V43, P240, DOI 10.1016/j.ympev.2006.09.017; Shouhani Hossein, 2014, Journal of Bioscience and Biotechnology, V3, P127; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sosa-Gomez DR, 2004, GENET MOL BIOL, V27, P378, DOI 10.1590/S1415-47572004000300012; Souza Giselle Anselmo de, 2008, Pesq. agropec. bras., V43, P843, DOI 10.1590/S0100-204X2008000700008; Specht A, 2004, REV BRASILEIRA AGROC, V4, P389; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Thomas JD, 1996, PESTIC BIOCHEM PHYS, V55, P1, DOI 10.1006/pest.1996.0029; TINGLE F C, 1977, Florida Entomologist, V60, P115, DOI 10.2307/3494389; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhu Xun, 2012, Acta Entomologica Sinica, V55, P981	54	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121260	10.1371/journal.pone.0121260	http://dx.doi.org/10.1371/journal.pone.0121260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816220	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600076
J	Park, WS; Sung, SI; Ahn, SY; Yoo, HS; Sung, DK; Im, GH; Choi, SJ; Chang, YS				Park, Won Soon; Sung, Se In; Ahn, So Yoon; Yoo, Hye Soo; Sung, Dong Kyung; Im, Geun Ho; Choi, Soo Jin; Chang, Yun Sil			Hypothermia Augments Neuroprotective Activity of Mesenchymal Stem Cells for Neonatal Hypoxic-Ischemic Encephalopathy	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; WHOLE-BODY HYPOTHERMIA; BRAIN-INJURY; BONE-MARROW; RAT MODEL; CHILDREN; OUTCOMES; INFANTS; DAMAGE	Though hypothermia is the only clinically available treatment for neonatal hypoxic-ischemic encephalopathy (HIE), it is not completely effective in severe cases. We hypothesized that combined treatment with hypothermia and transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) would synergistically attenuate severe HIE compared to stand-alone therapy. To induce hypoxia-ischemia (HI), male Sprague-Dawley rats were subjected to 8% oxygen for 120 min after unilateral carotid artery ligation on postnatal day (P)7. After confirmation of severe HIE involving >50% of the ipsilateral hemisphere volume as determined by diffusion-weighted brain magnetic resonance imaging (MRI) within 2 h after HI, intraventricular MSC transplantation (1 x 105 cells) and/or hypothermia with target temperature at 32 degrees C for 24 h were administered 6 h after induction of HI. Follow-up brain MRI at P12 and P42, sensorimotor function tests at P40-42, evaluation of cytokines in the cerebrospinal fluid (CSF) at P42, and histologic analysis of peri-infarct tissues at P42 were performed. Severe HI resulted in progressively increased brain infarction over time as assessed by serial MRI, increased number of cells positive for terminal deoxynucleotidyl transferase nick-end labeling, microgliosis and astrocytosis, increased CSF cytokine levels, and impaired function in behavioral tests such as rotarod and cylinder tests. All of the abnormalities observed in severe HIE showed greater improvement after combined treatment with hypothermia and MSC transplantation than with either therapy alone. Overall, these findings suggest that combined treatment with hypothermia and human UCB-derived MSC transplantation might be a novel therapeutic modality to improve the prognosis of severe HIE, an intractable disease that currently has no effective treatment.	[Park, Won Soon; Sung, Se In; Ahn, So Yoon; Yoo, Hye Soo; Chang, Yun Sil] Sungkyunkwan Univ, Dept Pediat, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Park, Won Soon; Sung, Dong Kyung; Im, Geun Ho; Chang, Yun Sil] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea; [Choi, Soo Jin] MEDIPOST Co Ltd, Biomed Res Inst, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; MEDIPOST	Chang, YS (corresponding author), Sungkyunkwan Univ, Dept Pediat, Samsung Med Ctr, Sch Med, Seoul, South Korea.	yunsil.chang@gmail.com			Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A110445]; Samsung Biomedical Research Institute [SMX1131761]; Korea Research Foundation grant from the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2011-0009092]	Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; Samsung Biomedical Research Institute(Samsung); Korea Research Foundation grant from the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A110445), by a Samsung Biomedical Research Institute grant (SMX1131761), by a Korea Research Foundation grant from the National Research Foundation of Korea (NRF), and by the Ministry of Education, Science, and Technology (2011-0009092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SY, 2013, STROKE, V44, P497, DOI 10.1161/STROKEAHA.112.679092; Aly H, 2006, BRAIN DEV-JPN, V28, P178, DOI 10.1016/j.braindev.2005.06.006; Ashwal S, 2007, PEDIATR RES, V61, P9, DOI 10.1203/01.pdr.0000251612.16069.4b; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Ennen CS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.025; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jang YK, 2006, ANN HEMATOL, V85, P212, DOI 10.1007/s00277-005-0047-3; Johnston MV, 1997, BRAIN DEV-JPN, V19, P235, DOI 10.1016/S0387-7604(96)00561-X; Kaneko Y, 2012, PLOS ONE, V7; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim ES, 2012, PEDIATR RES, V72, P277, DOI 10.1038/pr.2012.71; Lee BS, 2010, PEDIATR RES, V68, P303, DOI 10.1203/00006450-201011001-00592; Park WS, 2006, J KOREAN MED SCI, V21, P337, DOI 10.3346/jkms.2006.21.2.337; ROBERTSON C, 1985, DEV MED CHILD NEUROL, V27, P473; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Sabir H, 2012, STROKE, V43, P3364, DOI 10.1161/STROKEAHA.112.674481; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Spear LP, 2002, J STUD ALCOHOL, P71, DOI 10.15288/jsas.2002.s14.71; Towfighi J, 1997, DEV BRAIN RES, V100, P149, DOI 10.1016/S0165-3806(97)00036-9; van Velthoven CTJ, 2012, PEDIATR RES, V71, P474, DOI 10.1038/pr.2011.64; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; Wyatt JS, 2007, PEDIATRICS, V119, P912, DOI 10.1542/peds.2006-2839; Yager JY, 2009, PEDIATR NEUROL, V40, P156, DOI 10.1016/j.pediatrneurol.2008.10.025; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471	31	76	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120893	10.1371/journal.pone.0120893	http://dx.doi.org/10.1371/journal.pone.0120893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816095	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600051
J	You, J; Zhang, LH; Song, B; Qi, XQ; Chan, ZL				You, Jun; Zhang, Lihua; Song, Bo; Qi, Xiaoquan; Chan, Zhulong			Systematic Analysis and Identification of Stress-Responsive Genes of the NAC Gene Family in Brachypodium distachyon	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; LEAF SENESCENCE; COMPREHENSIVE ANALYSIS; FUNCTIONAL-ANALYSIS; DROUGHT RESISTANCE; REGULATORY NETWORK; CONSERVED DOMAIN; SALT TOLERANCE; ABSCISIC-ACID; GRAIN-YIELD	Plant-specific NAC proteins are one of the largest families of transcription factors in plants, and members of this family have been characterized with roles in the regulation of diverse biological processes, including development and stress responses. In the present study, we identified 101 putative NAC domain-encoding genes (BdNACs) through systematic sequence analysis in Brachypodium distachyon, a new model plant of family Poaceae. BdNAC proteins were phylogenetically clustered into 13 groups, and each group possesses similar motif compositions. Phylogenetic analysis using known stress-related NACs from Arabidopsis and rice as query sequences identified 18 BdNACs as putative stress-responsive genes. In silico promoter analysis showed that almost all BdNAC genes contain putative stress-related cis-elements in their promoter regions. Expression profile of BdNAC genes in response to abiotic stresses and phytohormones was analyzed by quantitative real-time RT-PCR. Several putative stress-responsive BdNAC genes, including BdNAC003 and BdNAC044 which is ortholog of known stress-responsive rice gene SNAC1 and SNAC2, respectively, were highly regulated by multiple abiotic stresses and stress-related phytohormone treatments. Taken together, our results presented here would be helpful in laying the foundation for understanding of the complex mechanisms of NAC mediated abiotic stress signaling transduction pathways in B. distachyon.	[You, Jun; Zhang, Lihua; Chan, Zhulong] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Song, Bo; Qi, Xiaoquan] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Chan, ZL (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China.	zhulongch@wbgcas.cn	Qi, Xiaoquan/G-1545-2010; Chan, Zhulong/AAM-5018-2020	Qi, Xiaoquan/0000-0001-7175-115X; Chan, Zhulong/0000-0002-1933-6837; You, Jun/0000-0001-8927-1015	Hundred Talents Program; Knowledge Innovative Key Program of Chinese Academy of Sciences [54Y154761O01076, 29Y329631O0263]	Hundred Talents Program(Chinese Academy of Sciences); Knowledge Innovative Key Program of Chinese Academy of Sciences	This research was supported by "the Hundred Talents Program", the Knowledge Innovative Key Program of Chinese Academy of Sciences (Grant No. 54Y154761O01076 and No. 29Y329631O0263) to Zhulong Chan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen QF, 2011, PROTEIN CELL, V2, P55, DOI 10.1007/s13238-011-1010-9; Chen X, 2014, PLANT CELL PHYSIOL, V55, P604, DOI 10.1093/pcp/pct204; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; Hickman R, 2013, PLANT J, V75, P26, DOI 10.1111/tpj.12194; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Jeong JS, 2010, PLANT PHYSIOL, V153, P185, DOI 10.1104/pp.110.154773; Kaneda T, 2009, EMBO J, V28, P926, DOI 10.1038/emboj.2009.39; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim HS, 2007, J BIOL CHEM, V282, P36292, DOI 10.1074/jbc.M705217200; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liang CZ, 2014, P NATL ACAD SCI USA, V111, P10013, DOI 10.1073/pnas.1321568111; Lin RM, 2007, PLANT SCI, V172, P120, DOI 10.1016/j.plantsci.2006.07.019; Mochida K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075265; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Ng S, 2013, PLANT CELL, V25, P3450, DOI 10.1105/tpc.113.113985; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Shi HT, 2013, J EXP BOT, V64, P1367, DOI 10.1093/jxb/ers400; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu ZY, 2013, PLANT CELL, V25, P4708, DOI 10.1105/tpc.113.119099; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yoon HK, 2008, MOL CELLS, V25, P438; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007; Zhou Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-132	54	42	47	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122027	10.1371/journal.pone.0122027	http://dx.doi.org/10.1371/journal.pone.0122027			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815771	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600137
J	Cao, ZH; Zheng, QY; Li, GQ; Hu, XB; Feng, SL; Xu, GL; Zhang, KQ				Cao, Zhao-hui; Zheng, Quan-you; Li, Gui-qing; Hu, Xiao-bo; Feng, Shao-long; Xu, Gui-lian; Zhang, Ke-qin			STAT1-Mediated Down-Regulation of Bcl-2 Expression Is Involved in IFN-gamma/TNF-alpha-Induced Apoptosis in NIT-1 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; PROINFLAMMATORY CYTOKINES; PATHWAY; ACTIVATION; DEATH; PROLIFERATION; CYTOTOXICITY; DYSFUNCTION; PROTEINS; NECROSIS	Tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma are the major pro-inflammatory cytokines involved in beta-cell destruction. The fate of islet beta-cells in the cytokine-induced intrinsic mitochondrial apoptotic pathway is determined by the interaction between members of the Bcl-2 family. However, the mechanism through which beta-cell apoptosis is regulated remains unclear. In this study, we treated the murine beta-cell line NIT-1 with TNF-alpha and IFN-gamma and then investigated the regulation of signal transducer and activator of transcription-1 (STAT-1) and expression of the members of the Bcl-2 family in this apoptotic pathway. Results showed that TNF-alpha and IFN-gamma synergistically reduced NIT-1 cell viability. In addition, the decrease in cell growth was due to apoptosis as shown by apoptotic body formation, detected by confocal laser microscope, and a significant increase in Annexin-Vup(+) cell percentage, detected by flow cytometry. Combination treatment with TNF-alpha and IFN-gamma caused a remarkable increase in the release of cytochrome c, and in the activation of caspase-9 and caspase-3, as well as, an obvious enhancement in STAT-1 phosphorylation; the treatment, however, resulted in the down-regulation in Bcl-2 expression. The enhancement in STAT-1 activity and a down-regulation in Bcl-2 expression was also observed in MIN6 cells, another murine beta-cell derived line, after cells exposure to the combination of TNF-alpha and IFN-gamma treatment. Knockdown of STAT-1 gene expression by siRNA or inhibition of STAT-1 activation with fludarabine reversed Bcl-2 down-expression and led to a significant decrease in apoptosis in TNF-alpha-and IFN-gamma-treated NIT-1 cells. Taken together, our results suggest that STAT1-mediated down-regulation of Bcl-2 is involved in NIT-1 cell apoptosis induced by combination treatment with TNF-alpha and IFN-gamma.	[Cao, Zhao-hui; Zheng, Quan-you; Zhang, Ke-qin] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Urol, Chongqing 400042, Peoples R China; [Li, Gui-qing; Xu, Gui-lian] Third Mil Med Univ, Dept Immunol, Chongqing, Peoples R China; [Cao, Zhao-hui; Hu, Xiao-bo] Univ South China, Sch Publ Hlth, Sch Pharm & Biol Sci, Dept Biochem & Mol Biol, Hengyang 421001, Peoples R China; [Feng, Shao-long] Univ South China, Sch Publ Hlth, Dept Hlth Lab Technol, Hengyang 421001, Peoples R China	Army Medical University; Army Medical University; University of South China; University of South China	Xu, GL (corresponding author), Third Mil Med Univ, Dept Immunol, Chongqing, Peoples R China.	xuguilian@yahoo.com; zhkq2004@163.com	zhang, ke/AAH-8217-2019	Feng, Shaolong/0000-0002-6757-8275	National Natural Science Foundation of China [30971394, 81170695]; Education Department Foundation of Hunan Province of China [12A118, 12C0359]; Science and Technology Department of Hengyang and Hunan Province of China [2013KS22, 2013SK3121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department Foundation of Hunan Province of China; Science and Technology Department of Hengyang and Hunan Province of China	Grants that have supported the work: National Natural Science Foundation of China (No. 30971394 and 81170695); Education Department Foundation of Hunan Province of China (No. 12A118 and 12C0359), and Science and Technology Department of Hengyang and Hunan Province of China (No. 2013KS22 and 2013SK3121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Augstein P, 2008, DIABETES VASC DIS RE, V5, P198, DOI 10.3132/dvdr.2008.032; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cao ZH, 2013, CELL BIOCHEM BIOPHYS, V67, P1239, DOI 10.1007/s12013-013-9642-4; Cervasi B, 2006, J VIROL, V80, P10335, DOI 10.1128/JVI.00472-06; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Dudek NL, 2012, DIABETES, V61, P3018, DOI 10.2337/db11-1333; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Gui SY, 2013, J CELL BIOCHEM, V114, P1488, DOI 10.1002/jcb.24490; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Kanno T, 2011, J CELL PHYSIOL, V226, P2329, DOI 10.1002/jcp.22571; Kim HS, 2009, CURR MOL MED, V9, P30, DOI 10.2174/156652409787314471; Kim S, 2007, DIABETES, V56, P2561, DOI 10.2337/db06-1372; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; McKenzie MD, 2006, INT IMMUNOL, V18, P837, DOI 10.1093/intimm/dxl020; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Shu B, 2009, TOXICOL IN VITRO, V23, P598, DOI 10.1016/j.tiv.2009.01.021; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Torella D, 2007, AM J PHYSIOL-HEART C, V292, pH2935, DOI 10.1152/ajpheart.00887.2006; Wang AP, 2013, ACTA DIABETOL, V50, P163, DOI 10.1007/s00592-010-0239-8; Zhu L, 2012, J CELL PHYSIOL, V227, P1814, DOI 10.1002/jcp.22906	32	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120921	10.1371/journal.pone.0120921	http://dx.doi.org/10.1371/journal.pone.0120921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811609	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700066
J	Das, A; Chai, JC; Kim, SH; Park, KS; Lee, YS; Jung, KH; Chai, YG				Das, Amitabh; Chai, Jin Choul; Kim, Sun Hwa; Park, Kyoung Sun; Lee, Young Seek; Jung, Kyoung Hwa; Chai, Young Gyu			Dual RNA Sequencing Reveals the Expression of Unique Transcriptomic Signatures in Lipopolysaccharide-Induced BV-2 Microglial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; DEMETHYLASE JMJD3; INFLAMMATION; MECHANISMS; DISEASE; HYBRIDIZATION; INFECTION; ENDOTOXIN; CHEMOKINE; CULTURE	Microglial cells become rapidly activated through interactions with pathogens, and the persistent activation of these cells is associated with various neurodegenerative diseases. Previous studies have investigated the transcriptomic signatures in microglia or macrophages using microarray technologies. However, this method has numerous restrictions, such as spatial biases, uneven probe properties, low sensitivity, and dependency on the probes spotted. To overcome this limitation and identify novel transcribed genes in response to LPS, we used RNA Sequencing (RNA-Seq) to determine the novel transcriptomic signatures in BV-2 microglial cells. Sequencing assessment and quality evaluation showed that approximately 263 and 319 genes (>= 1.5 log(2)-fold), such as cytokines and chemokines, were strongly induced after 2 and 4 h, respectively, and the induction of several genes with unknown immunological functions was also observed. Importantly, we observed that previously unidentified transcription factors (TFs) (irf1, irf7, and irf9), histone demethylases (kdm4a) and DNA methyltransferases (dnmt3l) were significantly and selectively expressed in BV-2 microglial cells. The gene expression levels, transcription start sites (TSS), isoforms, and differential promoter usage revealed a complex pattern of transcriptional and post-transcriptional gene regulation upon infection with LPS. In addition, gene ontology, molecular networks and pathway analyses identified the top significantly regulated functional classification, canonical pathways and network functions at each activation status. Moreover, we further analyzed differentially expressed genes to identify transcription factor (TF) motifs (-950 to +50 bp of the 5' upstream promoters) and epigenetic mechanisms. Furthermore, we confirmed that the expressions of key inflammatory genes as well as pro-inflammatory mediators in the supernatants were significantly induced in LPS treated primary microglial cells. This transcriptomic analysis is the first to show a comparison of the family-wide differential expression of most known immune genes and also reveal transcription evidence of multiple gene families in BV-2 microglial cells. Collectively, these findings reveal unique transcriptomic signatures in BV-2 microglial cells required for homeostasis and effective immune responses.	[Das, Amitabh; Chai, Young Gyu] Hanyang Univ, Dept Bionanotechnol, Seoul 133791, South Korea; [Chai, Jin Choul; Kim, Sun Hwa; Park, Kyoung Sun; Lee, Young Seek; Chai, Young Gyu] Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea; [Jung, Kyoung Hwa] Hanyang Univ, Inst Nat Sci & Technol, Ansan, South Korea	Hanyang University; Hanyang University; Hanyang University	Jung, KH (corresponding author), Hanyang Univ, Inst Nat Sci & Technol, Ansan, South Korea.	khjung2@gmail.com; ygchai@hanyang.ac.kr	Kim, Sun/GSN-4867-2022	Das, Ph.D., Amitabh/0000-0003-3299-1518	National Research Foundation of Korea (NRF); Korean government (MSIP) [2011-0030049]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MSIP)	This work was supported through funding from the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) 2011-0030049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli F, 2013, CURR PHARM DESIGN, V19, P578, DOI 10.2174/138161213804581918; Banisor I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-7; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bodea LG, 2014, J NEUROSCI, V34, P8546, DOI 10.1523/JNEUROSCI.5002-13.2014; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Butterfield DA, 2003, CURR MED CHEM, V10, P2651, DOI 10.2174/0929867033456422; Casneuf T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-461; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Das A, 2014, EXP CELL RES, V328, P361, DOI 10.1016/j.yexcr.2014.08.029; Das A, 2013, MOL IMMUNOL, V56, P113, DOI 10.1016/j.molimm.2013.04.013; Das Sarma Jayasri, 2009, J Neuroinflammation, V6, P14, DOI 10.1186/1742-2094-6-14; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Delputte PL, 2004, J VIROL, V78, P8094, DOI 10.1128/JVI.78.15.8094-8101.2004; Duke DC, 2004, DEV NEUROSCI-BASEL, V26, P30, DOI 10.1159/000080709; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Fitzgerald DC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-130; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; He LY, 2014, AM J NEPHROL, V40, P441, DOI 10.1159/000369220; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hirt UA, 2003, CELL DEATH DIFFER, V10, P1156, DOI 10.1038/sj.cdd.4401286; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Hwang SH, 2009, GENE, V443, P83, DOI 10.1016/j.gene.2009.04.024; Jeong Y, 2014, J LEUKOCYTE BIOL, V95, P651, DOI 10.1189/jlb.1013565; Juknat A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061462; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Kaushik DK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-57; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Lee EJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-116; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Maezawa I, 2011, J BIOL CHEM, V286, P3693, DOI 10.1074/jbc.M110.135244; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; Moreillon P, 2003, SCAND J INFECT DIS, V35, P632, DOI 10.1080/00365540310016259; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murdoch C, 2000, BLOOD, V95, P3032; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nalpas NC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-230; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nimmo Alan J, 2009, Recent Pat CNS Drug Discov, V4, P86; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sebastian A, 2006, J ENVIRON MONITOR, V8, P519, DOI 10.1039/b600706f; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Shakespear MR, 2013, J BIOL CHEM, V288, P25362, DOI 10.1074/jbc.M113.496281; Shen Q, 2006, BRAIN RES, V1086, P9, DOI 10.1016/j.brainres.2006.02.116; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Thomas DM, 2005, FASEB J, V19, P515, DOI 10.1096/fj.05-4873fje; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Watanabe J, 2003, J BIOL CHEM, V278, P42361, DOI 10.1074/jbc.M307752200; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Witting A, 2011, METHODS MOL BIOL, V758, P49, DOI 10.1007/978-1-61779-170-3_4; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078439; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang MQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S3	72	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121117	10.1371/journal.pone.0121117	http://dx.doi.org/10.1371/journal.pone.0121117			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811458	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700083
J	Ishimoto, K; Hayano, S; Yanagita, T; Kurosaka, H; Kawanabe, N; Itoh, S; Ono, M; Kuboki, T; Kamioka, H; Yamashiro, T				Ishimoto, Kazuya; Hayano, Satoru; Yanagita, Takeshi; Kurosaka, Hiroshi; Kawanabe, Noriaki; Itoh, Shinsuke; Ono, Mitsuaki; Kuboki, Takuo; Kamioka, Hiroshi; Yamashiro, Takashi			Topical Application of Lithium Chloride on the Pulp Induces Dentin Regeneration	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ONYCHO-DERMAL DYSPLASIA; STEM-CELLS; ODONTOBLAST DIFFERENTIATION; IN-VIVO; TOOTH; DSPP; DENTINOGENESIS; MUTATION; THERAPY	We herein describe a novel procedure for dentin regeneration that mimics the biological processes of tooth development in nature. The canonical Wnt signaling pathway is an important regulator of the Dentin sialophosphoprotein (Dspp) expression. Our approach mimics the biological processes underlying tooth development in nature and focuses on the activation of canonical Wnt signaling to trigger the natural process of dentinogenesis. The coronal portion of the dentin and the underlying pulp was removed from the first molars. We applied lithium chloride (LiCl), an activator of canonical Wnt signaling, on the amputated pulp surface to achieve transdifferentiation toward odontoblasts from the surrounding pulpal cells. MicroCT and microscopic analyses demonstrated that the topical application of LiCl induced dentin repair, including the formation of a complete dentin bridge. LiCl-induced dentin is a tubular dentin in which the pulp cells are not embedded within the matrix, as in primary dentin. In contrast, a dentin bridge was not induced in the control group treated with pulp capping with material carriers alone, although osteodentin without tubular formation was induced at a comparatively deeper position from the pulp exposure site. We also evaluated the influence of LiCl on differentiation toward odontoblasts in vitro. In the mDP odontoblast cell line, LiCl activated the mRNA expression of Dspp, Axin2 and Kallikrein 4 (Klk4) and downregulated the Osteopontin (Osp) expression. These results provide a scientific basis for the biomimetic regeneration of dentin using LiCl as a new capping material to activate dentine regeneration.	[Ishimoto, Kazuya; Hayano, Satoru; Kurosaka, Hiroshi; Kawanabe, Noriaki; Itoh, Shinsuke; Kamioka, Hiroshi; Yamashiro, Takashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthodont, Okayama, Japan; [Yanagita, Takeshi] Okayama Univ Hosp, Dept Orthodont, Okayama, Japan; [Ono, Mitsuaki; Kuboki, Takuo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Rehabil & Regenerat Med, Okayama, Japan	Okayama University; Okayama University; Okayama University	Yamashiro, T (corresponding author), Osaka Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Osaka, Japan.	yamashiro@dent.osaka-u.ac.jp	Yamashiro, Takashi/S-6010-2019; Kamioka, Hiroshi/B-2476-2011; Yamashiro, Takashi/Y-6411-2019	Yamashiro, Takashi/0000-0002-4419-9643; Kuboki, Takuo/0000-0003-3756-2835; Kurosaka, Hiroshi/0000-0002-8956-5467	Japan Society for the Promotion of Science (JSPS) [19390529, 24249093]; Grants-in-Aid for Scientific Research [26253088, 25242041] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (KAKENHI) 19390529 and 24249093 from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Aguilar P, 2011, J ENDODONT, V37, P581, DOI 10.1016/j.joen.2010.12.004; Cox CF, 1996, OPER DENT, V21, P4; Cruz EV, 2002, INT ENDOD J, V35, P330, DOI 10.1046/j.1365-2591.2002.00482.x; Dong F, 2012, CURR OPIN ORGAN TRAN, V17, P670, DOI 10.1097/MOT.0b013e328359a617; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Goldberg M, 2003, AM J DENT, V16, P66; Goldberg M, 2008, PHARMACOL RES, V58, P137, DOI 10.1016/j.phrs.2008.05.013; Gomes JE, 2012, J ENDODONT, V38, P91, DOI 10.1016/j.joen.2011.09.020; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Han NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088890; Hayano S, 2012, J BIOL CHEM, V287, P12217, DOI 10.1074/jbc.M111.332924; Hosoya A, 2006, J ORAL BIOSCI, V48, P132, DOI 10.2330/joralbiosci.48.132; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Huang George T-J, 2011, Front Biosci (Elite Ed), V3, P788, DOI 10.2741/e286; Ji YM, 2010, TISSUE ENG PT A, V16, P1823, DOI [10.1089/ten.tea.2009.0054, 10.1089/ten.TEA.2009.0054]; Kawanabe N, 2012, EXP CELL RES, V318, P453, DOI 10.1016/j.yexcr.2012.01.008; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Li ST, 2011, BIOCHEM BIOPH RES CO, V410, P698, DOI 10.1016/j.bbrc.2011.06.065; Lim WH, 2014, J BONE MINER RES, V29, P892, DOI 10.1002/jbmr.2088; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Lohi M, 2010, DEV DYNAM, V239, P160, DOI 10.1002/dvdy.22047; McGee-Lawrence ME, 2013, J BIOL CHEM, V288, P5291, DOI 10.1074/jbc.M112.414995; Nagano T, 2003, J DENT RES, V82, P982, DOI 10.1177/154405910308201209; Nakashima M, 2011, Adv Dent Res, V23, P313, DOI 10.1177/0022034511405323; Nakatomi M, 2013, J ENDODONT, V39, P612, DOI 10.1016/j.joen.2012.12.016; Nawaz S, 2009, EUR J HUM GENET, V17, P1600, DOI 10.1038/ejhg.2009.81; Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106; Takushige T, 2004, INT ENDOD J, V37, P132, DOI 10.1111/j.0143-2885.2004.00771.x; Tziafas D, 2000, J DENT, V28, P77, DOI 10.1016/S0300-5712(99)00047-0; Tziafas D, 2004, CARIES RES, V38, P314, DOI 10.1159/000077771; Wang YP, 2013, ARCH ORAL BIOL, V58, P1709, DOI 10.1016/j.archoralbio.2013.09.001; Wu N, 2010, ARCH ORAL BIOL, V55, P426, DOI 10.1016/j.archoralbio.2010.03.011; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamashiro T, 2007, DIFFERENTIATION, V75, P452, DOI 10.1111/j.1432-0436.2006.00150.x; Yamashiro T, 2002, MECH DEVELOP, V119, pS107, DOI 10.1016/S0925-4773(03)00101-1; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	42	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121938	10.1371/journal.pone.0121938	http://dx.doi.org/10.1371/journal.pone.0121938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812134	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700161
J	Muller, B; Manzoor, S; Niazi, A; Bongcam-Rudloff, E; Schnurer, A				Muller, Bettina; Manzoor, Shahid; Niazi, Adnan; Bongcam-Rudloff, Erik; Schnurer, Anna			Genome-Guided Analysis of Physiological Capacities of Tepidanaerobacter acetatoxydans Provides Insights into Environmental Adaptations and Syntrophic Acetate Oxidation	PLOS ONE			English	Article							CITRIC-ACID CYCLE; METHANE PRODUCTION; SP NOV.; GEN. NOV.; BACTERIUM; SEQUENCE; PATHWAY; SYSTEM; METABOLISM; TRANSPORT	This paper describes the genome-based analysis of Tepidanaerobacter acetatoxydans strain Re1, a syntrophic acetate-oxidising bacterium (SAOB). Principal issues such as environmental adaptations, metabolic capacities, and energy conserving systems have been investigated and the potential consequences for syntrophic acetate oxidation discussed. Briefly, in pure culture, T. acetatoxydans grows with different organic compounds and produces acetate as the main product. In a syntrophic consortium with a hydrogenotrophic methanogen, it can also reverse its metabolism and instead convert acetate to formate/H-2 and CO2. It can only proceed if the product formed is continuously removed. This process generates a very small amount of energy that is scarcely enough for growth, which makes this particular syntrophy of special interest. As a crucial member of the biogas-producing community in ammonium-rich engineered AD processes, genomic features conferring ammonium resistance, bacterial defense, oxygen and temperature tolerance were found, as well as attributes related to biofilm formation and flocculation. It is likely that T. acetatoxydans can form an electrochemical gradient by putative electron-bifurcating Rnf complex and [Fe-Fe] hydrogenases, as observed in other acetogens. However, genomic deficiencies related to acetogenic metabolism and anaerobic respiration were discovered, such as the lack of formate dehydrogenase and F1F0 ATP synthase. This has potential consequences for the metabolic pathways used under SAO and non-SAO conditions. The two complete sets of bacteriophage genomes, which were found to be encoded in the genome, are also worthy of mention.	[Muller, Bettina; Schnurer, Anna] Swedish Univ Agr Sci, Bioctr, Dept Microbiol, Uppsala, Sweden; [Manzoor, Shahid; Niazi, Adnan; Bongcam-Rudloff, Erik] Swedish Univ Agr Sci, SLU Global Bioinformat Ctr, Dept Anim Breeding & Genet Sci, Uppsala, Sweden; [Manzoor, Shahid] Univ Punjab, Lahore, Pakistan	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of Punjab	Muller, B (corresponding author), Swedish Univ Agr Sci, Bioctr, Dept Microbiol, Uppsala, Sweden.	Bettina.Muller@slu.se	Müller, Bettina/H-3276-2018	Müller, Bettina/0000-0002-0030-7710; Bongcam-Rudloff, Erik/0000-0002-1947-8288; Schnurer, Anna/0000-0003-0038-553X	Higher Education Commission (HEC), Pakistan; EU-COST action [BM1006-SeqAhead]; EU [289452]; Swedish Energy Agency [P36651-1]	Higher Education Commission (HEC), Pakistan(Higher Education Commission of Pakistan); EU-COST action(European Cooperation in Science and Technology (COST)European Commission); EU(European Commission); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	This work was supported by the Higher Education Commission (HEC), Pakistan to SM, EU-COST action BM1006-SeqAhead: SM EB-R. EU FP7 to EB-R, ALLBIO project, grant number 289452, www.allbioinformatics.eu to EB-R SM and the Swedish Energy Agency, www.energimyndigheten.se, project no. P36651-1) to AS BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRING BK, 1993, APPL ENVIRON MICROB, V59, P2538, DOI 10.1128/AEM.59.8.2538-2545.1993; Angelidaki I, 2011, METHOD ENZYMOL, V494, P327, DOI 10.1016/B978-0-12-385112-3.00016-0; [Anonymous], 2011, SICKLE SLIDING WINDO; Balk M, 2002, INT J SYST EVOL MICR, V52, P1361, DOI [10.1099/ijs.0.02165-0, 10.1099/00207713-52-4-1361]; Beaty S, 1991, 91 GEN M AM SOC MICR, P236; Bible AN, 2008, J BACTERIOL, V190, P6365, DOI 10.1128/JB.00734-08; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Chauhan A, 2006, APPL ENVIRON MICROB, V72, P2400, DOI 10.1128/AEM.72.4.2400-2406.2006; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chien IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081040; Conrad R, 1999, FEMS MICROBIOL ECOL, V28, P193, DOI 10.1016/S0168-6496(98)00086-5; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dassonville F, 2002, AGRONOMIE, V22, P51, DOI 10.1051/agro:2001001; Detsch C, 2003, MICROBIOL-SGM, V149, P3289, DOI 10.1099/mic.0.26512-0; Ferry James G., 1993, P304; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Gruber G, 2001, J EXP BIOL, V204, P2597; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; HARTMANIS MGN, 1984, APPL ENVIRON MICROB, V47, P1277, DOI 10.1128/AEM.47.6.1277-1283.1984; Hattori S, 2000, INT J SYST EVOL MICR, V50, P1601, DOI 10.1099/00207713-50-4-1601; Hattori S, 2005, J BACTERIOL, V187, P3471, DOI 10.1128/JB.187.10.3471-3476.2005; Hattori S, 2001, J BIOSCI BIOENG, V91, P294, DOI 10.1263/jbb.91.294; He K, 2014, TRENDS MICROBIOL, V22, P389, DOI 10.1016/j.tim.2014.04.004; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hosie AHF, 2002, J BACTERIOL, V184, P5436, DOI 10.1128/JB.184.19.5436-5448.2002; HUGENHOLTZ J, 1989, J BACTERIOL, V171, P2873, DOI 10.1128/jb.171.5.2873-2875.1989; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ingram-Smith C, 2005, J BACTERIOL, V187, P5059, DOI 10.1128/JB.187.14.5059.2005; Iyer PP, 2004, STRUCTURE, V12, P559, DOI 10.1016/j.str.2004.03.007; JETTEN MSM, 1992, FEMS MICROBIOL LETT, V88, P181, DOI 10.1111/j.1574-6968.1992.tb04987.x; Jolkver E, 2009, J BACTERIOL, V191, P940, DOI 10.1128/JB.01155-08; Karakashev D, 2005, APPL ENVIRON MICROB, V71, P331, DOI 10.1128/AEM.71.1.331-338.2005; Karakashev D, 2006, APPL ENVIRON MICROB, V72, P5138, DOI 10.1128/AEM.00489-06; Karnholz A, 2002, APPL ENVIRON MICROB, V68, P1005, DOI 10.1128/AEM.68.2.1005-1009.2002; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kusel K, 2001, APPL ENVIRON MICROB, V67, P4734, DOI 10.1128/AEM.67.10.4734-4741.2001; LEE MJ, 1988, APPL ENVIRON MICROB, V54, P124, DOI 10.1128/AEM.54.1.124-129.1988; Liu FH, 2010, ENVIRON MICROBIOL, V12, P2341, DOI 10.1111/j.1462-2920.2010.02289.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu W, 2012, P NATL ACAD SCI USA, V109, P13254, DOI 10.1073/pnas.1204201109; Lumppio HL, 2001, J BACTERIOL, V183, P2970; MANTSALA P, 1976, J BIOL CHEM, V251, P3300; Manzoor S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00213-12; Manzoor S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00107-13; MOLLER D, 1987, ARCH MICROBIOL, V148, P202, DOI 10.1007/BF00414812; Muller B, 2013, MICROBIOLOGYOPEN, V2, P35, DOI 10.1002/mbo3.50; Nazina TN, 2006, MICROBIOLOGY+, V75, P55, DOI 10.1134/S0026261706010115; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nusslein B, 2001, ENVIRON MICROBIOL, V3, P460, DOI 10.1046/j.1462-2920.2001.00215.x; Oehler D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-723; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Park MO, 2007, MICROB ECOL, V53, P98, DOI 10.1007/s00248-006-9053-9; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Pitluck S, 2010, STAND GENOMIC SCI, V3, P108, DOI 10.4056/sigs.1133078; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rui JP, 2011, FEMS MICROBIOL ECOL, V77, P264, DOI 10.1111/j.1574-6941.2011.01104.x; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; SCHAUDER R, 1989, ARCH MICROBIOL, V151, P84; SCHAUDER R, 1987, ARCH MICROBIOL, V148, P218, DOI 10.1007/BF00414815; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schnurer A, 2008, WATER SCI TECHNOL, V57, P735, DOI 10.2166/wst.2008.097; SCHNURER A, 1994, ARCH MICROBIOL, V162, P70; Schnurer A, 1996, INT J SYST BACTERIOL, V46, P1145, DOI 10.1099/00207713-46-4-1145; Schnurer A, 1999, FEMS MICROBIOL ECOL, V29, P249; Schnurer A, 1997, FEMS MICROBIOL LETT, V154, P331, DOI 10.1016/S0378-1097(97)00350-9; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Shrestha PM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00237; Starai VJ, 2003, GENETICS, V163, P545; Sun L, 2013, ENERGY SUSTAIN SOC, V3, DOI 10.1186/2192-0567-3-15; Sun L, 2014, J BIOTECHNOL, V171, P39, DOI 10.1016/j.jbiotec.2013.11.016; Tirtom NE, 2013, J BIOL CHEM, V288, P619, DOI 10.1074/jbc.M112.420729; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wang SN, 2013, J BACTERIOL, V195, P1267, DOI 10.1128/JB.02158-12; Westerholm M, 2012, APPL ENVIRON MICROB, V78, P7619, DOI 10.1128/AEM.01637-12; Westerholm M, 2011, ENV MICROBIOL REP, V3, P500, DOI 10.1111/j.1758-2229.2011.00249.x; Westerholm M, 2011, SYST APPL MICROBIOL, V34, P260, DOI 10.1016/j.syapm.2010.11.018; Westerholm M, 2010, FEMS MICROBIOL LETT, V309, P100, DOI 10.1111/j.1574-6968.2010.02023.x; Whittaker JW, 2012, ARCH BIOCHEM BIOPHYS, V525, P111, DOI 10.1016/j.abb.2011.12.008; WINTER JU, 1980, ARCH MICROBIOL, V124, P73, DOI 10.1007/BF00407031; Wisniewski-Dye F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002430; ZEHNDER AJB, 1980, ARCH MICROBIOL, V124, P1, DOI 10.1007/BF00407022; ZINDER SH, 1984, ARCH MICROBIOL, V138, P263, DOI 10.1007/BF00402133	89	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121237	10.1371/journal.pone.0121237	http://dx.doi.org/10.1371/journal.pone.0121237			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811859	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700087
J	Pape, UJ; Huckvale, K; Car, J; Majeed, A; Millett, C				Pape, Utz J.; Huckvale, Kit; Car, Josip; Majeed, Azeem; Millett, Christopher			Impact of 'Stretch' Targets for Cardiovascular Disease Management within a Local Pay-for-Performance Programme	PLOS ONE			English	Article							OUTCOMES FRAMEWORK; HEALTH-CARE; FINANCIAL INCENTIVES; QUALITY; INEQUALITIES	Pay-for-performance programs are often aimed to improve the management of chronic diseases. We evaluate the impact of a local pay for performance programme (QOF+), which rewarded financially more ambitious quality targets ('stretch targets') than those used nationally in the Quality and Outcomes Framework (QOF). We focus on targets for intermediate outcomes in patients with cardiovascular disease and diabetes. A difference-indifference approach is used to compare practice level achievements before and after the introduction of the local pay for performance program. In addition, we analysed patient-level data on exception reporting and intermediate outcomes utilizing an interrupted time series analysis. The local pay for performance program led to significantly higher target achievements (hypertension: p-value <0.001, coronary heart disease: p-values <0.001, diabetes: p-values <0.061, stroke: p-values <0.003). However, the increase was driven by higher rates of exception reporting (hypertension: p-value <0.001, coronary heart disease: p-values <0.03, diabetes: p-values <0.05) in patients with all conditions except for stroke. Exception reporting allows practitioners to exclude patients from target calculations if certain criteria are met, e.g. informed dissent of the patient for treatment. There were no statistically significant improvements in mean blood pressure, cholesterol or HbA1c levels. Thus, achievement of higher payment thresholds in the local pay for performance scheme was mainly attributed to increased exception reporting by practices with no discernable improvements in overall clinical quality. Hence, active monitoring of exception reporting should be considered when setting more ambitious quality targets. More generally, the study suggests a trade-off between additional incentive for better care and monitoring costs.	[Pape, Utz J.; Huckvale, Kit; Car, Josip; Majeed, Azeem; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Imperial College London	Pape, UJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	u.pape@imperial.ac.uk	Car, Josip/H-6755-2015	Car, Josip/0000-0001-8969-371X; Millett, Christopher/0000-0002-0793-9884; Majeed, Azeem/0000-0002-2357-9858	NHS Hammersmith and Fulham	NHS Hammersmith and Fulham	QOF+ was funded by NHS Hammersmith and Fulham. The Department of Primary Care & Public Health at Imperial College London received funds from NHS Hammersmith and Fulham to evaluate the QOF+ scheme. The authors are also grateful for support for the evaluation from the NW London NIHR Collaboration for Leadership in Applied Health Research & Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshamsan R, 2010, J HEALTH SERV RES PO, V15, P178, DOI 10.1258/jhsrp.2010.009113; Ashworth Mark, 2006, BMC Fam Pract, V7, P68, DOI 10.1186/1471-2296-7-68; Conrad DA, 2009, ANNU REV PUBL HEALTH, V30, P357, DOI 10.1146/annurev.publhealth.031308.100243; Dalton ARH, 2011, DIABETIC MED, V28, P525, DOI 10.1111/j.1464-5491.2011.03251.x; Department of Health, 2008, HIGH QUALITY CARE AL; Doran T, 2011, BMJ, V342; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Kontopantelis E, 2012, HEALTH SERV RES, V47, P1117, DOI 10.1111/j.1475-6773.2011.01362.x; Lee JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027236; Majeed Azeem, 2004, Health Stat Q, P5; McLean G, 2006, J EPIDEMIOL COMMUN H, V60, P917, DOI 10.1136/jech.2005.044628; MILLETT C, 2011, BMJ, V342; Office for National Statistics, 2007, IND MULT DEPR IMD 20; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Serumaga B, 2011, BMJ, V342; Shah SM, 2011, BMJ, V342; Sigfrid LA, 2006, J PUBLIC HEALTH-UK, V28, P221, DOI 10.1093/pubmed/fdl028; Tim D, 2012, BMJ, V344; Wright J, 2006, BRIT J GEN PRACT, V56, P277	20	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119185	10.1371/journal.pone.0119185	http://dx.doi.org/10.1371/journal.pone.0119185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811487	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700011
J	Wong, MK; Nicholson, CJ; Holloway, AC; Hardy, DB				Wong, Michael K.; Nicholson, Catherine J.; Holloway, Alison C.; Hardy, Daniel B.			Maternal Nicotine Exposure Leads to Impaired Disulfide Bond Formation and Augmented Endoplasmic Reticulum Stress in the Rat Placenta	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; INTRAUTERINE GROWTH RESTRICTION; ADIPOSE-TISSUE FUNCTION; CIGARETTE-SMOKE; ER STRESS; TRANSLATIONAL CONTROL; GENE-EXPRESSION; TOBACCO-SMOKE; NEONATAL EXPOSURE; MAMMALIAN-CELLS	Maternal nicotine exposure has been associated with many adverse fetal and placental outcomes. Although underlying mechanisms remain elusive, recent studies have identified that augmented endoplasmic reticulum (ER) stress is linked to placental insufficiency. Moreover, ER function depends on proper disulfide bond formation-a partially oxygen-dependent process mediated by protein disulfide isomerase (PDI) and ER oxidoreductases. Given that nicotine compromised placental development in the rat, and placental insufficiency has been associated with poor disulfide bond formation and ER stress, we hypothesized that maternal nicotine exposure leads to both placental ER stress and impaired disulfide bond formation. To test this hypothesis, female Wistar rats received daily subcutaneous injections of either saline (vehicle) or nicotine bitartrate (1 mg/kg) for 14 days prior to mating and during pregnancy. Placentas were harvested on embryonic day 15 for analysis. Protein and mRNA expression of markers involved in ER stress (e.g., phosphorylated eIF2 alpha, Grp78, Atf4, and CHOP), disulfide bond formation (e.g., PDI, QSOX1, VKORC1), hypoxia (Hif1 alpha), and amino acid deprivation (GCN2) were quantified via Western blot and/or Real-time PCR. Maternal nicotine exposure led to increased expression of Grp78, phosphorylated eIF2 alpha, Atf4, and CHOP (p<0.05) in the rat placenta, demonstrating the presence of augmented ER stress. Decreased expression of PDI and QSOX1 (p<0.05) reveal an impaired disulfide bond formation pathway, which may underlie nicotine-induced ER stress. Finally, elevated expression of Hif1 alpha and GCN2 (p<0.05) indicate hypoxia and amino acid deprivation in nicotine-exposed placentas, respectively, which may also cause impaired disulfide bond formation and augmented ER stress. This study is the first to link maternal nicotine exposure with both placental ER stress and disulfide bond impairment in vivo, providing novel insight into the mechanisms underlying nicotine exposure during pregnancy on placental health.	[Wong, Michael K.; Hardy, Daniel B.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Nicholson, Catherine J.; Holloway, Alison C.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Hardy, Daniel B.] Univ Western Ontario, Childrens Hlth Res Inst, Hlth Res Inst, Dept Obstet & Gynecol, London, ON, Canada	Western University (University of Western Ontario); McMaster University; Western University (University of Western Ontario)	Hardy, DB (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	daniel.hardy@schulich.uwo.ca	Hardy, Daniel/GYU-8976-2022	Hardy, Daniel/0000-0001-5445-273X	Canadian Institutes of Health Research [MOP 111011, MOP 86474]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (MOP 111011 to DBH and MOP 86474 to ACH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sahab B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-24; Ananth CV, 1999, OBSTET GYNECOL, V93, P622, DOI 10.1016/S0029-7844(98)00408-6; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ankarberg E, 2001, BEHAV BRAIN RES, V123, P185, DOI 10.1016/S0166-4328(01)00207-8; Benham AM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0403; Benowitz NL, 2004, NICOTINE TOB RES, V6, pS189, DOI 10.1080/14622200410001669169; Bernstein IM, 2005, OBSTET GYNECOL, V106, P986, DOI 10.1097/01.AOG.0000182580.78402.d2; Blumental-Perry A, 2012, CURR MOL MED, V12, P883, DOI 10.2174/156652412801318764; Bowker KA, 2014, NICOTINE TOB RES, V16, DOI 10.1093/ntr/ntu029; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Bull VH, 2012, ELECTROPHORESIS, V33, P1814, DOI 10.1002/elps.201100565; Cantin AM, 2012, CURR MOL MED, V12, P836; Chakravarthi S, 2007, BIOCHEM J, V404, P403, DOI 10.1042/BJ20061510; Chambers JE, 2014, AM J PHYSIOL-CELL PH, V307, pC657, DOI 10.1152/ajpcell.00183.2014; Chelmow D, 1996, OBSTET GYNECOL, V87, P703, DOI 10.1016/0029-7844(95)00471-8; Cui Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084640; De Long NE, 2014, EXPERT OPIN DRUG SAF, V13, P1721, DOI 10.1517/14740338.2014.973846; de Weerd S, 2002, ENVIRON RES, V90, P119, DOI 10.1006/enrs.2002.4395; Dhalwani NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072218; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; DuRose JB, 2009, MOL CELL BIOL, V29, P4295, DOI 10.1128/MCB.00260-09; Eckstein LW, 1997, DEV BRAIN RES, V103, P59, DOI 10.1016/S0165-3806(97)00117-X; Eskenazi B, 1995, AM J EPIDEMIOL, V142; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gan GX, 2011, CELL PHYSIOL BIOCHEM, V28, P725, DOI 10.1159/000335766; Gao YJ, 2005, OBES RES, V13, P687, DOI 10.1038/oby.2005.77; Gao YJ, 2008, EUR J PHARMACOL, V590, P264, DOI 10.1016/j.ejphar.2008.05.044; George L, 2006, EPIDEMIOLOGY, V17, P500, DOI 10.1097/01.ede.0000229984.53726.33; Goodwin RD, 2007, OBSTET GYNECOL, V109, P875, DOI 10.1097/01.AOG.0000255979.62280.e6; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Gruslin A, 2009, REPROD SCI, V16, P875, DOI 10.1177/1933719109337038; Gulow K, 2002, J CELL SCI, V115, P2443; Hafner E, 2003, PLACENTA, V24, P336, DOI 10.1053/plac.2002.0918; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hammoud AO, 2005, AM J OBSTET GYNECOL, V192, P1856, DOI 10.1016/j.ajog.2004.12.057; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Holloway AC, 2006, ENDOCRINE, V30, P213, DOI 10.1385/ENDO:30:2:213; Holloway AC, 2014, AM J PHYSIOL-ENDOC M, V306, pE443, DOI 10.1152/ajpendo.00478.2013; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Humeres C, 2014, TOXICOL IN VITRO, V28, P1443, DOI 10.1016/j.tiv.2014.07.013; Ilani T, 2013, SCIENCE, V341, P74, DOI 10.1126/science.1238279; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jain K, 2013, INT J CARDIOL, V168, P4667, DOI 10.1016/j.ijcard.2013.07.180; Jauniaux E, 1999, OBSTET GYNECOL, V93, P680, DOI 10.1016/S0029-7844(98)00548-1; Jauniaux E, 2007, EARLY HUM DEV, V83, P699, DOI 10.1016/j.earlhumdev.2007.07.016; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Kawakami T, 2014, TOXICOL APPL PHARM, V275, P134, DOI 10.1016/j.taap.2013.12.008; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Kelsen SG, 2012, PULM PHARMACOL THER, V25, P447, DOI 10.1016/j.pupt.2012.07.005; Kenche H, 2013, FASEB J, V27, P965, DOI 10.1096/fj.12-216234; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Lagunov A, 2011, REPROD TOXICOL, V31, P418, DOI 10.1016/j.reprotox.2010.12.004; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lee SI, 2012, J PERIODONTAL RES, V47, P299, DOI 10.1111/j.1600-0765.2011.01432.x; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; Lips KS, 2005, PLACENTA, V26, P735, DOI 10.1016/j.placenta.2004.10.009; Liu D, 2013, INT J NEUROSCI, V123, P155, DOI 10.3109/00207454.2012.746974; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma JA, 2011, J NEURO-ONCOL, V101, P41, DOI 10.1007/s11060-010-0237-2; Ma N, 2014, TOXICOL APPL PHARM, V275, P1, DOI 10.1016/j.taap.2013.12.010; Machaalani R, 2014, TOXICOL APPL PHARM, V276, P204, DOI 10.1016/j.taap.2014.02.015; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mitchell E. A., 2006, Reviews on Environmental Health, V21, P81; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Okuda A, 2014, FEBS J, V281, P5341, DOI 10.1111/febs.13079; Orton S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004915; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pastrakuljic A, 1999, PLACENTA, V20, P499, DOI 10.1053/plac.1999.0418; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Proctor LK, 2009, ULTRASOUND OBST GYN, V34, P274, DOI 10.1002/uog.7308; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Repo JK, 2014, TOXICOL LETT, V224, P264, DOI 10.1016/j.toxlet.2013.10.032; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; SARNOW P, 1989, P NATL ACAD SCI USA, V86, P5795, DOI 10.1073/pnas.86.15.5795; SASTRY BVR, 1991, REPROD FERT DEVELOP, V3, P355, DOI 10.1071/RD9910355; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Soares MJ, 2012, PLACENTA, V33, P233, DOI 10.1016/j.placenta.2011.11.026; Sood R, 2000, GENETICS, V154, P787; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Thame M, 2004, EUR J CLIN NUTR, V58, P894, DOI 10.1038/sj.ejcn.1601909; Tong V. T., 2013, MMWR-MORBID MORTAL W, V62, P1; van Schadewijk A, 2012, CELL STRESS CHAPERON, V17, P275, DOI 10.1007/s12192-011-0306-2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Wisborg K, 2001, AM J EPIDEMIOL, V154, P322, DOI 10.1093/aje/154.4.322; Yu SJ, 2012, J BIOENERG BIOMEMBR, V44, P101, DOI 10.1007/s10863-012-9416-5; Yung HW, 2014, J PATHOL, V234, P262, DOI 10.1002/path.4394; Yung HW, 2012, J PATHOL, V228, P554, DOI 10.1002/path.4068; Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com; Zhang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040433; Zhang LH, 2014, J BIOL CHEM, V289, P31188, DOI 10.1074/jbc.M114.602961; Zhao H, 2011, METHOD ENZYMOL, V489, P147, DOI 10.1016/B978-0-12-385116-1.00009-1; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	110	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122295	10.1371/journal.pone.0122295	http://dx.doi.org/10.1371/journal.pone.0122295			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811377	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700181
J	Collins-Hooper, H; Sartori, R; Giallourou, N; Matsakas, A; Mitchell, R; Mararenkova, H; Flasskamp, H; Macharia, R; Ray, S; Swann, JR; Sandri, M; Patel, K				Collins-Hooper, Henry; Sartori, Roberta; Giallourou, Natasa; Matsakas, Antonios; Mitchell, Robert; Mararenkova, Helen; Flasskamp, Hannah; Macharia, Raymond; Ray, Steve; Swann, Jonathan R.; Sandri, Marco; Patel, Ketan			Symmorphosis through Dietary Regulation: A Combinatorial Role for Proteolysis, Autophagy and Protein Synthesis in Normalising Muscle Metabolism and Function of Hypertrophic Mice after Acute Starvation	PLOS ONE			English	Article							SKELETAL-MUSCLE; CARNOSINE; ANSERINE; MASS; UNDERNUTRITION; EXPRESSION; PHENOTYPE; GROWTH; TISSUE; SERUM	Animals are imbued with adaptive mechanisms spanning from the tissue/organ to the cellular scale which insure that processes of homeostasis are preserved in the landscape of size change. However we and others have postulated that the degree of adaptation is limited and that once outside the normal levels of size fluctuations, cells and tissues function in an aberant manner. In this study we examine the function of muscle in the myostatin null mouse which is an excellent model for hypertrophy beyond levels of normal growth and consequeces of acute starvation to restore mass. We show that muscle growth is sustained through protein synthesis driven by Serum/Glucocorticoid Kinase 1 (SGK1) rather than Akt1. Furthermore our metabonomic profiling of hypertrophic muscle shows that carbon from nutrient sources is being channelled for the production of biomass rather than ATP production. However the muscle displays elevated levels of autophagy and decreased levels of muscle tension. We demonstrate the myostatin null muscle is acutely sensitive to changes in diet and activates both the proteolytic and autophagy programmes and shutting down protein synthesis more extensively than is the case for wild-types. Poignantly we show that acute starvation which is detrimental to wild-type animals is beneficial in terms of metabolism and muscle function in the myostatin null mice by normalising tension production.	[Collins-Hooper, Henry; Mitchell, Robert; Flasskamp, Hannah; Patel, Ketan] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Sartori, Roberta; Sandri, Marco] Univ Padua, Venetian Inst Mol Med, Padua, Italy; [Giallourou, Natasa; Swann, Jonathan R.] Univ Reading, Dept Food & Nutr Sci, Sch Chem Food & Pharm, Reading, Berks, England; [Matsakas, Antonios] Hull York Med Sch, Ctr Cardiovasc & Metab Res, Kingston Upon Hull, N Humberside, England; [Mararenkova, Helen] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Macharia, Raymond] Royal Vet Coll, Vet Basic Sci, London, England; [Ray, Steve] Univ Reading, Nat Biosci, Reading, Berks, England	University of Reading; University of Padua; Veneto Institute Molecular Medicine; University of Reading; University of Hull; University of York - UK; Scripps Research Institute; University of London; University of London Royal Veterinary College; University of Reading	Patel, K (corresponding author), Univ Reading, Sch Biol Sci, Whiteknights Campus, Reading, Berks, England.	ketan.patel@reading.ac.uk	Antonios Matsakas, SFHEA/I-6565-2019; Giallourou, Natasa/X-9045-2019; Sartori, Roberta/GRE-9950-2022	Antonios Matsakas, SFHEA/0000-0003-0746-0088; Giallourou, Natasa/0000-0001-5081-7367; Sartori, Roberta/0000-0002-2763-9838	BBSRC [BB/I015787/1, BBJ0164541]; BBSRC [BB/J016454/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1103836, BB/J016454/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC (BB/I015787/1, BBJ0164541). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835; Andres-Mateos E, 2013, EMBO MOL MED, V5, P80, DOI 10.1002/emmm.201201443; [Anonymous], 2013, LANCET; Aristoy MC, 1998, MEAT SCI, V50, P327, DOI 10.1016/S0309-1740(98)00037-0; AVENA RM, 1969, J BIOL CHEM, V244, P1600; Ballak S, 2014, AGEING RES REV; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; COLLISON DR, 1967, LANCET, V1, P112; CUENDET GS, 1975, AM J PHYSIOL, V228, P276, DOI 10.1152/ajplegacy.1975.228.1.276; DAVEY CL, 1960, ARCH BIOCHEM BIOPHYS, V89, P303, DOI 10.1016/0003-9861(60)90059-X; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Dunnett M, 1997, RES VET SCI, V62, P213, DOI 10.1016/S0034-5288(97)90192-2; Elia M, 2000, BRIT J NUTR, V84, P257, DOI 10.1017/S0007114500001525; GARLAND T, 1987, EVOLUTION, V41, P1404, DOI 10.1111/j.1558-5646.1987.tb02478.x; Garvey SM, 2006, HUM MOL GENET, V15, P2348, DOI 10.1093/hmg/ddl160; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; GOLDSPINK G, 1979, J PHYSIOL-LONDON, V296, P453, DOI 10.1113/jphysiol.1979.sp013016; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; JOHNSON P, 1982, BIOCHEM BIOPH RES CO, V109, P769, DOI 10.1016/0006-291X(82)92006-X; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Krieger M., 1921, ANAT KONSTITUTIONAL, V7, P87; Kurapati R, 2012, HUM MOL GENET, V21, P1706, DOI 10.1093/hmg/ddr605; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Macdonald EM, 2014, DIS MODEL MECH; Matsakas A, 2013, INT J SPORTS MED, V34, P223, DOI 10.1055/s-0032-1312605; Matsakas A, 2012, EXP PHYSIOL, V97, P125, DOI 10.1113/expphysiol.2011.063008; Matsakas A, 2010, REJUV RES, V13, P717, DOI 10.1089/rej.2010.1065; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mofarrahi M, 2013, AUTOPHAGY, V9, P1604, DOI 10.4161/auto.25955; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nemazanyy I, 2013, EMBO MOL MED, V5, P870, DOI 10.1002/emmm.201202057; RUNCIE J, 1970, BRIT MED J, V3, P432, DOI 10.1136/bmj.3.5720.432; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Savage KJ, 2010, MUSCLE NERVE, V42, P355, DOI 10.1002/mus.21688; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Smil V, 1999, BMJ-BRIT MED J, V319, P1619, DOI 10.1136/bmj.319.7225.1619; Song YH, 2005, J INVEST MED, V53, P135, DOI 10.2310/6650.2005.00309; TAYLOR CR, 1981, RESP PHYSIOL, V44, P1, DOI 10.1016/0034-5687(81)90073-6; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Uddin MN, 2011, BIOCHEM BIOPH RES CO, V407, P692, DOI 10.1016/j.bbrc.2011.03.077; Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI doi: 10.11267science. 1160809 PMID: 1 9460998; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Yoshioka Yoshichika, 2002, Magn Reson Med Sci, V1, P7, DOI 10.2463/mrms.1.7; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	49	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120524	10.1371/journal.pone.0120524	http://dx.doi.org/10.1371/journal.pone.0120524			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807490	Green Accepted, Green Published, gold			2022-12-26	WOS:000351880000081
J	Schultz, M; Molligan, J; Schon, L; Zhang, ZJ				Schultz, Melissa; Molligan, Jeremy; Schon, Lew; Zhang, Zijun			Pathology of the Calcified Zone of Articular Cartilage in Post-Traumatic Osteoarthritis in Rat Knees	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; SUBCHONDRAL BONE; JOINT; TIDEMARK; PATHOGENESIS; MORPHOLOGY; MODEL; DEEP; HIPS	Objectives This study aimed to investigate the pathology occurring at the calcified zone of articular cartilage (CZC) in the joints afflicted with post-traumatic osteoarthritis (PTOA). Methods Rats underwent bilateral anterior cruciate ligament (ACL) transection and medial meniscectomy to induce PTOA. Sham surgery was performed on another five rats to serve as controls. The rats were euthanized after four weeks of surgery and tibial plateaus were dissected for histology. The pathology of PTOA, CZC area and the tidemark roughness at six pre-defined locations on the tibial plateaus were quantified by histomorphometry. Results PTOA developed in the knees, generally more severe at the medial plateau than the lateral plateau, of rats in the experimental group. The CZC area was unchanged in the PTOA joints, but the topographic variations of CZC areas that presented in the control knees were reduced in the PTOA joints. The tidemark roughness decreased in areas of the medial plateau of PTOA joints and that was inversely correlated with the Mankin's score of PTOA pathology. Conclusion Reduced tidemark roughness and unchanged CZC area differentiate PTOA from primary osteoarthritis, which is generally believed to have the opposite pathology at CZC, and may contribute to the distinct disease progression of the two entities of arthropathy.	[Schultz, Melissa] St Louis Univ, Ctr Anat Sci, St Louis, MO 63103 USA; [Molligan, Jeremy; Schon, Lew; Zhang, Zijun] Medstar Union Mem Hosp, Orthobiol Lab, Baltimore, MD 21218 USA	Saint Louis University; Union Memorial Hospital	Zhang, ZJ (corresponding author), Medstar Union Mem Hosp, Orthobiol Lab, Baltimore, MD 21218 USA.	zijun.zhang@medstar.net			Saint Louis University	Saint Louis University	This research utilized no outside funding and was financed solely by funds issued to Zijun Zhang by Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Appleton CTG, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2120; Appleyard RC, 2003, OSTEOARTHR CARTILAGE, V11, P65, DOI 10.1053/joca.2002.0867; Arkill KP, 2008, OSTEOARTHR CARTILAGE, V16, P708, DOI 10.1016/j.joca.2007.10.001; Beckett J, 2012, J ORTHOP RES, V30, P1604, DOI 10.1002/jor.22124; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de; BULLOUGH PG, 1983, J BONE JOINT SURG BR, V65, P72, DOI 10.1302/0301-620X.65B1.6337169; Burr David B, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS20; Burr DB, 1997, MICROSC RES TECHNIQ, V37, P343, DOI 10.1002/(SICI)1097-0029(19970515)37:4<343::AID-JEMT9>3.0.CO;2-L; Chen R, 2011, ARCH ORAL BIOL, V56, P1390, DOI 10.1016/j.archoralbio.2011.04.007; Doube M, 2007, OSTEOARTHR CARTILAGE, V15, P1283, DOI 10.1016/j.joca.2007.04.003; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Goldring SR, 2012, THER ADV MUSCULOSKEL, V4, P249, DOI 10.1177/1759720X12437353; Han SK, 2010, J R SOC INTERFACE, V7, P895, DOI 10.1098/rsif.2009.0458; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; Kramer WC, 2011, INT J CLIN EXP MED, V4, P285; LANE LB, 1980, J BONE JOINT SURG BR, V62, P372, DOI 10.1302/0301-620X.62B3.7410471; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Lyons TJ, 2005, J MOL HISTOL, V36, P207, DOI 10.1007/s10735-005-3283-x; Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Mansfield JC, 2012, J ANAT, V220, P405, DOI 10.1111/j.1469-7580.2012.01479.x; Martinelli MJ, 2002, EQUINE VET J, V34, P274, DOI 10.2746/042516402776186100; McKinley TO, 2010, J ORTHOP TRAUMA, V24, P567, DOI 10.1097/BOT.0b013e3181ed298d; MEACHIM G, 1984, J ANAT, V139, P341; Natoli RM, 2009, BIORHEOLOGY, V46, P451, DOI 10.3233/BIR-2009-0554; OConnor KM, 1997, J BONE MINER RES, V12, P580, DOI 10.1359/jbmr.1997.12.4.580; Oegema TR, 1997, MICROSC RES TECHNIQ, V37, P324, DOI 10.1002/(SICI)1097-0029(19970515)37:4<324::AID-JEMT7>3.0.CO;2-K; OETTMEIER R, 1989, Acta Morphologica Hungarica, V37, P169; Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.20883; REVELL PA, 1990, RHEUMATOL INT, V10, P143, DOI 10.1007/BF02274838; Silver FH, 2004, MATRIX BIOL, V23, P467, DOI 10.1016/j.matbio.2004.08.003; Vrahas MS, 2004, CLIN ORTHOP RELAT R, P40, DOI 10.1097/01.blo.0000133567.28491.7d; Wang FY, 2009, J STRUCT BIOL, V168, P359, DOI 10.1016/j.jsb.2009.08.010	38	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120949	10.1371/journal.pone.0120949	http://dx.doi.org/10.1371/journal.pone.0120949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807537	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000114
J	Sokolov, I; Guz, NV; Iyer, S; Hewitt, A; Sokolov, NA; Erlichman, JS; Woodworth, CD				Sokolov, Igor; Guz, Natali V.; Iyer, Swaminathan; Hewitt, Amy; Sokolov, Nina A.; Erlichman, Joseph S.; Woodworth, Craig D.			Recovery of Aging-Related Size Increase of Skin Epithelial Cells: In vivo Mouse and In vitro Human Study	PLOS ONE			English	Article							GLYCATION; AGE	The size increase of skin epithelial cells during aging is well-known. Here we demonstrate that treatment of aging cells with cytochalasin B substantially decreases cell size. This decrease was demonstrated on a mouse model and on human skin cells in vitro. Six nude mice were treated by topical application of cytochalasin B on skin of the dorsal left midsection for 140 days (the right side served as control for placebo treatment). An average decrease in cell size of 56 +/- 16% resulted. A reduction of cell size was also observed on primary human skin epithelial cells of different in vitro age (passages from 1 to 8). A cell strain obtained from a pool of 6 human subjects was treated with cytochalasin B in vitro for 12 hours. We observed a decrease in cell size that became statistically significant and reached 20-40% for cells of older passage (6-8 passages) whereas no substantial change was observed for younger cells. These results may be important for understanding the aging processes, and for cosmetic treatment of aging skin.	[Sokolov, Igor] Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA; [Sokolov, Igor] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Sokolov, Igor] Tufts Univ, Dept Phys, Medford, MA 02155 USA; [Guz, Natali V.] Clarkson Univ, Dept Chem, Potsdam, NY USA; [Iyer, Swaminathan] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Hewitt, Amy] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Sokolov, Nina A.; Woodworth, Craig D.] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA; [Erlichman, Joseph S.] St Lawrence Univ, Dept Biol, Canton, NY 13617 USA	Tufts University; Tufts University; Tufts University; Clarkson University; University of Western Australia; Queens University - Canada; Clarkson University; Saint Lawrence University	Sokolov, I (corresponding author), Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.	igor.sokolov@tufts.edu	Iyer, Swaminathan/GRS-9668-2022; Sokolov, Igor/A-6858-2009	Sokolov, Igor/0000-0001-6260-4326	National Scicnce Foundation [CMMI-1435655]; National Cancer Institute [1 R15 CA173703-01]; NATIONAL CANCER INSTITUTE [R15CA173703] Funding Source: NIH RePORTER	National Scicnce Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This material is based upon work partially supported by CMMI-1435655 from National Scicnce Foundation (http://www.nsf.gov/) (IS) and 1 R15 CA173703-01 from the National Cancer Institute (http://www.nih.gov/) (CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspres Nicholas, 2003, Australas J Dermatol, V44, P19, DOI 10.1046/j.1440-0960.2003.00632.x; Baumann L, 2009, COSMETIC DERMATOLOGY; Berdyyeva TK, 2005, PHYS MED BIOL, V50, P81, DOI 10.1088/0031-9155/50/1/007; Bucala R, 1992, Adv Pharmacol, V23, P1; Castellani RJ, 2001, FREE RADICAL BIO MED, V31, P175, DOI 10.1016/S0891-5849(01)00570-6; CORCUFF P, 1988, PHOTODERMATOLOGY, V5, P110; Dadzie OE, 2013, ETHNIC DERMATOLOGY: PRINCIPLES AND PRACTICE, P1, DOI 10.1002/9781118497784; DiGiovanna AG, 2000, HUMAN AGING BIOL PER; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Farage MA, 2010, TXB AGING SKIN; GROVE GL, 1983, J GERONTOL, V38, P137, DOI 10.1093/geronj/38.2.137; Guz NV, 2009, SKIN RES TECHNOL, V15, P379, DOI 10.1111/j.1600-0846.2009.00369.x; LEVEQUE JL, 1984, INT J DERMATOL, V23, P322, DOI 10.1111/j.1365-4362.1984.tb04061.x; Schroeder BM, 2003, AM FAM PHYSICIAN, V67, P2011; Sokolov I, 2006, NANOMED-NANOTECHNOL, V2, P31, DOI 10.1016/j.nano.2005.12.002; Ulrich P, 1997, DIABETOLOGIA, V40, pS157, DOI 10.1007/s001250051437; WOODWORTH CD, 1989, J VIROL, V63, P159, DOI 10.1128/JVI.63.1.159-164.1989	17	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122774	10.1371/journal.pone.0122774	http://dx.doi.org/10.1371/journal.pone.0122774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807526	Green Submitted, gold, Green Published			2022-12-26	WOS:000351880000225
J	Yoshihara, M; Ohmiya, H; Hara, S; Kawasaki, S; Hayashizaki, Y; Itoh, M; Kawaji, H; Tsujikawa, M; Nishida, K				Yoshihara, Masahito; Ohmiya, Hiroko; Hara, Susumu; Kawasaki, Satoshi; Hayashizaki, Yoshihide; Itoh, Masayoshi; Kawaji, Hideya; Tsujikawa, Motokazu; Nishida, Kohji		FANTOM Consortium	Discovery of Molecular Markers to Discriminate Corneal Endothelial Cells in the Human Body	PLOS ONE			English	Article							GENE-EXPRESSION; ZONA-PELLUCIDA; NEURAL CREST; N-CADHERIN; STEM-CELLS; IN-VITRO; RNA-SEQ; PROTEINS; PUMP; TRANSPLANTATION	The corneal endothelium is a monolayer of hexagonal corneal endothelial cells (CECs) on the inner surface of the cornea. CECs are critical in maintaining corneal transparency through their barrier and pump functions. CECs in vivo have a limited capacity in proliferation, and loss of a significant number of CECs results in corneal edema called bullous keratopathy which can lead to severe visual loss. Corneal transplantation is the most effective method to treat corneal endothelial dysfunction, where it suffers from donor shortage. Therefore, regeneration of CECs from other cell types attracts increasing interests, and specific markers of CECs are crucial to identify actual CECs. However, the currently used markers are far from satisfactory because of their non-specific expression in other cell types. Here, we explored molecular markers to discriminate CECs from other cell types in the human body by integrating the published RNA-seq data of CECs and the FANTOM5 atlas representing diverse range of cell types based on expression patterns. We identified five genes, CLRN1, MRGPRX3, HTR1D, GRIP1 and ZP4 as novel markers of CECs, and the specificities of these genes were successfully confirmed by independent experiments at both the RNA and protein levels. Notably none of them have been documented in the context of CEC function. These markers could be useful for the purification of actual CECs, and also available for the evaluation of the products derived from other cell types. Our results demonstrate an effective approach to identify molecular markers for CECs and open the door for the regeneration of CECs in vitro.	[Yoshihara, Masahito; Hara, Susumu; Kawasaki, Satoshi; Tsujikawa, Motokazu; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan; [Yoshihara, Masahito; Ohmiya, Hiroko; Itoh, Masayoshi; Kawaji, Hideya] RIKEN, Div Genom Technol, Ctr Life Sci Technol, Yokohama, Kanagawa, Japan; [Ohmiya, Hiroko; Kawaji, Hideya] RIKEN, Prevent Med & Appl Genom Unit, Adv Ctr Comp & Commun, Yokohama, Kanagawa, Japan; [Hayashizaki, Yoshihide; Itoh, Masayoshi; Kawaji, Hideya] RIKEN, Prevent Med & Diag Innovat Program, Wako, Saitama, Japan	Osaka University; RIKEN; RIKEN; RIKEN	Kawaji, H (corresponding author), RIKEN, Div Genom Technol, Ctr Life Sci Technol, Yokohama, Kanagawa, Japan.	kawaji@gsc.riken.jp; knishida@ophthal.med.osaka-u.ac.jp	Bodega, Beatrice/I-4644-2018; Hide, Winston Hide/C-7217-2009; Kenna, Tony/A-6035-2011; Wolvetang, Ernst jurgen/D-6644-2017; Itoh, Masayoshi/N-5363-2015; Kere, Juha/A-9179-2008; Katayama, Shintaro/F-2958-2010; Hide, Winston/R-3815-2019; Ohno, Hiroshi/L-7899-2014; Hayashizaki, Yoshihide/N-6590-2015; Hide, Winston A/V-2727-2017; Yoshihara, Masahito/C-3711-2017; Mackay-Sim, Alan/C-3431-2008; Kawaji, Hideya/N-5116-2015	Bodega, Beatrice/0000-0003-0527-9234; Hide, Winston Hide/0000-0002-8621-3271; Wolvetang, Ernst jurgen/0000-0002-2146-6614; Itoh, Masayoshi/0000-0002-1772-318X; Kere, Juha/0000-0003-1974-0271; Katayama, Shintaro/0000-0001-7581-5157; Hide, Winston/0000-0002-8621-3271; Ohno, Hiroshi/0000-0001-8776-9661; Hide, Winston A/0000-0002-8621-3271; Yoshihara, Masahito/0000-0002-8915-9282; Mackay-Sim, Alan/0000-0003-4446-5371; Kawaji, Hideya/0000-0002-0575-0308; Wasserman, Wyeth/0000-0001-6098-6412; Ekwall, Karl/0000-0002-3029-4041; Alam, Intikhab/0000-0001-5306-847X; Meehan, Terrence/0000-0003-1980-3228; Burroughs, A. Max/0000-0002-2229-8771; Rackham, Owen/0000-0002-4390-0872; IIDA, Kei/0000-0001-7130-8705; Freeman, Thomas/0000-0001-5235-8483; Valen, Eivind/0000-0003-1840-6108; Moro, Kazuyo/0000-0002-7377-1303; Fisher, Malcolm/0000-0003-1074-8103; Heutink, Peter/0000-0001-5218-1737; Huminiecki, Lukasz/0000-0003-1943-4450; Nishida, Kohji/0000-0001-9069-3610	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT, Japan; Japan Science and Technology Agency (JST); MEXT; RIKEN Junior Research Associate program; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT, Japan; Japan Science and Technology Agency (JST); MEXT; RIKEN Junior Research Associate program; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007004] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Junior Research Associate program; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Junior Research Associate program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	FANTOM5 was made possible by a research grant for RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (Y.H.) and an Innovative Cell Biology by Innovative Technology (Cell Innovation Program) grant from the MEXT, Japan (Y.H.). This work is supported by the Highway Program for Realization of Regenerative Medicine from Japan Science and Technology Agency (JST) (K.N.), Research Grant from MEXT to the RIKEN Center for Life Science Technologies, Research Grant to RIKEN Preventive Medicine and Diagnosis Innovation Program from MEXT to Y.H., and RIKEN Junior Research Associate program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; BARRY PA, 1995, INVEST OPHTH VIS SCI, V36, P1115; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; Chen YY, 2013, HUM MOL GENET, V22, P1271, DOI 10.1093/hmg/dds527; Cheong YK, 2013, INVEST OPHTH VIS SCI, V54, P4538, DOI 10.1167/iovs.13-11754; Chiu PCN, 2008, BIOL REPROD, V79, P869, DOI 10.1095/biolreprod.108.069344; Chng ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067546; Diaz-Valle D, 1998, J CATARACT REFR SURG, V24, P951, DOI 10.1016/S0886-3350(98)80049-7; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Geller SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000607; Harriott AM, 2008, CEPHALALGIA, V28, P933, DOI 10.1111/j.1468-2982.2008.01635.x; HARTMANN JF, 1972, P NATL ACAD SCI USA, V69, P2767, DOI 10.1073/pnas.69.10.2767; Hatou S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0286; HODSON S, 1976, J PHYSIOL-LONDON, V263, P563, DOI 10.1113/jphysiol.1976.sp011645; HOWARTH AG, 1992, AM J PHYSIOL, V262, pC461, DOI 10.1152/ajpcell.1992.262.2.C461; Itoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030809; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Keenan TDL, 2012, ARCH OPHTHALMOL-CHIC, V130, P621, DOI 10.1001/archophthalmol.2011.2585; Kikuchi M, 2011, GENES CELLS, V16, P273, DOI 10.1111/j.1365-2443.2011.01485.x; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MAURICE DM, 1972, J PHYSIOL-LONDON, V221, P43, DOI 10.1113/jphysiol.1972.sp009737; MCCARTNEY MD, 1987, INVEST OPHTH VIS SCI, V28, P1955; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mobasheri A, 2000, BIOSCIENCE REP, V20, P51, DOI 10.1023/A:1005580332144; RODRIGUES M, 1987, DIFFERENTIATION, V34, P60, DOI 10.1111/j.1432-0436.1987.tb00051.x; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Schmedt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051427; Shimazaki J, 2004, TRANSPLANTATION, V78, P216, DOI 10.1097/01.tp.0000128329.28962.4a; SLINGSBY JG, 1981, ARCH OPHTHALMOL-CHIC, V99, P1041; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsuchiya B, 2006, ARCH HISTOL CYTOL, V69, P135, DOI 10.1679/aohc.69.135; Vassilev VS, 2012, INVEST OPHTH VIS SCI, V53, P7183, DOI 10.1167/iovs.12-9949; Vickaryous MK, 2006, BIOL REV, V81, P425, DOI 10.1017/S1464793106007068; ZAM ZS, 1980, INVEST OPHTH VIS SCI, V19, P648; Zhang K, 2014, STEM CELLS DEV, V23, P1340, DOI 10.1089/scd.2013.0510	43	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0117581	10.1371/journal.pone.0117581	http://dx.doi.org/10.1371/journal.pone.0117581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807145	Green Published, Green Accepted, gold			2022-12-26	WOS:000351880000006
J	Chaudhuri, AD; Kabaria, S; Choi, DC; Mouradian, MM; Junn, E				Chaudhuri, Amrita Datta; Kabaria, Savan; Choi, Doo Chul; Mouradian, M. Maral; Junn, Eunsung			MicroRNA-7 Promotes Glycolysis to Protect against 1-Methyl-4-phenylpyridinium-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; microRNA (miRNA); neurodegenerative disease; NF-kappa B (NF-KB); Parkinson disease; 1-methyl-4-phenylpyridinium; RelA; microRNA-7; glycolysis	NF-KAPPA-B; ALPHA-SYNUCLEIN EXPRESSION; MITOCHONDRIAL COMPLEX-I; PARKINSONS-DISEASE; ALLOSTERIC REGULATION; GENE-EXPRESSION; PYRUVATE-KINASE; NEUROBLASTOMA-CELLS; OXIDATIVE STRESS; BRAIN	Background: The dopaminergic neurotoxin, 1-methyl-4-phenylpyridinium (MPP+), kills cells by inhibiting mitochondrial oxidative phosphorylation. Results: MicroRNA-7-mediated repression of RelA expression and subsequent increase in glucose transporter Glut3 level augments glycolysis in neuronal cells. Conclusion: MicroRNA-7 protects cells against MPP+-induced cytotoxicity by enhancing glycolysis. Significance: MicroRNA-7 could potentially mitigate the effects of mitochondrial oxidative phosphorylation defects in Parkinson disease. Parkinson disease is associated with decreased activity of the mitochondrial electron transport chain. This defect can be recapitulated in vitro by challenging dopaminergic cells with 1-methyl-4-phenylpyridinium (MPP+), a neurotoxin that inhibits complex I of electron transport chain. Consequently, oxidative phosphorylation is blocked, and cells become dependent on glycolysis for ATP production. Therefore, increasing the rate of glycolysis might help cells to produce more ATP to meet their energy demands. In the present study, we show that microRNA-7, a non-coding RNA that protects dopaminergic neuronal cells against MPP+-induced cell death, promotes glycolysis in dopaminergic SH-SY5Y and differentiated human neural progenitor ReNcell VM cells, as evidenced by increased ATP production, glucose consumption, and lactic acid production. Through a series of experiments, we demonstrate that targeted repression of RelA by microRNA-7, as well as subsequent increase in the neuronal glucose transporter 3 (Glut3), underlies this glycolysis-promoting effect. Consistently, silencing Glut3 expression diminishes the protective effect of microRNA-7 against MPP+. Further, microRNA-7 fails to prevent MPP+-induced cell death when SH-SY5Y cells are cultured in a low glucose medium, as well as when differentiated ReNcell VM cells or primary mouse neurons are treated with the hexokinase inhibitor, 2-deoxy-d-glucose, indicating that a functional glycolytic pathway is required for this protective effect. In conclusion, microRNA-7, by down-regulating RelA, augments Glut3 expression, promotes glycolysis, and subsequently prevents MPP+-induced cell death. This protective effect of microRNA-7 could be exploited to correct the defects in oxidative phosphorylation in Parkinson disease.	[Chaudhuri, Amrita Datta; Kabaria, Savan; Choi, Doo Chul; Mouradian, M. Maral; Junn, Eunsung] Rutgers Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Junn, E (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurol, 683 Hoes Lane W,Rm 185, Piscataway, NJ 08854 USA.	junneu@rwjms.rutgers.edu	Regan, Clinton/E-6250-2012	Junn, Eunsung/0000-0001-5694-2599	National Institutes of Health [NS070898]; National Center for Complementary & Integrative Health [R01AT006868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073994, R01NS070898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS070898 (to E. J.).	BATES TE, 1994, J NEUROCHEM, V63, P640; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; CHAN P, 1993, J NEUROCHEM, V61, P610; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Choi DC, 2014, J NEUROSCI, V34, P12725, DOI 10.1523/JNEUROSCI.0985-14.2014; Clarke Donald D., 1999, P637; Cui HJ, 2002, MOL CANCER THER, V1, P679; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fragkouli A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00182; Harraz MM, 2011, J CHEM NEUROANAT, V42, P127, DOI 10.1016/j.jchemneu.2011.01.005; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kawauchi K, 2008, BIOCHEM BIOPH RES CO, V372, P137, DOI 10.1016/j.bbrc.2008.05.021; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Knight AL, 2014, CELL METAB, V20, P145, DOI 10.1016/j.cmet.2014.04.017; Koga K, 2006, EUR J NEUROSCI, V23, P1077, DOI 10.1111/j.1460-9568.2006.04610.x; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Mazzio E, 2003, NEUROTOXICOLOGY, V24, P137, DOI 10.1016/S0161-813X(02)00110-9; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Pollock A, 2014, CELL REP, V7, P1184, DOI 10.1016/j.celrep.2014.04.003; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Silva JLT, 2005, MOL CELL ENDOCRINOL, V240, P82, DOI 10.1016/j.mce.2005.05.006; Sommermann TG, 2011, CANCER RES, V71, P7291, DOI 10.1158/0008-5472.CAN-11-1715; Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Yelamanchili SV, 2010, J NEUROIMMUNE PHARM, V5, P63, DOI 10.1007/s11481-009-9172-4	37	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12425	12434		10.1074/jbc.M114.625962	http://dx.doi.org/10.1074/jbc.M114.625962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25814668	Green Published, hybrid			2022-12-26	WOS:000354388600050
J	Bergstrom, G; Fagerberg, B; Sallsten, G; Lundh, T; Barregard, L				Bergstrom, Goran; Fagerberg, Bjorn; Sallsten, Gerd; Lundh, Thomas; Barregard, Lars			Is Cadmium Exposure Associated with the Burden, Vulnerability and Rupture of Human Atherosclerotic Plaques?	PLOS ONE			English	Article							CAROTID PLAQUES; CARDIOVASCULAR-DISEASE; ULTRASOUND; RISK; ACCUMULATION; PREVALENCE; MECHANISMS; MORTALITY; DIRECTION; UPSTREAM	The general population is exposed to cadmium from food and smoking. Cadmium is a widely spread toxic pollutant that seems to be associated with cardiovascular diseases, although little is known if it contributes to the occurrence of atherosclerotic plaques and the process whereby plaques become vulnerable and are prone to rupture. We tested the hypotheses that cadmium exposure is associated not only with an increased subclinical burden of atherosclerotic plaques in different vascular territories and early signs of plaque vulnerability, but also with cadmium content and plaque-rupture in the clinical phase of the disease. Ultrasound technique was used to measure plaque prevalence and echogenicity in the carotid and femoral arteries in a population sample of women (n = 599) in whom blood cadmium was measured. In addition cadmium was measured in snap-frozen endarterectomies and whole blood obtained from patients who were referred to surgery because of symptomatic carotid plaques (n = 37). Sixteen endarterectomies were divided into three parts corresponding to different flow conditions and plaque vulnerability. In the population sample blood cadmium was associated with the number of vascular territories with plaques (p = 0.003 after adjustment for potential confounders). The cadmium concentrations in symptomatic plaques were 50-fold higher in plaque tissue than in blood. Cadmium levels in blood and plaque correlated, also after adjustment for smoking and other cardiovascular risk factors (p<0.001). Compared with the other parts of the plaque, the cadmium content was double as high in the part where plaque rupture usually occurs. In conclusion, the results show that cadmium exposure is associated with the burden of subclinical atherosclerosis in middle-aged women with different degrees of glucose tolerance, and that the content of cadmium in symptomatic plaques in patients is related to that in blood, but much higher, and preferentially located in the part of plaque where rupture often occurs.	[Bergstrom, Goran; Fagerberg, Bjorn] Sahlgrens Univ Hosp, Wallenberg Lab, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden; [Bergstrom, Goran; Fagerberg, Bjorn; Sallsten, Gerd; Barregard, Lars] Univ Gothenburg, Gothenburg, Sweden; [Sallsten, Gerd; Barregard, Lars] Sahlgrens Univ Hosp, Occupat & Environm Med, Gothenburg, Sweden; [Lundh, Thomas] Univ Lund Hosp, Dept Occupat & Environm Med, S-22185 Lund, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; Lund University; Skane University Hospital	Fagerberg, B (corresponding author), Sahlgrens Univ Hosp, Wallenberg Lab, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden.	bjorn.fagerberg@wlab.gu.se		Bergstrom, Goran/0000-0003-4289-5722	Swedish Heart-Lung Foundation (HLF) [20130594, 244002159 2]; Swedish Council for Working Life and Social Research (FAS) [2012-0025]; AstraZeneca R&D Molndal, Sweden (GU) [244002155]; Region Vastra Gotaland [ALFGBG-298291]; Sahlgrenska University Hospital [ALFGBG-298291]	Swedish Heart-Lung Foundation (HLF)(Swedish Heart-Lung Foundation); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); AstraZeneca R&D Molndal, Sweden (GU)(AstraZeneca); Region Vastra Gotaland; Sahlgrenska University Hospital	This study was supported the Swedish Heart-Lung Foundation (HLF nr 20130594, GU nr 244002159 2); Swedish Council for Working Life and Social Research (FAS) 2012-0025; AstraZeneca R&D Molndal, Sweden (GU nr 244002155), and the Regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital (ALFGBG-298291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALBERS TG, 1987, CLIN CHEM, V33, P2057; AALBERS TG, 1985, SCI TOTAL ENVIRON, V43, P255, DOI 10.1016/0048-9697(85)90133-0; Abu-Hayyeh S, 2001, ARTERIOSCL THROM VAS, V21, P863, DOI 10.1161/01.ATV.21.5.863; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aldemir E, 2012, J CLIN ULTRASOUND, V40, P399, DOI 10.1002/jcu.21951; Almenara CCP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068418; Barany E, 1997, J ANAL ATOM SPECTROM, V12, P1005, DOI 10.1039/a700904f; Brohall G, 2006, DIABETES CARE, V29, P363, DOI 10.2337/diacare.29.02.06.dc05-1229; Dirksen MT, 1998, CIRCULATION, V98, P2000, DOI 10.1161/01.CIR.98.19.2000; Fagerberg B, 2015, ENVIRON RES, V136, P67, DOI 10.1016/j.envres.2014.11.004; Fagerberg B, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002489; Fagerberg B, 2012, J INTERN MED, V272, P601, DOI 10.1111/j.1365-2796.2012.02578.x; Fagerberg B, 2010, J VASC RES, V47, P221, DOI 10.1159/000255965; GRAYWEALE AC, 1988, J CARDIOVASC SURG, V29, P676; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Joakimsen O, 1999, ARTERIOSCL THROM VAS, V19, P3007, DOI 10.1161/01.ATV.19.12.3007; Knoflach M, 2011, CIRC J, V75, P2491, DOI 10.1253/circj.CJ-11-0196; Lovett JK, 2003, CEREBROVASC DIS, V16, P369, DOI 10.1159/000072559; Mathiesen EB, 2001, CIRCULATION, V103, P2171; Menke A, 2009, ENVIRON HEALTH PERSP, V117, P190, DOI 10.1289/ehp.11236; Messner B, 2009, ARTERIOSCL THROM VAS, V29, P1392, DOI 10.1161/ATVBAHA.109.190082; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Nordestgaard BG, 2003, CURR OPIN LIPIDOL, V14, P505, DOI 10.1097/00041433-200310000-00012; Olson FJ, 2010, CLIN BIOCHEM, V43, P124, DOI 10.1016/j.clinbiochem.2009.09.028; Peters JL, 2010, ENVIRON RES, V110, P199, DOI 10.1016/j.envres.2009.12.004; Prahl U, 2010, ULTRASOUND MED BIOL, V36, P218, DOI 10.1016/j.ultrasmedbio.2009.10.002; Prozialeck WC, 2008, TOXICOL SCI, V102, P207, DOI 10.1093/toxsci/kfm263; Redgrave JNE, 2006, CIRCULATION, V113, P2320, DOI 10.1161/CIRCULATIONAHA.105.589044; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schmidt C, 2005, ATHEROSCLEROSIS, V181, P125, DOI 10.1016/j.atherosclerosis.2004.12.034; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Subramanyam G, 1992, Indian Heart J, V44, P177; Tellez-Plaza M, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0356-2; Tellez-Plaza M, 2013, EPIDEMIOLOGY, V24, P421, DOI 10.1097/EDE.0b013e31828b0631; Tellez-Plaza M, 2012, ENVIRON HEALTH PERSP, V120, P1017, DOI 10.1289/ehp.1104352; Tellez-Plaza M, 2010, AM J EPIDEMIOL, V172, P671, DOI 10.1093/aje/kwq172; Thim T, 2008, J INTERN MED, V263, P506, DOI 10.1111/j.1365-2796.2008.01947.x; THIND GS, 1975, EXP MOL PATHOL, V22, P326, DOI 10.1016/0014-4800(75)90077-5; VUORI E, 1979, SCAND J WORK ENV HEA, V5, P16, DOI 10.5271/sjweh.2670; Wendelhag I, 1997, STROKE, V28, P2195, DOI 10.1161/01.STR.28.11.2195; Yilmaz A, 2007, EXP MOL PATHOL, V82, P245, DOI 10.1016/j.yexmp.2006.10.008	41	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121240	10.1371/journal.pone.0121240	http://dx.doi.org/10.1371/journal.pone.0121240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816093	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600075
J	Brown, RM; Techow, NMSM; Wood, AG; Phillips, RA				Brown, Ruth M.; Techow, N. M. S. Mareile; Wood, Andrew G.; Phillips, Richard A.			Hybridization and Back-Crossing in Giant Petrels (Macronectes giganteus and M. halli) at Bird Island, South Georgia, and a Summary of Hybridization in Seabirds	PLOS ONE			English	Article							PATERNITY INFERENCE; HALDANE RULE; SEX-RATIO; HYBRID; INTROGRESSION; POPULATION; SPECIATION; EVOLUTION; SPP.; SELECTION	Hybridization in natural populations provides an opportunity to study the evolutionary processes that shape divergence and genetic isolation of species. The emergence of pre-mating barriers is often the precursor to complete reproductive isolation. However, in recently diverged species, pre-mating barriers may be incomplete, leading to hybridization between seemingly distinct taxa. Here we report results of a long-term study at Bird Island, South Georgia, of the extent of hybridization, mate fidelity, timing of breeding and breeding success in mixed and conspecific pairs of the sibling species, Macronectes halli (northern giant petrel) and M. giganteus (southern giant petrel). The proportion of mixed-species pairs varied annually from 0.4-2.4% (mean of 1.5%), and showed no linear trend with time. Mean laying date in mixed-species pairs tended to be later than in northern giant petrel, and always earlier than in southern giant petrel pairs, and their breeding success (15.6%) was lower than that of conspecific pairs. By comparison, mixed-species pairs at both Marion and Macquarie islands always failed before hatching. Histories of birds in mixed-species pairs at Bird Island were variable; some bred previously or subsequently with a conspecific partner, others subsequently with a different allospecific partner, and some mixed-species pairs remained together for multiple seasons. We also report the first verified back-crossing of a hybrid giant petrel with a female northern giant petrel. We discuss the potential causes and evolutionary consequences of hybridization and back-crossing in giant petrels and summarize the incidence of back-crossing in other seabird species.	[Brown, Ruth M.; Wood, Andrew G.; Phillips, Richard A.] British Antarctic Survey, Ecosyst Programme, Cambridge CB3 0ET, England; [Techow, N. M. S. Mareile] Univ Cape Town, Percy FitzPatrick Inst, DST NRF Ctr Excellence, ZA-7925 Cape Town, South Africa	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; National Research Foundation - South Africa; University of Cape Town	Phillips, RA (corresponding author), British Antarctic Survey, Ecosyst Programme, Cambridge CB3 0ET, England.	raphil@bas.ac.uk			Natural Environment Research Council; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (www.nerc.ac.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agreement on the Conservation of Albatrosses and Petrels, 2010, ACAP SPEC ASS NO GIA; Agreement on the Conservation of Albatrosses and Petrels, 2010, AGR CONS ALB PETR; Andersson M, 1999, P ROY SOC B-BIOL SCI, V266, P1579, DOI 10.1098/rspb.1999.0818; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Austin JJ, 2004, AUK, V121, P847, DOI 10.1642/0004-8038(2004)121[0847:AGMPOT]2.0.CO;2; Barton NH, 2013, J EVOLUTION BIOL, V26, P267, DOI 10.1111/jeb.12015; Bertellotti M, 2003, BIODIVERS CONSERV, V12, P743, DOI 10.1023/A:1022477029586; BOURNE WRP, 1966, ARDEA, V54, P45; Brooke M, 2004, ALBATROSSES PETRELS; Brown RM, 2010, MOL ECOL, V19, P3157, DOI 10.1111/j.1365-294X.2010.04719.x; Burg TM, 1999, MOL ECOL, V8, P338; BURGER AE, 1978, EMU, V78, P234, DOI 10.1071/MU9780234b; Carling MD, 2011, MOL ECOL, V20, P1166, DOI 10.1111/j.1365-294X.2010.04987.x; Concannon MR, 2012, MOL ECOL, V21, P1477, DOI 10.1111/j.1365-294X.2012.05474.x; Cooper John, 2001, International Journal of Ornithology, V4, P53; Copello S, 2006, EMU, V106, P141, DOI 10.1071/MU05033; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; FERRIS SD, 1983, P NATL ACAD SCI-BIOL, V80, P2290, DOI 10.1073/pnas.80.8.2290; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; Gonzalez-Solis J, 2000, MAR ECOL PROG SER, V204, P279, DOI 10.3354/meps204279; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Harrison RG, 1993, HYBRID ZONES EVOLUTI; Helbig AJ, 2002, IBIS, V144, P518, DOI 10.1046/j.1474-919X.2002.00091.x; Hermansen JS, 2011, MOL ECOL, V20, P3812, DOI 10.1111/j.1365-294X.2011.05183.x; HUNTER S, 1984, J ZOOL, V203, P441; HUNTER S, 1987, POLAR BIOL, V7, P295, DOI 10.1007/BF00443947; HUNTER S, 1983, J ZOOL, V200, P521, DOI 10.1111/j.1469-7998.1983.tb02813.x; HUNTER S, 1983, EMU S, V82, P312; Huxel GR, 1999, BIOL CONSERV, V89, P143, DOI 10.1016/S0006-3207(98)00153-0; JOHNSTONE GW, 1978, EMU, V78, P235, DOI 10.1071/MU9780235a; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Maroja LS, 2009, EVOLUTION, V63, P2999, DOI 10.1111/j.1558-5646.2009.00767.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mayr E, 1942, SYSTEMATICS ORIGIN S; Moore PJ, 2001, EMU, V101, P329, DOI 10.1071/MU00074; ORR HA, 1993, NATURE, V361, P532, DOI 10.1038/361532a0; Orr HA, 1997, ANNU REV ECOL SYST, V28, P195, DOI 10.1146/annurev.ecolsys.28.1.195; Patterson D. L., 2008, Marine Ornithology, V36, P115; Price T, 2008, SPECIATION BIRDS; Randler C, 2002, ANIM BEHAV, V63, P103, DOI 10.1006/anbe.2001.1884; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; Robertson C.J.R., 1993, CONSERVATION ADVISOR, V50; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; Smith PF, 2003, MOL ECOL, V12, P2497, DOI 10.1046/j.1365-294X.2003.01905.x; Sternkopf V, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-348; Taylor SA, 2012, J AVIAN BIOL, V43, P311, DOI 10.1111/j.1600-048X.2012.05660.x; Taylor SA, 2012, MAR ECOL PROG SER, V451, P285, DOI 10.3354/meps09694; Taylor SA, 2012, POLAR BIOL, V35, P931, DOI 10.1007/s00300-011-1141-8; Taylor SA, 2010, WATERBIRDS, V33, P251, DOI 10.1675/063.033.0215; Techow NMSM, 2010, MOL PHYLOGENET EVOL, V54, P472, DOI 10.1016/j.ympev.2009.09.005; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534	54	26	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121688	10.1371/journal.pone.0121688	http://dx.doi.org/10.1371/journal.pone.0121688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815478	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600112
J	Chen, JS; Li, HC; Lin, SI; Yang, CH; Chien, WY; Syu, CL; Lo, SY				Chen, Jhih-Si; Li, Hui-Chun; Lin, Shu-I; Yang, Chee-Hing; Chien, Wan-Yu; Syu, Ciao-Ling; Lo, Shih-Yen			Cleavage of Dicer Protein by I7 Protease during Vaccinia Virus Infection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; LIVER-SPECIFIC MICRORNA; RNA INTERFERENCE RNAI; CORE PROTEIN; ENCODED MICRORNAS; NUCLEAR EXPORT; REPLICATION; HOST; IDENTIFICATION; MECHANISMS	Dicer is the key component in the miRNA pathway. Degradation of Dicer protein is facilitated during vaccinia virus (VV) infection. A C-terminal cleaved product of Dicer protein was detected in the presence of MG132 during VV infection. Thus, it is possible that Dicer protein is cleaved by a viral protease followed by proteasome degradation of the cleaved product. There is a potential I7 protease cleavage site in the C-terminus of Dicer protein. Indeed, reduction of Dicer protein was detected when Dicer was co-expressed with I7 protease but not with an I7 protease mutant protein lack of the protease activity. Mutation of the potential I7 cleavage site in the C-terminus of Dicer protein resisted its degradation during VV infection. Furthermore, Dicer protein was reduced dramatically by recombinant VV vI7Li after the induction of I7 protease. If VV could facilitate the degradation of Dicer protein, the process of miRNA should be affected by VV infection. Indeed, accumulation of precursor miR122 was detected after VV infection or I7 protease expression. Reduction of miR122 would result in the suppression of HCV sub-genomic RNA replication, and, in turn, the amount of viral proteins. As expected, significant reduction of HCVNS5A protein was detected after VV infection and I7 protease expression. Therefore, our results suggest that VV could cleave Dicer protein through I7 protease to facilitate Dicer degradation, and in turn, suppress the processing of miRNAs. Effect of Dicer protein on VV replication was also studied. Exogenous expression of Dicer protein suppresses VV replication slightly while knockdown of Dicer protein does not affect VV replication significantly.	[Chen, Jhih-Si; Lin, Shu-I; Yang, Chee-Hing; Chien, Wan-Yu; Syu, Ciao-Ling; Lo, Shih-Yen] Tzu Chi Univ, Dept Lab Med & Med Biotechnol, Hualien, Taiwan; [Li, Hui-Chun] Tzu Chi Univ, Dept Biochem, Hualien, Taiwan; [Lo, Shih-Yen] Buddhist Tzu Chi Gen Hosp, Dept Lab Med, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Lo, SY (corresponding author), Tzu Chi Univ, Dept Lab Med & Med Biotechnol, Hualien, Taiwan.	losylo@mail.tcu.edu.tw		Yang, Chee-Hing/0000-0001-6129-272X	National Science Council of Taiwan [NSC 101-2320-B-320 -011 -MY3]; Tzu Chi University [TCIRP 101005-03, TCMRC-P-100003-01, TCMRC-P-101015]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi University	Funding: This work was supported by grants from the National Science Council of Taiwan (NSC 101-2320-B-320 -011 -MY3) to Dr. Shih-Yen Lo and from the Tzu Chi University to Dr. Shih-Yen Lo (TCIRP 101005-03) and to Dr. Hui-Chun Li (TCMRC-P-100003-01 and TCMRC-P-101015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansarah-Sobrinho C, 2004, J VIROL, V78, P6855, DOI 10.1128/JVI.78.13.6855-6863.2004; Ansarah-Sobrinho C, 2004, J VIROL, V78, P6335, DOI 10.1128/JVI.78.12.6335-6343.2004; Backes S, 2012, CELL HOST MICROBE, V12, P200, DOI 10.1016/j.chom.2012.05.019; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Byrd CA, 2003, J VIROL, V77, P11279, DOI 10.1128/JVI.77.20.11279-11283.2003; Byrd CM, 2002, J VIROL, V76, P8973, DOI 10.1128/JVI.76.17.8973-8976.2002; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan SC, 2011, BIOCHEM BIOPH RES CO, V404, P574, DOI 10.1016/j.bbrc.2010.12.037; Chang CW, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-80; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; de Vries W, 2008, INT J BIOCHEM CELL B, V40, P2007, DOI 10.1016/j.biocel.2008.04.015; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Fang CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068736; Fedorko DP, 2005, J CLIN MICROBIOL, V43, P4602, DOI 10.1128/JCM.43.9.4602-4606.2005; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grey F, 2008, J CLIN VIROL, V41, P186, DOI 10.1016/j.jcv.2007.11.024; Grinberg M, 2012, ARCH VIROL, V157, P1719, DOI 10.1007/s00705-012-1366-z; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Haasnoot J, 2011, METHODS MOL BIOL, V721, P23, DOI 10.1007/978-1-61779-037-9_2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jeang KT, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-58; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma HC, 2007, J BIOMED SCI, V14, P31, DOI 10.1007/s11373-006-9127-1; Moss B., 2007, FIELDS VIROLOGY, V2, P2905; Muller S, 2007, IMMUNITY, V27, P1, DOI 10.1016/j.immuni.2007.07.003; Parrish S, 2007, J VIROL, V81, P12973, DOI 10.1128/JVI.01668-07; Parrish S, 2007, P NATL ACAD SCI USA, V104, P2139, DOI 10.1073/pnas.0611685104; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wei WY, 2012, ARCH VIROL, V157, P635, DOI 10.1007/s00705-011-1221-7; Yang CH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-65; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	46	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120390	10.1371/journal.pone.0120390	http://dx.doi.org/10.1371/journal.pone.0120390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815818	gold, Green Submitted, Green Published			2022-12-26	WOS:000352133600034
J	Chi, Y; Guo, CY; Peng, Y; Qiao, LJ; Yang, L				Chi, Ying; Guo, Chunying; Peng, Yuan; Qiao, Lijun; Yang, Liu			A Prospective, Observational Study on the Application of Ultra-Wide-Field Angiography in the Evaluation and Management of Patients with Anterior Uveitis	PLOS ONE			English	Article							WIDEFIELD FLUORESCEIN ANGIOGRAPHY; RETINOPATHY; OPHTHALMOSCOPY; NONPERFUSION; AREAS	Purpose Evaluation of peripheral retinal vascular changes in anterior uveitis using ultra-wide-field fluorescein angiography. Design A prospective, observational study of a case series of patients diagnosed with anterior uveitis. Methods Setting: Clinical observation at an academic medical center. Patient or Study Population: A total of 65 eyes of 33 patients corresponded with the research criteria of anterior uveitis in the opinion of specialists of Peking University First Hospital. Observation Procedures: Patients were diagnosed primarily through clinical examinations and conventional fluorescein angiography. Subsequently, ultra-wide-field fluorescein angiograms were obtained for each patient. Main Outcome Measures: The main outcome was the detection of peripheral retinal changes by ultra-wide-field fluorescein angiography, and how these changes influenced the evaluation and management of the disease. Results Peripheral vessel leakage was detected in 27 eyes (42%) with anterior uveitis, of which 15 eyes displayed active inflammation and 12 eyes displayed inactive inflammation. Peripheral vessel leakage was found in seven of eight eyes with cystoid macular edema. Cystoid macular edema was detected in 7 of 27 eyes (26%) with peripheral vessel leakage, whereas 1 of 38 eyes (3%) did not display peripheral vessel leakage (p< 0.01). 44.4% of the patients with peripheral vessel leakage had a specific etiology. The relevant treatment strategies were modified based on the results of the ultra-wide-field fluorescein angiography. 12 patients with peripheral vessel leakage and a quiescent anterior segment were added to those receiving topical glucocorticoids, while 3 patients with serious peripheral vessel leakage and an active anterior segment received a sub-Tenon injection of triamcinolone acetonide. Conclusions Ultra-wide-field fluorescein angiography was very effective in detecting peripheral retinal vascular pathology in anterior uveitis. The changes found in the periphery were important in the evaluation and management of anterior uveitis.	[Yang, Liu] Peking Univ, Hosp 1, Dept Ophthalmol, Beijing 100871, Peoples R China; Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China	Peking University	Yang, L (corresponding author), Peking Univ, Hosp 1, Dept Ophthalmol, Beijing 100871, Peoples R China.	lucy02114@163.com						Anderson L, 2007, Semin Ophthalmol, V22, P43, DOI 10.1080/08820530601162867; Campbell JP, 2012, AM J OPHTHALMOL, V154, P908, DOI 10.1016/j.ajo.2012.05.019; Coffee RE, 2009, SEMIN OPHTHALMOL, V24, P34, DOI 10.1080/08820530802520194; Dai SA, 2011, CLIN EXP OPHTHALMOL, V39, P23, DOI 10.1111/j.1442-9071.2010.02399.x; Dhaliwal C, 2009, BRIT J OPHTHALMOL, V93, P355, DOI 10.1136/bjo.2008.148908; Hong BK, 2013, CAN J OPHTHALMOL, V48, P489, DOI 10.1016/j.jcjo.2013.05.009; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kaines A, 2009, SEMIN OPHTHALMOL, V24, P19, DOI 10.1080/08820530802520095; Kernt M, 2010, CLIN OPHTHALMOL, V4, P829; Leder HA, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-30; LOTMAR W, 1977, KLIN MONATSBL AUGENH, V170, P767; Oliver SCN, 2010, SEMIN OPHTHALMOL, V25, P27, DOI 10.3109/08820538.2010.481239; Prasad PS, 2010, OPHTHALMOLOGY, V117, P780, DOI 10.1016/j.ophtha.2009.09.019; Reeves GMB, 2013, ACTA OPHTHALMOL, V91, P48, DOI 10.1111/j.1755-3768.2011.02200.x; Salvanos P, 2013, RETINA-J RET VIT DIS, V33, P1421, DOI 10.1097/IAE.0b013e318283138d; Silva PS, 2013, OPHTHALMOLOGY, V120, P2587, DOI 10.1016/j.ophtha.2013.05.004; Spaide RF, 2013, RETINA-J RET VIT DIS, V33, P56, DOI 10.1097/IAE.0b013e3182641875; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P829, DOI 10.1097/IAE.0b013e31820c841e; Tsui I, 2009, SEMIN OPHTHALMOL, V24, P29, DOI 10.1080/08820530802520186; Wessel MM, 2012, RETINA-J RET VIT DIS, V32, P785, DOI 10.1097/IAE.0b013e3182278b64; Witmer MT, 2013, CLIN OPHTHALMOL, V7, P389, DOI 10.2147/OPTH.S41731; Witmer MT, 2013, SURV OPHTHALMOL, V58, P143, DOI 10.1016/j.survophthal.2012.07.003	22	20	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122749	10.1371/journal.pone.0122749	http://dx.doi.org/10.1371/journal.pone.0122749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815841	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600194
J	Clark, PR; Kim, RK; Pober, JS; Kluger, MS				Clark, Paul R.; Kim, Richard K.; Pober, Jordan S.; Kluger, Martin S.			Tumor Necrosis Factor Disrupts Claudin-5 Endothelial Tight Junction Barriers in Two Distinct NF-kappa B-Dependent Phases	PLOS ONE			English	Article							RHO-KINASE; CELL JUNCTIONS; PROTEIN-KINASE; ACTIVATION; PHOSPHORYLATION; MYOSIN; INHIBITION; EXPRESSION; CONTRIBUTES; INTEGRITY	Capillary leak in severe sepsis involves disruption of endothelial cell tight junctions. We modeled this process by TNF treatment of cultured human dermal microvascular endothelial cell (HDMEC) monolayers, which unlike human umbilical vein endothelial cells form claudin- 5-dependent tight junctions and a high-resistance permeability barrier. Continuous monitoring with electrical cell-substrate impedance sensing revealed that TNF disrupts tight junction-dependent HDMEC barriers in discrete steps: an similar to 5% increase in transendothelial electrical resistance over 40 minutes; a decrease to similar to 10% below basal levels over 2 hours (phase 1 leak); an interphase plateau of 1 hour; and a major fall in transendothelial electrical resistance to < 70% of basal levels by 8-10 hours (phase 2 leak), with EC50 values of TNF for phase 1 and 2 leak of similar to 30 and similar to 150 pg/ml, respectively. TNF leak is reversible and independent of cell death. Leak correlates with disruption of continuous claudin-5 immunofluorescence staining, myosin light chain phosphorylation and loss of claudin-5 co-localization with cortical actin. All these responses require NF-kappa B signaling, shown by inhibition with Bay 11 or overexpression of I.B super-repressor, and are blocked by H-1152 or Y-27632, selective inhibitors of Rho-associated kinase that do not block other NF-kappa B-dependent responses. siRNA combined knockdown of Rho-associated kinase-1 and -2 also prevents myosin light chain phosphorylation, loss of claudin-5/actin co-localization, claudin-5 reorganization and reduces phase 1 leak. However, unlike H-1152 and Y-27632, combined Rho-associated kinase-1/2 siRNA knockdown does not reduce the magnitude of phase 2 leak, suggesting that H-1152 and Y-27632 have targets beyond Rho-associated kinases that regulate endothelial barrier function. We conclude that TNF disrupts TJs in HDMECs in two distinct NF-kappa B-dependent steps, the first involving Rho-associated kinase and the second likely to involve an as yet unidentified but structurally related protein kinase(s).	[Kluger, Martin S.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT USA	Yale University; Yale University	Kluger, MS (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	martin.kluger@yale.edu		, Richard/0000-0002-3493-9679	National Heart, Lung and Blood Institute, National Institutes of Health [R01-HL036003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036003] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was supported by grant number R01-HL036003 to JSP and MSK from the National Heart, Lung and Blood Institute, National Institutes of Health located online at http://www.nhlbi.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Al-Lamki RS, 2009, AM J TRANSPLANT, V9, P2679, DOI 10.1111/j.1600-6143.2009.02831.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Bach FH, 1997, IMMUNOL TODAY, V18, P483, DOI 10.1016/S0167-5699(97)01129-8; Breslin JW, 2006, AM J PHYSIOL-HEART C, V290, pH741, DOI 10.1152/ajpheart.00238.2005; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Clark PR, 2007, J INVEST DERMATOL, V127, P762, DOI 10.1038/sj.jid.5700670; COLLINS T, 1993, TRENDS CARDIOVAS MED, V3, P92, DOI 10.1016/1050-1738(93)90030-A; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; COTRAN RS, 1964, AM J PATHOL, V45, P261; David S, 2011, ARTERIOSCL THROM VAS, V31, P2643, DOI 10.1161/ATVBAHA.111.233189; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis CT, 2014, J IMMUNOL, V192, P6045, DOI 10.4049/jimmunol.1400309; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893; Lentsch AB, 2000, J PATHOL, V190, P343; Li JH, 2005, J IMMUNOL, V175, P1858, DOI 10.4049/jimmunol.175.3.1858; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Marcus BC, 1998, ANN VASC SURG, V12, P384, DOI 10.1007/s100169900173; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Mong PY, 2009, J IMMUNOL, V182, P2385, DOI 10.4049/jimmunol.0802811; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Nwariaku FE, 2003, J APPL PHYSIOL, V95, P1889, DOI 10.1152/japplphysiol.00225.2003; Petrache I, 2001, AM J PHYSIOL-LUNG C, V280, pL1168, DOI 10.1152/ajplung.2001.280.6.L1168; Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; POBER JS, 1993, J IMMUNOL, V150, P5114; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; SIMIONESCU M, 1975, J CELL BIOL, V67, P863, DOI 10.1083/jcb.67.3.863; SLOWIK MR, 1993, AM J PATHOL, V143, P1724; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Waage A, 1998, LANCET, V351, P603, DOI 10.1016/S0140-6736(05)78598-6; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Wang C, 2014, J EXP MED, V211, P395, DOI 10.1084/jem.20131125; Wang JP, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-7; WEBER G, 1977, ATHEROSCLEROSIS, V26, P535, DOI 10.1016/0021-9150(77)90121-6; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603	53	47	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120075	10.1371/journal.pone.0120075	http://dx.doi.org/10.1371/journal.pone.0120075			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816133	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600028
J	Lessard, J; Pelletier, M; Biertho, L; Biron, S; Marceau, S; Hould, FS; Lebel, S; Moustarah, F; Lescelleur, O; Marceau, P; Tchernof, A				Lessard, Julie; Pelletier, Melissa; Biertho, Laurent; Biron, Simon; Marceau, Simon; Hould, Frederic-Simon; Lebel, Stefane; Moustarah, Fady; Lescelleur, Odette; Marceau, Picard; Tchernof, Andre			Characterization of Dedifferentiating Human Mature Adipocytes from the Visceral and Subcutaneous Fat Compartments: Fibroblast-Activation Protein Alpha and Dipeptidyl Peptidase 4 as Major Components of Matrix Remodeling	PLOS ONE			English	Article							ADIPOSE-TISSUE; GENE-EXPRESSION; DFAT CELLS; GROWTH; METALLOPROTEINASES; DIFFERENTIATION; ESTABLISHMENT; INHIBITOR; OBESITY; STRESS	Mature adipocytes can reverse their phenotype to become fibroblast-like cells. This is achieved by ceiling culture and the resulting cells, called dedifferentiated fat (DFAT) cells, are multipotent. Beyond the potential value of these cells for regenerative medicine, the dedifferentiation process itself raises many questions about cellular plasticity and the pathways implicated in cell behavior. This work has been performed with the objective of obtaining new information on adipocyte dedifferentiation, especially pertaining to new targets that may be involved in cellular fate changes. To do so, omental and subcutaneous mature adipocytes sampled from severely obese subjects have been dedifferentiated by ceiling culture. An experimental design with various time points along the dedifferentiation process has been utilized to better understand this process. Cell size, gene and protein expression as well as cytokine secretion were investigated. Il-6, IL-8, SerpinE1 and VEGF secretion were increased during dedifferentiation, whereas MIF-1 secretion was transiently increased. A marked decrease in expression of mature adipocyte transcripts (PPAR gamma 2, C/EBP alpha, LPL and Adiponectin) was detected early in the process. In addition, some matrix remodeling transcripts (FAP, DPP4, MMP1 and TGF beta 1) were rapidly and strongly up-regulated. FAP and DPP4 proteins were simultaneously induced in dedifferentiating mature adipocytes supporting a potential role for these enzymes in adipose tissue remodeling and cell plasticity.	[Lessard, Julie; Biertho, Laurent; Biron, Simon; Marceau, Simon; Hould, Frederic-Simon; Lebel, Stefane; Moustarah, Fady; Lescelleur, Odette; Marceau, Picard; Tchernof, Andre] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Pelletier, Melissa; Tchernof, Andre] CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Tchernof, Andre] Univ Laval, Dept Nutr, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Tchernof, A (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.	andre.tchernof@criucpq.ulaval.ca		Tchernof, Andre/0000-0002-2587-1000	Natural Sciences and Engineering Research Council of Canada Discovery Grant [371697-2011]	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Research Council of Canada Discovery Grant (371697-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahan CE, 2009, J NEUROSCI RES, V87, P964, DOI 10.1002/jnr.21903; Balaziova E, 2011, MOL CELL BIOCHEM, V354, P283, DOI 10.1007/s11010-011-0828-z; Blouin K, 2005, METABOLISM, V54, P1034, DOI 10.1016/j.metabol.2005.03.006; Blouin K, 2003, J CLIN ENDOCR METAB, V88, P5944, DOI 10.1210/jc.2003-030535; Blouin K, 2010, CLIN ENDOCRINOL, V72, P176, DOI 10.1111/j.1365-2265.2009.03645.x; Bouchard L, 2009, ACTA DIABETOL, V46, P13, DOI 10.1007/s00592-008-0049-4; Busek P, 2004, INT J BIOCHEM CELL B, V36, P408, DOI 10.1016/S1357-2725(03)00262-0; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Dienus K, 2010, ARCH DERMATOL RES, V302, P725, DOI 10.1007/s00403-010-1084-x; Dobrian AD, 2011, AM J PHYSIOL-ENDOC M, V300, pE410, DOI 10.1152/ajpendo.00463.2010; Frontini A, 2013, BBA-MOL CELL BIOL L, V1831, P950, DOI 10.1016/j.bbalip.2013.02.005; Gao D, 2011, J CELL PHYSIOL, V226, P2869, DOI 10.1002/jcp.22630; Gao Q, 2012, MOL BIOL REP, V39, P5791, DOI 10.1007/s11033-011-1371-4; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Huang Y, 2011, CLIN EXP METASTAS, V28, P567, DOI 10.1007/s10585-011-9392-x; Kelly T, 2012, INT REV CEL MOL BIO, V297, P83, DOI 10.1016/B978-0-12-394308-8.00003-0; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Kos K, 2009, DIABETES OBES METAB, V11, P285, DOI 10.1111/j.1463-1326.2008.00909.x; Lai DM, 2012, INT J ONCOL, V41, P541, DOI 10.3892/ijo.2012.1475; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Lee J, 2010, CURR OPIN CLIN NUTR, V13, P371, DOI 10.1097/MCO.0b013e32833aabef; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Nobusue H, 2008, CELL TISSUE RES, V332, P435, DOI 10.1007/s00441-008-0593-9; Nobusue H, 2010, J CELL BIOCHEM, V109, P542, DOI 10.1002/jcb.22431; O'Hara A, 2009, PFLUG ARCH EUR J PHY, V458, P1103, DOI 10.1007/s00424-009-0693-8; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ono H, 2011, BIOCHEM BIOPH RES CO, V407, P562, DOI 10.1016/j.bbrc.2011.03.063; Papazoglou D, 2010, EXP CLIN ENDOCR DIAB, V118, P730, DOI 10.1055/s-0030-1249671; Pare DP, 2009, BREAST CANCER-BASIC, V3, P9; Perrini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057892; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; Ross SA, 2010, CAN FAM PHYSICIAN, V56, P639; Shen JF, 2011, INT J ORAL SCI, V3, P117, DOI 10.4248/IJOS11044; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Turcot V, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-4; Turcot V, 2011, OBESITY, V19, P388, DOI 10.1038/oby.2010.198; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Wang XM, 2006, ADV EXP MED BIOL, V575, P213; Zhang HH, 2000, J ENDOCRINOL, V164, P119, DOI 10.1677/joe.0.1640119	46	36	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122065	10.1371/journal.pone.0122065	http://dx.doi.org/10.1371/journal.pone.0122065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816202	Green Submitted, gold, Green Published			2022-12-26	WOS:000352133600140
J	Song, B; Bian, Q; Shao, CH; Li, G; Liu, AA; Jing, W; Liu, R; Zhang, YJ; Zhou, YQ; Hu, XG; Jin, G				Song, Bin; Bian, Qi; Shao, Cheng Hao; Li, Gang; Liu, An An; Jing, Wei; Liu, Rui; Zhang, Yi-Jie; Zhou, Ying-Qi; Hu, Xian-Gui; Jin, Gang			Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy	PLOS ONE			English	Article							URINARY TRYPSIN-INHIBITOR; BREAST-CANCER; CARCINOMA CELLS; GROWTH; EXPRESSION; APOPTOSIS; CHEMOTHERAPY; MECHANISMS; DOCETAXEL; XENOGRAFT	During chemotherapy, drug resistance caused by autophagy remains a major challenge to successful treatment of cancer patients. The purpose of this study is to show that ulinastatin (UTI), a trypsin inhibitor, could reduce the resistance of liver cancer cells to chemotherapeutic agent epirubicin (EPI). We achieved this conclusion by analyzing the effect of EPI alone or UTI plus EPI on SMMC-7721 and MHCC-LM3 liver cancer cells. We also generated an EPI-resistant liver cancer cell line (MHCC-LM3er cells), and found that UTI could sensitize the LM3er cells to EPI. Autophagy usually functions to protect cancer cells during chemotherapy. Our study showed that UTI inhibited the autophagy induced by EPI in liver cancer cells, which promoted apoptosis, and therefore, reduced the resistance of the cancer cells to EPI. Further studies showed that the UTI-mediated inhibition on autophagy was achieved by inhibiting transcriptional factor nuclear factor-kappa B (NF-kappa B) signaling pathway. To verify our results in vivo, we injected MHCC-LM3 liver cancer cells or EPI-resistant LM3er cells into mice, and found that EPI could only effectively inhibit the growth of tumor in MHCC-LM3 cell-injected mice, but not in LM3er cell-injected mice. However, when UTI was also administered, the growth of tumor was inhibited in the MHCC-LM3er cell-injected mice as well. Our results suggest that UTI may be used in combination with anti-cancer drugs, such as EPI, to improve the outcome of cancer therapy.	[Song, Bin; Shao, Cheng Hao; Li, Gang; Liu, An An; Jing, Wei; Liu, Rui; Zhang, Yi-Jie; Zhou, Ying-Qi; Hu, Xian-Gui; Jin, Gang] Second Mil Med Univ, Changhai Hosp, Dept Gen Surg, Shanghai 200438, Peoples R China; [Bian, Qi] Second Mil Med Univ, Changhai Hosp, Dept Nephrol, Shanghai 200438, Peoples R China	Naval Medical University; Naval Medical University	Hu, XG (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gen Surg, Shanghai 200438, Peoples R China.	jingang@sohu.com; xianguihu@yahoo.com.cn						Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Bilir A, 2001, PATHOBIOLOGY, V69, P120, DOI 10.1159/000048766; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Cui JZ, 2013, BBA-REV CANCER, V1836, P15, DOI 10.1016/j.bbcan.2013.02.003; Gao F, 2013, CANCER BIOTHER RADIO, V28, P218, DOI 10.1089/cbr.2011.1122; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Luo J, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-71; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Oda T, 1984, Masui, V33, P137; Okuhama Y, 1999, J SURG RES, V82, P34, DOI 10.1006/jsre.1998.5496; Pugia MJ, 2007, ADV CLIN CHEM, V44, P223, DOI 10.1016/S0065-2423(07)44007-0; Rui M, 2012, RESPIRATION, V83, P335, DOI 10.1159/000333378; Schulze-Bergkamen H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-232; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Sun WL, 2011, AUTOPHAGY, V7, P1035, DOI 10.4161/auto.7.9.16521; Sun ZJ, 2010, J INT MED RES, V38, P967, DOI 10.1177/147323001003800323; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Wang H, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-2; Wang X, 2014, KIDNEY INT; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295; Wu YJ, 2009, HEPATOB PANCREAT DIS, V8, P53; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yoshioka I, 2005, ANTICANCER RES, V25, P815; Zhong BA, 2012, CANCER BIOTHER RADIO, V27, P252, DOI 10.1089/cbr.2011.1105	32	17	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120694	10.1371/journal.pone.0120694	http://dx.doi.org/10.1371/journal.pone.0120694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815885	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600042
J	Torina, AG; Reichert, K; Lima, F; Vilarinho, KAD; de Oliveira, PPM; do Carmo, HRP; de Carvalho, DD; Saad, MJA; Sposito, AC; Petrucci, O				Torina, Anali Galluce; Reichert, Karla; Lima, Fany; de Souza Vilarinho, Karlos Alexandre; Martins de Oliveira, Pedro Paulo; Pereira do Carmo, Helison Rafael; de Carvalho, Daniela Diogenes; Abdalla Saad, Mario Jose; Sposito, Andrei Carvalho; Petrucci, Orlando			Diacerein Improves Left Ventricular Remodeling and Cardiac Function by Reducing the Inflammatory Response after Myocardial Infarction	PLOS ONE			English	Article							NF-KAPPA-B; IKK-BETA INHIBITION; TNF-ALPHA; HEART-FAILURE; IN-VITRO; DYSFUNCTION; MODEL; CHONDROCYTES; ISCHEMIA; MICE	Background The inflammatory response has been implicated in the pathogenesis of left ventricular (LV) remodeling after myocardial infarction (MI). An anthraquinone compound with anti-inflammatory properties, diacerein inhibits the synthesis and activity of pro-inflammatory cytokines, such as tumor necrosis factor and interleukins 1 and 6. The purpose of this study was to investigate the effects of diacerein on ventricular remodeling in vivo. Methods and Results Ligation of the left anterior descending artery was used to induce MI in an experimental rat model. Rats were divided into two groups: a control group that received saline solution (n = 16) and a group that received diacerein (80 mg/kg) daily (n = 10). After 4 weeks, the LV volume, cellular signaling, caspase 3 activity, and nuclear factor kappa B (NF-kappa B) transcription were compared between the two groups. After 4 weeks, end-diastolic and end-systolic LV volumes were reduced in the treatment group compared to the control group (p < .01 and p < .01, respectively). Compared to control rats, diacerein-treated rats exhibited less fibrosis in the LV (14.65% +/- 7.27% vs. 22.57% +/- 8.94%; p < .01), lower levels of caspase-3 activity, and lower levels of NF-kappa B p65 transcription. Conclusions Treatment with diacerein once a day for 4 weeks after MI improved ventricular remodeling by promoting lower end-systolic and end-diastolic LV volumes. Diacerein also reduced fibrosis in the LV. These effects might be associated with partial blockage of the NF-kappa B pathway.	[Torina, Anali Galluce; Reichert, Karla; Lima, Fany; de Souza Vilarinho, Karlos Alexandre; Pereira do Carmo, Helison Rafael; de Carvalho, Daniela Diogenes; Petrucci, Orlando] State Univ Campinas UNICAMP, Fac Med Sci, Lab Myocardial Ischemia Reperfus, Campinas, SP, Brazil; [Martins de Oliveira, Pedro Paulo; Petrucci, Orlando] State Univ Campinas UNICAMP, Fac Med Sci, Dept Surg, Discipline Cardiac Surg, Campinas, SP, Brazil; [Abdalla Saad, Mario Jose; Sposito, Andrei Carvalho] State Univ Campinas UNICAMP, Fac Med Sci, Dept Internal Med, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Petrucci, O (corresponding author), State Univ Campinas UNICAMP, Fac Med Sci, Lab Myocardial Ischemia Reperfus, Campinas, SP, Brazil.	orlando@fcm.unicamp.br	Carvalho, Daniela/L-1944-2013; de Carvalho, Daniela/G-9453-2019; Petrucci, Orlando/B-5928-2008; Sposito, Andrei C/G-4116-2013; Saad, Mario/ABD-8262-2020	Carvalho, Daniela/0000-0002-2479-949X; Petrucci, Orlando/0000-0002-1455-7155; Sposito, Andrei C/0000-0001-7127-2052; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/14550-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant number 2011/14550-7.	Berthonneche C, 2004, AM J PHYSIOL-HEART C, V287, pH340, DOI 10.1152/ajpheart.01210.2003; Bolognesi R, 2004, J CARD FAIL, V10, P304, DOI 10.1016/j.cardfail.2003.10.010; Christia P, 2013, EUR J CLIN INVEST; Christia P, 2013, J HISTOCHEM CYTOCHEM, V61, P555, DOI 10.1369/0022155413493912; de Isla NG, 2008, BIO-MED MATER ENG, V18, pS99; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gao Y, 2014, FREE RADICAL BIO MED, V72, P104, DOI 10.1016/j.freeradbiomed.2014.04.001; Gigant-Huselstein C, 2002, BIORHEOLOGY, V39, P277; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Hamid T, 2011, CARDIOVASC RES, V89, P129, DOI 10.1093/cvr/cvq274; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ishikawa K, 2012, AM J PHYSIOL-HEART C, V302, pH1423, DOI 10.1152/ajpheart.01211.2011; Jatwa R, 2009, FUND CLIN PHARMACOL, V23, P465, DOI 10.1111/j.1472-8206.2009.00685.x; Kandalam V, 2011, CIRCULATION, V124, P2094, DOI 10.1161/CIRCULATIONAHA.111.030338; KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Kumar R, 2013, OCHSNER J, V13, P157; Lecour S, 2011, EUROPEAN HEART J; Lecour S, 2011, EUR HEART J, V32, P680, DOI 10.1093/eurheartj/ehq484; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Pasin JSM, 2010, INFLAMM RES, V59, P189, DOI 10.1007/s00011-009-0085-8; Moss NC, 2007, AM J PHYSIOL-HEART C, V293, pH2248, DOI 10.1152/ajpheart.00776.2007; Onai Y, 2007, AM J PHYSIOL-HEART C, V292, pH530, DOI 10.1152/ajpheart.00549.2006; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Routledge FS, 2010, CAN J CARDIOL, V26, P303, DOI 10.1016/S0828-282X(10)70395-0; SOGAARD P, 1993, CIRCULATION, V87, P1093; Vilarinho KAS, 2013, EUR J CARDIO-THORAC, V43, P156, DOI 10.1093/ejcts/ezs254; Stefanon I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064986; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Tang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025320; Tobar N, 2011, ENDOCRINOLOGY, V152, P4080, DOI 10.1210/en.2011-0249; Valen G, 2011, HEART FAIL REV, V16, P71, DOI 10.1007/s10741-010-9187-1; WALLACE AG, 1963, BIOCHIM BIOPHYS ACTA, V72, P30; Yoshiyama M, 2001, J MOL CELL CARDIOL, V33, P799, DOI 10.1006/jmcc.2001.1351; Zhou W, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.110	38	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121842	10.1371/journal.pone.0121842	http://dx.doi.org/10.1371/journal.pone.0121842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816098	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600123
J	Zakrzewska, KE; Samluk, A; Wierzbicki, M; Jaworski, S; Kutwin, M; Sawosz, E; Chwalibog, A; Pijanowska, DG; Pluta, KD				Zakrzewska, Karolina Ewa; Samluk, Anna; Wierzbicki, Mateusz; Jaworski, Slawomir; Kutwin, Marta; Sawosz, Ewa; Chwalibog, Andre; Pijanowska, Dorota Genowefa; Pluta, Krzysztof Dariusz			Analysis of the Cytotoxicity of Carbon-Based Nanoparticles, Diamond and Graphite, in Human Glioblastoma and Hepatoma Cell Lines	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SILICA NANOPARTICLES; PULMONARY TOXICITY; PARTICLE-SIZE; NANOTUBES; GRAPHENE; DELIVERY; NANOMATERIALS; APOPTOSIS; OXIDE	Nanoparticles have attracted a great deal of attention as carriers for drug delivery to cancer cells. However, reports on their potential cytotoxicity raise questions of their safety and this matter needs attentive consideration. In this paper, for the first time, the cytotoxic effects of two carbon based nanoparticles, diamond and graphite, on glioblastoma and hepatoma cells were compared. First, we confirmed previous results that diamond nanoparticles are practically nontoxic. Second, graphite nanoparticles exhibited a negative impact on glioblastoma, but not on hepatoma cells. The studied carbon nanoparticles could be a potentially useful tool for therapeutics delivery to the brain tissue with minimal side effects on the hepatocytes. Furthermore, we showed the influence of the nanoparticles on the stable, fluorescently labeled tumor cell lines and concluded that the labeled cells are suitable for drug cytotoxicity tests.	[Zakrzewska, Karolina Ewa; Samluk, Anna; Pijanowska, Dorota Genowefa; Pluta, Krzysztof Dariusz] Nalecz Inst Biocybernet & Biomed Engn PAS, Dept Hybrid Microbiosyst Engn, Warsaw, Poland; [Wierzbicki, Mateusz; Jaworski, Slawomir; Kutwin, Marta; Sawosz, Ewa] Warsaw Univ Life Sci, Fac Anim Sci, Div Nanobiotechnol, Warsaw, Poland; [Chwalibog, Andre] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Copenhagen, Denmark	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Warsaw University of Life Sciences; University of Copenhagen	Pluta, KD (corresponding author), Nalecz Inst Biocybernet & Biomed Engn PAS, Dept Hybrid Microbiosyst Engn, Warsaw, Poland.	kpluta@ibib.waw.pl	Pijanowska, Dorota/AAJ-3586-2021; Pijanowska, Dorota G/W-3182-2018; Jaworski, Sławomir/AAI-2313-2020; Wierzbicki, Mateusz/ABF-5482-2020	Pijanowska, Dorota/0000-0001-8431-8910; Pijanowska, Dorota G/0000-0001-8431-8910; Jaworski, Sławomir/0000-0002-4619-941X; Wierzbicki, Mateusz/0000-0003-3623-8929; Chwalibog, Andre/0000-0001-8150-2392; Zakrzewska, Karolina/0000-0002-1346-2445; Sawosz Chwalibog, Ewa/0000-0002-0016-4721; Kutwin, Marta/0000-0001-7059-7875; Pluta, Krzysztof/0000-0003-1706-2788	National Science Centre Poland NCN [2011/03/N/NZ9/04290]; European Regional Development Found within the POIG Programme: MNS-DIAG "Micro- and Nano-Systems for Chemistry and Biomedical Diagnostics" [POIG.01.03.01-00-014/08-02]	National Science Centre Poland NCN(National Science Centre, Poland); European Regional Development Found within the POIG Programme: MNS-DIAG "Micro- and Nano-Systems for Chemistry and Biomedical Diagnostics"	Funding provided by National Science Centre Poland NCN 2011/03/N/NZ9/04290, http://www.ncn.gov.pl MW; European Regional Development Found within the POIG Programme: MNS-DIAG "Micro- and Nano-Systems for Chemistry and Biomedical Diagnostics" (POIG.01.03.01-00-014/08-02), www.projekty.poig.gov.pl DGP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Jafar, 2011, Int J Nanomedicine, V6, P1117, DOI 10.2147/IJN.S16603; Almofti MR, 2003, MOL MEMBR BIOL, V20, P35, DOI 10.1080/09687680210035104; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Bakowicz-Mitura K, 2007, SURF COAT TECH, V201, P6131, DOI 10.1016/j.surfcoat.2006.08.142; Baudoin R, 2011, BIOCHEM ENG J, V53, P172, DOI 10.1016/j.bej.2010.10.007; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022; Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016; Choi MR, 2007, NANO LETT, V7, P3759, DOI 10.1021/nl072209h; De M, 2008, CHEM COMMUN, P3504, DOI 10.1039/b805242e; De Nicola M, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395013; Ding JX, 2013, J CONTROL RELEASE, V169, P193, DOI 10.1016/j.jconrel.2012.12.006; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Eisele G, 2013, CANCER LETT, V332, P335, DOI 10.1016/j.canlet.2010.12.012; Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K; Ferlay J, 2013, GLOBOCAN 2012 V10 CA; Fiorito S, 2006, J NANOSCI NANOTECHNO, V6, P591, DOI 10.1166/jnn.2006.125; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Graf D, 2014, EUR J INTERN MED, V25, P430, DOI 10.1016/j.ejim.2014.03.001; Jaworski S, 2013, INT J NANOMED, V8, P413, DOI 10.2147/IJN.S39456; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; Lammel T, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-27; Li Y, 2011, TOXICOL IN VITRO, V25, P1343, DOI 10.1016/j.tiv.2011.05.003; Li YQ, 2014, INT J NANOMED, V9, P1065, DOI 10.2147/IJN.S54864; Lin YC, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.101512; Lu X, 2011, INT J NANOMED, V6, P1889, DOI 10.2147/IJN.S24005; Mundra RV, 2014, CURR OPIN BIOTECH, V28, P25, DOI 10.1016/j.copbio.2013.10.012; Muro S, 2003, AM J PHYSIOL-CELL PH, V285, pC1339, DOI 10.1152/ajpcell.00099.2003; Panessa-Warren BJ, 2006, J PHYS-CONDENS MAT, V18, pS2185, DOI 10.1088/0953-8984/18/33/S34; Samluk A, 2013, ARTIF ORGANS, V37, pE123, DOI 10.1111/aor.12064; Sanchez VC, 2012, CHEM RES TOXICOL, V25, P15, DOI 10.1021/tx200339h; Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v; Singh DK, 2012, CARBON, V50, P4495, DOI 10.1016/j.carbon.2012.05.030; Tatur S, 2013, LANGMUIR, V29, P6606, DOI 10.1021/la401074y; Tian FR, 2006, TOXICOL IN VITRO, V20, P1202, DOI 10.1016/j.tiv.2006.03.008; Vaijayanthimala V, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425103; Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6; Wang YB, 2010, J PHYS CHEM C, V114, P4153, DOI 10.1021/jp9097793; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Westermark B, 2012, UPSALA J MED SCI, V117, P251, DOI 10.3109/03009734.2012.676574; Wierzbicki M, 2013, INT J NANOMED, V8, P3427, DOI 10.2147/IJN.S49745; Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050; Yuan JF, 2011, TOXICOL LETT, V207, P213, DOI 10.1016/j.toxlet.2011.09.014; Yuan L, 2014, TOXICOL LETT, V225, P294, DOI 10.1016/j.toxlet.2013.12.015; Zakrzewska KE, 2014, ACTA BIOCHIM POL, V61, P809; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935	48	43	44	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122579	10.1371/journal.pone.0122579	http://dx.doi.org/10.1371/journal.pone.0122579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816103	Green Published, gold			2022-12-26	WOS:000352133600187
J	Zhang, WZ; Zhai, TT; Lu, JY; Chen, JZ; Chen, ZJ; Li, DR; Chen, CZ				Zhang, Wu-Zhe; Zhai, Tian-Tian; Lu, Jia-Yang; Chen, Jian-Zhou; Chen, Zhi-Jian; Li, De-Rui; Chen, Chuang-Zhen			Volumetric Modulated Arc Therapy vs. c-IMRT for the Treatment of Upper Thoracic Esophageal Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-II TRIAL; RADIOTHERAPY; OXALIPLATIN; CARCINOMA	Objective To compare plans using volumetric-modulated arc therapy (VMAT) with conventional sliding window intensity-modulated radiation therapy (c-IMRT) to treat upper thoracic esophageal cancer (EC). Methods CT datasets of 11 patients with upper thoracic EC were identified. Four plans were generated for each patient: c-IMRT with 5 fields (5F) and VMAT with a single arc (1A), two arcs (2A), or three arcs (3A). The prescribed doses were 64 Gy/32 F for the primary tumor (PTV64). The dose-volume histogram data, the number of monitoring units (MUs) and the treatment time (TT) for the different plans were compared. Results All of the plans generated similar dose distributions for PTVs and organs at risk (OARs), except that the 2A- and 3A-VMAT plans yielded a significantly higher conformity index (CI) than the c-IMRT plan. The CI of the PTV64 was improved by increasing the number of arcs in the VMAT plans. The maximum spinal cord dose and the planning risk volume of the spinal cord dose for the two techniques were similar. The 2A- and 3A-VMAT plans yielded lower mean lung doses and heart V-50 values than the c-IMRT. The V-20 and V-30 for the lungs in all of the VMAT plans were lower than those in the c-IMRT plan, at the expense of increasing V-5, V-10 and V-13. The VMAT plan resulted in significant reductions in MUs and TT. Conclusion The 2A-VMAT plan appeared to spare the lungs from moderate-dose irradiation most effectively of all plans, at the expense of increasing the low-dose irradiation volume, and also significantly reduced the number of required MUs and the TT. The CI of the PTVs and the OARs was improved by increasing the arc-number from 1 to 2; however, no significant improvement was observed using the 3A-VMAT, except for an increase in the TT.	[Zhang, Wu-Zhe; Zhai, Tian-Tian; Lu, Jia-Yang; Chen, Jian-Zhou; Li, De-Rui; Chen, Chuang-Zhen] Shantou Univ, Coll Med, Canc Hosp, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China; [Chen, Zhi-Jian] Univ Hongkong, Shenzhen Hosp 1, Ctr Clin Oncol, Shenzhen, Peoples R China	Shantou University	Chen, CZ (corresponding author), Shantou Univ, Coll Med, Canc Hosp, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China.	stccz@139.com	Chen, Jianzhou/AAW-1443-2021		Science and Technology Planning Project of Shantou [2012-165-131]; Shantou University Medical College Clinical Research Enhancement Initivitate [201424]	Science and Technology Planning Project of Shantou; Shantou University Medical College Clinical Research Enhancement Initivitate	Support was provided by the Science and Technology Planning Project of Shantou: 2012-165-131, for CZC; Shantou University Medical College Clinical Research Enhancement Initivitate: 201424, for CZC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola BE, 2013, REP PRACT ONCOL RADI, V18, P383, DOI 10.1016/j.rpor.2013.07.005; Bertelsen A, 2010, RADIOTHER ONCOL, V95, P142, DOI 10.1016/j.radonc.2010.01.011; BRAHME A, 1988, RADIOTHER ONCOL, V12, P129, DOI 10.1016/0167-8140(88)90167-3; Burmeister BH, 2009, INVEST NEW DRUG, V27, P275, DOI 10.1007/s10637-008-9178-4; Chandra A, 2005, RADIOTHER ONCOL, V77, P247, DOI 10.1016/j.radonc.2005.10.017; Cozzi L, 2008, RADIOTHER ONCOL, V89, P180, DOI 10.1016/j.radonc.2008.06.013; Fu WH, 2004, WORLD J GASTROENTERO, V10, P1098; Graham MV, 1999, INT J RADIAT ONCOL, V45, P323, DOI 10.1016/S0360-3016(99)00183-2; Guckenberger M, 2009, RADIOTHER ONCOL, V93, P259, DOI 10.1016/j.radonc.2009.08.015; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Jiang ZQ, 2012, INT J RADIAT ONCOL, V83, P332, DOI 10.1016/j.ijrobp.2011.06.1963; Lee TF, 2012, CLIN ONCOL-UK, V24, P196, DOI 10.1016/j.clon.2011.06.006; Ma P, 2014, J APPL CLIN MED PHYS, V15, P221, DOI 10.1120/jacmp.v15i3.4732; Mayo CS, 2010, INT J RADIAT ONCOL, V78, P1457, DOI 10.1016/j.ijrobp.2009.10.005; Pera M, 2012, ANN ONCOL, V23, P664, DOI 10.1093/annonc/mdr291; Van Benthuysen L, 2011, MED DOSIM, V36, P404, DOI 10.1016/j.meddos.2010.09.009; Wagner D, 2009, RADIOTHER ONCOL, V93, P593, DOI 10.1016/j.radonc.2009.10.002; Wang J, 2008, INT J RADIAT ONCOL, V17, P275; Wang SL, 2006, INT J RADIAT ONCOL, V66, P1399, DOI 10.1016/j.ijrobp.2006.07.1337; Wolff D, 2009, RADIOTHER ONCOL, V93, P226, DOI 10.1016/j.radonc.2009.08.011; Wu QW, 2000, INT J RADIAT ONCOL, V46, P195, DOI 10.1016/S0360-3016(99)00304-1; Wu VWC, 2004, RADIOTHER ONCOL, V71, P201, DOI 10.1016/j.radonc.2004.03.004; Yin L, 2012, WORLD J GASTROENTERO, V18, P5266, DOI 10.3748/wjg.v18.i37.5266; [张丹丹 Zhang Dandan], 2012, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V21, P364	24	16	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121385	10.1371/journal.pone.0121385	http://dx.doi.org/10.1371/journal.pone.0121385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815477	Green Submitted, gold, Green Published			2022-12-26	WOS:000352133600088
J	Bravo, V; Puhar, A; Sansonetti, P; Parsot, C; Toro, CS				Bravo, Veronica; Puhar, Andrea; Sansonetti, Philippe; Parsot, Claude; Toro, Cecilia S.			Distinct Mutations Led to Inactivation of Type 1 Fimbriae Expression in Shigella spp.	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; UROPATHOGENIC ESCHERICHIA-COLI; FLAGELLAR MASTER OPERON; PHASE VARIATION; PATHOGENICITY ISLANDS; EVOLUTIONARY HISTORY; ANTIVIRULENCE GENES; BLACK-HOLES; FLEXNERI 2A; VIRULENCE	Shigella spp. are responsible for bacillary dysentery in humans. The acquisition or the modification of the virulence plasmid encoding factors promoting entry of bacteria into and dissemination within epithelial cells was a critical step in the evolution of these bacteria from their Escherichia coli ancestor(s). Incorporation of genomic islands (GI) and gene inactivation also shaped interactions between these pathogens and their human host. Sequence analysis of the GI inserted next to the leuX tRNA gene in S. boydii, S. dysenteriae, S. flexneri, S. sonnei and enteroinvasive E. coli (EIEC) suggests that this region initially carried the fec, yjhATS and fim gene clusters. The fim cluster encoding type I fimbriae is systematically inactivated in both reference strains and clinical isolates and distinct mutations are responsible for this inactivation in at least three phylogenetic groups. To investigate consequences of the presence of fimbriae on the outcome of the interaction of Shigella with host cells, we used a S. flexneri strain harboring a plasmid encoding the E. coli fim operon. Production of fimbriae by this recombinant strain increased the ability of bacteria to adhere to and enter into epithelial cells and had no effect on their ability to disseminate from cell to cell. The observations that production of type I fimbriae increases invasion of epithelial cells and that independent mutations abolish fimbriae production in Shigella suggest that these mutations correspond to pathoadaptive events.	[Bravo, Veronica; Toro, Cecilia S.] Univ Chile, Fac Med, ICBM, Programa Microbiol, Santiago, Chile; [Puhar, Andrea; Sansonetti, Philippe; Parsot, Claude] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Puhar, Andrea; Sansonetti, Philippe; Parsot, Claude] INSERM, Paris, France	Universidad de Chile; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Toro, CS (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.	cparsot@pasteur.fr; cetoro@med.uchile.cl		Puhar, Andrea/0000-0002-9915-002X	Comision Nacional de Investigacion Cientifica y Tecnologica, Chile (CONICYT); Universidad de Chile; Faculty of Medicine; CONICYT [ADI-08/2006]; World Bank	Comision Nacional de Investigacion Cientifica y Tecnologica, Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad de Chile; Faculty of Medicine; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); World Bank(The World Bank India)	VB was a recipient of Comision Nacional de Investigacion Cientifica y Tecnologica, Chile (CONICYT), Faculty of Medicine and Universidad de Chile fellowships. AP was a recipient of subsequent EMBO long-term and Marie Curie Intra-European fellowships. This work was supported by grant ADI-08/2006 from CONICYT and the World Bank (CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hasani K, 2000, INFECT IMMUN, V68, P2457, DOI 10.1128/IAI.68.5.2457-2463.2000; AlMamun AM, 1996, J BACTERIOL, V178, P3722, DOI 10.1128/jb.178.13.3722-3726.1996; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ashida H, 2007, MOL MICROBIOL, V63, P680, DOI 10.1111/j.1365-2958.2006.05547.x; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Ashkar AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000233; Ashton PM, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-7; Baker KS, 2014, LANCET, V384, P1691, DOI 10.1016/S0140-6736(14)61789-X; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bliven KA, 2012, INFECT IMMUN, V80, P4061, DOI 10.1128/IAI.00740-12; Bryan A, 2006, INFECT IMMUN, V74, P1072, DOI 10.1128/IAI.74.2.1072-1083.2006; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Capitani G, 2006, MICROBES INFECT, V8, P2284, DOI 10.1016/j.micinf.2006.03.013; CLERC P, 1987, INFECT IMMUN, V55, P2681, DOI 10.1128/IAI.55.11.2681-2688.1987; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Escobar-Paramo P, 2003, J MOL EVOL, V57, P140, DOI 10.1007/s00239-003-2460-3; Farfan MJ, 2010, EPIDEMIOL INFECT, V138, P525, DOI 10.1017/S0950268809990823; FEIN JE, 1981, J CLIN MICROBIOL, V13, P1088, DOI 10.1128/JCM.13.6.1088-1095.1981; Gally DL, 1996, MOL MICROBIOL, V21, P725, DOI 10.1046/j.1365-2958.1996.311388.x; GBARAH A, 1993, INFECT IMMUN, V61, P1687, DOI 10.1128/IAI.61.5.1687-1693.1993; Godaly G, 1998, MOL MICROBIOL, V30, P725, DOI 10.1046/j.1365-2958.1998.01104.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Lawrence JG, 2005, CURR OPIN GENET DEV, V15, P584, DOI 10.1016/j.gde.2005.09.007; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; MCCLAIN MS, 1991, J BACTERIOL, V173, P5308, DOI 10.1128/jb.173.17.5308-5314.1991; McCormick BA, 1999, CELL MICROBIOL, V1, P143, DOI 10.1046/j.1462-5822.1999.00014.x; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Mounier J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000271; NEWLAND JW, 1985, SCIENCE, V230, P179, DOI 10.1126/science.2994228; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Nie H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-173; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; Onodera NT, 2012, J BACTERIOL, V194, P3022, DOI 10.1128/JB.00393-12; ORNDORFF PE, 1984, J BACTERIOL, V160, P61, DOI 10.1128/JB.160.1.61-66.1984; Paciello I, 2013, P NATL ACAD SCI USA, V110, pE4345, DOI 10.1073/pnas.1303641110; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Prunier AL, 2007, MICROBIOL-SGM, V153, P2363, DOI 10.1099/mic.0.2007/006916-0; Puhar A, 2013, IMMUNITY, V39, P1121, DOI 10.1016/j.immuni.2013.11.013; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Sakellaris H, 2000, INFECT IMMUN, V68, P3780, DOI 10.1128/IAI.68.6.3780-3783.2000; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Snellings NJ, 1997, INFECT IMMUN, V65, P2462, DOI 10.1128/IAI.65.6.2462-2467.1997; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Tominaga A, 2005, J BACTERIOL, V187, P4295, DOI 10.1128/JB.187.12.4295-4302.2005; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Valenski ML, 2003, J BACTERIOL, V185, P5007, DOI 10.1128/JB.185.16.5007-5011.2003; Vokes SA, 1999, MOL MICROBIOL, V33, P63, DOI 10.1046/j.1365-2958.1999.01448.x; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Yang J, 2007, J MOL EVOL, V64, P71, DOI 10.1007/s00239-006-0052-8; Zhang N, 2014, J CLIN MICROBIOL, V52, P1119, DOI 10.1128/JCM.02669-13	69	12	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121785	10.1371/journal.pone.0121785	http://dx.doi.org/10.1371/journal.pone.0121785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811616	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700138
J	Gingo, MR; Zhang, YZ; Ghebrehawariat, KB; Jeong, JH; Chu, YX; Yang, QW; Lucht, L; Hanna, DB; Lazar, JM; Gladwin, MT; Morris, A				Gingo, Matthew R.; Zhang, Yingze; Ghebrehawariat, Kidane B.; Jeong, Jong-Hyeon; Chu, Yanxia; Yang, Quanwei; Lucht, Lorrie; Hanna, David B.; Lazar, Jason M.; Gladwin, Mark T.; Morris, Alison			Elevated NT-Pro-Brain Natriuretic Peptide Level Is Independently Associated with All-Cause Mortality in HIV-Infected Women in the Early and Recent HAART Eras in the Women's Interagency HIV Study Cohort	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; ACUTE MYOCARDIAL-INFARCTION; C VIRUS-INFECTION; HEART-FAILURE; PULMONARY-HYPERTENSION; RADIONUCLIDE VENTRICULOGRAPHY; CARDIAC-FUNCTION; RISK-FACTORS; DISEASE; BNP	Background HIV-infected individuals are at increased risk of right and left heart dysfunction. N-terminal-pro-brain natriuretic peptide (NT-proBNP), a marker of cardiac ventricular strain and systolic dysfunction, may be associated with all-cause mortality in HIV-infected women. The aim of this study was to determine if elevated levels of NT-proBNP is associated with increased mortality in HIV-infected women. Design Prospective cohort study. Methods and Results We measured NT-proBNP in 936 HIV-infected and 387 age-matched HIV-uninfected women early (10/11/94 to 7/17/97) and 1082 HIV-infected and 448 HIV-uninfected women late (4/1/08 to 10/7/08) in the highly active antiretroviral therapy (HAART) periods in the Women's Interagency HIV Study. An NT-proBNP > 75th percentile was more likely in HIV-infected persons, but only statistically significant in the late period (27% vs. 21%, unadjusted p = 0.03). In HIV-infected participants, NT-proBNP>75th percentile was independently associated with worse 5-year survival in the early HAART period (HR 1.8, 95% CI 1.3-2.4, p< 0.001) and remained a predictor of mortality in the late HAART period (HR 2.8, 95% CI 1.4-5.5, p = 0.002) independent of other established risk covariates (age, race/ethnicity, body mass index, smoking, hepatitis C serostatus, hypertension, renal function, and hemoglobin). NT-proBNP level was not associated with mortality in HIV-uninfected women. Conclusion NT-proBNP is a novel independent marker of mortality in HIV-infected women both when HAART was first introduced and currently. As NT-proBNP is often associated with both pulmonary hypertension and left ventricular dysfunction, these findings suggest that these conditions may contribute significantly to adverse outcomes in this population, requiring further definition of causes and treatments of elevated NT-proBNP in HIV-infected women.	[Gingo, Matthew R.; Zhang, Yingze; Chu, Yanxia; Yang, Quanwei; Lucht, Lorrie; Gladwin, Mark T.; Morris, Alison] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Ghebrehawariat, Kidane B.; Jeong, Jong-Hyeon] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA USA; [Hanna, David B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Lazar, Jason M.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Gladwin, Mark T.] Univ Pittsburgh, Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA USA; [Gladwin, Mark T.] UPMC, Pittsburgh, PA USA; [Morris, Alison] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yeshiva University; Albert Einstein College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gingo, MR (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	gingomr@upmc.edu		Jeong, Jong/0000-0003-0596-2201; Zhang, YIngze/0000-0001-8042-6105	National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); National Institute on Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and other Communication Disorders (NIDCD); NIH Office of Research on Women's Health; Gilead; Roche; NIH [K23 HL108697, P01 HL103455, R01 HL090339]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL108697, R01HL126543, R01HL090339, P01HL103455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034994, U01AI035004, U01AI034989, U01AI103397, U01AI034993, U01AI103390, U01AI031834, U01AI042590, U01AI103401, U01AI103408] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Gilead(Gilead Sciences); Roche(Roche Holding); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Women's Interagency HIV Study (WIHS) collected data in this manuscript. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). WIHS (Principal Investigators): UAB-MS WIHS (Michael Saag), U01-AI-103401; Atlanta WIHS (Ighovwerha Ofotokun and Gina Wingood), U01-AI-103408; Bronx WIHS (Kathryn Anastos), U01-AI-035004; Brooklyn WIHS (Howard Minkoff and Deborah Gustafson), U01-AI-031834; Chicago WIHS (Mardge Cohen), U01-AI-034993; Metropolitan Washington WIHS (Mary Young), U01-AI-034994; Miami WIHS (Margaret Fischl and Lisa Metsch), U01-AI-103397; UNC WIHS (Adaora Adimora), U01-AI-103390; Connie Wofsy Women's HIV Study, Northern California (Ruth Greenblatt, Bradley Aouizerat, and Phyllis Tien), U01-AI-034989; WIHS Data Management and Analysis Center (Stephen Gange and Elizabeth Golub), U01-AI-042590; Southern California WIHS (Alexandra Levine and Marek Nowicki), U01-HD-032632 (WIHS I-WIHS IV). The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WIHS data collection is also supported by UL1-TR000004 (UCSF CTSA) and UL1-TR000454 (Atlanta CTSA). Investigator-initiated research grants were from Gilead and Roche. This study was supported by the following NIH grants: K23 HL108697 (to MRG); P01 HL103455 (to MTG, AM); R01 HL090339 (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen AK, 2006, AM J CARDIOL, V98, P525, DOI 10.1016/j.amjcard.2006.02.061; Aquaro GD, 2014, INT J CARDIOL, V173, P614, DOI 10.1016/j.ijcard.2014.03.141; Aquaro GD, 2011, HEART, V97, P2056, DOI 10.1136/hrt.2011.226977; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Barbaro G, 1998, AIDS RES HUM RETROV, V14, P1071, DOI 10.1089/aid.1998.14.1071; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Bettencourt P, 2000, CARDIOLOGY, V93, P19, DOI 10.1159/000006997; Breuckmann F, 2007, EUR J MED RES, V12, P185; Carrillo-Jimenez Rodolfo, 2002, AIDS Read, V12, P501; CARRILLOJIMENEZ R, 2002, AIDS READ, V12, P508; Cauliez B, 2008, ANN CLIN BIOCHEM, V45, P318, DOI 10.1258/acb.2007.007187; Clerico A, 2011, AM J PHYSIOL-HEART C, V301, pH12, DOI 10.1152/ajpheart.00226.2011; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Del Ry S, 2013, PHARMACOL RES, V76, P190, DOI 10.1016/j.phrs.2013.08.006; DHHS/Henry J Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV Infection, 2008, GUID US ANT AG HIV I; Duprez DA, 2011, AIDS, V25, P651, DOI 10.1097/QAD.0b013e32834404a1; Fijalkowska A, 2006, CHEST, V129, P1313, DOI 10.1378/chest.129.5.1313; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; French AL, 2009, JAIDS-J ACQ IMM DEF, V51, P399, DOI 10.1097/QAI.0b013e3181acb4e5; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gale CP, 2011, J CARDIOVASC MED, V12, P613, DOI 10.2459/JCM.0b013e3283491780; Giralt M, 2010, CURR PHARM DESIGN, V16, P3372, DOI 10.2174/138161210793563527; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; GORE SM, 1984, J R STAT SOC C-APPL, V33, P176; Hsue PY, 2008, AIDS, V22, P825, DOI 10.1097/QAD.0b013e3282f7cd42; Iwanaga Y, 2006, J AM COLL CARDIOL, V47, P742, DOI 10.1016/j.jacc.2005.11.030; Kristoffersen US, 2008, HIV MED, V9, P180, DOI 10.1111/j.1468-1293.2007.00531.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lebech AM, 2004, AM HEART J, V147, P482, DOI 10.1016/j.ahj.2003.09.009; Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8; Mansoor A, 2009, AIDS RES HUM RETROV, V25, P997, DOI 10.1089/aid.2009.0038; Martinez-Rumayor A, 2008, AM J CARDIOL, V101, p3A, DOI 10.1016/j.amjcard.2007.11.012; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; Matsumori A, 2006, J CARD FAIL, V12, P293, DOI 10.1016/j.cardfail.2005.11.004; McDonald B, 2013, AIDS RES HUM RETROV, V29, P993, DOI [10.1089/aid.2012.0309, 10.1089/AID.2012.0309]; Monsuez JJ, 2007, INT J CARDIOL, V120, P150, DOI 10.1016/j.ijcard.2006.11.143; Morris A, 2012, AIDS, V26, P731, DOI 10.1097/QAD.0b013e32835099ae; Mueller T, 2004, CLIN CHEM LAB MED, V42, P942, DOI 10.1515/CCLM.2004.153; Neumann T, 2009, HERZ, V34, P634, DOI 10.1007/s00059-009-3313-7; Okabe M, 1997, CIRCULATION, V96, P22; Oluleye OW, 2013, ANN EPIDEMIOL, V23, P66, DOI 10.1016/j.annepidem.2012.11.004; Parikh RV, 2013, ATHEROSCLEROSIS, V229, P246, DOI 10.1016/j.atherosclerosis.2013.04.025; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tsutamoto T, 2006, J AM COLL CARDIOL, V47, P582, DOI 10.1016/j.jacc.2005.10.038; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0123389	10.1371/journal.pone.0123389	http://dx.doi.org/10.1371/journal.pone.0123389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811188	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000356353700216
J	Hajrezaie, M; Salehen, N; Karimian, H; Zahedifard, M; Shams, K; Al Batran, R; Majid, NA; Khalifa, SAM; Ali, HM; El-Seedi, H; Abdulla, MA				Hajrezaie, Maryam; Salehen, NurAin; Karimian, Hamed; Zahedifard, Maryam; Shams, Keivan; Al Batran, Rami; Majid, Nazia Abdul; Khalifa, Shaden A. M.; Ali, Hapipah Mohd; El-Seedi, Hesham; Abdulla, Mahmood Ameen			Biochanin A Gastroprotective Effects in Ethanol-Induced Gastric Mucosal Ulceration in Rats	PLOS ONE			English	Article							LEAF EXTRACT; ANTIOXIDANT; MECHANISMS; LESIONS	Background Biochanin A notable bioactive compound which is found in so many traditional medicinal plant. In vivo study was conducted to assess the protective effect of biochanin A on the gastric wall of Spraguedawley rats' stomachs. Methodology The experimental set included different animal groups. Specifically, four groups with gastric mucosal lesions were receiving either a) Ulcer control group treated with absolute ethanol (5 ml/kg), b) 20 mg/kg of omeprazole as reference group, c) 25 of biochanin A, d) 50 mg/kg of biochanin A. Histopathological sectioning followed by immunohistochemistry staining were undertaken to evaluate the influence of the different treatments on gastric wall mucosal layer. The gastric secretions were collected in the form of homogenate and exposed to superoxide dismutase (SOD) and nitric oxide enzyme (NO) and the level of malondialdehyde (MDA) and protein content were measured. Ulceration and patchy haemorrhage were clearly observed by light microscopy. The morphology of the gastric wall as confirmed by immunohistochemistry and fluorescent microscopic observations, exhibited sever deformity with notable thickness, oedematous and complete loss of the mucosal coverage however the biochanin-pretreated animals, similar to the omeprazole-pretreated animals, showed less damage compared to the ulcer control group. Moreover, up-regulation of Hsp70 protein and down-regulation of Bax protein were detected in the biochanin A pre-treated groups and the gastric glandular mucosa was positively stained with Periodic Acid Schiff (PAS) staining and the Leucocytes infiltration was commonly seen. Biochanin A displayed a great increase in SOD and NO levels and decreased the release of MDA. Conclusions This gastroprotective effect of biochanin A could be attributed to the enhancement of cellular metabolic cycles perceived as an increase in the SOD, NO activity, and decrease in the level of MDA, and also decrease in level of Bax expression and increase the Hsp70 expression level.	[Hajrezaie, Maryam; Salehen, NurAin; Karimian, Hamed; Zahedifard, Maryam; Shams, Keivan; Al Batran, Rami; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Hajrezaie, Maryam; Zahedifard, Maryam; Majid, Nazia Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Khalifa, Shaden A. M.; El-Seedi, Hesham] Karolinska Univ Hosp, Dept Expt Hematol, SE-14186 Stockholm, Sweden; [Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Kuala Lumpur 59100, Malaysia; [El-Seedi, Hesham] Uppsala Univ, Dept Med Chem, Div Pharmacognosy, SE-75123 Uppsala, Sweden	Universiti Malaya; Universiti Malaya; Karolinska Institutet; Karolinska University Hospital; Universiti Malaya; Uppsala University	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	El-Seedi, Hesham R./C-8627-2018; MAJID, NAZIA ABDUL/B-9215-2010; SALEHEN, NURAIN/T-4970-2019	MAJID, NAZIA ABDUL/0000-0002-6817-8046; 	University of Malaya [PV069-2012A]; HIR-MOHE from the Ministry of Higher Education Malaysia [F000009-21001]	University of Malaya(Universiti Malaya); HIR-MOHE from the Ministry of Higher Education Malaysia	The authors would like to thank the University of Malaya for supporting this project PV069-2012A, and HIR-MOHE (F000009-21001) from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Abdulla MA, 2009, BIOMED RES-INDIA, V20, P35; Al Batran R, 2013, J GASTROEN HEPATOL, V28, P1321, DOI 10.1111/jgh.12229; Almagrami AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096004; Alshawsh MA, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/103039; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Bardi DA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/918460; Bouayed J, 2011, J MED FOOD, V14, P1631, DOI 10.1089/jmf.2010.0260; Cao GH, 1998, AM J CLIN NUTR, V68, P1081, DOI 10.1093/ajcn/68.5.1081; Chai J, 2011, PEPTIC ULCER DIS, P437; Choi BS, 2010, NEUROCHEM RES, V35, P1269, DOI 10.1007/s11064-010-0185-4; CORNE SJ, 1974, J PHYSIOL-LONDON, V242, pP116; Gawel Stefan, 2004, Wiad Lek, V57, P453; Ghosh R, 2007, INDIAN J PHARMACOL, V39, P214, DOI 10.4103/0253-7613.36544; Golbabapour S, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/974185; Golbabapour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075036; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Johnson TL, 2010, EVID-BASED COMPL ALT, V7, P351, DOI 10.1093/ecam/nen011; Ketuly KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059296; Khazaei M, 2007, IJPT, V51, P43; Kim HP, 2006, EXPER OPIN THER TAR, V5, P267; Konturek PC, 2001, J PHYSIOLOGY-PARIS, V95, P361, DOI 10.1016/S0928-4257(01)00049-3; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mahmood A. A., 2011, Scientific Research and Essays, V6, P2306; Medeiros JVR, 2008, BRIT J PHARMACOL, V153, P721, DOI 10.1038/sj.bjp.0707605; Mofleh IA, 2010, SAUD JOF GASTROE, V14, P128; Mradul Goswami, 2011, Journal of Applied Pharmaceutical Science, V1, P69; National Research Council, 1985, GUIDE CARE USE LAB A; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; OBERRINGER M, 1995, BIOCHEM BIOPH RES CO, V214, P1009, DOI 10.1006/bbrc.1995.2386; Polat B, 2010, CHEM-BIOL INTERACT, V186, P82, DOI 10.1016/j.cbi.2010.03.041; Qui BS, 2004, WORLD J GASTROENTERO, V10, P594, DOI 10.3748/wjg.v10.i4.594; Rokutan K, 2000, J GASTROEN HEPATOL, V15, pD12, DOI 10.1046/j.1440-1746.2000.02144.x; Royer M, 2011, FOOD CHEM TOXICOL, V49, P2180, DOI 10.1016/j.fct.2011.06.003; Schneeweiss S, 2006, CLIN PHARMACOL THER, V79, P379, DOI 10.1016/j.clpt.2005.12.304; Szliszka E, 2013, UROL ONCOL-SEMIN ORI, V31, P331, DOI 10.1016/j.urolonc.2011.01.019; Tarnawski A, 2001, J PHYSIOL-PARIS, V95, P337, DOI 10.1016/S0928-4257(01)00046-8; Umamaheswari M, 2007, J ETHNOPHARMACOL, V109, P547, DOI 10.1016/j.jep.2006.08.020; Araujo DAOV, 2011, REV BRAS FARMACOGN, V21, P721, DOI 10.1590/S0102-695X2011005000117; Rios ERV, 2010, CHEM-BIOL INTERACT, V188, P246, DOI 10.1016/j.cbi.2010.07.020; Wasman SQ, 2011, INDIAN J EXP BIOL, V49, P767; Yuan YH, 2006, NAT CLIN PRACT GASTR, V3, P80, DOI 10.1038/ncpgasthep0393	44	53	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121529	10.1371/journal.pone.0121529	http://dx.doi.org/10.1371/journal.pone.0121529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811625	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700111
J	Hanks, LJ; Casazza, K; Judd, SE; Jenny, NS; Gutierrez, OM				Hanks, Lynae J.; Casazza, Krista; Judd, Suzanne E.; Jenny, Nancy S.; Gutierrez, Orlando M.			Associations of Fibroblast Growth Factor-23 with Markers of Inflammation, Insulin Resistance and Obesity in Adults	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; C-REACTIVE PROTEIN; ABO BLOOD-TYPE; RACIAL-DIFFERENCES; CARDIOVASCULAR-DISEASE; GLUCOSE-HOMEOSTASIS; MORTALITY; FGF23	Introduction Elevated fibroblast growth factor-23 (FGF23) is an established marker of cardiovascular disease. The underlying reason(s) for the rise accompanying cardiovascular health decline are unclear. Prior studies have shown that FGF23 concentrations are associated with markers of inflammation and insulin resistance but they have been limited by a focus on persons with chronic kidney disease (CKD) and lack of race and sex diversity. The objective of this study was to examine the associations of FGF23 and markers of inflammation, insulin resistance, and anthropometrics in a large cohort of community-dwelling adults. Methods Associations of FGF23 with markers of inflammation [interleukin-6 (IL-6), IL-10, high sensitivity-CRP (hsCRP)], insulin utilization [resistin, adiponectin, homeostatic model assessment of insulin resistance (HOMA-IR)] and anthropometrics [BMI and waist circumference (WC)] were examined cross-sectionally in a 1,040 participants randomly selected from the Reason for Geographic and Racial Differences in Stroke (REGARDS) Study, a national study of black and white adults >= 45 years. Effect modification by race and CKD status was tested, and stratified models were analyzed accordingly. Results Median FGF23 concentration was 69.6 RU/ml (IQR: 53.2, 102.7). Higher quartiles of FGF23 were associated with higher mean concentrations of IL-6, IL-10, hsCRP and resistin (P-trend< 0.001 for all). There were no significant differences in HOMA-IR, adiponectin concentrations, BMI, or WC across FGF23 quartiles in the crude analyses. CKD significantly modified the relationships between FGF23 and inflammatory markers, HOMA-IR, BMI and WC (P <= 0.01 for all). In linear regression models adjusted for sociodemographic and clinical variables, FGF23 was positively associated with IL-6, hsCRP, IL-10, HOMA-IR, BMI and WC in individuals without CKD, but not among individuals with CKD. Additionally, FGF23 was positively associated with resistin irrespective of CKD status. Conclusions Elevated FGF23 concentrations may be considered a biomarker for decline in metabolic function among individuals with normal kidney function.	[Hanks, Lynae J.; Casazza, Krista] Univ Alabama Birmingham, Dept Pediat, Childrens Hosp Alabama, Birmingham, AL USA; [Judd, Suzanne E.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Jenny, Nancy S.] Univ Vermont, Coll Med, Pathol & Lab Med, Colchester, Essex, England; [Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Gutierrez, OM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	ogutierr@uab.edu			National Institute of Neurological Disorders and Stroke, National Institutes of Health [U01 NS041588, R01NS080850]; National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health [T32DK007545, R03DK095005]; Amgen Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626, T32DK007545, R03DK095005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588, R01NS080850] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Amgen Corporation(Amgen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by a cooperative agreement U01 NS041588 and R01NS080850 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data. In addition, LJH was supported by T32DK007545 and OMG was supported by R03DK095005 from the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health. Additional funding was provided by an investigator-initiated grant-in-aid from Amgen Corporation. Amgen did not have any role in the design and conduct of the study, the collection, management, data analysis, or interpretation of the data, or the preparation of the manuscript. While funding was provided by an investigator initiated grant-in-aid from Amgen Corporation, Amgen did not have any role in the design and conduct of the study, the collection, management, data analysis, or interpretation of the data, or the preparation of the manuscript. Further, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Alexander KS, 2014, NEUROLOGY, V83, P1271, DOI 10.1212/WNL.0000000000000844; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Chen BH, 2009, DIABETES CARE, V32, P329, DOI 10.2337/dc08-1625; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Cushman M, 2009, CLIN CHEM, V55, P1627, DOI 10.1373/clinchem.2008.122093; Dai B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044161; Diez JJ, 2005, CLIN ENDOCRINOL, V62, P242, DOI 10.1111/j.1365-2265.2005.02207.x; Donate-Correa J, 2012, CYTOKINE GROWTH F R, V23, P37, DOI 10.1016/j.cytogfr.2012.01.004; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gao D, 2013, INT J OBESITY, V37, P357, DOI 10.1038/ijo.2012.53; Garland JS, 2014, J DIABETES COMPLICAT, V28, P61, DOI 10.1016/j.jdiacomp.2013.09.004; Gillett SR, 2014, CLIN BIOCH; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2011, CLIN J AM SOC NEPHRO, V6, P2871, DOI 10.2215/CJN.02740311; Harris TB, 2000, ANN NY ACAD SCI, V904, P462; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Hesse M, 2007, MATRIX BIOL, V26, P75, DOI 10.1016/j.matbio.2006.10.003; Hill JO, 1999, AM J CLIN NUTR, V69, P381; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Juppner H, 2010, J BONE MINER RES, V25, P2091, DOI 10.1002/jbmr.170; Kovesdy CP, 2013, NEPHROL DIAL TRANSPL, V28, P2228, DOI 10.1093/ndt/gft065; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Manghat P, 2010, OSTEOPOROSIS INT, V21, P1853, DOI 10.1007/s00198-009-1142-4; Fernandez-Real JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058961; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Mirza MAI, 2011, ARTERIOSCL THROM VAS, V31, P219, DOI 10.1161/ATVBAHA.110.214619; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Seiler S, 2009, KIDNEY INT, V76, pS34, DOI 10.1038/ki.2009.405; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Streicher C, 2012, ENDOCRINOLOGY, V153, P1795, DOI 10.1210/en.2011-1878; Suzuki T, 2014, DIABETES CARE, V37, P2284, DOI 10.2337/dc13-2059; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Wahl P, 2012, DIABETES CARE, V35, P994, DOI 10.2337/dc11-2235; Widjaja A, 2000, NEPHROL DIAL TRANSPL, V15, P846, DOI 10.1093/ndt/15.6.846; Wojcik M, 2012, J PEDIATR ENDOCR MET, V25, P687, DOI 10.1515/jpem-2012-0064; Wojcik M, 2012, CLIN ENDOCRINOL, V77, P537, DOI 10.1111/j.1365-2265.2011.04299.x; Zakai NA, 2014, J THROMB HAEMOST, V12, P564, DOI 10.1111/jth.12507	43	92	94	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122885	10.1371/journal.pone.0122885	http://dx.doi.org/10.1371/journal.pone.0122885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811862	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700204
J	Zheng, Q; Lu, ZT; Zhang, MH; Xu, L; Ma, H; Song, SL; Feng, QJ; Feng, YQ; Chen, WF; He, TG				Zheng, Qian; Lu, Zhentai; Zhang, Minghui; Xu, Lin; Ma, Huan; Song, Shengli; Feng, Qianjin; Feng, Yanqiu; Chen, Wufan; He, Taigang			Automatic Segmentation of Myocardium from Black-Blood MR Images Using Entropy and Local Neighborhood Information	PLOS ONE			English	Article							MAGNETIC-RESONANCE; ACTIVE CONTOURS; DRIVEN	By using entropy and local neighborhood information, we present in this study a robust adaptive Gaussian regularizing Chan-Vese (CV) model to segment the myocardium from magnetic resonance images with intensity inhomogeneity. By utilizing the circular Hough transformation (CHT) our model is able to detect epicardial and endocardial contours of the left ventricle (LV) as circles automatically, and the circles are used as the initialization. In the cost functional of our model, the interior and exterior energies are weighted by the entropy to improve the robustness of the evolving curve. Local neighborhood information is used to evolve the level set function to reduce the impact of the heterogeneity inside the regions and to improve the segmentation accuracy. An adaptive window is utilized to reduce the sensitivity to initialization. The Gaussian kernel is used to regularize the level set function, which can not only ensure the smoothness and stability of the level set function, but also eliminate the traditional Euclidean length term and re-initialization. Extensive validation of the proposed method on patient data demonstrates its superior performance over other state-of-the-art methods.	[Zheng, Qian; Ma, Huan; Song, Shengli] Zhengzhou Univ Light Ind, Zhengzhou 450002, Peoples R China; [Lu, Zhentai; Zhang, Minghui; Feng, Qianjin; Feng, Yanqiu; Chen, Wufan] Southern Med Univ, Sch Biomed Engn, Guangzhou 510515, Guangdong, Peoples R China; [Xu, Lin] Univ Elect Sci & Technol China, Chengdu 611731, Peoples R China; [He, Taigang] Univ London, Cardiovasc Sci Res Ctr, London SW17 0RE, England; [He, Taigang] Royal Brompton Hosp, Biomed Res Unit, London SW7 2AZ, England; [He, Taigang] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Zhengzhou University of Light Industry; Southern Medical University - China; University of Electronic Science & Technology of China; University of London; Royal Brompton Hospital; Imperial College London	Lu, ZT (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou 510515, Guangdong, Peoples R China.	luzhentai@gmail.com; qianjinfeng08@gmail.com	Feng, Qianjin/Y-5438-2019; feng, qianjin/GNM-7856-2022	feng, qianjin/0000-0002-3830-5120	National Science Foundation of China [31000450]; Guangzhou Science Foundation [2012J2200041]; Major State Basic Research Development Program of China (973 Program) [2010CB732500]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science Foundation; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	The National Science Foundation of China (Project No. 31000450) had a role in study design. The Guangzhou Science Foundation (No. 2012J2200041) had a role in decision to publish as well as the preparation of the manuscript. The Major State Basic Research Development Program of China (973 Program, No. 2010CB732500) had a role in data collection and analysis.	Alt H, 2000, HANDBOOK OF COMPUTATIONAL GEOMETRY, P121, DOI 10.1016/B978-044482537-7/50004-8; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; BESAG J, 1986, J R STAT SOC B, V48, P259; CERNY V, 1985, J OPTIMIZ THEORY APP, V45, P41, DOI 10.1007/BF00940812; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Cocosco CA, 2008, J MAGN RESON IMAGING, V28, P366, DOI 10.1002/jmri.21451; de Albuquerque MP, 2004, PATTERN RECOGN LETT, V25, P1059, DOI 10.1016/j.patrec.2004.03.003; Diniz PRB, 2010, BRAZ J MED BIOL RES, V43, P77, DOI 10.1590/S0100-879X2009007500019; GATH I, 1989, IEEE T PATTERN ANAL, V11, P773, DOI 10.1109/34.192473; Goldenberg R, 2001, IEEE T IMAGE PROCESS, V10, P1467, DOI 10.1109/83.951533; Huang S., 2009, MIDAS J CARD MR LEFT; Jolly M., 2009, MIDAS J CARDIAC MR L, V4; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kichenassamy S, 1996, ARCH RATION MECH AN, V134, P275, DOI 10.1007/BF00379537; KIMME C, 1975, COMMUN ACM, V18, P120, DOI 10.1145/360666.360677; Lankton S, 2007, HYBRID GEODESIC REGI; LI C, 2007, P IEEE C COMP VIS PA, V1, P1, DOI DOI 10.1109/CVPR.2007.383014; Mayer A, 2009, IEEE T MED IMAGING, V28, P1238, DOI 10.1109/TMI.2009.2013850; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Paragios N, 2010, HDB MATH MODELS COMP; Rohlfing T, 2004, IEEE T MED IMAGING, V23, P983, DOI 10.1109/TMI.2004.830803; Schillo C, 1995, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOLS I-III, pC560; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Shi YG, 2005, PROC CVPR IEEE, P34; Singh V, 2004, J STRUCT BIOL, V145, P123, DOI 10.1016/j.jsb.2003.11.028; Smith GC, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-21; Sum KW, 2008, IEEE T BIO-MED ENG, V55, P358, DOI 10.1109/TBME.2007.896587; Sum K W, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3126; Wang XF, 2010, PATTERN RECOGN, V43, P603, DOI 10.1016/j.patcog.2009.08.002; WOODS JW, 1987, IEEE T PATTERN ANAL, V9, P245, DOI 10.1109/TPAMI.1987.4767898; Xi-ping Luo, 2002, Journal of Software, V13, P1050; Zhang KH, 2010, PATTERN RECOGN, V43, P1199, DOI 10.1016/j.patcog.2009.10.010; Zhang T, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1056, DOI 10.1109/ICCV.2003.1238466; Zheng Q, 2013, GAUSSIAN REGULARIZIN, P1832; Zheng Q, 2015, J MAGN RESON IMAGING, V41, P1242, DOI 10.1002/jmri.24662	37	3	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120018	10.1371/journal.pone.0120018	http://dx.doi.org/10.1371/journal.pone.0120018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811976	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700034
J	Brousseau, L; Foll, M; Scotti-Saintagne, C; Scotti, I				Brousseau, Louise; Foll, Matthieu; Scotti-Saintagne, Caroline; Scotti, Ivan			Neutral and Adaptive Drivers of Microgeographic Genetic Divergence within Continuous Populations: The Case of the Neotropical Tree Eperua falcata (Aubl.)	PLOS ONE			English	Article							BEECH FAGUS-SYLVATICA; POLLEN DISPERSAL; NATURAL-SELECTION; LOCAL ADAPTATION; GENOME SCANS; SPATIAL SCALE; MOLECULAR MARKERS; CANDIDATE GENES; ESTIMATING SEED; TROPICAL TREES	Background In wild plant populations, genetic divergence within continuous stands is common, sometimes at very short geographical scales. While restrictions to gene flow combined with local inbreeding and genetic drift may cause neutral differentiation among subpopulations, micro-geographical variations in environmental conditions can drive adaptive divergence through natural selection at some targeted loci. Such phenomena have recurrently been observed in plant populations occurring across sharp environmental boundaries, but the interplay between selective processes and neutral genetic divergence has seldom been studied. Methods We assessed the extent of within-stand neutral and environmentally-driven divergence in the Neotropical tree Eperua falcate Aubl. (Fabaceae) through a genome-scan approach. Populations of this species grow in dense stands that cross the boundaries between starkly contrasting habitats. Within-stand phenotypic and candidate-gene divergence have already been proven, making this species a suitable model for the study of genome-wide micro-geographic divergence. Thirty trees from each of two habitats (seasonally flooded swamps and well-drained plateaus) in two separate populations were genotyped using thousands of AFLPs markers. To avoid genotyping errors and increase marker reliability, each sample was genotyped twice and submitted to a rigorous procedure for data cleaning, which resulted in 1196 reliable and reproducible markers. Results Despite the short spatial distances, we detected within-populations genetic divergence, probably caused by neutral processes, such as restrictions in gene flow. Moreover, habitat-structured subpopulations belonging to otherwise continuous stands also diverge in relation to environmental variability and habitat patchiness: we detected convincing evidence of divergent selection at the genome-wide level and for a fraction of the analyzed loci (comprised between 0.25% and 1.6%). Simulations showed that the levels of differentiation for these outliers are compatible with scenarios of strong divergent selection.	[Brousseau, Louise; Scotti-Saintagne, Caroline; Scotti, Ivan] INRA, EcoFoG Ecol Guyane UMR745, F-97379 Kourou, France; [Brousseau, Louise] Univ Lorraine, INRA, EEF Ecol & Ecophysiol Forestiere UMR1137, F-54280 Champenoux, France; [Brousseau, Louise; Scotti-Saintagne, Caroline; Scotti, Ivan] INRA, URFM Ecol Forets Mediterraneennes UR629, F-84914 Avignon 9, France; [Foll, Matthieu] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Foll, Matthieu] Swiss Inst Bioinformat, Lausanne, Switzerland	INRAE; INRAE; Universite de Lorraine; INRAE; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Brousseau, L (corresponding author), INRA, EcoFoG Ecol Guyane UMR745, Campus Agron BP316, F-97379 Kourou, France.	louise.brousseau@ecofog.gf	Scotti-Saintagne, Caroline/AAC-1938-2020; Brousseau, Louise/E-5346-2015; Foll, Matthieu/A-8561-2014	Brousseau, Louise/0000-0003-2769-2767; Foll, Matthieu/0000-0001-9006-8436; Scotti-Saintagne, Caroline/0000-0001-6891-7315	ANR-BIOADAPT FLAG program [ANR-12-ADAP-0007-01]; 'Investissement d'Avenir' grant (CEBA) [ANR-10-LABX-0025]; Ivan Scotti and Caroline Scotti-Saintagne	ANR-BIOADAPT FLAG program(French National Research Agency (ANR)); 'Investissement d'Avenir' grant (CEBA)(French National Research Agency (ANR)); Ivan Scotti and Caroline Scotti-Saintagne	This study was funded by the ANR-BIOADAPT FLAG program (ANR-12-ADAP-0007-01) and by an 'Investissement d'Avenir' grant (CEBA, ANR-10-LABX-0025), both managed by The French National Research Agency (ANR, France, www.agence-nationale-recherche.fr) and granted to Ivan Scotti and Caroline Scotti-Saintagne. Louise Brousseau's Ph.D. thesis and Post-doc were funded by a 'Young Scientist Contract' ('CJS') of the French National Institute for Agronomical Research (INRA, France, www.inra.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto FJ, 2013, GENETICS, V195, P495, DOI 10.1534/genetics.113.153783; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; Antao T, 2011, MCHEZA A WORKBENCH T; Arrigo N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-33; Audigeos D, 2013, J EVOLUTION BIOL, V26, P529, DOI 10.1111/jeb.12069; Bacles CFE, 2011, TRENDS PLANT SCI, V16, P13, DOI 10.1016/j.tplants.2010.10.002; Baraloto C, 2007, ECOLOGY, V88, P478, DOI 10.1890/0012-9658(2007)88[478:SWSTAH]2.0.CO;2; Barrett BA, 1998, CROP SCI, V38, P1271, DOI 10.2135/cropsci1998.0011183X003800050026x; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bierne N, 2013, MOL ECOL, V22, P2061, DOI 10.1111/mec.12241; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Born C, 2008, MOL ECOL, V17, P2041, DOI 10.1111/j.1365-294X.2007.03685.x; BRADSHAW A. D., 1960, NEW PHYTOL, V59, P92, DOI 10.1111/j.1469-8137.1960.tb06206.x; Brousseau L, 2013, ANN BOT-LONDON, V112, P1169, DOI 10.1093/aob/mct176; Burgarella C, 2012, MOL ECOL, V21, P3006, DOI 10.1111/j.1365-294X.2012.05532.x; Campbell D, 2004, MOL BIOL EVOL, V21, P945, DOI 10.1093/molbev/msh101; Campbell D, 2003, MOL ECOL, V12, P1979, DOI 10.1046/j.1365-294X.2003.01856.x; Cavers S, 2005, HEREDITY, V95, P281, DOI 10.1038/sj.hdy.6800709; Chen DH, 1999, PLANT MOL BIOL REP, V17, P53, DOI 10.1023/A:1007585532036; Chybicki IJ, 2011, HEREDITY, V107, P589, DOI 10.1038/hdy.2011.51; Cloutier D, 2006, MOL ECOL, V16, P1; Collevatti RG, 2010, NAT CONSERVACAO, V8, P54, DOI 10.4322/natcon.00801008; Colpaert N, 2005, SILVAE GENET, V54, P265, DOI 10.1515/sg-2005-0038; Cowan RS, 1975, MONOGRAPH GENUS EPER; Crawford LA, 2012, MOL ECOL, V21, P5911, DOI 10.1111/mec.12069; Csillery K, 2014, MOL ECOL, V23, P4696, DOI 10.1111/mec.12902; Dasmahapatra KK, 2008, HEREDITY, V100, P286, DOI 10.1038/sj.hdy.6801075; Degen B, 2004, HEREDITY, V93, P585, DOI 10.1038/sj.hdy.6800560; Degen B, 2004, BIOTROPICA, V36, P165; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Dick CW, 2003, MOL ECOL, V12, P753, DOI 10.1046/j.1365-294X.2003.01760.x; Doligez A, 1997, HEREDITY, V79, P72, DOI 10.1038/hdy.1997.124; Doyle J. J., 1987, PHYTOCHEM B, P11; Dutech C, 2002, MOL ECOL, V11, P725, DOI 10.1046/j.1365-294X.2002.01475.x; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fortunel C, 2012, FUNCT ECOL, V26, P1153, DOI 10.1111/j.1365-2435.2012.02020.x; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Gagnaire PA, 2009, MOL ECOL, V18, P1678, DOI 10.1111/j.1365-294X.2009.04142.x; Galindo J, 2009, MOL ECOL, V18, P919, DOI 10.1111/j.1365-294X.2008.04076.x; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Hampe A, 2010, MOL ECOL, V19, P459, DOI 10.1111/j.1365-294X.2009.04492.x; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; HAMRICK JL, 1972, P NATL ACAD SCI USA, V69, P2100, DOI 10.1073/pnas.69.8.2100; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2003, MOL ECOL, V12, P1577, DOI 10.1046/j.1365-294X.2003.01835.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hardy OJ, 1999, HEREDITY, V83, P145, DOI 10.1046/j.1365-2540.1999.00558.x; Hermisson J, 2009, HEREDITY, V103, P283, DOI 10.1038/hdy.2009.101; Heuertz M, 2003, MOL ECOL, V12, P2483, DOI 10.1046/j.1365-294X.2003.01923.x; JAIN SK, 1966, HEREDITY, V21, P407, DOI 10.1038/hdy.1966.42; Jump AS, 2012, HEREDITY, V108, P633, DOI 10.1038/hdy.2012.1; Jump AS, 2007, MOL ECOL, V16, P925, DOI 10.1111/j.1365-294X.2006.03203.x; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; KAHN F, 1987, EXPERIENTIA, V43, P251, DOI 10.1007/BF01945548; Konuma A, 2000, MOL ECOL, V9, P1843, DOI 10.1046/j.1365-294x.2000.01081.x; Kopelman NM, CLUMPAK PROGRA UNPUB; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Latouche-Halle C, 2004, MOL ECOL, V13, P1055, DOI 10.1111/j.1365-294X.2004.02127.x; Le Corre V, 2012, MOL ECOL, V21, P1548, DOI 10.1111/j.1365-294X.2012.05479.x; Leonardi S, 1996, HEREDITY, V77, P359, DOI 10.1038/hdy.1996.154; Ley AC, 2013, MOL ECOL, V22, P1984, DOI 10.1111/mec.12214; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Lowe AJ, 2003, HEREDITY, V90, P268, DOI 10.1038/sj.hdy.6800247; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Meier K, 2011, HEREDITY, V106, P488, DOI 10.1038/hdy.2010.164; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Montemurro C, 2008, EUR FOOD RES TECHNOL, V226, P1439, DOI 10.1007/s00217-007-0675-z; NEVO E, 1983, THEOR APPL GENET, V64, P123, DOI 10.1007/BF00272719; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Oddou-Muratorio S, 2010, FOREST ECOL MANAG, V259, P2151, DOI 10.1016/j.foreco.2010.03.001; Oetjen K, 2007, MOL ECOL, V16, P5156, DOI 10.1111/j.1365-294X.2007.03577.x; Paris M, 2012, MOL ECOL, V21, P1672, DOI 10.1111/j.1365-294X.2012.05499.x; Pariset L, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-7; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pritchard JK, 2000, GENETICS, V155, P945; Prunier J, 2011, MOL ECOL, V20, P1702, DOI 10.1111/j.1365-294X.2011.05045.x; Richardson JL, 2014, TRENDS ECOL EVOL, V29, P165, DOI 10.1016/j.tree.2014.01.002; Sagnard F, 2011, TREE GENET GENOMES, V7, P37, DOI 10.1007/s11295-010-0313-y; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; SCHMITT J, 1990, EVOLUTION, V44, P2022, DOI 10.1111/j.1558-5646.1990.tb04308.x; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Soto-Cerda BJ, 2013, PLANT MOL BIOL REP, P1; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Storz JF, 2004, EVOLUTION, V58, P1342; Streiff R, 1998, MOL ECOL, V7, P317, DOI 10.1046/j.1365-294X.1998.00360.x; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Veron V, 2005, SILVAE GENET, V54, P275, DOI 10.1515/sg-2005-0040; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Ward M, 2005, HEREDITY, V95, P246, DOI 10.1038/sj.hdy.6800712	109	15	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121394	10.1371/journal.pone.0121394	http://dx.doi.org/10.1371/journal.pone.0121394			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807272	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000151
J	Capone, C; Filosa, C; Gigante, G; Ricci-Tersenghi, F; Del Giudice, P				Capone, Cristiano; Filosa, Carla; Gigante, Guido; Ricci-Tersenghi, Federico; Del Giudice, Paolo			Inferring Synaptic Structure in Presence of Neural Interaction Time Scales	PLOS ONE			English	Article							CORTICAL NETWORKS; NEURONS; POPULATION; STATES	Biological networks display a variety of activity patterns reflecting a web of interactions that is complex both in space and time. Yet inference methods have mainly focused on reconstructing, from the network's activity, the spatial structure, by assuming equilibrium conditions or, more recently, a probabilistic dynamics with a single arbitrary time-step. Here we show that, under this latter assumption, the inference procedure fails to reconstruct the synaptic matrix of a network of integrate-and-fire neurons when the chosen time scale of interaction does not closely match the synaptic delay or when no single time scale for the interaction can be identified; such failure, moreover, exposes a distinctive bias of the inference method that can lead to infer as inhibitory the excitatory synapses with interaction time scales longer than the model's time-step. We therefore introduce a new two-step method, that first infers through cross-correlation profiles the delay-structure of the network and then reconstructs the synaptic matrix, and successfully test it on networks with different topologies and in different activity regimes. Although step one is able to accurately recover the delay-structure of the network, thus getting rid of any a priori guess about the time scales of the interaction, the inference method introduces nonetheless an arbitrary time scale, the time-bin dt used to binarize the spike trains. We therefore analytically and numerically study how the choice of dt affects the inference in our network model, finding that the relationship between the inferred couplings and the real synaptic efficacies, albeit being quadratic in both cases, depends critically on dt for the excitatory synapses only, whilst being basically independent of it for the inhibitory ones.	[Capone, Cristiano; Filosa, Carla; Ricci-Tersenghi, Federico] Univ Roma La Sapienza, Dept Phys, Rome, Italy; [Capone, Cristiano; Gigante, Guido; Del Giudice, Paolo] Italian Inst Hlth, Rome, Italy; [Gigante, Guido] Mperience Srl, Rome, Italy; [Ricci-Tersenghi, Federico] UOS Roma, IPCF CNR, Rome, Italy; [Capone, Cristiano; Ricci-Tersenghi, Federico; Del Giudice, Paolo] Ist Nazl Fis Nucl, Sez Roma 1, Milan, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); Istituto Nazionale di Fisica Nucleare (INFN)	Capone, C (corresponding author), Univ Roma La Sapienza, Dept Phys, Rome, Italy.	cristiano.capone@iss.infn.it	Del Giudice, Paolo/N-4655-2015; Capone, Cristiano/AFS-4717-2022	Del Giudice, Paolo/0000-0002-5633-8241; Gigante, Guido/0000-0003-1899-4579; Capone, Cristiano/0000-0002-9958-2551; Ricci-Tersenghi, Federico/0000-0003-4970-7376	Italian Research Minister through the FIRB Project [RBFR086NN1]; European Research Council (ERC) [247328]; Italian National Institute for Nuclear Research through the Project Discosynp; EU Project Coronet; Mperience srl	Italian Research Minister through the FIRB Project; European Research Council (ERC)(European Research Council (ERC)); Italian National Institute for Nuclear Research through the Project Discosynp; EU Project Coronet; Mperience srl	This research has received financial support from the Italian Research Minister through the FIRB Project No. RBFR086NN1 (http://hubmiur.pubblica.istruzione.it/web/ricerca/home), the European Research Council (ERC) through grant agreement No. 247328, the Italian National Institute for Nuclear Research through the Project Discosynp (http://www.infn.it/index.php?option = com_content&view = article&id=266&Itemid-145&lang = it) and from the EU Project Coronet (http://www.coronet-project.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author GG is affiliated with Mperience srl., but this does not alter the authors adherence to PLOS ONE policies on sharing data and materials. Mperience srl provided support in the form of salaries for authors [GG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bialek W., 2012, BIOPHYSICS SEARCHING; Cocco S, 2009, P NATL ACAD SCI USA, V106, P14058, DOI 10.1073/pnas.0906705106; Cox D. R., 1965, THEORY STOCHASTIC PR; EGGERMONT JJ, 1990, CORRELATIVE BRAIN; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Hertz JA, 2013, PRINCIPLES OF NEURAL CODING, P527; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Marre O, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.138101; Mattia M, 2000, NEURAL COMPUT, V12, P2305, DOI 10.1162/089976600300014953; Pernice V, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/03/P03008; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Renart A, 2004, MATH COMP BIOL SER, P431; Roudi Y, 2015, CURR OPIN NEUROBIOL, V32, P38, DOI 10.1016/j.conb.2014.10.011; Roudi Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048702; Roudi Y, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.022.2009; Roudi Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051915; Roudi Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000380; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719	21	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0118412	10.1371/journal.pone.0118412	http://dx.doi.org/10.1371/journal.pone.0118412			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807389	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000008
J	Feng, J; Auwaerter, PG; Zhang, Y				Feng, Jie; Auwaerter, Paul G.; Zhang, Ying			Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline	PLOS ONE			English	Article							LYME-DISEASE; CYSTIC FORMS; TOLERANCE; CEFTRIAXONE; VANCOMYCIN; MORPHOLOGY; INFECTION	Although most Lyme disease patients can be cured with antibiotics doxycycline or amoxicillin using 2-4 week treatment durations, some patients suffer from persistent arthritis or post-treatment Lyme disease syndrome. Why these phenomena occur is unclear, but possibilities include host responses, antigenic debris, or B. burgdorferi organisms remaining despite antibiotic therapy. In vitro, B. burgdorferi developed increasing antibiotic tolerance as morphology changed from typical spirochetal form in log phase growth to variant round body and microcolony forms in stationary phase. B. burgdorferi appeared to have higher persister frequencies than E. coli as a control as measured by SYBR Green I/propidium iodide (PI) viability stain and microscope counting. To more effectively eradicate the different persister forms tolerant to doxycycline or amoxicillin, drug combinations were studied using previously identified drugs from an FDA-approved drug library with high activity against such persisters. Using a SYBR Green/PI viability assay, daptomycin-containing drug combinations were the most effective. Of studied drugs, daptomycin was the common element in the most active regimens when combined with doxycycline plus either beta-lactams (cefoperazone or carbenicillin) or an energy inhibitor (clofazimine). Daptomycin plus doxycycline and cefoperazone eradicated the most resistant microcolony form of B. burgdorferi persisters and did not yield viable spirochetes upon subculturing, suggesting durable killing that was not achieved by any other two or three drug combinations. These findings may have implications for improved treatment of Lyme disease, if persistent organisms or detritus are responsible for symptoms that do not resolve with conventional therapy. Further studies are needed to validate whether such combination antimicrobial approaches are useful in animal models and human infection.	[Feng, Jie; Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA; [Auwaerter, Paul G.] Johns Hopkins Univ, Sch Med, Fisher Ctr Environm Infect Dis, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Zhang, Y (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	yzhang@jhsph.edu	Feng, Jie/AAZ-1723-2021	Feng, Jie/0000-0001-8358-5654	Lyme Research Alliance (Tick Borne Disease Alliance)	Lyme Research Alliance (Tick Borne Disease Alliance)	Lyme Research Alliance (Tick Borne Disease Alliance) http://www.lymeresearchalliance.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban PS, 2000, MICROBIOL-SGM, V146, P119, DOI 10.1099/00221287-146-1-119; Barthold SW, 2010, ANTIMICROB AGENTS CH, V54, P643, DOI 10.1128/AAC.00788-09; Berndtson K, 2013, INT J GEN MED, V6, P291, DOI 10.2147/IJGM.S44114; Bockenstedt LK, 2012, J CLIN INVEST, V122, P2652, DOI 10.1172/JCI58813; Brorson O, 1998, INFECTION, V26, P144, DOI 10.1007/BF02771839; Brorson O, 2009, P NATL ACAD SCI USA, V106, P18656, DOI 10.1073/pnas.0908236106; Casjens S, 2000, J MOL MICROB BIOTECH, V2, P401; Clinical and Laboratory Standards Institute [CLSI], 2007, M100S17 CLSI, P154; DEVER LL, 1993, ANTIMICROB AGENTS CH, V37, P1115, DOI 10.1128/AAC.37.5.1115; Dhand A, 2011, CLIN INFECT DIS, V53, P158, DOI 10.1093/cid/cir340; Diterich I, 2003, INFECT IMMUN, V71, P3979, DOI 10.1128/IAI.71.7.3979-3987.2003; Embers ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029914; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Feng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111809; Feng J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.53; Hodzic E, 2008, ANTIMICROB AGENTS CH, V52, P1728, DOI 10.1128/AAC.01050-07; Hodzic E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086907; Hunfeld KP, 2006, WIEN KLIN WOCHENSCHR, V118, P659, DOI 10.1007/s00508-006-0693-z; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; KERSTEN A, 1995, ANTIMICROB AGENTS CH, V39, P1127, DOI 10.1128/AAC.39.5.1127; Klempner MS, 2013, AM J MED, V126, P665, DOI 10.1016/j.amjmed.2013.02.014; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Lantos PM, 2014, CLIN INFECT DIS, V58, P663, DOI 10.1093/cid/cit810; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; Marques A, 2014, CLIN INFECT DIS, V58, P937, DOI 10.1093/cid/cit939; Miklossy J, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-40; MORRIS CM, 1995, J ANTIBIOT, V48, P67, DOI 10.7164/antibiotics.48.67; Murgia R, 2004, APMIS, V112, P57, DOI 10.1111/j.1600-0463.2004.apm1120110.x; Pogliano J, 2012, J BACTERIOL, V194, P4494, DOI 10.1128/JB.00011-12; Sapi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048277; Sapi Eva, 2011, Infect Drug Resist, V4, P97, DOI 10.2147/IDR.S19201; Shopov A, 2000, AQUAT MICROB ECOL, V22, P103, DOI 10.3354/ame022103; Snyder AH, 2014, J ANTIMICROB CHEMOTH, V69, P2148, DOI 10.1093/jac/dku113; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; Straubinger RK, 1997, J CLIN MICROBIOL, V35, P111, DOI 10.1128/JCM.35.1.111-116.1997; VANDENBOSSCHE H, 1989, MYCOSES, V32, P35, DOI 10.1111/j.1439-0507.1989.tb02293.x; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Xu J, 2012, INT J TUBERC LUNG D, V16, P1119, DOI 10.5588/ijtld.11.0752; Zhang Y, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.3	39	65	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0117207	10.1371/journal.pone.0117207	http://dx.doi.org/10.1371/journal.pone.0117207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806811	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000004
J	Gelding, RW; Thompson, WF; Johnson, BW				Gelding, Rebecca W.; Thompson, William Forde; Johnson, Blake W.			The Pitch Imagery Arrow Task: Effects of Musical Training, Vividness, and Mental Control	PLOS ONE			English	Article							AUDITORY IMAGERY; WORKING-MEMORY; SHORT-TERM; CORTEX; PERCEPTION; ACTIVATION; SEQUENCES; MUSICIANS; SOUND; TIME	Musical imagery is a relatively unexplored area, partly because of deficiencies in existing experimental paradigms, which are often difficult, unreliable, or do not provide objective measures of performance. Here we describe a novel protocol, the Pitch Imagery Arrow Task (PIAT), which induces and trains pitch imagery in both musicians and non-musicians. Given a tonal context and an initial pitch sequence, arrows are displayed to elicit a scale-step sequence of imagined pitches, and participants indicate whether the final imagined tone matches an audible probe. It is a staircase design that accommodates individual differences in musical experience and imagery ability. This new protocol was used to investigate the roles that musical expertise, self-reported auditory vividness and mental control play in imagery performance. Performance on the task was significantly better for participants who employed a musical imagery strategy compared to participants who used an alternative cognitive strategy and positively correlated with scores on the Control subscale from the Bucknell Auditory Imagery Scale (BAIS). Multiple regression analysis revealed that Imagery performance accuracy was best predicted by a combination of strategy use and scores on the Vividness subscale of BAIS. These results confirm that competent performance on the PIAT requires active musical imagery and is very difficult to achieve using alternative cognitive strategies. Auditory vividness and mental control were more important than musical experience in the ability to perform manipulation of pitch imagery.	[Gelding, Rebecca W.; Johnson, Blake W.] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia; [Gelding, Rebecca W.; Thompson, William Forde; Johnson, Blake W.] Macquarie Univ, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW 2109, Australia; [Thompson, William Forde] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	Macquarie University; Macquarie University; Macquarie University	Gelding, RW (corresponding author), Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia.	rebecca.gelding@students.mq.edu.au	Johnson, Blake/B-3104-2014	Johnson, Blake/0000-0002-0598-4358; Thompson, William/0000-0002-4256-1338; Gelding, Rebecca/0000-0003-4883-8075	HearingCRC; Australian Research Council Centre of Excellence in Cognition and its Disorders [CE110001021]	HearingCRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Research Council Centre of Excellence in Cognition and its Disorders(Australian Research Council)	This work was supported by HearingCRC, and the Australian Research Council Centre of Excellence in Cognition and its Disorders (CE110001021), http://www.ccd.eduau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2000, NEUROPSYCHOLOGIA, V38, P1664, DOI 10.1016/S0028-3932(00)00079-8; Baddeley A.D., 1992, AUDITORY IMAGERY WOR, VInc, P179; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bailes F, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00525; Cebrian AN, 2010, BRAIN RES, V1342, P39, DOI 10.1016/j.brainres.2010.04.026; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Foster NEV, 2013, NEUROIMAGE, V75, P27, DOI 10.1016/j.neuroimage.2013.02.044; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Halpern AR, 1992, AUDITORY IMAGERY; Halpern AR, PSYCHOMUSICOLO UNPUB; Hansen M, 2013, PSYCHOL MUSIC, V41, P779, DOI 10.1177/0305735612452186; Herholz SC, 2012, J COGNITIVE NEUROSCI, V24, P1382, DOI 10.1162/jocn_a_00216; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hubbard T. L., 2013, MULTISENSORY IMAGERY, P51, DOI [DOI 10.1007/978-1-4614-5879-1_4, 10.1007/978-1-4614-5879-14]; Hubbard TL, 2010, PSYCHOL BULL, V136, P302, DOI 10.1037/a0018436; Janata P, 2006, PERCEPT PSYCHOPHYS, V68, P829, DOI 10.3758/BF03193705; Keller PE, 2012, ANN NY ACAD SCI, V1252, P206, DOI 10.1111/j.1749-6632.2011.06439.x; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; Kozhevnikov M, 2005, MEM COGNITION, V33, P710, DOI 10.3758/BF03195337; Kraemer DJM, 2005, NATURE, V434, P158, DOI 10.1038/434158a; Kuchenbuch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030171; Leaver AM, 2009, J NEUROSCI, V29, P2477, DOI 10.1523/JNEUROSCI.4921-08.2009; Neisser U, 1972, FUNCTION NATURE IMAG, P233; Pascual-Leone A, 2003, COGNITIVE NEUROSCIEN, P396, DOI DOI 10.1093/ACPROF:OSO/9780198525202.003.0026; Pfordresher PQ, 2013, PSYCHON B REV, V20, P747, DOI 10.3758/s13423-013-0401-8; Schaefer RS, 2011, INT J PSYCHOPHYSIOL, V82, P254, DOI 10.1016/j.ijpsycho.2011.09.007; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013; Yumoto M, 2005, NEUROREPORT, V16, P1175, DOI 10.1097/00001756-200508010-00008; Zatorre RJ, 2005, NEURON, V47, P9, DOI 10.1016/j.neuron.2005.06.013; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29; Zatorre RJ, 2012, ANN NY ACAD SCI, V1252, P222, DOI 10.1111/j.1749-6632.2011.06437.x; Zatorre RJ, 2010, J COGNITIVE NEUROSCI, V22, P775, DOI 10.1162/jocn.2009.21239	33	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121809	10.1371/journal.pone.0121809	http://dx.doi.org/10.1371/journal.pone.0121809			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25807078	Green Submitted, gold, Green Published			2022-12-26	WOS:000351880000182
J	Gregorius, HR; Gillet, EM				Gregorius, Hans-Rolf; Gillet, Elizabeth M.			Classifying Measures of Biological Variation	PLOS ONE			English	Article							CONSISTENT TERMINOLOGY; SPECIES-DIVERSITY; DIFFERENTIATION; COMMUNITIES; DISSIMILARITIES; COEFFICIENTS; RESOLUTION	Biological variation is commonly measured at two basic levels: variation within individual communities, and the distribution of variation over communities or within a metacommunity. We develop a classification for the measurement of biological variation on both levels: Within communities into the categories of dispersion and diversity, and within metacommunities into the categories of compositional differentiation and partitioning of variation. There are essentially two approaches to characterizing the distribution of trait variation over communities in that individuals with the same trait state or type tend to occur in the same community (describes differentiation tendencies), and individuals with different types tend to occur in different communities (describes apportionment tendencies). Both approaches can be viewed from the dual perspectives of trait variation distributed over communities (CT perspective) and community membership distributed over trait states (TC perspective). This classification covers most of the relevant descriptors (qualified measures) of biological variation, as is demonstrated with the help of major families of descriptors. Moreover, the classification is shown to open ways to develop new descriptors that meet current needs. Yet the classification also reveals the misclassification of some prominent and widely applied descriptors: Dispersion is often misclassified as diversity, particularly in cases where dispersion descriptor allow for the computation of effective numbers; the descriptor G(ST) of population genetics is commonly misclassified as compositional differentiation and confused with partitioning-oriented differentiation, whereas it actually measures partitioning-oriented apportionment; descriptors of beta-diversity are ambiguous about the differentiation effects they are supposed to represent and therefore require conceptual reconsideration.	[Gregorius, Hans-Rolf; Gillet, Elizabeth M.] Univ Gottingen, Busgen Inst Forstgenet & Forstpflanzenzuchtung, D-37073 Gottingen, Germany; [Gregorius, Hans-Rolf] Inst Okolog & Populat Genet, Gottingen, Germany	University of Gottingen	Gregorius, HR (corresponding author), Univ Gottingen, Busgen Inst Forstgenet & Forstpflanzenzuchtung, D-37073 Gottingen, Germany.	hgregor@gwdg.de			Deutsche Forschungsgemeinschaft [Zi 662/5-2]; Gottingen University; Biotechnology and Biological Sciences Research Council [BB/J020567/1] Funding Source: researchfish; BBSRC [BB/J020567/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gottingen University; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Financial support was provided by the Deutsche Forschungsgemeinschaft Zi 662/5-2 (to EMG) and the Open Access Publication Funds of the Gottingen University.	Bock H, 1972, AUTOMATISCHE KLASSIF; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brandon R.N., 1990, ADAPTATION ENV; Cadotte MW, 2010, ECOL LETT, V13, P96, DOI 10.1111/j.1461-0248.2009.01405.x; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; EXCOFFIER L, 1992, GENETICS, V131, P479; GADAGKAR R, 1989, OECOLOGIA, V80, P140, DOI 10.1007/BF00789944; Gregorius HR, 2014, ECOL MODEL, V279, P24, DOI 10.1016/j.ecolmodel.2014.02.002; Gregorius HR, 2012, ECOL MODEL, V224, P1, DOI 10.1016/j.ecolmodel.2011.10.025; Gregorius Hans-Rolf, 2010, Diversity, V2, P370; Gregorius HR, 2009, THEOR BIOSCI, V128, P179, DOI 10.1007/s12064-009-0064-1; GREGORIUS HR, 1984, BIOMETRICAL J, V26, P13, DOI 10.1002/bimj.4710260103; Gregorius HR, 1996, ACTA BIOTHEOR, V44, P23, DOI 10.1007/BF00046433; Gregorius HR, 2003, BIOMETRICAL J, V45, P959, DOI 10.1002/bimj.200390063; Gregorius HR, 2003, PERSPECT PLANT ECOL, V5, P209, DOI 10.1078/1433-8319-00035; GREGORIUS HR, 1991, THEOR POPUL BIOL, V40, P269, DOI 10.1016/0040-5809(91)90056-L; GREGORIUS HR, 1986, THEOR APPL GENET, V71, P826, DOI 10.1007/BF00276425; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HUBALEK Z, 1982, BIOL REV, V57, P669, DOI 10.1111/j.1469-185X.1982.tb00376.x; Hubalek Z, 2000, FOLIA ZOOL, V49, P241; Jost L., 2009, ECOL ECON, V68, P925, DOI DOI 10.1016/J.ECOLECON.2008.10.015; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jurasinski G, 2011, OECOLOGIA, V167, P893, DOI 10.1007/s00442-011-2126-6; Jurasinski G, 2009, OECOLOGIA, V159, P15, DOI 10.1007/s00442-008-1190-z; Kaplan Jonathan Michael, 2013, Biology Theory, V7, P401, DOI 10.1007/s13752-012-0048-0; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; LEVINS RICHARD, 1968; Namkoong G, 1988, MONOGRAPHS ON THEORE, V11; PATIL GP, 1982, J AM STAT ASSOC, V77, P548, DOI 10.2307/2287709; Pavoine S, 2005, THEOR POPUL BIOL, V67, P231, DOI 10.1016/j.tpb.2005.01.004; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Renyi A, 1961, P 4 BERK S MATH STAT, V1; Ricotta C, 2005, ACTA BIOTHEOR, V53, P29, DOI 10.1007/s10441-005-7001-6; Ricotta C, 2009, THEOR POPUL BIOL, V76, P299, DOI 10.1016/j.tpb.2009.10.001; ROUTLEDGE RD, 1979, J THEOR BIOL, V76, P503, DOI 10.1016/0022-5193(79)90015-8; Sarkar S, 1999, BIOL PHILOS, V14, P235, DOI 10.1023/A:1006690502648; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Woltereck R., 1909, VERH DTSCH ZOOL GES, V19, P110, DOI DOI 10.1007/BF01876686; Wright S, 1978, EVOLUTION AND THE GE, VIV	44	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0115312	10.1371/journal.pone.0115312	http://dx.doi.org/10.1371/journal.pone.0115312			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807558	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000002
J	Schurz, M; Kogler, C; Scherndl, T; Kronbichler, M; Kuhberger, A				Schurz, Matthias; Kogler, Christoph; Scherndl, Thomas; Kronbichler, Martin; Kuehberger, Anton			Differentiating Self-Projection from Simulation during Mentalizing: Evidence from fMRI	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; SOCIAL COGNITION; METAANALYSIS; BRAIN; COLOR; JUDGMENTS; REFLECTION; OTHERS; HUMANS; MIND	We asked participants to predict which of two colors a similar other (student) and a dissimilar other (retiree) likes better. We manipulated if color-pairs were two hues from the same color-category (e.g. green) or two conceptually different colors (e.g. green versus blue). In the former case, the mental state that has to be represented (i.e., the percept of two different hues of green) is predominantly non-conceptual or phenomenal in nature, which should promote mental simulation as a strategy for mentalizing. In the latter case, the mental state (i.e. the percept of green versus blue) can be captured in thought by concepts, which facilitates the use of theories for mentalizing. In line with the self-projection hypothesis, we found that cortical midline areas including vmPFC/orbitofrontal cortex and precuneus were preferentially activated for mentalizing about a similar other. However, activation was not affected by the nature of the color-difference, suggesting that self-projection subsumes simulation-like processes but is not limited to them. This indicates that self-projection is a universal strategy applied in different contexts-irrespective of the availability of theories for mentalizing. Along with midline activations linked to self-projection, we also observed activation in right lateral frontal and dorsal parietal areas showing a theory-like pattern. Taken together, this shows that mentalizing does not operate based on simulation or theory, but that both strategies are used concurrently to predict the choices of others.	[Schurz, Matthias; Scherndl, Thomas; Kronbichler, Martin; Kuehberger, Anton] Salzburg Univ, Ctr Cognit Neurosci, A-5020 Salzburg, Austria; [Kogler, Christoph] Univ Vienna, Fac Psychol, Vienna, Austria; [Kronbichler, Martin] Paracelsus Med Univ, Christian Doppler Clin, Neurosci Inst, Salzburg, Austria	Salzburg University; University of Vienna; Paracelsus Private Medical University	Schurz, M (corresponding author), Salzburg Univ, Ctr Cognit Neurosci, A-5020 Salzburg, Austria.	Matthias.Schurz@sbg.ac.at	Kronbichler, Martin/AAY-1519-2021; Kronbichler, Martin/A-5599-2008	Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Scherndl, Thomas/0000-0001-5755-9073; Kuhberger, Anton/0000-0001-5786-5943; Kogler, Christoph/0000-0002-8443-6009; Schurz, Matthias/0000-0002-6344-9943	Austrian Science Fund (FWF) [P20718-G14]; Austrian Science Fund (FWF) [P 20718] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (https://www.fwf.ac.at/; FWF Grant # P20718-G14) to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames DR, 2005, J EXP SOC PSYCHOL, V41, P271, DOI 10.1016/j.jesp.2004.07.003; Bates D., 2014, PREPRINT; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bird CM, 2014, P NATL ACAD SCI USA, V111, P4590, DOI 10.1073/pnas.1315275111; Boghossian P., 1995, COMPANION METAPHYSIC, P94; Bzdok D, 2012, BRAIN STRUCT FUNCT, V217, P783, DOI 10.1007/s00429-012-0380-y; Cheadle SW, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00535; CHURCHLAND PM, 1981, J PHILOS, V78, P67, DOI 10.2307/2025900; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Davidoff J, 2001, TRENDS COGN SCI, V5, P382, DOI 10.1016/S1364-6613(00)01726-5; Dunning D, 1996, J PERS SOC PSYCHOL, V71, P213, DOI 10.1037//0022-3514.71.2.213; Fodor J., 1987, PSYCHOSEMANTICS PROB; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gordon R., 1986, MIND LAN GUAGE, V1, P158, DOI [10.1111/j.1468-0017.1986.tb00324.x, DOI 10.1111/J.1468-0017.1986.TB00324.X]; Heal J., 1996, THEORIES THEORIES MI, P75, DOI [10.1017/CBO9780511597985.006, DOI 10.1017/CBO9780511597985.006]; HEIDER ER, 1972, COGNITIVE PSYCHOL, V3, P337, DOI 10.1016/0010-0285(72)90011-4; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; KAY P, 1984, AM ANTHROPOL, V86, P65, DOI 10.1525/aa.1984.86.1.02a00050; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2005, TRENDS COGN SCI, V9, P363, DOI 10.1016/j.tics.2005.06.010; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Murray RJ, 2012, NEUROSCI BIOBEHAV R, V36, P1043, DOI 10.1016/j.neubiorev.2011.12.013; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pitt D., 2013, STANFORD ENCY PHILOS; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Schurz M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00712; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Tamir DI, 2010, P NATL ACAD SCI USA, V107, P10827, DOI 10.1073/pnas.1003242107; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; Zeki S, 2013, NEUROIMAGE, V73, P156, DOI 10.1016/j.neuroimage.2013.02.001	37	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121405	10.1371/journal.pone.0121405	http://dx.doi.org/10.1371/journal.pone.0121405			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807390	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000152
J	Fu, W; Shi, DY; Westaway, D; Jhamandas, JH				Fu, Wen; Shi, Diya; Westaway, David; Jhamandas, Jack H.			Bioenergetic Mechanisms in Astrocytes May Contribute to Amyloid Plaque Deposition and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; METABOLISM; NEURONS; BRAIN; PROTEIN; GLYCOLYSIS; EXPRESSION; CANCER; ENERGY	Alzheimer disease (AD) is characterized neuropathologically by synaptic disruption, neuronal loss, and deposition of amyloid beta (A beta) protein in brain structures that are critical for memory and cognition. There is increasing appreciation, however, that astrocytes, which are the major non-neuronal glial cells, may play an important role in AD pathogenesis. Unlike neurons, astrocytes are resistant to A beta cytotoxicity, which may, in part, be related to their greater reliance on glycolytic metabolism. Here we show that, in cultures of human fetal astrocytes, pharmacological inhibition or molecular down-regulation of a main enzymatic regulator of glycolysis, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB3), results in increased accumulation of A beta within and around astrocytes and greater vulnerability of these cells to A beta toxicity. We further investigated age-dependent changes in PFKFB3 and astrocytes in AD transgenic mice (TgCRND8) that overexpress human A beta. Using a combination of Western blotting and immunohistochemistry, weidentified an increase in glial fibrillary acidic protein expression in astrocytes that paralleled the escalation of the A beta plaque burden in TgCRND8 mice in an age-dependent manner. Furthermore, PFKFB3 expression also demonstrated an increase in these mice, although at a later age (9 months) than GFAP and A beta. Immunohistochemical staining showed significant reactive astrogliosis surrounding A beta plaques with increased PFKFB3 activity in 12-month-old TgCRND8 mice, an age when AD pathology and behavioral deficits are fully manifested. These studies shed light on the unique bioenergetic mechanisms within astrocytes that may contribute to the development of AD pathology.	[Fu, Wen; Shi, Diya; Westaway, David; Jhamandas, Jack H.] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB T6G 2S2, Canada; [Westaway, David] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Fu, Wen; Shi, Diya; Westaway, David; Jhamandas, Jack H.] Univ Alberta, Inst Neurosci & Mental Hlth, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta	Jhamandas, JH (corresponding author), Univ Alberta, Dept Med Neurol, Heritage Med Res Ctr 530, Edmonton, AB T6G 2S2, Canada.	jack.jhamandas@ualberta.ca			Alberta Bio-Solutions (Alberta Prion Research Institute); Alzheimer's Society of Alberta and Nunavut; University Hospital Foundation (FoMD/UHF medical grants competition)	Alberta Bio-Solutions (Alberta Prion Research Institute); Alzheimer's Society of Alberta and Nunavut; University Hospital Foundation (FoMD/UHF medical grants competition)	This research was supported by grants from Alberta Bio-Solutions (Alberta Prion Research Institute), the Alzheimer's Society of Alberta and Nunavut, and the University Hospital Foundation (FoMD/UHF medical grants competition).	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Demetrius LA, 2013, BIOGERONTOLOGY, V14, P641, DOI 10.1007/s10522-013-9479-7; Demetrius LA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0006; Demetrius LA, 2012, BIOGERONTOLOGY, V13, P583, DOI 10.1007/s10522-012-9403-6; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Fu W, 2013, NEUROSCIENCE, V250, P520, DOI 10.1016/j.neuroscience.2013.07.029; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Jhamandas JH, 2011, AM J PATHOL, V178, P140, DOI 10.1016/j.ajpath.2010.11.022; Kamphuis W, 2014, NEUROBIOL AGING, V35, P492, DOI 10.1016/j.neurobiolaging.2013.09.035; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lynch AM, 2010, AGING DIS, V1, P262; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Sotroniew M. V., 2010, ACTA NEUROPATHOL, V119, P7; Swerdlow RH, 2007, NEUROBIOL AGING, V28, P1465, DOI 10.1016/j.neurobiolaging.2006.06.021; Tomi M, 2013, BRAIN RES, V1495, P61, DOI 10.1016/j.brainres.2012.11.050; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005	41	43	45	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12504	12513		10.1074/jbc.M114.618157	http://dx.doi.org/10.1074/jbc.M114.618157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25814669	Green Published, hybrid			2022-12-26	WOS:000354569000007
J	Leslie, PL; Ke, HM; Zhang, YP				Leslie, Patrick L.; Ke, Hengming; Zhang, Yanping			The MDM2 RING Domain and Central Acidic Domain Play Distinct Roles in MDM2 Protein Homodimerization and MDM2-MDMX Protein Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE ACTIVITY; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; P53 ACTIVITY; DNA-DAMAGE; E3; DEGRADATION; STABILITY; PROMOTES; RESCUE	The oncoprotein murine double minute 2 (MDM2) is an E3 ligase that plays a prominent role in p53 suppression by promoting its polyubiquitination and proteasomal degradation. In its active form, MDM2 forms homodimers as well as heterodimers with the homologous protein murine double minute 4 (MDMX), both of which are thought to occur through their respective C-terminal RING (really interesting new gene) domains. In this study, using multiple MDM2 mutants, we show evidence suggesting that MDM2 homo-and heterodimerization occur through distinct mechanisms because MDM2 RING domain mutations that inhibit MDM2 interaction with MDMX do not affect MDM2 interaction with WT MDM2. Intriguingly, deletion of a portion of the MDM2 central acidic domain selectively inhibits interaction with MDM2 while leaving intact the ability of MDM2 to interact with MDMX and to ubiquitinate p53. Further analysis of an MDM2 C-terminal deletion mutant reveals that the C-terminal residues of MDM2 are required for both MDM2 and MDMX interaction. Collectively, our results suggest a model in which MDM2-MDMX heterodimerization requires the extreme C terminus and proper RING domain structure of MDM2, whereas MDM2 homodimerization requires the extreme C terminus and the central acidic domain of MDM2, suggesting that MDM2 homo- and heterodimers utilize distinct MDM2 domains. Our study is the first to report mutations capable of separating MDM2 homo-and heterodimerization.	[Leslie, Patrick L.; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27514 USA; [Leslie, Patrick L.] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA; [Ke, Hengming] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27514 USA; [Leslie, Patrick L.; Zhang, Yanping] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Xuzhou Med Coll, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Inst Canc, Xuzhou 221002, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Xuzhou Medical University	Zhang, YP (corresponding author), Univ N Carolina, Dept Pharmacol, Dept Radiat Oncol, 450 West Dr, Chapel Hill, NC 27599 USA.	ypzhang@med.unc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [CA127770, CA167637]; American Cancer Society; University of North Carolina Genetics and Molecular Biology Training Grant [5T32 GM007092]; NSFC; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy; NATIONAL CANCER INSTITUTE [R01CA127770, R01CA100302, R01CA155235, R01CA167637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of North Carolina Genetics and Molecular Biology Training Grant; NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by National Institutes of Health Grants CA127770 and CA167637 (to Y. Z.). This work was also supported by a grant from the American Cancer Society (to Y. Z.), a fellowship from the University of North Carolina Genetics and Molecular Biology Training Grant 5T32 GM007092 (to P. L.), and grants from the NSFC and Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy (to Y. Z.).	Argentini M, 2001, ONCOGENE, V20, P1267, DOI 10.1038/sj.onc.1204241; Cheng Q, 2011, MOL CELL BIOL, V31, P4951, DOI 10.1128/MCB.05553-11; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dang JJ, 2002, CANCER RES, V62, P1222; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Dolezelova P, 2012, CELL CYCLE, V11, P953, DOI 10.4161/cc.11.5.19445; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito M, 2011, CLIN CANCER RES, V17, P416, DOI 10.1158/1078-0432.CCR-10-2050; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kulikov R, 2010, P NATL ACAD SCI USA, V107, P10038, DOI 10.1073/pnas.0911716107; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Li X, 2012, ONCOGENE, V31, P3721, DOI 10.1038/onc.2011.534; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; LUNA RMD, 1995, NATURE, V378, P203; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Zhu QZ, 2001, J BIOL CHEM, V276, P29695, DOI 10.1074/jbc.M102634200	36	33	37	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12941	12950		10.1074/jbc.M115.644435	http://dx.doi.org/10.1074/jbc.M115.644435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25809483	hybrid, Green Published			2022-12-26	WOS:000354569000043
J	Barkho, BZ; Monuki, ES				Barkho, Basam Z.; Monuki, Edwin S.			Proliferation of Cultured Mouse Choroid Plexus Epithelial Cells	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; IN-VITRO; BRAIN; DIFFERENTIATION; TRANSTHYRETIN; TRANSPLANTS; EXPRESSION; PHENOTYPE; BARRIER; REPAIR	The choroid plexus (ChP) epithelium is a multifunctional tissue found in the ventricles of the brain. The major function of the ChP epithelium is to produce cerebrospinal fluid (CSF) that bathes and nourishes the central nervous system (CNS). In addition to the CSF, ChP epithelial cells (CPECs) produce and secrete numerous neurotrophic factors that support brain homeostasis, such as adult hippocampal neurogenesis. Accordingly, damage and dysfunction to CPECs are thought to accelerate and intensify multiple disease phenotypes, and CPEC regeneration would represent a potential therapeutic approach for these diseases. However, previous reports suggest that CPECs rarely divide, although this has not been extensively studied in response to extrinsic factors. Utilizing a cell-cycle reporter mouse line and live cell imaging, we identified scratch injury and the growth factors insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF) as extrinsic cues that promote increased CPEC expansion in vitro. Furthermore, we found that IGF-1 and EGF treatment enhances scratch injury-induced proliferation. Finally, we established whole tissue explant cultures and observed that IGF-1 and EGF promote CPEC division within the intact ChP epithelium. We conclude that although CPECs normally have a slow turnover rate, they expand in response to external stimuli such as injury and/or growth factors, which provides a potential avenue for enhancing ChP function after brain injury or neurodegeneration.	[Barkho, Basam Z.; Monuki, Edwin S.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Barkho, Basam Z.; Monuki, Edwin S.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Monuki, Edwin S.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Monuki, ES (corresponding author), Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA.	emonuki@uci.edu			California Institute for Regenerative Medicine (CIRM) Training Grant II from the University of California, Irvine [TG2-012252]; CIRM New Faculty Award [RN2-00915-1]; National Institutes of Health R01 Grant [NS064587]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064587] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) Training Grant II from the University of California, Irvine; CIRM New Faculty Award; National Institutes of Health R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a California Institute for Regenerative Medicine (CIRM) Training Grant II TG2-012252 from the University of California, Irvine (B.Z.B.), CIRM New Faculty Award RN2-00915-1 and National Institutes of Health R01 Grant NS064587 (E.S.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borlongan CV, 2007, CELL TRANSPLANT, V16, P987, DOI 10.3727/000000007783472426; CHAUHAN AN, 1979, NEUROPATH APPL NEURO, V5, P303, DOI 10.1111/j.1365-2990.1979.tb00629.x; DUNCAN MD, 1994, DIGEST DIS SCI, V39, P2197, DOI 10.1007/BF02090371; Emerich DF, 2005, BIOESSAYS, V27, P262, DOI 10.1002/bies.20193; Emerich DF, 2006, NEUROBIOL DIS, V23, P471, DOI 10.1016/j.nbd.2006.04.014; Gabrion JB, 1998, MICROSC RES TECHNIQ, V41, P124, DOI 10.1002/(SICI)1097-0029(19980415)41:2<124::AID-JEMT3>3.0.CO;2-U; Gath U, 1997, EUR J CELL BIOL, V74, P68; Gonzalez AM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-6; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Huang X, 2009, DEVELOPMENT, V136, P2535, DOI 10.1242/dev.033795; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Johansson PA, 2013, DEVELOPMENT, V140, P1055, DOI 10.1242/dev.090860; KAPLAN MS, 1980, ANAT REC, V197, P495, DOI 10.1002/ar.1091970411; Kassem NA, 2006, AM J PHYSIOL-REG I, V291, pR1310, DOI 10.1152/ajpregu.00789.2005; Korzhevskii D E, 2000, Neurosci Behav Physiol, V30, P509, DOI 10.1007/BF02462607; Kwon GS, 2009, GENESIS, V47, P447, DOI 10.1002/dvg.20522; Li Y, 2002, J NEUROL SCI, V193, P137, DOI 10.1016/S0022-510X(01)00657-8; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Matsumoto N, 2010, NEUROSCI LETT, V469, P283, DOI 10.1016/j.neulet.2009.09.060; Menheniott TR, 2010, METHODS MOL BIOL, V633, P207, DOI 10.1007/978-1-59745-019-5_15; Mesquita SD, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00025; Podvin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024609; Qureshi FG, 1997, J SURG RES, V69, P354, DOI 10.1006/jsre.1997.5080; Redzic ZB, 2004, ADV DRUG DELIVER REV, V56, P1695, DOI 10.1016/j.addr.2004.07.005; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sathyanesan M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.64; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; Skinner SJM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065001; Thanos CG, 2010, ADV EXP MED BIOL, V670, P80; Watanabe M, 2012, J NEUROSCI, V32, P15934, DOI 10.1523/JNEUROSCI.3227-12.2012; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Worster DT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001986; Zappaterra MW, 2012, CELL MOL LIFE SCI, V69, P2863, DOI 10.1007/s00018-012-0957-x; Zheng W, 1998, IN VITRO CELL DEV-AN, V34, P40	34	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121738	10.1371/journal.pone.0121738	http://dx.doi.org/10.1371/journal.pone.0121738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815836	gold, Green Published			2022-12-26	WOS:000352133600114
J	Combaz, A; Van Hulle, MM				Combaz, Adrien; Van Hulle, Marc M.			Simultaneous Detection of P300 and Steady-State Visually Evoked Potentials for Hybrid Brain-Computer Interface	PLOS ONE			English	Article							MENTAL PROSTHESIS; RESPONSES	Objective We study the feasibility of a hybrid Brain-Computer Interface (BCI) combining simultaneous visual oddball and Steady-State Visually Evoked Potential (SSVEP) paradigms, where both types of stimuli are superimposed on a computer screen. Potentially, such a combination could result in a system being able to operate faster than a purely P300-based BCI and encode more targets than a purely SSVEP-based BCI. Approach We analyse the interactions between the brain responses of the two paradigms, and assess the possibility to detect simultaneously the brain activity evoked by both paradigms, in a series of 3 experiments where EEG data are analysed offline. Main Results Despite differences in the shape of the P300 response between pure oddball and hybrid condition, we observe that the classification accuracy of this P300 response is not affected by the SSVEP stimulation. We do not observe either any effect of the oddball stimulation on the power of the SSVEP response in the frequency of stimulation. Finally results from the last experiment show the possibility of detecting both types of brain responses simultaneously and suggest not only the feasibility of such hybrid BCI but also a gain over pure oddball-and pure SSVEP-based BCIs in terms of communication rate.	[Combaz, Adrien; Van Hulle, Marc M.] Katholieke Univ Leuven, Lab Neuro & Psychofysiol, Leuven, Belgium	KU Leuven	Combaz, A (corresponding author), Katholieke Univ Leuven, Lab Neuro & Psychofysiol, Leuven, Belgium.	Adrien.Combaz@med.kuleuven.be		Van Hulle, Marc/0000-0003-1060-7044	Agentschap voor Innovatie door Wetenschap en Technologie (IWT, Flemish Agency for Innovation through Science and Technology) [093038]; KU Leuven [PFV/10/008]; Belgian Fund for Scientific Research - Flanders [G088314N, G0A0914N]; Interuniversity Attraction Poles Programme - Belgian Science Policy [IUAP P7/11]; Flemish Regional Ministry of Education (Belgium) [GOA 10/019]; Flemish Agency for Innovation by Science and Technology (TETRA project Spellbinder); SWIFT prize of the King Baudouin Foundation of Belgium	Agentschap voor Innovatie door Wetenschap en Technologie (IWT, Flemish Agency for Innovation through Science and Technology); KU Leuven(KU Leuven); Belgian Fund for Scientific Research - Flanders(FWO); Interuniversity Attraction Poles Programme - Belgian Science Policy(Belgian Federal Science Policy Office); Flemish Regional Ministry of Education (Belgium)(FWO); Flemish Agency for Innovation by Science and Technology (TETRA project Spellbinder); SWIFT prize of the King Baudouin Foundation of Belgium	AC conducted this study while being supported by the Agentschap voor Innovatie door Wetenschap en Technologie (IWT, Flemish Agency for Innovation through Science and Technology, 093038). MMVH is supported by research grants received from the program Financing program (PFV/10/008) of the KU Leuven, the Belgian Fund for Scientific Research - Flanders (G088314N, G0A0914N), the Interuniversity Attraction Poles Programme - Belgian Science Policy (IUAP P7/11), the Flemish Regional Ministry of Education (Belgium) (GOA 10/019), the Flemish Agency for Innovation by Science and Technology (TETRA project Spellbinder), and by the SWIFT prize of the King Baudouin Foundation of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bianchi L, 2010, BRAIN TOPOGR, V23, P180, DOI 10.1007/s10548-010-0143-0; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunner C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025010; Chumerin N., 2011, Proceedings of the 2011 IEEE 6th International Conference on Intelligent Data Acquisition and Advanced Computing Systems: Technology and Applications (IDAACS 2011), P369, DOI 10.1109/IDAACS.2011.6072776; Combaz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073691; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kaufmann T, 2011, 5 INT BRAIN COMP INT, P49; Keerthi SS, 2005, J MACH LEARN RES, V6, P341; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; McFarland DJ, 2003, BIOL PSYCHOL, V63, P237, DOI 10.1016/S0301-0511(03)00073-5; Nijboer F, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00055; Panicker RC, 2011, IEEE T BIO-MED ENG, V58, P1781, DOI 10.1109/TBME.2011.2116018; Parini Sergio, 2009, Comput Intell Neurosci, P864564, DOI 10.1155/2009/864564; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Pinheiro J, 2000, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; REGAN D, 1966, ELECTROEN CLIN NEURO, V20, P238, DOI 10.1016/0013-4694(66)90088-5; Segers H, 2011, IFMBE PROC, V34, P164; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Xu MP, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026001; Yin EW, 2014, IEEE T BIO-MED ENG, V61, P473, DOI 10.1109/TBME.2013.2281976; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012	39	25	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121481	10.1371/journal.pone.0121481	http://dx.doi.org/10.1371/journal.pone.0121481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815815	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600098
J	Egui, A; Thomas, MC; Carrilero, B; Segovia, M; Alonso, C; Maranon, C; Lopez, MC				Egui, Adriana; Carmen Thomas, M.; Carrilero, Bartolome; Segovia, Manuel; Alonso, Carlos; Maranon, Concepcion; Carlos Lopez, Manuel			Differential Phenotypic and Functional Profiles of TcCA-2-Specific Cytotoxic CD8(+) T Cells in the Asymptomatic versus Cardiac Phase in Chagasic Patients	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; CHRONIC VIRAL-INFECTION; HEART-DISEASE; PARASITE PERSISTENCE; RECOMBINANT ANTIGENS; CUTTING EDGE; EPITOPES; MEMORY; PROTEIN; IDENTIFICATION	It has been reported that the immune response mediated by T CD8(+) lymphocytes plays a critical role in the control of Trypanosoma cruzi infection and that the clinical symptoms of Chagas disease appear to be related to the competence of the CD8(+) T immune response against the parasite. Herewith, in silico prediction and binding assays on TAP-deficient T2 cells were used to identify potential HLA-A*02:01 ligands in the T. cruzi TcCA-2 protein. The TcCA-2-specific CD8(+) T cells were functionality evaluated by Granzyme B and cytokine production in peripheral blood mononuclear cells (PBMC) from Chagas disease patients stimulated with the identified HLA-A*02:01 peptides. The specific cells were phenotypically characterized by flow cytometry using several surface markers and HLA-A*02: 01 APC-labeled dextramer loaded with the peptides. In the T. cruzi TcCA-2 protein four T CD8(+) epitopes were identified which are processed and presented during Chagas disease. Interestingly, a differential cellular phenotypic profile could be correlated with the severity of the disease. The TcCA-2-specific T CD8(+) cells from patients with cardiac symptoms are mainly effector memory cells (T-EM and T-EMRA) while, those present in the asymptomatic phase are predominantly naive cells (T-NAIVE). Moreover, in patients with cardiac symptoms the percentage of cells with senescence features is significantly higher than in patients at the asymptomatic phase of the disease. We consider that the identification of these new class I-restricted epitopes are helpful for designing biomarkers of sickness pathology as well as the development of immunotherapies against T. cruzi infection.	[Egui, Adriana; Carmen Thomas, M.; Carlos Lopez, Manuel] PTS Granada, CSIC, IPBLN, Granada 18016, Spain; [Carrilero, Bartolome; Segovia, Manuel] Hosp Virgen Arrixaca, Unidad Reg Med Trop, Murcia 30120, Spain; [Alonso, Carlos] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Maranon, Concepcion] Univ Granada, Andalusian Reg Govt, Ctr Genom & Oncol Res GENYO Pfizer, Genom Med Dept,PTS Granada, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Clinico Universitario Virgen de la Arrixaca; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Pfizer; University of Granada	Lopez, MC (corresponding author), PTS Granada, CSIC, IPBLN, Avda Conocimiento S-N, Granada 18016, Spain.	mclopez@ipb.csic.es	Thomas, María Carmen PhD/D-9065-2016; C, maranon/E-1484-2013; Lopez, Manuel/Z-5641-2019; Egui, Adriana/AAA-5983-2019	C, maranon/0000-0002-7827-6301; Egui, Adriana/0000-0002-3038-0468; Carrilero Fernandez, Bartolome/0000-0002-0110-603X; Thomas, M Carmen/0000-0003-3586-9657; Lopez, Manuel Carlos/0000-0003-0002-3678	Programa Estatal I+D+i (MINECO) [SAF2012-35777, SAF2013-48527-R]; Network of Tropical Diseases Research RICET (MSSSI, Spain) [RD12/0018/0021, RD12/0018/0018]; FEDER; Medicine Department, GENYO [2009SGR385]	Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research RICET (MSSSI, Spain); FEDER(European Commission); Medicine Department, GENYO	This work was supported by grants SAF2012-35777 and SAF2013-48527-R from Programa Estatal I+D+i (MINECO); Network of Tropical Diseases Research RICET, grants RD12/0018/0021 and RD12/0018/0018 (MSSSI, Spain) and FEDER. MS and BC were also supported by grant FIS, 2009SGR385 from ISCIII (MSSSI, Spain). Coauthor Concepcion Maranon is employed by Genomic Medicine Department, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government provided support in the form of salaries for author Concepcion Maranon, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Abel LCJ, 2005, MICROBES INFECT, V7, P1184, DOI 10.1016/j.micinf.2005.03.033; Albareda MC, 2006, INT IMMUNOL, V18, P465, DOI 10.1093/intimm/dxh387; Marcon GEB, 2011, MEM I OSWALDO CRUZ, V106, P85, DOI 10.1590/S0074-02762011000100014; Bixby LM, 2008, J IMMUNOL, V181, P2644, DOI 10.4049/jimmunol.181.4.2644; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; Thomas MC, 2012, CLIN VACCINE IMMUNOL, V19, P167, DOI 10.1128/CVI.05566-11; Carrasco J, 2006, BLOOD, V108, P2897, DOI 10.1182/blood-2005-11-007237; Albareda MC, 2009, J IMMUNOL, V183, P4103, DOI 10.4049/jimmunol.0900852; Chatelain E, 2015, J BIOMOL SCREEN, V20, P22, DOI 10.1177/1087057114550585; Dominguez MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022011; Dumonteil E, 2004, INFECT IMMUN, V72, P46, DOI 10.1128/IAI.72.1.46-53.2004; Egui A, 2012, MOL IMMUNOL, V52, P289, DOI 10.1016/j.molimm.2012.05.021; Fonseca SG, 2005, MICROBES INFECT, V7, P688, DOI 10.1016/j.micinf.2005.01.001; FRASCH ACC, 1991, PARASITOL TODAY, V7, P148, DOI 10.1016/0169-4758(91)90284-U; Garg N, 2002, INFECT IMMUN, V70, P5547, DOI 10.1128/IAI.70.10.5547-5555.2002; Gowthaman U, 2010, AMINO ACIDS, V39, P1333, DOI 10.1007/s00726-010-0579-2; GRUBER A, 1993, EXP PARASITOL, V76, P1, DOI 10.1006/expr.1993.1001; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HOFT DF, 1989, INFECT IMMUN, V57, P1959, DOI 10.1128/IAI.57.7.1959-1967.1989; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Pinazo MJ, 2010, GASTROENT HEPAT-BARC, V33, P191, DOI 10.1016/j.gastrohep.2009.07.009; KRAUSA P, 1995, TISSUE ANTIGENS, V45, P223, DOI 10.1111/j.1399-0039.1995.tb02444.x; Lasso P, 2010, PARASITE IMMUNOL, V32, P494, DOI 10.1111/j.1365-3024.2010.01206.x; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Leavey JK, 2003, J IMMUNOL, V170, P2264, DOI 10.4049/jimmunol.170.5.2264; Lewis MD, 2014, CELL MICROBIOL, V16, P1285, DOI 10.1111/cmi.12297; Maranon C, 2001, MOL IMMUNOL, V38, P279, DOI 10.1016/S0161-5890(01)00059-1; Maranon C, 2011, MICROBES INFECT, V13, P1025, DOI 10.1016/j.micinf.2011.05.010; Marin-Neto JA, 2009, MEM I OSWALDO CRUZ, V104, P319, DOI 10.1590/S0074-02762009000900042; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Miyahira Y, 2008, PARASITOL INT, V57, P38, DOI 10.1016/j.parint.2007.07.005; Molina I, 2014, NEW ENGL J MED, V371, P966, DOI 10.1056/NEJMc1407914; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Punukollu G, 2007, INT J CARDIOL, V115, P279, DOI 10.1016/j.ijcard.2006.03.004; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rosenberg CS, 2010, J IMMUNOL, V185, P560, DOI 10.4049/jimmunol.1000432; Sabbaj S, 2007, J INFECT DIS, V195, P108, DOI 10.1086/509510; Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093; Sepulveda P, 2000, INFECT IMMUN, V68, P4986, DOI 10.1128/IAI.68.9.4986-4991.2000; SETTE A, 1994, J IMMUNOL, V153, P5586; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; Tarleton RL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001861; Teixeira ARL, 2011, CLIN MICROBIOL REV, V24, P592, DOI 10.1128/CMR.00063-10; Till BG, 2012, IMMUNOTHERAPY-UK, V4, P483, DOI [10.2217/IMT.12.33, 10.2217/imt.12.33]; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Umezawa ES, 1999, J CLIN MICROBIOL, V37, P1554, DOI 10.1128/JCM.37.5.1554-1560.1999; van der Aar AMG, 2011, J IMMUNOL, V187, P3488, DOI 10.4049/jimmunol.1101105; Vazquez-Chagoyan JC, 2011, ADV PARASIT, V75, P121, DOI 10.1016/B978-0-12-385863-4.00006-X; Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13; Virgilio FD, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/243786; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wizel B, 1997, J IMMUNOL, V159, P6120; World Health Organization (WHO), 2020, CHAG DIS AM TRYP; ZWEERINK HJ, 1993, J IMMUNOL, V150, P1763	62	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122115	10.1371/journal.pone.0122115	http://dx.doi.org/10.1371/journal.pone.0122115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816096	Green Published, gold			2022-12-26	WOS:000352133600147
J	Harada, A; Suzuki, K; Kamiguchi, N; Miyamoto, M; Tohyama, K; Nakashima, K; Taniguchi, T; Kimura, H				Harada, Akina; Suzuki, Kazunori; Kamiguchi, Naomi; Miyamoto, Maki; Tohyama, Kimio; Nakashima, Kosuke; Taniguchi, Takahiko; Kimura, Haruhide			Characterization of Binding and Inhibitory Properties of TAK-063, a Novel Phosphodiesterase 10A Inhibitor	PLOS ONE			English	Article							VIVO RECEPTOR OCCUPANCY; IMMUNOHISTOCHEMICAL LOCALIZATION; SIGNALING PATHWAYS; PDE10A; DISCOVERY; STRIATUM; SYMPTOMS; MEMORY; DRUGS; RATS	Phosphodiesterase 10A (PDE10A) inhibition is a novel and promising approach for the treatment of central nervous system disorders such as schizophrenia and Huntington's disease. A novel PDE10A inhibitor, TAK-063 [1-[2-fluoro-4-(1H-pyrazol-1-yl) phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)-pyridazin-4(1H)-one] has shown high inhibitory activity and selectivity for human recombinant PDE10A2 in vitro; the half-maximal inhibitory concentration was 0.30 nM, and selectivity over other phosphodiesterases (PDEs) was more than 15000-fold. TAK-063 at 10 mu M did not show more than 50% inhibition or stimulation of 91 enzymes or receptors except for PDEs. In vitro autoradiography (ARG) studies using rat brain sections revealed that [H-3]TAK-063 selectively accumulated in the caudate putamen (CPu), nucleus accumbens (NAc), globus pallidus, substantia nigra, and striatonigral projection, where PDE10A is highly expressed. This [H-3]TAK-063 accumulation was almost entirely blocked by an excess amount of MP-10, a PDE10A selective inhibitor, and the accumulation was not observed in brain slices of Pde10a-knockout mice. In rat brain sections, [H-3]TAK-063 bound to a single high-affinity site with mean +/- SEM dissociation constants of 7.2 +/- 1.2 and 2.6 +/- 0.5 nM for the CPu and NAc shell, respectively. Orally administered [C-14] TAK-063 selectively accumulated in PDE10A expressing brain regions in an in vivo ARG study in rats. Striatal PDE10A occupancy by TAK-063 in vivo was measured using T-773 as a tracer and a dose of 0.88 mg/kg (p.o.) was calculated to produce 50% occupancy in rats. Translational studies with TAK-063 and other PDE10A inhibitors such as those presented here will help us better understand the pharmacological profile of this class of potential central nervous system drugs.	[Harada, Akina; Suzuki, Kazunori; Taniguchi, Takahiko; Kimura, Haruhide] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cent Nervous Syst Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Kamiguchi, Naomi; Miyamoto, Maki; Tohyama, Kimio] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, Fujisawa, Kanagawa, Japan; [Nakashima, Kosuke] Takeda Pharmaceut Co Ltd, Discovery Res Labs, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Kimura, H (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Cent Nervous Syst Drug Discovery Unit, Fujisawa, Kanagawa, Japan.	haruhide.kimura@takeda.com			Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This work was funded by Takeda Pharmaceutical Company Limited who provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akar F, 2014, DRUG TARGET INSIGHT, V8, P23, DOI 10.4137/DTI.S14813; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Chernet E, 2005, LIFE SCI, V78, P340, DOI 10.1016/j.lfs.2005.04.075; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Giampa C, 2009, NEUROBIOL DIS, V34, P450, DOI 10.1016/j.nbd.2009.02.014; Grauer SM, 2009, J PHARMACOL EXP THER, V331, P574, DOI 10.1124/jpet.109.155994; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Harada A, 2015, NUCL MED BIOL, V42, P146, DOI 10.1016/j.nucmedbio.2014.09.005; Karam CS, 2010, TRENDS PHARMACOL SCI, V31, P381, DOI 10.1016/j.tips.2010.05.004; Kehler J, 2011, CURR PHARM DESIGN, V17, P137, DOI 10.2174/138161211795049624; Kleiman RJ, 2011, J PHARMACOL EXP THER, V336, P64, DOI 10.1124/jpet.110.173294; Krebs M, 2006, EXPERT OPIN PHARMACO, V7, P1005, DOI 10.1517/14656566.7.8.1005; Kunitomo J, 2014, J MED CHEM, V57, P9627, DOI 10.1021/jm5013648; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Menniti FS, 2007, CURR OPIN INVESTIG D, V8, P54; Mori F, 2010, J CHEM NEUROANAT, V40, P36, DOI 10.1016/j.jchemneu.2010.03.004; Nirogi R, 2012, J PHARMACOL TOX MET, V65, P115, DOI 10.1016/j.vascn.2012.03.003; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Reneerkens OAH, 2013, BEHAV BRAIN RES, V236, P16, DOI 10.1016/j.bbr.2012.08.019; Rourke C, 2006, PSYCHOPHARMACOLOGY, V184, P107, DOI 10.1007/s00213-005-0230-1; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Thakur T, 2013, EUR J PHARMACOL, V714, P515, DOI 10.1016/j.ejphar.2013.06.035; Verhoest PR, 2009, J MED CHEM, V52, P7946, DOI 10.1021/jm9015334	31	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122197	10.1371/journal.pone.0122197	http://dx.doi.org/10.1371/journal.pone.0122197			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815469	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600152
J	Kasteridis, P; Mason, AR; Goddard, MK; Jacobs, R; Santos, R; McGonigal, G				Kasteridis, Panagiotis; Mason, Anne R.; Goddard, Maria K.; Jacobs, Rowena; Santos, Rita; McGonigal, Gerard			The Influence of Primary Care Quality on Hospital Admissions for People with Dementia in England: A Regression Analysis	PLOS ONE			English	Article							PERFORMANCE; PAY; UK; ASSOCIATION; MANAGEMENT; DISEASE	Objectives To test the impact of a UK pay-for-performance indicator, the Quality and Outcomes Framework (QOF) dementia review, on three types of hospital admission for people with dementia: emergency admissions where dementia was the primary diagnosis; emergency admissions for ambulatory care sensitive conditions (ACSCs); and elective admissions for cataract, hip replacement, hernia, prostate disease, or hearing loss. Methods Count data regression analyses of hospital admissions from 8,304 English general practices from 2006/7 to 2010/11. We identified relevant admissions from national Hospital Episode Statistics and aggregated them to practice level. We merged these with practice-level data on the QOF dementia review. In the base case, the exposure measure was the reported QOF register. As dementia is commonly under-diagnosed, we tested a predicted practice register based on consensus estimates. We adjusted for practice characteristics including measures of deprivation and uptake of a social benefit to purchase care services (Attendance Allowance). Results In the base case analysis, higher QOF achievement had no significant effect on any type of hospital admission. However, when the predicted register was used to account for underdiagnosis, a one-percentage point improvement in QOF achievement was associated with a small reduction in emergency admissions for both dementia (-0.1%; P=0.011) and ACSCs (-0.1%; P=0.001). In areas of greater deprivation, uptake of Attendance Allowance was consistently associated with significantly lower emergency admissions. In all analyses, practices with a higher proportion of nursing home patients had significantly lower admission rates for elective and emergency care. Conclusion In one of three analyses at practice level, the QOF review for dementia was associated with a small but significant reduction in unplanned hospital admissions. Given the rising prevalence of dementia, increasing pressures on acute hospital beds and poor outcomes associated with hospital stays for this patient group, this small change may be clinically and economically relevant.	[Kasteridis, Panagiotis; Mason, Anne R.; Goddard, Maria K.; Jacobs, Rowena; Santos, Rita] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [McGonigal, Gerard] York Teaching Hosp NHS Fdn Trust, Dept Med Elderly, York, N Yorkshire, England	University of York - UK	Kasteridis, P (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	panos.kasteridis@york.ac.uk		Mason, Anne/0000-0002-5823-3064; Santos, Rita/0000-0001-7953-1960; Goddard, Maria Karen/0000-0002-1517-7461; Jacobs, Rowena/0000-0001-5225-6321	Department of Health (England, UK) [103/0001]; National Institute for Health Research [PDA/02/06/038] Funding Source: researchfish	Department of Health (England, UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The work was funded by the Department of Health (England, UK) to the Policy Research Unit in the Economics of Social and Health Care [103/0001]. The funders have approved the manuscript for submission but had no role in the design or conduct of the study. The views expressed are those of the authors and not necessarily those of the funders.	Audit Commission, 2000, FORG ME NOT MENT HLT; Banerjee S, 2003, J NEUROL NEUROSUR PS, V74, P1315, DOI 10.1136/jnnp.74.9.1315; Bardsley M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002007; Bliss RL, 2012, MED CARE, V50, P99, DOI 10.1097/MLR.0b013e31822944d1; Bottle A, 2008, J GEN INTERN MED, V23, P135, DOI 10.1007/s11606-007-0390-2; Bottle A, 2008, J AMBUL CARE MANAG, V31, P226, DOI 10.1097/01.JAC.0000324668.83530.6d; Bynum JPW, 2004, J AM GERIATR SOC, V52, P187, DOI 10.1111/j.1532-5415.2004.52054.x; Calderon-Larranaga A, 2011, THORAX, V66, P191, DOI 10.1136/thx.2010.147058; Cameron A., 1998, ECONOMETRIC SOC MONO; Care Quality Commission, 2013, STAT HLTH CAR AD SOC; Care Services Improvement Partnership, 2005, EV BUS INT MENT HLTH; Department of Health, 2013, DEM STAT NAT REP DEM; Department of Health, 2012, PRIM MIN CHALL DEM D; Department of Health, 2009, LIVING WELL DEMENTIA; Department of Health, 2011, OP FRAM NHS 2012 13; Doran T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2405; Downing A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-166; Dusheiko M, 2009, GISRUK 2009 P GIS RE, P1; Dusheiko M, 2011, HEALTH SERV RES, V46, P27, DOI 10.1111/j.1475-6773.2010.01184.x; Forder J, 2009, HEALTH ECON, V18, P1322, DOI 10.1002/hec.1438; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Gravelle H, 2010, ECON J, V120, pF129, DOI 10.1111/j.1468-0297.2009.02340.x; HAUSMAN J, 1984, ECONOMETRICA, V52, P909, DOI 10.2307/1911191; HSCIC Clinical Indicators Team, 2014, NHS OUTC FRAM 2014 1; Knapp M, 2013, INT J GERIATR PSYCH, V28, P551, DOI 10.1002/gps.3864; Knapp Martin, 2007, DEMENTIA UK; Lakey L., 2009, COUNTING COST CARING; Lin PJ, 2013, ALZHEIMERS DEMENT, V9, P30, DOI 10.1016/j.jalz.2012.11.002; Natalwala A, 2008, DEMENT GERIATR COGN, V26, P499, DOI 10.1159/000171044; National Institute for Health and Care Excellence, 2013, Q30 QUAL STAND SUPP; NHS England Urgent and Emergency Care Review Team, 2014, TRANSF URG EM CAR SE; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; Purdy S, 2011, PUBLIC HEALTH, V125, P46, DOI 10.1016/j.puhe.2010.07.006; Purdy S, 2009, PUBLIC HEALTH, V123, P169, DOI 10.1016/j.puhe.2008.11.001; Purdy S, 2010, AVOIDING HOSPITAL AD; Royal College of Psychiatrists, 2013, REP NAT AUD DEM CAR; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Shohet C, 2007, SEIZURE-EUR J EPILEP, V16, P351, DOI 10.1016/j.seizure.2007.02.005; Soljak M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X613142; Toot S, 2013, J AM MED DIR ASSOC, V14, P463, DOI 10.1016/j.jamda.2013.01.011; Vroomen JM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-10; World Health Organization Alzheimer's Disease International, 2012, ALZH DIS INT DEM PUB, DOI [10.1186/alzrt143, DOI 10.1186/ALZRT143]	42	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121506	10.1371/journal.pone.0121506	http://dx.doi.org/10.1371/journal.pone.0121506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25816231	Green Submitted, Green Published, gold			2022-12-26	WOS:000352133600101
J	Vugrin, ED; Rostron, BL; Verzi, SJ; Brodsky, NS; Brown, TJ; Choiniere, CJ; Coleman, BN; Paredes, A; Apelberg, BJ				Vugrin, Eric D.; Rostron, Brian L.; Verzi, Stephen J.; Brodsky, Nancy S.; Brown, Theresa J.; Choiniere, Conrad J.; Coleman, Blair N.; Paredes, Antonio; Apelberg, Benjamin J.			Modeling the Potential Effects of New Tobacco Products and Policies: A Dynamic Population Model for Multiple Product Use and Harm	PLOS ONE			English	Article							SMOKING-ATTRIBUTABLE MORTALITY; SIMSMOKE SIMULATION-MODEL; UNITED-STATES; REDUCING SMOKING; PUBLIC-POLICIES; PREVALENCE; DEATHS; CESSATION; IMPACT; PREVENTION	Background Recent declines in US cigarette smoking prevalence have coincided with increases in use of other tobacco products. Multiple product tobacco models can help assess the population health impacts associated with use of a wide range of tobacco products. Methods and Findings We present a multi-state, dynamical systems population structure model that can be used to assess the effects of tobacco product use behaviors on population health. The model incorporates transition behaviors, such as initiation, cessation, switching, and dual use, related to the use of multiple products. The model tracks product use prevalence and mortality attributable to tobacco use for the overall population and by sex and age group. The model can also be used to estimate differences in these outcomes between scenarios by varying input parameter values. We demonstrate model capabilities by projecting future cigarette smoking prevalence and smoking-attributable mortality and then simulating the effects of introduction of a hypothetical new lower-risk tobacco product under a variety of assumptions about product use. Sensitivity analyses were conducted to examine the range of population impacts that could occur due to differences in input values for product use and risk. We demonstrate that potential benefits from cigarette smokers switching to the lower-risk product can be offset over time through increased initiation of this product. Model results show that population health benefits are particularly sensitive to product risks and initiation, switching, and dual use behaviors. Conclusion Our model incorporates the variety of tobacco use behaviors and risks that occur with multiple products. As such, it can evaluate the population health impacts associated with the introduction of new tobacco products or policies that may result in product switching or dual use. Further model development will include refinement of data inputs for non-cigarette tobacco products and inclusion of health outcomes such as morbidity and disability.	[Vugrin, Eric D.; Brodsky, Nancy S.] Sandia Natl Labs, Resilience & Regulatory Effects, Albuquerque, NM 87185 USA; [Rostron, Brian L.; Choiniere, Conrad J.; Coleman, Blair N.; Paredes, Antonio; Apelberg, Benjamin J.] US FDA, Ctr Tobacco Prod, Silver Spring, MD USA; [Verzi, Stephen J.] Sandia Natl Labs, Syst Res Anal & Applicat, Albuquerque, NM 87185 USA; [Brown, Theresa J.] Sandia Natl Labs, Policy & Decis Analyt, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories; US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP); United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Vugrin, ED (corresponding author), Sandia Natl Labs, Resilience & Regulatory Effects, POB 5800, Albuquerque, NM 87185 USA.	edvugri@sandia.gov	Choiniere, Conrad/AAG-3364-2020; Verzi, Stephen/AAA-8442-2022; Wojciechowski, Sara/AAO-7293-2021	Verzi, Stephen/0000-0003-2152-851X	U.S. Food and Drug Administration through U.S. Department of Energy/Sandia National Laboratories [224109011]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	U.S. Food and Drug Administration through U.S. Department of Energy/Sandia National Laboratories; U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was funded by the U.S. Food and Drug Administration through a contract with the U.S. Department of Energy/Sandia National Laboratories (funding document 224109011). Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. The funders, other than employees named as authors or described in the acknowledgments, had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This article represents the views of the authors, and should not be construed to represent U.S. Food and Drug Administration's views or policies.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Anderson CM, 2012, RISK ANAL, V32, pS14, DOI 10.1111/j.1539-6924.2011.01703.x; [Anonymous], 2006, NATL VITAL STAT REPO, V54; [Anonymous], 2012, CISNET BIRTH COHORT; [Anonymous], 2004, NATL VITAL STAT REPO, V53; Bachand AM, 2013, REGUL TOXICOL PHARM, V67, P246, DOI 10.1016/j.yrtph.2013.08.003; Boshuizen HC, 2012, DEMOGRAPHY, V49, P1259, DOI 10.1007/s13524-012-0122-z; Carreras G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-183; CDC (Centers for Disease Control and Prevention), 2007, NATL VITAL STAT REPO, V55; Centers for Disease Control and Prevention, 2012, MORBIDITY MORTA 0803; Currie LM, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2011-050248; Evans W K, 1995, Can J Oncol, V5, P408; Ferrante D, 2007, REV PANAM SALUD PUBL, V21, P37, DOI 10.1590/S1020-49892007000100005; Holford T, 2013, AM J PREVENTIVE MED, V46; Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Hoogenveen Rudolf T, 2008, Cost Eff Resour Alloc, V6, P1, DOI 10.1186/1478-7547-6-1; King B, 2012, AM J PUBLIC HLTH, V102; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Kulik MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032363; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Levy DT, 2008, TOB CONTROL, V17, P53, DOI 10.1136/tc.2007.022319; Levy D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001336; Levy D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-709; Levy DT, 2013, EUR J PUBLIC HEALTH, V23, P201, DOI 10.1093/eurpub/cks090; Levy DT, 2013, NICOTINE TOB RES, V15, P465, DOI 10.1093/ntr/nts158; Levy DT, 2012, SCAND J PUBLIC HEALT, V40, P544, DOI 10.1177/1403494812456635; Levy David T, 2002, Health Care Manag Sci, V5, P113, DOI 10.1023/A:1014476916361; Levy DT, 2010, AM J PUBLIC HEALTH, V100, P1267, DOI 10.2105/AJPH.2009.166900; Levy David T., 2008, Central European Journal of Public Health, V16, P189; Levy DT, 2006, SOC SCI MED, V62, P1819, DOI 10.1016/j.socscimed.2005.08.043; Levy DT, 2005, TOB CONTROL, V14, pI45, DOI 10.1136/tc.2003.005660; Levy DT, 2002, TOB CONTROL, V11, P47, DOI 10.1136/tc.11.1.47; Levy DT, 2013, HLTH POLICY PLAN; Mejia AB, 2010, TOB CONTROL, V19, P297, DOI 10.1136/tc.2009.031427; Mendez D, 2004, AM J PUBLIC HEALTH, V94, P251, DOI 10.2105/AJPH.94.2.251; Mendez D, 1998, AM J EPIDEMIOL, V148, P249; Mendez D, 2000, AM J PUBLIC HEALTH, V90, P401, DOI 10.2105/AJPH.90.3.401; Mendez D, 2008, AM J PUBLIC HEALTH, V98, P556, DOI 10.2105/AJPH.2006.107441; Mendez D, 2013, TOB CONTROL, V22, P46, DOI 10.1136/tobaccocontrol-2011-050147; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Nagelhout GE, 2012, ADDICTION, V107, P407, DOI 10.1111/j.1360-0443.2011.03642.x; National Center for Health Statistics, 2009, NATL VITAL STAT REPO, V57; National Center for Health Statistics, 2013, NHIS LINKED MORTALIT; National Vital Statistics Report National Center for Health Statistics., 2008, NATL VITAL STAT REPO, V56; Near AM, 2014, EUR J PUBLIC HEALTH, V24, P451, DOI 10.1093/eurpub/ckt178; Organization WH, 2009, GLOB HLTH RISKS MORT; Preston S., 2011, INT DIFFERENCES MORT, P105; Preston S., 2000, DEMOGRAPHY MEASURING; Rostron B, 2008, NICOTINE TOB RES, V15, P238; Tworek C, 2014, AM J PREV MED, V47, pS15, DOI 10.1016/j.amepre.2014.05.009; U.S. Census Bureau, 2011, STAT ABSTR US 2012; United States Census Bureau U.S. Population Projections, 2008, PROJ POP SINGL YEAR; US Census Bureau, 2008, PROJ DEATHS SEX RAC; US Census Bureau, 2008, 2008 NAT POP PROJ; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; Vijgen SMC, 2008, HEALTH EDUC RES, V23, P310, DOI 10.1093/her/cym024; Warner KE, 2012, AM J PUBLIC HEALTH, V102, P2045, DOI 10.2105/AJPH.2012.300771; Wolfson Michael C., 1994, World Health Statistics Quarterly, V47, P157	59	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121008	10.1371/journal.pone.0121008	http://dx.doi.org/10.1371/journal.pone.0121008			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8ZT	25815840	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600058
J	Cellier, G; Moreau, A; Chabirand, A; Hostachy, B; Ailloud, F; Prior, P				Cellier, Gilles; Moreau, Aurelie; Chabirand, Aude; Hostachy, Bruno; Ailloud, Florent; Prior, Philippe			A Duplex PCR Assay for the Detection of Ralstonia solanacearum Phylotype II Strains in Musa spp.	PLOS ONE			English	Article							BLOOD-DISEASE BACTERIUM; PSEUDOMONAS-SYZYGII; PHYLOGENETIC-RELATIONSHIPS; TOP; PROPOSAL; NOV.	Banana wilt outbreaks that are attributable to Moko disease-causing strains of the pathogen Ralstonia solanacearum (Rs) remain a social and economic burden for both multinational corporations and subsistence farmers. All known Moko strains belong to the phylotype II lineage, which has been previously recognized for its broad genetic basis. Moko strains are paraphyletic and are distributed among seven related but distinct phylogenetic clusters (sequevars) that are potentially major threats to Musaceae, Solanaceae, and ornamental crops in many countries. Although clustered within the Moko IIB-4 sequevar, strains of the epidemiologically variant IIB-4NPB do not cause wilt on Cavendish or plantain bananas; instead, they establish a latent infection in the vascular tissues of plantains and demonstrate an expanded host range and high aggressiveness toward Solanaceae and Cucurbitaceae. Although most molecular diagnostic methods focus on strains that wilt Solanaceae (particularly potato), no relevant protocol has been described that universally detects strains of the Musaceae-infecting Rs phylotype II. Thus, a duplex PCR assay targeting Moko and IIB-4NPB variant strains was developed, and its performance was assessed using an extensive collection of 111 strains representing the known diversity of Rs Moko-related strains and IIB-4NPB variant strains along with certain related strains and families. The proposed diagnostic protocol demonstrated both high accuracy (inclusivity and exclusivity) and high repeatability, detected targets on either pure culture or spiked plant extracts. Although they did not belong to the Moko clusters described at the time of the study, recently discovered banana-infecting strains from Brazil were also detected. According to our comprehensive evaluation, this duplex PCR assay appears suitable for both research and diagnostic laboratories and provides reliable detection of phylotype II Rs strains that infect Musaceae.	[Cellier, Gilles; Moreau, Aurelie; Chabirand, Aude; Hostachy, Bruno; Ailloud, Florent] French Agcy Food Environm & Occupat Hlth & Safety, Plant Hlth Lab LSV, Trop Pests & Dis Unit, F-97410 St Pierre, Reunion, France; [Ailloud, Florent] Ctr Cooperat Int Rech Agron Dev CIRAD, PVBMT, UMR, F-97410 St Pierre, Reunion, France; [Prior, Philippe] INRA, Dept Plant Hlth & Environm SPE, Ctr Cooperat Int Rech Agron Dev CIRAD, UMR,PVBMT, F-97410 St Pierre, Reunion, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; CIRAD; CIRAD; INRAE	Cellier, G (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Plant Hlth Lab LSV, Trop Pests & Dis Unit, F-97410 St Pierre, Reunion, France.	gilles.cellier@anses.fr	Ailloud, Florent/GXG-4465-2022; Cellier, Gilles/B-5891-2015	Ailloud, Florent/0000-0001-9063-0839; Cellier, Gilles/0000-0003-2587-3169	French Agency for Food, Environmental and Occupational Health AMP; Safety (ANSES) - Plant Health Laboratory (LSV) - Tropical Pests and Diseases unit	French Agency for Food, Environmental and Occupational Health AMP; Safety (ANSES) - Plant Health Laboratory (LSV) - Tropical Pests and Diseases unit	This work was funded by the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) - Plant Health Laboratory (LSV) - Tropical Pests and Diseases unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque GM, 2014, PHYTOPATHOLOGY; [Anonymous], 2010, EPPO B, V40, P5, DOI DOI 10.1111/J.1365-2338.2009.02347.X; BUDDENHAGEN IW, 1962, NATURE, V194, P164, DOI 10.1038/194164a0; Cellier G, 2012, APPL ENVIRON MICROB, V78, P2367, DOI 10.1128/AEM.06123-11; Cellier G, 2010, PHYTOPATHOLOGY, V100, P1250, DOI 10.1094/PHYTO-02-10-0059; Communities E, 2006, OFFICIAL J L, VL206, P71; DALE JL, 1987, ADV VIRUS RES, V33, P301, DOI 10.1016/S0065-3527(08)60321-8; Das RN, 2006, MOL DIVERSITY MOKO D; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; EPPO, 2006, EPPO B, V40, P350; Fegan M, 2006, AUSTRALAS PLANT PATH, V35, P93, DOI 10.1071/AP05105; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Fegan M, 1998, BACTERIAL WILT DISEASE, P19; GRIMAULT V, 1994, PLANT PATHOL, V43, P663, DOI 10.1111/j.1365-3059.1994.tb01604.x; ISO (International Organization for Standardization), 2005, 14502128 ISO, P28; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lenarcic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096027; Li X, 2014, J APPL MICROBIOL; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Opina N, 1997, ASIA-PAC J MOL BIOL, V5, P19; Prior P., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P405; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raymundo A. K., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P387; Safni I, 2014, INT J SYST EVOL MICR, V64, P3087, DOI 10.1099/ijs.0.066712-0; SEAL SE, 1993, J GEN MICROBIOL, V139, P1587, DOI 10.1099/00221287-139-7-1587; Sequeira L, 1998, BACTERIAL WILT DISEASE, P6; Swanson JK, 2005, PHYTOPATHOLOGY, V95, P136, DOI 10.1094/PHYTO-95-0136; Taghavi M, 1996, INT J SYST BACTERIOL, V46, P10, DOI 10.1099/00207713-46-1-10; Thwaites R., 2000, P213; Tripathi L, 2009, PLANT DIS, V93, P440, DOI 10.1094/PDIS-93-5-0440; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Vaneechoutte M, 2004, INT J SYST EVOL MICR, V54, P317, DOI 10.1099/ijs.0.02754-0; Villa Joselito E., 2005, Journal of General Plant Pathology, V71, P39, DOI 10.1007/s10327-004-0156-1; Wicker E, 2007, APPL ENVIRON MICROB, V73, P6790, DOI 10.1128/AEM.00841-07	35	10	13	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122182	10.1371/journal.pone.0122182	http://dx.doi.org/10.1371/journal.pone.0122182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811378	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700172
J	Giallo, R; Bahreinian, S; Brown, S; Cooklin, A; Kingston, D; Kozyrskyj, A				Giallo, Rebecca; Bahreinian, Salma; Brown, Stephanie; Cooklin, Amanda; Kingston, Dawn; Kozyrskyj, Anita			Maternal Depressive Symptoms across Early Childhood and Asthma in School Children: Findings from a Longitudinal Australian Population Based Study	PLOS ONE			English	Article							PREVALENCE; TRAJECTORIES; PREGNANCY; DISTRESS; EXPOSURE; CORTISOL; INFANCY; STRESS; BIRTH; RISK	There is a growing body of evidence attesting to links between early life exposure to stress and childhood asthma. However, available evidence is largely based on small, genetically high risk samples. The aim of this study was to explore the associations between the course of maternal depressive symptoms across early childhood and childhood asthma in a nationally representative longitudinal cohort study of Australian children. Participants were 4164 children and their biological mothers from the Longitudinal Study of Australian Children. Latent class analysis identified three trajectories of maternal depressive symptoms across four biennial waves from the first postnatal year to when children were 6-7 years: minimal symptoms (74.6%), sub-clinical symptoms (20.8%), and persistent and increasing high symptoms (4.6%). Logistic regression analyses revealed that childhood asthma at age 6-7 years was associated with persistent and increasing high depressive symptoms after accounting for known risk factors including smoking during pregnancy and maternal history of asthma (adjusted OR 2.36, 95% CI 1.61-3.45), p.001). Our findings from a nationally representative sample of Australian children provide empirical support for a relationship between maternal depressive symptoms across the early childhood period and childhood asthma. The burden of disease from childhood asthma may be reduced by strengthening efforts to promote maternal mental health in the early years of parenting.	[Giallo, Rebecca; Brown, Stephanie] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Bahreinian, Salma; Kingston, Dawn; Kozyrskyj, Anita] Univ Alberta, Edmonton, AB, Canada; [Cooklin, Amanda] La Trobe Univ, Judith Lumley Ctr, Bundoora, Vic 3086, Australia	Murdoch Children's Research Institute; University of Alberta; La Trobe University	Giallo, R (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	rebecca.giallo@mcri.edu.au	Brown, Stephanie/AAE-1662-2019	Giallo, Rebecca/0000-0002-1065-2921; Brown, Stephanie/0000-0001-9812-0067	Victorian Government; ARC [IDFT110101036]	Victorian Government; ARC(Australian Research Council)	This study was supported by the Victorian Governments' Operational Infrastructure Support Program and an ARC Future Fellowship (IDFT110101036) awarded to SJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; [Anonymous], 2005, 1 LSAC; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Asthma G., 2020, GLOB STRAT ASTHM MAN; Australian Bureau of Statistics, 2013, 4727 0 55 001 AUSTR; Australian Centre for Asthma Monitoring, 2011, ASTHM AUSTR 2011; Bahreinian S, 2013, AM J RESP CRIT CARE, V187, P144, DOI 10.1164/rccm.201201-0025OC; Brennan PA, 2008, J CHILD PSYCHOL PSYC, V49, P1099, DOI 10.1111/j.1469-7610.2008.01914.x; Cookson H, 2009, J ALLERGY CLIN IMMUN, V123, P847, DOI 10.1016/j.jaci.2009.01.042; Dreger LC, 2010, J ALLERGY CLIN IMMUN, V125, P116, DOI 10.1016/j.jaci.2009.09.051; Egliston KA, 2007, PSYCHONEUROENDOCRINO, V32, P1, DOI 10.1016/j.psyneuen.2006.10.003; El-Mohandes AAE, 2011, MATERN CHILD HLTH J, V15, P19, DOI [10.1007/s10995-009-0557-z, 10.1007/s10995-011-0843-4, 10.1007/s10995-011-0856-z]; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Giallo R, 2014, ARCH WOMEN MENT HLTH, V17, P115, DOI 10.1007/s00737-014-0411-1; Guxens M, 2014, J ALLERGY CLIN IMMUN, V133, P59, DOI 10.1016/j.jaci.2013.04.044; *IBM CORP, 2012, IBM SPSS STAT VERS 2; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Klinnert MD, 2008, FAM PROCESS, V47, P41, DOI 10.1111/j.1545-5300.2008.00238.x; Klinnert MD, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.4.e69; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Kozyrskyj AL, 2010, AM J PUBLIC HEALTH, V100, P540, DOI 10.2105/AJPH.2008.150771; Lefevre F, 2011, PEDIAT ALLERG IMM-UK, V22, P608, DOI 10.1111/j.1399-3038.2011.01155.x; Muthen B., 2010, MPLUS USERS GUIDE; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; Patel SP, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-57; Subbarao P, 2009, EXPERT REV CLIN IMMU, V5, P77, DOI 10.1586/1744666X.5.1.77; Woolhouse H, 2015, BJOG-INT J OBSTET GY, V122, P312, DOI 10.1111/1471-0528.12837; World Health Organization, 2002, WHO STRAT PREV CONTR; World Health Organization and Calouste Gulbenkian Foundation, 2014, INT RESP MENT DIS OT; Wright RJ, 2002, AM J RESP CRIT CARE, V165, P358, DOI 10.1164/ajrccm.165.3.2102016; Wright RJ, 2010, BIOL PSYCHOL, V84, P46, DOI 10.1016/j.biopsycho.2010.01.007	33	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121459	10.1371/journal.pone.0121459	http://dx.doi.org/10.1371/journal.pone.0121459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811851	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700104
J	Han, DL; Han, G; Zhao, XH; Rao, NG; Messina, JL; Marzban, SS; Sarnaik, AA; Cruse, CW; Sondak, VK; Zager, JS				Han, Dale; Han, Gang; Zhao, Xiuhua; Rao, Nikhil G.; Messina, Jane L.; Marzban, Suroosh S.; Sarnaik, Amod A.; Cruse, C. Wayne; Sondak, Vernon K.; Zager, Jonathan S.			Clinicopathologic Predictors of Survival in Patients with Desmoplastic Melanoma	PLOS ONE			English	Article							LYMPH-NODE BIOPSY; NEUROTROPIC MELANOMA; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; CLINICAL-BEHAVIOR; PURE	Background and Objectives Desmoplastic melanoma is a unique subtype of melanoma which typically affects older patients who often have comorbidities that can adversely affect survival. We sought to identify melanoma-specific factors influencing survival in patients with desmoplastic melanoma. Methods Retrospective review from 1993 to 2011 identified 316 patients with primary desmoplastic melanoma. Clinicopathologic characteristics were correlated with nodal status and outcome. Results Fifty-five patients (17.4%) had nodal disease: 33 had a positive sentinel lymph node biopsy and 22 developed nodal recurrences (no sentinel lymph node biopsy or false-negative sentinel lymph node biopsy). Nodal disease occurred more often in younger patients and in cases with mixed compared with pure histology (26.7% vs. 14.6%); both of these variables significantly predicted nodal status on multivariable analysis (p < 0.05). After a median follow-up of 5.3 years, recurrence developed in 87 patients (27.5%), and 111 deaths occurred. The cause of death was known in 79 cases, with 47 deaths (59.5%) being melanoma-related. On multivariable analysis, Breslow thickness, mitotic rate >=/mm(2) and nodal status significantly predicted melanoma-specific survival (p< 0.05). Conclusions Nodal status predicts melanoma-specific survival in patients with desmoplastic melanoma. However, since patients with desmoplastic melanoma represent an older population, and a considerable proportion of deaths are not melanoma-related (40.5%), comorbidities should be carefully considered in making staging and treatment decisions in this population.	[Han, Dale] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA; [Han, Gang] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA; [Zhao, Xiuhua] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Biostat, Tampa, FL 33682 USA; [Rao, Nikhil G.] Florida Hosp, Dept Radiat Oncol, Orlando, FL USA; [Messina, Jane L.; Marzban, Suroosh S.; Sarnaik, Amod A.; Cruse, C. Wayne; Sondak, Vernon K.; Zager, Jonathan S.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Cutaneous Oncol, Tampa, FL 33682 USA; [Messina, Jane L.] Univ S Florida, Morsani Coll Med, Dept Pathol, Tampa, FL USA; [Messina, Jane L.] Univ S Florida, Morsani Coll Med, Dept Cell Biol & Dermatol, Tampa, FL USA; [Sarnaik, Amod A.; Cruse, C. Wayne; Sondak, Vernon K.; Zager, Jonathan S.] Univ S Florida, Morsani Coll Med, Dept Oncol Sci, Tampa, FL USA; [Sarnaik, Amod A.; Cruse, C. Wayne; Sondak, Vernon K.; Zager, Jonathan S.] Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL USA	Yale University; Yale University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Adventist Health Services; AdventHealth; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Han, DL (corresponding author), Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA.	dale.han@yale.edu	Sarnaik, Amod/W-5536-2019	Han, Gang/0000-0002-5781-5169	NATIONAL CANCER INSTITUTE [K23CA178083, R25CA174664] Funding Source: NIH RePORTER; NCI NIH HHS [R25 CA174664, K23 CA178083] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Busam KJ, 2005, ADV ANAT PATHOL, V12, P92, DOI 10.1097/01.pap.0000155071.86944.a6; Busam KJ, 2004, AM J SURG PATHOL, V28, P1518, DOI 10.1097/01.pas.0000141391.91677.a4; CONLEY J, 1971, CANCER, V28, P914, DOI 10.1002/1097-0142(1971)28:4<914::AID-CNCR2820280415>3.0.CO;2-E; Feng Z, 2011, J CUTAN PATHOL, V38, P616, DOI 10.1111/j.1600-0560.2011.01704.x; George E, 2009, J CUTAN PATHOL, V36, P425, DOI 10.1111/j.1600-0560.2008.01058.x; Gyorki DE, 2003, ANN SURG ONCOL, V10, P403, DOI 10.1245/ASO.2003.04.003; Han D, 2013, ANN SURG ONCOL, V20, P2345, DOI 10.1245/s10434-013-2883-z; Hawkins WG, 2005, ANN SURG ONCOL, V12, P207, DOI 10.1245/ASO.2005.03.022; Jaroszewski DE, 2001, AM J SURG, V182, P590, DOI 10.1016/S0002-9610(01)00819-4; Lens MB, 2005, BRIT J DERMATOL, V152, P673, DOI 10.1111/j.1365-2133.2005.06462.x; Livestro DP, 2005, J CLIN ONCOL, V23, P6739, DOI 10.1200/JCO.2005.04.515; Maurichi A, 2010, ANN SURG, V252, P1052, DOI 10.1097/SLA.0b013e3181efc23c; Mohebati A, 2012, ANN SURG ONCOL, V19, P4307, DOI 10.1245/s10434-012-2468-2; Murali R, 2011, HISTOPATHOLOGY, V58, P886, DOI 10.1111/j.1365-2559.2011.03808.x; Murali R, 2010, CANCER-AM CANCER SOC, V116, P4130, DOI 10.1002/cncr.25148; Pawlik TM, 2006, CANCER-AM CANCER SOC, V106, P900, DOI 10.1002/cncr.21635; Posther KE, 2006, ANN SURG ONCOL, V13, P728, DOI 10.1245/ASO.2006.03.091; Quinn MJ, 1998, CANCER-AM CANCER SOC, V83, P1128, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1128::AID-CNCR11>3.3.CO;2-Y; Sondak VK, 2004, ANN SURG ONCOL, V11, P247, DOI 10.1245/ASO.2004.03.044; Su LD, 2004, CANCER-AM CANCER SOC, V100, P598, DOI 10.1002/cncr.11947; Thelmo MC, 2001, J AM ACAD DERMATOL, V44, P451, DOI 10.1067/mjd.2001.110881; Wasif N, 2011, J SURG ONCOL, V103, P158, DOI 10.1002/jso.21778; White RL, 2011, ANN SURG ONCOL, V18, P3593, DOI 10.1245/s10434-011-1826-9	24	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119716	10.1371/journal.pone.0119716	http://dx.doi.org/10.1371/journal.pone.0119716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811671	Green Published, Green Submitted			2022-12-26	WOS:000356353700022
J	Iotzova-Weiss, G; Dziunycz, PJ; Freiberger, SN; Lauchli, S; Hafner, J; Vogl, T; French, LE; Hofbauer, GFL				Iotzova-Weiss, Guergana; Dziunycz, Piotr J.; Freiberger, Sandra N.; Laeuchli, Severin; Hafner, Juerg; Vogl, Thomas; French, Lars E.; Hofbauer, Guenther F. L.			S100A8/A9 Stimulates Keratinocyte Proliferation in the Development of Squamous Cell Carcinoma of the Skin via the Receptor for Advanced Glycation-End Products	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; KAPPA-B; ACTINIC KERATOSIS; SURFACE RECEPTOR; S100 PROTEINS; RAGE; EXPRESSION; INFLAMMATION; ROLES; DIFFERENTIATION	Squamous cell carcinoma (SCC) is the most common neoplasm in organ transplant recipients (OTR) on long-term immunosuppression and occurs 60-to 100-fold more frequently than in the general population. Here, we present the receptor for advanced glycation end products (RAGE) and S100A8/A9 as important factors driving normal and tumor keratinocyte proliferation. RAGE and S100A8/A9 were transcriptionally upregulated in SCC compared to normal epidermis, as well as in OTR compared to immunocompetent patients (IC) with SCC. The proliferation of normal and SCC keratinocytes was induced by exposure to exogenous S100A8/A9 which in turn was abolished by blocking of RAGE. The migratory activities of normal and SCC keratinocytes were also increased upon exposure to S100A8/A9. We demonstrated that exogenous S100A8/A9 induces phosphorylation of p38 and SAPK/JNK followed by activation of ERK1/2. We hypothesize that RAGE and S100A8/A9 contribute to the development of human SCC by modulating keratinocyte growth and migration. These processes do not seem to be impaired by profound drug-mediated immunosuppression in OTR.	[Iotzova-Weiss, Guergana; Dziunycz, Piotr J.; Freiberger, Sandra N.; Laeuchli, Severin; Hafner, Juerg; French, Lars E.; Hofbauer, Guenther F. L.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Vogl, Thomas] Univ Clin Munster, Inst Immunol, Munster, Germany	University of Zurich; University Zurich Hospital; University of Munster	Iotzova-Weiss, G (corresponding author), Univ Zurich Hosp, Dept Dermatol, Gloriastr 31, CH-8091 Zurich, Switzerland.	geri.weiss@web.de	Freiberger, Sandra/AAT-5527-2020; Hofbauer, Gunther/B-2671-2010; French, Lars/AAL-5977-2020	Hofbauer, Gunther/0000-0003-0542-7989; French, Lars/0000-0002-4629-1486	EMDO Stiftung [SCC001]; Olga-Mayenfisch Stiftung [SCC002]	EMDO Stiftung; Olga-Mayenfisch Stiftung	This work was supported by SCC001 EMDO Stiftung (http://www.researchers.uzh.ch/static/fnf/stiftungen/stiftung.php?id=173), and SCC002 Olga-Mayenfisch Stiftung (http://www.med.uzh.ch/StiftungenundPreise/olgamayenfischstiftung.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AB, 2006, BRIT J DERMATOL, V155, P9, DOI 10.1111/j.1365-2133.2005.07121.x; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; Bando M, 2013, BBA-GENE REGUL MECH, V1829, P954, DOI 10.1016/j.bbagrm.2013.03.010; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bluth MJ, 2009, J INVEST DERMATOL, V129, P2451, DOI 10.1038/jid.2009.96; Brooks YS, 2014, J CLIN INVEST, V124, P2260, DOI 10.1172/JCI72718; Choi DK, 2014, ARCH DERMATOLOGICAL; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Djerbi N, 2013, JAMA DERMATOL, V149, P236, DOI 10.1001/jamadermatol.2013.836; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dziunycz P, 2010, EXPERT REV CLIN IMMU, V6, P359, DOI [10.1586/eci.10.21, 10.1586/ECI.10.21]; Dziunycz PJ, 2014, J INVEST DERMATOL, V134, P1998, DOI 10.1038/jid.2014.77; Eue I, 2001, ATHEROSCLEROSIS, V154, P505, DOI 10.1016/S0021-9150(00)00678-X; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Foell D, 2003, THORAX, V58, P613, DOI 10.1136/thorax.58.7.613; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Fuchs A, 2007, DERMATOL SURG, V33, P1099, DOI 10.1111/j.1524-4725.2007.33224.x; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Ghavami S, 2009, CELL RES; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; Ghavami S, 2008, BBA-MOL CELL RES, V1783, P297, DOI 10.1016/j.bbamcr.2007.10.015; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hofbauer GF, 2010, EXP DERMATOL; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kerkhoff C, 1998, BBA-MOL CELL RES, V1448, P200, DOI 10.1016/S0167-4889(98)00144-X; Kerkhoff C, 1999, FEBS LETT, V460, P134, DOI 10.1016/S0014-5793(99)01322-8; Kerkhoff C, 2012, EXP DERMATOL, V21, P822, DOI 10.1111/j.1600-0625.2012.01571.x; Kosmidis M, 2010, J IMMUNOTHER, V33, P538, DOI 10.1097/CJI.0b013e3181cc2615; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Leibold JS, 2013, J INVEST DERMATOL, V133, P2400, DOI 10.1038/jid.2013.185; McNeill E, 2014, INT J CANC; Mitsui H, 2014, J INVEST DERMATOL, V134, P1418, DOI 10.1038/jid.2013.494; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; Muhleisen B, 2009, HISTOPATHOLOGY, V55, P67, DOI 10.1111/j.1365-2559.2009.03324.x; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; MURAO S, 1990, CELL GROWTH DIFFER, V1, P447; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nukui T, 2008, J CELL BIOCHEM, V104, P453, DOI 10.1002/jcb.21639; Qin F, 2009, PATHOL ONCOL RES; Rammes A, 1997, J BIOL CHEM, V272, P9496; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; RUGTVEIT J, 1995, GUT, V37, P367, DOI 10.1136/gut.37.3.367; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Shen JJ, 2012, CARCINOGENESIS, V33, P2208, DOI 10.1093/carcin/bgs213; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Stern D, 2002, ADV DRUG DELIVER REV, V54, P1615, DOI 10.1016/S0169-409X(02)00160-6; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Xu XC, 2013, EUR J HISTOCHEM, V57, P240, DOI 10.4081/ejh.2013.e36	66	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120971	10.1371/journal.pone.0120971	http://dx.doi.org/10.1371/journal.pone.0120971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811984	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000356353700070
J	Niragire, F; Achia, TNO; Lyambabaje, A; Ntaganira, J				Niragire, Francois; Achia, Thomas N. O.; Lyambabaje, Alexandre; Ntaganira, Joseph			Bayesian Mapping of HIV Infection among Women of Reproductive Age in Rwanda	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; SOCIOECONOMIC-STATUS; PREVALENCE; PEOPLE; HIV/AIDS; DETERMINANTS; HEALTH; STIGMA; TRANSMISSION; POPULATION	HIV prevalence is rising and has been consistently higher among women in Rwanda whereas a decreasing national HIV prevalence rate in the adult population has stabilised since 2005. Factors explaining the increased vulnerability of women to HIV infection are not currently well understood. A statistical mapping at smaller geographic units and the identification of key HIV risk factors are crucial for pragmatic and more efficient interventions. The data used in this study were extracted from the 2010 Rwanda Demographic and Health Survey data for 6952 women. A full Bayesian geo-additive logistic regression model was fitted to data in order to assess the effect of key risk factors and map district-level spatial effects on the risk of HIV infection. The results showed that women who had STIs, concurrent sexual partners in the 12 months prior to the survey, a sex debut at earlier age than 19 years, were living in a woman-headed or high-economic status household were significantly associated with a higher risk of HIV infection. There was a protective effect of high HIV knowledge and perception. Women occupied in agriculture, and those residing in rural areas were also associated with lower risk of being infected. This study provides district-level maps of the variation of HIV infection among women of child-bearing age in Rwanda. The maps highlight areas where women are at a higher risk of infection; the aspect that proximate and distal factors alone could not uncover. There are distinctive geographic patterns, although statistically insignificant, of the risk of HIV infection suggesting potential effectiveness of district specific interventions. The results also suggest that changes in sexual behaviour can yield significant results in controlling HIV infection in Rwanda.	[Niragire, Francois] Univ Rwanda, Dept Appl Stat, Coll Business & Econ, Kigali, Rwanda; [Achia, Thomas N. O.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Lyambabaje, Alexandre] Univ Rwanda, Dept Human Nutr & Dietet, Coll Med & Hlth Sci, Kigali, Rwanda; [Ntaganira, Joseph] Univ Rwanda, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Kigali, Rwanda	University of Rwanda; University of Witwatersrand; University of Rwanda; University of Rwanda	Niragire, F (corresponding author), Univ Rwanda, Dept Appl Stat, Coll Business & Econ, Kigali, Rwanda.	fniragire@ur.ac.rw	Achia, Thomas N. O./I-3674-2013; Niragire, François/GMX-0394-2022	Achia, Thomas N. O./0000-0002-0700-9468; Niragire, François/0000-0003-0473-387X	Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (United Kingdom) [087547/Z/08/Z]; Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York [B 8606]; Ford Foundation [1100-0399]; Google.Org [191994]; Sida [54100029]; MacArthur Foundation [10-95915-000-INP]	Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (United Kingdom)(Wellcome Trust); Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE); Carnegie Corporation of New York; Ford Foundation; Google.Org; Sida; MacArthur Foundation	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Wellcome Trust (United Kingdom) (Grant No: 087547/Z/08/Z), the Department for International Development (DfID) under the Development Partnerships in Higher Education (DelPHE), the Carnegie Corporation of New York (Grant No: B 8606), the Ford Foundation (Grant No: 1100-0399), Google.Org (Grant No: 191994), Sida (Grant No: 54100029) and MacArthur Foundation Grant No: 10-95915-000-INP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achia TNO, 2013, AFR J PRIM HEALTH CA, V5, DOI 10.4102/phcfm.v5i1.547; Adebayo SB, 2011, SAHARA J-J SOC ASP H, V8, P115, DOI 10.1080/17290376.2011.9724994; [Anonymous], 2012, GLOB REP UNAIDS REP; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Belitz C, 2012, VERSION 2 0 1 METHOD; Betsi NA, 2006, AIDS CARE, V18, P356, DOI 10.1080/09540120500200856; Boerma JT, 2005, J INFECT DIS, V191, pS61, DOI 10.1086/425282; Brezger A, 2005, J STAT SOFTW, V14, P1; Burgoyne Amy D, 2008, Afr J Reprod Health, V12, P14; Cassels S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066342; Catherine A., 2002, AIDS, V16, P2245; Chimoyi LA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-555; Cogneau D, 2006, POPUL RES POLICY REV, V25, P393, DOI 10.1007/s11113-006-9008-3; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Fahrmeir L, 2009, J STAT PLAN INFER, V139, P843, DOI 10.1016/j.jspi.2008.05.036; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Goudge J, 2009, SAHARA J-J SOC ASP H, V6, P94, DOI 10.1080/17290376.2009.9724937; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Hennerfeind A, 2008, STAT MODEL, V8, P117, DOI 10.1177/1471082X0800800201; Institut National de la Statistique du Rwanda (INSR) and ORC Macro, 2006, RWAND DEM HLTH SURV; Jesmin SS, 2013, HEALTH CARE WOMEN IN, V34, P303, DOI 10.1080/07399332.2012.736571; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kalichman SC, 2007, SEX TRANSM INFECT, V83, P371, DOI 10.1136/sti.2006.023630; Kammann EE, 2003, J R STAT SOC C-APPL, V52, P1, DOI 10.1111/1467-9876.00385; Kandala NB, 2012, HIV AIDS-RES PALLIAT, V4, P95, DOI 10.2147/HIV.S30537; Kandala NB, 2009, POPUL SPACE PLACE, V15, P461, DOI 10.1002/psp.524; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Kwena ZA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054523; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Lawson A.B, 2013, BAYESIAN DIS MAPPING, Vsecond; Lemme F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066287; Maharaj P, 2004, STUD FAMILY PLANN, V35, P116, DOI 10.1111/j.1728-4465.2004.00013.x; McIntosh WA, 2004, SOCIOL QUART, V45, P303, DOI 10.1525/tsq.2004.45.2.303; Mmbaga EJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-58; Nakiyingi JS, 2003, AIDS, V17, P1827, DOI 10.1097/00002030-200308150-00012; National Institute of Statistics of Rwanda, 2008, RWAND SERV PROV ASS; National Institute of Statistics of Rwanda (NISR) [Rwanda] Ministry of Health (MOH) [ Rwanda] and ICF International, 2010, RWAND DEM HLTH SURV; Ngesa O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103299; NISR, 2012, RWAND STAT YB 2012; NISR MINECOFIN, 2014, RWAND 4 POP HOUS CEN; Orubuloye I. O., 1993, INT FAMILY PLANNING, V19, P71; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Rabbi AFJJoSR., 2012, J SCI RES, V4, P383; Reniers G, 2009, AIDS, V23, P621, DOI 10.1097/QAD.0b013e3283269e13; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Rutstein S. O., 2004, DHS COMP REPORTS; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS/WHO, 2000, EP FACT SHEET HIV AI; United Nations, 2011, MILL DEV GOALS REP 2; Villamor E, 2005, INT J EPIDEMIOL, V34, P61, DOI 10.1093/ije/dyh378; Voeten HACM, 2010, SEX TRANSM DIS, V37, P240, DOI 10.1097/OLQ.0b013e3181c3f2d0; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wand H, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-28; WHO, 2010, PMTCT STRAT VIS 2010, DOI [10.1016/S0140-6736(14)60844-8, DOI 10.1016/S0140-6736(14)60844-8]; Yang H, 2006, AIDS CARE, V18, P717, DOI 10.1080/09540120500303403	60	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119944	10.1371/journal.pone.0119944	http://dx.doi.org/10.1371/journal.pone.0119944			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811462	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700029
J	Numico, G; Cristofano, A; Mozzicafreddo, A; Cursio, OE; Franco, P; Courthod, G; Trogu, A; Malossi, A; Cucchi, M; Sirotova, Z; Alvaro, MR; Stella, A; Grasso, F; Spinazze, S; Silvestris, N				Numico, Gianmauro; Cristofano, Antonella; Mozzicafreddo, Alessandro; Cursio, Olga Elisabetta; Franco, Pierfrancesco; Courthod, Giulia; Trogu, Antonio; Malossi, Alessandra; Cucchi, Mariella; Sirotova, Zuzana; Alvaro, Maria Rosa; Stella, Anna; Grasso, Fulvia; Spinazze, Silvia; Silvestris, Nicola			Hospital Admission of Cancer Patients: Avoidable Practice or Necessary Care?	PLOS ONE			English	Article							HEALTH-CARE; LIFE; END; OUTPATIENTS; QUALITY	Background Cancer patients are frequently admitted to hospital due to acute conditions or refractory symptoms. This occurs through the emergency departments and requires medical oncologists to take an active role. The use of acute-care hospital increases in the last months of life. Patients and methods We aimed to describe the admissions to a medical oncology inpatient service within a 16-month period with respect to patients and tumor characteristics, and the outcome of the hospital stay. Results 672 admissions of 454 patients were analysed. The majority of admissions were urgent (74.1%), and were due to uncontrolled symptoms (79.6%). Among the chief complaints, dyspnoea occurred in 15.7%, pain in 15.2%, and neurological symptoms in 14.5%. The majority of the hospitalizations resulted in discharge to home (60.6%); in 26.5% the patient died and in 11.0% was transferred to a hospice. Admissions due to symptoms correlated with a longer hospital stay and a higher incidence of in-hospital death. Conclusion We suggest that hospital use is not necessarily a sign of inappropriately aggressive care: inpatient care is probably an unavoidable step in the cancer trajectory. Optimization of inpatient supportive procedures should be a specific task of modern medical oncology.	[Numico, Gianmauro; Cristofano, Antonella; Mozzicafreddo, Alessandro; Cursio, Olga Elisabetta; Courthod, Giulia; Trogu, Antonio; Malossi, Alessandra; Cucchi, Mariella; Sirotova, Zuzana; Alvaro, Maria Rosa; Stella, Anna; Grasso, Fulvia; Spinazze, Silvia] Azienda USL Aosta, Med Oncol & Hematol, I-11100 Aosta, Italy; [Franco, Pierfrancesco] Univ Turin, Dept Oncol, Radiat Oncol Unit, I-10126 Turin, Italy; [Silvestris, Nicola] Natl Canc Res Ctr, Ist Tumori Giovanni Paolo II, Med Oncol Unit, I-70124 Bari, Italy	University of Turin; IRCCS Istituto Tumori Bari Giovanni Paolo II	Numico, G (corresponding author), Azienda USL Aosta, Med Oncol & Hematol, Viale Ginevra 3, I-11100 Aosta, Italy.	gnumico@ausl.vda.it	Silvestris, Nicola/K-5889-2012; Numico, Gianmauro/AAE-4489-2020	Silvestris, Nicola/0000-0001-7814-7318; Numico, Gianmauro/0000-0003-3253-2960; Franco, Pierfrancesco/0000-0003-2276-0687				Alonso-Babarro A, 2011, J CLIN ONCOL, V29, P1159, DOI 10.1200/JCO.2010.31.6752; Aprile G, 2013, SUPPORT CARE CANCER, V21, P397, DOI 10.1007/s00520-012-1524-6; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Barbera L, 2010, CAN MED ASSOC J, V182, P563, DOI 10.1503/cmaj.091187; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beccaro M, 2006, J EPIDEMIOL COMMUN H, V60, P412, DOI 10.1136/jech.2005.043646; Brooks GA, 2014, J CLIN ONCOL, V32, P496, DOI 10.1200/JCO.2013.52.4330; Chastek B, 2013, J ONCOL PRACTICE, V8, P75; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; De Korte-Verhoef MC, 2014, SUPPORT CARE CANCER, V22, P645, DOI 10.1007/s00520-013-2019-9; Delgado-Guay MO, 2015, J PAIN SYMPTOM MANAG, V49, P497, DOI 10.1016/j.jpainsymman.2014.07.007; DiMartino LD, 2014, J PALLIAT MED, V17, P1384, DOI 10.1089/jpm.2014.0092; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Espinosa E, 2010, SUPPORT CARE CANCER, V18, P1231, DOI 10.1007/s00520-010-0903-0; Foltran L, 2014, SUPPORT CARE CANCER, V22, P2527, DOI 10.1007/s00520-014-2234-z; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Hjermstad MJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002515; Huang J, 2002, J CLIN ONCOL, V20, P1584, DOI 10.1200/JCO.20.6.1584; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Mansour D, 2011, CLIN ONCOL-UK, V23, P168, DOI 10.1016/j.clon.2010.12.005; Manzano JGM, 2014, J CLIN ONCOL, V32, P3527, DOI 10.1200/JCO.2014.55.3131; Mayer DK, 2011, J CLIN ONCOL, V29, P2683, DOI 10.1200/JCO.2010.34.2816; Numico G, 2011, SUPPORT CARE CANCER, V19, P1823, DOI 10.1007/s00520-010-1024-5; Popescu RA, 2014, ANN ONCOL, V25, P9, DOI 10.1093/annonc/mdt522; Reuben DB, 2014, NEW ENGL J MED, V370, P694, DOI 10.1056/NEJMp1315568; Rocque GB, 2013, J ONCOL PRACT, V9, P51, DOI 10.1200/JOP.2012.000698; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; Wright AA, 2014, J CLIN ONCOL, V32, P3534, DOI 10.1200/JCO.2014.55.5383; Yates M, 2009, CLIN ONCOL-UK, V21, P226, DOI 10.1016/j.clon.2008.12.006	31	78	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120827	10.1371/journal.pone.0120827	http://dx.doi.org/10.1371/journal.pone.0120827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812117	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700062
J	Rombout, A; Stamatopoulos, B; Lagneaux, L; Lust, S; Offner, F; Naessens, E; Vanderstraeten, H; Verhasselt, B; Philippe, J				Rombout, Ans; Stamatopoulos, Basile; Lagneaux, Laurence; Lust, Sofie; Offner, Fritz; Naessens, Evelien; Vanderstraeten, Hanne; Verhasselt, Bruno; Philippe, Jan			Lipoprotein Lipase SNPs rs13702 and rs301 Correlate with Clinical Outcome in Chronic Lymphocytic Leukemia Patients	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; RISK; PHENOTYPE; PROMOTER; VARIANT; GAIN	Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world and is characterized by a heterogeneous clinical course. This variability in clinical course has spiked the search for prognostic markers able to predict patient evolution at the moment of diagnosis. Markers demonstrated to be of value are the mutation status of the immunoglobulin heavy chain variable region genes (IGHV) and lipoprotein lipase (LPL) expression. High LPL mRNA expression has been associated with short treatment free (TFS) and decreased overall survival (OS) in CLL. The LPL SNPs rs301 (T<C), rs328 (C<G) and rs13702 (T<C) have been associated with various metabolic disorders, but the association with CLL evolution is unknown. Here, in a cohort of 248 patients, we show that patients with the LPL SNP rs13702 wild-type T/T genotype had significantly shorter OS than patients with C/C and T/C genotypes (median time until CLL related death: 90 and 156 months respectively, p=0.008). The same was observed for LPL SNP rs301 (median time until CLL related death T/T: 102 and C/C, T/C: 144 months, p=0.03). Both SNPs rs301 and rs13702 were significantly associated with each other and notably, no association was found between IGHV status and presence of the SNP genotypes, indicating that these LPL SNPs are reliable prognostic markers that could add extra prognostic and predictive information to classical markers and help to improve the management of CLL.	[Rombout, Ans; Naessens, Evelien; Vanderstraeten, Hanne; Verhasselt, Bruno; Philippe, Jan] Univ Ghent, Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Stamatopoulos, Basile; Lagneaux, Laurence] Univ Libre Bruxelles, Inst Jules Bordet, Lab Clin Therapy, Brussels, Belgium; [Lust, Sofie; Offner, Fritz] Univ Ghent, Ghent Univ Hosp, Dept Hematol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Institut Jules Bordet; Universite Libre de Bruxelles; Ghent University; Ghent University Hospital	Philippe, J (corresponding author), Univ Ghent, Ghent Univ Hosp, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium.	Jan.Philippe@UGent.be	philippé, jan/AAG-8964-2019	philippé, jan/0000-0003-4857-5746; Verhasselt, Bruno/0000-0002-4645-1144	Research Foundation - Flanders (FWO)	Research Foundation - Flanders (FWO)(FWO)	This work was supported by grants from the Research Foundation - Flanders (FWO) to AR and JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Dicker F, 2005, J NATL CANCER I, V97, P1092, DOI 10.1093/jnci/dji192; Dong HJ, 2012, INT J CANCER, V130, P2054, DOI 10.1002/ijc.26222; Ghia P, 2007, CRIT REV ONCOL HEMAT, V64, P234, DOI 10.1016/j.critrevonc.2007.04.008; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Goldin LR, 2009, HAEMATOL-HEMATOL J, V94, P647, DOI 10.3324/haematol.2008.003632; Heintel D, 2005, LEUKEMIA, V19, P1216, DOI 10.1038/sj.leu.2403748; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Malek S, 2013, ADV EXP MED BIOL, V792, P193, DOI 10.1007/978-1-4614-8051-8_9; Mansouri M, 2010, LEUKEMIA RES, V34, P301, DOI 10.1016/j.leukres.2009.07.032; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Nuckel H, 2007, BLOOD, V109, P290, DOI 10.1182/blood-2006-03-007567; Pede V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060275; Pflug N, 2014, BLOOD, V124, P49, DOI 10.1182/blood-2014-02-556399; Ranganathan G, 2012, ATHEROSCLEROSIS, V221, P143, DOI 10.1016/j.atherosclerosis.2011.12.028; Richardson K, 2013, AM J HUM GENET, V92, P5, DOI 10.1016/j.ajhg.2012.10.020; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Shanafelt TD, 2007, BRIT J HAEMATOL, V139, P255, DOI 10.1111/j.1365-2141.2007.06791.x; Stamatopoulos B, 2009, BLOOD, V113, P5237, DOI 10.1182/blood-2008-11-189407; Van Bockstaele F, 2007, CLIN CHEM, V53, P204, DOI 10.1373/clinchem.2006.076331; van't Veer MB, 2006, HAEMATOLOGICA, V91, P56; Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859	25	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121526	10.1371/journal.pone.0121526	http://dx.doi.org/10.1371/journal.pone.0121526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811490	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700110
J	De Grave, S; Smith, KG; Adeler, NA; Allen, DJ; Alvarez, F; Anker, A; Cai, YX; Carrizo, SF; Klotz, W; Mantelatto, FL; Page, TJ; Shy, JY; Villalobos, JL; Wowor, D				De Grave, Sammy; Smith, Kevin G.; Adeler, Nils A.; Allen, Dave J.; Alvarez, Fernando; Anker, Arthur; Cai, Yixiong; Carrizo, Savrina F.; Klotz, Werner; Mantelatto, Fernando L.; Page, Timothy J.; Shy, Jhy-Yun; Luis Villalobos, Jose; Wowor, Daisy			Dead Shrimp Blues: A Global Assessment of Extinction Risk in Freshwater Shrimps (Crustacea: Decapoda: Caridea)	PLOS ONE			English	Article							CONSERVATION; BIODIVERSITY; DIVERSITY; GENUS; RADIATION; THREATS; TRENDS; LAKES	We present the first global assessment of extinction risk for a major group of freshwater invertebrates, caridean shrimps. The risk of extinction for all 763 species was assessed using the IUCN Red List criteria that include geographic ranges, habitats, ecology and past and present threats. The Indo-Malayan region holds over half of global species diversity, with a peak in Indo-China and southern China. Shrimps primarily inhabit flowing water; however, a significant subterranean component is present, which is more threatened than the surface fauna. Two species are extinct with a further 10 possibly extinct, and almost one third of species are either threatened or Near Threatened (NT). Threats to freshwater shrimps include agricultural and urban pollution impact over two-thirds of threatened and NT species. Invasive species and climate change have the greatest overall impact of all threats (based on combined timing, scope and severity of threats).	[De Grave, Sammy] Univ Oxford, Museum Nat Hist, Oxford, England; [Smith, Kevin G.; Adeler, Nils A.; Allen, Dave J.; Carrizo, Savrina F.] Int Union Conservat Nat, Global Species Programme, Cambridge, England; [Alvarez, Fernando; Luis Villalobos, Jose] Univ Nacl Autonoma Mexico, Inst Biol, Colecc Nacl Crustaceos, Mexico City 04510, DF, Mexico; [Anker, Arthur] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore; [Cai, Yixiong] Natl Pk Board, Singapore, Singapore; [Mantelatto, Fernando L.] Univ Sao Paulo, Dept Biol, Lab Bioecol & Crustacean Systemat, BR-14049 Ribeirao Preto, Brazil; [Page, Timothy J.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Shy, Jhy-Yun] Natl Penghu Univ Sci & Technol, Penghu, Taiwan; [Wowor, Daisy] Indonesian Inst Sci LIPI, Biol Res Ctr, Div Zool, Cibinong, Indonesia	University of Oxford; Universidad Nacional Autonoma de Mexico; National University of Singapore; Universidade de Sao Paulo; Griffith University; National Penghu University of Science & Technology; Indonesian Institute of Sciences	De Grave, S (corresponding author), Univ Oxford, Museum Nat Hist, Oxford, England.	sammy.degrave@oum.ox.ac.uk	Álvarez, Fernando/G-6503-2018; Mantelatto, Fernando/N-9536-2019; Klotz, Werner/L-2803-2019; Mantelatto, Fernando/GQI-1333-2022; Anker, Arthur/AAL-5555-2021; Page, Timothy/B-9000-2008	Álvarez, Fernando/0000-0002-7347-5483; Mantelatto, Fernando/0000-0002-8497-187X; Mantelatto, Fernando/0000-0002-8497-187X; Klotz, Werner/0000-0002-1104-5613; Villalobos Hiriart, Jose Luis/0000-0001-6810-2300; Page, Timothy/0000-0002-3521-3503	'Biodiversity of Freshwater Ecosystems: Trends, Pressures and Conservation Priorities (BioFresh)' FP7 project - European Union	'Biodiversity of Freshwater Ecosystems: Trends, Pressures and Conservation Priorities (BioFresh)' FP7 project - European Union	This work was supported through the 'Biodiversity of Freshwater Ecosystems: Trends, Pressures and Conservation Priorities (BioFresh)' FP7 project funded by the European Union.	[Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Balian EV, 2008, HYDROBIOLOGIA, V595, P627, DOI 10.1007/s10750-007-9246-3; Balian EV, 2008, HYDROBIOLOGIA, V595, P3, DOI [10.1007/s10750-007-9235-6, 10.1007/978-1-4020-8259-7]; Bauer Raymond T., 2011, V15, P145; Cai YX, 2005, RAFFLES B ZOOL, P39; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Clausnitzer V, 2012, FRONT ECOL ENVIRON, V10, P129, DOI 10.1890/110247; Cumberlidge N, 2009, BIOL CONSERV, V142, P1665, DOI 10.1016/j.biocon.2009.02.038; Darwall W. R. T., 2011, DIVERSITY LIFE AFRIC; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; De Grave S, 2008, HYDROBIOLOGIA, V595, P287, DOI 10.1007/s10750-007-9024-2; De Grave S., 2011, Zoologische Mededelingen (Leiden), V85, P195; De Grave S, 2013, IUCN RED LIST THREAT; De Grave S, 2014, ZOOL SCR, V43, P496, DOI 10.1111/zsc.12067; Eberhard Stefan, 2005, Subterranean Biology, V3, P13; Fryer G, 2006, HYDROBIOLOGIA, V568, P131, DOI 10.1007/s10750-006-0322-x; Gleick PH, 1996, WATER INT, V21, P83, DOI 10.1080/02508069608686494; Herder F, 2012, AQUAT INVASIONS, V7, P521, DOI 10.3391/ai.2012.7.4.009; Holthuis L.B., 1980, FAO SPECIES CATALOGU, V125, P1; IUCN, 2014, 2014 IUCN RED LIST T; Jugovic J, 2012, ZOOTAXA, P1; Lehner B, 2013, HYDROL PROCESS, V27, P2171, DOI 10.1002/hyp.9740; Martin JW, 2004, J CRUSTACEAN BIOL, V24, P447, DOI 10.1651/C-2451; Mwangi MAK, 2010, BIRD CONSERV INT, V20, P215, DOI 10.1017/S0959270910000456; New MB, 2012, AQUAC RES, V43, P960, DOI 10.1111/j.1365-2109.2011.03008.x; Page TJ, 2013, BIOTROPICA, V45, P236, DOI 10.1111/j.1744-7429.2012.00900.x; Richman NI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0060; Russi D., 2013, EC ECOSYSTEMS BIODIV; Short J. W., 2003, NATURAL HIST MADAGAS, P603; Sket B, 2009, ZOOL J LINN SOC-LOND, V155, P786, DOI 10.1111/j.1096-3642.2008.00473.x; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; von Rintelen K, 2010, EVOLUTION, V64, P3287, DOI 10.1111/j.1558-5646.2010.01043.x; WWF, 2014, SPEC SPAC PEOPL PLAC; Xie P, 1999, AMBIO, V28, P674	35	54	55	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120198	10.1371/journal.pone.0120198	http://dx.doi.org/10.1371/journal.pone.0120198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807292	Green Submitted, Green Published, gold			2022-12-26	WOS:000351880000071
J	Gavai, AK; Supandi, F; Hettling, H; Murrell, P; Leunissen, JAM; van Beek, JHGM				Gavai, Anand K.; Supandi, Farahaniza; Hettling, Hannes; Murrell, Paul; Leunissen, Jack A. M.; van Beek, Johannes H. G. M.			Using Bioconductor Package BiGGR for Metabolic Flux Estimation Based on Gene Expression Changes in Brain	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ENERGY-METABOLISM; GLUCOSE; BIOLOGY; OXYGEN	Predicting the distribution of metabolic fluxes in biochemical networks is of major interest in systems biology. Several databases provide metabolic reconstructions for different organisms. Software to analyze flux distributions exists, among others for the proprietary MATLAB environment. Given the large user community for the R computing environment, a simple implementation of flux analysis in R appears desirable and will facilitate easy interaction with computational tools to handle gene expression data. We extended the R software package BiGGR, an implementation of metabolic flux analysis in R. BiGGR makes use of public metabolic reconstruction databases, and contains the BiGG database and the reconstruction of human metabolism Recon2 as Systems Biology Markup Language (SBML) objects. Models can be assembled by querying the databases for pathways, genes or reactions of interest. Fluxes can then be estimated by maximization or minimization of an objective function using linear inverse modeling algorithms. Furthermore, BiGGR provides functionality to quantify the uncertainty in flux estimates by sampling the constrained multidimensional flux space. As a result, ensembles of possible flux configurations are constructed that agree with measured data within precision limits. BiGGR also features automatic visualization of selected parts of metabolic networks using hypergraphs, with hyperedge widths proportional to estimated flux values. BiGGR supports import and export of models encoded in SBML and is therefore interoperable with different modeling and analysis tools. As an application example, we calculated the flux distribution in healthy human brain using a model of central carbon metabolism. We introduce a new algorithm termed Least-squares with equalities and inequalities Flux Balance Analysis (Lsei-FBA) to predict flux changes from gene expression changes, for instance during disease. Our estimates of brain metabolic flux pattern with Lsei-FBA for Alzheimer's disease agree with independent measurements of cerebral metabolism in patients. This second version of BiGGR is available from Bioconductor.	[Gavai, Anand K.; Hettling, Hannes; van Beek, Johannes H. G. M.] Vrije Univ Amsterdam, Ctr Integrat Bioinformat, Amsterdam, Netherlands; [Gavai, Anand K.; Hettling, Hannes; van Beek, Johannes H. G. M.] NCSB, Amsterdam, Netherlands; [Supandi, Farahaniza; van Beek, Johannes H. G. M.] Vrije Univ Amsterdam, Med Ctr, Sect Funct Genom, Dept Clin Genet, Amsterdam, Netherlands; [Murrell, Paul] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [Leunissen, Jack A. M.] Wageningen Univ, Lab Bioinformat, NL-6700 AP Wageningen, Netherlands; [Supandi, Farahaniza] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Auckland; Wageningen University & Research; Universiti Malaya	Gavai, AK (corresponding author), Vrije Univ Amsterdam, Ctr Integrat Bioinformat, Amsterdam, Netherlands.	anand.gavai@bioinformatics.nl	/GOP-0313-2022; Supandi, Farahaniza/B-8486-2010	/0000-0002-4738-190X; Supandi, Farahaniza/0000-0001-5671-5986	Netherlands Consortium for Systems Biology - Dutch Government via the Netherlands Genomics Initiative; Netherlands Bioinformatics Centre - Dutch Government via the Netherlands Genomics Initiative	Netherlands Consortium for Systems Biology - Dutch Government via the Netherlands Genomics Initiative; Netherlands Bioinformatics Centre - Dutch Government via the Netherlands Genomics Initiative	This work was supported by the Netherlands Consortium for Systems Biology and the Netherlands Bioinformatics Centre, both funded by the Dutch Government via the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Boele J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-8; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Chelliah Vijayalakshmi, 2013, Methods Mol Biol, V1021, P189, DOI 10.1007/978-1-62703-450-0_10; Cloutier M, 2009, J COMPUT NEUROSCI, V27, P391, DOI 10.1007/s10827-009-0152-8; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Gangadharan A, 2012, ABCDEFBA ABCDE FBA B; Gavai A, 2013, BIGGR CREATES INTERF; Gelius-Dietrich G, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-125; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gevorgyan A, 2011, BIOINFORMATICS, V27, P433, DOI 10.1093/bioinformatics/btq679; Gilks WR, 1996, MARKOV CHAIN MONTE C; Grafahrend-Belau E, 2009, BIOINFORMATICS, V25, P2755, DOI 10.1093/bioinformatics/btp408; Gudmundsson S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-489; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Heino J, 2007, J THEOR BIOL, V248, P91, DOI 10.1016/j.jtbi.2007.04.002; Heino J, 2010, COMPUT METH PROG BIO, V97, P151, DOI 10.1016/j.cmpb.2009.07.007; Hettling H, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-82; HOLLIDAY MA, 1971, PEDIATRICS, V47, P169; HOYER S, 1992, MOL CHEM NEUROPATHOL, V16, P207, DOI 10.1007/BF03159971; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ishii K, 1997, J NUCL MED, V38, P925; Ishii K, 1996, J NUCL MED, V37, P1159; Jensen PA, 2011, BIOINFORMATICS, V27, P541, DOI 10.1093/bioinformatics/btq702; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Klamt S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000385; Lakshmanan M, 2014, BRIEF BIOINFORM, V15, P108, DOI 10.1093/bib/bbs069; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Liguori C, 2015, J NEUROL NEUROSUR PS, V86, P655, DOI 10.1136/jnnp-2014-308577; LYINGTUNELL U, 1980, ACTA NEUROL SCAND, V62, P265; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Murrell P, HYPERDRAW VISUALIZIN; Navid A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-150; Occhipinti R, 2009, J NEUROPHYSIOL, V101, P2528, DOI 10.1152/jn.90377.2008; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; R Development Core Team, 2005, R LANG ENV STAT COMP; Radrich K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-114; Redjems-Bennani N, 1998, GERONTOLOGY, V44, P300, DOI 10.1159/000022031; Rocha I, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-45; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; van Beek JHGM, 2011, PHILOS T R SOC A, V369, P4295, DOI 10.1098/rsta.2011.0166; Van den Meersche K., 2009, J STAT SOFTW, V30, P1, DOI [DOI 10.18637/JSS.V030.C01, 10.1002/wics.10., DOI 10.18637/jss.v030.c01]; van Oevelen D, 2010, ECOSYSTEMS, V13, P32, DOI 10.1007/s10021-009-9297-6; Zur H, 2010, BIOINFORMATICS, V26, P3140, DOI 10.1093/bioinformatics/btq602	58	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119016	10.1371/journal.pone.0119016	http://dx.doi.org/10.1371/journal.pone.0119016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806817	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000012
J	Mathew, SF; Crowe-McAuliffe, C; Graves, R; Cardno, TS; McKinney, C; Poole, ES; Tate, WP				Mathew, Suneeth F.; Crowe-McAuliffe, Caillan; Graves, Ryan; Cardno, Tony S.; McKinney, Cushla; Poole, Elizabeth S.; Tate, Warren P.			The Highly Conserved Codon following the Slippery Sequence Supports-1 Frameshift Efficiency at the HIV-1 Frameshift Site	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROGRAMMED-1 RIBOSOMAL FRAMESHIFT; ROUS-SARCOMA-VIRUS; RENILLA-RENIFORMIS LUCIFERASE; MESSENGER-RNA; STIMULATORY SIGNAL; ESCHERICHIA-COLI; RELEASE FACTOR-2; VIRAL-RNA; TRANSLATION TERMINATION	HIV-1 utilises -1 programmed ribosomal frameshifting to translate structural and enzymatic domains in a defined proportion required for replication. A slippery sequence, U UUU UUA, and a stem-loop are well-defined RNA features modulating -1 frameshifting in HIV-1. The GGG glycine codon immediately following the slippery sequence (the 'intercodon') contributes structurally to the start of the stem-loop but has no defined role in current models of the frameshift mechanism, as slippage is inferred to occur before the intercodon has reached the ribosomal decoding site. This GGG codon is highly conserved in natural isolates of HIV. When the natural intercodon was replaced with a stop codon two different decoding molecules-eRF1 protein or a cognate suppressor tRNA-were able to access and decode the intercodon prior to -1 frameshifting. This implies significant slippage occurs when the intercodon is in the (perhaps distorted) ribosomal A site. We accommodate the influence of the intercodon in a model of frame maintenance versus frameshifting in HIV-1.	[Mathew, Suneeth F.; Crowe-McAuliffe, Caillan; Graves, Ryan; Cardno, Tony S.; McKinney, Cushla; Poole, Elizabeth S.; Tate, Warren P.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	University of Otago	Tate, WP (corresponding author), Univ Otago, Dept Biochem, Dunedin 9054, New Zealand.	warren.tate@otago.ac.nz	McKinney, Cushla/A-7407-2012	McKinney, Cushla/0000-0002-7051-6876; Crowe-McAuliffe, Caillan/0000-0003-2157-4639; Tate, Warren/0000-0002-6971-7734	Health Research Council of New Zealand [HRC 05/195]; University of Otago	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago	This work was supported by a grant from the Health Research Council of New Zealand (http://www.hrc.govt.nz/) to WPT and ESP [grant number HRC 05/195]; and University of Otago Postgraduate Scholarships (http://www.otago.ac.nz/) to SFM and to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani VM, 2013, TRANSLATION, V1, DOI 10.4161/trla.24418; Baranov PV, 2004, RNA, V10, P221, DOI 10.1261/rna.5122604; Baril M, 2003, J MOL BIOL, V331, P571, DOI 10.1016/S0022-2836(03)00784-8; Barry JK, 2002, P NATL ACAD SCI USA, V99, P11133, DOI 10.1073/pnas.162223099; Bekaert M, 2005, MOL CELL, V17, P61, DOI 10.1016/j.molcel.2004.12.009; BELCOURT MF, 1990, CELL, V62, P339, DOI 10.1016/0092-8674(90)90371-K; Belew AT, 2014, NATURE, V512, P265, DOI 10.1038/nature13429; Bertrand C, 2002, RNA, V8, P16, DOI 10.1017/S1355838202012086; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Biswas P, 2004, J VIROL, V78, P2082, DOI 10.1128/JVI.78.4.2082-2087.2004; Brakier-Gingras L, 2012, EXPERT OPIN THER TAR, V16, P249, DOI 10.1517/14728222.2012.665879; BRAULT V, 1992, P NATL ACAD SCI USA, V89, P2262, DOI 10.1073/pnas.89.6.2262; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Brierley I, 2010, NUCLEIC ACIDS MOL BI, V24, P149, DOI 10.1007/978-0-387-89382-2_7; Budkevich TV, 2014, CELL, V158, P121, DOI 10.1016/j.cell.2014.04.044; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; CAPONE JP, 1985, EMBO J, V4, P213, DOI 10.1002/j.1460-2075.1985.tb02338.x; Cardno TS, 2009, RNA, V15, P1614, DOI 10.1261/rna.1586709; Carnes J, 2003, RNA, V9, P648, DOI 10.1261/rna.5280103; Chamanian M, 2013, CELL HOST MICROBE, V13, P181, DOI 10.1016/j.chom.2013.01.007; Charbonneau J, 2012, RNA, V18, P519, DOI 10.1261/rna.030346.111; Chen J, 2014, NATURE, V512, P328, DOI 10.1038/nature13428; Clark MB, 2007, J BIOL CHEM, V282, P37359, DOI 10.1074/jbc.M705676200; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; Cridge AG, 2006, NUCLEIC ACIDS RES, V34, P1959, DOI 10.1093/nar/gkl074; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Dulude D, 2006, VIROLOGY, V345, P127, DOI 10.1016/j.virol.2005.08.048; Dulude D, 2002, NUCLEIC ACIDS RES, V30, P5094, DOI 10.1093/nar/gkf657; Gaudin C, 2005, J MOL BIOL, V349, P1024, DOI 10.1016/j.jmb.2005.04.045; Gendron K, 2008, NUCLEIC ACIDS RES, V36, P30, DOI 10.1093/nar/gkm906; GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; HORSFIELD JA, 1995, NUCLEIC ACIDS RES, V23, P1487, DOI 10.1093/nar/23.9.1487; Huang XL, 2014, RNA, V20, P587, DOI 10.1261/rna.042457.113; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; Janzen DM, 2004, NUCLEIC ACIDS RES, V32, P4491, DOI 10.1093/nar/gkh791; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kim YG, 2001, NUCLEIC ACIDS RES, V29, P1125, DOI 10.1093/nar/29.5.1125; Kobayashi Y, 2010, J BIOL CHEM, V285, P19776, DOI 10.1074/jbc.M109.085621; Leger M, 2004, RNA, V10, P1225, DOI 10.1261/rna.7670704; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; LeGoff X, 1997, MOL CELL BIOL, V17, P3164, DOI 10.1128/MCB.17.6.3164; Li YH, 2014, P NATL ACAD SCI USA, V111, pE2172, DOI 10.1073/pnas.1321930111; Liao PY, 2008, NUCLEIC ACIDS RES, V36, P2619, DOI 10.1093/nar/gkn100; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; Lorgeoux RP, 2013, VIROLOGY, V443, P384, DOI 10.1016/j.virol.2013.05.026; Low JT, 2014, BIOCHEMISTRY-US, V53, P4282, DOI 10.1021/bi5004926; Major LL, 1996, NUCLEIC ACIDS RES, V24, P2673, DOI 10.1093/nar/24.14.2673; Marczinke B, 1998, J MOL BIOL, V284, P205, DOI 10.1006/jmbi.1998.2186; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; Mouzakis KD, 2013, NUCLEIC ACIDS RES, V41, P1901, DOI 10.1093/nar/gks1254; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; PANDE S, 1995, MOL CELL BIOL, V15, P298, DOI 10.1128/MCB.15.1.298; Plant EP, 2006, RNA, V12, P666, DOI 10.1261/rna.2225206; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; Poole ES, 1998, NUCLEIC ACIDS RES, V26, P954, DOI 10.1093/nar/26.4.954; Qin PW, 2014, EMBO REP, V15, P185, DOI 10.1002/embr.201337762; Qu XH, 2011, NATURE, V475, P118, DOI 10.1038/nature10126; Sharma V, 2014, NUCLEIC ACIDS RES, V42, P7210, DOI 10.1093/nar/gku386; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Srikantha T, 1996, J BACTERIOL, V178, P121, DOI 10.1128/jb.178.1.121-129.1996; Staple DW, 2005, J MOL BIOL, V349, P1011, DOI 10.1016/j.jmb.2005.03.038; Stewart CK, 2008, BIOCHEM BIOPH RES CO, V370, P113, DOI 10.1016/j.bbrc.2008.03.041; Tanguay RL, 1996, MOL CELL BIOL, V16, P146; TATE WP, 1983, J BIOL CHEM, V258, P360; Telenti A, 2002, J VIROL, V76, P7868, DOI 10.1128/JVI.76.15.7868-7873.2002; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; WEISS R B, 1989, New Biologist, V1, P159; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	80	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122176	10.1371/journal.pone.0122176	http://dx.doi.org/10.1371/journal.pone.0122176			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807539	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000210
J	Ogata, K; Shintani, N; Hayata-Takano, A; Kamo, T; Higashi, S; Seiriki, K; Momosaki, H; Vaudry, D; Vaudry, H; Galas, L; Kasai, A; Nagayasu, K; Nakazawa, T; Hashimoto, R; Ago, Y; Matsuda, T; Baba, A; Hashimoto, H				Ogata, Katsuya; Shintani, Norihito; Hayata-Takano, Atsuko; Kamo, Toshihiko; Higashi, Shintaro; Seiriki, Kaoru; Momosaki, Hisae; Vaudry, David; Vaudry, Hubert; Galas, Ludovic; Kasai, Atsushi; Nagayasu, Kazuki; Nakazawa, Takanobu; Hashimoto, Ryota; Ago, Yukio; Matsuda, Toshio; Baba, Akemichi; Hashimoto, Hitoshi			PACAP Enhances Axon Outgrowth in Cultured Hippocampal Neurons to a Comparable Extent as BDNF	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; MESSENGER-RNA EXPRESSION; VASOACTIVE-INTESTINAL-PEPTIDE; LONG-TERM POTENTIATION; STRIA TERMINALIS BNST; NEURITE OUTGROWTH; DEFICIENT MICE; NEUROTROPHIC FACTOR; DENTATE GYRUS; BED NUCLEUS	Pituitary adenylate cyclase-activating polypeptide (PACAP) exerts neurotrophic activities including modulation of synaptic plasticity and memory, hippocampal neurogenesis, and neuroprotection, most of which are shared with brain-derived neurotrophic factor (BDNF). Therefore, the aim of this study was to compare morphological effects of PACAP and BDNF on primary cultured hippocampal neurons. At days in vitro (DIV) 3, PACAP increased neurite length and number to similar levels by BDNF, but vasoactive intestinal polypeptide showed much lower effects. In addition, PACAP increased axon, but not dendrite, length, and soma size at DIV 3 similarly to BDNF. The PACAP antagonist PACAP6-38 completely blocked the PACAP-induced increase in axon, but not dendrite, length. Interestingly, the BDNF-induced increase in axon length was also inhibited by PACAP6-38, suggesting a mechanism involving PACAP signaling. K252a, a TrkB receptor inhibitor, inhibited axon outgrowth induced by PACAP and BDNF without affecting dendrite length. These results indicate that in primary cultured hippocampal neurons, PACAP shows morphological actions via its cognate receptor PAC1, stimulating neurite length and number, and soma size to a comparable extent as BDNF, and that the increase in total neurite length is ascribed to axon outgrowth.	[Ogata, Katsuya; Shintani, Norihito; Kamo, Toshihiko; Higashi, Shintaro; Seiriki, Kaoru; Momosaki, Hisae; Kasai, Atsushi; Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan; [Hayata-Takano, Atsuko; Hashimoto, Ryota; Matsuda, Toshio; Hashimoto, Hitoshi] Chiba Univ, Hamamatsu Univ Sch Med, Kanazawa Univ, Osaka Univ,United Grad Sch Child Dev,Mol Res Ctr, Suita, Osaka, Japan; [Hayata-Takano, Atsuko; Hashimoto, Ryota; Matsuda, Toshio; Hashimoto, Hitoshi] Univ Fukui, Suita, Osaka, Japan; [Seiriki, Kaoru; Kasai, Atsushi] Osaka Univ, Inst Acad Initiat, Interdisciplinary Program Biomed Sci, Suita, Osaka, Japan; [Vaudry, David; Vaudry, Hubert] Univ Rouen, Neurotroph Factor & Neuronal Differentiat Team, INSERM U982, DC2N, Mont St Aignan, France; [Vaudry, David; Vaudry, Hubert; Galas, Ludovic] Univ Rouen, IRIB, PRIMACEN, Cell Imaging Platform Normandy, Mont St Aignan, France; [Nagayasu, Kazuki; Nakazawa, Takanobu; Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Brain Neuropharmacol &, Suita, Osaka, Japan; [Hashimoto, Ryota] Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka, Japan; [Ago, Yukio; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Suita, Osaka, Japan; [Baba, Akemichi] Hyogo Univ Hlth Sci, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo, Japan	Osaka University; Chiba University; Kanazawa University; Osaka University; University of Fukui; Osaka University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; Osaka University; Osaka University; Osaka University	Hashimoto, H (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan.	hasimoto@phs.osaka-u.ac.jp	Kasai, Atsushi/C-8073-2011; Hashimoto, Ryota/AAE-3200-2019; Hashimoto, Ryota/P-8572-2014; Hashimoto, Hitoshi/D-1209-2010; VAUDRY, David/M-1454-2018; Ago, Yukio/H-9142-2019; Shintani, Norihito/D-5860-2014; Shintani, Norihito/N-1600-2019	Kasai, Atsushi/0000-0002-1612-3078; Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Hitoshi/0000-0001-6548-4016; VAUDRY, David/0000-0003-3567-7452; Ago, Yukio/0000-0001-7562-4000; Shintani, Norihito/0000-0002-7850-9064; Shintani, Norihito/0000-0002-7850-9064; NAKAZAWA, Takanobu/0000-0003-4863-1277	Japan Society for the Promotion of Science (JSPS), KAKENHI [10335367, 25670038, 25460100, 25670037, 26293020, 26670122]; Funding Program for Next Generation World-Leading Researchers [LS081]; Research Fellowships for Young Scientists; Japan-France Integrated Action Program (SAKURA) - JSPS; Ministere des Affaires Etrangeres in France; Senri Life Science Foundation; Uehara Memorial Foundation, Japan; Grants-in-Aid for Scientific Research [14J01466] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan-France Integrated Action Program (SAKURA) - JSPS; Ministere des Affaires Etrangeres in France; Senri Life Science Foundation; Uehara Memorial Foundation, Japan(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research, KAKENHI, Grant Nos 10335367, 25670038 (N.S.), 25460100 (A.H.-T.), 25670037 (A.K.), 26293020 and 26670122 (H.H.); the Funding Program for Next Generation World-Leading Researchers, Grant No. LS081 (H.H.); Research Fellowships for Young Scientists (K.O., S.H. and K.S.); the Japan-France Integrated Action Program (SAKURA) funded by JSPS and the Ministere des Affaires Etrangeres in France (H.H. and D.V.); and grants for research from the Senri Life Science Foundation (N.S.); and the Uehara Memorial Foundation, Japan (N.S. and H.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago Y, 2011, NEUROSCIENCE, V172, P554, DOI 10.1016/j.neuroscience.2010.10.044; Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011; Cazillis M, 2004, EUR J NEUROSCI, V19, P798, DOI 10.1111/j.0953-816X.2004.03138.x; Cheng MC, 2012, PROG NEURO-PSYCHOPH, V39, P149, DOI 10.1016/j.pnpbp.2012.06.004; Dong YX, 2010, NEUROSCI LETT, V484, P174, DOI 10.1016/j.neulet.2010.08.044; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Drahushuk K, 2002, J NEUROSCI, V22, P6560; Freson K, 2004, J CLIN INVEST, V113, P905, DOI 10.1172/JCI200419252; Gaszner B, 2012, NEUROSCIENCE, V202, P283, DOI 10.1016/j.neuroscience.2011.11.046; Gonzalez BJ, 1997, NEUROSCIENCE, V78, P419, DOI 10.1016/S0306-4522(96)00617-3; Hammack SE, 2010, J MOL NEUROSCI, V42, P327, DOI 10.1007/s12031-010-9364-7; Hammack SE, 2009, PSYCHONEUROENDOCRINO, V34, P833, DOI 10.1016/j.psyneuen.2008.12.013; Hashimoto H, 2000, J NEUROCHEM, V75, P1810, DOI 10.1046/j.1471-4159.2000.0751810.x; Hashimoto H, 2000, J NEUROCHEM, V74, P501, DOI 10.1046/j.1471-4159.2000.740501.x; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hashimoto H, 2011, CURR PHARM DESIGN, V17, P985, DOI 10.2174/138161211795589382; Hashimoto H, 2009, J NEUROCHEM, V110, P595, DOI 10.1111/j.1471-4159.2009.06168.x; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hattori Satoko, 2012, Front Behav Neurosci, V6, P58, DOI 10.3389/fnbeh.2012.00058; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Hazama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089153; Henle F, 2006, J BIOL CHEM, V281, P24955, DOI 10.1074/jbc.M604114200; Ishihama T, 2010, BEHAV BRAIN RES, V209, P274, DOI 10.1016/j.bbr.2010.02.009; Jaworski DM, 2000, DEV BRAIN RES, V120, P27, DOI 10.1016/S0165-3806(99)00192-3; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kambe Y, 2012, J MOL NEUROSCI, V48, P550, DOI 10.1007/s12031-012-9754-0; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Lazarovici P, 2012, J MOL NEUROSCI, V48, P526, DOI 10.1007/s12031-012-9818-1; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; MacDonald JF, 2007, BBA-BIOMEMBRANES, V1768, P941, DOI 10.1016/j.bbamem.2006.12.006; Matsuyama S, 2003, NEUROREPORT, V14, P2095, DOI 10.1097/00001756-200311140-00017; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Nielsen KM, 2004, MOL CELL NEUROSCI, V25, P629, DOI 10.1016/j.mcn.2003.12.004; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Otto C, 2001, J NEUROSCI, V21, P5520, DOI 10.1523/JNEUROSCI.21-15-05520.2001; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; PATEL MN, 1995, NEUROSCIENCE, V69, P763, DOI 10.1016/0306-4522(95)00281-M; Pego JM, 2008, EUR J NEUROSCI, V27, P1503, DOI 10.1111/j.1460-9568.2008.06112.x; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Reglodi D, 2012, J MOL NEUROSCI, V48, P482, DOI 10.1007/s12031-012-9762-0; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Roberto M, 2001, LEARN MEMORY, V8, P265, DOI 10.1101/lm.40501; Sakai Y, 2004, MOL BRAIN RES, V123, P18, DOI 10.1016/j.molbrainres.2003.12.013; Sakai Y, 2001, BIOCHEM BIOPH RES CO, V285, P656, DOI 10.1006/bbrc.2001.5244; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Shi GX, 2008, MOL CELL BIOL, V28, P4940, DOI 10.1128/MCB.02193-07; Smith CB, 2012, J MOL NEUROSCI, V48, P403, DOI 10.1007/s12031-012-9749-x; Szabadfi K, 2012, NEUROTOX RES, V21, P41, DOI 10.1007/s12640-011-9254-y; Tajiri M, 2012, J MOL NEUROSCI, V48, P473, DOI 10.1007/s12031-012-9861-y; Tanaka K, 2006, J NEUROSCI, V26, P5091, DOI 10.1523/JNEUROSCI.4376-05.2006; Tsukiyama N, 2011, STRESS, V14, P368, DOI 10.3109/10253890.2010.544345; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Watanabe K, 2012, J CELL SCI, V125, P2198, DOI 10.1242/jcs.097709; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; Yamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008596; Zink M, 2004, NEUROSCI LETT, V360, P106, DOI 10.1016/j.neulet.2004.01.030	60	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120526	10.1371/journal.pone.0120526	http://dx.doi.org/10.1371/journal.pone.0120526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807538	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000082
J	Souri, M; Osaki, T; Ichinose, A				Souri, Masayoshi; Osaki, Tsukasa; Ichinose, Akitada			The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood; Coagulation Factor; Fibrin; Protein Cross-linking; Transglutaminase; Bleeding Disease	PLASMA FACTOR-XIII; BLOOD-COAGULATION; 3-DIMENSIONAL STRUCTURE; THROMBIN; DEFICIENCY; PEPTIDE; POLYMERIZATION; ACTIVATION; PROTEINS; CALCIUM	Background: The B subunit of factor XIII (FXIII-B) was previously thought to inhibit fibrin cross-linking by preventing thrombin-mediated activation of the A subunit (FXIII-A). Results: FXIII-B accelerated FXIII-A activation and subsequent fibrin cross-linking by formation of an FXIII-A, fibrinogen, and thrombin ternary complex. Conclusion: FXIII-B accelerated fibrin cross-linking. Significance: FXIII-B deficiency leads to impaired fibrin stabilization. Covalent cross-linking of fibrin chains is required for stable blood clot formation, which is catalyzed by coagulation factor XIII (FXIII), a proenzyme of plasma transglutaminase consisting of catalytic A (FXIII-A) and non-catalytic B subunits (FXIII-B). Herein, we demonstrate that FXIII-B accelerates fibrin cross-linking. Depletion of FXIII-B from normal plasma supplemented with a physiological level of recombinant FXIII-A resulted in delayed fibrin cross-linking, reduced incorporation of FXIII-A into fibrin clots, and impaired activation peptide cleavage by thrombin; the addition of recombinant FXIII-B restored normal fibrin cross-linking, FXIII-A incorporation into fibrin clots, and activation peptide cleavage by thrombin. Immunoprecipitation with an anti-fibrinogen antibody revealed an interaction between the FXIII heterotetramer and fibrinogen mediated by FXIII-B and not FXIII-A. FXIII-B probably binds the -chain of fibrinogen with its D-domain, which is near the fibrin polymerization pockets, and dissociates from fibrin during or after cross-linking between -chains. Thus, FXIII-B plays important roles in the formation of a ternary complex between proenzyme FXIII, prosubstrate fibrinogen, and activator thrombin. Accordingly, congenital or acquired FXIII-B deficiency may result in increased bleeding tendency through impaired fibrin stabilization due to decreased FXIII-A activation by thrombin and secondary FXIII-A deficiency arising from enhanced circulatory clearance.	[Souri, Masayoshi; Osaki, Tsukasa; Ichinose, Akitada] Yamagata Univ, Sch Med, Dept Mol Pathobiochem & Pathobiol, Yamagata 9909585, Japan	Yamagata University	Ichinose, A (corresponding author), Yamagata Univ, Sch Med, Dept Mol Pathobiochem & Pathobiol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	aichinos@med.id.yamagata-u.ac.jp		Osaki, Tsukasa/0000-0002-9487-3253	Japanese Ministry of Education, Culture, Sports, Science, and Technology	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a research grant from the Japanese Ministry of Education, Culture, Sports, Science, and Technology and was presented in part at the 35th Annual Meeting of the Japanese Society on Thrombosis and Hemostasis in Yamagata in May 2013 and at the 24th Congress of the International Society on Thrombosis and Hemostasis in Amsterdam in July 2013.	BINNIE CG, 1993, BLOOD, V81, P3186; BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0; CREDO RB, 1978, P NATL ACAD SCI USA, V75, P4234, DOI 10.1073/pnas.75.9.4234; CURTIS CG, 1974, BIOCHEMISTRY-US, V13, P3774, DOI 10.1021/bi00715a024; GREENBERG CS, 1985, BLOOD, V66, P1028; GREENBERG CS, 1985, BLOOD, V66, P466; GREENBERG CS, 1987, BLOOD, V69, P867; GREENBERG CS, 1982, J BIOL CHEM, V257, P6096; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P4633, DOI 10.1021/bi00364a027; Ivaskevicius V, 2010, HAEMOPHILIA, V16, P675, DOI 10.1111/j.1365-2516.2010.02207.x; Iwata H, 2009, J THROMB HAEMOST, V7, P1084, DOI 10.1111/j.1538-7836.2009.03443.x; Izumi T, 1996, BLOOD, V87, P2769, DOI 10.1182/blood.V87.7.2769.bloodjournal8772769; JANUS TJ, 1983, BIOCHEMISTRY-US, V22, P6269, DOI 10.1021/bi00295a035; Katona E, 2014, BLOOD, V123, P1757, DOI 10.1182/blood-2013-10-533596; Koseki S, 2001, BLOOD, V97, P2667, DOI 10.1182/blood.V97.9.2667; LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085; LEWIS SD, 1985, BIOCHEMISTRY-US, V24, P6772, DOI 10.1021/bi00345a007; LOEWY AG, 1961, J BIOL CHEM, V236, P2634; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; MARY A, 1987, BIOCHEM BIOPH RES CO, V147, P608, DOI 10.1016/0006-291X(87)90974-0; Moaddel M, 2000, BIOCHEMISTRY-US, V39, P6698, DOI 10.1021/bi000098u; OLEXA SA, 1980, P NATL ACAD SCI-BIOL, V77, P1374, DOI 10.1073/pnas.77.3.1374; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Pechik I, 2004, P NATL ACAD SCI USA, V101, P2718, DOI 10.1073/pnas.0303440101; PIZZO SV, 1973, J BIOL CHEM, V248, P4584; Pratt KP, 1997, P NATL ACAD SCI USA, V94, P7176, DOI 10.1073/pnas.94.14.7176; RADEK JT, 1993, BIOCHEMISTRY-US, V32, P3527, DOI 10.1021/bi00065a002; Saha N, 2000, GENET EPIDEMIOL, V19, P440, DOI 10.1002/1098-2272(200012)19:4<440::AID-GEPI14>3.0.CO;2-8; SAITO M, 1990, BRIT J HAEMATOL, V74, P290, DOI 10.1111/j.1365-2141.1990.tb02585.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206; Souri M, 2008, BIOCHEMISTRY-US, V47, P8656, DOI 10.1021/bi8006143; Souri M, 2008, INT J HEMATOL, V87, P60, DOI 10.1007/s12185-007-0005-z; Tsurupa G, 2010, BIOCHEMISTRY-US, V49, P7643, DOI 10.1021/bi1010317; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yuasa Y, 2014, THER APHER DIAL, V18, P93, DOI 10.1111/1744-9987.12056	36	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12027	12039		10.1074/jbc.M114.608570	http://dx.doi.org/10.1074/jbc.M114.608570			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809477	Green Published, hybrid			2022-12-26	WOS:000354388600018
J	Ndusilo, ND; Heysell, SK; Mpagama, SG; Gratz, J; Segesela, FH; Pazia, SJ; Wang, XQ; Houpt, ER; Kibiki, GS				Ndusilo, Norah D.; Heysell, Scott K.; Mpagama, Stellah G.; Gratz, Jean; Segesela, Farida H.; Pazia, Saumu J.; Wang, Xin-Qun; Houpt, Eric R.; Kibiki, Gibson S.			Improvement in Plasma Drug Activity during the Early Treatment Interval among Tanzanian Patients with Multidrug-Resistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TIME; PERMEABILITY; GROWTH	Background Individual pharmacokinetic variability may be common in patients treated for multidrug-resistant tuberculosis (MDR-TB) but data are sparse from resource-limited settings and across the early treatment interval. Methods Plasma drug activity, as measured by the TB Drug Activity (TDA) assay at 2 and 4 weeks of treatment with a standardized MDR-TB regimen was performed in patients with pulmonary MDR-TB from Tanzania. TDA values were correlated with measures of early treatment outcome including every two week collection of sputum for time-to-positivity (TTP) in liquid culture from the MGIT 960 automated system. Patients were evaluated at 24 weeks and those surviving without delayed sputum culture conversion (> 8 weeks), culture reversion after previously negative, or weight loss were defined as having a favorable outcome. Results Twenty-five patients were enrolled with a mean age of 37 +/- 12 years. All were culture positive from the pretreatment sputum sample with a mean TTP in MGIT of 257 +/- 134 hours, and the median time to culture conversion on treatment was 6 weeks. Twenty patients (80%) had an increase in TDA, with the overall mean TDA at 2 weeks of 2.1 +/- 0.7 compared to 2.4 +/- 0.8 at 4 weeks (p = 0.005). At 2 weeks 13 subjects (52%) had a TDA value > 2-log killing against their own M. tuberculosis isolate compared to 17 subjects (68%) at 4 weeks (McNemar's exact test p = 0.29). An interim treatment outcome was able to be determined in 23 patients (92%), of whom 7 had a poor outcome (30%). An increase in TDA from week 2 to week 4 was associated with favorable outcome, [unadjusted OR = 20.0, 95% CI: 1.61-247.98, exact p = 0.017 and adjusted OR = 19.33, 95% CI: 1.55-241.5, exact p = 0.023]. Conclusions The majority of patients with MDR-TB in Tanzania had an increase in plasma drug activity from week 2 to week 4 of treatment as measured by the TDA assay. Understanding the etiology and full impact of this dynamic may inform therapeutic intervention.	[Ndusilo, Norah D.; Mpagama, Stellah G.; Gratz, Jean; Segesela, Farida H.; Pazia, Saumu J.; Kibiki, Gibson S.] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Heysell, Scott K.; Gratz, Jean; Houpt, Eric R.] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Heysell, Scott K.; Mpagama, Stellah G.] Kibongoto Infect Dis Hosp, Sanya Juu, Tanzania; [Wang, Xin-Qun] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA	University of Virginia; University of Virginia	Heysell, SK (corresponding author), Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	skh8r@virginia.edu			National Institutes of Health [R01AI093358, K23AI099019]; National Institutes of Health/Fogarty training grant [D43 TW008270]; FOGARTY INTERNATIONAL CENTER [D43TW008270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093358, K23AI099019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/Fogarty training grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health grant R01AI093358 (to ERH), the National Institutes of Health grant K23AI099019 (to SKH) and the National Institutes of Health/Fogarty training grant D43 TW008270 (to ERH and GSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso EC, 2009, AM J TROP MED HYG, V81, P322, DOI 10.4269/ajtmh.2009.81.322; Cegielski JP, 2014, CLIN INFECT DIS, V59, P1049, DOI 10.1093/cid/ciu572; Collett D., 2003, MODELING BINARY DATA; Diacon AH, 2010, EUR J CLIN MICROBIOL, V29, P1561, DOI 10.1007/s10096-010-1043-7; Heysell SK, 2011, ANTIMICROB AGENTS CH, V55, P5819, DOI 10.1128/AAC.05561-11; Hoa NB, 2013, INT J TUBERC LUNG D, V17, P61, DOI 10.5588/ijtld.12.0369; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Mpagama Stellah G, 2012, Tuberc Res Treat, V2012, P128057, DOI 10.1155/2012/128057; Mpagama SG, 2014, ANTIMICROB AGENTS CH, V58, P782, DOI 10.1128/AAC.01549-13; Mpagama SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062034; O'Shea MK, 2014, CLIN INFECT DIS, V59, P177, DOI 10.1093/cid/ciu244; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Peloquin CA, 2008, ANTIMICROB AGENTS CH, V52, P852, DOI 10.1128/AAC.01036-07; Pheiffer C, 2008, INT J TUBERC LUNG D, V12, P792; SCHLICHTER JG, 1949, AM J MED SCI, V217, P600, DOI 10.1097/00000441-194906000-00002; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Srivastava S, 2011, J INFECT DIS, V204, P1951, DOI 10.1093/infdis/jir658; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679	19	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122769	10.1371/journal.pone.0122769	http://dx.doi.org/10.1371/journal.pone.0122769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816161	Green Submitted, gold, Green Published			2022-12-26	WOS:000352133600196
J	Dobyns, AE; Goyal, R; Carpenter, LG; Freeman, TC; Longo, LD; Yellon, SM				Dobyns, Abigail E.; Goyal, Ravi; Carpenter, Lauren Grisham; Freeman, Tom C.; Longo, Lawrence D.; Yellon, Steven M.			Macrophage Gene Expression Associated with Remodeling of the Prepartum Rat Cervix: Microarray and Pathway Analyses	PLOS ONE			English	Article							PARTURITION; SIGNALS; UTERUS; CELLS	As the critical gatekeeper for birth, prepartum remodeling of the cervix is associated with increased resident macrophages (M phi), proinflammatory processes, and extracellular matrix degradation. This study tested the hypothesis that expression of genes unique to M phi s characterizes the prepartum from unremodeled nonpregnant cervix. Perfused cervix from prepartum day 21 postbreeding (D21) or nonpregnant (NP) rats, with or without M phi s, had RNA extracted and whole genome microarray analysis performed. By subtractive analyses, expression of 194 and 120 genes related to Mfs in the cervix from D21 rats were increased and decreased, respectively. In both D21 and NP groups, 158 and 57 M phi genes were also more or less up- or down-regulated, respectively. Mf gene expression patterns were most strongly correlated within groups and in 5 major clustering patterns. In the cervix from D21 rats, functional categories and canonical pathways of increased expression by Mf gene related to extracellular matrix, cell proliferation, differentiation, as well as cell signaling. Pathways were characteristic of inflammation and wound healing, e.g., CD163, CD206, and CCR2. Signatures of only inflammation pathways, e.g., CSF1R, EMR1, and MMP12 were common to both D21 and NP groups. Thus, a novel and complex balance of M phi genes and clusters differentiated the degraded extracellular matrix and cellular genomic activities in the cervix before birth from the unremodeled state. Predicted Mf activities, pathways, and networks raise the possibility that expression patterns of specific genes characterize and promote prepartum remodeling of the cervix for parturition at term and with preterm labor.	[Dobyns, Abigail E.; Goyal, Ravi; Carpenter, Lauren Grisham; Longo, Lawrence D.; Yellon, Steven M.] Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [Longo, Lawrence D.; Yellon, Steven M.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA; [Goyal, Ravi; Longo, Lawrence D.; Yellon, Steven M.] Loma Linda Univ, Sch Med, Div Physiol, Pediat, Loma Linda, CA 92350 USA; [Freeman, Tom C.] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Freeman, Tom C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland	Loma Linda University; Loma Linda University; Loma Linda University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Yellon, SM (corresponding author), Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA 92350 USA.	syellon@LLU.edu		Freeman, Thomas/0000-0001-5235-8483; Yellon, Steven/0000-0003-4850-3590	National Institutes of Health [HD054931, HD03807]; Loma Linda University School of Medicine Dean; Department of Pediatrics; UK-US Fulbright Commission; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD054931, R01HD003807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loma Linda University School of Medicine Dean; Department of Pediatrics; UK-US Fulbright Commission; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported in part by National Institutes of Health HD054931 (SMY), HD03807 (LDL), the Loma Linda University School of Medicine Dean and the Department of Pediatrics, as well as the UK-US Fulbright Commission for a 2013-14 All Disciplines Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollopragada S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.032; Boyd JW, 2009, REPRODUCTION, V137, P739, DOI 10.1530/REP-08-0507; Clyde LA, 2011, BIOL REPROD, V84, P587, DOI 10.1095/biolreprod.110.086207; Cohen HB, 2013, J LEUKOCYTE BIOL, V94, P913, DOI 10.1189/jlb.0413236; Conway BR, 2012, J AM SOC NEPHROL, V23, P405, DOI 10.1681/ASN.2011060577; Dubicke A, 2010, J REPROD IMMUNOL, V84, P176, DOI 10.1016/j.jri.2009.12.004; Freeman TC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-90; Gonzalez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026877; Gonzalez JM, 2009, BIOL REPROD, V81, P1226, DOI 10.1095/biolreprod.108.075309; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, P491; Kishore AH, 2014, J CLIN ENDOCR METAB, V99, P1006, DOI 10.1210/jc.2013-3392; Lucovnik M, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/165913; Mackler AM, 1999, BIOL REPROD, V61, P879, DOI 10.1095/biolreprod61.4.879; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; Mowa CN, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-64; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Payne KJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101840; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Sahlin L, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-36; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Timmons Brenda C, 2007, Reprod Sci, V14, P53, DOI 10.1177/1933719107309587; Xu H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.029; Yang ZY, 2011, INT IMMUNOPHARMACOL, V11, P1442, DOI 10.1016/j.intimp.2011.04.024; Yellon SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081340; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	28	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119782	10.1371/journal.pone.0119782	http://dx.doi.org/10.1371/journal.pone.0119782			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811906	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700025
J	Ivanova, EA; De Leo, MG; Van Den Heuvel, L; Pastore, A; Dijkman, H; De Matteis, MA; Levtchenko, EN				Ivanova, Ekaterina A.; De Leo, Maria Giovanna; Van Den Heuvel, Lambertus; Pastore, Anna; Dijkman, Henry; De Matteis, Maria Antonietta; Levtchenko, Elena N.			Endo-Lysosomal Dysfunction in Human Proximal Tubular Epithelial Cells Deficient for Lysosomal Cystine Transporter Cystinosin	PLOS ONE			English	Article							NEPHROPATHIC CYSTINOSIS; SUBCELLULAR-LOCALIZATION; CYSTEAMINE THERAPY; PROTEIN; MECHANISMS; DISEASE; TRAFFICKING; ENDOSOMES; CHILDREN; ACCUMULATION	Nephropathic cystinosis is a lysosomal storage disorder caused by mutations in the CTNS gene encoding cystine transporter cystinosin that results in accumulation of amino acid cystine in the lysosomes throughout the body and especially affects kidneys. Early manifestations of the disease include renal Fanconi syndrome, a generalized proximal tubular dysfunction. Current therapy of cystinosis is based on cystine-lowering drug cysteamine that postpones the disease progression but offers no cure for the Fanconi syndrome. We studied the mechanisms of impaired reabsorption in human proximal tubular epithelial cells (PTEC) deficient for cystinosin and investigated the endo-lysosomal compartments of cystinosin-deficient PTEC by means of light and electron microscopy. We demonstrate that cystinosin-deficient cells had abnormal shape and distribution of the endo-lysosomal compartments and impaired endocytosis, with decreased surface expression of multiligand receptors and delayed lysosomal cargo processing. Treatment with cysteamine improved surface expression and lysosomal cargo processing but did not lead to a complete restoration and had no effect on the abnormal morphology of endo-lysosomal compartments. The obtained results improve our understanding of the mechanism of proximal tubular dysfunction in cystinosis and indicate that impaired protein reabsorption can, at least partially, be explained by abnormal trafficking of endosomal vesicles.	[Ivanova, Ekaterina A.; Van Den Heuvel, Lambertus; Levtchenko, Elena N.] Univ Hosp Leuven, Dept Pediat Nephrol & Growth & Regenerat, Leuven, Belgium; [Ivanova, Ekaterina A.; Van Den Heuvel, Lambertus; Levtchenko, Elena N.] Katholieke Univ Leuven, Leuven, Belgium; [De Leo, Maria Giovanna; De Matteis, Maria Antonietta] TIGEM, Naples, Italy; [Van Den Heuvel, Lambertus] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Pediat Nephrol, NL-6525 ED Nijmegen, Netherlands; [Pastore, Anna] Childrens Hosp & Res Inst Bambino Gesu IRCCS, Lab Prote & Metabol, Rome, Italy; [Dijkman, Henry] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands	KU Leuven; University Hospital Leuven; KU Leuven; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Radboud University Nijmegen; IRCCS Bambino Gesu; Radboud University Nijmegen	Levtchenko, EN (corresponding author), Univ Hosp Leuven, Dept Pediat Nephrol & Growth & Regenerat, Leuven, Belgium.	elena.levtchenko@uzleuven.be	De Matteis, Maria Antonietta/AHE-5161-2022; Pastore, Anna/J-8409-2014; van den Heuvel, Lambertus/AAM-1772-2021; Dijkman, Henry/L-4274-2015; van den Heuvel, L.P.W.J./H-8044-2014; Levtchenko, Elena/AAO-7125-2020	De Matteis, Maria Antonietta/0000-0003-0053-3061; Pastore, Anna/0000-0002-0990-9419; van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; 	Cystinosis Research Foundation; fund for Scientific Research, Flanders (F.W.O. Vlaanderen) [1801110N]; Telethon Foundation	Cystinosis Research Foundation; fund for Scientific Research, Flanders (F.W.O. Vlaanderen)(FWO); Telethon Foundation(Fondazione Telethon)	This work was sponsored by Cystinosis Research Foundation (www.cystinosisresearch.org). Elena Levtchenko is supported by the fund for Scientific Research, Flanders (F.W.O. Vlaanderen) grant 1801110N (www.fwo.be). Maria Antonietta De Matteis was supported by Telethon Foundation (www.telethon.it).	Bandyopadhyay D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086847; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Cherqui S, 2002, MOL CELL BIOL, V22, P7622, DOI 10.1128/MCB.22.21.7622-7632.2002; Chevronnay HPG, 2014, J AM SOC NEPHROL, V25, P1256, DOI 10.1681/ASN.2013060598; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Fan CD, 2006, BIOORGAN MED CHEM, V14, P3218, DOI 10.1016/j.bmc.2005.12.035; GAHL WA, 1987, NEW ENGL J MED, V316, P971, DOI 10.1056/NEJM198704163161602; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; Haq MR, 2002, J AM SOC NEPHROL, V13, P2046, DOI 10.1097/01.ASN.0000022012.95680.BA; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Jezegou A, 2012, P NATL ACAD SCI USA, V109, pE3434, DOI 10.1073/pnas.1211198109; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Johnson JL, 2013, MOL CELL BIOL, V33, P2950, DOI 10.1128/MCB.00417-13; Kalatzis V, 2004, HUM MOL GENET, V13, P1361, DOI 10.1093/hmg/ddh152; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; KIMONIS VE, 1995, J CLIN ENDOCR METAB, V80, P3257, DOI 10.1210/jc.80.11.3257; Kleta R, 2004, J PEDIATR-US, V145, P555, DOI 10.1016/j.jpeds.2004.03.056; Levtchenko E, 2006, ACTA PAEDIATR, V95, P379; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; Nesterova G, 2013, PEDIATR NEPHROL, V28, P51, DOI 10.1007/s00467-012-2242-5; Nevo N, 2010, NEPHROL DIAL TRANSPL, V25, P1059, DOI 10.1093/ndt/gfp553; Raggi C, 2014, HUM MOL GENET, V23, P2266, DOI 10.1093/hmg/ddt617; Reed AAC, 2010, AM J PHYSIOL-RENAL, V298, pF365, DOI 10.1152/ajprenal.00038.2009; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Ruivo R, 2012, P NATL ACAD SCI USA, V109, pE210, DOI 10.1073/pnas.1115581109; SCARDIGLI K, 1977, CLIN CHIM ACTA, V75, P13, DOI 10.1016/0009-8981(77)90495-8; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Taranta A, 2008, AM J PHYSIOL-RENAL, V294, pF1101, DOI 10.1152/ajprenal.00413.2007; Taranta A, 2012, HISTOCHEM CELL BIOL, V138, P351, DOI 10.1007/s00418-012-0958-8; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Vicinanza M, 2011, EMBO J, V30, P4970, DOI 10.1038/emboj.2011.354; Wilmer MJ, 2008, AM J KIDNEY DIS, V51, P893, DOI 10.1053/j.ajkd.2008.03.010; Wilmer MJ, 2011, BBA-MOL BASIS DIS, V1812, P643, DOI 10.1016/j.bbadis.2011.02.010; Wilmer MJ, 2011, PEDIATR NEPHROL, V26, P205, DOI 10.1007/s00467-010-1627-6; Wilmer MJ, 2010, AM J PHYSIOL-RENAL, V299, pF905, DOI 10.1152/ajprenal.00318.2010; Wilmer MJ, 2010, CELL TISSUE RES, V339, P449, DOI 10.1007/s00441-009-0882-y; Wilmer MJG, 2005, BIOCHEM BIOPH RES CO, V337, P610, DOI 10.1016/j.bbrc.2005.09.094; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	41	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120998	10.1371/journal.pone.0120998	http://dx.doi.org/10.1371/journal.pone.0120998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811383	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700073
J	Li, Q; Szatmary, P; Liu, YY; Ding, ZY; Zhou, J; Sun, Y; Luo, F; Yan, W; Zhu, J				Li, Qing; Szatmary, Peter; Liu, Yanyang; Ding, Zhenyu; Zhou, Jin; Sun, Yi; Luo, Feng; Wang, Yan; Zhu, Jiang			Orthotopic Transplantation of Cryopreserved Mouse Ovaries and Gonadotrophin Releasing Hormone Analogues in the Restoration of Function following Chemotherapy-Induced Ovarian Damage	PLOS ONE			English	Article							NEEDLE IMMERSED VITRIFICATION; BREAST-CANCER; TISSUE CRYOPRESERVATION; FEMALE RATS; FERTILITY; CYCLOPHOSPHAMIDE; AGONIST; FAILURE; PREGNANCIES; PREVENTION	Therapy advances are constantly improving survival rates of cancer patients, however the toxic effects of chemotherapy drugs can seriously affect patients' quality of life. In women, fertility and premature ovarian endocrine dysfunction are of particular concern. It is urgently we find methods to preserve or reconstruct ovarian function for these women. This study compares GnRHa treatment with ovarian tissue cryopreservation and orthotopic transplantation in a chemotherapy-induced ovarian damage murine model. 56 inbred Lewis rats were divided into 4 treatment groups: Saline control (group I); cyclophosphamide only (group II); cyclophosphamide plus GnRHa (group III); cyclophosphamide and grafting of thawed cryopreserved ovaries (group IV). Body weight, estrous cycle recovery time, ovarian weight, morphology and follicle count, as well as breeding and fertility were compared among groups. Only group IV was able to restore to normal body weight by the end of the observation period and resumed normal estrous cycles in a shorter time compared to other treatment groups. There was a decrease in primordial follicles in all treatment groups, but group III had the greatest reduction. Although, there was no difference in pregnancy, only one animal littered normal pups in group II, none littered in group III and four littered in group IV. Thus, cryopreservation and orthotopic transplantation of ovarian tissue can restore the fertility of rats subjected to chemotherapy in a manner that is superior to GnRHa treatment. We also observed increased rates of hepatic, splenic and pulmonary haemorrhage in group III, suggesting there may be synergistic toxicity of GnRHa and cyclophosphamide.	[Li, Qing; Sun, Yi] 452nd Hosp Peoples Liberat Army, Dept Oncol, Chengdu, Sichuan, Peoples R China; [Szatmary, Peter] Univ Liverpool, Royal Liverpool Univ Hosp, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England; [Li, Qing; Liu, Yanyang] Sichuan Univ, West China Sch Med, Chengdu 610064, Sichuan, Peoples R China; [Ding, Zhenyu] Sichuan Univ, West China Hosp, Dept Thorac Oncol, Chengdu 610064, Sichuan, Peoples R China; [Zhou, Jin] Sichuan Canc Hosp, Dept Chemotherapy, Chengdu, Sichuan, Peoples R China; [Luo, Feng] Sichuan Univ, West China Hosp, Ctr Canc, Dept Med Oncol, Chengdu 610064, Sichuan, Peoples R China; [Luo, Feng] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Wang, Yan] Sichuan Univ, West China Hosp 2, Dept IVF, Chengdu 610064, Sichuan, Peoples R China	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Sichuan University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Yan, W (corresponding author), Sichuan Univ, West China Hosp 2, Dept IVF, Chengdu 610064, Sichuan, Peoples R China.	wangyy1210@163.com; J.Zhu1976@hotmail.com		Szatmary, Peter/0000-0002-7454-9851	National Natural Science Foundation of China [81001032]; National Institute for Health Research [ACF-2009-07-002] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors are grateful to the National Natural Science Foundation of China (81001032) (http://www.nsfc.gov.cn/) for providing funds for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almodin CG, 2004, HUM REPROD, V19, P1287, DOI 10.1093/humrep/deh246; Andersen CY, 2008, HUM REPROD, V23, P2266, DOI 10.1093/humrep/den244; ATAYA K, 1995, BIOL REPROD, V52, P365, DOI 10.1095/biolreprod52.2.365; ATAYA K, 1993, REPROD TOXICOL, V7, P229, DOI 10.1016/0890-6238(93)90229-Z; ATAYA KM, 1985, CANCER RES, V45, P3651; Beck-Fruchter R, 2008, HUM REPROD UPDATE, V14, P553, DOI 10.1093/humupd/dmn041; BOKSER L, 1990, BRIT J CANCER, V61, P861, DOI 10.1038/bjc.1990.192; Bosch P, 2004, THERIOGENOLOGY, V61, P581, DOI 10.1016/S0093-691X(03)00244-9; Candy CJ, 2000, HUM REPROD, V15, P1300, DOI 10.1093/humrep/15.6.1300; Chen SU, 2000, FERTIL STERIL, V74, P804, DOI 10.1016/S0015-0282(00)01516-8; Chen SU, 2000, HUM REPROD, V15, P2598, DOI 10.1093/humrep/15.12.2598; Dolmans MM, 2005, FERTIL STERIL, V83, P897, DOI 10.1016/j.fertnstert.2004.08.035; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Donnez J., 2011, FERTIL STERIL, V95, P1787, DOI DOI 10.1016/J.FERTNSTERT.2010.11.041; Ghosh S, 2001, REPROD TOXICOL, V15, P221, DOI 10.1016/S0890-6238(01)00114-9; Imai A, 2007, GYNECOL OBSTET INVES, V63, P102, DOI 10.1159/000096062; Key T, 2002, JNCI-J NATL CANCER I, V94, P606, DOI DOI 10.1093/JNCI/94.8.606; Letterie GS, 2004, HUM REPROD, V19, P831, DOI 10.1093/humrep/deh120; Levine J, 2010, J CLIN ONCOL, V28, P4831, DOI 10.1200/JCO.2009.22.8312; Liu L, 2008, HUM REPROD, V23, P122, DOI 10.1093/humrep/dem348; Migishima F, 2003, BIOL REPROD, V68, P881, DOI 10.1095/biolreprod.102.007948; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Oktay K, 2006, FERTIL STERIL, V86, P70, DOI 10.1016/j.fertnstert.2006.03.017; Peccatori F, 2009, FERTIL STERIL, V92, pE33, DOI 10.1016/j.fertnstert.2009.06.002; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Revelli A, 2013, FERTIL STERIL, V99, P227, DOI 10.1016/j.fertnstert.2012.09.029; Ruddy KJ, 2012, J CLIN ONCOL, V30, P3705, DOI 10.1200/JCO.2012.42.1966; RUGH R, 1990, MOUSE ITS REPRODUCTI; Rugo HS, 2011, JAMA-J AM MED ASSOC, V306, P312, DOI 10.1001/jama.2011.1019; Salle B, 2003, FERTIL STERIL, V80, P172, DOI 10.1016/S0015-0282(03)00554-5; Schover LR, 2008, J CLIN ONCOL, V26, P753, DOI 10.1200/JCO.2007.14.1655; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793; Wang Y, 2008, HUM REPROD, V23, P2256, DOI 10.1093/humrep/den255; Xiao Z, 2010, FERTIL STERIL, V94, P2323, DOI 10.1016/j.fertnstert.2010.01.011; Yeoman RR, 2005, FERTIL STERIL, V83, P1248, DOI 10.1016/j.fertnstert.2004.11.036	36	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120736	10.1371/journal.pone.0120736	http://dx.doi.org/10.1371/journal.pone.0120736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811681	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700058
J	Quan, XJ; Luo, HS; Liu, Y; Xia, H; Chen, W; Tang, QC				Quan, Xiaojing; Luo, Hesheng; Liu, Yin; Xia, Hong; Chen, Wei; Tang, Qincai			Hydrogen Sulfide Regulates the Colonic Motility by Inhibiting Both L-Type Calcium Channels and BKCa Channels in Smooth Muscle Cells of Rat Colon	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; K-CA CHANNELS; LARGE-CONDUCTANCE; RYANODINE RECEPTORS; CARBON-MONOXIDE; NITRIC-OXIDE; GUINEA-PIG; CONTRACTION; MECHANISMS; PATTERNS	Objective To examine the hypothesis that hydrogen sulfide (H2S) regulates the colonic motility by modulating both L-type voltage-dependent calcium channels and large conductance Ca2+-activated K+ (BKCa) channels. Methods Immunohistochemistry was performed on rat colonic samples to investigate the localization of the H2S-producing enzymes cystathionine-beta-synthase (CBS) and cystathionine-gamma-lyase (CSE). The contractions of proximal colonic smooth muscle were studied in an organ bath system. The whole-cell patch-clamp technique was used to record both L-type calcium currents (I-Ca,I-L) and BKCa currents in colonic smooth muscle cells (SMCs) isolated from male Wistar rats. Results Immunohistochemistry revealed the presence of CBS and CSE in mucosa, smooth muscle cells and myenteric neurons. The H2S donor NaHS inhibited spontaneous contractions of the longitudinal muscle and circular muscle strips in a dose-dependent manner, and the inhibitory effects were not blocked by tetrodotoxin. NaHS inhibited the peak I-Ca,I-L in colonic SMCs at a membrane potential of 0 mV. The current-voltage (I-V) relationship of L-type calcium channels was modified by NaHS, and the peak of the I-V curve was shifted to the right. NaHS (200 mu M) evoked a significant rightward shift of the steady-state activation curve and inhibited the inactivation of L-type calcium channels. Furthermore, NaHS reversibly decreased the peak I-Ca,I-L in a dose-dependent manner. Likewise, BKCa channels were significantly inhibited by NaHS, and the addition of NaHS caused a time- and dose-dependent reduction in the BKCa current. Conclusion The relaxant effect of H2S on colonic muscle strips may be associated with the direct inhibition of H2S on L-type calcium channels. H2S may be involved in the regulation of calcium homeostasis in colonic SMCs of rat colon.	[Quan, Xiaojing; Luo, Hesheng; Xia, Hong; Chen, Wei; Tang, Qincai] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Liu, Yin] Guilin Med Coll, Affiliated Hosp, Dept Gastroenterol, Guilin, Peoples R China; [Xia, Hong] Key Lab Hubei Prov Digest Syst Dis, Wuhan, Peoples R China	Wuhan University; Guilin Medical University	Luo, HS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China.	xhnk@163.com			National Natural Science Foundation of China [81070297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81070297). The URL of the funder's website is (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Garcia-Bereguiain MA, 2008, ANTIOXID REDOX SIGN, V10, P31, DOI 10.1089/ars.2007.1656; Bolton TB, 1999, ANNU REV PHYSIOL, V61, P85, DOI 10.1146/annurev.physiol.61.1.85; Farrugia G, 2014, GASTROENTEROLOGY, V147, P303, DOI 10.1053/j.gastro.2014.04.041; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Gade AR, 2013, MOL PHARMACOL, V83, P294, DOI 10.1124/mol.112.081596; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P1306, DOI 10.1111/j.1365-2982.2008.01201.x; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Gil V, 2013, BRIT J PHARMACOL, V169, P34, DOI 10.1111/bph.12100; Gil V, 2011, BRIT J PHARMACOL, V164, P485, DOI 10.1111/j.1476-5381.2011.01431.x; Han YF, 2011, EUR J PHARMACOL, V673, P85, DOI 10.1016/j.ejphar.2011.10.018; Hansen MB, 2003, PHARMACOL TOXICOL, V92, P249, DOI 10.1034/j.1600-0773.2003.920601.x; Hennig B, 2009, BRIT J PHARMACOL, V158, P1263, DOI 10.1111/j.1476-5381.2009.00385.x; Jackson-Weaver O, 2013, AM J PHYSIOL-HEART C, V304, pH1446, DOI 10.1152/ajpheart.00506.2012; Liang CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031774; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Liu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056562, 10.1371/journal.pone.0055853]; Martin GR, 2010, DIGEST LIVER DIS, V42, P103, DOI 10.1016/j.dld.2009.05.016; Mistry DK, 1998, BRIT J PHARMACOL, V124, P1131, DOI 10.1038/sj.bjp.0701940; Moore PK, 2003, TRENDS PHARMACOL SCI, V24, P609, DOI 10.1016/j.tips.2003.10.007; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Nagao M, 2012, J GASTROINTEST SURG, V16, P334, DOI 10.1007/s11605-011-1734-0; PALLOTTA BS, 1985, J GEN PHYSIOL, V86, P601, DOI 10.1085/jgp.86.5.601; Perez GJ, 1999, J GEN PHYSIOL, V113, P229, DOI 10.1085/jgp.113.2.229; RANNOU F, 1995, J MOL CELL CARDIOL, V27, P1225, DOI 10.1016/0022-2828(95)90059-4; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Sanders KM, 2001, J APPL PHYSIOL, V91, P1438, DOI 10.1152/jappl.2001.91.3.1438; Schicho R, 2006, GASTROENTEROLOGY, V131, P1542, DOI 10.1053/j.gastro.2006.08.035; Sitdikova GF, 2010, PFLUG ARCH EUR J PHY, V459, P389, DOI 10.1007/s00424-009-0737-0; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Telezhkin V, 2009, ADV EXP MED BIOL, V648, P65, DOI 10.1007/978-90-481-2259-2_7; Wang R, 1997, J BIOL CHEM, V272, P8222, DOI 10.1074/jbc.272.13.8222; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; WARENYCIA MW, 1989, BIOCHEM PHARMACOL, V38, P973, DOI 10.1016/0006-2952(89)90288-8; Wegener JW, 2006, FASEB J, V20, P1260, DOI 10.1096/fj.05-5292fje; Xu L, 2007, CLIN EXP PHARMACOL P, V34, P120, DOI 10.1111/j.1440-1681.2007.04465.x; Yong QC, 2010, NEUROCHEM INT, V56, P508, DOI 10.1016/j.neuint.2009.12.011; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014	37	24	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121331	10.1371/journal.pone.0121331	http://dx.doi.org/10.1371/journal.pone.0121331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811907	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700097
J	She, RC; Alrabaa, S; Lee, SH; Norvell, M; Wilson, A; Petti, CA				She, Rosemary C.; Alrabaa, Sally; Lee, Seung Heon; Norvell, Meghan; Wilson, Andrew; Petti, Cathy A.			Survey of Physicians' Perspectives and Knowledge about Diagnostic Tests for Bloodstream Infections	PLOS ONE			English	Article							GRAM-POSITIVE COCCI; RAPID IDENTIFICATION; DIRECT INOCULATION; NEGATIVE RODS; CULTURES; DETERMINANT; SYSTEM; IMPACT; TIME	Background Physicians rely on blood culture to diagnose bloodstream infections (BSI) despite its limitations. As new technologies emerge for rapid BSI diagnosis, optimization of their application to patient care requires an understanding of clinicians' perspectives on BSI diagnosis and how a rapid test would influence medical decisions. Methods We administered a 26-question survey to practitioners in infectious diseases/microbiology, critical care, internal medicine, and hematology/oncology services in USA and Germany about current standards in diagnosing and treating BSI and a hypothetical rapid BSI test. Results Responses from 242 providers had roughly equal representation across specialties. For suspected BSI patients, 78% of practitioners would administer empiric broad spectrum antibiotics although they estimated, on average, that 31% of patients received incorrect antibiotics while awaiting blood culture results. The ability of blood culture to rule in or rule out infection was very/extremely acceptable in 67% and 36%, respectively. Given rapid test results, 60-87% of practitioners would narrow the spectrum of antimicrobial therapy depending on the microorganism detected, with significantly higher percentages when resistance determinants were also tested. Over half of respondents felt a rapid test would be very/extremely influential on clinical practice. Conclusions Limitations of blood culture were perceived as a barrier to patient care. A rapid test to diagnose BSI would impact clinical practice, but the extent of impact may be limited by prevailing attitudes and practices. Opportunities exist for interventions to influence practitioners' behaviors in BSI management particularly with emergence of newer diagnostic tests.	[She, Rosemary C.; Lee, Seung Heon] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Alrabaa, Sally; Petti, Cathy A.] Univ S Florida, Morsani Sch Med, Dept Med, Tampa, FL USA; [Norvell, Meghan] NanoMR Inc, Albuquerque, NM USA; [Wilson, Andrew] Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT USA; [Petti, Cathy A.] HealthSpring Global Inc, Bradenton, FL USA	University of Southern California; State University System of Florida; University of South Florida; Utah System of Higher Education; University of Utah	She, RC (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	rosemary.she@med.usc.edu		Wilson, Andrew/0000-0003-3679-9232	nanoMR; HealthSpring Global Inc.	nanoMR; HealthSpring Global Inc.	nanoMR provided funding to develop the survey and collection of data in non-academic settings. HealthSpring Global Inc. provided support in the form of salaries for author CAP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alvarez R, 2012, EUR J CLIN MICROBIOL, V31, P2191, DOI 10.1007/s10096-012-1554-5; Borde JP, 2014, INFECTION, V42, P713, DOI 10.1007/s15010-014-0633-1; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Frye AM, 2012, J CLIN MICROBIOL, V50, P127, DOI 10.1128/JCM.06169-11; Funke G, 2004, J CLIN MICROBIOL, V42, P1466, DOI 10.1128/JCM.42.4.1466-1470.2004; Gastmeier P, 2007, INFECT CONT HOSP EP, V28, P466, DOI 10.1086/510810; Gherardi G, 2012, DIAGN MICR INFEC DIS, V72, P20, DOI 10.1016/j.diagmicrobio.2011.09.015; Jorgensen JH, 1997, J CLIN MICROBIOL, V35, P53, DOI 10.1128/JCM.35.1.53-58.1997; Kim J, 2010, J INFECTION, V61, P197, DOI 10.1016/j.jinf.2010.06.001; Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Lupetti A, 2010, CLIN MICROBIOL INFEC, V16, P986, DOI 10.1111/j.1469-0691.2009.03006.x; Nagel JL, 2014, J CLIN MICROBIOL, V52, P2849, DOI 10.1128/JCM.00682-14; Odaga J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008998.pub2; Perez KK, 2013, ARCH PATHOL LAB MED, V137, P1247, DOI 10.5858/arpa.2012-0651-OA; Schmitz RPH, 2013, CRIT CARE, V17, DOI 10.1186/cc13074; Yonetani S, 2012, DIAGN MICR INFEC DIS, V73, P129, DOI 10.1016/j.diagmicrobio.2012.03.004	20	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121493	10.1371/journal.pone.0121493	http://dx.doi.org/10.1371/journal.pone.0121493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811910	Green Submitted, gold, Green Published			2022-12-26	WOS:000356353700105
J	Xu, XY; Hall, J; Byles, J; Shi, ZM				Xu, Xiaoyue; Hall, John; Byles, Julie; Shi, Zumin			Assessing Dietary Quality of Older Chinese People Using the Chinese Diet Balance Index (DBI)	PLOS ONE			English	Article							CARDIOMETABOLIC RISK; MEDITERRANEAN DIET; BLOOD-PRESSURE; NUTRITION; CHILDREN; HEALTH; TRENDS; ADOLESCENTS; OBESITY; CONSUMPTION	Background/Objectives Few studies have applied the Chinese Diet Balance Index (DBI) in evaluating dietary quality for Chinese people. The present cross-sectional study assessed dietary quality based on DBI for older people, and the associated factors, in four socioeconomically distinct regions in China. Methods The China Health and Nutrition Survey (CHNS) involves 2745 older Chinese people, aged 60 or over, from four regions (Northeast, East Coast, Central and West) in 2009. Dietary data were obtained by interviews using 24 hour-recall over three consecutive days. Four indicators: Total Score (TS), Lower Bound Score (LBS), Higher Bound Score (HBS) and Diet Quality Distance (DQD) from DBI were calculated for assessing dietary quality in different aspects. Results 68.9% of older people had different levels of excessive cereals intake. More than 50% of older people had moderate or severe surplus of oil (64.9%) and salt (58.6%). Intake of vegetables and fruit, milk and soybeans, water, and dietary variety were insufficient, especially for milk and soybeans. 80.8% of people had moderate or severe unbalanced diet consumption. The largest differences of DQD scores have been found for people with different education levels and urbanicity levels. People with higher education levels have lower DQD scores (p<0.001), and people living in medium and low urbanicity areas had 2.8 and 8.9 higher DQD scores than their high urbanicity counterparts (p<0.001). Also, significant differences of DQD scores have been found according to gender, marital status, work status and regions (p<0.001). Conclusion DBI can reveal problems of dietary quality for older Chinese people. Rectifying unbalanced diet intake may lead to prevention of non-communicable diseases (NCDs). Dieticians and health care professionals need to increase dissemination and uptake of nutrition education, with interventions targeted at regions of lower socioeconomic status.	[Xu, Xiaoyue; Byles, Julie] Univ Newcastle, Hunter Med Res Inst, Sch Med & Publ Hlth, Prior Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia; [Xu, Xiaoyue; Hall, John] Univ Newcastle, Hunter Med Res Inst, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; [Shi, Zumin] Univ Adelaide, Sch Med, Adelaide, SA, Australia	Hunter Medical Research Institute; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Adelaide	Xu, XY (corresponding author), Univ Newcastle, Hunter Med Res Inst, Sch Med & Publ Hlth, Prior Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia.	xiaoyue.xu@uon.edu.au	Shi, Zumin/A-1093-2009	Shi, Zumin/0000-0002-3099-3299; Hall, John/0000-0001-9839-5626; Xu, Xiaoyue/0000-0003-4787-6547	National Institute of Nutrition and Food Safety; China Center for Disease Control and Prevention; Carolina Population Center [5 R24 HD050924]; University of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350, R24 HD050924, R01-HD38700]; Fogarty International Center, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, R01HD030880] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	National Institute of Nutrition and Food Safety; China Center for Disease Control and Prevention; Carolina Population Center; University of North Carolina at Chapel Hill; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. This research uses data from China Health and Nutrition Survey (CHNS). The National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention, Carolina Population Center (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the Fogarty International Center, NIH provide financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health provide support for CHNS 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrup A, 2008, OBES REV, V9, P48, DOI 10.1111/j.1467-789X.2007.00438.x; Brownie Sonya, 2006, Int J Nurs Pract, V12, P110, DOI 10.1111/j.1440-172X.2006.00557.x; Cai F, 2006, J PUBLIC ECON, V90, P2229, DOI 10.1016/j.jpubeco.2006.03.004; Carolina Population Center, 2011, CHIN HLTH NUTR SURV; Chinese Nutr Soc, 2000, J AM DIET ASSOC, V100, P886; Cowan DT, 2004, INT J NURS STUD, V41, P225, DOI 10.1016/S0020-7489(03)00131-7; Cui ZH, 2012, BRIT J NUTR, V108, P1292, DOI 10.1017/S0007114511006891; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Du SF, 2014, OBES REV, V15, P8, DOI 10.1111/obr.12122; Esposito K, 2009, DIABETIC MED, V26, P900, DOI 10.1111/j.1464-5491.2009.02798.x; Ford DW, 2014, J ACAD NUTR IN PRESS; Guenther PM, 2014, J NUTR, V144, P399, DOI 10.3945/jn.113.183079; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He Yu-Na, 2005, Wei Sheng Yan Jiu, V34, P442; He YuNa, 2009, Acta Nutrimenta Sinica, V31, P532; Hu G, 2002, BRIT J NUTR, V88, P91, DOI 10.1079/BJNBJN2002590; Hu YH, 2011, J INT MED RES, V39, P23, DOI 10.1177/147323001103900103; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025; Li Y, 2012, NUTRITION, V28, P504, DOI 10.1016/j.nut.2011.07.023; Li YC, 2011, ADDICTION, V106, P1946, DOI 10.1111/j.1360-0443.2011.03514.x; Liang YJ, 2011, BLOOD PRESSURE, V20, P45, DOI 10.3109/08037051.2010.524085; Liu F., 2009, REGIONAL EC DEV CHIN, P9; Maynard M, 2006, EUR J PUBLIC HEALTH, V16, P315, DOI 10.1093/eurpub/cki167; McCullough ML, 2006, PUBLIC HEALTH NUTR, V9, P152, DOI 10.1079/PHN2005938; Meng LP, 2009, PUBLIC HEALTH NUTR, V12, P1540, DOI 10.1017/S1368980008004606; Popkin BM, 2006, OBES REV, V7, P271, DOI 10.1111/j.1467-789X.2006.00230.x; Shi ZM, 2010, BRIT J NUTR, V104, P457, DOI 10.1017/S0007114510000760; Sicular T, 2007, REV INCOME WEALTH, V53, P93, DOI 10.1111/j.1475-4991.2007.00219.x; Sotos-Prieto M, 2014, BRIT J NUTR, V112, P122, DOI 10.1017/S0007114514000580; Stookey JD, 2000, EUR J CLIN NUTR, V54, P811, DOI 10.1038/sj.ejcn.1601098; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; Wang Y, 2008, FOOD NUTR BULL, V29, P172, DOI 10.1177/156482650802900303; World Health Organization, 2014, PROM FRUIT VEG CONS; World Health Organization, 2014, DIET NUTR PREV CHRON; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yan S, 2012, OBES REV, V13, P810, DOI 10.1111/j.1467-789X.2012.01016.x; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087539; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119; Zhang JZ, 2014, ANN BIOMED ENG, V42, P1658, DOI 10.1007/s10439-014-1017-5; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	43	35	40	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121618	10.1371/journal.pone.0121618	http://dx.doi.org/10.1371/journal.pone.0121618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811834	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700122
J	Baldini, E; Tuccilli, C; Prinzi, N; Sorrenti, S; Falvo, L; De Vito, C; Catania, A; Tartaglia, F; Mocini, R; Coccaro, C; Alessandrini, S; Barollo, S; Mian, C; Antonelli, A; De Antoni, E; D'Armiento, M; Ulisse, S				Baldini, Enke; Tuccilli, Chiara; Prinzi, Natalie; Sorrenti, Salvatore; Falvo, Laura; De Vito, Corrado; Catania, Antonio; Tartaglia, Francesco; Mocini, Renzo; Coccaro, Carmela; Alessandrini, Stefania; Barollo, Susi; Mian, Caterina; Antonelli, Alessandro; De Antoni, Enrico; D'Armiento, Massimino; Ulisse, Salvatore			Deregulated Expression of Aurora Kinases Is Not a Prognostic Biomarker in Papillary Thyroid Cancer Patients	PLOS ONE			English	Article							B OVEREXPRESSION; POOR-PROGNOSIS; PREDICTS POOR; CARCINOMA; SURVIVAL; INSTABILITY; RECEPTOR; SURGERY; TARGETS; MARKER	A number of reports indicated that Aurora-A or Aurora-B overexpression represented a negative prognostic factor in several human malignancies. In thyroid cancer tissues a deregulated expression of Aurora kinases has been also demonstrated, butno information regarding its possible prognostic role in differentiated thyroid cancer is available. Here, weevaluated Aurora-A and Aurora-B mRNA expression and its prognostic relevance in a series of 87 papillary thyroid cancers (PTC), with a median follow-up of 63 months. The analysis of Aurora-A and Aurora-B mRNA levels in PTC tissues, compared to normal matched tissues, revealed that their expression was either up-or down-regulatedin the majority of cancer tissues. In particular, Aurora-A and Aurora-B mRNA levels were altered, respectively, in 55 (63.2%) and 79 (90.8%) out of the 87 PTC analyzed. A significant positive correlation between Aurora-A and Aurora-B mRNAswas observed (p=0.001). The expression of both Aurora genes was not affected by the BRAF(V600E) mutation. Univariate, multivariate and Kaplan-Mayer analyses documented the lack of association between Aurora-A or Aurora-B expression and clinicopathological parameterssuch as gender, age, tumor size, histology, TNM stage, lymph node metastasis and BRAF status as well asdisease recurrences or disease-free interval. Only Aurora-B mRNA was significantly higher in T(3-4) tissues, with respect to T(1-2) PTC tissues. The data reported here demonstrate that the expression of Aurora kinases is deregulated in the majority of PTC tissues, likely contributing to PTC progression. However, differently from other human solid cancers, detection of Aurora-A or Aurora-B mRNAs is not a prognostic biomarker inPTC patients.	[Baldini, Enke; Tuccilli, Chiara; Prinzi, Natalie; Coccaro, Carmela; Alessandrini, Stefania; D'Armiento, Massimino; Ulisse, Salvatore] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Sorrenti, Salvatore; Falvo, Laura; Catania, Antonio; Tartaglia, Francesco; Mocini, Renzo; De Antoni, Enrico] Univ Roma La Sapienza, Dept Surg Sci, I-00185 Rome, Italy; [De Vito, Corrado] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Barollo, Susi; Mian, Caterina] Univ Padua, Dept Med, Padua, Italy; [Antonelli, Alessandro] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; University of Padua; University of Pisa	Ulisse, S (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	salvatore.ulisse@uniroma1.it	Sorrenti, Salvatore/AGZ-2978-2022; Ulisse, Salvatore/H-5362-2019; Tartaglia, Francesco/P-8443-2019; Prinzi, Natalie/AAA-7518-2019	Sorrenti, Salvatore/0000-0003-0427-6648; Ulisse, Salvatore/0000-0002-7573-0759; Tartaglia, Francesco/0000-0003-2943-8551; Prinzi, Natalie/0000-0002-6261-7239; CATANIA, Antonio/0000-0003-0424-1189; MIAN, CATERINA/0000-0003-2615-8001; DE VITO, CORRADO/0000-0002-7846-672X	Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN 2010BX2SNA_007]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was support by a grant (PRIN 2010BX2SNA_007) of the Ministero dell'Istruzione, dell'Universita e della Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2014, ANN SURG, V260, P601, DOI 10.1097/SLA.0000000000000925; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Are C, 2006, ANN SURG ONCOL, V13, P453, DOI 10.1245/ASO.2006.05.042; Arlot-Bonnemains Y, 2008, ENDOCR-RELAT CANCER, V15, P559, DOI 10.1677/ERC-08-0021; Baldini E, 2013, J BIOL REG HOMEOS AG, V27, P705; Baldini E, 2012, CLIN TER, V163, pE457; Baldini E, 2012, CLIN TER, V163, pE307; Baldini E, 2012, G CHIR, V33, P305; Baldini E, 2014, ENDOCR-RELAT CANCER, V21, P797, DOI 10.1530/ERC-14-0299; Baldini E, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/816430; Barollo S, 2010, EUR J ENDOCRINOL, V163, P659, DOI 10.1530/EJE-10-0290; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Borges KS, 2013, PEDIATR BLOOD CANCER, V60, P1809, DOI 10.1002/pbc.24653; Castagna MG, 2011, EUR J ENDOCRINOL, V165, P441, DOI 10.1530/EJE-11-0466; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chou CK, 2013, J CLIN ENDOCR METAB, V98, pE196, DOI 10.1210/jc.2012-2666; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Dotan E, 2012, BRIT J CANCER, V106, P748, DOI 10.1038/bjc.2011.587; Enjoji M, 2009, MOL MED REP, V2, P589, DOI 10.3892/mmr_00000142; Erpolat OP, 2012, STRAHLENTHER ONKOL, V188, P248, DOI 10.1007/s00066-011-0042-7; Eustatia-Rutten CFA, 2006, J CLIN ENDOCR METAB, V91, P313, DOI 10.1210/jc.2005-1322; Fagin JA, 2002, MOL ENDOCRINOL, V16, P903, DOI 10.1210/me.16.5.903; Gospodarowicz MK, PROGNOSTIC FACTORS C; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Handkiewicz-Junak D, 2010, MOL CELL ENDOCRINOL, V322, P8, DOI 10.1016/j.mce.2010.01.007; HEDINGER C, 1989, CANCER-AM CANCER SOC, V63, P908, DOI 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I; Heikkila A, 2013, THYROID, V23, P456, DOI 10.1089/thy.2012.0363; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kinder BK, 2003, CURR OPIN ONCOL, V15, P71, DOI 10.1097/00001622-200301000-00011; Lei Y, 2011, ACTA HISTOCHEM, V113, P514, DOI 10.1016/j.acthis.2010.05.004; Liu ZG, 2012, ONCOL LETT, V3, P1237, DOI 10.3892/ol.2012.660; Mendiola M, 2009, HUM PATHOL, V40, P631, DOI 10.1016/j.humpath.2008.10.011; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Orosco RK, 2015, THYROID, V25, P125, DOI 10.1089/thy.2014.0116; Pasieka JL, 2003, CURR OPIN ONCOL, V15, P78, DOI 10.1097/00001622-200301000-00012; Passler C, 2004, ENDOCR-RELAT CANCER, V11, P131, DOI 10.1677/erc.0.0110131; Patel Kepal N, 2006, Cancer Control, V13, P119; Shahedian B, 2001, MOL GENET METAB, V72, P155, DOI 10.1006/mgme.2000.3114; Sharma A, 2013, AM J PATHOL, V182, P1151, DOI 10.1016/j.ajpath.2012.12.019; Shibru D, 2008, CURR OPIN ONCOL, V20, P13, DOI 10.1097/CCO.0b013e3282f27e49; Sorrentino R, 2005, J CLIN ENDOCR METAB, V90, P928, DOI 10.1210/jc.2004-1518; Takeshita M, 2013, LUNG CANCER, V80, P85, DOI 10.1016/j.lungcan.2012.12.018; Trimboli P, 2006, THYROID, V16, P1151, DOI 10.1089/thy.2006.16.1151; Ulisse S, 2007, ENDOCR-RELAT CANCER, V14, P827, DOI 10.1677/ERC-07-0053; Ulisse S, 2006, INT J CANCER, V119, P275, DOI 10.1002/ijc.21842; Ulisse S, 2012, CLIN ENDOCRINOL, V77, P780, DOI 10.1111/j.1365-2265.2012.04465.x; Ulisse S, 2011, J CLIN ENDOCR METAB, V96, P504, DOI 10.1210/jc.2010-1688; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang J, 2011, ONCOL REP, V26, P23, DOI 10.3892/or.2011.1250; Wreesmann VB, 2002, AM J PATHOL, V161, P1549, DOI 10.1016/S0002-9440(10)64433-1; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056919; Yang F, 2011, MODERN PATHOL, V24, P836, DOI 10.1038/modpathol.2011.44	52	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121514	10.1371/journal.pone.0121514	http://dx.doi.org/10.1371/journal.pone.0121514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807528	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000161
J	Caceres, S; Pena, L; de Andres, PJ; Illera, MJ; Lopez, MS; Woodward, WA; Reuben, JM; Illera, JC				Caceres, Sara; Pena, Laura; de Andres, Paloma J.; Illera, Maria J.; Lopez, Mirtha S.; Woodward, Wendy A.; Reuben, James M.; Illera, Juan C.			Establishment and Characterization of a New Cell Line of Canine Inflammatory Mammary Cancer: IPC-366	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; E-CADHERIN; CLINICAL-IMPLICATIONS; VASCULOGENIC MIMICRY; VIMENTIN EXPRESSION; METASTASIS; CARCINOMA; SURVIVAL; TUMORS	Canine inflammatory mammary cancer (IMC) shares epidemiologic, histopathological and clinical characteristics with the disease in humans and has been proposed as a natural model for human inflammatory breast cancer (IBC). The aim of this study was to characterize a new cell line from IMC (IPC-366) for the comparative study of both IMC and IBC. Tumors cells from a female dog with clinical IMC were collected. The cells were grown under adherent conditions. The growth, cytological, ultrastructural and immunohistochemical (IHC) characteristics of IPC-366 were evaluated. Ten female Balb/SCID mice were inoculated with IPC-366 cells to assess their tumorigenicity and metastatic potential. Chromosome aberration test and Karyotype revealed the presence of structural aberration, numerical and neutral rearrangements, demonstrating a chromosomal instability. Microscopic examination of tumor revealed an epithelial morphology with marked anysocytosis. Cytological and histological examination of smears and ultrathin sections by electron microscopy revealed that IPC-366 is formed by highly malignant large round or polygonal cells characterized by marked atypia and prominent nucleoli and frequent multinucleated cells. Some cells had cytoplasmic empty spaces covered by cytoplasmic membrane resembling capillary endothelial cells, a phenomenon that has been related to s vasculogenic mimicry. IHC characterization of IPC-366 was basal-like: epithelial cells (AE1/AE3+, CK14+, vimentin+, actin-, p63-, ER-, PR-, HER-2, E-cadherin, overexpressed COX-2 and high Ki-67 proliferation index (87.15 %). At 2 weeks after inoculating the IPC-366 cells, a tumor mass was found in 100% of mice. At 4 weeks metastases in lung and lymph nodes were found. Xenograph tumors maintained the original IHC characteristics of the female dog tumor. In summary, the cell line IPC-366 is a fast growing malignant triple negative cell line model of inflammatory mammary carcinoma that can be used for the comparative study of both IMC and IBC.	[Caceres, Sara; Illera, Maria J.; Illera, Juan C.] Univ Complutense Madrid, Sch Vet Med, Dept Anim Physiol Surg & Pathol, E-28040 Madrid, Spain; [Pena, Laura; de Andres, Paloma J.] Univ Complutense Madrid, Sch Vet Med, Dept Anim Med Surg & Pathol, E-28040 Madrid, Spain; [Lopez, Mirtha S.; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Complutense University of Madrid; Complutense University of Madrid; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Reuben, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.	jreuben@mdanderson.org	Peña, Laura/M-7820-2014; Woodward, Wendy/AAX-6593-2020	Peña, Laura/0000-0001-7135-6280; Woodward, Wendy/0000-0002-7935-739X	Spanish Ministry of Science and Education [SAF 2009-10572]	Spanish Ministry of Science and Education(Spanish Government)	Funding was provided by the Spanish Ministry of Science and Education (research project no. SAF 2009-10572) to SC, LP, PJA, MJI, and JCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenza MDP, 2001, J AM VET MED ASSOC, V219, P1110, DOI 10.2460/javma.2001.219.1110; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Bocca C, 2014, EXPERT OPIN THER TAR, V18, P121, DOI 10.1517/14728222.2014.860447; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Camacho L, 2013, RES VET SCI, V95, P1068, DOI 10.1016/j.rvsc.2013.07.017; Carkaci S, 2013, EUR J NUCL MED MOL I, V40, P1809, DOI 10.1007/s00259-013-2506-8; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Chen A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-552; Clemente M, 2010, J COMP PATHOL, V143, P157, DOI 10.1016/j.jcpa.2010.02.002; Clemente M, 2013, VET J, V197, P427, DOI 10.1016/j.tvjl.2013.02.009; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Fernandez SV, 2013, BREAST CANCER RES TR, V140, P23, DOI 10.1007/s10549-013-2600-4; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Giordano SH, 2003, BREAST CANCER RES, V5, P284, DOI 10.1186/bcr608; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Gracanin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098698; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; HEATLEY M, 1993, J CLIN PATHOL, V46, P441, DOI 10.1136/jcp.46.5.441; Hiraguri S, 1998, CANCER RES, V58, P1972; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hsiao YL, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0229-0; Kleer CG, 2000, BREAST CANCER RES, V2, P423, DOI 10.1186/bcr89; Klopp AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012180; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Krol M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083995; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Majchrzak K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076789; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Markosyan N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3469; Martinez-Carpio PA, 2003, REV ONCOL, V5, P184; Michishita M, 2011, RES VET SCI, V91, P254, DOI 10.1016/j.rvsc.2010.11.016; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Pang LY, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0184-9; Pena L, 2014, VET PATHOL, V51, P127, DOI 10.1177/0300985813509388; Pena L, 2003, BREAST CANCER RES TR, V78, P141, DOI 10.1023/A:1022991802116; Pena LL, 1998, J VET DIAGN INVEST, V10, P237, DOI 10.1177/104063879801000303; Robertson Fredika M, 2008, J Exp Ther Oncol, V7, P299; SEABRIGH.M, 1971, LANCET, V2, P971; Shirakawa K, 2002, INT J CANCER, V99, P821, DOI 10.1002/ijc.10423; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; SUSANECK SJ, 1983, J AM ANIM HOSP ASSOC, V19, P971; Tavassoli F. A., 1999, PATHOLOGY BREAST, P538; Thanan R, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/165879; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomas R, 2007, J HERED, V98, P474, DOI 10.1093/jhered/esm053; Tomlinson JS, 2001, CANCER RES, V61, P5231; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Vora HH, 2009, INT J BIOL MARKER, V24, P38, DOI 10.1177/172460080902400106; Yamauchi H, 2012, ONCOLOGIST, V17, P891, DOI 10.1634/theoncologist.2012-0039; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; Ye Y, 2010, ANTICANCER RES, V30, P3903	56	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122277	10.1371/journal.pone.0122277	http://dx.doi.org/10.1371/journal.pone.0122277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807360	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000216
J	Guan, YJ; Li, Z; He, F; Huang, YT; Song, WJ; Hu, J				Guan, Yajing; Li, Zhan; He, Fei; Huang, Yutao; Song, Wenjian; Hu, Jin			"On-Off" Thermoresponsive Coating Agent Containing Salicylic Acid Applied to Maize Seeds for Chilling Tolerance	PLOS ONE			English	Article							POLY N-ISOPROPYLACRYLAMIDE; PHYSIOLOGICAL-CHANGES; OXIDATIVE STRESS; SEEDLING GROWTH; GERMINATION; MEMBRANES; INJURY; LEAVES; COLD	Chilling stress is an important constraint for maize seed establishment in the field. In this study, a type of "on-off" thermoresponsive coating agent containing poly (N-isopropylacrylamide-co-butylmethacrylate) (Abbr. P(NIPAm-co-BMA)) hydrogel was developed to improve the chilling tolerance of coated maize seed. The P(NIPAm-co-BMA) hydrogel was synthesized by free-radical polymerization of N-isopropylacrylamide (NIPAm) and butylmethacrylate (BMA). Salicylic acid (SA) was loaded in the hydrogel as the chilling resistance agent. SA-loaded P (NIPAm-co-BMA) was used for seed film-coating of two maize varieties, Huang C (HC, chilling-tolerant) and Mo17 (chilling-sensitive), to investigate the coated seed germination and seedling growth status under chilling stress. The results showed that the hydrogel obtained a phase transition temperature near 12 degrees C with a NIPAM to MBA weight ratio of 1: 0.1988 (w/w). The temperature of 12 degrees C was considered the "on-off" temperature for chilling-resistant agent release; the SA was released from the hydrogel more rapidly at external temperatures below 12 degrees C than above 12 degrees C. In addition, when seedlings of both maize varieties suffered a short chilling stress (5 degrees C), higher concentrations of SA-loaded hydrogel resulted in increased germination energy, germination percentage, germination index, root length, shoot height, dry weight of roots and shoots and protective enzyme activities and a decreased malondialdehyde content in coatedmaize seeds compared to single SA treatments. The majority of these physiological and biochemical parameters achieved significant levels compared with the control. Therefore, SA-loaded P(NIPAm-co-BMA), a nontoxic thermoresponsive hydrogel, can be used as an effective material for chilling tolerance in film-coated maize seeds.	[Guan, Yajing; Li, Zhan; He, Fei; Huang, Yutao; Song, Wenjian; Hu, Jin] Zhejiang Univ, Coll Agr & Biotechnol, Seed Sci Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, J (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Seed Sci Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	jhu@zju.edu.cn			Special Fund for Agro-scientific Research in the Public Interest [201203052]; National Natural Science Fund [31201279, 31371708]; Project of the Science and Technology Department of Zhejiang Province, P.R. China [2013C32023, 2012C12902-65, 2013C02005]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Project of the Science and Technology Department of Zhejiang Province, P.R. China	This research was supported by the Special Fund for Agro-scientific Research in the Public Interest (No. 201203052), the National Natural Science Fund (No. 31201279 and 31371708) and the Project of the Science and Technology Department of Zhejiang Province (No. 2013C32023, 2012C12902-65, 2013C02005), P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481; Cai Chuan-Jie, 2003, Acta Botanica Yunnanica, V25, P700; Cao DD, 2010, SCI HORTIC-AMSTERDAM, V123, P301, DOI 10.1016/j.scienta.2009.10.006; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Fundueanu G, 2009, ACTA BIOMATER, V5, P363, DOI 10.1016/j.actbio.2008.07.011; Gao CH, 2009, PLANT GROWTH REGUL, V57, P31, DOI 10.1007/s10725-008-9315-2; Guan YJ, 2009, J ZHEJIANG UNIV-SC B, V10, P427, DOI 10.1631/jzus.B0820373; Gunes A, 2007, J PLANT PHYSIOL, V164, P728, DOI 10.1016/j.jplph.2005.12.009; HOPE HJ, 1992, CAN J PLANT SCI, V72, P83, DOI 10.4141/cjps92-009; Horvath E, 2007, BIOL PLANTARUM, V51, P480, DOI 10.1007/s10535-007-0101-1; Horvath E, 2007, J PLANT GROWTH REGUL, V26, P290, DOI 10.1007/s00344-007-9017-4; Hu J, 2006, SEED SCI TECHNOL, V34, P199, DOI 10.15258/sst.2006.34.1.22; Hu J, 2005, SEED SCI TECHNOL, V33, P243, DOI 10.15258/sst.2005.33.1.25; Hu J, 2010, SEED STORAGE PROCESS; Janda T, 1999, PLANTA, V208, P175, DOI 10.1007/s004250050547; Kang GZ, 2003, ENVIRON EXP BOT, V50, P9, DOI 10.1016/S0098-8472(02)00109-0; Kang HM, 2002, PHYSIOL PLANTARUM, V115, P571, DOI 10.1034/j.1399-3054.2002.1150411.x; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Li LiQing, 2004, Journal of Zhejiang University (Agriculture and Life Sciences), V30, P311; Li SK, 2003, INT J PHARM, V267, P27, DOI 10.1016/j.ijpharm.2003.07.009; Li XY, 2008, CARBOHYD POLYM, V71, P394, DOI 10.1016/j.carbpol.2007.06.005; Lue SJ, 2007, J MEMBRANE SCI, V301, P142, DOI 10.1016/j.memsci.2007.06.020; Lukatkin AS, 2003, RUSS J PLANT PHYSL+, V50, P243, DOI 10.1023/A:1022985500733; Ma XM, 2005, POLYM INT, V54, P83, DOI 10.1002/pi.1619; Makino K, 2000, COLLOID SURFACE B, V19, P197, DOI 10.1016/S0927-7765(00)00155-7; [毛华华 MAO Huahua], 2008, [功能高分子学报, Journal of Functional Polymer], V21, P432; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Qiu J, 2005, PLANT GROWTH REGUL, V47, P75, DOI 10.1007/s10725-005-2451-z; SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R; Soumen Bhattacharjee, 2012, Journal of Botany, V2012, P985298; Tasgin E, 2003, PLANT GROWTH REGUL, V41, P231, DOI 10.1023/B:GROW.0000007504.41476.c2; Wang Y, 2012, BOTANY, V90, P845, DOI [10.1139/b2012-055, 10.1139/B2012-055]; WISE RR, 1995, PHOTOSYNTH RES, V45, P79, DOI 10.1007/BF00032579; Zhang CF, 2007, SEED SCI TECHNOL, V35, P733, DOI 10.15258/sst.2007.35.3.19; Zhang HaiQing, 2007, Agricultural Sciences in China, V6, P792, DOI 10.1016/S1671-2927(07)60114-X; Zhang Q, 2010, THESIS HARBIN U SCI; Zheng YunYe, 2006, Journal of Zhejiang University (Agriculture and Life Sciences), V32, P41	37	18	20	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120695	10.1371/journal.pone.0120695	http://dx.doi.org/10.1371/journal.pone.0120695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807522	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000097
J	Rossetti, L; Digiuni, M; Rosso, A; Riva, R; Barbaro, G; Smolek, MK; Orzalesi, N; De Cilla, S; Autelitano, A; Fogagnolo, P				Rossetti, Luca; Digiuni, Maurizio; Rosso, Alberto; Riva, Roberta; Barbaro, Giuliano; Smolek, Michael K.; Orzalesi, Nicola; De Cilla, Stefano; Autelitano, Alessandro; Fogagnolo, Paolo			Compass: Clinical Evaluation of a New Instrument for the Diagnosis of Glaucoma	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPEN-ANGLE GLAUCOMA; MICROPERIMETER MP-1; AUTOMATED PERIMETRY; FIXATION BEHAVIOR; STANDARD	Aims To evaluate Compass, a new instrument for glaucoma screening and diagnosis that combines scanning ophthalmoscopy, automated perimetry, and eye tracking. Materials and Methods A total of 320 human subjects (200 normal, 120 with glaucoma) underwent full ophthalmological evaluation and perimetric evaluation using the Humphrey SITA standard 24 degrees test (HFA), and the Compass test that consisted of a full-threshold program on the central 24 degrees with a photograph of the central 30 degrees of the retina. A subgroup of normal subjects and glaucoma patients underwent a second Compass test during the same day in order to study test-retest variability. After exclusion of 30 patients due to protocol rules, a database was created to compare the Compass to the HFA, and to evaluate retinal image quality and fixation stability. Results The difference in mean sensitivity between Compass and HFA was -1.02 +/- 1.55 dB in normal subjects (p< 0.001) and -1.01 +/- 2.81 dB in glaucoma (p< 0.001). Repeatability SD for the average sensitivity was 1.53 for normal subjects and 1.84 for glaucoma. Test time with the Compass was 634+/-96 s (607+/-78 for normals, 678+/-108 for glaucoma). Compass analysis showed the percentage of fixation within the central 1 degrees was 86.6% in normal subjects, and 79.3% in glaucoma patients. Color image quality was sufficient for diagnostic use in > 65% of cases; Image-based diagnosis was in accordance with the initial diagnosis in 85% of the subjects. Conclusions Based on preliminary results, Compass showed useful diagnostic characteristics for the study of glaucoma, and combined morphological information with functional data.	[Rossetti, Luca; Digiuni, Maurizio; Riva, Roberta; Orzalesi, Nicola; De Cilla, Stefano; Autelitano, Alessandro; Fogagnolo, Paolo] Univ Milan, Osped San Paolo, Dept Med Surg & Odontoiatry, Eye Clin, Milan, Italy; [Rosso, Alberto; Barbaro, Giuliano] CenterVue, Padua, Italy; [Smolek, Michael K.] CLEVER Eye Inst, Slidell, LA USA; [De Cilla, Stefano] Osped Maggiore La Carita, Unit Ophthalmol, Novara, Italy	San Paolo-Polo Universitaria Hospital; University of Milan	Fogagnolo, P (corresponding author), Univ Milan, Osped San Paolo, Dept Med Surg & Odontoiatry, Eye Clin, Milan, Italy.	fogagnolopaolo@googlemail.com		Rossetti, Luca/0000-0002-7027-3173; AUTELITANO, ALESSANDRO/0000-0001-9380-2173	CenterVue; CLEVER Eye Institute	CenterVue; CLEVER Eye Institute	CenterVue has funded this work. The funders had a role in study design and preparation of the manuscript. Co-authors Giuliano Barbaro, Alberto Rosso are employed by CenterVue. Luca Rossetti, Nicola Orzalesi, Paolo Fogagnolo and Michael K Smolek were paid consultants of CenterVue. The specific roles of these authors is articulated in the 'author contributions' section. Co-author Michael K Smolek is employed by CLEVER Eye Institute. CLEVER Eye Institute provided support in the form of salary for author MKS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Acton JH, 2011, OPTOMETRY VISION SCI, V88, P1288, DOI 10.1097/OPX.0b013e31822b3746; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Bosworth C F, 2000, Semin Ophthalmol, V15, P172, DOI 10.3109/08820530009037869; Ferreras A, 2008, INVEST OPHTH VIS SCI, V49, P3018, DOI 10.1167/iovs.08-1775; Fogagnolo P, 2008, PROG BRAIN RES, V173, P101, DOI 10.1016/S0079-6123(08)01108-4; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1737, DOI 10.1016/S0161-6420(02)01120-X; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; Kameda T, 2009, JPN J OPHTHALMOL, V53, P580, DOI 10.1007/s10384-009-0735-y; Leske MC, 1999, OPHTHALMOLOGY, V106, P2144, DOI 10.1016/S0161-6420(99)90497-9; LESKE MC, 1979, AM J EPIDEMIOL, V109, P250, DOI 10.1093/oxfordjournals.aje.a112680; MIGLIOR S, 1994, AM J OPHTHALMOL, V118, P16, DOI 10.1016/S0002-9394(14)72837-5; Redmond T, 2013, INVEST OPHTH VIS SCI, V54, P2153, DOI 10.1167/iovs.12-10342; Shi Y, 2013, J GLAUCOMA, V22, P169, DOI 10.1097/IJG.0b013e3182311dce; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wohlrab TM, 2002, OPHTHALMOLOGICA, V216, P96, DOI 10.1159/000048306; Wright HR, 2015, BRIT J OPHTHALMOL, V99, P313, DOI 10.1136/bjophthalmol-2014-305588	16	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122157	10.1371/journal.pone.0122157	http://dx.doi.org/10.1371/journal.pone.0122157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807241	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000207
J	Solomon, R; Zhang, WB; McCrann, G; Bliska, JB; Viboud, GI				Solomon, Rebecca; Zhang, Weibing; McCrann, Grace; Bliska, James B.; Viboud, Gloria I.			Random Mutagenesis Identifies a C-Terminal Region of YopD Important for Yersinia Type III Secretion Function	PLOS ONE			English	Article							PORE FORMATION; TARGET-CELL; TYROSINE-PHOSPHATASE; SIGNALING RESPONSES; TRANSLOCATORS YOPB; PLASMA-MEMBRANE; DOWN-REGULATION; PSEUDOTUBERCULOSIS; PROTEIN; SYSTEM	A common virulence mechanism among bacterial pathogens is the use of specialized secretion systems that deliver virulence proteins through a translocation channel inserted in the host cell membrane. During Yersinia infection, the host recognizes the type III secretion system mounting a pro-inflammatory response. However, soon after they are translocated, the effectors efficiently counteract that response. In this study we sought to identify YopD residues responsible for type III secretion system function. Through random mutagenesis, we identified eight Y. pseudotuberculosis yopD mutants with single amino acid changes affecting various type III secretion functions. Three severely defective mutants had substitutions in residues encompassing a 35 amino acid region (residues 168-203) located between the transmembrane domain and the C-terminal putative coiled-coil region of YopD. These mutations did not affect regulation of the low calcium response or YopB-YopD interaction but markedly inhibited MAPK and NF B activation. When some of these mutations were introduced into the native yopD gene, defects in effector translocation and pore formation were also observed. We conclude that this newly identified region is important for YopD translocon function. The role of this domain in vivo remains elusive, as amino acid substitutions in that region did not significantly affect virulence of Y. pseudotuberculosis in orogastrically-infected mice.	[Solomon, Rebecca; Zhang, Weibing; McCrann, Grace; Viboud, Gloria I.] SUNY Stony Brook, Clin Sci Lab, Sch Hlth Technol & Management, Stony Brook, NY 11794 USA; [Solomon, Rebecca; Zhang, Weibing; Bliska, James B.; Viboud, Gloria I.] SUNY Stony Brook, Sch Med, Ctr Infect Dis, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Viboud, GI (corresponding author), SUNY Stony Brook, Clin Sci Lab, Sch Hlth Technol & Management, Stony Brook, NY 11794 USA.	gloria.viboud@stonybrook.edu			National Institutes of Health [R21-AI073815, R01AI099222]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073815, R01AI099222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by a grant from the National Institutes of Health R21-AI073815 awarded to GIV and NIH R01AI099222 to JBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli M, 2008, INT J MED MICROBIOL, V298, P183, DOI 10.1016/j.ijmm.2007.04.007; Amer AAA, 2011, J BACTERIOL, V193, P6683, DOI 10.1128/JB.00210-11; Anderson DM, 2002, J BACTERIOL, V184, P1287, DOI 10.1128/JB.184.5.1287-1295.2002; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; Bliska JB, 2013, CELL MICROBIOL, V15, P1622, DOI 10.1111/cmi.12164; BLISKA JB, 1993, CELL, V73, P903, DOI 10.1016/0092-8674(93)90270-Z; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Chen YQ, 2011, MOL MICROBIOL, V80, P966, DOI 10.1111/j.1365-2958.2011.07623.x; Chung LK, 2014, MBIO, V5, DOI 10.1128/mBio.01402-14; Costa TRD, 2012, INFECT GENET EVOL, V12, P1729, DOI 10.1016/j.meegid.2012.07.016; Costa TRD, 2010, J BIOL CHEM, V285, P25269, DOI 10.1074/jbc.M110.144311; Fowler JM, 2009, MICROBIOL-SGM, V155, P2509, DOI 10.1099/mic.0.028852-0; Francis MS, 2000, MOL MICROBIOL, V38, P85, DOI 10.1046/j.1365-2958.2000.02112.x; Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garcia JT, 2006, INFECT IMMUN, V74, P5645, DOI 10.1128/IAI.00690-06; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x; Ivanov MI, 2008, INFECT IMMUN, V76, P5181, DOI 10.1128/IAI.00189-08; Kopaskie KS, 2013, J BIOL CHEM, V288, P35478, DOI 10.1074/jbc.M113.504811; Kwuan L, 2013, INFECT IMMUN, V81, P905, DOI 10.1128/IAI.01014-12; Luo WS, 2011, J BACTERIOL, V193, P2972, DOI 10.1128/JB.00153-11; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; Mejia E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040003; Montagna LG, 2001, J BIOL CHEM, V276, P5005, DOI 10.1074/jbc.M009045200; Montagner C, 2011, J BACTERIOL, V193, P6923, DOI 10.1128/JB.05555-11; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Noel BL, 2009, CLIN VACCINE IMMUNOL, V16, P1457, DOI 10.1128/CVI.00172-09; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Palmer LE, 1999, INFECT IMMUN, V67, P708, DOI 10.1128/IAI.67.2.708-716.1999; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Schreiner M, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-13; SIMONET M, 1992, INFECT IMMUN, V60, P4414, DOI 10.1128/IAI.60.10.4414-4417.1992; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Viboud GI, 2003, MOL MICROBIOL, V47, P1305, DOI 10.1046/j.1365-2958.2003.03350.x; Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373; Viboud GI, 2006, CELL MICROBIOL, V8, P1504, DOI 10.1111/j.1462-5822.2006.00729.x; Wang TH, 2011, J IMMUNOL, V186, P708, DOI 10.4049/jimmunol.1001203; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120471	10.1371/journal.pone.0120471	http://dx.doi.org/10.1371/journal.pone.0120471			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807250	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000079
J	Ueda, S; Blee, AM; Macway, KG; Renner, DJ; Yamada, S				Ueda, Shuji; Blee, Alexandra M.; Macway, Katherine G.; Renner, Derrick J.; Yamada, Soichiro			Force Dependent Biotinylation of Myosin IIA by alpha-Catenin Tagged with a Promiscuous Biotin Ligase	PLOS ONE			English	Article							E-CADHERIN; ACTIN-BINDING; CELL-ADHESION; BETA-CATENIN; F-ACTIN; TENSION; MECHANOTRANSDUCTION; RECRUITMENT; JUNCTIONS; PROTEINS	Tissues and organs undergo constant physical perturbations and individual cells must respond to mechanical forces to maintain tissue integrity. However, molecular interactions underlying mechano-transduction are not fully defined at cell-cell junctions. This is in part due to weak and transient interactions that are likely prevalent in force-induced protein complexes. Using in situ proximal biotinylation by the promiscuous biotin ligase BirA tagged to alpha-catenin and a substrate stretch cell chamber, we sought to identify force-dependent molecular interactions surrounding alpha-catenin, an actin regulator at the sites of cadherin mediated cell-cell adhesion. While E-cadherin, alpha-catenin, vinculin and actin localize with alpha-catenin at cell-cell contacts in immuno-fluorescent staining, only beta-catenin and plakoglobin were biotinylated, suggesting that this proximal biotinylation is limited to the molecules that are in the immediate vicinity of alpha-catenin. In mechanically stretched samples, increased biotinylation of non-muscle myosin IIA, but not myosin IIB, suggests close spatial proximity between alpha-catenin and myosin IIA during substrate stretching. This force-induced biotinylation diminished as myosin II activity was inhibited by blebbistatin. Taken together, this promising technique enables us to identify force sensitive complexes that may be essential for mechano-responses in force bearing cell adhesion.	[Ueda, Shuji] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 657, Japan; [Blee, Alexandra M.; Macway, Katherine G.; Renner, Derrick J.; Yamada, Soichiro] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Kobe University; University of California System; University of California Davis	Yamada, S (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	syamada@ucdavis.edu	Yamada, Soichiro/B-7360-2019	Yamada, Soichiro/0000-0001-6413-0814; Blee, Alexandra/0000-0003-4959-5466	National Institute of Health [EUREKA R01GM094798]; Kobe University Institutional Program for Young Researcher Overseas Visits; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094798] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kobe University Institutional Program for Young Researcher Overseas Visits; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institute of Health EUREKA R01GM094798 (SY), and Kobe University Institutional Program for Young Researcher Overseas Visits (SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Bard L, 2008, J NEUROSCI, V28, P5879, DOI 10.1523/JNEUROSCI.5331-07.2008; Barry AK, 2014, J CELL SCI, V127, P1779, DOI 10.1242/jcs.139014; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Hansen SD, 2013, MOL BIOL CELL, V24, P3710, DOI 10.1091/mbc.E13-07-0388; Hirata H, 2014, PROG MOL BIOL TRANSL, V126, P135, DOI 10.1016/B978-0-12-394624-9.00006-3; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Jahed Z, 2014, INT REV CEL MOL BIO, V310, P171, DOI 10.1016/B978-0-12-800180-6.00005-0; Jorrisch MH, 2013, BIOL OPEN, V2, P368, DOI 10.1242/bio.20133707; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsuda T, 2005, BIOCHEM BIOPH RES CO, V326, P228, DOI 10.1016/j.bbrc.2004.11.019; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Sumida GM, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-48; Thomas WA, 2013, J BIOL CHEM, V288, P4957, DOI 10.1074/jbc.M112.403774; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Van Itallie CM, 2013, J BIOL CHEM, V288, P13775, DOI 10.1074/jbc.M113.466193; Van Itallie CM, 2014, J CELL SCI, V127, P885; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2011, BIOESSAYS, V33, P732, DOI 10.1002/bies.201100064; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhurinsky J, 2000, J CELL SCI, V113, P3127	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122886	10.1371/journal.pone.0122886	http://dx.doi.org/10.1371/journal.pone.0122886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806963	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000229
J	Civra, A; Giuffrida, MG; Donalisio, M; Napolitano, L; Takada, Y; Coulson, BS; Conti, A; Lembo, D				Civra, Andrea; Giuffrida, Maria Gabriella; Donalisio, Manuela; Napolitano, Lorenzo; Takada, Yoshikazu; Coulson, Barbara S.; Conti, Amedeo; Lembo, David			Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; integrin; peptides; proteomics; RNA virus; donkey; lactadherin; milk; rotavirus	ALPHA-2-BETA-1 INTEGRIN; HUMAN-MILK; I-DOMAIN; CELL-BINDING; PROTEIN; VP4; ATTACHMENT; GROWTH; VIRUS; ENTRY	Background: Human milk lactadherin protects breastfed infants against symptomatic rotavirus infections. Results: A 20-aa peptide (namely pDGE-RGD) derived from equine lactahderin inhibits human rotavirus infectivity. Conclusion: pDGE-RGD interacts specifically with 21 integrin, thus hindering the rotavirus-cell attachment process. Significance: The discovery of the pDGE-RGD peptide may prove useful in the development of inhibitors of receptor recognition by rotavirus or other integrin-using viruses. Human rotavirus is the leading cause of severe gastroenteritis in infants and children under the age of 5 years in both developed and developing countries. Human lactadherin, a milk fat globule membrane glycoprotein, inhibits human rotavirus infection in vitro, whereas bovine lactadherin is not active. Moreover, it protects breastfed infants against symptomatic rotavirus infections. To explore the potential antiviral activity of lactadherin sourced by equines, we undertook a proteomic analysis of milk fat globule membrane proteins from donkey milk and elucidated its amino acid sequence. Alignment of the human, bovine, and donkey lactadherin sequences revealed the presence of an Asp-Gly-Glu (DGE) (21) integrin-binding motif in the N-terminal domain of donkey sequence only. Because integrin (21) plays a critical role during early steps of rotavirus host cell adhesion, we tested a minilibrary of donkey lactadherin-derived peptides containing DGE sequence for anti-rotavirus activity. A 20-amino acid peptide containing both DGE and RGD motifs (named pDGE-RGD) showed the greatest activity, and its mechanism of antiviral action was characterized; pDGE-RGD binds to integrin (21) by means of the DGE motif and inhibits rotavirus attachment to the cell surface. These findings suggest the potential anti-rotavirus activity of equine lactadherin and support the feasibility of developing an anti-rotavirus peptide that acts by hindering virus-receptor binding.	[Civra, Andrea; Donalisio, Manuela; Lembo, David] Univ Turin, Dept Clin & Biol Sci, S Luigi Gonzaga Hosp, I-10043 Turin, Italy; [Giuffrida, Maria Gabriella; Napolitano, Lorenzo; Conti, Amedeo] Inst Sci Food Prod Natl Res Council ISPA CNR, Bioind Pk SilvanoFumero, Turin, Italy; [Takada, Yoshikazu] Univ Calif Davis, Dept Dermatol & Biochem & Mol Med, Sch Med, Sacramento, CA 95817 USA; [Coulson, Barbara S.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia	University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); University of California System; University of California Davis; University of Melbourne	Lembo, D (corresponding author), Univ Turin, Dept Clin & Biol Sci, S Luigi Gonzaga Hosp, Reg Gonzole 10, I-10043 Turin, Italy.	david.lembo@unito.it	Giuffrida, Maria Gabriella/AAY-6314-2020	Giuffrida, Maria Gabriella/0000-0002-1297-2558; Lembo, David/0000-0002-0969-100X; Coulson, Barbara/0000-0002-2110-8147; takada, yoshikazu/0000-0001-5481-9589	Rotalactis; Piedmont Regional Call for Innovation Poles (POR-FESR Asse I-I.1.3 Innovation and SMEs): "Development of a food supplement based on equine milk for the prevention of Rotavirus infections"	Rotalactis; Piedmont Regional Call for Innovation Poles (POR-FESR Asse I-I.1.3 Innovation and SMEs): "Development of a food supplement based on equine milk for the prevention of Rotavirus infections"	This work was supported by a grant from the Piedmont Regional Call for Innovation Poles 2007-2013 (POR-FESR Asse I-I.1.3 Innovation and SMEs): "Development of a food supplement based on equine milk for the prevention of Rotavirus infections" received through Rotalactis s.r.l. A. C. and D. L. are founders of the start-up company Rotalactis that partially funded the research.	Ahrens IG, 2006, EXP CELL RES, V312, P925, DOI 10.1016/j.yexcr.2005.11.036; Azab W, 2012, J VIROL, V86, P2031, DOI 10.1128/JVI.06555-11; Barello C, 2008, MOL NUTR FOOD RES, V52, P1448, DOI 10.1002/mnfr.200700311; BASS DM, 1991, VIROLOGY, V183, P602, DOI 10.1016/0042-6822(91)90989-O; BERGELSON JM, 1994, CELL ADHES COMMUN, V2, P455, DOI 10.3109/15419069409004455; Cavaletto M, 2004, CLIN CHIM ACTA, V347, P41, DOI 10.1016/j.cccn.2004.04.026; Cebo C, 2012, J DAIRY SCI, V95, P1085, DOI 10.3168/jds.2011-4455; Ciarlet M, 2002, J VIROL, V76, P1109, DOI 10.1128/JVI.76.3.1109-1123.2002; COHEN J, 1979, ARCH VIROL, V60, P177, DOI 10.1007/BF01317489; Coulson B. S., 1997, LEUCOCYTE TYPING, P391; Coulson BS, 1997, P NATL ACAD SCI USA, V94, P5389, DOI 10.1073/pnas.94.10.5389; COULSON BS, 1985, J VIROL, V54, P14, DOI 10.1128/JVI.54.1.14-20.1985; D'Ambrosio C, 2008, PROTEOMICS, V8, P3657, DOI 10.1002/pmic.200701148; Desselberger U, 2014, VIRUS RES, V190, P75, DOI 10.1016/j.virusres.2014.06.016; Diaz-Salinas MA, 2014, J VIROL, V88, P4389, DOI 10.1128/JVI.03457-13; ESPEJO RT, 1981, J VIROL, V37, P156, DOI 10.1128/JVI.37.1.156-160.1981; ESTES MK, 1979, J GEN VIROL, V43, P403, DOI 10.1099/0022-1317-43-2-403; ESTES MK, 1981, J VIROL, V39, P879, DOI 10.1128/JVI.39.3.879-888.1981; Fleming FE, 2014, J VIROL, V88, P4558, DOI 10.1128/JVI.03431-13; Fortunato D, 2003, PROTEOMICS, V3, P897, DOI 10.1002/pmic.200300367; Gilbert JM, 1998, J VIROL, V72, P5323, DOI 10.1128/JVI.72.6.5323-5327.1998; Gleizes O, 2006, PEDIATR INFECT DIS J, V25, pS12, DOI 10.1097/01.inf.0000197563.03895.91; Graham KL, 2006, J GEN VIROL, V87, P1275, DOI 10.1099/vir.0.81580-0; Graham KL, 2004, J VIROL, V78, P11786, DOI 10.1128/JVI.78.21.11786-11797.2004; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Hoffmann C, 2010, J CELL SCI, V123, P4280, DOI 10.1242/jcs.064006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAMATA T, 1995, J BIOL CHEM, V270, P12531, DOI 10.1074/jbc.270.21.12531; King SL, 1997, J BIOL CHEM, V272, P28518, DOI 10.1074/jbc.272.45.28518; Kirkwood CD, 1998, J VIROL, V72, P9348, DOI 10.1128/JVI.72.11.9348-9352.1998; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kurugol Z, 2003, TURKISH J PEDIATR, V45, P290; Kvistgaard AS, 2004, J DAIRY SCI, V87, P4088, DOI 10.3168/jds.S0022-0302(04)73551-1; Lambri M, 2012, LWT-FOOD SCI TECHNOL, V46, P460, DOI 10.1016/j.lwt.2011.11.022; Londrigan SL, 2000, J GEN VIROL, V81, P2203, DOI 10.1099/0022-1317-81-9-2203; Lopez AM, 2007, BREASTFEED REV, V15, P15; Ludert JE, 1996, J VIROL, V70, P487, DOI 10.1128/JVI.70.1.487-493.1996; Mori S., 2013, MED SCI, V1, P20; Morrow Ardythe L, 2004, Semin Pediatr Infect Dis, V15, P221, DOI 10.1053/j.spid.2004.07.002; NAGESHA HS, 1988, J CLIN MICROBIOL, V26, P171, DOI 10.1128/JCM.26.2.171-174.1988; Newburg DS, 1998, LANCET, V351, P1160, DOI 10.1016/S0140-6736(97)10322-1; Ning Y, 2007, J BIOL CHEM, V282, P6380, DOI 10.1074/jbc.M610915200; PAPPIN DJC, 1993, CURR BIOL, V3, P487; Pisanu S, 2011, J PROTEOMICS, V74, P350, DOI 10.1016/j.jprot.2010.11.011; Prameela K K, 2012, Malays J Nutr, V18, P103; Ravindran MS, 2013, TRAFFIC, V14, P1182, DOI 10.1111/tra.12100; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Reuter A, 2005, PROTEOMICS, V5, P282, DOI 10.1002/pmic.200400874; Shaw AL, 1996, ARCH VIROL, P21; Spertino S, 2012, MOL BIOSYST, V8, P967, DOI 10.1039/c2mb05400k; TAKADA Y, 1992, J CELL BIOL, V119, P913, DOI 10.1083/jcb.119.4.913; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Taylor MR, 1997, DNA CELL BIOL, V16, P861, DOI 10.1089/dna.1997.16.861; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; YEAGER M, 1994, EMBO J, V13, P1011, DOI 10.1002/j.1460-2075.1994.tb06349.x; Zarate S, 2000, J VIROL, V74, P593, DOI 10.1128/JVI.74.2.593-599.2000	62	11	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12403	12414		10.1074/jbc.M114.620500	http://dx.doi.org/10.1074/jbc.M114.620500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25814665	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000354388600048
J	Jokela, T; Oikari, S; Takabe, P; Rilla, K; Karna, R; Tammi, M; Tammi, R				Jokela, Tiina; Oikari, Sanna; Takabe, Piia; Rilla, Kirsi; Karna, Riikka; Tammi, Markku; Tammi, Raija			Interleukin-1-induced Reduction of CD44 Ser-325 Phosphorylation in Human Epidermal Keratinocytes Promotes CD44 Homomeric Complexes, Binding to Ezrin, and Extended, Monocyte-adhesive Hyaluronan Coats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; Hyaluronan; Inflammation; Interleukin-1 (IL-1); Keratinocyte	EZRIN/RADIXIN/MOESIN ERM PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; CYTOPLASMIC DOMAIN; CELL-SURFACE; CYTOSKELETAL INTERACTION; PERICELLULAR HYALURONAN; ENDOTHELIAL-CELLS; HOMING RECEPTOR; ORGAN-CULTURE; CANCER-CELLS	Background: Interleukin-1 recruits leukocytes at the site of inflammation. Results: The interleukin-1-induced hyaluronan coat increased monocyte binding to keratinocytes through ezrin-associated CD44 homomers, enabled by reduced serine 325 phosphorylation. Conclusion: The organization of the cell surface hyaluronan coat is controlled by phosphorylation of CD44. Significance: Interleukin-1 release in inflamed tissues triggers signals that increase hyaluronan-dependent leukocyte binding. The proinflammatory cytokine interleukin-1 (IL-1) attracts leukocytes to sites of inflammation. One of the recruitment mechanisms involves the formation of extended, hyaluronan-rich pericellular coats on local fibroblasts, endothelial cells, and epithelial cells. In the present work, we studied how IL-1 turns on the monocyte adhesion of the hyaluronan coat on human keratinocytes. IL-1 did not influence hyaluronan synthesis or increase the amount of pericellular hyaluronan in these cells. Instead, we found that the increase in the hyaluronan-dependent monocyte binding was associated with the CD44 of the keratinocytes. Although IL-1 caused a small increase in the total amount of CD44, a more marked impact was the decrease of CD44 phosphorylation at serine 325. At the same time, IL-1 increased the association of CD44 with ezrin and complex formation of CD44 with itself. Treatment of keratinocyte cultures with KN93, an inhibitor of calmodulin kinase 2, known to phosphorylate Ser-325 in CD44, caused similar effects as IL-1 (i.e. homomerization of CD44 and its association with ezrin) and resulted in increased monocyte binding to keratinocytes in a hyaluronan-dependent way. Overexpression of wild type CD44 standard form, but not a corresponding CD44 mutant mimicking the Ser-325-phosphorylated form, was able to induce monocyte binding to keratinocytes. In conclusion, treatment of human keratinocytes with IL-1 changes the structure of their hyaluronan coat by influencing the amount, post-translational modification, and cytoskeletal association of CD44, thus enhancing monocyte retention on keratinocytes.	[Jokela, Tiina; Oikari, Sanna; Takabe, Piia; Rilla, Kirsi; Karna, Riikka; Tammi, Markku; Tammi, Raija] Univ Eastern Finland, Inst Biomed, Dept Med, Kuopio 70211, Finland	University of Eastern Finland	Oikari, S (corresponding author), Univ Eastern Finland, Inst Biomed, Dept Med, Yliopistonranta 1E,POB 1627, Kuopio 70211, Finland.	sanna.oikari@uef.fi	Tammi, Markku/AAQ-7878-2021; Jokela, Tiina/O-9206-2015	Jokela, Tiina/0000-0002-7521-3866; Rilla, Kirsi/0000-0002-7862-5727	Juselius Foundation; Cancer Center of the University of Eastern Finland; Saimaa Cancer Foundation; Special Government Funding of Kuopio University Hospital	Juselius Foundation; Cancer Center of the University of Eastern Finland; Saimaa Cancer Foundation; Special Government Funding of Kuopio University Hospital	This work was supported by grants from the Juselius Foundation (to R. T. and M. T.), the Cancer Center of the University of Eastern Finland (to R. T. and M. T.), the Saimaa Cancer Foundation (to S. O), and Special Government Funding of Kuopio University Hospital (M. T.).	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourguignon LYW, 2011, CYTOSKELETON, V68, P671, DOI 10.1002/cm.20544; Bourguignon LYW, 2000, J CELL BIOL, V150, P177, DOI 10.1083/jcb.150.1.177; Breitkreutz D, 1998, EUR J CELL BIOL, V75, P273, DOI 10.1016/S0171-9335(98)80123-4; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Buckley ST, 2011, AM J PHYSIOL-LUNG C, V300, pL548, DOI 10.1152/ajplung.00230.2010; Buerger C, 2012, J INVEST DERMATOL, V132, P2206, DOI 10.1038/jid.2012.123; CAMP RL, 1991, J CELL BIOL, V115, P1283, DOI 10.1083/jcb.115.5.1283; Campo GM, 2012, GENE, V494, P24, DOI 10.1016/j.gene.2011.11.064; CULTY M, 1994, J CELL PHYSIOL, V160, P275, DOI 10.1002/jcp.1041600209; Dai XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067666; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Desai B, 2009, J CELL BIOCHEM, V108, P272, DOI 10.1002/jcb.22248; Diaz-Perales A, 2005, J BIOL CHEM, V280, P30367, DOI 10.1074/jbc.M504533200; Donatello S, 2012, AM J PATHOL, V181, P2172, DOI 10.1016/j.ajpath.2012.08.025; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; GROVES RW, 1994, AM J PATHOL, V145, P1048; Heldin P, 2008, CONNECT TISSUE RES, V49, P215, DOI 10.1080/03008200802143323; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; HUA Q, 1993, J CELL SCI, V106, P365; Huang ZD, 2014, J IMMUNOL, V192, P5285, DOI 10.4049/jimmunol.1303060; Ibrahim EM, 2006, INT J GYNECOL CANCER, V16, P1631, DOI 10.1111/j.1525-1438.2006.00637.x; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jensen LE, 2010, CURR OPIN INVEST DR, V11, P1211; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jiang H, 2001, ARTHRITIS RHEUM-US, V44, P2599, DOI 10.1002/1529-0131(200111)44:11<2599::AID-ART440>3.0.CO;2-Y; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jokela TA, 2013, WOUND REPAIR REGEN, V21, P247, DOI 10.1111/wrr.12022; Kaneko F, 1991, Fukushima J Med Sci, V37, P103; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kim JH, 2000, EXP CELL RES, V256, P445, DOI 10.1006/excr.2000.4852; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Knudson W, 1996, EXP CELL RES, V228, P216, DOI 10.1006/excr.1996.0320; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Kozlova I, 2012, CELL SIGNAL, V24, P1856, DOI 10.1016/j.cellsig.2012.05.013; KUGELMAN LC, 1992, J INVEST DERMATOL, V99, P886; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lefebvre DC, 2010, MOL IMMUNOL, V47, P1882, DOI 10.1016/j.molimm.2010.03.018; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; Lewis CA, 2001, BIOCHEM J, V357, P843, DOI 10.1042/0264-6021:3570843; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Liu DC, 1998, CELL IMMUNOL, V190, P132, DOI 10.1006/cimm.1998.1397; Liu YY, 2008, CRIT CARE, V12, DOI 10.1186/cc6982; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mee JB, 2007, AM J PATHOL, V171, P32, DOI 10.2353/ajpath.2007.061067; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Meran S, 2013, AM J PATHOL, V182, P2223, DOI 10.1016/j.ajpath.2013.02.038; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Nasti TH, 2012, PHOTOCHEM PHOTOBIOL, V88, P1111, DOI 10.1111/j.1751-1097.2012.01182.x; NEAME SJ, 1992, EMBO J, V11, P4733, DOI 10.1002/j.1460-2075.1992.tb05578.x; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; Oikari S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P39; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen S, 2012, HISTOCHEM CELL BIOL, V137, P107, DOI 10.1007/s00418-011-0883-2; Peck D, 1998, J CELL SCI, V111, P1595; PERSCHL A, 1995, EUR J IMMUNOL, V25, P495, DOI 10.1002/eji.1830250228; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Rauhala L, 2013, J BIOL CHEM, V288, P17999, DOI 10.1074/jbc.M113.472530; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Siiskonen H, 2014, EXP CELL RES, V320, P153, DOI 10.1016/j.yexcr.2013.09.021; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Skandalis SS, 2010, IUBMB LIFE, V62, P833, DOI 10.1002/iub.392; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; TAMMI R, 1994, ARCH DERMATOL RES, V286, P21, DOI 10.1007/BF00375839; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tsubaki H, 2005, EUR J OBSTET GYN R B, V122, P156, DOI 10.1016/j.ejogrb.2005.01.007; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Tuhkanen AL, 1997, J INVEST DERMATOL, V109, P213, DOI 10.1111/1523-1747.ep12319402; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Wagner S, 2013, ANTIOXID REDOX SIGN, V18, P1063, DOI 10.1089/ars.2012.4818; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Wong NKY, 2011, CELL SIGNAL, V23, P812, DOI 10.1016/j.cellsig.2011.01.003; Wu Y, 2011, J PATHOL, V225, P438, DOI 10.1002/path.2947; Xiao YJ, 2014, RHEUMATOLOGY, V53, P1291, DOI 10.1093/rheumatology/keu013; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497	106	14	15	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12379	12393		10.1074/jbc.M114.620864	http://dx.doi.org/10.1074/jbc.M114.620864			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25809479	hybrid, Green Published			2022-12-26	WOS:000354388600046
J	Brooks, BD; Sinclair, KD; Grainger, DW; Brooks, AE				Brooks, Benjamin D.; Sinclair, Kristofer D.; Grainger, David W.; Brooks, Amanda E.			A Resorbable Antibiotic-Eluting Polymer Composite Bone Void Filler for Perioperative Infection Prevention in a Rabbit Radial Defect Model	PLOS ONE			English	Article							IN-VITRO; GENTAMICIN-RELEASE; EPSILON-CAPROLACTONE; LOCAL-DELIVERY; POLYMETHYLMETHACRYLATE; SCAFFOLDS; OSTEOMYELITIS; HIP; TOBRAMYCIN; CIPROFLOXACIN	Nearly 1.3 million total joint replacement procedures are performed in the United States annually, with numbers projected to rise exponentially in the coming decades. Although finite infection rates for these procedures remain consistently low, device-related infections represent a significant cause of implant failure, requiring secondary or revision procedures. Revision procedures manifest several-fold higher infection recurrence rates. Importantly, many revision surgeries, infected or not, require bone void fillers to support the host bone and provide a sufficient tissue bed for new hardware placement. Antibiotic-eluting bone void fillers (ABVF), providing both osteoconductive and antimicrobial properties, represent one approach for reducing rates of orthopedic device-related infections. Using a solvent-free, molten-cast process, a polymer-controlled antibiotic-eluting calcium carbonate hydroxyapatite (HAP) ceramic composite BVF (ABVF) was fabricated, characterized, and evaluated in vivo using a bacterial challenge in a rabbit radial defect window model. ABVF loaded with tobramycin eliminated the infectious burden in rabbits challenged with a clinically relevant strain of Staphylococcus aureus (inoculum as high as 107 CFU). Histological, microbiological, and radiographic methods were used to detail the effects of ABVF on microbial challenge to host bone after 8 weeks in vivo. In contrast to the HAP/BVF controls, which provided no antibiotic protection and required euthanasia 3 weeks post-operatively, tobramycin-releasing ABVF animals showed no signs of infection (clinical, microbiological, or radiographic) when euthanized at the 8-week study endpoint. ABVF sites did exhibit fibrous encapsulation around the implant at 8 weeks. Local antibiotic release from ABVF to orthopedic sites requiring bone void fillers eliminated the periprosthetic bacterial challenge in this 8-week in vivo study, confirming previous in vitro results.	[Brooks, Benjamin D.; Grainger, David W.; Brooks, Amanda E.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA; [Grainger, David W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Sinclair, Kristofer D.] Elute Inc, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Brooks, AE (corresponding author), N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA.	Amanda.e.brooks@ndsu.edu			University of Utah Technology Commercialization Office; Elute, Inc.; Elute Inc., Salt Lake City, UT	University of Utah Technology Commercialization Office; Elute, Inc.; Elute Inc., Salt Lake City, UT	Funding: This work was supported by the University of Utah Technology Commercialization Office. The funder, Elute, Inc. provided support in the form of salaries for authors [AEB and KS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, KS is employed by the study sponsor, Elute Inc., Salt Lake City, UT. DG, KS and AB have consulting and/or equity interests in the study sponsor, Elute Inc., Salt Lake City, UT. The specific roles of these authors are articulated in the 'author contributions' section.	An YH, 2006, INT J ARTIF ORGANS, V29, P407, DOI 10.1177/039139880602900411; Anagnostakos K, 2006, ACTA ORTHOP, V77, P628, DOI 10.1080/17453670610012719; Antoci V, 2007, CLIN ORTHOP RELAT R, P200, DOI 10.1097/BLO.0b013e31811ff866; Arciola CR, 2002, BIOMATERIALS, V23, P1495, DOI 10.1016/S0142-9612(01)00275-7; Bostrom Mathias P G, 2005, HSS J, V1, P9, DOI 10.1007/s11420-005-0111-5; Brooks AE, 2013, DRUG DELIV TRANSL RE, V3, P518, DOI 10.1007/s13346-013-0155-x; Brooks B.D., 2013, BIOMATERIALS ASS INF, VVolume 9781461410, P307; Brooks BD, 2014, J BIOMED MATER RES B, V102, P1074, DOI 10.1002/jbm.b.33089; Business Wire, 2010, BUSINESS WIRE; Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005; Checketts RG, 2000, ORTHOFIX EXTERNAL FIXATION IN TRAUMA AND ORTHOPAEDICS, P97; Conterno LO, 2009, COCHRANE DATABASE SY, V3; Coombes A. G. A., 1994, Clinical Materials, V17, P35; Davidoff Sherry N, 2010, Biomed Sci Instrum, V46, P184; Davidoff SN., 2013, INT J BIOMED MAT RES, V1, P21; Degooyer Jason, 2014, Biomed Sci Instrum, V50, P47; Della Valle AG, 2001, ACTA ORTHOP SCAND, V72, P237; DIMAIO FR, 1994, J ORTHOPAED RES, V12, P79, DOI 10.1002/jor.1100120110; Ekholm M, 1999, BIOMATERIALS, V20, P1257, DOI 10.1016/S0142-9612(97)00080-X; Evans RP, 2005, CLIN ORTHOP RELAT R, P4, DOI 10.1097/01.blo.0000183276.33237.24; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Gunnam R, 2010, FUTURE ORTHOPEDIC IM; Hernigou P, 2005, J BONE JOINT SURG BR, V87B, P896, DOI 10.1302/0301-620X.87B7.16289; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; Holmbom J, 2005, J BIOMED MATER RES A, V75A, P308, DOI 10.1002/jbm.a.30418; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Isaacson BM, 2011, J SURG RES, V167, pE163, DOI 10.1016/j.jss.2010.12.047; Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003; Ketonis C, 2011, BONE, V48, P631, DOI 10.1016/j.bone.2010.10.171; Ketonis C, 2010, CLIN ORTHOP RELAT R, V468, P2113, DOI 10.1007/s11999-010-1322-8; Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371; Koort JK, 2005, ANTIMICROB AGENTS CH, V49, P1502, DOI 10.1128/AAC.49.4.1502-1508.2005; Koort JK, 2006, J BIOMED MATER RES A, V78A, P532, DOI 10.1002/jbm.a.30766; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Landersdorfer CB, 2009, CLIN PHARMACOKINET, V48, P89, DOI [10.2165/00003088-200948020-00002, 10.2165/0003088-200948020-00002]; Lee K, 2008, EXPERT REV MED DEVIC, V5, P383, DOI 10.1586/17434440.5.3.383; McKee MD, 2002, J ORTHOP TRAUMA, V16, P622, DOI 10.1097/00005131-200210000-00002; Miyai T, 2008, BIOMATERIALS, V29, P350, DOI 10.1016/j.biomaterials.2007.09.040; Mourino V, 2013, EXPERT OPIN DRUG DEL, V10, P1353, DOI 10.1517/17425247.2013.808183; Nandi S., 2010, ORTHOPAEDIC APPL BON; Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2; Neut D, 2003, ACTA ORTHOP SCAND, V74, P670, DOI 10.1080/00016470310018180; Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885; Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Richards RG, 2012, J ORTHOP TRAUMA, V26, P703, DOI 10.1097/BOT.0b013e31826e37a2; Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055; Sevy Justin O, 2010, Biomed Sci Instrum, V46, P136; Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005; Sinclair KD, 2013, J BIOMED MATER RES B, V101, P1143, DOI 10.1002/jbm.b.32924; Smeltzer MS, 1997, J ORTHOPAED RES, V15, P414, DOI 10.1002/jor.1100150314; Surgeons, 2013, JOINT REV SURG WHEN; Tan HL, 2012, INT J ARTIF ORGANS, V35, P832, DOI 10.5301/ijao.5000163; Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8; van de Belt H, 2000, ACTA ORTHOP SCAND, V71, P625, DOI 10.1080/000164700317362280; Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]; Winkler H, 2008, J BONE JOINT SURG BR, V90B, P1580, DOI 10.1302/0301-620X.90B12.20742; Winkler H, 2000, J ANTIMICROB CHEMOTH, V46, P423, DOI 10.1093/jac/46.3.423; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; WORLOCK P, 1988, BRIT J EXP PATHOL, V69, P235; Yeo A, 2008, J BIOMED MATER RES A, V84A, P208, DOI 10.1002/jbm.a.31454	62	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0118696	10.1371/journal.pone.0118696	http://dx.doi.org/10.1371/journal.pone.0118696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815727	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600009
J	Kim, HM; Lee, ES; Lee, BR; Yadav, D; Kim, YM; Ko, HJ; Park, KS; Lee, EY; Chung, CH				Kim, Hong-Min; Lee, Eun Soo; Lee, Bo Ra; Yadav, Dhananjay; Kim, You Mi; Ko, Hyun-Jeong; Park, Kyu Sang; Lee, Eun Young; Chung, Choon Hee			C-C Chemokine Receptor 2 Inhibitor Ameliorates Hepatic Steatosis by Improving ER Stress and Inflammation in a Type 2 Diabetic Mouse Model	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; RECRUITMENT; MACROPHAGES; ACTIVATION; LIPOGENESIS; DEFENSE; TISSUE	Hepatic steatosis is the accumulation of excess fat in the liver. Recently, hepatic steatosis has become more important because it occurs in the patients with obesity, type 2 diabetes, and hyperlipidemia and is associated with endoplasmic reticulum (ER) stress and insulin resistance. C-C chemokine receptor 2 (CCR2) inhibitor has been reported to improve inflammation and glucose intolerance in diabetes, but its mechanisms remained unknown in hepatic steatosis. We examined whether CCR2 inhibitor improves ER stress-induced hepatic steatosis in type 2 diabetic mice. In this study, db/db and db/m (n = 9) mice were fed CCR2 inhibitor (2 mg/kg/day) for 9 weeks. In diabetic mice, CCR2 inhibitor decreased plasma and hepatic triglycerides levels and improved insulin sensitivity. Moreover, CCR2 inhibitor treatment decreased ER stress markers (e.g., BiP, ATF4, CHOP, and XBP-1) and inflammatory cytokines (e.g., TNF alpha, IL-6, and MCP-1) while increasing markers of mitochondrial biogenesis (e.g., PGC-1 alpha, Tfam, and COX1) in the liver. We suggest that CCR2 inhibitor may ameliorate hepatic steatosis by reducing ER stress and inflammation in type 2 diabetes mellitus.	[Kim, Hong-Min; Lee, Eun Soo; Yadav, Dhananjay; Kim, You Mi; Chung, Choon Hee] Yonsei Univ, Grad Sch, Dept Med, Wonju, South Korea; [Lee, Bo Ra; Ko, Hyun-Jeong] Kangwon Natl Univ, Coll Pharm, Chunchon, South Korea; [Lee, Eun Young] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Park, Kyu Sang] Yonsei Univ, Grad Sch, Dept Physiol, Wonju, South Korea; [Park, Kyu Sang; Chung, Choon Hee] Yonsei Univ, Inst Lifestyle Med, Wonju, South Korea	Yonsei University; Kangwon National University; Soonchunhyang University; Yonsei University; Yonsei University	Lee, EY (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	eylee@sch.ac.kr; cchung@yonsei.ac.kr	Yadav, Dhananjay/AAZ-9435-2021; Lee, Eun Young/Q-6592-2019	Yadav, Dhananjay/0000-0003-4047-7236; Lee, Eun Young/0000-0002-4513-9888; Chung, Choon/0000-0003-1144-7206; Ko, Hyun-Jeong/0000-0002-3844-928X; Park, Kyu-Sang/0000-0003-0322-9807	National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology (MEST) of the Korean Government [2010-0005071, 2012R1A1A2044121]	National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology (MEST) of the Korean Government	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) of the Korean Government (2010-0005071, 2012R1A1A2044121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1997, LANCET, V349, P490, DOI 10.1016/S0140-6736(96)07524-1; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Barzilay JI, 2003, METAB SYNDR RELAT D, V1, P55, DOI 10.1089/154041903321648252; Bloomgarden ZT, 2003, DIABETES CARE, V26, P1922, DOI 10.2337/diacare.26.6.1922; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Cherney RJ, 2008, J MED CHEM, V51, P721, DOI 10.1021/jm701488f; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Jensen-Urstad APL, 2012, BBA-MOL CELL BIOL L, V1821, P747, DOI 10.1016/j.bbalip.2011.09.017; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021533; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Liu J, 2010, J GASTROEN HEPATOL, V25, P613, DOI 10.1111/j.1440-1746.2009.06086.x; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ou HY, 2012, ENDOCRINOLOGY, V153, P2974, DOI 10.1210/en.2011-2043; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Pettinelli P, 2011, NUTR HOSP, V26, P441, DOI [10.3305/nh.2011.26.3.5119, 10.1590/S0212-16112011000300003]; Portincasa P, 2005, CLIN BIOCHEM, V38, P203, DOI 10.1016/j.clinbiochem.2004.10.014; Ramirez T, 2012, ALCOHOL ALCOHOLISM, DOI 10.1093/alcalc/ags106; Seok SJ, 2013, NEPHROL DIAL TRANSPL, V28, P1700, DOI 10.1093/ndt/gfs555; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smith BW, 2011, CRIT REV CL LAB SCI, V48, P97, DOI 10.3109/10408363.2011.596521; Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633; Tamura Y, 2010, J ATHEROSCLER THROMB, V17, P219, DOI 10.5551/jat.3368; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	38	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120711	10.1371/journal.pone.0120711	http://dx.doi.org/10.1371/journal.pone.0120711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816097	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600043
J	Klimek-Piotrowska, W; Koziej, M; Holda, MK; Piatek, K; Wszolek, K; Tyszka, A; Kmiotek, E; Pliczko, M; Sliwinska, A; Krauss, K; Miszczyk, M; Walocha, J				Klimek-Piotrowska, Wieslawa; Koziej, Mateusz; Holda, Mateusz K.; Piatek, Katarzyna; Wszolek, Karolina; Tyszka, Anna; Kmiotek, Elizabeth; Pliczko, Mateusz; Sliwinska, Aleksandra; Krauss, Klaudia; Miszczyk, Marcin; Walocha, Jerzy			Anthropometry and Body Composition of Adolescents in Cracow, Poland	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; WAIST CIRCUMFERENCE; FAT DISTRIBUTION; PERCENTILE CURVES; SKINFOLD THICKNESS; HEIGHT RATIO; MASS INDEX; GROWTH; TRENDS; TRICEPS	Background and Objective The aim of the present study was to determine the level of adiposity and obesity in Polish adolescents and compare the results with earlier studies conducted in this population as well as those carried out in other populations. Methods The study group consisted of 456 boys and 514 girls aged 14-18 years living in Cracow chosen from randomly selected secondary schools. Weight, height, waist, and hip circumference (WC, HC) as well as triceps, biceps, subscapular, and suprailiac skinfold thickness (SFT) were measured. Body mass index (BMI), waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), subscapular/triceps skinfold ratio (STR), and percentage body fat were computed. The prevalence of overweight and obesity based on Polish children growth reference were calculated and age-dependent and gender-specific smoothed percentile curves for BMI and ROC curves were generated. Results Weight, height, WC, HC (up 16yr), WHtR (up 15yr), and WHR were considerably higher in males than females. Weight, height, and HC increased with age; WHtR remained the same. The prevalence of overweight and obesity were 10.2% (boys 10.3%; girls 10.1%) and 4.2% (boys 5.3%; girls 3.3%). ROC analysis revealed that WHtR was the best tool for detection of obesity (AUC of 0.982 +/- 0.007) in males, whereas the sum of four SFTs (AUC: 0.968 +/- 0.011) and WHtR (AUC: 0.963 +/- 0.012) were the best predictors of obesity in females. Conclusions The level of adiposity in Cracow adolescents increased during the last decade. However, it is still lower than in other well-developed societies struggling with obesity epidemics.	[Klimek-Piotrowska, Wieslawa; Koziej, Mateusz; Holda, Mateusz K.; Piatek, Katarzyna; Wszolek, Karolina; Tyszka, Anna; Kmiotek, Elizabeth; Pliczko, Mateusz; Sliwinska, Aleksandra; Krauss, Klaudia; Miszczyk, Marcin; Walocha, Jerzy] Jagiellonian Univ, Coll Med, Dept Anat, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Klimek-Piotrowska, W (corresponding author), Jagiellonian Univ, Coll Med, Dept Anat, Krakow, Poland.	wkpiotrowska@gmail.com	Hołda, Mateusz K./H-4705-2019; Hołda, Mateusz K/U-3199-2017; Walocha, Jerzy/ABB-9607-2021; Walocha, Jerzy/AAS-9174-2020	Hołda, Mateusz K./0000-0001-5754-594X; Hołda, Mateusz K/0000-0001-5754-594X; Miszczyk, Marcin/0000-0002-4375-0827; Pliczko, Mateusz/0000-0001-6713-3228; Koziej, Mateusz/0000-0002-2635-0776				[Anonymous], 1995, PHYS STAT US INT ANT; Aronne LJ, 2002, OBES RES, V10, p14S, DOI 10.1038/oby.2002.184; Baya Botti A, 2009, NUTR HOSP, V24, P304; Burniat W, 2002, CHILD ADOLESCENT OBE; Chrzanowska M, 2008, AM J HUM BIOL, V20, P424, DOI 10.1002/ajhb.20749; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Galcheva SV, 2009, INT J PEDIATR OBES, V4, P381, DOI 10.3109/17477160902846195; Gharib NM, 2009, ANN SAUDI MED, V29, P258, DOI 10.4103/0256-4947.55309; Golab S, 2000, POZIOM ROZWOJU BIOL; Haas GM, 2011, WORLD J PEDIATR, V7, P16, DOI 10.1007/s12519-011-0241-4; Hughes JM, 1997, ARCH DIS CHILD, V76, P182, DOI 10.1136/adc.76.3.182; Jaworski M, 2012, EUR J PEDIATR, V171, P1215, DOI 10.1007/s00431-012-1717-5; Jodkowska Maria, 2007, Przegl Epidemiol, V61, P585; Kim K, 2013, J KOREAN MED SCI, V28, P443, DOI 10.3346/jkms.2013.28.3.443; Kulaga Z, 2011, EUR J PEDIATR, V170, P599, DOI 10.1007/s00431-010-1329-x; Kulaga Z, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-109; Lee J, 2012, J KOREAN MED SCI, V27, P184, DOI 10.3346/jkms.2012.27.2.184; Li CY, 2006, PEDIATRICS, V118, pE1390, DOI 10.1542/peds.2006-1062; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; McCarthy HD, 2005, INT J OBESITY, V29, P157, DOI 10.1038/sj.ijo.0802849; McDowell Margaret A, 2009, Vital Health Stat 11, P1; Moreno LA, 2007, INT J OBESITY, V31, P1798, DOI 10.1038/sj.ijo.0803670; Moreno LA, 2003, NUTRITION, V19, P481, DOI 10.1016/S0899-9007(03)00040-6; Murabito JM, 2012, OBESITY SILVER SPRIN, V21, P1713; Musaiger AO, 2012, J OBES, V2012, DOI 10.1155/2012/981390; Nawarycz Tadeusz, 2007, Pol Merkur Lekarski, V23, P264; Nooyens ACJ, 2007, AM J CLIN NUTR, V85, P1533, DOI 10.1093/ajcn/85.6.1533; Sardinha LB, 1999, AM J CLIN NUTR, V70, P1090; Savva SC, 2001, OBES RES, V9, P754, DOI 10.1038/oby.2001.104; Senbanjo IO, 2013, AM J PHYS ANTHROPOL, V150, P647, DOI 10.1002/ajpa.22241; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Stomfai S, 2011, INT J OBESITY, V35, pS45, DOI 10.1038/ijo.2011.34; Sung RYT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-324; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569	37	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122274	10.1371/journal.pone.0122274	http://dx.doi.org/10.1371/journal.pone.0122274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815816	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600162
J	Teaniniuraitemoana, V; Huvet, A; Levy, P; Gaertner-Mazouni, N; Gueguen, Y; Le Moullac, G				Teaniniuraitemoana, Vaihiti; Huvet, Arnaud; Levy, Peva; Gaertner-Mazouni, Nabila; Gueguen, Yannick; Le Moullac, Gilles			Molecular Signatures Discriminating the Male and the Female Sexual Pathways in the Pearl Oyster Pinctada margaritifera	PLOS ONE			English	Article							GENE-EXPRESSION; CRASSOSTREA-GIGAS; PACIFIC OYSTER; C-ELEGANS; TEMPERATURE; DIFFERENTIATION; GAMETOGENESIS; IDENTIFICATION; TRANSCRIPTOME; REPRODUCTION	The genomics of economically important marine bivalves is studied to provide better understanding of the molecular mechanisms underlying their different reproductive strategies. The recently available gonad transcriptome of the black-lip pearl oyster Pinctada margaritifera is a novel and powerful resource to study these mechanisms in marine mollusks displaying hermaphroditic features. In this study, RNAseq quantification data of the P. margaritifera gonad transcriptome were analyzed to identify candidate genes in histologically-characterized gonad samples to provide molecular signatures of the female and male sexual pathway in this pearl oyster. Based on the RNAseq data set, stringent expression analysis identified 1,937 contigs that were differentially expressed between the gonad histological categories. From the hierarchical clustering analysis, a new reproduction model is proposed, based on a dual histo-molecular analytical approach. Nine candidate genes were identified as markers of the sexual pathway: 7 for the female pathway and 2 for the male one. Their mRNA levels were assayed by real-time PCR on a new set of gonadic samples. A clustering method revealed four principal expression patterns based on the relative gene expression ratio. A multivariate regression tree realized on these new samples and validated on the previously analyzed RNAseq samples showed that the sexual pathway of P. margaritifera can be predicted by a 3-gene-pair expression ratio model of 4 different genes: pmarg-43476, pmarg-foxl2, pmarg-54338 and pmarg-fem1-like. This 3-gene-pair expression ratio model strongly suggests only the implication of pmarg-foxl2 and pmarg-fem1-like in the sex inversion of P. margaritifera. This work provides the first histo-molecular model of P. margaritifera reproduction and a gene expression signature of its sexual pathway discriminating the male and female pathways. These represent useful tools for understanding and studying sex inversion, sex differentiation and sex determinism in this species and other related species for aquaculture purposes such as genetic selection programs.	[Teaniniuraitemoana, Vaihiti; Levy, Peva; Gueguen, Yannick; Le Moullac, Gilles] IFREMER, UMR Ecosyst Insulaires Oceaniens EIO 241, Labex Corail, Ctr Pacifique, BP 7004, F-98719 Taravao, Tahiti, France; [Huvet, Arnaud] IFREMER, UMR Lab Sci Environm Marin LEMAR 6539, F-29280 Plouzane, France; [Gaertner-Mazouni, Nabila] Univ Polynesie Francaise, UMR Ecosyst Insulaires Oceaniens EIO 241, Labex Corail, F-98702 Faaa, Tahiti, France; [Gueguen, Yannick] Univ Montpellier, IFREMER, UMR Ecol Syst Marins Cotiers ECOSYM 5119, Labex Corail, F-34095 Montpellier 5, France	Ifremer; Ifremer; Ifremer; Ifremer; Universite de Montpellier	Le Moullac, G (corresponding author), IFREMER, UMR Ecosyst Insulaires Oceaniens EIO 241, Labex Corail, Ctr Pacifique, BP 7004, F-98719 Taravao, Tahiti, France.	Gilles.Le.Moullac@ifremer.fr	Gueguen, Yannick/O-3248-2014	Gueguen, Yannick/0000-0002-8749-9582; Le Moullac, Gilles/0000-0003-3749-8239; Huvet, Arnaud/0000-0001-6912-881X	ANR [ANR-11-AGRO-006]; French Government through the Contract Project BiodiPerl; Ifremer; la Delegation a la Recherche de Polynesie francaise	ANR(French National Research Agency (ANR)); French Government through the Contract Project BiodiPerl; Ifremer; la Delegation a la Recherche de Polynesie francaise	This study was financially supported by ANR funding (POLYPERL project, reference ANR-11-AGRO-006) and by the French Government through the Contract Project BiodiPerl 2011-2013. VT is a Ph.D. student financially supported by Ifremer and holds a grant from la Delegation a la Recherche de Polynesie francaise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon-Noriega EA, 2007, J SHELLFISH RES, V26, P423, DOI 10.2983/0730-8000(2007)26[423:MRGDAS]2.0.CO;2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arnaud-Haond S, 2007, MAR BIOTECHNOL, V9, P113, DOI 10.1007/s10126-006-6033-5; Banni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018904; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blay C, 2014, AQUACULT INT, V22, P937, DOI 10.1007/s10499-013-9719-5; Chavez-Villalba J, 2003, J SHELLFISH RES, V22, P721; Chavez-Villalba J, 2011, J SHELLFISH RES, V30, P231, DOI 10.2983/035.030.0206; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; de Sousa JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092202; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Dheilly NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036353; Dutertre M, 2009, AQUAT LIVING RESOUR, V22, P319, DOI 10.1051/alr/2009042; Enriquez-Diaz M, 2009, AQUACULT INT, V17, P491, DOI 10.1007/s10499-008-9219-1; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; Fournier J, 2012, MAR POLLUT BULL, V65, P463, DOI 10.1016/j.marpolbul.2012.03.027; Gavery MR, 2013, PEERJ, V1, DOI 10.7717/peerj.215; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Gueguen Y., 2011, RECENT ADV PEARL RES, P183; Guo XM, 1998, EVOLUTION, V52, P394, DOI 10.1111/j.1558-5646.1998.tb01640.x; Haag ES, 2005, PLOS BIOL, V3, P21, DOI 10.1371/journal.pbio.0030021; Hedrick PW, 2010, J HERED, V101, P602, DOI 10.1093/jhered/esq065; HODGKIN J, 1986, GENETICS, V114, P15; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Ky CL, 2014, AQUACULTURE, V432, P154, DOI 10.1016/j.aquaculture.2014.05.002; Ky CL, 2013, AQUAT LIVING RESOUR, V26, P133, DOI 10.1051/alr/2013055; Le Moullac G, 2013, AQUAC RES, V44, P404, DOI 10.1111/j.1365-2109.2011.03045.x; Le Pennec M, 2010, HUITRE PERLIERE PERL, P204; Li Q, 2013, ISJ-INVERT SURVIV J, V10, P84; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llera-Herrera R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073176; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Matsumoto T, 2003, ZOOL SCI, V20, P37, DOI 10.2108/zsj.20.37; Matsumoto T, 2013, ZOOL SCI, V30, P826, DOI 10.2108/zsj.30.826; Meng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064485; Naimi A, 2009, COMP BIOCHEM PHYS A, V152, P189, DOI 10.1016/j.cbpa.2008.09.019; Naimi A, 2009, COMP BIOCHEM PHYS B, V154, P134, DOI 10.1016/j.cbpb.2009.05.011; Piferrer F, 2008, REV FISH SCI, V16, P35, DOI 10.1080/10641260802324644; R Development Core Team R, 2011, LANG ENV STAT COMP, P409; Rosa RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-252; Santerre C, 2012, SEX DEV, V6, P210, DOI 10.1159/000338085; Santerre C, 2014, COMP BIOCHEM PHYS A, V167, P68, DOI 10.1016/j.cbpa.2013.09.018; Santerre C, 2013, COMP BIOCHEM PHYS A, V165, P61, DOI 10.1016/j.cbpa.2013.02.007; Saout C, 1999, AQUACULTURE, V172, P301, DOI 10.1016/S0044-8486(98)00406-2; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; SHAFEE M S, 1991, Aquaculture and Fisheries Management, V22, P203, DOI 10.1111/j.1365-2109.1991.tb00510.x; Shi Y, 2014, GENE, V538, P313, DOI 10.1016/j.gene.2014.01.031; Steele S, 1999, J MAR BIOL ASSOC UK, V79, P673, DOI 10.1017/S0025315498000836; Strauss TJ, 2011, REPRODUCTION, V141, P173, DOI 10.1530/REP-10-0376; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Therneau T., 2013, R PACKAGE VERSION 16; Thielley M, 1993, COMP AVEC CYCLE PINC, P233; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vahirua-Lechat I, 2008, AQUAC RES, V39, P1739, DOI 10.1111/j.1365-2109.2008.02050.x; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Yusa Y, 2007, AM MALACOL BULL, V23, P89, DOI 10.4003/0740-2783-23.1.89; ZARKOWER D, 1993, NUCLEIC ACIDS RES, V21, P3691, DOI 10.1093/nar/21.16.3691; ZARKOWER D, 1992, CELL, V70, P237, DOI 10.1016/0092-8674(92)90099-X	60	18	20	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122819	10.1371/journal.pone.0122819	http://dx.doi.org/10.1371/journal.pone.0122819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815473	Green Published, gold			2022-12-26	WOS:000352133600200
J	Yang, JB; Wang, YC; Guo, L; Xue, DY				Yang, Jingbiao; Wang, Yi Chen; Guo, Luo; Xue, Dayuan			Patterns and Structures of Land Use Change in the Three Rivers Headwaters Region of China	PLOS ONE			English	Article							COVER CHANGE; LANDSCAPE	Located in Qinghai Province of China, the Three Rivers Headwaters Region is the source region of the Yangtze, Yellow and Lantsang Rivers, and plays an important role in biodiversity conservation and regulating water supply. Despite many efforts on land use change in Qinghai, knowledge of the spatial variation of land use change is still lacking. This study examines the patterns of land use change across various watersheds, prefectures and the temple surroundings. Remote sensing images of 1987, 1997 and 2007 were analyzed to derive land use distributions; patterns and structures of the landscape were then quantified with landscape metrics. The results illustrated that the Yangtze River headwater region had more diverse and more evenly distributed landscape, while the Lantsang and the Yellow headwater regions showed a decline in landscape diversity. Comparison of the land use patterns of four prefectures revealed that Yushu Prefecture experienced an increase in landscape diversity from 1987 to 2007 while the land use patches in Guoluo Prefecture exhibited more aggregated patterns than other prefectures. Analysis of the spatial variations of land use change in the temple surroundings illustrated that 19.7% and 35.9% of the temples in Guoluo and Yushu Prefectures, respectively, encountered land use change for their immediate areas within 2 km. Comparison of the surroundings of temples and human settlements found that land use change was not evenly distributed, and that greater land use change had occurred for the surroundings of human settlements. Such findings provided insights into the spatial variation of land use change in the Three Rivers Headwaters Region.	[Yang, Jingbiao] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Wang, Yi Chen] Natl Univ Singapore, Dept Geog, Singapore 117548, Singapore; [Guo, Luo; Xue, Dayuan] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China	Beijing Forestry University; National University of Singapore; Minzu University of China	Xue, DY (corresponding author), Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China.	xuedayuan@hotmail.com	Wang, Yi-Chen/F-6885-2012	Wang, Yi-Chen/0000-0002-3034-7377	National Natural Science Foundation of China [31370480]; 111 program of Minzu University of China [2008-B08044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 program of Minzu University of China	Funding: This work was partially funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) with the No. 31370480 and 111 program of Minzu University of China with the No. 2008-B08044. The founders of No. 31370480 funded the section of data collection, and No. 2008-B08044 will fund the fees for publishing. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	[邴龙飞 BING Longfei], 2011, 地球信息科学学报, V13, P289; Burnett C, 2003, ECOL MODEL, V168, P233, DOI 10.1016/S0304-3800(03)00139-X; Chen H, 2009, J GEOINFORMATION SCI, V11, P390; Dale V.H., 1993, EFFECT LAND USE CHAN; ERDAS, 2006, ERDAS IMAGINE 8 7; Fairman JG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014712; Fang YP, 2013, AMBIO, V42, P566, DOI 10.1007/s13280-012-0366-2; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gomi T, 2002, BIOSCIENCE, V52, P905, DOI 10.1641/0006-3568(2002)052[0905:UPADLO]2.0.CO;2; Guo L, 2013, INT J APPL EARTH OBS, V21, P384, DOI 10.1016/j.jag.2011.11.003; Guo Luo, 2012, Yingyong Shengtai Xuebao, V23, P1219; Guo Luo, 2011, Journal of Resources and Ecology, V2, P158; Hamilton CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055737; Kaushal SS, 2006, ECOL APPL, V16, P299, DOI 10.1890/05-0134; Li D., 2002, BIODIVERSITY 3 RIVER; Li DQ, 2009, J CUN NATURAL SCI ED, V18, P18; [刘纪远 LIU Jiyuan], 2008, [地理学报, Acta Geographica Sinica], V63, P364; McGarigal K., 2002, FRAGSTATS V3 3 SPATI; Ponette-Gonzalez AG, 2010, GLOBAL CHANGE BIOL, V16, P946, DOI 10.1111/j.1365-2486.2009.01985.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; [邵景安 SHAO Jingan], 2008, [自然资源学报, Journal of Natural Resources], V23, P643; The People's Government of Qinghai Province, 1996, J QINGHAI ENV, V4, P157; Turner MG, 2003, LANDSCAPE ECOL, V18, P449, DOI 10.1023/A:1026033116193; [王根绪 Wang Genxu], 2004, [地理学报, Acta Geographica Sinica], V59, P163; Wang YC, 2011, INT J REMOTE SENS, V32, P3765, DOI 10.1080/01431161.2010.540590; [徐新良 XU Xinliang], 2008, [地理研究, Geographical Research], V27, P829; Zhang XS, 2008, PLASMA SCI TECHNOL, V10, P645, DOI 10.1088/1009-0630/10/5/23; [张镱锂 Zhang Yili], 2006, [地理学报, Acta Geographica Sinica], V61, P3; [张镱锂 ZHANG Yili], 2007, [地理研究, Geographical Research], V26, P500; [赵志平 Zhao Zhiping], 2010, [地理科学, Scientia Geographica Sinica], V30, P415; Zhou XL, 2011, LANDSCAPE URBAN PLAN, V100, P268, DOI 10.1016/j.landurbplan.2010.12.013; [No title captured]	32	9	10	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0119121	10.1371/journal.pone.0119121	http://dx.doi.org/10.1371/journal.pone.0119121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816147	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600012
J	Brand, Y; Levano, S; Radojevic, V; Naldi, AM; Setz, C; Ryan, AF; Pak, K; Hemmings, BA; Bodmer, D				Brand, Yves; Levano, Soledad; Radojevic, Vesna; Naldi, Arianne Monge; Setz, Cristian; Ryan, Allen F.; Pak, Kwang; Hemmings, Brian A.; Bodmer, Daniel			All Akt Isoforms (Akt1, Akt2, Akt3) Are Involved in Normal Hearing, but Only Akt2 and Akt3 Are Involved in Auditory Hair Cell Survival in the Mammalian Inner Ear	PLOS ONE			English	Article							NF-KAPPA-B; THREONINE PROTEIN-KINASE; MICE LACKING; GLUCOSE-HOMEOSTASIS; SIGNAL-TRANSDUCTION; REGULATED KINASES; MOLECULAR-CLONING; IN-VITRO; APOPTOSIS; PATHWAY	The kinase Akt is a key downstream mediator of the phosphoinositide-3-kinase signaling pathway and participates in a variety of cellular processes. Akt comprises three isoforms each encoded by a separate gene. There is evidence to indicate that Akt is involved in the survival and protection of auditory hair cells in vitro. However, little is known about the physiological role of Akt in the inner ear-especially in the intact animal. To elucidate this issue, we first analyzed the mRNA expression of the three Akt isoforms in the inner ear of C57/BL6 mice by real-time PCR. Next, we tested the susceptibility to gentamicin-induced auditory hair cell loss in isoform-specific Akt knockout mice compared to wild-types (C57/BL6) in vitro. To analyze the effect of gene deletion in vivo, hearing and cochlear microanatomy were evaluated in Akt isoform knockout animals. In this study, we found that all three Akt isoforms are expressed in the cochlea. Our results further indicate that Akt2 and Akt3 enhance hair cell resistance to ototoxicity, while Akt1 does not. Finally, we determined that untreated Akt1 and Akt2/Akt3 double knockout mice display significant hearing loss, indicating a role for these isoforms in normal hearing. Taken together, our results indicate that each of the Akt isoforms plays a distinct role in the mammalian inner ear.	[Brand, Yves; Levano, Soledad; Radojevic, Vesna; Setz, Cristian; Bodmer, Daniel] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Brand, Yves; Levano, Soledad; Radojevic, Vesna; Setz, Cristian; Bodmer, Daniel] Univ Basel Hosp, Clin Otolaryngol Head & Neck Surg, CH-4031 Basel, Switzerland; [Naldi, Arianne Monge] Univ Zurich Hosp, Clin Otolaryngol Head & Neck Surg, Inner Ear Res, CH-8091 Zurich, Switzerland; [Ryan, Allen F.; Pak, Kwang] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [Ryan, Allen F.; Pak, Kwang] Univ Calif San Diego, Sch Med, Dept Otolaryngol, La Jolla, CA 92093 USA; [Ryan, Allen F.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Ryan, Allen F.; Pak, Kwang] San Diego VA Med Ctr, San Diego, CA 92161 USA; [Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Mech Canc Program, Basel, Switzerland	University of Basel; University of Basel; University of Zurich; University Zurich Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Friedrich Miescher Institute for Biomedical Research	Bodmer, D (corresponding author), Univ Basel Hosp, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland.	Daniel.bodmer@usb.ch		Petkovic, Vesna/0000-0002-0741-9774; Setz, Cristian/0000-0001-9011-2898; Levano, Soledad/0000-0002-0963-7951	Medizinische Abteilung der Margarete und Walter Lichtsteiner-Stiftung, Basel, Switzerland; Schwerhorigenverein Nordwestschweiz; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000139] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001205] Funding Source: NIH RePORTER	Medizinische Abteilung der Margarete und Walter Lichtsteiner-Stiftung, Basel, Switzerland; Schwerhorigenverein Nordwestschweiz; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs)	Supported by Medizinische Abteilung der Margarete und Walter Lichtsteiner-Stiftung, Basel, Switzerland (YB) and the Schwerhorigenverein Nordwestschweiz (DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand Y, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-114; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Caelers A, 2010, AUDIOL NEURO-OTOL, V15, P282, DOI 10.1159/000279760; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chang Z, 2010, DEV BIOL, V347, P384, DOI 10.1016/j.ydbio.2010.08.033; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chung WH, 2006, JARO-J ASSOC RES OTO, V7, P373, DOI 10.1007/s10162-006-0050-y; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guo HF, 2006, J NEUROSCI, V26, P4004, DOI 10.1523/JNEUROSCI.3616-05.2006; Haake SM, 2009, HEARING RES, V255, P22, DOI 10.1016/j.heares.2009.05.003; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hess A, 2006, EUR ARCH OTO-RHINO-L, V263, P75, DOI 10.1007/s00405-005-0953-y; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Jiang H, 2006, J NEUROCHEM, V99, P269, DOI 10.1111/j.1471-4159.2006.04117.x; Jiang HY, 2005, J NEUROSCI RES, V79, P644, DOI 10.1002/jnr.20392; JONES PF, 1991, CELL REGUL, V2, P1001, DOI 10.1091/mbc.2.12.1001; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Masure S, 1999, EUR J; Nagy I, 2005, JARO-J ASSOC RES OTO, V6, P260, DOI 10.1007/s10162-005-0006-7; Nagy I, 2007, AUDIOL NEURO-OTOL, V12, P209, DOI 10.1159/000101328; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Orike N, 2001, J CELL BIOL, V154, P995, DOI 10.1083/jcb.200101068; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	43	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121599	10.1371/journal.pone.0121599	http://dx.doi.org/10.1371/journal.pone.0121599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811375	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700118
J	Brusselaers, N; Mattsson, F; Lindblad, M; Lagergren, J				Brusselaers, Nele; Mattsson, Fredrik; Lindblad, Mats; Lagergren, Jesper			Association between Education Level and Prognosis after Esophageal Cancer Surgery: A Swedish Population-Based Cohort Study	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; SURVIVAL; ADENOCARCINOMA; DEPRIVATION; SMOKING; MORTALITY; DEATH; RISK	Background An association between education level and survival after esophageal cancer has recently been indicated, but remains uncertain. We conducted a large study with long follow-up to address this issue. Methods This population-based cohort study included all patients operated for esophageal cancer in Sweden between 1987 and 2010 with follow-up until 2012. Level of education was categorized as compulsory (<= 9 years), intermediate (10-12 years), or high (>= 13 years). The main outcome measure was overall 5-year mortality after esophagectomy. Cox regression was used to estimate associations between education level and mortality, expressed as hazard ratios (HRs) with 95% confidence intervals (CIs), with adjustment for sex, age, co-morbidity, tumor stage, tumor histology, and assessing the impact of education level over time. Results Compared to patients with high education, the adjusted HR for mortality was 1.29 (95% CI 1.07-1.57) in the intermediate educated group and 1.42 (95% CI 1.17-1.71) in the compulsory educated group. The largest differences were found in early tumor stages (T-stage 0-1), with HRs of 1.73 (95% CI 1.00-2.99) and 2.58 (95% CI 1.51-4.42) for intermediate and compulsory educated patients respectively; and for squamous cell carcinoma, with corresponding HRs of 1.38 (95% CI 1.07-1.79) and 1.52 (95% CI 1.19-1.95) respectively. Conclusions This Swedish population-based study showed an association between higher education level and improved survival after esophageal cancer surgery, independent of established prognostic factors. The associations were stronger in patients of an early tumor stage and squamous cell carcinoma.	[Brusselaers, Nele; Mattsson, Fredrik; Lagergren, Jesper] Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden; [Lindblad, Mats] Karolinska Univ Hosp, Dept Surg Gastroenterol, Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of London; King's College London	Brusselaers, N (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden.	nele.brusselaers@ki.se	Lindblad, Mats/AEP-3569-2022; Brusselaers, Nele/I-3501-2012	Brusselaers, Nele/0000-0003-0137-447X; Lindblad, Mats/0000-0003-3575-6986	Swedish Research Council (SIMSAM); Swedish Cancer Society	Swedish Research Council (SIMSAM)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by the Swedish Research Council (SIMSAM) and Swedish Cancer Society. The funding sources had no role in the design and conduct of the study, collection, management, analysis and interpretation of the data, or preparation review or approval of the manuscript.	Bentley R, 2008, CANCER CAUSE CONTROL, V19, P183, DOI 10.1007/s10552-007-9084-7; Brusselaers N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003754; Cavalli-Bjorkman N, 2011, EUR J CANCER, V47, P1398, DOI 10.1016/j.ejca.2010.12.013; Cavelaars AEJM, 2000, BRIT MED J, V320, P1102, DOI 10.1136/bmj.320.7242.1102; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen MF, 2013, ANN SURG ONCOL; Derogar M, 2013, J CLIN ONCOL, V31, P551, DOI 10.1200/JCO.2012.46.1517; Eloranta S, 2010, EUR J CANCER, V46, P2965, DOI 10.1016/j.ejca.2010.05.028; Frederiksen BL, 2009, SOC SCI MED, V69, P1107, DOI 10.1016/j.socscimed.2009.07.040; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531; Gossage JA, 2009, INT J CLIN PRACT, V63, P859, DOI 10.1111/j.1742-1241.2009.02004.x; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Jansson C, 2005, CANCER EPIDEM BIOMAR, V14, P1754, DOI 10.1158/1055-9965.EPI-05-0140; Kulik MC, 2014, NICOTINE TOB RES, V16, P507, DOI 10.1093/ntr/ntt175; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Leigh Y, 2006, BRIT J CANCER, V95, P940, DOI 10.1038/sj.bjc.6603315; Little R.J.A., 2002, STAT ANAL MISSING DA; Morgan MA, 2007, SCAND J GASTROENTERO, V42, P1230, DOI 10.1080/00365520701320471; Nordahl H, 2014, EPIDEMIOLOGY, V25, P389, DOI 10.1097/EDE.0000000000000080; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Rouvelas I, 2005, LANCET ONCOL, V6, P864, DOI 10.1016/S1470-2045(05)70347-8; Sobin LH., 2002, INT UNION CANC UICC, V6; Sorbye H, 2009, CANCER, V115, P4679, DOI 10.1002/cncr.24527; Statistics Sweden, 2013, YB ED STAT, P8; Thrift AP, 2012, CANCER CAUSE CONTROL, V23, P555, DOI 10.1007/s10552-012-9913-1	25	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121928	10.1371/journal.pone.0121928	http://dx.doi.org/10.1371/journal.pone.0121928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811880	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700159
J	Calenge, C; Chadoeuf, J; Giraud, C; Huet, S; Julliard, R; Monestiez, P; Piffady, J; Pinaud, D; Ruette, S				Calenge, Clement; Chadoeuf, Joel; Giraud, Christophe; Huet, Sylvie; Julliard, Romain; Monestiez, Pascal; Piffady, Jeremy; Pinaud, David; Ruette, Sandrine			The Spatial Distribution of Mustelidae in France	PLOS ONE			English	Article							FOXES VULPES-VULPES; PINE MARTEN; MELES-MELES; FIELD SIGNS; RED FOX; POPULATION; CARNIVORES	We estimated the spatial distribution of 6 Mustelidae species in France using the data collected by the French national hunting and wildlife agency under the "small carnivorous species logbooks" program. The 1500 national wildlife protection officers working for this agency spend 80% of their working time traveling in the spatial area in which they have authority. During their travels, they occasionally detect dead or living small and medium size carnivorous animals. Between 2002 and 2005, each car operated by this agency was equipped with a logbook in which officers recorded information about the detected animals (species, location, dead or alive, date). Thus, more than 30000 dead or living animals were detected during the study period. Because a large number of detected animals in a region could have been the result of a high sampling pressure there, we modeled the number of detected animals as a function of the sampling effort to allow for unbiased estimation of the species density. For dead animals - mostly roadkill - we supposed that the effort in a given region was proportional to the distance traveled by the officers. For living animals, we had no way to measure the sampling effort. We demonstrated that it was possible to use the whole dataset (dead and living animals) to estimate the following: (i) the relative density i.e., the density multiplied by an unknown constant - of each species of interest across the different French agricultural regions, (ii) the sampling effort for living animals for each region, and (iii) the relative detection probability for various species of interest.	[Calenge, Clement; Ruette, Sandrine] Off Natl Chasse & Faune Sauvage, Direct Etud & Rech, F-78612 Le Perray En Yvelines, France; [Chadoeuf, Joel] UR1052, Stat, F-84143 Montfavet, France; [Giraud, Christophe] Ecole Polytech, CMAP, UMR 7641, Palaiseau, France; [Giraud, Christophe] Univ Paris 11, Lab Math Orsay, UMR 8628, Orsay, France; [Huet, Sylvie] INRA, UR MIA 341, F-78352 Jouy En Josas, France; [Julliard, Romain] MNHN CNRS UPMC, UMR 7204, CESCO, F-75005 Paris, France; [Monestiez, Pascal] INRA, Unite BioSp, F-84914 Avignon 9, France; [Piffady, Jeremy] Ctr Lyon Villeurbanne, IRSTEA, UR MALY, F-69626 Villeurbanne, France; [Pinaud, David] Univ La Rochelle, CNRS, CEBC, UMR 7372, F-79360 Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; INRAE; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Calenge, C (corresponding author), Off Natl Chasse & Faune Sauvage, Direct Etud & Rech, BP 20, F-78612 Le Perray En Yvelines, France.	clement.calenge@oncfs.gouv.fr	Pinaud, David/B-6326-2008; Ruette, Sandrine/GQQ-0903-2022; Calenge, Clément/AAK-4846-2021	Pinaud, David/0000-0003-0815-9668; Ruette, Sandrine/0000-0002-7355-3592; Calenge, Clément/0000-0001-7741-8016; Monestiez, Pascal/0000-0001-5851-2699	MASTODONS of the Centre national de la recherche scientifique; Institut national de la recherche agronomique; program "Chaire de modelisation mathematique et biodiversite" from Veolia, Ecole Polytechnique and Museum national d'histoire naturelle	MASTODONS of the Centre national de la recherche scientifique; Institut national de la recherche agronomique; program "Chaire de modelisation mathematique et biodiversite" from Veolia, Ecole Polytechnique and Museum national d'histoire naturelle	This paper was partially funded by: The program MASTODONS of the Centre national de la recherche scientifique (http://www.cnrs.fr/mi/spip.php?article53&lang = fr), under the title "Statistiques Crowdsourcing biodiversite" (funded author RR). The program CiSStats funded by the program "reseaux incitatifs" of the Institut national de la recherche agronomique (funded author PM, http://ciam.inra.fr/cisstats/). The program "Chaire de modelisation mathematique et biodiversite" from Veolia, Ecole Polytechnique and Museum national d'histoire naturelle (funded authors CG and RJ; http://www.cmap.polytechnique.fr/chaire-mmb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaret M, 2008, FAUNE SAUVAGE, V295, P39; Baker PJ, 2004, MAMMAL REV, V34, P115, DOI 10.1046/j.0305-1838.2003.00024.x; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; Birks J, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P235; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Cameron A, 1998, ECONOMETRIC SOCIETY, V30; Clarke GP, 1998, BIOL CONSERV, V86, P117, DOI 10.1016/S0006-3207(98)00018-4; Conn PB, 2013, ECOLOGY, V94, P2607, DOI 10.1890/12-2124.1; DARROCH JN, 1983, ANN STAT, V11, P724, DOI 10.1214/aos/1176346240; Davison A, 2002, J ZOOL, V257, P141, DOI 10.1017/S0952836902000730; Gibbons DW, 2007, BIRD STUDY, V54, P324, DOI 10.1080/00063650709461492; Grilo C, 2011, EUR J WILDLIFE RES, V57, P707, DOI 10.1007/s10344-010-0478-6; Harris S, 2004, MAMMAL REV, V34, P157, DOI 10.1046/j.0305-1838.2003.00030.x; Hastie T., 2009, THE ELEMENTS OF STAT, DOI DOI 10.1007/B94608; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Hounsome TD, 2005, J ZOOL, V266, P81, DOI 10.1017/S0952836905006606; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Kindberg J, 2009, BIOL CONSERV, V142, P159, DOI 10.1016/j.biocon.2008.10.009; Kurki S, 1998, J ANIM ECOL, V67, P874, DOI 10.1046/j.1365-2656.1998.6760874.x; Lindsey JK, 1999, J ROY STAT SOC C-APP, V48, P553, DOI 10.1111/1467-9876.00171; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Lucentini L, 2007, CONSERV GENET, V8, P757, DOI 10.1007/s10592-006-9203-0; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; Malbasa V, 2011, PROCEEDINGS OF THE 1, P1352; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; Mergey M, 2011, J MAMMAL, V92, P328, DOI 10.1644/09-MAMM-A-366.1; R Core Team, 2013, R A LANGUAGE AND ENV; Rondinini C, 2002, ECOGRAPHY, V25, P257, DOI 10.1034/j.1600-0587.2002.250301.x; Ruette S, 2003, WILDLIFE BIOL, V9, P11, DOI 10.2981/wlb.2003.003; Sadlier LMJ, 2004, MAMMAL REV, V34, P75, DOI 10.1046/j.0305-1838.2003.00029.x; Seber G. A. F., 1982, THE ESTIMATION OF AN; SILVERMAN B. W., 1986, DENSITY ESTIMATION F; Wilson GJ, 2001, WILDLIFE RES, V28, P151, DOI 10.1071/WR00033; Xie Y, 2013, KNITR A GENERAL PURP; Zalewski A, 2006, ECOGRAPHY, V29, P31, DOI 10.1111/j.2005.0906-7590.04313.x	36	10	10	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121689	10.1371/journal.pone.0121689	http://dx.doi.org/10.1371/journal.pone.0121689			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811456	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700128
J	Calvitti, M; Marini, F; Desiderio, A; Puggioli, A; Moretti, R				Calvitti, Maurizio; Marini, Francesca; Desiderio, Angiola; Puggioli, Arianna; Moretti, Riccardo			Wolbachia Density and Cytoplasmic Incompatibility in Aedes albopictus: Concerns with Using Artificial Wolbachia Infection as a Vector Suppression Tool	PLOS ONE			English	Article							CHIKUNGUNYA VIRUS; DROSOPHILA-SIMULANS; EXPRESSION; TRANSINFECTION; POPULATIONS; PERFORMANCE; DYNAMICS; OUTBREAK; BACTERIA; STRAINS	The mosquito Aedes albopictusi is a competent vector of harmful human pathogens, including viruses causing dengue and chikungunya. Cytoplasmic incompatibility (CI) induced by endosymbiotic Wolbachia can be used to produce functionally sterile males that can be released in the field as a suppression tool against this mosquito. Because the available sexing methods are not efficient enough to avoid unintentional release of a few transinfected females, we assessed the CI pattern in crosses between wPip Wolbachia-transinfected (ARwP) females and wild-type males of Ae. albopictus in this study. Quantitative polymerase chain reaction was used to monitor the titer of the Wolbachia strains that naturally infect Ae. albopictus, that is, wAlbA and wAlbB, in age-controlled males and females. Data were coupled with incompatibility level detected when the above-mentioned males were crossed with ARwP females. Wolbachia infection titer was also monitored in samples of wild caught males. Incompatibility level was positively correlated only with wAlbA density. Crosses between wild-type males having very low wAlbA density (<0.001 wAlbA/actin copy numbers) and ARwP females were partially fertile (CIcorr = 68.06 +/- 6.20). Individuals with low wAlbA titer were frequently found among sampled wild males (30%-50% depending on the site and period). ARwP males can be as considered as a very promising tool for suppressing Ae. albopictus. However, crosses between wild males having low wAlbA density and ARwP females may be partially fertile. In the case of local establishment of the transinfected mosquito line, this occurrence may favor the replacement of the wild-type mosquitoes with the ARwP line, thus reducing the long-term efficacy of incompatible insect technique. Various alternative strategies have been discussed to prevent this risk and to exploit Wolbachia as a tool to control Ae. albopictus.	[Calvitti, Maurizio; Marini, Francesca; Moretti, Riccardo] ENEA Italian Natl Agcy New Technol Energy & Susta, Lab Sustainable Management Agroecosyst, Rome, Italy; [Marini, Francesca] Ist Zooprofilatt Sperimentale Lazio & Toscana, Lab Parasitol & Entomol Surveillance, Rome, Italy; [Desiderio, Angiola] ENEA Italian Natl Agcy New Technol Energy & Susta, Biotechnol Lab, Rome, Italy; [Puggioli, Arianna] Agr & Environm Ctr G Nicoli, Med & Vet Entomol, Bologna, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; IZS Lazio e Toscana; Italian National Agency New Technical Energy & Sustainable Economics Development	Calvitti, M (corresponding author), ENEA Italian Natl Agcy New Technol Energy & Susta, Lab Sustainable Management Agroecosyst, Rome, Italy.	maurizio.calvitti@enea.it	Marini, Francesca/AAE-9300-2020	Marini, Francesca/0000-0002-7207-5891; Moretti, Riccardo/0000-0003-1654-9383				Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Atyame CM, 2015, MOL ECOL, V24, P508, DOI 10.1111/mec.13035; Atyame CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087336; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; BINNINGTON KC, 1989, J INVERTEBR PATHOL, V54, P344, DOI 10.1016/0022-2011(89)90118-3; Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Bourtzis K, 1996, GENETICS, V144, P1063; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; BOURTZIS K, 1999, RICKETTSIAE RICKETTS, P199; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; BREEUWER JAJ, 1993, GENETICS, V135, P565; Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254; Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140; Curtis C. F., 1976, P 15 INT C ENT 1976, P106; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dobson SL, 2002, GENETICS, V160, P1087; Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876; Dyck VA, 2005, STERILE INSECT TECHN, DOI [10.1007/1-4020-4051-2, DOI 10.1007/1-4020-4051-2]; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Floate KD, 2006, BIOCONTROL SCI TECHN, V16, P767, DOI 10.1080/09583150600699606; GHELELOVITCH S, 1952, CR HEBD ACAD SCI, V234, P2386; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Hughes GL, 2014, INSECT MOL BIOL, V23, P141, DOI 10.1111/imb.12066; Issack MI, 2010, EMERG INFECT DIS, V16, P716, DOI 10.3201/eid1604.091582; Jamnongluk W, 2000, J MED ENTOMOL, V37, P53, DOI 10.1603/0022-2585-37.1.53; Josseran L, 2006, EMERG INFECT DIS, V12, P1994; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; Kittayapong P, 2002, HEREDITY, V88, P270, DOI 10.1038/sj.hdy.6800039; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Marshall JF, 2009, P R ENTOMOL SOC LO A, V12, P17, DOI [10.1111/j.1365-3032.1937.tb00911.x, DOI 10.1111/J.1365-3032.1937.TB00911.X]; MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446; Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x; Noda H, 2001, INSECT BIOCHEM MOLEC, V31, P727, DOI 10.1016/S0965-1748(00)00180-6; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Oliva CF, 2014, ACTA TROP, V132, pS130, DOI 10.1016/j.actatropica.2013.11.019; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Poinsot D, 1998, GENETICS, V150, P227; Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2; Puggioli A, 2014, PLOS ONE, V9, DOI [10.1371/ journal. pone. 0091914, DOI 10.1371/J0URNAL.P0NE.0091914]; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918; SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; TURELLI M, 1995, GENETICS, V140, P1319; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Veneti Z, 2003, GENETICS, V164, P545; Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921; Weeks AR, 2002, TRENDS ECOL EVOL, V17, P257, DOI 10.1016/S0169-5347(02)02480-1; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Xu G, 2007, AM J TROP MED HYG, V76, P1182; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Zabalou S, 2009, ENTOMOL EXP APPL, V132, P232, DOI 10.1111/j.1570-7458.2009.00886.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	67	45	47	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121813	10.1371/journal.pone.0121813	http://dx.doi.org/10.1371/journal.pone.0121813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812130	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700143
J	Imberti, B; Corna, D; Rizzo, P; Xinaris, C; Abbate, M; Longaretti, L; Cassis, P; Benedetti, V; Benigni, A; Zoja, C; Remuzzi, G; Morigi, M				Imberti, Barbara; Corna, Daniela; Rizzo, Paola; Xinaris, Christodoulos; Abbate, Mauro; Longaretti, Lorena; Cassis, Paola; Benedetti, Valentina; Benigni, Ariela; Zoja, Carlamaria; Remuzzi, Giuseppe; Morigi, Marina			Renal Primordia Activate Kidney Regenerative Events in a Rat Model of Progressive Renal Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; I ACCELERATES RECOVERY; IMPAIRED ANGIOGENESIS; VEGF EXPRESSION; STEM-CELLS; FAILURE; TRANSPLANTATION; INJURY; REPAIR; PROTEINURIA	New intervention tools for severely damaged kidneys are in great demand to provide patients with a valid alternative to whole organ replacement. For repairing or replacing injured tissues, emerging approaches focus on using stem and progenitor cells. Embryonic kidneys represent an interesting option because, when transplanted to sites such as the renal capsule of healthy animals, they originate new renal structures. Here, we studied whether metanephroi possess developmental capacity when transplanted under the kidney capsule of MWF male rats, a model of spontaneous nephropathy. We found that six weeks post-transplantation, renal primordia developed glomeruli and tubuli able to filter blood and to produce urine in cyst-like structures. Newly developed metanephroi were able to initiate a regenerative-like process in host renal tissues adjacent to the graft in MWF male rats as indicated by an increase in cell proliferation and vascular density, accompanied by mRNA and protein upregulation of VEGF, FGF2, HGF, IGF-1 and Pax-2. The expression of SMP30 and NCAM was induced in tubular cells. Oxidative stress and apoptosis markedly decreased. Our study shows that embryonic kidneys generate functional nephrons when transplanted into animals with severe renal disease and at the same time activate events at least partly mimicking those observed in kidney tissues during renal regeneration.	[Imberti, Barbara; Corna, Daniela; Rizzo, Paola; Xinaris, Christodoulos; Abbate, Mauro; Longaretti, Lorena; Benedetti, Valentina; Benigni, Ariela; Zoja, Carlamaria; Remuzzi, Giuseppe; Morigi, Marina] Ctr Anna Maria Astori, IRCCS Ist Ric Farmacol Mario Negri, Bergamo, Italy; [Imberti, Barbara] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Cassis, Paola; Remuzzi, Giuseppe] Ctr Ric Trapianti Chiara Cucchi Alessandri & Gilb, IRCCS Ist Ric Farmacol Mario Negri, Bergamo, Italy; [Remuzzi, Giuseppe] AO Papa Giovanni XXIII, Unit Nephrol & Dialysis, Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Fondazione San Matteo; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII	Imberti, B (corresponding author), Ctr Anna Maria Astori, IRCCS Ist Ric Farmacol Mario Negri, Sci & Technology Pk Kilometro Rosso, Bergamo, Italy.	barbara.imberti@marionegri.it	Imberti, Barbara/AAA-6424-2020; zoja, carlamaria/ABF-5896-2020; Xinaris, Christodoulos/ABI-2297-2020; Corna, Daniela/ABF-4496-2020; Ariela, Benigni/ABH-3492-2020; Morigi, Marina/ABH-3131-2020; Longaretti, Lorena/ABG-1258-2020; Mauro, Abbate/ABH-3533-2020; Rizzo, Paola/ABF-4483-2020; Remuzzi, Giuseppe/V-9766-2017	Imberti, Barbara/0000-0001-5005-2536; zoja, carlamaria/0000-0003-2507-8894; Xinaris, Christodoulos/0000-0002-6464-9541; Corna, Daniela/0000-0002-7907-3047; Ariela, Benigni/0000-0002-4721-5485; Morigi, Marina/0000-0001-8029-7382; Longaretti, Lorena/0000-0002-4366-4152; Mauro, Abbate/0000-0002-2092-7474; Rizzo, Paola/0000-0001-9160-8000; Remuzzi, Giuseppe/0000-0002-6194-3446	Ministero della Salute [GR-2009-1547415]; Fondazione Aiuti per la Ricerca sulle Malattie Rare (ARMR), Bergamo, Italy	Ministero della Salute(Ministry of Health, Italy); Fondazione Aiuti per la Ricerca sulle Malattie Rare (ARMR), Bergamo, Italy	The author received funding from Ministero della Salute, grant "Bando progetti di ricerca, Giovani ricercatori - Ricerca finalizzata 2009" cod. GR-2009-1547415 and Fondazione Aiuti per la Ricerca sulle Malattie Rare (ARMR), Bergamo, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 1999, AM J PHYSIOL-RENAL, V277, pF454, DOI 10.1152/ajprenal.1999.277.3.F454; ABRAHAMSON DR, 1991, LAB INVEST, V64, P629; Basile DP, 2008, AM J PHYSIOL-RENAL, V294, pF928, DOI 10.1152/ajprenal.00596.2007; Beckert S, 2006, BIOCHEM BIOPH RES CO, V341, P67, DOI 10.1016/j.bbrc.2005.12.148; Benigni A, 2011, AM J PATHOL, V179, P628, DOI 10.1016/j.ajpath.2011.04.003; Chade Alejandro R, 2012, F1000 Med Rep, V4, P1, DOI 10.3410/M4-1; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; DING H, 1993, J CLIN INVEST, V91, P2281, DOI 10.1172/JCI116456; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; FRIEDLAENDER M, 1995, J AM SOC NEPHROL, V5, P1782; Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3; GOHDA E, 1994, CYTOKINE, V6, P633, DOI 10.1016/1043-4666(94)90051-5; Hammerman MR, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/501749; Hammerman MR, 2003, NEPHRON EXP NEPHROL, V93, pE58, DOI 10.1159/000068516; Hammerman MR, 2002, CLIN SCI, V103, P599, DOI 10.1042/cs1030599; HAMMERMAN MR, 1994, J AM SOC NEPHROL, V5, P1; Harari-Steinberg O, 2013, EMBO MOL MED, V5, P1556, DOI 10.1002/emmm.201201584; Hirschberg R, 1998, MINER ELECTROL METAB, V24, P211, DOI 10.1159/000057373; Iliescu R, 2010, NEPHROL DIAL TRANSPL, V25, P1079, DOI 10.1093/ndt/gfp605; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Kiepe D, 2012, ENDOCRIN METAB CLIN, V41, P351, DOI 10.1016/j.ecl.2012.04.015; KLEIN G, 1988, DEVELOPMENT, V102, P749; Lindoso RS, 2009, NEPHROL DIAL TRANSPL, V24, P2628, DOI 10.1093/ndt/gfp307; Matsumoto K, 2002, NEPHROL DIAL TRANSPL, V17, P59, DOI 10.1093/ndt/17.suppl_9.59; MILLER SB, 1992, P NATL ACAD SCI USA, V89, P11876, DOI 10.1073/pnas.89.24.11876; Miyata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079093; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Norman JT, 2006, CLIN EXP PHARMACOL P, V33, P989, DOI 10.1111/j.1440-1681.2006.04476.x; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; REMUZZI A, 1988, KIDNEY INT, V34, P481, DOI 10.1038/ki.1988.206; REMUZZI A, 1992, LAB INVEST, V67, P572; Remuzzi A, 2002, KIDNEY INT, V62, P885, DOI 10.1046/j.1523-1755.2002.00526.x; Rogers SA, 2001, AM J PHYSIOL-REG I, V281, pR661, DOI 10.1152/ajpregu.2001.281.2.R661; Rogers SA, 1998, KIDNEY INT, V54, P27, DOI 10.1046/j.1523-1755.1998.00971.x; Sagrinati C, 2008, TRENDS MOL MED, V14, P277, DOI 10.1016/j.molmed.2008.05.005; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Villanueva S, 2014, AM J PHYSIOL-RENAL, V306, pF430, DOI 10.1152/ajprenal.00720.2012; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; WOOLF AS, 1990, KIDNEY INT, V38, P991, DOI 10.1038/ki.1990.303; Xinaris C, 2012, J AM SOC NEPHROL, V23, P1857, DOI 10.1681/ASN.2012050505; Yokoo T, 2008, KIDNEY INT, V74, P847, DOI 10.1038/ki.2008.327; Yokote S, 2013, CURR OPIN ORGAN TRAN, V18, P186, DOI 10.1097/MOT.0b013e32835f070d; Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120235	10.1371/journal.pone.0120235	http://dx.doi.org/10.1371/journal.pone.0120235			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811887	gold, Green Published			2022-12-26	WOS:000356353700043
J	Manrique, WG; Claudiano, GD; de Castro, MP; Petrillo, TR; Figueiredo, MAP; Belo, MAD; Berdeal, MIQ; de Moraes, JER; de Moraes, FR				Manrique, Wilson Gomez; Claudiano, Gustavo da Silva; de Castro, Marcello Pardi; Petrillo, Thalita Regina; Pereira Figueiredo, Mayra Araguaia; de Andrade Belo, Marco Antonio; Quiroga Berdeal, Maria Isabel; Rodini de Moraes, Julieta Engracia; de Moraes, Flavio Ruas			Expression of Cellular Components in Granulomatous Inflammatory Response in Piaractus mesopotamicus Model	PLOS ONE			English	Article							ACUTE AEROCYSTITIS; FISH; CELLS; MYCOBACTERIOSIS; ZEBRAFISH; CHROMIUM	The present study aimed to describe and characterize the cellular components during the evolution of chronic granulomatous inflammation in the teleost fish pacus (P. mesopotamicus) induced by Bacillus Calmette-Guerin (BCG), using S-100, iNOS and cytokeratin antibodies. 50 fish (120 +/- 5.0 g) were anesthetized and 45 inoculated with 20 mu L (40 mg/mL) (2.0 x 10(6) CFU/mg) and five inoculated with saline (0,65%) into muscle tissue in the laterodorsal region. To evaluate the inflammatory process, nine fish inoculated with BCG and one control were sampled in five periods: 3rd, 7th, 14th, 21st and 33rd days post-inoculation (DPI). Immunohistochemical examination showed that the marking with anti-S-100 protein and anti-iNOS antibodies was weak, with a diffuse pattern, between the third and seventh DPI. From the 14th to the 33rd day, the marking became stronger and marked the cytoplasm of the macrophages. Positivity for cytokeratin was initially observed in the 14th DPI, and the stronger immunostaining in the 33rd day, period in which the epithelioid cells were more evident and the granuloma was fully formed. Also after the 14th day, a certain degree of cellular organization was observed, due to the arrangement of the macrophages around the inoculated material, with little evidence of edema. The arrangement of the macrophages around the inoculum, the fibroblasts, the lymphocytes and, in most cases, the presence of melanomacrophages formed the granuloma and kept the inoculum isolated in the 33rd DPI. The present study suggested that the granulomatous experimental model using teleost fish P. mesopotamicus presented a similar response to those observed in mammals, confirming its importance for studies of chronic inflammatory reaction.	[Manrique, Wilson Gomez; Claudiano, Gustavo da Silva; de Castro, Marcello Pardi; Petrillo, Thalita Regina; Pereira Figueiredo, Mayra Araguaia; de Andrade Belo, Marco Antonio; Rodini de Moraes, Julieta Engracia; de Moraes, Flavio Ruas] Sao Paulo State Univ, Sch Agrarian & Vet Sci, Dept Vet Pathol, Sao Paulo, Brazil; [Quiroga Berdeal, Maria Isabel] Univ Santiago de Compostela, Coll Vet, Dept Pathol Anat, Lugo, Spain	Universidade Estadual Paulista; Universidade de Santiago de Compostela	de Moraes, FR (corresponding author), Sao Paulo State Univ, Sch Agrarian & Vet Sci, Dept Vet Pathol, Jaboticabal Campus, Sao Paulo, Brazil.	fruasmoraes@gmail.com	MANRIQUE, WILSON GOMEZ/D-9477-2012; MORAES, JULIETA/AAC-3365-2019; Moraes, Julieta R. E./L-8484-2017; Belo, Marco/H-2183-2013; Ruas de Moraes, Flavio/D-3758-2013; Figueiredo, Mayra/H-1756-2016	MANRIQUE, WILSON GOMEZ/0000-0003-3097-3770; MORAES, JULIETA/0000-0002-8384-8781; Moraes, Julieta R. E./0000-0002-8384-8781; Belo, Marco/0000-0001-5845-3940; Ruas de Moraes, Flavio/0000-0001-6607-8650; Figueiredo, Mayra/0000-0002-5809-8878	Sao Paulo Research Foundation-FAPESP [2010/086245]; FAPESP [2009/17640-7]	Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Sao Paulo Research Foundation-FAPESP (grant 2010/086245). WGM was supported by a PhD scholarship from FAPESP (grant 2009/17640-7). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AguiarPasseti T, 1997, J LEUKOCYTE BIOL, V62, P852, DOI 10.1002/jlb.62.6.852; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Barros SF, 1998, MEDIAT INFLAMM, V7, P339, DOI 10.1080/09629359890866; Belo MAA, 2005, J COMP PATHOL, V133, P146, DOI 10.1016/j.jcpa.2005.04.004; Boyd CE., 1990, WATER QUALITY IN PON; Campos-Perez JJ, 2000, IMMUNOLOGY, V99, P153, DOI 10.1046/j.1365-2567.2000.00914.x; Castro MP, 2014, FISH SHELLFISH IMMUN, V36, P284, DOI 10.1016/j.fsi.2013.11.012; Castro MP, 2014, B ENVIRON CONTAM TOX, V92, P213, DOI 10.1007/s00128-013-1174-5; Claudiano GD, 2013, FISH SHELLFISH IMMUN, V34, P1057, DOI 10.1016/j.fsi.2013.01.006; Belo MAD, 2012, PESQUI AGROPECU BRAS, V47, P1015, DOI 10.1590/S0100-204X2012000700019; Gauthier DT, 2003, DIS AQUAT ORGAN, V54, P105, DOI 10.3354/dao054105; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; GOMEZ S, 1993, J FISH DIS, V16, P137, DOI 10.1111/j.1365-2761.1993.tb00857.x; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Kumar V, 2005, ROBBINS COTRANS PATO; Laing KJ, 1999, DEV COMP IMMUNOL, V23, P71, DOI 10.1016/S0145-305X(98)00036-6; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Manrique WG, 2014, J APPL ICHTHYOL, V30, P1001, DOI 10.1111/jai.12445; Mariano M., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P161, DOI 10.1590/S0036-46651995000200012; MOMOTANI E, 1993, J COMP PATHOL, V108, P291, DOI 10.1016/S0021-9975(08)80292-7; NOGA EJ, 1989, VET PATHOL, V26, P429, DOI 10.1177/030098588902600508; Ramakrishnan L, 2013, ADV EXP MED BIOL, V783, P251, DOI 10.1007/978-1-4614-6111-1_13; Reque VR, 2010, AQUACULTURE, V300, P37, DOI 10.1016/j.aquaculture.2009.12.014; Romano LA, 2012, PESQUI VET BRASIL, V32, P254, DOI 10.1590/S0100-736X2012000300013; Sado RY, 2008, BRAZ ARCH BIOL TECHN, V51, P929, DOI 10.1590/S1516-89132008000500009; Sakabe R, 2013, PESQUI AGROPECU BRAS, V48, P313, DOI 10.1590/S0100-204X2013000300010; *SAS I INC, 2001, SAS STAT SOFTW CHANG; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Snedecor GW, 1980, STAT METHODS, V7th; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657	31	26	27	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121625	10.1371/journal.pone.0121625	http://dx.doi.org/10.1371/journal.pone.0121625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811875	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700123
J	Masson, GS; Nair, AR; Dange, RB; Silva-Soares, PP; Michelini, LC; Francis, J				Masson, Gustavo S.; Nair, Anand R.; Dange, Rahul B.; Silva-Soares, Pedro Paulo; Michelini, Lisete C.; Francis, Joseph			Toll-Like Receptor 4 Promotes Autonomic Dysfunction, Inflammation and Microglia Activation in the Hypothalamic Paraventricular Nucleus: Role of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							II-INDUCED HYPERTENSION; VENTROLATERAL MEDULLA CONTRIBUTE; FACTOR-KAPPA-B; NEUROGENIC HYPERTENSION; BAROREFLEX SENSITIVITY; MYOCARDIAL-INFARCTION; HEART-FAILURE; ER STRESS; RAT-BRAIN; CYTOKINES	Background & Purpose Toll-like receptor 4 (TLR4) signaling induces tissue pro-inflammatory cytokine release and endoplasmic reticulum (ER) stress. We examined the role of TLR4 in autonomic dysfunction and the contribution of ER stress. Experimental approach Our study included animals divided in 6 experimental groups: rats treated with saline (i. v., 0.9%), LPS (i. v., 10mg/kg), VIPER (i. v., 0.1 mg/kg), or 4-PBA (i. p., 10 mg/kg). Two other groups were pretreated either with VIPER (TLR4 viral inhibitory peptide) LPS + VIPER (i. v., 0.1 mg/kg) or 4-Phenyl butyric acid (4-PBA) LPS + PBA (i. p., 10 mg/kg). Arterial pressure (AP) and heart rate (HR) were measured in conscious Sprague-Dawley rats. AP, HR variability, as well as baroreflex sensitivity (BrS), was determined after LPS or saline treatment for 2 hours. Immunofluorescence staining for NeuN, Ib1 alpha, TLR4 and GRP78 in the hypothalamic paraventricular nucleus (PVN) was performed. TNF-alpha, TLR4 and GRP78 protein expression in the PVN were evaluated by western blot. Plasma norepinephrine levels were determined by ELISA. Key Results Acute LPS treatment increased HR and plasma norepinephrine concentration. It also decreased HR variability and high frequency (HF) components of HR variability, as well BrS. Acute LPS treatment increased TLR4 and TNF-alpha protein expression in the PVN. These hemodynamic and molecular effects were partially abrogated with TLR4 blocker or ER stress inhibitor pretreatment. In addition, immunofluorescence study showed that TLR4 is co-localized with GRP78in the neurons. Further inhibition of TLR4 or ER stress was able to attenuate the LPS-induced microglia activation. Conclusions & Implications TLR4 signaling promotes autonomic dysfunction, inflammation and microglia activation, through neuronal ER stress, in the PVN.	[Masson, Gustavo S.; Nair, Anand R.; Dange, Rahul B.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Masson, Gustavo S.; Michelini, Lisete C.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Silva-Soares, Pedro Paulo] Univ Fed Fluminense, Dept Pharmacol, Rio De Janeiro, Brazil	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Universidade de Sao Paulo; Universidade Federal Fluminense	Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	jfrancis@lsu.edu	da Silva Soares, Pedro Paulo/AAM-7383-2021	da Silva Soares, Pedro Paulo/0000-0001-9589-4294				Bell MT, 2013, CIRCULATION, V128, pS152, DOI 10.1161/CIRCULATIONAHA.112.000024; Buttini M, 1996, NEUROCHEM INT, V29, P25, DOI 10.1016/0197-0186(95)00141-7; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Ceroni A, 2009, EXP PHYSIOL, V94, P630, DOI 10.1113/expphysiol.2008.046128; Chao YM, 2013, HYPERTENSION, V61, P1270, DOI 10.1161/HYPERTENSIONAHA.111.00469; Cohuet G, 2006, PHARMACOL THERAPEUT, V111, P81, DOI 10.1016/j.pharmthera.2005.09.002; Dange RB, 2014, CARDIOVASC RES, V103, P17, DOI 10.1093/cvr/cvu067; Guggilam A, 2008, EUR J HEART FAIL, V10, P625, DOI 10.1016/j.ejheart.2008.05.004; Hines DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060388; Kang YM, 2009, CARDIOVASC RES, V83, P737, DOI 10.1093/cvr/cvp160; Kang YM, 2009, CARDIOVASC RES, V82, P503, DOI 10.1093/cvr/cvp073; Kim S, 2014, INNATE IMMUN-LONDON, V20, P799, DOI 10.1177/1753425913508593; La Rovere MT, 2002, CIRCULATION, V106, P945, DOI 10.1161/01.CIR.0000027565.12764.E1; Lippai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070945; Nair AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111976; Nair AR, 2014, FREE RADICAL BIO MED, V71, P16, DOI 10.1016/j.freeradbiomed.2014.03.012; O'Neill CM, 2013, ENDOCRINOLOGY, V154, P3077, DOI 10.1210/en.2012-2138; Ogawa K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069053; Ormezzano O, 2008, J HYPERTENS, V26, P1373, DOI 10.1097/HJH.0b013e3283015e5a; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Rana I, 2010, BRAIN RES, V1326, P96, DOI 10.1016/j.brainres.2010.02.028; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Shi P, 2010, HYPERTENSION, V56, P297, DOI 10.1161/HYPERTENSIONAHA.110.150409; Shi Z, 2011, ACTA PHYSIOL, V203, P289, DOI 10.1111/j.1748-1716.2011.02313.x; Sriramula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063847; Wu KLH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-212; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Young CN, 2012, J CLIN INVEST, V122, P3960, DOI 10.1172/JCI64583	28	50	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122850	10.1371/journal.pone.0122850	http://dx.doi.org/10.1371/journal.pone.0122850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811788	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700203
J	Sakai, M; Martinez-Arguelles, DB; Patterson, NH; Chaurand, P; Papadopoulos, V				Sakai, Monica; Martinez-Arguelles, Daniel B.; Patterson, Nathan H.; Chaurand, Pierre; Papadopoulos, Vassilios			In Search of the Molecular Mechanisms Mediating the Inhibitory Effect of the GnRH Antagonist Degarelix on Human Prostate Cell Growth	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; ANDROGEN DEPRIVATION THERAPY; LINES CHARACTERISTICS; SIGNALING PATHWAYS; MASS-SPECTROMETRY; BREAST-CANCER; HYPERPLASIA; RECEPTOR; CETRORELIX; TISSUES	Degarelix is a gonadrotropin-releasing hormone (GnRH) receptor (GnRHR) antagonist used in patients with prostate cancer who need androgen deprivation therapy. GnRHRs have been found in extra-pituitary tissues, including prostate, which may be affected by the GnRH and GnRH analogues used in therapy. The direct effect of degarelix on human prostate cell growth was evaluated. Normal prostate myofibroblast WPMY-1 and epithelial WPE1-NA22 cells, benign prostatic hyperplasia (BPH)-1 cells, androgen-independent PC-3 and androgen-dependent LNCaP prostate cancer cells, as well as VCaP cells derived from a patient with castration-resistant prostate cancer were used. Discriminatory protein and lipid fingerprints of normal, hyperplastic, and cancer cells were generated by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS). The investigated cell lines express GNRHR1 and GNRHR2 and their endogenous ligands. Degarelix treatment reduced cell viability in all prostate cell lines tested, with the exception of the PC-3 cells; this can be attributed to increased apoptosis, as indicated by increased caspase 3/7, 8 and 9 levels. WPE1-NA22, BPH-1, LNCaP, and VCaP cell viability was not affected by treatment with the GnRH agonists leuprolide and goserelin. Using MALDI MS, we detected changes in m/z signals that were robust enough to create a complete discriminatory profile induced by degarelix. Transcriptomic analysis of BPH-1 cells provided a global map of genes affected by degarelix and indicated that the biological processes affected were related to cell growth, G-coupled receptors, the mitogen-activated protein kinase (MAPK) pathway, angiogenesis and cell adhesion. Taken together, these data demonstrate that (i) the GnRH antagonist degarelix exerts a direct effect on prostate cell growth through apoptosis; (ii) MALDI MS analysis provided a basis to fingerprint degarelix-treated prostate cells; and (iii) the clusters of genes affected by degarelix suggest that this compound, in addition to its known use in the treatment of prostate cancer, may be efficacious in BPH.	[Sakai, Monica; Martinez-Arguelles, Daniel B.; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Sakai, Monica; Martinez-Arguelles, Daniel B.; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ, Canada; [Patterson, Nathan H.; Chaurand, Pierre] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Papadopoulos, V (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568	Ferring Pharmaceuticals (Saint-Prex, Switzerland); Canada Research Chair in Biochemical Pharmacology; MITACS program; center grant from Fonds de la Recherche Quebec - Sante; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada	Ferring Pharmaceuticals (Saint-Prex, Switzerland); Canada Research Chair in Biochemical Pharmacology; MITACS program; center grant from Fonds de la Recherche Quebec - Sante; Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from Ferring Pharmaceuticals (Saint-Prex, Switzerland) and a Canada Research Chair in Biochemical Pharmacology (to V.P.). M.S. and D.B.M. were supported in part by the MITACS program. The Research Institute of the McGill University Health Centre is supported in part by a center grant from Fonds de la Recherche Quebec - Sante. P.C. and N. H.P. acknowledge funding from the Canadian Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada.	Aguilar-Rojas A, 2009, ONCOL REP, V22, P981, DOI 10.3892/or_00000525; Anderson J, 2013, UROL INT, V90, P321, DOI 10.1159/000345423; Axcrona K, 2012, BJU INT, V110, P1721, DOI 10.1111/j.1464-410X.2012.11107.x; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Bernadett R, 2011, PROSTATE, V71, P445, DOI 10.1002/pros.21258; Bono AV, 2002, ANAL QUANT CYTOL, V24, P221; Bostanci Y, 2013, CURR OPIN UROL, V23, P5, DOI 10.1097/MOU.0b013e32835abd4a; Chatzaki E, 1996, CANCER RES, V56, P2059; Cheung LWT, 2008, FEBS J, V275, P5479, DOI 10.1111/j.1742-4658.2008.06677.x; Clementi M, 2009, PROSTATE, V69, P1025, DOI 10.1002/pros.20954; Comaru-Schally AM, 1998, J CLIN ENDOCR METAB, V83, P3826, DOI 10.1210/jc.83.11.3826; Crawford ED, 2014, UROLOGY; Debruyne F, 2008, EUR UROL, V54, P170, DOI 10.1016/j.eururo.2008.03.069; Dondi D, 1998, INT J CANCER, V76, P506, DOI 10.1002/(SICI)1097-0215(19980518)76:4<506::AID-IJC11>3.0.CO;2-5; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Ghiringhelli F, 2013, WORLD J GASTROENTERO, V19, P769, DOI 10.3748/wjg.v19.i5.769; GONZALEZBARCENA D, 1994, PROSTATE, V24, P84, DOI 10.1002/pros.2990240206; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Hensley P, 2013, BIOL CHEM; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Klotz L, 2014, EUR UROL; Klotz L, 2008, BJU INT, V102, P1531, DOI 10.1111/j.1464-410X.2008.08183.x; Kraus S, 2001, ARCH MED RES, V32, P499, DOI 10.1016/S0188-4409(01)00331-9; Lepor Herbert, 2006, Rev Urol, V8, P183; Limonta P, 2013, CANC TREAT REV; Limonta P, 2012, ENDOCR REV, V33, P784, DOI 10.1210/er.2012-1014; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Martinez-Arguelles DB, 2014, ENDOCRINOLOGY, V155, P1667, DOI 10.1210/en.2013-1921; Mason M, 2013, CLIN ONCOL-UK, V25, P190, DOI 10.1016/j.clon.2012.09.010; McArdle C. A., 2002, Archives of Physiology and Biochemistry, V110, P113, DOI 10.1076/apab.110.1.113.893; Munteanu B, 2013, BIOANALYSIS, V5, P885, DOI [10.4155/BIO.13.47, 10.4155/bio.13.47]; Munteanu B, 2012, ANAL BIOANAL CHEM, V404, P2277, DOI 10.1007/s00216-012-6357-0; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Park MK, 2013, GEN COMP ENDOCR, V181, P259, DOI 10.1016/j.ygcen.2012.09.023; Pommerville PJ, 2010, CAN J UROL, V17, P5063; Ramakrishnappa N, 2005, ANIM REPROD SCI, V88, P95, DOI 10.1016/j.anireprosci.2005.05.009; Rho OK, 2011, MOL CARCINOGEN, V50, P264, DOI 10.1002/mc.20665; Rick FG, 2013, ONCOTARGETS THER, V6, P391, DOI 10.2147/OTT.S32426; Rick FG, 2013, PROSTATE, V73, P873, DOI 10.1002/pros.22633; Rick FG, 2011, PROSTATE, V71, P736, DOI 10.1002/pros.21289; Schroder F, 2012, BJU INT, V109, P1, DOI 10.1111/j.1464-410X.2012.11215.x; Schwamborn K, 2010, NAT REV CANCER, V10, P639, DOI 10.1038/nrc2917; Sedgley KR, 2006, J ENDOCRINOL, V191, P625, DOI 10.1677/joe.1.07067; Seeley EH, 2011, J BIOL CHEM, V286, P25459, DOI 10.1074/jbc.R111.225854; Shore ND, 2013, PROSTATE CANCER P D, V16, P7, DOI 10.1038/pcan.2012.25; Shore ND, 2013, THER ADV UROL, V5, P11, DOI 10.1177/1756287212461048; Siejka A, 2010, BJU INT, V106, P1382, DOI 10.1111/j.1464-410X.2010.09215.x; Steinberg M, 2009, CLIN THER, V31, P2312, DOI 10.1016/j.clinthera.2009.11.009; Sviridonov L, 2013, MOL CELL ENDOCRINOL, V369, P107, DOI 10.1016/j.mce.2013.01.010; Tan O, 2011, CURR OPIN OBSTET GYN, V23, P238, DOI 10.1097/GCO.0b013e328348a3ce; Tank?, 2010, UROTODAY INT J, V03; Van Poppel H, 2012, INT J UROL, V19, P594, DOI 10.1111/j.1442-2042.2012.02997.x; Van Poppel Hendrik, 2010, Cancer Manag Res, V2, P39; Vignozzi L, 2013, PROSTATE, V73, P789, DOI 10.1002/pros.22623; Webber MM, 1997, PROSTATE, V30, P58; Webber MM, 1996, PROSTATE, V29, P386, DOI 10.1002/(SICI)1097-0045(199612)29:6<386::AID-PROS7>3.0.CO;2-6; Webber MM, 1997, PROSTATE, V30, P136, DOI 10.1002/(SICI)1097-0045(19970201)30:2<136::AID-PROS9>3.0.CO;2-M; Wu HM, 2009, REPRODUCTION, V137, P769, DOI 10.1530/REP-08-0397; Yang D, 2012, J HUAZHONG U SCI-MED, V32, P389, DOI 10.1007/s11596-012-0067-x; Yoo TK, 2012, KOREAN J UROL, V53, P139, DOI 10.4111/kju.2012.53.3.139; Zattoni Filiberto, 2012, Arch Ital Urol Androl, V84, P111; Zhang X, 2006, J AM SOC MASS SPECTR, V17, P490, DOI 10.1016/j.jasms.2005.12.007	66	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120670	10.1371/journal.pone.0120670	http://dx.doi.org/10.1371/journal.pone.0120670			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811175	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700054
J	Bai, XF; Zhang, X; Li, YS; Lu, L; Li, B; He, XF				Bai, Xiaofeng; Zhang, Xia; Li, Yanshu; Lu, Li; Li, Bo; He, Xiaofan			Sex Differences in Peripheral Mu-Opioid Receptor Mediated Analgesia in Rat Orofacial Persistent Pain Model	PLOS ONE			English	Article							GONADAL-HORMONES; FEMALE RATS; MORPHINE ANALGESIA; MYOSITIS CONDITION; VISCERAL PAIN; EXPRESSION; AGE; ACTIVATION; GANGLIA; MUSCLE	Unilateral ligation of the tendon of anterior superficial part of rat masseter muscle (TASM) leads to long-lasting allodynia. Sex differences in peripheral mu-opioid receptor (MOR)-mediated analgesia under persistent myogenic pain are not well understood. In this study, we examined (1) whether locally applied MOR agonists attenuate persistent pain following TASM ligation in a sex dependent manner, (2) whether there are sex differences of MOR expression changes in rat trigeminal ganglia (TG). The effects of MOR agonist, D-Ala2, N-Me-Phe4, Gly5-ol]-Enkephalin acetate salt (DAMGO), were assessed 14 days after TASM ligation in male, female and orchidectomized (GDX) male rats. MOR mRNA and protein levels in TG 14 days following tendon ligation were also determined. The mechanical thresholds of the injured side were significantly decreased in both male and female rats, from 3 days to 28 days after TASM ligation. A10 mu g DAMGO significantly attenuated allodynia in male rats. A 10-fold higher dose of DAMGO was required in female and GDX male rats to produce the level of anti-allodynia achieved in male rats. The level of MOR mRNA in TG from male rats was significantly greater 14 days after TASM ligation compared with the sham-operated male rats, but not from female and GDX male rats. After TASM ligation, males had significantly more MOR immunoreactivity in TG compared to sham-operated males. The MOR levels increased to 181.8% of the sham level in male rats receiving tendon injury. But there was no significant change in female rats receiving tendon injury compared to the sham female rats. Taken together, our data suggest that there were sex differences in the effects of peripheral MOR agonists between male and female rats under TASM ligation developing long-lasting pain condition, which is partly mediated by sex differences in the changes of MOR expressions and testosterone is an important factor in the regulation of MOR.	[Bai, Xiaofeng] China Med Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Shenyang 110002, Peoples R China; [Zhang, Xia] China Med Univ, Sch & Hosp Stomatol, Dept Anesthesiol, Shenyang 110002, Peoples R China; [Li, Yanshu] China Med Univ, Dept Cell Biol, Shenyang 110001, Peoples R China; [Lu, Li] China Med Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Shenyang 110002, Peoples R China; [Li, Bo] China Med Univ, Sch Stomatol, Dept Oral Anat & Physiol, Shenyang 110002, Peoples R China; [He, Xiaofan] China Med Univ, Sch & Hosp Stomatol, Dept Anesthesiol, Shenyang 110002, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Zhang, X (corresponding author), China Med Univ, Sch & Hosp Stomatol, Dept Anesthesiol, Shenyang 110002, Peoples R China.	xiaofengbai@sina.cn; zhangxiamd@126.com	lu, lu/HII-7530-2022	Bai, Xiaofeng/0000-0003-0195-6779; Zhang, Xia/0000-0002-7996-4843	National Natural Science Foundation of China [81400530]; Technology Foundation for Selected Overseas Chinese Scholar, Ministry of Personnel of China [[2014]240]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Foundation for Selected Overseas Chinese Scholar, Ministry of Personnel of China	These studies were supported by grants from the National Natural Science Foundation of China (81400530) and Technology Foundation for Selected Overseas Chinese Scholar, Ministry of Personnel of China ([2014]240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi AM, 2007, PAIN, V132, pS60, DOI 10.1016/j.pain.2007.02.006; Aubrun F, 2005, ANESTHESIOLOGY, V103, P156, DOI 10.1097/00000542-200507000-00023; Auh QS, 2012, NEUROSCI LETT, V524, P111, DOI 10.1016/j.neulet.2012.07.018; Carretero J, 2004, NEUROPEPTIDES, V38, P63, DOI 10.1016/j.npep.2004.01.004; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; De Cosmo G, 2008, CLIN J PAIN, V24, P399, DOI 10.1097/AJP.0b013e3181671a08; Fernandez-Liz E, 2008, BRIT J CLIN PHARMACO, V65, P407, DOI 10.1111/j.1365-2125.2007.03029.x; Guo W, 2011, STEM CELLS, V29, P1294, DOI 10.1002/stem.667; Guo W, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-40; Hagiwara H, 2013, NEUROREPORT, V24, P181, DOI 10.1097/WNR.0b013e32835d8540; Isacson D, 2002, EUR J ANAESTH, V19, P5, DOI 10.1097/00003643-200219261-00003; Ji YP, 2007, J PAIN, V8, P494, DOI 10.1016/j.jpain.2007.01.006; Ji YP, 2006, AM J PHYSIOL-REG I, V291, pR307, DOI 10.1152/ajpregu.00824.2005; Kest B, 2000, ANESTHESIOLOGY, V93, P539, DOI 10.1097/00000542-200008000-00034; Kren MC, 2008, EUR J PHARMACOL, V578, P177, DOI 10.1016/j.ejphar.2007.08.036; Loyd DR, 2008, J NEUROSCI, V28, P14007, DOI 10.1523/JNEUROSCI.4123-08.2008; Mousa SA, 2003, ADV EXP MED BIOL, V521, P77; Niu K, 2011, NEUROSCIENCE, V180, P344, DOI 10.1016/j.neuroscience.2011.01.045; Niu KY, 2012, PAIN, V153, P2283, DOI 10.1016/j.pain.2012.07.037; Nunez S, 2007, NEUROSCIENCE, V146, P1346, DOI 10.1016/j.neuroscience.2007.02.024; Puehler W, 2004, NEUROSCIENCE, V129, P473, DOI 10.1016/j.neuroscience.2004.06.086; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Saloman JL, 2011, NEUROSCIENCE, V190, P379, DOI 10.1016/j.neuroscience.2011.05.062; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Truong W, 2003, ANN NEUROL, V53, P366, DOI 10.1002/ana.10465; Van Kempen TA, 2013, NEUROSCI LETT, V552, P66, DOI 10.1016/j.neulet.2013.07.048; Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Zhang X, 2014, EUR J PAIN, V18, P151, DOI 10.1002/j.1532-2149.2013.00352.x	30	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122924	10.1371/journal.pone.0122924	http://dx.doi.org/10.1371/journal.pone.0122924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807259	gold, Green Submitted, Green Published			2022-12-26	WOS:000351880000231
J	Buys, L; Vine, D; Ledwich, G; Bell, J; Mengersen, K; Morris, P; Lewis, J				Buys, Laurie; Vine, Desley; Ledwich, Gerard; Bell, John; Mengersen, Kerrie; Morris, Peter; Lewis, Jim			A Framework for Understanding and Generating Integrated Solutions for Residential Peak Energy Demand	PLOS ONE			English	Article							SYSTEM DYNAMICS; CLIMATE-CHANGE; ELECTRICITY CONSUMPTION; CARBON EMISSIONS; EFFICIENCY GAP; LIFE-STYLE; MODEL; UK; PRICE; CONSERVATION	Supplying peak energy demand in a cost effective, reliable manner is a critical focus for utilities internationally. Successfully addressing peak energy concerns requires understanding of all the factors that affect electricity demand especially at peak times. This paper is based on past attempts of proposing models designed to aid our understanding of the influences on residential peak energy demand in a systematic and comprehensive way. Our model has been developed through a group model building process as a systems framework of the problem situation to model the complexity within and between systems and indicate how changes in one element might flow on to others. It is comprised of themes (social, technical and change management options) networked together in a way that captures their influence and association with each other and also their influence, association and impact on appliance usage and residential peak energy demand. The real value of the model is in creating awareness, understanding and insight into the complexity of residential peak energy demand and in working with this complexity to identify and integrate the social, technical and change management option themes and their impact on appliance usage and residential energy demand at peak times.	[Buys, Laurie; Vine, Desley; Morris, Peter] Queensland Univ Technol, Sch Design, Creat Ind Fac, Brisbane, Qld 4001, Australia; [Ledwich, Gerard] Queensland Univ Technol, Sch Elect Engineer & Comp Sci, Fac Sci & Engn, Brisbane, Qld 4001, Australia; [Bell, John] Queensland Univ Technol, Sch Chem Phys & Mech Engn, Fac Sci & Engn, Brisbane, Qld 4001, Australia; [Mengersen, Kerrie; Lewis, Jim] Queensland Univ Technol, Sch Math & Stat Sci, Fac Sci & Engn, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Vine, D (corresponding author), Queensland Univ Technol, Sch Design, Creat Ind Fac, Brisbane, Qld 4001, Australia.	d.vine@qut.edu.au	Ledwich, Gerard F/I-9684-2012; Mengersen, Kerrie/AHC-4096-2022	Ledwich, Gerard F/0000-0001-7474-0309; Buys, Laurie/0000-0001-8917-0863; Lewis, Jim/0000-0003-4484-8567; Vine, Desley/0000-0002-8414-9210; Mengersen, Kerrie/0000-0001-8625-9168	Australian Research Council's Linkage Project funding scheme [LP110201139]	Australian Research Council's Linkage Project funding scheme(Australian Research Council)	This research was supported under Australian Research Council's Linkage Project funding scheme (project number LP110201139). The findings and views expressed in this article are those of the authors and are not necessarily those of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albadi MH, 2007, DEMAND RESPONSE IN E; Allcott H, 2012, CONTRACT NO 17766; Ambroz K, 2010, KYBERNETES, V39, P1583, DOI 10.1108/03684921011081187; Anastasi G, 2009, AD HOC NETW, V7, P537, DOI 10.1016/j.adhoc.2008.06.003; [Anonymous], 2011, ENERGY EFFICIENT STR; [Anonymous], 2011, JOURNAL OF PUBLIC EC; Baker KJ, 2008, APPL ENERG, V85, P475, DOI 10.1016/j.apenergy.2007.09.004; Barlas Y, 1996, SYST DYNAM REV, V12, P183, DOI 10.1002/(SICI)1099-1727(199623)12:3<183::AID-SDR103>3.0.CO;2-4; Bartusch C, 2011, ENERG POLICY, V39, P5008, DOI 10.1016/j.enpol.2011.06.013; Bin S, 2005, ENERG POLICY, V33, P197, DOI 10.1016/S0301-4215(03)00210-6; Brown MA, 2001, ENERG POLICY, V29, P1197, DOI 10.1016/S0301-4215(01)00067-2; Clement MT, 2011, SOCIOL FORUM, V26, P581, DOI 10.1111/j.1573-7861.2011.01263.x; Crosbie T., 2006, ENERGY ENV, V17, P735, DOI DOI 10.1260/0958-305X.17.5.735; Croucher M, 2011, ENERG POLICY, V39, P5795, DOI 10.1016/j.enpol.2011.07.011; Defeuilley C, 2009, ENERG POLICY, V37, P377, DOI 10.1016/j.enpol.2008.07.025; Department of Employment Economic Development and Innovation, 2009, ENERGY CONSERVATION; Dietz T, 2005, ANNU REV ENV RESOUR, V30, P335, DOI 10.1146/annurev.energy.30.050504.144444; Dixon RK, 2010, ENERG POLICY, V38, P6398, DOI 10.1016/j.enpol.2010.01.038; Druckman A, 2008, ENERG POLICY, V36, P3177, DOI 10.1016/j.enpol.2008.03.021; Ellegard K, 2011, APPL ENERG, V88, P1920, DOI 10.1016/j.apenergy.2010.11.019; Everett R, 2012, ENERGY SYSTEMS AND S; Fang RS, 2003, IEEE T POWER SYST, V18, P374, DOI 10.1109/TPWRS.2002.807083; Faruqui A, 2010, ENERGY, V35, P1598, DOI 10.1016/j.energy.2009.07.042; Filippini M, 2004, ENERG POLICY, V32, P429, DOI 10.1016/S0301-4215(02)00314-2; Filippini M, 2011, ENERG POLICY, V39, P5811, DOI 10.1016/j.enpol.2011.06.002; Fischer C, 2008, ENERG EFFIC, V1, P79, DOI 10.1007/s12053-008-9009-7; Gellings CW, 2004, PHYS TODAY, V57, P45, DOI 10.1063/1.1878334; Georgopoulou E, 1997, EUR J OPER RES, V103, P38, DOI 10.1016/S0377-2217(96)00263-9; Giannakis D, 2005, ENERG POLICY, V33, P2256, DOI 10.1016/j.enpol.2004.04.021; Gillingham K, 2009, CONTRACT NO 15031; Green BE, 2004, INT J SOCIOLOGY, V34, P9; Grossler A, 2008, SYST RES BEHAV SCI, V25, P467, DOI 10.1002/sres.908; Guy S, 2006, ENVIRON PLANN C, V24, P645, DOI 10.1068/c0607j; Gyamfi S, 2011, ENERG POLICY, V39, P2993, DOI 10.1016/j.enpol.2011.03.012; HACKETT B, 1991, SOCIOL FORUM, V6, P449, DOI 10.1007/BF01114472; Hart M, 2004, ENERG BUILDINGS, V36, P161, DOI 10.1016/j.enbuild.2003.10.009; Hazas M, 2011, IEEE PERVAS COMPUT, V10, P13, DOI 10.1109/MPRV.2010.89; HEBERLEIN TA, 1983, J ECON PSYCHOL, V4, P107; Herter K, 2007, ENERG POLICY, V35, P2121, DOI 10.1016/j.enpol.2006.06.019; Herter K, 2007, ENERGY, V32, P25, DOI 10.1016/j.energy.2006.01.014; Herter K, 2010, ENERGY, V35, P1561, DOI 10.1016/j.energy.2009.07.022; Hinrichs RA, 2013, ENERGY ITS USE AND T; Hovmand PS, 2012, SYST RES BEHAV SCI, V29, P179, DOI 10.1002/sres.2105; JAFFE AB, 1994, ENERG POLICY, V22, P804, DOI 10.1016/0301-4215(94)90138-4; Kamenica E, 2011, AM ECON REV, V101, P417, DOI 10.1257/aer.101.3.417; Keirstead J, 2006, ENERG POLICY, V34, P3065, DOI 10.1016/j.enpol.2005.06.004; Kirshen P, 2008, CLIMATIC CHANGE, V86, P105, DOI 10.1007/s10584-007-9252-5; Kowsari R, 2011, ENERG POLICY, V39, P7505, DOI 10.1016/j.enpol.2011.06.030; Kurtz CF, 2003, IBM SYST J, V42, P462, DOI 10.1147/sj.423.0462; Leadbetter J, 2012, ENERG BUILDINGS, V55, P685, DOI 10.1016/j.enbuild.2012.09.035; Lorenzoni I, 2007, GLOBAL ENVIRON CHANG, V17, P445, DOI 10.1016/j.gloenvcha.2007.01.004; Lovell H, 2005, HOUSING STUD, V20, P815, DOI 10.1080/02673030500214118; Lutzenhiser L, 2002, ORGAN ENVIRON, V15, P5, DOI 10.1177/1086026602151001; LUTZENHISER L, 1992, ENERGY, V17, P47, DOI 10.1016/0360-5442(92)90032-U; LUTZENHISER L, 1993, ANNU REV ENERG ENV, V18, P247, DOI 10.1146/annurev.energy.18.1.247; Mazur A, 2013, ENERGY AND ELECTRICI; Miller NL, 2008, CLIMATE EXTREME HEAT; Neenan B, 2009, FINAL REPORT; Newsham GR, 2010, ENERG POLICY, V38, P3289, DOI 10.1016/j.enpol.2010.01.027; Parag Y, 2009, ENERG POLICY, V37, P3984, DOI 10.1016/j.enpol.2009.04.044; Parker P, 2003, CAN GEOGR-GEOGR CAN, V47, P169, DOI 10.1111/1541-0064.00006; Pearson B., 2014, NO END IN SIGHT TO S; Pelenur MJ, 2012, ENERGY, V47, P348, DOI 10.1016/j.energy.2012.09.058; Pierce J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1985; Poortinga W, 2004, ENVIRON BEHAV, V36, P70, DOI 10.1177/0013916503251466; Pyrko J, 2011, ENERG EFFIC, V4, P393, DOI 10.1007/s12053-010-9099-x; Rehfuess EA, 2010, ENVIRON RES, V110, P725, DOI 10.1016/j.envres.2010.07.006; Reiss PC, 2008, RAND J ECON, V39, P636, DOI 10.1111/j.1756-2171.2008.00032.x; Rouwette EAJA, 2002, SYST DYNAM REV, V18, P5, DOI 10.1002/sdr.229; S Kishore, 2010, SMARTGRIDCOMM FIRST; Sadineni SB, 2012, APPL ENERG, V92, P204, DOI 10.1016/j.apenergy.2011.10.026; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Schwaninger M, 2008, SYST RES BEHAV SCI, V25, P447, DOI 10.1002/sres.914; Shove Elizabeth, 2003, COMFORT CLEANLINESS; Simshauser P, 2010, AUST ECON REV, V43, P114, DOI 10.1111/j.1467-8462.2010.00584.x; Snowden D., 2002, Journal of Knowledge Management, V6, P100, DOI 10.1108/13673270210424639; Soytas U, 2009, ECOL ECON, V68, P1667, DOI 10.1016/j.ecolecon.2007.06.014; Steg L, 2008, ENERG POLICY, V36, P4449, DOI 10.1016/j.enpol.2008.09.027; Stephenson J, 2010, ENERG POLICY, V38, P6120, DOI 10.1016/j.enpol.2010.05.069; Sterman JD, 2002, SYST DYNAM REV, V18, P501, DOI 10.1002/sdr.261; Sterman JD, 2001, CALIF MANAGE REV, V43, P8, DOI 10.2307/41166098; Stern N, 2008, AM ECON REV, V98, P1, DOI 10.1257/aer.98.2.1; Stern P., 1999, J CONSUM POLICY, V22, P461, DOI [DOI 10.1023/A:1006211709570, 10.1023/A:1006211709570]; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; STERN PC, 1992, AM PSYCHOL, V47, P1224, DOI 10.1037/0003-066X.47.10.1224; Strengers Y, 2012, ENERG POLICY, V44, P226, DOI 10.1016/j.enpol.2012.01.046; Susnik J, 2013, WATER RESOUR MANAG, V27, P819, DOI 10.1007/s11269-012-0217-8; Swan LG, 2009, RENEW SUST ENERG REV, V13, P1819, DOI 10.1016/j.rser.2008.09.033; Torriti J, 2012, ENERGY, V44, P576, DOI 10.1016/j.energy.2012.05.043; United States. Congress. House. Committee on Science and Technology. Subcommittee on Research and Science Education, 2007, CONTRACT NO 110 55; van den Bergh JCJM, 2011, ENVIRON RESOUR ECON, V48, P43, DOI 10.1007/s10640-010-9396-z; van Vliet B, 2005, INFRASTRUCTURES OF C; VANRAAIJ WF, 1983, J ECON PSYCHOL, V3, P39, DOI 10.1016/0167-4870(83)90057-0; Vennix J.A., 1996, ENCY LIFE SUPPORT SY, V2, P97; Wei YM, 2007, ENERG POLICY, V35, P247, DOI 10.1016/j.enpol.2005.11.020; Weron R, 2000, PHYSICA A, V283, P462, DOI 10.1016/S0378-4371(00)00231-4; Whitmarsh L, 2012, ENGAGING THE PUBLIC; Whitmarsh L, 2011, GLOBAL ENVIRON CHANG, V21, P56, DOI 10.1016/j.gloenvcha.2010.07.011; Whitmarsh L, 2009, PUBLIC UNDERST SCI, V18, P401, DOI 10.1177/0963662506073088; Wilhite H, 2000, ADV GLOB CHANGE RES, V8, P109; Wilk R, 2002, GLOBAL ENVIRON CHANG, V12, P5, DOI 10.1016/S0959-3780(01)00028-0; Wilson C, 2007, ANNU REV ENV RESOUR, V32, P169, DOI 10.1146/annurev.energy.32.053006.141137; Wilson CM, 2010, OXFORD ECON PAP, V62, P647, DOI 10.1093/oep/gpq006; Yohanis YG, 2008, ENERG BUILDINGS, V40, P1053, DOI 10.1016/j.enbuild.2007.09.001; Yuan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091012; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	106	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121195	10.1371/journal.pone.0121195	http://dx.doi.org/10.1371/journal.pone.0121195			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25807384	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000136
J	Strain, EMA; van Belzen, J; van Dalen, J; Bouma, TJ; Airoldi, L				Strain, Elisabeth M. A.; van Belzen, Jim; van Dalen, Jeroen; Bouma, Tjeerd J.; Airoldi, Laura			Management of Local Stressors Can Improve the Resilience of Marine Canopy Algae to Global Stressors	PLOS ONE			English	Article							NUTRIENT ENRICHMENT; LIGHT PENETRATION; CLIMATE-CHANGE; FORMING ALGAE; ADRIATIC SEA; KELP FORESTS; SEDIMENTATION; ECOSYSTEMS; CONSEQUENCES; RESPONSES	Coastal systems are increasingly threatened by multiple local anthropogenic and global climatic stressors. With the difficulties in remediating global stressors, management requires alternative approaches that focus on local scales. We used manipulative experiments to test whether reducing local stressors (sediment load and nutrient concentrations) can improve the resilience of foundation species (canopy algae along temperate rocky coastlines) to future projected global climate stressors (high wave exposure, increasing sea surface temperature), which are less amenable to management actions. We focused on Fucoids (Cystoseira barbata) along the north-western Adriatic coast in the Mediterranean Sea because of their ecological relevance, sensitivity to a variety of human impacts, and declared conservation priority. At current levels of sediment and nutrients, C. barbata showed negative responses to the simulated future scenarios of high wave exposure and increased sea surface temperature. However, reducing the sediment load increased the survival of C. barbata recruits by 90.24% at high wave exposure while reducing nutrient concentrations resulted in a 20.14% increase in the survival and enhanced the growth of recruited juveniles at high temperature. We conclude that improving water quality by reducing nutrient concentrations, and particularly the sediment load, would significantly increase the resilience of C. barbata populations to projected increases in climate stressors. Developing and applying appropriate targets for specific local anthropogenic stressors could be an effective management action to halt the severe and ongoing loss of key marine habitats.	[Strain, Elisabeth M. A.; Airoldi, Laura] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Ravenna, Italy; [van Belzen, Jim; van Dalen, Jeroen; Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res, Spatial Ecol Dept, Yerseke, Netherlands	University of Bologna; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Strain, EMA (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Ravenna, Italy.	strain.beth@gmail.com	Airoldi, Laura/I-3553-2019; Strain, Elisabeth/U-3520-2017	Airoldi, Laura/0000-0001-5046-0871; Strain, Elisabeth/0000-0003-2165-9544; van Belzen, Jim/0000-0003-2099-1545; Bouma, Tjeerd/0000-0001-7824-7546	projects Observing, modelling and Testing synergies and TRade-offs for the adaptive management of multiple Impacts in coastal Systems (PRIN, MIUR); Innovative multi-purpose off-shore platforms: planning, design and operation (EU FP7-Ocean) [288710]; THESEUS-Innovative technologies for safer European coasts in a changing climate [EU-FP7-ENV2009-1, 244104]	projects Observing, modelling and Testing synergies and TRade-offs for the adaptive management of multiple Impacts in coastal Systems (PRIN, MIUR)(Ministry of Education, Universities and Research (MIUR)); Innovative multi-purpose off-shore platforms: planning, design and operation (EU FP7-Ocean); THESEUS-Innovative technologies for safer European coasts in a changing climate	The work was supported by the projects Observing, modelling and Testing synergies and TRade-offs for the adaptive management of multiple Impacts in coastal Systems (PRIN 2010-2011, MIUR); Innovative multi-purpose off-shore platforms: planning, design and operation (EU FP7-Ocean-2011, grant: 288710), http://www.mermaidproject.eu/; THESEUS-Innovative technologies for safer European coasts in a changing climate (EU-FP7-ENV2009-1, grant: 244104), http://www.theseusproject.eu/. The funders had no role in study	Accoroni S, 2011, MAR POLLUT BULL, V62, P2512, DOI 10.1016/j.marpolbul.2011.08.003; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 1998, MAR ECOL PROG SER, V165, P271, DOI 10.3354/meps165271; Airoldi L, 2014, P 5 MED S MAR VEG PO, P13; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Araujo R, 2012, J EXP MAR BIOL ECOL, V422, P1, DOI 10.1016/j.jembe.2012.04.006; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; Bergstrom L, 2003, EUR J PHYCOL, V38, P41, DOI 10.1080/0967026031000096236; Bianchi CN, 2014, MEDITERR MAR SCI, V15, P482, DOI 10.12681/mms.678; Bianchi C. N., 2012, LIFE MEDITERRANEAN S, P1; BRAGA AD, 1994, PHYCOLOGIA, V33, P271, DOI 10.2216/i0031-8884-33-4-271.1; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Campbell AH, 2011, GLOBAL CHANGE BIOL, V17, P2958, DOI 10.1111/j.1365-2486.2011.02456.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Coleman MA, 2008, J PHYCOL, V44, P897, DOI 10.1111/j.1529-8817.2008.00541.x; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Deiman M, 2012, ALGAE-SEOUL, V27, P115, DOI 10.4490/algae.2012.27.2.115; DEVINNY JS, 1978, MAR BIOL, V48, P343, DOI 10.1007/BF00391638; Eriksson BK, 2005, OECOLOGIA, V143, P438, DOI 10.1007/s00442-004-1810-1; Falkenberg LJ, 2013, J APPL ECOL, V50, P51, DOI 10.1111/1365-2664.12019; Falkenberg LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033841; Fernandes N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050854; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; Gorman D, 2009, J APPL ECOL, V46, P1258, DOI 10.1111/j.1365-2664.2009.01711.x; Irving AD, 2002, MAR ECOL PROG SER, V245, P83, DOI 10.3354/meps245083; Irving AD, 2009, MAR BIOL, V156, P1223, DOI 10.1007/s00227-009-1164-7; Krause-Jensen D, 2008, ECOL INDIC, V8, P515, DOI 10.1016/j.ecolind.2007.06.004; KREMER B P, 1982, Marine Ecology, V3, P75, DOI 10.1111/j.1439-0485.1982.tb00106.x; La Nafie YA, 2012, LIMNOL OCEANOGR, V57, P1664, DOI 10.4319/lo.2012.57.6.1664; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2011, TRENDS ECOL EVOL, V26, P595, DOI 10.1016/j.tree.2011.07.008; Munda IM, 1996, BOT MAR, V39, P297, DOI 10.1515/botm.1996.39.1-6.297; Nikolic V, 2013, ECOL INDIC, V34, P87, DOI 10.1016/j.ecolind.2013.04.021; Parravicini V, 2014, PLOS ONE, V8; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; *RAC SPA, 2006, ACT PLAN CONS MAR VE; Russell BD, 2012, MAR BIOL, V159, P2633, DOI 10.1007/s00227-011-1863-8; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Singh RP, 2014, FEMS MICROBIOL ECOL, V88, P213, DOI 10.1111/1574-6941.12297; Somot S, 2008, GLOBAL PLANET CHANGE, V63, P112, DOI 10.1016/j.gloplacha.2007.10.003; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Strain EMA, 2014, GLOBAL CHANGE BIOL, V20, P3300, DOI 10.1111/gcb.12619; Wahl M, 2011, ADV MAR BIOL, V59, P37, DOI 10.1016/B978-0-12-385536-7.00002-9; Xu J, 2013, MICROB ECOL, V66, P60, DOI 10.1007/s00248-013-0207-2; YARISH C, 1990, HYDROBIOLOGIA, V204, P505, DOI 10.1007/BF00040278	52	34	35	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120837	10.1371/journal.pone.0120837	http://dx.doi.org/10.1371/journal.pone.0120837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807516	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000105
J	Uryash, A; Bassuk, J; Kurlansky, P; Altamirano, F; Lopez, JR; Adams, JA				Uryash, Arkady; Bassuk, Jorge; Kurlansky, Paul; Altamirano, Francisco; Lopez, Jose R.; Adams, Jose A.			Non-Invasive Technology That Improves Cardiac Function after Experimental Myocardial Infarction: Whole Body Periodic Acceleration (pGz)	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; LEFT-VENTRICULAR FUNCTION; PULSATILE SHEAR-STRESS; HEART-FAILURE; EUROPEAN-SOCIETY; FAILING HEART; EXERCISE; CONTRACTION; EXPRESSION	Myocardial infarction (MI) may produce significant inflammatory changes and adverse ventricular remodeling leading to heart failure and premature death. Pharmacologic, stem cell transplantation, and exercise have not halted the inexorable rise in the prevalence and great economic costs of heart failure despite extensive investigations of such treatments. New therapeutic modalities are needed. Whole Body Periodic Acceleration (pGz) is a non-invasive technology that increases pulsatile shear stress to the endothelium thereby producing several beneficial cardiovascular effects as demonstrated in animal models, normal humans and patients with heart disease. pGz upregulates endothelial derived nitric oxide synthase (eNOS) and its phosphorylation (p-eNOS) to improve myocardial function in models of myocardial stunning and preconditioning. Here we test whether pGz applied chronically after focal myocardial infarction in rats improves functional outcomes from MI. Focal MI was produced by left coronary artery ligation. One day after ligation animals were randomized to receive daily treatments of pGz for four weeks (MI-pGz) or serve as controls (MI-CONT), with an additional group as non-infarction controls (Sham). Echocardiograms and invasive pressure volume loop analysis were carried out. Infarct transmurality, myocardial fibrosis, and markers of inflammatory and anti-inflammatory cytokines were determined along with protein analysis of eNOS, p-eNOS and inducible nitric oxide synthase (iNOS). At four weeks, survival was 80% in MI-pGz vs 50% in MI-CONT (p< 0.01). Ejection fraction and fractional shortening and invasive pressure volume relation indices of afterload and contractility were significantly better in MI-pGz. The latter where associated with decreased infarct transmurality and decreased fibrosis along with increased eNOS, p-eNOS. Additionally, MI-pGz had significantly lower levels of iNOS, inflammatory cytokines (IL-6, TNF-alpha), and higher level of anti-inflammatory cytokine (IL-10). pGz improved survival and contractile performance, associated with improved myocardial remodeling. pGz may serve as a simple, safe, non-invasive therapeutic modality to improve myocardial function after MI.	[Uryash, Arkady; Bassuk, Jorge; Adams, Jose A.] Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA; [Kurlansky, Paul] Columbia Univ, Coll Phys & Surg, Columbia Heart Source, New York, NY USA; [Altamirano, Francisco; Lopez, Jose R.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA	Mount Sinai Medical Center; Columbia University; University of California System; University of California Davis	Adams, JA (corresponding author), Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA.	tony-adams@msmc.com	Adams, Jose Antonio/AAI-2342-2020; Altamirano, Francisco/I-1928-2013; Adams, Jose Antonio/ABC-2699-2021	Adams, Jose Antonio/0000-0002-9401-2226; Altamirano, Francisco/0000-0002-1612-2729; Adams, Jose Antonio/0000-0002-9401-2226	Florida Heart Research Institute	Florida Heart Research Institute	This work was funded by a grant from the Florida Heart Research Institute (http://www.floridaheart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsaether E, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-23; Adams JA, 2005, J APPL PHYSIOL, V98, P1083, DOI 10.1152/japplphysiol.00662.2004; Adams JA, 2003, ANN BIOMED ENG, V31, P1337, DOI 10.1114/1.1623486; Adams JA, 2001, CRIT CARE MED, V29, P1983, DOI 10.1097/00003246-200110000-00022; Adams JA, 2010, LIFE SCI, V86, P707, DOI 10.1016/j.lfs.2010.02.022; Adams JA, 2009, PEPTIDES, V30, P373, DOI 10.1016/j.peptides.2008.10.014; Aragon JP, 2011, J AM COLL CARDIOL, V58, P2683, DOI 10.1016/j.jacc.2011.09.033; Balady GJ, 2007, CIRCULATION, V115, P2675, DOI 10.1161/CIRCULATIONAHA.106.180945; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Carstens E, 2000, ILAR J, V41, P62; Committee on Recognition and Alleviation of Pain in Laboratory Animals National Research Council, 2009, REC ALL PAIN LAB AN; Crisafulli A, 2004, AM J PHYSIOL-HEART C, V287, pH235, DOI 10.1152/ajpheart.00989.2003; Das DK, 2006, CARDIOVASC RES, V70, P254, DOI 10.1016/j.cardiores.2006.02.023; Despa S, 2013, J MOL CELL CARDIOL, V61, P2, DOI 10.1016/j.yjmcc.2013.04.011; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Espey MG, 2002, ANN NY ACAD SCI, V962, P195, DOI 10.1111/j.1749-6632.2002.tb04068.x; Fukuda S, 2010, AM HEART J, V159, P620, DOI 10.1016/j.ahj.2009.12.034; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Giallauria F, 2012, EUR J PREV CARDIOL, V19, P1410, DOI 10.1177/1741826711425427; Gilson WD, 2007, J AM COLL CARDIOL, V50, P1799, DOI 10.1016/j.jacc.2007.07.047; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldhaber JI, 2013, ADV EXP MED BIOL, V961, P355, DOI 10.1007/978-1-4614-4756-6_30; Gomez AM, 2001, CIRCULATION, V104, P688, DOI 10.1161/hc3201.092285; Guha K, 2013, CURR CARDIOL REV, V9, P123, DOI 10.2174/1573403X11309020005; Hamilton KL, 2003, FREE RADICAL BIO MED, V34, P800, DOI 10.1016/S0891-5849(02)01431-4; Hare JM, 2003, J MOL CELL CARDIOL, V35, P719, DOI 10.1016/S0022-2828(03)00143-3; Haykowsky M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-92; Haywood GA, 1996, CIRCULATION, V93, P1087, DOI 10.1161/01.CIR.93.6.1087; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Hemalatha T, 2010, BIOCHEM CELL BIOL, V88, P491, DOI [10.1139/O09-165, 10.1139/o09-165]; Horinaka S, 2003, INT J CARDIOL, V91, P25, DOI 10.1016/S0167-5273(02)00587-9; HUTCHESON IR, 1991, AM J PHYSIOL, V261, pH257, DOI 10.1152/ajpheart.1991.261.1.H257; Jain M, 2001, CIRCULATION, V103, P1920; Jugdutt BL, 2003, HEART FAIL REV, V8, P29, DOI 10.1023/A:1022190820131; Jugdutt Bodh I, 2002, Heart Fail Rev, V7, P391, DOI 10.1023/A:1020718619155; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Khan M, 2007, AM J PHYSIOL-HEART C, V293, pH2129, DOI 10.1152/ajpheart.00677.2007; KISHIMOTO A, 1983, J BIOL CHEM, V258, P1156; Kohler M, 2007, VASA-J VASCULAR DIS, V36, P261, DOI 10.1024/0301-1526.36.4.261; Kohn F D, TEM GUIDELINES ASSES; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Kraljevic J, 2013, CARDIOVASC RES, V99, P55, DOI 10.1093/cvr/cvt080; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li Y, 2005, ENDOTHELIUM-J ENDOTH, V12, P21, DOI 10.1080/10623320590933743; Lim G, 2008, CARDIOVASC RES, V77, P256, DOI 10.1093/cvr/cvm012; Liu YH, 2005, AM J PHYSIOL-HEART C, V289, pH2616, DOI 10.1152/ajpheart.00546.2005; Loga F, 2013, CARDIOVASC RES, V100, P280, DOI 10.1093/cvr/cvt176; Lopez JR, 2011, CIRCULATION, V124; Ma HJ, 2014, CELL PHYSIOL BIOCHEM, V34, P313, DOI 10.1159/000363001; Marini M, 2007, EUR J APPL PHYSIOL, V99, P503, DOI 10.1007/s00421-006-0369-4; Martinez A, 2008, PEPTIDES, V29, P73, DOI 10.1016/j.peptides.2007.10.021; Matsuhisa S, 2008, ANTIOXID REDOX SIGN, V10, P1999, DOI 10.1089/ars.2008.2069; MCELROY CL, 1978, CIRCULATION, V57, P958, DOI 10.1161/01.CIR.57.5.958; Miyamoto S, 2011, AM J CARDIOL, V107, P168, DOI 10.1016/j.amjcard.2010.09.007; Morton D B, 2000, ILAR J, V41, P80; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Nilsson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055477; Nunes RB, 2013, CLINICS, V68, P876, DOI 10.6061/clinics/2013(06)24; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Ottolia M, 2013, J MOL CELL CARDIOL, V61, P28, DOI 10.1016/j.yjmcc.2013.06.001; PARR DR, 1975, CARDIOVASC RES, V9, P366, DOI 10.1093/cvr/9.3.366; Pogwizd SM, 2003, CARDIOVASC RES, V57, P887, DOI 10.1016/S0008-6363(02)00735-6; Ramani R, 2004, AM J PHYSIOL-HEART C, V287, pH1369, DOI 10.1152/ajpheart.00641.2003; Sackner MA, 2005, CHEST, V128, P2794, DOI 10.1378/chest.128.4.2794; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Schulz R, 2009, CIRCULATION, V119, P1355, DOI 10.1161/CIRCULATIONAHA.108.846105; Schulz R, 2008, J MOL CELL CARDIOL, V45, P712, DOI 10.1016/j.yjmcc.2008.09.119; Seferovic PM, 2013, EUR J HEART FAIL, V15, P947, DOI 10.1093/eurjhf/hft092; Siwik DA, 2004, HEART FAIL REV, V9, P43, DOI 10.1023/B:HREV.0000011393.40674.13; Song L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065702; Stefanon I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064986; Stumpf C, 2009, CLIN SCI, V116, P45, DOI 10.1042/CS20080042; Thibault H, 2007, AM J PHYSIOL-HEART C, V293, pH496, DOI 10.1152/ajpheart.00087.2007; Tian H, 2012, CELL TRANSPLANT, V21, P1039, DOI 10.3727/096368911X601000; Toth L A, 2000, ILAR J, V41, P72; Trescher K, 2006, CARDIOVASC RES, V69, P746, DOI 10.1016/j.cardiores.2005.11.027; Uryash A, 2012, LIFE SCI, V91, P178, DOI 10.1016/j.lfs.2012.06.031; Uryash A, 2009, J APPL PHYSIOL, V106, P1840, DOI 10.1152/japplphysiol.91612.2008; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Vaughan-Jones RD, 2014, J PHYSIOL-LONDON, V592, P3177, DOI 10.1113/jphysiol.2014.278697; Wakabayashi S, 2013, J MOL CELL CARDIOL, V61, P68, DOI 10.1016/j.yjmcc.2013.02.007; Wu H, 2009, NITRIC OXIDE-BIOL CH, V21, P63, DOI 10.1016/j.niox.2009.05.004; Yao A, 1998, AM J PHYSIOL-HEART C, V275, pH1441, DOI 10.1152/ajpheart.1998.275.4.H1441; Yoshida H, 2003, CARDIOVASC RES, V59, P419, DOI 10.1016/S0008-6363(03)00385-7	84	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121069	10.1371/journal.pone.0121069	http://dx.doi.org/10.1371/journal.pone.0121069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807532	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000130
J	Vargas, P; Rumeu, B; Heleno, RH; Traveset, A; Nogales, M				Vargas, Pablo; Rumeu, Beatriz; Heleno, Ruben H.; Traveset, Anna; Nogales, Manuel			Historical Isolation of the Galapagos Carpenter Bee (Xylocopa darwini) despite Strong Flight Capability and Ecological Amplitude	PLOS ONE			English	Article							GENE GENEALOGIES; COLONIZATION; ISLANDS; DIVERSIFICATION; MITOCHONDRIAL; ARCHIPELAGO; ORIGIN; PHYLOGEOGRAPHY; CONSERVATION; DISPERSAL	Colonization across the Galapagos Islands by the carpenter bee (Xylocopa darwini) was reconstructed based on distribution of mitochondrial haplotypes (cytochrome oxidase II (COII) sequences) and haplotype lineages. A total of 12 haplotypes were found in 118 individuals of X. darwini. Distributional, phylogenetic and phylogeographic analyses suggest early colonization of most islands followed by historical isolation in two main groups: eastern and central-western islands. Evidence of recurrent inter-island colonization of haplotypes is largely lacking, despite strong flight capability and ecological amplitude of the species. Recent palaeogeographic data suggest that several of the current islands were connected in the past and thus the isolation pattern may have been even more pronounced. A contrast analysis was also carried out on 10 animal groups of the Galapagos Islands, and on haplotype colonization of seven animal and plant species from several oceanic archipelagos (the Galapagos, Azores, Canary Islands). New colonization metrics on the number of potential vs. inferred colonization events revealed that the Galapagos carpenter bee shows one of the most significant examples of geographic isolation.	[Vargas, Pablo; Rumeu, Beatriz] Real Jardin Bot Madrid CSIC RJB, Madrid, Spain; [Heleno, Ruben H.] Univ Coimbra, Ctr Funct Ecol, Dept Life Sci, Coimbra, Portugal; [Traveset, Anna] Inst Mediterrani Estudis Avancats CSIC UIB, Lab Int Cambio Global LINC Global, Mallorca, Balearic Island, Spain; [Nogales, Manuel] Inst Prod Nat & Agrobiol CSIC IPNA, Isl Ecol & Evolut Res Grp, Tenerife, Canary Islands, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA)	Vargas, P (corresponding author), Real Jardin Bot Madrid CSIC RJB, Madrid, Spain.	vargas@rjb.csic.es	Traveset, Anna V/D-7802-2011; Rumeu, Beatriz/ABF-6936-2020; Nogales, Manuel/I-9831-2014; Heleno, Ruben Huttel/A-5778-2011	Rumeu, Beatriz/0000-0002-9017-5466; Nogales, Manuel/0000-0002-5327-3104; Heleno, Ruben Huttel/0000-0002-4808-4907				Aguin-Pombo D., 2009, ENCY ISLANDS, P582; Ali JR, 2014, J BIOGEOGR, V41, P1227, DOI 10.1111/jbi.12313; Arbogast BS, 2006, EVOLUTION, V60, P370, DOI 10.1111/j.0014-3820.2006.tb01113.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Benavides E, 2009, EVOLUTION, V63, P1606, DOI 10.1111/j.1558-5646.2009.00617.x; Bianchi FA, 1962, J EXP STA HAWAIIAN S, V18, P111; Bollmer JL, 2006, MOL PHYLOGENET EVOL, V39, P237, DOI 10.1016/j.ympev.2005.11.014; Chamorro S, 2012, ANN BOT-LONDON, V110, P1489, DOI 10.1093/aob/mcs132; Chaves JA, 2012, J EVOLUTION BIOL, V25, P509, DOI 10.1111/j.1420-9101.2011.02447.x; CHEESMAN L. EVELYN, 1929, TRANS ENT SOC LONDON, V77, P141; CLAUSEN CP, 1976, ANNU REV ENTOMOL, V21, P343, DOI 10.1146/annurev.en.21.010176.002015; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cockerell T. D. A., 1935, Proceedings of the California Academy of Science (4th Series), V21, P379; Darwin C., 1839, J RES NATURAL HIST G; Darwin C, 1859, ORIGIN SPECIES MEANS; Drummond AJ, 2010, GENEIOUS V5 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fernandez-Mazuecos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017172; Ferreira RC, 2011, EUR J FOREST RES, V130, P181, DOI 10.1007/s10342-010-0420-1; Franck P, 1998, EVOLUTION, V52, P1119, DOI [10.2307/2411242, 10.1111/j.1558-5646.1998.tb01839.x]; Garcia-Verdugo C, 2010, EVOLUTION, V64, P3525, DOI 10.1111/j.1558-5646.2010.01091.x; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; HURD PAUL D., 1958, JOUR KANSAS ENT SOC, V31, P249; Hurd PD., 1978, ANNOTATED CATALOG CA; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; LINSLEY E. G., 1966, PROC CALIF ACAD SCI, V33, P113; Linsley EG, 1966, THE GALAPAGOS P GALA; Michener C.D., 2007, BEES WORLD, Vsecond; Parent CE, 2008, PHILOS T R SOC B, V363, P3347, DOI 10.1098/rstb.2008.0118; Parent CE, 2006, EVOLUTION, V60, P2311, DOI 10.1554/06-366.1; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulakakis N, 2012, MOL ECOL, V21, P160, DOI 10.1111/j.1365-294X.2011.05370.x; Rambaut A, 2009, TRACER V1 5; Rasmussen C, 2012, PAN-PAC ENTOMOL, V88, P98, DOI 10.3956/2012-04.1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz D, 2012, C DARWIN FDN GALAPAG; Rumeu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027697; Schmitz P, 2007, MOL PHYLOGENET EVOL, V45, P180, DOI 10.1016/j.ympev.2007.05.010; Sequeira AS, 2008, PHILOS T R SOC B, V363, P3439, DOI 10.1098/rstb.2008.0109; Sequeira AS, 2000, HEREDITY, V85, P20, DOI 10.1046/j.1365-2540.2000.00690.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Torres-Carvajal O, 2014, J BIOGEOGR, V41, P1883, DOI 10.1111/jbi.12375; Traveset A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3040; Vargas P, 2014, BOT J LINN SOC, V174, P349, DOI 10.1111/boj.12142; Vargas P, 2012, ECOGRAPHY, V35, P33, DOI 10.1111/j.1600-0587.2011.06980.x; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x	48	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120597	10.1371/journal.pone.0120597	http://dx.doi.org/10.1371/journal.pone.0120597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807496	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000089
J	Wei, ZG; Qu, ZS; Zhang, LJ; Zhao, SJ; Bi, ZH; Ji, XH; Wang, XW; Wei, HR				Wei, Zhigang; Qu, Zanshuang; Zhang, Lijie; Zhao, Shuanjing; Bi, Zhihong; Ji, Xiaohui; Wang, Xiaowen; Wei, Hairong			Overexpression of Poplar Xylem Sucrose Synthase in Tobacco Leads to a Thickened Cell Wall and Increased Height	PLOS ONE			English	Article							MONOCOT-DICOT DIVERGENCE; CELLULOSE BIOSYNTHESIS; SINK STRENGTH; ANTISENSE REPRESSION; PHOSPHATE SYNTHASE; MAIZE ENDOSPERM; HIGHER-PLANTS; TOMATO FRUIT; COTTON FIBER; EXPRESSION	Sucrose synthase (SuSy) is considered the first key enzyme for secondary growth because it is a highly regulated cytosolic enzyme that catalyzes the reversible conversion of sucrose and UDP into UDP-glucose and fructose. Although SuSy enzymes preferentially functions in the direction of sucrose cleavage at most cellular condition, they also catalyze the synthetic reaction. We isolated a gene that encodes a SuSy from Populus simoniixPopulus nigra and named it PsnSuSy2 because it shares high similarity to SuSy2 in Populus trichocarpa. RT-PCR revealed that PsnSuSy2 was highly expressed in xylem, but lowly expressed in young leaves. To characterize its functions in secondary growth, multiple tobacco overexpression transgenic lines of PnsSuSy2 were generated via Agrobacterium-mediated transformation. The PsnSuSy2 expression levels and altered wood properties in stem segments from the different transgenic lines were carefully characterized. The results demonstrated that the levels of PsnSuSy2 enzyme activity, chlorophyll content, total soluble sugars, fructose and glucose increased significantly, while the sucrose level decreased significantly. Consequently, the cellulose content and fiber length increased, whereas the lignin content decreased, suggesting that PsnSuSy2 plays a significant role in cleaving sucrose into UDP-glucose and fructose to facilitate cellulose biosynthesis and that promotion of cellulose biosynthesis suppresses lignin biosynthesis. Additionally, the noticeable increase in the lodging resistance in transgenic tobacco stem suggested that the cell wall characteristics were altered by PsnSuSy2 overexpression. Scanning electron microscopy was performed to study the cell wall morphology of stem, and surprisingly, we found that the secondary cell wall was significantly thicker in transgenic tobacco. However, the thickened secondary cell wall did not negatively affect the height of the plants because the PsnSuSy2-overexpressing lines grew taller than the wildtype plants. This systematic analysis demonstrated that PsnSuSy2 plays an important role in cleaving sucrose coupled with cellulose biosynthesis in wood tissue.	[Wei, Zhigang; Qu, Zanshuang; Zhang, Lijie; Zhao, Shuanjing; Bi, Zhihong; Wang, Xiaowen] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Heilongjiang, Peoples R China; [Ji, Xiaohui] Northeast Forestry Univ, Coll Informat & Comp Engn, Harbin, Heilongjiang, Peoples R China; [Wei, Hairong] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Northeast Forestry University - China; Northeast Forestry University - China; Michigan Technological University	Wei, HR (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	hairong@mtu.edu	wei, zhigang/AAR-9836-2021; wei, hairong/GNM-7061-2022	wei, hairong/0000-0002-3551-4998	National Natural Science Foundation of China [31170562]; Program for New Century Excellent Talents in University, Ministry of Education [NCET-13-0713]; National High Technology Research and Development 863 Program from Chinese Ministry of Science and Technology [2013AA102702]; Fundamental Research Funds for the National Key Lab [2013B01]; Forestry Industry Research Special Funds for Public Welfare Projects [201004046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University, Ministry of Education(Program for New Century Excellent Talents in University (NCET)); National High Technology Research and Development 863 Program from Chinese Ministry of Science and Technology(National High Technology Research and Development Program of China); Fundamental Research Funds for the National Key Lab; Forestry Industry Research Special Funds for Public Welfare Projects	This research was supported by (1) National Natural Science Foundation of China (http://www.nsfc.gov.cn) (No. 31170562); (2) Program for New Century Excellent Talents in University, Ministry of Education (http://www.moe.edu.cn) (grant No. NCET-13-0713); (3) The National High Technology Research and Development 863 Program from Chinese Ministry of Science and Technology (http://www.most.gov.cn/eng/) (grant No. 2013AA102702); (4) Fundamental Research Funds for the National Key Lab (http://tblab.nefu.edu.cn/) (grant No. 2013B01); and (5) the Forestry Industry Research Special Funds for Public Welfare Projects (www.forestry.gov.cn) (NO. 201004046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht G, 2003, PLANTA, V217, P252, DOI 10.1007/s00425-003-0995-6; AMOR Y, 1991, PLANT CELL, V3, P989, DOI 10.1105/tpc.3.9.989; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Babb VM, 2001, PLANT PHYSIOL, V127, P1234, DOI 10.1104/pp.010424; Baier MC, 2007, PLANT PHYSIOL, V145, P1600, DOI 10.1104/pp.107.106955; Boex-Fontvieille E, 2014, J EXP BOT, V65, P4997, DOI 10.1093/jxb/eru268; Buckeridge MS, 1999, PLANT PHYSIOL, V120, P1105, DOI 10.1104/pp.120.4.1105; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; CHOUREY PS, 1981, MOL GEN GENET, V184, P372, DOI 10.1007/BF00352507; Chourey PS, 1998, MOL GEN GENET, V259, P88, DOI 10.1007/s004380050792; Coleman HD, 2006, PLANT BIOTECHNOL J, V4, P87, DOI 10.1111/j.1467-7652.2005.00160.x; Coleman HD, 2009, P NATL ACAD SCI USA, V106, P13118, DOI 10.1073/pnas.0900188106; Craig S, 1996, J MICROSC-OXFORD, V182, P102, DOI 10.1046/j.1365-2818.1996.128409.x; D'Aoust MA, 1999, PLANT CELL, V11, P2407, DOI 10.1105/tpc.11.12.2407; Dejardin A, 1999, BIOCHEM J, V344, P503, DOI 10.1042/0264-6021:3440503; DELMER DP, 1995, PLANT CELL, V7, P987, DOI 10.1105/tpc.7.7.987; FU HY, 1995, PLANT CELL, V7, P1369, DOI 10.1105/tpc.7.9.1369; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Gerber L, 2014, NEW PHYTOL, V203, P1220, DOI 10.1111/nph.12888; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; Hanggi H, 2001, PLANTA, V214, P326; Hauch S, 1998, PLANTA, V207, P266, DOI 10.1007/s004250050482; Herbers K, 1998, CURR OPIN PLANT BIOL, V1, P207, DOI 10.1016/S1369-5266(98)80106-4; Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398; Joshi CP, 2004, NEW PHYTOL, V164, P53, DOI 10.1111/j.1469-8137.2004.01155.x; Kennedy J. F., 1983, CHEM BIOCH BIOL; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Kolosova N, 2004, NAT REV GENET, V2, P353; Komina O, 2002, PLANT PHYSIOL, V129, P1664, DOI 10.1104/pp.002360; Konishi T, 2004, PLANT PHYSIOL, V134, P1146, DOI 10.1104/pp.103.033167; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Levy M, 2004, PLANT PHYSIOL, V135, P2392, DOI 10.1104/pp.104.044859; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Nakai T, 1999, P NATL ACAD SCI USA, V96, P14, DOI 10.1073/pnas.96.1.14; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Persia D, 2008, PLANT PHYSIOL, V147, P1603, DOI 10.1104/pp.108.115956; Ruan YL, 1997, PLANT PHYSIOL, V115, P375, DOI 10.1104/pp.115.2.375; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Ruan YL, 2007, FUNCT PLANT BIOL, V34, P1, DOI 10.1071/FP06234; Salnikov VV, 2003, PROTOPLASMA, V221, P175, DOI 10.1007/s00709-002-0079-7; Salnikov VV, 2001, PHYTOCHEMISTRY, V57, P823, DOI 10.1016/S0031-9422(01)00045-0; Sarkanen K.V., 1971, LIGNINS OCCURRENCE F; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Subbaiah CC, 2001, PLANT PHYSIOL, V125, P585, DOI 10.1104/pp.125.2.585; SUN JD, 1992, PLANT PHYSIOL, V98, P1163, DOI 10.1104/pp.98.3.1163; Tang GQ, 1999, PLANT MOL BIOL, V41, P465, DOI 10.1023/A:1006327606696; Taylor NG, 2008, NEW PHYTOL, V178, P239, DOI 10.1111/j.1469-8137.2008.02385.x; Winter H, 1997, FEBS LETT, V420, P151, DOI 10.1016/S0014-5793(97)01506-8; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Xu Fuyu, 2010, Advances in Bioscience and Biotechnology, V1, P426, DOI 10.4236/abb.2010.15056; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Xue GP, 2008, PLANT PHYSIOL, V146, P441, DOI 10.1104/pp.107.113076; Zhang DQ, 2011, TREE GENET GENOMES, V7, P443, DOI 10.1007/s11295-010-0346-2; Zhu XH, 2010, MOL PLANT, V3, P818, DOI 10.1093/mp/ssq023; ZRENNER R, 1995, PLANT J, V7, P97, DOI 10.1046/j.1365-313X.1995.07010097.x	59	34	40	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120669	10.1371/journal.pone.0120669	http://dx.doi.org/10.1371/journal.pone.0120669			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807295	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000095
J	Zhang, JS; Zhang, SJ; Li, Q; Liu, YH; He, N; Zhang, J; Zhou, PH; Li, M; Guan, T; Liu, JR				Zhang, Jing-Shu; Zhang, Shu-Jing; Li, Qian; Liu, Ying-Hua; He, Ning; Zhang, Jing; Zhou, Peng-Hui; Li, Min; Guan, Tong; Liu, Jia-Ren			Tocotrienol-Rich Fraction (TRF) Suppresses the Growth of Human Colon Cancer Xenografts in Balb/C Nude Mice by the Wnt Pathway	PLOS ONE			English	Article							GAMMA-TOCOTRIENOL; PALM TOCOTRIENOLS; BETA-IONONE; VITAMIN-E; MAMMARY CARCINOGENESIS; TUMOR-GROWTH; CELL-CYCLE; APOPTOSIS; PROLIFERATION; CATENIN	Tocotrienols have been shown many biologic functions such as antioxidant, anti-cancer, maintaining fertility and regulating the immune system and so on. In this study, after feeding with tocotrienol-rich fraction from palm oil (TRF) for 2 weeks, Balb/c nude mice were inoculated human colon SW620 cancer cell and then continued to feed TRF for 4 weeks. At termination of experiments, xenografts were removed and determined the expression of Wnt-pathways related protein by immunohistochemistry or western blotting. Liver tissues were homogenated for determining the levels of antioxidative enzymes activity or malondialdehyde (MDA). The results showed that TRF significantly inhibited the growth of xenografts in nude mice. TRF also affected the activity of antioxidative enzymes in the liver tissue of mice. These changes were partly contributed to activation of wnt pathways or affecting their related protein. Thus, these finding suggested that the potent anticancer effect of TRF is associated with the regulation of Wnt signal pathways.	[Zhang, Jing-Shu; Zhang, Shu-Jing; Li, Qian; Liu, Ying-Hua; He, Ning; Zhang, Jing; Zhou, Peng-Hui; Li, Min; Guan, Tong] Tianjin Ctr Dis Control & Prevent, Dept Toxicol, Tianjin, Peoples R China; [Zhang, Jing-Shu; Zhang, Shu-Jing; Li, Qian; Zhou, Peng-Hui] Tianjin Med Univ, Coll Publ Hlth, Tianjin, Peoples R China; [Liu, Jia-Ren] Boston Childrens Hosp, Boston, MA USA; [Liu, Jia-Ren] Harvard Univ, Sch Med, Boston, MA USA	Tianjin Center for Disease Control & Prevention; Tianjin Medical University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Zhang, JS (corresponding author), Tianjin Ctr Dis Control & Prevent, Dept Toxicol, Tianjin, Peoples R China.	rainbow7546@163.com; Jia-Ren.Liu@childrens.harvard.edu	Liu, Jia-Ren/V-9031-2019; Liu, Jia-Ren/G-1455-2011; LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022	Liu, Jia-Ren/0000-0001-6653-0053; 	National Natural Science Foundation of China [30771801, 81472968]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (No. 30771801;81472968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 1996, PHARMACOL TOXICOL, V79, P334, DOI 10.1111/j.1600-0773.1996.tb00019.x; Agarwal MK, 2004, CELL CYCLE, V3, P205; Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043; [Anonymous], 2014, EMBO MOL MED; Ashokkumar P, 2011, INVEST NEW DRUG, V29, P273, DOI 10.1007/s10637-009-9359-9; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; Bi S, 2010, TOXICOLOGY, V274, P27, DOI 10.1016/j.tox.2010.05.002; Boutros M, 2000, SCIENCE, V288, P1825, DOI 10.1126/science.288.5472.1825; Chen H, 2014, PROTEOMICS, V14, P51, DOI 10.1002/pmic.201300101; Chi HD, 2013, LIFE SCI, V93, P986, DOI 10.1016/j.lfs.2013.10.028; Devi RR, 2007, FOOD CHEM TOXICOL, V45, P2014, DOI 10.1016/j.fct.2007.04.020; Dong HW, 2013, ARCH TOXICOL, V87, P1797, DOI 10.1007/s00204-013-1041-5; Eitsuka T, 2006, BIOCHEM BIOPH RES CO, V348, P170, DOI 10.1016/j.bbrc.2006.07.029; Giammanco A, 2014, CANCER RES, V74, P5322, DOI 10.1158/0008-5472.CAN-14-0726; HEINONEN M, 1991, INT J VITAM NUTR RES, V61, P27; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hunter DD, 2004, MOL CELL NEUROSCI, V27, P477, DOI 10.1016/j.mcn.2004.08.003; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Jamieson C, 2014, SEMIN CANCER BIOL, V27, P20, DOI 10.1016/j.semcancer.2014.04.012; Jass Jeremy R., 2006, Critical Reviews in Oncogenesis, V12, P273; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Jiang F, 2011, PANCREAS, V40, P1091, DOI 10.1097/MPA.0b013e31821b59c6; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Lavergne E, 2011, ONCOGENE, V30, P423, DOI 10.1038/onc.2010.432; Lee SP, 2009, EUR J APPL PHYSIOL, V107, P587, DOI 10.1007/s00421-009-1159-6; Lee SY, 2013, CANCER PREV RES, V6, P1356, DOI 10.1158/1940-6207.CAPR-13-0241; Li Y, 2011, J NUTR BIOCHEM, V22, P1127, DOI 10.1016/j.jnutbio.2010.09.012; Liu JR, 2008, INT J CANCER, V122, P2689, DOI 10.1002/ijc.23453; Liu JR, 2010, NUTR CANCER, V62, P58, DOI 10.1080/01635580903191510; Liu Q, 2013, ARCH TOXICOL, V87, P481, DOI 10.1007/s00204-012-0962-8; Luk SU, 2011, INT J CANCER, V128, P2182, DOI 10.1002/ijc.25546; Luo W, 2005, J BIOL CHEM, V280, P5054, DOI 10.1074/jbc.M412340200; Manu KA, 2012, CLIN CANCER RES, V18, P2220, DOI 10.1158/1078-0432.CCR-11-2470; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Nafeeza M I, 2001, Malays J Pathol, V23, P17; Nesaretnam K, 2004, LIPIDS, V39, P459, DOI 10.1007/s11745-004-1251-1; Pierpaoli E, 2013, CARCINOGENESIS, V34, P1352, DOI 10.1093/carcin/bgt064; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Qureshi AA, 2002, ATHEROSCLEROSIS, V161, P199, DOI 10.1016/S0021-9150(01)00619-0; Raila J, 2011, BRIT J NUTR, V106, pS116, DOI 10.1017/S0007114511000511; Selvaduray KR, 2012, GENES NUTR, V7, P53, DOI 10.1007/s12263-011-0223-0; Selvaduray KR, 2010, J INTERF CYTOK RES, V30, P909, DOI 10.1089/jir.2010.0021; Sookwong P, 2010, J AGR FOOD CHEM, V58, P3350, DOI 10.1021/jf903663k; SUARNA C, 1993, BIOCHIM BIOPHYS ACTA, V1166, P163, DOI 10.1016/0005-2760(93)90092-N; Sun WG, 2009, J NUTR BIOCHEM, V20, P276, DOI 10.1016/j.jnutbio.2008.03.003; Suzuki Hiromu, 2005, Nihon Rinsho, V63, P707; Tan BL, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-304; Vikram A, 2014, ARTERIOSCL THROM VAS, V34, P2301, DOI 10.1161/ATVBAHA.114.304338; Weng-Yew W, 2009, NUTR CANCER, V61, P367, DOI 10.1080/01635580802582736; West JD, 2006, CHEM RES TOXICOL, V19, P173, DOI 10.1021/tx050321u; Xu WL, 2009, NUTRITION, V25, P555, DOI 10.1016/j.nut.2008.10.019; Xu WL, 2012, J NUTR BIOCHEM, V23, P800, DOI 10.1016/j.jnutbio.2011.04.003; Zhang JS, 2011, TOXICOLOGY, V285, P8, DOI 10.1016/j.tox.2011.03.011; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	55	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122175	10.1371/journal.pone.0122175	http://dx.doi.org/10.1371/journal.pone.0122175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807493	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000209
J	Lee, JR; Muthukumar, T; Dadhania, D; Taur, Y; Jenq, RR; Toussaint, NC; Ling, LL; Pamer, E; Suthanthiran, M				Lee, John R.; Muthukumar, Thangamani; Dadhania, Darshana; Taur, Ying; Jenq, Robert R.; Toussaint, Nora C.; Ling, Lilan; Pamer, Eric; Suthanthiran, Manikkam			Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; PHARMACOKINETIC INTERACTION; GENETIC-VARIANTS; DRUG-METABOLISM; P-GLYCOPROTEIN; TROUGH LEVELS; RECIPIENTS; CYCLOSPORINE; DIARRHEA; DOMINATION	Tacrolimus dosing to establish therapeutic levels in recipients of organ transplants is a challenging task because of much interpatient and intrapatient variability in drug absorption, metabolism, and disposition. In view of the reported impact of gut microbial species on drug metabolism, we investigated the relationship between the gut microbiota and tacrolimus dosing requirements in this pilot study of adult kidney transplant recipients. Serial fecal specimens were collected during the first month of transplantation from 19 kidney transplant recipients who either required a 50% increase from initial tacrolimus dosing during the first month of transplantation (Dose Escalation Group, n=5) or did not require such an increase (Dose Stable Group, n=14). We characterized bacterial composition in the fecal specimens by deep sequencing of the PCR amplified 16S rRNA V4-V5 region and we investigated the hypothesis that gut microbial composition is associated with tacrolimus dosing requirements. Initial tacrolimus dosing was similar in the Dose Escalation Group and in the Stable Group (4.2 +/- 1.1 mg/day vs. 3.8 +/- 0.8 mg/day, respectively, P=0.61, two-way between-group ANOVA using contrasts) but became higher in the Dose Escalation Group than in the Dose Stable Group by the end of the first transplantation month (9.6 +/- 2.4 mg/day vs. 3.3 +/- 1.5 mg/day, respectively, P<0.001). Our systematic characterization of the gut microbial composition identified that fecal Faecalibacterium prausnitzii abundance in the first week of transplantation was 11.8% in the Dose Escalation Group and 0.8% in the Dose Stable Group (P=0.002, Wilcoxon Rank Sum test, P<0.05 after Benjamini-Hochberg correction for multiple hypotheses). Fecal Faecalibacterium prausnitzii abundance in the first week of transplantation was positively correlated with future tacrolimus dosing at 1 month (R=0.57, P=0.01) and had a coefficient +/- standard error of 1.0 +/- 0.6 (P=0.08) after multivariable linear	[Lee, John R.; Muthukumar, Thangamani; Dadhania, Darshana; Suthanthiran, Manikkam] Weill Cornell Med Coll, Dept Med, Div Nephrol & Hypertens, New York, NY 10065 USA; [Lee, John R.; Muthukumar, Thangamani; Dadhania, Darshana; Suthanthiran, Manikkam] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Transplantat Med, New York, NY USA; [Taur, Ying; Toussaint, Nora C.; Pamer, Eric] Mem Sloan Kettering Canc Ctr, Dept Med Infect Dis Serv, New York, NY 10021 USA; [Taur, Ying; Jenq, Robert R.; Ling, Lilan; Pamer, Eric] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY 10021 USA; [Taur, Ying; Jenq, Robert R.; Pamer, Eric] Weill Cornell Med Coll, New York, NY USA; [Jenq, Robert R.] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY 10021 USA	Cornell University; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Lee, JR (corresponding author), Weill Cornell Med Coll, Dept Med, Div Nephrol & Hypertens, New York, NY 10065 USA.	jrl2002@med.cornell.edu	Dadhania, Darshana/L-4651-2019; Suthanthiran, Manikkam/AAL-9104-2020	Ling, Lilan/0000-0001-6961-7787; Taur, Ying/0000-0002-6601-8284; Toussaint, Nora/0000-0001-7911-7647	National Center for Advancing Translational Sciences, National Institute of Health [KL2-TR000458]; National Institute of Diabetic and Digestive and Kidney Diseases, National Institute of Health [K08-DK087824]; National Institute of Allergy and Infectious Diseases, National Institute of Health [R37AI051652]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002384, UL1TR000457, KL2TR000458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK087824] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institute of Health; National Institute of Diabetic and Digestive and Kidney Diseases, National Institute of Health; National Institute of Allergy and Infectious Diseases, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported, in part, by a KL2-TR000458 from the National Center for Advancing Translational Sciences, National Institute of Health (JL), a K08-DK087824 from the National Institute of Diabetic and Digestive and Kidney Diseases, National Institute of Health (TM), and an R37AI051652 from the National Institute of Allergy and Infectious Diseases, National Institute of Health (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglicheau D, 2003, NEPHROL DIAL TRANSPL, V18, P2409, DOI 10.1093/ndt/gfg381; Beermann KJ, 2014, CLIN TRANSPLANT, V28, P762, DOI 10.1111/ctr.12376; Boughton O, 2013, BRIT J CLIN PHARMACO, V76, P425, DOI 10.1111/bcp.12076; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; CAO Y, 2014, GASTROENT RES PRACT, V2014, DOI DOI 10.1155/2014/872725; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Federico S, 2006, CLIN PHARMACOKINET, V45, P169, DOI 10.2165/00003088-200645020-00003; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Haiser HJ, 2012, SCIENCE, V336, P1253, DOI 10.1126/science.1224396; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jacobson PA, 2011, TRANSPLANTATION, V91, P300, DOI 10.1097/TP.0b013e318200e991; Kang MJ, 2013, EXPERT OPIN DRUG MET, V9, P1295, DOI 10.1517/17425255.2013.807798; Lee JR, 2014, TRANSPLANTATION, V98, P697, DOI 10.1097/TP.0000000000000370; Lemahieu W, 2005, AM J TRANSPLANT, V5, P1383, DOI 10.1111/j.1600-6143.2005.00844.x; Li H, 2013, CLIN PHARMACOL THER, V94, P574, DOI 10.1038/clpt.2013.157; Li L, 2011, EUR J CLIN PHARMACOL, V67, P787, DOI 10.1007/s00228-011-1010-y; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lunde I, 2014, EUR J CLIN PHARMACOL, V70, P685, DOI 10.1007/s00228-014-1656-3; Maes BD, 2002, AM J TRANSPLANT, V2, P989, DOI 10.1034/j.1600-6143.2002.21018.x; Maezono S, 2005, PEDIATR TRANSPLANT, V9, P315, DOI 10.1111/j.1399-3046.2005.00315.x; Magurran AE, 2005, CURR BIOL, V15, pR116, DOI 10.1016/j.cub.2005.02.006; Matas AJ, 2014, AM J TRANSPLANT, V14, P11, DOI 10.1111/ajt.12579; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Nakamura A, 2014, TRANSPL P, V46, P592, DOI 10.1016/j.transproceed.2013.11.040; Page RL, 2005, ANN PHARMACOTHER, V39, P1109, DOI 10.1345/aph.1E399; Passey C, 2011, BRIT J CLIN PHARMACO, V72, P948, DOI 10.1111/j.1365-2125.2011.04039.x; Provenzani A, 2013, WORLD J GASTROENTERO, V19, P9156, DOI 10.3748/wjg.v19.i48.9156; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sato K, 2004, CLIN TRANSPLANT, V18, P585, DOI 10.1111/j.1399-0012.2004.00232.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Shullo MA, 2010, TRANSPL P, V42, P1870, DOI 10.1016/j.transproceed.2010.02.095; SINCLAIR NR, 1986, NEW ENGL J MED, V314, P1219; Stratta P, 2012, EUR J CLIN PHARMACOL, V68, P671, DOI 10.1007/s00228-011-1150-0; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Tsunashima D, 2014, CLIN THER, V36, P748, DOI 10.1016/j.clinthera.2014.02.021; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Venkataramanan R, 1995, CLIN PHARMACOKINET, V29, P404, DOI 10.2165/00003088-199529060-00003; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	43	87	90	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122399	10.1371/journal.pone.0122399	http://dx.doi.org/10.1371/journal.pone.0122399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815766	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600177
J	Coulson, TJD; Patten, CL				Coulson, Thomas J. D.; Patten, Cheryl L.			The TyrR Transcription Factor Regulates the Divergent akr-ipdC Operons of Enterobacter cloacae UW5	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; TRYPTOPHAN-SPECIFIC PERMEASE; ESCHERICHIA-COLI GENOME; NUCLEOTIDE-SEQUENCE; MEDIATED ACTIVATION; MOLECULAR ANALYSIS; SELF-ASSOCIATION; BINDING-SITES; PROTEIN TYRR; DNA-SEQUENCE	The TyrR transcription factor regulates genes involved in the uptake and biosynthesis of aromatic amino acids in Enterobacteriaceae. Genes may be positively or negatively regulated depending on the presence or absence of each aromatic amino acid, all three of which function as cofactors for TyrR. In this report we detail the transcriptional control of two divergently transcribed genes, akr and ipdC, by TyrR, elucidated by promoter fusion expression assays and electrophoretic mobility shift assays to assess protein-DNA interactions. Expression of both genes was shown to be controlled by TyrR via interactions with two TyrR boxes located within the akr-ipdC intergenic region. Expression of ipdC required TyrR bound to the proximal strong box, and is strongly induced by phenylalanine, and to a lesser extent by tryptophan and tyrosine. Down-regulation of akr was reliant on interactions with the weak box, and may also require a second, as yet unidentified protein for further repression. Tyrosine enhanced repression of akr. Electrophoretic mobility shift assays demonstrated that TyrR interacts with both the strong and weak boxes, and that binding of the weak box in vitro requires an intact adjacent strong box. While the strong box shows a high degree of conservation with the TyrR binding site consensus sequence, the weak box has atypical spacing of the two half sites comprising the palindromic arms. Site-directed mutagenesis demonstrated sequence-specific interaction between TyrR and the weak box. This is the first report of TyrR-controlled expression of two divergent protein-coding genes, transcribed from independent promoters. Moreover, the identification of a predicted aldo-keto reductase as a member of the TyrR regulon further extends the function of the TyrR regulon.	[Coulson, Thomas J. D.; Patten, Cheryl L.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada	University of New Brunswick	Patten, CL (corresponding author), Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada.	pattenc@unb.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by a Discovery Grant to C.L.P. and a Post-Graduate Scholarship D to T.J.D.C. from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS AE, 1991, J BACTERIOL, V173, P5068, DOI 10.1128/jb.173.16.5068-5078.1991; [Anonymous], 1989, JMP VERS 7; ARGAET VP, 1994, J BIOL CHEM, V269, P5171; Bailey MF, 1996, J MOL BIOL, V263, P671, DOI 10.1006/jmbi.1996.0607; BASEGGIO N, 1990, J BACTERIOL, V172, P2547, DOI 10.1128/jb.172.5.2547-2557.1990; CAMAKARIS H, 1982, J BACTERIOL, V150, P70, DOI 10.1128/JB.150.1.70-75.1982; Herrera MC, 2010, ENVIRON MICROBIOL, V12, P1427, DOI 10.1111/j.1462-2920.2009.02124.x; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; CORNISH EC, 1986, J BIOL CHEM, V261, P403; Cowie A, 2006, APPL ENVIRON MICROB, V72, P7156, DOI 10.1128/AEM.01397-06; Cummings S., 2009, ENV BIOTECHNOL, V5, P43; Djordjevic M, 2011, J BACTERIOL, V193, P6305, DOI 10.1128/JB.05947-11; Eraso JM, 2008, J BACTERIOL, V190, P4831, DOI 10.1128/JB.00301-08; Eraso JM, 2009, J BACTERIOL, V191, P4353, DOI 10.1128/JB.00244-09; Grant AW, 2003, FEMS MICROBIOL LETT, V218, P93, DOI 10.1111/j.1574-6968.2003.tb11503.x; HEATWOLE VM, 1991, J BACTERIOL, V173, P3601, DOI 10.1128/jb.173.11.3601-3604.1991; HEATWOLE VM, 1991, J BACTERIOL, V173, P108, DOI 10.1128/jb.173.1.108-115.1991; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Kilfoil PJ, 2013, CIRC RES, V112, P721, DOI 10.1161/CIRCRESAHA.111.247940; Klasens BIF, 1999, BBA-GENE STRUCT EXPR, V1444, P355, DOI 10.1016/S0167-4781(99)00011-1; KOGA J, 1992, J BIOL CHEM, V267, P15823; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; LAWLEY B, 1995, J BACTERIOL, V177, P238, DOI 10.1128/jb.177.1.238-241.1995; Mao LY, 2005, MICROBIOL-SGM, V151, P3197, DOI 10.1099/mic.0.28167-0; Mindnich Rebekka D., 2009, Human Genomics, V3, P362; Niedziela-Majka A, 2005, J BIOL CHEM, V280, P38219, DOI 10.1074/jbc.M507984200; Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x; Patten CL, 2013, CRIT REV MICROBIOL, V39, P395, DOI 10.3109/1040841X.2012.716819; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Peer WA, 2011, MOL PLANT, V4, P487, DOI 10.1093/mp/ssr034; PITTARD AJ, 1991, MOL MICROBIOL, V5, P1585, DOI 10.1111/j.1365-2958.1991.tb01904.x; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; Rodionov DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S1-S3; Ryu RJ, 2008, J BACTERIOL, V190, P7200, DOI 10.1128/JB.00804-08; SARSERO JP, 1991, J BACTERIOL, V173, P7701, DOI 10.1128/jb.173.23.7701-7704.1991; SARSERO JP, 1991, J BACTERIOL, V173, P4133, DOI 10.1128/jb.173.13.4133-4143.1991; Sawyer WH, 2000, BIOCHEMISTRY-US, V39, P5653, DOI 10.1021/bi0000723; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Song J, 1996, MOL MICROBIOL, V22, P497, DOI 10.1046/j.1365-2958.1996.00131.x; Wade JT, 2007, MOL MICROBIOL, V65, P21, DOI 10.1111/j.1365-2958.2007.05781.x; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Wang PX, 1997, J BACTERIOL, V179, P4213, DOI 10.1128/jb.179.13.4213-4218.1997; Wang PX, 1997, J BACTERIOL, V179, P4206, DOI 10.1128/jb.179.13.4206-4212.1997; WILSON TJ, 1994, J MOL BIOL, V238, P309, DOI 10.1006/jmbi.1994.1294; WILSON TJ, 1995, MOL MICROBIOL, V17, P483, DOI 10.1111/j.1365-2958.1995.mmi_17030483.x; Yang J, 1997, J BACTERIOL, V179, P6187, DOI 10.1128/jb.179.19.6187-6191.1997; Yang J, 2004, MOL MICROBIOL, V52, P243, DOI 10.1111/j.1365-2958.2003.03965.x; Yang J, 1996, J BACTERIOL, V178, P6389, DOI 10.1128/jb.178.21.6389-6393.1996; Yang J, 1999, J BACTERIOL, V181, P6411, DOI 10.1128/JB.181.20.6411-6418.1999; Yang J, 2007, J BACTERIOL, V189, P6080, DOI 10.1128/JB.00482-07; YANG JI, 1987, J BACTERIOL, V169, P4710, DOI 10.1128/jb.169.10.4710-4715.1987; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	53	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121241	10.1371/journal.pone.0121241	http://dx.doi.org/10.1371/journal.pone.0121241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811953	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700088
J	Stanifer, JW; Karia, F; Voils, CI; Turner, EL; Maro, V; Shimbi, D; Kilawe, H; Lazaro, M; Patel, UD				Stanifer, John W.; Karia, Francis; Voils, Corrine I.; Turner, Elizabeth L.; Maro, Venance; Shimbi, Dionis; Kilawe, Humphrey; Lazaro, Matayo; Patel, Uptal D.			Development and Validation of a Cross-Cultural Knowledge, Attitudes, and Practices Survey Instrument for Chronic Kidney Disease in a Swahili-Speaking Population	PLOS ONE			English	Article								Introduction Non-communicable diseases are a growing global burden, and structured surveys can identify critical gaps to address this epidemic. In sub-Saharan Africa, there are very few well-tested survey instruments measuring population attributes related to non-communicable diseases. To meet this need, we have developed and validated the first instrument evaluating knowledge, attitudes and practices pertaining to chronic kidney disease in a Swahili-speaking population. Methods and Results Between December 2013 and June 2014, we conducted a four-stage, mixed-methods study among adults from the general population of northern Tanzania. In stage 1, the survey instrument was constructed in English by a group of cross-cultural experts from multiple disciplines and through content analysis of focus group discussions to ensure local significance. Following translation, in stage 2, we piloted the survey through cognitive and structured interviews, and in stage 3, in order to obtain initial evidence of reliability and construct validity, we recruited and then administered the instrument to a random sample of 606 adults. In stage 4, we conducted analyses to establish test-retest reliability and known-groups validity which was informed by thematic analysis of the qualitative data in stages 1 and 2. The final version consisted of 25 items divided into three conceptual domains: knowledge, attitudes and practices. Each item demonstrated excellent test-retest reliability with established content and construct validity. Conclusions We have developed a reliable and valid cross-cultural survey instrument designed to measure knowledge, attitudes and practices of chronic kidney disease in a Swahili-speaking population of Northern Tanzania. This instrument may be valuable for addressing gaps in non-communicable diseases care by understanding preferences regarding healthcare, formulating educational initiatives, and directing development of chronic disease management programs that incorporate chronic kidney disease across sub-Saharan Africa.	[Stanifer, John W.; Voils, Corrine I.; Patel, Uptal D.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Stanifer, John W.; Turner, Elizabeth L.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Karia, Francis; Maro, Venance; Shimbi, Dionis; Kilawe, Humphrey; Lazaro, Matayo] Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Voils, Corrine I.; Patel, Uptal D.] Durham Vet Affairs Med Ctr, Hlth Serv Res & Dev, Durham, NC USA; [Turner, Elizabeth L.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Patel, Uptal D.] Duke Univ, Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Stanifer, JW (corresponding author), Duke Univ, Dept Med, Durham, NC 27710 USA.	john.stanifer@duke.edu			National Institutes of Health Research Training Grant - Fogarty International Center [R25 TW009337]; National Institute of Mental Health, a Research and Prevention Grant - International Society of Nephrology (ISN) Global Outreach Committee; Masters of Science research stipend - Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER	National Institutes of Health Research Training Grant - Fogarty International Center; National Institute of Mental Health, a Research and Prevention Grant - International Society of Nephrology (ISN) Global Outreach Committee; Masters of Science research stipend - Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by a National Institutes of Health Research Training Grant (#R25 TW009337) funded by the Fogarty International Center and the National Institute of Mental Health, a Research and Prevention Grant funded by the International Society of Nephrology (ISN) Global Outreach Committee, and a Masters of Science research stipend funded by the Duke Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, UN REP TANZ ED SECT; BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305; Bowden A, 2002, HEALTH POLICY PLANN, V17, P322, DOI 10.1093/heapol/17.3.322; Bowling A., 1997, RESEARCH METHODS IN; Brock-Utne B, 2001, OXFORD REV EDUC, V27, P115; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; DeVellis R., 2017, SCALE DEV THEORY APP, V4; Ferguson E, 1993, INT J SEL ASSESS, V1, P84, DOI DOI 10.1111/J.1468-2389.1993.TB00092.X; Gadermann Anne M, 2012, PRACTICAL ASSESSMENT, V17; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Irele FA, 2010, OXFORD ENCY AFRICAN; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Marian V, 2000, J EXP PSYCHOL GEN, V129, P361, DOI 10.1037//0096-3445.129.3.361; MOSHI L., 2006, SEL P 36 ANN C AFR L, P166; Pluye P., 2011, PROPOSAL MIXED METHO; Priest J, 1995, NURSE RES, V2, P69, DOI DOI 10.7748/nr.2.4.69.s8; Rattray J, 2007, J CLIN NURS, V16, P234, DOI 10.1111/j.1365-2702.2006.01573.x; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; The United Republic of Tanzania, 2013, POPULATION DISTRIBUT; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; United Nations Office of the Secretary General, 2011, 19 UNAIDS C; Voils CI, 2011, J CLIN EPIDEMIOL, V64, P250, DOI 10.1016/j.jclinepi.2010.07.014; Willis G.B, 2004, COGNITIVE INTERVIEWI; Zumbo BD, 2007, J MOD APPL STAT METH, V6, P21, DOI 10.22237/jmasm/1177992180	24	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121722	10.1371/journal.pone.0121722	http://dx.doi.org/10.1371/journal.pone.0121722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811781	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700130
J	Tyagi, P; Singh, M; Kumari, H; Kumari, A; Mukhopadhyay, K				Tyagi, Poonam; Singh, Madhuri; Kumari, Himani; Kumari, Anita; Mukhopadhyay, Kasturi			Bactericidal Activity of Curcumin I Is Associated with Damaging of Bacterial Membrane	PLOS ONE			English	Article							ANTIBACTERIAL; BIOAVAILABILITY; KINETICS; LONGA; VITRO	Curcumin, an important constituent of turmeric, is known for various biological activities, primarily due to its antioxidant mechanism. The present study focused on the antibacterial activity of curcumin I, a significant component of commercial curcumin, against four genera of bacteria, including those that are Gram-positive (Staphylococcus aureus and Enterococcus faecalis) and Gram-negative (Escherichia coli and Pseudomonas aeruginosa). These represent prominent human pathogens, particularly in hospital settings. Our study shows the strong antibacterial potential of curcumin I against all the tested bacteria from Gram-positive as well as Gram-negative groups. The integrity of the bacterial membrane was checked using two differential permeabilization indicating fluorescent probes, namely, propidium iodide and calcein. Both the membrane permeabilization assays confirmed membrane leakage in Gram-negative and Gram-positive bacteria on exposure to curcumin I. In addition, scanning electron microscopy and fluorescence microscopy were employed to confirm the membrane damages in bacterial cells on exposure to curcumin I. The present study confirms the broad-spectrum antibacterial nature of curcumin I, and its membrane damaging property. Findings from this study could provide impetus for further research on curcumin I regarding its antibiotic potential against rapidly emerging bacterial pathogens.	[Tyagi, Poonam; Singh, Madhuri; Kumari, Himani; Kumari, Anita; Mukhopadhyay, Kasturi] Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Mukhopadhyay, K (corresponding author), Jawaharlal Nehru Univ, Sch Environm Sci, New Delhi 110067, India.	kasturim@mail.jnu.ac.in		Kumari, Anita/0000-0003-0826-6682	Indian Council of Medical Research [5/3/3/24/2010-ECD-1]; Department of Biotechnology [BT/PR9582/Med/29/34/2007]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology	This research was supported by a grant from the Indian Council of Medical Research (No. 5/3/3/24/2010-ECD-1) and the Department of Biotechnology (BT/PR9582/Med/29/34/2007), India, to Kasturi Mukhopadhyay. The funding agencies had no role in study design, data collection and analysis, or preperation of the manuscript.	Aggarwal B. B., 2013, British Journal of Pharmacology, V169, P1672, DOI 10.1111/bph.12131; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Barry J, 2009, J AM CHEM SOC, V131, P4490, DOI 10.1021/ja809217u; Betts JW, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-172; Cepinskas G, 2008, J CLIN BIOCHEM NUTR, V42, P175, DOI 10.3164/jcbn.2008026; Chakraborty SP, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/942123; Chen MH, 2012, INT J MOL MED, V30, P1021, DOI 10.3892/ijmm.2012.1096; Dewan PC, 2009, BIOCHEMISTRY-US, V48, P5642, DOI 10.1021/bi900272r; Di Mario F, 2007, HELICOBACTER, V12, P238, DOI 10.1111/j.1523-5378.2007.00497.x; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kaur S, 2010, EUR J MED CHEM, V45, P4209, DOI 10.1016/j.ejmech.2010.06.015; Liang G, 2008, CHEM PHARM BULL, V56, P162, DOI 10.1248/cpb.56.162; Luer S, 2012, NUTR CANCER, V64, P975, DOI 10.1080/01635581.2012.713161; Madhuri, 2009, PEPTIDES, V30, P1627, DOI 10.1016/j.peptides.2009.06.020; Marchiani A, 2014, CURR MED CHEM, V21, P204; Moghaddam K. M., 2009, International Journal of Green Pharmacy, V3, P141, DOI 10.4103/0973-8258.54906; Mun SH, 2013, PHYTOMEDICINE, V20, P714, DOI 10.1016/j.phymed.2013.02.006; Neelofar K, 2011, CAN J MICROBIOL, V57, P204, DOI 10.1139/W10-117; Perez-Lara A, 2010, J PHYS CHEM B, V114, P9778, DOI 10.1021/jp101045p; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Rex JH, 2013, LANCET INFECT DIS, V13, P269, DOI 10.1016/S1473-3099(12)70293-1; Rio-Marques L, 2014, MICROB DRUG RESIST, V20, P539, DOI 10.1089/mdr.2014.0059; Rudrappa T, 2008, J AGR FOOD CHEM, V56, P1955, DOI 10.1021/jf072591j; Singh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073815; Singh M, 2011, ANTIMICROB AGENTS CH, V55, P1920, DOI 10.1128/AAC.00957-10; Singh RK, 2010, EUR J MED CHEM, V45, P1078, DOI 10.1016/j.ejmech.2009.12.002; Song J, 2012, EUR J CLIN MICROBIOL, V31, P1347, DOI 10.1007/s10096-011-1448-y; TONNESEN HH, 1987, J PHARM SCI, V76, P371, DOI 10.1002/jps.2600760506; Varshney GK, 2013, LANGMUIR, V29, P2912, DOI 10.1021/la304778d; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P3114, DOI 10.1128/AAC.49.8.3114-3121.2005	33	333	345	19	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121313	10.1371/journal.pone.0121313	http://dx.doi.org/10.1371/journal.pone.0121313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811596	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700093
J	Zhang, CZ; Yu, YJ; Zhang, ZX; Wang, QG; Zheng, LF; Feng, Y; Zhou, ZG; Zhang, GX; Li, KA				Zhang, Chengzhong; Yu, Yuejun; Zhang, Zaixian; Wang, Qingguo; Zheng, Linfeng; Feng, Yan; Zhou, Zhiguo; Zhang, Guixiang; Li, Kangan			Imaging Quality Evaluation of Low Tube Voltage Coronary CT Angiography Using Low Concentration Contrast Medium	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; DIFFERENT IODINE CONCENTRATIONS; ACUTE KIDNEY INJURY; VASCULAR ENHANCEMENT; CHEST CT; PROTOCOLS; MDCT; ARTERIES; WEIGHT; IMPACT	Purpose To compare the image quality of prospectively ECG-gated low voltage coronary computed tomography angiography (CTA) with an administration of low concentration contrast medium. Method and Materials A total of 101 patients, each with a heart rate below 65 beats per minute (BPM), underwent a prospectively ECG-gated axial scan in CT coronary angiography on a 64-slice CT scanner. All patients were allocated in three groups (group A: n=31, 80kVp, 300 mgI/ml; group B: n=34, 100kVp, 300 mgI/ml; group C: n=36, 120kVp, 370 mgI/ml). The CT attenuation values of aortic root (AR), left main coronary artery (LMA), right main coronary artery (RMA) and chest subcutaneous fat tissue were measured. The contrast-to-noise ratio (CNR) of AR, LMA and RMA were calculated according to the formulas below. The values of computed tomography dose index (CTDI) and dose-length product (DLP) were recorded. Image quality was assessed on a 5-point scale. The results were compared using the one-way ANOVA and rank sum tests. Results The values of CNR and SNR for vessels in group A and group B were not significantly different from group C (each p > 0.05). The effective radiation dose in group A (1.51 +/- 0.70 mSv) and group B (2.59 +/- 1.24 mSv) were both lower than group C (4.92 +/- 2.82 mSv) (each p < 0.05). There was no significant difference among the image quality scores of group A (4.10 +/- 0.41), group B (3.90 +/- 0.48) and group C (4.04 +/- 0.36) (each P > 0.05). Conclusion Low tube voltage coronary CT angiography using low concentration contrast medium does not affect the imaging quality for assessing the coronary arteries compared with high voltage coronary CT angiography using high concentration contrast medium. Meanwhile low concentration contrast medium allowed 47-69% of radiation dose reduction.	[Zhang, Chengzhong; Zhang, Zaixian; Wang, Qingguo; Zheng, Linfeng; Feng, Yan; Zhou, Zhiguo; Zhang, Guixiang; Li, Kangan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Yu, Yuejun] Weifang Peoples Hosp, Dept Intervent Radiol, Weifang, Shandong, Peoples R China	Shanghai Jiao Tong University	Li, KA (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	kangan.li@sjtu.edu.cn			National Natural Science Foundation of China [GXZ 21273032, 81101150]; Shanghai Pujiang Project [KAL 2014PJD028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Project(Shanghai Pujiang Program)	This research is financially supported by the National Natural Science Foundation of China (GXZ 21273032 and 81101150 http://www.nsfc.gov.cn/) and the Shanghai Pujiang Project (KAL 2014PJD028 http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abada HT, 2006, AM J ROENTGENOL, V186, pS387, DOI 10.2214/AJR.05.0216; Andreucci M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/362725; Bae KT, 2008, AM J ROENTGENOL, V190, P777, DOI 10.2214/AJR.07.2765; Cademartiri F, 2005, RADIOLOGY, V236, P661, DOI 10.1148/radiol.2362040468; Faggioni L, 2012, AM J ROENTGENOL, V199, P1220, DOI 10.2214/AJR.11.8122; Hausleiter J, 2006, CIRCULATION, V113, P1305, DOI 10.1161/CIRCULATIONAHA.105.602490; Heyer CM, 2007, RADIOLOGY, V245, P577, DOI 10.1148/radiol.2452061919; Jensen H, 2013, EXP TOXICOL PATHOL, V65, P601, DOI 10.1016/j.etp.2012.06.003; Jung SC, 2011, KOREAN J RADIOL, V12, P714, DOI 10.3348/kjr.2011.12.6.714; Kim MJ, 2009, J COMPUT ASSIST TOMO, V33, P416, DOI 10.1097/RCT.0b013e318181fab5; Komatsu S, 2011, CIRC J, V75, P1515, DOI 10.1253/circj.CJ-11-0252; Limbruno U, 2014, J CARDIOVASC MED, V15, P587, DOI 10.2459/JCM.0b013e3283638e56; Ludwig U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/308316; Malago R, 2012, RADIOL MED, V117, P939, DOI 10.1007/s11547-012-0842-6; Marchiano A, 2005, ABDOM IMAGING, V30, P274, DOI 10.1007/s00261-004-0233-0; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Moon JS, 2013, DIABETES METAB J, V37, P54, DOI 10.4093/dmj.2013.37.1.54; Moore A, 2014, CURR PROBL DIAGN RAD, V43, P237, DOI 10.1067/j.cpradiol.2014.05.001; Moselewski F, 2004, AM J CARDIOL, V94, P1294, DOI 10.1016/j.amjcard.2004.07.117; Nakaura T, 2008, INVEST RADIOL, V43, P512, DOI 10.1097/RLI.0b013e3181727505; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Niemann T, 2013, EUR RADIOL, V23, P2643, DOI 10.1007/s00330-013-2887-x; Oda S, 2011, ACAD RADIOL, V18, P991, DOI 10.1016/j.acra.2011.03.007; Paul JF, 2011, INT J CARDIOVAS IMAG, V27, P53, DOI 10.1007/s10554-011-9960-9; Ramgren B, 2012, ACTA RADIOL, V53, P929, DOI 10.1258/ar.2012.120218; Ramirez Ribelles C, 2014, RADIOLOGIA; Ropers D, 2006, CIRCULATION, V114, P2334, DOI 10.1161/CIRCULATIONAHA.106.631051; Rutten A, 2010, EUR RADIOL, V20, P1917, DOI 10.1007/s00330-010-1752-4; Sandstede JJW, 2005, EUR RADIOL, V15, P1211, DOI 10.1007/s00330-005-2677-1; Schreyer AG, 2005, ROFO-FORTSCHR RONTG, V177, P1430, DOI 10.1055/s-2005-858606; Schueller-Weidekamm C, 2006, RADIOLOGY, V241, P899, DOI 10.1148/radiol.2413040128; Setty BN, 2006, J COMPUT ASSIST TOMO, V30, P818, DOI 10.1097/01.rct.0000229999.30897.3b; Tran DN, 2009, ACAD RADIOL, V16, P160, DOI 10.1016/j.acra.2008.09.004; Zhang WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081486; Zheng MW, 2014, EUR J RADIOL, V83, pE92, DOI 10.1016/j.ejrad.2013.11.006	35	13	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120539	10.1371/journal.pone.0120539	http://dx.doi.org/10.1371/journal.pone.0120539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811785	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700050
J	Rudant, J; Orsi, L; Bonaventure, A; Goujon-Bellec, S; Baruchel, A; Petit, A; Bertrand, Y; Nelken, B; Pasquet, M; Michel, G; Saumet, L; Chastagner, P; Ducassou, S; Reguerre, Y; Hemon, D; Clavel, J				Rudant, Jeremie; Orsi, Laurent; Bonaventure, Audrey; Goujon-Bellec, Stephanie; Baruchel, Andre; Petit, Arnaud; Bertrand, Yves; Nelken, Brigitte; Pasquet, Marlene; Michel, Gerard; Saumet, Laure; Chastagner, Pascal; Ducassou, Stephane; Reguerre, Yves; Hemon, Denis; Clavel, Jacqueline			ARID5B, IKZF1 and Non-Genetic Factors in the Etiology of Childhood Acute Lymphoblastic Leukemia: The ESCALE Study	PLOS ONE			English	Article							GENERAL-PRACTITIONER RECORDS; HEMATOPOIETIC MALIGNANCIES; INFECTIONS; CHILDREN; CANCER; RISK; VARIANTS; EPIGENETICS; PESTICIDES; EXPOSURE	Genome-wide association studies (GWAS) have identified that frequent polymorphisms in ARID5B and IKZF1, two genes involved in lymphoid differentiation, increase the risk of childhood acute lymphoblastic leukemia (ALL). These findings markedly modified the current field of research on the etiology of ALL. In this new context, the present exploratory study investigated the possible interactions between these at-risk alleles and the non-genetic suspected ALL risk factors that were of sufficient prevalence in the French ESCALE study: maternal use of home insecticides during pregnancy, preconception paternal smoking, and some proxies for early immune modulation, i.e. breastfeeding, history of common infections before age one year, and birth order. The analyses were based on 434 ALL cases and 442 controls of European origin, drawn from the nationwide population-based case-control study ESCALE. Information on non-genetic factors was obtained by standardized telephone interview. Interactions between rs10740055 in ARID5B or rs4132601 in IKZF1 and each of the suspected non-genetic factors were tested, with the SNPs coded as counts of minor alleles (trend variable). Statistical interactions were observed between rs4132601 and maternal insecticide use (p = 0.012), breastfeeding p = 0.017) and repeated early common infections (p = 0.0070), with allelic odds ratios (OR) which were only increased among the children not exposed to insecticides (OR = 1.8, 95% CI: 1.3, 2.4), those who had been breastfed (OR = 1.8, 95% CI: 1.3, 2.5) and those who had had repeated early common infections (OR = 2.4, 95% CI: 1.5, 3.8). The allelic ORs were close to one among children exposed to insecticides, who had not been breastfed and who had had no or few common infections. Repeated early common infections interacted with rs10740055 (p = 0.018) in the case-only design. Further studies are needed to evaluate whether these observations of a modification of the effect of the at-risk alleles by non-genetic factors are chance findings or reflect true underlying mechanisms.	[Rudant, Jeremie; Orsi, Laurent; Bonaventure, Audrey; Goujon-Bellec, Stephanie; Hemon, Denis; Clavel, Jacqueline] Epidemiol & Biostatist Sorbonne Paris Cite Ctr CR, Epidemiol Childhood & Adolescent Cancers Team, INSERM, U1153, Villejuif, France; [Rudant, Jeremie; Orsi, Laurent; Goujon-Bellec, Stephanie; Hemon, Denis; Clavel, Jacqueline] Paris Descartes Univ, Epidemiol & Biostatist Sorbonne Paris Cite Ctr CR, UMRS 1153, Paris, France; [Rudant, Jeremie; Goujon-Bellec, Stephanie; Clavel, Jacqueline] French Natl Registry Childhood Hematopoiet Malign, Villejuif, France; [Baruchel, Andre] Hop Robert Debre, AP HP, F-75019 Paris, France; [Baruchel, Andre] Sorbonne Paris Cite, Univ Paris Diderot Paris 7, Paris, France; [Petit, Arnaud] Hop Trousseau, HUEP, AP HP, F-75571 Paris, France; [Petit, Arnaud] Univ Paris 06, Sorbonne Univ, UMRS 938, Paris, France; [Bertrand, Yves] Inst Hemato Oncol Pediatr, Lyon, France; [Bertrand, Yves] Univ Lyon 1, Lyon, France; [Nelken, Brigitte] CHRU, Pole Enfant, Lille, France; [Nelken, Brigitte] Univ Lille Nord France, Lille, France; [Pasquet, Marlene] CHU Toulouse, Hematol Pediatr, INSERM, U1037,CRCT,Oncopole, Toulouse, France; [Michel, Gerard] Timone Enfants Hosp, Dept Pediat Hematol & Oncol, Marseille, France; [Michel, Gerard] Aix Marseille Univ, Marseille, France; [Saumet, Laure] Hop Arnaud Villeneuve, Montpellier, France; [Chastagner, Pascal] CHU Nancy, Hop Enfants, Vandoeuvre Les Nancy, France; [Ducassou, Stephane] Hop Pellegrin Tripode, Bordeaux, France; [Reguerre, Yves] CHU Felix Guyon, St Denis, Reunion, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; CHU de Montpellier; CHU de Nancy; CHU Bordeaux; CHU Reunion	Rudant, J (corresponding author), Epidemiol & Biostatist Sorbonne Paris Cite Ctr CR, Epidemiol Childhood & Adolescent Cancers Team, INSERM, U1153, Villejuif, France.	jeremie.rudant@inserm.fr	pasquet, marlene/W-8568-2019; Clavel, Jacqueline/Q-2750-2016; Hémon, Denis/P-8695-2017; Orsi, Laurent/H-7863-2018; A, Petit/H-1633-2011	Clavel, Jacqueline/0000-0002-3616-7676; Orsi, Laurent/0000-0002-9332-3620; A, Petit/0000-0001-8363-1622; Bonaventure, Audrey/0000-0001-6665-8145; Nelken, Brigitte/0000-0003-1048-1517	INSERM; Fondation de France; Association pour la Recherche sur le Cancer (ARC); Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS); Agence Francaise de - Securite Sanitaire de l'Environnement et du Travail (AFSSET); PNREST Anses; Cancer TMOI AVIESAN [2013/1/248]; association Cent pour sang la vie; Institut National du Cancer (INCa); Agence Nationale de la Recherche (ANR); Canceropole Ile de France; INSERM; Fondation de France; Association pour la Recherche sur le Cancer (ARC); Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS); Agence Francaise de - Securite Sanitaire de l'Environnement et du Travail (AFSSET); PNREST Anses; Cancer TMOI AVIESAN [2013/1/248]; association Cent pour sang la vie; Institut National du Cancer (INCa); Agence Nationale de la Recherche (ANR); Canceropole Ile de France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS); Agence Francaise de - Securite Sanitaire de l'Environnement et du Travail (AFSSET); PNREST Anses; Cancer TMOI AVIESAN; association Cent pour sang la vie; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Canceropole Ile de France(Region Ile-de-France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS); Agence Francaise de - Securite Sanitaire de l'Environnement et du Travail (AFSSET); PNREST Anses; Cancer TMOI AVIESAN; association Cent pour sang la vie; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Canceropole Ile de France(Region Ile-de-France)	This work was supported by grants from INSERM, the Fondation de France, the Association pour la Recherche sur le Cancer (ARC), the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS), the Agence Francaise de - Securite Sanitaire de l'Environnement et du Travail (AFSSET), the PNREST Anses, the Cancer TMOI AVIESAN, 2013/1/248, the association Cent pour sang la vie, the Institut National du Cancer (INCa), the Agence Nationale de la Recherche (ANR), and Canceropole Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; ALHO OP, 1990, AM J EPIDEMIOL, V132, P1164, DOI 10.1093/oxfordjournals.aje.a115759; Amigou A, 2012, CANCER CAUSE CONTROL, V23, P1265, DOI 10.1007/s10552-012-0004-0; Cardwell CR, 2008, BRIT J CANCER, V99, P1529, DOI 10.1038/sj.bjc.6604696; Chang JS, 2012, INT J EPIDEMIOL, V41, P1050, DOI 10.1093/ije/dys113; Clavel J, 2004, EUR J CANCER PREV, V13, P97, DOI 10.1097/00008469-200404000-00002; Collotta M, 2013, TOXICOLOGY, V307, P35, DOI 10.1016/j.tox.2013.01.017; Crouch S, 2012, AM J EPIDEMIOL, V176, P402, DOI 10.1093/aje/kws180; Desandes E, 2004, PEDIATR BLOOD CANCER, V43, P749, DOI 10.1002/pbc.20148; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Ellinghaus E, 2012, LEUKEMIA, V26, P902, DOI 10.1038/leu.2011.302; Evans TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110255; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Imamura L, 2002, ARCH TOXICOL, V76, P392, DOI 10.1007/s00204-002-0358-2; Kastner P, 2013, AM J BLOOD RES, V3, P1; Kim KY, 2010, ENVIRON HEALTH PERSP, V118, P370, DOI 10.1289/ehp.0901131; Kojima H, 2012, TOXICOL APPL PHARM, V259, P338, DOI 10.1016/j.taap.2012.01.011; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; Lacour B, 2010, EUR J CANCER PREV, V19, P173, DOI 10.1097/CEJ.0b013e32833876c0; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Linabery AM, 2013, LEUKEMIA RES, V37, P936, DOI 10.1016/j.leukres.2013.04.022; MCKINNEY PA, 1991, J PUBLIC HEALTH MED, V13, P13, DOI 10.1093/oxfordjournals.pubmed.a042571; Migliorini G, 2013, BLOOD, V30, P30, DOI [10.5339/qmj.2013.6, DOI 10.5339/QMJ.2013.6]; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Obermann-Borst SA, 2013, PEDIATR RES, V74, P344, DOI 10.1038/pr.2013.95; Orsi L, 2012, LEUKEMIA, V26, P2561, DOI 10.1038/leu.2012.148; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Perez-Andreu V, 2013, NAT GENET, V45, P1494, DOI 10.1038/ng.2803; Roman E, 2007, AM J EPIDEMIOL, V165, P496, DOI 10.1093/aje/kwk039; Roman E, 2009, BLOOD CELL MOL DIS, V42, P126, DOI 10.1016/j.bcmd.2008.10.007; Rudant J, 2008, CANCER CAUSE CONTROL, V19, P1277, DOI 10.1007/s10552-008-9199-5; Rudant J, 2007, ENVIRON HEALTH PERSP, V115, P1787, DOI 10.1289/ehp.10596; Rudant J, 2010, AM J EPIDEMIOL, V172, P1015, DOI 10.1093/aje/kwq233; Sellars Maclean, 2011, World J Biol Chem, V2, P132, DOI 10.4331/wjbc.v2.i6.132; Simpson J, 2007, EUR J CANCER, V43, P2396, DOI 10.1016/j.ejca.2007.07.027; Tijchon E, 2013, LEUKEMIA, V27, P541, DOI 10.1038/leu.2012.293; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Urayama KY, 2013, INT J HEMATOL, V97, P3, DOI 10.1007/s12185-012-1220-9; Vestergaard TR, 2013, PEDIATR BLOOD CANCER, V60, P428, DOI 10.1002/pbc.24286; Weinberg Clarice R, 2012, Int J Epidemiol, V41, P705, DOI 10.1093/ije/dys048; Wiemels J, 2012, CHEM-BIOL INTERACT, V196, P59, DOI 10.1016/j.cbi.2012.01.007; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042	45	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121348	10.1371/journal.pone.0121348	http://dx.doi.org/10.1371/journal.pone.0121348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806972	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000149
J	Ugrinov, KG; Freed, SD; Thomas, CL; Lee, SW				Ugrinov, Krastyu G.; Freed, Stefan D.; Thomas, Clayton L.; Lee, Shaun W.			A Multiparametric Computational Algorithm for Comprehensive Assessment of Genetic Mutations in Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome)	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISORDERS; PROTEIN-MISFOLDING DISEASES; SYNDROME TYPE-A; PHARMACOLOGICAL CHAPERONES; MPS IIIA; IN-VIVO; SULFAMIDASE; IDENTIFICATION; TRANSLATION; STABILITY	Mucopolysaccharidosis type IIIA (MPS-IIIA, Sanfilippo syndrome) is a Lysosomal Storage Disease caused by cellular deficiency of N-sulfoglucosamine sulfohydrolase (SGSH). Given the large heterogeneity of genetic mutations responsible for the disease, a comprehensive understanding of the mechanisms by which these mutations affect enzyme function is needed to guide effective therapies. We developed a multiparametric computational algorithm to assess how patient genetic mutations in SGSH affect overall enzyme biogenesis, stability, and function. 107 patient mutations for the SGSH gene were obtained from the Human Gene Mutation Database representing all of the clinical mutations documented for Sanfilippo syndrome. We assessed each mutation individually using ten distinct parameters to give a comprehensive predictive score of the stability and misfolding capacity of the SGSH enzyme resulting from each of these mutations. The predictive score generated by our multiparametric algorithm yielded a standardized quantitative assessment of the severity of a given SGSH genetic mutation toward overall enzyme activity. Application of our algorithm has identified SGSH mutations in which enzymatic malfunction of the gene product is specifically due to impairments in protein folding. These scores provide an assessment of the degree to which a particular mutation could be treated using approaches such as chaperone therapies. Our multiparametric protein biogenesis algorithm advances a key understanding in the overall biochemical mechanism underlying Sanfilippo syndrome. Importantly, the design of our multiparametric algorithm can be tailored to many other diseases of genetic heterogeneity for which protein misfolding phenotypes may constitute a major component of disease manifestation.	[Ugrinov, Krastyu G.; Freed, Stefan D.; Thomas, Clayton L.; Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Ugrinov, Krastyu G.; Freed, Stefan D.; Thomas, Clayton L.; Lee, Shaun W.] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Lee, SW (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	lee.310@nd.edu			NIGMS NIH HHS [T32 GM075762] Funding Source: Medline; NIH HHS [DP2 OD008468] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008468] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amaral MD, 2006, J INHERIT METAB DIS, V29, P477, DOI 10.1007/s10545-006-0251-x; BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Beesley CE, 2000, J MED GENET, V37, P704, DOI 10.1136/jmg.37.9.704; Bielicki J, 1998, BIOCHEM J, V329, P145, DOI 10.1042/bj3290145; Blech-Hermoni YN, 2010, MOL GENET METAB, V99, P275, DOI 10.1016/j.ymgme.2009.10.189; Boyd RE, 2013, J MED CHEM, V56, P2705, DOI 10.1021/jm301557k; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Clark PL, 2004, TRENDS BIOCHEM SCI, V29, P527, DOI 10.1016/j.tibs.2004.08.008; Clarke TF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-118; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Cramer D., 1997, BASIC STAT SOCIAL RE; Cunningham EL, 1999, P NATL ACAD SCI USA, V96, P11008, DOI 10.1073/pnas.96.20.11008; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; de Ruijter J, 2011, CURR PHARM BIOTECHNO, V12, P923, DOI 1389-2010/11 $58.00+.00; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Esposito S, 2000, BBA-MOL BASIS DIS, V1501, P1, DOI 10.1016/S0925-4439(99)00118-0; Fedyunin I, 2012, FEBS LETT, V586, P3336, DOI 10.1016/j.febslet.2012.07.012; Feldhammer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007434; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hemsley KM, 2009, MOL GENET METAB, V98, P383, DOI 10.1016/j.ymgme.2009.07.013; Heron B, 2011, AM J MED GENET A, V155A, P58, DOI 10.1002/ajmg.a.33779; Karageorgos L E, 1996, DNA Res, V3, P269, DOI 10.1093/dnares/3.4.269; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Langford-Smith A, 2012, MOL THER, V20, P1610, DOI 10.1038/mt.2012.82; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Meikle PJ, 2003, EUR J PEDIATR, V4, P677; Meyer A, 2007, PEDIATRICS, V120, pE1255, DOI 10.1542/peds.2007-0282; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Narayan M, 2012, FEBS J, V279, P2272, DOI 10.1111/j.1742-4658.2012.08636.x; O'Brien EP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1850; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Piotrowska E, 2008, CURR THER RES CLIN E, V69, P166, DOI 10.1016/j.curtheres.2008.04.002; Pollard LM, 2013, J INHERIT METAB DIS, V36, P179, DOI 10.1007/s10545-012-9533-7; Poupetova H, 2010, J INHERIT METAB DIS, V33, P387, DOI 10.1007/s10545-010-9093-7; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; SCOTT HS, 1995, NAT GENET, V11, P465, DOI 10.1038/ng1295-465; Sidhu NS, 2014, ACTA CRYSTALLOGR D, V70, P1321, DOI 10.1107/S1399004714002739; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Skidmore MA, 2008, CONNECT TISSUE RES, V49, P140, DOI 10.1080/03008200802148595; Smithson DC, 2013, METHOD ENZYMOL, V521, P3, DOI 10.1016/B978-0-12-391862-8.00001-6; Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Stephens MA, 1986, GOODNESS OF FIT TECH; Studer RA, 2013, BIOCHEM J, V449, P581, DOI 10.1042/BJ20121221; Tardieu M, 2014, HUM GENE THER, V25, P506, DOI 10.1089/hum.2013.238; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5; Valstar MJ, 2010, ANN NEUROL, V68, P876, DOI 10.1002/ana.22092; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Waldow A, 1999, J BIOL CHEM, V274, P12284, DOI 10.1074/jbc.274.18.12284; Weber B, 1997, HUM MOL GENET, V6, P1573, DOI 10.1093/hmg/6.9.1573; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; Yogalingam G, 2001, HUM MUTAT, V18, P264, DOI 10.1002/humu.1189; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhang Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/805827; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	78	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121511	10.1371/journal.pone.0121511	http://dx.doi.org/10.1371/journal.pone.0121511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807448	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000160
J	Bian, F; Yue, SS; Peng, ZY; Zhang, XW; Chen, G; Yu, JH; Xuan, N; Bi, YP				Bian, Fei; Yue, Shousong; Peng, Zhenying; Zhang, Xiaowei; Chen, Gao; Yu, Jinhui; Xuan, Ning; Bi, Yuping			A Comprehensive Alanine-Scanning Mutagenesis Study Reveals Roles for Salt Bridges in the Structure and Activity of Pseudomonas aeruginosa Elastase	PLOS ONE			English	Article							THERMOLYSIN FAMILY; 3-DIMENSIONAL STRUCTURE; ZINC METALLOPROTEASES; PSYCHROPHILIC ENZYMES; MOLECULAR-DYNAMICS; COLD ADAPTATION; DEEP-SEA; FLEXIBILITY; PARAMETERS; PROTEASES	The relationship between salt bridges and stability/enzymatic activity is unclear. We studied this relationship by systematic alanine-scanning mutation analysis using the typical M4 family metalloprotease Pseudomonas aeruginosa elastase (PAE, also known as pseudolysin) as a model. Structural analysis revealed seven salt bridges in the PAE structure. We constructed ten mutants for six salt bridges. Among these mutants, six (Asp189Ala, Arg179Ala, Asp201Ala, Arg205Ala, Arg245Ala and Glu249Ala) were active and four (Asp168Ala, Arg198Ala, Arg253Ala, and Arg279Ala) were inactive. Five mutants were purified, and their catalytic efficiencies (k(cat)/K-m), half-lives (t(1/2)) and thermal unfolding curves were compared with those of PAE. Mutants Asp189Ala and Arg179Ala both showed decreased thermal stabilities and increased activities, suggesting that the salt bridge Asp189-Arg179 stabilizes the protein at the expense of catalytic efficiency. In contrast, mutants Asp201Ala and Arg205Ala both showed slightly increased thermal stability and slightly decreased activity, suggesting that the salt bridge Asp201-Arg205 destabilizes the protein. Mutant Glu249Ala is related to a C-terminal salt bridge network and showed both decreased thermal stability and decreased activity. Furthermore, Glu249Ala showed a thermal unfolding curve with three discernable states [the native state (N), the partially unfolded state (I) and the unfolded state (U)]. In comparison, there were only two discernable states (N and U) in the thermal unfolding curve of PAE. These results suggest that Glu249 is important for catalytic efficiency, stability and unfolding cooperativity. This study represents a systematic mutational analyses of salt bridges in the model metalloprotease PAE and provides important insights into the structure-function relationship of enzymes.	[Bian, Fei; Yue, Shousong; Peng, Zhenying; Zhang, Xiaowei; Chen, Gao; Xuan, Ning; Bi, Yuping] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China; [Bian, Fei; Yue, Shousong; Peng, Zhenying; Zhang, Xiaowei; Chen, Gao; Xuan, Ning] Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China; [Yu, Jinhui] Shandong Acad Agr Sci, Shandong Crop Germplasm Ctr, Jinan, Peoples R China; [Bi, Yuping] Shandong Acad Agr Sci, Grad Educ Ctr, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Bian, F (corresponding author), Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China.	feifeibian@gmail.com; yuping_bi@hotmail.com			Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences [2014QNZ05]; Shandong Provincial Natural Science Foundation [ZR2014CQ043]; International Science & Technology Cooperation Program of China [2012DFA30450]	Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); International Science & Technology Cooperation Program of China	This work was supported by the Youth Scientific Research Foundation of Shandong Academy of Agricultural Sciences (2014QNZ05) to FB, the Shandong Provincial Natural Science Foundation (ZR2014CQ043) to FB, and the International Science & Technology Cooperation Program of China (2012DFA30450) to YB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekoya OA, 2009, CHEM BIOL DRUG DES, V73, P7, DOI 10.1111/j.1747-0285.2008.00757.x; ARGOS P, 1978, J MOL BIOL, V126, P141, DOI 10.1016/0022-2836(78)90356-X; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen XL, 2003, MAR BIOL, V143, P989, DOI 10.1007/s00227-003-1128-2; EIJSINK VGH, 1995, NAT STRUCT BIOL, V2, P374, DOI 10.1038/nsb0595-374; FEDER J, 1968, BIOCHEM BIOPH RES CO, V32, P326, DOI 10.1016/0006-291X(68)90389-6; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; Mock WL, 1996, BIOCHEMISTRY-US, V35, P7369, DOI 10.1021/bi952827p; OHTA Y, 1966, J BIOL CHEM, V241, P5919; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; THAYER MM, 1991, J BIOL CHEM, V266, P2864; TITANI K, 1972, NATURE-NEW BIOL, V238, P35, DOI 10.1038/newbio238035a0; TRONRUD DE, 1987, SCIENCE, V235, P571, DOI 10.1126/science.3810156; Xie BB, 2009, J BIOL CHEM, V284, P9257, DOI 10.1074/jbc.M808421200	20	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121108	10.1371/journal.pone.0121108	http://dx.doi.org/10.1371/journal.pone.0121108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815820	gold, Green Submitted, Green Published			2022-12-26	WOS:000352133600066
J	Echigoya, Y; Mouly, V; Garcia, L; Yokota, T; Duddy, W				Echigoya, Yusuke; Mouly, Vincent; Garcia, Luis; Yokota, Toshifumi; Duddy, William			In Silico Screening Based on Predictive Algorithms as a Design Tool for Exon Skipping Oligonucleotides in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							ANTISENSE OLIGONUCLEOTIDES; SECONDARY STRUCTURE; HUMAN MYOBLASTS; MUSCLE; THERAPIES; PROGRESS; RESCUE; ACCESSIBILITY; STRATEGIES; INDUCTION	The use of antisense 'splice-switching' oligonucleotides to induce exon skipping represents a potential therapeutic approach to various human genetic diseases. It has achieved greatest maturity in exon skipping of the dystrophin transcript in Duchenne muscular dystrophy (DMD), for which several clinical trials are completed or ongoing, and a large body of data exists describing tested oligonucleotides and their efficacy. The rational design of an exon skipping oligonucleotide involves the choice of an antisense sequence, usually between 15 and 32 nucleotides, targeting the exon that is to be skipped. Although parameters describing the target site can be computationally estimated and several have been identified to correlate with efficacy, methods to predict efficacy are limited. Here, an in silico pre-screening approach is proposed, based on predictive statistical modelling. Previous DMD data were compiled together and, for each oligonucleotide, some 60 descriptors were considered. Statistical modelling approaches were applied to derive algorithms that predict exon skipping for a given target site. We confirmed (1) the binding energetics of the oligonucleotide to the RNA, and (2) the distance in bases of the target site from the splice acceptor site, as the two most predictive parameters, and we included these and several other parameters (while discounting many) into an in silico screening process, based on their capacity to predict high or low efficacy in either phosphorodiamidate morpholino oligomers (89% correctly predicted) and/or 2'O Methyl RNA oligonucleotides (76% correctly predicted). Predictions correlated strongly with in vitro testing for sixteen de novo PMO sequences targeting various positions on DMD exons 44 (R-2 0.89) and 53 (R-2 0.89), one of which represents a potential novel candidate for clinical trials. We provide these algorithms together with a computational tool that facilitates screening to predict exon skipping efficacy at each position of a target exon.	[Echigoya, Yusuke; Yokota, Toshifumi] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada; [Mouly, Vincent; Duddy, William] Univ Paris 06, Sorbonne Univ, INSERM, UMRS974,CNRS,FRE 3617,Ctr Res Myol, F-75651 Paris 13, France; [Garcia, Luis] Univ Versailles St Quentin En Yvelines, UFR Sci Sante, F-78180 Montigny Le Bretonneux, France; [Yokota, Toshifumi] Univ Alberta, Muscular Dystrophy Canada Res Chair, Edmonton, AB, Canada	University of Alberta; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; University of Alberta	Yokota, T (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada.	toshifumi.yokota@ualberta.ca; william.duddy@upmc.fr	Duddy, William/S-9773-2019	Duddy, William/0000-0003-2239-9094; , toshifumi/0000-0001-6672-6742; Mouly, Vincent/0000-0003-3809-4033; Aartsma-Rus, Annemieke/0000-0003-1565-654X; Echigoya, Yusuke/0000-0003-1573-4819; Yokota, Toshifumi/0000-0001-7316-3546	Duchenne Ireland; French Muscular Dystrophy Association (AFM); Netherlands Duchenne Parent Project; Muscular Dystrophy Canada; University of Alberta Faculty of Medicine and Dentistry; Parent Project Muscular Dystrophy (USA); Canadian Institutes of Health Research; Friends of Garrett Cumming Research Funds; HM Toupin Neurological Science Research Funds; Canada Foundation for Innovation; Alberta Enterprise and Advanced Education; Women and Children's Health Research Institute (WCHRI)	Duchenne Ireland; French Muscular Dystrophy Association (AFM)(Association Francaise contre les Myopathies); Netherlands Duchenne Parent Project; Muscular Dystrophy Canada(Muscular Dystrophy Association); University of Alberta Faculty of Medicine and Dentistry(University of Alberta); Parent Project Muscular Dystrophy (USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Friends of Garrett Cumming Research Funds; HM Toupin Neurological Science Research Funds; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Enterprise and Advanced Education; Women and Children's Health Research Institute (WCHRI)	Funding: This work was supported by Duchenne Ireland (http://www.duchenne.ie); the French Muscular Dystrophy Association (AFM; http://www.afm-telethon.fr); the Netherlands Duchenne Parent Project (https://www.duchenne.nl); Muscular Dystrophy Canada (http://muscle.ca); The University of Alberta Faculty of Medicine and Dentistry; Parent Project Muscular Dystrophy (USA; http://www.parentprojectmd.org/); The Canadian Institutes of Health Research; The Friends of Garrett Cumming Research Funds; HM Toupin Neurological Science Research Funds; Canada Foundation for Innovation (http://www.innovation.ca); Alberta Enterprise and Advanced Education (http://eae.alberta.ca); and the Women and Children's Health Research Institute (WCHRI; http://wchri.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Aartsma-Rus A, 2010, OLIGONUCLEOTIDES, V20, P69, DOI 10.1089/oli.2009.0215; Aartsma-Rus A, 2009, MOL THER, V17, P548, DOI 10.1038/mt.2008.205; Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; Aoki Y, 2013, HUM MOL GENET, V22, P4914, DOI 10.1093/hmg/ddt341; Arechavala-Gomeza V, 2012, CURR GENE THER, V12, P152, DOI 10.2174/156652312800840621; Betts C, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.30; Blazquez L, 2013, HUM MUTAT, V34, P1387, DOI 10.1002/humu.22379; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fairclough RJ, 2011, EXP PHYSIOL, V96, P1101, DOI 10.1113/expphysiol.2010.053025; Gedicke-Hornung C, 2013, EMBO MOL MED, V5, P1128, DOI 10.1002/emmm.201202168; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Hammond SM, 2011, TRENDS GENET, V27, P196, DOI 10.1016/j.tig.2011.02.004; Harding PL, 2007, MOL THER, V15, P157, DOI 10.1038/sj.mt.6300006; Hoffman EP, 2011, AM J PATHOL, V179, P12, DOI 10.1016/j.ajpath.2011.03.050; Kieny P., 2013, Annals of Physical and Rehabilitation Medicine, V56, P443, DOI 10.1016/j.rehab.2013.06.002; KOENIG M, 1989, AM J HUM GENET, V45, P498; Lange SJ, 2012, NUCLEIC ACIDS RES, V40, P5215, DOI 10.1093/nar/gks181; Lehto T, 2014, NUCLEIC ACIDS RES, V42, P3207, DOI 10.1093/nar/gkt1220; Li HL, 2014, STEM CELL REPORTS; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Malueka RG, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-23; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; MENDELL J, 2013, ANN NEUROL; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; Partridge TA, 2011, CURR OPIN NEUROL, V24, P415, DOI 10.1097/WCO.0b013e32834aa3f1; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Popplewell LJ, 2012, METHODS MOL BIOL, V867, P143, DOI 10.1007/978-1-61779-767-5_10; Popplewell LJ, 2009, MOL THER, V17, P554, DOI 10.1038/mt.2008.287; Pramono ZAD, 2012, HUM GENE THER, V23, P781, DOI 10.1089/hum.2011.205; Renault V, 2000, EXP GERONTOL, V35, P711, DOI 10.1016/S0531-5565(00)00151-0; Rendu J, 2013, HUM GENE THER, V24, P702, DOI 10.1089/hum.2013.052; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Seo J, 2013, BBA-MOL BASIS DIS, V1832, P2180, DOI 10.1016/j.bbadis.2013.08.005; Stadler MB, 2006, PLOS GENET, V2, P1849, DOI 10.1371/journal.pgen.0020191; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; Touznik A, 2014, EXPERT OPIN BIOL TH, V14, P809, DOI 10.1517/14712598.2014.896335; Vulin A, 2012, MOL THER, V20, P2120, DOI 10.1038/mt.2012.181; Wan J, 2009, INT J CANCER, V124, P772, DOI 10.1002/ijc.24052; Wee KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001844; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; Yilmaz-Elis AS, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.58; Yin HF, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.51; Zhou HL, 2014, NUCLEIC ACIDS RES, V42, P701, DOI 10.1093/nar/gkt875; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	54	40	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120058	10.1371/journal.pone.0120058	http://dx.doi.org/10.1371/journal.pone.0120058			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816009	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600027
J	Juhas, M; Ajioka, JW				Juhas, Mario; Ajioka, James W.			Identification and Validation of Novel Chromosomal Integration and Expression Loci in Escherichia coli Flagellar Region 1	PLOS ONE			English	Article							P-RING COMPONENT; ESSENTIAL GENES; PROTEIN; DNA; PCR; CLONING; GENOME	Escherichia coli is used as a chassis for a number of Synthetic Biology applications. The lack of suitable chromosomal integration and expression loci is among the main hurdles of the E. coli engineering efforts. We identified and validated chromosomal integration and expression target sites within E. coli K12 MG1655 flagellar region 1. We analyzed five open reading frames of the flagellar region 1, flgA, flgF, flgG, flgI, and flgJ, that are well-conserved among commonly-used E. coli strains, such as MG1655, W3110, DH10B and BL21-DE3. The efficiency of the integration into the E. coli chromosome and the expression of the introduced genetic circuit at the investigated loci varied significantly. The integrations did not have a negative impact on growth; however, they completely abolished motility. From the investigated E. coli K12 MG1655 flagellar region 1, flgA and flgG are the most suitable chromosomal integration and expression loci.	[Juhas, Mario; Ajioka, James W.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Juhas, M (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mj417@cam.ac.uk			United Kingdom Engineering and Physical Sciences Research Council (EPSRC)	United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the United Kingdom Engineering and Physical Sciences Research Council (EPSRC).	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cunningham DS, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-27; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Herlihey FA, 2014, J BIOL CHEM, V289, P31029, DOI 10.1074/jbc.M114.603944; Hizukuri Y, 2008, MICROBIOL-SGM, V154, P810, DOI 10.1099/mic.0.2007/013854-0; Hizukuri Y, 2006, J BACTERIOL, V188, P4190, DOI 10.1128/JB.01896-05; Hizukuri Y, 2010, J BIOCHEM, V148, P309, DOI 10.1093/jb/mvq067; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Juhas M, 2016, CRIT REV BIOTECHNOL, V36, P416, DOI 10.3109/07388551.2014.989423; Juhas M, 2014, MICROBIOL-SGM, V160, P2341, DOI 10.1099/mic.0.079376-0; Juhas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111451; Juhas M, 2013, BIOTECHNOL J, V8, P761, DOI 10.1002/biot.201300042; Juhas M, 2012, TRENDS BIOTECHNOL, V30, P601, DOI 10.1016/j.tibtech.2012.08.002; Juhas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040064; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Matsunami H, 2012, ACTA CRYSTALLOGR F, V68, P310, DOI 10.1107/S1744309112001327; MIESCHENDAHL M, 1985, J BACTERIOL, V164, P1366, DOI 10.1128/JB.164.3.1366-1369.1985; Miller E M, 1995, Methods Mol Biol, V47, P105; Minty JJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-18; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Sabri S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-60; Saijo-Hamano Y, 2004, J MOL BIOL, V339, P423, DOI 10.1016/j.jmb.2004.03.070; St-Pierre F, 2013, ACS SYNTH BIOL, V2, P537, DOI 10.1021/sb400021j; Ublinskaya AA, 2012, J MICROBIOL METH, V89, P167, DOI 10.1016/j.mimet.2012.03.013; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]	33	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0123007	10.1371/journal.pone.0123007	http://dx.doi.org/10.1371/journal.pone.0123007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816013	Green Submitted, gold, Green Published			2022-12-26	WOS:000352133600203
J	Li, XH; Ha, CT; Fu, DD; Landauer, MR; Ghosh, SP; Xiao, M				Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Landauer, Michael R.; Ghosh, Sanchita P.; Xiao, Mang			Delta-Tocotrienol Suppresses Radiation-Induced MicroRNA-30 and Protects Mice and Human CD34+Cells from Radiation Injury	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC PROGENITORS; MESSENGER-RNAS; CANCER; INTERLEUKIN-1; IRRADIATION; EXPRESSION; MOUSE; DEATH	We reported that microRNA-30c (miR-30c) plays a key role in radiation-induced human cell damage through an apoptotic pathway. Herein we further evaluated radiation-induced miR-30 expression and mechanisms of delta-tocotrienol (DT3), a radiation countermeasure candidate, for regulating miR-30 in a mouse model and human hematopoietic CD34+ cells. CD2F1 mice were exposed to 0 (control) or 7-12.5 Gy total-body gamma-radiation, and CD34+ cells were irradiated with 0, 2 or 4 Gy of radiation. Single doses of DT3 (75 mg/kg, subcutaneous injection for mice or 2 mu M for CD34+ cell culture) were administrated 24 h before irradiation and animal survival was monitored for 30 days. Mouse bone marrow (BM), jejunum, kidney, liver and serum as well as CD34+ cells were collected at 1, 4, 8, 24, 48 or 72 h after irradiation to determine apoptotic markers, pro-inflammatory cytokines interleukin (IL)-1 beta and IL-6, miR-30, and stress response protein expression. Our results showed that radiation-induced IL-1 beta release and cell damage are pathological states that lead to an early expression and secretion of miR-30b and miR-30c in mouse tissues and serum and in human CD34+ cells. DT3 suppressed IL-1 beta and miR-30 expression, protected against radiation-induced apoptosis in mouse and human cells, and increased survival of irradiated mice. Furthermore, an anti-IL-1 beta antibody downregulated radiation-induced NF kappa Bp65 phosphorylation, inhibited miR-30 expression and protected CD34+ cells from radiation exposure. Knockdown of NF kappa Bp65 by small interfering RNA (siRNA) significantly suppressed radiation-induced miR-30 expression in CD34+ cells. Our data suggest that DT3 protects human and mouse cells from radiation damage may through suppression of IL-1 beta-induced NF kappa B/miR-30 signaling.	[Li, Xiang Hong; Ha, Cam T.; Fu, Dadin; Landauer, Michael R.; Ghosh, Sanchita P.; Xiao, Mang] Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Xiao, M (corresponding author), Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA.	mang.xiao@usuhs.edu		Ghosh, Sanchita/0000-0002-0261-460X	Armed Forces Radiobiology Research Institute [RAB2GO, RAB22676, RAA610]	Armed Forces Radiobiology Research Institute	This study was supported by Armed Forces Radiobiology Research Institute intramural grants (RAB2GO and RAB22676) to MX and RAA610 to SPG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; De DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073409; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukumoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058389; Ha CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109249; Ha CT, 2013, RADIAT RES, V180, P316, DOI 10.1667/RR3326.1; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; HASEGAWA A T, 1970, Radiation Research, V44, P738, DOI 10.2307/3573153; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Herodin F, 2007, EXP HEMATOL, V35, P28, DOI 10.1016/j.exphem.2007.01.009; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Kamat JP, 1997, MOL CELL BIOCHEM, V170, P131, DOI 10.1023/A:1006853419214; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XH, 2013, RADIAT RES, V180, P649, DOI 10.1667/RR13398.1; Li XH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039690, 10.1371/journal.pone.0036604]; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Ling MT, 2012, CARCINOGENESIS, V33, P233, DOI 10.1093/carcin/bgr261; Ling SB, 2014, ONCOL LETT, V7, P1747, DOI 10.3892/ol.2014.2003; Lukens JR, 2012, J IMMUNOL, V188, P3107, DOI 10.4049/jimmunol.1103308; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; MCBRIDE WH, 1989, CANCER RES, V49, P169; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nesaretnam K, 2008, CANCER LETT, V269, P388, DOI 10.1016/j.canlet.2008.03.063; Ng MH, 2004, LIPIDS, V39, P1031, DOI 10.1007/s11745-004-1327-y; Patnaik SK, 2010, ANAL BIOCHEM, V407, P147, DOI 10.1016/j.ab.2010.08.004; Poudel S, 2013, BIOCHEM BIOPH RES CO, V431, P572, DOI 10.1016/j.bbrc.2013.01.012; Quintavalle C, 2013, ONCOGENE, V32, P4001, DOI 10.1038/onc.2012.410; Robertson Barbara, 2010, Silence, V1, P10, DOI 10.1186/1758-907X-1-10; Satyamitra MM, 2011, RADIAT RES, V175, P736, DOI 10.1667/RR2460.1; Sen CK, 2006, LIFE SCI, V78, P2088, DOI 10.1016/j.lfs.2005.12.001; Shih KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042389; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Tan SW, 2011, CELL IMMUNOL, V271, P205, DOI 10.1016/j.cellimm.2011.07.012; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144; Whitnall MH, 2000, INT J IMMUNOPHARMACO, V22, P1, DOI 10.1016/S0192-0561(99)00059-4; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Xiao M, 2007, MOL PHARMACOL, V72, P370, DOI 10.1124/mol.107.035394; Yam ML, 2009, LIPIDS, V44, P787, DOI 10.1007/s11745-009-3326-2; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zhang M, 2012, CYTOKINE, V58, P169, DOI 10.1016/j.cyto.2011.12.023	47	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122258	10.1371/journal.pone.0122258	http://dx.doi.org/10.1371/journal.pone.0122258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815474	gold, Green Published, Green Submitted			2022-12-26	WOS:000352133600160
J	Frias, M; Rivero-Juarez, A; Gordon, A; Camacho, A; Cantisan, S; Cuenca-Lopez, F; Torre-Cisneros, J; Pena, J; Rivero, A				Frias, Mario; Rivero-Juarez, Antonio; Gordon, Ana; Camacho, Angela; Cantisan, Sara; Cuenca-Lopez, Francisca; Torre-Cisneros, Julian; Pena, Jose; Rivero, Antonio			Persistence of Pathological Distribution of NK Cells in HIV-Infected Patients with Prolonged Use of HAART and a Sustained Immune Response	PLOS ONE			English	Article							NATURAL-KILLER-CELL; RECEPTORS NKP46; RECONSTITUTION; INDIVIDUALS; EXPRESSION; DISEASE; NKP30	Objective A prospective analysis of the distribution of NK subsets and natural cytotoxicity receptors (NKp30/NKp46) in HIV patients with long-term HAART use and sustained virological and immunological response. Methods The main inclusion criteria were: at least 3 years' receipt of HAART; current CD4(+) count >= 500 cells/mm(3); undetectable viral load for at least 24 months; no hepatotropic virus co-infection. Percentages of CD56(dim), CD56(bright) NK cells and CD56(neg) CD16(+) cells were obtained. Expression of the NCRs, NKp30 and NKp46 was analysed in CD56(+) cells. Thirty-nine infected patients and sixteen healthy donors were included in the study. Results The percentages of total CD56(+) and CD56(dim) NK cells were significantly lower in HIV-infected patients than in healthy donors (70.4 vs. 50.3 and 80.9 vs. 66.1 respectively). The percentage of total CD56(+) NK cells expressing NCR receptors was lower in HIV patients than in healthy donors (NKp30: 25.20 vs. 58.63; NKp46: 24.8 vs. 50.59). This was also observed for CD56(dim) and CD56(bright) NK cells. Length of time with undetectable HIV viral load was identified as an independent factor associated with higher expression of NKp30 and NKp46. Conclusion Despite the prolonged and effective use of HAART, HIV-infected patients do not fully reconstitute the distribution of NK cells. Length of time with an undetectable viral load was related to greater recovery of NKp30/NKp46 receptors.	[Frias, Mario; Rivero-Juarez, Antonio; Gordon, Ana; Camacho, Angela; Cantisan, Sara; Cuenca-Lopez, Francisca; Torre-Cisneros, Julian; Rivero, Antonio] Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain; [Pena, Jose] Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Immunol Unit, Cordoba, Spain	Hospital Universitario Reina Sofia - Cordoba; Hospital Universitario Reina Sofia - Cordoba	Rivero, A (corresponding author), Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Infect Dis Unit, Cordoba, Spain.	ariveror@gmail.com	Rivero-Juarez, Antonio/E-4528-2019; Gordon, Ana/Q-5853-2018; Cantisán, Sara/AAS-3490-2021; DE LA TORRE CISNEROS, JULIAN/AAL-5723-2021; Espejo, Angela Camacho/AAM-9991-2021; Rivero, Antonio/ABE-5294-2020; Frias, Mario/AAL-6494-2021	Rivero-Juarez, Antonio/0000-0002-5813-6889; Gordon, Ana/0000-0002-4911-1436; Rivero Roman, Antonio/0000-0002-8643-4250; Rivero, Antonio/0000-0001-5005-8268	Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia [PI-0430/2012, PI-0247/2010, PI-0208/2008, PI-0124/2008, PI-0305/2009]; Consejeria de Salud, Innovacion y Ciencia de la Junta de Andalucia; Consejeria de Igualdad, Salud y Politicas Sociales [RH-0024-2013]	Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Consejeria de Salud, Innovacion y Ciencia de la Junta de Andalucia; Consejeria de Igualdad, Salud y Politicas Sociales	The study was funded by Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (grants for health research projects: refs. PI-0430/2012; PI-0247/2010; PI-0208/2008; PI-0124/2008; PI-0305/2009). AR has received a Research Extension Grant from the Consejeria de Salud, Innovacion y Ciencia de la Junta de Andalucia. ARJ is the recipient of a post-doctoral perfection grant, in the recently-qualified doctors category, from the Consejeria de Igualdad, Salud y Politicas Sociales (RH-0024-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Biassoni R, 2001, IMMUNOL REV, V181, P203, DOI 10.1034/j.1600-065X.2001.1810117.x; Bisio F, 2013, IMMUNOL LETT, V152, P16, DOI 10.1016/j.imlet.2013.03.003; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Brunetta E, 2010, J LEUKOCYTE BIOL, V88, P1119, DOI 10.1189/jlb.0410225; Chehimi J, 2007, J IMMUNOL, V179, P2642, DOI 10.4049/jimmunol.179.4.2642; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; De Maria A, 2008, CURR HIV RES, V6, P433, DOI 10.2174/157016208785861221; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; HU PF, 1995, J ACQ IMMUN DEF SYND, V10, P331; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Michaelsson J, 2008, J INFECT DIS, V197, P117, DOI 10.1086/524141; Milush JM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-158; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Scott-Algara Daniel, 2002, Current Molecular Medicine (Hilversum), V2, P757, DOI 10.2174/1566524023361781	18	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121019	10.1371/journal.pone.0121019	http://dx.doi.org/10.1371/journal.pone.0121019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811634	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700075
J	Huang, Y; Yu, Y; Gao, JM; Li, R; Zhang, CM; Zhao, HC; Zhao, Y; Qiao, J				Huang, Ying; Yu, Yang; Gao, Jiangman; Li, Rong; Zhang, Chunmei; Zhao, Hongcui; Zhao, Yue; Qiao, Jie			Impaired Oocyte Quality Induced by Dehydroepiandrosterone Is Partially Rescued by Metformin Treatment	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; IN-VITRO; INSULIN-RESISTANCE; OXIDATIVE STRESS; RESPIRATORY-CHAIN; COMPLEX-I; METABOLISM; STIMULATION; INHIBITION; CLOMIPHENE	The present study evaluated the influence of hyperandrogenism on oocyte quality using a murine PCOS model induced by dehydroepiandrosterone (DHEA) and further explored the effect of metformin treatment. Female BALB/c mice were treated with a vehicle control or DHEA (6 mg/100 g body weight) or DHEA plus metformin (50 mg/100 g body weight) for 20 consecutive days. DHEA-induced mice resembled some characters of human PCOS, such as irregular sexual cycles and polycystic ovaries. After the model validation was completed, metaphase II (MII) oocytes were retrieved and subsequent analyses of oocyte quality were performed. DHEA-treated mice yielded fewer MII oocytes, which displayed decreased mtDNA copy number, ATP content, inner mitochondrial membrane potential, excessive oxidative stress and impaired embryo development competence compared with those in control mice. Metformin treatment partially attenuated those damages, as evidenced by the increased fertilization and blastocyst rate, ATP content, GSH concentration and GSH/GSSG ratio, and decreased reactive oxygen species levels. No significant difference in normal spindle assembly was observed among the three groups. During in vitro maturation (IVM), the periods of germinal vesicle breakdown (GVBD) and the first polar body (PB1) extrusion were extended and the maturation rate of GVBD oocytes was decreased in DHEA mice compared with controls. Metformin treatment decreased the time elapsed of GVBD while had no effect on PB1 extrusion. These results indicated that excessive androgen is detrimental to oocyte quality while metformin treatment is, directly or indirectly, beneficial for oocyte quality improvement.	[Huang, Ying; Yu, Yang; Gao, Jiangman; Li, Rong; Zhang, Chunmei; Zhao, Hongcui; Zhao, Yue; Qiao, Jie] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Reprod Med Ctr, Beijing 100871, Peoples R China; [Huang, Ying; Yu, Yang; Zhang, Chunmei; Zhao, Yue; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing, Peoples R China; [Huang, Ying; Gao, Jiangman; Li, Rong; Zhao, Hongcui; Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China	Peking University	Zhao, Y (corresponding author), Peking Univ, Hosp 3, Dept Obstet & Gynecol, Reprod Med Ctr, Beijing 100871, Peoples R China.	zhaoyue0630@163.com; jie.qiao@263.net		Qiao, Jie/0000-0003-2126-1376; Yu, Yang/0000-0002-4310-1966	Ministry of Science and Technology of China [2014CB943203]; National Natural Science Foundation of China [31230047, 31371521, 81300457]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was partially supported by the Ministry of Science and Technology of China Grants (973 Program 2014CB943203) and the National Natural Science Foundation of China (31230047, 31371521 and 81300457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgorosky D, 2010, REPROD BIOMED ONLINE, V20, P797, DOI 10.1016/j.rbmo.2010.02.012; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Corbould A, 2007, J ENDOCRINOL, V192, P585, DOI 10.1677/joe.1.07070; Creanga AA, 2008, OBSTET GYNECOL, V111, P959, DOI 10.1097/AOG.0b013e31816a4ed4; Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Escrich L, 2012, FERTIL STERIL, V98, P1147, DOI 10.1016/j.fertnstert.2012.07.1116; Franks S, 2006, J CLIN ENDOCR METAB, V91, P786, DOI 10.1210/jc.2005-2501; Gonzalez F, 2012, J CLIN ENDOCR METAB, V97, P2836, DOI 10.1210/jc.2012-1259; Harris SE, 2010, HUM REPROD, V25, P2305, DOI 10.1093/humrep/deq181; Ibanez L, 2003, CLIN ENDOCRINOL, V58, P372, DOI 10.1046/j.1365-2265.2003.01728.x; Izumo K, 2009, FREE RADICAL RES, V43, P922, DOI 10.1080/10715760903137093; Jang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087623; Jimenez PT, 2013, ENDOCRINOLOGY, V154, P4835, DOI 10.1210/en.2012-2140; Kane DA, 2010, FREE RADICAL BIO MED, V49, P1082, DOI 10.1016/j.freeradbiomed.2010.06.022; Karbowska J, 2012, STEROIDS, V77, P1359, DOI 10.1016/j.steroids.2012.08.002; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Li M, 2013, HUM REPROD, V28, P1309, DOI 10.1093/humrep/det014; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; MAHESH VB, 1962, J CLIN ENDOCR METAB, V22, P441, DOI 10.1210/jcem-22-4-441; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; MCINTOSH MK, 1993, COMP BIOCHEM PHYS A, V104, P147, DOI 10.1016/0300-9629(93)90022-V; Moll E, 2006, BRIT MED J, V332, P1485, DOI 10.1136/bmj.38867.631551.55; Ou XH, 2012, HUM REPROD, V27, P2130, DOI 10.1093/humrep/des137; Palomba S, 2007, J CLIN ENDOCR METAB, V92, P3498, DOI 10.1210/jc.2007-1009; Palomba S, 2010, HUM REPROD, V25, P1005, DOI 10.1093/humrep/dep466; de Heredia FP, 2007, BRIT J NUTR, V97, P464, DOI 10.1017/S0007114507332546; Qiao J, 2011, HUM REPROD UPDATE, V17, P17, DOI 10.1093/humupd/dmq032; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Richardson MC, 2009, J CLIN ENDOCR METAB, V94, P670, DOI 10.1210/jc.2008-2025; ROY S, 1962, NATURE, V196, P42, DOI 10.1038/196042a0; Sabatini ME, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-8; Safiulina D, 2006, TOXICOL SCI, V93, P348, DOI 10.1093/toxsci/kfl064; Sander V, 2006, REPRODUCTION, V131, P591, DOI 10.1530/rep.1.00941; Sengoku K, 1997, HUM REPROD, V12, P474; Sutton-McDowall ML, 2010, REPRODUCTION, V139, P685, DOI 10.1530/REP-09-0345; Swierczynski J, 1996, J STEROID BIOCHEM, V58, P599, DOI 10.1016/0960-0760(96)00081-7; Teissier MP, 2000, HUM REPROD, V15, P2471, DOI 10.1093/humrep/15.12.2471; TESARIK J, 1995, J CLIN ENDOCR METAB, V80, P1438, DOI 10.1210/jc.80.4.1438; Ubaldi F, 2008, PLACENTA, V29, pS115, DOI 10.1016/j.placenta.2008.08.009; VELAZQUEZ EM, 1994, METABOLISM, V43, P647, DOI 10.1016/0026-0495(94)90209-7; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; Yang NC, 2002, LIFE SCI, V70, P1979, DOI 10.1016/S0024-3205(01)01542-9; Zhang XL, 2013, HUM REPROD, V28, P3074, DOI 10.1093/humrep/det341	46	39	44	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122370	10.1371/journal.pone.0122370	http://dx.doi.org/10.1371/journal.pone.0122370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811995	Green Published, Green Submitted, gold			2022-12-26	WOS:000356353700187
J	Paal, T; Bereczkei, T				Paal, Tuende; Bereczkei, Tamas			Punishment as a Means of Competition: Implications for Strong Reciprocity Theory	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; HUMAN COOPERATION; BEHAVIOR; TOURNAMENTS; IMPACT	Strong negative reciprocity, that is, sanctions imposed on norm violators at the punisher's own expense, has powerful cooperation-enhancing effects in both real-life and experimental game situations. However, it is plausible that punishment may obtain alternative roles depending on social context and the personality characteristics of participants. We examined the occurrence of punishing behavior among 80 subjects in a strongly competitive Public Goods game setting. Despite the punishment condition, the amount of the contributions decreased steadily during the game. The amount of contributions had no significant effect on received and imposed punishments. The results indicate that certain social contexts (in this case, intensive competition) exert modifying effects on the role that punishment takes on. Subjects punished each other in order to achieve a higher rank and a financially better outcome. Punishment primarily functioned as a means of rivalry, instead of as a way of second-order cooperation, as strong reciprocity suggests. These results indicate the need for the possible modification of the social conditions of punishment mechanisms described by the strong reciprocity theory as an evolutionary explanation of human cooperation.	[Paal, Tuende; Bereczkei, Tamas] Univ Pecs, Inst Psychol, Pecs, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Pecs	Paal, T (corresponding author), Univ Pecs, Inst Psychol, Pecs, Hungary.	tunde.paal@gmail.com		Paal, Tunde/0000-0003-4950-1722	Hungarian National Development Agency [SROP-4.2.1.B-10/2/KONV-2010-0002]; MTA (Hungarian Academy of Sciences) - Ryoichi Sasakawa Young Leaders Fellowship Fund	Hungarian National Development Agency; MTA (Hungarian Academy of Sciences) - Ryoichi Sasakawa Young Leaders Fellowship Fund	The study was supported by the Hungarian National Development Agency: SROP-4.2.1.B-10/2/KONV-2010-0002, Developing the South-Transdanubian Regional University Competitiveness, URL: 4kki.pte.hu. TP was supported by the MTA (Hungarian Academy of Sciences) - Ryoichi Sasakawa Young Leaders Fellowship Fund, URL: www.tokyofoundation.org/sylff/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; BOWLES S, 2011, COOP SPEC HUM REC, P1; BULL C, 1987, J POLIT ECON, V95, P1, DOI 10.1086/261439; Burks SV, 2013, IZA DISCUSSION PAPER; Camerer C., 2004, FDN HUMAN SOCIALITY, P55, DOI DOI 10.1093/0199262055.003.0003; Carpenter Jeffrey P., 2006, BE J ECON ANAL POLI, V5, P1; CHAGNON NA, 1988, SCIENCE, V239, P985, DOI 10.1126/science.239.4843.985; Chen KP, 2003, J LAW ECON ORGAN, V19, P119, DOI 10.1093/jleo/19.1.119; Deng XY, 2014, J THEOR BIOL, V361, P81, DOI 10.1016/j.jtbi.2014.07.009; Eibl-Eibesfeldt I., 1989, HUMAN ETHOLOGY; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2003, DAHL WS ENV, P55; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2004, CURR OPIN NEUROBIOL, V14, P784, DOI 10.1016/j.conb.2004.10.007; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fehr E., 2005, ANAL KRITIK, V27, P6, DOI [DOI 10.1515/AUK-2005-0101, 10.1515/auk-2005-0101]; Fehr E, 2008, AM ECON REV, V98, P494, DOI 10.1257/aer.98.2.494; Fehr E, 2007, ANNU REV SOCIOL, V33, P43, DOI 10.1146/annurev.soc.33.040406.131812; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gintis H, 2008, FDN EVOLUTIONARY PSY, P313; Gintis H, 2008, SOC JUSTICE RES, V21, P241, DOI 10.1007/s11211-008-0067-y; Gintis H, 2008, SCIENCE, V319, P1345, DOI 10.1126/science.1155333; Gintis H, 2009, BOUNDS OF REASON: GAME THEORY AND THE UNIFICATION OF THE BEHAVIORAL SCIENCES, P45; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; LAZEAR EP, 1981, J POLIT ECON, V89, P841, DOI 10.1086/261010; Magyar Pszichologiai Tarsasag (Hungarian Psychological Society), PSZICH SZAKM ET KOD; McElreath R, 2003, DAHL WS ENV, P125; Mulder LB, 2008, J EXP SOC PSYCHOL, V44, P1436, DOI 10.1016/j.jesp.2008.06.004; Nicklisch A, 2009, WORKING PAPER SERIES, V40, P1; Nikiforakis N, 2010, GAME ECON BEHAV, V68, P689, DOI 10.1016/j.geb.2009.09.004; Paal T, EGYUTTM KODES UNPUB; ROSEN S, 1986, AM ECON REV, V76, P701; Van Lange P.A., 2007, SELF INTEREST BASIC; Van Lange PAM, 2008, SOC ISS POLICY REV, V2, P127, DOI 10.1111/j.1751-2409.2008.00013.x; Van Vugt M., 2006, EVOLUTION SOCIAL PSY, P237; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Yuan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091012; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	51	3	3	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120394	10.1371/journal.pone.0120394	http://dx.doi.org/10.1371/journal.pone.0120394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6QW	25811464	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700047
J	Andren, H; Liberg, O				Andren, Henrik; Liberg, Olof			Large Impact of Eurasian Lynx Predation on Roe Deer Population Dynamics	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; HOME-RANGE SIZE; ENVIRONMENTAL PRODUCTIVITY; CAPREOLUS-CAPREOLUS; RED DEER; PREY; CLIMATE; MORTALITY; DENSITY; FLUCTUATIONS	The effects of predation on ungulate populations depend on several factors. One of the most important factors is the proportion of predation that is additive or compensatory respectively to other mortality in the prey, i.e., the relative effect of top-down and bottom-up processes. We estimated Eurasian lynx (Lynx lynx) kill rate on roe deer (Capreolus capreolus) using radio-collared lynx. Kill rate was strongly affected by lynx social status. For males it was 4.85 +/- 1.30 S.E. roe deer per 30 days, for females with kittens 6.23 +/- 0.83 S.E. and for solitary females 2.71 +/- 0.47 S.E. We found very weak support for effects of prey density (both for Type I (linear) and Type II (non-linear) functional responses) and of season (winter, summer) on lynx kill rate. Additionally, we analysed the growth rate in a roe deer population from 1985 to 2005 in an area, which lynx naturally re-colonized in 1996. The annual roe deer growth rate was lower after lynx re-colonized the study area, but it was also negatively influenced by roe deer density. Before lynx colonized the area roe deer growth rate was lambda = 1.079 (+/- 0.061 S.E.), while after lynx re-colonization it was lambda = 0.94 (+/- 0.051 S.E.). Thus, the growth rate in the roe deer population decreased by Delta lambda = 0.14 (+/- 0.080 S.E.) after lynx re-colonized the study area, which corresponded to the estimated lynx predation rate on roe deer (0.11 +/- 0.042 S.E.), suggesting that lynx predation was mainly additive to other mortality in roe deer. To conclude, this study suggests that lynx predation together with density dependent factors both influence the roe deer population dynamics. Thus, both top-down and bottom-up processes operated at the same time in this predator-prey system.	[Andren, Henrik; Liberg, Olof] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Swedish University of Agricultural Sciences	Andren, H (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden.	henrik.andren@slu.se	Andrén, Henrik/C-8995-2015	Andren, Henrik/0000-0002-5616-2426	Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; World Wide Fund for Nature (Sweden); Swedish University of Agricultural Sciences; Swedish National Forest Enterprise; Olle och Signhild Engkvists Stiftelser; Carl Tryggers stiftelse; Marie-Claire Cronstedts Stiftelse; Swedish Research Council	Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; World Wide Fund for Nature (Sweden); Swedish University of Agricultural Sciences; Swedish National Forest Enterprise; Olle och Signhild Engkvists Stiftelser; Carl Tryggers stiftelse; Marie-Claire Cronstedts Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by the Swedish Environmental Protection Agency, the Swedish Association for Hunting and Wildlife Management, the World Wide Fund for Nature (Sweden), the Swedish University of Agricultural Sciences, the Swedish National Forest Enterprise, the private foundations Olle och Signhild Engkvists Stiftelser, Carl Tryggers stiftelse and Marie-Claire Cronstedts Stiftelse. The long-term roe deer, vole and red fox surveys within Grimso wildlife research area are part of SITES (Swedish infrastructure for ecosystem science) funded by Swedish Research Council. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes R, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P139; Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Andersen R, 2007, WILDLIFE BIOL, V13, P467, DOI 10.2981/0909-6396(2007)13[467:SOELLL]2.0.CO;2; ANDERSSON M, 1977, OIKOS, V29, P591, DOI 10.2307/3543597; ANGELSTAM P, 1984, OECOLOGIA, V62, P199, DOI 10.1007/BF00379014; [Anonymous], LODJURET VILTET EKOL; [Anonymous], 2007, HDB WILDLIFE CHEM IM; Arnemo JM, BIOMEDICAL PROTOCOLS; BARTMANN RM, 1992, WILDLIFE MONOGR, P1; Bishop CJ, WILDLIFE MONOGRAPHS, V172, P1; Boyce MS, 1999, OIKOS, V87, P419, DOI 10.2307/3546808; Breitenmoser-Wursten C, 2007, WILDLIFE BIOL, V13, P365, DOI 10.2981/0909-6396(2007)13[365:SASSOA]2.0.CO;2; Cederlund G., 1995, RADJURET VILTET EKOL; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; ERRINGTON PL, 1946, Q REV BIOL, V21, P144, DOI 10.1086/395220; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Gervasi V, 2014, J ZOOL, V292, P175, DOI 10.1111/jzo.12088; Gervasi V, 2012, J ANIM ECOL, V78, P939; GOLLEY FRANK B., 1965, J WILDLIFE MANAGE, V29, P442, DOI 10.2307/3798041; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; Grotan V, 2005, ECOLOGY, V86, P1472, DOI 10.1890/04-1502; Hagen Y., 1952, ROVFUGLENE VILTPLEIE; Haglund B, 1966, SWEDISH WILDLIFE RES, V4, P81; Hebblewhite M, 2011, J WILDLIFE MANAGE, V75, P1724, DOI 10.1002/jwmg.206; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Heurich M, 2012, EUR J WILDLIFE RES, V58, P567, DOI 10.1007/s10344-011-0606-y; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Husseman JS, 2003, OIKOS, V101, P591, DOI 10.1034/j.1600-0706.2003.12230.x; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; JEDRZEJEWSKI W, 1993, ACTA THERIOL, V38, P385; Kjellander P, 2006, OECOLOGIA, V146, P521, DOI 10.1007/s00442-005-0188-z; Kjellander P, 2003, OIKOS, V101, P338, DOI 10.1034/j.1600-0706.2003.11986.x; Lack D., 1954, P343; Liberg O, 2006, LYNX POPULATION SWED; Liberg O, 2000, LYNX WOLF SURVEY SWE; LINDSTROM ER, 1994, ECOLOGY, V75, P1042, DOI 10.2307/1939428; Linnell JDC, 2001, ENVIRON MANAGE, V27, P869; Mattisson J, 2011, CAN J ZOOL, V89, P79, DOI 10.1139/Z10-097; Melis C, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00099.1; Melis C, 2010, ECOSCIENCE, V17, P166, DOI 10.2980/17-2-3314; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Molinari-Jobin A, 2002, WILDLIFE BIOL, V8, P109, DOI 10.2981/wlb.2002.015; Munoz-Garcia A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1039, DOI 10.1086/432852; NEFF DJ, 1968, J WILDLIFE MANAGE, V32, P597, DOI 10.2307/3798941; Nilsen EB, J ANIMAL ECOLOGY, V78, P585; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; Odden J, 2008, J WILDLIFE MANAGE, V72, P276, DOI 10.2193/2005-537; Odden J, 2006, EUR J WILDLIFE RES, V52, P237, DOI 10.1007/s10344-006-0052-4; OGARA BW, 1988, J WILDLIFE MANAGE, V52, P316, DOI 10.2307/3801242; OKARMA H, 1984, ACTA THERIOL, V29, P283, DOI 10.4098/AT.arch.84-28; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Samelius G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075469; SKOGLAND T, 1991, OIKOS, V61, P401, DOI 10.2307/3545248; Sokal RR, 1995, BIOMETRY; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Tveraa T, 2003, OECOLOGIA, V137, P370, DOI 10.1007/s00442-003-1373-6; Vucetich JA, 2005, OIKOS, V111, P259, DOI 10.1111/j.0030-1299.2005.14180.x	58	39	40	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120570	10.1371/journal.pone.0120570	http://dx.doi.org/10.1371/journal.pone.0120570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806949	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000351880000085
J	Brzoska, T; Tanaka-Murakami, A; Suzuki, Y; Sano, H; Kanayama, N; Urano, T				Brzoska, Tomasz; Tanaka-Murakami, Aki; Suzuki, Yuko; Sano, Hideto; Kanayama, Naohiro; Urano, Tetsumei			Endogenously Generated Plasmin at the Vascular Wall Injury Site Amplifies Lysine Binding Site-Dependent Plasminogen Accumulation in Microthrombi	PLOS ONE			English	Article							ACTIVATOR; FIBRINOLYSIS; UROKINASE; THROMBOPROPHYLAXIS; THROMBOLYSIS; PLATELETS	The fibrinolytic system plays a pivotal role in the regulation of hemostasis; however, it remains unclear how and when the system is triggered to induce thrombolysis. Using intravital confocal fluorescence microscopy, we investigated the process of plasminogen binding to laser-induced platelet-rich microthrombi generated in the mesenteric vein of transgenic mice expressing green fluorescent protein (GFP). The accumulation of GFP-expressing platelets as well as exogenously infused Alexa Fluor 568-labeled Glu-plasminogen (Glu-plg) on the injured vessel wall was assessed by measuring the increase in the corresponding fluorescence intensities. Glu-plg accumulated in a time-dependent manner in the center of the microthrombus, where phosphatidylserine is exposed on platelet surfaces and fibrin formation takes place. The rates of binding of Glu-plg in the presence of e-aminocaproic acid and carboxypeptidase B, as well as the rates of binding of mini-plasminogen lacking kringle domains 1-4 and lysine binding sites, were significantly lower than that of Glu-plg alone, suggesting that the binding was dependent on lysine binding sites. Furthermore, aprotinin significantly suppressed the accumulation of Glu-plg, suggesting that endogenously generated plasmin activity is a prerequisite for the accumulation. In spite of the endogenous generation of plasmin and accumulation of Glu-plg in the center of microthrombi, the microthrombi did not change in size during the 2-hour observation period. When human tissue plasminogen activator was administered intravenously, Glu-plg further accumulated and the microthrombi were lysed. Glu-plg appeared to accumulate in the center of microthrombi in the early phase of microthrombus formation, and plasmin activity and lysine binding sites were required for this accumulation.	[Brzoska, Tomasz; Tanaka-Murakami, Aki; Suzuki, Yuko; Sano, Hideto; Urano, Tetsumei] Hamamatsu Univ, Sch Med, Dept Med Physiol, Hamamatsu, Shizuoka, Japan; [Tanaka-Murakami, Aki; Kanayama, Naohiro] Hamamatsu Univ, Sch Med, Dept Gynecol, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Urano, T (corresponding author), Hamamatsu Univ, Sch Med, Dept Med Physiol, Hamamatsu, Shizuoka, Japan.	uranot@hama-med.ac.jp	Sano, Hideto/GZM-5074-2022	Sano, Hideto/0000-0002-4185-3224; Urano, Tetsumei/0000-0002-7398-9732	Japan Society for the Promotion of Science [80707000, 24590273, 25461123, 24591420]; Smoking Research Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [25461123, 24590273] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (young scientists B:80707000 [T.B.], C:24590273 [T.U.], C:25461123 [Y.S.] and C:24591420 [H.S.]) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/), and by grants from the Smoking Research Foundation [T.U.] (http://www.srf.or.jp/english/) and the Naito Foundation [Y.S.] (https://www.naito-f.or.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN B, 1988, BLOOD, V72, P1530; Brzoska T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055466; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; CHRISTODOULIDES M, 1990, BIOLOGICALS, V18, P103, DOI 10.1016/1045-1056(90)90019-V; Collen D, 2004, J THROMB HAEMOST, V2, P541, DOI 10.1111/j.1538-7933.2004.00645.x; Ding BS, 2008, BLOOD, V111, P1999, DOI 10.1182/blood-2007-07-103002; Donnan GA, 2011, NAT REV NEUROL, V7, P400, DOI 10.1038/nrneurol.2011.89; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Hagemeyer CE, 2004, J THROMB HAEMOST, V2, P797, DOI 10.1111/j.1538-7836.2004.00697.x; Hayashi T, 2008, PFLUG ARCH EUR J PHY, V456, P1239, DOI 10.1007/s00424-008-0466-9; Lacroix R, 2012, HAEMATOL-HEMATOL J, V97, P1864, DOI 10.3324/haematol.2012.066167; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; MILES LA, 1986, J CLIN INVEST, V77, P2001, DOI 10.1172/JCI112529; Morrissey JH, 2011, J THROMB HAEMOST, V9, P162, DOI 10.1111/j.1538-7836.2011.04300.x; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; POWELL JR, 1980, J BIOL CHEM, V255, P5329; Rybaltowski M, 2011, PFLUG ARCH EUR J PHY, V461, P623, DOI 10.1007/s00424-011-0958-x; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Suzuki Y, 2011, BLOOD, V118, P3182, DOI 10.1182/blood-2011-05-353912; Wang XW, 2014, CIRC RES, V114, P1083, DOI 10.1161/CIRCRESAHA.114.302514; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Zaitsev S, 2010, BLOOD, V115, P5241, DOI 10.1182/blood-2010-01-261610	23	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0122196	10.1371/journal.pone.0122196	http://dx.doi.org/10.1371/journal.pone.0122196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806939	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000213
J	Figueredo, GP; Siebers, PO; Aickelin, U; Whitbrook, A; Garibaldi, JM				Figueredo, Grazziela P.; Siebers, Peer-Olaf; Aickelin, Uwe; Whitbrook, Amanda; Garibaldi, Jonathan M.			Juxtaposition of System Dynamics and Agent-Based Simulation for a Case Study in Immunosenescence	PLOS ONE			English	Article							T-CELLS; BLOOD	Advances in healthcare and in the quality of life significantly increase human life expectancy. With the aging of populations, new un-faced challenges are brought to science. The human body is naturally selected to be well-functioning until the age of reproduction to keep the species alive. However, as the lifespan extends, unseen problems due to the body deterioration emerge. There are several age-related diseases with no appropriate treatment; therefore, the complex aging phenomena needs further understanding. It is known that immunosenescence is highly correlated to the negative effects of aging. In this work we advocate the use of simulation as a tool to assist the understanding of immune aging phenomena. In particular, we are comparing system dynamics modelling and simulation (SDMS) and agent-based modelling and simulation (ABMS) for the case of age-related depletion of naive T cells in the organism. We address the following research questions: Which simulation approach is more suitable for this problem? Can these approaches be employed interchangeably? Is there any benefit of using one approach compared to the other? Results show that both simulation outcomes closely fit the observed data and existing mathematical model; and the likely contribution of each of the naive T cell repertoire maintenance method can therefore be estimated. The differences observed in the outcomes of both approaches are due to the probabilistic character of ABMS contrasted to SDMS. However, they do not interfere in the overall expected dynamics of the populations. In this case, therefore, they can be employed interchangeably, with SDMS being simpler to implement and taking less computational resources.	[Figueredo, Grazziela P.; Siebers, Peer-Olaf; Aickelin, Uwe; Garibaldi, Jonathan M.] Univ Nottingham, Sch Comp Sci, Nottingham NG7 2RD, England; [Figueredo, Grazziela P.; Garibaldi, Jonathan M.] Univ Nottingham, Adv Data Anal Ctr, Nottingham NG7 2RD, England; [Whitbrook, Amanda] Univ Loughborough, Dept Comp Sci, Loughborough, Leics, England	University of Nottingham; University of Nottingham; Loughborough University	Figueredo, GP (corresponding author), Univ Nottingham, Sch Comp Sci, Jubilee Campus, Nottingham NG7 2RD, England.	grazziela.figueredo@nottingham.ac.uk	Siebers, Peer-Olaf/AAY-5033-2020; Aickelin, Uwe/AAO-2464-2020	Aickelin, Uwe/0000-0002-2679-2275; Garibaldi, Jonathan/0000-0002-9690-7074; Figueredo, Grazziela/0000-0003-4094-7680; Siebers, Peer-Olaf/0000-0002-0603-5904				Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Borshchev A, 2004, P 22 INT C SYST DYN; Bulatti M, 2008, IMMUNITY AGEING, P5; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Cossarizza A, 1996, MECH AGEING DEV, V86, P173, DOI 10.1016/0047-6374(95)01691-0; Figueredo G. P., 2010, P SUMM COMP SIM C; Figueredo GP, 2012, THESIS U NOTTINGHAM; Figueredo GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095150; FORRESTER JW, 1958, HARVARD BUS REV, V36, P37; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Kirkwood C.W., 1998, SYSTEM DYNAMICS METH; Lorenz T, 2009, LECT NOTES ARTIF INT, V5466, P141, DOI 10.1007/978-3-642-01109-2_11; Lorenzi AR, 2008, J IMMUNOL METHODS, V339, P185, DOI 10.1016/j.jim.2008.09.013; Macal CM, 2010, J SIMUL, V4, P151, DOI 10.1057/jos.2010.3; Macal CM, 2010, P WINT SIM C; Murray JM, 2003, IMMUNOL CELL BIOL, V81, P487, DOI 10.1046/j.1440-1711.2003.01191.x; Pidd, 2003, TOOLS THINKING MODEL; Pourdehnad J, 2002, P 20 INT C SYST DYN; Ramandad H, 2008, MANAGE SCI, P5; Richardson G.P., 1981, INTRO SYSTEM DYNAMIC; Robinson S., 2014, SIMULATION PRACTICE, V2nd ed.; Schieritz N, 2004, P SYST DYN C; Schieritz N, 2003, P 21 INT C SYST DYN; Schieritz N, 2002, P 20 INT C SYST DYN; Scholl HJ, 2001, P 34 ANN HAW INT C S; Siebers PO, 2007, ENCY DECISION MAKING, P554; Stemate L, 2007, P WINT SIM C; Wooldridge M, 2012, INTRO MULTIAGENT SYS	28	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0118359	10.1371/journal.pone.0118359	http://dx.doi.org/10.1371/journal.pone.0118359			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807273	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000351880000007
J	Schroeter, C; Ehrenthal, JC; Giulini, M; Neubauer, E; Gantz, S; Amelung, D; Balke, D; Schiltenwolf, M				Schroeter, Corinna; Ehrenthal, Johannes C.; Giulini, Martina; Neubauer, Eva; Gantz, Simone; Amelung, Dorothee; Balke, Doreen; Schiltenwolf, Marcus			Attachment, Symptom Severity, and Depression in Medically Unexplained Musculoskeletal Pain and Osteoarthritis: A Cross-Sectional Study	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; ADULT ATTACHMENT; ROMANTIC ATTACHMENT; ILLNESS BEHAVIOR; SELF; MODELS; STYLE; RELIABILITY; DIMENSIONS; PATTERNS	Background Attachment insecurity relates to the onset and course of chronic pain via dysfunctional reactions to pain. However, few studies have investigated the proportion of insecure attachment styles in different pain conditions, and results regarding associations between attachment, pain severity, and disability in chronic pain are inconsistent. This study aims to clarify the relationships between insecure attachment and occurrence or severity of chronic pain with and without clearly defined organic cause. To detect potential differences in the importance of global and romantic attachment representations, we included both concepts in our study. Methods 85 patients with medically unexplained musculoskeletal pain (UMP) and 89 patients with joint pain from osteoarthritis (OA) completed self-report measures of global and romantic attachment, pain intensity, physical functioning, and depression. Results Patients reporting global insecure attachment representations were more likely to suffer from medically unexplained musculoskeletal pain (OR 3.4), compared to securely attached patients. Romantic attachment did not differ between pain conditions. Pain intensity was associated with romantic attachment anxiety, and this relationship was more pronounced in the OA group compared to the UMP group. Both global and romantic attachment anxiety predicted depression, accounting for 15% and 17% of the variance, respectively. Disability was independent from attachment patterns. Conclusions Our results indicate that global insecure attachment is associated with the experience of medically unexplained musculoskeletal pain, but not with osteoarthritis. In contrast, insecure attachment patterns seem to be linked to pain intensity and pain-related depression in unexplained musculoskeletal pain and in osteoarthritis. These findings suggest that relationship-informed focused treatment strategies may alleviate pain severity and psychological distress in chronic pain independent of underlying pathology.	[Schroeter, Corinna; Giulini, Martina; Neubauer, Eva; Gantz, Simone; Amelung, Dorothee; Schiltenwolf, Marcus] Univ Heidelberg Hosp, Dept Orthoped Trauma Surg & Paraplegiol, D-69118 Heidelberg, Germany; [Ehrenthal, Johannes C.] Univ Heidelberg Hosp, Dept Gen Internal Med & Psychosomat, D-69115 Heidelberg, Germany; [Balke, Doreen] SRH Gesundheitszentrum Bad Wimpfen, D-74206 Bad Wimpfen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schroeter, C (corresponding author), Univ Heidelberg Hosp, Dept Orthoped Trauma Surg & Paraplegiol, Schlierbacher Landstr 200a, D-69118 Heidelberg, Germany.	corinna_schroeter@t-online.de	Ehrenthal, Johannes C./HHC-3877-2022	Ehrenthal, Johannes C./0000-0002-9428-3763	private foundation "Psychosomatik der Wirbelsaulenerkrankungen" ("Psychosomatics of spine disorders"); Ruprecht-Karls-Universitat Heidelberg; Deutsche Forschungsgemeinschaft (German Research Foundation)	private foundation "Psychosomatik der Wirbelsaulenerkrankungen" ("Psychosomatics of spine disorders"); Ruprecht-Karls-Universitat Heidelberg; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was supported by the private foundation "Psychosomatik der Wirbelsaulenerkrankungen" ("Psychosomatics of spine disorders"), which is held in trust by the following attorneys: Dr. Klaus Kessler, Dr. Morita Weber, Konigsstrasse 84, 70173, Stuttgart, Germany, E-mail. kessler@schelling.de; weber@schelling. This foundation does not run a URL. The funding was committed for this specific purpose to the University Hospital Heidelberg. The authors also would like to acknowledge financial support by the Deutsche Forschungsgemeinschaft (German Research Foundation) and Ruprecht-Karls-Universitat Heidelberg within the funding program "Open Access Publishing." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bjelland I, 2001, J PSYCHOSOM RES, V42, P17; Ciechanowski P, 2003, PAIN, V104, P627, DOI 10.1016/S0304-3959(03)00120-9; Ciechanowski PS, 2002, PSYCHOSOM MED, V64, P660, DOI 10.1097/01.PSY.0000021948.90613.76; Ciechanowski PS, 2002, PSYCHOSOMATICS, V43, P206, DOI 10.1176/appi.psy.43.3.206; Davies KA, 2009, PAIN, V143, P200, DOI 10.1016/j.pain.2009.02.013; Davila J, 1999, J PERS SOC PSYCHOL, V76, P783, DOI 10.1037/0022-3514.76.5.783; Dozier M., 2008, HDB ATTACHMENT THEOR, P718; Ehrenthal Johannes C, 2009, Psychother Psychosom Med Psychol, V59, P215, DOI 10.1055/s-2008-1067425; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Flor H, 2004, PROG PAIN RES MANAG, V27, P47; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Graetz C, 2013, J CLIN PERIODONTOL, V40, P1087, DOI 10.1111/jcpe.12159; GRIFFIN D, 1994, J PERS SOC PSYCHOL, V67, P430, DOI 10.1037/0022-3514.67.3.430; Herrmann C., 1995, HADS D HOSP ANXIETY; Holtzman S, 2007, PAIN, V131, P202, DOI 10.1016/j.pain.2007.04.005; Hunt IM, 1999, RHEUMATOLOGY, V38, P275, DOI 10.1093/rheumatology/38.3.275; Hunter JJ, 2001, GEN HOSP PSYCHIAT, V23, P177, DOI 10.1016/S0163-8343(01)00141-4; Jacobvitz D, 2002, ATTACH HUM DEV, V4, P703; Lahmann C, 2010, PSYCHIAT DANUB, V22, P453; Leak GK, 2001, SOC BEHAV PERSONAL, V29, P21, DOI 10.2224/sbp.2001.29.1.21; MacDonald G, 2006, J SOC PERS RELAT, V23, P291, DOI 10.1177/0265407506062481; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; McWilliams LA, 2000, CLIN J PAIN, V16, P360, DOI 10.1097/00002508-200012000-00014; McWilliams LA, 2007, PAIN, V127, P27, DOI 10.1016/j.pain.2006.07.020; McWilliams LA, 2010, HEALTH PSYCHOL, V29, P446, DOI 10.1037/a0020061; Meredith P, 2006, PAIN, V123, P146, DOI 10.1016/j.pain.2006.02.025; Meredith P, 2008, CLIN PSYCHOL REV, V28, P407, DOI 10.1016/j.cpr.2007.07.009; Meredith PJ, 2007, EUR J PAIN, V11, P164, DOI 10.1016/j.ejpain.2006.01.004; Meredith PJ, 2006, PAIN, V120, P44, DOI 10.1016/j.pain.2005.10.008; Mestel R, 2009, DRV SCHRIFTEN, P418; Mickelson KD, 1997, J PERS SOC PSYCHOL, V73, P1092, DOI 10.1037/0022-3514.73.5.1092; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Mikulincer M, 1988, ATTACHMENT THEORY CL, P143; Mikulincer M., 2007, ATTACHMENT ADULTHOOD, p[81, 324]; Mikulincer M, 2007, ATTACHMENT ADULTHOOD, P369; Overall NC, 2003, PERS SOC PSYCHOL B, V29, P1479, DOI 10.1177/0146167203251519; Martinez MP, 2012, SCAND J PSYCHOL, V53, P54, DOI 10.1111/j.1467-9450.2011.00925.x; Porter LS, 2007, PAIN, V128, P195, DOI 10.1016/j.pain.2007.02.001; Quirin M, 2008, PSYCHONEUROENDOCRINO, V33, P581, DOI 10.1016/j.psyneuen.2008.01.013; Rumble M, 2006, J PAIN, V7, P33; SCHARFE E, 1994, PERS RELATIONSHIP, V1, P23, DOI DOI 10.1111/J.1475-6811.1994.TB00053.X; Schmitt DP, 2004, J CROSS CULT PSYCHOL, V35, P367, DOI 10.1177/0022022104266105; Shaver, 2007, ATTACHMENT ADULTHOOD, P116; Shear MK, 2000, AM J PSYCHIAT, V157, P581, DOI 10.1176/appi.ajp.157.4.581; Sibley CG, 2005, PERS SOC PSYCHOL B, V31, P1524, DOI 10.1177/0146167205276865; Slawsby EA, 1995, THESIS U MASSACHUSET; Stanton SCE, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095359, DOI 10.1371/JOURNAL.PONE.0095359]; Turk DC, 2005, CLIN J PAIN, V21, P44, DOI 10.1097/00002508-200501000-00006; Waller E, 2004, J NERV MENT DIS, V192, P200, DOI 10.1097/01.nmd.0000116463.17588.07; Weiser G., 2009, THESIS U HEIDELBERG; Wilson CL, 2011, PERS RELATIONSHIP, V18, P242, DOI 10.1111/j.1475-6811.2011.01359.x; WMA, 2008, DECLARATION HELSINKI	56	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119052	10.1371/journal.pone.0119052	http://dx.doi.org/10.1371/journal.pone.0119052			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25807172	Green Submitted, gold, Green Published			2022-12-26	WOS:000351880000014
J	Shakeel, SN; Gao, ZY; Amir, M; Chen, YF; Rai, MI; Ul Haq, N; Schaller, GE				Shakeel, Samina N.; Gao, Zhiyong; Amir, Madiha; Chen, Yi-Feng; Rai, Muneeza Iqbal; Ul Haq, Noor; Schaller, G. Eric			Ethylene Regulates Levels of Ethylene Receptor/CTR1 Signaling Complexes in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; histidine kinase; hormone receptor; membrane protein; protein complex; protein turnover; serine; threonine protein kinase; ethylene	HISTIDINE KINASE-ACTIVITY; SEEDLING-GROWTH-RESPONSE; RAF-LIKE KINASE; ENDOPLASMIC-RETICULUM; FAMILY-MEMBERS; ETR1; CTR1; GENE; PATHWAY; INSENSITIVITY	Background: Plant responses to the hormone ethylene depend on ethylene receptors and the kinase CTR1. Results: The receptors and CTR1 exist as signaling complexes whose levels change in response to ethylene. Conclusion: A model incorporating transcriptional induction and ethylene-dependent turnover of receptor/CTR1 complexes is proposed. Significance: Results presented here reconcile molecular responses at the receptor level with physiological changes in sensitivity to ethylene. The plant hormone ethylene is perceived by a five-member family of receptors in Arabidopsis thaliana. The receptors function in conjunction with the Raf-like kinase CTR1 to negatively regulate ethylene signal transduction. CTR1 interacts with multiple members of the receptor family based on co-purification analysis, interacting more strongly with receptors containing a receiver domain. Levels of membrane-associated CTR1 vary in response to ethylene, doing so in a post-transcriptional manner that correlates with ethylene-mediated changes in levels of the ethylene receptors ERS1, ERS2, EIN4, and ETR2. Interactions between CTR1 and the receptor ETR1 protect ETR1 from ethylene-induced turnover. Kinetic and dose-response analyses support a model in which two opposing factors control levels of the ethylene receptor/CTR1 complexes. Ethylene stimulates the production of new complexes largely through transcriptional induction of the receptors. However, ethylene also induces turnover of receptors, such that levels of ethylene receptor/CTR1 complexes decrease at higher ethylene concentrations. Implications of this model for ethylene signaling are discussed.	[Shakeel, Samina N.; Gao, Zhiyong; Amir, Madiha; Chen, Yi-Feng; Rai, Muneeza Iqbal; Ul Haq, Noor; Schaller, G. Eric] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Shakeel, Samina N.; Amir, Madiha; Rai, Muneeza Iqbal; Ul Haq, Noor] Quaid I Azam Univ, Dept Biochem, Islamabad 45320, Pakistan; [Chen, Yi-Feng] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing 210014, Peoples R China	Dartmouth College; Quaid I Azam University; Jiangsu Academy of Agricultural Sciences	Schaller, GE (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	george.e.schaller@dartmouth.edu	Chen, Yi/HIR-2608-2022	RAI, MUNEEZA IQBAL/0000-0001-5016-9451	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Dept. of Energy [DE-FG02-05ER15704]; International Research Support Initiative Program of Higher Education Commission of Pakistan	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Dept. of Energy; International Research Support Initiative Program of Higher Education Commission of Pakistan	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Dept. of Energy (Grant no. DE-FG02-05ER15704, to G. E. S.) and by the International Research Support Initiative Program of Higher Education Commission of Pakistan (to M. A., M. I. R., and N. U. H.).	Abeles F, 1992, ETHYLENE PLANT BIOL; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Binder BM, 2012, ANNU PLANT REV, V44, P117, DOI 10.1002/9781118223086.ch5; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Christians MJ, 2008, PLANT J, V55, P467, DOI 10.1111/j.1365-313X.2008.03521.x; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Gao ZY, 2009, PLANT SIGNAL BEHAV, V4, P1152, DOI 10.4161/psb.4.12.9943; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall BP, 2012, PLANT PHYSIOL, V159, P682, DOI 10.1104/pp.112.196790; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen PB, 2003, PLANT J, V34, P709, DOI 10.1046/j.1365-313X.2003.01762.x; Liu Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-60; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; O'Malley RC, 2005, PLANT J, V41, P651, DOI 10.1111/j.1365-313X.2004.02331.X; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; Schaller GE, 1995, METHOD CELL BIOL, V50, P129, DOI 10.1016/S0091-679X(08)61027-4; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635	47	44	50	7	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12415	12424		10.1074/jbc.M115.652503	http://dx.doi.org/10.1074/jbc.M115.652503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25814663	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000354388600049
J	Akintayo, A; Legare, C; Sullivan, R				Akintayo, Ayodele; Legare, Christine; Sullivan, Robert			Dicarbonyl L-Xylulose Reductase (DCXR), a "Moonlighting Protein" in the Bovine Epididymis	PLOS ONE			English	Article							GENE-EXPRESSION; SPERM PROTEIN; INTRALUMINAL COMPARTMENT; URETERAL OBSTRUCTION; CAUDA EPIDIDYMIDIS; ZONA-PELLUCIDA; SURFACE; P34H; IDENTIFICATION; LOCALIZATION	During maturation and the acquisition of their fertilization potential, male germ cells are subjected to various sequential modifications that occur in the epididymis. Protein addition, reorganization or withdrawal, comprise some of these modifications. Dicarbonyl L-xylulose reductase (DCXR), a multifunctional protein involved in various enzymatic and protein interaction processes in different physiological systems, is one of the proteins added to spermatozoa in the epididymis. DCXR is a well-conserved protein with multiple characteristics including enzymatic activities and mediation of cell-cell interaction. In this study, we characterized the DCXR gene and protein expression in the bovine epididymis. Dicarbonyl L-xylulose reductase mRNA is differentially expressed in the caput, corpus, and cauda epididymide epithelial cells with a higher level observed in the cauda region. Tissue protein expression follows the same pattern as the corresponding mRNA expression with a cytoplasmic and apical distribution in the corpus and cauda epithelial cells, respectively. The protein can also be found with a nuclear localization in cauda epididymidis epithelial cells. Dicarbonyl L-xylulose reductase is secreted in the epididymis luminal compartment in the soluble fraction and is associated with microvesicular elements named epididymosomes. In spermatozoa, the DCXR protein was found in the cytoplasmic and membranous fractions. Expression of the DCXR protein is higher on caput spermatozoa but finally shows a weak detection in semen. These data describe DCXR in the bovine epididymis and reveal that its behavior differs from that found in humans. It seems that, in this model, the DCXR protein might have a questionable involvement in the fertilization process.	[Akintayo, Ayodele; Legare, Christine; Sullivan, Robert] Univ Laval, Fac Med, Ctr Rech, Dept Obstet Gynecol & Reprod,CHU Quebec, Quebec City, PQ G1K 7P4, Canada	Laval University	Sullivan, R (corresponding author), Univ Laval, Fac Med, Ctr Rech, Dept Obstet Gynecol & Reprod,CHU Quebec, Quebec City, PQ G1K 7P4, Canada.	robert.sullivan@crchul.ulaval.ca		Akintayo, Ayodele/0000-0003-3366-4447	Natural Sciences and engineering research council of Canada [184793-2010]	Natural Sciences and engineering research council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and engineering research council of Canada grant 184793-2010 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andonian S, 1999, J ANDROL, V20, P158; Asami J, 2006, BIOSCI BIOTECH BIOCH, V70, P2899, DOI 10.1271/bbb.60311; Belleannee C, 2012, CELL TISSUE RES, V349, P717, DOI 10.1007/s00441-012-1381-0; Belleannee C, 2011, J PROTEOMICS, V74, P59, DOI 10.1016/j.jprot.2010.07.013; Boue F, 1996, BIOL REPROD, V54, P1018, DOI 10.1095/biolreprod54.5.1018; BOUE F, 1994, BIOL REPROD, V51, P577, DOI 10.1095/biolreprod51.4.577; Caballero J, 2012, J CELL PHYSIOL, V227, P3876, DOI 10.1002/jcp.24099; Cho-Vega JH, 2007, CANCER EPIDEM BIOMAR, V16, P2615, DOI 10.1158/1055-9965.EPI-07-0684; Cho-Vega JH, 2007, J CUTAN PATHOL, V34, P535, DOI 10.1111/J.1600-0560.2006.00661.X; COOPER TG, 1979, J REPROD FERTIL, V56, P159; CRICHTON EG, 1994, AM J PHYSIOL-REG I, V267, pR1363, DOI 10.1152/ajpregu.1994.267.5.R1363; Dube E, 2007, BIOL REPROD, V76, P1034, DOI 10.1095/biolreprod.106.059246; Ebert B, 2014, BIOL REV CAMBRIDGE P; Frenette G, 2003, BIOL REPROD, V69, P1586, DOI 10.1095/biolreprod.103.019216; Frenette G, 2001, MOL REPROD DEV, V59, P115, DOI 10.1002/mrd.1013; Frenette G, 2006, BIOL REPROD, V75, P885, DOI 10.1095/biolreprod.106.054692; Frenette G, 2010, BIOL REPROD, V83, P473, DOI 10.1095/biolreprod.109.082438; Girouard J, 2011, INT J ANDROL, V34, pE475, DOI 10.1111/j.1365-2605.2011.01203.x; Girouard J, 2009, BIOL REPROD, V80, P965, DOI 10.1095/biolreprod.108.073551; HINTON BT, 1981, INT J ANDROL, V4, P457, DOI 10.1111/j.1365-2605.1981.tb00730.x; JONES R, 1978, COMP BIOCHEM PHYS B, V61, P365, DOI 10.1016/0305-0491(78)90138-4; Lamontagne N, 2001, MOL REPROD DEV, V59, P431, DOI 10.1002/mrd.1050; Lawson C, 2008, BIOL REPROD, V79, P657, DOI 10.1095/biolreprod.108.070367; Lee SK, 2013, INT J BIOCHEM CELL B, V45, P2563, DOI 10.1016/j.biocel.2013.08.010; Legare C, 1999, ENDOCRINOLOGY, V140, P3318, DOI 10.1210/en.140.7.3318; Legare C, 2004, MOL HUM REPROD, V10, P697, DOI 10.1093/molehr/gah087; Lessard C, 2000, J ANDROL, V21, P700; Nakagawa J, 2002, J BIOL CHEM, V277, P17883, DOI 10.1074/jbc.M110703200; Odani H, 2008, ANN NY ACAD SCI, V1126, P320, DOI 10.1196/annals.1433.003; Rossato M, 1996, MOL HUM REPROD, V2, P903, DOI 10.1093/molehr/2.12.903; St-Cyr A, 2004, MOL REPROD DEV, V69, P137, DOI 10.1002/mrd.20089; Sudo T, 2005, EXP ANIM TOKYO, V54, P385, DOI 10.1538/expanim.54.385; Sullivan R, 2006, FERTIL STERIL, V85, P1557, DOI 10.1016/j.fertnstert.2005.10.070; Thimon V, 2007, MOL HUM REPROD, V13, P691, DOI 10.1093/molehr/gam051; Vandesompele J, 2002, ANAL BIOCHEM, V303, P95, DOI 10.1006/abio.2001.5564; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; White I G, 1973, J Reprod Fertil Suppl, V18, P225; Yeung CH, 2001, MOL HUM REPROD, V7, P819, DOI 10.1093/molehr/7.9.819; Zabner J, 2000, P NATL ACAD SCI USA, V97, P11614, DOI 10.1073/pnas.97.21.11614	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0120869	10.1371/journal.pone.0120869	http://dx.doi.org/10.1371/journal.pone.0120869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815750	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600049
J	El Mendili, MM; Chen, R; Tiret, B; Villard, N; Trunet, S; Pelegrini-Issac, M; Lehericy, S; Pradat, PF; Benali, H				El Mendili, Mohamed-Mounir; Chen, Raphael; Tiret, Brice; Villard, Noemie; Trunet, Stephanie; Pelegrini-Issac, Melanie; Lehericy, Stephane; Pradat, Pierre-Francois; Benali, Habib			Fast and Accurate Semi-Automated Segmentation Method of Spinal Cord MR Images at 3T Applied to the Construction of a Cervical Spinal Cord Template	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; VOXEL-BASED ANALYSIS; MULTIPLE-SCLEROSIS; INTENSITY NONUNIFORMITY; SPATIAL NORMALIZATION; ATROPHY; INJURY; BRAIN; DISABILITY; INVOLVEMENT	Objective To design a fast and accurate semi-automated segmentation method for spinal cord 3T MR images and to construct a template of the cervical spinal cord. Materials and Methods A semi-automated double threshold-based method (DTbM) was proposed enabling both cross-sectional and volumetric measures from 3D T-2-weighted turbo spin echo MR scans of the spinal cord at 3T. Eighty-two healthy subjects, 10 patients with amyotrophic lateral sclerosis, 10 with spinal muscular atrophy and 10 with spinal cord injuries were studied. DTbM was compared with active surface method (ASM), threshold-based method (TbM) and manual outlining (ground truth). Accuracy of segmentations was scored visually by a radiologist in cervical and thoracic cord regions. Accuracy was also quantified at the cervical and thoracic levels as well as at C2 vertebral level. To construct a cervical template from healthy subjects' images (n=59), a standardization pipeline was designed leading to well-centered straight spinal cord images and accurate probability tissue map. Results Visual scoring showed better performance for DTbM than for ASM. Mean Dice similarity coefficient (DSC) was 95.71% for DTbM and 90.78% for ASM at the cervical level and 94.27% for DTbM and 89.93% for ASM at the thoracic level. Finally, at C2 vertebral level, mean DSC was 97.98% for DTbM compared with 98.02% for TbM and 96.76% for ASM. DTbM showed similar accuracy compared with TbM, but with the advantage of limited manual interaction. Conclusion A semi-automated segmentation method with limited manual intervention was introduced and validated on 3T images, enabling the construction of a cervical spinal cord template.	[El Mendili, Mohamed-Mounir; Chen, Raphael; Tiret, Brice; Villard, Noemie; Pelegrini-Issac, Melanie; Pradat, Pierre-Francois; Benali, Habib] Univ Paris 06, INSERM, Univ Sorbonne, CNRS,Lab Imagerie Biomed, F-75013 Paris, Ile De France, France; [Trunet, Stephanie; Lehericy, Stephane] Grp Hosp Pitie Salpetriere, AP HP, Serv Neuroradiol, F-75013 Paris, Ile De France, France; [Lehericy, Stephane] Univ Paris 06, INSERM, U975,Ctr Neuroimagerie Rech CENIR, Univ Sorbonne,UMR S975,CNRS,UMR7225,Ctr Rech,Inst, F-75013 Paris, Ile De France, France; [Pradat, Pierre-Francois] Grp Hosp Pitie Salpetriere, AP HP, Dept Malad Syst Nerveux, F-75013 Paris, Ile De France, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	El Mendili, MM (corresponding author), Univ Paris 06, INSERM, Univ Sorbonne, CNRS,Lab Imagerie Biomed, F-75013 Paris, Ile De France, France.	mounir.elmendili@lib.upmc.fr		Tiret, Brice/0000-0002-4843-9130; Pelegrini-Issac, Melanie/0000-0003-3260-5795	Association Francaise contre les Myopathies (AFM); Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME); program "Investissements d'avenir" [ANR-10-IAIHU-06]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME); program "Investissements d'avenir"(French National Research Agency (ANR))	This study was supported by the Association Francaise contre les Myopathies (AFM) and the Institut pour la Recherche sur la Moelle epiniere et l'Encephale (IRME). The research leading to these results has also received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06.	Agosta F, 2009, J NEUROL NEUROSUR PS, V80, P53, DOI 10.1136/jnnp.2008.154252; Asman AJ, 2014, MED IMAGE ANAL, V18, P460, DOI 10.1016/j.media.2014.01.003; Bede P, 2013, NEUROLOGY, V81, P2107, DOI 10.1212/01.wnl.0000437313.80913.2c; Bellec P, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00007; Bergo F.P.G., 2012, CISTI 2012 7 CONFERE, V2, P400; Boyes RG, 2008, NEUROIMAGE, V39, P1752, DOI 10.1016/j.neuroimage.2007.10.026; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Branco LMT, 2014, AMYOTROPH LAT SCL FR, V15, P93, DOI 10.3109/21678421.2013.852589; Cadotte D, 2012, P 18 ANN M ORG HUM B; Cadotte DW, 2014, AJNR AM J N IN PRESS; Carbonell-Caballero J, 2006, MAGN RESON MATER PHY, V19, P237, DOI 10.1007/s10334-006-0052-0; Chen M, 2013, NEUROIMAGE, V83, P1051, DOI 10.1016/j.neuroimage.2013.07.060; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Cohen AB, 2012, J NEUROIMAGING, V22, P122, DOI 10.1111/j.1552-6569.2011.00589.x; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Cohen-Adad J, 2013, AMYOTROPH LAT SCL FR, V14, P30, DOI 10.3109/17482968.2012.701308; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Del Grande F., 2012, RHEUMATOLOGY NETW; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; El Mendili MM, 2012, P 10 ANN M EUR NETW; El Mendili MM, 2015, J MAGN RESON IMAGING, V41, P454, DOI 10.1002/jmri.24571; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; ElMendili MM, 2014, P 20 ANN M ORG HUM B; Fonov VS, 2014, NEUROIMAGE, V102, P817, DOI 10.1016/j.neuroimage.2014.08.057; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Fradet L, 2014, SPINE, V39, pE262, DOI 10.1097/BRS.0000000000000125; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Freund PAB, 2010, J MAGN RESON IMAGING, V32, P1242, DOI 10.1002/jmri.22340; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Hickman SJ, 2004, MAGN RESON IMAGING, V22, P891, DOI 10.1016/j.mri.2004.01.056; Horsfield MA, 2010, NEUROIMAGE, V50, P446, DOI 10.1016/j.neuroimage.2009.12.121; Kameyama T, 1996, SPINE, V21, P1285, DOI 10.1097/00007632-199606010-00001; Katsuno M, 2010, ADV EXP MED BIOL, V685, P64; Kearney H, 2014, J MAGN RESON IMAGING, V39, P617, DOI 10.1002/jmri.24194; Klein JP, 2011, AM J NEURORADIOL, V32, P1138, DOI 10.3174/ajnr.A2459; Ko HY, 2004, SPINAL CORD, V42, P35, DOI 10.1038/sj.sc.3101538; Korzan JR, 2002, J MAGN RESON IMAGING, V16, P21, DOI 10.1002/jmri.10137; Kwon JW, 2012, CLIN RADIOL, V67, P106, DOI 10.1016/j.crad.2011.06.011; Leary SM, 1999, MAGN RESON IMAGING, V17, P773, DOI 10.1016/S0730-725X(99)00005-3; Lee S, 2014, ACTA RADIOL IN PRESS; Lichy MP, 2005, INVEST RADIOL, V40, P754, DOI 10.1097/01.rli.0000185880.92346.9e; Lin X, 2004, J NEUROIMAGING, V14, p20S, DOI 10.1111/j.1552-6569.2004.tb00275.x; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lukas C, 2013, RADIOLOGY, V269, P541, DOI 10.1148/radiol.13122566; Lundell H, 2011, SPINAL CORD, V49, P70, DOI 10.1038/sc.2010.87; McIntosh C., 2011, 2011 IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology, P25, DOI 10.1109/HISB.2011.42; Meindl T, 2009, EUR RADIOL, V19, P713, DOI 10.1007/s00330-008-1175-7; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Nobuyuki Otsu, 1979, IEEE T, V9, P62, DOI DOI 10.1109/TSMC.1979.4310076; Rocca MA, 2013, J NEUROL NEUROSUR PS, V84, P35, DOI 10.1136/jnnp-2012-303821; Rodegerdts EA, 2006, ACTA RADIOL, V47, P488, DOI 10.1080/02841850600647116; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Stroman PW, 2008, MAGN RESON IMAGING, V26, P809, DOI 10.1016/j.mri.2008.01.038; Taso M, 2014, MAGN RESON MATER PHY, V27, P257, DOI 10.1007/s10334-013-0403-6; Tench CR, 2005, J MAGN RESON IMAGING, V21, P197, DOI 10.1002/jmri.20253; Tins B, 2012, BRIT J RADIOL, V85, pE480, DOI 10.1259/bjr/25760339; Valsasina P, 2012, AM J NEURORADIOL, V33, P2195, DOI 10.3174/ajnr.A3139; Valsasina P, 2013, RADIOLOGY, V266, P853, DOI 10.1148/radiol.12120813; Wang YL, 2011, NEUROIMAGE, V56, P1993, DOI 10.1016/j.neuroimage.2011.03.040; Wang YL, 2010, NEUROIMAGE, V49, P2141, DOI 10.1016/j.neuroimage.2009.10.086; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Zheng WL, 2009, NEUROIMAGE, V48, P73, DOI 10.1016/j.neuroimage.2009.06.039; Zivadinov R, 2008, AM J NEURORADIOL, V29, P319, DOI 10.3174/ajnr.A0813	69	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122224	10.1371/journal.pone.0122224	http://dx.doi.org/10.1371/journal.pone.0122224			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816143	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600156
J	Haralambieva, IH; Painter, SD; Kennedy, RB; Ovsyannikova, IG; Lambert, ND; Goergen, KM; Oberg, AL; Poland, GA				Haralambieva, Iana H.; Painter, Scott D.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Lambert, Nathaniel D.; Goergen, Krista M.; Oberg, Ann L.; Poland, Gregory A.			The Impact of Immunosenescence on Humoral Immune Response Variation after Influenza A/H1N1 Vaccination in Older Subjects	PLOS ONE			English	Article							VIRUS-SPECIFIC EFFECTOR; AGE-RELATED-CHANGES; B-CELL RESPONSES; TELOMERASE ACTIVITY; CLASS SWITCH; ADULTS; IMMUNIZATION; VACCINES; REGULARIZATION; MAINTENANCE	Background Although influenza causes significant morbidity and mortality in the elderly, the factors underlying the reduced vaccine immunogenicity and efficacy in this age group are not completely understood. Age and immunosenescence factors, and their impact on humoral immunity after influenza vaccination, are of growing interest for the development of better vaccines for the elderly. Methods We assessed associations between age and immunosenescence markers (T cell receptor rearrangement excision circles -TREC content, peripheral white blood cell telomerase - TERT expression and CD28 expression on T cells) and influenza A/H1N1 vaccine-induced measures of humoral immunity in 106 older subjects at baseline and three timepoints post-vaccination. Results TERT activity (TERT mRNA expression) was significantly positively correlated with the observed increase in the influenza-specific memory B cell ELISPOT response at Day 28 compared to baseline (p-value=0.025). TREC levels were positively correlated with the baseline and early (Day 3) influenza A/H1N1-specific memory B cell ELISPOT response (p-value=0.042 and p-value=0.035, respectively). The expression and/or expression change of CD28 on CD4+ and/or CD8+ T cells at baseline and Day 3 was positively correlated with the influenza A/H1N1-specific memory B cell ELISPOT response at baseline, Day 28 and Day 75 post-vaccination. In a multivariable analysis, the peak antibody response (HAI and/or VNA at Day 28) was negatively associated with age, the percentage of CD8+CD28low T cells, IgD+CD27-naive B cells, and percentage overall CD20-B cells and plasmablasts, measured at Day 3 post-vaccination. The early change in influenza-specific memory B cell ELISPOT response was positively correlated with the observed increase in influenza A/H1N1-specific HAI antibodies at Day 28 and Day 75 relative to baseline (p-value=0.007 and p-value=0.005, respectively). Conclusion Our data suggest that influenza-specific humoral immunity is significantly influenced by age, and that specific markers of immunosenescence (e.g., the baseline/early expression of CD28 on CD4+ and/or CD8+ T cells and T cell immune abnormalities) are correlated with different humoral immune response outcomes observed after vaccination in older individuals, and thus can be potentially used to predict vaccine immunogenicity.	[Haralambieva, Iana H.; Painter, Scott D.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Lambert, Nathaniel D.; Goergen, Krista M.; Oberg, Ann L.; Poland, Gregory A.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55902 USA; [Haralambieva, Iana H.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Lambert, Nathaniel D.; Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodefense, Rochester, MN USA; [Oberg, Ann L.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Poland, Gregory A.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55902 USA.	poland.gregory@mayo.edu		Kennedy, Rick/0000-0001-6164-4967	National Institute of Allergy And Infectious Diseases of the National Institutes of Health [U01AI089859]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI089859] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U01AI089859. This publication was supported by Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademokun A, 2010, BIOGERONTOLOGY, V11, P125, DOI 10.1007/s10522-009-9256-9; Aspinall R, 2007, REJUV RES, V10, P5, DOI 10.1089/rej.2006.9098; Auletta JJ, 2005, BONE MARROW TRANSPL, V35, P835, DOI 10.1038/sj.bmt.1704966; Bernstein E, 1999, VACCINE, V17, P82, DOI 10.1016/S0264-410X(98)00117-0; Brydak LB, 2000, VACCINE, V18, P3280, DOI 10.1016/S0264-410X(00)00126-2; Cancro MP, 2009, TRENDS IMMUNOL, V30, P313, DOI 10.1016/j.it.2009.04.005; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; Cheong HJ, 2011, CLIN VACCINE IMMUNOL, V18, P1358, DOI 10.1128/CVI.05111-11; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Deans GD, 2010, J INTERN MED, V267, P220, DOI 10.1111/j.1365-2796.2009.02201.x; Dorrington MG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00171; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Frasca D, 2005, SEMIN IMMUNOL, V17, P378, DOI 10.1016/j.smim.2005.05.005; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gardner EM, 2006, VACCINE, V24, P1609, DOI 10.1016/j.vaccine.2005.09.058; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Gorse GJ, 2004, J INFECT DIS, V190, P11, DOI 10.1086/421121; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Halliley JL, 2010, VACCINE, V28, P3582, DOI 10.1016/j.vaccine.2010.02.088; Hathcock KS, 2003, J IMMUNOL, V170, P147, DOI 10.4049/jimmunol.170.1.147; Hernandez-Vargas EA, 2014, J VIROL, V88, P4123, DOI 10.1128/JVI.03644-13; Igarashi H, 1997, BLOOD, V89, P1299, DOI 10.1182/blood.V89.4.1299; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Kogut I, 2012, SEMIN IMMUNOL, V24, P342, DOI 10.1016/j.smim.2012.04.004; Kurupati RK, 2013, AGING-US, V5, P209, DOI 10.18632/aging.100541; Lang PO, 2012, CLIN INTERV AGING, V7, P55, DOI 10.2147/CIA.S25215; LEVINE M, 1987, CAN MED ASSOC J, V137, P722; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; McElhaney JE, 2011, AGEING RES REV, V10, P379, DOI 10.1016/j.arr.2010.10.008; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; McElhaney JE, 2009, VACCINE, V27, P2418, DOI 10.1016/j.vaccine.2009.01.136; Miraglia JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027214; Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Painter SD, 2014, VIRAL IMMUNOL, V27, P32, DOI 10.1089/vim.2013.0099; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Reber A, 2013, EXPERT REV VACCINES, V12, P519, DOI [10.1586/erv.13.35, 10.1586/ERV.13.35]; Reber AJ, 2012, AGING DIS, V3, P68; Rizza SA, 2008, FRONT BIOSCI-LANDMRK, V13, P1605, DOI 10.2741/2784; Salk HM, 2013, J IMMUNOL METHODS, V398, P44, DOI 10.1016/j.jim.2013.09.007; Sambhara S, 2009, CURR TOP MICROBIOL, V333, P413, DOI 10.1007/978-3-540-92165-3_20; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Targonski PV, 2007, CLIN PHARMACOL THER, V82, P694, DOI 10.1038/sj.clpt.6100410; Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Trzonkowski P, 2009, BIOGERONTOLOGY, V10, P83, DOI 10.1007/s10522-008-9155-5; Umlauf BJ, 2012, VIRAL IMMUNOL, V25, P29, DOI 10.1089/vim.2011.0051; Wang SX, 2006, J VIROL, V80, P11628, DOI 10.1128/JVI.01065-06; Warrington KJ, 2003, BLOOD, V101, P3543, DOI 10.1182/blood-2002-08-2574; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yu MC, 2012, P NATL ACAD SCI USA, V109, pE879, DOI 10.1073/pnas.1109797109; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	65	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122282	10.1371/journal.pone.0122282	http://dx.doi.org/10.1371/journal.pone.0122282			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816015	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600163
J	Bahaji, A; Sanchez-Lopez, AM; De Diego, N; Munoz, FJ; Baroja-Fernandez, E; Li, J; Ricarte-Bermejo, A; Baslam, M; Aranjuelo, I; Almagro, G; Humplik, JF; Novak, O; Spichal, L; Dolezal, K; Pozueta-Romero, J				Bahaji, Abdellatif; Sanchez-Lopez, Angela M.; De Diego, Nuria; Munoz, Francisco J.; Baroja-Fernandez, Edurne; Li, Jun; Ricarte-Bermejo, Adriana; Baslam, Marouane; Aranjuelo, Iker; Almagro, Goizeder; Humplik, Jan F.; Novak, Ondrej; Spichal, Lukas; Dolezal, Karel; Pozueta-Romero, Javier			Plastidic Phosphoglucose Isomerase Is an Important Determinant of Starch Accumulation in Mesophyll Cells, Growth, Photosynthetic Capacity, and Biosynthesis of Plastidic Cytokinins in Arabidopsis	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; PENTOSE-PHOSPHATE PATHWAY; POSTTRANSLATIONAL REDOX-MODIFICATION; ALTERED ENDOGENOUS CYTOKININ; TRANSGENIC TOBACCO PLANTS; SUCROSE SYNTHASE ACTIVITY; EXCEPTIONALLY HIGH-LEVELS; POTATO SOLANUM-TUBEROSUM; BETA-AMYLASE; MOLECULAR CHARACTERIZATION	Phosphoglucose isomerase (PGI) catalyzes the reversible isomerization of glucose-6-phosphate and fructose-6-phosphate. It is involved in glycolysis and in the regeneration of glucose-6-P molecules in the oxidative pentose phosphate pathway (OPPP). In chloroplasts of illuminated mesophyll cells PGI also connects the Calvin-Benson cycle with the starch biosynthetic pathway. In this work we isolated pgi1-3, a mutant totally lacking pPGI activity as a consequence of aberrant intron splicing of the pPGI encoding gene, PGI1. Starch content in pgi1-3 source leaves was ca. 10-15% of that of wild type (WT) leaves, which was similar to that of leaves of pgi1-2, a T-DNA insertion pPGI null mutant. Starch deficiency of pgi1 leaves could be reverted by the introduction of a sex1 null mutation impeding beta-amylolytic starch breakdown. Although previous studies showed that starch granules of pgi1-2 leaves are restricted to both bundle sheath cells adjacent to the mesophyll and stomata guard cells, microscopy analyses carried out in this work revealed the presence of starch granules in the chloroplasts of pgi1-2 and pgi1-3 mesophyll cells. RT-PCR analyses showed high expression levels of plastidic and extra-plastidic beta-amylase encoding genes in pgi1 leaves, which was accompanied by increased beta-amylase activity. Both pgi1-2 and pgi1-3 mutants displayed slow growth and reduced photosynthetic capacity phenotypes even under continuous light conditions. Metabolic analyses revealed that the adenylate energy charge and the NAD(P) H/NAD(P) ratios in pgi1 leaves were lower than those of WT leaves. These analyses also revealed that the content of plastidic 2-C-methyl-D-erythritol 4-phosphate (MEP)-pathway derived cytokinins (CKs) in pgi1 leaves were exceedingly lower than in WT leaves. Noteworthy, exogenous application of CKs largely reverted the low starch content phenotype of pgi1 leaves. The overall data show that pPGI is an important determinant of photosynthesis, energy status, growth and starch accumulation in mesophyll cells likely as a consequence of its involvement in the production of OPPP/glycolysis intermediates necessary for the synthesis of plastidic MEP-pathway derived hormones such as CKs.	[Bahaji, Abdellatif; Sanchez-Lopez, Angela M.; Munoz, Francisco J.; Baroja-Fernandez, Edurne; Li, Jun; Ricarte-Bermejo, Adriana; Baslam, Marouane; Almagro, Goizeder; Pozueta-Romero, Javier] Inst Agrobiotecnol CSIC UPNA Gobierno Navarra, Mutiloabeti 31192, Nafarroa, Spain; [De Diego, Nuria; Humplik, Jan F.; Novak, Ondrej; Spichal, Lukas] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Chem Biol & Genet, CZ-78371 Olomouc, Czech Republic; [Aranjuelo, Iker; Dolezal, Karel] Univ Basque Country, Fac Sci & Technol, Plant Biol & Ecol Dept, Leioa 48940, Spain; Palacky Univ, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Fac Sci, CZ-78371 Olomouc, Czech Republic; ASCR, Inst Expt Bot, CZ-78371 Olomouc, Czech Republic	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Palacky University Olomouc; University of Basque Country; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Pozueta-Romero, J (corresponding author), Inst Agrobiotecnol CSIC UPNA Gobierno Navarra, Irunako Etorbidea 123, Mutiloabeti 31192, Nafarroa, Spain.	javier.pozueta@unavarra.es	Sánchez-López, Ángela María/Y-9884-2019; Pozueta-Romero, Javier/G-3766-2011; Muñoz, Francisco/I-3547-2012; Almagro, Goizeder/Y-9900-2019; Aranjuelo, Iker/L-4204-2014; BASLAM, Marouane/K-9312-2014; Doležal, Karel/H-2436-2014; Edurne, Baroja-Fernandez/I-4037-2012; Bahaji, Abdellatif/C-4105-2015; Pozueta-Romero, Javier/AAP-9341-2021; Aranjuelo, Iker/N-5635-2019; De Diego, Nuria/G-9658-2014; NOVAK, Ondrej/F-7031-2014; Humplik, Jan F./H-4444-2019	Sánchez-López, Ángela María/0000-0001-9620-0258; Pozueta-Romero, Javier/0000-0002-0335-9663; Muñoz, Francisco/0000-0002-0426-2118; Almagro, Goizeder/0000-0001-7035-9965; Aranjuelo, Iker/0000-0002-8231-5043; BASLAM, Marouane/0000-0003-3598-7565; Doležal, Karel/0000-0003-4938-0350; Edurne, Baroja-Fernandez/0000-0003-0049-6045; Bahaji, Abdellatif/0000-0002-5270-497X; Pozueta-Romero, Javier/0000-0002-0335-9663; Aranjuelo, Iker/0000-0002-8231-5043; De Diego, Nuria/0000-0003-4539-2696; NOVAK, Ondrej/0000-0003-3452-0154; Humplik, Jan F./0000-0002-8915-4369; Spichal, Lukas/0000-0001-6483-8628; Ricarte-Bermejo, Adriana/0000-0003-3051-876X	Comision Interministerial de Ciencia y Tecnologia; Fondo Europeo de Desarrollo Regional (Spain) [BIO2010-18239, BIO2013-C2-1-P]; Government of Navarra [IIM010491.RI1]; Ministry of Education, Youth and Sports of the Czech Republich from the National Program of Sustainability [L01204]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0004]; Spanish Ministry of Science and Innovation; Public University of Navarra	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Fondo Europeo de Desarrollo Regional (Spain)(European Commission); Government of Navarra; Ministry of Education, Youth and Sports of the Czech Republich from the National Program of Sustainability; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Public University of Navarra	This work was partially supported by the Comision Interministerial de Ciencia y Tecnologia and Fondo Europeo de Desarrollo Regional (Spain) [grant numbers BIO2010-18239 and BIO2013-C2-1-P] and by the Government of Navarra [grant number IIM010491.RI1], the Ministry of Education, Youth and Sports of the Czech Republich [Grant L01204 from the National Program of Sustainability] and the European Social Fund and the state budget of the Czech Republic [project POST-UP, reg. No. CZ.1.07/2.3.00/30.0004]. AMS-L acknowledges a predoctoral fellowship from the Spanish Ministry of Science and Innovation. MB acknowledges a post-doctoral fellowship from the Public University of Navarra.	ARNON DI, 1955, SCIENCE, V122, P9, DOI 10.1126/science.122.3157.9; Astot C, 2000, P NATL ACAD SCI USA, V97, P14778, DOI 10.1073/pnas.260504097; Bahaji A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104997; Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Bahaji A, 2011, PLANT CELL PHYSIOL, V52, P1162, DOI 10.1093/pcp/pcr067; Baroja-Fernandez E, 2004, P NATL ACAD SCI USA, V101, P13080, DOI 10.1073/pnas.0402883101; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, P321, DOI 10.1073/pnas.1117099109; Baroja-Fernandez E, 2009, PLANT CELL PHYSIOL, V50, P1651, DOI 10.1093/pcp/pcp108; Bowsher CG, 2007, J EXP BOT, V58, P1109, DOI 10.1093/jxb/erl269; BOWSHER CG, 1992, PLANT J, V2, P893, DOI 10.1111/j.1365-313X.1992.00893.x; Brauner K, 2014, PLANT J, V79, P82, DOI 10.1111/tpj.12555; Bussell JD, 2013, PLANT J, V75, P578, DOI 10.1111/tpj.12222; CASPAR T, 1989, P NATL ACAD SCI USA, V86, P5830, DOI 10.1073/pnas.86.15.5830; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Cho MH, 2011, NEW PHYTOL, V190, P101, DOI 10.1111/j.1469-8137.2010.03580.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cortleven A, 2012, PHYSIOL PLANTARUM, V144, P394, DOI 10.1111/j.1399-3054.2011.01558.x; Cortleven A, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-33; DIETZ KJ, 1985, BIOCHIM BIOPHYS ACTA, V839, P240, DOI 10.1016/0304-4165(85)90004-2; DREIER W, 1995, J PLANT PHYSIOL, V145, P342, DOI 10.1016/S0176-1617(11)81900-0; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Eicks M, 2002, PLANT PHYSIOL, V128, P512, DOI 10.1104/pp.010576; Erickson JL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-127; Ezquer I, 2010, PLANT CELL PHYSIOL, V51, P1674, DOI 10.1093/pcp/pcq126; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; Fox SR, 2000, BIOCHEM J, V352, P525, DOI 10.1042/0264-6021:3520525; FREHNER M, 1990, PLANT PHYSIOL, V94, P538, DOI 10.1104/pp.94.2.538; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; GIBBS M, 1957, P NATL ACAD SCI USA, V43, P446, DOI 10.1073/pnas.43.6.446; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Giese JO, 2005, FEBS LETT, V579, P827, DOI 10.1016/j.febslet.2004.12.071; HANSON KR, 1988, PLANT PHYSIOL, V88, P838, DOI 10.1104/pp.88.3.838; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; Helliwell CA, 2001, PLANT J, V28, P201, DOI 10.1046/j.1365-313X.2001.01150.x; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; HEUER B, 1982, PLANT PHYSIOL, V69, P1404, DOI 10.1104/pp.69.6.1404; HUBER SC, 1992, PLANT PHYSIOL, V99, P1449, DOI 10.1104/pp.99.4.1449; JONES TWA, 1986, PLANT PHYSIOL, V81, P367, DOI 10.1104/pp.81.2.367; Jong F, 2014, PLANT PHYSIOL, V164, P308, DOI [10.1104/pp.113.230599, DOI 10.1104/PP.113.230599]; JOURNET EP, 1985, PLANT PHYSIOL, V79, P458, DOI 10.1104/pp.79.2.458; Kammerer B, 1998, PLANT CELL, V10, P105, DOI 10.1105/tpc.10.1.105; KANDLER O, 1956, PLANT PHYSIOL, V31, P411, DOI 10.1104/pp.31.5.411; Kang F, 1996, PLANTA, V199, P321; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kasahara H, 2004, J BIOL CHEM, V279, P14049, DOI 10.1074/jbc.M314195200; Kirchsteiger K, 2012, PLANT CELL, V24, P1534, DOI 10.1105/tpc.111.092304; Kleczkowski LA, 2000, BBA-PROTEIN STRUCT M, V1476, P103, DOI 10.1016/S0167-4838(99)00229-0; Kleczkowski LA, 1999, FEBS LETT, V448, P153, DOI 10.1016/S0014-5793(99)00346-4; KLECZKOWSKI LA, 1986, PLANT PHYSIOL, V81, P1110, DOI 10.1104/pp.81.4.1110; Ko D, 2014, P NATL ACAD SCI USA, V111, P7150, DOI 10.1073/pnas.1321519111; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Kofler H, 2000, MOL GEN GENET, V263, P978, DOI 10.1007/PL00008698; KRALL JP, 1992, PHYSIOL PLANTARUM, V86, P180, DOI 10.1111/j.1399-3054.1992.tb01328.x; KRUCKEBERG AL, 1989, BIOCHEM J, V261, P457, DOI 10.1042/bj2610457; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; Kunz HH, 2014, PLANT PHYSIOL, V166, P753, DOI 10.1104/pp.114.241091; Lao NT, 1999, PLANT J, V20, P519, DOI 10.1046/j.1365-313X.1999.00625.x; Lejay L, 2008, PLANT PHYSIOL, V146, P2036, DOI 10.1104/pp.107.114710; Lepisto A, 2009, PLANT PHYSIOL, V149, P1261, DOI 10.1104/pp.108.133777; Li J, 2012, PLANT CELL PHYSIOL, V53, P433, DOI 10.1093/pcp/pcr193; Li J, 2011, MOL PLANT MICROBE IN, V24, P1165, DOI 10.1094/MPMI-05-11-0112; Lichtenthaler HK, 1997, FEBS LETT, V400, P271, DOI 10.1016/S0014-5793(96)01404-4; LIN TP, 1988, PLANT PHYSIOL, V86, P1131, DOI 10.1104/pp.86.4.1131; LINDEN JC, 1975, Z PFLANZENPHYSIOL, V76, P176, DOI 10.1016/S0044-328X(75)80035-3; Liu XL, 2005, CHEMOSPHERE, V61, P293, DOI 10.1016/j.chemosphere.2005.01.088; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Miyazawa Y, 1999, PLANT PHYSIOL, V121, P461, DOI 10.1104/pp.121.2.461; MORALES F, 1991, PLANT PHYSIOL, V97, P886, DOI 10.1104/pp.97.3.886; Munoz-Bertomeu J, 2011, J EXP BOT, V62, P1229, DOI 10.1093/jxb/erq353; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; OGREN E, 1993, PLANTA, V189, P182, DOI 10.1007/BF00195075; Oh MH, 2011, PLANT PHYSIOL, V157, P120, DOI 10.1104/pp.111.182741; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Perez P, 2005, ENVIRON EXP BOT, V53, P13, DOI 10.1016/j.envexpbot.2004.02.008; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; POZUETAROMERO J, 1991, PLANT PHYSIOL, V97, P1565, DOI 10.1104/pp.97.4.1565; Pulido P, 2012, MOL PLANT, V5, P964, DOI 10.1093/mp/sss088; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; QUICK WP, 1995, PLANT PHYSIOL, V109, P113, DOI 10.1104/pp.109.1.113; Ragel P, 2013, PLANT PHYSIOL, V163, P75, DOI 10.1104/pp.113.223420; Ramon M, 2007, PLANT MOL BIOL, V63, P195, DOI 10.1007/s11103-006-9082-2; Rao M, 1995, PLANT PHYSIOL, V107, P195; REES TA, 1975, BIOCHIM BIOPHYS ACTA, V385, P145, DOI 10.1016/0304-4165(75)90082-3; Rivero RM, 2009, PLANT PHYSIOL, V150, P1530, DOI 10.1104/pp.109.139378; Schluter U, 2002, PLANT CELL ENVIRON, V25, P783, DOI 10.1046/j.1365-3040.2002.00860.x; Schneider A, 2002, PLANT J, V32, P685, DOI 10.1046/j.1365-313X.2002.01460.x; SCHULZE W, 1991, PLANT PHYSIOL, V95, P890, DOI 10.1104/pp.95.3.890; SHARKEY TD, 1989, PLANT PHYSIOL, V90, P385, DOI 10.1104/pp.90.2.385; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Spichal L, 2012, FUNCT PLANT BIOL, V39, P267, DOI 10.1071/FP11276; STITT M, 1991, PLANT CELL ENVIRON, V14, P741, DOI 10.1111/j.1365-3040.1991.tb01440.x; STITT M, 1989, PHYSIOL PLANTARUM, V77, P633, DOI 10.1111/j.1399-3054.1989.tb05402.x; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb S, 2009, PLANT PHYSIOL, V151, P1769, DOI 10.1104/pp.109.144931; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Sweetlove LJ, 1996, BIOCHEM J, V320, P493, DOI 10.1042/bj3200493; Synkova H, 1999, J PLANT PHYSIOL, V155, P173, DOI 10.1016/S0176-1617(99)80004-2; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Tanaka Y, 2006, J EXP BOT, V57, P2259, DOI 10.1093/jxb/erj193; Tsai HL, 2009, PLANT PHYSIOL, V151, P1582, DOI 10.1104/pp.109.144196; Valerio C, 2011, J EXP BOT, V62, P545, DOI 10.1093/jxb/erq288; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Weber A, 2000, PLANT CELL, V12, P787, DOI 10.1105/tpc.12.5.787; Weber A, 2002, J EXP BOT, V53, P865, DOI 10.1093/jexbot/53.370.865; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Werner T, 2008, J EXP BOT, V59, P2659, DOI 10.1093/jxb/ern134; Xiong YQ, 2009, PLANT CELL PHYSIOL, V50, P1277, DOI 10.1093/pcp/pcp070; Yang SH, 2003, FEBS LETT, V555, P291, DOI 10.1016/S0014-5793(03)01259-6; Yaronskaya E, 2006, PLANTA, V224, P700, DOI 10.1007/s00425-006-0249-5; Yu TS, 2000, PLANT PHYSIOL, V123, P319, DOI 10.1104/pp.123.1.319; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Zhang L, 2008, PLANT BIOTECHNOL J, V6, P453, DOI 10.1111/j.1467-7652.2008.00332.x	121	29	29	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0119641	10.1371/journal.pone.0119641	http://dx.doi.org/10.1371/journal.pone.0119641			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811607	Green Published, gold			2022-12-26	WOS:000356353700021
J	Maeda, K; Maruyama, R; Nagae, T; Inoue, M; Aonishi, T; Miyakawa, H				Maeda, Kazuma; Maruyama, Ryuichi; Nagae, Toru; Inoue, Masashi; Aonishi, Toru; Miyakawa, Hiroyoshi			Weak Sinusoidal Electric Fields Entrain Spontaneous Ca Transients in the Dendritic Tufts of CA1 Pyramidal Cells in Rat Hippocampal Slice Preparations	PLOS ONE			English	Article							SOURCE DENSITY ANALYSIS; EPILEPTIFORM ACTIVITY; SYNAPTIC ACTIVATION; THETA OSCILLATIONS; CALCIUM DYNAMICS; RELEASE EVENTS; SPIKES; WAVES; 4-AMINOPYRIDINE; SYNCHRONIZATION	Neurons might interact via electric fields and this notion has been referred to as ephaptic interaction. It has been shown that various types of ion channels are distributed along the dendrites and are capable of supporting generation of dendritic spikes. We hypothesized that generation of dendritic spikes play important roles in the ephaptic interactions either by amplifying the impact of electric fields or by providing current source to generate electric fields. To test if dendritic activities can be modulated by electric fields, we developed a method to monitor local Ca-transients in the dendrites of a neuronal population in acute rat hippocampal slices by applying spinning-disk confocal microscopy and multi-cell dye loading technique. In a condition in which the dendrites of CA1 pyramidal neurons show spontaneous Ca-transients due to added 50 mu M 4-aminopyridine to the bathing medium and adjusted extracellular potassium concentration, we examined the impact of sinusoidal electric fields on the Ca-transients. We have found that spontaneously occurring fast-Catransients in the tufts of the apical dendrites of CA1 pyramidal neurons can be blocked by applying 1 mu M tetrodotoxin, and that the timing of the transients become entrained to subthreshold 1-4 Hz electric fields with an intensity as weak as 0.84 mV/mm applied parallel to the somato-dendritic axis of the neurons. The extent of entrainment increases with intensity below 5 mV/mm, but does not increase further over the range of 5-20 mV/mm. These results suggest that population of pyramidal cells might be able to detect electric fields with biologically relevant intensity by modulating the timing of dendritic spikes.	[Maeda, Kazuma; Nagae, Toru; Inoue, Masashi; Miyakawa, Hiroyoshi] Tokyo Univ Pharm & Life Sci, Lab Cellular Neurobiol, Hachioji, Tokyo 19203, Japan; [Maruyama, Ryuichi; Aonishi, Toru] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Midori Ku, Tokyo, Kanagawa, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo Institute of Technology	Miyakawa, H (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Cellular Neurobiol, 1432-1 Horinouchi, Hachioji, Tokyo 19203, Japan.	miyakawa@toyaku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23500375]; Grants-in-Aid for Scientific Research [26120512] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research(C) [No. 23500375] from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2011, BRAIN RES, V1383, P22, DOI 10.1016/j.brainres.2011.01.097; Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; Avoli M, 1996, J PHYSIOL-LONDON, V493, P707, DOI 10.1113/jphysiol.1996.sp021416; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deans JK, 2007, J PHYSIOL-LONDON, V583, P555, DOI 10.1113/jphysiol.2007.137711; FISHER NI, 1987, J CLIM APPL METEOROL, V26, P1522, DOI 10.1175/1520-0450(1987)026<1522:PWTCDO>2.0.CO;2; Fisher NI, 1995, STAT ANAL CIRCULAR D; Francis JT, 2003, J NEUROSCI, V23, P7255; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Ghai RS, 2000, J NEUROPHYSIOL, V84, P274, DOI 10.1152/jn.2000.84.1.274; Gluckman BJ, 1996, J NEUROPHYSIOL, V76, P4202, DOI 10.1152/jn.1996.76.6.4202; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Hazra A, 2012, J NEUROPHYSIOL, V108, P658, DOI 10.1152/jn.00708.2011; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HU PS, 1991, BRIT J PHARMACOL, V102, P764, DOI 10.1111/j.1476-5381.1991.tb12247.x; IVES AE, 1990, NEUROSCI LETT, V112, P239, DOI 10.1016/0304-3940(90)90210-Z; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Jefferys JG, 1995, PHYSIOL REV, V5, P89; Jefferys JG, 1981, J PHYSL, V319, P43; Kamiya H, 1999, J PHYSL, V72, P15; Kamondi A, 1998, J NEUROSCI, V18, P3919; Koizumi S, 2010, FEBS J, V277, P286, DOI 10.1111/j.1742-4658.2009.07438.x; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Magee JC, 2007, DENDRITES, P226; Manita S, 2011, J PHYSIOL-LONDON, V589, P4903, DOI 10.1113/jphysiol.2011.216564; Manita S, 2009, J NEUROSCI, V29, P7833, DOI 10.1523/JNEUROSCI.0573-09.2009; Maruyama R, 2014, NEURAL NETWORKS, V55, P11, DOI 10.1016/j.neunet.2014.03.007; Mehta M., 2010, DYNAMIC COORDINATION, P133; MIYAKAWA H, 1986, BRAIN RES, V399, P303, DOI 10.1016/0006-8993(86)91520-9; Miyazaki K, 2012, CELL CALCIUM, V52, P422, DOI 10.1016/j.ceca.2012.08.001; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Murayama M, 2005, EUR J NEUROSCI, V21, P3349, DOI 10.1111/j.1460-9568.2005.04167.x; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Oikonomou KD, 2012, FRONT PHYSIOL, V3, P1, DOI [10.3389/fphys.2012.00001, DOI 10.3389/FPHYS.2012.00001]; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Palmer LM, 2014, BRAIN RES BULL, V103, P2, DOI 10.1016/j.brainresbull.2013.09.010; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; Ross WN, 2012, NAT REV NEUROSCI, V13, P157, DOI 10.1038/nrn3168; Schechter LE, 1997, J PHARMACOL EXP THER, V282, P262; Sinha SR, 2001, J NEUROPHYSIOL, V86, P381, DOI 10.1152/jn.2001.86.1.381; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Spruston N., 2007, DENDRITES, P351; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TRAUB RD, 1995, J PHYSIOL-LONDON, V489, P127, DOI 10.1113/jphysiol.1995.sp021036; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Weaver JC, 1998, BIOPHYS J, V75, P2251, DOI 10.1016/S0006-3495(98)77669-6; Weiss SA, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00015; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; YLINEN A, 1995, J NEUROSCI, V15, P30; Yoshida Y, 2005, J PHARMACOL SCI, V97, P212, DOI 10.1254/jphs.FP0040722; Zar J.H., 2009, BIOSTATISTICAL ANAL	66	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122263	10.1371/journal.pone.0122263	http://dx.doi.org/10.1371/journal.pone.0122263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811836	gold, Green Submitted, Green Published			2022-12-26	WOS:000356353700176
J	Maharana, J; Sahoo, BR; Bej, A; Jena, I; Parida, A; Sahoo, JR; Dehury, B; Patra, MC; Martha, SR; Balabantray, S; Pradhan, SK; Behera, BK				Maharana, Jitendra; Sahoo, Bikash Ranjan; Bej, Aritra; Jena, Itishree; Parida, Arunima; Sahoo, Jyoti Ranjan; Dehury, Budheswar; Patra, Mahesh Chandra; Martha, Sushma Rani; Balabantray, Sucharita; Pradhan, Sukanta Kumar; Behera, Bijay Kumar			Structural Models of Zebrafish (Danio rerio) NOD1 and NOD2 NACHT Domains Suggest Differential ATP Binding Orientations: Insights from Computational Modeling, Docking and Molecular Dynamics Simulations	PLOS ONE			English	Article							NUCLEOTIDE-BINDING; MURAMYL DIPEPTIDE; CRITICAL RESIDUES; CARD15 MUTATIONS; INNATE IMMUNITY; WEB SERVER; RECEPTOR; IDENTIFICATION; RECOGNITION; PROTEINS	Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) and NOD2 are cytosolic pattern recognition receptors playing pivotal roles in innate immune signaling. NOD1 and NOD2 recognize bacterial peptidoglycan derivatives iE-DAP and MDP, respectively and undergoes conformational alternation and ATP-dependent self-oligomerization of NACHT domain followed by downstream signaling. Lack of structural adequacy of NACHT domain confines our understanding about the NOD-mediated signaling mechanism. Here, we predicted the structure of NACHT domain of both NOD1 and NOD2 from model organism zebrafish (Danio rerio) using computational methods. Our study highlighted the differential ATP binding modes in NOD1 and NOD2. In NOD1, gamma-phosphate of ATP faced toward the central nucleotide binding cavity like NLRC4, whereas in NOD2 the cavity was occupied by adenine moiety. The conserved 'Lysine' at Walker A formed hydrogen bonds (H-bonds) and Aspartic acid (Walker B) formed electrostatic interaction with ATP. At Sensor 1, Arg328 of NOD1 exhibited an H-bond with ATP, whereas corresponding Arg404 of NOD2 did not. 'Proline' of GxP motif (Pro386 of NOD1 and Pro464 of NOD2) interacted with adenine moiety and His511 at Sensor 2 of NOD1 interacted with gamma-phosphate group of ATP. In contrast, His579 of NOD2 interacted with the adenine moiety having a relatively inverted orientation. Our findings are well supplemented with the molecular interaction of ATP with NLRC4, and consistent with mutagenesis data reported for human, which indicates evolutionary shared NOD signaling mechanism. Together, this study provides novel insights into ATP binding mechanism, and highlights the differential ATP binding modes in zebrafish NOD1 and NOD2.	[Maharana, Jitendra; Sahoo, Bikash Ranjan; Bej, Aritra; Jena, Itishree; Parida, Arunima; Sahoo, Jyoti Ranjan; Patra, Mahesh Chandra; Martha, Sushma Rani; Balabantray, Sucharita; Pradhan, Sukanta Kumar] Orissa Univ Agr & Technol, Dept Bioinformat, Bhubaneswar 751003, Odisha, India; [Maharana, Jitendra; Behera, Bijay Kumar] ICAR Cent Inland Fisheries Res Inst, Biotechnol Lab, Kolkata, W Bengal, India; [Dehury, Budheswar] Reg Med Res Inst ICMR, Biomed Informat Ctr, Bhubaneswar, Odisha, India	Orissa University of Agriculture & Technology; Indian Council of Agricultural Research (ICAR); ICAR - Central Inland Fisheries Research Institute; Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar	Maharana, J (corresponding author), Orissa Univ Agr & Technol, Dept Bioinformat, Bhubaneswar 751003, Odisha, India.	jitued@gmail.com; beherabk18@yahoo.co.in	DEHURY, BUDHESWAR/G-9330-2017; Behera, Bijay Kumar/AGZ-8213-2022; Sahoo, Bikash Ranjan/H-7399-2012; Maharana, Jitendra/B-5210-2014; Behera, Bijay Kumar/AAU-3873-2021; Bej, Aritra/GON-5952-2022; Patra, Mahesh/I-9746-2014	DEHURY, BUDHESWAR/0000-0002-9726-8454; Behera, Bijay Kumar/0000-0003-4960-9768; Sahoo, Bikash Ranjan/0000-0002-3683-1178; Maharana, Jitendra/0000-0003-4628-5956; Behera, Bijay Kumar/0000-0003-4960-9768; Bej, Aritra/0000-0002-5561-1891; Patra, Mahesh/0000-0003-0471-6236				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berjanskii M, 2010, NUCLEIC ACIDS RES, V38, pW633, DOI 10.1093/nar/gkq375; Berjanskii M, 2009, NUCLEIC ACIDS RES, V37, pW670, DOI 10.1093/nar/gkp280; Boyle JP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140178; Boyle JP, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00317; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Forster MJ, 2002, MICRON, V33, P365, DOI 10.1016/S0968-4328(01)00035-X; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Hahn JS, 2005, FEBS LETT, V579, P4513, DOI 10.1016/j.febslet.2005.07.024; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Henckaerts L, 2007, INFLAMM BOWEL DIS, V13, P235, DOI 10.1002/ibd.20066; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Laroui H, 2011, J BIOL CHEM, V286, P31003, DOI 10.1074/jbc.M111.257501; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Bourhis L, 2007, BIOCHEM SOC T, V35, P1479, DOI 10.1042/BST0351479; Lee KH, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410027; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Lushington GH, 2015, METHODS MOL BIOL, V1215, P309, DOI 10.1007/978-1-4939-1465-4_14; MacDonald JA, 2013, IUBMB LIFE, V65, P851, DOI 10.1002/iub.1210; Maharana J, 2014, MOL BIOSYST, V10, P2942, DOI 10.1039/c4mb00212a; Maharana J, 2014, J MOL RECOGNIT, V27, P260, DOI 10.1002/jmr.2357; Maharana J, 2013, FISH PHYSIOL BIOCHEM, V39, P1007, DOI 10.1007/s10695-012-9758-2; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Monie TP, 2009, TRENDS BIOCHEM SCI, V34, P553, DOI 10.1016/j.tibs.2009.06.011; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Oehlers SH, 2011, DIS MODEL MECH, V4, P832, DOI 10.1242/dmm.006122; Parkhouse R, 2014, FEBS LETT, V588, P2830, DOI 10.1016/j.febslet.2014.06.035; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Sahoo BR, 2014, MOL BIOSYST, V10, P1104, DOI 10.1039/c3mb70600a; Sahoo BR, 2013, APPL BIOCHEM BIOTECH, V170, P1282, DOI 10.1007/s12010-013-0263-6; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Suarez E, 2013, J COMPUT CHEM, V34, P2041, DOI 10.1002/jcc.23350; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Ye ZM, 2008, MOL CELL BIOL, V28, P1841, DOI 10.1128/MCB.01468-07; Yuriev E, 2013, J MOL RECOGNIT, V26, P215, DOI 10.1002/jmr.2266; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zurek B, 2012, INNATE IMMUN-LONDON, V18, P100, DOI 10.1177/1753425910394002	72	26	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121415	10.1371/journal.pone.0121415	http://dx.doi.org/10.1371/journal.pone.0121415			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811192	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700099
J	Arthur, B; Hindell, M; Bester, M; Trathan, P; Jonsen, I; Staniland, I; Oosthuizen, WC; Wege, M; Lea, MA				Arthur, Benjamin; Hindell, Mark; Bester, Marthan; Trathan, Phil; Jonsen, Ian; Staniland, Iain; Oosthuizen, W. Chris; Wege, Mia; Lea, Mary-Anne			Return Customers: Foraging Site Fidelity and the Effect of Environmental Variability in Wide-Ranging Antarctic Fur Seals	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; ARCTOCEPHALUS-GAZELLA; HOME-RANGE; ANIMAL MOVEMENT; NEW-ZEALAND; OCEANOGRAPHIC FEATURES; CALLORHINUS-URSINUS; MACARONI PENGUINS; MARINE PREDATOR; INDIAN-OCEAN	Strategies employed by wide-ranging foraging animals involve consideration of habitat quality and predictability and should maximise net energy gain. Fidelity to foraging sites is common in areas of high resource availability or where predictable changes in resource availability occur. However, if resource availability is heterogeneous or unpredictable, as it often is in marine environments, then habitat familiarity may also present ecological benefits to individuals. We examined the winter foraging distribution of female Antarctic fur seals, Arctocephalus gazelle, over four years to assess the degree of foraging site fidelity at two scales; within and between years. On average, between-year fidelity was strong, with most individuals utilising more than half of their annual foraging home range over multiple years. However, fidelity was a bimodal strategy among individuals, with five out of eight animals recording between-year overlap values of greater than 50%, while three animals recorded values of less than 5%. High long-term variance in sea surface temperature, a potential proxy for elevated long-term productivity and prey availability, typified areas of overlap. Within-year foraging site fidelity was weak, indicating that successive trips over the winter target different geographic areas. We suggest that over a season, changes in prey availability are predictable enough for individuals to shift foraging area in response, with limited associated energetic costs. Conversely, over multiple years, the availability of prey resources is less spatially and temporally predictable, increasing the potential costs of shifting foraging area and favouring long-term site fidelity. In a dynamic and patchy environment, multi-year foraging site fidelity may confer a long-term energetic advantage to the individual. Such behaviours that operate at the individual level have evolutionary and ecological implications and are potential drivers of niche specialization and modifiers of intra-specific competition.	[Arthur, Benjamin; Hindell, Mark; Lea, Mary-Anne] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Bester, Marthan; Oosthuizen, W. Chris; Wege, Mia] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Trathan, Phil; Staniland, Iain] British Antarctic Survey, Cambridge CB3 0ET, England; [Jonsen, Ian] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	University of Tasmania; University of Pretoria; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Macquarie University	Arthur, B (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Benjamin.Arthur@utas.edu.au	Oosthuizen, W. Chris/I-2947-2016; Bester, Marthán N/E-5387-2010; Lea, Mary-Anne/E-9054-2013; Wege, Mia/B-1103-2016	Oosthuizen, W. Chris/0000-0003-2905-6297; Lea, Mary-Anne/0000-0001-8318-9299; Wege, Mia/0000-0002-9022-3069; Arthur, Benjamin/0000-0002-1390-5760; Staniland, Iain/0000-0003-2736-9134; Hindell, Mark/0000-0002-7823-7185; Chiaradia, Andre/0000-0002-6178-4211; Jonsen, Ian/0000-0001-5423-6076	Australian Research Council; Sea World Research and Rescue Foundation Inc. Australia [SWR/6/2013]; Holsworth Wildlife Research Endowment [L0020491]; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Australian Research Council(Australian Research Council); Sea World Research and Rescue Foundation Inc. Australia; Holsworth Wildlife Research Endowment; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the Australian Research Council, Sea World Research and Rescue Foundation Inc. Australia (SWR/6/2013) and the Holsworth Wildlife Research Endowment (L0020491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1980, J ANIM ECOL, V49, P175, DOI 10.2307/4282; [Anonymous], 2013, ADEHABITATHR HOME RA; Ansorge IJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022588; Auge AA, 2014, ANIM CONSERV, V17, P61, DOI 10.1111/acv.12056; Authier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032026; Avens L, 2003, MAR BIOL, V143, P211, DOI 10.1007/s00227-003-1085-9; Bailleul F, 2005, MAR ECOL PROG SER, V293, P273, DOI 10.3354/meps293273; Baylis AMM, 2012, MAR MAMMAL SCI, V28, P276, DOI 10.1111/j.1748-7692.2011.00487.x; Benoit-Bird KJ, 2013, MAR ECOL PROG SER, V479, P283, DOI 10.3354/meps10209; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P4; Boivin G, 2004, OECOLOGIA, V138, P640, DOI 10.1007/s00442-003-1469-z; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bonadonna F, 2001, MAR ECOL PROG SER, V223, P287, DOI 10.3354/meps223287; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Boyd IL, 1996, J MAMMAL, V77, P124, DOI 10.2307/1382714; Boyd IL, 2002, MAR ECOL PROG SER, V242, P285, DOI 10.3354/meps242285; BOYD IL, 1994, J ANIM ECOL, V63, P703, DOI 10.2307/5235; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Budillon G, 2003, ANTARCT SCI, V15, P141, DOI 10.1017/S0954102003001135; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calambokidis J, 2001, MAR MAMMAL SCI, V17, P769, DOI 10.1111/j.1748-7692.2001.tb01298.x; Call KA, 2008, DEEP-SEA RES PT II, V55, P1883, DOI 10.1016/j.dsr2.2008.04.022; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chilvers BL, 2008, J ZOOL, V276, P28, DOI 10.1111/j.1469-7998.2008.00463.x; Coleman JTH, 2005, WATERBIRDS, V28, P498, DOI 10.1675/1524-4695(2005)28[498:FLASFO]2.0.CO;2; Cottin M, 2012, MAR BIOL, V159, P1843, DOI 10.1007/s00227-012-1974-x; COWIE RJ, 1977, NATURE, V268, P137, DOI 10.1038/268137a0; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; DOWER KM, 1993, MAR ECOL PROG SER, V95, P141, DOI 10.3354/meps095141; Dragon A.-C., 2011, KERGUELEN PLATEAU MA, P57; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; FRESNEAU D, 1985, INSECT SOC, V32, P109, DOI 10.1007/BF02224226; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Latta SC, 2001, CONDOR, V103, P455, DOI 10.1650/0010-5422(2001)103[0455:WSFOPW]2.0.CO;2; Lea M.-A., 2014, BIRD ISLAND FEMALE A; Lea M-A, CIRCUMPOLAR IN PRESS; Lea M-A, 2014, OOSTHUIZEN C MARION; Lea MA, 2003, ICES J MAR SCI, V60, P990, DOI 10.1016/S1054-3139(03)00101-2; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; Lowther AD, 2011, MAR ECOL PROG SER, V443, P249, DOI 10.3354/meps09392; LUTJEHARMS JRE, 1984, DEEP-SEA RES, V31, P1461, DOI 10.1016/0198-0149(84)90082-7; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; McConnell B, 2002, J ANIM ECOL, V71, P65, DOI 10.1046/j.0021-8790.2001.00576.x; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Moore JK, 2002, J MARINE SYST, V37, P69, DOI 10.1016/S0924-7963(02)00196-3; Morris DW, 2000, ECOLOGY, V81, P2061, DOI 10.1890/0012-9658(2000)081[2061:OFMMPU]2.0.CO;2; Murphy EJ, 2007, P ROY SOC B-BIOL SCI, V274, P3057, DOI 10.1098/rspb.2007.1180; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; Orians G.H., 1979, P155; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Perry G, 1997, TRENDS ECOL EVOL, V12, P360, DOI 10.1016/S0169-5347(97)01097-5; Robson BW, 2004, CAN J ZOOL, V82, P20, DOI 10.1139/Z03-208; RYDELL J, 1989, J MAMMAL, V70, P614, DOI 10.2307/1381433; Schaefer JA, 2000, LANDSCAPE ECOL, V15, P731, DOI 10.1023/A:1008160408257; Schofield G, 2010, DIVERS DISTRIB, V16, P840, DOI 10.1111/j.1472-4642.2010.00694.x; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Shields W.M., 1988, P189; Silverman B.W., 1986, DENSITY ESTIMATION S; Sokolov S, 2002, J MARINE SYST, V37, P151, DOI 10.1016/S0924-7963(02)00200-2; STAMPS J, 1995, AM NAT, V146, P41, DOI 10.1086/285786; Staniland IJ, 2011, MAR ECOL PROG SER, V434, P183, DOI 10.3354/meps09201; Staniland IJ, 2012, MAR BIOL, V159, P291, DOI 10.1007/s00227-011-1807-3; Staniland IJ, 2004, MAR ECOL PROG SER, V275, P263, DOI 10.3354/meps275263; STEWART BS, 1995, J MAMMAL, V76, P196, DOI 10.2307/1382328; Sumner M, 2010, TRIPESTIMATION METRO; Sumner MD, 2003, REMOTE SENS ENVIRON, V84, P161, DOI 10.1016/S0034-4257(02)00103-7; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; SWITZER PV, 1993, EVOL ECOL, V7, P533, DOI 10.1007/BF01237820; Trathan PN, 2006, MAR ECOL PROG SER, V323, P239, DOI 10.3354/meps323239; Trathan PN, 1998, MAR ECOL PROG SER, V169, P263, DOI 10.3354/meps169263; Verweij MC, 2007, HYDROBIOLOGIA, V592, P257, DOI 10.1007/s10750-007-0772-9; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wolf M, 2009, ECOGRAPHY, V32, P401, DOI 10.1111/j.1600-0587.2008.05626.x	83	58	58	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120888	10.1371/journal.pone.0120888	http://dx.doi.org/10.1371/journal.pone.0120888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807082	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000351880000110
J	Bhatta, A; Yao, L; Toque, HA; Shatanawi, A; Xu, ZM; Caldwell, RB; Caldwell, RW				Bhatta, Anil; Yao, Lin; Toque, Haroldo A.; Shatanawi, Alia; Xu, Zhimin; Caldwell, Ruth B.; Caldwell, R. William			Angiotensin II-Induced Arterial Thickening, Fibrosis and Stiffening Involves Elevated Arginase Function	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PULSE-WAVE VELOCITY; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL DYSFUNCTION; VASCULAR DYSFUNCTION; COLLAGEN-SYNTHESIS; AORTIC STIFFNESS; CARDIOVASCULAR MORTALITY; ORNITHINE-DECARBOXYLASE; CORPORA CAVERNOSA	Background Arterial stiffness (AS) is an independent risk factor for cardiovascular morbidity/mortality. Smooth muscle cell (SMC) proliferation and increased collagen synthesis are key features in development of AS. Arginase (ARG), an enzyme implicated in many cardiovascular diseases, can compete with nitric oxide (NO) synthase for their common substrate, L-arginine. Increased arginase can also provide ornithine for synthesis of polyamines via ornithine decarboxylase (ODC) and proline/collagen via ornithine aminotransferase (OAT), leading to vascular cell proliferation and collagen formation, respectively. We hypothesized that elevated arginase activity is involved in Ang II-induced arterial thickening, fibrosis, and stiffness and that limiting its activity can prevent these changes. Methods and Results We tested this by studies in mice lacking one copy of the ARG1 gene that were treated with angiotensin II (Ang II, 4 weeks). Studies were also performed in rat aortic Ang II-treated SMC. InWT mice treated with Ang II, we observed aortic stiffening (pulse wave velocity) and aortic and coronary fibrosis and thickening that were associated with increases in ARG1 and ODC expression/activity, proliferating cell nuclear antigen, hydroxyproline levels, and collagen 1 protein expression. ARG1 deletion prevented each of these alterations. Furthermore, exposure of SMC to Ang II (1 mu M, 48 hrs) increased ARG1 expression, ARG activity, ODC mRNA and activity, cell proliferation, collagen 1 protein expression and hydroxyproline content. Treatment with ABH prevented these changes. Conclusion Arginase 1 is crucially involved in Ang II-induced SMC proliferation and arterial fibrosis and stiffness and represents a promising therapeutic target.	[Bhatta, Anil; Yao, Lin; Toque, Haroldo A.; Shatanawi, Alia; Caldwell, R. William] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Xu, Zhimin; Caldwell, Ruth B.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA USA; [Caldwell, Ruth B.] Charlie Norwood VA Med Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caldwell, RW (corresponding author), Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	wcaldwel@gru.edu	Shatanawi, Alia/D-2562-2015	Shatanawi, Alia/0000-0003-1092-6096; Caldwell, Ruth/0000-0003-0168-0354	National Institutes of Health [HL70215, EY11766]; NATIONAL EYE INSTITUTE [R01EY011766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL70215 (to RWC) and EY11766 (to RBC and RWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnost T, 2010, CARDIOVASC RES, V87, P569, DOI 10.1093/cvr/cvq081; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x; COOK JA, 1989, ANAL BIOCHEM, V179, P1, DOI 10.1016/0003-2697(89)90191-7; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Csiszar A, 2003, FASEB J, V17, P1183, DOI 10.1096/fj.02-1049fje; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; Das P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000899; Durante W, 2000, FASEB J, V14, P1775, DOI 10.1096/fj.99-0960com; Durante W, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00111; Elms SC, 2013, DIABETOLOGIA, V56, P654, DOI 10.1007/s00125-012-2789-5; FRONEK K, 1978, EXP MOL PATHOL, V28, P279, DOI 10.1016/0014-4800(78)90002-3; Gao X, 2007, ARTERIOSCL THROM VAS, V27, P1269, DOI 10.1161/ATVBAHA.107.142521; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; JONES ME, 1985, J NUTR, V115, P509, DOI 10.1093/jn/115.4.509; Jung C, 2010, CARDIOVASC RES, V85, P147, DOI 10.1093/cvr/cvp303; Kashyap SR, 2008, DIABETES CARE, V31, P134, DOI 10.2337/dc07-1198; KATO H, 1991, J HYPERTENS, V9, P17; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Kuo Lih, 2012, Mol Med Ther, V1; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Majeed B, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/126365; Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Munakata M, 2004, AM J HYPERTENS, V17, P1050, DOI 10.1016/j.amjhyper.2004.06.028; Narayanan SP, 2013, PROG RETIN EYE RES, V36, P260, DOI 10.1016/j.preteyeres.2013.06.002; Neves MF, 2003, J HYPERTENS, V21, P189, DOI 10.1097/00004872-200301000-00029; PAPADAKI M, 1998, AM J PHYSIOL, V274, pH616; Park S, 2012, YONSEI MED J, V53, P258, DOI 10.3349/ymj.2012.53.2.258; Patel RS, 2011, ATHEROSCLEROSIS, V218, P90, DOI 10.1016/j.atherosclerosis.2011.04.033; Peyton KJ, 2009, ARTERIOSCL THROM VAS, V29, P488, DOI 10.1161/ATVBAHA.108.183392; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; RICHMAN RA, 1971, P SOC EXP BIOL MED, V138, P880; Rizvi MAD, 1996, J MOL CELL CARDIOL, V28, P243, DOI 10.1006/jmcc.1996.0023; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Romero MJ, 2012, AM J PHYSIOL-HEART C, V302, pH159, DOI 10.1152/ajpheart.00774.2011; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Sailer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063950; Shatanawi A, 2011, AM J PHYSIOL-CELL PH, V300, pC1181, DOI 10.1152/ajpcell.00328.2010; Shoji T, 2001, J AM SOC NEPHROL, V12, P2117, DOI 10.1681/ASN.V12102117; Singh A, 1996, AM J HYPERTENS, V9, P867, DOI 10.1016/S0895-7061(96)00104-5; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Takami T, 2003, HYPERTENS RES, V26, P609, DOI 10.1291/hypres.26.609; Toque HA, 2011, J SEX MED, V8, P722, DOI 10.1111/j.1743-6109.2010.02098.x; Toque HA, 2010, J SEX MED, V7, P3857, DOI 10.1111/j.1743-6109.2010.01996.x; Vockley JG, 1996, GENOMICS, V38, P118, DOI 10.1006/geno.1996.0606; Wallace SML, 2007, HYPERTENSION, V50, P228, DOI 10.1161/HYPERTENSIONAHA.107.089391; Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409; Wang XK, 2008, CARDIOVASC THER, V26, P214, DOI 10.1111/j.1755-5922.2008.00051.x; WEBER H, 1994, J CLIN INVEST, V93, P788, DOI 10.1172/JCI117033; Wei LH, 2001, P NATL ACAD SCI USA, V98, P9260, DOI 10.1073/pnas.161294898; Zhang CH, 2010, BASIC RES CARDIOL, V105, P453, DOI 10.1007/s00395-010-0083-6	63	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121727	10.1371/journal.pone.0121727	http://dx.doi.org/10.1371/journal.pone.0121727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807386	Green Published, gold			2022-12-26	WOS:000351880000176
J	Costabile, A; Walton, GE; Tzortzis, G; Vulevic, J; Charalampopoulos, D; Gibson, GR				Costabile, Adele; Walton, Gemma E.; Tzortzis, George; Vulevic, Jelena; Charalampopoulos, Dimitris; Gibson, Glenn R.			Effects of Orange Juice Formulation on Prebiotic Functionality Using an In Vitro Colonic Model System	PLOS ONE			English	Article							DOUBLE-BLIND; GALACTO-OLIGOSACCHARIDES; OLIGONUCLEOTIDE PROBES; BACTERIAL-POPULATIONS; SITU HYBRIDIZATION; HEALTHY HUMANS; GUT MICROBIOTA; BIFIDOBACTERIUM; FERMENTATION; MODULATION	A three-stage continuous fermentative colonic model system was used to monitor in vitro the effect of different orange juice formulations on prebiotic activity. Three different juices with and without Bimuno, a GOS mixture containing galactooligosaccharides (B-GOS) were assessed in terms of their ability to induce a bifidogenic microbiota. The recipe development was based on incorporating 2.75g B-GOS into a 250 ml serving of juice (65 degrees Brix of concentrate juice). Alongside the production of B-GOS juice, a control juice - orange juice without any additional Bimuno and a positive control juice, containing all the components of Bimuno (glucose, galactose and lactose) in the same relative proportions with the exception of B-GOS were developed. Ion Exchange Chromotography analysis was used to test the maintenance of bimuno components after the production process. Data showed that sterilisation had no significant effect on concentration of B-GOS and simple sugars. The three juice formulations were digested under conditions resembling the gastric and small intestinal environments. Main bacterial groups of the faecal microbiota were evaluated throughout the colonic model study using 16S rRNA-based fluorescence in situ hybridization (FISH). Potential effects of supplementation of the juices on microbial metabolism were studied measuring short chain fatty acids (SCFAs) using gas chromatography. Furthermore, B-GOS juices showed positive modulations of the microbiota composition and metabolic activity. In particular, numbers of faecal bifidobacteria and lactobacilli were significantly higher when B-GOS juice was fermented compared to controls. Furthermore, fermentation of B-GOS juice resulted in an increase in Roseburia subcluster and concomitantly increased butyrate production, which is of potential benefit to the host. In conclusion, this study has shown B-GOS within orange juice can have a beneficial effect on the fecal microbiota.	[Costabile, Adele; Walton, Gemma E.; Charalampopoulos, Dimitris; Gibson, Glenn R.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Tzortzis, George; Vulevic, Jelena] Clasado Res Serv Ltd, Ctr Sci & Technol, Reading, Berks, England	University of Reading	Costabile, A (corresponding author), Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England.	a.costabile@reading.ac.uk	Tzortzis, George/GLU-1095-2022	Costabile, Adele/0000-0003-3185-030X	BBSRC [BB/HOO4734/1]; Clasado Ltd.; BBSRC [BB/H004734/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H004734/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Clasado Ltd.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	GW and AC were supported by the BBSRC grant (contract number BB/HOO4734/1). Jelena Vulevic and George Tzortzis, are employed by Clasado Ltd, who provided the B-GOS product used within this research. Clasado Ltd. provided support in the form of salaries for authors JV and GT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; CHERRINGTON CA, 1991, J APPL BACTERIOL, V70, P161, DOI 10.1111/j.1365-2672.1991.tb04442.x; De Slegte J, 2002, J AOAC INT, V85, P417; Depeint F, 2008, AM J CLIN NUTR, V87, P785, DOI 10.1093/ajcn/87.3.785; Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06; Fanaro S, 2009, J PEDIATR GASTR NUTR, V48, P82, DOI 10.1097/MPG.0b013e31817b6dd2; Flint HJ, 2011, J CLIN GASTROENTEROL, V45, pS128, DOI 10.1097/MCG.0b013e31821f44c4; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Fuller R, 1998, SCIENCE, V147, P747; GIBSON GR, 1994, J APPL BACTERIOL, V77, P412, DOI 10.1111/j.1365-2672.1994.tb03443.x; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; ITO M, 1990, Microbial Ecology in Health and Disease, V3, P285; Klewicki R, 2007, LWT-FOOD SCI TECHNOL, V40, P1259, DOI 10.1016/j.lwt.2006.08.008; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Lucker S, 2007, J MICROBIOL METH, V69, P523, DOI 10.1016/j.mimet.2007.02.009; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Maccaferri S, 2012, MOL NUTR FOOD RES, V56, P1342, DOI 10.1002/mnfr.201200046; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martin-Pelaez S, 2008, FEMS MICROBIOL ECOL, V66, P608, DOI 10.1111/j.1574-6941.2008.00610.x; Meydani SN, 2000, AM J CLIN NUTR, V71, P861; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Pachikian BD, 2013, MOL NUTR FOOD RES, V57, P347, DOI 10.1002/mnfr.201200364; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; Sangwan V, 2011, J FOOD SCI, V76, pR103, DOI 10.1111/j.1750-3841.2011.02131.x; Silk DBA, 2009, ALIMENT PHARM THER, V29, P508, DOI 10.1111/j.1365-2036.2008.03911.x; Steer T, 2000, NUTR RES REV, V13, P229, DOI 10.1079/095442200108729089; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Torres DPM, 2010, COMPR REV FOOD SCI F, V9, P438, DOI 10.1111/j.1541-4337.2010.00119.x; Vulevic J, 2008, AM J CLIN NUTR, V88, P1438, DOI 10.3945/ajcn.2008.26242; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005	34	20	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121955	10.1371/journal.pone.0121955	http://dx.doi.org/10.1371/journal.pone.0121955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807417	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000351880000192
J	Reid, AT; Anderson, AL; Roman, SD; McLaughlin, EA; McCluskey, A; Robinson, PJ; Aitken, RJ; Nixon, B				Reid, Andrew T.; Anderson, Amanda L.; Roman, Shaun D.; McLaughlin, Eileen A.; McCluskey, Adam; Robinson, Phillip J.; Aitken, R. John; Nixon, Brett			Glycogen synthase kinase 3 regulates acrosomal exocytosis in mouse spermatozoa via dynamin phosphorylation	FASEB JOURNAL			English	Article						acrosome reaction; sperm maturation; epididymal dense bodies	BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; MALE REPRODUCTIVE-TRACT; SPERM MOTILITY; SERINE PHOSPHORYLATION; PHOSPHATASE 1; MEMBRANE; IDENTIFICATION; CAPACITATION; HEAT-SHOCK-PROTEIN-1; CHAPERONES	The dynamin family of GTPases has been implicated as novel regulators of the acrosome reaction, a unique exocytotic event that is essential for fertilization. Dynamin activity during the acrosome reaction is accompanied by phosphorylation of key serine residues. We now tested the hypothesis that glycogen synthase kinase 3 (GSK3) is the protein kinase responsible for dynamin phosphorylation at these phosphosites in mouse spermatozoa. Pharmacologic inhibition of GSK3 inmature mouse spermatozoa (CHIR99021: IC50 = 6.7 nM) led to a significant reduction in dynamin phosphorylation (10.3% vs. 27.3%; P < 0.001), acrosomal exocytosis (9.7% vs. 25.7%; P < 0.01), and in vitro fertilization (53% vs. 100%; P < 0.01). GSK3 was shown to be present in developing germ cells where it colocalized with dynamin in the peri-acrosomal domain. However, additional GSK3 was acquired by maturing mouse spermatozoa within the male reproductive tract, via a novel mechanism involving direct interaction of sperm heads with extracellular structures known as epididymal dense bodies. These data reveal a novel mode for the cellular acquisition of a protein kinase and identify a key role for GSK3 in the regulation of sperm maturation and acrosomal exocytosis.	[Reid, Andrew T.; Anderson, Amanda L.; Roman, Shaun D.; McLaughlin, Eileen A.; Aitken, R. John; Nixon, Brett] Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia; [McCluskey, Adam] Univ Newcastle, Sch Environm & Life Sci, Discipline Chem, Callaghan, NSW 2308, Australia; [Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	University of Newcastle; University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Nixon, B (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Univ Dr, Callaghan, NSW 2308, Australia.	brett.nixon@newcastle.edu.au	McLaughlin, Eileen A/G-7620-2013; Roman, Shaun/AFR-5087-2022; Robinson, Phillip J/G-4008-2011; Aitken, Robert John/AAY-8238-2020; McLaughlin, Eileen/AAF-5588-2021; Nixon, Brett/B-5121-2012; ROMAN, SHAUN/G-7047-2013	Robinson, Phillip J/0000-0002-7878-0313; Aitken, Robert John/0000-0002-9152-156X; McLaughlin, Eileen/0000-0002-5837-3876; Nixon, Brett/0000-0003-2745-8188; ROMAN, SHAUN/0000-0002-7758-7757; Reid, Andrew/0000-0001-5751-7025; McCluskey, Adam/0000-0001-7125-863X	National Health and Medical Research Council of Australia; Hunter Medical Research Institute; University of Newcastle	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; University of Newcastle	The authors are grateful for financial support from the National Health and Medical Research Council of Australia (to P.J.R. and A.M.), the Hunter Medical Research Institute (to B.N. and E.A.M.), and the University of Newcastle (to B.N., E.A.M., and A.M.). The authors declare no conflicts of interest.	Aitken RJ, 2007, ASIAN J ANDROL, V9, P554, DOI 10.1111/j.1745-7262.2007.00280.x; AITKEN RJ, 1993, J ANDROL, V14, P132; Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Ando S, 2005, MOL CELL ENDOCRINOL, V245, P1, DOI 10.1016/j.mce.2005.09.011; Aparicio IM, 2007, REPRODUCTION, V134, P435, DOI 10.1530/REP-06-0388; Aquila S, 2005, J CLIN ENDOCR METAB, V90, P4753, DOI 10.1210/jc.2004-2233; Asquith KL, 2005, BIOL REPROD, V72, P328, DOI 10.1095/biolreprod.104.034470; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Ballester J, 2000, MOL REPROD DEV, V56, P207, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;207::AID-MRD12&gt;3.0.CO;2-4; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dun MD, 2011, J BIOL CHEM, V286, P36875, DOI 10.1074/jbc.M110.188888; Dun Matthew D, 2010, Handb Exp Pharmacol, P139, DOI 10.1007/978-3-642-02062-9_9; Etter G, 2014, HIPPOCAMPUS, V24, P725, DOI 10.1002/hipo.22280; Frayne J, 1998, MOL REPROD DEV, V49, P454, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt;454::AID-MRD13&gt;3.0.CO;2-U; Guo TB, 2003, J ANDROL, V24, P332; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; Haidl G, 1997, HUM REPROD, V12, P2720, DOI 10.1093/humrep/12.12.2720; Holz RW, 2013, SCIENCE, V339, P1392, DOI 10.1126/science.1236005; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Jones R, 2007, ASIAN J ANDROL, V9, P438, DOI 10.1111/j.1745-7262.2007.00282.x; Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085; Krapf D, 2012, DEV BIOL, V369, P43, DOI 10.1016/j.ydbio.2012.06.017; Li K, 2013, REPRODUCTION, V146, P135, DOI 10.1530/REP-13-0127; Lin MJ, 2006, BIOL REPROD, V75, P588, DOI 10.1095/biolreprod.106.052712; Martin TFJ, 2003, BBA-MOL CELL RES, V1641, P157, DOI 10.1016/S0167-4889(03)00093-4; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Monclus MDLA, 2007, ANAT REC, V290, P814, DOI 10.1002/ar.20555; MORTIMER D, 1987, J REPROD FERTIL, V81, P127; Mulherkar N, 2011, VIROLOGY, V419, P72, DOI 10.1016/j.virol.2011.08.009; Nakamura N, 2010, BIOL REPROD, V82, P504, DOI 10.1095/biolreprod.109.080580; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; NIKOLOPOULOU M, 1985, BIOCHIM BIOPHYS ACTA, V815, P486, DOI 10.1016/0005-2736(85)90377-3; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Redgrove KA, 2011, DEV BIOL, V356, P460, DOI 10.1016/j.ydbio.2011.05.674; Reid AT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392803; Rosales JL, 2004, J BIOL CHEM, V279, P1224, DOI 10.1074/jbc.M310867200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Somanath PR, 2004, J ANDROL, V25, P605; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tardif S, 2012, MOL HUM REPROD, V18, P298, DOI 10.1093/molehr/gas009; Vemuganti SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-285; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Vijayaraghavan S, 2000, BIOL REPROD, V62, P1647, DOI 10.1095/biolreprod62.6.1647; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Yano R, 2010, J ANDROL, V31, P201, DOI 10.2164/jandrol.109.007880; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035892	53	16	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2872	2882		10.1096/fj.14-265553	http://dx.doi.org/10.1096/fj.14-265553			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25808536				2022-12-26	WOS:000356859100017
J	Asfaw, A; Ali, D; Eticha, T; Alemayehu, A; Alemayehu, M; Kindeya, F				Asfaw, Addisu; Ali, Dagim; Eticha, Tadele; Alemayehu, Adissu; Alemayehu, Mussie; Kindeya, Filmon			CD4 Cell Count Trends after Commencement of Antiretroviral Therapy among HIV-Infected Patients in Tigray, Northern Ethiopia: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; INITIATION; AFRICA; MORTALITY; CD4+COUNT; RECOVERY; OUTCOMES	Background The rate and extent of CD4 cell recovery varies widely among HIV-infected patients with different baseline CD4 cell count strata. The objective of the study was to assess trends in CD4 cell counts in HIV-infected patients after initiation of antiretroviral therapy in Tigray, Northern Ethiopia. Methods A retrospective cross-sectional study was conducted by reviewing medical records of HIV patients who received antiretroviral treatment at twenty health centers in Tigray region during 2008-2012. Multi-stage cluster sampling technique was employed to collect data, and the data were analyzed using SPSS version 20.0 software. Results The median change from baseline to the most recent CD4 cell count was +292 cells/mu l. By 5 years, the overall median (inter-quartile range, IQR) CD4 cell count was 444(263-557) cells/mu l while the median (IQR) CD4 cell count was 342(246-580) cells/mu l among patients with baseline CD4 cell counts <= 200 cells/mu l, 500(241-557) cells/mu l among those with baseline CD4 cell counts of 201-350 cells/mu l, and 652(537-767) cells/mu l among those with baseline CD4 cell counts >350 cells/mu l. Higher baseline CD4 cell counts and being male were independently associated with the risk of immunological non-response at 12 months. Furthermore, it was also investigated that these factors were significant predictors of subsequent CD4 cell recovery. Conclusions Patients with higher baseline CD4 cell stratum returned to normal CD4 Cell counts though they had an increased risk of immunological non-response at 12 months compared to those with the least baseline CD4 cell stratum. The findings suggest that consideration be given to initiation of HAART at a CD4 cell count >350 cells/mu l to achieve better immune recovery, and to HIV-infected male patients to improve their health seeking behavior.	[Asfaw, Addisu; Ali, Dagim; Eticha, Tadele; Alemayehu, Adissu] Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia; [Alemayehu, Mussie] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia; [Kindeya, Filmon] Tigray Reg Hlth Bur, Social Mobilizat, Advocacy & Commun HIV Div, Mekelle, Ethiopia	Mekelle University; Mekelle University	Eticha, T (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Pharm, Mekelle, Ethiopia.	td.eticha@gmail.com	Alemayehu, Mussie/AAH-3016-2019	Alemayehu, Mussie/0000-0002-0035-631X	MSH/USAID under Ethiopian Network for HIV/AIDS Treatment, Care and Support programme	MSH/USAID under Ethiopian Network for HIV/AIDS Treatment, Care and Support programme(United States Agency for International Development (USAID))	This study was funded by MSH/USAID under Ethiopian Network for HIV/AIDS Treatment, Care and Support programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anude CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-113; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Fox M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069300; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kilaru KR, 2006, HIV MED, V7, P99, DOI 10.1111/j.1468-1293.2006.00347.x; Kyaw NL, 2013, SE ASIAN J TROP MED, V44, P232; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lepri AC, 2001, AIDS, V15, P983, DOI 10.1097/00002030-200105250-00006; Malaza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070126; Michael CG, 2002, SCAND J INFECT DIS, V34, P45, DOI 10.1080/00365540110076930; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Rajasekaran S, 2009, J POSTGRAD MED, V55, P261, DOI 10.4103/0022-3859.58929; Reda AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058595; Shastri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072188; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; WHO, 2010, ANT THER HIV INF AD	23	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0122583	10.1371/journal.pone.0122583	http://dx.doi.org/10.1371/journal.pone.0122583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816222	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600188
J	Cao, XR; Luo, Y; Zhou, YL; Fan, JR; Xu, XM; West, JS; Duan, XY; Cheng, DF				Cao, Xueren; Luo, Yong; Zhou, Yilin; Fan, Jieru; Xu, Xiangming; West, Jonathan S.; Duan, Xiayu; Cheng, Dengfa			Detection of Powdery Mildew in Two Winter Wheat Plant Densities and Prediction of Grain Yield Using Canopy Hyperspectral Reflectance	PLOS ONE			English	Article							LEAF-AREA INDEX; VEGETATION INDEXES; DISEASE DETECTION; BROAD-BAND; SEVERITY; MIXTURES; BARLEY; RUST	To determine the influence of plant density and powdery mildew infection of winter wheat and to predict grain yield, hyperspectral canopy reflectance of winter wheat was measured for two plant densities at Feekes growth stage (GS) 10.5.3, 10.5.4, and 11.1 in the 2009-2010 and 2010-2011 seasons. Reflectance in near infrared (NIR) regions was significantly correlated with disease index at GS 10.5.3, 10.5.4, and 11.1 at two plant densities in both seasons. For the two plant densities, the area of the red edge peak (Sigma(dr680-760 nm)), difference vegetation index (DVI), and triangular vegetation index (TVI) were significantly correlated negatively with disease index at three GSs in two seasons. Compared with other parameters Sigma(dr680-760 nm) was the most sensitive parameter for detecting powdery mildew. Linear regression models relating mildew severity to Sigma(dr680-760 nm) were constructed at three GSs in two seasons for the two plant densities, demonstrating no significant difference in the slope estimates between the two plant densities at three GSs. Sigma(dr680-760) (nm) was correlated with grain yield at three GSs in two seasons. The accuracies of partial least square regression (PLSR) models were consistently higher than those of models based on Sigma(dr680760 nm) for disease index and grain yield. PLSR can, therefore, provide more accurate estimation of disease index of wheat powdery mildew and grain yield using canopy reflectance.	[Cao, Xueren; Zhou, Yilin; Fan, Jieru; Duan, Xiayu; Cheng, Dengfa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Cao, Xueren] Chinese Acad Trop Agr Sci, Key Lab Integrated Pest Management Trop Crops, Minist Agr, Environm & Plant Protect Inst, Haikou, Peoples R China; [Luo, Yong] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [Xu, Xiangming] East Malling Res, East Malling, Kent, England; [West, Jonathan S.] Rothamsted Res, Harpenden, Herts, England	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; China Agricultural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Zhou, YL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yilinzhou6@aliyun.com	West, Jonathan S/D-6098-2011; Xu, Xiangming/I-3050-2014	West, Jonathan S/0000-0002-5211-2405; Xu, Xiangming/0000-0002-4567-7117	National Key Basic Research Program of China [2013CB127704, 2010CB951503]; Special Fund for Agro-Scientific Research in the Public Interest [201303016]; National Key Technology R&D Programs of China [2012BAD19B04]	National Key Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-Scientific Research in the Public Interest; National Key Technology R&D Programs of China(National Key Technology R&D Program)	This work was financially supported by National Key Basic Research Program of China (2013CB127704, 2010CB951503), Special Fund for Agro-Scientific Research in the Public Interest (201303016), and National Key Technology R&D Programs of China (2012BAD19B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio N, 2000, AGRON J, V92, P83, DOI 10.2134/agronj2000.92183x; Babar MA, 2006, CROP SCI, V46, P578, DOI 10.2135/cropsci2005.0059; Bauriegel E, 2011, COMPUT ELECTRON AGR, V75, P304, DOI 10.1016/j.compag.2010.12.006; Bock CH, 2010, CRIT REV PLANT SCI, V29, P59, DOI 10.1080/07352681003617285; Bravo C, 2003, BIOSYST ENG, V84, P137, DOI 10.1016/S1537-5110(02)00269-6; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Cao XR, 2014, J INTEGR AGR, V13, P1530, DOI 10.1016/S2095-3119(14)60806-6; Cao XR, 2013, CROP PROT, V45, P124, DOI 10.1016/j.cropro.2012.12.002; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; FILELLA I, 1995, CROP SCI, V35, P1400, DOI 10.2135/cropsci1995.0011183X003500050023x; Finckh MR, 1999, PLANT PATHOL, V48, P807, DOI 10.1046/j.1365-3059.1999.00398.x; Franke J, 2007, PRECIS AGRIC, V8, P161, DOI 10.1007/s11119-007-9036-y; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Garrett KA, 2000, PHYTOPATHOLOGY, V90, P1313, DOI 10.1094/PHYTO.2000.90.12.1313; GAUSMAN HW, 1985, GRADUATE STUDIES TEX, V29, P78; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Gitelson AA, 2001, PHOTOCHEM PHOTOBIOL, V74, P38, DOI 10.1562/0031-8655(2001)074&lt;0038:OPANEO&gt;2.0.CO;2; Gong P, 2002, INT J REMOTE SENS, V23, P1827, DOI 10.1080/01431160110075622; Graeff S, 2006, CENT EUR J BIOL, V1, P275, DOI 10.2478/s11535-006-0020-8; Guan J, 2002, COMPUT ELECTRON AGR, V37, P97, DOI 10.1016/S0168-1699(02)00113-8; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; HATFIELD JL, 1993, CROP PROT, V12, P403, DOI 10.1016/0261-2194(93)90001-Y; Hikishima M, 2010, TROP PLANT PATHOL, V35, P96, DOI 10.1590/S1982-56762010000200004; JACKSON RD, 1986, ANNU REV PHYTOPATHOL, V24, P265, DOI 10.1146/annurev.py.24.090186.001405; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; Kobayashi Takashi, 2003, Journal of General Plant Pathology, V69, P17, DOI 10.1007/s10327-002-0006-y; LARGE EC, 1954, PLANT PATHOL, V3, P128, DOI [10.1111/j.1365-3059.1954.tb00687.x, 10.1111/j.1365-3059.1954.tb00674.x]; Larsolle A, 2007, PRECIS AGRIC, V8, P37, DOI 10.1007/s11119-006-9027-4; Liu W.C., 1994, PLANT PROTECTION TEC, V6, P17; LORENZEN B, 1989, REMOTE SENS ENVIRON, V27, P201, DOI 10.1016/0034-4257(89)90018-7; Mahlein AK, 2010, PRECIS AGRIC, V11, P413, DOI 10.1007/s11119-010-9180-7; Merton R., 1999, P 8 ANN JPL AIRB EAR; Merzlyak MN, 1999, PHYSIOL PLANTARUM, V106, P135, DOI 10.1034/j.1399-3054.1999.106119.x; Moshou D, 2004, COMPUT ELECTRON AGR, V44, P173, DOI 10.1016/j.compag.2004.04.003; Myers V. I., 1983, Manual of remote sensing. Volume 2. Interpretation and applications, P2111; NILSSON HE, 1995, ANNU REV PHYTOPATHOL, V33, P489, DOI 10.1146/annurev.py.33.090195.002421; Nutter FW, 1996, CROP PROT, V15, P135, DOI 10.1016/0261-2194(95)00084-4; Prasad B, 2007, CROP SCI, V47, P1426, DOI 10.2135/cropsci2006.07.0492; Reynolds GJ, 2012, PLANT DIS, V96, P497, DOI 10.1094/PDIS-11-10-0831; Rodriguez D, 2006, AUST J AGR RES, V57, P781, DOI 10.1071/AR05361; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; SAARI EE, 1975, PLANT DIS REP, V59, P377; Schepers H. T. A. M., 1996, Bulletin OEPP, V26, P623, DOI 10.1111/j.1365-2338.1996.tb01505.x; Scotford IM, 2005, BIOSYST ENG, V90, P235, DOI 10.1016/j.biosystemseng.2004.11.010; Sheng BQ, 1991, BEIJING AGR SCI, V1, P38; Steddom K, 2003, PHYTOPATHOLOGY, V93, P720, DOI 10.1094/PHYTO.2003.93.6.720; Sun H, 2010, SPECTROSC SPECT ANAL, V30, P192, DOI 10.3964/j.issn.1000-0593(2010)01-0192-05; Thenkabail PS, 2002, PHOTOGRAMM ENG REM S, V68, P607; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; Tsai Fuan, 1998, REMOTE SENS ENVIRON, V66, P4151; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; West JS, 2003, ANNU REV PHYTOPATHOL, V41, P593, DOI 10.1146/annurev.phyto.41.121702.103726; Whaley JM, 2000, ANN APPL BIOL, V137, P165, DOI 10.1111/j.1744-7348.2000.tb00048.x; WOLFE MS, 1984, PLANT PATHOL, V33, P451, DOI 10.1111/j.1365-3059.1984.tb02868.x; Yang CM, 2010, PRECIS AGRIC, V11, P61, DOI 10.1007/s11119-009-9122-4; Yuan L, 2014, FIELD CROP RES, V156, P199, DOI 10.1016/j.fcr.2013.11.012; Zhang JC, 2012, COMPUT ELECTRON AGR, V85, P13, DOI 10.1016/j.compag.2012.03.006; Zhang JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093107; Zhang M., 2003, INT J APPL EARTH OBS, V4, P295, DOI 10.1016/S0303-2434(03)00008-4	60	24	29	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121462	10.1371/journal.pone.0121462	http://dx.doi.org/10.1371/journal.pone.0121462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25815468	Green Published, gold, Green Submitted			2022-12-26	WOS:000352133600096
J	Chavan, SG; Deobagkar, DD				Chavan, Sonali Gopichand; Deobagkar, Deepti Dileep			An In Silico Insight into Novel Therapeutic Interaction of LTNF Peptide-LT10 and Design of Structure Based Peptidomimetics for Putative Anti-Diabetic Activity	PLOS ONE			English	Article							INSULIN-DEGRADING ENZYME; TYPE-2 DIABETES-MELLITUS; STRUCTURE PREDICTION; ACCURATE DOCKING; FORCE-FIELD; PEP-FOLD; PROTEIN; DYNAMICS; GLIDE; DEGRADATION	Lethal Toxin Neutralizing Factor (LTNF) obtained from Opossum serum (Didephis virginiana) is known to exhibit toxin-neutralizing activity for envenomation caused by animals, plants and bacteria. Small synthetic peptide-LT10 (10mer) derived from N-terminal fraction of LTNF exhibit similar anti-lethal and anti-allergic property. In our in silico study, we identified Insulin Degrading Enzyme (IDE) as a potential target of LT10 peptide followed by molecular docking and molecular dynamic (MD) simulation studies which revealed relatively stable interaction of LT10 peptide with IDE. Moreover, their detailed interaction analyses dictate IDE-inhibitory interactions of LT10 peptide. This prediction ofLT10 peptide as a novel putative IDE-inhibitor suggests its possible role in anti-diabetic treatment since IDE-inhibitors are known to assist treatment of Diabetes mellitus by enhancing insulin signalling. Furthermore, series of structure based peptidomimetics were designed from LT10 peptide and screened for their inhibitory interactions which ultimately led to a small set of peptidomimetic inhibitors of IDE. These peptidomimetic thus might provide a new class of IDE-inhibitors, those derived from LT10 peptide.	[Chavan, Sonali Gopichand; Deobagkar, Deepti Dileep] Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India; [Deobagkar, Deepti Dileep] Univ Pune, Dept Zool, Ctr Adv Studies, Pune, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University	Deobagkar, DD (corresponding author), Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India.	deepti.deobagkar@gmail.com			DST-PURSE	DST-PURSE	Funding for this work was provided by DST-PURSE (http://www.fist-dst.org/html-flies/purse.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Chavan S, 2014, SILICO MOL INTERACTI; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1981, ENDOCR REV, V2, P210, DOI 10.1210/edrv-2-2-210; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Giugliano D, 2009, ACTA DIABETOL, V46, P173, DOI 10.1007/s00592-009-0134-3; Goede A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-11; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hulse RE, 2009, VITAM HORM, V80, P635, DOI 10.1016/S0083-6729(08)00622-5; HUMPHREYS DD, 1994, J PHYS CHEM-US, V98, P6885, DOI 10.1021/j100078a035; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kinnings SL, 2011, J CHEM INF MODEL, V51, P624, DOI 10.1021/ci1003174; Leissring MA, 2006, NATURE, V443, P761, DOI 10.1038/nature05210; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; LIPPS B., 2000, J VENOM ANIM TOXINS, V6, P77; LIPPS B. V., 2002, J. Venom. Anim. Toxins, V8, P214, DOI 10.1590/S0104-79302002000200003; Lipps B.V., 1999, J VENOM ANIM TOXINS, V5, P56, DOI [10.1590/S0104-79301999000100005, DOI 10.1590/S0104-79301999000100005]; Makarova KS, 1999, J MOL BIOL, V292, P11, DOI 10.1006/jmbi.1999.3059; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; MIRSKY IA, 1955, SCIENCE, V122, P559, DOI 10.1126/science.122.3169.559; MIRSKY IA, 1957, RECENT PROG HORM RES, V13, P429; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; Ver Lipps B, FOOD POISONING TOXIN; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	41	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2015	10	3							e0121860	10.1371/journal.pone.0121860	http://dx.doi.org/10.1371/journal.pone.0121860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8ZT	25816209	Green Published, Green Submitted, gold			2022-12-26	WOS:000352133600124
J	Bartonkova, I; Novotna, A; Dvorak, Z				Bartonkova, Iveta; Novotna, Aneta; Dvorak, Zdenek			Novel Stably Transfected Human Reporter Cell Line AIZ-AR as a Tool for an Assessment of Human Androgen Receptor Transcriptional Activity	PLOS ONE			English	Article							CHEMICALS; ESTROGEN	Androgen receptor plays multiple physiological and pathological roles in human organism. In the current paper, we describe construction and characterization of a novel stably transfected human reporter cell line AIZ-AR for assessment of transcriptional activity of human androgen receptor. Cell line AIZ-AR is derived from human prostate carcinoma epithelial cell line 22Rv1 that was transfected with reporter plasmid containing 3 copies of androgen response regions (ARRs) followed by a single copy of androgen response element (ARE) from the promoter region of human prostate specific antigen (PSA) gene. AIZ-AR cells remained fully functional for more than 60 days and over 25 passages in the culture and even after cryopreservation. Time-course analyses showed that AIZ-AR cells allow detection of AR ligands as soon as after 8 hours of the treatment. We performed dose-response analyses with 23 steroids in 96-well plate format. We observed activation of AR by androgens, but not by estrogens and mineralocorticoids. Some glucocorticoids and progesterone also induced luciferase, but their potencies were 2-3 orders of magnitude weaker as compared to androgens. Taken together, we have developed a rapid, sensitive, selective, high-throughput and reproducible tool for detection of human AR ligands, with potential use in pharmacological and environmental applications.	[Bartonkova, Iveta; Novotna, Aneta; Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic.	moulin@email.cz	Grycova, Aneta/AGH-1515-2022	Grycova, Aneta/0000-0002-2134-1125; Dvorak, Zdenek/0000-0002-3938-3585	Czech Scientific Agency GACR [303/12/G163]	Czech Scientific Agency GACR(Grant Agency of the Czech Republic)	The authors' laboratory is supported by the grant from Czech Scientific Agency GACR 303/12/G163. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankvoort BMG, 2001, ANAL BIOCHEM, V298, P93, DOI 10.1006/abio.2001.5352; CHANG CS, 1995, CRIT REV EUKAR GENE, V5, P97, DOI 10.1615/CritRevEukarGeneExpr.v5.i2.10; Gauthier S, 2012, J STEROID BIOCHEM, V132, P93, DOI 10.1016/j.jsbmb.2012.02.006; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; JENSTER G, 1993, BIOCHEM J, V293, P761, DOI 10.1042/bj2930761; Kassotis CD, 2014, ENDOCRINOLOGY, V155, P897, DOI 10.1210/en.2013-1697; Mertl J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100952; Orton F, 2014, TOXICOL APPL PHARM, V278, P201, DOI 10.1016/j.taap.2013.09.008; Ostby J, 1999, TOXICOL IND HEALTH, V15, P80; Sonneveld E, 2005, TOXICOL SCI, V83, P136, DOI 10.1093/toxsci/kfi005; Terouanne B, 2000, MOL CELL ENDOCRINOL, V160, P39, DOI 10.1016/S0303-7207(99)00251-8; Vinggaard AM, 1999, TOXICOL APPL PHARM, V155, P150, DOI 10.1006/taap.1998.8598; Vinggaard AM, 2008, CHEM RES TOXICOL, V21, P813, DOI 10.1021/tx7002382; Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69	14	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121316	10.1371/journal.pone.0121316	http://dx.doi.org/10.1371/journal.pone.0121316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811655	gold, Green Published, Green Submitted			2022-12-26	WOS:000356353700094
J	Bernal-Bernal, D; Gallego-Garcia, A; Garcia-Martinez, G; Garcia-Heras, F; Jimenez, MA; Padmanabhan, S; Elias-Arnanz, M				Bernal-Bernal, Diego; Gallego-Garcia, Aranzazu; Garcia-Martinez, Gema; Garcia-Heras, Francisco; Angeles Jimenez, Maria; Padmanabhan, S.; Elias-Arnanz, Montserrat			Structure-Function Dissection of Myxococcus xanthus CarD N-Terminal Domain, a Defining Member of the CarD_CdnL_TRCF Family of RNA Polymerase Interacting Proteins	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; BACTERIAL; BETA; COMPLEX; EXPRESSION; BACKBONE; REVEALS; MODULES	Two prototypes of the large CarD_CdnL_TRCF family of bacterial RNA polymerase (RNAP)-binding proteins, Myxococcus xanthus CarD and CdnL, have distinct functions whose molecular basis remain elusive. CarD, a global regulator linked to the action of several extracytoplasmic function (ECF) sigma-factors, binds to the RNAP beta subunit (RNAP-beta) and to protein CarG via an N-terminal domain, CarDNt, and to DNA via an intrinsically unfolded C-terminal domain resembling eukaryotic high-mobility-group A (HMGA) proteins. CdnL, a CarDNt-like protein that is essential for cell viability, is implicated in sigma(A)-dependent rRNA promoter activation and interacts with RNAP-beta but not with CarG. While the HMGA-like domain of CarD by itself is inactive, we find that CarDNt has low but observable ability to activate ECF sigma-dependent promoters in vivo, indicating that the C-terminal DNA-binding domain is required to maximize activity. Our structure-function dissection of CarDNt reveals an N-terminal, five-stranded beta -sheet Tudor-like domain, CarD(1-72), whose structure and contacts with RNAP-beta mimic those of CdnL. Intriguingly, and in marked contrast to CdnL, CarD mutations that disrupt its interaction with RNAP-beta did not annul activity. Our data suggest that the CarDNt C-terminal segment, CarD(61-179), may be structurally distinct from its CdnL counterpart, and that it houses at least two distinct and crucial function determinants: (a) CarG-binding, which is specific to CarD; and (b) a basic residue stretch, which is also conserved and functionally required in CdnL. This study highlights the evolution of shared and divergent interactions in similar protein modules that enable the distinct activities of two related members of a functionally important and widespread bacterial protein family.	[Bernal-Bernal, Diego; Gallego-Garcia, Aranzazu; Garcia-Martinez, Gema; Garcia-Heras, Francisco; Elias-Arnanz, Montserrat] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Area Genet Unidad Asociada,IQFR,CSIC, Murcia, Spain; [Angeles Jimenez, Maria; Padmanabhan, S.] CSIC, IQFR, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Jimenez, MA (corresponding author), CSIC, IQFR, Madrid, Spain.	melias@um.es; padhu@iqfr.csic.es; majimenez@iqfr.csic.es	Padmanabhan, S./E-8943-2017; Jimenez, M. Angeles/C-7193-2008; Elías-Arnanz, Montserrat/H-4707-2015	Jimenez, M. Angeles/0000-0001-6835-5850; Elías-Arnanz, Montserrat/0000-0003-1980-3092; Padmanabhan, S./0000-0002-8772-0152; Gallego Garcia, Aranzazu/0000-0001-6149-0742	Ministerio de Ciencia e Innovacion, Spain; Ministerio de Economia y Competitividad, Spain [BFU2012-40184-C02-02, CTQ2011-22514, BFU2012-40184-C02-01]; European Union; Ministerio de Economia y Competitividad, Spain	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad, Spain(Spanish Government); European Union(European Commission); Ministerio de Economia y Competitividad, Spain(Spanish Government)	This work was supported by Ministerio de Ciencia e Innovacion, Spain, and Ministerio de Economia y Competitividad, Spain [grants BFU2012-40184-C02-02 to SP, CTQ2011-22514 to MAJ, and BFU2012-40184-C02-01 co-financed by the European Union to MEA.; Ph.D. fellowships to DBB. and AGG]. Funding for open access: Ministerio de Economia y Competitividad, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellon-Ruiz J, 2014, ENVIRON MICROBIOL, V16, P2475, DOI 10.1111/1462-2920.12386; Arkov AL, 2010, TRENDS CELL BIOL, V20, P482, DOI 10.1016/j.tcb.2010.05.004; Cayuela ML, 2003, J BACTERIOL, V185, P3527, DOI 10.1128/JB.185.12.3527-3537.2003; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Elias-Arnanz M, 2010, FEMS MICROBIOL REV, V34, P764, DOI 10.1111/j.1574-6976.2010.00235.x; Elias-Arnanz M, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P211; Gallego-Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108946; Gallego-Garcia A, 2012, J BIOMOL NMR, V53, P355, DOI 10.1007/s10858-012-9648-z; Garcia-Heras F, 2013, J BACTERIOL, V195, P378, DOI [10.1128/JB.01766-12, DOI 10.1128/JB.01766-12]; Garcia-Heras F, 2009, P NATL ACAD SCI USA, V106, P13546, DOI 10.1073/pnas.0902233106; Garcia-Moreno D, 2010, NUCLEIC ACIDS RES, V38, P4586, DOI 10.1093/nar/gkq214; Garner AL, 2014, MOL MICROBIOL, V93, P682, DOI 10.1111/mmi.12681; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gulten G, 2013, STRUCTURE, V21, P1859, DOI 10.1016/j.str.2013.08.014; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HODGSON DA, 1993, MOL MICROBIOL, V7, P471, DOI 10.1111/j.1365-2958.1993.tb01138.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Kaur G, 2014, PROTEINS, V82, P879, DOI 10.1002/prot.24419; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Landick R, 2014, GENOM DATA, V2, P110, DOI 10.1016/j.gdata.2014.05.012; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mirassou Y, 2013, BIOMOL NMR ASSIGN, V7, P51, DOI 10.1007/s12104-012-9375-0; Mirassou Y, 2009, BIOMOL NMR ASSIGN, V3, P9, DOI 10.1007/s12104-008-9128-2; NICOLAS FJ, 1994, GENE DEV, V8, P2375, DOI 10.1101/gad.8.19.2375; Nicolas FJ, 1996, P NATL ACAD SCI USA, V93, P6881, DOI 10.1073/pnas.93.14.6881; Padmanabhan S, 2001, J BIOL CHEM, V276, P41566, DOI 10.1074/jbc.M106352200; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Penalver-Mellado M, 2006, MOL MICROBIOL, V61, P910, DOI 10.1111/j.1365-2958.2006.05289.x; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; Rohl CA, 1997, BIOCHEMISTRY-US, V36, P8435, DOI 10.1021/bi9706677; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Srivastava DB, 2013, P NATL ACAD SCI USA, V110, P12619, DOI 10.1073/pnas.1308270110; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; Whitworth DE, 2004, J BACTERIOL, V186, P7836, DOI 10.1128/JB.186.23.7836-7846.2004; Yang XF, 2008, INFECT IMMUN, V76, P4439, DOI 10.1128/IAI.00740-08	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121322	10.1371/journal.pone.0121322	http://dx.doi.org/10.1371/journal.pone.0121322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811865	Green Published, gold			2022-12-26	WOS:000356353700096
J	Chen, C; Khismatullin, DB				Chen, Chong; Khismatullin, Damir B.			Oxidized Low-Density Lipoprotein Contributes to Atherogenesis via Co-activation of Macrophages and Mast Cells	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; TNF-ALPHA; P-SELECTIN; ATHEROSCLEROTIC PLAQUE; SHOULDER REGION; LDL; EXPRESSION; HISTAMINE	Oxidized low-density lipoprotein (OxLDL) is a risk factor for atherosclerosis, due to its role in endothelial dysfunction and foam cell formation. Tissue-resident cells such as macrophages and mast cells release inflammatory mediators upon activation that in turn cause endothelial activation and monocyte adhesion. Two of these mediators are tumor necrosis factor (TNF)-alpha, produced by macrophages, and histamine, produced by mast cells. Static and microfluidic flow experiments were conducted to determine the number of adherent monocytes on vascular endothelium activated by supernatants of oxLDL-treated macrophages and mast cells or directly by oxLDL. The expression of adhesion molecules on activated endothelial cells and the concentration of TNF-alpha and histamine in the supernatants were measured by flow cytometry and enzyme-linked immunosorbent assay, respectively. A low dose of oxLDL (8 mu g/ml), below the threshold for the clinical presentation of coronary artery disease, was sufficient to activate both macrophages and mast cells and synergistically increase monocyte-endothelium adhesion via released TNF-a and histamine. The direct exposure of endothelial cells to a much higher dose of oxLDL (80 mu g/ml) had less effect on monocyte adhesion than the indirect activation via oxLDL-treated macrophages and mast cells. The results of this work indicate that the co-activation of macrophages and mast cells by oxLDL is an important mechanism for the endothelial dysfunction and atherogenesis. The observed synergistic effect suggests that both macrophages and mast cells play a significant role in early stages of atherosclerosis. Allergic patients with a lipid-rich diet may be at high risk for cardiovascular events due to high concentration of low-density lipoprotein and histamine in arterial vessel walls.	[Chen, Chong; Khismatullin, Damir B.] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA	Tulane University	Khismatullin, DB (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	damir@tulane.edu	Khismatullin, Damir B/A-2104-2012	Khismatullin, Damir B/0000-0002-7533-8132	Louisiana Board of Regents [LEQSF (2011-14)-RD-A-24, LEQSF (2007-12)-ENH-PKSFI-PRS-01]; American Heart Association [13GRNT17200013]	Louisiana Board of Regents; American Heart Association(American Heart Association)	This work was supported by Louisiana Board of Regents (https://web.laregents.org/) grants LEQSF (2011-14)-RD-A-24 and LEQSF (2007-12)-ENH-PKSFI-PRS-01 and American Heart Association (http://www.heart.org/) grant 13GRNT17200013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2003, J ALLERGY CLIN IMMUN, V112, P15, DOI 10.1067/mai.2003.1585; Amberger A, 1997, CELL STRESS CHAPERON, V2, P94, DOI 10.1379/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2; American Heart Association, HEART DIS STROK STAT; [Anonymous], CARDIOVASC RES, V32, P733; [Anonymous], AM HEART J, V138, pS419; Badimon L, 2012, ANN NY ACAD SCI, V1254, P18, DOI 10.1111/j.1749-6632.2012.06480.x; Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Bot I, 2008, CURR CARDIOL REV, V4, P170, DOI 10.2174/157340308785160624; Byfield FJ, 2006, J LIPID RES, V47, P715, DOI 10.1194/jlr.M500439-JLR200; Chen C, 2014, CANCER LETT, V345, P75, DOI 10.1016/j.canlet.2013.11.022; Chen C, 2013, INFLAMMATION, V36, P309, DOI 10.1007/s10753-012-9548-0; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Chisolm GM, 1999, J BIOL CHEM, V274, P25959, DOI 10.1074/jbc.274.37.25959; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; GEBUHRER V, 1995, BIOCHEM J, V306, P293, DOI 10.1042/bj3060293; Green CE, 2004, J IMMUNOL, V172, P7780, DOI 10.4049/jimmunol.172.12.7780; HALLER H, 1995, HYPERTENSION, V25, P511, DOI 10.1161/01.HYP.25.4.511; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Holum J, 1996, ORGANIC BIOL CHEM; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Huang Y, 1999, ARTERIOSCL THROM VAS, V19, P2640, DOI 10.1161/01.ATV.19.11.2640; Inoue N, 1998, AM J PHYSIOL-HEART C, V274, pH1928, DOI 10.1152/ajpheart.1998.274.6.H1928; Itabe H, 2011, J LIPIDS, V2011, DOI 10.1155/2011/418313; Jeziorska M, 1997, J PATHOL, V182, P115, DOI 10.1002/(SICI)1096-9896(199705)182:1<115::AID-PATH806>3.0.CO;2-9; Jeziorska M, 1998, J PATHOL, V185, P10; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; KAARTINEN M, 1994, ARTERIOSCLER THROMB, V14, P966, DOI 10.1161/01.ATV.14.6.966; KAARTINEN M, 1994, CIRCULATION, V90, P1669, DOI 10.1161/01.CIR.90.4.1669; Kaartinen M, 1996, ATHEROSCLEROSIS, V123, P123, DOI 10.1016/0021-9150(95)05794-3; KHAN BV, 1995, J CLIN INVEST, V95, P1262, DOI 10.1172/JCI117776; Knoflach M, 2005, ARCH INTERN MED, V165, P2521, DOI 10.1001/archinte.165.21.2521; KOVANEN PT, 1995, CHEM IMMUNOL, V62, P132; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; KUTSCH CL, 1993, J INVEST DERMATOL, V101, P79, DOI 10.1111/1523-1747.ep12360119; Laidlaw TM, 2011, J ALLERGY CLIN IMMUN, V127, P815, DOI 10.1016/j.jaci.2010.12.1101; Lappalainen J, 2011, ATHEROSCLEROSIS, V214, P357, DOI 10.1016/j.atherosclerosis.2010.11.024; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Li DY, 2003, ARTERIOSCL THROM VAS, V23, P816, DOI 10.1161/01.ATV.0000066685.13434.FA; Li DY, 2000, CIRCULATION, V101, P2889, DOI 10.1161/01.CIR.101.25.2889; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Ma H, 2000, ARTERIOSCL THROM VAS, V20, pE134, DOI 10.1161/01.ATV.20.12.e134; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; Marone G, 2001, INT ARCH ALLERGY IMM, V124, P249, DOI 10.1159/000053725; Mata P, 1996, ARTERIOSCL THROM VAS, V16, P1347, DOI 10.1161/01.ATV.16.11.1347; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Obarzanek E, 2001, PEDIATRICS, V107, P256, DOI 10.1542/peds.107.2.256; Ohta MY, 2000, DIABETES RES CLIN PR, V48, P171, DOI 10.1016/S0168-8227(00)00128-5; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Olsson N, 2001, CELL SIGNAL, V13, P483, DOI 10.1016/S0898-6568(01)00176-0; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; PARTHASARATHY S, 1989, P NATL ACAD SCI USA, V86, P1046, DOI 10.1073/pnas.86.3.1046; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Rajman I, 1999, BRIT J CLIN PHARMACO, V48, P125, DOI 10.1046/j.1365-2125.1999.00991.x; Rios FJO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076893; Rozenberg I, 2010, ARTERIOSCL THROM VAS, V30, P923, DOI 10.1161/ATVBAHA.109.201079; SATOH T, 1994, ATHEROSCLEROSIS, V110, P53, DOI 10.1016/0021-9150(94)90067-1; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schmidt A, 2002, ATHEROSCLEROSIS, V164, P57, DOI 10.1016/S0021-9150(02)00053-9; Simon SI, 2000, J IMMUNOL, V164, P4348, DOI 10.4049/jimmunol.164.8.4348; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Talreja J, 2004, IMMUNOLOGY, V113, P224, DOI 10.1111/j.1365-2567.2004.01946.x; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; TOMPKINS RG, 1989, AM J PHYSIOL, V257, pH452, DOI 10.1152/ajpheart.1989.257.2.H452; Vignola AM, 1996, CLIN EXP IMMUNOL, V106, P114, DOI 10.1046/j.1365-2249.1996.d01-811.x; Vora DK, 1997, CIRC RES, V80, P810; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038	71	58	61	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0123088	10.1371/journal.pone.0123088	http://dx.doi.org/10.1371/journal.pone.0123088			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811595	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700210
J	Gil-Duran, C; Rojas-Aedo, JF; Medina, E; Vaca, I; Garcia-Rico, RO; Villagran, S; Levican, G; Chavez, R				Gil-Duran, Carlos; Rojas-Aedo, Juan F.; Medina, Exequiel; Vaca, Inmaculada; Garcia-Rico, Ramon O.; Villagran, Sebastian; Levican, Gloria; Chavez, Renato			The pcz1 Gene, which Encodes a Zn(II)(2)Cys(6) Protein, Is Involved in the Control of Growth, Conidiation, and Conidial Germination in the Filamentous Fungus Penicillium roqueforti	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; ALPHA-SUBUNIT; CHRYSOGENUM; CLUSTER; PGA1	Proteins containing Zn(II)(2)Cys(6) domains are exclusively found in fungi and yeasts. Genes encoding this class of proteins are broadly distributed in fungi, but few of them have been functionally characterized. In this work, we have characterized a gene from the filamentous fungus Penicillium roqueforti that encodes a Zn(II)(2)Cys(6) protein, whose function to date remains unknown. We have named this gene pcz1. We showed that the expression of pcz1 is negatively regulated in a P. roqueforti strain containing a dominant active Gai protein, suggesting that pcz1 encodes a downstream effector that is negatively controlled by Gai. More interestingly, the silencing of pcz1 in P. roqueforti using RNAi-silencing technology resulted in decreased apical growth, the promotion of conidial germination (even in the absence of a carbon source), and the strong repression of conidiation, concomitant with the downregulation of the genes of the central conidiation pathway brlA, abaA and wetA. A model for the participation of pcz1 in these physiological processes in P. roqueforti is proposed.	[Gil-Duran, Carlos; Rojas-Aedo, Juan F.; Medina, Exequiel; Villagran, Sebastian; Levican, Gloria; Chavez, Renato] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile; [Vaca, Inmaculada] Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile; [Garcia-Rico, Ramon O.] Univ Pamplona, Fac Basic Sci, Dept Microbiol, GIMBIO Grp, Pamplona, Colombia	Universidad de Santiago de Chile; Universidad de Chile	Chavez, R (corresponding author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile.	renato.chavez@usach.cl	Garcia-Rico, Ramon Ovidio/N-4289-2019; Medina, Exequiel/AAA-9367-2022; Levican, Gloria/R-5191-2019; García-Rico, Ramón Ovidio/E-6404-2014; Vaca, Inmaculada/I-2758-2013	Garcia-Rico, Ramon Ovidio/0000-0002-2451-7958; Medina, Exequiel/0000-0002-1040-6720; Levican, Gloria/0000-0002-1275-7399; García-Rico, Ramón Ovidio/0000-0002-2451-7958; Vaca, Inmaculada/0000-0002-8952-9036; Gil-Duran, Carlos Andres/0000-0001-9638-6902; Chavez, Renato/0000-0003-1754-3610	project FONDECYT [1120833]; DICYT-USACH; CONICYT-PFCHA/Doctorado Nacional [2014-63140056, 2013-21130251]	project FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DICYT-USACH; CONICYT-PFCHA/Doctorado Nacional	This work was supported by project FONDECYT grant 1120833 (RC) and DICYT-USACH (GL, RC). CGD and JFRA have received doctoral fellowships CONICYT-PFCHA/Doctorado Nacional/2014-63140056 and CONICYT-PFCHA/Doctorado Nacional/2013-21130251, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2006, BBA-GENE STRUCT EXPR, V1759, P410, DOI 10.1016/j.bbaexp.2006.08.001; BAINBRIDGE BW, 1990, FEMS MICROBIOL LETT, V66, P113, DOI [10.1111/j.1574-6968.1990.tb03981.x, 10.1016/0378-1097(90)90267-T]; Canovas D, 2006, MOL MICROBIOL, V62, P1725, DOI 10.1111/j.1365-2958.2006.05477.x; Chang PK, 2013, APPL MICROBIOL BIOT, V97, P4289, DOI 10.1007/s00253-013-4865-2; Chavez R, 2010, MYCOSCIENCE, V51, P84, DOI 10.1007/s10267-009-0004-4; Cheeseman K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3876; Chung H, 2013, FUNGAL GENET BIOL, V61, P133, DOI 10.1016/j.fgb.2013.10.004; dEnfert C, 1997, FUNGAL GENET BIOL, V21, P163, DOI 10.1006/fgbi.1997.0975; Diaz R, 1997, GENE, V187, P247, DOI 10.1016/S0378-1119(96)00762-7; Fierro F, 1996, APPL MICROBIOL BIOT, V44, P597; Garcia-Rico RO, 2007, RES MICROBIOL, V158, P437, DOI 10.1016/j.resmic.2007.03.001; Garcia-Rico RO, 2009, INT MICROBIOL, V12, P123, DOI 10.2436/20.1501.01.89; Garcia-Rico RO, 2008, BIOCHEM CELL BIOL, V86, P57, DOI [10.1139/O07-148, 10.1139/o07-148]; Hidalgo PI, 2014, FUNGAL GENET BIOL, V62, P11, DOI 10.1016/j.fgb.2013.10.009; Ivey FD, 1996, MOL BIOL CELL, V7, P1283, DOI 10.1091/mbc.7.8.1283; Klagges C., 2012, Mycology - An International Journal on Fungal Biology, V3, P109; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; Lee BY, 2005, J MICROBIOL, V43, P523; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Park HS, 2012, CURR OPIN MICROBIOL, V15, P669, DOI 10.1016/j.mib.2012.09.006; Ravanal MC, 2012, MYCOSCIENCE, V53, P152, DOI 10.1007/s10267-011-0144-1; Seo JA, 2006, GENETICS, V172, P1535, DOI 10.1534/genetics.105.052258; Shimizu K, 2001, GENETICS, V157, P591; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Tag A, 2000, MOL MICROBIOL, V38, P658, DOI 10.1046/j.1365-2958.2000.02166.x; TAO P, 1990, P NATL ACAD SCI USA, V87, P2077, DOI 10.1073/pnas.87.6.2077; Ullan RV, 2008, J MICROBIOL METH, V75, P209, DOI 10.1016/j.mimet.2008.06.001; Yabe K, 2004, APPL MICROBIOL BIOT, V64, P745, DOI 10.1007/s00253-004-1566-x; Yu JH, 1996, EMBO J, V15, P5184, DOI 10.1002/j.1460-2075.1996.tb00903.x	30	19	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120740	10.1371/journal.pone.0120740	http://dx.doi.org/10.1371/journal.pone.0120740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811807	Green Submitted, Green Published, gold			2022-12-26	WOS:000356353700059
J	Letouzey, V; Huberlant, S; Cornille, A; Blanquer, S; Guillaume, O; Lemaire, L; Garric, X; de Tayrac, R				Letouzey, Vincent; Huberlant, Stephanie; Cornille, Arnaud; Blanquer, Sebastien; Guillaume, Olivier; Lemaire, Laurent; Garric, Xavier; de Tayrac, Renaud			Tolerance and Long-Term MRI Imaging of Gadolinium-Modified Meshes Used in Soft Organ Repair	PLOS ONE			English	Article							ABDOMINAL-WALL DEFECTS; POLYPROPYLENE MESH; HERNIA REPAIR; SURGERY; PROLAPSE; TISSUE; VISUALIZATION; PROSTHESES; IMPLANTS; BEHAVIOR	Background Synthetic meshes are frequently used to reinforce soft tissues. The aim of this translational study is to evaluate tolerance and long-term MRI visibility of two recently developed Gadolinium-modified meshes in a rat animal model. Materials and Methods Gadolinium-poly-e-caprolactone (Gd-PCL) and Gadolinium-polymethylacrylate (Gd-PMA) modified meshes were implanted in Wistar rats and their tolerance was assessed daily. Inflammation and biocompatibility of the implants were assessed by histology and immunohistochemistry after 30 days post implantation. Implants were visualised by 7T and 3T MRI at day 30 and at day 90. Diffusion of Gadolinium in the tissues of the implanted animals was assessed by Inductively Coupled Plasma Mass Spectrometry. Results Overall Gd-PMA coated implants were better tolerated as compared to those coated with Gd-PCL. In fact, Gd-PMA implants were characterised by a high ratio collagen I/III and good vascularisation of the integration tissues. High resolution images of the coated mesh were obtained in vivo with experimental 7T as well as 3T clinical MRI. Mass spectrometry analyses showed that levels of Gadolinium in animals implanted with coated mesh were similar to those of the control group. Conclusions Meshes coated with Gd-PMA are better tolerated as compared to those coated with Gd-PCL as no signs of erosion or significant inflammation were detected at 30 days post implantation. Also, Gd-PMA coated meshes were clearly visualised with both 7T and 3T MRI devices. This new technique of mesh optimisation may represent a valuable tool in soft tissue repair and management.	[Letouzey, Vincent; Huberlant, Stephanie; Cornille, Arnaud; de Tayrac, Renaud] Univ Nimes Hosp, Dept Obstet & Gynecol, F-30000 Nimes, France; [Blanquer, Sebastien; Guillaume, Olivier; Garric, Xavier] CNRS, UMR 5247, Max Mousseron Inst Biomol, Dept Artificial Polymers, F-34000 Montpellier, France; [Lemaire, Laurent] MINT, INSERM, UMR S 1066, F-49000 Angers, France	Universite de Montpellier; CHU de Nimes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Letouzey, V (corresponding author), Univ Nimes Hosp, Dept Obstet & Gynecol, Pl Pr R Debre, F-30000 Nimes, France.	vincent.letouzey@chu-nimes.fr	Garric, Xavier/ABE-6895-2021; Guillaume, Olivier/ABF-1855-2020; LEMAIRE, Laurent/A-3100-2011; guillaume, olivier/AAK-1702-2021	Guillaume, Olivier/0000-0003-0735-113X; LEMAIRE, Laurent/0000-0002-1308-9345; Blanquer, Sebastien/0000-0002-5366-6530				ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8; Alt CD, 2014, ACTA RADIOL, V55, P495, DOI 10.1177/0284185113497201; Altman D, 2011, NEW ENGL J MED, V364, P1826, DOI 10.1056/NEJMoa1009521; AMID PK, 1994, LANGENBECK ARCH CHIR, V379, P168, DOI 10.1007/BF00680113; Bellon JM, 2004, BRIT J SURG, V91, P489, DOI 10.1002/bjs.4451; Birch C, 2002, CURR OPIN OBSTET GYN, V14, P527, DOI 10.1097/00001703-200210000-00015; Blanquer S, 2012, ACTA BIOMATER, V8, P1339, DOI 10.1016/j.actbio.2011.11.009; Boyd AS, 2010, J AM ACAD DERMATOL, V62, P337, DOI 10.1016/j.jaad.2009.04.010; Coda A, 2012, HERNIA, V16, P9, DOI 10.1007/s10029-011-0868-z; de Tayrac R, 2011, INT UROGYNECOL J, V22, P775, DOI 10.1007/s00192-011-1405-4; Fischer T, 2007, EUR RADIOL, V17, P3123, DOI 10.1007/s00330-007-0678-y; Franconi F, 2014, MAGN RESON MED, V71, P313, DOI 10.1002/mrm.24666; Garcia-Moreno F, 2014, SURG ENDOSC, V28, P3479, DOI 10.1007/s00464-014-3633-4; Gruber-Blum S, 2011, BRIT J SURG, V98, P442, DOI 10.1002/bjs.7334; Guillaume O, 2012, MACROMOL BIOSCI, V12, P1364, DOI 10.1002/mabi.201200208; Hansen NL, 2013, INVEST RADIOL, V48, P770, DOI 10.1097/RLI.0b013e31829806ce; Harth KC, 2013, SURGERY, V153, P481, DOI 10.1016/j.surg.2012.08.064; Hellebrekers BWJ, 2000, HUM REPROD, V15, P1358, DOI 10.1093/humrep/15.6.1358; Jia X, 2008, BJOG-INT J OBSTET GY, V115, P1350, DOI 10.1111/j.1471-0528.2008.01845.x; Letouzey V, 2010, EUR J OBSTET GYN R B, V151, P101, DOI 10.1016/j.ejogrb.2010.03.013; Maher C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub3; Mamy L, 2011, INT UROGYNECOL J, V22, P47, DOI 10.1007/s00192-010-1245-7; Onal S, 2014, INT UROGYNECOL J, V25, P767, DOI 10.1007/s00192-013-2287-4; Paine M, 2010, AM J OBSTET GYNECOL, V203, pE11, DOI 10.1016/j.ajog.2010.04.028; Pascual G, 2012, SURGERY, V152, P886, DOI 10.1016/j.surg.2012.03.009; Reijnen MMPJ, 1999, ARCH SURG-CHICAGO, V134, P997, DOI 10.1001/archsurg.134.9.997; Romero-Aburto R, 2013, ADV MATER, V25, P5632, DOI 10.1002/adma201301804; Sivaslioglu AA, 2008, INT UROGYNECOL J, V19, P467, DOI 10.1007/s00192-007-0465-y; Szabo A, 2000, EUR SURG RES, V32, P125, DOI 10.1159/000008751; White GW, 2006, INVEST RADIOL, V41, P272, DOI 10.1097/01.rli.0000186569.32408.95; Willinek WA, 2008, EUR J RADIOL, V65, P2, DOI 10.1016/j.ejrad.2007.11.006; WOLSTENHOLME JT, 1956, ARCH SURG-CHICAGO, V73, P1004	32	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0120218	10.1371/journal.pone.0120218	http://dx.doi.org/10.1371/journal.pone.0120218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811855	Green Published, gold			2022-12-26	WOS:000356353700042
J	Scott, C; Cha, K; Rao, R; Liddle, C; George, J; Gunton, JE				Scott, Christopher; Cha, Kuan; Rao, Renuka; Liddle, Christopher; George, Jacob; Gunton, Jenny E.			Hepatocyte- Specific Deletion of ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) Results in Altered Fibrotic Gene Expression in the Thioacetamide Model of Liver Injury	PLOS ONE			English	Article							LIPID-ACCUMULATION; HYPOXIA; ARNT/HIF1-BETA; TRANSCRIPTION; INVOLVEMENT; ACTIVATION; FIBROSIS; GROWTH; CELLS	Background & Aims Recent studies have shown that increased expression of liver hypoxia inducible factor 2-alpha (HIF-2 alpha) leads to liver inflammation and a pro-fibrotic gene expression signature. Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) is required for HIF-2 alpha transcriptional activity and has previously been shown to regulate hepatic metabolism in mice. In these studies we examined the role of hepatocyte ARNT in the thioacetamide (TAA)-induced model of liver fibrosis. Methods Hepatocyte-specific ARNT-null (LARNT) mice were created using an albumin promoter-driven Cre recombinase. LARNT and floxed control (FC) littermates were placed on chow diet and received twice weekly intraperitoneal injections of 0.15mg/g body weight of TAA for 13 weeks. Results TAA treated LARNT and FC mice had a similar pattern of fibrosis. Quantification of Sirius red histology staining and hydroxyproline content revealed mixed results in terms of collagen deposition in LARNT livers. There was no significant difference in hepatocyte apoptosis or proliferation, as assessed by cleaved Caspase-3 and Ki67 respectively. LARNT mice had decreased macrophage accumulation, and decreased liver mRNA expression of Col1A1, Col1A2, Col5A1, Tgf beta 1, Tgf beta 2, Timp1 and Timp2. Conclusions Deletion of hepatocyte ARNT leads to altered expression of collagen associated mRNA and reduced macrophage infiltration in the TAA-induced model of liver fibrosis. It appears that hepatocyte ARNT is not a requirement for initiation of liver fibrogenesis, but does regulate pro-fibrotic gene expression and macrophage accumulation.	[Scott, Christopher; Cha, Kuan; Gunton, Jenny E.] Westmead Hosp, Westmead Millennium Inst, Diabet Obes & Endocrinol Grp, Sydney, NSW, Australia; [Scott, Christopher; George, Jacob; Gunton, Jenny E.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Scott, Christopher; Cha, Kuan; Gunton, Jenny E.] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia; [Rao, Renuka; Liddle, Christopher; George, Jacob] Westmead Millennium Inst, Storr Liver Unit, Sydney, NSW, Australia; [Rao, Renuka; Liddle, Christopher; George, Jacob] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia; [Gunton, Jenny E.] Univ NSW, St Vincents Clin Sch, Sydney, NSW, Australia; [Gunton, Jenny E.] Westmead Hosp, Dept Endocrinol & Diabet, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Garvan Institute of Medical Research; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of New South Wales Sydney; University of Sydney	Gunton, JE (corresponding author), Westmead Hosp, Westmead Millennium Inst, Diabet Obes & Endocrinol Grp, Sydney, NSW, Australia.	jenny.gunton@sydney.edu.au	Gunton, Jenny E/AAH-7719-2021; George, jacob/P-1496-2014		NHMRC grants; University of Sydney Postgraduate Award; Sydney Medical Foundation; NHMRC; DART/NHMRC Fellowship	NHMRC grants(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Postgraduate Award(University of Sydney); Sydney Medical Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); DART/NHMRC Fellowship	This research was funded by NHMRC grants. In addition CS was supported by a University of Sydney Postgraduate Award. JG is supported by the Robert W. Storr bequest to the Sydney Medical Foundation and the NHMRC. JEG was supported by a DART/NHMRC Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Crean JK, 2003, EXPER OPIN THER TAR, V5, P519; FALANGA V, 1991, J INVEST DERMATOL, V97, P634, DOI 10.1111/1523-1747.ep12483126; Falanga V, 2002, J CELL PHYSIOL, V191, P42, DOI 10.1002/jcp.10065; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Nishiyama Y, 2012, J HEPATOL, V56, P441, DOI 10.1016/j.jhep.2011.07.024; Park KT, 2005, MOL PHARMACOL, V67, P612, DOI 10.1124/mol.104.005223; Qi Z, 1999, P NATL ACAD SCI USA, V96, P2345, DOI 10.1073/pnas.96.5.2345; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Salceda S, 1996, ARCH BIOCHEM BIOPHYS, V334, P389, DOI 10.1006/abbi.1996.0469; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Schnur J, 2004, EUR J GASTROEN HEPAT, V16, P127, DOI 10.1097/00042737-200402000-00002; Shek FWT, 2002, AM J PATHOL, V160, P1787, DOI 10.1016/S0002-9440(10)61125-X; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313	27	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121650	10.1371/journal.pone.0121650	http://dx.doi.org/10.1371/journal.pone.0121650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25812120	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700125
J	Stratmann, A; Frohlich, EKF; Harlander-Matauschek, A; Schrader, L; Toscano, MJ; Wurbel, H; Gebhardt-Henrich, SG				Stratmann, Ariane; Froehlich, Ernst K. F.; Harlander-Matauschek, Alexandra; Schrader, Lars; Toscano, Michael J.; Wuerbel, Hanno; Gebhardt-Henrich, Sabine G.			Soft Perches in an Aviary System Reduce Incidence of Keel Bone Damage in Laying Hens	PLOS ONE			English	Article							FURNISHED CAGES; HOUSING SYSTEM; EGG-PRODUCTION; BROKEN BONES; STRENGTH; FRACTURES; DEFORMITIES; PREVALENCE; DESIGN; OSTEOPOROSIS	Keel bone fractures and deviations are one of the major welfare and health issues in commercial laying hens. In non-cage housing systems like aviaries, falls and collisions with perches and other parts of the housing system are assumed to be one of the main causes for the high incidence of keel bone damage. The objectives of this study were to investigate the effectiveness of a soft perch material to reduce keel bone fractures and deviations in white (Dekalb White) and brown laying hens (ISA Brown) kept in an aviary system under commercial conditions. In half of 20 pens, all hard, metal perches were covered with a soft polyurethane material. Palpation of 20 hens per pen was conducted at 18, 21, 23, 30, 38, 44 and 64 weeks of age. Production data including egg laying rate, floor eggs, mortality and feed consumption were collected over the whole laying period. Feather condition and body mass was assessed twice per laying period. The results revealed that pens with soft perches had a reduced number of keel bone fractures and deviations. Also, an interaction between hybrid and age indicated that the ISA hybrid had more fractured keel bones and fewer non-damaged keel bones compared with the DW hybrid at 18 weeks of age, a response that was reversed at the end of the experiment. This is the first study providing evidence for the effectiveness of a soft perch material within a commercial setting. Due to its compressible material soft perches are likely to absorb kinetic energy occurring during collisions and increase the spread of pressure on the keel bone during perching, providing a mechanism to reduce keel bone fractures and deviations, respectively. In combination with genetic selection for more resilient bones and new housing design, perch material is a promising tool to reduce keel bone damage in commercial systems.	[Stratmann, Ariane; Toscano, Michael J.; Wuerbel, Hanno; Gebhardt-Henrich, Sabine G.] Univ Bern, Div Anim Welf, Poultry & Rabbits ZTHZ, Res Ctr Proper Housing, Bern, Switzerland; [Froehlich, Ernst K. F.] Fed Food Safety & Vet Off, Poultry & Rabbits ZTHZ, Res Ctr Proper Housing, Bern, Switzerland; [Harlander-Matauschek, Alexandra] Univ Guelph, Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Schrader, Lars] Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Celle, Germany	University of Bern; University of Guelph; Friedrich Loeffler Institute	Stratmann, A (corresponding author), Univ Bern, Div Anim Welf, Poultry & Rabbits ZTHZ, Res Ctr Proper Housing, Bern, Switzerland.	arianestratmann@gmail.com	; Wuerbel, Hanno/D-6281-2012	Gebhardt, Sabine Gabriele/0000-0001-6289-5784; Schrader, Lars/0000-0003-1696-1562; Wuerbel, Hanno/0000-0002-2934-3010	Federal Food Safety and Veterinary Office (BLV), Switzerland [2.11.05]	Federal Food Safety and Veterinary Office (BLV), Switzerland	The study was funded by the Federal Food Safety and Veterinary Office (BLV), Switzerland (2.11.05). The funder was involved in research questions and study design.	Alghamdi AAA, 2001, THIN WALL STRUCT, V39, P189, DOI 10.1016/S0263-8231(00)00048-3; Bishop SC, 2000, BRIT POULTRY SCI, V41, P33, DOI 10.1080/00071660086376; Budgell KL, 2004, CAN J ANIM SCI, V84, P745, DOI 10.4141/A04-040; Clark WD, 2008, POULTRY SCI, V87, P1964, DOI 10.3382/ps.2008-00115; Donaldson CJ, 2012, POULTRY SCI, V91, P304, DOI 10.3382/ps.2011-01774; DUNCAN ET, 1992, BRIT POULTRY SCI, V33, P25, DOI 10.1080/00071669208417441; FAWC, 2013, KEEL BON FRACT LAY H; FAWC, 2010, OP OST BON FRACT LAY; Fleming RH, 2006, BRIT POULTRY SCI, V47, P742, DOI 10.1080/00071660601077949; Fleming RH, 1998, BRIT POULTRY SCI, V39, P434, DOI 10.1080/00071669889024; Gebhardt-Henrich SG, 2012, KTBL SCHRIFT, V496, P52; Gentle MJ, 2011, APPL ANIM BEHAV SCI, V135, P252, DOI 10.1016/j.applanim.2011.10.023; Gregory NG, 1996, NEW ZEAL VET J, V44, P31, DOI 10.1080/00480169.1996.35928; GREGORY NG, 1990, BRIT POULTRY SCI, V31, P59, DOI 10.1080/00071669008417231; Kappeli S, 2011, BRIT POULTRY SCI, V52, P531, DOI 10.1080/00071668.2011.615059; Kappeli S, 2011, POULTRY SCI, V90, P1637, DOI 10.3382/ps.2011-01379; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; Kowalski A, 2006, MED WETER, V62, P1188; McCoy MA, 1996, RES VET SCI, V60, P185, DOI 10.1016/S0034-5288(96)90017-X; Nasr MAF, 2013, APPL ANIM BEHAV SCI, V147, P127, DOI 10.1016/j.applanim.2013.04.015; Nasr MAF, 2013, BRIT POULTRY SCI, V54, P165, DOI 10.1080/00071668.2013.767437; Nasr MAF, 2012, ANIM WELFARE, V21, P127, DOI 10.7120/096272812799129376; Nasr MAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042420; Olsson IAS, 2000, APPL ANIM BEHAV SCI, V68, P243, DOI 10.1016/S0168-1591(00)00097-6; Pickel T, 2011, POULTRY SCI, V90, P715, DOI 10.3382/ps.2010-01025; Pickel T, 2010, APPL ANIM BEHAV SCI, V127, P37, DOI 10.1016/j.applanim.2010.08.005; Richards GJ, 2011, VET REC, V169, P279, DOI 10.1136/vr.d4404; Riczu CM, 2004, POULTRY SCI, V83, P375, DOI 10.1093/ps/83.3.375; Rodenburg TB, 2008, ANIM WELFARE, V17, P363; Sandilands V, 2009, BRIT POULTRY SCI, V50, P395, DOI 10.1080/00071660903110844; Scholz B, 2008, BERL MUNCH TIERARZTL, V121, P89, DOI 10.2376/0005-9366-121-89; Struelens E, 2009, ANIM WELFARE, V18, P533; TAUSON R, 1994, ACTA AGR SCAND A-AN, V44, P110, DOI 10.1080/09064709409410189; Tauson R., 1984, ACTA AGR SCAND, V34, P350; Toscano MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066215; Viera AJ, 2005, FAM MED, V37, P360; Vits A, 2005, POULTRY SCI, V84, P1511, DOI 10.1093/ps/84.10.1511; Wahlstrom A, 2001, POULTRY SCI, V80, P266, DOI 10.1093/ps/80.3.266; Wilkins LJ, 2011, VET REC, V169, P414, DOI 10.1136/vr.d4831; Wilkins LJ, 2004, VET REC, V155, P547, DOI 10.1136/vr.155.18.547; Wood-Gush D. G. M., 1976, Applied Animal Ethology, V2, P255, DOI 10.1016/0304-3762(76)90057-2	41	57	57	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0122568	10.1371/journal.pone.0122568	http://dx.doi.org/10.1371/journal.pone.0122568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811980	Green Published, gold			2022-12-26	WOS:000356353700196
J	Wang, DL; Li, H; Liang, RQ; Bao, JX				Wang, David L.; Li, Hui; Liang, Ruqiang; Bao, Jianxin			Identification of Multiple Metabolic Enzymes from Mice Cochleae Tissue Using a Novel Functional Proteomics Technology	PLOS ONE			English	Article							MESSENGER-RNA; DRAFT	A new type of technology in proteomics was developed in order to separate a complex protein mixture and analyze protein functions systematically. The technology combines the ability of two-dimensional gel electrophoresis (2-DE) to separate proteins with a protein elution plate (PEP) to recover active proteins for functional analysis and mass spectrometry (MS)-based identification. In order to demonstrate the feasibility of this functional proteomics approach, NADH and NADPH-dependent oxidases, major redox enzyme families, were identified from mice cochlear tissue after a specific drug treatment. By comparing the enzymatic activity between mice that were treated with a drug and a control group significant changes were observed. Using MS, five NADH-dependent oxidases were identified that showed highly altered enzymatic activities due to the drug treatment. In essence, the PEP technology allows for a systematic analysis of a large enzyme family from a complex proteome, providing insights in understanding the mechanism of drug treatment.	[Wang, David L.] Vanderbilt Univ, Dept Biol, Nashville, TN 37235 USA; [Li, Hui; Liang, Ruqiang; Bao, Jianxin] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA	Vanderbilt University; Washington University (WUSTL)	Bao, JX (corresponding author), Northeast Ohio Med Univ, Dept Anat & Neurobiol, Translat Res Ctr, Rootstown, OH 44272 USA.	jbao@neomed.edu		Liang, Ruqiang/0000-0002-3075-4554	National Institute of Health [DC010489, DC011793]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011793, R21DC010489, R33DC010489] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The project was supported by the National Institute of Health grants (DC010489 and DC011793) awarded to J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2013, J PROTEOME RES, V12, P23, DOI 10.1021/pr301151m; Araujo EP, 2006, CURR CANCER DRUG TAR, V6, P77, DOI 10.2174/156800906775471734; Asplund A, 2008, BRIT J DERMATOL, V158, P527, DOI 10.1111/j.1365-2133.2007.08418.x; Bao JX, 2013, HEARING RES, V304, P33, DOI 10.1016/j.heares.2013.06.004; Barvkar VT, 2012, J PROTEOME RES, V11, P6264, DOI 10.1021/pr300984r; Bielefeld EC, 2013, J AM ACAD AUDIOL, V24, P461, DOI 10.3766/jaaa.24.6.3; Birsoy KD, 2012, NAT MED, V18, P2; Bischoff KM, 1998, ANAL BIOCHEM, V260, P1, DOI 10.1006/abio.1998.2680; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chiaradonna F, 2012, BIOTECHNOL ADV, V30, P30, DOI 10.1016/j.biotechadv.2011.07.006; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Farrah T, 2013, J PROTEOME RES, V12, P162, DOI [10.1021/Pr301012j, 10.1021/pr301012j]; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schmidinger H, 2006, AMINO ACIDS, V30, P333, DOI 10.1007/s00726-006-0305-2; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Thiele A, 2011, MOL BIOTECHNOL, V49, P283, DOI 10.1007/s12033-011-9402-x; Uttamchandani M, 2009, ACCOUNTS CHEM RES, V42, P1183, DOI 10.1021/ar9000586; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wennemers M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049439; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2015	10	3							e0121826	10.1371/journal.pone.0121826	http://dx.doi.org/10.1371/journal.pone.0121826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6QW	25811366	Green Published, gold, Green Submitted			2022-12-26	WOS:000356353700145
J	Alert, B; Michalik, A; Helduser, S; Mouritsen, H; Gunturkun, O				Alert, Bianca; Michalik, Andreas; Helduser, Sascha; Mouritsen, Henrik; Guentuerkuen, Onur			Perceptual Strategies of Pigeons to Detect a Rotational Centre-A Hint for Star Compass Learning?	PLOS ONE			English	Article							MAGNETIC COMPASS; MIGRATORY ORIENTATION; CELESTIAL ROTATION; PASSERCULUS-SANDWICHENSIS; PATTERN-RECOGNITION; GARDEN WARBLERS; REACTION-TIME; VISUAL-FIELD; MOTION; DISCRIMINATION	Birds can rely on a variety of cues for orientation during migration and homing. Celestial rotation provides the key information for the development of a functioning star and/or sun compass. This celestial compass seems to be the primary reference for calibrating the other orientation systems including the magnetic compass. Thus, detection of the celestial rotational axis is crucial for bird orientation. Here, we use operant conditioning to demonstrate that homing pigeons can principally learn to detect a rotational centre in a rotating dot pattern and we examine their behavioural response strategies in a series of experiments. Initially, most pigeons applied a strategy based on local stimulus information such as movement characteristics of single dots. One pigeon seemed to immediately ignore eccentric stationary dots. After special training, all pigeons could shift their attention to more global cues, which implies that pigeons can learn the concept of a rotational axis. In our experiments, the ability to precisely locate the rotational centre was strongly dependent on the rotational velocity of the dot pattern and it crashed at velocities that were still much faster than natural celestial rotation. We therefore suggest that the axis of the very slow, natural, celestial rotation could be perceived by birds through the movement itself, but that a time-delayed pattern comparison should also be considered as a very likely alternative strategy.	[Alert, Bianca; Michalik, Andreas; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany; [Alert, Bianca; Michalik, Andreas; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Helduser, Sascha; Guentuerkuen, Onur] Ruhr Univ Bochum, Biopsychol, Inst Cognit Neurosci, Dept Psychol, D-44780 Bochum, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Ruhr University Bochum	Alert, B (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany.	Bianca.Alert@gmail.com	Mouritsen, Henrik/A-5401-2010	Mouritsen, Henrik/0000-0001-7082-4839; Gunturkun, Onur/0000-0003-4173-5233	German Federal Ministry of Education and Research [01 GQ 0962, 01 GQ 0963]; German Research Foundation [MO 1408/1-2]; Volkswagenstiftung	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen)	Funding provided by German Federal Ministry of Education and Research (www.bmbf.de): consortium grant "Varying Tunes" 01 GQ 0962 to HM and 01 GQ 0963 to OG; German Research Foundation (www.dfg.de): MO 1408/1-2 to HM; Volkswagenstiftung (www.volkswagenstiftung.de): "Lichtenberg Professur" to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLE KP, 1990, ANIM BEHAV, V39, P905, DOI 10.1016/S0003-3472(05)80955-8; ABLE KP, 1993, NATURE, V364, P523, DOI 10.1038/364523a0; ABLE KP, 1990, ANIM BEHAV, V39, P1189, DOI 10.1016/S0003-3472(05)80791-2; ABLE KP, 1990, NATURE, V347, P378, DOI 10.1038/347378a0; ALLAN RW, 1989, PHYSIOL BEHAV, V45, P1215, DOI 10.1016/0031-9384(89)90112-1; Batschelet E, 1981, CIRCULAR STAT BIOL; Bischof WF, 1999, PERCEPT PSYCHOPHYS, V61, P1089, DOI 10.3758/BF03207616; BLOUGH DS, 1977, SCIENCE, V196, P1013, DOI 10.1126/science.860129; BRAVO H, 1981, J COMP NEUROL, V199, P419, DOI 10.1002/cne.901990307; Cavoto KK, 2001, J EXP PSYCHOL-ANIM B, V27, P3, DOI 10.1037//0097-7403.27.1.3; CERELLA J, 1980, PATTERN RECOGN, V12, P1, DOI 10.1016/0031-3203(80)90048-5; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; DELIUS JD, 1987, BEHAV BRAIN RES, V23, P251, DOI 10.1016/0166-4328(87)90025-8; DELIUS JD, 1995, J COMP PSYCHOL, V109, P278, DOI 10.1037/0735-7036.109.3.278; DiPietro NT, 2002, PERCEPTION, V31, P1299, DOI 10.1068/p3441; DITTRICH WH, 1993, J EXP ANAL BEHAV, V59, P115, DOI 10.1901/jeab.1993.59-115; Emlen S.T., 1972, NASA SPECIAL PUBLICA, V162, P191; EMLEN ST, 1970, SCIENCE, V170, P1198, DOI 10.1126/science.170.3963.1198; EMLEN ST, 1967, AUK, V84, P463, DOI 10.2307/4083330; Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; Fremouw T, 1998, J EXP PSYCHOL-ANIM B, V24, P278, DOI 10.1037/0097-7403.24.3.278; Fremouw T, 2002, ANIM COGN, V5, P233, DOI 10.1007/s10071-002-0152-9; Frost BJ, 2006, CURR OPIN NEUROBIOL, V16, P481, DOI 10.1016/j.conb.2006.06.005; Frost BJ, 2010, BRAIN BEHAV EVOLUT, V75, P218, DOI 10.1159/000314284; FROST BJ, 1990, VISION RES, V30, P1677, DOI 10.1016/0042-6989(90)90152-B; Furuya I., 1997, INT J COMP PSYCHOL, V10, P111; Goto K, 2004, ANIM COGN, V7, P109, DOI 10.1007/s10071-003-0193-8; GRIFFIN DR, 1952, BIOL REV, V27, P359, DOI 10.1111/j.1469-185X.1952.tb01509.x; Gunturkun O, 1999, BEHAV BRAIN RES, V98, P193, DOI 10.1016/S0166-4328(98)00084-9; HAHMANN U, 1993, VISION RES, V33, P1659, DOI 10.1016/0042-6989(93)90031-Q; Hamm J, 1997, J COMP PSYCHOL, V111, P76; Hein CM, 2009, J R SOC INTERFACE, pS227, DOI [10.1098/rsif.2009.0376.focus, DOI 10.1098/RSIF.2009.0376]; Helduser S, 2013, J NEUROPHYSIOL, V109, P958, DOI 10.1152/jn.00763.2012; Helduser S, 2012, BEHAV BRAIN RES, V230, P132, DOI 10.1016/j.bbr.2012.02.013; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; HODOS W, 1976, J EXP ANAL BEHAV, V25, P143, DOI 10.1901/jeab.1976.25-143; HOLLARD VD, 1982, SCIENCE, V218, P804, DOI 10.1126/science.7134976; JAGER R, 1991, BEHAV BRAIN RES, V45, P65, DOI 10.1016/S0166-4328(05)80181-0; Keary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011912; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Koban A, 2009, J EXP PSYCHOL ANIM B, V35, P250, DOI 10.1037/a0013874; Kramer G., 1954, Verhandlungen der Deutschen Zoologischen Gesellschaft, V1952, P72; LOHMANN A, 1988, J COMP PSYCHOL, V102, P3, DOI 10.1037/0735-7036.102.1.3; MARTINOYA C, 1983, BEHAV BRAIN RES, V8, P375, DOI 10.1016/0166-4328(83)90182-1; Martinoya C., 1983, ADV VERTEBRATE NEURO, P359, DOI [10.1007/978-1-4684-4412-4_18, DOI 10.1007/978-1-4684-4412-4_18]; Michalik A, 2014, J ORNITHOL, V155, P225, DOI 10.1007/s10336-013-1004-x; MILLER J, 1981, J EXP PSYCHOL HUMAN, V7, P1161, DOI 10.1037/0096-1523.7.6.1161; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2001, J EXP BIOL, V204, P3855; Muheim R, 2006, J EXP BIOL, V209, P2, DOI 10.1242/jeb.01960; MULVANNY P, 1978, VISION RES, V18, P531, DOI 10.1016/0042-6989(78)90198-0; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Peissig Jessie J., 2012, P233; Peissig JJ, 2000, J EXP PSYCHOL ANIM B, V26, P115, DOI 10.1037//0097-7403.26.2.115; POWELL RW, 1967, PSYCHOL REC, V17, P151, DOI 10.1007/BF03393699; Rastogi A, 2011, EUR J NEUROSCI, V34, P99, DOI 10.1111/j.1460-9568.2011.07737.x; REGOLIN L, 1995, PERCEPT PSYCHOPHYS, V57, P971, DOI 10.3758/BF03205456; Rose J, 2008, J NEUROSCI METH, V175, P104, DOI 10.1016/j.jneumeth.2008.08.006; SAUER EGF, 1960, COLD SPRING HARB SYM, V25, P463, DOI 10.1101/SQB.1960.025.01.048; SCHMIDTKOENIG K, 1960, SCIENCE, V131, P826, DOI 10.1126/science.131.3403.826; SCHMIDTKOENIG K, 1990, EXPERIENTIA, V46, P336, DOI 10.1007/BF01952166; Spetch ML, 2003, PSYCHON B REV, V10, P135, DOI 10.3758/BF03196477; Troje NF, 2013, VISION RES, V79, P47, DOI 10.1016/j.visres.2013.01.002; VALLORTIGARA G, 1990, ETHOLOGY, V85, P89; Vickrey C, 2000, PSYCHON B REV, V7, P284, DOI 10.3758/BF03212983; WALLRAFF HG, 1968, NATURWISSENSCHAFTEN, V55, P235, DOI 10.1007/BF00606230; Wallraff HG, 1972, ANIMAL ORIENTATION N, P211; WASSERMAN EA, 1993, PSYCHOL SCI, V4, P336, DOI 10.1111/j.1467-9280.1993.tb00575.x; Watanabe S, 1997, BEHAV PROCESS, V39, P257, DOI 10.1016/S0376-6357(96)00762-0; WATSON A. B, 1986, HDB PERCEPTION HUMAN; Weindler P, 1998, ETHOLOGY, V104, P905; Weindler P, 1997, J EXP BIOL, V200, P2107; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; WILTSCHKO R, 1990, J ORNITHOL, V131, P1; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko R, 2009, AUK, V126, P717, DOI 10.1525/auk.2009.11009; WILTSCHKO W, 1987, ETHOLOGY, V74, P285; Yamazaki Y, 2007, COGNITION, V104, P315, DOI 10.1016/j.cognition.2006.07.004; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	79	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119919	10.1371/journal.pone.0119919	http://dx.doi.org/10.1371/journal.pone.0119919			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807499	gold, Green Published			2022-12-26	WOS:000351880000049
J	Bi, X; Yu, Q; Siler, J; Li, C; Khan, A				Bi, Xin; Yu, Qun; Siler, Jasmine; Li, Chong; Khan, Ali			Functions of Fun30 Chromatin Remodeler in Regulating Cellular Resistance to Genotoxic Stress	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; HOMOLOGOUS RECOMBINATION; DNA TOPOISOMERASE; ERROR-FREE; I DNA; SRS2; DAMAGE; YEAST; REPLICATION	The Saccharomyces cerevisiae Fun30 chromatin remodeler has recently been shown to facilitate long-range resection of DNA double strand break (DSB) ends, which proceeds homologous recombination (HR). This is believed to underlie the role of Fun30 in promoting cellular resistance to DSB inducing agent camptothecin. We show here that Fun30 also contributes to cellular resistance to genotoxins methyl methanesulfonate (MMS) and hydroxyurea (HU) that can stall the progression of DNA replication. We present evidence implicating DNA end resection in Fun30-dependent MMS-resistance. On the other hand, we show that Fun30 deletion suppresses the MMS- and HU-sensitivity of cells lacking the Rad5/Mms2/Ubc13-dependent error-free DNA damage tolerance mechanism. This suppression is not the result of a reduction in DNA end resection, and is dependent on the key HR component Rad51. We further show that Fun30 negatively regulates the recovery of rad5 Delta mutant from MMS induced G2/M arrest. Therefore, Fun30 has two functions in DNA damage repair: one is the promotion of cellular resistance to genotoxic stress by aiding in DNA end resection, and the other is the negative regulation of a Rad51-dependent, DNA end resection-independent mechanism for countering replicative stress. The latter becomes manifest when Rad51-dependent DNA damage tolerance is impaired. In addition, we find that the putative ubiquitin-binding CUE domain of Fun30 serves to restrict the ability of Fun30 to hinder MMS-and HU-tolerance in the absence of Rad5.	[Bi, Xin; Yu, Qun; Siler, Jasmine; Li, Chong; Khan, Ali] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Bi, X (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	xin.bi@rochester.edu			NSF [MCB-1158008]	NSF(National Science Foundation (NSF))	This work was supported by NSF grant MCB-1158008 to X.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010397; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Byeon B, 2013, J BIOL CHEM, V288, P23182, DOI 10.1074/jbc.M113.471979; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Chiruvella KK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012757; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; DARPA P, 1989, BIOCHIM BIOPHYS ACTA, V989, P163, DOI 10.1016/0304-419X(89)90041-3; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Eapen VV, 2012, MOL CELL BIOL, V32, P4727, DOI 10.1128/MCB.00566-12; ELFORD HL, 1968, BIOCHEM BIOPH RES CO, V33, P129, DOI 10.1016/0006-291X(68)90266-0; Fan HY, 1996, GENETICS, V142, P749; Ghosal G, 2013, TRANSL CANCER RES, V2, P107, DOI 10.3978/j.issn.2218-676X.2013.04.01; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hishida T, 2010, MOL CELL BIOL, V30, P4840, DOI 10.1128/MCB.00453-10; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Huang DQ, 2013, MOL CELL BIOL, V33, P1515, DOI 10.1128/MCB.01392-12; Jossen Rachel, 2013, Frontiers in Genetics, V4, DOI 10.3389/fgene.2013.00026; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Marini V, 2010, DNA REPAIR, V9, P268, DOI 10.1016/j.dnarep.2010.01.007; Moreau S, 2001, GENETICS, V159, P1423; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Sale JE, 2012, J CELL SCI, V125, P1633, DOI 10.1242/jcs.094748; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; SIKORSKI RS, 1989, GENETICS, V122, P19; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tsabar M, 2013, CURR OPIN GENET DEV, V23, P166, DOI 10.1016/j.gde.2012.11.015; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Xiao W, 1998, CURR GENET, V33, P92, DOI 10.1007/s002940050313; Xiao W, 1996, CURR GENET, V30, P461, DOI 10.1007/s002940050157; Yeung M, 2011, DNA REPAIR, V10, P1213, DOI 10.1016/j.dnarep.2011.09.005; Yu Q, 2011, J BIOL CHEM, V286, P14659, DOI 10.1074/jbc.M110.183269	53	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121341	10.1371/journal.pone.0121341	http://dx.doi.org/10.1371/journal.pone.0121341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25806814	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000148
J	Chang, CH; Chen, YC; Zhang, WC; Leung, PSC; Gershwin, ME; Chuang, YH				Chang, Chao-Hsuan; Chen, Ying-Chun; Zhang, Weici; Leung, Patrick S. C.; Gershwin, M. Eric; Chuang, Ya-Hui			Innate Immunity Drives the Initiation of a Murine Model of Primary Biliary Cirrhosis	PLOS ONE			English	Article							KILLER T-CELLS; INVARIANT NKT CELLS; AUTOIMMUNE CHOLANGITIS; CYTOKINE PROFILE; REGULATORY CELLS; MOUSE MODEL; IN-VIVO; B-CELLS; ACTIVATION; LIVER	Invariant natural killer T (iNKT) cells play complex roles in bridging innate and adaptive immunity by engaging with glycolipid antigens presented by CD1d. Our earlier work suggested that iNKT cells were involved in the initiation of the original loss of tolerance in primary biliary cirrhosis (PBC). To address this issue in more detail and, in particular, to focus on whether iNKT cells activated by a Th2-biasing agonist (2s, 3s, 4r)-1-O-(alpha-(D)-galactopyranosyl)-N-tetracosanoyl-2-amino-1,3,4-nonanetriol (OCH), can influence the development of PBC in a xenobiotic-induced PBC murine model. Groups of mice were treated with either OCH or, as a control, alpha-galactosylceramide (alpha-GalCer) and thence serially followed for cytokine production, markers of T cell activation, liver histopathology and anti-mitochondrial antibody responses. Further, additional groups of CD1d deleted mice were similarly studied. Our data indicate that administration of OCH has a dramatic influence with exacerbation of portal inflammation and hepatic fibrosis similar to mice treated with alpha-GalCer. Further, iNKT cell deficient CD1d knockout mice have decreased inflammatory portal cell infiltrates and reduced anti-mitochondrial antibody responses. We submit that activation of iNKT cells can occur via overlapping and/or promiscuous pathways and highlight the critical role of innate immunity in the natural history of autoimmune cholangitis. These data have implications for humans with PBC and emphasize that therapeutic strategies must focus not only on suppressing adaptive responses, but also innate immunity.	[Chang, Chao-Hsuan; Chen, Ying-Chun; Chuang, Ya-Hui] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Zhang, Weici; Leung, Patrick S. C.; Gershwin, M. Eric] Univ Calif Davis, Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA	National Taiwan University; University of California System; University of California Davis	Chuang, YH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	yahuichuang@ntu.edu.tw	chen, ying/HHS-8254-2022	CHUANG, YA-HUI/0000-0003-0857-0035	National Health Research Institutes, Taiwan [NHRI-EX103-10027SC]; National Institutes of Health grant [DK067003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090019, R01DK067003] Funding Source: NIH RePORTER	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Health Research Institutes, Taiwan (NHRI-EX103-10027SC) and a National Institutes of Health grant, DK067003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini YM, 2011, CLIN EXP IMMUNOL, V166, P110, DOI 10.1111/j.1365-2249.2011.04453.x; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chang CH, 2014, CLIN EXP IMMUNOL, V177, P373, DOI 10.1111/cei.12298; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Chuang YH, 2008, CLIN LIVER DIS, V12, P333, DOI 10.1016/j.cld.2008.02.011; Chuang YH, 2008, HEPATOLOGY, V47, P571, DOI 10.1002/hep.22052; Chuang YH, 2006, J AUTOIMMUN, V26, P232, DOI 10.1016/j.jaut.2006.04.001; Cullen R, 2009, J IMMUNOL, V183, P5807, DOI 10.4049/jimmunol.0803520; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Detre C, 2012, BLOOD, V120, P122, DOI 10.1182/blood-2011-11-395913; Dhirapong A, 2013, HEPATOLOGY, V57, P708, DOI 10.1002/hep.26067; Gershwin ME, 2008, HEPATOLOGY, V47, P737, DOI 10.1002/hep.22042; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Harada K, 2009, CLIN EXP IMMUNOL, V157, P261, DOI 10.1111/j.1365-2249.2009.03947.x; Harada K, 1997, HEPATOLOGY, V25, P791, DOI 10.1002/hep.510250402; He XS, 2006, CELL IMMUNOL, V239, P1, DOI 10.1016/j.cellimm.2006.04.006; Huang WT, 2014, J AUTOIMMUN, V50, P123, DOI 10.1016/j.jaut.2014.01.034; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Kawata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074225; Kawata K, 2013, HEPATOLOGY, V58, P1094, DOI 10.1002/hep.26418; Krams SM, 1996, CLIN IMMUNOL IMMUNOP, V80, P311, DOI 10.1006/clin.1996.0129; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Lee IF, 2011, J IMMUNOL, V187, P2898, DOI 10.4049/jimmunol.1002551; Liaskou E, 2014, SEMIN IMMUNOPATHOL, V36, P553, DOI 10.1007/s00281-014-0439-3; Lleo A, 2014, HEPATOLOGY, V60, P1314, DOI 10.1002/hep.27230; Mattner J, 2008, CELL HOST MICROBE, V3, P304, DOI 10.1016/j.chom.2008.03.009; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Mizuno M, 2004, J AUTOIMMUN, V23, P293, DOI 10.1016/j.jaut.2004.09.008; Nagano T, 1999, J CLIN IMMUNOL, V19, P422, DOI 10.1023/A:1020511002025; Okada C, 2005, LIVER INT, V25, P595, DOI 10.1111/j.1478-3231.2005.01043.x; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Rong G, 2009, CLIN EXP IMMUNOL, V156, P217, DOI 10.1111/j.1365-2249.2009.03898.x; Shimoda S, 2012, CLIN EXP IMMUNOL, V168, P279, DOI 10.1111/j.1365-2249.2012.04581.x; Shimoda S, 2011, HEPATOLOGY, V53, P1270, DOI 10.1002/hep.24194; Viale Rachael, 2012, Current Immunology Reviews, V8, P287; Walker KM, 2012, IMMUNOL CELL BIOL, V90, P630, DOI 10.1038/icb.2011.78; Wu SJ, 2011, HEPATOLOGY, V53, P915, DOI 10.1002/hep.24113; Yang CY, 2014, HEPATOLOGY, V59, P1944, DOI 10.1002/hep.26979; Yao Y, 2014, J AUTOIMMUN, V51, P99, DOI 10.1016/j.jaut.2014.02.009; Zeng SG, 2013, J IMMUNOL, V191, P1666, DOI 10.4049/jimmunol.1202223; Zhang J, 2014, HEPATOLOGY, V60, P1708, DOI 10.1002/hep.27313; Zhang W, 2009, CLIN EXP IMMUNOL, V157, P359, DOI 10.1111/j.1365-2249.2009.03971.x	48	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121320	10.1371/journal.pone.0121320	http://dx.doi.org/10.1371/journal.pone.0121320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807531	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000146
J	Egawa, J; Watanabe, Y; Wang, C; Inoue, E; Sugimoto, A; Sugiyama, T; Igeta, H; Nunokawa, A; Shibuya, M; Kushima, I; Orime, N; Hayashi, T; Okada, T; Uno, Y; Ozaki, N; Someya, T				Egawa, Jun; Watanabe, Yuichiro; Wang, Chenyao; Inoue, Emiko; Sugimoto, Atsunori; Sugiyama, Toshiro; Igeta, Hirofumi; Nunokawa, Ayako; Shibuya, Masako; Kushima, Itaru; Orime, Naoki; Hayashi, Taketsugu; Okada, Takashi; Uno, Yota; Ozaki, Norio; Someya, Toshiyuki			Novel Rare Missense Variations and Risk of Autism Spectrum Disorder: Whole-Exome Sequencing in Two Families with Affected Siblings and a Two-Stage Follow-Up Study in a Japanese Population	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; MUTATIONS; CLN8	Rare inherited variations in multiplex families with autism spectrum disorder (ASD) are suggested to play a major role in the genetic etiology of ASD. To further investigate the role of rare inherited variations, we performed whole-exome sequencing (WES) in two families, each with three affected siblings. We also performed a two-stage follow-up case-control study in a Japanese population. WES of the six affected siblings identified six novel rare missense variations. Among these variations, CLN8 R24H was inherited in one family by three affected siblings from an affected father and thus co-segregated with ASD. In the first stage of the follow-up study, we genotyped the six novel rare missense variations identified by WES in 241 patients and 667 controls (the Niigata sample). Only CLN8 R24H had higher mutant allele frequencies in patients (1/482) compared with controls (1/1334). In the second stage, this variation was further genotyped, yet was not detected in a sample of 309 patients and 350 controls (the Nagoya sample). In the combined Niigata and Nagoya samples, there was no significant association (odds ratio = 1.8, 95% confidence interval = 0.1-29.6). These results suggest that CLN8 R24H plays a role in the genetic etiology of ASD, at least in a subset of ASD patients.	[Egawa, Jun; Watanabe, Yuichiro; Inoue, Emiko; Sugimoto, Atsunori; Igeta, Hirofumi; Nunokawa, Ayako; Shibuya, Masako; Orime, Naoki; Hayashi, Taketsugu; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan; [Egawa, Jun] Niigata Univ, Ctr Transdisciplinary Res, Dept Pediat Psychiat, Niigata, Japan; [Watanabe, Yuichiro] Niigata Univ, Fac Med, Sch Med, Div Med Educ,Comprehens Med Educ Ctr, Niigata, Japan; [Wang, Chenyao; Kushima, Itaru; Okada, Takashi; Uno, Yota; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Sugiyama, Toshiro] Hamamatsu Univ Sch Med, Dept Child & Adolescent Psychiat, Hamamatsu, Shizuoka 4313192, Japan; [Nunokawa, Ayako] Oojima Hosp, Sanjo, Niigata, Japan; [Shibuya, Masako] Niigata Univ, Headquarters Hlth Adm, Hlth Adm Ctr, Niigata, Japan	Niigata University; Niigata University; Niigata University; Nagoya University; Hamamatsu University School of Medicine; Niigata University	Watanabe, Y (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan.	yuichiro@med.niigata-u.ac.jp	SUGIMOTO, Atsunori/ABD-1064-2021; Someya, Toshiyuki/ABD-1878-2021; Watanabe, Yuichiro/ABB-7176-2021; KUSHIMA, Itaru/M-8872-2014; Egawa, Jun/GVS-0721-2022; Ozaki, Norio/M-8908-2014; UNO, Yota/M-8928-2014; OKADA, Takashi/M-8902-2014	SUGIMOTO, Atsunori/0000-0002-6684-0016; Watanabe, Yuichiro/0000-0002-5496-5997; Ozaki, Norio/0000-0002-7360-4898; OKADA, Takashi/0000-0001-5580-9913; Kushima, Itaru/0000-0002-0018-5178	Japan Foundation for Neuroscience and Mental Health; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Japan Foundation for Neuroscience and Mental Health, and by a Grant-in-Aid for "Integrated research on neuropsychiatric disorders" carried out under the Strategic Research Program for Brain Sciences of the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chien WH, 2010, CLIN GENET, V78, P449, DOI 10.1111/j.1399-0004.2010.01395.x; Egawa J, 2015, PSYCHIAT CLIN NEUROS, V69, P131, DOI 10.1111/pcn.12205; Fein D, 2013, J CHILD PSYCHOL PSYC, V54, P195, DOI 10.1111/jcpp.12037; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lonka L, 2004, J NEUROSCI RES, V76, P862, DOI 10.1002/jnr.20133; Lonka L, 2000, HUM MOL GENET, V9, P1691, DOI 10.1093/hmg/9.11.1691; Nunokawa A, 2010, SCHIZOPHR RES, V116, P61, DOI 10.1016/j.schres.2009.10.016; Ranta S, 2004, HUM MUTAT, V23, P300, DOI 10.1002/humu.20018; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; Toma C, 2014, MOL PSYCHIATR, V19, P784, DOI 10.1038/mp.2013.106; Vantaggiato C, 2009, HUM MUTAT, V30, P1104, DOI 10.1002/humu.21012; Watanabe Y, 2006, SCHIZOPHR RES, V84, P29, DOI 10.1016/j.schres.2006.03.011; Wei HG, 2014, INT J DEV NEUROSCI, V36, P13, DOI 10.1016/j.ijdevneu.2014.04.004; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002	17	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119413	10.1371/journal.pone.0119413	http://dx.doi.org/10.1371/journal.pone.0119413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE5MO	25806950	gold, Green Published, Green Submitted			2022-12-26	WOS:000351880000029
J	Hung, TH; Hsieh, TT; Liu, HP				Hung, Tai-Ho; Hsieh, T'sang-T'ang; Liu, Hung-Pin			Differential Effects of Epidural Analgesia on Modes of Delivery and Perinatal Outcomes between Nulliparous and Multiparous Women: A Retrospective Cohort Study	PLOS ONE			English	Article							INSTRUMENTAL DELIVERY; LABOR; POPULATION; RISK; LENGTH; AGE	Background Epidural analgesia is considered one of the most effective methods for pain relief during labor. However, it is not clear whether similar effects of epidural analgesia on the progression of labor, modes of delivery, and perinatal outcomes exist between nulliparous and multiparous women. Methodology/Principal Findings A retrospective cohort study was conducted to analyze all deliveries after 37 weeks of gestation, with the exclusion of pregnancies complicated by multiple gestations and fetal anomalies and deliveries without trials of labor; these criteria produced a study population of n = 16,852. A multivariable logistic regression model was constructed to control for confounders. In total, 7260 of 10,175 (71.4%) nulliparous and 2987 of 6677 (44.7%) multiparous parturients were administered epidural analgesia. The independent factors for intrapartum epidural analgesia included a low prepregnancy body mass index, genetic amniocentesis, group B streptococcal colonization of the genito-rectal tract, and augmentation and induction of labor. In the nulliparous women, epidural analgesia was a significant risk factor for operative vaginal delivery (adjusted odds ratio [OR] 2.14, 95% confidence interval [CI] 1.80-2.54); however, it was a protective factor against Caesarean delivery (adjusted OR 0.62, 95% CI 0.55-0.69). Epidural analgesia remained a significant risk factor for operative vaginal delivery (adjusted OR 2.17, 95% CI 1.58-2.97) but not for Caesarean delivery (adjusted OR 1.09, 95% CI 0.77-1.55) in the multiparous women. Furthermore, the women who were administered epidural analgesia during the trials of labor had similar rates of adverse perinatal outcomes compared with the women who were not administered epidural analgesia, except that a higher rate of 1-minute Apgar scores less than 7 was noted in the nulliparous women who were administered epidural analgesia. Conclusions/Significance Intrapartum epidural analgesia has differential effects on the modes of delivery between nulliparous and multiparous women, and it is not associated with adverse perinatal outcomes.	[Hung, Tai-Ho; Hsieh, T'sang-T'ang] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Dept Chinese Med, Coll Med, Taoyuan, Taiwan; [Liu, Hung-Pin] Chang Gung Mem Hosp, Dept Anesthesiol, Taipei 10591, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Hung, TH (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	thh20@cgmh.org.tw	Hung, Tai-Ho/ABD-1800-2020; Hung, Tai-Ho/C-7584-2011	Hung, Tai-Ho/0000-0003-2354-7060				Anim-Somuah M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000331.pub3; Boyle A, 2013, OBSTET GYNECOL, V122, P33, DOI 10.1097/AOG.0b013e3182952242; Decca L, 2004, J Matern Fetal Neonatal Med, V16, P115; Ekeus C, 2009, ACTA OBSTET GYN SCAN, V88, P397, DOI 10.1080/00016340902763236; Eriksen LM, 2011, BIRTH-ISS PERINAT C, V38, P317, DOI 10.1111/j.1523-536X.2011.00486.x; Eriksson SL, 2006, EUR J OBSTET GYN R B, V128, P270, DOI 10.1016/j.ejogrb.2005.10.030; Halpern SH, 2010, CURR OPIN ANESTHESIO, V23, P317, DOI 10.1097/ACO.0b013e3283385492; Hasegawa J, 2013, J ANESTH, V27, P43, DOI 10.1007/s00540-012-1480-9; Hsieh TT, 2010, EUR J OBSTET GYN R B, V148, P21, DOI 10.1016/j.ejogrb.2009.08.022; HUESTON WJ, 1994, OBSTET GYNECOL, V84, P579; Hung TH, 2013, INT J GYNECOL OBSTET, V122, P212, DOI 10.1016/j.ijgo.2013.03.033; Indraccolo U, 2012, CLIN EXP OBSTET GYN, V39, P310; Jones L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009234.pub2; Koteles J, 2012, INT J OBSTET ANESTH, V21, P317, DOI 10.1016/j.ijoa.2012.06.006; Lee Hui-Ling, 2008, Chang Gung Med J, V31, P395; Liu EHC, 2004, BMJ-BRIT MED J, V328, P1410, DOI 10.1136/bmj.38097.590810.7C; NERI A, 1986, EUR J OBSTET GYN R B, V22, P1, DOI 10.1016/0028-2243(86)90083-3; Nguyen USDT, 2010, MATERN CHILD HLTH J, V14, P705, DOI 10.1007/s10995-009-0515-9; O'Hana HP, 2008, J MATERN-FETAL NEO M, V21, P517, DOI 10.1080/14767050802040864; Sheiner E, 2000, ANESTH ANALG, V90, P109, DOI 10.1097/00000539-200001000-00024; Wassen MMLH, 2011, BJOG-INT J OBSTET GY, V118, P655, DOI 10.1111/j.1471-0528.2011.02906.x; Worstell T, 2014, OBSTET GYNECOL, V123, p84S, DOI 10.1097/01.AOG.0000447412.62293.82; WUITCHIK M, 1989, OBSTET GYNECOL, V73, P35	23	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0120907	10.1371/journal.pone.0120907	http://dx.doi.org/10.1371/journal.pone.0120907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807240	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000111
J	Shanavas, KV; Singh, DJ				Shanavas, K. V.; Singh, David J.			Itinerant Magnetism in Metallic CuFe2Ge2	PLOS ONE			English	Article								Theoretical calculations are performed to understand the electronic structure and magnetic properties of CuFe2Ge2. The band structure reveals large electron density N(E-F) at the Fermi level suggesting a strong itinerant character of magnetism. The Fermi surface is dominated by two dimensional sheet like structures, with potentially strong nesting between them. The magnetic ground state appears to be ferromagnetic along a and antiferromagnetic in other directions. These results show that CuFe2Ge2 is an antiferromagnetic metal, with similarities to the Fe-based superconductors; such as magnetism with substantial itinerant character and coupling between magnetic order and electrons at the Fermi energy.	[Shanavas, K. V.; Singh, David J.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Shanavas, KV (corresponding author), Oak Ridge Natl Lab, 1 Bethel Valley Rd, Oak Ridge, TN 37831 USA.	kavungalvees@ornl.gov			United States Department of Energy, Basic Energy Sciences, Office of Science, Materials Sciences and Engineering Division	United States Department of Energy, Basic Energy Sciences, Office of Science, Materials Sciences and Engineering Division	This research was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, Materials Sciences and Engineering Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.147201; Blaha P., 2001, WIEN2K; Bondino F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267001; Chen GF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247002; Dai PC, 2012, NAT PHYS, V8, P709, DOI 10.1038/NPHYS2438; Fujita M, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.011007; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Mazin II, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085104; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; Singh DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.237003; Singh DJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024505; Stewart GR, 2011, REV MOD PHYS, V83, P1589, DOI 10.1103/RevModPhys.83.1589; Subedi A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024504; ZAVALIJ IY, 1987, KRISTALLOGRAFIYA+, V32, P66; Zou Y, 2014, PHYS STATUS SOLIDI-R, V9999, P1	17	5	5	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121186	10.1371/journal.pone.0121186	http://dx.doi.org/10.1371/journal.pone.0121186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807140	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000134
J	Xiao, XY; Zhang, W; Zou, XF				Xiao, Xiangyun; Zhang, Wei; Zou, Xiufen			A New Asynchronous Parallel Algorithm for Inferring Large-Scale Gene Regulatory Networks	PLOS ONE			English	Article							MUTUAL INFORMATION; EXPRESSION DATA; INFERENCE	The reconstruction of gene regulatory networks (GRNs) from high-throughput experimental data has been considered one of the most important issues in systems biology research. With the development of high-throughput technology and the complexity of biological problems, we need to reconstruct GRNs that contain thousands of genes. However, when many existing algorithms are used to handle these large-scale problems, they will encounter two important issues: low accuracy and high computational cost. To overcome these difficulties, the main goal of this study is to design an effective parallel algorithm to infer large-scale GRNs based on high-performance parallel computing environments. In this study, we proposed a novel asynchronous parallel framework to improve the accuracy and lower the time complexity of large-scale GRN inference by combining splitting technology and ordinary differential equation (ODE)-based optimization. The presented algorithm uses the sparsity and modularity of GRNs to split whole large-scale GRNs into many small-scale modular subnetworks. Through the ODE-based optimization of all subnetworks in parallel and their asynchronous communications, we can easily obtain the parameters of the whole network. To test the performance of the proposed approach, we used well-known benchmark datasets from Dialogue for Reverse Engineering Assessments and Methods challenge (DREAM), experimentally determined GRN of Escherichia coli and one published dataset that contains more than 10 thousand genes to compare the proposed approach with several popular algorithms on the same high-performance computing environments in terms of both accuracy and time complexity. The numerical results demonstrate that our parallel algorithm exhibits obvious superiority in inferring large-scale GRNs.	[Xiao, Xiangyun; Zou, Xiufen] Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China; [Zhang, Wei] East China Jiaotong Univ, Sch Sci, Nanchang, Peoples R China	Wuhan University; East China Jiaotong University	Zou, XF (corresponding author), Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China.	xfzou@whu.edu.cn			Major Research Plan of the National Natural Science Foundation of China [91230118]; National Basic Research Program of China (973 Program) [2013CB911100]; Chinese National Natural Science Foundation [61173060]; Fundamental Research Funds for the Central Universities [2014201020201]	Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Major Research Plan of the National Natural Science Foundation of China (No. 91230118), the National Basic Research Program of China (973 Program) (No. 2013CB911100), the Chinese National Natural Science Foundation (No. 61173060) and the Fundamental Research Funds for the Central Universities (No. 2014201020201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdam R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092600; Altay G, 2010, BIOINFORMATICS, V26, P1738, DOI 10.1093/bioinformatics/btq259; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Brunel H, 2010, BIOINFORMATICS, V26, P1811, DOI 10.1093/bioinformatics/btq273; Chen L, 2010, BIOINFORMATICS, V26, P1416, DOI 10.1093/bioinformatics/btq144; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Frenzel S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.204101; Jin SQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03799; Jin SQ, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-105; Lee WP, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-5; Li YK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05764; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Nadakuditi RR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.188701; Qin J, 2014, METHODS, V67, P294, DOI 10.1016/j.ymeth.2014.03.006; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Tan JY, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413501800; Tan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048114; Wang YB, 2015, MATH BIOSCI, V262, P198, DOI 10.1016/j.mbs.2015.01.008; Xie WC, 2013, SOFT COMPUT, V17, P1511, DOI 10.1007/s00500-012-0962-x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang W, 2014, NEW METHOD DETECTING, DOI [10.1109/TCBB.2014.2386314, DOI 10.1109/TCBB.2014.2386314]; Zhang XJ, 2013, BIOINFORMATICS, V29, P106, DOI 10.1093/bioinformatics/bts619; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626; Zhao XM, 2010, INT J PATTERN RECOGN, V24, P651, DOI 10.1142/S0218001410008056; Zhao XM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn145	28	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0119294	10.1371/journal.pone.0119294	http://dx.doi.org/10.1371/journal.pone.0119294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807392	Green Published, gold, Green Submitted			2022-12-26	WOS:000351880000024
J	Zhang, C; Che, JB; Yu, JH; Yu, LL; Yu, D; Zhao, GP				Zhang, Chi; Che, Jingbin; Yu, Jianhong; Yu, Linli; Yu, Dan; Zhao, Gangping			Using Femtosecond Laser to Create Customized Corneal Flaps for Patients with Low and Moderate Refractive Error Differing in Corneal Thickness	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; IN-SITU KERATOMILEUSIS; STROMAL THICKNESS; LASIK FLAP; ANTERIOR SEGMENT; IATROGENIC KERATECTASIA; VISUAL PERFORMANCE; PROBABILITY MODEL; MICROKERATOME; REPRODUCIBILITY	This study is designed to evaluate the visual outcomes, accuracy, and predictability of corneal flaps with different thicknesses created by 60-kHz femtosecond laser according to different corneal thicknesses in the patients with low and moderate refractive error. A total of 182 eyes were divided according to the central corneal thickness (470 mu m-499 mu m in Group A, 500 mu m-549 mu m in Group B, and 550 mu m-599 mu m in Group C) and underwent femtosecond laser-assisted LASIK for a target corneal flap thickness (100 mu m for Group A, 110 mu m for Group B, and 120 mu m for Group C). Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and refractive status were examined. The flap thickness of each eye was measured by anterior segment optical coherence tomography (AS-OCT) on 30 points at 1-month follow-up to assess the accuracy and predictability. Post-operatively, at least 75% of eyes had a UDVA of 20/16 or better, less than 2% of eyes lost one line, over 30% of eyes gained one or more lines in CDVA, at least 95% of eyes had astigmatism of less than 0.25 D, all eyes achieved a correction within +/- 1.00 D from the target spherical equivalent refraction. The visual and refractive outcomes did not differ significantly in all groups (P > 0.05). The mean flap thickness was 100.36 +/- 4.32 mu m (range: 95-113 mu m) in Group A, 111.64 +/- 3.62 mu m (range: 108-125 mu m) in Group B, and 122.32 +/- 2.88 mu m (range: 112-128 mu m) in Group C. The difference at each measured point among the three groups was significant (P < 0.05). The accuracy and predictability were satisfactory in all three groups. In conclusion, this customized treatment yielded satisfactory clinical outcomes with accurate and predictable flap thickness for patients with low and moderate refractive error.	[Zhang, Chi; Yu, Jianhong; Yu, Linli; Yu, Dan; Zhao, Gangping] First Peoples Hosp Foshan, Dept Ophthalmol, Foshan, Guangdong, Peoples R China; [Che, Jingbin] Peoples Hosp Laiwu, Dept Ophthalmol, Laiwu, Shandong, Peoples R China		Zhao, GP (corresponding author), First Peoples Hosp Foshan, Dept Ophthalmol, Foshan, Guangdong, Peoples R China.	gpzhao@126.com						Ahn H, 2011, J CATARACT REFR SURG, V37, P349, DOI 10.1016/j.jcrs.2010.08.042; Applegate RA, 2000, J REFRACT SURG, V16, P507; Azar Dimitri T, 2012, Cornea, V31 Suppl 1, pS9, DOI 10.1097/ICO.0b013e31826ab0a7; Cheng ACK, 2008, J REFRACT SURG, V24, P879, DOI 10.3928/1081597X-20081101-05; Cheng HC, 2008, OPHTHAL SURG LAS IM, V39, P107, DOI 10.3928/15428877-20080301-05; Choe CH, 2010, J CATARACT REFR SURG, V36, P1912, DOI 10.1016/j.jcrs.2010.09.003; Choudhri SA, 2005, J REFRACT SURG, V21, P253; Dawson DG, 2008, J REFRACT SURG, V24, P90, DOI 10.3928/1081597X-20080101-16; Flanagan GW, 2003, J REFRACT SURG, V19, P113; Hatch BB, 2011, CLIN OPHTHALMOL, V5, P451, DOI 10.2147/OPTH.S18967; Holzer MP, 2006, INVEST OPHTH VIS SCI, V47, P2828, DOI 10.1167/iovs.05-1123; Hsu SY, 2009, OPHTHAL SURG LAS IM, V40, P448, DOI 10.3928/15428877-20090901-02; Issa A, 2011, J CATARACT REFR SURG, V37, P665, DOI 10.1016/j.jcrs.2010.10.049; IZATT JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1584, DOI 10.1001/archopht.1994.01090240090031; Kanellopoulos AJ, 1997, J CATARACT REFR SURG, V23, P34, DOI 10.1016/S0886-3350(97)80148-4; Kasetsuwan N, 2001, CORNEA, V20, P41, DOI 10.1097/00003226-200101000-00008; Kezirian GM, 2004, J CATARACT REFR SURG, V30, P804, DOI 10.1016/j.jcrs.2003.10.026; Koch DD, 1999, J CATARACT REFR SURG, V25, P453, DOI 10.1016/S0886-3350(99)80027-3; Kohnen T, 2002, J CATARACT REFR SURG, V28, P2065, DOI 10.1016/S0886-3350(02)01879-5; Lazaro C, 2013, Arch Soc Esp Oftalmol, V88, P45, DOI 10.1016/j.oftal.2012.05.008; Li HY, 2010, J REFRACT SURG, V26, P99, DOI 10.3928/1081597X-20100121-05; Li Y, 2007, OPHTHALMOLOGY, V114, P1124, DOI 10.1016/j.ophtha.2006.09.031; Marcos S, 2001, J REFRACT SURG, V17, pS596; Miranda D, 2003, OPHTHALMOLOGY, V110, P1931, DOI 10.1016/S0161-6420(03)00786-3; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Netto MV, 2007, J REFRACT SURG, V23, P667; Prakash G, 2010, J REFRACT SURG, V26, P392, DOI 10.3928/1081597X-20090728-02; Radhakrishnan S, 2001, ARCH OPHTHALMOL-CHIC, V119, P1179, DOI 10.1001/archopht.119.8.1179; Randleman JB, 2008, J REFRACT SURG, V24, P85; Reinstein DZ, 2006, J REFRACT SURG, V22, P851, DOI 10.3928/1081-597X-20061101-04; Reinstein DZ, 2006, J REFRACT SURG, V22, P861, DOI 10.3928/1081-597X-20061101-05; Solomon KD, 2004, J CATARACT REFR SURG, V30, P964, DOI 10.1016/j.jcrs.2004.01.023; Stahl JE, 2007, J REFRACT SURG, V23, P555; Talamo JH, 2006, J REFRACT SURG, V22, P556; Thomas J, 2006, J REFRACT SURG, V22, P671, DOI 10.3928/1081-597X-20060901-08; Zhou YH, 2011, J REFRACT SURG, V27, P408, DOI 10.3928/1081597X-20101029-01	36	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2015	10	3							e0121291	10.1371/journal.pone.0121291	http://dx.doi.org/10.1371/journal.pone.0121291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE5MO	25807232	Green Published, Green Submitted, gold			2022-12-26	WOS:000351880000143
